(dp1
S'to,decrease,serum'
p2
S'false'
p3
sS'have,a,clinically'
p4
g3
sS'as,marplan,parnate'
p5
g3
sS'n,maintained,on'
p6
g3
sS'initial,dose,modification'
p7
g3
sS'tmax,by,and'
p8
S'true'
p9
sS'and,inhibits,the'
p10
g9
sS'pediatric,powder,for'
p11
g9
sS'secretion,may,impair'
p12
g3
sS'concluded,that,modulates'
p13
g9
sS'or,the,patient'
p14
g3
sS'hypertension,was,controlled'
p15
g9
sS'significant,effect,after'
p16
g3
sS'may,also,interact'
p17
g3
sS'of,patients,received'
p18
g3
sS'and,the,fractional'
p19
g3
sS'treated,with,the'
p20
g9
sS'with,a,risk'
p21
g3
sS'fumarate,did,not'
p22
g3
sS'therefore,when,meclofenamate'
p23
g9
sS'of,concomitantly,with'
p24
g9
sS'beta-blocking,agents,the'
p25
g3
sS'interactive,effect,on'
p26
g3
sS'considers,the,mode'
p27
g3
sS'feso4,or,supplemented'
p28
g9
sS'potentiate,a,possible'
p29
g9
sS'uricosuric,agents,the'
p30
g3
sS'of,tumor,versus'
p31
g3
sS'increases,and,decreases'
p32
g9
sS'readings,were,reported'
p33
g3
sS'suggest,a,possible'
p34
g9
sS'sampling,for,the'
p35
g3
sS'supplementary,oral,and'
p36
g3
sS'four,times,a'
p37
g3
sS'hepatic,impairment,in'
p38
g3
sS'tricyclic,antidepressant,may'
p39
g3
sS'of,these,observations'
p40
g3
sS'of,the,thioether'
p41
g3
sS'or,by,radioimmunoassay'
p42
g3
sS'enzyme,would,not'
p43
g3
sS'plasma,protein,bound'
p44
g3
sS'p-450,linked,drug-metabolizing'
p45
g3
sS'and,with,reduced'
p46
g9
sS'with,natrecor,were'
p47
g3
sS'inhibitor,because,of'
p48
g3
sS'have,occurred,with'
p49
g9
sS'on,either,interaction'
p50
g3
sS'administration,of,once'
p51
g9
sS'approximately,to,minutes'
p52
g3
sS'distinguishes,it,from'
p53
g3
sS'minimally,elevated,by'
p54
g3
sS'of,clostridium,were'
p55
g3
sS'exert,particular,caution'
p56
g9
sS'had,no,effects'
p57
g3
sS'racemic,combined,administration'
p58
g9
sS'of,saline,g'
p59
g3
sS'that,or,acth'
p60
g3
sS'c9,ic50,g'
p61
g3
sS'patients,who,require'
p62
g3
sS'by,about,three-fold'
p63
g3
sS'with,ibandronate,mg'
p64
g3
sS'use,of,levo-dromoran'
p65
g9
sS'agents,no,effect'
p66
g3
sS'results,show,that'
p67
g3
sS'serum,levels,has'
p68
g9
sS'potentiate,the,hypotension'
p69
g9
sS'however,the,clinical'
p70
g3
sS'of,is,reduced'
p71
g9
sS'multi-day,course,of'
p72
g9
sS'other,drugs,at'
p73
g3
sS'mg,did,not'
p74
g3
sS'did,not,increase'
p75
g3
sS'receiving,injection,who'
p76
g3
sS'associated,with,a'
p77
g9
sS'pharmacokinetics,of,higher'
p78
g3
sS'ponstel,and,is'
p79
g9
sS'the,myocardium,may'
p80
g9
sS'function,studies,in'
p81
g3
sS'no,well-known,interactions'
p82
g3
sS'of,n-acetyltransferase,may'
p83
g9
sS'folic,acid,antagonists'
p84
g9
sS'as,part,of'
p85
g3
sS'dpcpx-induced,anxiogenic,effects'
p86
g9
sS'lapatinib,is,a'
p87
g3
sS'is,desired,this'
p88
g3
sS'toxicity,and,should'
p89
g3
sS'including,normal,healthy'
p90
g3
sS'or,the,pharmacokinetics'
p91
g3
sS'of,the,systemic'
p92
g9
sS'administration,one,hour'
p93
g3
sS'that,inhibit,metabolism'
p94
g3
sS'and,h2,antagonists'
p95
g3
sS'of,other,potential'
p96
g3
sS'other,channel,blockers'
p97
g9
sS'kg,per,day'
p98
g9
sS'medications,may,be'
p99
g9
sS'to,and,during'
p100
g3
sS'made,to,pursue'
p101
g3
sS'the,study,with'
p102
g3
sS'all,volunteers,took'
p103
g3
sS'with,and,have'
p104
g3
sS'is,a,theoretical'
p105
g9
sS'rifampin,may,decrease'
p106
g9
sS'may,reduce,or'
p107
g9
sS'to,a,single'
p108
g3
sS'and,exacerbation,of'
p109
g3
sS'status,in,an'
p110
g3
sS'normal,metab-olizers,resemble'
p111
g3
sS'long-term,safety,studies'
p112
g3
sS'antiasthmatic,dose,of'
p113
g3
sS'in,decreased,efficacy'
p114
g9
sS'both,as,compared'
p115
g9
sS'does,not,interact'
p116
g3
sS'induction,of,apoptosis'
p117
g3
sS'contribution,to,the'
p118
g3
sS'to,units,day'
p119
g3
sS'acth,may,potentiate'
p120
g9
sS'cyp3a,to,a'
p121
g3
sS'secondary,to,high'
p122
g3
sS'juice,resulted,in'
p123
g3
sS'inhibitors,are,known'
p124
g3
sS'as,not,be'
p125
g9
sS'the,intravenous,injection'
p126
g9
sS'castor,oil,ml'
p127
g3
sS'd6,may,require'
p128
g3
sS'interaction,studies,have'
p129
g3
sS'reverse,transcriptase,inhibitors'
p130
g3
sS'potential,input,impedance'
p131
g3
sS'of,produced,a'
p132
g9
sS'and,inducible,vana'
p133
g3
sS'symptoms,occur,physicians'
p134
g9
sS'concurrently,with,central'
p135
g9
sS'enhance,s,nephrotoxicity'
p136
g3
sS'corticosteroids,dexamethasone,aprepitant'
p137
g9
sS'of,bradycardia,sinus'
p138
g3
sS'tissue,although,the'
p139
g3
sS'blood,glucose,lowering'
p140
g9
sS'concentrates,or,prothrombin'
p141
g3
sS'plasma,renin,activity'
p142
g3
sS'dosed,simultaneously,with'
p143
g9
sS'potent,against,micrococcus'
p144
g3
sS'caution,and,should'
p145
g9
sS'to,exposure,in'
p146
g3
sS'may,rise,resulting'
p147
g3
sS'and,tnf,blocking'
p148
g3
sS'may,have,synergistic'
p149
g9
sS'consulting,the,physician'
p150
g3
sS'by,blocking,the'
p151
g9
sS'if,such,are'
p152
g3
sS'again,given,by'
p153
g3
sS'plasma,exposure,or'
p154
g3
sS'excretion,of,and'
p155
g9
sS'inhaler,take,first'
p156
g9
sS'than,has,not'
p157
g3
sS'mode,of,action'
p158
g3
sS'human,breast,cancer'
p159
g9
sS'congestive,heart,failure'
p160
g9
sS'of,renal,function'
p161
g9
sS'only,slightly,reduced'
p162
g9
sS'factors,ii,vii'
p163
g3
sS'since,is,the'
p164
g9
sS'hydrochloride,including,anti-arrhythmic'
p165
g3
sS'more,possibly,due'
p166
g9
sS'received,an,equivalent'
p167
g3
sS'decreased,protein,binding'
p168
g9
sS'examine,some,molecular'
p169
g3
sS'compounds,may,be'
p170
g3
sS'that,a,reduction'
p171
g3
sS'available,data,suggest'
p172
g3
sS'can,give,a'
p173
g3
sS'completion,of,dosing'
p174
g9
sS'patients,receiving,both'
p175
g3
sS'from,the,intestinal'
p176
g3
sS'physicians,should,consider'
p177
g9
sS'effect,of,beta-adrenoceptor'
p178
g9
sS'with,depression,in'
p179
g3
sS'noted,at,the'
p180
g3
sS'therapy,with,bextra'
p181
g9
sS'disease,in,general'
p182
g3
sS'orange,juices,compared'
p183
g3
sS'highly,protein,bound'
p184
g3
sS'medline,premedline,and'
p185
g3
sS'the,pharmacological,properties'
p186
g3
sS'endogenous,and,vasopressin'
p187
g3
sS'to,be,artifactually'
p188
g3
sS'each,year,indicating'
p189
g3
sS'multiple,interacting,mechanisms'
p190
g3
sS'impaired,cardiac,function'
p191
g3
sS'and,its,two'
p192
g3
sS'depressed,in,a'
p193
g9
sS'cautiously,in,the'
p194
g9
sS'to,study,cocaine-induced'
p195
g3
sS'signalled-unsignalled,differential-reinforcement,of-low'
p196
g3
sS'percent,of,chop-haart'
p197
g3
sS'two,were,administered'
p198
g9
sS'adjustments,patients,may'
p199
g9
sS'is,a,newly'
p200
g3
sS'to,outweigh,the'
p201
g9
sS'equetrotm,is,taken'
p202
g9
sS'were,pharmacokinetic,parameters'
p203
g3
sS'volunteers,toradoloral,was'
p204
g3
sS'tysabri,dose,to'
p205
g3
sS'mediate,and,xenobiotic'
p206
g3
sS'infusion,rates,of'
p207
g9
sS'resulting,in,serum'
p208
g9
sS'lexapro,and,had'
p209
g3
sS'dysrhythmias,torsades,de'
p210
g3
sS'the,highest,dose'
p211
g3
sS'similar,metabolism,may'
p212
g3
sS'bleeding,have,also'
p213
g9
sS'or,cyp-mediated,drug'
p214
g3
sS'abortifacient,or,teratogenic'
p215
g3
sS'local,since,the'
p216
g9
sS'which,involved,concomitant'
p217
g9
sS'residues,may,be'
p218
g3
sS'when,selecting,an'
p219
g9
sS'concentration,which,was'
p220
g3
sS'bone,loss,between'
p221
g3
sS'of,disease,states'
p222
g3
sS'activity,is,in'
p223
g3
sS'enhance,activity,transient'
p224
g9
sS'beta,blockers,concurrently'
p225
g3
sS'postmarketing,experience,there'
p226
g3
sS'oil-concomitant,intake,of'
p227
g9
sS'of,treatment,should'
p228
g3
sS'of,the,to'
p229
g3
sS'ratio,r,p'
p230
g3
sS'cause,in,vivo'
p231
g3
sS'lesions,have,been'
p232
g3
sS'paroxetine,coadministration,of'
p233
g3
sS'a,weak,inducer'
p234
g3
sS'steroidal,antiinflammatory,agent'
p235
g9
sS'much,more,severe'
p236
g3
sS'in,our,laboratory'
p237
g3
sS'drug-drug,interactions,have'
p238
g3
sS'days,and,increased'
p239
g9
sS'gastrointestinal,events,in'
p240
g3
sS'to,prescribe,this'
p241
g3
sS'failure,and,av'
p242
g3
sS'inducer,decreased,auc'
p243
g9
sS'hydroxide,containing,for'
p244
g9
sS'cytoskeleton-associated,that,encodes'
p245
g3
sS'inducer,may,be'
p246
g9
sS'result,that,are'
p247
g3
sS'may,increase,absorption'
p248
g9
sS'meal,h,following'
p249
g9
sS'e,mesylate,injection'
p250
g9
sS'negative,symptoms,and'
p251
g3
sS'infusions,myelosuppression,was'
p252
g9
sS'of,these,subjects'
p253
g9
sS'but,the,possibility'
p254
g3
sS'vioxx,mg,administered'
p255
g9
sS'a,chemical,carcinogen'
p256
g3
sS'literature,article,reported'
p257
g9
sS'implants,and,injectables'
p258
g3
sS'interactions,under,clinical'
p259
g3
sS'interference,between,solvents'
p260
g3
sS'of,felbatol,as'
p261
g9
sS'pressure,lowering,effects'
p262
g9
sS'days,decreased,the'
p263
g9
sS'be,administered,alternately'
p264
g3
sS'atracurium,was,again'
p265
g3
sS'of,felbatol,at'
p266
g9
sS'decreased,the,amount'
p267
g3
sS'hydroalcoholic,solutions,containing'
p268
g3
sS'interaction,include,the'
p269
g3
sS'however,patients,on'
p270
g9
sS'not,associated,with'
p271
g3
sS'prostaglandin,synthesis,interfere'
p272
g3
sS'containing,preparations,sunscreens'
p273
g9
sS'important,alterations,of'
p274
g3
sS'locomotor,activity,induced'
p275
g3
sS'performed,with,caution'
p276
g9
sS'novolog,with,of'
p277
g3
sS'sprycel,must,be'
p278
g3
sS'in,this,study'
p279
g3
sS'unlikely,that,this'
p280
g3
sS'fluid,were,increased'
p281
g9
sS'mg,qd,increased'
p282
g9
sS'additional,concomitant,medications'
p283
g3
sS'gene,transcription,was'
p284
g3
sS'kidney,and,liver'
p285
g3
sS'combination,with,maois'
p286
g9
sS'dependent,oxidation,is'
p287
g3
sS'use,with,general'
p288
g3
sS'on,drug,interaction'
p289
g3
sS'were,and,increases'
p290
g3
sS'embryogenesis,of,nmda-ergic'
p291
g3
sS'indocin,does,not'
p292
g3
sS'd,dosage,of'
p293
g9
sS'increased,the,area'
p294
g9
sS'oxidase,inhibitors,coadministration'
p295
g9
sS'showed,that,had'
p296
g3
sS'criteria,for,liver'
p297
g3
sS'dyspnea,concomitant,administration'
p298
g9
sS'as,hours,after'
p299
g9
sS'a,is,also'
p300
g9
sS'been,evaluated,in'
p301
g3
sS'of,the,possible'
p302
g3
sS'extent,of,dissolution'
p303
g3
sS'plasma,and,urine'
p304
g3
sS'clinical,dose,of'
p305
g3
sS'and,or,prolongation'
p306
g9
sS'diabetic,chinese,hamster'
p307
g3
sS'findings,indicate,that'
p308
g3
sS'a,reliable,method'
p309
g9
sS'changes,in,plasma'
p310
g9
sS'dose,of,in'
p311
g3
sS'that,had,no'
p312
g3
sS'or,igm,can'
p313
g3
sS'ccnu,is,given'
p314
g3
sS'm,enhance,the'
p315
g9
sS'any,changes,in'
p316
g3
sS'r,or,s'
p317
g9
sS'foradil,fumarate,capsules'
p318
g3
sS'this,drug,interaction'
p319
g3
sS'dose,of,is'
p320
g3
sS'of,enbrel,was'
p321
g3
sS'unavailable,a,tarceva'
p322
g3
sS'of,with,did'
p323
g3
sS'agents,highly,bound'
p324
g3
sS'other,cytochrome,p450'
p325
g3
sS'this,interaction,also'
p326
g3
sS'agent,and,should'
p327
g3
sS'elimination,and,distribution'
p328
g3
sS'and,because,there'
p329
g3
sS'or,s,nor'
p330
g3
sS'dopamine,antagonists,since'
p331
g9
sS'and,cause,cardio'
p332
g3
sS'at,the,lowest'
p333
g9
sS'and,prolonged,by'
p334
g9
sS'taking,amevive,who'
p335
g3
sS'adjustment,as,appropriate'
p336
g3
sS'leukocyte,production,including'
p337
g3
sS'that,the,plasma'
p338
g3
sS'of,trimethyl,lead'
p339
g3
sS'bumetanide-induced,increase,in'
p340
g9
sS'the,potent,cyp3a4'
p341
g9
sS'counter,cough,cold'
p342
g3
sS'received,general,utilizing'
p343
g3
sS'has,been,one'
p344
g9
sS'and,confirmed,by'
p345
g3
sS'serious,adverse,effects'
p346
g3
sS'diminished,prothrombin,response'
p347
g9
sS'interactions,occurred,when'
p348
g3
sS'unresponsive,to,the'
p349
g3
sS'ethinyl,estradiol,levels'
p350
g9
sS'presumably,resulting,from'
p351
g3
sS'combining,these,agents'
p352
g3
sS'of,akathisia,in'
p353
g9
sS'to,various,combinations'
p354
g3
sS'theophylline-related,side-effects,in'
p355
g9
sS'history,of,diabetes'
p356
g3
sS'of,elimination,the'
p357
g9
sS'discontinuation,of,therapy'
p358
g9
sS'n1,while,attenuating'
p359
g9
sS'associated,with,in'
p360
g3
sS'and,the,effects'
p361
g9
sS'the,following,information'
p362
g3
sS'hypoglycemics,initiating,replacement'
p363
g3
sS'administered,with,an'
p364
g3
sS'be,inhibited,in'
p365
g3
sS'time,is,to'
p366
g9
sS'eg,commonly,results'
p367
g9
sS'cases,of,increased'
p368
g9
sS'of,aed,on'
p369
g3
sS'increasing,concentration,to'
p370
g3
sS'formally,evaluated,in'
p371
g3
sS'dietary,salt,restriction'
p372
g9
sS'pressure,should,be'
p373
g3
sS'resistant,to,the'
p374
g9
sS'a,lesser,but'
p375
g3
sS'cause,increases,ranging'
p376
g3
sS'inhibitory,potential,of'
p377
g3
sS'dosing,at,mg'
p378
g3
sS'renal,clearance,and'
p379
g9
sS'two-hour,period,after'
p380
g3
sS'the,serum,half-life'
p381
g9
sS'may,produce,significant'
p382
g3
sS'raise,the,serum'
p383
g9
sS'in,patients,lacking'
p384
g3
sS'insufficiency,resulted,in'
p385
g3
sS'had,liver,injury'
p386
g3
sS'necessary,when,simulect'
p387
g3
sS'of,ions,are'
p388
g3
sS'increased,auc,by'
p389
g3
sS'medications,with,orencia'
p390
g3
sS'with,the,adverse'
p391
g3
sS'lower,than,usual'
p392
g3
sS'isozyme,and,thus'
p393
g3
sS'and,evening,should'
p394
g3
sS'demonstrated,that,and'
p395
g9
sS'is,a,blocker'
p396
g3
sS'cautiously,and,confirmed'
p397
g3
sS'as,a,class'
p398
g3
sS'but,should,be'
p399
g9
sS'the,insulin-sensitizing,effects'
p400
g3
sS'meal,would,not'
p401
g3
sS'potential,of,enhancing'
p402
g3
sS'regimen,reduces,the'
p403
g3
sS'given,on,separate'
p404
g9
sS'the,curve,after'
p405
g9
sS'by,without,preventing'
p406
g9
sS'and,discontinuation,of'
p407
g9
sS'therapy,a,rate'
p408
g9
sS'decreases,of,and'
p409
g9
sS'copegus,are,excreted'
p410
g3
sS'death,in,users'
p411
g3
sS'mg,total,daily'
p412
g3
sS'may,cause,myopathy'
p413
g3
sS'that,no,change'
p414
g9
sS'could,contribute,to'
p415
g3
sS'oxidase,inhibitors,maois'
p416
g9
sS'swelling,at,the'
p417
g3
sS'of,contraception,is'
p418
g3
sS'been,case,reports'
p419
g3
sS'activated,the,ca'
p420
g3
sS'data,that,conclusively'
p421
g3
sS'mice,after,chronic'
p422
g3
sS'mononitrate,may,be'
p423
g9
sS'may,also,contribute'
p424
g3
sS'geriatric,subjects,n'
p425
g3
sS'a,literature,article'
p426
g9
sS'formed,cysts,had'
p427
g3
sS'as,and,or'
p428
g9
sS'may,sometimes,be'
p429
g3
sS'to,cause,peripheral'
p430
g3
sS'analysis,of,side'
p431
g3
sS'clinical,use,of'
p432
g9
sS'valproic,acid,using'
p433
g9
sS'studies,with,sprycel'
p434
g3
sS'ophthalmic,solution,the'
p435
g9
sS'of,higher,doses'
p436
g3
sS'clinical,trials,the'
p437
g3
sS'other,day,until'
p438
g3
sS'epinephrine,should,not'
p439
g9
sS'bioavailability,auc,of'
p440
g9
sS'in,female,animals'
p441
g3
sS'patients,may,turn'
p442
g3
sS'of,decreased,protein'
p443
g9
sS'these,stimulants,are'
p444
g3
sS'methotrexate,concomitant,administration'
p445
g9
sS'in,cell,type'
p446
g3
sS'appear,in,the'
p447
g3
sS'use,of,antizol'
p448
g9
sS'the,usual,dosage'
p449
g3
sS'not,vary,as'
p450
g3
sS'macrolide,inhibit,the'
p451
g9
sS'central,pathways,are'
p452
g3
sS'metabolic,interactions,caused'
p453
g3
sS'activity,of,clostridium'
p454
g3
sS'is,expected,that'
p455
g9
sS'that,range,of'
p456
g9
sS'apparently,through,an'
p457
g9
sS'pi,affecting,patients'
p458
g3
sS'more,than,parkinsons'
p459
g3
sS'may,increase,two-fold'
p460
g9
sS'inhibitors,and,cyp1a2'
p461
g3
sS'the,pharmacokinetic,and'
p462
g3
sS'to,measure,plasma'
p463
g3
sS'phosphorylation,in,a'
p464
g9
sS'mg,kg,ip'
p465
g9
sS'disease,patients,in'
p466
g3
sS'clearance,of,chronic'
p467
g9
sS'concentrations,of,metabolized'
p468
g3
sS'enhancement,effect,of'
p469
g9
sS'before,or,within'
p470
g3
sS'allopurinol,in,a'
p471
g3
sS'was,increased,above'
p472
g3
sS'the,following,symptoms'
p473
g3
sS'and,non-gastrointestinal,bleedings'
p474
g3
sS'dilation,associated,with'
p475
g9
sS'and,gi,bleeding'
p476
g3
sS'on,the,minimum'
p477
g3
sS'treatment,for,extravasation'
p478
g3
sS'p,app,polymer'
p479
g3
sS'a,potentiation,of'
p480
g9
sS'listed,below,are'
p481
g3
sS'addition,of,mg'
p482
g9
sS'full,recovery,in'
p483
g3
sS'when,taking,acarbose'
p484
g9
sS'vs,end,of'
p485
g3
sS'and,frequently,thereafter'
p486
g9
sS'doses,that,produced'
p487
g3
sS'decrease,by,approximately'
p488
g3
sS'of,cytochrome,p450-mediated'
p489
g3
sS'counteract,the,antinaturetic'
p490
g9
sS'depletion,of,already'
p491
g9
sS'peak,plasma,concentrations'
p492
g9
sS'no,in,vivo'
p493
g9
sS'the,flavonoids,alone'
p494
g3
sS'present,whether,the'
p495
g3
sS'acetazolamide,increases,excretion'
p496
g9
sS'crossover,double-blind,placebo-controlled'
p497
g3
sS'of,by,confidence'
p498
g3
sS'theories,have,been'
p499
g3
sS'and,nonadditive,independent'
p500
g3
sS'significantly,to,plasma'
p501
g3
sS'aprepitant,given,concomitantly'
p502
g9
sS'of,wellbutrin,tablets'
p503
g9
sS'to,as,these'
p504
g9
sS'other,cardiovascular,agents'
p505
g3
sS'with,prolongation,of'
p506
g3
sS'potential,of,other'
p507
g9
sS'monitored,when,concomitant'
p508
g9
sS'an,approximately,decrease'
p509
g9
sS'dysfunction,eg,esophageal'
p510
g3
sS'must,be,taken'
p511
g9
sS'beta-receptor,agonist,in'
p512
g3
sS'that,inhibit,cyp3a4'
p513
g3
sS'combination,with,has'
p514
g3
sS'or,four,hours'
p515
g3
sS'of,cyp,isoenzymes'
p516
g3
sS'other,agents,which'
p517
g3
sS'time,pt,and'
p518
g9
sS'revealed,no,significant'
p519
g3
sS'these,cyp3a4,or'
p520
g3
sS'which,were,due'
p521
g3
sS'in,a,genetically'
p522
g3
sS'present,clearly,show'
p523
g3
sS'however,serious,opportunistic'
p524
g3
sS'recommended,due,to'
p525
g9
sS'together,as,a'
p526
g3
sS'the,post-marketing,experience'
p527
g9
sS'nucleolin,c23,down-regulation'
p528
g3
sS'of,severe,malaria'
p529
g3
sS'effects,of,hmg-coa'
p530
g3
sS'the,suppression,test'
p531
g3
sS'interference,with,standard'
p532
g3
sS'and,urine,levels'
p533
g9
sS'possible,or,closely'
p534
g3
sS'with,caution,if'
p535
g9
sS'that,tests,to'
p536
g3
sS'is,possible,that'
p537
g9
sS'evoked,potential,components'
p538
g3
sS'with,caution,in'
p539
g9
sS'hydroxylamine,dha,was'
p540
g3
sS'acute,phase,and'
p541
g3
sS'fluvastatin,is,the'
p542
g3
sS'patient,may,increase'
p543
g9
sS'associated,with,modest'
p544
g9
sS'or,a,chop-like'
p545
g3
sS'administered,safely,without'
p546
g3
sS'expected,antidepressant,levels'
p547
g9
sS'and,doses,should'
p548
g3
sS'as,the,physician'
p549
g3
sS'modified,if,they'
p550
g3
sS'elimination,the,effect'
p551
g9
sS'activity,acute,toxicity'
p552
g3
sS'alteration,in,uptake-1'
p553
g3
sS'range,reported,for'
p554
g3
sS'were,increased,because'
p555
g3
sS'particularly,those,of'
p556
g3
sS'by,multiple,cytochrome'
p557
g3
sS'decreases,in,cmax'
p558
g3
sS'effects,were,antagonized'
p559
g3
sS'inhibit,drug,transport'
p560
g3
sS'incidence,of,adverse'
p561
g9
sS'half-life,of,is'
p562
g9
sS'of,the,in'
p563
g3
sS'a,small,number'
p564
g3
sS'infectious,complications,that'
p565
g3
sS'the,during,and'
p566
g9
sS'of,the,is'
p567
g3
sS'a,daily,dose'
p568
g9
sS'dose,mg,and'
p569
g3
sS'take,this,medicine'
p570
g3
sS'triazolam,combined,administration'
p571
g3
sS'dofetilide,is,eliminated'
p572
g3
sS'vardenafil,should,not'
p573
g9
sS'who,was,taking'
p574
g3
sS'and,norethindrone,coadministration'
p575
g9
sS'meth,administration,affects'
p576
g3
sS'controlled,trials,that'
p577
g3
sS'or,delay,premature'
p578
g3
sS'subjects,with,specific'
p579
g3
sS'ephedrine,may,enhance'
p580
g9
sS'assistance,in,detecting'
p581
g3
sS'possible,explanation,for'
p582
g3
sS'diamond,trials,patients'
p583
g3
sS'of,both,control'
p584
g3
sS'given,concomitantly,only'
p585
g3
sS'of,pcp,were'
p586
g3
sS'concentration,accompanied,by'
p587
g9
sS'other,drugs,given'
p588
g3
sS'use,of,aczone'
p589
g3
sS'concentration,of,by'
p590
g9
sS'as,a,moderate'
p591
g3
sS'substantially,greater,therapeutic'
p592
g3
sS'danger,of,a'
p593
g9
sS'patients,may,need'
p594
g3
sS'between,single,oral'
p595
g9
sS'fold,accumulation,of'
p596
g3
sS'a,diminished,response'
p597
g9
sS'and,to,lower'
p598
g3
sS'antidiabetic,agents,insulin'
p599
g3
sS'was,and,hours'
p600
g3
sS'should,be,warned'
p601
g3
sS'increased,the,concentration'
p602
g9
sS'the,syndrome,requires'
p603
g3
sS'x,xii,vii-x'
p604
g3
sS'chlorpromazine,blocks,and'
p605
g9
sS'that,the,presence'
p606
g3
sS'sulfacetamide,preparations,are'
p607
g9
sS'reveiving,phenytoin,and'
p608
g9
sS'to,that,seen'
p609
g3
sS'requirement,may,be'
p610
g3
sS'other,nsaids,may'
p611
g9
sS'reductase,inhibitors,inhibitors'
p612
g3
sS'pigeons,nanm,was'
p613
g3
sS'treatments,of,depletion'
p614
g3
sS'animal,source,or'
p615
g3
sS'to,antagonize,the'
p616
g9
sS'secretion,of,in'
p617
g9
sS'with,celebrex,mg'
p618
g9
sS'may,become,more'
p619
g3
sS'may,increase,serum'
p620
g9
sS'of,pi,was'
p621
g3
sS'natriuresis,and,hyperreninemia'
p622
g9
sS'administration,of,cefotan'
p623
g3
sS'user,such,as'
p624
g3
sS'when,macrolide,or'
p625
g3
sS'and,reuptake,inhibitor'
p626
g9
sS'based,on,clinical'
p627
g9
sS'or,on,insulins'
p628
g3
sS'post-heparin,lipolytic,activity'
p629
g9
sS'of,other,drugs'
p630
g3
sS'the,rate-limiting,step'
p631
g3
sS'elapse,before,blood'
p632
g9
sS'two,hormonal,components'
p633
g9
sS'same,day,as'
p634
g9
sS'use,of,nimbex'
p635
g3
sS'or,other,drugs'
p636
g9
sS'g,day,have'
p637
g9
sS'psychotropic,medications,the'
p638
g9
sS'unstable,with,a'
p639
g3
sS'three-period,randomized,crossover'
p640
g3
sS'by,active,organic'
p641
g3
sS'blocking,agents,along'
p642
g9
sS'antiepilepsy,drugs,aeds'
p643
g9
sS'monitoring,of,plasma'
p644
g3
sS'increased,plasma,hdl'
p645
g3
sS'its,efficacy,as'
p646
g3
sS'which,confirms,the'
p647
g3
sS'effects,on,the'
p648
g3
sS'cold,remedies,and'
p649
g9
sS'microg,ml,in'
p650
g3
sS'weaker,inhibitors,grapefruit'
p651
g3
sS'serious,reactions,such'
p652
g3
sS'experimental,designs,for'
p653
g3
sS'at,a,concentration'
p654
g3
sS'was,estimated,as'
p655
g3
sS'clinical,isolates,of'
p656
g3
sS'people,use,both'
p657
g3
sS'nor,binding,to'
p658
g3
sS'and,test,strips'
p659
g3
sS'in,patients,already'
p660
g9
sS'of,dose,ranging'
p661
g9
sS'a,rapidly,growing'
p662
g3
sS'in,vitro,tests'
p663
g3
sS'two-fold,or,more'
p664
g9
sS'october,of,each'
p665
g3
sS'dst,should,be'
p666
g3
sS'a,four-session,placebo-controlled'
p667
g3
sS'or,should,be'
p668
g3
sS'impotence,inability,to'
p669
g3
sS'indicated,that,hydrochloride'
p670
g3
sS'main,hemostatic,defense'
p671
g9
sS'of,crixivan,to'
p672
g9
sS'and,potential,for'
p673
g3
sS'dosage,adjustment,is'
p674
g3
sS'catecholamine-depleting,agents,patients'
p675
g9
sS'the,specific,objectives'
p676
g3
sS'reverse,triiodothyronine,levels'
p677
g3
sS'flares,coupled,with'
p678
g3
sS'cbg,sex,hormone'
p679
g3
sS'be,undertaken,only'
p680
g9
sS'extensively,metabolized,the'
p681
g3
sS'metabolized,to,the'
p682
g3
sS'to,the,actions'
p683
g3
sS'theoretically,it,may'
p684
g3
sS'antidepressants,use,of'
p685
g9
sS'factor,vii,when'
p686
g3
sS'picr,so,as'
p687
g3
sS'of,resulting,in'
p688
g9
sS'of,the,odontoid'
p689
g3
sS'and,concurrently,and'
p690
g9
sS'increased,and,efficacy'
p691
g9
sS'shown,increased,sedation'
p692
g3
sS'mg,to,mg'
p693
g9
sS'motor,skills,or'
p694
g3
sS'cyp3a,a,minor'
p695
g9
sS'incisive,by,therapeutic'
p696
g3
sS'that,there,is'
p697
g3
sS'and,decrease,in'
p698
g9
sS'a,high,performance'
p699
g3
sS'produce,electrocardiographic,abnormalities'
p700
g9
sS'a,variety,of'
p701
g3
sS'or,may,develop'
p702
g9
sS'or,undesirable,involving'
p703
g3
sS'therefore,such,combined'
p704
g9
sS'suggest,that,absorption'
p705
g3
sS'in,addition,alone'
p706
g9
sS'intestinal,adenocarcinomas,induced'
p707
g9
sS'interaction,studies,were'
p708
g3
sS'fondaparinux,neither,influenced'
p709
g3
sS'of,the,plasma'
p710
g3
sS'nephrotoxic,potential,there'
p711
g3
sS'in,high,concentrations'
p712
g3
sS'have,led,to'
p713
g3
sS'while,taking,beta'
p714
g3
sS'use,clinicians,should'
p715
g9
sS'cause,a,reduction'
p716
g9
sS'cases,of,serious'
p717
g3
sS'eg,could,cause'
p718
g9
sS'monitoring,of,renal'
p719
g3
sS'to,examine,the'
p720
g3
sS'taking,or,within'
p721
g9
sS'acid,are,not'
p722
g3
sS'closely,monitored,in'
p723
g9
sS'or,x,l'
p724
g3
sS'and,to,potentiate'
p725
g9
sS'is,a,poor'
p726
g3
sS'closely,monitored,if'
p727
g9
sS'the,kidney,which'
p728
g3
sS'uniformity,and,time'
p729
g3
sS'formal,laboratory,test'
p730
g3
sS'bolus-ifl,in,combination'
p731
g3
sS'monitored,by,measuring'
p732
g3
sS'in,sub-therapeutic,concentrations'
p733
g9
sS'myopathy,rhabdomyolysis,is'
p734
g9
sS'micrograms,ml,or'
p735
g3
sS'iodinated,cholestographic,agents'
p736
g3
sS'that,affect,cyp3a4'
p737
g3
sS'this,paper,lists'
p738
g3
sS'a,similar,association'
p739
g3
sS'the,physician,is'
p740
g3
sS'the,pharmacokinetic,disposition'
p741
g3
sS'conducted,to,investigate'
p742
g3
sS'other,inhaled,medications'
p743
g3
sS'that,of,subjects'
p744
g3
sS'inhibitor,therapy,should'
p745
g9
sS'rhabdomyolysis,resulting,from'
p746
g3
sS'of,a,single'
p747
g3
sS'thrombolytic,agents,have'
p748
g3
sS'a,safety,concern'
p749
g3
sS'clinically,normal,dogs'
p750
g3
sS'tablets,to,patients'
p751
g9
sS'ibuprofen,ibuprofen,is'
p752
g3
sS'cause,of,infection'
p753
g9
sS'treatment,of,complicated'
p754
g3
sS'while,additional,research'
p755
g3
sS'pressor,response,to'
p756
g9
sS'humans,have,been'
p757
g3
sS'is,augmented,by'
p758
g9
sS'delta,and,kappa-selective'
p759
g3
sS'depression,than,the'
p760
g3
sS'ascorbic,acid,for'
p761
g3
sS'combination,of,and'
p762
g9
sS'causes,an,increase'
p763
g9
sS'through,a,combined'
p764
g3
sS'either,one,or'
p765
g9
sS'treatment,or,during'
p766
g3
sS'normal,tissues,from'
p767
g9
sS'on,the,above'
p768
g3
sS'prior,to,but'
p769
g9
sS'hctz,alone,auc'
p770
g9
sS'inducers,inhibitors,and'
p771
g9
sS'with,because,they'
p772
g9
sS'for,the,period'
p773
g9
sS'a,significant,deterioration'
p774
g3
sS'that,glucose,tests'
p775
g3
sS'the,concentration,or'
p776
g3
sS'or,ugt,enzymes'
p777
g3
sS'patient,population,affected'
p778
g3
sS'antagonists,tested,here'
p779
g3
sS'therapeutic,to,human'
p780
g3
sS'or,radiation,therapy'
p781
g3
sS'than,mg,day'
p782
g9
sS'sodium,bicarbonate,etc'
p783
g9
sS'coronary,artery,vasospasm'
p784
g9
sS'most,of,plasma'
p785
g3
sS'signs,of,toxicity'
p786
g3
sS'were,indifferent,for'
p787
g9
sS'is,further,metabolized'
p788
g3
sS'effects,if,any'
p789
g3
sS'be,an,increase'
p790
g3
sS'are,administered,concurrently'
p791
g9
sS'is,displaced,from'
p792
g9
sS'that,in,acutely'
p793
g3
sS'reduced,by,with'
p794
g9
sS'h,concomitant,administration'
p795
g3
sS'mg,kg,increased'
p796
g9
sS'aptt,such,as'
p797
g3
sS'reported,predominantly,in'
p798
g9
sS'in,human,milk'
p799
g3
sS'doses,of,oral'
p800
g3
sS'lime,should,be'
p801
g3
sS'of,iressa,and'
p802
g9
sS'to,know,how'
p803
g3
sS'other,or,medications'
p804
g9
sS'experience,may,reveal'
p805
g3
sS'taxol,mg,m2'
p806
g9
sS'particularly,the,hippocampus'
p807
g3
sS'inr,values,were'
p808
g3
sS'hydrochloric,acid,secretion'
p809
g3
sS'often,administered,concurrently'
p810
g3
sS'theoretical,basis,that'
p811
g9
sS'not,exceed,a'
p812
g9
sS'node,higher,degrees'
p813
g9
sS'effect,of,temperature'
p814
g3
sS'the,curve,of'
p815
g9
sS'to,be,antagonistic'
p816
g9
sS'http,www,rxlist'
p817
g3
sS'serum,meq,l'
p818
g9
sS'reaction,at,the'
p819
g3
sS'plasma,concentrations,of'
p820
g9
sS'parameter,values,were'
p821
g3
sS'opioids,co-administration,of'
p822
g9
sS'blocking,agent,administered'
p823
g3
sS'bovine,thyroglobulin,in'
p824
g3
sS'those,with,overdosage'
p825
g9
sS'it,may,have'
p826
g3
sS'and,anxiety,depressive'
p827
g3
sS'hand,intrathecal,micrograms'
p828
g9
sS'decreases,the,biologic'
p829
g9
sS'to,be,low'
p830
g3
sS'or,magnesium-containing,concomitant'
p831
g9
sS'drugs,that,could'
p832
g9
sS'pi-based,therapy,for'
p833
g3
sS'consisted,of,erythema'
p834
g3
sS'higher,cardiac,output'
p835
g9
sS'toxicity,may,result'
p836
g9
sS'may,be,aggravated'
p837
g9
sS'these,concomitant,n'
p838
g9
sS'ulceration,or,other'
p839
g9
sS'concomitantly,and,channel'
p840
g9
sS'excretion,of,the'
p841
g3
sS'and,proleukin,including'
p842
g9
sS'week,plasma,levels'
p843
g9
sS'experimental,toxic,and'
p844
g9
sS'is,involved,in'
p845
g3
sS'in,a,week'
p846
g3
sS'p-glycoprotein,substrate,with'
p847
g9
sS'been,attributed,at'
p848
g9
sS'xr,patients,received'
p849
g3
sS'other,non-steroidal,and'
p850
g9
sS'with,extracellular,rr'
p851
g9
sS'down-regulation,of,nucleophosmin'
p852
g3
sS'defined,medium,consisting'
p853
g3
sS'expected,that,use'
p854
g9
sS'a,precipitous,reduction'
p855
g9
sS'antibiotics,and,has'
p856
g9
sS'the,brain,memory'
p857
g3
sS'inhibitors,and,levo-dromoran'
p858
g9
sS'bleeding,complications,considerably'
p859
g3
sS'h,period,demonstrated'
p860
g3
sS'skeletal,myopathy,in'
p861
g3
sS'have,to,be'
p862
g3
sS'reduced,clearance,of'
p863
g3
sS'coadministration,of,neurontin'
p864
g3
sS'as,there,is'
p865
g3
sS'bolus-ifl,alone,and'
p866
g3
sS'therefore,more,frequent'
p867
g3
sS'mptp-induced,neuronal,damage'
p868
g9
sS'shown,that,indocin'
p869
g3
sS'lower,the,degree'
p870
g9
sS'changed,to,mg'
p871
g3
sS'ptx,was,discussed'
p872
g3
sS'the,outset,of'
p873
g3
sS'understanding,of,drug'
p874
g3
sS'elderly,and,caution'
p875
g3
sS'blood,pressure,has'
p876
g3
sS'produced,their,effects'
p877
g3
sS'pharmacokinetics,of,r-'
p878
g3
sS'which,suggests,that'
p879
g9
sS'cmin,increased,to'
p880
g3
sS'or,because,the'
p881
g9
sS'changes,were,not'
p882
g3
sS'a,helpful,means'
p883
g3
sS'or,more,than'
p884
g9
sS'linked,to,carbodiimide'
p885
g3
sS'of,scotland,were'
p886
g3
sS'any,other,medication'
p887
g3
sS'of,the,octapeptide'
p888
g3
sS'taking,mg,three'
p889
g9
sS'the,liver,weight'
p890
g3
sS'with,cholesterol,synthesis'
p891
g3
sS'in,desloratadine,and'
p892
g3
sS'doses,of,sonata'
p893
g9
sS'of,cyp3a4,would'
p894
g3
sS'anti-inflammatory,nsaids,without'
p895
g3
sS'before,blood,is'
p896
g9
sS'dosage,one,or'
p897
g3
sS'potential,for,drug'
p898
g3
sS'cigarettes,and,other'
p899
g3
sS'the,hepatic,microsomal'
p900
g3
sS'when,suprax,is'
p901
g9
sS'by,about,when'
p902
g9
sS'compete,for,the'
p903
g3
sS'do,not,act'
p904
g3
sS'patients,taking,coumarin-derivative'
p905
g9
sS'activity,they,should'
p906
g3
sS'lower,than,those'
p907
g9
sS'its,major,metabolite'
p908
g3
sS'hemostasis,and,nsaids'
p909
g9
sS'or,clastogenic,in'
p910
g3
sS'foradil,should,not'
p911
g3
sS'ca,concentration,ca'
p912
g9
sS'and,rhabdomyolysis,have'
p913
g3
sS'associated,with,transient'
p914
g9
sS'compounds,attenuate,morphine-induced'
p915
g3
sS'its,synergism,with'
p916
g9
sS'results,of,using'
p917
g9
sS'including,preparations,glyceryl'
p918
g3
sS'they,are,using'
p919
g3
sS'respectively,by,the'
p920
g9
sS'particularly,susceptible,to'
p921
g3
sS'of,other,antiepileptic'
p922
g9
sS'c9,c19,e1'
p923
g3
sS'inr,international,normalized'
p924
g9
sS'taken,for,hours'
p925
g3
sS'interaction,study,evaluating'
p926
g9
sS'the,predominant,plasma'
p927
g3
sS'be,active,in'
p928
g9
sS'and,that,no'
p929
g3
sS'sulfate,may,interact'
p930
g9
sS'plus,for,days'
p931
g3
sS'variation,in,ultimate'
p932
g9
sS'is,the,active'
p933
g9
sS'patients,when,was'
p934
g9
sS'with,mao,inhibitors'
p935
g9
sS'can,be,used'
p936
g9
sS'macrolide,azole,antifungal'
p937
g9
sS'vasoconstriction,in,some'
p938
g9
sS'that,peak,concentrations'
p939
g3
sS'center,italy,from'
p940
g3
sS'in,urine,after'
p941
g3
sS'significantly,prolonged,the'
p942
g9
sS'other,antiepileptic,the'
p943
g3
sS'have,been,compared'
p944
g3
sS'on,the,single'
p945
g3
sS'there,were,and'
p946
g3
sS'of,further,alterations'
p947
g9
sS'cmin,plasma,concentration'
p948
g3
sS'in,a,p53'
p949
g3
sS'could,be,enhanced'
p950
g9
sS'vitro,studies,of'
p951
g9
sS'to,decrease,plasma'
p952
g9
sS'most,notably,nondepolarizing'
p953
g9
sS'of,cyp3a4,can'
p954
g3
sS'hydroxide,cerivastatin,plasma'
p955
g3
sS'were,sacrificed,and'
p956
g3
sS'for,ketones,and'
p957
g3
sS'p450,d6,include'
p958
g3
sS'prothrombin,time,responses'
p959
g3
sS'disulfiram-like,reaction,may'
p960
g3
sS'hcl,and,agents'
p961
g9
sS'in,vitro,glucuronidation'
p962
g3
sS'induced,by,nonlethal'
p963
g3
sS'and,such,an'
p964
g9
sS'events,compared,to'
p965
g9
sS'novoseven,and,coagulation'
p966
g3
sS'clinical,data,suggest'
p967
g9
sS'of,coagulation,alterations'
p968
g3
sS'small,clinical,trial'
p969
g3
sS'excessive,prolongation,of'
p970
g9
sS'inhibit,aldehyde,oxidase'
p971
g3
sS'to,provide,therapeutic'
p972
g3
sS'that,the,concomitant'
p973
g9
sS'females,and,and'
p974
g3
sS'against,mycobacteriumavium-intracellulare,complex'
p975
g3
sS'for,of,the'
p976
g9
sS'a,to,dose-related'
p977
g9
sS'and,or,that'
p978
g9
sS'glucose,intolerance,prior'
p979
g3
sS'an,adequate,period'
p980
g3
sS'and,zdv,has'
p981
g3
sS'of,is,increased'
p982
g9
sS'iiia4,inhibitor,it'
p983
g9
sS'acetazolamide,decreases,urinary'
p984
g9
sS'frequency,of,rejection'
p985
g3
sS'genetically,diabetic,cinese'
p986
g3
sS'cells,and,may'
p987
g3
sS'captopril,may,cause'
p988
g3
sS'subjects,were,administered'
p989
g3
sS'was,especially,resistant'
p990
g3
sS'subjects,was,associated'
p991
g9
sS'the,central,effects'
p992
g9
sS'milk,there,is'
p993
g3
sS'arthritis,concomitant,medications'
p994
g3
sS'interactions,between,mentax'
p995
g3
sS'be,crucial,to'
p996
g3
sS'the,minor,side'
p997
g3
sS'five,days,in'
p998
g3
sS'other,taken,in'
p999
g9
sS'that,tam,significantly'
p1000
g9
sS'significantly,inhibit,alfenta'
p1001
g9
sS'costs,inpatient,and'
p1002
g3
sS'treatment,is,continued'
p1003
g3
sS'bid,n,vs'
p1004
g3
sS'be,potential,pharmacokinetic'
p1005
g3
sS'as,long,as'
p1006
g9
sS'reported,rarely,with'
p1007
g9
sS'whether,meth,administration'
p1008
g3
sS'capsule,formulation,of'
p1009
g9
sS'a4,to,the'
p1010
g3
sS'repeated,if,the'
p1011
g3
sS'with,the,use'
p1012
g3
sS'a,minor,metabolic'
p1013
g3
sS'activity,however,did'
p1014
g3
sS'containing,buffer,should'
p1015
g9
sS'were,inhibited,by'
p1016
g3
sS'thorazine,prolixin,permitil'
p1017
g3
sS'an,empty,stomach'
p1018
g3
sS'exists,between,vitamin'
p1019
g9
sS'consistent,effects,with'
p1020
g3
sS'in,dentistry,cannot'
p1021
g3
sS'dose,or,two'
p1022
g9
sS'cells,either,by'
p1023
g3
sS'phenylbutazone,causes,increase'
p1024
g9
sS'profiles,of,and'
p1025
g3
sS'of,vardenafil,experienced'
p1026
g9
sS'as,great,an'
p1027
g3
sS'dry,mouth,and'
p1028
g9
sS'injectable,implantable,insertable'
p1029
g3
sS'but,are,relatively'
p1030
g3
sS'include,extreme,agitation'
p1031
g9
sS'were,no,clinically'
p1032
g3
sS'extended,a,similar'
p1033
g9
sS'monitored,when,it'
p1034
g9
sS'monitored,when,is'
p1035
g9
sS'the,committed,step'
p1036
g9
sS'st,johns,wort'
p1037
g3
sS'of,had,to'
p1038
g3
sS'medications,which,interfere'
p1039
g3
sS'patients,were,mainly'
p1040
g3
sS'subjects,receiving,both'
p1041
g9
sS'women,receiving,the'
p1042
g3
sS'to,but,have'
p1043
g3
sS'prolong,bleeding,time'
p1044
g3
sS'other,the,administration'
p1045
g3
sS'important,that,health'
p1046
g3
sS'nor,is,the'
p1047
g3
sS'antiparkinsonism,agents,in'
p1048
g3
sS'be,temporarily,discontinued'
p1049
g9
sS'three,hours,concurrently'
p1050
g3
sS'angiotensin-converting,enzyme,inhibitor'
p1051
g9
sS'immunodeficiency-associated,lymphocyte,disorders'
p1052
g3
sS'of,and,also'
p1053
g9
sS'hepatic,metabolism,are'
p1054
g3
sS'indocin,and,has'
p1055
g9
sS'under,treatment,with'
p1056
g9
sS'without,doctor,or'
p1057
g3
sS'also,shown,to'
p1058
g3
sS'to,mg,for'
p1059
g9
sS'a,regimen,consisting'
p1060
g9
sS'reproducible,pattern,of'
p1061
g3
sS'vii,when,compared'
p1062
g3
sS'clinical,trial,as'
p1063
g9
sS'narcotics,non-narcotic,analgesics'
p1064
g9
sS'test,interferences,dicumarol'
p1065
g3
sS'had,a,non-significantly'
p1066
g3
sS'interactions,toxicity,associated'
p1067
g9
sS'be,reduced,and'
p1068
g3
sS'irritation,subjects,received'
p1069
g3
sS'long,and,variable'
p1070
g3
sS'may,depend,on'
p1071
g3
sS'aged,years,total'
p1072
g3
sS'hypertension,administration,of'
p1073
g9
sS'potentiated,the,blood'
p1074
g9
sS'consideration,before,such'
p1075
g3
sS'for,chronic,indications'
p1076
g3
sS'mutagenesis,pegasys,did'
p1077
g3
sS'metabolite,i,potency'
p1078
g3
sS'many,people,use'
p1079
g3
sS'be,indicated,in'
p1080
g3
sS'or,more,competing'
p1081
g3
sS'these,effects,have'
p1082
g3
sS'be,increased,if'
p1083
g9
sS'seen,with,treatment'
p1084
g3
sS'l-ccg,upon,pcp'
p1085
g3
sS'the,initial,treatment'
p1086
g3
sS'brevibloc,and,showed'
p1087
g3
sS'carefully,monitored,when'
p1088
g9
sS'dose,of,aprepitant'
p1089
g9
sS'unlikely,that,will'
p1090
g3
sS'greater,ischemic,response'
p1091
g9
sS'following,nimbex,is'
p1092
g9
sS'the,urine,by'
p1093
g3
sS'bioavailability,is,mildly'
p1094
g9
sS'that,physicians,query'
p1095
g3
sS'abnormalities,has,been'
p1096
g3
sS'and,s-warfarin,and'
p1097
g9
sS'a,small,but'
p1098
g9
sS'potent,in,lysing'
p1099
g3
sS'observed,after,administration'
p1100
g3
sS'been,demonstrated,that'
p1101
g9
sS'by,the,porter-silber'
p1102
g3
sS'reduction,for,equetrotm'
p1103
g3
sS'of,other,antiepilepsy'
p1104
g9
sS'of,ace,inhibitors'
p1105
g3
sS'enzyme,systems,has'
p1106
g9
sS'of,pegasys,to'
p1107
g3
sS'however,if,argatroban'
p1108
g3
sS'agents,including,remicade'
p1109
g9
sS'injections,of,aom'
p1110
g3
sS'of,bronchodilator,may'
p1111
g3
sS'the,risk,factors'
p1112
g9
sS'cyp2d6,because,cyp2d6'
p1113
g3
sS'to,affect,safety'
p1114
g3
sS'enzyme,inhibitors,the'
p1115
g9
sS'balance,technique,and'
p1116
g3
sS'antihypertensive,agents,that'
p1117
g9
sS'blockers,or,proton'
p1118
g9
sS'total,rna,from'
p1119
g3
sS'indicate,that,coadministration'
p1120
g9
sS'of,a,false-positive'
p1121
g3
sS'or,dosage,and'
p1122
g3
sS'of,at,least'
p1123
g3
sS'hydrochloride,before,each'
p1124
g3
sS'of,cyp,enzymes'
p1125
g9
sS'interactions,could,occur'
p1126
g3
sS'cyp3a4,isoform,and'
p1127
g3
sS'to,be,ingested'
p1128
g9
sS'reported,in,association'
p1129
g9
sS'not,affect,behaviors'
p1130
g3
sS'azithromycin,did,not'
p1131
g3
sS'the,sole,method'
p1132
g9
sS'in,the,diamond'
p1133
g3
sS'patients,may,require'
p1134
g9
sS'indicated,that,may'
p1135
g3
sS'paper,attempts,to'
p1136
g3
sS'no,dosage,adjustment'
p1137
g3
sS'sustained-release,tablets,with'
p1138
g3
sS'intestine,kidneys,and'
p1139
g3
sS'injection,usp,is'
p1140
g9
sS'while,the,fraction'
p1141
g3
sS'other,certain,such'
p1142
g9
sS'xanthine,and,an'
p1143
g9
sS'from,existing,clinical'
p1144
g3
sS'both,at,the'
p1145
g3
sS'population,with,hepatic'
p1146
g3
sS'be,done,with'
p1147
g3
sS'depends,on,clinical'
p1148
g3
sS'and,diabetes,coagulation'
p1149
g3
sS'and,constructive,alternatives'
p1150
g3
sS'aware,that,variable'
p1151
g9
sS'levels,of,although'
p1152
g9
sS'linezolid,is,a'
p1153
g3
sS'interaction,which,has'
p1154
g9
sS'well,controlled,trials'
p1155
g3
sS'regular,basis,it'
p1156
g3
sS'augments,the,action'
p1157
g9
sS'of,glucose,intolerance'
p1158
g3
sS'the,cyp2d6,isoenzyme'
p1159
g9
sS'caution,since,they'
p1160
g3
sS'inhibitors,prolong,and'
p1161
g9
sS'administered,in,combination'
p1162
g9
sS'including,the,concurrent'
p1163
g3
sS'rarely,when,ht1'
p1164
g9
sS'risk,than,normal'
p1165
g3
sS'on,a,with'
p1166
g3
sS'was,also,diminished'
p1167
g3
sS'be,confirmed,for'
p1168
g3
sS'of,septic,shock'
p1169
g3
sS'healthy,volunteers,either'
p1170
g9
sS'limit,of,the'
p1171
g3
sS'rhabdomyolysis,were,reported'
p1172
g3
sS'foradil,other,inhaled'
p1173
g3
sS'rhabdomyolysis,some,associated'
p1174
g3
sS'gel,should,not'
p1175
g9
sS'abnormal,renal,uptake'
p1176
g9
sS'agent,known,to'
p1177
g3
sS'of,in,de'
p1178
g3
sS'ventricular,function,or'
p1179
g3
sS'soft-gelatin,capsule,formulation'
p1180
g9
sS'volunteers,established,on'
p1181
g3
sS'all,animals,in'
p1182
g3
sS'both,the,magnitude'
p1183
g9
sS'be,monitored,by'
p1184
g3
sS'continues,to,be'
p1185
g3
sS'aid,in,elucidating'
p1186
g3
sS'of,patients,with'
p1187
g3
sS'before,or,for'
p1188
g3
sS'intestinal,lumen,to'
p1189
g3
sS'substrate,for,deoxycytidine'
p1190
g3
sS'noted,that,haldol'
p1191
g9
sS'clinically,significant,inhibition'
p1192
g3
sS'and,no,differential'
p1193
g3
sS'given,concurrently,the'
p1194
g3
sS'with,rheumatoid,arthritis'
p1195
g3
sS'coadministration,of,significantly'
p1196
g9
sS'ki,values,were'
p1197
g3
sS'affected,by,multiple-dose'
p1198
g3
sS'toxicity,and,cause'
p1199
g3
sS'be,undertaken,with'
p1200
g9
sS'effect,of,beta-receptor'
p1201
g3
sS'day,approximately,times'
p1202
g3
sS'rats,in,vitro'
p1203
g3
sS'function,testing,transaminases'
p1204
g3
sS'may,experience,large'
p1205
g3
sS'these,may,also'
p1206
g3
sS'receiving,mg,of'
p1207
g3
sS'taking,chronically,had'
p1208
g9
sS'limited,sampling,the'
p1209
g3
sS'of,new,therapeutic'
p1210
g3
sS'in,the,year'
p1211
g3
sS'is,minimally,absorbed'
p1212
g9
sS'vardenafil,dose,should'
p1213
g9
sS'pharmacokinetics,of,or'
p1214
g3
sS'be,coadministered,with'
p1215
g3
sS'paid,to,possible'
p1216
g3
sS'fulminant,rhabdomyolysis,has'
p1217
g9
sS'be,elevated,in'
p1218
g3
sS'main,indications,are'
p1219
g3
sS'immunosuppressant,metabolized,by'
p1220
g3
sS'coad-ministered,with,caution'
p1221
g3
sS'or,hctz,mg'
p1222
g3
sS'a,result,when'
p1223
g3
sS'for,longer,than'
p1224
g9
sS'or,patients,should'
p1225
g3
sS'consideration,in,the'
p1226
g3
sS'with,conventional,it'
p1227
g3
sS'concomitantly,with,and'
p1228
g3
sS'cytochrome,p-450,is'
p1229
g3
sS'potential,effects,on'
p1230
g9
sS'so,for,the'
p1231
g3
sS'marketing,experiences,of'
p1232
g9
sS'thrombin,clotting,time'
p1233
g3
sS'potential,effects,of'
p1234
g9
sS'to,days,the'
p1235
g3
sS'with,without,coadministered'
p1236
g3
sS'of,component,p2'
p1237
g3
sS'plenaxis,is,highly'
p1238
g3
sS'labetalol,hcl,is'
p1239
g9
sS'citrate,has,been'
p1240
g3
sS'another,oral,azole'
p1241
g9
sS'invirase,kaletra,norvir'
p1242
g9
sS'not,conclude,that'
p1243
g3
sS'mhd,the,predominant'
p1244
g3
sS'release,but,presumably'
p1245
g3
sS'to,decrease,elimination'
p1246
g9
sS'or,an,oral'
p1247
g9
sS'oral,hypoglycemics,agents'
p1248
g9
sS'labetalol,hcl,in'
p1249
g9
sS'patients,receiving,ace'
p1250
g9
sS'results,during,the'
p1251
g3
sS'blocking,agents,negative'
p1252
g9
sS'approximate,the,steady'
p1253
g3
sS'are,used,together'
p1254
g9
sS'peripheral,wasting,facial'
p1255
g3
sS'the,rat,s'
p1256
g3
sS'in,the,non-myelinated'
p1257
g3
sS'with,simulect,with'
p1258
g3
sS'cyp3a4,inducers,drugs'
p1259
g3
sS'of,romazicon,is'
p1260
g3
sS'of,humorsol,with'
p1261
g9
sS'part,of,the'
p1262
g3
sS'lodine,indocin,relafen'
p1263
g3
sS'with,the,known'
p1264
g3
sS'relevant,alterations,in'
p1265
g3
sS'for,which,effectiveness'
p1266
g3
sS'group,than,in'
p1267
g3
sS'using,these,medicines'
p1268
g9
sS'cortex,of,chronically'
p1269
g3
sS'actions,of,ophthalmic'
p1270
g3
sS'concentrations,c,max'
p1271
g3
sS'micrograms,caused,a'
p1272
g9
sS'the,likelihood,of'
p1273
g9
sS'concentration-time,curve,from'
p1274
g3
sS'and,non-steroidal,agents'
p1275
g9
sS'but,this,is'
p1276
g9
sS'dose,study,of'
p1277
g9
sS'an,increased,prothrombin'
p1278
g9
sS'noradrenaline-precontracted,arteries,from'
p1279
g3
sS'metabolized,by,cyp3a'
p1280
g3
sS'effects,of,lapatinib'
p1281
g3
sS'chronic,treatment,for'
p1282
g3
sS'increased,exposure,of'
p1283
g9
sS'aeds,and,were'
p1284
g3
sS'nifedipine,did,not'
p1285
g3
sS'ccnu,was,times'
p1286
g3
sS'and,antagonists,may'
p1287
g9
sS'would,be,unlikely'
p1288
g3
sS'tapering,of,the'
p1289
g3
sS'efficacy,should,be'
p1290
g3
sS'timi-ii,isis-2,currently'
p1291
g3
sS'depressants,and,may'
p1292
g9
sS'beta,blockers,and'
p1293
g9
sS'type,diabetics,die'
p1294
g3
sS'potential,for,adverse'
p1295
g3
sS'interaction,between,ssris'
p1296
g3
sS'care,as,they'
p1297
g9
sS'in,the,safety'
p1298
g3
sS'under,therapy,should'
p1299
g9
sS'it,is,taken'
p1300
g3
sS'rhabdomyolysis,particularly,in'
p1301
g3
sS'with,nitrous,oxide'
p1302
g9
sS'documented,prothrombin,times'
p1303
g3
sS'calcium,channel,blocking'
p1304
g3
sS'of,ergocalcitriol,will'
p1305
g3
sS'found,to,affect'
p1306
g3
sS'of,aprepitant,on'
p1307
g9
sS'with,ethyl,mao'
p1308
g9
sS'ace,inhibitors,during'
p1309
g9
sS'nac,and,the'
p1310
g3
sS'ld50,of,with'
p1311
g9
sS'some,agents,such'
p1312
g3
sS'this,may,lead'
p1313
g3
sS'reduction,tests,benedicts'
p1314
g3
sS'with,d2-antagonists,such'
p1315
g9
sS'effect,of,a'
p1316
g3
sS'relevance,to,humans'
p1317
g3
sS'dose,group,developed'
p1318
g3
sS'max,were,noted'
p1319
g3
sS'vitamin,a,to'
p1320
g9
sS'anionic-binding,has,a'
p1321
g9
sS'rate-limiting,step,in'
p1322
g3
sS'cyp3a4,inhibitors,may'
p1323
g3
sS'in,general,these'
p1324
g3
sS'the,constituents,of'
p1325
g3
sS'of,sodium,from'
p1326
g9
sS'potential,for,hepatic'
p1327
g3
sS'interval,significantly,increased'
p1328
g9
sS'this,was,prevented'
p1329
g9
sS'qtc,prolongation,with'
p1330
g3
sS'to,discontinue,therapy'
p1331
g9
sS'acute,toxicity,and'
p1332
g3
sS'could,theoretically,occur'
p1333
g3
sS'that,no,igg'
p1334
g3
sS'the,mg,kg'
p1335
g3
sS'exposure,the,toxicokinetic'
p1336
g3
sS'infarction,there,may'
p1337
g3
sS'prolonged,therapy,including'
p1338
g3
sS'show,that,a'
p1339
g3
sS'the,urine,may'
p1340
g3
sS'a,chylomicron-like,emulsion'
p1341
g3
sS'the,with,the'
p1342
g9
sS'on,platelet,aggregation'
p1343
g9
sS'these,interactions,is'
p1344
g3
sS'temporarily,suspending,use'
p1345
g9
sS'produce,malabsorption,of'
p1346
g9
sS'to,attenuate,some'
p1347
g3
sS'there,is,inadequate'
p1348
g3
sS'certain,including,products'
p1349
g9
sS'be,effective,due'
p1350
g9
sS'a,placebo-controlled,phase'
p1351
g3
sS'for,the,cocaine-treated'
p1352
g3
sS'were,as,much'
p1353
g3
sS'oral,phenytoin,protease'
p1354
g9
sS'phase,and,for'
p1355
g3
sS'minor,changes,in'
p1356
g9
sS's,disease,who'
p1357
g3
sS'schedule,of,sodium'
p1358
g3
sS'coma,have,been'
p1359
g9
sS'may,be,a'
p1360
g3
sS'case,study,has'
p1361
g9
sS'cimetidines,known,inhibition'
p1362
g9
sS'and,rarely,dry'
p1363
g3
sS'fold,in,females'
p1364
g3
sS'either,tagamet,mg'
p1365
g9
sS'conclusions,interpretation,glucose'
p1366
g3
sS'segment,of,the'
p1367
g3
sS'activation,of,nmda'
p1368
g3
sS'isozymes,responsible,for'
p1369
g9
sS'warfarin,and,anticoagulants'
p1370
g9
sS'systems,for,and'
p1371
g3
sS'the,same,metabolic'
p1372
g3
sS'if,cefotan,and'
p1373
g9
sS'may,antagonise,the'
p1374
g3
sS'concern,thus,could'
p1375
g3
sS'subjects,should,be'
p1376
g9
sS'with,multiple,effects'
p1377
g9
sS'methotrexate,cyclosporine,diclofenac'
p1378
g3
sS'effectiveness,of,argatroban'
p1379
g3
sS'of,the,th'
p1380
g3
sS'under,similar,conditions'
p1381
g3
sS'nardil,matulane,eldepryl'
p1382
g3
sS'because,the,combination'
p1383
g9
sS'on,tyrosine,phosphorylation'
p1384
g9
sS'accordingly,careful,patient'
p1385
g9
sS'nifedipine,may,be'
p1386
g3
sS'are,cyp,inducers'
p1387
g9
sS'oxidase,inhibitors,psychotropic'
p1388
g9
sS'creatinine,levels,should'
p1389
g3
sS'hyperglycemia,were,reported'
p1390
g3
sS'one,should,consider'
p1391
g3
sS'cause,arrhythmias,in'
p1392
g3
sS'patients,the,metabolic'
p1393
g9
sS'leucovorin,may,enhance'
p1394
g9
sS'b-lactam,renal,excretion'
p1395
g9
sS't24,cells,but'
p1396
g9
sS'have,any,clinically'
p1397
g3
sS'proportion,of,patients'
p1398
g9
sS'allows,to,open'
p1399
g9
sS'the,toxicity,may'
p1400
g9
sS'the,chick,by'
p1401
g3
sS'on,activity,persists'
p1402
g9
sS'other,agents,may'
p1403
g9
sS'studies,with,no'
p1404
g3
sS'protease,inhibitors,amprenavir'
p1405
g9
sS'small,but,statistically'
p1406
g9
sS'vardenafil,with,mg'
p1407
g9
sS'h,among,the'
p1408
g9
sS'very,strong,and'
p1409
g9
sS'as,v,concentration'
p1410
g3
sS'and,not,by'
p1411
g3
sS'was,explored,further'
p1412
g3
sS'average,decreases,of'
p1413
g9
sS'of,concurrent,use'
p1414
g9
sS'excretion,compared,with'
p1415
g9
sS'the,anion,itself'
p1416
g3
sS'of,a,chemical'
p1417
g3
sS'inhibitors,and,other'
p1418
g9
sS'effects,of,isosorbide'
p1419
g9
sS'risk,of,increased'
p1420
g3
sS'lectin,and,should'
p1421
g3
sS'mg,twice-daily,with'
p1422
g9
sS'those,of,the'
p1423
g9
sS'or,mg,qd'
p1424
g3
sS'two,should,not'
p1425
g3
sS'with,impaired,cardiac'
p1426
g3
sS'significance,the,two'
p1427
g3
sS'required,when,is'
p1428
g9
sS'addition,there,have'
p1429
g9
sS'fat,redistribution,redistribution'
p1430
g3
sS'given,with,or'
p1431
g3
sS'patients,on,than'
p1432
g9
sS'mean,auc,increased'
p1433
g9
sS'of,in,anhydrous'
p1434
g9
sS'secretion,of,colonic'
p1435
g3
sS'experiments,reactions,to'
p1436
g3
sS'agents,seizures,have'
p1437
g9
sS'cyclosporin,after,introduction'
p1438
g9
sS'cyp1a2,and,cyp3a4'
p1439
g3
sS'may,not,require'
p1440
g3
sS'two,are,coadministered'
p1441
g9
sS'and,other,certain'
p1442
g9
sS'although,results,have'
p1443
g3
sS'metabolites,including,the'
p1444
g3
sS'not,ordinarily,recommended'
p1445
g9
sS'altered,plasma,concentrations'
p1446
g3
sS'other,is,catalyzed'
p1447
g3
sS'such,interactions,should'
p1448
g3
sS'studies,also,suggest'
p1449
g3
sS'advised,when,is'
p1450
g9
sS'pharmacokinetics,of,when'
p1451
g3
sS'these,areas,examines'
p1452
g3
sS'known,strong,inhibitor'
p1453
g3
sS'either,by,overcoming'
p1454
g3
sS'are,other,agents'
p1455
g3
sS'suggests,that,coadministration'
p1456
g9
sS'plus,highly,active'
p1457
g3
sS'the,results,from'
p1458
g3
sS'that,xanthine-derived,antagonists'
p1459
g3
sS'arteries,from,male'
p1460
g3
sS'differently,from,the'
p1461
g3
sS'increase,may,be'
p1462
g3
sS'f2alpha,and,in'
p1463
g9
sS'first,rapid,contraction'
p1464
g3
sS'are,administered,alone'
p1465
g3
sS'possible,that,may'
p1466
g9
sS'levels,and,a'
p1467
g9
sS'mg,combined,with'
p1468
g9
sS'the,increased,risk'
p1469
g3
sS'a,dose-related,blockade'
p1470
g9
sS'form,or,may'
p1471
g9
sS'of,orally,administered'
p1472
g3
sS'between,and,has'
p1473
g3
sS'cyp3a4,isoenzyme,could'
p1474
g3
sS'also,received,ace'
p1475
g3
sS'synthetic,galloyl,esters'
p1476
g3
sS'the,neuron,blockade'
p1477
g9
sS'pbi,levels,may'
p1478
g3
sS'time,zero,to'
p1479
g3
sS'eg,selective,serotonin'
p1480
g3
sS'or,qtc,interval'
p1481
g3
sS'did,not,appear'
p1482
g3
sS'very,little,progression'
p1483
g3
sS'reactions,including,hyperthermia'
p1484
g9
sS'mean,of,and'
p1485
g9
sS'create,possible,additive'
p1486
g3
sS'levels,in,of'
p1487
g9
sS'are,substrates,for'
p1488
g3
sS'shown,that,concomitan'
p1489
g9
sS'chills,nausea,vomiting'
p1490
g3
sS'dose,of,sensipar'
p1491
g9
sS'other,hand,intrathecal'
p1492
g9
sS'specifically,lipid,metabolism'
p1493
g3
sS'the,following,lipid-lowering'
p1494
g3
sS'recommended,since,may'
p1495
g9
sS'of,angiomax,and'
p1496
g3
sS'rate,of,excretion'
p1497
g9
sS'this,may,increase'
p1498
g3
sS'synthetic,and,catabolic'
p1499
g9
sS'reduction,in,effect'
p1500
g9
sS'monitored,and,adjustment'
p1501
g9
sS'trileptal,with,hormonal'
p1502
g9
sS'to,any,nonlinear'
p1503
g3
sS'also,been,observed'
p1504
g3
sS'use,with,would'
p1505
g9
sS'of,fetal,abnormalities'
p1506
g3
sS'treated,aggressively,with'
p1507
g3
sS'profound,collapse,and'
p1508
g3
sS'in,vivo,resulted'
p1509
g3
sS'of,exposure,compared'
p1510
g3
sS'decrease,in,bioavailability'
p1511
g9
sS'breast,cancer,were'
p1512
g9
sS'affect,the,results'
p1513
g3
sS'in,a,four-session'
p1514
g3
sS'use,has,been'
p1515
g9
sS'of,similar,potential'
p1516
g9
sS'for,potentially,serious'
p1517
g9
sS'indicate,that,does'
p1518
g3
sS'slow,chylomicron,intravascular'
p1519
g3
sS'egf,ng,ml'
p1520
g3
sS'administrative,arrangements,in'
p1521
g3
sS'that,could,increase'
p1522
g3
sS'of,romazicon,may'
p1523
g3
sS'effects,of,indocin'
p1524
g9
sS'microsomes,appears,to'
p1525
g3
sS'the,aviano,cancer'
p1526
g3
sS'the,primary,effect'
p1527
g9
sS'vasoconstrictive,and,inotropic'
p1528
g9
sS'the,k,contribution'
p1529
g3
sS'respiration,and,cell'
p1530
g3
sS'metabolizers,with,regard'
p1531
g3
sS'in,children,has'
p1532
g3
sS'consume,and,hydroxy-1'
p1533
g9
sS'from,a,bioequivalence'
p1534
g3
sS'could,occur,following'
p1535
g3
sS'cyclosporine,elevated,serum'
p1536
g9
sS'a,pharmacokinetic,interaction'
p1537
g3
sS'prevention,studies,used'
p1538
g3
sS'to,enhance,in'
p1539
g9
sS'thus,impairing,absorption'
p1540
g9
sS'dark,test,in'
p1541
g3
sS'effects,on,in'
p1542
g3
sS'established,in,experiments'
p1543
g3
sS'the,effect,on'
p1544
g3
sS'ethopropazine,may,interact'
p1545
g9
sS'interresponse,times,as'
p1546
g3
sS'to,show,that'
p1547
g3
sS'the,effect,of'
p1548
g3
sS'fold,elevation,in'
p1549
g9
sS'small,increase,in'
p1550
g3
sS'other,creams,lotions'
p1551
g3
sS'pressure,caution,in'
p1552
g9
sS'oxidase,inhibitors,maoi'
p1553
g9
sS'area,of,scotland'
p1554
g3
sS'mg,produced,an'
p1555
g9
sS'performed,with,fondaparinux'
p1556
g3
sS'additive,effects,caution'
p1557
g3
sS'antagonistic,effect,of'
p1558
g9
sS'after,a,week'
p1559
g9
sS'pharmacologic,activities,similar'
p1560
g3
sS'schizoaffective,disorder,or'
p1561
g9
sS'valproic,acid,or'
p1562
g9
sS'in,caution,in'
p1563
g3
sS'three,study,periods'
p1564
g3
sS'be,alert,to'
p1565
g9
sS'thiazide,diuretics,the'
p1566
g9
sS'neural,plasticity,ieg'
p1567
g3
sS'with,coenzyme,a'
p1568
g3
sS'occur,between,epa'
p1569
g9
sS'may,ameliorate,increased'
p1570
g9
sS'have,demonstrated,moderate'
p1571
g9
sS'another,study,with'
p1572
g3
sS'sgot,s-ast,and'
p1573
g3
sS'azopt,ophthalmic,suspension'
p1574
g3
sS'relafen,daypro,and'
p1575
g3
sS'other,ht1b,d'
p1576
g9
sS'binds,differently,than'
p1577
g3
sS'response,and,there'
p1578
g3
sS'week,of,and'
p1579
g3
sS'to,when,trileptal'
p1580
g9
sS'autoimmune,and,inflammatory'
p1581
g9
sS'weeks,after,bilateral'
p1582
g3
sS'not,equivalent,in'
p1583
g3
sS'homodimeric,disintegrin,was'
p1584
g3
sS'in,period,b'
p1585
g3
sS'tricyclic,and,may'
p1586
g9
sS'medication,interferes,with'
p1587
g3
sS'remaining,ci,by'
p1588
g3
sS'no,relevant,effect'
p1589
g3
sS'of,the,injection'
p1590
g3
sS'has,been,demonstrated'
p1591
g9
sS'lactic,acidosis,have'
p1592
g3
sS'intricately,associated,with'
p1593
g3
sS'paresthesia,muscle,pain'
p1594
g3
sS'hormone,activity,may'
p1595
g3
sS'to,occur,when'
p1596
g3
sS'formed,by,cytochrome'
p1597
g3
sS'looks,at,five'
p1598
g3
sS'coating,that,resists'
p1599
g3
sS'continued,if,vioxx'
p1600
g9
sS'of,a,day'
p1601
g9
sS'a,modest,inhibition'
p1602
g3
sS'decrease,in,anti-inflammatory'
p1603
g9
sS'other,nonsteroidal,anti-inflammatory'
p1604
g3
sS'activation,of,caspase-3'
p1605
g3
sS'cholestytamine,and,have'
p1606
g9
sS'when,was,taken'
p1607
g9
sS'oral,medications,containing'
p1608
g9
sS'at,microm,preferentially'
p1609
g9
sS'weight,was,ineffective'
p1610
g3
sS'cancer,center,italy'
p1611
g3
sS'co-administration,of,at'
p1612
g9
sS'study,of,arava'
p1613
g9
sS'flolan,is,administered'
p1614
g9
sS'a,tablet,formulation'
p1615
g9
sS'time,inr,should'
p1616
g9
sS'caution,especially,in'
p1617
g3
sS'of,plasma,is'
p1618
g3
sS'has,resulted,in'
p1619
g3
sS'allow,for,an'
p1620
g3
sS'on,a,given'
p1621
g3
sS'additionally,brevibloc,should'
p1622
g9
sS'prolongation,of,plasma'
p1623
g9
sS'much,as,hours'
p1624
g9
sS'by,this,class'
p1625
g3
sS'rats,appear,to'
p1626
g3
sS'than,one-tenth,of'
p1627
g9
sS'ingested,being,converted'
p1628
g9
sS'thrombin,or,red'
p1629
g3
sS'of,plasma,protein'
p1630
g3
sS'addition,the,beneficial'
p1631
g9
sS'observed,when,vardenafil'
p1632
g3
sS'the,severity,of'
p1633
g9
sS'administered,concomitantly,to'
p1634
g9
sS'however,has,the'
p1635
g9
sS'other,progestational,eg'
p1636
g3
sS'either,the,normal'
p1637
g3
sS'when,coadministered,with'
p1638
g9
sS'one-stage,coagulation,assays'
p1639
g3
sS'mucosal,cells,at'
p1640
g3
sS'and,pharmacologic,effects'
p1641
g3
sS'medications,most,commonly'
p1642
g3
sS'for,abilify,to'
p1643
g3
sS'other,or,maois'
p1644
g3
sS'produce,significant,inhibition'
p1645
g9
sS'such,interactions,were'
p1646
g3
sS'resistance,in,class'
p1647
g3
sS'been,extensively,studied'
p1648
g3
sS'developmental,acquisition,after'
p1649
g3
sS'was,resistant,to'
p1650
g3
sS'study,co-administration,of'
p1651
g9
sS'infants,from,amevive'
p1652
g3
sS'produce,false,increases'
p1653
g3
sS'active,metabolite,which'
p1654
g9
sS'causally,related,to'
p1655
g3
sS'inhibitors,hypertensive,reactions'
p1656
g9
sS'neuropathy,during,videx'
p1657
g3
sS'nanm,but,not'
p1658
g9
sS'tinnitus,and,decreased'
p1659
g9
sS'endogenous,plasma,levels'
p1660
g9
sS'activity,towards,cyp1a2'
p1661
g9
sS'either,nanm,or'
p1662
g9
sS'contribution,of,receptors'
p1663
g3
sS'seen,in,a'
p1664
g3
sS'more,in,some'
p1665
g9
sS'that,resulted,in'
p1666
g9
sS'in,a,female'
p1667
g3
sS'ibuprofen,is,known'
p1668
g3
sS'gabitril,with,other'
p1669
g3
sS'of,r-warfarin,and'
p1670
g9
sS'or,citrate,accumulation'
p1671
g3
sS'pharmacological,interaction,this'
p1672
g9
sS'with,only,n3'
p1673
g3
sS'the,higher,concentrations'
p1674
g3
sS'that,taking,the'
p1675
g3
sS'closely,monitored,for'
p1676
g9
sS'in,chemotherapy,or'
p1677
g3
sS'group,of,newly'
p1678
g3
sS'therapeutic,regimen,as'
p1679
g3
sS'strongly,suppressed,by'
p1680
g3
sS'antagonists,co-administration,of'
p1681
g9
sS'patients,the,steady-state'
p1682
g9
sS'given,mg,day'
p1683
g3
sS'therapeutic,levels,did'
p1684
g3
sS'appeared,to,function'
p1685
g3
sS'heparin-induced,thrombocytopenia,the'
p1686
g3
sS'modulation,of,allergic'
p1687
g9
sS'be,discontinued,if'
p1688
g3
sS'myopathy,in,a'
p1689
g3
sS'were,administered,hydrochloride'
p1690
g3
sS'be,lower,and'
p1691
g9
sS'reports,of,pregnancy'
p1692
g3
sS'are,listed,in'
p1693
g3
sS'of,its,affinity'
p1694
g3
sS'who,have,benign'
p1695
g3
sS'neuroeffector,defects,occur'
p1696
g3
sS'interaction,with,fluoxetine'
p1697
g3
sS'using,isoform,selective'
p1698
g3
sS'coadministration,of,invirase'
p1699
g3
sS'daily,had,no'
p1700
g3
sS'not,include,sufficient'
p1701
g3
sS'sufficient,however,to'
p1702
g3
sS'micrograms,completely,blocked'
p1703
g9
sS'of,osteomalacia,in'
p1704
g3
sS'interactions,in,individuals'
p1705
g3
sS'intake,for,longer'
p1706
g9
sS'should,be,approached'
p1707
g9
sS'the,acid-catalyzed,ethanol-drug'
p1708
g3
sS'other,antipsychotic,agents'
p1709
g9
sS'increases,inrifabutin,exposure'
p1710
g3
sS'have,decreased,plasma'
p1711
g9
sS'gm,day,days'
p1712
g9
sS'and,the,magnitude'
p1713
g3
sS'patient,appeared,to'
p1714
g9
sS'of,addiction,while'
p1715
g3
sS'is,being,developed'
p1716
g3
sS'of,effective,contraception'
p1717
g3
sS'paralysis,may,be'
p1718
g3
sS'due,to,effects'
p1719
g3
sS'that,inhibit,the'
p1720
g3
sS'iga,is,the'
p1721
g3
sS'with,ribavirin,see'
p1722
g3
sS'kg,induced,a'
p1723
g3
sS'and,indicated,that'
p1724
g3
sS'reduce,the,oral'
p1725
g9
sS'sometimes,mcg,per'
p1726
g3
sS'between,and,both'
p1727
g3
sS'period,after,discontinuation'
p1728
g3
sS'metabolism,of,commonly'
p1729
g3
sS'degree,when,it'
p1730
g3
sS'release,tablets,administration'
p1731
g9
sS'and,other,ventricular'
p1732
g3
sS'controlled,clinical,studies'
p1733
g3
sS'and,and,are'
p1734
g3
sS'clinically,meaningful,reductions'
p1735
g9
sS'prior,to,a'
p1736
g9
sS'cytochrome,p450,isoenzymes'
p1737
g3
sS'adjustment,should,be'
p1738
g9
sS'of,suprax,may'
p1739
g3
sS'illnesses,dose,of'
p1740
g3
sS'use,of,clozapine'
p1741
g9
sS'observed,in,dogs'
p1742
g3
sS'elevations,less,than'
p1743
g9
sS'generally,do,not'
p1744
g3
sS'including,the,administration'
p1745
g3
sS'patients,on,coumarin-type'
p1746
g9
sS'performed,in,patients'
p1747
g3
sS'cognitive,enhancing,effects'
p1748
g3
sS'inhibitor,and,initiation'
p1749
g9
sS'been,adequately,studied'
p1750
g3
sS'decreased,to,micrograms'
p1751
g9
sS'comprehensive,review,was'
p1752
g3
sS'maximal,to,days'
p1753
g9
sS'date,show,that'
p1754
g3
sS'on,plasma,concentrations'
p1755
g3
sS'and,titration,to'
p1756
g9
sS'or,two,mg'
p1757
g9
sS'system,by,intrathecal'
p1758
g3
sS'and,intraindividual,interoccasion'
p1759
g3
sS'the,and,chop'
p1760
g3
sS'conditions,and,concomitantly'
p1761
g3
sS'exposure,in,these'
p1762
g3
sS'serious,infections,was'
p1763
g9
sS'medicines,with,l-tryptophan'
p1764
g3
sS'believed,that,the'
p1765
g9
sS'initial,doses,and'
p1766
g9
sS'particularly,if,administered'
p1767
g3
sS'use,short-acting,because'
p1768
g9
sS'clinical,trials,hypoglycemia'
p1769
g3
sS'rate,requirements,may'
p1770
g9
sS'the,study,were'
p1771
g3
sS'median,of,the'
p1772
g9
sS'resistant,to,chelated'
p1773
g3
sS'nodular,acne,transient'
p1774
g3
sS'from,the,body'
p1775
g9
sS'increase,plasmaconcentration,of'
p1776
g9
sS'probenecid,increases,both'
p1777
g9
sS'antibiotics,chloramphenicol,or'
p1778
g9
sS'fraction,of,at'
p1779
g3
sS'shown,to,change'
p1780
g9
sS'showed,differential,effects'
p1781
g3
sS'exhibit,additive,effects'
p1782
g3
sS'all,when,potent'
p1783
g9
sS'cmin,decreased,to'
p1784
g9
sS'chronic,toxicity,study'
p1785
g3
sS'effect,on,renal'
p1786
g9
sS'therefore,to,hours'
p1787
g9
sS'rate,constant,was'
p1788
g3
sS'local,breast,cancer'
p1789
g3
sS'with,and,including'
p1790
g3
sS'clearance,that,results'
p1791
g9
sS'trisenox,is,coadministered'
p1792
g9
sS'oxidase,the,aldehyde'
p1793
g3
sS'was,delayed,until'
p1794
g3
sS'an,inhibitor,of'
p1795
g3
sS'is,administered,in'
p1796
g9
sS'ml,h,among'
p1797
g9
sS'administration,of,ect'
p1798
g3
sS'and,platelets,recover'
p1799
g3
sS'vs,logs,of'
p1800
g3
sS'initiation,of,hormone'
p1801
g3
sS'clearance,of,may'
p1802
g9
sS'initial,doses,of'
p1803
g3
sS'the,blood,pressure'
p1804
g3
sS'tricor,and,hmg-coa'
p1805
g9
sS'significantly,longer,latencies'
p1806
g3
sS'volunteers,with,oral'
p1807
g3
sS'may,result,if'
p1808
g9
sS'risk,of,coronary'
p1809
g3
sS'administration,of,multiple'
p1810
g9
sS'may,result,in'
p1811
g9
sS'required,concentrations,and'
p1812
g9
sS'to,this,therapy'
p1813
g3
sS'administered,concurrently,subjects'
p1814
g9
sS'inhibitors,of,possible'
p1815
g9
sS'decreased,core,temperature'
p1816
g3
sS'a,together,may'
p1817
g9
sS'male,partners,of'
p1818
g3
sS'not,known,it'
p1819
g9
sS'be,made,with'
p1820
g9
sS'cbg,sex,hormone-binding'
p1821
g3
sS'messages,advise,on'
p1822
g3
sS'also,markedly,inhibits'
p1823
g9
sS'calcium-channel,blockers,cardiac'
p1824
g3
sS'not,known,if'
p1825
g3
sS'cremophor,el,eg'
p1826
g9
sS'seen,as,an'
p1827
g3
sS'when,administered,concurrently'
p1828
g9
sS'inducers,include,but'
p1829
g3
sS'cyclosporine,digoxin,methotrexate'
p1830
g9
sS'condition,corrected,whenever'
p1831
g3
sS'essentially,no,effect'
p1832
g3
sS'recent,study,has'
p1833
g9
sS'reaction,may,occur'
p1834
g9
sS'at,about,x'
p1835
g9
sS'of,among,patients'
p1836
g9
sS'initial,doses,or'
p1837
g3
sS'of,n,later'
p1838
g3
sS'in,prolonging,av'
p1839
g9
sS'or,may,potentiate'
p1840
g9
sS'reported,when,toradol'
p1841
g9
sS'increase,the,hypotensive'
p1842
g9
sS'mg,sustained-release,tablets'
p1843
g3
sS'loads,treated,with'
p1844
g3
sS'concentrations,and,possible'
p1845
g3
sS'risk,of,hemorrhage'
p1846
g3
sS'inducers,are,unlikely'
p1847
g3
sS'altered,biodistribution,may'
p1848
g3
sS'that,a,smaller'
p1849
g9
sS'lack,of,platelet'
p1850
g3
sS'peak,serum,level'
p1851
g9
sS'increased,the,number'
p1852
g3
sS'increasing,the,rate'
p1853
g3
sS'nsaids,have,produced'
p1854
g9
sS'were,unaffected,by'
p1855
g3
sS'urine,test,for'
p1856
g3
sS'treatment,is,essential'
p1857
g3
sS'indications,use,instructions'
p1858
g3
sS'causes,no,more'
p1859
g3
sS'if,it,is'
p1860
g9
sS'or,changing,therapy'
p1861
g9
sS'ethinyl,estradiol,following'
p1862
g3
sS'patients,receiving,similar'
p1863
g3
sS'abruptly,discontinued,increase'
p1864
g3
sS'therapy,omnicef,should'
p1865
g9
sS'may,include,one'
p1866
g3
sS'results,the,geometric'
p1867
g9
sS'cyp3a4,increased,exposure'
p1868
g9
sS'nsaids,antigout,oral'
p1869
g3
sS'prior,to,infusions'
p1870
g9
sS'day,variability,in'
p1871
g3
sS'sprycel,close,monitoring'
p1872
g3
sS'been,reports,of'
p1873
g9
sS'administered,in,single'
p1874
g3
sS'use,of,tablets'
p1875
g9
sS'psychoactive,drugs,hallucinations'
p1876
g9
sS'vasopressors,thyroxine,increases'
p1877
g9
sS'to,cause,renal'
p1878
g9
sS'inhibitors,maoi,as'
p1879
g9
sS'co-administration,of,orally'
p1880
g9
sS'globulin,shbg,leading'
p1881
g3
sS'or,its,metabolites'
p1882
g3
sS'recorded,from,the'
p1883
g3
sS'reduce,plasma,concentrations'
p1884
g9
sS'methotrexate,caution,should'
p1885
g9
sS'levels,aldosterone,excretion'
p1886
g3
sS'by,especially,when'
p1887
g9
sS'of,the,new'
p1888
g3
sS'the,prevalence,of'
p1889
g3
sS'this,can,be'
p1890
g3
sS'flare,were,significantly'
p1891
g3
sS'this,enzyme,system'
p1892
g3
sS'may,have,a'
p1893
g3
sS'that,are,inducers'
p1894
g3
sS'n-desmethyldiazepam,to,a'
p1895
g3
sS'approximately,or,more'
p1896
g3
sS'the,dosage,are'
p1897
g9
sS'a,previously,effective'
p1898
g9
sS'pigeons,and,mixed'
p1899
g3
sS'sandimmune,hiv,classified'
p1900
g9
sS'since,is,a'
p1901
g3
sS'appearing,on,the'
p1902
g3
sS'and,no,clear'
p1903
g3
sS'can,take,to'
p1904
g3
sS'that,is,significantly'
p1905
g3
sS'daily,did,not'
p1906
g3
sS'injection,of,pcp'
p1907
g3
sS'increased,over,those'
p1908
g9
sS'metabolism,and,decrease'
p1909
g3
sS'seen,but,brevibloc'
p1910
g9
sS'dmpge2,were,more'
p1911
g3
sS'population,who,are'
p1912
g3
sS'mg,kg,produced'
p1913
g9
sS'volunteers,have,failed'
p1914
g3
sS'intables,and,are'
p1915
g3
sS'patients,who,must'
p1916
g3
sS'activity,large,doses'
p1917
g3
sS'inhibitor,plus,experienced'
p1918
g9
sS'also,verified,by'
p1919
g3
sS'use,of,l-tyrosine'
p1920
g9
sS'cross-reactions,with,non-aspergillus'
p1921
g3
sS'tbars,in,both'
p1922
g3
sS'levels,as,measured'
p1923
g3
sS'the,optimal,dosing'
p1924
g3
sS'receiving,increased,sgot'
p1925
g3
sS'sular,tended,to'
p1926
g9
sS'clearance,was,reduced'
p1927
g3
sS'reductase,inhibitors,prostaglandin'
p1928
g3
sS'reduced,by,pretreatment'
p1929
g9
sS'digitalis,glycosides,amphotericin'
p1930
g9
sS'effects,of,nanm'
p1931
g9
sS'racemic,was,seen'
p1932
g3
sS'into,consideration,before'
p1933
g3
sS'in,rare,cases'
p1934
g3
sS'or,with,parasite'
p1935
g3
sS'testicular,leydig,cell'
p1936
g3
sS'during,transfer,to'
p1937
g3
sS'the,pharmacokinetics,of'
p1938
g3
sS'reported,significantly,more'
p1939
g3
sS'vary,as,a'
p1940
g3
sS'cyp,drug-metabolizing,enzymes'
p1941
g3
sS'increases,in,dose'
p1942
g9
sS'mtx,in,approximately'
p1943
g3
sS'may,occur,if'
p1944
g9
sS'cardiac,function,should'
p1945
g3
sS'the,pharmacokinetics,or'
p1946
g3
sS'of,endotoxin-induced,deaths'
p1947
g9
sS'is,also,taking'
p1948
g9
sS'metabolite,of,d'
p1949
g3
sS'cimetidine,inhibits,cyp3a4'
p1950
g9
sS'may,occur,in'
p1951
g3
sS'of,the,hydrophilic'
p1952
g3
sS'mg,kg,induced'
p1953
g3
sS'mao,inhibitors,prolong'
p1954
g9
sS'vioxx,mg,once'
p1955
g3
sS'be,aware,that'
p1956
g9
sS'transdermal,with,or'
p1957
g9
sS'general,concern,regarding'
p1958
g3
sS'and,increased,breakthrough'
p1959
g3
sS'public,feels,that'
p1960
g3
sS'certain,nonsteroidal,anti-inflammatory'
p1961
g9
sS'nonsteroial,anti-inflammatory,concomitantly'
p1962
g9
sS'phenytoin,intoxication,prior'
p1963
g9
sS'receiving,beta,blockers'
p1964
g3
sS'existing,therapy,did'
p1965
g3
sS'basal,and,dmpge2-induced'
p1966
g3
sS'dysfunction,as,indicated'
p1967
g3
sS'colazal,however,the'
p1968
g3
sS'however,adenocard,should'
p1969
g3
sS'coated,aspirin,should'
p1970
g9
sS'and,b,the'
p1971
g3
sS'cgs,an,a2-selective'
p1972
g9
sS'were,also,collected'
p1973
g3
sS'hepatotoxicity,asymptomatic,increases'
p1974
g3
sS'have,been,isolated'
p1975
g9
sS'the,selective,serotonin'
p1976
g3
sS'pregnancy,category,x'
p1977
g3
sS'excessive,release,but'
p1978
g3
sS'influenza,virus,vaccine'
p1979
g9
sS'patients,with,weakness'
p1980
g9
sS'halved,and,titration'
p1981
g9
sS'd,have,not'
p1982
g3
sS'after,intravenous,administration'
p1983
g3
sS'persistently,elevated,plasma'
p1984
g3
sS'of,oral,erection-supporting'
p1985
g3
sS'pregnancy,category,c'
p1986
g3
sS'toxicity,in,these'
p1987
g9
sS'period,with,n'
p1988
g3
sS'some,patients,predisposing'
p1989
g9
sS'of,barrier,contraception'
p1990
g9
sS'cytosine,arabinoside,a'
p1991
g9
sS'depression,hallucinations,paresthesia'
p1992
g3
sS'safety,of,such'
p1993
g3
sS'chemically,modify,exposed'
p1994
g3
sS'ventricular,cardiac,preparations'
p1995
g3
sS'and,the,renal'
p1996
g3
sS'more,likely,to'
p1997
g3
sS'pediatrics,mean,increase'
p1998
g9
sS'alone,produced,a'
p1999
g3
sS'results,that,falsely'
p2000
g3
sS'channel,blockers,derivatives'
p2001
g9
sS'cyp2d6,eg,or'
p2002
g9
sS'capsule,twice,daily'
p2003
g3
sS'report,suggesting,that'
p2004
g9
sS'to,healthy,volunteers'
p2005
g3
sS'adsorption,of,onto'
p2006
g9
sS'closely,for,changes'
p2007
g3
sS'including,oral,estrogens'
p2008
g9
sS'the,limbic,system'
p2009
g3
sS'antinociceptive,effect,between'
p2010
g9
sS'agonists,because,the'
p2011
g9
sS'grapefruit,juice,resulted'
p2012
g3
sS'p450iid6,cyp2d6,many'
p2013
g3
sS'following,medications,have'
p2014
g3
sS'day,of,was'
p2015
g3
sS'action,on,smooth'
p2016
g3
sS'was,related,to'
p2017
g3
sS'tests,using,but'
p2018
g3
sS'shown,that,does'
p2019
g3
sS'pipracil,produces,an'
p2020
g9
sS'drugs,tend,to'
p2021
g3
sS'this,finding,no'
p2022
g3
sS'alone,had,no'
p2023
g9
sS'remain,to,orders'
p2024
g3
sS'for,the,presence'
p2025
g3
sS'general,clinical,conditions'
p2026
g9
sS'with,these,disturbances'
p2027
g9
sS'of,warfarin-type,certain'
p2028
g9
sS'interactions,on,mean'
p2029
g3
sS'other,or,alternatively'
p2030
g3
sS'evaluated,by,using'
p2031
g3
sS'those,concomitant,medications'
p2032
g3
sS'addition,under,the'
p2033
g3
sS'when,it,combines'
p2034
g3
sS'given,concomitantly,including'
p2035
g3
sS'bradycardia,sinus,arrest'
p2036
g3
sS'inducers,of,cytochrome'
p2037
g3
sS'reactions,after,therapy'
p2038
g3
sS'used,in,the'
p2039
g3
sS'found,that,chronic'
p2040
g9
sS'similarly,in,the'
p2041
g3
sS'zebeta,be,discontinued'
p2042
g9
sS'levels,cfu,ml'
p2043
g3
sS'frequent,determination,of'
p2044
g3
sS'when,given,simultaneously'
p2045
g9
sS'frequently,to,maintain'
p2046
g3
sS'studies,involving,alprazolam'
p2047
g9
sS'another,such,as'
p2048
g9
sS'concentrations,of,increased'
p2049
g9
sS'was,replaced,by'
p2050
g3
sS'cyp2d6,inhibitory,effect'
p2051
g9
sS'studies,wshow,that'
p2052
g9
sS'time,were,assessed'
p2053
g3
sS'therefore,and,indocin'
p2054
g9
sS'auc0-12,of,hydroxylamine'
p2055
g3
sS'this,paper,attempts'
p2056
g3
sS'the,therapeutic,regimen'
p2057
g3
sS'brovana,as,with'
p2058
g9
sS'possibility,of,skin'
p2059
g3
sS'dependent,areas,in'
p2060
g3
sS'hepatic,metabolic,clearance'
p2061
g3
sS'antihypertensive,therapy,nicotinic'
p2062
g9
sS'and,well-controlled,studies'
p2063
g3
sS'are,activated,during'
p2064
g3
sS'known,that,patients'
p2065
g9
sS'concentration-time,curve,of'
p2066
g3
sS'function,the,value'
p2067
g3
sS'other,by,mouth'
p2068
g3
sS'to,produce,any'
p2069
g9
sS'of,c,p'
p2070
g3
sS'treated,with,who'
p2071
g3
sS'test,dst,in'
p2072
g3
sS'combination,in,ameliorating'
p2073
g3
sS'also,appears,to'
p2074
g3
sS'the,major,metabolites'
p2075
g3
sS'nor,does,affect'
p2076
g3
sS'appear,to,increase'
p2077
g9
sS'b,or,potassium-depleting'
p2078
g3
sS'acetate,stimulated,but'
p2079
g9
sS'prolonged,concurrent,use'
p2080
g3
sS'for,days,of'
p2081
g3
sS'first,synthetic,hydroxy-3'
p2082
g3
sS'concentrations,below,the'
p2083
g9
sS'nanm,was,about'
p2084
g3
sS'ml,for,and'
p2085
g3
sS'colestid,tablets,and'
p2086
g3
sS'is,within,the'
p2087
g3
sS'when,prescribing,for'
p2088
g3
sS'possible,rapid,fluctuations'
p2089
g9
sS'increased,gleevec,oral-dose'
p2090
g9
sS'use,in,women'
p2091
g3
sS'to,inhibit,or'
p2092
g3
sS'agents,contraindicated,since'
p2093
g3
sS'mg,in,combination'
p2094
g3
sS'a,patient,currently'
p2095
g9
sS'mechanism,of,these'
p2096
g3
sS'evaluate,the,pharmacokinetic'
p2097
g3
sS'amprenavir,and,and'
p2098
g9
sS'of,theophylline,mg'
p2099
g3
sS'administered,safely,to'
p2100
g3
sS'of,with,vitamin'
p2101
g9
sS'therefore,the,addition'
p2102
g9
sS'when,taken,orally'
p2103
g9
sS'activity,than,that'
p2104
g3
sS'is,sensitive,to'
p2105
g3
sS'contrast,to,the'
p2106
g3
sS'the,mean,sd'
p2107
g3
sS'taken,with,food'
p2108
g9
sS'on,than,in'
p2109
g9
sS'casodex,can,displace'
p2110
g9
sS'other,significantly,eliminated'
p2111
g9
sS'start,of,treatment'
p2112
g9
sS'were,administered,following'
p2113
g3
sS'differences,may,be'
p2114
g3
sS'the,bio-rad,laboratories'
p2115
g3
sS'mg,kg,s'
p2116
g9
sS'remedy,use,may'
p2117
g3
sS'agents,enhanced,bone'
p2118
g9
sS'mg,kg,w'
p2119
g9
sS'possibly,increase,the'
p2120
g9
sS'keys,to,maximizing'
p2121
g3
sS'mg,kg,x'
p2122
g9
sS'tdp,in,patients'
p2123
g3
sS'the,striatum,and'
p2124
g9
sS'in,particular,and'
p2125
g3
sS'essential,conduct,close'
p2126
g3
sS'by,a,homodimeric'
p2127
g3
sS'for,individual,and'
p2128
g3
sS'experiment,rats,were'
p2129
g3
sS'use,of,st'
p2130
g3
sS'should,be,necessary'
p2131
g3
sS'this,risk,is'
p2132
g3
sS'reaction,and,clinical'
p2133
g3
sS'taking,or,may'
p2134
g9
sS'interacting,with,which'
p2135
g3
sS'in,patients,undergoing'
p2136
g9
sS'ace,inhibitors,mao'
p2137
g3
sS'of,time,it'
p2138
g3
sS'considerable,caution,should'
p2139
g9
sS'certain,including,those'
p2140
g9
sS'digoxin,volume,of'
p2141
g3
sS'and,synthetic,on'
p2142
g3
sS'activity,has,been'
p2143
g3
sS'a,possible,explanation'
p2144
g3
sS'group,that,received'
p2145
g3
sS'was,measured,near'
p2146
g3
sS'of,exogenously,infused'
p2147
g3
sS'of,tambocor,and'
p2148
g9
sS'drug,nutritional,supplement'
p2149
g3
sS'increase,in,metabolic'
p2150
g9
sS'during,therapy,with'
p2151
g9
sS'to,be,without'
p2152
g9
sS'they,may,share'
p2153
g3
sS'the,same,group'
p2154
g3
sS'of,urate,uricosuric'
p2155
g9
sS'other,drug,classes'
p2156
g3
sS'when,contrast,media'
p2157
g3
sS'collagen-induced,platelet,aggregation'
p2158
g3
sS'with,administered,alone'
p2159
g9
sS'the,auc,and'
p2160
g3
sS'produce,toxicity,of'
p2161
g3
sS'relation,to,the'
p2162
g3
sS'alteration,caused,by'
p2163
g3
sS'doxazosin,mesylate,tablets'
p2164
g3
sS'classes,ii,to'
p2165
g3
sS'protein,zaleplon,is'
p2166
g3
sS'agents,ammonium,chloride'
p2167
g9
sS'plasma,levels,and'
p2168
g9
sS'administered,following,varying'
p2169
g3
sS'injection,of,in'
p2170
g9
sS'oral,potently,inhibits'
p2171
g9
sS'following,have,been'
p2172
g3
sS'significant,reductions,in'
p2173
g9
sS'heart,rate,and'
p2174
g9
sS'functioning,gland,who'
p2175
g9
sS'auc,by,to'
p2176
g9
sS'and,evidence,of'
p2177
g9
sS'surgery,because,is'
p2178
g3
sS'that,the,absorption'
p2179
g9
sS'nsaids,and,are'
p2180
g9
sS'test,interactions,interactions'
p2181
g3
sS'decline,in,glomerular'
p2182
g3
sS'this,paper,we'
p2183
g3
sS'with,nephrotoxic,potential'
p2184
g9
sS'average,infusion,rate'
p2185
g3
sS'ellence,after,previous'
p2186
g3
sS'implant,have,not'
p2187
g3
sS'cautioned,about,the'
p2188
g3
sS'of,acetylsalicylic,acid'
p2189
g3
sS'day,group,were'
p2190
g9
sS'by,high,doses'
p2191
g9
sS'of,the,target'
p2192
g3
sS'equivalent,in,their'
p2193
g3
sS'thereby,potentially,aggravating'
p2194
g9
sS'decrease,serum,concentration'
p2195
g9
sS'the,type,c'
p2196
g3
sS'factor,for,realization'
p2197
g3
sS'it,is,advisable'
p2198
g3
sS'is,limited,evidence'
p2199
g3
sS'trials,due,to'
p2200
g3
sS'combined,use,of'
p2201
g9
sS'be,flexible,and'
p2202
g3
sS'findings,suggest,that'
p2203
g3
sS'insufficiency,or,renal'
p2204
g3
sS'be,reduced,to'
p2205
g9
sS'increased,following,administration'
p2206
g9
sS'in,creatinine,clearance'
p2207
g9
sS'reports,of,withdrawal'
p2208
g9
sS'well,and,the'
p2209
g3
sS'in,cmax,of'
p2210
g9
sS'and,mu,systems'
p2211
g3
sS'in,the,testes'
p2212
g3
sS'cmi,because,of'
p2213
g9
sS'background,since,its'
p2214
g3
sS'treatment,cessation,such'
p2215
g3
sS'we,could,observe'
p2216
g3
sS'lectin,which,we'
p2217
g3
sS'follow-up,study,in'
p2218
g3
sS'and,minimal,experimental'
p2219
g3
sS'to,gonadotropin-releasing,hormone'
p2220
g3
sS'of,hypotension,and'
p2221
g9
sS'orencia,administered,concurrently'
p2222
g9
sS'week,prior,to'
p2223
g9
sS'data,do,not'
p2224
g3
sS'may,selectively,prevent'
p2225
g9
sS'profound,hypotension,and'
p2226
g9
sS'neurons,including,biocytin'
p2227
g3
sS'carcinogenic,potential,of'
p2228
g3
sS'capsules,garlic,capsules'
p2229
g3
sS'with,a,median'
p2230
g3
sS'to,generate,the'
p2231
g3
sS'decreases,clearance,of'
p2232
g9
sS'juice,and,other'
p2233
g9
sS'of,a,regimen'
p2234
g9
sS'of,other,including'
p2235
g9
sS'with,and,other'
p2236
g9
sS'initiating,replacement,therapy'
p2237
g3
sS'from,the,visual'
p2238
g3
sS'and,therefore,no'
p2239
g3
sS'twice,daily,resulted'
p2240
g9
sS'increase,in,central'
p2241
g9
sS'therefore,potentially,may'
p2242
g9
sS'atp,oxaloacetate,and'
p2243
g3
sS'comparable,to,or'
p2244
g9
sS'concomitantly,receiving,azole'
p2245
g9
sS'plasma,protein-,bound'
p2246
g3
sS'and,fold,the'
p2247
g3
sS'platelets,in,a'
p2248
g3
sS'such,as,a'
p2249
g3
sS'be,considered,and'
p2250
g3
sS'of,these,findings'
p2251
g3
sS'effects,and,in'
p2252
g3
sS'and,platelet,aggregation'
p2253
g9
sS'oral,a,potent'
p2254
g9
sS'resulting,in,lower'
p2255
g9
sS'g,kg,m'
p2256
g3
sS'minimal,alterations,of'
p2257
g3
sS'mentax,butenafine,hcl'
p2258
g3
sS'expected,to,increase'
p2259
g3
sS'such,as,k'
p2260
g3
sS'determine,if,there'
p2261
g3
sS'have,neuromuscular,blocking'
p2262
g9
sS'argatroban,and,mg'
p2263
g9
sS'of,collapse,respiratory'
p2264
g3
sS'extent,than,the'
p2265
g3
sS'not,be,exceeded'
p2266
g9
sS'order,to,confirm'
p2267
g3
sS'inspra,mg,combined'
p2268
g9
sS'following,information,was'
p2269
g3
sS'a,lower,relative'
p2270
g3
sS'consume,greater,than'
p2271
g3
sS'patients,gland,has'
p2272
g3
sS'drug-drug,interactions,no'
p2273
g3
sS'coadministration,loratadine,mg'
p2274
g3
sS'vivo,rodent,study'
p2275
g3
sS'to,the,female'
p2276
g3
sS'with,concurrent,ingestion'
p2277
g9
sS'drug-interaction,studies,performed'
p2278
g3
sS'bleeding,if,administered'
p2279
g9
sS'extraneal,in,diabetic'
p2280
g9
sS'pcp,produced,distinctive'
p2281
g3
sS'of,this,review'
p2282
g3
sS'histaminergic,and,serotoninergic'
p2283
g3
sS'activity,of,gl'
p2284
g3
sS'following,the,initiation'
p2285
g9
sS'single,compound,is'
p2286
g3
sS'equetrotm,to,a'
p2287
g3
sS'the,potential,interaction'
p2288
g9
sS'who,have,previously'
p2289
g9
sS'patients,and,healthy'
p2290
g3
sS'campath,may,interfere'
p2291
g3
sS'of,tubular,secretion'
p2292
g9
sS'caution,is,warranted'
p2293
g9
sS'medications,the,use'
p2294
g9
sS'decrease,the,antinociceptive'
p2295
g9
sS'patient,taking,another'
p2296
g3
sS'organoleads,are,present'
p2297
g3
sS'toxicity,of,patients'
p2298
g3
sS'and,symptoms,of'
p2299
g9
sS'efficacy,as,a'
p2300
g3
sS'since,the,sedative'
p2301
g9
sS'and,it,is'
p2302
g9
sS'sign,of,seriously'
p2303
g3
sS'followed,and,the'
p2304
g3
sS'two,weeks,after'
p2305
g3
sS'peripheral,vasospasm,and'
p2306
g3
sS'by,active,renal'
p2307
g9
sS'dose,should,then'
p2308
g3
sS'may,sterilize,the'
p2309
g3
sS'levels,of,the'
p2310
g9
sS'to,concomitant,therapy'
p2311
g3
sS'the,class,of'
p2312
g3
sS'for,a,role'
p2313
g3
sS'dynacirc,has,been'
p2314
g3
sS'a,crossover,study'
p2315
g9
sS'as,arrhythmias,may'
p2316
g9
sS'mean,clearances,of'
p2317
g9
sS'trecator,may,potentiate'
p2318
g9
sS'concentration,of,cmc-cys'
p2319
g3
sS'severity,and,or'
p2320
g9
sS'that,at,these'
p2321
g9
sS'from,patients,receiving'
p2322
g3
sS'to,which,ssri-tcainteractions'
p2323
g9
sS'higher,rate,of'
p2324
g3
sS'dependent,diabetic,patients'
p2325
g3
sS'strongly,suggest,that'
p2326
g3
sS'higher,and,excretion'
p2327
g3
sS's,or,fehling'
p2328
g3
sS'peritoneal,cavity,or'
p2329
g3
sS'mask,the,signs'
p2330
g3
sS'antibiotics,such,as'
p2331
g9
sS'and,valproic,acid'
p2332
g9
sS'in,europe,nimotop'
p2333
g9
sS'trans-3,dimethyl-4,hydroxyphenyl'
p2334
g9
sS'of,loop,potassium-sparing'
p2335
g9
sS'incubation,in,the'
p2336
g3
sS'discontinued,increase,the'
p2337
g3
sS'for,an,increase'
p2338
g3
sS'metabolism,may,be'
p2339
g3
sS'administration,of,to'
p2340
g9
sS'enzyme,prolongs,and'
p2341
g3
sS'state,on,the'
p2342
g3
sS'gastrointestinal,disturbances,such'
p2343
g3
sS'with,care,in'
p2344
g9
sS'with,cns,depressants'
p2345
g9
sS'renal,clearance,leading'
p2346
g3
sS'day,withdrawal,the'
p2347
g3
sS'tested,the,antimicrobial'
p2348
g3
sS'containing,trisilicate,when'
p2349
g9
sS'although,in,vivo'
p2350
g9
sS'convulsions,and,cardiac'
p2351
g9
sS'clearance,of,to'
p2352
g9
sS'days,resulted,in'
p2353
g9
sS'felbatol,to,antiepileptic'
p2354
g9
sS'of,cyp,a4'
p2355
g3
sS'anti-anxiety,used,to'
p2356
g3
sS'no,experience,on'
p2357
g3
sS'inhibition,of,n-acetyltransferase'
p2358
g9
sS'was,inserted,between'
p2359
g3
sS'peak,concentrations,were'
p2360
g3
sS'agents,that,affect'
p2361
g3
sS'of,tricyclic,with'
p2362
g3
sS'mind,when,another'
p2363
g3
sS'considered,in,place'
p2364
g9
sS'vi,of,the'
p2365
g3
sS'patients,may,precipitate'
p2366
g9
sS'that,may,enhance'
p2367
g9
sS'systemic,data,have'
p2368
g3
sS'by,mu-,delta'
p2369
g3
sS'the,third,group'
p2370
g3
sS'that,cause,significant'
p2371
g9
sS'is,inhibited,by'
p2372
g9
sS'has,orphan,status'
p2373
g3
sS'hyperglycemia,but,also'
p2374
g3
sS'microsomes,demonstrated,no'
p2375
g3
sS'sst,and,randomly'
p2376
g3
sS'this,study,investigated'
p2377
g3
sS'only,observed,between'
p2378
g3
sS'moderate,inhibitor,and'
p2379
g3
sS'underlying,the,development'
p2380
g3
sS'was,between,and'
p2381
g3
sS'drugs,based,on'
p2382
g3
sS'of,both,cyp1a2'
p2383
g3
sS'concentration,of,cmi'
p2384
g9
sS'this,information,should'
p2385
g3
sS'single,mg,oral'
p2386
g3
sS'important,for,drugs'
p2387
g3
sS'potential,benefit,justifies'
p2388
g3
sS'pharmacokinetic,variables,for'
p2389
g3
sS'efficacy,of,may'
p2390
g9
sS'corresponding,increase,in'
p2391
g9
sS'for,altering,cyp1a2-mediated'
p2392
g3
sS'a,short-term,controlled'
p2393
g3
sS'beta-receptor,blockers,have'
p2394
g3
sS'used,to,test'
p2395
g3
sS'recalcitrant,nodular,acne'
p2396
g3
sS'toxicity,and,or'
p2397
g9
sS'h2,receptor,antagonists'
p2398
g9
sS'not,systematically,alter'
p2399
g3
sS'when,eulexin,capsules'
p2400
g9
sS'given,to,the'
p2401
g3
sS'scale,of,hansten'
p2402
g3
sS'from,neuromuscular,blockade'
p2403
g3
sS'compared,to,has'
p2404
g9
sS'malignancy,and,increasingly'
p2405
g3
sS'while,they,cause'
p2406
g3
sS'after,or,in'
p2407
g3
sS'plasma,concentration,was'
p2408
g3
sS'stimulated,with,greater'
p2409
g3
sS'known,if,mepron'
p2410
g3
sS'assess,the,safety'
p2411
g9
sS'the,overall,direct'
p2412
g3
sS'beta-blockers,serum,concentrations'
p2413
g3
sS'with,other,chelator'
p2414
g3
sS'since,some,medications'
p2415
g3
sS'estimated,as,of'
p2416
g3
sS'general,most,patients'
p2417
g3
sS'hydroxy-estazolam,and,the'
p2418
g3
sS'in,tbg,concentrations'
p2419
g3
sS'man,the,c'
p2420
g9
sS'with,beta-receptor,blockers'
p2421
g3
sS'all,the,renal'
p2422
g3
sS'salicylic,acid,decrease'
p2423
g9
sS'stimulator,of,metabolism'
p2424
g9
sS'probenecid,slows,the'
p2425
g3
sS'shown,to,affect'
p2426
g9
sS'in,hyperthyroid,patients'
p2427
g3
sS'african,trypanosomiasis,in'
p2428
g3
sS'decrease,in,average'
p2429
g9
sS'phosphate-binding,agents,since'
p2430
g3
sS'is,necessary,when'
p2431
g9
sS'if,a,patient'
p2432
g3
sS'antagonists,appear,to'
p2433
g3
sS'channel,blockers,beta'
p2434
g3
sS'and,mixed,signalled-unsignalled'
p2435
g3
sS'levels,are,above'
p2436
g3
sS'oral,erection-supporting,medication'
p2437
g3
sS'excreted,via,the'
p2438
g3
sS'addition,other,have'
p2439
g9
sS'are,also,extensively'
p2440
g3
sS'jaffe,reaction,since'
p2441
g3
sS'symptomatic,hyperlactatemia,lactic'
p2442
g3
sS'you,are,using'
p2443
g9
sS'as,v,has'
p2444
g3
sS'intravenous,and,amphotericin'
p2445
g9
sS'important,in,supporting'
p2446
g3
sS'cyp3a4,inhibitors,are'
p2447
g3
sS'with,laboratory,tests'
p2448
g3
sS'that,include,extreme'
p2449
g9
sS'of,withdrawal,and'
p2450
g9
sS'and,beta-blocking,agents'
p2451
g3
sS'methylthiadiazole,can,cause'
p2452
g3
sS'do,not,suggest'
p2453
g3
sS'known,cyp3a4,inducers'
p2454
g9
sS'at,least,an'
p2455
g3
sS'when,a,euthyroid'
p2456
g3
sS'an,effective,first-line'
p2457
g3
sS'have,negative,inotropic'
p2458
g9
sS'serious,gi,bleeding'
p2459
g9
sS'on,treatment,should'
p2460
g9
sS'times,as,high'
p2461
g3
sS'patient,monitoring,and'
p2462
g9
sS'another,and,but'
p2463
g9
sS'dose,to,maintain'
p2464
g3
sS'mixed,agonist-antagonist,effects'
p2465
g3
sS'is,clinically,compatible'
p2466
g3
sS'in,class,a'
p2467
g3
sS'tremulousness,and,confusion'
p2468
g9
sS'other,populations,are'
p2469
g3
sS'in,hematologic,studies'
p2470
g3
sS'is,also,shown'
p2471
g3
sS'with,active,ra'
p2472
g9
sS'to,alter,cardiac'
p2473
g9
sS'tricyclic,may,block'
p2474
g9
sS'clinical,trials,with'
p2475
g9
sS'disease,medications,were'
p2476
g3
sS'if,a,potentially'
p2477
g9
sS'class,is,increased'
p2478
g3
sS'changes,in,function'
p2479
g3
sS'vitro,has,been'
p2480
g3
sS'conditioning,processes,automatic'
p2481
g3
sS'of,the,immunodepressant--the'
p2482
g3
sS'platelet,function,studies'
p2483
g3
sS'relevance,picr,in'
p2484
g3
sS'at,that,time'
p2485
g3
sS'cyp3a4,inhibitors,felodipine'
p2486
g3
sS'xa,and,antithrombin'
p2487
g3
sS'or,cardiac,glycosides'
p2488
g3
sS'either,was,observed'
p2489
g3
sS'the,plasma,enzymes'
p2490
g3
sS'and,normal,subjects'
p2491
g9
sS'and,pharmaco-dynamic,effects'
p2492
g3
sS'catecholamine-depleting,may,have'
p2493
g9
sS'antiplatelet,and,medication'
p2494
g9
sS'orudis,orudis,kt'
p2495
g3
sS'reuptake,of,disrupts'
p2496
g3
sS'study,in,niddm'
p2497
g3
sS'mean,t,max'
p2498
g3
sS'any,other,nsaid'
p2499
g9
sS'known,to,interact'
p2500
g9
sS'certain,including,nonsteroidal'
p2501
g9
sS'functional,coupling,between'
p2502
g3
sS'crossover,study,in'
p2503
g9
sS'ucb,l057,was'
p2504
g3
sS'on,the,cardiovascular'
p2505
g9
sS'concomitantly,without,a'
p2506
g3
sS'weeks,after,the'
p2507
g3
sS'either,on,alone'
p2508
g3
sS'of,pegasys,alone'
p2509
g3
sS'population,in,general'
p2510
g3
sS'equetrotm,and,then'
p2511
g9
sS'as,bradycardia,and'
p2512
g9
sS'was,noted,that'
p2513
g3
sS'exceeded,of,the'
p2514
g3
sS'qd,has,not'
p2515
g3
sS'of,preparations,by'
p2516
g9
sS'example,since,may'
p2517
g9
sS'either,alone,or'
p2518
g3
sS'to,be,exacerbated'
p2519
g9
sS'the,first,and'
p2520
g3
sS'the,vitamin,d'
p2521
g3
sS'all,agents,to'
p2522
g3
sS'of,human,african'
p2523
g3
sS'been,conducted,for'
p2524
g3
sS'spinal,cord,injuries'
p2525
g3
sS'acting,triclofos,sodium'
p2526
g9
sS'that,both,angiotensins'
p2527
g3
sS'values,of,and'
p2528
g3
sS'important,regulation,of'
p2529
g3
sS'for,clinical,evidence'
p2530
g3
sS'also,to,an'
p2531
g9
sS'cyp3a4,inhibitor,cannot'
p2532
g3
sS'studies,tilade,has'
p2533
g3
sS'used,in,turn'
p2534
g3
sS'glucose,concentrations,should'
p2535
g9
sS'if,necessary,can'
p2536
g3
sS'animal,studies,wshow'
p2537
g9
sS'those,off,medications'
p2538
g3
sS'including,yields,a'
p2539
g9
sS'time,monitored,and'
p2540
g9
sS'approximately,when,and'
p2541
g9
sS'such,as,acute'
p2542
g3
sS'with,doses,of'
p2543
g3
sS'with,emphasis,on'
p2544
g3
sS'urine,sampling,were'
p2545
g3
sS'were,short-lasting,as'
p2546
g3
sS'combination,with,potentially'
p2547
g9
sS'toxic,metabolites,in'
p2548
g3
sS'borderline,statistical,significance'
p2549
g3
sS'of,enterococci,vre'
p2550
g3
sS'when,equetrotm,is'
p2551
g9
sS'are,critical,to'
p2552
g3
sS'on,insulins,ability'
p2553
g3
sS'another,extended,release'
p2554
g3
sS'one,study,in'
p2555
g9
sS'since,ancobon,does'
p2556
g3
sS'administered,with,its'
p2557
g9
sS'and,host,defense'
p2558
g3
sS'when,using,immunoanalytical'
p2559
g3
sS'response,suggest,that'
p2560
g3
sS'type,diabetes,were'
p2561
g3
sS'which,are,metabolized'
p2562
g9
sS'chemotherapy,agents,in'
p2563
g3
sS'edecrin,and,non-'
p2564
g9
sS'on,sensipar,sensipar'
p2565
g3
sS'are,a,family'
p2566
g3
sS'individual,and,joint'
p2567
g3
sS'on,blood,pressure'
p2568
g3
sS'at,risk,for'
p2569
g3
sS'failed,to,alter'
p2570
g3
sS'hydroxides,does,not'
p2571
g3
sS'pointes,most,like'
p2572
g9
sS'in,situ,and'
p2573
g3
sS'other,specific,drug'
p2574
g3
sS'as,noted,with'
p2575
g9
sS'not,a,substitute'
p2576
g3
sS'approximately,one,week'
p2577
g9
sS'severe,adverse,reaction'
p2578
g3
sS'modest,cyp2d6,inhibitory'
p2579
g9
sS'the,interference,with'
p2580
g9
sS'comprehensive,information,concerning'
p2581
g3
sS'becomes,complete,after'
p2582
g3
sS'deferasirox,should,be'
p2583
g3
sS'increased,altretamines,half-life'
p2584
g9
sS'level,by,the'
p2585
g3
sS'platelet,aggregation,time'
p2586
g3
sS'increased,bioavailability,and'
p2587
g3
sS'information,on,concurrent'
p2588
g3
sS'concurrently,with,cardiac'
p2589
g3
sS'clinicians,have,noted'
p2590
g3
sS'whereas,the,medial'
p2591
g3
sS'relaxants,and,the'
p2592
g9
sS'difluoro-2,propanol,mg'
p2593
g9
sS'date,has,not'
p2594
g3
sS'were,not,reported'
p2595
g9
sS'on,the,tyrosine'
p2596
g3
sS'gastrointestinal,toxicity,than'
p2597
g9
sS'with,cordarone,i'
p2598
g3
sS'setting,rural,primary'
p2599
g3
sS'facilitate,and,reinstate'
p2600
g3
sS'used,in,ms'
p2601
g3
sS'engaging,in,hazardous'
p2602
g3
sS'were,administered,together'
p2603
g3
sS'which,ssri-tca,interactions'
p2604
g9
sS'pharmacokinetic,profile,of'
p2605
g9
sS'exogenous,co-factors,could'
p2606
g3
sS'by,such,without'
p2607
g3
sS'antabuse-like,side,effects'
p2608
g9
sS'concentration,is,reduced'
p2609
g9
sS'healthy,males,who'
p2610
g3
sS'following,are,administered'
p2611
g3
sS'concomitantly,physicians,are'
p2612
g9
sS'of,low-dose,hcl'
p2613
g9
sS'interact,pharmacologically,with'
p2614
g9
sS'cyp,enzyme,a4'
p2615
g3
sS'you,are,taking'
p2616
g3
sS'incidence,of,akathisia'
p2617
g9
sS'of,action,or'
p2618
g3
sS'days,received,mg'
p2619
g3
sS'frequently,limits,the'
p2620
g3
sS'for,worsening,renal'
p2621
g3
sS'paper,reviews,recent'
p2622
g3
sS'results,in,reduced'
p2623
g9
sS'increased,sedation,or'
p2624
g3
sS'mixtures,at,concentrations'
p2625
g3
sS'gel,interacts,with'
p2626
g3
sS'no,change,in'
p2627
g3
sS'mug,ml,whereas'
p2628
g3
sS'caspase-3,and,induction'
p2629
g3
sS'trough,serum,valproic'
p2630
g3
sS'adverse,events,reported'
p2631
g3
sS'concentrations,were,not'
p2632
g3
sS'antagonists,and,could'
p2633
g3
sS'in,addition,based'
p2634
g3
sS'ml,maalox,tc'
p2635
g9
sS'greater,than,or'
p2636
g3
sS'to,avoid,additive'
p2637
g9
sS'doses,and,small'
p2638
g9
sS'half-life,increased,approximately'
p2639
g9
sS'indicate,that,starlix'
p2640
g3
sS'that,are,facilitated'
p2641
g3
sS'potentiate,adverse,events'
p2642
g9
sS'such,as,nimbex'
p2643
g9
sS'to,decreased,concentrations'
p2644
g9
sS'zebeta,should,be'
p2645
g9
sS'studies,had,no'
p2646
g3
sS'was,increased,in'
p2647
g3
sS'thus,when,vioxx'
p2648
g9
sS'showed,no,influence'
p2649
g3
sS'carbohydrate-splitting,enzymes,may'
p2650
g9
sS'a,are,critical'
p2651
g3
sS'as,loop,or'
p2652
g9
sS'on,both,chylomicron'
p2653
g3
sS'as,his,own'
p2654
g3
sS'intravenous,mg,clo-4'
p2655
g3
sS'by,xanthine,oxidase'
p2656
g3
sS'neurological,effects,and'
p2657
g3
sS'described,little,is'
p2658
g3
sS'pathway,may,have'
p2659
g3
sS'patient,taking,mg'
p2660
g9
sS'lower,affinities,than'
p2661
g3
sS'placebo,n,had'
p2662
g3
sS'by,glucuronidation,is'
p2663
g3
sS'from,these,patients'
p2664
g9
sS'reported,cases,from'
p2665
g3
sS'to,determine,the'
p2666
g3
sS'been,reported,during'
p2667
g9
sS'into,account,when'
p2668
g3
sS'serum,txb2,generation'
p2669
g3
sS'the,drug,is'
p2670
g9
sS'fifteen,to,minutes'
p2671
g3
sS'measurements,are,necessary'
p2672
g3
sS'amphetamines,may,enhance'
p2673
g9
sS'when,rebif,is'
p2674
g3
sS'additive,adverse,effects'
p2675
g9
sS'the,repeat,dose'
p2676
g3
sS'weekly,dose,resulted'
p2677
g3
sS'would,seem,to'
p2678
g9
sS'competes,for,active'
p2679
g9
sS'severe,events,such'
p2680
g3
sS'that,did,not'
p2681
g3
sS'or,discontinues,therapy'
p2682
g9
sS'receiving,coumarin-type,the'
p2683
g9
sS'and,iv,is'
p2684
g9
sS'different,botulinum,neurotoxin'
p2685
g3
sS'angina,patients,receiving'
p2686
g3
sS'to,mg,to'
p2687
g9
sS'any,that,may'
p2688
g3
sS'high,percentage,of'
p2689
g3
sS'reactions,resemble,the'
p2690
g3
sS'no,reported,cases'
p2691
g3
sS'solution,should,not'
p2692
g9
sS'slight,effects,on'
p2693
g3
sS'antipsychotic,efficacy,compared'
p2694
g3
sS'enzymes,are,expected'
p2695
g3
sS'studies,suggest,that'
p2696
g3
sS'a,sulfonamide,is'
p2697
g9
sS'indicated,that,the'
p2698
g3
sS'may,be,mediated'
p2699
g9
sS'the,steady-state,epoxide'
p2700
g9
sS'statistically,or,clinically'
p2701
g3
sS'pharmacokinetic,interaction,studies'
p2702
g3
sS'the,kd,and'
p2703
g3
sS'recommended,when,a'
p2704
g9
sS'b3,niacin,antihypertensive'
p2705
g9
sS'hind,paw,at'
p2706
g3
sS'and,to,decrease'
p2707
g3
sS'hiv-related,systemic,non-hodgkin'
p2708
g3
sS'indicating,induction,of'
p2709
g3
sS'response,to,insulin-induced'
p2710
g3
sS'certain,metabolizing,enzymes'
p2711
g3
sS'absolute,abstinence,is'
p2712
g3
sS'an,aluminum,hydroxide-'
p2713
g3
sS'excretion,of,nalfon'
p2714
g9
sS'antineoplastic,agents,may'
p2715
g9
sS'dose,if,or'
p2716
g9
sS'ci,by,monitoring'
p2717
g3
sS'who,received,under'
p2718
g3
sS'the,therapy,of'
p2719
g9
sS'a,interaction,study'
p2720
g3
sS'or,hypotension,with'
p2721
g9
sS'conduction,can,result'
p2722
g9
sS'dose,of,was'
p2723
g3
sS'taken,in,divided'
p2724
g3
sS'metabolites,induce,or'
p2725
g3
sS'worsen,the,incidence'
p2726
g9
sS'drug-drug,pharmacokinetic,interactions'
p2727
g3
sS'in,vitro,experiments'
p2728
g3
sS'the,non-ionized,species'
p2729
g9
sS'to,enroll,patients'
p2730
g3
sS'of,cyp3a4,nor'
p2731
g3
sS'as,those,elevations'
p2732
g3
sS'not,be,given'
p2733
g9
sS'difficult,to,situate'
p2734
g3
sS'not,been,found'
p2735
g3
sS'p,but,not'
p2736
g9
sS'antagonists,cyp1a2,inducers'
p2737
g3
sS'area,and,may'
p2738
g3
sS'the,germinal,centers'
p2739
g3
sS'if,they,do'
p2740
g3
sS'tiagabine,had,no'
p2741
g3
sS'antiretroviral,plasma,and'
p2742
g3
sS'approximately,fold,of'
p2743
g9
sS'block,morphine-induced,and'
p2744
g9
sS'the,str,was'
p2745
g3
sS'no,abortifacient,or'
p2746
g3
sS'therapy,has,not'
p2747
g3
sS'metabolism,in,the'
p2748
g9
sS'dysrhythmias,some,resulting'
p2749
g9
sS'were,deaths,in'
p2750
g3
sS'in,the,clinical'
p2751
g3
sS'wshow,no,evidence'
p2752
g3
sS'such,as,renal'
p2753
g3
sS'decreased,effectiveness,of'
p2754
g3
sS'in,a,substantial'
p2755
g9
sS'binding,decrease,in'
p2756
g9
sS'etc,is,indicated'
p2757
g9
sS'cortisol,thyroid-stimulating,hormone'
p2758
g3
sS'potential,for,ototoxicity'
p2759
g9
sS'sustained-release,calan,sr'
p2760
g9
sS'is,therefore,necessary'
p2761
g3
sS'substrate,trough,concentration'
p2762
g9
sS'during,days,of'
p2763
g3
sS'oxide,with,a'
p2764
g3
sS'functional,or,structural'
p2765
g3
sS'than,normal,daily'
p2766
g3
sS'two,strains,of'
p2767
g3
sS'elimination,or,altered'
p2768
g3
sS'on,metabolic,effects'
p2769
g3
sS'g,kg,for'
p2770
g9
sS'years,old,participated'
p2771
g3
sS'hexalen,and,plus'
p2772
g9
sS'implantable,contraceptives,an'
p2773
g9
sS'inhibitors,or,substrates'
p2774
g9
sS'p450,isoenzyme,cyp3a4'
p2775
g3
sS'cytochrome,p450,metabolism'
p2776
g3
sS'be,increased,in'
p2777
g9
sS'of,with,mhd'
p2778
g3
sS'of,the,reported'
p2779
g3
sS'when,norpace,was'
p2780
g3
sS'blocking,agents,may'
p2781
g9
sS'enhance,the,locomotor'
p2782
g3
sS'induced,hypokalemia,which'
p2783
g9
sS'structurally,related,to'
p2784
g9
sS'other,agents,having'
p2785
g3
sS'interactions,alteration,in'
p2786
g3
sS'use,of,one'
p2787
g3
sS'generally,not,been'
p2788
g3
sS'further,alterations,in'
p2789
g9
sS'products,containing,containing'
p2790
g9
sS'should,be,weighed'
p2791
g3
sS'quantitatively,related,to'
p2792
g3
sS'that,no,relevant'
p2793
g3
sS'however,no,deleterious'
p2794
g3
sS'there,is,an'
p2795
g3
sS'of,ganglionic,blocking'
p2796
g9
sS'increase,of,crixivan'
p2797
g9
sS'hypoglycemic,agents,there'
p2798
g9
sS'has,been,attributed'
p2799
g3
sS'for,dosage,modifications'
p2800
g3
sS'an,increase,or'
p2801
g3
sS'effect,of,on'
p2802
g3
sS'as,impulsivity,and'
p2803
g3
sS'subjects,who,have'
p2804
g9
sS'use,of,with'
p2805
g9
sS'an,increase,of'
p2806
g3
sS'for,either,the'
p2807
g3
sS'the,locomotor,activities'
p2808
g3
sS'only,if,the'
p2809
g9
sS'effect,of,or'
p2810
g9
sS'in,patients,whose'
p2811
g3
sS'increase,in,free'
p2812
g3
sS'of,administered,concomitantly'
p2813
g3
sS'low,therapeutic,ratio'
p2814
g3
sS'inhibitors,amprenavir,and'
p2815
g9
sS'as,a,premedication'
p2816
g3
sS'with,or,other'
p2817
g9
sS'acidifying,agents,gastrointestinal'
p2818
g9
sS'of,affected,by'
p2819
g3
sS'that,prolong,the'
p2820
g3
sS'm,g,m2'
p2821
g3
sS'with,the,assay'
p2822
g3
sS'adjustment,of,hypoglycemic'
p2823
g9
sS'reciprocal,interactions,may'
p2824
g9
sS'degree,of,variability'
p2825
g3
sS'increased,and,prolonged'
p2826
g9
sS'effect,with,this'
p2827
g3
sS'those,obtained,when'
p2828
g9
sS'within,the,limits'
p2829
g3
sS'value,is,not'
p2830
g3
sS'colostrum,iga,is'
p2831
g3
sS'a,c,and'
p2832
g9
sS'allergic,reactions,including'
p2833
g3
sS'the,psychostimulant,effects'
p2834
g3
sS'absence,of,kidney'
p2835
g3
sS'progestin-only,pills,is'
p2836
g9
sS'male,rats,that'
p2837
g3
sS'not,require,interruption'
p2838
g3
sS'of,with,each'
p2839
g3
sS'days,in,combination'
p2840
g3
sS'action,of,is'
p2841
g9
sS'action,of,it'
p2842
g9
sS'scotland,were,accompanied'
p2843
g3
sS'quinolone,antibiotics,and'
p2844
g9
sS'factors,involved,in'
p2845
g3
sS'upper,gastrointestinal,events'
p2846
g3
sS'n,mean,auc'
p2847
g9
sS'prolonged,infusion,or'
p2848
g3
sS'in,the,three'
p2849
g3
sS'of,or,toxoids'
p2850
g9
sS'reduction,of,mean'
p2851
g9
sS'antihypertensive,effects,of'
p2852
g9
sS'm,g,ml'
p2853
g9
sS'short-term,controlled,study'
p2854
g3
sS'increased,plasma,clearance'
p2855
g9
sS'valproate,available,data'
p2856
g3
sS'prothrombin,times,without'
p2857
g3
sS'is,used,concomitantly'
p2858
g9
sS'has,a,lower'
p2859
g9
sS'there,does,not'
p2860
g3
sS'im,has,been'
p2861
g3
sS'which,significantly,p'
p2862
g9
sS'cholestyramine,may,increase'
p2863
g9
sS'vitro,studies,show'
p2864
g3
sS'abrupt,suppression,of'
p2865
g9
sS'triple-immunosuppression,regimens,including'
p2866
g3
sS'response,rates,in'
p2867
g3
sS'and,laboratory,monitoring'
p2868
g3
sS'and,angiotensin,converting'
p2869
g3
sS'clinical,trial,there'
p2870
g3
sS'channels,in,bovine'
p2871
g3
sS'a4,enzyme,system'
p2872
g3
sS'recommended,that,the'
p2873
g9
sS'been,characterized,to'
p2874
g3
sS'inhibitors,elevated,blood'
p2875
g3
sS'iv,is,augmented'
p2876
g9
sS'of,allergic,reaction'
p2877
g9
sS'slight,increases,in'
p2878
g9
sS'diethylnitrosamine,during,the'
p2879
g3
sS'hormones,were,investigated'
p2880
g3
sS'or,a,dose'
p2881
g3
sS'medication,and,instruct'
p2882
g3
sS'did,produce,inhibition'
p2883
g3
sS'was,shown,in'
p2884
g3
sS'theophylline-related,side,effects'
p2885
g9
sS'topamax,felbatol,gris-peg'
p2886
g9
sS'the,group,the'
p2887
g3
sS'limited,inhibitory,activity'
p2888
g9
sS'anesthetized,swine,has'
p2889
g3
sS'and,histamine-induced,gastric'
p2890
g3
sS'however,a,crossover'
p2891
g9
sS'levels,achieved,in'
p2892
g3
sS'cells,and,in'
p2893
g3
sS'evident,on,excystment'
p2894
g3
sS'if,other,alternatives'
p2895
g3
sS'take,into,account'
p2896
g3
sS'of,interaction,studies'
p2897
g3
sS'administration,of,itraconazole'
p2898
g9
sS'are,at,greater'
p2899
g3
sS'with,or,carbidopa-levodopa'
p2900
g3
sS'over,weeks,as'
p2901
g3
sS'inhibit,and,stimulate'
p2902
g9
sS'peripheral,blood,cell'
p2903
g3
sS'p,app,control'
p2904
g3
sS'or,and,hydroxides'
p2905
g9
sS'in,pharmacokinetics,were'
p2906
g3
sS'was,not,substantially'
p2907
g9
sS'administered,with,caution'
p2908
g9
sS'and,auc,increased'
p2909
g9
sS'inducers,or,inhibitors'
p2910
g3
sS'between,the,excreted'
p2911
g3
sS'in,inr,and'
p2912
g9
sS'agents,although,ipratropium'
p2913
g9
sS'therefore,patients,receiving'
p2914
g9
sS'and,you,may'
p2915
g9
sS'in,hypercholesterolemic,noninsulin'
p2916
g3
sS'fronti,res,is'
p2917
g3
sS'might,also,modify'
p2918
g3
sS'given,did,not'
p2919
g3
sS'reporter,gene,under'
p2920
g3
sS'hyperpolarization,and,membrane'
p2921
g3
sS'nutraceutical,st,johns'
p2922
g3
sS'adversely,influence,the'
p2923
g9
sS'day,and,every'
p2924
g3
sS'cimetldine,cerivastatin,plasma'
p2925
g3
sS'cancer,cells,including'
p2926
g3
sS'to,mg,week'
p2927
g9
sS'of,nmda-ergic,activation'
p2928
g3
sS'were,to,years'
p2929
g3
sS'in,clinical,practice'
p2930
g9
sS'potent,inducer,of'
p2931
g9
sS'constituent,precipitated,by'
p2932
g3
sS'that,when,compared'
p2933
g9
sS'a,dopa,decarboxylase'
p2934
g3
sS'fosinopril,may,cause'
p2935
g3
sS'and,decrease,metabolism'
p2936
g9
sS'metabotropic,glutamate,mglur'
p2937
g3
sS'serum,and,urine'
p2938
g9
sS'of,isosorbide,mononitrate'
p2939
g9
sS'in,a,false-positive'
p2940
g3
sS'death,associated,with'
p2941
g9
sS'hepatic,extraction,has'
p2942
g3
sS'using,induced,skin'
p2943
g3
sS'for,the,same'
p2944
g3
sS'compliance,especially,neglect'
p2945
g3
sS'prospective,study,involving'
p2946
g3
sS'to,admission,the'
p2947
g3
sS'data,appeared,well'
p2948
g3
sS'tagamet,mg,q'
p2949
g9
sS'picr,detected,in'
p2950
g3
sS'tnf,antagonists,is'
p2951
g9
sS'management,and,discusses'
p2952
g3
sS'have,been,receiving'
p2953
g3
sS'steady,state,conditions'
p2954
g3
sS'half-life,and,enhanced'
p2955
g3
sS'test,but,was'
p2956
g3
sS'clinically,significant,increases'
p2957
g9
sS'cassette,fully,restored'
p2958
g3
sS'of,the,hydroxylation'
p2959
g3
sS'desmopressin,is,very'
p2960
g3
sS'with,alone,and'
p2961
g9
sS'agents,has,not'
p2962
g3
sS'and,stimulate,egf-'
p2963
g9
sS'in,elevated,creatinine'
p2964
g3
sS'deterioration,of,asthma'
p2965
g3
sS'were,increased,decreased'
p2966
g9
sS'gleevec,with,inhibitors'
p2967
g9
sS'comparative,study,week'
p2968
g3
sS'be,advised,against'
p2969
g9
sS'an,hydroxide,containing'
p2970
g9
sS'food,interactions,the'
p2971
g3
sS'due,to,changes'
p2972
g3
sS'infusion,of,amicar'
p2973
g3
sS'survanta,increased,the'
p2974
g3
sS'other,as,used'
p2975
g9
sS'inserts,of,medication'
p2976
g3
sS'endotoxin-treated,rats,did'
p2977
g3
sS'the,conclusion,that'
p2978
g9
sS'decreases,urinary,excretion'
p2979
g9
sS'may,be,unresponsive'
p2980
g3
sS'be,anticipated,and'
p2981
g9
sS'treatment,of,angina'
p2982
g3
sS'at,h,also'
p2983
g3
sS'even,though,has'
p2984
g3
sS'with,or,minutes'
p2985
g9
sS'period,in,which'
p2986
g9
sS'containing,may,substantially'
p2987
g9
sS'due,to,adverse'
p2988
g3
sS'undergoes,extensive,metabolism'
p2989
g3
sS'non-steroidal,agent,can'
p2990
g9
sS'patients,receiving,may'
p2991
g9
sS'cytochromes,p450,a2'
p2992
g3
sS'of,recovery,and'
p2993
g3
sS'showed,the,most'
p2994
g3
sS'cyp1a2,cyp2c9,cyp2d6'
p2995
g3
sS'used,concurrently,with'
p2996
g3
sS'can,decrease,the'
p2997
g3
sS'to,the,differences'
p2998
g3
sS'a,synergistic,effect'
p2999
g3
sS'after,day,of'
p3000
g3
sS'by,this,isozyme'
p3001
g9
sS'cyp3a4,inhibitors,dasatinib'
p3002
g3
sS'in,mcf-7,cells'
p3003
g3
sS'excretion,is,via'
p3004
g3
sS'thereby,cause,arrhythmias'
p3005
g3
sS'a,substantial,period'
p3006
g3
sS'auc,but,no'
p3007
g9
sS'tarsal,flexure,of'
p3008
g3
sS'consequences,of,concomitant'
p3009
g3
sS'ptx,c129h223n3o54,isolated'
p3010
g3
sS'found,to,be'
p3011
g3
sS'to,serum,protein'
p3012
g9
sS'an,elevation,in'
p3013
g3
sS'with,the,extent'
p3014
g3
sS'c,max,were'
p3015
g3
sS'more,specific,applications'
p3016
g3
sS'of,this,drug'
p3017
g3
sS'when,taken,concurrently'
p3018
g3
sS'action,of,oleate'
p3019
g3
sS'nucleolin,c23,in'
p3020
g3
sS'day,im,twice'
p3021
g3
sS'humans,demonstrated,that'
p3022
g3
sS'drug,treatment,of'
p3023
g3
sS'of,oral,increased'
p3024
g9
sS'particularly,if,their'
p3025
g9
sS'leukopenia,especially,in'
p3026
g3
sS'with,caution,to'
p3027
g9
sS'reported,during,the'
p3028
g9
sS'you,take,a'
p3029
g3
sS'or,pharmacodynamic,profile'
p3030
g3
sS'in,pharmacological,effect'
p3031
g9
sS'no,specific,pharmacokinetic'
p3032
g3
sS'sequestered,in,fat'
p3033
g3
sS'serum,half-life,or'
p3034
g9
sS'important,drug,interactions'
p3035
g9
sS'tumors,of,more'
p3036
g3
sS'producing,medications,concurrent'
p3037
g3
sS'patients,receiving,camptosar'
p3038
g9
sS'carefully,if,high'
p3039
g9
sS'ethyl,is,known'
p3040
g3
sS'nsaids,on,gi'
p3041
g9
sS'initial,treatment,of'
p3042
g3
sS'potentiated,the,cns-impairing'
p3043
g9
sS'eg,and,or'
p3044
g9
sS'hour,before,the'
p3045
g9
sS'function,eg,and'
p3046
g9
sS'absorption,of,agents'
p3047
g9
sS'in,a,complex'
p3048
g3
sS'lead,to,loss'
p3049
g3
sS'identification,of,limit'
p3050
g3
sS'for,establishing,interactions'
p3051
g3
sS'that,would,warrant'
p3052
g3
sS'releaser,and,reuptake'
p3053
g9
sS'before,starting,a'
p3054
g9
sS'importantly,we,demonstrate'
p3055
g3
sS'dextromethorphan,is,primarily'
p3056
g3
sS'diminish,fluoride,or'
p3057
g3
sS'interaction,between,single'
p3058
g9
sS'either,these,medications'
p3059
g9
sS'gentamicin,is,an'
p3060
g3
sS'acute,angina,attacks'
p3061
g3
sS'decreased,by,while'
p3062
g9
sS'there,were,deaths'
p3063
g3
sS'of,proleukin,and'
p3064
g9
sS'pharmacological,treatment,produced'
p3065
g3
sS'anti-inflammatory,but,not'
p3066
g3
sS'daily,the,auc'
p3067
g9
sS'had,a,dramatic'
p3068
g3
sS'sudden,death,potentially'
p3069
g9
sS'nucleus,accumbens,nac'
p3070
g3
sS'atherosclerotic,cardiovascular,disease'
p3071
g3
sS'from,the,seminiferous'
p3072
g3
sS'urinary,acidifying,agents'
p3073
g9
sS'inducers,of,hepatic'
p3074
g3
sS'and,human,growth'
p3075
g9
sS'it,is,especially'
p3076
g9
sS'other,oral,hypoglycemic'
p3077
g9
sS'subjects,decreases,in'
p3078
g3
sS'toradol,iv,im'
p3079
g9
sS'dose,of,liquid'
p3080
g3
sS'tml,or,mg'
p3081
g3
sS'toxicity,resulting,from'
p3082
g3
sS'interactions,with,emtriva'
p3083
g3
sS'concentrations,of,serum'
p3084
g9
sS'neurons,fired,spontaneous'
p3085
g3
sS'but,would,be'
p3086
g3
sS'solutions,containing,or'
p3087
g9
sS'the,maintenance,of'
p3088
g3
sS'sporanox,lipitor,atromid-s'
p3089
g9
sS'administration,of,sonata'
p3090
g9
sS'extremely,cautiously,and'
p3091
g9
sS'the,anorectic,and'
p3092
g9
sS'cyp2c9,and,c19'
p3093
g3
sS'intake,and,pharmacological'
p3094
g3
sS'these,levels,then'
p3095
g3
sS'as,a,guide'
p3096
g9
sS'and,proposed,as'
p3097
g3
sS'when,other,potent'
p3098
g9
sS'sildenafil,has,demonstrated'
p3099
g3
sS'no,inhibition,of'
p3100
g3
sS'the,chop-haart,group'
p3101
g3
sS'solution,of,was'
p3102
g3
sS'potentiate,the,increase'
p3103
g3
sS'doses,of,with'
p3104
g9
sS'like,cannot,be'
p3105
g3
sS'serum,exposure,compared'
p3106
g9
sS'medicine,due,to'
p3107
g3
sS'camp-stimulated,acid,secretion'
p3108
g9
sS'not,confirm,the'
p3109
g3
sS'of,cyp3a4,or'
p3110
g3
sS'could,increase,or'
p3111
g3
sS'the,retention,of'
p3112
g9
sS'in,the,current'
p3113
g3
sS'dosage,of,theo-dur'
p3114
g9
sS'inflammatory,arthritis,thyroiditis'
p3115
g9
sS'that,buspirone,hydrochloride'
p3116
g9
sS'of,rhabdomyolysis,have'
p3117
g3
sS'type,diabetes,mellitus'
p3118
g3
sS'preservative,in,the'
p3119
g9
sS'enhance,the,adrenergic'
p3120
g9
sS'warranted,and,therapeutic'
p3121
g9
sS'than,mm,fractional'
p3122
g3
sS'mg,kg,week'
p3123
g3
sS'of,rats,as'
p3124
g3
sS'cases,of,combined'
p3125
g3
sS'in,mean,peak'
p3126
g9
sS'the,end,of'
p3127
g3
sS'or,repeated,doses'
p3128
g3
sS'no,specific,clinical'
p3129
g3
sS'pressure,or,metabolic'
p3130
g3
sS'used,concurrently,patient'
p3131
g3
sS'in,serum,i'
p3132
g3
sS'adjust,dosage,of'
p3133
g3
sS'function,and,or'
p3134
g3
sS'decrease,mean,trough'
p3135
g3
sS'alter,the,pharmacokinetic'
p3136
g3
sS'with,other,calcium-containing'
p3137
g3
sS'of,were,observed'
p3138
g3
sS'a,maximum,relaxation'
p3139
g3
sS'prolongation,cardiac,arrest'
p3140
g3
sS'trials,however,beta'
p3141
g3
sS'compatibility,data,are'
p3142
g3
sS'plasma,protein,carbamazepine'
p3143
g3
sS'predictable,and,manageable'
p3144
g3
sS'toxic,when,given'
p3145
g3
sS'is,considered,to'
p3146
g3
sS'would,be,useful'
p3147
g3
sS'with,may,be'
p3148
g3
sS'might,help,to'
p3149
g3
sS'to,in,rat'
p3150
g3
sS'vitro,interaction,studies'
p3151
g3
sS'both,angiotensins,inhibited'
p3152
g3
sS'efficacy,of,its'
p3153
g3
sS'cyclosporine,because,can'
p3154
g9
sS'after,completion,of'
p3155
g9
sS'cardiovascular,directly,affect'
p3156
g3
sS'bmax,of,d2'
p3157
g3
sS'variety,of,hepatic'
p3158
g3
sS'center,inventory,the'
p3159
g3
sS'metabolic,activation,factor'
p3160
g3
sS'the,above,listed'
p3161
g3
sS'assessed,by,ex'
p3162
g3
sS'effects,of,oral'
p3163
g9
sS'to,initiation,of'
p3164
g3
sS'nevertheless,caution,is'
p3165
g9
sS'this,procedure,it'
p3166
g3
sS'interventions,each,subject'
p3167
g3
sS'since,has,a'
p3168
g3
sS'synergism,between,xanthine'
p3169
g9
sS'directly,affect,the'
p3170
g3
sS'for,weeks,has'
p3171
g9
sS'concomitantly,administered,intravenously'
p3172
g9
sS'conditions,concentrations,were'
p3173
g3
sS'depressants,may,have'
p3174
g3
sS'and,other,products'
p3175
g3
sS'other,nonsteroidal,has'
p3176
g9
sS'ingestion,of,grapefruit'
p3177
g3
sS'done,with,extreme'
p3178
g3
sS'administered,with,nitrous'
p3179
g9
sS'but,also,have'
p3180
g3
sS'demonstrated,a,rapid'
p3181
g3
sS'shown,that,tikosyn'
p3182
g3
sS'west,midlands,a'
p3183
g3
sS'patients,want,to'
p3184
g3
sS'and,older,who'
p3185
g3
sS'of,contrast,reactions'
p3186
g3
sS'known,to,effect'
p3187
g3
sS'considered,when,treatment'
p3188
g3
sS'than,the,usual'
p3189
g3
sS'in,a,and'
p3190
g9
sS'day,before,meals'
p3191
g3
sS'concentration,dependent,labelling'
p3192
g3
sS'for,p-glycoprotein,and'
p3193
g3
sS'mothers,it,is'
p3194
g3
sS'potassium-sparing,diuretics,fosinopril'
p3195
g9
sS'forms,of,deficit'
p3196
g3
sS'inducers,of,these'
p3197
g3
sS'on,the,electrocardiographic'
p3198
g3
sS'are,not,potent'
p3199
g3
sS'any,significant,changes'
p3200
g3
sS'severe,hypoglycemia,has'
p3201
g9
sS'enzyme,system,probably'
p3202
g3
sS'renal,transplant,recipients'
p3203
g3
sS'however,because,nafarelin'
p3204
g3
sS'effects,when,administered'
p3205
g9
sS'tyrosine,phosphorylation,status'
p3206
g3
sS'of,foscavir,should'
p3207
g9
sS'structural,alterations,underlying'
p3208
g3
sS'radioligand,binding,experiments'
p3209
g3
sS'intervals,between,doses'
p3210
g9
sS'of,tumors,by'
p3211
g3
sS'large,increases,inrifabutin'
p3212
g3
sS'of,patients,on'
p3213
g9
sS'gender,race,intercurrent'
p3214
g3
sS'data,beyond,days'
p3215
g3
sS'recommendations,for,sustiva'
p3216
g3
sS'depressant,should,be'
p3217
g9
sS'important,relationships,among'
p3218
g3
sS'and,lower,in'
p3219
g9
sS'compared,to,results'
p3220
g9
sS'sulfate,and,hc1'
p3221
g9
sS'lower,plasma,levels'
p3222
g9
sS'observed,with,co-administration'
p3223
g3
sS'or,without,bleeding'
p3224
g9
sS'except,at,concentrations'
p3225
g3
sS'patients,with,baseline'
p3226
g3
sS'monitored,regularly,during'
p3227
g3
sS'lower,intestine,so'
p3228
g9
sS'of,status,which'
p3229
g3
sS'mm,and,mm'
p3230
g3
sS'phenytoin,and,may'
p3231
g9
sS'accompanied,by,profound'
p3232
g3
sS'inhibitors,agenerase,crixivan'
p3233
g9
sS'durations,of,sleep'
p3234
g3
sS'possible,drug,interaction'
p3235
g9
sS'carcinogenicity,or,fertility'
p3236
g3
sS'needed,careful,consideration'
p3237
g3
sS'of,dosage,of'
p3238
g3
sS'antagonists,and,loop'
p3239
g3
sS'metabolized,by,one'
p3240
g3
sS'received,mg,twice'
p3241
g3
sS'synthesis,interfere,with'
p3242
g3
sS'peak,and,the'
p3243
g3
sS'the,blood,coagulation'
p3244
g3
sS'hypotension,which,may'
p3245
g9
sS'retention,of,was'
p3246
g9
sS'copd,symptoms,and'
p3247
g3
sS'with,other,carbonic'
p3248
g3
sS'by,a,dose-dependent'
p3249
g9
sS'is,co-administered,particularly'
p3250
g9
sS'appears,that,may'
p3251
g9
sS'bedtime,and,given'
p3252
g3
sS'have,an,effect'
p3253
g3
sS'other,binding,proteins'
p3254
g3
sS'as,the,cyp'
p3255
g3
sS'these,enzymes,are'
p3256
g3
sS'with,orally,administered'
p3257
g9
sS'these,peptides,in'
p3258
g3
sS'by,a,cascade'
p3259
g3
sS'deficit,and,to'
p3260
g3
sS'justifies,the,potential'
p3261
g3
sS'of,in,conjunction'
p3262
g3
sS'known,to,sensitize'
p3263
g3
sS'naflu,and,model'
p3264
g3
sS'effect,of,sular'
p3265
g9
sS'bleeding,a,complication'
p3266
g3
sS'antidepressant,agent,may'
p3267
g3
sS'dosages,or,concomitantly'
p3268
g9
sS'indomethacin,indomethacin,blunts'
p3269
g9
sS'label,should,be'
p3270
g9
sS'days,showed,a'
p3271
g3
sS'laboratory,test,interaction'
p3272
g3
sS'before,carrying,out'
p3273
g3
sS'administered,did,not'
p3274
g3
sS'not,interact,significantly'
p3275
g3
sS'and,possible,pharmacokinetic'
p3276
g9
sS'in,reduced,protein'
p3277
g9
sS'auc,and,half-life'
p3278
g3
sS'and,lower,auc'
p3279
g3
sS'since,a,clinically'
p3280
g3
sS'induces,apoptosis,in'
p3281
g3
sS'studies,with,hcl'
p3282
g3
sS'of,the,inhibition'
p3283
g9
sS'a,maintenance,dose'
p3284
g9
sS'vasoconstrictive,action,of'
p3285
g9
sS'camptosar,with,irradiation'
p3286
g3
sS'reports,we,have'
p3287
g3
sS'trials,showed,that'
p3288
g3
sS'and,testicular,leydig'
p3289
g3
sS'its,metabolites,is'
p3290
g3
sS'decrease,of,ci'
p3291
g3
sS'subjects,by,approximately'
p3292
g9
sS'use,of,preparations'
p3293
g9
sS'amevive,on,pregnancy'
p3294
g3
sS'and,that,the'
p3295
g9
sS'respiratory,and,or'
p3296
g3
sS'co-administered,avonex,indicates'
p3297
g3
sS'with,that,have'
p3298
g9
sS'i,increase,due'
p3299
g9
sS'lung,has,the'
p3300
g3
sS'in,death,have'
p3301
g9
sS'nephrotoxic,agents,should'
p3302
g9
sS'clinical,trials,flolan'
p3303
g9
sS'likelihood,of,substantial'
p3304
g9
sS'is,summarized,in'
p3305
g3
sS'studies,hydrochloride,mg'
p3306
g3
sS'of,flolan,in'
p3307
g3
sS'events,is,unknown'
p3308
g3
sS'side,chain,is'
p3309
g3
sS'increasing,the,bound'
p3310
g3
sS'due,to,limited'
p3311
g3
sS'of,when,co-administered'
p3312
g3
sS'mechanisms,underlying,the'
p3313
g3
sS'respectively,when,administered'
p3314
g9
sS'therapeutic,levels,of'
p3315
g3
sS'catecholamines,after,withdrawal'
p3316
g3
sS'doses,is,a'
p3317
g9
sS'a,major,contributing'
p3318
g9
sS'daily,was,similar'
p3319
g3
sS'the,control,at'
p3320
g3
sS'and,of,ergot-type'
p3321
g3
sS'iatrogenic,alteration,caused'
p3322
g3
sS'dramatic,effect,on'
p3323
g3
sS'of,hexanal-induced,sleep'
p3324
g3
sS'effects,when,and'
p3325
g9
sS'appropriate,laboratory,testing'
p3326
g9
sS'a4,and,c9'
p3327
g3
sS'used,during,therapy'
p3328
g3
sS'specific,patient,populations'
p3329
g3
sS'phenytoin,dilantin,use'
p3330
g9
sS'altered,when,and'
p3331
g3
sS'when,used,concomitantly'
p3332
g9
sS'be,markedly,reduced'
p3333
g9
sS'with,reduce,both'
p3334
g9
sS'in,men,with'
p3335
g3
sS'methods,toxi-lab,a'
p3336
g3
sS'or,during,the'
p3337
g3
sS'taking,bextra,concomitantly'
p3338
g9
sS'is,a,known'
p3339
g3
sS'aluminum-containing,preparations,has'
p3340
g3
sS'groups,but,colony'
p3341
g3
sS'when,and,certain'
p3342
g9
sS'excystment,rates,over'
p3343
g3
sS'renal,failure,in'
p3344
g9
sS'zarontin,may,interact'
p3345
g9
sS'therapy,and,frequently'
p3346
g9
sS'at,bedtime,has'
p3347
g3
sS'for,extravasation,reactions'
p3348
g3
sS'when,ponstel,is'
p3349
g3
sS'should,be,coad-ministered'
p3350
g3
sS'observed,during,administration'
p3351
g3
sS'however,no,specific'
p3352
g3
sS'of,type,diabetics'
p3353
g3
sS'susceptible,to,inhibitory'
p3354
g3
sS'interactions,when,co-administered'
p3355
g9
sS'men,years,of'
p3356
g3
sS'has,proven,efficacy'
p3357
g3
sS'liver,cytochrome,p450'
p3358
g3
sS'and,or,nephrotoxic'
p3359
g3
sS'or,would,be'
p3360
g3
sS'and,day,of'
p3361
g9
sS'is,about,of'
p3362
g3
sS'suprax,may,result'
p3363
g3
sS'arrhythmias,during,can'
p3364
g9
sS'is,recommended,when'
p3365
g9
sS'of,per,day'
p3366
g3
sS'cytochrome,p-450,a4'
p3367
g3
sS'data,available,from'
p3368
g3
sS'or,vitamin,e'
p3369
g9
sS'cardiovascular,disease,in'
p3370
g3
sS'porter-silber,test,do'
p3371
g3
sS'effects,concerning,have'
p3372
g9
sS'with,any,routine'
p3373
g3
sS'the,geometric,mean'
p3374
g9
sS'erythromycin,and,ketoconazole'
p3375
g3
sS'laboratory,studies,to'
p3376
g3
sS'possible,increase,in'
p3377
g9
sS'between,argatroban,and'
p3378
g3
sS'by,infusion,in'
p3379
g3
sS'of,abnormal,handling'
p3380
g3
sS'auc,of,less'
p3381
g9
sS'systems,most,of'
p3382
g3
sS'neurological,complications,and'
p3383
g3
sS'enzymes,evaluated,cyp1a2'
p3384
g3
sS'of,and,therapy'
p3385
g3
sS'given,at,doses'
p3386
g9
sS'mhd,to,plasma'
p3387
g3
sS'between,and,antidiuretic'
p3388
g3
sS'corticosteroids,a,relationship'
p3389
g9
sS'warfarin,concomitant,administration'
p3390
g3
sS'prostigmin,may,have'
p3391
g3
sS'thrombocytopenia,the,potential'
p3392
g3
sS'inhibitors,ssris,have'
p3393
g9
sS'other,especially,or'
p3394
g3
sS'antagonize,the,effects'
p3395
g9
sS'the,body,it'
p3396
g3
sS'which,have,a'
p3397
g9
sS'activities,such,as'
p3398
g3
sS'this,may,potentiate'
p3399
g3
sS'usually,mild,and'
p3400
g3
sS'v,cmc-cys7,a'
p3401
g3
sS'hours,after,and'
p3402
g9
sS'nevirapine,is,known'
p3403
g3
sS'observations,suggest,that'
p3404
g3
sS'the,same,enzyme'
p3405
g3
sS'sprycel,should,not'
p3406
g3
sS'regimens,containing,sequential'
p3407
g9
sS'kg,such,an'
p3408
g3
sS'or,female,have'
p3409
g3
sS'to,have,neuromuscular'
p3410
g9
sS'endogenous,marker,of'
p3411
g9
sS'atrioventricular,conduction,disturbances'
p3412
g9
sS'in,studies,of'
p3413
g3
sS'sodium,plasma,concentrations'
p3414
g9
sS'phenyltheophylline,and,cyclopentyl-1'
p3415
g3
sS'between,novoseven,and'
p3416
g3
sS'will,increase,plasmaconcentration'
p3417
g9
sS'with,can,lead'
p3418
g3
sS'avoid,intoxication,plasma'
p3419
g3
sS'nonetheless,the,range'
p3420
g3
sS'observed,effects,on'
p3421
g3
sS'differences,between,cecectomized'
p3422
g3
sS'same,study,alone'
p3423
g3
sS'depletor,should,therefore'
p3424
g3
sS'therefore,a,potent'
p3425
g3
sS'an,interaction,with'
p3426
g3
sS'when,the,medication'
p3427
g3
sS'investigate,the,possibility'
p3428
g3
sS'days,while,plasma'
p3429
g9
sS'trial,showed,comparable'
p3430
g3
sS'metabolized,by,cyp3a4'
p3431
g3
sS'of,and,increases'
p3432
g9
sS'neonates,and,infants'
p3433
g3
sS'general,the,anesthesiologist'
p3434
g3
sS'with,hormonal,and'
p3435
g3
sS'other,medical,considerations'
p3436
g3
sS'kg,week,about'
p3437
g3
sS'on,other,drugs'
p3438
g3
sS'and,were,each'
p3439
g3
sS'approximately,in,the'
p3440
g9
sS'and,the,mean'
p3441
g9
sS'pulmozyme,can,be'
p3442
g3
sS'infection,is,dealt'
p3443
g3
sS'the,fed,state'
p3444
g9
sS'toxicity,was,usually'
p3445
g9
sS'not,show,any'
p3446
g3
sS'in,the,rabbit'
p3447
g3
sS'chylomicron,metabolism,was'
p3448
g3
sS'nucleophosmin,b23,is'
p3449
g3
sS'the,cold,binding'
p3450
g3
sS'regimen,includes,both'
p3451
g9
sS'considered,and,dosage'
p3452
g3
sS'together,during,the'
p3453
g9
sS'many,drugs,are'
p3454
g3
sS'monitored,carefully,if'
p3455
g9
sS'pharmacogenetics,pharmacogenetics,deals'
p3456
g3
sS'pcp,or,either'
p3457
g9
sS'warfarin,anticoagulant,activity'
p3458
g9
sS'adverse,effects,resulting'
p3459
g9
sS'certain,compounds,such'
p3460
g9
sS'activities,of,the'
p3461
g3
sS'in,human,plasma'
p3462
g3
sS'and,other,are'
p3463
g3
sS'cortex,and,subcortical'
p3464
g3
sS'indicating,that,several'
p3465
g3
sS'to,an,increase'
p3466
g9
sS'of,colony,forming'
p3467
g3
sS'vitamin,d,but'
p3468
g9
sS'medicinal,products,with'
p3469
g9
sS'was,determined,after'
p3470
g3
sS'or,ibuprofen,and'
p3471
g9
sS'significantly,alter,the'
p3472
g9
sS'a,higher,absolute'
p3473
g3
sS'alteration,of,the'
p3474
g3
sS'complex,of,treatment'
p3475
g3
sS'results,from,clinical'
p3476
g3
sS'filtration,may,prolong'
p3477
g3
sS'half-life,of,in'
p3478
g9
sS'aerosolized,has,not'
p3479
g3
sS'results,with,wshow'
p3480
g3
sS'ml,approximately,times'
p3481
g3
sS'reduced,in,myocardium'
p3482
g3
sS'like,other,nonsteroidal'
p3483
g9
sS'competitive,suppression,of'
p3484
g3
sS'hormone,or,nor'
p3485
g3
sS'following,chronic,administration'
p3486
g3
sS'difference,in,pharmacodynamic'
p3487
g3
sS'weight,and,have'
p3488
g3
sS'exacerbated,in,patients'
p3489
g3
sS'which,d,h'
p3490
g9
sS'may,potentiate,the'
p3491
g9
sS'pharmacokinetics,produced,by'
p3492
g9
sS'pt,and,inr'
p3493
g3
sS'during,administration,of'
p3494
g9
sS'did,not,lead'
p3495
g3
sS'use,of,nalfon'
p3496
g9
sS'pointes,have,occurred'
p3497
g3
sS'though,less,marked'
p3498
g3
sS'inhibit,these,isoenzymes'
p3499
g3
sS'x,m,inhibits'
p3500
g9
sS'side,effect,of'
p3501
g3
sS'prolong,the,one-stage'
p3502
g3
sS'is,adjusted,upward'
p3503
g9
sS'effect,when,used'
p3504
g3
sS'edemas,that,mg'
p3505
g9
sS'sleep,drowsiness-causing,any'
p3506
g3
sS'be,expected,to'
p3507
g3
sS'and,carbonate,or'
p3508
g9
sS'clinically,or,statistically'
p3509
g3
sS'dogs,with,gastric'
p3510
g3
sS'and,the,above'
p3511
g3
sS'p-450,enzymes,and'
p3512
g3
sS'year,monthly,comparison'
p3513
g3
sS'such,drugs,are'
p3514
g3
sS'fluothane,augments,the'
p3515
g9
sS'therapy,any,form'
p3516
g3
sS'after,to,days'
p3517
g3
sS'mg,in,a'
p3518
g9
sS'of,hexalen,and'
p3519
g9
sS'of,dcg-iv,were'
p3520
g9
sS'monitored,closely,when'
p3521
g9
sS'addition,to,the'
p3522
g3
sS'at,a,later'
p3523
g3
sS'sodium,sulfate,prednisolone'
p3524
g3
sS'an,enhancement,effect'
p3525
g9
sS'in,ethinyl,estradiol'
p3526
g9
sS'transferase,level,was'
p3527
g3
sS'absorption,site,fecal'
p3528
g3
sS'displays,both,and'
p3529
g3
sS'because,higher,doses'
p3530
g3
sS'oral,form,a'
p3531
g9
sS'in,the,post-marketing'
p3532
g9
sS'urine,which,may'
p3533
g3
sS'patient,specific,and'
p3534
g3
sS'substrates,that,have'
p3535
g9
sS'in,prothrombin,time'
p3536
g3
sS'interaction,between,both'
p3537
g3
sS'by,using,four'
p3538
g3
sS'of,the,antihypertensive'
p3539
g9
sS'using,the,commercially'
p3540
g3
sS'of,vardenafil,and'
p3541
g9
sS'expression,was,evaluated'
p3542
g3
sS'antithrombin,iii,human'
p3543
g9
sS'were,administered,in'
p3544
g3
sS'with,or,within'
p3545
g9
sS'different,way,crossover'
p3546
g3
sS'coumarin,anticoagulants,in'
p3547
g3
sS'in,a,linear'
p3548
g3
sS'inhibitors,that,have'
p3549
g9
sS'the,same,age'
p3550
g3
sS'account,for,proper'
p3551
g3
sS'be,decreased,increased'
p3552
g9
sS'role,for,and'
p3553
g3
sS'that,it,is'
p3554
g9
sS'being,reached,after'
p3555
g3
sS'alterations,in,pharmacokinetics'
p3556
g9
sS'these,alterations,in'
p3557
g9
sS'at,higher,than'
p3558
g9
sS'a,strong,drying'
p3559
g3
sS'require,close,monitoring'
p3560
g9
sS'isoenzymes,carbamazepine,is'
p3561
g3
sS'interactions,between,revia'
p3562
g3
sS'p,this,was'
p3563
g9
sS'increase,the,ototoxic'
p3564
g9
sS'of,endoscopic,gastroduodenal'
p3565
g3
sS'compromised,uptake-1,in'
p3566
g3
sS'of,a,role'
p3567
g3
sS'suggested,that,these'
p3568
g3
sS'patients,with,hiv-nhl'
p3569
g3
sS'decreased,from,ng'
p3570
g3
sS'assessed,in,clinical'
p3571
g3
sS'given,in,conjunction'
p3572
g9
sS'if,such,measurements'
p3573
g3
sS'occurrence,of,peripheral'
p3574
g3
sS'colchicine,may,increase'
p3575
g9
sS'that,require,careful'
p3576
g3
sS'developed,severe,autonomic'
p3577
g3
sS'time,for,recovery'
p3578
g3
sS'the,advantages,and'
p3579
g3
sS'given,once,daily'
p3580
g9
sS'induce,an,inflammatory'
p3581
g3
sS'without,the,addition'
p3582
g3
sS'hot,weather,prolonged'
p3583
g9
sS'adjusted,in,those'
p3584
g9
sS'between,intravenous,and'
p3585
g3
sS'the,case-control,and'
p3586
g9
sS'are,to,be'
p3587
g9
sS'due,to,high'
p3588
g3
sS'are,adequate,methods'
p3589
g3
sS'by,elevated,cerebral'
p3590
g9
sS'coagulation,parameters,and'
p3591
g9
sS'with,see,clinical'
p3592
g9
sS'cytochrome,p-450,for'
p3593
g9
sS'absorption,of,various'
p3594
g9
sS'cyp450,isoenzymes,cyp1a2'
p3595
g3
sS'of,previously,administered'
p3596
g3
sS'a,is,added'
p3597
g9
sS'tikosyn,had,a'
p3598
g3
sS'times,without,clinically'
p3599
g3
sS'selected,a,subclone'
p3600
g3
sS'hmg-coa,reductase,inhibitors'
p3601
g9
sS'are,performed,if'
p3602
g3
sS'prothrombin,times,can'
p3603
g3
sS'human,red,blood'
p3604
g3
sS'a,parallel,group'
p3605
g3
sS'indinavir,mg,t'
p3606
g9
sS'both,agents,zyvox'
p3607
g9
sS'in,a,hour'
p3608
g9
sS'or,hot,drinks'
p3609
g3
sS'a,precipitating,factor'
p3610
g3
sS'voltage-dependent,ca,channels'
p3611
g3
sS'decrease,in,plasma'
p3612
g9
sS'pegasys,is,to'
p3613
g3
sS'rabbit,gastric,glands'
p3614
g3
sS'in,significant,reductions'
p3615
g9
sS'compared,to,patients'
p3616
g9
sS'slow,the,metabolism'
p3617
g9
sS'metabolized,mainly,via'
p3618
g3
sS'no,causal,relationship'
p3619
g3
sS'cases,presented,with'
p3620
g3
sS'mg,bid,a'
p3621
g9
sS'in,urine,allow'
p3622
g3
sS'other,potentially,irritating'
p3623
g3
sS'conference,reviews,recent'
p3624
g3
sS'acute,symptoms,should'
p3625
g3
sS'in,two,multiple-dose'
p3626
g3
sS'basic,area,of'
p3627
g3
sS'corticosteroids,acth,intensified'
p3628
g3
sS'of,hypoglycemic,medications'
p3629
g9
sS'though,individual,levels'
p3630
g3
sS'thus,concentrations,which'
p3631
g3
sS'similarly,the,acute'
p3632
g3
sS'necessary,to,be'
p3633
g3
sS'but,the,difference'
p3634
g3
sS'demonstrated,a,significant'
p3635
g9
sS'a,tca,is'
p3636
g3
sS'in,the,rate'
p3637
g3
sS'were,identified,as'
p3638
g3
sS'on,the,palytoxin-induced'
p3639
g3
sS'weak,inhibitory,effects'
p3640
g3
sS'crixivan,to,mg'
p3641
g9
sS'clinical,studies,to'
p3642
g3
sS'or,had,a'
p3643
g9
sS'and,which,may'
p3644
g3
sS'tam,enhances,the'
p3645
g9
sS'studies,in,rats'
p3646
g9
sS'seeds,of,artocarpus'
p3647
g3
sS'introduction,of,oral'
p3648
g9
sS'problems,will,depend'
p3649
g9
sS'recovery,and,define'
p3650
g3
sS'interactions,associated,with'
p3651
g3
sS'alterations,of,status'
p3652
g3
sS'during,controlled,hypotensive'
p3653
g9
sS'false-negative,results,in'
p3654
g3
sS'presents,information,on'
p3655
g3
sS'zero,to,h'
p3656
g3
sS'm,inhibits,proliferation'
p3657
g9
sS'diphenhydramine,diphenhydramine,is'
p3658
g3
sS'patients,taking,concurrent'
p3659
g9
sS'hydrochloride,has,additive'
p3660
g9
sS'of,apoptosis,in'
p3661
g3
sS'limbic,system,particularly'
p3662
g3
sS'potentiation,effects,have'
p3663
g3
sS'decrease,in,temperature'
p3664
g3
sS'on,different,days'
p3665
g3
sS'kaolin-pectin,certain,anticancer'
p3666
g9
sS'free,will,result'
p3667
g3
sS'in,a,pharmacokinetic'
p3668
g3
sS'indicated,the,presence'
p3669
g3
sS'initiating,extraneal,in'
p3670
g9
sS'agents,and,dosage'
p3671
g3
sS'contraction,and,release'
p3672
g3
sS'relationship,to,therapy'
p3673
g3
sS'but,had,a'
p3674
g3
sS'adverse,effects,and'
p3675
g3
sS'these,blocking,agents'
p3676
g3
sS'alert,for,possible'
p3677
g3
sS'in,em,individuals'
p3678
g9
sS'with,cyp1a2,cyp3a'
p3679
g9
sS'and,squirrel,monkeys'
p3680
g3
sS'may,increase,or'
p3681
g3
sS'and,is,not'
p3682
g9
sS'the,aptt,assay'
p3683
g3
sS'vivo,as,indicated'
p3684
g9
sS'to,reassess,the'
p3685
g3
sS'fluvoxamine,has,also'
p3686
g9
sS'were,recorded,at'
p3687
g3
sS'induce,inhibit,or'
p3688
g9
sS'of,indocin,with'
p3689
g9
sS'administration,of,repeat'
p3690
g3
sS'those,patients,with'
p3691
g3
sS'oral,anticoagulents,may'
p3692
g3
sS'acid,increased,the'
p3693
g9
sS'n-demethylated,metabolite,metabolite'
p3694
g3
sS'in,an,open-label'
p3695
g3
sS'study,a,single'
p3696
g9
sS'and,retard,the'
p3697
g3
sS'mixed--pharmacological,and,aetiopathogenic--'
p3698
g3
sS'hypertension,some,of'
p3699
g9
sS'the,p-glycoprotein,transporter'
p3700
g3
sS'of,their,blood'
p3701
g9
sS'administered,to,patients'
p3702
g3
sS'primarily,eliminated,by'
p3703
g3
sS'be,titrated,with'
p3704
g9
sS'serotonergic,agents,was'
p3705
g3
sS'depressants,including,and'
p3706
g9
sS'may,need,to'
p3707
g9
sS'may,also,prolong'
p3708
g3
sS'blocking,add,some'
p3709
g9
sS'ephesus,patients,receiving'
p3710
g3
sS'effects,of,loop'
p3711
g9
sS'increased,prothrombin,response'
p3712
g9
sS'with,intestinal,absorption'
p3713
g9
sS'and,depend,upon'
p3714
g3
sS'taking,beta,blockers'
p3715
g3
sS'with,tenormin,plus'
p3716
g3
sS'after,stopping,an'
p3717
g9
sS'that,occurred,three'
p3718
g3
sS'out,studies,in'
p3719
g3
sS'flecainide,is,not'
p3720
g3
sS'may,affect,patient'
p3721
g3
sS'should,be,avoided'
p3722
g9
sS'well,as,decreasing'
p3723
g9
sS'co-administered,with,natrecor'
p3724
g3
sS'falsely,elevated,glucose'
p3725
g3
sS'not,recommended,that'
p3726
g9
sS'in,an,adequate'
p3727
g3
sS'effects,although,theophylline-induced'
p3728
g3
sS'therefore,the,disposition'
p3729
g3
sS'the,biological,indicators'
p3730
g3
sS'systemic,may,inhibit'
p3731
g3
sS'in,dose,selection'
p3732
g3
sS'inhibiting,cryptosporidium,parvum'
p3733
g9
sS'usp,have,not'
p3734
g3
sS'some,has,been'
p3735
g9
sS'concurrently,it,is'
p3736
g3
sS'auc,of,by'
p3737
g9
sS'from,week,intraperitoneal'
p3738
g3
sS'giving,these,concomitantly'
p3739
g3
sS'of,and,served'
p3740
g3
sS'six,cytochrome,p450'
p3741
g3
sS'and,maalox,tc'
p3742
g9
sS'single,oral,mg'
p3743
g3
sS'cases,your,doctor'
p3744
g3
sS'brain,chemical,i'
p3745
g3
sS'peptidase,and,not'
p3746
g3
sS'activity,the,sympathetic'
p3747
g3
sS'inhibition,of,these'
p3748
g3
sS'prudent,medical,practice'
p3749
g9
sS'reduced,by,tromethamine'
p3750
g9
sS'compounds,in,these'
p3751
g9
sS'the,plasma,of'
p3752
g3
sS'minutes,of,an'
p3753
g9
sS'used,together,the'
p3754
g9
sS'a,patient,during'
p3755
g3
sS'red,on,inositol'
p3756
g3
sS'drug-induced,renal,toxicity'
p3757
g3
sS'digestive,enzyme,preparations'
p3758
g9
sS'on,that,are'
p3759
g3
sS'therapeutic,monitoring,tdm'
p3760
g3
sS'large,well,controlled'
p3761
g3
sS'total,daily,dose'
p3762
g3
sS'neutrophils,recover,to'
p3763
g3
sS'study,of,eleven'
p3764
g9
sS'in,over,patients'
p3765
g9
sS'potential,risk,to'
p3766
g3
sS'components,p1,and'
p3767
g3
sS'possible,index,of'
p3768
g3
sS'unpredictable,potentiation,by'
p3769
g9
sS'mechanism,underlying,many'
p3770
g3
sS'randomized,crossover,double-blind'
p3771
g3
sS'receiving,other,local'
p3772
g9
sS'test,interactions,false'
p3773
g3
sS'potential,to,decrease'
p3774
g9
sS'or,h2antagonists,reduced'
p3775
g9
sS'treatment,of,pregnant'
p3776
g3
sS'adjustments,considered,for'
p3777
g9
sS'salts,may,reduce'
p3778
g9
sS'responses,to,exposure'
p3779
g3
sS'the,time,spent'
p3780
g9
sS'decrease,the,hemodynamic'
p3781
g9
sS'of,patients,under'
p3782
g3
sS'occur,when,infection'
p3783
g9
sS'monoamine,oxidases,and'
p3784
g3
sS'efficacy,has,emerged'
p3785
g3
sS'antiemetic,prophylaxis,may'
p3786
g9
sS'is,a,potent'
p3787
g9
sS'the,stomach,of'
p3788
g9
sS'bioavailability,of,relative'
p3789
g3
sS'number,of,deaths'
p3790
g3
sS'prevents,morphine-induced,increases'
p3791
g9
sS'inadequate,systematic,experience'
p3792
g3
sS'concentrations,and,this'
p3793
g9
sS'with,faslodex,in'
p3794
g3
sS'of,the,muscle'
p3795
g9
sS'endocrine,function,hmg-coa'
p3796
g3
sS'reduced,by,increasing'
p3797
g3
sS'proton,pump,inhibitors'
p3798
g9
sS'muscle,cell,and'
p3799
g3
sS'study,in,healthy'
p3800
g9
sS'an,evaluation,of'
p3801
g3
sS'cholestyramine,and,charcoal'
p3802
g9
sS'of,food,in'
p3803
g3
sS'effect,in,some'
p3804
g9
sS'potentiate,any,hypokalemic'
p3805
g9
sS'receiving,and,or'
p3806
g9
sS'concomitantly,administered,did'
p3807
g3
sS'cecectomized,than,in'
p3808
g3
sS'of,agents,of'
p3809
g3
sS'between,the,hydantoin'
p3810
g9
sS'may,block,the'
p3811
g9
sS'platelet,inhibitors,drugs'
p3812
g9
sS'above,this,study'
p3813
g3
sS'external,subcutaneous,infusion'
p3814
g3
sS'eight-fold,increase,in'
p3815
g9
sS'reported,in,diabetic'
p3816
g3
sS'administration,of,vioxx'
p3817
g3
sS'mortality,is,not'
p3818
g3
sS'therefore,monitoring,of'
p3819
g3
sS'the,qt,interval'
p3820
g9
sS'time,by,means'
p3821
g9
sS'found,in,coffee'
p3822
g3
sS'several,have,been'
p3823
g9
sS'or,discontinued,because'
p3824
g3
sS'auranofin,should,be'
p3825
g9
sS'when,or,nitrous'
p3826
g3
sS'and,at,mg'
p3827
g9
sS'chewable,dispersible,buffered'
p3828
g9
sS'to,be,seen'
p3829
g9
sS'skin,discoloration,or'
p3830
g3
sS'stable,as,that'
p3831
g3
sS'drugs,are,excreted'
p3832
g3
sS'or,in,vivo'
p3833
g9
sS'with,or,since'
p3834
g3
sS'interactions,with,oral'
p3835
g3
sS'shown,to,inhibit'
p3836
g9
sS'second,generation,atypical'
p3837
g3
sS'nnrti,based,regimens'
p3838
g3
sS'for,possible,diminished'
p3839
g3
sS'weight,to,erythro-fluorocitrate'
p3840
g9
sS'cardiac,arrest,during'
p3841
g3
sS'but,not,all'
p3842
g3
sS'of,renal,cationic'
p3843
g3
sS'serious,or,fatal'
p3844
g3
sS'approximately,and,the'
p3845
g9
sS'heparin,sodium,may'
p3846
g3
sS'enzymes,are,the'
p3847
g9
sS'zalcitabine,also,has'
p3848
g9
sS'its,components,are'
p3849
g3
sS'shown,on,the'
p3850
g3
sS'drug,interactions,use'
p3851
g3
sS'exists,for,interaction'
p3852
g3
sS'persons,taking,most'
p3853
g3
sS'blockers,patients,with'
p3854
g3
sS'anticoagulants,combination,hormonal'
p3855
g9
sS'medications,to,predict'
p3856
g3
sS'with,the,exception'
p3857
g3
sS'and,might,also'
p3858
g9
sS'conduction,through,the'
p3859
g9
sS'phospholipids,as,well'
p3860
g3
sS'maintenance,dose,of'
p3861
g9
sS'serious,arrhythmias,in'
p3862
g3
sS'produces,a,reduction'
p3863
g9
sS'however,in,patients'
p3864
g9
sS'hydration,sodium,bicarbonate'
p3865
g3
sS'theophylline,alone,caused'
p3866
g3
sS'or,its,breakdown'
p3867
g9
sS'reduced,approximately,when'
p3868
g9
sS'abnormalities,arrhythmia,bradycardia'
p3869
g9
sS'below,the,measurable'
p3870
g9
sS'with,cyp3a4,substrate'
p3871
g3
sS'greater,fecal,blood'
p3872
g3
sS'shown,in,vitro'
p3873
g9
sS'a,satisfactory,hypotensive'
p3874
g9
sS'because,their,vasospastic'
p3875
g9
sS'highly,plasma,protein'
p3876
g3
sS'common,with,other'
p3877
g9
sS'previously,reported,that'
p3878
g3
sS'with,the,absorption'
p3879
g9
sS'concurrently,with,medications'
p3880
g3
sS'metabolites,may,color'
p3881
g3
sS'when,administering,with'
p3882
g9
sS'acute,renal,failure'
p3883
g9
sS'alveoli,of,the'
p3884
g3
sS'chemical,carcinogen,may'
p3885
g3
sS'intravenous,hydration,sodium'
p3886
g3
sS'at,least,two'
p3887
g3
sS'but,have,no'
p3888
g3
sS'the,mean,percentage'
p3889
g9
sS'long,surgical,procedures'
p3890
g9
sS'used,concurrently,increases'
p3891
g9
sS'on,warfarin-type,therapy'
p3892
g9
sS'mind,in,the'
p3893
g9
sS'for,human,liver'
p3894
g3
sS'and,potassium-sparing,diuretics'
p3895
g9
sS'studies,involving,healthy'
p3896
g3
sS'in,cocaine-treated,groups'
p3897
g3
sS'hydrate,and,agonists'
p3898
g3
sS'use,of,l-phenylalanine'
p3899
g9
sS'when,potent,inhalational'
p3900
g9
sS'and,their,o-desacetyl'
p3901
g3
sS'observed,between,argatroban'
p3902
g3
sS'considered,to,be'
p3903
g3
sS'not,likely,to'
p3904
g3
sS'oral,heparin,sodium'
p3905
g3
sS'also,albumin,bound'
p3906
g3
sS'been,proposed,in'
p3907
g3
sS'significance,of,this'
p3908
g3
sS'but,can,completely'
p3909
g9
sS'antiepileptic,aeds,affects'
p3910
g9
sS'at,therapeutic,levels'
p3911
g3
sS'two,different,tasks'
p3912
g3
sS'levels,of,tricyclic'
p3913
g9
sS'cimetidine,coadministration,leads'
p3914
g9
sS'should,if,possible'
p3915
g9
sS'be,rarely,associated'
p3916
g9
sS'liver,and,or'
p3917
g9
sS'of,although,it'
p3918
g9
sS'beverages,in,the'
p3919
g3
sS'bmax,in,the'
p3920
g3
sS'to,monitor,concentrations'
p3921
g9
sS'blood,thinners,may'
p3922
g9
sS'levosimendan,does,not'
p3923
g3
sS'more,competing,memory'
p3924
g3
sS'and,concurrently,plasma'
p3925
g9
sS'fentanyl,is,metabolized'
p3926
g3
sS'low,for,commonly'
p3927
g3
sS'and,can,result'
p3928
g9
sS'hypoxic,respiratory,failure'
p3929
g3
sS'the,volunteers,were'
p3930
g3
sS'danger,of,the'
p3931
g9
sS'types,of,therapy'
p3932
g3
sS'for,the,understanding'
p3933
g3
sS'possibility,of,increased'
p3934
g3
sS'tysabri,and,concomitant'
p3935
g3
sS'increased,exposures,of'
p3936
g9
sS'or,hypotension,which'
p3937
g9
sS'potassium-sparing,supplements,or'
p3938
g3
sS'patient,or,guardian'
p3939
g3
sS'result,at,least'
p3940
g3
sS'resistant,to,oh'
p3941
g3
sS'csf,primarily,as'
p3942
g3
sS'were,given,mg'
p3943
g3
sS'the,tail-flick,and'
p3944
g3
sS'possibility,of,increases'
p3945
g9
sS'not,known,at'
p3946
g3
sS'cytochrome,p450,isoen-zymes'
p3947
g3
sS'with,platelet,function'
p3948
g3
sS'pronounced,in,cecectomized'
p3949
g3
sS'interaction,of,this'
p3950
g9
sS'potentiate,and,prolong'
p3951
g3
sS'and,on,antinociceptive'
p3952
g3
sS'cases,of,low'
p3953
g9
sS'a,significantly,higher'
p3954
g3
sS'the,mode,of'
p3955
g3
sS'some,strains,combinations'
p3956
g3
sS'moderate,cyp3a4,inhibitors'
p3957
g9
sS'interaction,between,toradol'
p3958
g9
sS'as,this,may'
p3959
g3
sS'fashion,as,much'
p3960
g9
sS'which,may,prolong'
p3961
g9
sS'be,capable,of'
p3962
g9
sS'to,hypoglycemia,oral'
p3963
g3
sS'closely,related,member'
p3964
g9
sS'exists,in,regard'
p3965
g3
sS'dexamethasone,is,a'
p3966
g3
sS'products,and,in'
p3967
g9
sS'as,beta-adrenergic,blocking'
p3968
g3
sS'delirium,has,been'
p3969
g9
sS'age,and,in'
p3970
g3
sS'an,oral,increased'
p3971
g9
sS'absence,of,other'
p3972
g3
sS'it,increased,the'
p3973
g3
sS'presence,of,exogenously'
p3974
g3
sS'variety,of,other'
p3975
g3
sS'cause,peripheral,neuropathy'
p3976
g3
sS'most,cases,of'
p3977
g3
sS'following,treatment,with'
p3978
g3
sS'via,cyp3a4,in'
p3979
g3
sS'were,evident,on'
p3980
g3
sS'single,tonic,convulsion'
p3981
g3
sS'is,no,doubt'
p3982
g3
sS'products,including,and'
p3983
g9
sS'reports,in,the'
p3984
g9
sS'receiving,tambocor,and'
p3985
g9
sS'type,caution,should'
p3986
g9
sS'flupenthixol,and,ethanol'
p3987
g9
sS'diethyl,pyrocarbonate,could'
p3988
g3
sS'measurements,should,be'
p3989
g3
sS'the,number,of'
p3990
g3
sS'have,been,seen'
p3991
g9
sS'were,measured,by'
p3992
g3
sS'peripheral,blood,mononuclear'
p3993
g9
sS'the,nac,decreased'
p3994
g3
sS'of,sonata,mg'
p3995
g9
sS'time,when,administered'
p3996
g3
sS'fondaparinux,the,concomitant'
p3997
g3
sS'decreased,the,urinary'
p3998
g9
sS'methylpyrazole,seen,in'
p3999
g9
sS'experiments,on,white'
p4000
g3
sS'needed,the,initial'
p4001
g3
sS'of,x,mg'
p4002
g9
sS'amine,since,it'
p4003
g9
sS'transient,hypotensive,response'
p4004
g3
sS'concomitant,medications,with'
p4005
g3
sS'on,these,medications'
p4006
g3
sS'duration,of,action'
p4007
g3
sS'either,prophylactic,low'
p4008
g3
sS'one,of,the'
p4009
g3
sS'mics,of,against'
p4010
g3
sS'values,were,only'
p4011
g3
sS'commonly,involved,in'
p4012
g3
sS'however,decreases,in'
p4013
g3
sS'in,density,bmax'
p4014
g3
sS't3,uptake,is'
p4015
g3
sS'well-controlled,patients,undergoing'
p4016
g9
sS'however,beta,blockers'
p4017
g3
sS'are,so,called'
p4018
g3
sS'infection,and,are'
p4019
g9
sS'additive,ocular,and'
p4020
g3
sS'interactions,would,not'
p4021
g3
sS'resulted,in,levels'
p4022
g3
sS'means,of,selective'
p4023
g9
sS'with,other,metabolized'
p4024
g3
sS'must,have,a'
p4025
g3
sS'of,the,calculated'
p4026
g3
sS'initiated,after,cessation'
p4027
g3
sS'c,up,to'
p4028
g3
sS'be,discontinued,in'
p4029
g3
sS'may,either,increase'
p4030
g9
sS'behavioral,or,subjective'
p4031
g3
sS'hypokalemia,or,hypomagnesemia'
p4032
g3
sS'systemic,levels,considerably'
p4033
g9
sS'vasopressor,for,the'
p4034
g9
sS'presents,a,diagnostic'
p4035
g3
sS'vitro,studies,were'
p4036
g3
sS'and,efficacy,should'
p4037
g3
sS'acth,induced,hypertension'
p4038
g3
sS'appropriate,doses,for'
p4039
g3
sS'for,a,third'
p4040
g3
sS'on,or,before'
p4041
g3
sS'by,ecg,changes'
p4042
g3
sS'certain,types,of'
p4043
g9
sS'regimen,efficacy,in'
p4044
g3
sS'as,mg,on'
p4045
g9
sS'epirubicin,is,extensively'
p4046
g3
sS'in,layers,iv'
p4047
g3
sS'nsaid,while,taking'
p4048
g9
sS'and,the,production'
p4049
g9
sS'as,mg,of'
p4050
g3
sS'the,increases,in'
p4051
g9
sS'they,may,vary'
p4052
g3
sS'to,wshow,an'
p4053
g3
sS'day,in,order'
p4054
g9
sS'index,of,intestinal'
p4055
g3
sS'interactions,have,been'
p4056
g3
sS'and,cyp3a4,in'
p4057
g9
sS'that,the,pancreatic'
p4058
g3
sS'drug,interaction,has'
p4059
g3
sS'patients,with,ischemic'
p4060
g3
sS'drugs,on,aliskiren'
p4061
g3
sS'significantly,when,administered'
p4062
g3
sS'median,tmax,was'
p4063
g3
sS'blocking,agents,a'
p4064
g3
sS'increased,with,concurrent'
p4065
g9
sS'coadministered,with,dopa'
p4066
g3
sS'which,concurrent,therapy'
p4067
g3
sS'is,administered,at'
p4068
g9
sS'and,iv,attenuate'
p4069
g9
sS'use,of,these'
p4070
g3
sS'of,doses,there'
p4071
g3
sS'fold,range,of'
p4072
g3
sS'and,electrolyte,alterations'
p4073
g3
sS'tissues,of,rats'
p4074
g3
sS'with,potentiates,a'
p4075
g3
sS'when,administered,to'
p4076
g3
sS'a,complex,fashion'
p4077
g3
sS'on,mean,aucs'
p4078
g3
sS'studies,did,not'
p4079
g3
sS'than,two-fold,increases'
p4080
g9
sS'initiated,cell,the'
p4081
g3
sS'patients,and,increased'
p4082
g3
sS'to,a,stable'
p4083
g3
sS'the,plasma,concentration'
p4084
g9
sS'vitro,in,peripheral'
p4085
g9
sS'affected,by,cercariae'
p4086
g3
sS'with,breast,cancer'
p4087
g9
sS'h,was,discontinued'
p4088
g3
sS'with,a,main'
p4089
g3
sS'lead,to,exaggerated'
p4090
g3
sS'creatinine,clearance,ml'
p4091
g3
sS'chronic,therapy,had'
p4092
g3
sS'that,at,high'
p4093
g3
sS'trough,cmin,concentration'
p4094
g9
sS'ulcers,in,patients'
p4095
g3
sS'co-administered,has,been'
p4096
g9
sS'pain,arthralgia,limb'
p4097
g3
sS'for,cytochrome,p450'
p4098
g3
sS'be,discontinued,it'
p4099
g9
sS'hydrocodone,coadministration,of'
p4100
g3
sS'auc,hours,based'
p4101
g3
sS'been,shown,to'
p4102
g9
sS'treatment,with,other'
p4103
g3
sS'blunting,of,the'
p4104
g9
sS'therefore,if,is'
p4105
g9
sS'renal,clearance,mechanisms'
p4106
g3
sS'monohydroxy,metabolite,mhd'
p4107
g3
sS'and,no,evidence'
p4108
g3
sS'be,used,and'
p4109
g3
sS'in,unconjugated,nacmc'
p4110
g3
sS'reported,in,elderly'
p4111
g9
sS'c9,with,glucuronidation'
p4112
g3
sS'that,this,can'
p4113
g3
sS'bid,was,increased'
p4114
g9
sS'and,is,particularly'
p4115
g3
sS'be,used,while'
p4116
g3
sS'endothelium,from,the'
p4117
g9
sS'dysregulation,of,the'
p4118
g3
sS'chapter,presents,findings'
p4119
g3
sS'compounds--can,be,inactivated'
p4120
g3
sS'although,no,drug-drug'
p4121
g3
sS'to,patients,anaesthetised'
p4122
g9
sS'the,plasma,auc'
p4123
g9
sS'administration,of,single'
p4124
g3
sS'may,require,increases'
p4125
g9
sS'in,plasma,m1'
p4126
g9
sS'results,of,assays'
p4127
g3
sS'with,the,metabolism'
p4128
g9
sS'have,a,higher'
p4129
g3
sS'of,using,the'
p4130
g9
sS'by,the,comparative'
p4131
g3
sS'that,is,unlikely'
p4132
g3
sS'physicians,are,overly'
p4133
g3
sS'as,determined,by'
p4134
g3
sS'evaluated,these,were'
p4135
g3
sS'atropine-like,effects,may'
p4136
g3
sS'activity,and,to'
p4137
g3
sS'buspirone,hcl,with'
p4138
g9
sS'unknown,whether,the'
p4139
g3
sS'of,approximately,when'
p4140
g9
sS'the,fourth,group'
p4141
g3
sS'were,mp,aza'
p4142
g3
sS'other,at,least'
p4143
g3
sS'is,proposed,that'
p4144
g3
sS'these,differences,were'
p4145
g3
sS'closely,for,development'
p4146
g9
sS'by,is,expected'
p4147
g3
sS'treatment,with,pegasys'
p4148
g9
sS'receiving,the,dosage'
p4149
g9
sS'risk,of,gastrointestinal'
p4150
g9
sS'was,treated,with'
p4151
g3
sS'pharmacokinetic,data,indicate'
p4152
g9
sS'dependence,of,each'
p4153
g3
sS'which,require,a'
p4154
g9
sS'the,following,medications'
p4155
g9
sS'produced,by,without'
p4156
g9
sS'activity,pra,as'
p4157
g3
sS'therefore,caution,should'
p4158
g3
sS'of,the,store'
p4159
g3
sS'known,inhibition,of'
p4160
g3
sS'or,non-opioid,analgesics'
p4161
g3
sS'the,european,and'
p4162
g3
sS'responding,in,monkeys'
p4163
g3
sS'co-infected,with,tuberculosis'
p4164
g3
sS'but,no,change'
p4165
g9
sS'watery,stool,in'
p4166
g3
sS'suggested,that,may'
p4167
g9
sS'is,the,possibility'
p4168
g3
sS'well-controlled,studies,of'
p4169
g3
sS'concentrations,of,each'
p4170
g3
sS'with,glycosides,heart'
p4171
g9
sS'is,extensively,bound'
p4172
g3
sS'is,unclear,patients'
p4173
g3
sS'at,recovery,of'
p4174
g9
sS'maximally,suppresses,gastric'
p4175
g3
sS'fec-100,chemotherapies,breast'
p4176
g3
sS'birth,control,pills'
p4177
g3
sS'mixing,novolog,with'
p4178
g3
sS'on,pharmacokinetics,have'
p4179
g3
sS'mg,by,hours'
p4180
g9
sS'of,large,size'
p4181
g3
sS'digitalis,vitamin,d'
p4182
g9
sS'action,of,other'
p4183
g9
sS'a,double-blind,randomized'
p4184
g3
sS'color,alkaline,urine'
p4185
g3
sS'of,newly,diagnosed'
p4186
g3
sS'should,it,be'
p4187
g9
sS'enhanced,or,prolonged'
p4188
g3
sS'and,sulfate,may'
p4189
g9
sS'clinical,study,who'
p4190
g9
sS'warfarin-type,therapy,may'
p4191
g9
sS'when,nimbex,is'
p4192
g3
sS'and,mg,twice'
p4193
g9
sS'and,the,bmax'
p4194
g3
sS'supplements,can,correct'
p4195
g3
sS'renal,function,or'
p4196
g3
sS'intensified,electrolyte,depletion'
p4197
g3
sS'receiving,comedication,particularly'
p4198
g9
sS'change,after,a'
p4199
g3
sS'aprepitant,with,that'
p4200
g3
sS'mouth,and,associated'
p4201
g9
sS'is,suggested,to'
p4202
g9
sS'there,were,pi'
p4203
g3
sS'inhibited,gastric,acid'
p4204
g3
sS'therapy,in,healthy'
p4205
g3
sS'and,result,in'
p4206
g9
sS'importance,brevibloc,should'
p4207
g9
sS'with,therapeutic,doses'
p4208
g9
sS'cmax,of,both'
p4209
g3
sS'ascorbic,acid,vitamin'
p4210
g9
sS'are,coadministered,the'
p4211
g9
sS'with,other,has'
p4212
g9
sS'reach,toxic,levels'
p4213
g3
sS'studies,including,normal'
p4214
g3
sS'pci,co-administration,of'
p4215
g9
sS'toxicity,with,little'
p4216
g9
sS'with,of,this'
p4217
g3
sS'a,plasma,concentration'
p4218
g3
sS'and,an,increased'
p4219
g3
sS'induced,a,soft'
p4220
g3
sS'dehydration,secondary,to'
p4221
g9
sS'day,there,were'
p4222
g3
sS'which,in,turn'
p4223
g9
sS'a,mouse,model'
p4224
g3
sS'mechanism,of,resveratrol-induced'
p4225
g3
sS'to,or,potentiate'
p4226
g9
sS'rifampin,coadministration,of'
p4227
g9
sS'two,of,subjects'
p4228
g9
sS'interaction,between,and'
p4229
g3
sS'and,concomitantly,toxicity'
p4230
g9
sS'the,muscle,was'
p4231
g3
sS'to,miracidia,are'
p4232
g3
sS'general,any,added'
p4233
g3
sS'and,cardiovascular,collapse'
p4234
g3
sS'mononuclear,cell,infiltration'
p4235
g3
sS'or,those,who'
p4236
g3
sS'within,a,week'
p4237
g3
sS'receiving,hydrochloride,concomitantly'
p4238
g3
sS'be,allowed,before'
p4239
g9
sS'triiodothyronine,levels,but'
p4240
g3
sS'monitored,when,and'
p4241
g9
sS'are,likely,and'
p4242
g3
sS'it,is,critically'
p4243
g3
sS'study,demonstrates,that'
p4244
g9
sS'ventricular,arrhythmias,and'
p4245
g9
sS'memory,that,are'
p4246
g3
sS'beginning,or,stopping'
p4247
g9
sS'mylotarg,is,not'
p4248
g3
sS'not,affect,bleeding'
p4249
g3
sS'for,evidence,of'
p4250
g3
sS'tambocor,has,been'
p4251
g3
sS'as,much,as'
p4252
g3
sS'concomitantly,with,more'
p4253
g9
sS'digoxin,did,not'
p4254
g3
sS'ergotamine-containing,when,co-administered'
p4255
g9
sS'auc,and,the'
p4256
g9
sS'dosing,caution,should'
p4257
g9
sS'activity,against,gram-negative'
p4258
g3
sS'is,either,added'
p4259
g9
sS'of,this,increased'
p4260
g3
sS'where,endothelial,function'
p4261
g3
sS'chemical,or,laboratory'
p4262
g3
sS'it,is,structurally'
p4263
g3
sS'a,dose-related,increase'
p4264
g9
sS'intramuscularly,injected,and'
p4265
g3
sS'nnrtis,appears,generally'
p4266
g3
sS'of,this,the'
p4267
g3
sS'can,significantly,reduce'
p4268
g3
sS'type,may,be'
p4269
g3
sS'and,tam,enhances'
p4270
g9
sS'of,free,is'
p4271
g9
sS'resulted,in,interactions'
p4272
g9
sS'lead,to,phenytoin'
p4273
g9
sS'used,concomitantly,only'
p4274
g3
sS'dose,unfractionated,up'
p4275
g3
sS'lanoxicaps,that,gets'
p4276
g9
sS'may,underlie,its'
p4277
g3
sS'when,a,potent'
p4278
g3
sS'subjects,receiving,multiple'
p4279
g9
sS'you,more,information'
p4280
g3
sS'pathways,on,exposure'
p4281
g3
sS'until,specific,compatibility'
p4282
g3
sS'to,several-,fold'
p4283
g3
sS'steady-state,trough,cmin'
p4284
g3
sS'when,arava,and'
p4285
g9
sS'whole-cell,recording,higher'
p4286
g3
sS'mask,or,mimic'
p4287
g3
sS'as,mg,was'
p4288
g3
sS'based,on,adult'
p4289
g9
sS'of,cyp3a4,and'
p4290
g3
sS'orally,for,days'
p4291
g9
sS'be,alerted,to'
p4292
g3
sS'implication,that,intoxication'
p4293
g9
sS'platelet,nucleotide,release'
p4294
g3
sS'two,groups,sh'
p4295
g3
sS'hours,after,a'
p4296
g9
sS'of,d-penicillamine,or'
p4297
g3
sS'of,av,conduction'
p4298
g9
sS'was,not,affected'
p4299
g3
sS'occurrence,of,torsade'
p4300
g9
sS'nonsteroidal,agents,have'
p4301
g9
sS'oral,channel,blockers'
p4302
g3
sS'kg,s,c'
p4303
g9
sS'human,liver,cytochrome'
p4304
g3
sS'cyp2d6,and,which'
p4305
g9
sS'clinical,pharmacology,study'
p4306
g9
sS'can,deplete,and'
p4307
g9
sS'profile,of,mood'
p4308
g3
sS'substrate,and,fold'
p4309
g9
sS'cause,dna,damage'
p4310
g3
sS'anti-inflammatory,agents,nsaids'
p4311
g9
sS'liver,microsome,studies'
p4312
g3
sS'of,those,in'
p4313
g3
sS'for,the,maintenance'
p4314
g3
sS'combinations,were,determined'
p4315
g3
sS'both,groups,ie'
p4316
g3
sS'mice,a,bar-press'
p4317
g3
sS'the,hypotension,induced'
p4318
g9
sS'of,and,have'
p4319
g3
sS'interactions,may,also'
p4320
g3
sS'these,recommendations,are'
p4321
g3
sS'in,this,paper'
p4322
g3
sS'and,oral,were'
p4323
g9
sS'theophylline,enoxacin,is'
p4324
g9
sS'who,received,chop-haart'
p4325
g3
sS'that,from,the'
p4326
g3
sS'of,the,action'
p4327
g3
sS'non-steroidal,agents,seizures'
p4328
g9
sS'decrease,metabolism,and'
p4329
g9
sS'addition,and,mhd'
p4330
g3
sS'drugs,given,concurrently'
p4331
g3
sS'reductase,may,cause'
p4332
g3
sS'clinical,course,of'
p4333
g3
sS'are,metabolized,and'
p4334
g3
sS'are,associated,with'
p4335
g3
sS'for,the,pharmacokinetics'
p4336
g3
sS'metabolites,interfere,with'
p4337
g3
sS'lymphoma,cells,and'
p4338
g3
sS'indicated,that,significantly'
p4339
g9
sS'established,and,discontinuation'
p4340
g3
sS'developing,peripheral,neuropathy'
p4341
g9
sS'enhanced,absorption,or'
p4342
g3
sS'concentrations,and,would'
p4343
g3
sS'serum,creatinine,and'
p4344
g9
sS'tinnitus,slurred,speech'
p4345
g3
sS'on,pharmacokinetics,of'
p4346
g3
sS'these,events,required'
p4347
g3
sS'the,cognitive,and'
p4348
g9
sS'caspofungin,is,not'
p4349
g3
sS'and,administration,of'
p4350
g3
sS'structural,similarity,to'
p4351
g9
sS'treated,with,or'
p4352
g9
sS'cmax,and,increase'
p4353
g9
sS'were,undetectable,ng'
p4354
g3
sS'day,was,studied'
p4355
g3
sS'cimetidine,inhibits,both'
p4356
g9
sS'careful,adjustment,should'
p4357
g9
sS'n,n,with'
p4358
g3
sS'syncope,presyncope,or'
p4359
g9
sS'also,were,taken'
p4360
g3
sS'was,significantly,increased'
p4361
g3
sS'on,chronic,treatment'
p4362
g9
sS'of,in,healthy'
p4363
g3
sS'and,smx,were'
p4364
g3
sS'evoked,potentials,were'
p4365
g3
sS'both,compounds,attenuate'
p4366
g3
sS'reverse,resistance,in'
p4367
g3
sS'maintain,the,desired'
p4368
g3
sS'that,seeds,of'
p4369
g3
sS'grams,daily,taken'
p4370
g3
sS'of,an,adverse'
p4371
g3
sS'with,in,several'
p4372
g3
sS'be,reviewed,and'
p4373
g9
sS'of,depression,the'
p4374
g3
sS'increased,ectopic,pacemaker'
p4375
g9
sS'baseline,vs,end'
p4376
g3
sS'was,given,after'
p4377
g9
sS'the,net,effect'
p4378
g3
sS'cytochrome,p450,inhibitors'
p4379
g3
sS'necrotizing,myopathy,secondary'
p4380
g3
sS'and,the,levels'
p4381
g3
sS'glucocorticoid-induced,gene,expression'
p4382
g3
sS'study,of,mg'
p4383
g9
sS'recall,has,been'
p4384
g3
sS'specific,effects,of'
p4385
g9
sS'known,metabolic,profiles'
p4386
g3
sS'steady-state,blood,concentrations'
p4387
g3
sS'with,mg,times'
p4388
g9
sS'in,bile,and'
p4389
g9
sS'in,the,design'
p4390
g3
sS'enterococcus,faecium,to'
p4391
g3
sS'inhibit,k,epoxide'
p4392
g3
sS'be,considered,when'
p4393
g9
sS'careful,monitoring,or'
p4394
g9
sS'videx,chewable,buffered'
p4395
g9
sS'reductase,inhibitors,the'
p4396
g9
sS'how,the,effect'
p4397
g3
sS'several,medicinal,products'
p4398
g9
sS'must,have,negative'
p4399
g3
sS'with,the,administration'
p4400
g9
sS'tablets,was,not'
p4401
g3
sS'human,serum,proteins'
p4402
g3
sS'complex,between,or'
p4403
g9
sS'in,vitro,against'
p4404
g3
sS'times,higher,than'
p4405
g3
sS'show,any,changes'
p4406
g3
sS'correlate,with,release'
p4407
g3
sS'oxidase,inhibition,linezolid'
p4408
g3
sS'of,with,grapefruit'
p4409
g3
sS'indinavir,has,been'
p4410
g9
sS'narrow,therapeutic,ratio'
p4411
g3
sS'dose,was,co-administered'
p4412
g3
sS'of,herbal,therapy'
p4413
g3
sS'decreased,and,decreased'
p4414
g9
sS'photosensitizing,agents,such'
p4415
g9
sS'are,discussed,especially'
p4416
g3
sS'q,d,were'
p4417
g9
sS'is,probably,secondary'
p4418
g9
sS'and,healthy,subjects'
p4419
g3
sS'when,administering,taxol'
p4420
g3
sS'urobilin,due,to'
p4421
g3
sS'those,found,in'
p4422
g9
sS'carboxymethylcellulose,nacmc,and'
p4423
g3
sS'plasma,hdl,and'
p4424
g3
sS'injection,of,at'
p4425
g9
sS'increase,in,exposure'
p4426
g9
sS'mefloquineuine,causes,a'
p4427
g3
sS'demonstrated,efficacy,and'
p4428
g3
sS'resulting,interference,with'
p4429
g9
sS'interactions,with,clomiphene'
p4430
g3
sS'particularly,since,exhibits'
p4431
g9
sS'turn,controls,levels'
p4432
g3
sS'isozyme,and,it'
p4433
g9
sS'innovar,vet,or'
p4434
g9
sS'small,decrease,in'
p4435
g9
sS'after,overload,both'
p4436
g3
sS'however,because,both'
p4437
g3
sS'initiating,therapy,with'
p4438
g9
sS'vitro,activity,of'
p4439
g3
sS'increased,metabolism,due'
p4440
g9
sS'should,not,concurrently'
p4441
g9
sS'was,thus,not'
p4442
g3
sS'and,beta-adrenergic,blocking'
p4443
g9
sS'inhibitor,of,any'
p4444
g3
sS'kg,bwt,were'
p4445
g3
sS'recommended,that,gaba-positive'
p4446
g3
sS'concomitant,were,used'
p4447
g3
sS'possible,that,dopamine'
p4448
g9
sS'assay,with,solid'
p4449
g3
sS'be,diminished,when'
p4450
g9
sS'increased,by,about'
p4451
g9
sS'administration,of,colestid'
p4452
g3
sS'targets,and,has'
p4453
g3
sS'mg,times,the'
p4454
g3
sS'metabolites,n-desmethylclozapine,and'
p4455
g3
sS'that,demonstrate,very'
p4456
g3
sS'either,or,its'
p4457
g3
sS'was,inadequate,to'
p4458
g3
sS'spinal,substantia,gelatinosa'
p4459
g3
sS'is,also,to'
p4460
g3
sS'dpcpx,in,a'
p4461
g3
sS'patient,receiving,acarbose'
p4462
g3
sS'also,concomitant,administration'
p4463
g9
sS'for,the,training'
p4464
g3
sS'of,hyperkalemia,serum'
p4465
g9
sS'side,or,in'
p4466
g3
sS'estradiol,and,levels'
p4467
g3
sS'isoenzymes,and,or'
p4468
g3
sS'laboratory,evidence,of'
p4469
g3
sS'doses,of,vitamin'
p4470
g3
sS'insp,together,with'
p4471
g9
sS'increased,norepinephrine-induced,platel'
p4472
g3
sS'a,given,plasma'
p4473
g3
sS'concentrations,of,patients'
p4474
g3
sS'of,high,doses'
p4475
g3
sS'with,care,as'
p4476
g9
sS'of,a,mao'
p4477
g9
sS'interactions,mediated,by'
p4478
g3
sS'cmin,were,increased'
p4479
g9
sS'cyp2d6,isoenzyme,including'
p4480
g9
sS'watched,during,initiation'
p4481
g3
sS'with,other,was'
p4482
g3
sS'of,transient,thrombocytopenia'
p4483
g3
sS'selective,agonists,compared'
p4484
g3
sS'besides,their,action'
p4485
g3
sS'the,same,time'
p4486
g3
sS'exjade,pharmacokinetics,has'
p4487
g3
sS'shown,no,clinically'
p4488
g3
sS'of,and,the'
p4489
g3
sS'to,broadly,the'
p4490
g3
sS'de,pointes-type,ventricular'
p4491
g3
sS'progression,in,cell'
p4492
g3
sS'of,similar,to'
p4493
g9
sS'in,such,cases'
p4494
g3
sS'other,agents,has'
p4495
g9
sS'shown,that,precipitation'
p4496
g3
sS'pharmacodynamic,interaction,is'
p4497
g3
sS'are,metabolized,via'
p4498
g3
sS'diuretics,patients,on'
p4499
g9
sS'does,not,enhance'
p4500
g9
sS'as,measured,by'
p4501
g3
sS'agents,insulin,sulfonylureas'
p4502
g3
sS'nuprin,others,orudis'
p4503
g3
sS'if,such,an'
p4504
g3
sS'strabismus,miosis,mydriasis'
p4505
g3
sS'acute,pretreatment,on'
p4506
g3
sS'thiazides,thiazides,are'
p4507
g3
sS'increase,to,mg'
p4508
g3
sS'with,nonsteroidal,anti-inflammatory'
p4509
g9
sS'tylenol,such,as'
p4510
g9
sS'examining,potential,interactions'
p4511
g3
sS'in,another,interaction'
p4512
g9
sS'be,determined,by'
p4513
g3
sS'therefore,be,closely'
p4514
g3
sS'natural,and,synthetic'
p4515
g3
sS'laboratory,preliminary,whole-cell'
p4516
g3
sS'with,vioxx,is'
p4517
g9
sS'several,which,may'
p4518
g3
sS'as,muscle,pain'
p4519
g3
sS'lymphocytopenia,has,been'
p4520
g9
sS'enter,the,csf'
p4521
g3
sS'a,were,not'
p4522
g3
sS'neuropathy,or,neurotoxic'
p4523
g3
sS'reported,to,blunt'
p4524
g9
sS'to,block,the'
p4525
g9
sS'the,compromised,cardiovascular'
p4526
g3
sS'control,and,the'
p4527
g3
sS'depressant,and,general'
p4528
g9
sS'the,and,classes'
p4529
g9
sS'reaction,for,urinary'
p4530
g3
sS'racemic,mg,given'
p4531
g9
sS'as,and,ethacrynic'
p4532
g9
sS'not,expected,between'
p4533
g3
sS'recovery,and,the'
p4534
g3
sS'at,as,great'
p4535
g3
sS'usually,reversible,upon'
p4536
g9
sS'free,t4,and'
p4537
g3
sS'fe,over,a'
p4538
g3
sS'mmol,day,for'
p4539
g3
sS'over,of,the'
p4540
g3
sS'alone,produced,less'
p4541
g3
sS'diarrhea-inducing,effects,of'
p4542
g3
sS'male,volunteers,ingesting'
p4543
g9
sS'their,guardians,carefully'
p4544
g3
sS'enteric,coated,plus'
p4545
g3
sS'cause,renal,and'
p4546
g3
sS'if,their,tolerance'
p4547
g9
sS'at,the,recommended'
p4548
g3
sS'medicines,central,nervous'
p4549
g9
sS'recommended,for,coadministration'
p4550
g3
sS'drops,unless,there'
p4551
g3
sS'urine,red-orange,which'
p4552
g3
sS'after,insertion,of'
p4553
g3
sS'concentrations,and,prothrombin'
p4554
g3
sS'disease,and,pulmonary'
p4555
g3
sS'and,hours,for'
p4556
g3
sS'indications,specific,for'
p4557
g3
sS'isolated,cases,of'
p4558
g9
sS'interference,of,biocytin'
p4559
g3
sS'not,significantly,affected'
p4560
g3
sS'pulmonary,symptomatology,due'
p4561
g9
sS'have,significant,metabolism'
p4562
g9
sS'administration,but,these'
p4563
g3
sS'of,vardenafil,with'
p4564
g9
sS'inhibitor,however,and'
p4565
g3
sS'about,minutes,before'
p4566
g9
sS'receiving,tablets,compared'
p4567
g3
sS'of,auc,and'
p4568
g9
sS'patients,the,incidence'
p4569
g3
sS'dsst,symbol,copying'
p4570
g9
sS'produced,plasma,drug'
p4571
g3
sS'of,approximately,in'
p4572
g9
sS'reduces,the,renal'
p4573
g9
sS'methotrexate-related,toxicity,should'
p4574
g9
sS'a,laser,interferometric'
p4575
g3
sS'lower,total,daily'
p4576
g3
sS'of,a,non-steroidal'
p4577
g9
sS'were,drinking,during'
p4578
g9
sS'the,tubular,secretion'
p4579
g9
sS'however,usually,give'
p4580
g3
sS'and,triglycerides,sgot'
p4581
g9
sS'innovar,on,tolerance'
p4582
g3
sS'aspirin,may,decrease'
p4583
g9
sS'the,cns-depressive,effect'
p4584
g9
sS'these,effects,may'
p4585
g9
sS'attempts,to,provide'
p4586
g3
sS'ineffective,if,the'
p4587
g9
sS'observed,for,several'
p4588
g9
sS'capable,of,metabolizing'
p4589
g3
sS'taken,when,the'
p4590
g9
sS'when,evaluating,men'
p4591
g3
sS'placental,margin,after'
p4592
g3
sS'currently,no,clinical'
p4593
g3
sS'n-allylnormetazocine,nanm,were'
p4594
g3
sS'placebo-controlled,phase,i'
p4595
g3
sS'cause,severe,hypotension'
p4596
g9
sS'and,mean,scores'
p4597
g9
sS'and,low-dose,has'
p4598
g9
sS'physician,wishing,to'
p4599
g3
sS'cell,including,an'
p4600
g3
sS'and,significant,decrease'
p4601
g9
sS'evident,following,a'
p4602
g3
sS'sodium,enhances,the'
p4603
g9
sS'antipyrine,pharmacokinetics,were'
p4604
g3
sS'n-type,channel,an'
p4605
g3
sS'be,included,into'
p4606
g3
sS'estradiol,the,estrogenic'
p4607
g3
sS'elevated,blood,levels'
p4608
g3
sS'renal,tubular,transport'
p4609
g9
sS'sensitization,similar,to'
p4610
g3
sS'of,the,prevalence'
p4611
g3
sS'or,clinically,significant'
p4612
g3
sS'decreased,an,average'
p4613
g9
sS'most,other,hypotensive'
p4614
g9
sS'at,least,in'
p4615
g3
sS'exhibiting,m,m'
p4616
g3
sS'less,than,mg'
p4617
g3
sS'dose,was,not'
p4618
g3
sS'advised,when,trisenox'
p4619
g9
sS'negatively,impacted,by'
p4620
g3
sS'eliminated,by,active'
p4621
g9
sS'to,patients,on'
p4622
g9
sS'or,in,transfusion'
p4623
g3
sS'expression,by,the'
p4624
g3
sS'was,observed,during'
p4625
g3
sS'its,acid,metabolite'
p4626
g3
sS'inhibition,of,cholino-'
p4627
g3
sS'nm,oh,d3'
p4628
g3
sS'when,a,single'
p4629
g9
sS'potassium-depleting,agents,when'
p4630
g9
sS'approximately,decrease,in'
p4631
g9
sS'vioxx,should,be'
p4632
g3
sS'with,renal,dysfunction'
p4633
g9
sS'did,not,depend'
p4634
g3
sS'this,combination,arenot'
p4635
g3
sS'suggest,that,genetic'
p4636
g3
sS'rhabdomyolysis,and,acute'
p4637
g9
sS'or,inhibitors,of'
p4638
g3
sS'in,the,embryogenesis'
p4639
g3
sS'human,lymphocytes,in'
p4640
g3
sS'otc,dose,resulted'
p4641
g9
sS'cisapride,should,not'
p4642
g9
sS'secondary,to,hypertensive'
p4643
g3
sS'urine,immunoreactive,concentrations'
p4644
g3
sS'appropriate,monitoring,of'
p4645
g9
sS'agonists,at,receptors'
p4646
g9
sS'of,serum,prostate-specific'
p4647
g3
sS'for,adult-onset,diabetics'
p4648
g9
sS'are,also,being'
p4649
g9
sS'not,inhibitors,of'
p4650
g3
sS'clinical,trials,database'
p4651
g3
sS'levels,and,clearance'
p4652
g3
sS'volunteers,n,in'
p4653
g3
sS'used,at,the'
p4654
g9
sS'related,may,increase'
p4655
g9
sS'of,blood,levels'
p4656
g3
sS'levels,in,patients'
p4657
g3
sS'juice,given,to'
p4658
g3
sS'function,hmg-coa,reductase'
p4659
g3
sS'widening,of,the'
p4660
g9
sS'that,of,users'
p4661
g9
sS'ganciclovir,the,pharmacokinetics'
p4662
g3
sS'exercised,if,leustatin'
p4663
g3
sS'substrate,agent,may'
p4664
g3
sS'other,cardioactive,drugs'
p4665
g3
sS'cyp3a4,rifampicin,racemic'
p4666
g9
sS'of,deep-seated,infection'
p4667
g3
sS'one,mg,dose'
p4668
g9
sS'and,have,demonstrated'
p4669
g3
sS'of,per,mac'
p4670
g3
sS'of,or,nsaids'
p4671
g9
sS'risk,of,neuropathy'
p4672
g3
sS'therefore,injection,of'
p4673
g3
sS'thermal,analysis,and'
p4674
g3
sS'cyp1a2,a6,and'
p4675
g3
sS'concomitantly,with,medications'
p4676
g9
sS'effect,on,pupil'
p4677
g9
sS'all,in,patients'
p4678
g3
sS'were,randomized,in'
p4679
g3
sS'receiving,a,course'
p4680
g9
sS'of,with,itraconazole'
p4681
g9
sS'and,agitation,while'
p4682
g3
sS'hormonalmethods,of,birth'
p4683
g9
sS'of,these,medicines'
p4684
g9
sS'test,in,clinical'
p4685
g3
sS'tdm,of,therapy'
p4686
g3
sS'cases,from,spontaneous'
p4687
g3
sS'antithyroid,agents,may'
p4688
g9
sS'in,hospitals,resulting'
p4689
g3
sS'concomitantly,with,that'
p4690
g9
sS'and,to,determine'
p4691
g3
sS'assessed,using,morphological'
p4692
g9
sS'to,limited,renal'
p4693
g3
sS'of,total,cholesterol'
p4694
g3
sS'oral,such,as'
p4695
g9
sS'were,dose,proportional'
p4696
g3
sS'volunteers,n,demonstrated'
p4697
g3
sS'blood,levels,of'
p4698
g9
sS'initiating,combination,therapy'
p4699
g9
sS'mg,was,evaluated'
p4700
g3
sS'patients,with,hereditary'
p4701
g9
sS'channel-blockers,ace,inhibitors'
p4702
g3
sS'potassium,kinetics,and'
p4703
g9
sS'prostaglandins,may,cause'
p4704
g9
sS'who,received,tended'
p4705
g3
sS'possibly,causing,uterine'
p4706
g9
sS'although,is,not'
p4707
g3
sS'inducers,and,inhibitors'
p4708
g9
sS'with,by,about'
p4709
g3
sS'the,cyp3a4,substrate'
p4710
g3
sS'is,known,about'
p4711
g3
sS'growth,both,in'
p4712
g3
sS'cytochrome,p450,c9'
p4713
g3
sS'administration,or,salt'
p4714
g3
sS'should,elapse,between'
p4715
g9
sS'and,may,include'
p4716
g3
sS'intravenous,agents,and'
p4717
g3
sS'expected,with,other'
p4718
g3
sS'with,increased,risks'
p4719
g9
sS'on,certain,brain'
p4720
g3
sS'times,or,a'
p4721
g3
sS'their,reappearance,on'
p4722
g3
sS'to,ensure,that'
p4723
g9
sS'mediated,by,cytochrome'
p4724
g3
sS'of,with,lowered'
p4725
g9
sS'using,clinitest,benedicts'
p4726
g3
sS'temperatures,in,eagles'
p4727
g3
sS'pivoxil,be,taken'
p4728
g9
sS'kaletra,norvir,viracept'
p4729
g9
sS'cyclosporine,large,quantities'
p4730
g3
sS'sildenafil,is,contraindicated'
p4731
g9
sS'effect,of,levels'
p4732
g9
sS'beverages,are,not'
p4733
g3
sS'contrast,in,ontario'
p4734
g3
sS'other,additive,effect'
p4735
g3
sS'general,local,like'
p4736
g3
sS'considerations,as,the'
p4737
g3
sS'necessary,for,the'
p4738
g3
sS'with,kemstrotm,was'
p4739
g3
sS'the,usual,prescription'
p4740
g9
sS'administered,at,either'
p4741
g3
sS'their,dosages,may'
p4742
g3
sS'a,study,in'
p4743
g9
sS'cytochrome,p450,substrates'
p4744
g3
sS'chromatin,and,cytoplasmic'
p4745
g3
sS'in,vitro,upon'
p4746
g9
sS'synthetic,possibly,by'
p4747
g9
sS'the,properties,of'
p4748
g3
sS'he,was,treated'
p4749
g3
sS'presence,or,the'
p4750
g3
sS'clinically,compatible,with'
p4751
g3
sS'duration,of,central'
p4752
g9
sS'for,hepatic,injury'
p4753
g3
sS'have,identified,potentially'
p4754
g9
sS'affect,the,hematopoietic'
p4755
g3
sS'by,approximately,mean'
p4756
g9
sS'result,in,falsely'
p4757
g3
sS'concentrations,of,vitamin'
p4758
g9
sS'in,increased,clinical'
p4759
g9
sS'to,and,leading'
p4760
g9
sS'in,nursing,infants'
p4761
g3
sS'be,a,complication'
p4762
g3
sS'induced,by,was'
p4763
g9
sS'mean,values,of'
p4764
g3
sS'hour,period,in'
p4765
g9
sS'to,produce,hyperglycemia'
p4766
g3
sS'binding,and,the'
p4767
g3
sS'states,and,a'
p4768
g3
sS'disease,on,the'
p4769
g3
sS'the,intravenous,self-administration'
p4770
g9
sS'factors,of,and'
p4771
g3
sS'was,significantly,lower'
p4772
g3
sS'including,anaphylaxis,have'
p4773
g3
sS'a,result,that'
p4774
g3
sS'hemabate,may,augment'
p4775
g9
sS'may,potentiate,adverse'
p4776
g9
sS'is,low,clinically'
p4777
g3
sS'been,formally,evaluated'
p4778
g3
sS'elimination,was,prolonged'
p4779
g3
sS'with,difluoroacetone,did'
p4780
g3
sS'the,following,anti-anxiety'
p4781
g3
sS'showed,that,the'
p4782
g3
sS'oral,and,discontinuation'
p4783
g9
sS'phenytoin,serum,level'
p4784
g9
sS'solution,one,study'
p4785
g9
sS'toxicity,of,cadmium'
p4786
g3
sS'p,decreased,mean'
p4787
g9
sS'added,to,the'
p4788
g9
sS'metabolism,of,certain'
p4789
g9
sS'maintained,between,the'
p4790
g9
sS'about,possible,dosage'
p4791
g3
sS'and,be,prepared'
p4792
g3
sS'fold,at,steady'
p4793
g9
sS'of,clearance,in'
p4794
g3
sS'grouped,as,ace'
p4795
g3
sS'does,not,greatly'
p4796
g3
sS'results,from,the'
p4797
g9
sS'homodimeric,structure,of'
p4798
g3
sS'trileptal,topamax,felbatol'
p4799
g9
sS'and,angiotensin,ii'
p4800
g9
sS'agents,causing,renin'
p4801
g9
sS'levels,for,diagnosis'
p4802
g3
sS'steady-state,maximum,concentration'
p4803
g3
sS'dicumarol,and,indanedione'
p4804
g3
sS'and,decrease,platelet'
p4805
g3
sS'the,three,types'
p4806
g3
sS'coumarin,anticoagulants,there'
p4807
g9
sS'administering,taxol,to'
p4808
g3
sS'overall,treatment,costs'
p4809
g3
sS'is,cleared,primarily'
p4810
g3
sS'permeation,of,sodium'
p4811
g3
sS'of,cardiopulmonary,arrest'
p4812
g3
sS'volunteers,has,been'
p4813
g3
sS'the,immune,response'
p4814
g3
sS'of,clolar,with'
p4815
g3
sS'use,if,possible'
p4816
g3
sS'an,alternative,treatment'
p4817
g3
sS'combination,therapy,did'
p4818
g3
sS'are,indeed,agents'
p4819
g3
sS'globulin,cbg,sex'
p4820
g3
sS'their,capacity,for'
p4821
g3
sS'was,initiated,apparent'
p4822
g9
sS'oral,medication,such'
p4823
g9
sS'results,of,interaction'
p4824
g3
sS'and,motor,skills'
p4825
g3
sS'serotonin2-receptors,underlies,the'
p4826
g3
sS'either,before,or'
p4827
g3
sS'age,and,is'
p4828
g3
sS'on,natriuresis,is'
p4829
g9
sS'one,possible,index'
p4830
g3
sS'sustained-release,with,no'
p4831
g3
sS'furosemide,administered,concurrently'
p4832
g3
sS'significantly,inhibit,the'
p4833
g3
sS'interactions,of,humorsol'
p4834
g9
sS'for,weeks,with'
p4835
g3
sS'significantly,without,changes'
p4836
g3
sS'number,of,human'
p4837
g9
sS'although,has,a'
p4838
g9
sS'studied,with,inhibition'
p4839
g9
sS'strong,cyp3a4,inducer'
p4840
g9
sS'helpful,means,of'
p4841
g3
sS'and,in,humans'
p4842
g9
sS'inhibitors,without,any'
p4843
g3
sS'limited,evidence,that'
p4844
g3
sS'in,patients,being'
p4845
g9
sS'significant,elevation,in'
p4846
g9
sS'day,and,by'
p4847
g9
sS'fertility,were,observed'
p4848
g3
sS'in,platelets,leukocytes'
p4849
g3
sS'the,antiepileptic,effect'
p4850
g9
sS'however,the,use'
p4851
g3
sS'parts,of,the'
p4852
g9
sS'models,based,on'
p4853
g3
sS'population,plasma,concentrations'
p4854
g3
sS'to,fully,define'
p4855
g3
sS'co-administration,of,fluvoxamine'
p4856
g9
sS'that,the,oral'
p4857
g9
sS'altered,hypo-prothrombinemic,effect'
p4858
g3
sS'cyp3a4,inducer,should'
p4859
g9
sS'until,data,on'
p4860
g9
sS'sulfosalicylic,acid,precipitation'
p4861
g3
sS'studies,sodium,was'
p4862
g3
sS'the,cns,depressive'
p4863
g9
sS'further,data,are'
p4864
g3
sS'the,known,property'
p4865
g9
sS'can,be,given'
p4866
g3
sS'dose-response,curves,derived'
p4867
g9
sS'diabetes,mellitus,ischemic'
p4868
g3
sS'prolong,and,effects'
p4869
g3
sS'dose,and,pharmacological'
p4870
g3
sS'and,ketoconazole,fexofenadine'
p4871
g3
sS'clinically,significant,interactions'
p4872
g3
sS'known,caution,is'
p4873
g9
sS'systemic,exposure,approximately'
p4874
g3
sS'of,this,particular'
p4875
g3
sS'especially,patients,with'
p4876
g3
sS'systems,responsible,for'
p4877
g3
sS'sulfide,metabolite,by'
p4878
g9
sS'of,by,m'
p4879
g9
sS's,wort,in'
p4880
g3
sS'isozyme,and,make'
p4881
g3
sS'of,by,a'
p4882
g9
sS'other,multivalent,cations'
p4883
g9
sS'each,month,prior'
p4884
g3
sS'methotrexate,nsaids,have'
p4885
g9
sS'more,than,for'
p4886
g9
sS'hours,based,on'
p4887
g3
sS'as,the,was'
p4888
g3
sS'the,prophylactic,and'
p4889
g9
sS'exjade,and,aluminum-containing'
p4890
g3
sS'and,the,herbal'
p4891
g3
sS'interaction,with,erythromycin'
p4892
g3
sS'by,the,pathway'
p4893
g3
sS'dose,of,be'
p4894
g9
sS'in,de,novo'
p4895
g3
sS'is,felt,that'
p4896
g9
sS'cerebral,and,hepatic'
p4897
g9
sS'used,concomitantly,with'
p4898
g9
sS'increasing,salt,intake'
p4899
g9
sS'other,cause,striking'
p4900
g9
sS'not,significantly,different'
p4901
g3
sS'by,reductions,in'
p4902
g3
sS'qtc,increase,over'
p4903
g3
sS'have,been,received'
p4904
g3
sS'inhibition,of,the'
p4905
g3
sS'reduced,twitch,strength'
p4906
g3
sS'plasma,concentrations,following'
p4907
g3
sS'therapy,mainly,concerns'
p4908
g3
sS'cases,of,medical'
p4909
g3
sS'pharmacokinetic,studies,showed'
p4910
g9
sS'lasting,depletions,of'
p4911
g9
sS'serosal,surfaces,of'
p4912
g3
sS'not,altered,to'
p4913
g3
sS'since,it,palliates'
p4914
g3
sS'that,coadministration,of'
p4915
g9
sS'into,a,complex'
p4916
g3
sS'angiotensin-converting,enzyme,ace'
p4917
g3
sS'on,concomitant,compared'
p4918
g3
sS'a,major,metabolic'
p4919
g3
sS'myocardial,infarction,patients'
p4920
g3
sS'digoxin,coadministration,of'
p4921
g9
sS'sustiva,has,the'
p4922
g9
sS'of,and,during'
p4923
g3
sS'the,transcriptional,regulation'
p4924
g3
sS'therapies,are,effective'
p4925
g3
sS'open,air,passages'
p4926
g9
sS'cavity,or,on'
p4927
g3
sS'by,a,mean'
p4928
g9
sS'medicines,such,as'
p4929
g9
sS'the,dosage,range'
p4930
g9
sS'ellence,when,used'
p4931
g3
sS'hour,period,when'
p4932
g9
sS'multiple-dose,interaction,studies'
p4933
g3
sS'these,observations,suggest'
p4934
g3
sS'control,group,vs'
p4935
g3
sS'additionally,did,not'
p4936
g3
sS'an,interval,as'
p4937
g3
sS'and,free,t3'
p4938
g3
sS'day,has,not'
p4939
g3
sS'total,cholesterol,and'
p4940
g3
sS'exposure,with,a'
p4941
g9
sS'no,specific,interaction'
p4942
g3
sS'conducted,concomitant,administration'
p4943
g9
sS'similar,with,and'
p4944
g3
sS'to,affect,abilify'
p4945
g3
sS'such,as,or'
p4946
g9
sS'determining,the,magnitude'
p4947
g3
sS'twitch,was,again'
p4948
g3
sS'cyp3a4,substrates,and'
p4949
g3
sS'cyp1a2,activity,and'
p4950
g3
sS'with,serial,pharmacokinetic'
p4951
g3
sS'transdermal,and,implantable'
p4952
g9
sS'their,vasospastic,effects'
p4953
g9
sS'agents,may,be'
p4954
g3
sS'oil,ml,day'
p4955
g3
sS'treated,concurrently,with'
p4956
g9
sS'to,three,weeks'
p4957
g9
sS'range,of,mg'
p4958
g9
sS'should,be,closely'
p4959
g9
sS'not,interfere,with'
p4960
g3
sS'daily,to,healthy'
p4961
g3
sS'inhibitor,which,also'
p4962
g9
sS'with,lodine,as'
p4963
g3
sS'displacement,of,the'
p4964
g3
sS'interrupted,or,discontinued'
p4965
g3
sS'theoretically,possible,that'
p4966
g9
sS'is,not,higher'
p4967
g3
sS'half,life,of'
p4968
g9
sS'but,also,across'
p4969
g3
sS'in,liver,increasing'
p4970
g3
sS'to,control,hyperuricemia'
p4971
g3
sS'for,interactions,among'
p4972
g3
sS'air,passages,increasing'
p4973
g9
sS'drugs,which,inhibit'
p4974
g3
sS'receiving,with,agents'
p4975
g9
sS'have,been,studied'
p4976
g3
sS'and,the,ht3'
p4977
g3
sS'the,was,fold'
p4978
g3
sS'five-fold,increase,in'
p4979
g9
sS'is,altered,before'
p4980
g3
sS'after,ethyl,increases'
p4981
g9
sS'may,necessitate,raising'
p4982
g9
sS'toxicity,because,of'
p4983
g3
sS'relaxants,that,resulted'
p4984
g3
sS'cell-independent,activator,of'
p4985
g3
sS'restricted,pulmonary,or'
p4986
g3
sS'severe,myopathy,rhabdomyolysis'
p4987
g9
sS'the,auc,more'
p4988
g3
sS'aspecific,treatments,of'
p4989
g3
sS'are,using,it'
p4990
g9
sS'to,those,found'
p4991
g9
sS'administration,of,should'
p4992
g3
sS'solution,or,with'
p4993
g3
sS'benefit,balance,patient'
p4994
g3
sS'of,normal,and'
p4995
g3
sS'barbiturates,or,increased'
p4996
g9
sS'may,be,improved'
p4997
g3
sS'therefore,concomitant,administration'
p4998
g9
sS'and,factors,vii'
p4999
g3
sS'concentration-time,curve,was'
p5000
g3
sS'platelet,function,may'
p5001
g3
sS'a,main,meal'
p5002
g3
sS'by,other,manufacturers'
p5003
g3
sS'may,cause,elevated'
p5004
g9
sS'when,therapy,with'
p5005
g9
sS'desirable,to,monitor'
p5006
g3
sS'noted,when,hydrochloride'
p5007
g3
sS'cells,mm3,and'
p5008
g3
sS'patients,with,either'
p5009
g3
sS'including,combined,with'
p5010
g3
sS'for,example,the'
p5011
g3
sS'very,low,compared'
p5012
g3
sS'magnitude,lower,than'
p5013
g3
sS'may,accentuate,the'
p5014
g9
sS'and,screening,for'
p5015
g3
sS'indocin,resulted,in'
p5016
g9
sS'in,inhibiting,cryptosporidium'
p5017
g9
sS'ergosterol,the,major'
p5018
g3
sS'demonstrated,hypokalemia,they'
p5019
g3
sS'however,because,bleeding'
p5020
g9
sS'significantly,higher,as'
p5021
g9
sS'for,creatinine,if'
p5022
g3
sS'taking,tricyclic,in'
p5023
g9
sS'alone,or,when'
p5024
g3
sS's,response,to'
p5025
g9
sS'studies,and,no'
p5026
g3
sS'and,gram,negative'
p5027
g3
sS'medicines,with,may'
p5028
g9
sS'of,or,affect'
p5029
g3
sS'to,be,no'
p5030
g3
sS'used,to,detect'
p5031
g3
sS'however,this,sample'
p5032
g3
sS'either,singly,or'
p5033
g3
sS'a,href,bupropz_od'
p5034
g9
sS'in,addition,we'
p5035
g3
sS'renal,clearance,were'
p5036
g3
sS'mechanisms,with,some'
p5037
g3
sS'if,hypotension,occurs'
p5038
g3
sS'oral,mg,daily'
p5039
g3
sS'of,the,sirolimus-diltiazem'
p5040
g9
sS'when,encountered,such'
p5041
g3
sS'convulsions,have,been'
p5042
g9
sS'produced,by,explain'
p5043
g9
sS'resulted,in,significant'
p5044
g9
sS'clear,whether,this'
p5045
g3
sS'increased,and,its'
p5046
g9
sS'of,neurological,and'
p5047
g3
sS'interaction,began,within'
p5048
g3
sS'auc,of,is'
p5049
g9
sS'descending,epsilon,and'
p5050
g3
sS'essentially,completely,metabolised'
p5051
g3
sS'since,vitamin,d'
p5052
g3
sS'and,the,inr'
p5053
g3
sS'pathways,are,involved'
p5054
g3
sS'other,drugs,and'
p5055
g3
sS'clinically,significant,qtc'
p5056
g3
sS'based,on,previous'
p5057
g3
sS'hemoptysis,hematemesis,hematuria'
p5058
g3
sS'inhibitory,effect,of'
p5059
g9
sS'of,several,proteins'
p5060
g3
sS'inhibitors,concomitantly,should'
p5061
g3
sS'the,last,intravenous'
p5062
g9
sS'of,compounds,taken'
p5063
g9
sS'excess,may,decrease'
p5064
g9
sS'combination,procedures,in'
p5065
g3
sS'of,systemic,antimicrobial'
p5066
g3
sS'potent,loop,such'
p5067
g9
sS'such,as,myelosuppression'
p5068
g9
sS'the,dose-limiting,organ'
p5069
g3
sS'and,renal,excretion'
p5070
g3
sS'fall,in,the'
p5071
g3
sS'of,toradol,to'
p5072
g9
sS'rating,scale,were'
p5073
g9
sS'inducers,and,cyp1a2'
p5074
g3
sS'care,professional,know'
p5075
g9
sS'this,change,was'
p5076
g3
sS'of,mefloquineuine,on'
p5077
g3
sS'patients,taking,vioxx'
p5078
g9
sS'doses,mg,of'
p5079
g9
sS'hematemesis,hematuria,and'
p5080
g3
sS'to,days,for'
p5081
g3
sS'effect,of,coadministered'
p5082
g3
sS'dopamine-induced,renal,and'
p5083
g3
sS'with,intramuscular,doses'
p5084
g3
sS'tests,with,and'
p5085
g3
sS'medications,other,especially'
p5086
g3
sS'in,particular,convulsions'
p5087
g9
sS'receiving,nalfon,and'
p5088
g9
sS'been,studied,extensively'
p5089
g3
sS'established,a,cause'
p5090
g9
sS'documented,however,the'
p5091
g3
sS'before,such,are'
p5092
g3
sS'to,the,lowest'
p5093
g9
sS'of,a,possible'
p5094
g3
sS'efficacy,and,side'
p5095
g3
sS'with,potentially,nephrotoxic'
p5096
g9
sS'cells,but,dose-dependently'
p5097
g9
sS'reports,suggest,that'
p5098
g9
sS'hyperpyrexia,can,occur'
p5099
g3
sS'was,again,given'
p5100
g3
sS'since,they,may'
p5101
g3
sS'h2,blockers,although'
p5102
g9
sS'trial,of,hexalen'
p5103
g9
sS'manifested,by,increased'
p5104
g3
sS'interaction,effects,of'
p5105
g3
sS'cell,resistance,or'
p5106
g3
sS'additive,effects,of'
p5107
g3
sS'therapeutic,effects,are'
p5108
g9
sS'may,diminish,its'
p5109
g9
sS'an,oral,for'
p5110
g9
sS'and,sustain,plasma'
p5111
g3
sS'to,a,greater'
p5112
g9
sS'of,gastric,acid'
p5113
g9
sS'and,cyp3a5,responsible'
p5114
g3
sS'inhibitors,prostaglandin,synthetase'
p5115
g3
sS'juice,with,increases'
p5116
g3
sS'history,of,serious'
p5117
g9
sS'of,was,evaluated'
p5118
g3
sS'in,failing,hearts'
p5119
g3
sS'to,cause,or'
p5120
g3
sS'significant,drug,or'
p5121
g3
sS'taking,a,talk'
p5122
g3
sS'may,be,greater'
p5123
g9
sS'before,morning,doses'
p5124
g3
sS'by,thyroxine-binding,prealbumin'
p5125
g3
sS'with,the,other'
p5126
g3
sS'cover,interactions,with'
p5127
g3
sS'potentials,were,recorded'
p5128
g3
sS'be,changed,and'
p5129
g3
sS'profile,in,subjects'
p5130
g3
sS'gastrointestinal,adverse,events'
p5131
g3
sS'the,ionized,species'
p5132
g9
sS'dependent,measures,included'
p5133
g3
sS'the,value,of'
p5134
g3
sS'increased,serum,potassium'
p5135
g9
sS'of,metabolic,interactions'
p5136
g3
sS'because,nalfon,has'
p5137
g9
sS'nanm,or,pcp'
p5138
g9
sS'clinically,relevant,concentrations'
p5139
g3
sS'be,monitored,particularly'
p5140
g9
sS'administration,and,on'
p5141
g9
sS'inflammation,is,an'
p5142
g3
sS'response,is,almost'
p5143
g3
sS'was,increased,to'
p5144
g9
sS'acid,hepatotoxic,influenza'
p5145
g9
sS'the,mean,elimination'
p5146
g9
sS'induced,by,single'
p5147
g9
sS'immediate,side,effects'
p5148
g3
sS'supervision,after,the'
p5149
g9
sS'over,several,days'
p5150
g9
sS'in,metabolic,clearance'
p5151
g9
sS'with,based,on'
p5152
g3
sS'a6,c9,c19'
p5153
g3
sS'patients,response,to'
p5154
g3
sS'of,is,impaired'
p5155
g9
sS'cervical,breast,and'
p5156
g3
sS'additive,effects,with'
p5157
g9
sS'acid,derivatives,niacin'
p5158
g3
sS'if,an,interaction'
p5159
g3
sS'animals,in,both'
p5160
g3
sS'p-glycoprotein,loop,sparing'
p5161
g3
sS'of,after,a'
p5162
g3
sS'these,would,be'
p5163
g9
sS'antagonists,in,studies'
p5164
g3
sS'metabolites,is,a'
p5165
g3
sS'of,or,with'
p5166
g3
sS'reliable,affinity,chromatography'
p5167
g3
sS'this,article,will'
p5168
g3
sS'combination,may,increase'
p5169
g9
sS'linear,regression,and'
p5170
g3
sS'times,were,observed'
p5171
g3
sS'of,a,direct'
p5172
g3
sS'on,arteries,from'
p5173
g3
sS'these,increases,is'
p5174
g3
sS'is,in,cardiovascular'
p5175
g3
sS'healthy,subjects,receiving'
p5176
g9
sS'these,pharmacokinetic,changes'
p5177
g9
sS'combination,hormonal,may'
p5178
g9
sS'intravenous,may,have'
p5179
g9
sS'skin,reactions,dyspnea'
p5180
g3
sS'added,beta-adrenergic,blocking'
p5181
g9
sS'reports,of,bleeding'
p5182
g3
sS'in,glucose,concentrations'
p5183
g9
sS'with,which,cause'
p5184
g9
sS'prolong,the,qt'
p5185
g9
sS'against,taking,vitamin'
p5186
g9
sS'including,adverse,effects'
p5187
g3
sS'blockers,beta,blockers'
p5188
g3
sS'of,relevant,pharmacokinetic'
p5189
g3
sS'doxil,be,mixed'
p5190
g3
sS'nonsteroidal,anti-inflammatory,have'
p5191
g9
sS'strength,mg,mg'
p5192
g3
sS'effect,when,given'
p5193
g9
sS'lower,blood,pressure'
p5194
g9
sS'system,cyp3a4,therefore'
p5195
g3
sS'defects,occur,in'
p5196
g3
sS'with,concurrent,kineret'
p5197
g9
sS'for,occult,blood'
p5198
g3
sS'understanding,of,its'
p5199
g3
sS'dysfunction,by,increasing'
p5200
g9
sS'reactions,such,as'
p5201
g3
sS'and,sex,men'
p5202
g3
sS'at,the,lower'
p5203
g9
sS'by,patients,on'
p5204
g9
sS'of,reportedly,are'
p5205
g9
sS'placebo,and,treatments'
p5206
g3
sS'interactions,and,clinical'
p5207
g9
sS'nervous,system,regardless'
p5208
g9
sS'steady-state,concentrations,of'
p5209
g3
sS'effects,of,supplementary'
p5210
g3
sS'mg,kg,subcutaneous'
p5211
g3
sS'operating,machinery,or'
p5212
g3
sS'concomitantly,showed,that'
p5213
g3
sS'well,correlated,with'
p5214
g3
sS'clinical,evidence,of'
p5215
g3
sS'th,day,of'
p5216
g9
sS'days,was,decreased'
p5217
g9
sS'males,the,systemic'
p5218
g3
sS'care,in,the'
p5219
g3
sS'alterations,in,their'
p5220
g9
sS'this,increase,may'
p5221
g3
sS'vanillylmandelic,acid,when'
p5222
g3
sS'the,oral,bioavailability'
p5223
g9
sS'chop,patients,developed'
p5224
g3
sS'therapy,the,patient'
p5225
g3
sS'vitro,study,cytochrome'
p5226
g3
sS'four,kinds,of'
p5227
g3
sS'effect,of,pgf2alpha'
p5228
g9
sS'is,the,first'
p5229
g3
sS'capsules,should,not'
p5230
g3
sS'intramuscular,injection,of'
p5231
g9
sS'absorption,but,had'
p5232
g3
sS'blunt,the,hypotensive'
p5233
g9
sS'pharmacokinetics,after,days'
p5234
g3
sS'str,may,contribute'
p5235
g3
sS'each,dose,administered'
p5236
g3
sS'injection,produced,some'
p5237
g3
sS'hiv,status,and'
p5238
g3
sS'combined,with,local'
p5239
g3
sS'nuromax,and,other'
p5240
g3
sS'sodium,may,reduce'
p5241
g9
sS'induction,potential,should'
p5242
g3
sS'displacement,of,by'
p5243
g3
sS'reported,to,produce'
p5244
g3
sS'was,evaluated,as'
p5245
g3
sS'the,importance,of'
p5246
g3
sS'trans-placental,passage,and'
p5247
g3
sS'study,alone,produced'
p5248
g3
sS'not,altered,in'
p5249
g3
sS'of,rashes,in'
p5250
g9
sS'that,both,products'
p5251
g3
sS'itraconazole,and,may'
p5252
g9
sS'produce,inhibition,of'
p5253
g3
sS'by,ergosterol,the'
p5254
g3
sS'of,rashes,is'
p5255
g9
sS'period,in,healthy'
p5256
g3
sS'because,unexpected,hypotension'
p5257
g3
sS'be,an,inadequate'
p5258
g9
sS'longitudinal,studies,on'
p5259
g3
sS'marked,interference,with'
p5260
g9
sS'include,such,considerations'
p5261
g3
sS'of,is,to'
p5262
g9
sS'reductase,inhibitors,should'
p5263
g9
sS'blockers,certain,hmg-coa'
p5264
g9
sS'range,observed,with'
p5265
g3
sS'anticoagulants,altered,coagulation'
p5266
g9
sS'affected,significantly,with'
p5267
g3
sS'an,interval,of'
p5268
g3
sS'in,response,to'
p5269
g3
sS'of,a,previously'
p5270
g9
sS'leads,to,a'
p5271
g3
sS'and,study,with'
p5272
g3
sS'different,before,and'
p5273
g3
sS'atypical,antipsychotic,was'
p5274
g3
sS'related,to,diseases'
p5275
g3
sS'to,these,effects'
p5276
g3
sS'of,an,active'
p5277
g3
sS'of,as,a'
p5278
g3
sS'different,responses,in'
p5279
g3
sS'that,chronic,concurrent'
p5280
g9
sS'strain,were,divided'
p5281
g3
sS'study,the,effect'
p5282
g3
sS'of,coadministration,with'
p5283
g9
sS'mean,concentrations,of'
p5284
g3
sS'possible,increases,in'
p5285
g3
sS'angiomax,in,clinical'
p5286
g3
sS'mean,auc,decreased'
p5287
g9
sS'disease,states,or'
p5288
g3
sS'a,small,n'
p5289
g9
sS'of,as,v'
p5290
g3
sS'overdose,cholinergic,crisis'
p5291
g3
sS'that,also,markedly'
p5292
g9
sS'increasing,gastric,emptying'
p5293
g9
sS'ganglionic,or,peripheral'
p5294
g3
sS'control,rats,whereas'
p5295
g3
sS'single,small,pulse'
p5296
g3
sS'mean,standard,deviation'
p5297
g9
sS'the,including,produce'
p5298
g9
sS'hour,after,the'
p5299
g3
sS'when,administering,mepron'
p5300
g3
sS'and,its,dosage'
p5301
g9
sS'pronounced,if,a'
p5302
g9
sS'action,of,preparations'
p5303
g9
sS'wort,should,be'
p5304
g3
sS'observed,carefully,in'
p5305
g3
sS'with,may,also'
p5306
g9
sS'responding,significantly,in'
p5307
g3
sS'another,known,to'
p5308
g3
sS'days,and,males'
p5309
g3
sS'interval,for,placebo'
p5310
g3
sS'these,effects,although'
p5311
g3
sS'complications,in,neonates'
p5312
g3
sS'oz,has,no'
p5313
g3
sS'prophylactic,doses,of'
p5314
g3
sS'results,of,clinical'
p5315
g3
sS'monkeys,following,intravenous'
p5316
g3
sS'of,revia,and'
p5317
g9
sS'and,its,derivatives'
p5318
g9
sS'lanoxin,lanoxicaps,that'
p5319
g9
sS'flupenthixol,may,interact'
p5320
g9
sS'affect,patient,response'
p5321
g3
sS'determined,definitely,that'
p5322
g3
sS'laceration,especially,in'
p5323
g9
sS'test,is,to'
p5324
g3
sS'every,hours,is'
p5325
g9
sS'administration,of,permits'
p5326
g9
sS'blood,which,could'
p5327
g9
sS'nonetheless,individual,patients'
p5328
g9
sS'hypertension,have,been'
p5329
g3
sS'for,documented,hypokalemia'
p5330
g3
sS'systemic,exposure,is'
p5331
g3
sS'meaningful,changes,in'
p5332
g3
sS'therapy,dose,should'
p5333
g9
sS'of,daily,administration'
p5334
g3
sS'frequently,and,monitored'
p5335
g3
sS'and,in,treatment-experienced'
p5336
g3
sS'cmc-cys7,from,m'
p5337
g3
sS'that,the,phenotype'
p5338
g3
sS'ace,inhibitors,reports'
p5339
g9
sS'and,sucralfate,and'
p5340
g9
sS'bismuth,bismuth,subsalicylate'
p5341
g9
sS'that,these,aeds'
p5342
g3
sS'plasma,levels,by'
p5343
g9
sS'are,given,lodine'
p5344
g3
sS'mg,qd,for'
p5345
g9
sS'eight,target,added'
p5346
g3
sS'to,their,corresponding'
p5347
g3
sS'deep,tendon,reflexes'
p5348
g3
sS'mobilization,of,ions'
p5349
g3
sS'these,usually,clear'
p5350
g3
sS'of,other,may'
p5351
g3
sS'no,interactions,were'
p5352
g3
sS'or,herbs,do'
p5353
g3
sS'in,susceptible,patients'
p5354
g9
sS'diclofenac,like,other'
p5355
g3
sS'metabolized,and,renal'
p5356
g3
sS'redistribution,accumulation,of'
p5357
g3
sS'before,intramuscular,injection'
p5358
g9
sS'cyp3a4,and,can'
p5359
g9
sS'prolong,both,therapeutic'
p5360
g3
sS'deaths,have,been'
p5361
g9
sS'physciains,it,is'
p5362
g3
sS'olanzapine,demonstrated,superior'
p5363
g3
sS'affecting,blood,elements'
p5364
g9
sS'as,proof,of'
p5365
g3
sS'creatinine,despite,reduction'
p5366
g3
sS'discriminate,between,deficiency'
p5367
g3
sS'in,a,non-comparative'
p5368
g9
sS'used,and,blood'
p5369
g3
sS'prolongs,the,sleeping'
p5370
g9
sS'cellular,uptake,and'
p5371
g9
sS'administration,of,ellence'
p5372
g3
sS'may,intensify,the'
p5373
g9
sS'enzyme,inducers,indicate'
p5374
g9
sS'it,has,been'
p5375
g9
sS'may,be,active'
p5376
g9
sS'laboratory,assessments,of'
p5377
g3
sS'female,and,male'
p5378
g3
sS'significantly,affect,the'
p5379
g3
sS'transplant,recipients,over'
p5380
g3
sS'nonsteroidal,agents,of'
p5381
g3
sS'mild,and,consisted'
p5382
g3
sS'regimen,be,altered'
p5383
g3
sS'instances,of,interactions'
p5384
g9
sS'or,discontinue,pegasys'
p5385
g3
sS'failure,and,dosage'
p5386
g9
sS'these,data,raise'
p5387
g3
sS'epididymides,had,not'
p5388
g3
sS'and,mononuclear,cell'
p5389
g3
sS'mcg,once,daily'
p5390
g3
sS'hyperplasia,bph,psa'
p5391
g3
sS'a,all,volunteers'
p5392
g3
sS'and,subcortical,structures'
p5393
g3
sS'marked,symptomatic,orthostatic'
p5394
g9
sS'inhibition,of,p450'
p5395
g9
sS'however,it,may'
p5396
g3
sS'exhibit,characteristic,apoptotic'
p5397
g3
sS'are,analgesic,adjuvants'
p5398
g3
sS'nutrient,absorption,in'
p5399
g9
sS'bind,other,given'
p5400
g9
sS'because,is,extensively'
p5401
g3
sS'advisable,to,avoid'
p5402
g9
sS'receiving,replacement,therapy'
p5403
g9
sS'cause,a,false-positive'
p5404
g3
sS'demonstrated,that,is'
p5405
g9
sS'in,cecectomized,than'
p5406
g3
sS'ldl-c,reduction,were'
p5407
g3
sS'healthy,volunteers,treatment'
p5408
g3
sS'presence,of,at'
p5409
g9
sS'however,was,increased'
p5410
g3
sS'and,mm,had'
p5411
g3
sS'after,concomitant,therapy'
p5412
g9
sS'two,on,certain'
p5413
g3
sS'weeks,as,initial'
p5414
g3
sS'levels,or,the'
p5415
g3
sS'cyp3a4,activity,predominantly'
p5416
g3
sS'active,tubular,secretion'
p5417
g9
sS'loss,results,from'
p5418
g3
sS'parenteral,except,with'
p5419
g3
sS'presence,of,an'
p5420
g3
sS'sedation,or,potentially'
p5421
g9
sS'which,clearance,accelerated'
p5422
g9
sS'receiving,decreased,the'
p5423
g9
sS'mg,of,alone'
p5424
g3
sS'higher,than,those'
p5425
g9
sS'interval,and,decrease'
p5426
g3
sS'increased,interaction,should'
p5427
g3
sS'taking,which,prolong'
p5428
g3
sS'and,variable,half-life'
p5429
g3
sS'use,of,ascorbic'
p5430
g3
sS'from,displacement,of'
p5431
g3
sS'that,concurrent,administration'
p5432
g9
sS'management,of,patients'
p5433
g3
sS'in,concentrations,from'
p5434
g9
sS'strong,evidence,that'
p5435
g3
sS'studied,and,coadministration'
p5436
g9
sS'is,reduced,in'
p5437
g3
sS'medications,with,a'
p5438
g3
sS'pharmacological,pharmacodynamic,interactions'
p5439
g9
sS'ergamisol,levamisole,hydrochloride'
p5440
g9
sS'such,as,hypotension'
p5441
g3
sS'and,qtc,intervals'
p5442
g3
sS'and,other,monoamines'
p5443
g3
sS'of,dialyzable,may'
p5444
g3
sS'it,is,presently'
p5445
g3
sS'also,in,switching'
p5446
g9
sS'b,estradiol,and'
p5447
g3
sS'influence,of,aed'
p5448
g3
sS'two,controlled,crossover'
p5449
g3
sS'treatment,with,or'
p5450
g9
sS'to,those,obtained'
p5451
g9
sS'maleate,its,dose'
p5452
g9
sS'reflecting,the,absence'
p5453
g3
sS'to,decrease,platelet'
p5454
g3
sS'and,cause,qt'
p5455
g3
sS'mixing,of,an'
p5456
g9
sS'in,using,such'
p5457
g9
sS'pharmacokinetic,screening,in'
p5458
g3
sS'agitation,progressing,to'
p5459
g9
sS'systematically,between,june'
p5460
g3
sS'strong,cyp,a4'
p5461
g3
sS'agents,or,including'
p5462
g3
sS'ophthalmic,and,systemic'
p5463
g9
sS'or,predicted,interactions'
p5464
g3
sS'hydrocarbon,increase,cardiac'
p5465
g9
sS'develop,physiological,tolerance'
p5466
g3
sS's,determined,on'
p5467
g9
sS'reported,in,some'
p5468
g9
sS'been,done,to'
p5469
g9
sS'very,high,concentrations'
p5470
g3
sS'mg,kg,and'
p5471
g9
sS'compared,to,co-administration'
p5472
g3
sS'psychoses,to,a'
p5473
g3
sS'and,mixed,agonist-antagonist'
p5474
g3
sS'and,placebo,coadministered'
p5475
g3
sS'the,less,active'
p5476
g9
sS'to,severe,cardiovascular'
p5477
g9
sS'volunteers,significantly,reduced'
p5478
g9
sS'some,patients,this'
p5479
g3
sS'systemic,levels,of'
p5480
g3
sS'to,avoid,possible'
p5481
g9
sS'mentioned,above,and'
p5482
g3
sS'test,a,confirmation'
p5483
g3
sS'on,the,anti-coagulant'
p5484
g3
sS'enhance,the,possibility'
p5485
g9
sS'and,blood,sugar'
p5486
g3
sS'primidone,no,formal'
p5487
g3
sS'may,modify,the'
p5488
g3
sS'known,to,alter'
p5489
g9
sS'twice,daily,taken'
p5490
g9
sS'in,an,elisa'
p5491
g3
sS'pharmacokinetics,of,ethinyl'
p5492
g3
sS'time,be,determined'
p5493
g9
sS'd6,and,or'
p5494
g3
sS'following,medicines,or'
p5495
g9
sS'on,diastolic,or'
p5496
g3
sS'of,oral,such'
p5497
g9
sS'other,for,which'
p5498
g3
sS'that,a,dosing'
p5499
g3
sS'antiepileptic,drugs,phenytoin'
p5500
g9
sS'menstrual,cycle,irregularities'
p5501
g3
sS'improvements,in,general'
p5502
g3
sS'for,any,of'
p5503
g3
sS'is,very,unlikely'
p5504
g3
sS'and,reduces,the'
p5505
g9
sS'enhanced,the,likelihood'
p5506
g9
sS'not,change,the'
p5507
g3
sS'chemotherapy,can,have'
p5508
g3
sS'marketed,chewable,dispersible'
p5509
g9
sS'in,liver,function'
p5510
g3
sS'this,practice,resulted'
p5511
g3
sS'for,an,in'
p5512
g3
sS'similar,study,with'
p5513
g9
sS'agents,produced,reliable'
p5514
g3
sS'percentage,of,patients'
p5515
g3
sS'in,two,of'
p5516
g9
sS'increase,the,bioavailability'
p5517
g9
sS'johns,wort,may'
p5518
g3
sS'of,or,its'
p5519
g9
sS'protect,against,the'
p5520
g9
sS'a,two-way,interaction'
p5521
g9
sS'influence,limbic,integration'
p5522
g3
sS'implications,of,these'
p5523
g3
sS'of,another,extended'
p5524
g3
sS'the,cyp450,isoenzymes'
p5525
g3
sS'pgf2alpha,upon,the'
p5526
g9
sS'advised,to,monitor'
p5527
g3
sS'suggestive,of,toxicity'
p5528
g9
sS'myopathy,and,rhabdomyolysis'
p5529
g3
sS'are,vasoconstrictive,and'
p5530
g9
sS'bactrim,septra,gantrisin'
p5531
g3
sS'pi-based,regimens,in'
p5532
g3
sS'a,and,lower'
p5533
g3
sS'does,not,induce'
p5534
g3
sS'and,apoptosis,induced'
p5535
g3
sS'may,be,crucial'
p5536
g3
sS'combined,use,clinicians'
p5537
g9
sS'girdle,and,pre-sacral'
p5538
g3
sS'significantly,improves,the'
p5539
g3
sS'receiving,single,weekly'
p5540
g3
sS'characterized,by,peripheral'
p5541
g3
sS'for,interaction,between'
p5542
g3
sS'resistance,to,hormone'
p5543
g3
sS'especially,important,that'
p5544
g9
sS'an,interaction,will'
p5545
g9
sS'in,cervical,mucus'
p5546
g3
sS'a,slight,intrinsic'
p5547
g9
sS'levels,and,prolong'
p5548
g9
sS'with,the,conventional'
p5549
g3
sS'of,serum,concentration'
p5550
g9
sS'and,joint,exposure'
p5551
g3
sS'accutane,to,a'
p5552
g9
sS'of,which,required'
p5553
g3
sS'and,the,clinician'
p5554
g3
sS'contraceptives,multiple,doses'
p5555
g3
sS'of,protease,inhibitors'
p5556
g3
sS'with,a,may'
p5557
g9
sS'days,after,sudden'
p5558
g9
sS'in,vivo,by'
p5559
g3
sS'furosemide-stimulated,diuresis,natriuresis'
p5560
g3
sS'mg,three,times'
p5561
g9
sS'orencia,and,tnf'
p5562
g9
sS'acid,derivatives,nicotinic'
p5563
g3
sS'the,serum,levels'
p5564
g9
sS'and,life-threatening,reactions'
p5565
g3
sS'sumatriptan,there,have'
p5566
g9
sS'in,r-values,of'
p5567
g3
sS'patients,under,therapy'
p5568
g9
sS'medrol,others,prelone'
p5569
g3
sS'for,protein,mna'
p5570
g3
sS'phenytoin,causes,an'
p5571
g9
sS'have,shown,increased'
p5572
g3
sS'weeks,were,found'
p5573
g3
sS'peptide,and,in'
p5574
g3
sS'the,elimination,of'
p5575
g9
sS'hour,lag,phase'
p5576
g3
sS'plus,haart,on'
p5577
g3
sS'all,antagonists,decreased'
p5578
g3
sS'experiencing,severe,or'
p5579
g3
sS'the,patch,pipette'
p5580
g3
sS'non-steroidal,anti-inflammatory,agents'
p5581
g9
sS'was,coadministered,intravenously'
p5582
g9
sS'key,to,maximizing'
p5583
g3
sS'differential,effects,on'
p5584
g3
sS'morphine,analgesia,and'
p5585
g3
sS'local,solutions,containing'
p5586
g9
sS'rats,whereas,the'
p5587
g3
sS'cationic,secretion,are'
p5588
g3
sS'marine,coelenterates,of'
p5589
g3
sS'but,only,at'
p5590
g3
sS'urticaria,require,immediate'
p5591
g3
sS'the,vasodilating,effects'
p5592
g9
sS'of,the,following'
p5593
g3
sS'reduction,of,blood'
p5594
g9
sS'appropriately,regardless,of'
p5595
g3
sS'completely,blocked,the'
p5596
g9
sS'and,in,and'
p5597
g3
sS'without,consulting,the'
p5598
g3
sS'patient,requires,tikosyn'
p5599
g9
sS'sodium,carboxymethylcellulose,nacmc'
p5600
g3
sS'are,tolerated,in'
p5601
g3
sS'effects,of,atrovent'
p5602
g3
sS'serum,sex,hormone'
p5603
g9
sS'metabolite,which,may'
p5604
g9
sS'special,attention,should'
p5605
g3
sS'combination,of,before'
p5606
g9
sS'poorly,understood,and'
p5607
g3
sS'hypertensive,responses,have'
p5608
g9
sS'include,acute,intake'
p5609
g9
sS'are,either,inhibitors'
p5610
g3
sS'of,other,have'
p5611
g3
sS'protease,inhibitors,nefazodone'
p5612
g3
sS'of,administered,in'
p5613
g9
sS'that,can,modulate'
p5614
g3
sS'predominantly,eliminated,in'
p5615
g3
sS'pressor,agents,only'
p5616
g3
sS'has,been,titrated'
p5617
g3
sS'if,the,concomitant'
p5618
g3
sS'excretion,seen,during'
p5619
g9
sS'patients,or,their'
p5620
g3
sS'gemzar,and,in'
p5621
g3
sS'coadministered,and,on'
p5622
g3
sS'whereas,exogenous,respiration'
p5623
g3
sS'invirase,or,fortovase'
p5624
g3
sS'from,muscle,cells'
p5625
g3
sS'be,falsely,elevated'
p5626
g3
sS'and,pharmacodynamics,ecg'
p5627
g3
sS'approximately,twofold,from'
p5628
g9
sS'be,assumed,to'
p5629
g3
sS'alcohol,in,particular'
p5630
g3
sS'which,could,contribute'
p5631
g3
sS'c19,inhibitors,in'
p5632
g3
sS'occurred,between,the'
p5633
g3
sS'its,active,hydroxy'
p5634
g9
sS'inhibitors,including,sulfate'
p5635
g9
sS'of,substances,that'
p5636
g3
sS'were,more,efficiently'
p5637
g3
sS'that,not,be'
p5638
g9
sS'b-,induced,hypokalemia'
p5639
g9
sS'by,administration,of'
p5640
g9
sS'and,similar,compounds'
p5641
g3
sS'individuals,known,or'
p5642
g3
sS'in,preterm,neonates'
p5643
g3
sS'doctor,before,taking'
p5644
g3
sS'times,day,days'
p5645
g3
sS'of,tbg,deficiency'
p5646
g3
sS'increased,prothrombin,and'
p5647
g3
sS'and,other,multivalent'
p5648
g9
sS'of,sympatholytic,medicinal'
p5649
g3
sS'of,bleeding,events'
p5650
g3
sS'day,each,volunteer'
p5651
g3
sS'instruct,the,patient'
p5652
g3
sS'patients,taking,to'
p5653
g9
sS'exercised,when,known'
p5654
g3
sS'betagan,used,alone'
p5655
g9
sS'and,ventral,tubercle'
p5656
g3
sS'acamprosate,concomitantly,with'
p5657
g9
sS'cohort,then,received'
p5658
g3
sS'result,when,giving'
p5659
g3
sS'because,of,this'
p5660
g3
sS'with,brevibloc,esmolol'
p5661
g3
sS'and,hydroxide-containing,maalox'
p5662
g3
sS'hump,peripheral,wasting'
p5663
g3
sS'active,isomer,of'
p5664
g9
sS'lack,of,the'
p5665
g3
sS'one,day,fecal'
p5666
g3
sS'reported,to,occur'
p5667
g3
sS'of,pcp,treatment'
p5668
g9
sS'instances,of,dyspnea'
p5669
g3
sS'rearrangements,of,genomes'
p5670
g3
sS'in,proportion,to'
p5671
g3
sS'of,liver,cytochrome'
p5672
g3
sS'could,observe,that'
p5673
g3
sS'eliminated,in,the'
p5674
g3
sS'absorption,in,the'
p5675
g9
sS'degree,of,accumulation'
p5676
g3
sS'alveolar,concentration,may'
p5677
g9
sS'same,procedure,should'
p5678
g3
sS'binding,of,therapeutic'
p5679
g3
sS'agents,and,local'
p5680
g3
sS'by,camptosar,the'
p5681
g9
sS'oxidase,mao,inhibitors'
p5682
g3
sS'hydroxytolbutamide,and,was'
p5683
g3
sS'chronic,dosing,is'
p5684
g3
sS'the,general,public'
p5685
g3
sS'protease,inhibitors,or'
p5686
g3
sS'necessary,the,use'
p5687
g3
sS'after,was,washed'
p5688
g3
sS'environment,and,seem'
p5689
g3
sS'gradual,withdrawal,of'
p5690
g3
sS'to,hyperglycemia,in'
p5691
g3
sS'may,affect,the'
p5692
g3
sS'prolong,the,duration'
p5693
g9
sS'vital,signs,and'
p5694
g3
sS'receiving,for,heart'
p5695
g3
sS'anticholinesterases,neostgmine,can'
p5696
g3
sS'has,been,observed'
p5697
g3
sS'strains,of,enterococcus'
p5698
g3
sS'increase,blood,glucose'
p5699
g9
sS'less,well,studied'
p5700
g3
sS'administration,of,sprycel'
p5701
g9
sS'increased,effects,lower'
p5702
g3
sS'or,no,effect'
p5703
g9
sS'to,monitor,plasma'
p5704
g3
sS'receiving,including,antiparkinsonism'
p5705
g3
sS'compared,to,prinivil'
p5706
g3
sS'of,h-triglyceride,fractional'
p5707
g9
sS'low,as,judged'
p5708
g3
sS'several,aed,s'
p5709
g9
sS'rat,fibroblast,y1'
p5710
g3
sS'these,medications,at'
p5711
g3
sS'indifferent,for,and'
p5712
g9
sS'carefully,monitored,and'
p5713
g9
sS'increased,incidence,of'
p5714
g3
sS'from,the,peritoneal'
p5715
g3
sS'reduce,renal,function'
p5716
g3
sS'inhibitors,guanethidine,or'
p5717
g3
sS'accordingly,when,is'
p5718
g9
sS'interactions,were,assessed'
p5719
g3
sS'to,examine,some'
p5720
g3
sS'use,of,sodium'
p5721
g9
sS'the,mg,h'
p5722
g9
sS'vary,by,such'
p5723
g3
sS'taken,at,least'
p5724
g9
sS'bound,to,the'
p5725
g3
sS'been,established,but'
p5726
g9
sS'dst,false-negative,results'
p5727
g3
sS'to,days,has'
p5728
g3
sS'each,study,volunteers'
p5729
g3
sS'the,rat,stomach'
p5730
g9
sS'in,the,chop-haart'
p5731
g3
sS'enzymes,would,therefore'
p5732
g3
sS'and,consisted,of'
p5733
g3
sS'most,and,invalidate'
p5734
g3
sS'avoid,possible,over-'
p5735
g9
sS'auc,a,single'
p5736
g9
sS'derivatives,niacin,nicotinic'
p5737
g3
sS'potential,for,seizures'
p5738
g3
sS'precise,and,not'
p5739
g3
sS'diuresis,electrocardiogram,and'
p5740
g3
sS'necessitating,an,increased'
p5741
g3
sS'therapy,is,required'
p5742
g9
sS'in,a,literature'
p5743
g3
sS'and,should,be'
p5744
g9
sS'case,report,of'
p5745
g9
sS'were,identified,in'
p5746
g9
sS'syndrome,characterized,by'
p5747
g9
sS'mice,induced,lower'
p5748
g3
sS'of,therapy,and'
p5749
g3
sS'bactericidal,concentration,of'
p5750
g3
sS'the,first,test'
p5751
g3
sS'of,diabetes,have'
p5752
g3
sS'of,hydrochloride,does'
p5753
g3
sS'to,open,air'
p5754
g9
sS'cases,of,a'
p5755
g3
sS'was,reported,in'
p5756
g9
sS'in,the,cocaine-treated'
p5757
g3
sS'of,adrenocorticoids,is'
p5758
g3
sS'acute,toxicity,was'
p5759
g3
sS'normal,or,logistic'
p5760
g3
sS'of,schizophrenic,patients'
p5761
g9
sS'one-third,to,one-half'
p5762
g3
sS'of,the,ingested'
p5763
g9
sS'was,present,for'
p5764
g3
sS'of,indigestion,remedies'
p5765
g9
sS'the,other,currently'
p5766
g3
sS'explored,with,the'
p5767
g3
sS'test,interactions,there'
p5768
g3
sS'the,steady-state,cmin'
p5769
g3
sS'with,at,high'
p5770
g9
sS'the,caucasian,population'
p5771
g3
sS'free,hormone,concentrations'
p5772
g3
sS'an,used,to'
p5773
g3
sS'in,both,dose'
p5774
g3
sS'acute,ergot,toxicity'
p5775
g3
sS'pharmacokinetics,of,cancidas'
p5776
g3
sS'can,then,be'
p5777
g3
sS'during,initial,treatment'
p5778
g3
sS'anafranil,caution,is'
p5779
g3
sS'vitro,metabolism,studies'
p5780
g3
sS'embryos,similarly,as'
p5781
g3
sS'is,due,to'
p5782
g9
sS'produce,local,irritation'
p5783
g3
sS'times,mouse,and'
p5784
g3
sS'on,day9,of'
p5785
g9
sS'anion,itself,could'
p5786
g3
sS'protease,inhibitors,indinavir'
p5787
g9
sS'on,voltage-dependent,ca'
p5788
g3
sS'be,increased,during'
p5789
g9
sS'adrenergic,are,to'
p5790
g9
sS'and,mg,kg'
p5791
g9
sS'his,risk,for'
p5792
g3
sS'inhibit,the,desired'
p5793
g9
sS'form,of,at'
p5794
g3
sS'maintain,concentrations,within'
p5795
g3
sS'increased,lipid,levels'
p5796
g3
sS'volunteers,were,randomized'
p5797
g3
sS'to,high,inter-patient'
p5798
g3
sS'increase,in,glycemia'
p5799
g3
sS'more,importantly,we'
p5800
g3
sS'is,potentiated,and'
p5801
g9
sS'and,were,co-administered'
p5802
g9
sS'therapy,on,the'
p5803
g9
sS'multivalent,cations,including'
p5804
g9
sS'in,healthy,young'
p5805
g3
sS'romazicon,blocks,the'
p5806
g9
sS'elc,should,be'
p5807
g9
sS'to,serum,proteins'
p5808
g9
sS'of,adverse,experiences'
p5809
g9
sS'patients,receiving,concomitant'
p5810
g9
sS'of,to,bovine'
p5811
g3
sS'environmental,may,alter'
p5812
g9
sS'viii,ix,and'
p5813
g3
sS'in,rheumatoid,arthritis'
p5814
g3
sS'two,other,cell'
p5815
g9
sS'estimates,of,steady-state'
p5816
g3
sS'greatest,value,of'
p5817
g3
sS'because,of,foscarnets'
p5818
g9
sS'focused,on,aspects'
p5819
g3
sS'standard,monitoring,of'
p5820
g9
sS'and,weight,gain'
p5821
g9
sS'and,watery,stool'
p5822
g3
sS'in,insulin-dependent,diabetic'
p5823
g3
sS'cell,tumors,was'
p5824
g3
sS'as,that,in'
p5825
g3
sS'daily,oral,dose'
p5826
g3
sS'no,drug-specific,interactions'
p5827
g3
sS'before,being,treated'
p5828
g3
sS'should,consider,starting'
p5829
g3
sS'density,of,d2'
p5830
g3
sS'of,nonsteroial,anti-inflammatory'
p5831
g9
sS'n,received,mg'
p5832
g3
sS'importance,to,all'
p5833
g3
sS'metabolism,may,result'
p5834
g3
sS'patient,was,also'
p5835
g3
sS'that,a,statistically'
p5836
g3
sS'be,administered,orally'
p5837
g9
sS'albumin,bound,and'
p5838
g3
sS'showing,a,higher'
p5839
g3
sS'if,a,antimicrobial'
p5840
g9
sS'potentially,alter,the'
p5841
g3
sS'laboratory,tests,performed'
p5842
g3
sS'thrombolytic,agents,the'
p5843
g3
sS'in,uterine,hypertonus'
p5844
g9
sS'gris-peg,nizoral,sporanox'
p5845
g9
sS'a,year,controlled'
p5846
g3
sS'at,lower,doses'
p5847
g9
sS'listed,agents,has'
p5848
g3
sS'that,decreases,stomach'
p5849
g3
sS'all,prescription,and'
p5850
g3
sS'are,above,or'
p5851
g3
sS'demonstrated,that,has'
p5852
g3
sS'had,no,effect'
p5853
g3
sS'rate,of,elimination'
p5854
g9
sS'were,enrolled,in'
p5855
g3
sS'dental,complications,blurred'
p5856
g9
sS'exjade,had,no'
p5857
g3
sS'inhibitors,but,which'
p5858
g3
sS'using,long-acting,or'
p5859
g9
sS'decrease,in,excretion'
p5860
g9
sS'or,other,concurrent'
p5861
g9
sS'concurrently,patient,should'
p5862
g3
sS'acidic,such,as'
p5863
g9
sS'variety,of,neurological'
p5864
g3
sS'hypercholesterolemic,patients,steady-state'
p5865
g9
sS'was,altered,in'
p5866
g3
sS'four,chemotherapeutic,agents'
p5867
g3
sS'exposure,and,active'
p5868
g9
sS'mg,bid,have'
p5869
g3
sS'effects,of,both'
p5870
g3
sS'an,effect,is'
p5871
g3
sS'dose,proportional,over'
p5872
g3
sS'to,other,asthma'
p5873
g3
sS'advised,to,refrain'
p5874
g3
sS'on,in,vitro'
p5875
g3
sS'when,lexapro,and'
p5876
g9
sS'prevent,absorption,of'
p5877
g3
sS'dsm-iv,diagnosed,schizophrenia'
p5878
g9
sS'with,adrenergic,blockers'
p5879
g3
sS'platelet,function,there'
p5880
g9
sS'the,commonly,used'
p5881
g3
sS'is,potentially,toxic'
p5882
g3
sS'extend,the,half-life'
p5883
g9
sS'measuring,locomotor,activity'
p5884
g3
sS'agents,have,not'
p5885
g3
sS'dopa,decarboxylase,inhibitor'
p5886
g3
sS'every,hours,are'
p5887
g9
sS'population,has,reduced'
p5888
g3
sS'a,possible,lack'
p5889
g3
sS'of,serum,binding'
p5890
g9
sS'concurrent,therapy,discontinuation'
p5891
g9
sS'may,require,a'
p5892
g3
sS'may,be,worsened'
p5893
g3
sS'and,had,an'
p5894
g3
sS'the,antimicrobial,activity'
p5895
g3
sS'spinal,endorphinergic,system'
p5896
g3
sS'the,bioavailability,auc'
p5897
g9
sS'when,nsaids,are'
p5898
g9
sS'therapeutic,effects,of'
p5899
g9
sS'bind,the,and'
p5900
g9
sS'sulfapyridine,may,interact'
p5901
g9
sS'being,observed,with'
p5902
g3
sS'cardiac,abnormalities,arrhythmia'
p5903
g9
sS'responses,to,ptx'
p5904
g9
sS'diuretics,fosinopril,sodium'
p5905
g9
sS'mg,day,of'
p5906
g3
sS'mg,or,of'
p5907
g3
sS'other,caution,is'
p5908
g9
sS'evidence,in,the'
p5909
g3
sS'potentiate,the,analgesic'
p5910
g9
sS'mg,day,on'
p5911
g9
sS'an,containing,gram'
p5912
g9
sS'see,warnings,and'
p5913
g3
sS'altered,serum,levels'
p5914
g9
sS'for,preparation,before'
p5915
g3
sS'nsaids,concomitant,administration'
p5916
g9
sS'be,transiently,elevated'
p5917
g3
sS'to,approximately,one-third'
p5918
g9
sS'normal,and,genetically'
p5919
g3
sS'nonbenzodiazepine,agonists,at'
p5920
g9
sS'and,single,dose'
p5921
g3
sS'by,its,ability'
p5922
g9
sS'moderate,to,marked'
p5923
g9
sS'but,mc,potentiates'
p5924
g9
sS'with,preparations,since'
p5925
g9
sS'm,v,to'
p5926
g3
sS'casodex,is,started'
p5927
g9
sS'a,dysregulation,of'
p5928
g3
sS'without,an,agent'
p5929
g9
sS'diminished,by,a'
p5930
g3
sS'sustiva,is,recommended'
p5931
g3
sS'near,the,placental'
p5932
g3
sS'elimination,of,and'
p5933
g3
sS'developed,a,b-cell'
p5934
g3
sS'the,inhibition,of'
p5935
g9
sS'result,is,true'
p5936
g3
sS'response,in,man'
p5937
g9
sS'v,v,solution'
p5938
g3
sS'fr,schedule,of'
p5939
g3
sS'lists,of,multiple'
p5940
g3
sS'required,to,antagonize'
p5941
g9
sS'of,the,cardiovascular'
p5942
g3
sS'phencyclidine,pcp,produces'
p5943
g3
sS'administration,of,may'
p5944
g3
sS'in,platelet,aggregation'
p5945
g3
sS'stomach,does,not'
p5946
g3
sS'a,hour,period'
p5947
g9
sS'hen,f1,that'
p5948
g3
sS'microvascular,complications,of'
p5949
g3
sS'eliminated,from,the'
p5950
g9
sS'effects,on,dosing'
p5951
g3
sS'cytochalasin,d,redistributed'
p5952
g3
sS'many,such,reactions'
p5953
g3
sS'duration,of,hexanal-induced'
p5954
g3
sS'in,whom,either'
p5955
g3
sS'plasma,is,not'
p5956
g3
sS'interactions,were,found'
p5957
g3
sS'the,trans-diol,by'
p5958
g3
sS'shown,that,small'
p5959
g3
sS'of,these,interactions'
p5960
g3
sS'even,when,was'
p5961
g9
sS'the,present,work'
p5962
g3
sS'whether,also,fulfils'
p5963
g3
sS'on,the,efficacy'
p5964
g3
sS'bsa,for,weeks'
p5965
g3
sS'first,days,of'
p5966
g3
sS'but,no,clinically'
p5967
g9
sS'digoxin,concomitant,administration'
p5968
g9
sS'thereafter,at,intervals'
p5969
g3
sS'or,corticosteroids,or'
p5970
g3
sS'combinational,action,in'
p5971
g3
sS'provide,the,patient'
p5972
g3
sS'mean,aucs,and'
p5973
g3
sS'of,binding,to'
p5974
g3
sS'of,dosage,should'
p5975
g3
sS'can,the,therapeutic'
p5976
g3
sS'interferences,dicumarol,and'
p5977
g3
sS'enhanced,secretion,of'
p5978
g3
sS'but,was,found'
p5979
g3
sS'discontinuation,of,a'
p5980
g9
sS'note,dissolution,of'
p5981
g3
sS'and,triazole,have'
p5982
g3
sS'may,also,cause'
p5983
g3
sS'associated,with,the'
p5984
g9
sS'voltage-dependent,ca,currents'
p5985
g3
sS'nph,human,immediately'
p5986
g3
sS'and,will,have'
p5987
g3
sS'are,predictable,and'
p5988
g3
sS'more,frequently,with'
p5989
g3
sS'doses,because,of'
p5990
g9
sS'were,decreased,on'
p5991
g9
sS'in,rabbits,backwards'
p5992
g3
sS'fat-soluble,including,vitamin'
p5993
g9
sS'to,phenytoin,intoxication'
p5994
g9
sS'blood,samples,were'
p5995
g3
sS'demonstrated,marked,reductions'
p5996
g3
sS'of,oral,administration'
p5997
g9
sS'bextra,is,either'
p5998
g3
sS'they,may,provoke'
p5999
g3
sS'or,dialysis,may'
p6000
g9
sS'doses,nanm,decreased'
p6001
g3
sS'with,higher,doses'
p6002
g9
sS'with,triamterene,concomitant'
p6003
g3
sS'presence,of,phenolic'
p6004
g3
sS'longer,in,the'
p6005
g9
sS'been,proposed,as'
p6006
g3
sS'blocking,agents,now'
p6007
g3
sS'conjugation,through,udp-glucuronyl'
p6008
g3
sS'to,this,effort'
p6009
g3
sS'tested,for,subjects'
p6010
g3
sS'antagonists,since,is'
p6011
g9
sS'patients,stabilized,on'
p6012
g9
sS'patients,receiving,could'
p6013
g3
sS'inhibitors,of,p-glycoprotein'
p6014
g3
sS'had,minimal,effects'
p6015
g3
sS'formation,that,affect'
p6016
g3
sS'therapeutic,index,including'
p6017
g9
sS'although,clinical,studies'
p6018
g9
sS'events,including,gastrointestinal'
p6019
g3
sS'those,elevations,of'
p6020
g3
sS'the,milk,secretion'
p6021
g3
sS'of,conjugated,and'
p6022
g3
sS'while,taking,amevive'
p6023
g3
sS'study,of,with'
p6024
g3
sS'benefits,of,this'
p6025
g9
sS'heparin,since,is'
p6026
g3
sS'exercised,in,using'
p6027
g3
sS'regularly,for,alterations'
p6028
g9
sS'metabolic,effects,specifically'
p6029
g3
sS'resulting,in,elevated'
p6030
g9
sS'activity,of,the'
p6031
g3
sS'therapy,such,as'
p6032
g9
sS'ketoconazole,and,isoniazid'
p6033
g9
sS'result,may,occur'
p6034
g3
sS'except,for,an'
p6035
g3
sS'these,agents,ammonium'
p6036
g9
sS'the,required,infusion'
p6037
g9
sS'formulation,of,with'
p6038
g3
sS'the,traction,of'
p6039
g3
sS'patients,taking,these'
p6040
g3
sS'of,therapeutic,to'
p6041
g3
sS'in,the,development'
p6042
g3
sS'in,situations,in'
p6043
g3
sS'received,alone,and'
p6044
g3
sS'thioethers,in,urine'
p6045
g3
sS'of,and,mg'
p6046
g9
sS'to,therapy,plasma'
p6047
g9
sS'corneal,lesions,in'
p6048
g9
sS'particular,low,doses'
p6049
g3
sS'function,are,considerably'
p6050
g3
sS'positive,and,negative'
p6051
g3
sS'because,of,possible'
p6052
g3
sS'epoxide,hydrolase,carbamazepine'
p6053
g3
sS'days,was,associated'
p6054
g9
sS'interactions,with,noted'
p6055
g3
sS'differences,in,clearance'
p6056
g3
sS'its,effectiveness,in'
p6057
g3
sS'vivo,clinically,in'
p6058
g3
sS'on,day,and'
p6059
g9
sS'generally,not,be'
p6060
g3
sS'cyp3a4,activity,in'
p6061
g9
sS'of,the,control'
p6062
g3
sS'd,at,microm'
p6063
g9
sS'interactions,between,and'
p6064
g3
sS'of,kidney,function'
p6065
g3
sS'of,the,acid'
p6066
g3
sS'should,be,assumed'
p6067
g3
sS'human,growth,hormone'
p6068
g9
sS'body,increase,in'
p6069
g3
sS'alpha-agonists,as,a'
p6070
g3
sS'evidently,a,later'
p6071
g3
sS'and,alone,and'
p6072
g3
sS'for,increased,risk'
p6073
g9
sS'and,left,ventricular'
p6074
g9
sS'hyperglycemia,has,also'
p6075
g3
sS'some,pronestyl,sulfa'
p6076
g9
sS'determination,of,prothrombin'
p6077
g3
sS'with,the,label'
p6078
g9
sS'of,elimination,is'
p6079
g3
sS'profound,sedation,or'
p6080
g9
sS'fluvoxamine,is,a'
p6081
g3
sS'kits,such,as'
p6082
g3
sS'of,chemicals,that'
p6083
g3
sS'introduced,atypical,antipsychotic'
p6084
g3
sS'the,metabolism,or'
p6085
g9
sS'who,had,had'
p6086
g3
sS'of,body,fat'
p6087
g3
sS'highly,fortified,with'
p6088
g3
sS'treated,according,to'
p6089
g3
sS'neither,sufficient,to'
p6090
g3
sS'the,metabolism,of'
p6091
g9
sS'in,serious,or'
p6092
g3
sS'and,high,blood'
p6093
g9
sS'although,no,clinical'
p6094
g9
sS'norvir,viracept,astramorph'
p6095
g9
sS'mg,qd,mg'
p6096
g9
sS'completed,at,least'
p6097
g3
sS'compared,with,neurons'
p6098
g3
sS'action,of,zebeta'
p6099
g9
sS'were,on,chronic'
p6100
g3
sS'triglycerides,sgot,ast'
p6101
g9
sS'pharmacokinetics,were,assessed'
p6102
g3
sS'the,patient,should'
p6103
g3
sS'reduced,or,abolished'
p6104
g9
sS'isocarboxazid,and,begin'
p6105
g3
sS'demonstrated,that,the'
p6106
g9
sS'at,m,v'
p6107
g3
sS'antagonism,between,and'
p6108
g9
sS'observed,to,enhance'
p6109
g9
sS'cardiovascular,disease,or'
p6110
g9
sS'with,celebrex,may'
p6111
g9
sS'potential,bleeding,international'
p6112
g3
sS'size,to,the'
p6113
g3
sS'of,and,may'
p6114
g9
sS'ieg,arc,activity-regulated'
p6115
g3
sS'of,coadministered,medicinal'
p6116
g3
sS'including,robust,induction'
p6117
g3
sS'the,inhibitor,on'
p6118
g3
sS'uganda,since,the'
p6119
g3
sS'vitro,perfused,pancreases'
p6120
g3
sS'isolated,rabbit,gastric'
p6121
g3
sS'which,interfere,with'
p6122
g3
sS'appropriate,dosage,adjustment'
p6123
g9
sS'no,are,known'
p6124
g3
sS'of,hcl,is'
p6125
g9
sS'hours,after,cholestyramine'
p6126
g3
sS'and,is,therefore'
p6127
g9
sS'toxicity,characterized,by'
p6128
g3
sS'antiarrhythmics,other,such'
p6129
g3
sS'patients,with,heart'
p6130
g3
sS'of,each,agent'
p6131
g3
sS'drug-drug,interactions,posed'
p6132
g3
sS'in,march,citrate'
p6133
g3
sS'took,mg,of'
p6134
g3
sS'are,made,they'
p6135
g3
sS'disposition,of,was'
p6136
g3
sS'sufficient,function,the'
p6137
g3
sS'investigated,whether,these'
p6138
g3
sS'non-nucleoside,reverse,transcriptase'
p6139
g3
sS'additive,pharmacodynamic,effect'
p6140
g3
sS'vitro,binding,studies'
p6141
g3
sS'results,suggest,that'
p6142
g3
sS'adversely,affect,disease'
p6143
g9
sS'cyp2d6,increased,the'
p6144
g9
sS'discussed,in,chapter'
p6145
g3
sS'taking,placebo,as'
p6146
g3
sS'when,using,romazicon'
p6147
g9
sS'by,dmpge2,given'
p6148
g3
sS'pharmacokinetics,or,pharmacodynamics'
p6149
g3
sS'or,that,inhibit'
p6150
g9
sS'or,caused,excessive'
p6151
g3
sS'cause,pancreatitis,may'
p6152
g3
sS'of,mg,once'
p6153
g9
sS'adversely,affect,the'
p6154
g3
sS'chemicals,that,includes'
p6155
g3
sS'supraventricular,arrhythmia,and'
p6156
g9
sS'micrograms,kg,of'
p6157
g3
sS'eg,or,than'
p6158
g9
sS'effected,by,endothelial'
p6159
g3
sS'may,not,be'
p6160
g3
sS'but,may,be'
p6161
g3
sS'of,caused,by'
p6162
g9
sS'of,already,accumulated'
p6163
g9
sS'benzodiazepines,metabolized,by'
p6164
g9
sS'when,a,hypothyroid'
p6165
g3
sS'practice,the,greatest'
p6166
g3
sS'or,since,it'
p6167
g3
sS'in,another,study'
p6168
g3
sS'provoke,convulsions,in'
p6169
g3
sS'no,formal,assessments'
p6170
g3
sS'evidence,in,clinical'
p6171
g3
sS'agents,may,potentiate'
p6172
g9
sS'alter,the,pharmacokinetics'
p6173
g3
sS'resulting,from,vasodilating'
p6174
g3
sS'organophosphorous,compound,and'
p6175
g3
sS'lymphocyte,disorders,plasmacytic'
p6176
g3
sS'with,coadministration,up'
p6177
g9
sS'hydrochloride,given,prior'
p6178
g9
sS'and,the,cmax'
p6179
g9
sS'specific,methods,such'
p6180
g3
sS'and,is,accelerated'
p6181
g9
sS'day,dosing,with'
p6182
g3
sS'combined,with,the'
p6183
g9
sS'that,gaba-positive,be'
p6184
g3
sS'if,the,porter-silber'
p6185
g3
sS'since,these,patients'
p6186
g9
sS'and,moderate,cyp1a2'
p6187
g9
sS'derivatives,dihydroergotamine,contraindicated'
p6188
g3
sS'thiazide,and,even'
p6189
g9
sS'for,hours,after'
p6190
g3
sS'no,carcinogenicity,or'
p6191
g3
sS'isuprel,should,be'
p6192
g9
sS'between,a,macrolide'
p6193
g3
sS'an,nsaid,or'
p6194
g9
sS'sandimmune--on,hepatic,microsomal'
p6195
g3
sS'epinephrine,may,antagonize'
p6196
g9
sS'therapy,and,that'
p6197
g9
sS'a,cyp2d6,substrate'
p6198
g9
sS'as,a,consequence'
p6199
g9
sS'auc,and,increases'
p6200
g3
sS'monitored,and,any'
p6201
g3
sS'of,other,agents'
p6202
g3
sS'positive,level,to'
p6203
g9
sS'acid,in,combination'
p6204
g3
sS'or,slightly,greater'
p6205
g9
sS'alone,the,possible'
p6206
g9
sS'a4,isozyme,which'
p6207
g3
sS'of,biocytin,inclusion'
p6208
g3
sS'recognized,that,a'
p6209
g3
sS'pediatric,and,the'
p6210
g3
sS'of,from,midcycle'
p6211
g3
sS'during,the,cure'
p6212
g9
sS'or,but,not'
p6213
g9
sS'phenytoin,phenytoin,causes'
p6214
g9
sS'schizophrenia,schizoaffective,disorder'
p6215
g9
sS'the,interpretation,of'
p6216
g3
sS'of,mg,neurontin'
p6217
g3
sS'for,cmax,when'
p6218
g9
sS'enzyme,induction,thus'
p6219
g9
sS'given,hours,prior'
p6220
g9
sS'reinstate,psychostimulant,self-administration'
p6221
g3
sS'that,mg,kg'
p6222
g9
sS'above,or,near'
p6223
g9
sS'have,all,been'
p6224
g3
sS'is,not,all'
p6225
g3
sS'including,those,undergoing'
p6226
g3
sS'mucosal,cells,to'
p6227
g3
sS'ketoconazole,in,healthy'
p6228
g9
sS'can,prolong,bleeding'
p6229
g3
sS'mm,was,a'
p6230
g3
sS'only,one,contra-indication'
p6231
g3
sS'blood,pressure,after'
p6232
g9
sS'mg,qd,days'
p6233
g9
sS'to,pentobarbital-induced,sedation'
p6234
g3
sS'ast,sgot,alt'
p6235
g3
sS'suitability,of,the'
p6236
g3
sS'metabolized,via,cyp3a4'
p6237
g9
sS'differ,and,they'
p6238
g3
sS'of,this,increase'
p6239
g3
sS'increase,plasma,concentrations'
p6240
g3
sS'restricted,and,an'
p6241
g3
sS'functions,i,relational'
p6242
g3
sS'our,objective,was'
p6243
g3
sS'cytotoxic,agents,enhanced'
p6244
g9
sS'changes,and,or'
p6245
g9
sS'be,low,for'
p6246
g3
sS'dimethyl-4,hydroxyphenyl,piperidine'
p6247
g9
sS'studies,including,interactions'
p6248
g3
sS'min,interval,significantly'
p6249
g9
sS'common,comorbidity,and'
p6250
g3
sS'in,rheumatic,disease'
p6251
g9
sS'agents,nsaids,monoamine'
p6252
g9
sS'is,inadvisable,to'
p6253
g9
sS'duragesic,is,given'
p6254
g3
sS'cmc-cys,conjugates,on'
p6255
g3
sS'and,azoles,are'
p6256
g3
sS'agents,should,be'
p6257
g9
sS'of,cyclic,amp'
p6258
g3
sS'levels,of,have'
p6259
g9
sS'basis,it,is'
p6260
g3
sS'aims,hypothesis,there'
p6261
g3
sS'serious,and,unexpected'
p6262
g3
sS'of,hydroxytolbutamide,and'
p6263
g3
sS'on,the,microsomal'
p6264
g3
sS'conditioning,and,a'
p6265
g3
sS'tambocor,unless,in'
p6266
g9
sS'a,fold,increase'
p6267
g9
sS'of,phosphatases,in'
p6268
g3
sS'of,the,macrolide'
p6269
g9
sS'mevacor,in,hypercholesterolemic'
p6270
g3
sS'co-administration,of,plendil'
p6271
g3
sS'small,intestinal,transits'
p6272
g3
sS'as,a,d'
p6273
g3
sS'of,u,of'
p6274
g3
sS'to,decrease,glutathione'
p6275
g9
sS'in,particular,a2'
p6276
g3
sS'specific,method,such'
p6277
g3
sS'of,interaction,with'
p6278
g3
sS'circulation,there,is'
p6279
g9
sS'established,therapy,with'
p6280
g9
sS'not,significant,contributors'
p6281
g3
sS'growth,hormone,concomitant'
p6282
g9
sS'tachycardia,do,not'
p6283
g3
sS'effects,of,diethyl'
p6284
g3
sS'dosage,of,upward'
p6285
g3
sS'reduced,subjects,reports'
p6286
g3
sS'premedicated,with,such'
p6287
g3
sS'urate,uricosuric,agents'
p6288
g9
sS'or,without,clinical'
p6289
g9
sS'can,interact,with'
p6290
g9
sS'and,concurrently,the'
p6291
g9
sS'by,jaffe,reaction'
p6292
g3
sS'possible,that,concomitant'
p6293
g9
sS'information,is,available'
p6294
g3
sS'day,or,placebo'
p6295
g3
sS'qd,and,mg'
p6296
g9
sS'is,offset,by'
p6297
g3
sS'concomitantly,administered,highly'
p6298
g3
sS'alcohol-related,deaths,is'
p6299
g3
sS'induce,fungal,resistance'
p6300
g9
sS'do,not,metabolize'
p6301
g3
sS'advisable,not,to'
p6302
g3
sS'than,parkinsons,disease'
p6303
g3
sS'excreted,unchanged,in'
p6304
g3
sS'by,p450,d6'
p6305
g3
sS'artifactually,altered,it'
p6306
g3
sS'of,to,the'
p6307
g3
sS'a,significant,impact'
p6308
g3
sS'also,refer,to'
p6309
g3
sS'are,not,equivalent'
p6310
g3
sS'clinical,experience,indicates'
p6311
g9
sS'of,medline,premedline'
p6312
g3
sS'angiotensinogen,renin,substrate'
p6313
g3
sS'that,caution,may'
p6314
g3
sS'metabolized,by,nor'
p6315
g3
sS'unrelated,to,sexual'
p6316
g3
sS'garlic,allium,sativum'
p6317
g9
sS'h,s,regimen'
p6318
g9
sS'with,in,causing'
p6319
g9
sS'advised,and,downward'
p6320
g9
sS'the,renal,excretion'
p6321
g9
sS'in,vitro,may'
p6322
g9
sS'hamster,responds,excessively'
p6323
g3
sS'interactions,particularly,in'
p6324
g3
sS'ergot-type,medications,like'
p6325
g9
sS'with,extreme,caution'
p6326
g9
sS'methadone,coadministration,of'
p6327
g9
sS'substrate,of,the'
p6328
g3
sS'show,that,and'
p6329
g9
sS'and,exert,direct'
p6330
g3
sS'this,combination,with'
p6331
g3
sS'as,in,the'
p6332
g3
sS'on,stable,therapy'
p6333
g3
sS'deletion,of,any'
p6334
g3
sS'in,a,parallel'
p6335
g3
sS'hours,of,administration'
p6336
g3
sS'possible,complications,of'
p6337
g9
sS'adverse,reactions,from'
p6338
g3
sS'bioavailability,studies,in'
p6339
g3
sS'enzymes,lapatinib,undergoes'
p6340
g3
sS'related,both,to'
p6341
g3
sS'by,the,prescriber'
p6342
g3
sS'administration,of,peptide'
p6343
g3
sS'when,another,drug'
p6344
g3
sS'induced,diarrhea,but'
p6345
g3
sS'antizol,mg,kg'
p6346
g9
sS'whereas,h-spiroperidol,binding'
p6347
g3
sS'halogenated,hydrocarbon,general'
p6348
g9
sS'attention,and,may'
p6349
g3
sS'and,side,effect'
p6350
g3
sS'concentrations,of,among'
p6351
g9
sS'reuptake,inhibitors,ssris'
p6352
g3
sS'levo-dromoran,with,all'
p6353
g9
sS'may,have,lower'
p6354
g3
sS'patients,consuming,while'
p6355
g9
sS'of,co-administration,with'
p6356
g3
sS'of,anaphylactic,shock'
p6357
g9
sS'with,have,been'
p6358
g3
sS'of,non-potassium,sparing'
p6359
g9
sS'and,pharmacokinetics,at'
p6360
g3
sS'more,efficient,substrate'
p6361
g3
sS'a,single,mg'
p6362
g9
sS'however,is,small'
p6363
g9
sS'inhibitor,of,c'
p6364
g9
sS'patients,with,creatinine'
p6365
g3
sS'particularly,with,higher'
p6366
g9
sS'clinical,trials,to'
p6367
g3
sS'the,pressor,activity'
p6368
g3
sS'temperature,returned,to'
p6369
g3
sS'failed,to,increase'
p6370
g3
sS'be,displaced,from'
p6371
g9
sS'unless,there,are'
p6372
g3
sS'and,use,as'
p6373
g3
sS'that,modulates,in'
p6374
g9
sS'prostatic,epithelium,proliferates'
p6375
g3
sS'concurrently,with,compared'
p6376
g9
sS'ethynyl,and,to'
p6377
g3
sS'probenecid,probenecid,is'
p6378
g9
sS'warning,signs,irrespective'
p6379
g3
sS'nephrotoxicity,and,or'
p6380
g3
sS'requirements,for,or'
p6381
g3
sS'alone,at,recommended'
p6382
g9
sS'vitamin,d3,administration'
p6383
g9
sS'concomitant,medications,should'
p6384
g3
sS'such,it,may'
p6385
g3
sS'doses,there,were'
p6386
g3
sS'is,needed,the'
p6387
g9
sS'pheochromocytoma,and,being'
p6388
g3
sS'maximum,recommended,human'
p6389
g3
sS'keppra,and,other'
p6390
g3
sS'preparations,in,the'
p6391
g3
sS'also,appeared,to'
p6392
g9
sS'of,nondepolarizing,agents'
p6393
g9
sS'in,rats,tarsal'
p6394
g3
sS'encephalopathy,are,occurred'
p6395
g3
sS'inducers,of,the'
p6396
g3
sS'potentiating,action,of'
p6397
g9
sS'age,and,older'
p6398
g3
sS'system,is,less'
p6399
g3
sS'must,take,into'
p6400
g3
sS'in,reduced,clearance'
p6401
g9
sS'anhydrase,inhibitors,and'
p6402
g9
sS'increase,steady-state,plasma'
p6403
g3
sS'dosage,of,equetrotm'
p6404
g3
sS'further,kidney,damage'
p6405
g3
sS'vitro,studies,angiomax'
p6406
g3
sS'prostaglandin,synthesis,it'
p6407
g9
sS'and,then,titrated'
p6408
g9
sS'the,conventional,formulation'
p6409
g3
sS'of,different,on'
p6410
g3
sS'to,survive,in'
p6411
g3
sS'post,myocardial,infarction'
p6412
g3
sS'that,alters,hormone'
p6413
g3
sS'size,of,wheal'
p6414
g3
sS'levels,and,lessened'
p6415
g9
sS'similar,effect,in'
p6416
g3
sS'of,temperature,changes'
p6417
g3
sS'sedation,within,hours'
p6418
g3
sS'their,relevance,continues'
p6419
g3
sS'to,lead,to'
p6420
g9
sS'twofold,increase,in'
p6421
g9
sS'antagonism,of,the'
p6422
g9
sS'induction,by,a'
p6423
g3
sS'because,cyp,a4'
p6424
g3
sS'or,therapy,on'
p6425
g9
sS'concomitantly,with,prothrombin'
p6426
g9
sS'subjects,who,received'
p6427
g3
sS'in,a,dose-dependent'
p6428
g9
sS'or,h1-blocking,agents'
p6429
g9
sS'interactions,in,vitro'
p6430
g3
sS'to,significant,shifts'
p6431
g3
sS'phenobarbital,coadministration,of'
p6432
g9
sS'too,small,to'
p6433
g3
sS'inducer,of,metabolism'
p6434
g9
sS'co-factors,could,be'
p6435
g3
sS'increase,with,multiple'
p6436
g9
sS'or,induce,cytochromes'
p6437
g3
sS'mcf-7,cells,treated'
p6438
g3
sS'the,electrolyte,loss'
p6439
g9
sS'to,substances,of'
p6440
g3
sS'of,and,minimizes'
p6441
g9
sS'with,c,diethyl'
p6442
g3
sS'anion-exchange,resins,an'
p6443
g9
sS'of,wellbutrin,and'
p6444
g9
sS'state,therefore,the'
p6445
g3
sS'normovolemic,healthy,subjects'
p6446
g9
sS'increase,in,uremic'
p6447
g3
sS'cardiovascular,system,can'
p6448
g9
sS'employed,in,determining'
p6449
g3
sS'by,either,discontinuing'
p6450
g9
sS'advice,of,a'
p6451
g9
sS'synergistic,depressant,effects'
p6452
g3
sS'meal,resulted,in'
p6453
g9
sS'cardiac,enlargement,and'
p6454
g9
sS'enhance,the,nephrotoxicity'
p6455
g9
sS'liver,to,the'
p6456
g3
sS'compounds,such,as'
p6457
g9
sS'of,and,an'
p6458
g9
sS'a,dosing,schedule'
p6459
g3
sS'metabolic,reactions,was'
p6460
g3
sS'without,mg,of'
p6461
g3
sS'coadministering,these,agents'
p6462
g9
sS'such,as,cyp3a4'
p6463
g9
sS'sodium,pertechnetate,tc99m'
p6464
g3
sS'thiazide,acidic,or'
p6465
g9
sS'interact,with,wthionamide'
p6466
g3
sS'with,major,psychotic'
p6467
g9
sS'with,alkaline,earth'
p6468
g3
sS'bleeding,is,advised'
p6469
g3
sS'a,c,a'
p6470
g9
sS'and,partly,antagonized'
p6471
g9
sS'interactions,of,clolar'
p6472
g3
sS'state,following,dosing'
p6473
g3
sS'have,pre-existing,cardiac'
p6474
g9
sS'mesenteric,ganglion,hypogastric'
p6475
g3
sS'busulfex,may,result'
p6476
g9
sS'of,deaths,associated'
p6477
g3
sS'normal,volunteers,have'
p6478
g9
sS'may,give,false'
p6479
g9
sS'indanyl,sodium,blood'
p6480
g9
sS'may,develop,higher'
p6481
g3
sS'activity,while,only'
p6482
g9
sS'cyclosporine,concomitant,administration'
p6483
g3
sS'review,is,presented'
p6484
g3
sS'these,experiences,have'
p6485
g3
sS'significant,shifts,in'
p6486
g3
sS'at,mg,bid'
p6487
g9
sS'protein,eszopiclone,is'
p6488
g3
sS'comt,hormone,levels'
p6489
g3
sS'usual,prescription,dose'
p6490
g9
sS'co-administration,of,precedex'
p6491
g9
sS'no,signs,of'
p6492
g3
sS'is,administered,to'
p6493
g9
sS'metabolic,effects,of'
p6494
g9
sS'has,been,established'
p6495
g9
sS'diminish,oral,response'
p6496
g9
sS'a,increase,of'
p6497
g9
sS'stereoisomers,of,n-allylnormetazocine'
p6498
g3
sS'medical,intervention,in'
p6499
g3
sS'no,signs,or'
p6500
g9
sS'of,antimicrobial,combinations'
p6501
g3
sS'to,approximately,times'
p6502
g3
sS'high,degree,of'
p6503
g3
sS'with,a,partially'
p6504
g3
sS'factors,as,age'
p6505
g3
sS'to,obstetric,blocks'
p6506
g9
sS'and,i,sodium'
p6507
g3
sS'by,the,simultaneous'
p6508
g9
sS'not,affect,distribution'
p6509
g3
sS'adequate,methods,of'
p6510
g3
sS'metabolism,of,antagonists'
p6511
g3
sS'with,haca,titers'
p6512
g3
sS'cobalt,excretion,was'
p6513
g3
sS'volunteers,no,clinically'
p6514
g3
sS'single,high,dose'
p6515
g9
sS'presumably,by,inhibition'
p6516
g9
sS'properties,on,renal'
p6517
g3
sS'even,when,parenteral'
p6518
g3
sS'false,increases,in'
p6519
g3
sS'hypothalamic-pituitary,testicular,axis'
p6520
g3
sS'exhibit,doubling,times'
p6521
g3
sS'mao,inhibition,of'
p6522
g3
sS'in,concert,with'
p6523
g3
sS'formation,in,u937'
p6524
g9
sS'others,or,supplements'
p6525
g3
sS'increases,of,previously'
p6526
g9
sS'used,after,insertion'
p6527
g3
sS'hypotension,could,result'
p6528
g3
sS'well,as,diminished'
p6529
g9
sS'the,decreased,urinary'
p6530
g3
sS'common,phenotypic,subset'
p6531
g3
sS'arthritis,clinical,trials'
p6532
g3
sS'and,and,have'
p6533
g3
sS'gram,negative,bacteria'
p6534
g3
sS'have,been,taking'
p6535
g3
sS'bar-press,behavior,in'
p6536
g3
sS'when,is,started'
p6537
g9
sS'thioxanthene,and,butyrophenone'
p6538
g9
sS'approximate,reduction,of'
p6539
g9
sS'release,formulation,of'
p6540
g3
sS'study,in,which'
p6541
g9
sS'omnicef,for,oral'
p6542
g3
sS'likely,that,a'
p6543
g3
sS'a,and,decrease'
p6544
g9
sS'small,n,combination'
p6545
g9
sS'misuse,of,and'
p6546
g9
sS'combination,of,amprenavir'
p6547
g9
sS'hormonal,replacement,increases'
p6548
g3
sS'dependent,oxidation,responsible'
p6549
g9
sS'available,to,direct'
p6550
g3
sS'primarily,h2,blockers'
p6551
g3
sS'effect,of,extraneal'
p6552
g3
sS'upward,the,dose'
p6553
g9
sS'meal,or,at'
p6554
g3
sS'interactions,general,although'
p6555
g3
sS'plasmacytic,hyperplasia,polymorphic'
p6556
g3
sS'work,has,focused'
p6557
g3
sS'carbamazepine,population,pharmacokinetic'
p6558
g9
sS'cautiously,and,perhaps'
p6559
g3
sS'the,consumption,of'
p6560
g9
sS'rule,out,possible'
p6561
g3
sS'while,not,systematically'
p6562
g9
sS'cytochrome,p-450,isoenzymes'
p6563
g9
sS'not,compensate,for'
p6564
g9
sS'inhibited,to,an'
p6565
g3
sS'metabolized,mainly,by'
p6566
g3
sS'of,inhibition,are'
p6567
g9
sS'are,illustrated,by'
p6568
g3
sS'a,recent,case'
p6569
g9
sS'status,of,several'
p6570
g3
sS'positive,for,an'
p6571
g3
sS'cell,body,and'
p6572
g3
sS'sgot,ast,and'
p6573
g9
sS'in,patients,concurrently'
p6574
g3
sS'are,required,when'
p6575
g9
sS'l,for,single'
p6576
g3
sS'eg,may,have'
p6577
g9
sS'for,exjade,should'
p6578
g9
sS'antagonist,class,including'
p6579
g9
sS'dose,ranging,from'
p6580
g9
sS'of,may,even'
p6581
g9
sS'duragesic,transdermal,system'
p6582
g9
sS'treatment,with,there'
p6583
g9
sS'a,d,e'
p6584
g3
sS'and,prolongation,of'
p6585
g9
sS'limited,comparative,data'
p6586
g3
sS'atherosclerotic,disease,is'
p6587
g3
sS'is,neither,metabolized'
p6588
g3
sS'with,the,glucose'
p6589
g3
sS'in,alcoholic,beverages'
p6590
g9
sS'increased,dramatically,from'
p6591
g3
sS'co-administered,with,potent'
p6592
g3
sS'have,not,reported'
p6593
g3
sS'long-acting,such,as'
p6594
g3
sS'rise,to,additive'
p6595
g3
sS'during,the,concomitant'
p6596
g9
sS'other,ergot,alkaloids'
p6597
g9
sS'administration,of,cmi'
p6598
g9
sS'concentrations,were,similar'
p6599
g3
sS'the,free,concentration'
p6600
g3
sS'against,symptoms,of'
p6601
g3
sS'laboratories,platelia,aspergillus'
p6602
g3
sS'vasodilators,the,following'
p6603
g9
sS'in,a,limited'
p6604
g3
sS'insertion,of,a'
p6605
g3
sS'a,volatile,agent'
p6606
g3
sS'not,affect,plasma'
p6607
g9
sS'on,the,variability'
p6608
g3
sS'concurrently,the,should'
p6609
g9
sS'agents,including,protease'
p6610
g3
sS'and,fold,in'
p6611
g3
sS'data,relating,to'
p6612
g3
sS'increased,risk,for'
p6613
g9
sS'drug,metabolizing,enzymes'
p6614
g3
sS'plasma,levels,in'
p6615
g9
sS'prior,to,during'
p6616
g9
sS'patients,receiving,single'
p6617
g3
sS'hemodialysis,until,his'
p6618
g3
sS'with,activity,effects'
p6619
g3
sS'results,in,excessive'
p6620
g9
sS'reaction,while,taking'
p6621
g3
sS'substituted,for,other'
p6622
g3
sS'the,relationship,of'
p6623
g9
sS'treated,simultaneously,with'
p6624
g3
sS'the,potential,effect'
p6625
g3
sS'test,interactions,corticosteroids'
p6626
g3
sS'oral,unreliable,prothrombin'
p6627
g9
sS'confidence,interval,for'
p6628
g3
sS'effect,of,ace'
p6629
g9
sS'metabolism,of,labetalol'
p6630
g3
sS'ml,or,m'
p6631
g3
sS'resulting,in,rare'
p6632
g9
sS'higher,dosage,of'
p6633
g3
sS'simultaneous,dosing,of'
p6634
g9
sS'demonstrated,the,following'
p6635
g3
sS'of,cns,stimulation'
p6636
g9
sS'may,impair,fertility'
p6637
g3
sS'antagonists,cimetidine,coadministration'
p6638
g9
sS'are,not,limited'
p6639
g3
sS'properties,can,blunt'
p6640
g3
sS'to,accident,suicide'
p6641
g3
sS'milk,at,levels'
p6642
g3
sS'that,and,oral'
p6643
g9
sS'interaction,involving,the'
p6644
g9
sS'valdecoxib,caused,a'
p6645
g9
sS'of,is,not'
p6646
g3
sS'decreases,renal,clearance'
p6647
g9
sS'to,be,particularly'
p6648
g3
sS'resulting,in,adverse'
p6649
g3
sS'year,pharmacokinetics,exposure-response'
p6650
g3
sS'coadministered,with,other'
p6651
g9
sS'agents,nitrogen,mustard'
p6652
g3
sS'the,nerve,transmission'
p6653
g3
sS'qtc,values,of'
p6654
g9
sS'precipitate,is,formed'
p6655
g3
sS'to,those,with'
p6656
g9
sS'potentially,toxic,that'
p6657
g3
sS'we,investigated,whether'
p6658
g3
sS'a,baseline,phenytoin'
p6659
g9
sS'absorption,of,bezalip'
p6660
g9
sS'interaction,information,digoxin'
p6661
g3
sS'to,the,platelets'
p6662
g3
sS'now,available,in'
p6663
g3
sS'exercised,when,considering'
p6664
g9
sS'therapy,may,need'
p6665
g9
sS'these,above,findings'
p6666
g3
sS'glucose,and,concentrations'
p6667
g3
sS'redistributed,type,inositol'
p6668
g3
sS'not,affect,idv'
p6669
g3
sS'concurrently,with,d2-antagonists'
p6670
g9
sS'of,these,compounds'
p6671
g3
sS'nevertheless,the,effects'
p6672
g9
sS'of,aminotransferase,sgot'
p6673
g3
sS'can,induce,early'
p6674
g3
sS'the,auc,of'
p6675
g9
sS'on,the,mean'
p6676
g3
sS'state,auc,ss'
p6677
g9
sS'renal,excretion,ibuprofen'
p6678
g3
sS'interaction,can,the'
p6679
g3
sS'ml,h,to'
p6680
g9
sS'inhibits,or,induces'
p6681
g3
sS'increase,the,pharmacologic'
p6682
g9
sS'd3,exhibit,characteristic'
p6683
g3
sS'with,natrecor,in'
p6684
g3
sS'tumors,was,evident'
p6685
g3
sS'bsa,caused,a'
p6686
g3
sS'is,important,for'
p6687
g3
sS'for,the,wild-type'
p6688
g3
sS'two,patients,with'
p6689
g9
sS'test,for,ketones'
p6690
g3
sS'in,chick,embryos'
p6691
g3
sS'times,increase,in'
p6692
g9
sS'this,has,been'
p6693
g3
sS'to,inactive,metabolites'
p6694
g3
sS'preparations,has,not'
p6695
g3
sS'as,and,because'
p6696
g9
sS'cyp3a4,inhibitors,eg'
p6697
g3
sS'the,underlying,mechanism'
p6698
g9
sS'interactions,certain,endocrine'
p6699
g3
sS'of,grams,three'
p6700
g9
sS'together,especially,in'
p6701
g3
sS'carefully,and,in'
p6702
g3
sS'had,less,than'
p6703
g9
sS'some,of,a'
p6704
g3
sS'reversible,impairment,of'
p6705
g9
sS'false-positive,findings,in'
p6706
g3
sS'a,relationship,of'
p6707
g9
sS'therapy,a,combination'
p6708
g3
sS'impair,liver,function'
p6709
g3
sS'the,histology,of'
p6710
g3
sS'of,caucasians,are'
p6711
g3
sS'beta-blocking,agents,has'
p6712
g3
sS'in,greater,gastrointestinal'
p6713
g9
sS'the,dose,that'
p6714
g3
sS'mean,auc,c'
p6715
g3
sS'mammary,tumor,virus'
p6716
g3
sS'on,blocking,the'
p6717
g3
sS'are,observed,in'
p6718
g3
sS'effect,of,sensipar'
p6719
g3
sS'the,interaction,may'
p6720
g3
sS'pharmacodynamic,interactions,the'
p6721
g9
sS'is,the,binding'
p6722
g3
sS'concentration,index,fici'
p6723
g3
sS'v,readily,penetrates'
p6724
g3
sS'to,be,adjusted'
p6725
g3
sS'year,risk,of'
p6726
g3
sS'secretion,or,resistance'
p6727
g3
sS'harm,to,the'
p6728
g3
sS'that,administration,of'
p6729
g3
sS'dosing,of,aprepitant'
p6730
g9
sS'potentiated,by,monoamine'
p6731
g9
sS'kilometers,of,walking'
p6732
g3
sS'normalized,ratio,and'
p6733
g3
sS'use,of,h2'
p6734
g9
sS'to,or,withdrawn'
p6735
g9
sS'dilantin,use,of'
p6736
g9
sS'and,and,at'
p6737
g9
sS'chronic,treatments,corrective'
p6738
g3
sS'the,mediated,reduction'
p6739
g3
sS'dose,of,these'
p6740
g9
sS'intestinal,tumors,and'
p6741
g3
sS'that,pulmozyme,can'
p6742
g3
sS'with,diagnostic,or'
p6743
g3
sS'of,this,product'
p6744
g3
sS'or,severity,of'
p6745
g9
sS'lansoprazole,is,metabolized'
p6746
g3
sS'nursing,infants,from'
p6747
g3
sS'eg,dizziness,nausea'
p6748
g3
sS'a,mg,once-daily'
p6749
g3
sS'including,the,corrected'
p6750
g3
sS'healthy,subjects,given'
p6751
g9
sS'coadministration,of,an'
p6752
g9
sS'vii,viii,ix'
p6753
g3
sS'administered,radiographic,iodinated'
p6754
g9
sS'release,whereas,the'
p6755
g3
sS'cells,with,tam'
p6756
g3
sS'increase,the,effects'
p6757
g9
sS'serum,proteins,or'
p6758
g9
sS'ns,were,not'
p6759
g3
sS'levels,of,corticosteroid-binding'
p6760
g3
sS'markedly,increases,the'
p6761
g9
sS'studies,oral,and'
p6762
g3
sS'other,tegretol,tagamet'
p6763
g3
sS'triacylglycerol,synthesis,to'
p6764
g3
sS'coadminstration,with,agents'
p6765
g3
sS'concurrently,with,cerubidine'
p6766
g9
sS'secretory,diarrhea,model'
p6767
g3
sS'the,added,concentration'
p6768
g3
sS'in,the,extent'
p6769
g3
sS'by,explain,the'
p6770
g9
sS'of,felbatol,therapy'
p6771
g3
sS'mg,day,orally'
p6772
g9
sS'asthma,control,and'
p6773
g3
sS'however,to,predict'
p6774
g3
sS'seal,recordings,of'
p6775
g3
sS'inclusion,on,responses'
p6776
g3
sS'the,renal,clearance'
p6777
g9
sS'overload,both,in'
p6778
g3
sS'omeprazole,no,clinically'
p6779
g3
sS'receiving,both,and'
p6780
g9
sS'severe,prolonged,hypotension'
p6781
g9
sS'the,sst,were'
p6782
g3
sS'filtration,or,tubular'
p6783
g3
sS'with,various,oral'
p6784
g3
sS'with,other,including'
p6785
g3
sS'excitement,depression,hallucinations'
p6786
g3
sS'rare,instances,of'
p6787
g9
sS'the,last,years'
p6788
g3
sS'female,n,in'
p6789
g3
sS'microm,which,was'
p6790
g3
sS'avoided,in,combination'
p6791
g9
sS'of,p,and'
p6792
g9
sS'treatments,to,this'
p6793
g3
sS'of,see,warnings'
p6794
g9
sS'as,or,in'
p6795
g9
sS'and,lipids,were'
p6796
g3
sS'receiving,sprycel,should'
p6797
g3
sS'effects,of,when'
p6798
g9
sS'auc,was,and'
p6799
g3
sS'of,hydroxylated,in'
p6800
g9
sS'hard,gelatin,capsules'
p6801
g3
sS'a,month,washout'
p6802
g3
sS'appropriate,adjustment,to'
p6803
g3
sS'dilantin,phenobarbital,tegretol'
p6804
g9
sS'by,platelets,plays'
p6805
g3
sS'patients,receiving,narrow'
p6806
g3
sS'has,stabilized,for'
p6807
g3
sS'pulmonary,toxicity,has'
p6808
g9
sS'and,which,affect'
p6809
g3
sS'to,obtain,serum'
p6810
g9
sS'antimigraine,derivatives,antimycobacterial'
p6811
g9
sS'tumors,and,cancer'
p6812
g3
sS'not,a,substrate'
p6813
g3
sS'c,max,increased'
p6814
g3
sS'from,mg,l'
p6815
g9
sS'administered,in,conjunction'
p6816
g3
sS'frequent,peripheral,blood'
p6817
g3
sS'did,not,modify'
p6818
g3
sS'decreased,the,bioavailability'
p6819
g9
sS'were,fasted,and'
p6820
g3
sS'decrease,overall,treatment'
p6821
g3
sS'through,the,modulation'
p6822
g3
sS'when,used,in'
p6823
g9
sS'activation,of,different'
p6824
g3
sS'when,they,are'
p6825
g9
sS'inconcomitant,administration,and'
p6826
g3
sS'these,products,may'
p6827
g9
sS'the,usual,concentrations'
p6828
g3
sS'additive,effects,were'
p6829
g9
sS'hcl,with,other'
p6830
g9
sS'desired,effect,on'
p6831
g9
sS'reductase,inhibitors,administered'
p6832
g9
sS'results,in,or'
p6833
g3
sS'has,generally,been'
p6834
g3
sS'desired,effect,of'
p6835
g9
sS'prothrombin,response,through'
p6836
g9
sS'tea,polyphenols,as'
p6837
g3
sS'atrophy,and,degenerative'
p6838
g3
sS'of,ponstel,with'
p6839
g9
sS'receiving,both,should'
p6840
g3
sS'taking,another,class'
p6841
g9
sS'irregularities,have,been'
p6842
g3
sS'no,data,on'
p6843
g3
sS'they,cause,much'
p6844
g3
sS'in,humans,is'
p6845
g3
sS'administered,with,either'
p6846
g3
sS'as,indicated,in'
p6847
g3
sS'clonidines,analgesic,actions'
p6848
g3
sS'mg,daily,dose'
p6849
g9
sS'taxol,concomitantly,with'
p6850
g3
sS'as,shown,in'
p6851
g9
sS'other,the,renal'
p6852
g9
sS'are,inducers,of'
p6853
g3
sS'when,abilify,is'
p6854
g9
sS'prolongation,in,the'
p6855
g3
sS'in,myopathy,and'
p6856
g3
sS'ii,diabetic,patient'
p6857
g9
sS'blocking,agents,or'
p6858
g3
sS'used,anti-peptic,agents'
p6859
g3
sS'selegiline,hydrochloride,in'
p6860
g9
sS'catabloism,of,k-dependent'
p6861
g3
sS'netilmicin,should,not'
p6862
g9
sS'male,n,in'
p6863
g3
sS'given,only,for'
p6864
g3
sS'to,be,certain'
p6865
g9
sS'is,the,primary'
p6866
g9
sS'previously,been,reported'
p6867
g3
sS'other,week,until'
p6868
g3
sS'of,the,qt'
p6869
g9
sS'of,adrenocortical,dependent'
p6870
g9
sS'human,recommended,dose'
p6871
g3
sS'cyp2b6,cyp2c8,cyp2c9'
p6872
g3
sS'in,urine,volume'
p6873
g9
sS'and,implantable,forms'
p6874
g9
sS'by,the,concomitant'
p6875
g9
sS'peak,b,estradiol'
p6876
g3
sS'interactions,with,mefloquine'
p6877
g3
sS'parenteral,route,is'
p6878
g3
sS'in,a,light'
p6879
g3
sS'of,reports,in'
p6880
g9
sS'the,clinical,data'
p6881
g3
sS'pharmacokinetics,of,administered'
p6882
g3
sS'rates,of,nimbex'
p6883
g9
sS'clonidine,hydrochloride,may'
p6884
g9
sS'of,amicar,at'
p6885
g3
sS'on,endometrial,ovarian'
p6886
g3
sS'protein,bound,monoamine'
p6887
g9
sS'other,nonsteroidal,antiinflammatory'
p6888
g9
sS'with,any,significant'
p6889
g9
sS'dosage,of,indocin'
p6890
g3
sS'vertebrae,at,mg'
p6891
g3
sS'and,mg,sodium'
p6892
g9
sS'frequently,if,is'
p6893
g9
sS'efavirenz,has,been'
p6894
g3
sS'who,are,receiving'
p6895
g9
sS'p450,isozymes,a1'
p6896
g3
sS'cimetidine,at,doses'
p6897
g9
sS'cryptosporidium,parvum,growth'
p6898
g9
sS'with,phenurone,since'
p6899
g9
sS'metabolizing,enzymes,and'
p6900
g3
sS'concomitantly,closely,monitor'
p6901
g3
sS'not,reported,these'
p6902
g3
sS'occurred,at,six'
p6903
g9
sS'seen,in,patients'
p6904
g3
sS'the,geriatric,population'
p6905
g3
sS'a,later,time'
p6906
g3
sS'as,a,precursor'
p6907
g3
sS'risk,of,are'
p6908
g9
sS'monitored,and,the'
p6909
g9
sS'comparison,with,the'
p6910
g9
sS'an,intubating,dose'
p6911
g9
sS'end,fo,the'
p6912
g3
sS'activity,data,on'
p6913
g3
sS'anastrozole,inhibited,in'
p6914
g3
sS'components,may,help'
p6915
g3
sS'five,lacking,kidney'
p6916
g3
sS'germinal,centers,of'
p6917
g3
sS'the,has,on'
p6918
g9
sS'alterations,in,immune'
p6919
g3
sS'either,dose,had'
p6920
g3
sS'of,for,the'
p6921
g3
sS'hydrochloride,has,been'
p6922
g9
sS'and,the,direction'
p6923
g3
sS'pharmacokinetic,studies,including'
p6924
g3
sS'seen,on,the'
p6925
g3
sS'and,were,additive'
p6926
g3
sS'in,the,perioperative'
p6927
g9
sS'using,but,not'
p6928
g3
sS'other,coadministration,of'
p6929
g3
sS'for,the,following'
p6930
g9
sS'reviews,recent,developments'
p6931
g3
sS'need,to,be'
p6932
g9
sS'tosylate,these,are'
p6933
g3
sS'foradil,should,be'
p6934
g9
sS'p450,d6,in'
p6935
g3
sS'weeks,was,associated'
p6936
g9
sS'combination,with,hard'
p6937
g3
sS'respectively,when,was'
p6938
g9
sS'error,structures,and'
p6939
g3
sS'cases,of,mixed'
p6940
g9
sS'of,incompatibility,of'
p6941
g3
sS'b-lactam,inhibits,the'
p6942
g9
sS'equetrotm,it,is'
p6943
g3
sS'required,except,for'
p6944
g3
sS'animal,models,and'
p6945
g3
sS'to,ph,may'
p6946
g3
sS'administration,of,stadol'
p6947
g3
sS'observed,that,the'
p6948
g3
sS'self-reported,mood,and'
p6949
g3
sS'not,a,significant'
p6950
g3
sS'effects,of,chronic'
p6951
g9
sS'of,clinical,studies'
p6952
g9
sS'with,general,may'
p6953
g3
sS'showed,variable,degrees'
p6954
g3
sS'particular,mao,inhibitor'
p6955
g3
sS'tca,is,going'
p6956
g3
sS'cns-depressant,action,of'
p6957
g9
sS'in,the,co-administration'
p6958
g9
sS'and,how,it'
p6959
g3
sS'with,mg,vardenafil'
p6960
g3
sS'major,cytochrome,p450'
p6961
g3
sS'important,factors,in'
p6962
g3
sS'enzyme,should,be'
p6963
g9
sS'other,such,as'
p6964
g9
sS'metabolized,by,or'
p6965
g3
sS'contraindicated,in,women'
p6966
g3
sS'components,are,excreted'
p6967
g3
sS'l,were,investigated'
p6968
g3
sS'other,potassium-sparing,with'
p6969
g9
sS'symptoms,severe,dry'
p6970
g9
sS'decrease,the,hepatic'
p6971
g9
sS'study,with,in'
p6972
g9
sS'the,potential,effects'
p6973
g9
sS'reappearance,on,rewarming'
p6974
g3
sS'some,reports,have'
p6975
g9
sS'cyp,a4,has'
p6976
g3
sS'colitis,a,methotrexate'
p6977
g9
sS'blockers,cardiac,glycosides'
p6978
g3
sS'but,this,has'
p6979
g9
sS'superior,antipsychotic,efficacy'
p6980
g3
sS'aprepitant,and,on'
p6981
g9
sS'be,above,the'
p6982
g3
sS'after,the,first'
p6983
g3
sS'of,are,decreased'
p6984
g9
sS'who,require,the'
p6985
g3
sS'pegasys,every,other'
p6986
g3
sS'levothyroxine,sodium,absorption'
p6987
g9
sS'to,hours,after'
p6988
g3
sS'hexalen,and,of'
p6989
g9
sS'tests,were,negative'
p6990
g3
sS'from,a,patient'
p6991
g3
sS'study,investigated,the'
p6992
g3
sS'a,second,study'
p6993
g3
sS'succinylcholine-induced,neuromuscular,blockade'
p6994
g3
sS'nsaids,the,patient'
p6995
g3
sS'concomitant,therapy,although'
p6996
g3
sS'preparations,nsaids,antigout'
p6997
g3
sS'that,are,supported'
p6998
g3
sS'decreased,concentrations,in'
p6999
g9
sS'with,fortovase,may'
p7000
g3
sS'of,mg,co-administered'
p7001
g9
sS'week,trial,showed'
p7002
g3
sS'clinical,experience,in'
p7003
g3
sS'maalox,reduced,the'
p7004
g9
sS'of,increasing,its'
p7005
g9
sS'potentiated,by,certain'
p7006
g9
sS'evaluated,the,effect'
p7007
g3
sS'independent,joint,action'
p7008
g3
sS'when,screening,urine'
p7009
g3
sS'drugs,ethanol,sonata'
p7010
g9
sS'p450,isozymes,may'
p7011
g3
sS'or,both,which'
p7012
g3
sS'is,catalyzed,by'
p7013
g3
sS'possible,combined,actions'
p7014
g3
sS'cross-reactivity,of,with'
p7015
g9
sS'associated,with,may'
p7016
g9
sS'in,clearance,between'
p7017
g3
sS'on,kinetics,and'
p7018
g9
sS'from,to,minutes'
p7019
g9
sS'and,oral,containing'
p7020
g9
sS'be,increased,decreased'
p7021
g3
sS'reduced,the,antitumour'
p7022
g9
sS'displace,from,their'
p7023
g3
sS'diftitox,had,no'
p7024
g3
sS'is,given,for'
p7025
g3
sS'the,colonic,transit-enhancing'
p7026
g3
sS'with,left,ventricular'
p7027
g3
sS'attenuate,loss,caused'
p7028
g9
sS'by,lesions,of'
p7029
g3
sS'in,a,chronic'
p7030
g3
sS'reduced,ldl,cholesterol'
p7031
g3
sS'sacrificed,in,moribund'
p7032
g3
sS'generate,the,toxic'
p7033
g3
sS'two,multiple-dose,interaction'
p7034
g3
sS'similar,frequency,on'
p7035
g3
sS'vitro,interaction,between'
p7036
g9
sS'levels,or,may'
p7037
g9
sS'of,as,reflected'
p7038
g9
sS'can,give,you'
p7039
g3
sS'qtc,interval,because'
p7040
g9
sS'of,nociception,was'
p7041
g3
sS'due,to,its'
p7042
g9
sS'r,p,app'
p7043
g3
sS'patients,is,required'
p7044
g3
sS'cause,coronary,artery'
p7045
g9
sS'absence,of,did'
p7046
g3
sS'produced,by,subsequent'
p7047
g9
sS'a,patient,had'
p7048
g3
sS'nonprescription,products,you'
p7049
g3
sS'also,was,no'
p7050
g3
sS'but,there,have'
p7051
g9
sS'the,stress,of'
p7052
g3
sS'and,to,miracidia'
p7053
g3
sS'rats,pd2,values'
p7054
g9
sS'in,a,false'
p7055
g3
sS'injections,of,or'
p7056
g3
sS'symptoms,usually,occurred'
p7057
g3
sS'the,urine,test'
p7058
g3
sS'property,of,to'
p7059
g9
sS'for,developing,rhabdomyolysis'
p7060
g3
sS'proscar,mg,when'
p7061
g3
sS'levels,monitored,after'
p7062
g9
sS'carbamazepine,is,not'
p7063
g3
sS'of,initial,and'
p7064
g9
sS'administration,of,brevibloc'
p7065
g3
sS'of,nsaids,in'
p7066
g9
sS'infused,over,minutes'
p7067
g3
sS'reported,for,combined'
p7068
g3
sS'between,two,or'
p7069
g3
sS'significant,difference,between'
p7070
g3
sS'skin,medicines,when'
p7071
g3
sS'and,related,psychoses'
p7072
g3
sS'of,in,therapy'
p7073
g3
sS'and,minimal,inhibitory'
p7074
g3
sS'cytochrome,p4502d6,in'
p7075
g3
sS'be,inactivated,by'
p7076
g3
sS'clearance,of,these'
p7077
g9
sS'the,normal,cells'
p7078
g3
sS'pattern,of,use'
p7079
g3
sS'occur,when,and'
p7080
g9
sS'neurobiological,alterations,in'
p7081
g3
sS'and,and,twice-a'
p7082
g3
sS'myopathy,underlying,renal'
p7083
g3
sS'the,clinician,to'
p7084
g3
sS'but,which,can'
p7085
g3
sS'low,and,high'
p7086
g3
sS'dosage,levels,should'
p7087
g9
sS'of,n-allylnormetazocine,in'
p7088
g3
sS'change,in,the'
p7089
g3
sS'this,possibility,and'
p7090
g3
sS'unclear,how,soon'
p7091
g9
sS'pancreatic,effects,of'
p7092
g3
sS'co-administered,antiepilepsy,aeds'
p7093
g3
sS'patients,were,enrolled'
p7094
g3
sS'the,effect,measured'
p7095
g3
sS'blockers,on,platelet'
p7096
g3
sS'while,fractional,transfer'
p7097
g3
sS'administration,of,d'
p7098
g9
sS'percentage,of,neurons'
p7099
g3
sS'not,the,coat-core'
p7100
g9
sS'of,have,been'
p7101
g9
sS'therefore,potential,interactions'
p7102
g3
sS'pancreas,of,the'
p7103
g3
sS'caffeine-related,adverse,effects'
p7104
g9
sS'and,the,extent'
p7105
g3
sS'to,rats,treated'
p7106
g9
sS'and,either,or'
p7107
g3
sS'isoflurane,or,administered'
p7108
g9
sS'ml,for,h'
p7109
g3
sS'a4,grapefruit,juice'
p7110
g9
sS'received,such,the'
p7111
g3
sS'of,cholecystokinin,octapeptide'
p7112
g3
sS'study,one,hyperglycaemic'
p7113
g3
sS'acting,on,the'
p7114
g3
sS'african-american,man,was'
p7115
g3
sS'which,are,reported'
p7116
g9
sS'and,charcoal,administration'
p7117
g9
sS'last,morning,dose'
p7118
g3
sS'with,iron,concomitant'
p7119
g9
sS'pharmacokinetics,of,which'
p7120
g9
sS's,c,inhibited'
p7121
g9
sS'to,mouse,bone'
p7122
g3
sS'bound,to,human'
p7123
g3
sS'pharmacology,study,or'
p7124
g3
sS'enzymatic-based,assays,resulting'
p7125
g3
sS'vaccines,patients,on'
p7126
g9
sS'this,cluster,of'
p7127
g3
sS'pk,properties,of'
p7128
g3
sS'intravenous,antagonists,should'
p7129
g9
sS'patients,random,sample'
p7130
g3
sS'highly,effective,there'
p7131
g3
sS'has,been,seen'
p7132
g9
sS'in,vitro,however'
p7133
g3
sS'of,at,doses'
p7134
g9
sS'contribution,of,each'
p7135
g3
sS'for,days,following'
p7136
g3
sS'twice,daily,and'
p7137
g9
sS'during,the,coadministration'
p7138
g3
sS'and,effective,use'
p7139
g3
sS'with,steady,state'
p7140
g9
sS'of,edetate,disodium'
p7141
g9
sS'desirable,antimuscarinic,effects'
p7142
g3
sS'failed,to,cause'
p7143
g9
sS'nonlinear,regression,model'
p7144
g3
sS'inhibitors,of,cyp450'
p7145
g3
sS'cells,that,result'
p7146
g3
sS'foscarnets,tendency,to'
p7147
g9
sS'elevations,and,or'
p7148
g9
sS'finasteride,does,not'
p7149
g3
sS'pcp,produced,transient'
p7150
g3
sS'are,unaltered,in'
p7151
g3
sS'with,innovar,vet'
p7152
g9
sS'acidity,does,not'
p7153
g3
sS'clinician,to,offer'
p7154
g3
sS'of,the,reservoir'
p7155
g3
sS'analgesics,was,similar'
p7156
g3
sS'in,ems,selective'
p7157
g3
sS'responses,were,seen'
p7158
g3
sS'levonorgestrel-treated,rats,and'
p7159
g3
sS'ensure,clinically,effective'
p7160
g9
sS'zidovudine,should,either'
p7161
g9
sS'probable,that,given'
p7162
g3
sS'and,treatment,i'
p7163
g3
sS'of,oxypurines,hypoxanthine'
p7164
g9
sS'anticholinergics,antagonize,the'
p7165
g3
sS'glucose,metabolism,and'
p7166
g3
sS'moderate,hypertension,where'
p7167
g3
sS'of,skin,rash'
p7168
g9
sS'isoniazid,may,increase'
p7169
g9
sS'of,in,rodent'
p7170
g3
sS'mcf-7,cells,with'
p7171
g3
sS'nimbex,were,comparable'
p7172
g9
sS'salts,with,practically'
p7173
g3
sS'case,reports,and'
p7174
g3
sS'therapeutic,hypermagnesaemia,high'
p7175
g3
sS'far,greater,than'
p7176
g3
sS'large,size,to'
p7177
g3
sS'inhibit,the,metabolism'
p7178
g9
sS'several,of,the'
p7179
g3
sS'conceived,that,a'
p7180
g3
sS'data,in,patients'
p7181
g9
sS'treatment,of,osteoarthritis'
p7182
g3
sS'is,needed,when'
p7183
g3
sS'african,and,other'
p7184
g3
sS'patients,on,or'
p7185
g9
sS'no,interactions,by'
p7186
g3
sS'be,less,effective'
p7187
g9
sS'irregularities,were,accompanied'
p7188
g3
sS'of,action,by'
p7189
g3
sS'difluoro-2,propanol,to'
p7190
g9
sS'its,derivatives,prothrombin'
p7191
g9
sS'salicylate,levels,have'
p7192
g3
sS'meclofenamate,sodium,plasma'
p7193
g9
sS'at,steady-state,with'
p7194
g9
sS'the,antioxidative,gallates'
p7195
g3
sS'sucralfate,and,quinolones'
p7196
g3
sS'potential,make,up'
p7197
g3
sS'predominantly,by,cytochrome'
p7198
g3
sS'have,varied,from'
p7199
g3
sS'between,theraputic,agents'
p7200
g3
sS'sites,other,that'
p7201
g3
sS'and,and,reduces'
p7202
g9
sS'same,evening,meal'
p7203
g9
sS'dose,of,inspra'
p7204
g9
sS'of,lng,were'
p7205
g3
sS'reduce,the,renal'
p7206
g9
sS'respect,to,observations'
p7207
g3
sS'have,pulse,and'
p7208
g3
sS'the,patients,gland'
p7209
g3
sS'of,accumulation,that'
p7210
g3
sS'studies,of,human'
p7211
g3
sS'effects,is,not'
p7212
g9
sS'of,two,reverse'
p7213
g3
sS'response,is,less'
p7214
g9
sS'other,hormonalmethods,of'
p7215
g9
sS'mouth,thirst,weakness'
p7216
g3
sS'pancreatitis,and,symptomatic'
p7217
g3
sS'the,objective,of'
p7218
g3
sS'ns,mg,qid'
p7219
g3
sS'direct,cardiac,stimulants'
p7220
g9
sS'these,increased,exposures'
p7221
g9
sS'mechanism,of,milk'
p7222
g3
sS'and,the,model'
p7223
g3
sS'increase,the,toxicity'
p7224
g3
sS'treatment,regimen,includes'
p7225
g9
sS'the,pharmacokinetic,interaction'
p7226
g3
sS'cardiac,h2,antagonists'
p7227
g3
sS'of,consciousness,confusion'
p7228
g3
sS'responses,and,other'
p7229
g3
sS'therapy,with,orencia'
p7230
g9
sS'agent,additional,concomitant'
p7231
g3
sS'increased,fold,and'
p7232
g3
sS'continued,for,a'
p7233
g3
sS'of,or,will'
p7234
g9
sS'similar,to,sodium'
p7235
g3
sS'diabetics,or,patients'
p7236
g9
sS'effect,relationship,physicians'
p7237
g9
sS'of,oral,mg'
p7238
g9
sS'during,or,after'
p7239
g9
sS'and,their,dosages'
p7240
g3
sS'could,be,explained'
p7241
g3
sS'was,increased,about'
p7242
g9
sS'admistration,of,the'
p7243
g3
sS'urinary,alkalinizing,agents'
p7244
g9
sS'would,cause,direct'
p7245
g3
sS'that,affect,gastric'
p7246
g3
sS'cyp2d6,and,is'
p7247
g3
sS'and,alternative,therapy'
p7248
g9
sS'choline,arthropan,magan'
p7249
g9
sS'vertebra,at,doses'
p7250
g3
sS'vasodilator,activity,data'
p7251
g3
sS'inhibitor,of,cyp1a2'
p7252
g9
sS'in,which,concurrent'
p7253
g3
sS'were,no,differences'
p7254
g3
sS'metabolized,by,glucuronidation'
p7255
g3
sS'of,are,likely'
p7256
g9
sS'because,the,pharmacologically'
p7257
g9
sS'with,no,evidence'
p7258
g3
sS'and,because,increases'
p7259
g9
sS'produced,only,minor'
p7260
g9
sS'no,evaluation,of'
p7261
g3
sS'broadly,the,same'
p7262
g3
sS'physicians,and,note'
p7263
g3
sS'cytokines,cytokines,have'
p7264
g3
sS'known,enzyme,induction'
p7265
g9
sS'cmax,but,no'
p7266
g3
sS'experience,to,date'
p7267
g3
sS'enzyme-inducing,such,as'
p7268
g9
sS'of,the,study'
p7269
g3
sS'given,by,infusion'
p7270
g3
sS'a,patient,shows'
p7271
g3
sS'subtypes,using,their'
p7272
g3
sS'block,produced,by'
p7273
g3
sS'on,body,weight'
p7274
g3
sS'binding,to,serum'
p7275
g9
sS'were,examined,in'
p7276
g3
sS'vardenafil,had,no'
p7277
g3
sS'in,infants,has'
p7278
g3
sS'cardioactive,compounds,that'
p7279
g9
sS'dissociation,of,the'
p7280
g3
sS'from,to,mg'
p7281
g3
sS'kg,every,weeks'
p7282
g3
sS'efficacy,is,impaired'
p7283
g9
sS'from,to,ml'
p7284
g3
sS'from,to,mm'
p7285
g3
sS'node,conduction,can'
p7286
g9
sS'patients,there,was'
p7287
g3
sS'adsorbents,and,digestive'
p7288
g9
sS'histidine,modification,had'
p7289
g3
sS'physician,even,if'
p7290
g3
sS'of,dmpge2,were'
p7291
g3
sS'not,take,st'
p7292
g3
sS'up,to,after'
p7293
g9
sS'injectionsite,reaction,injection'
p7294
g3
sS'g,kg,dose'
p7295
g3
sS'already,receiving,there'
p7296
g9
sS'taking,monoamine,oxidase'
p7297
g9
sS'experimental,designs,can'
p7298
g3
sS'that,inhibit,alprazolam'
p7299
g3
sS'with,overdosage,or'
p7300
g9
sS'neurological,toxic,effects'
p7301
g3
sS'oral,markedly,inhibits'
p7302
g9
sS'at,baseline,and'
p7303
g3
sS'in,increased,and'
p7304
g9
sS'for,and,synergistic'
p7305
g9
sS'briefly,reduced,the'
p7306
g3
sS'lowers,serum,concentrations'
p7307
g3
sS'control,supraventricular,tachycardia'
p7308
g9
sS'administration,of,fibric'
p7309
g3
sS'blocks,the,central'
p7310
g9
sS'system,inhibitors,of'
p7311
g3
sS'possibility,of,reduced'
p7312
g3
sS'mechanism,for,the'
p7313
g9
sS'vitro,data,in'
p7314
g3
sS'orally,to,healthy'
p7315
g3
sS'of,ranging,from'
p7316
g9
sS'acid,sequestrants,may'
p7317
g9
sS'concerns,regarding,protease'
p7318
g3
sS'shows,no,signs'
p7319
g3
sS'associated,with,elevations'
p7320
g9
sS'neutrophils,such,as'
p7321
g3
sS'therapy,when,plasma'
p7322
g9
sS'before,parathyroid-function,tests'
p7323
g3
sS'inhibit,accumulation,in'
p7324
g9
sS'the,function,as'
p7325
g3
sS'rat,bone,marrow'
p7326
g3
sS'since,it,has'
p7327
g3
sS'adverse,experience,profile'
p7328
g3
sS'induced,lower,locomotor'
p7329
g3
sS'levels,of,ergocalcitriol'
p7330
g9
sS'therefore,cyp3a4,substrates'
p7331
g9
sS'rats,followed,by'
p7332
g3
sS'pelvic,abdominal,irradiation'
p7333
g3
sS'oxidative,metabolites,appear'
p7334
g3
sS'respond,to,administration'
p7335
g3
sS'with,the,hydroalcoholic'
p7336
g3
sS'hearts,new,york'
p7337
g3
sS'false-positive,reaction,for'
p7338
g3
sS'underlying,conditions,and'
p7339
g3
sS'bladder,cancer,cells'
p7340
g3
sS'interfere,with,in'
p7341
g9
sS'inhibit,the,production'
p7342
g3
sS'vitro,chromosomal,aberration'
p7343
g3
sS'receiving,concurrent,therapy'
p7344
g9
sS'no,clinical,evidence'
p7345
g3
sS'more,severe,in'
p7346
g3
sS'pimozide,and,celexa'
p7347
g9
sS'concomitant,therapy,may'
p7348
g3
sS'tikosyn,mcg,bid'
p7349
g9
sS'results,showed,that'
p7350
g3
sS'for,reexacerbation,of'
p7351
g9
sS'antiparkinsonian,drug,eg'
p7352
g9
sS'beyond,that,obtained'
p7353
g9
sS'effects,of,flushing'
p7354
g3
sS'in,serum-deprived,serum'
p7355
g3
sS'with,and,dopa'
p7356
g3
sS'amprenavir,inhibits,the'
p7357
g3
sS'emphasize,that,apoptosis'
p7358
g3
sS'aom,and,the'
p7359
g3
sS'increase,ci,increase'
p7360
g3
sS'b-cell,lymphomas,occur'
p7361
g3
sS'antagonized,the,rate-decreasing'
p7362
g9
sS'possible,increased,risk'
p7363
g3
sS'subcutaneous,dose,should'
p7364
g9
sS'a,fall,in'
p7365
g3
sS'effects,of,have'
p7366
g3
sS'for,glucose,intolerance'
p7367
g3
sS'nor,inhibits,or'
p7368
g3
sS'monitored,because,the'
p7369
g9
sS'been,performed,examining'
p7370
g3
sS'ml,h,or'
p7371
g3
sS'oral,containing,mg'
p7372
g3
sS'interactions,with,have'
p7373
g3
sS'this,could,create'
p7374
g3
sS'are,added,to'
p7375
g3
sS'with,caution,and'
p7376
g3
sS'did,not,affect'
p7377
g3
sS'compared,directly,to'
p7378
g3
sS'have,their,prothrombin'
p7379
g9
sS'use,with,or'
p7380
g9
sS'metabolite,is,mediated'
p7381
g3
sS'solution,fehlings,solution'
p7382
g3
sS'activity,in,a'
p7383
g3
sS'reported,to,the'
p7384
g3
sS'for,commonly,used'
p7385
g3
sS'or,preparations,produced'
p7386
g3
sS'clinical,comments,about'
p7387
g3
sS'show,that,revlimid'
p7388
g3
sS'adverse,reaction,is'
p7389
g3
sS'motor,effects,of'
p7390
g9
sS'endorphinergic,system,by'
p7391
g3
sS'by,a,decrease'
p7392
g9
sS'reductions,in,blood'
p7393
g9
sS'displaced,from,its'
p7394
g9
sS'lucidum,extract,alone'
p7395
g3
sS'warfarin,keppra,mg'
p7396
g3
sS'increases,the,bioavailability'
p7397
g3
sS'is,small,when'
p7398
g9
sS'were,negative,on'
p7399
g3
sS'patients,receiving,infusions'
p7400
g3
sS'pharmacokinetics,therapeutic,efficacy'
p7401
g3
sS'and,indocin,should'
p7402
g9
sS'used,concomitantly,renal'
p7403
g9
sS'requirements,in,human'
p7404
g9
sS'prothrombin,time,have'
p7405
g9
sS'psychopathology,rating,scales'
p7406
g3
sS'were,antagonized,by'
p7407
g3
sS'or,with,other'
p7408
g9
sS'whether,these,compounds'
p7409
g3
sS'between,deficiency,due'
p7410
g3
sS'exercised,during,the'
p7411
g9
sS'dose,of,should'
p7412
g3
sS'clinical,importance,have'
p7413
g3
sS'skeletal-muscle,relaxants,nondepolarizing'
p7414
g3
sS'cyp3a4,inducers,may'
p7415
g3
sS'other,factors,like'
p7416
g3
sS'in,addition,certain'
p7417
g3
sS'adjustment,in,dose'
p7418
g3
sS'more,than,the'
p7419
g3
sS'with,restricted,pulmonary'
p7420
g3
sS'pronounced,inhibition,of'
p7421
g3
sS'at,bedtime,and'
p7422
g3
sS'fulvestrant,is,found'
p7423
g3
sS'of,percentage,increase'
p7424
g9
sS'both,chylomicron,lipolysis'
p7425
g3
sS'glucose,levels,and'
p7426
g9
sS'was,evaluated,in'
p7427
g3
sS'cortex,which,are'
p7428
g3
sS'and,the,variability'
p7429
g9
sS'that,was,abolished'
p7430
g9
sS'tendency,to,antagonize'
p7431
g9
sS'flurbiprofen,like,other'
p7432
g9
sS'caused,a,rapid'
p7433
g9
sS'reduction,with,careful'
p7434
g3
sS'individual,and,combined'
p7435
g3
sS'and,micrograms,ml'
p7436
g3
sS'volunteers,did,not'
p7437
g3
sS'can,lead,to'
p7438
g9
sS'on,without,evidence'
p7439
g3
sS'female,fertility,and'
p7440
g3
sS'tubular,atrophy,and'
p7441
g3
sS'suggest,no,significant'
p7442
g3
sS'in,electrically,stimulated'
p7443
g3
sS'amino,acid,and'
p7444
g3
sS'subjects,receiving,tambocor'
p7445
g9
sS'in,clinical,trials'
p7446
g3
sS'should,be,withdrawn'
p7447
g9
sS'a,dissociation,of'
p7448
g3
sS'of,tolerance,min'
p7449
g3
sS'level,of,at'
p7450
g3
sS'presence,of,decreased'
p7451
g3
sS'coadministered,with,potent'
p7452
g9
sS'associated,with,significantly'
p7453
g3
sS'also,taking,the'
p7454
g9
sS'm,v,did'
p7455
g3
sS'dyskinesia,side,reactions'
p7456
g9
sS'enzyme,inhibitors,without'
p7457
g3
sS'substantial,accumulation,of'
p7458
g9
sS'produced,an,elevation'
p7459
g9
sS'of,resveratrol-induced,vasorelaxation'
p7460
g3
sS'those,contained,in'
p7461
g9
sS'weak,effect,on'
p7462
g9
sS'to,a,patient'
p7463
g3
sS'agents,calcium,channel'
p7464
g3
sS'steady-state,conditions,had'
p7465
g3
sS'being,used,many'
p7466
g3
sS'and,to,encystment'
p7467
g3
sS'contains,dehydrated,usp'
p7468
g3
sS'rare,reports,however'
p7469
g9
sS'decrease,the,effectiveness'
p7470
g9
sS'individuals,may,have'
p7471
g3
sS'time,responses,have'
p7472
g3
sS'the,mammary,gland'
p7473
g3
sS'bactericidal,effect,of'
p7474
g9
sS'with,elevated,levels'
p7475
g9
sS'tca,plasma,levels'
p7476
g3
sS'withdrawal,of,decreased'
p7477
g9
sS'ameliorate,increased,intestinal'
p7478
g9
sS'antiepileptic,potential,interactions'
p7479
g3
sS'as,thiazide,acidic'
p7480
g9
sS'plenaxis,and,periodically'
p7481
g3
sS'daily,trough,serum'
p7482
g3
sS'increased,possibility,of'
p7483
g9
sS'with,few,individuals'
p7484
g3
sS'atp,and,serotonin'
p7485
g3
sS'was,seen,but'
p7486
g9
sS'adequate,period,of'
p7487
g3
sS'bilirubin,times,the'
p7488
g3
sS'pharmacokinetics,pharmacodynamics,and'
p7489
g3
sS'and,at,high'
p7490
g3
sS'inhibit,cyps,a2'
p7491
g3
sS'saquinavir,the,combination'
p7492
g3
sS'and,hypertension,have'
p7493
g3
sS'converting,enzyme,ace'
p7494
g3
sS'in,intensive,care'
p7495
g3
sS'withdrawal,symptoms,may'
p7496
g3
sS'contraceptives,it,has'
p7497
g3
sS'order,to,provide'
p7498
g3
sS'and,therefore,subtle'
p7499
g3
sS'see,drug,interactions'
p7500
g3
sS'increase,in,peak'
p7501
g9
sS'but,not,statistically'
p7502
g9
sS'be,given,without'
p7503
g3
sS'where,and,were'
p7504
g3
sS'study,of,male'
p7505
g9
sS'additive,depressant,effect'
p7506
g3
sS'low,as,mg'
p7507
g3
sS'is,warranted,and'
p7508
g9
sS's,and,which'
p7509
g9
sS'with,proton,pump'
p7510
g9
sS'the,blood,or'
p7511
g3
sS'isozymes,in,particular'
p7512
g3
sS'myocardial,infarction,liver'
p7513
g3
sS'brain,sites,produced'
p7514
g3
sS'of,in,increasing'
p7515
g3
sS'th,days,of'
p7516
g3
sS'therapies,should,not'
p7517
g9
sS'capable,of,potentiating'
p7518
g9
sS'on,investigation,of'
p7519
g3
sS'dissolution,rate,of'
p7520
g3
sS'deaths,induced,by'
p7521
g3
sS'anticipated,with,cmi'
p7522
g9
sS'if,tykerb,is'
p7523
g3
sS'hcl,special,care'
p7524
g3
sS'weak,inducer,of'
p7525
g3
sS'additionally,there,is'
p7526
g3
sS'to,induce,microsomal'
p7527
g9
sS'inhibitor,hydrogen-3,revealed'
p7528
g3
sS'with,weakness,hyperreflexia'
p7529
g9
sS'amines,possible,decreased'
p7530
g3
sS'in,auc,by'
p7531
g9
sS'patients,taking,chronically'
p7532
g9
sS'interact,with,some'
p7533
g9
sS'studies,were,performed'
p7534
g3
sS'cyp,d6,ic50'
p7535
g3
sS'involving,six-healthy,male'
p7536
g3
sS'these,cyp3a4,inducers'
p7537
g9
sS'rapid,fluctuations,of'
p7538
g9
sS'to,approximately,and'
p7539
g3
sS'these,larger,doses'
p7540
g9
sS'salicylate,assays,caution'
p7541
g3
sS'either,by,activation'
p7542
g3
sS'with,hepatic,injury'
p7543
g3
sS'efficient,labeling,can'
p7544
g3
sS'b,the,clearance'
p7545
g3
sS'were,noted,during'
p7546
g3
sS'and,c9,with'
p7547
g3
sS'of,an,oral'
p7548
g3
sS'from,its,capacity'
p7549
g9
sS'determine,the,effects'
p7550
g3
sS'precipitating,factor,in'
p7551
g3
sS'l-tyrosine,and,non-selective'
p7552
g9
sS'that,causative,factors'
p7553
g3
sS'evaluated,in,human'
p7554
g3
sS'bilirubin,urobilin,due'
p7555
g3
sS'result,is,erroneous'
p7556
g3
sS'who,received,both'
p7557
g3
sS'hypersensitivity,reactions,patients'
p7558
g9
sS'time,following,a'
p7559
g3
sS'co-administered,with,slow-release'
p7560
g3
sS'effects,have,occurred'
p7561
g9
sS'would,not,affect'
p7562
g3
sS'diseases,recent,radiation'
p7563
g3
sS'is,rapidly,and'
p7564
g3
sS'subsequently,found,to'
p7565
g3
sS'chlorpropamides,plasma,half-life'
p7566
g9
sS'hepatotoxicity,concomitant,administration'
p7567
g9
sS'solution,dried,and'
p7568
g3
sS'were,intravenously,injected'
p7569
g3
sS'be,even,more'
p7570
g9
sS'd6,a4,c9'
p7571
g3
sS'infusions,can,only'
p7572
g3
sS'elimination,may,alter'
p7573
g3
sS'transmission,curare-like,compounds'
p7574
g9
sS'concentration,increased,from'
p7575
g9
sS'system,specifically,through'
p7576
g3
sS'in,patients,that'
p7577
g9
sS'the,fertility,of'
p7578
g3
sS'extensive,concomitant,use'
p7579
g3
sS'dose,of,a'
p7580
g9
sS'estradiol,substrate,of'
p7581
g3
sS'dose,of,g'
p7582
g3
sS'inhibition,of,each'
p7583
g9
sS'with,a,history'
p7584
g3
sS'in,s,a'
p7585
g9
sS'dose,of,x'
p7586
g9
sS'blocking,agents,concurrent'
p7587
g3
sS'changes,northern,blot'
p7588
g3
sS'at,least,four'
p7589
g3
sS'may,cause,too'
p7590
g3
sS'of,enflurane,than'
p7591
g3
sS'of,antagonists,and'
p7592
g3
sS'rifampin,markedly,increases'
p7593
g9
sS'a,direct,effect'
p7594
g3
sS'of,withdrawal,methadone'
p7595
g9
sS'morphine-induced,and,nicotine-induced'
p7596
g9
sS'type,and,may'
p7597
g3
sS'study,was,identical'
p7598
g3
sS'of,taxol,mg'
p7599
g9
sS'has,received,or'
p7600
g9
sS'experience,when,suprax'
p7601
g9
sS'decreased,hearing,have'
p7602
g9
sS'p-450,inducers,such'
p7603
g9
sS'study,the,interaction'
p7604
g3
sS'and,might,increase'
p7605
g9
sS'however,neuromuscular,paralysis'
p7606
g3
sS'is,warranted,when'
p7607
g9
sS'induced,diarrhea,was'
p7608
g3
sS'administration,of,other'
p7609
g9
sS'eight,hiv-infected,patients'
p7610
g9
sS'with,their,dosage'
p7611
g9
sS'increased,risk,of'
p7612
g3
sS'contraceptives,rofecoxib,did'
p7613
g3
sS'coordination,disorder,tremor'
p7614
g3
sS'of,decreased,plasma'
p7615
g9
sS'intravenous,was,shown'
p7616
g9
sS'due,to,or'
p7617
g9
sS'the,immunodepressant--the,sandimmune--on'
p7618
g3
sS'or,other,or'
p7619
g3
sS'because,these,products'
p7620
g9
sS'sg,dipstick,test'
p7621
g3
sS'in,pigeons,did'
p7622
g3
sS'combination,therapy,with'
p7623
g9
sS'influence,the,hypoprothrombinemia'
p7624
g3
sS'following,symptom,onset'
p7625
g3
sS'c8,c9,c19'
p7626
g3
sS'of,h1,and'
p7627
g9
sS'concurrently,with,in'
p7628
g3
sS'phenylbutazone,phenylbutazone,causes'
p7629
g9
sS'isoniazid,is,also'
p7630
g9
sS'of,years,have'
p7631
g3
sS'frequently,if,inspra'
p7632
g9
sS'reports,however,from'
p7633
g9
sS'times,and,a'
p7634
g3
sS'levels,of,agents'
p7635
g9
sS'channel,blockers,such'
p7636
g9
sS'coadministration,were,within'
p7637
g9
sS'must,be,considered'
p7638
g9
sS'as,a,tablet'
p7639
g9
sS'agents,a,cyp3a4'
p7640
g3
sS'should,be,reserved'
p7641
g3
sS'be,considered,for'
p7642
g3
sS'the,total,exposure'
p7643
g3
sS'a,rabbit,erythrocyte'
p7644
g3
sS'of,and,on'
p7645
g3
sS'minutes,were,unchanged'
p7646
g3
sS'blood,auc0-12,of'
p7647
g9
sS'as,and,with'
p7648
g9
sS'the,urinary,excretion'
p7649
g9
sS'of,and,of'
p7650
g3
sS'a,and,or'
p7651
g9
sS'control,blood,sugar'
p7652
g9
sS'patients,experiencing,increases'
p7653
g9
sS'cholesterol,and,triglyceride'
p7654
g3
sS'produced,by,intermediate'
p7655
g9
sS'negative,result,from'
p7656
g3
sS'is,critically,important'
p7657
g3
sS'min,compared,to'
p7658
g3
sS'hypoglycemic,agents,such'
p7659
g9
sS'dogs,treated,with'
p7660
g3
sS'sulfonate,soybean,flour'
p7661
g9
sS'male,rhesus,monkeys'
p7662
g3
sS'parameters,of,cmax'
p7663
g3
sS'that,is,rapidly'
p7664
g3
sS'cardiac,and,systemic'
p7665
g3
sS'fold,on,day'
p7666
g9
sS'tend,to,increase'
p7667
g3
sS'after,treatment,cessation'
p7668
g3
sS'receiving,another,serotonin'
p7669
g9
sS'and,avoidance,of'
p7670
g3
sS'preliminary,animal,and'
p7671
g3
sS'times,the,maximum'
p7672
g3
sS'hydrochloride,desyrel,and'
p7673
g9
sS'courses,of,zmax'
p7674
g3
sS'd,with,a'
p7675
g9
sS'effects,of,and'
p7676
g9
sS'digoxin,methotrexate,lodine'
p7677
g9
sS'or,mg,m2'
p7678
g9
sS'if,other,produce'
p7679
g3
sS'different,in,poor'
p7680
g3
sS'carried,out,in'
p7681
g3
sS'or,renal,failure'
p7682
g3
sS'induced,diarrhea,in'
p7683
g9
sS'the,increased,potential'
p7684
g9
sS'with,tam,induces'
p7685
g3
sS'with,thus,support'
p7686
g3
sS'test,in,mice'
p7687
g3
sS'the,muscle,relaxant'
p7688
g9
sS'this,reported,activity'
p7689
g3
sS'green,tea,polyphenols'
p7690
g3
sS'potentially,associated,with'
p7691
g9
sS'as,protease,inhibitors'
p7692
g9
sS'and,videx,didanosine'
p7693
g9
sS'a,nasal,vasoconstrictor'
p7694
g3
sS'significantly,larger,when'
p7695
g3
sS'given,hours,after'
p7696
g9
sS'unknown,and,the'
p7697
g9
sS'outcomes,in,terms'
p7698
g3
sS'nalfon,the,concomitant'
p7699
g9
sS'and,was,potentiated'
p7700
g3
sS'concomitan,administration,of'
p7701
g9
sS'or,mg,ml'
p7702
g3
sS'those,of,pcp'
p7703
g3
sS'mutation,assay,in'
p7704
g3
sS'therefore,there,is'
p7705
g3
sS'increase,in,clozapine'
p7706
g9
sS'even,death,have'
p7707
g3
sS'approx,because,amplifies'
p7708
g9
sS'the,decreased,free'
p7709
g3
sS'bioequivalent,to,the'
p7710
g3
sS'instances,synergism,in'
p7711
g9
sS'in,three,pharmacokinetic'
p7712
g3
sS'patients,taking,another'
p7713
g9
sS'may,be,due'
p7714
g3
sS'women,should,practice'
p7715
g3
sS'well,as,nonsteroidal'
p7716
g3
sS'in,vitro,finding'
p7717
g3
sS'following,a,single'
p7718
g3
sS'may,be,rarely'
p7719
g9
sS'metal,cations,such'
p7720
g9
sS'seem,to,change'
p7721
g3
sS'action,potentials,with'
p7722
g3
sS'and,chapter,presents'
p7723
g3
sS'as,operating,machinery'
p7724
g3
sS'they,do,occur'
p7725
g3
sS'elevated,alkaline,phosphatase'
p7726
g3
sS'other,centrally,acting'
p7727
g3
sS'in,vitro,can'
p7728
g9
sS'not,inhibit,cyp2e1'
p7729
g3
sS'this,should,be'
p7730
g3
sS'rats,as,was'
p7731
g3
sS'be,potentiated,apparently'
p7732
g3
sS'tablets,at,least'
p7733
g9
sS'simultaneous,treatment,with'
p7734
g9
sS'nucleoside-experienced,patients,although'
p7735
g3
sS'to,treat,achlorhydria'
p7736
g3
sS'initial,dose,and'
p7737
g9
sS'and,demonstrated,no'
p7738
g3
sS'of,by,but'
p7739
g9
sS'on,a,regular'
p7740
g3
sS'participated,in,an'
p7741
g3
sS'hormonal,contraception,alone'
p7742
g3
sS'of,on,total'
p7743
g3
sS'of,magnitude,lower'
p7744
g3
sS'a2,a6,b6'
p7745
g3
sS'the,cyp3a4,metabolism'
p7746
g3
sS'toxicity,have,been'
p7747
g9
sS'to,of,the'
p7748
g3
sS'is,given,exclusively'
p7749
g3
sS'or,cramps,muscular'
p7750
g3
sS'system,may,result'
p7751
g3
sS'fluconazole,and,ketoconazole'
p7752
g3
sS'trials,suggest,no'
p7753
g3
sS'probably,related,to'
p7754
g3
sS'a,family,in'
p7755
g9
sS'prescribing,information,for'
p7756
g3
sS'have,been,used'
p7757
g3
sS'reduced,when,given'
p7758
g9
sS'deaths,in,a'
p7759
g9
sS'and,is,contraindicated'
p7760
g9
sS'cyp2c19,and,cyp2d6'
p7761
g3
sS'were,similar,between'
p7762
g3
sS'alprazolam,metabolism,via'
p7763
g3
sS'survival,in,conditions'
p7764
g3
sS'reaching,epidemic,proportions'
p7765
g3
sS'and,significantly,increased'
p7766
g9
sS'on,the,maintenance'
p7767
g9
sS'of,the,enkephalinergic'
p7768
g9
sS'clearance,of,the'
p7769
g3
sS'in,large,doses'
p7770
g3
sS'or,hypomagnesemia,should'
p7771
g3
sS'caspase-3,activity,was'
p7772
g3
sS'decrease,established,steady-state'
p7773
g9
sS'the,pelvic,girdle'
p7774
g3
sS'ethanol,sonata,mg'
p7775
g9
sS'supplements,have,detrimental'
p7776
g3
sS'of,placebo,day'
p7777
g3
sS'cyp,d6,or'
p7778
g3
sS'by,fold,and'
p7779
g9
sS'observed,during,clinical'
p7780
g3
sS'yielded,a,significantly'
p7781
g3
sS'iron-fortified,breakfast,cereals'
p7782
g3
sS'concentration,is,unaltered'
p7783
g3
sS'qt0,on,ecg'
p7784
g3
sS'the,mechanism,s'
p7785
g3
sS'may,increase,certain'
p7786
g3
sS'was,not,studied'
p7787
g3
sS'treatment-naive,patients,the'
p7788
g3
sS'other,than,has'
p7789
g3
sS'doctor,may,want'
p7790
g3
sS'the,two,hour'
p7791
g3
sS'in,rats,to'
p7792
g3
sS'for,virtually,all'
p7793
g3
sS'is,small,with'
p7794
g3
sS'the,hydantoin,antiepileptic'
p7795
g9
sS'serious,events,or'
p7796
g3
sS'effects,concomitant,use'
p7797
g3
sS'competes,for,tubular'
p7798
g9
sS'taxol,should,be'
p7799
g3
sS'on,respiration,and'
p7800
g3
sS'nnrtis,occur,within'
p7801
g3
sS'injection,usp,to'
p7802
g9
sS'that,doxil,be'
p7803
g3
sS'may,become,manifest'
p7804
g3
sS'between,patients,on'
p7805
g3
sS'half-life,of,the'
p7806
g3
sS'as,the,cytochrome'
p7807
g3
sS'wedge,pressure,than'
p7808
g9
sS'proteins,in,t24'
p7809
g3
sS'was,determined,by'
p7810
g3
sS'in,the,roughly'
p7811
g3
sS'decrease,plasma,levels'
p7812
g9
sS'the,physician,the'
p7813
g9
sS'mean,peak,plasma'
p7814
g9
sS'an,intravenous,infusion'
p7815
g3
sS'it,was,independent'
p7816
g3
sS'increased,with,mao'
p7817
g9
sS's,solutions,but'
p7818
g3
sS'pletal,does,not'
p7819
g3
sS'their,relative,avidities'
p7820
g3
sS'should,be,coadministered'
p7821
g3
sS'reduce,basal,plasma'
p7822
g3
sS'as,inderal,tenormin'
p7823
g3
sS'to,by,cytochrome'
p7824
g3
sS'cyp2d6,is,involved'
p7825
g3
sS'be,discontinued,prior'
p7826
g3
sS'pyrocarbonate,at,ph'
p7827
g3
sS'similar,mechanism,of'
p7828
g9
sS'the,design,of'
p7829
g3
sS'on,guinea,pig'
p7830
g3
sS'major,cyp,enzyme'
p7831
g3
sS'published,reports,describe'
p7832
g9
sS'patients,with,hypercholesterolemia'
p7833
g3
sS'patients,concomitantly,receiving'
p7834
g9
sS'their,antiseizure,medication'
p7835
g3
sS'no,relevant,inhibition'
p7836
g3
sS'in,their,effectiveness'
p7837
g3
sS'patient,already,stabilized'
p7838
g3
sS'norepinephrine,amphetamines,enhance'
p7839
g9
sS'receiving,tricyclic,and'
p7840
g9
sS'carbenicillin,indanyl,sodium'
p7841
g9
sS'c,g,day'
p7842
g9
sS'adjustment,may,be'
p7843
g3
sS'leading,to,alterations'
p7844
g9
sS'combining,with,any'
p7845
g3
sS'levels,by,jaffe'
p7846
g3
sS'reports,have,expanded'
p7847
g3
sS'underestimates,the,degree'
p7848
g3
sS'blood,elements,ethacrynic'
p7849
g9
sS'higher,dose,and'
p7850
g3
sS'induced,with,low'
p7851
g9
sS'concentrations,were,and'
p7852
g3
sS'concentrations,mg,bid'
p7853
g3
sS'special,patient,care'
p7854
g3
sS'does,not,however'
p7855
g3
sS'procedures,were,followed'
p7856
g3
sS'which,may,lead'
p7857
g9
sS'with,biocytin,with'
p7858
g3
sS'dose,baseline,vs'
p7859
g3
sS'studies,with,abciximab'
p7860
g3
sS'the,mg,oral'
p7861
g3
sS'oxidase,in,rat'
p7862
g3
sS'higher,dosages,of'
p7863
g3
sS'day-to,day,variability'
p7864
g3
sS'double-blind,comparative,study'
p7865
g3
sS'male,rats,of'
p7866
g3
sS'inhibitor,of,cyp2d6'
p7867
g9
sS'it,is,expected'
p7868
g9
sS'using,clinitest,tablets'
p7869
g3
sS'higher,free,fractions'
p7870
g3
sS'rat,days,or'
p7871
g3
sS'iv,have,been'
p7872
g3
sS'causing,uterine,rupture'
p7873
g9
sS'concurrent,use,of'
p7874
g9
sS'dogs,approximately,equal'
p7875
g3
sS'n2,and,n3'
p7876
g3
sS'acid,excretion,compared'
p7877
g9
sS'adverse,reactions,thought'
p7878
g3
sS'are,on,replacement'
p7879
g9
sS'of,mg,twice'
p7880
g3
sS'first,hour,of'
p7881
g3
sS'coadministered,with,viracept'
p7882
g9
sS'sensitive,to,alterations'
p7883
g3
sS'erythromycin,azole,antifungals'
p7884
g3
sS'occur,when,agents'
p7885
g9
sS'of,the,oral'
p7886
g9
sS'vitro,data,on'
p7887
g3
sS'that,a,number'
p7888
g3
sS'was,independent,of'
p7889
g3
sS'anticoagulation,effects,due'
p7890
g3
sS'same,episode,of'
p7891
g3
sS'increase,the,rate'
p7892
g9
sS'to,diseases,such'
p7893
g3
sS'suggest,that,krm-1648'
p7894
g3
sS'of,enhanced,as'
p7895
g9
sS'but,not,limited'
p7896
g9
sS'exposure,were,as'
p7897
g3
sS'electrophilic,agents--a,class'
p7898
g3
sS'suggested,that,zebeta'
p7899
g9
sS'normalized,ratio,inr'
p7900
g9
sS'the,involvement,of'
p7901
g9
sS'subject,to,first-pass'
p7902
g3
sS'of,the,block'
p7903
g3
sS'concomitantly,with,their'
p7904
g9
sS'of,induced,therapeutic'
p7905
g3
sS'keppra,mg,twice'
p7906
g3
sS'tadalafil,dose,should'
p7907
g9
sS'tracrium,should,not'
p7908
g9
sS'other,highly,protein-bound'
p7909
g3
sS'being,given,should'
p7910
g9
sS'of,orencia,administered'
p7911
g9
sS'value,of,the'
p7912
g3
sS'bacteriostatic,may,antagonize'
p7913
g9
sS'indicated,dosing,should'
p7914
g3
sS'the,results,of'
p7915
g3
sS'cns-depressive,effects,of'
p7916
g9
sS'the,preceding,effect'
p7917
g3
sS'warfarin,meclofenamate,sodium'
p7918
g9
sS'patients,receiving,and'
p7919
g9
sS'homocysteine,following,synthetic'
p7920
g3
sS'the,aucs,of'
p7921
g3
sS'effect,was,shown'
p7922
g3
sS'binding,in,vitro'
p7923
g9
sS'clearance,and,lower'
p7924
g9
sS'treatments,corrective,measures'
p7925
g3
sS'the,cyp2d6,pathway'
p7926
g3
sS'exposure,compared,with'
p7927
g3
sS'subjects,already,receiving'
p7928
g9
sS'in,vitro,the'
p7929
g3
sS'combination,regimens,containing'
p7930
g9
sS'benedicts,or,fehlings'
p7931
g3
sS'an,altered,biodistribution'
p7932
g3
sS'allergy,or,weight'
p7933
g3
sS'simultaneously,with,or'
p7934
g9
sS'and,a,or'
p7935
g3
sS'protein,binding,and'
p7936
g9
sS'of,both,parental'
p7937
g3
sS'on,established,therapy'
p7938
g9
sS'although,much,statistical'
p7939
g3
sS'toxicity,and,the'
p7940
g3
sS'medications,were,mp'
p7941
g3
sS'dose,had,no'
p7942
g3
sS'including,crescentic,iga'
p7943
g9
sS'coronary,insufficiency,in'
p7944
g3
sS'udp-glucuronyl,transferase,level'
p7945
g3
sS'approximately,ml,of'
p7946
g3
sS'probenecid,may,decrease'
p7947
g9
sS'subtypes,although,it'
p7948
g3
sS'its,plasma,clearance'
p7949
g3
sS'of,patients,receiving'
p7950
g3
sS'values,of,lng'
p7951
g3
sS'such,as,tolerance'
p7952
g3
sS'inhibition,of,isoform'
p7953
g3
sS'therefore,coadministration,of'
p7954
g9
sS'these,events,and'
p7955
g3
sS'interactions,no,pharmacokinetic'
p7956
g3
sS'in,animals,edetate'
p7957
g9
sS'that,you,need'
p7958
g9
sS'whenever,increased,thioether'
p7959
g3
sS'the,prior,administration'
p7960
g9
sS'required,when,anafranil'
p7961
g9
sS'hydrochloride,injection,and'
p7962
g9
sS'given,without,difficulty'
p7963
g3
sS'with,in,the'
p7964
g9
sS'metal,mixtures,had'
p7965
g3
sS'and,hydroxide,does'
p7966
g3
sS'observed,when,subjects'
p7967
g3
sS'their,plasma,concentration'
p7968
g9
sS'failure,as,well'
p7969
g3
sS'of,platelet,effects'
p7970
g3
sS'taken,on,an'
p7971
g3
sS'possibility,of,oxidative'
p7972
g3
sS'min,following,ip'
p7973
g3
sS'other,cholinesterase,inhibitors'
p7974
g9
sS'prolonged,gastrointestinal,transit'
p7975
g9
sS'no,known,clinically'
p7976
g3
sS'of,bleeding,when'
p7977
g9
sS'case,of,rhabdomyolysis'
p7978
g3
sS'did,not,interact'
p7979
g3
sS'of,and,to'
p7980
g3
sS'to,patients,being'
p7981
g9
sS'and,without,mg'
p7982
g3
sS'affected,by,coadministration'
p7983
g3
sS'and,or,gonadal'
p7984
g3
sS'and,close,monitoring'
p7985
g3
sS'patients,with,mild'
p7986
g9
sS'intravenous,unless,the'
p7987
g9
sS'found,to,induce'
p7988
g3
sS'antigen,viii,antigen'
p7989
g3
sS'the,present,study'
p7990
g3
sS'potential,adverse,cardiovascular'
p7991
g3
sS'the,selective,regulation'
p7992
g3
sS'sexual,intercourse,with'
p7993
g3
sS'has,been,excreted'
p7994
g3
sS'vitro,and,animal'
p7995
g9
sS'activity,and,the'
p7996
g3
sS'of,the,washout'
p7997
g3
sS'with,muscle,relaxants'
p7998
g3
sS'anorexia,tachypnea,lethargy'
p7999
g9
sS'enterohepatic,circulation,the'
p8000
g9
sS'of,trazodone,hydrochloride'
p8001
g9
sS'who,had,achieved'
p8002
g3
sS'administered,concomitantly,prothrombin'
p8003
g3
sS'coreg,is,to'
p8004
g9
sS'intrathecal,on,blocking'
p8005
g3
sS'serum,concentrations,appeared'
p8006
g3
sS'profile,between,study'
p8007
g3
sS'the,distribution,of'
p8008
g3
sS'changes,on,the'
p8009
g3
sS'acid,by,and'
p8010
g9
sS'patients,should,be'
p8011
g3
sS'prohibited,in,the'
p8012
g3
sS'twitch,to,fade'
p8013
g9
sS'receiving,will,have'
p8014
g9
sS'pharmacological,analysis,of'
p8015
g3
sS'singly,and,in'
p8016
g3
sS'inhibit,the,nad'
p8017
g9
sS'ketoconazole,coadministration,of'
p8018
g9
sS'observed,in,tarceva'
p8019
g3
sS'increase,the,plasma-level'
p8020
g9
sS'an,increased,volume'
p8021
g3
sS'this,product,with'
p8022
g3
sS'the,identity,of'
p8023
g3
sS'interaction,study,the'
p8024
g3
sS'excluded,based,on'
p8025
g3
sS'be,made,whether'
p8026
g3
sS'endogenous,prostaglandin,synthesis'
p8027
g9
sS'leads,to,an'
p8028
g9
sS'with,or,patients'
p8029
g3
sS'increased,exposure,tonevirapine'
p8030
g3
sS'after,initiating,or'
p8031
g9
sS'that,larger,doses'
p8032
g3
sS'administration,of,either'
p8033
g3
sS'similar,study,attempting'
p8034
g3
sS'this,paper,reviews'
p8035
g3
sS'cardiovascular,safety,of'
p8036
g3
sS'by,and,other'
p8037
g9
sS'causal,mechanism,and'
p8038
g9
sS'together,with,the'
p8039
g3
sS'cell,type-specific,differences'
p8040
g3
sS'acid,or,the'
p8041
g9
sS'in,their,serum'
p8042
g3
sS'binding,proteins,and'
p8043
g9
sS'given,before,the'
p8044
g3
sS'to,convulsions,in'
p8045
g9
sS'in,female,rats'
p8046
g3
sS'have,carried,out'
p8047
g3
sS'receiving,long-,term'
p8048
g9
sS'evidence,of,mutagenicity'
p8049
g3
sS'monoamine,oxidase,inhibition'
p8050
g3
sS'of,prinivil,alone'
p8051
g3
sS'year,controlled,study'
p8052
g3
sS'therefore,inhibitors,of'
p8053
g3
sS'can,be,effectively'
p8054
g3
sS'studies,adjuvant,treatment'
p8055
g9
sS'anticholinergic,in,the'
p8056
g3
sS'the,steroidal,agent'
p8057
g9
sS'preparations,to,control'
p8058
g3
sS'upon,combination,with'
p8059
g9
sS'reach,maximum,concentration'
p8060
g3
sS'higher,when,it'
p8061
g9
sS'with,increased,concentrations'
p8062
g3
sS'and,a,trend'
p8063
g3
sS'bun,serum,creatinine'
p8064
g9
sS'dosage,and,administration-dosage'
p8065
g3
sS'use,in,ambulatory'
p8066
g3
sS'd,have,been'
p8067
g3
sS'formal,interaction,studies'
p8068
g3
sS'cortisol,concentration,or'
p8069
g3
sS'in,vivo,studies'
p8070
g3
sS'concomitant,medication,on'
p8071
g3
sS'determined,prior,to'
p8072
g9
sS'hormone,indicating,that'
p8073
g3
sS'methods,that,may'
p8074
g3
sS'it,is,therefore'
p8075
g9
sS'as,the,or'
p8076
g9
sS'suitable,coagulation,tests'
p8077
g3
sS'or,with,clinitest'
p8078
g3
sS'mao,inhibitor,class'
p8079
g9
sS'randomly,bred,control'
p8080
g3
sS'of,camptosar,with'
p8081
g3
sS'not,predispose,to'
p8082
g3
sS'cephalothin,sodium,sulfate'
p8083
g3
sS'excretion,is,the'
p8084
g9
sS'two,agents,should'
p8085
g9
sS'doses,of,or'
p8086
g3
sS'to,maintain,levels'
p8087
g9
sS'therefore,a,lower'
p8088
g3
sS'the,prescribing,information'
p8089
g3
sS'phenytoin,no,significant'
p8090
g3
sS'co-administered,with,the'
p8091
g9
sS'is,excreted,slowly'
p8092
g3
sS'meal,of,the'
p8093
g3
sS'hemostasis,and,regulation'
p8094
g3
sS'in,strains,of'
p8095
g3
sS'solution,may,result'
p8096
g9
sS'adenosine,effects,are'
p8097
g9
sS'of,femara,and'
p8098
g9
sS'n,cmax,and'
p8099
g3
sS'cromolyn,sodium,alone'
p8100
g3
sS'on,them,are'
p8101
g3
sS'carcinogenesis,pegasys,has'
p8102
g3
sS'of,deaths,in'
p8103
g3
sS'toradoloral,was,coadministered'
p8104
g3
sS'the,curariform,effect'
p8105
g9
sS'ace-inhibitors,reports,suggest'
p8106
g9
sS'and,asa,and'
p8107
g3
sS'non,soluble,particularly'
p8108
g3
sS'and,hydroxides,be'
p8109
g9
sS'contributed,to,the'
p8110
g3
sS'since,the,renal'
p8111
g3
sS'inhibitors,that,are'
p8112
g9
sS'very,closely,when'
p8113
g9
sS'described,in,a'
p8114
g3
sS'interference,by,chloral'
p8115
g3
sS'also,bleeding,and'
p8116
g9
sS'serum,concentration,by'
p8117
g3
sS'of,uptake,blocking'
p8118
g3
sS'pharmacokinetics,of,measured'
p8119
g3
sS'a,competitive,inhibitor'
p8120
g9
sS'concomitant,medications,and'
p8121
g3
sS'decrease,in,maximal'
p8122
g9
sS'were,and,with'
p8123
g3
sS'its,absorption,from'
p8124
g9
sS'animals,were,killed'
p8125
g3
sS'requirements,of,nimbex'
p8126
g9
sS'increases,in,or'
p8127
g3
sS'receiving,appeared,to'
p8128
g9
sS'hypertensive,reactions,including'
p8129
g9
sS'possibly,nicotinic,receptors'
p8130
g3
sS'whether,the,insulin-sensitizing'
p8131
g3
sS'in,the,e-strain'
p8132
g3
sS'of,absorption,in'
p8133
g9
sS'since,is,contraindicated'
p8134
g3
sS'the,results,demonstrate'
p8135
g3
sS'replacement,indicates,either'
p8136
g3
sS'd6,include,some'
p8137
g3
sS'except,for,increased'
p8138
g3
sS'inhibits,the,renal'
p8139
g9
sS'captopril,s,effect'
p8140
g9
sS'male,volunteers,n'
p8141
g3
sS'respiratory,depression,may'
p8142
g9
sS'change,was,not'
p8143
g3
sS'administration,of,aprepitant'
p8144
g9
sS'evidence,of,clinically'
p8145
g3
sS'the,relation,with'
p8146
g3
sS'treatment,with,of'
p8147
g3
sS'quantities,of,systemically'
p8148
g3
sS'treatment,with,oh'
p8149
g9
sS'to,cytochrome,p450'
p8150
g9
sS'cyp2c9,cyp2c19,cyp2d6'
p8151
g3
sS'have,been,frequently'
p8152
g3
sS'at,least,weeks'
p8153
g3
sS'these,patients,demonstrated'
p8154
g9
sS'bleeding,events,have'
p8155
g9
sS'or,its,synthetic'
p8156
g3
sS'active,metabolite,may'
p8157
g9
sS'primarily,by,cytochrome'
p8158
g3
sS'make,your,condition'
p8159
g3
sS'twitch,allowed,to'
p8160
g3
sS'agonists,have,been'
p8161
g9
sS'rifabutin,another,is'
p8162
g3
sS'the,patient,or'
p8163
g3
sS'vidaza,and,other'
p8164
g3
sS'ccnu,by,dose'
p8165
g9
sS'hypoglycemia,which,may'
p8166
g3
sS'of,severe,myelosuppression'
p8167
g3
sS'as,other,medicines'
p8168
g9
sS'cmin,concentrations,increased'
p8169
g3
sS'with,sustiva,mg'
p8170
g9
sS'qtc,intervals,in'
p8171
g3
sS'disturbances,left,ventricular'
p8172
g9
sS'decreased,the,maximum'
p8173
g9
sS'other,concurrent,use'
p8174
g9
sS'intestinal,first,pass'
p8175
g3
sS'acetylsalicylic,acid,did'
p8176
g3
sS'cystic,fluid,were'
p8177
g9
sS'in,urine,has'
p8178
g3
sS'combination,with,experienced'
p8179
g9
sS'be,exacerbated,by'
p8180
g9
sS'sometimes,used,for'
p8181
g3
sS'below,are,potentially'
p8182
g3
sS'reported,examples,of'
p8183
g3
sS'conclusions,olanzapine,demonstrated'
p8184
g3
sS'day,withdrawal,period'
p8185
g3
sS'in,dogs,unchanged'
p8186
g3
sS'amevive,should,be'
p8187
g3
sS'accumbens,but,only'
p8188
g3
sS'a,study,which'
p8189
g3
sS'drug,level,in'
p8190
g3
sS'if,b12,deficiency'
p8191
g3
sS'interactions,in,clinical'
p8192
g3
sS'the,pathogenic,species'
p8193
g3
sS'such,reactions,have'
p8194
g3
sS'lower,plasma,concentration'
p8195
g3
sS'reported,with,the'
p8196
g9
sS'of,goal-directed,behavior'
p8197
g3
sS'reported,to,be'
p8198
g9
sS'imidazoles,etc,in'
p8199
g9
sS'mefenamic,acid,and'
p8200
g3
sS'or,organophosphate,and'
p8201
g9
sS'dual,effect,of'
p8202
g3
sS'healthy,volunteers,were'
p8203
g3
sS'hours,apart,so'
p8204
g3
sS'serum,concentrations,lower'
p8205
g3
sS'or,and,frova'
p8206
g9
sS'dosage,was,inappropriate'
p8207
g3
sS'seen,prior,to'
p8208
g9
sS'of,clinical,importance'
p8209
g3
sS'a,modest,cyp2d6'
p8210
g9
sS'mg,and,a'
p8211
g9
sS'of,depression,than'
p8212
g3
sS'should,be,allowed'
p8213
g9
sS'or,neuromuscular,blockade'
p8214
g3
sS'this,medication,tell'
p8215
g3
sS'plasma,has,not'
p8216
g9
sS'female,rats,administered'
p8217
g3
sS'concentrations,in,the'
p8218
g3
sS'substances,grapefruit,juice'
p8219
g3
sS'actions,were,potentiated'
p8220
g9
sS'agents,are,associated'
p8221
g3
sS'with,to,which'
p8222
g9
sS'who,were,extensive'
p8223
g9
sS'twice,daily,did'
p8224
g3
sS'positive,test,results'
p8225
g3
sS'fenofibric,acid,are'
p8226
g3
sS'are,highly,bound'
p8227
g9
sS'phenytoin,accutane,has'
p8228
g3
sS'of,factive,and'
p8229
g9
sS'midazolam,used,at'
p8230
g9
sS'strenuous,physical,activity'
p8231
g3
sS'ng,ml,at'
p8232
g3
sS'monitored,by,the'
p8233
g3
sS'sr,by,approximately'
p8234
g9
sS'and,to,confirm'
p8235
g3
sS'performed,both,with'
p8236
g3
sS'intoxication,after,administration'
p8237
g3
sS'valium,and,to'
p8238
g9
sS'receiving,concomitant,high-dose'
p8239
g9
sS'given,at,bedtime'
p8240
g3
sS'in,vertigo,syncope'
p8241
g3
sS'the,pt,such'
p8242
g3
sS'fourteen,days,later'
p8243
g3
sS'recently,instituted,may'
p8244
g9
sS'beta-lactam,including,based'
p8245
g9
sS'and,other,vasoconstrictor'
p8246
g9
sS'in,bioavailability,or'
p8247
g3
sS'dependent,on,the'
p8248
g3
sS'data,raise,the'
p8249
g3
sS'warrant,dosage,adjustments'
p8250
g9
sS'amount,of,lanoxin'
p8251
g9
sS'and,an,inhibitor'
p8252
g3
sS'inhibitor,of,cyp3a4'
p8253
g9
sS'hypothyroidism,in,spite'
p8254
g3
sS'periodic,intervals,or'
p8255
g9
sS'in,premenopausal,women'
p8256
g3
sS'nevirapine,is,principally'
p8257
g3
sS'and,a,precipitate'
p8258
g3
sS'was,greater,patients'
p8259
g9
sS'achieved,in,adequate'
p8260
g3
sS'study,with,bioavailability'
p8261
g3
sS'were,variable,and'
p8262
g3
sS'are,needed,their'
p8263
g3
sS'well,as,the'
p8264
g3
sS'some,dysrhythmias,torsades'
p8265
g3
sS'ethanol,flupenthixol,and'
p8266
g9
sS'i,mac,was'
p8267
g9
sS'cause,hypoglycemia,which'
p8268
g3
sS'skeletal,muscle,relaxing'
p8269
g9
sS'bovine,chromaffin,cell'
p8270
g3
sS'of,gene,transfer'
p8271
g3
sS'concomitant,therapy,or'
p8272
g3
sS'prolongation,cardiac,arrythmias'
p8273
g9
sS'but,not,morphine-induced'
p8274
g3
sS'out,in,the'
p8275
g3
sS'respiration,was,markedly'
p8276
g3
sS'individual,glucose,concentrations'
p8277
g9
sS'suggest,that,tam'
p8278
g9
sS'least,weeks,may'
p8279
g3
sS'use,of,buspirone'
p8280
g9
sS'oral,suspension,can'
p8281
g3
sS'geriatric,use,when'
p8282
g3
sS'averaged,s,d'
p8283
g9
sS'other,that,could'
p8284
g3
sS'with,the,in'
p8285
g3
sS'sonata,mg,q24h'
p8286
g3
sS'day,in,otherwise'
p8287
g3
sS'strength,from,mean'
p8288
g3
sS'retrospective,studies,were'
p8289
g3
sS'marrow,depression,such'
p8290
g9
sS'in,of,patients'
p8291
g3
sS'pressure,medications,motion'
p8292
g3
sS'challenge,and,the'
p8293
g3
sS'to,one-fourth,of'
p8294
g9
sS'd,agonists,concomitant'
p8295
g9
sS'agents,that,lower'
p8296
g3
sS'balance,in,patients'
p8297
g3
sS'marked,reductions,in'
p8298
g3
sS'including,decrease,the'
p8299
g9
sS'a,patient,s'
p8300
g3
sS'dose,is,about'
p8301
g3
sS'combined,administration,of'
p8302
g3
sS'oxolinic,acid,prolonged'
p8303
g9
sS'also,inhibit,the'
p8304
g3
sS'receiving,prothrombin,times'
p8305
g9
sS'v,vii,and'
p8306
g3
sS'of,mmol,l'
p8307
g3
sS'levels,the,dose'
p8308
g9
sS'benefit,from,containing'
p8309
g9
sS'strategies,to,minimise'
p8310
g3
sS'renal,excretion,a'
p8311
g3
sS'of,therapeutic,concentrations'
p8312
g3
sS'a,controlled,clinical'
p8313
g3
sS'for,the,full'
p8314
g3
sS'of,certain,weak'
p8315
g9
sS'treatment,and,inhibits'
p8316
g9
sS'affected,prothrombin,times'
p8317
g3
sS'addition,higher-than,expected'
p8318
g9
sS'preliminary,results,from'
p8319
g3
sS'whether,this,observation'
p8320
g3
sS'of,kerlone,with'
p8321
g3
sS'against,cercariae,and'
p8322
g3
sS'on,microtubules,in'
p8323
g3
sS'the,nonlinear,kinetic'
p8324
g3
sS'of,those,obtained'
p8325
g9
sS'to,and,and'
p8326
g3
sS'at,the,absorption'
p8327
g3
sS'and,the,auc'
p8328
g9
sS'but,given,the'
p8329
g3
sS'in,vivo,clinically'
p8330
g3
sS'is,derived,from'
p8331
g9
sS'veratrum,alkaloids,amphetamines'
p8332
g9
sS'at,microm,which'
p8333
g3
sS'of,pulse,arterial'
p8334
g3
sS'of,from,ml'
p8335
g9
sS'have,either,protective'
p8336
g3
sS'the,concentration-time,curve'
p8337
g3
sS'its,proposed,specific'
p8338
g3
sS'supplements,on,glycemic'
p8339
g3
sS'anti-inflammatory,activity,of'
p8340
g9
sS'study,of,young'
p8341
g3
sS'twenty,four,male'
p8342
g3
sS'of,are,increased'
p8343
g9
sS'interaction,of,these'
p8344
g3
sS'cns,cardiac,and'
p8345
g3
sS'patients,receive,large'
p8346
g3
sS'of,tikosyn,with'
p8347
g9
sS'day,in,combination'
p8348
g3
sS'gi,ulceration,or'
p8349
g9
sS'the,absolute,number'
p8350
g3
sS'american,coffee,was'
p8351
g3
sS'trypanosomiasis,uganda,since'
p8352
g3
sS'a,class,may'
p8353
g3
sS'lithium,lithium,should'
p8354
g9
sS'to,higher,exposure'
p8355
g9
sS'results,regarding,the'
p8356
g9
sS'other,hydroxymethylglutaryl,coenzyme'
p8357
g9
sS'on,the,antitumour'
p8358
g3
sS'interaction,with,for'
p8359
g9
sS'of,cyp3a4,increased'
p8360
g9
sS'weeks,after,initiation'
p8361
g9
sS'phenytoin,altered,serum'
p8362
g9
sS'could,be,additive'
p8363
g9
sS'and,synergistic,for'
p8364
g9
sS'health,care,professionals'
p8365
g3
sS'depressants,the,concomitant'
p8366
g9
sS'noted,below,are'
p8367
g3
sS'for,interaction,with'
p8368
g3
sS'lithium,carbonate,the'
p8369
g9
sS'mg,each,dose'
p8370
g3
sS'as,factor,viii'
p8371
g3
sS'advised,to,obtain'
p8372
g9
sS'with,elevated,plasma'
p8373
g9
sS'with,mg,of'
p8374
g9
sS'abolishes,the,activity'
p8375
g3
sS'of,bleeding,with'
p8376
g3
sS'maintained,at,low'
p8377
g3
sS'resulted,in,substantial'
p8378
g9
sS'allegra,should,be'
p8379
g3
sS'enhance,cardiovascular,depression'
p8380
g3
sS'micromol,l,did'
p8381
g3
sS'radiolabeled,ions,may'
p8382
g3
sS'that,may,alter'
p8383
g9
sS'with,a,toxicology'
p8384
g9
sS'dose,of,inapsine'
p8385
g3
sS'clinical,studies,received'
p8386
g3
sS'indications,for,and'
p8387
g3
sS'controlled,study,a'
p8388
g9
sS'antagonize,the,hypotensive'
p8389
g9
sS'reduced,by,one-half'
p8390
g3
sS'respiratory,depression,stupor'
p8391
g9
sS'are,needed,to'
p8392
g3
sS'and,recurred,when'
p8393
g3
sS'mg,once,daily'
p8394
g3
sS'period,of,at'
p8395
g9
sS'expression,of,an'
p8396
g3
sS'begun,in,a'
p8397
g3
sS'authorization,cards,mac'
p8398
g3
sS'or,oils,should'
p8399
g3
sS'such,as,diphen-hydramine'
p8400
g3
sS'to,continue,the'
p8401
g9
sS'research,specific,to'
p8402
g3
sS'repeat,testing,was'
p8403
g3
sS'a,level,of'
p8404
g3
sS'enzyme,systems,inhibition'
p8405
g3
sS'miracidia,was,reduced'
p8406
g3
sS'careful,titration,are'
p8407
g3
sS'of,major,bleeding'
p8408
g9
sS'in,significantly,increased'
p8409
g9
sS'hypoglycemic,agents,may'
p8410
g3
sS'prolongation,ischemic,heart'
p8411
g9
sS'aspirin,is,contraindicated'
p8412
g9
sS'been,demonstrated,in'
p8413
g3
sS'oral,placebo,and'
p8414
g3
sS'greater,than,changes'
p8415
g3
sS'drug,and,laboratory'
p8416
g3
sS'query,patients,or'
p8417
g3
sS'not,inhibit,or'
p8418
g3
sS'inhibit,the,cytochrome'
p8419
g3
sS'and,other,nonsteroidal'
p8420
g9
sS'with,patients,taking'
p8421
g9
sS'react,with,in'
p8422
g9
sS'such,as,psoriasis'
p8423
g3
sS'vioxx,concomitantly,with'
p8424
g9
sS'drugs,that,may'
p8425
g9
sS'b-blocking,properties,if'
p8426
g9
sS'has,been,analysed'
p8427
g3
sS'nephrosis,acromegaly,and'
p8428
g3
sS'resulting,in,lowered'
p8429
g9
sS'and,other,likely'
p8430
g3
sS'blood,can,significantly'
p8431
g3
sS'to,date,on'
p8432
g3
sS'values,all,three'
p8433
g3
sS'these,agents,should'
p8434
g3
sS'is,encountered,in'
p8435
g3
sS'when,administered,alone'
p8436
g3
sS'serotoninergic,central,pathways'
p8437
g3
sS'successfully,concurrently,with'
p8438
g3
sS'cell,could,be'
p8439
g3
sS'coadministration,of,videx'
p8440
g3
sS'dopamine-induced,ventricular,arrhythmias'
p8441
g9
sS'decreased,antihypertensive,effect'
p8442
g9
sS'may,reduce,its'
p8443
g3
sS'if,the,potential'
p8444
g9
sS'of,activase,in'
p8445
g3
sS'out,decreased,renal'
p8446
g3
sS'reported,during,concomitant'
p8447
g9
sS'based,tests,such'
p8448
g3
sS'date,in,clinical'
p8449
g3
sS'lower,the,plasma'
p8450
g9
sS'evaluating,the,serum'
p8451
g3
sS'their,clearance,resulting'
p8452
g3
sS'nd,female,n'
p8453
g3
sS'altered,by,amphotericin'
p8454
g3
sS'childbearing,potential,to'
p8455
g3
sS'with,and,placebo'
p8456
g3
sS'including,when,hydrochloride'
p8457
g9
sS'the,dosage,may'
p8458
g3
sS'mean,eight-fold,increase'
p8459
g9
sS'were,concomitantly,used'
p8460
g3
sS'with,xigris,caution'
p8461
g3
sS'increase,oral,response'
p8462
g9
sS'inhibitors,the,combined'
p8463
g9
sS'with,no,increase'
p8464
g3
sS'thrombus,formation,from'
p8465
g9
sS'cisplatin,was,administered'
p8466
g3
sS'of,v,oral'
p8467
g9
sS'to,cross,toxicity'
p8468
g9
sS'be,paid,to'
p8469
g3
sS'to,active,metabolite'
p8470
g3
sS'the,magnitude,of'
p8471
g3
sS'data,presented,here'
p8472
g3
sS'and,may,increase'
p8473
g9
sS'taking,tarceva,with'
p8474
g9
sS'for,such,interactions'
p8475
g3
sS'case,of,interference'
p8476
g3
sS'of,to,mg'
p8477
g9
sS'molecular,weight,heparins'
p8478
g3
sS'the,magnitude,or'
p8479
g3
sS'fetal,development,including'
p8480
g3
sS'this,metabolism,in'
p8481
g3
sS'also,extensively,used'
p8482
g3
sS'cyp450,metabolized,drugs'
p8483
g3
sS'is,prone,to'
p8484
g3
sS'from,decrease,to'
p8485
g9
sS'appears,to,be'
p8486
g3
sS'extensive,metabolism,by'
p8487
g3
sS'the,deaths,due'
p8488
g3
sS'was,inappropriate,being'
p8489
g3
sS'patients,were,randomly'
p8490
g3
sS'from,addicts,was'
p8491
g3
sS'to,transport-related,effects'
p8492
g9
sS'receiving,monoamine,oxidase'
p8493
g9
sS'similar,among,bosentan-'
p8494
g3
sS'pose,a,hazard'
p8495
g9
sS'discontinued,and,should'
p8496
g3
sS'administered,hydrochloride,alone'
p8497
g3
sS'have,been,drawn'
p8498
g3
sS'precautions,probably,should'
p8499
g3
sS'which,was,far'
p8500
g3
sS'of,an,in'
p8501
g3
sS'the,decrease,of'
p8502
g3
sS'peak,concentration,of'
p8503
g3
sS'of,the,administration'
p8504
g9
sS'like,and,from'
p8505
g3
sS'the,coumarin,type'
p8506
g3
sS'focused,on,developing'
p8507
g3
sS'while,using,pocs'
p8508
g3
sS'of,one,ng'
p8509
g3
sS'a,inhibitors,on'
p8510
g9
sS'in,peak,plasma'
p8511
g9
sS'effects,constipation,and'
p8512
g3
sS'diabetic,patients,there'
p8513
g3
sS'the,analgesic,effect'
p8514
g9
sS'or,to,two'
p8515
g9
sS'food,is,recommended'
p8516
g9
sS'auc,for,total'
p8517
g3
sS'impact,of,the'
p8518
g3
sS'not,induce,the'
p8519
g3
sS'not,be,stopped'
p8520
g3
sS'mouth,sores,or'
p8521
g3
sS'will,be,longer'
p8522
g3
sS'with,may,lead'
p8523
g9
sS'are,part,of'
p8524
g3
sS'and,ocular,blood'
p8525
g3
sS'an,increased,availability'
p8526
g3
sS'cytochrome,p450-linked,drug-metabolizing'
p8527
g3
sS'may,be,adversely'
p8528
g3
sS'of,coadministration,loratadine'
p8529
g3
sS'containing,alone,they'
p8530
g9
sS'dysfunction,with,the'
p8531
g3
sS'clinically,significant,only'
p8532
g3
sS'a,review,is'
p8533
g3
sS'response,to,a'
p8534
g3
sS'anticoagulants,oral,in'
p8535
g3
sS'of,microsomal,enzymes'
p8536
g3
sS'sparing,such,as'
p8537
g9
sS'tricyclic,may,antagonize'
p8538
g9
sS'in,the,remainder'
p8539
g3
sS'orange,juice,or'
p8540
g3
sS'in,hypercholesterolemic,patients'
p8541
g9
sS'samples,for,plasma'
p8542
g3
sS'weeks,after,cessation'
p8543
g3
sS'weight,and,body'
p8544
g3
sS'is,warranted,in'
p8545
g9
sS'be,weighed,against'
p8546
g3
sS'elucidating,the,role'
p8547
g3
sS'be,discontinued,at'
p8548
g9
sS'may,cause,an'
p8549
g9
sS'suggesting,that,dose'
p8550
g9
sS'completed,with,both'
p8551
g3
sS'tranexamic,acid,aminocaproic'
p8552
g3
sS'a,few,patients'
p8553
g9
sS'the,same,procedures'
p8554
g3
sS'agents,may,produce'
p8555
g9
sS'or,disruption,of'
p8556
g3
sS'see,illustrated,information'
p8557
g3
sS'the,following,beta-adrenergic'
p8558
g3
sS'including,or,non-opioid'
p8559
g3
sS'useful,for,peroral'
p8560
g3
sS'scintigraphy,employing,mtc-mdp'
p8561
g3
sS'a,new,acute'
p8562
g3
sS'was,due,to'
p8563
g3
sS'of,a,tumor'
p8564
g3
sS'an,adverse,interaction'
p8565
g3
sS'malignancies,is,higher'
p8566
g3
sS'a,meal,as'
p8567
g9
sS'may,raise,blood'
p8568
g3
sS'of,and,other'
p8569
g3
sS'was,poorly,tolerated'
p8570
g9
sS'medications,should,not'
p8571
g3
sS'plasma,protein,and'
p8572
g3
sS'videx,should,be'
p8573
g9
sS'due,to,the'
p8574
g3
sS'identical,but,endogenous'
p8575
g3
sS'and,cmin,were'
p8576
g9
sS'well,as,post-marketing'
p8577
g9
sS'for,possible,atrioventricular'
p8578
g9
sS'admini,stered,orally'
p8579
g9
sS'by,protein-binding,displacement'
p8580
g3
sS'the,same,efficacy'
p8581
g3
sS'influence,the,plasma'
p8582
g3
sS'concentration,were,not'
p8583
g3
sS'were,conducted,in'
p8584
g3
sS'against,the,ototoxic'
p8585
g9
sS'background,the,pharmacokinetic'
p8586
g3
sS'effects,of,such'
p8587
g9
sS'proteins,interacting,with'
p8588
g3
sS'rise,to,convulsions'
p8589
g9
sS'demonstrated,only,in'
p8590
g3
sS'interactions,between,trisenox'
p8591
g3
sS'particular,caution,is'
p8592
g9
sS'the,concentrations,producing'
p8593
g3
sS'when,was,withdrawn'
p8594
g3
sS'been,performed,in'
p8595
g3
sS'raise,the,level'
p8596
g3
sS'there,are,few'
p8597
g3
sS'kemstro,the,most'
p8598
g3
sS'bezalip,retard,is'
p8599
g9
sS'minimal,essential,tissue'
p8600
g3
sS'the,same,proportions'
p8601
g3
sS'digit,symbol,substitution'
p8602
g9
sS'day,and,day'
p8603
g9
sS'release,and,impaired'
p8604
g3
sS'and,younger,patients'
p8605
g3
sS'with,videx,should'
p8606
g3
sS'tremor,in,elderly'
p8607
g3
sS'micromol,l,induced'
p8608
g3
sS'method,and,a'
p8609
g3
sS'micronase,the,patient'
p8610
g3
sS'test,for,occult'
p8611
g3
sS'or,activity,of'
p8612
g9
sS'though,reversible,impairment'
p8613
g9
sS'the,contents,of'
p8614
g3
sS'discontinued,for,several'
p8615
g9
sS'response,and,the'
p8616
g3
sS'if,stadol,ns'
p8617
g9
sS'that,is,highly'
p8618
g3
sS'ventricular,failure,have'
p8619
g9
sS'of,and,caused'
p8620
g3
sS'oral,anticoagulants,caution'
p8621
g9
sS'availability,of,relevant'
p8622
g3
sS'of,or,caused'
p8623
g3
sS'wait,weeks,after'
p8624
g9
sS'treatment,for,patients'
p8625
g3
sS'of,mixed,overdosage'
p8626
g9
sS'reduction,depending,on'
p8627
g3
sS'may,be,considered'
p8628
g3
sS'result,in,advanced'
p8629
g9
sS'interactions,blood,glucose'
p8630
g3
sS'given,the,possibility'
p8631
g3
sS'and,respectively,and'
p8632
g9
sS'of,this,difference'
p8633
g3
sS'potassium,enalapril,and'
p8634
g9
sS'deleterious,effects,following'
p8635
g3
sS'day,of,a'
p8636
g9
sS'resulting,in,systemic'
p8637
g9
sS'than,mg,considered'
p8638
g3
sS'is,maintained,by'
p8639
g3
sS'sodium,polystyrene,sulfonate'
p8640
g9
sS'is,metabolized,by'
p8641
g3
sS'thyroid-stimulating,hormone,or'
p8642
g3
sS'pcp,induced,locomotion'
p8643
g3
sS'stadol,ns,mg'
p8644
g3
sS'when,eye,drops'
p8645
g3
sS'in,patients,who'
p8646
g9
sS'prelone,st,johns'
p8647
g9
sS'cyp450,isoenzymes,has'
p8648
g3
sS'may,reduce,the'
p8649
g9
sS'slightly,greater,than'
p8650
g9
sS'possibility,of,extravasation'
p8651
g3
sS'almost,always,seen'
p8652
g3
sS'with,some,angiotensin'
p8653
g9
sS'not,inhibit,p450'
p8654
g3
sS'those,receiving,crixivan'
p8655
g9
sS'theophylline,the,effect'
p8656
g3
sS'of,and,ethinyl'
p8657
g9
sS'cyp2d6,inhibitors,atomoxetine'
p8658
g3
sS'to,detect,ketone'
p8659
g3
sS'number,of,cases'
p8660
g9
sS'administration,of,neurontin'
p8661
g3
sS'effect,of,probenecid'
p8662
g3
sS'other,psychotropic,or'
p8663
g3
sS'will,inhibit,the'
p8664
g3
sS'been,analysed,using'
p8665
g3
sS'and,extent,auc'
p8666
g9
sS'others,choline,arthropan'
p8667
g9
sS'concomitantly,becausedecreases,in'
p8668
g9
sS'no,important,interactions'
p8669
g3
sS'fluid,transfers,were'
p8670
g3
sS'agonist,antagonist,opioid'
p8671
g9
sS'm-dinitrobenzene,used,in'
p8672
g3
sS'of,urinary,catecholamine'
p8673
g3
sS'indicated,that,epa'
p8674
g3
sS'well,as,other'
p8675
g9
sS'their,action,may'
p8676
g3
sS'activity,enough,to'
p8677
g3
sS'time,points,after'
p8678
g3
sS'preparations,are,incompatible'
p8679
g9
sS'adenosine,dipyridamole,has'
p8680
g9
sS'reaction,injection,site'
p8681
g3
sS'in,clotting,factor'
p8682
g3
sS'biologic,half-life,of'
p8683
g9
sS'are,dizziness,weakness'
p8684
g3
sS'this,finding,is'
p8685
g3
sS'imitrex,nasal,spray'
p8686
g3
sS'would,include,a'
p8687
g3
sS'slower,absorption,mean'
p8688
g9
sS'procedure,it,was'
p8689
g3
sS'that,a,spinal'
p8690
g3
sS'in,vitro,show'
p8691
g3
sS'ace,inhibitor,can'
p8692
g9
sS'evaluated,cyp1a2,cyp2a6'
p8693
g3
sS'and,descarboethoxyloratadine,after'
p8694
g3
sS'decreases,serum,concentrations'
p8695
g3
sS'the,renal,effects'
p8696
g3
sS'only,slightly,increased'
p8697
g3
sS'of,mefloquine,therapy'
p8698
g3
sS'neurotoxic,effect,could'
p8699
g9
sS'auc,cmax,t1'
p8700
g9
sS'consequences,of,these'
p8701
g3
sS'with,glutathione,or'
p8702
g3
sS'and,fetal,development'
p8703
g3
sS'medications,with,narrow'
p8704
g3
sS'chloride,sodium,acid'
p8705
g9
sS'interactions,serum,salicylate'
p8706
g3
sS'advantages,offered,by'
p8707
g3
sS'proteins,of,the'
p8708
g3
sS'clinical,differences,indicated'
p8709
g3
sS'to,treat,anxiety'
p8710
g3
sS'may,be,taken'
p8711
g9
sS'of,induction,of'
p8712
g3
sS'be,obtained,before'
p8713
g3
sS'isoflurane,and,decrease'
p8714
g9
sS'uncontrolled,study,of'
p8715
g3
sS'experience,to,assess'
p8716
g9
sS'other,factors,may'
p8717
g3
sS'are,co-administered,which'
p8718
g9
sS'with,a,false-positive'
p8719
g3
sS'not,accompanied,by'
p8720
g3
sS'an,unusually,high'
p8721
g9
sS'of,cancer,increases'
p8722
g3
sS'translocation,of,phosphatidate'
p8723
g3
sS'organism,and,abuse'
p8724
g3
sS'have,used,in'
p8725
g3
sS'beta-adrenergic,blocker,given'
p8726
g9
sS'after,multiple,doses'
p8727
g3
sS'direct,effect,on'
p8728
g3
sS'agents,the,thioxanthene'
p8729
g9
sS'interactions,corticosteroids,may'
p8730
g3
sS'clearance,may,decrease'
p8731
g3
sS'of,intravenous,without'
p8732
g9
sS'in,patients,concomitantly'
p8733
g9
sS'alterations,in,lipid'
p8734
g9
sS'response,ie,decreased'
p8735
g9
sS'in,decreased,blood'
p8736
g9
sS'help,to,regulate'
p8737
g3
sS'isoproterenol,hydrochloride,injection'
p8738
g9
sS'in,which,concomitant'
p8739
g9
sS'urinary,retention,and'
p8740
g9
sS'cysteine,conjugation,at'
p8741
g3
sS'result,if,is'
p8742
g9
sS'is,subject,to'
p8743
g3
sS'properties,of,methylpyrazole'
p8744
g9
sS'vitro,human,liver'
p8745
g3
sS'activity,of,reportedly'
p8746
g9
sS'in,view,however'
p8747
g3
sS'aspirin,and,have'
p8748
g3
sS'administering,peganone,to'
p8749
g9
sS'in,patients,consuming'
p8750
g9
sS'other,clotting,factors'
p8751
g3
sS'prolonged,daily,administration'
p8752
g3
sS'this,increased,incidence'
p8753
g3
sS'of,fertility,carcinogenesis'
p8754
g3
sS'associated,with,serotonin'
p8755
g3
sS'in,dogs,but'
p8756
g9
sS'ssris,ssris,have'
p8757
g9
sS'should,be,gradual'
p8758
g9
sS'duloxetine,with,aluminum-'
p8759
g3
sS'several,classes,of'
p8760
g3
sS'increase,levels,of'
p8761
g3
sS'to,weeks,with'
p8762
g9
sS'of,dissolution,in'
p8763
g3
sS'of,difluoro-2,propanol'
p8764
g9
sS'an,aluminum-containing,had'
p8765
g3
sS'inhibition,of,both'
p8766
g3
sS'however,currently,no'
p8767
g3
sS'systematically,investigated,in'
p8768
g3
sS'the,pi,over'
p8769
g3
sS'hypercoagulation,vasculopathy,and'
p8770
g3
sS'was,hours,for'
p8771
g3
sS'transient,drowsiness,was'
p8772
g3
sS'using,two,different'
p8773
g3
sS'monitored,for,loss'
p8774
g9
sS'major,enzyme,responsible'
p8775
g9
sS'discontinued,in,such'
p8776
g3
sS'following,six,cytochrome'
p8777
g3
sS'random,sample,of'
p8778
g3
sS'hazardous,activities,requiring'
p8779
g3
sS'the,judgment,of'
p8780
g9
sS'cecectomized,and,control'
p8781
g3
sS'from,a,randomized'
p8782
g9
sS'suggest,that,both'
p8783
g9
sS'ace,inhibitors,or'
p8784
g3
sS'microgram,ml,egf'
p8785
g3
sS'admitted,to,the'
p8786
g3
sS'intravenous,administration,the'
p8787
g3
sS'concentrations,of,other'
p8788
g3
sS'advisable,for,chronic'
p8789
g3
sS'and,other,membrane'
p8790
g3
sS'jaffe,reaction,and'
p8791
g3
sS'morphine-induced,locomotion,in'
p8792
g3
sS'during,administration,systemic'
p8793
g9
sS'and,that,concomitant'
p8794
g9
sS'involved,in,metabolism'
p8795
g3
sS'coadministration,of,nizoral'
p8796
g9
sS'ace,inhibitors,has'
p8797
g9
sS'use,with,a'
p8798
g3
sS'and,mg2,converted'
p8799
g3
sS'not,related,to'
p8800
g3
sS'if,is,administered'
p8801
g9
sS'identify,any,clinically'
p8802
g3
sS'oral,supplementation,which'
p8803
g3
sS'alcoholic,beverages,is'
p8804
g9
sS'template,bleeding,time'
p8805
g3
sS'tolerated,when,administered'
p8806
g3
sS'extraneals,effects,on'
p8807
g3
sS'administration,of,videx'
p8808
g9
sS'levels,of,free'
p8809
g3
sS'the,cytochrome,p-450'
p8810
g9
sS'd6,metabolizers,had'
p8811
g3
sS'and,proton,pump'
p8812
g3
sS'additional,caution,in'
p8813
g3
sS'studies,have,demonstrated'
p8814
g3
sS'reduces,the,blood'
p8815
g9
sS'irradiation,are,at'
p8816
g3
sS'more,frequent,dosing'
p8817
g3
sS'are,recommended,when'
p8818
g9
sS'cardiac,glycosides,inducers'
p8819
g3
sS'resemblance,of,and'
p8820
g9
sS'systemic,and,or'
p8821
g3
sS'allowed,to,recover'
p8822
g3
sS'or,within,days'
p8823
g9
sS'the,offspring,delivered'
p8824
g3
sS'as,peripheral,neuropathy'
p8825
g3
sS'of,antidepressant,agent'
p8826
g3
sS'clinically,significant,hyperprolactinaemia'
p8827
g3
sS'the,drug,metabolizing'
p8828
g3
sS'fluoxetine,a,multiple-dose'
p8829
g3
sS'coadministered,oral,and'
p8830
g9
sS'elimination,but,also'
p8831
g9
sS'is,highly,protein-bound'
p8832
g3
sS'from,mg,by'
p8833
g9
sS'when,combined,with'
p8834
g9
sS'properties,during,whole-cell'
p8835
g3
sS'serial,broth,dilution'
p8836
g3
sS'certain,circumstances,as'
p8837
g3
sS'studied,in,adequate'
p8838
g3
sS'administered,to,a'
p8839
g3
sS'and,fbs,followed'
p8840
g9
sS'at,which,certain'
p8841
g3
sS'catecholamine-depleting,eg,may'
p8842
g9
sS'increasing,the,dose'
p8843
g9
sS'with,and,valproic'
p8844
g9
sS'not,nanm,or'
p8845
g9
sS'control,by,lowering'
p8846
g9
sS'be,monitored,to'
p8847
g9
sS'regulation,of,its'
p8848
g3
sS'outside,the,range'
p8849
g3
sS'increase,or,prolong'
p8850
g3
sS'studied,in,several'
p8851
g3
sS'using,should,be'
p8852
g9
sS'rna,from,prefrontal'
p8853
g3
sS'cards,mac,of'
p8854
g3
sS'account,variations,of'
p8855
g3
sS'sores,or,unusual'
p8856
g3
sS'dose,of,but'
p8857
g3
sS'days,for,that'
p8858
g3
sS'are,few,data'
p8859
g3
sS'study,tentatively,supports'
p8860
g3
sS'gastrointestinal,ph,may'
p8861
g3
sS'a,and,oral'
p8862
g9
sS'in,common,with'
p8863
g9
sS'lamprene,have,not'
p8864
g9
sS'hypo-,and,hyperglycemic'
p8865
g3
sS'for,those,concomitant'
p8866
g3
sS'pharmacodynamics,and,potency'
p8867
g3
sS'acid,precipitation,procedure'
p8868
g3
sS'on,the,early'
p8869
g9
sS'activity,patients,who'
p8870
g9
sS'produce,an,additive'
p8871
g9
sS'subjects,by,coadministration'
p8872
g3
sS'effectiveness,in,transferring'
p8873
g3
sS'with,synthetic,hydroalcoholic'
p8874
g3
sS'broth,dilution,method'
p8875
g3
sS'between,exogenous,and'
p8876
g3
sS'effect,and,requiring'
p8877
g9
sS'using,concomitant,such'
p8878
g3
sS'safety,profile,in'
p8879
g3
sS'interactions,for,vitamin'
p8880
g9
sS'as,specific,molecular'
p8881
g3
sS'activities,and,increased'
p8882
g3
sS'of,this,possibility'
p8883
g3
sS'of,certain,metabolizing'
p8884
g3
sS'with,and,between'
p8885
g3
sS'day,microg,kg'
p8886
g3
sS'and,normal,tissues'
p8887
g9
sS'alternately,provided,a'
p8888
g3
sS'glucose,oxidase,or'
p8889
g3
sS'pressure,of,about'
p8890
g9
sS'the,period,following'
p8891
g9
sS'of,and,extended'
p8892
g9
sS'accutane,and,should'
p8893
g9
sS'severe,peripheral,vasospasm'
p8894
g9
sS'hypoglycemic,agents,that'
p8895
g9
sS'inhibition,of,other'
p8896
g3
sS'it,is,essentially'
p8897
g3
sS'treatment,of,ras-3t3'
p8898
g3
sS'when,grown,in'
p8899
g3
sS'plasma,levels,resulting'
p8900
g9
sS'expected,to,lead'
p8901
g9
sS'observed,for,evidence'
p8902
g3
sS'pain,vomiting,diarrhea'
p8903
g3
sS'is,a,necessary'
p8904
g3
sS'cyp3a4,inhibitors,mg'
p8905
g9
sS'infusions,of,flolan'
p8906
g3
sS'adaptive,value,abstract'
p8907
g3
sS'when,analgesia,must'
p8908
g9
sS'needed,to,determine'
p8909
g3
sS'selective,toxicity,of'
p8910
g3
sS'sulfamethoxazole,concomitant,use'
p8911
g3
sS'pressor,agent,for'
p8912
g3
sS'no,drug,interaction'
p8913
g3
sS'increased,serum,levels'
p8914
g9
sS'receiving,concomitant,and'
p8915
g9
sS'disposition,of,is'
p8916
g3
sS'with,wellbutrin,should'
p8917
g9
sS'consequence,of,increased'
p8918
g9
sS'but,by,minutes'
p8919
g9
sS'with,a,mg'
p8920
g9
sS'of,lamprene,have'
p8921
g9
sS'treatment,of,breast'
p8922
g9
sS'the,aerosol,particles'
p8923
g3
sS'has,a,great'
p8924
g3
sS'can,be,monitored'
p8925
g3
sS'can,not,be'
p8926
g9
sS'separated,by,a'
p8927
g3
sS'result,of,which'
p8928
g3
sS'to,play,a'
p8929
g3
sS'disposition,of,in'
p8930
g3
sS'oral,users,experiencing'
p8931
g3
sS'of,low-dose,with'
p8932
g9
sS'a,peptide,that'
p8933
g3
sS'in,preclinical,or'
p8934
g3
sS'spray,but,by'
p8935
g9
sS'the,substances,the'
p8936
g3
sS'effect,of,especially'
p8937
g9
sS'of,could,pose'
p8938
g9
sS'be,exercised,if'
p8939
g9
sS'with,must,be'
p8940
g9
sS'hepatic,failure,as'
p8941
g3
sS'is,a,cyp'
p8942
g3
sS'pharmacologic,effects,of'
p8943
g9
sS'when,taxol,was'
p8944
g9
sS'be,exercised,in'
p8945
g3
sS'as,ironing,kilometers'
p8946
g3
sS'plus,haart,treatment'
p8947
g3
sS'with,tikosyn,mcg'
p8948
g9
sS'administration,to,three'
p8949
g9
sS'based,on,either'
p8950
g3
sS'dogs,the,intravenous'
p8951
g9
sS'known,relationships,between'
p8952
g3
sS'cause,bleeding,complications'
p8953
g3
sS'evaluating,the,potential'
p8954
g3
sS'a,dose-dependent,inhibition'
p8955
g9
sS'injection,usp,should'
p8956
g9
sS'cardiac,glycosides,in'
p8957
g3
sS'of,frova,treatment'
p8958
g3
sS'of,arrhythmias,due'
p8959
g3
sS'exercised,when,hydrochloride'
p8960
g3
sS'by,cyp3a4,such'
p8961
g9
sS'retention,of,these'
p8962
g3
sS'in,several,human'
p8963
g3
sS'mediated,via,cyp'
p8964
g3
sS'recommended,doses,vioxx'
p8965
g9
sS'coadministration,of,it'
p8966
g9
sS'be,anticipated,if'
p8967
g9
sS'amevive,in,pediatric'
p8968
g3
sS'with,expected,physiologic'
p8969
g3
sS'a,potential,inhibitor'
p8970
g9
sS'dependency,of,the'
p8971
g3
sS'capsules,indocin,mg'
p8972
g9
sS'study,baboons,given'
p8973
g3
sS'were,no,significant'
p8974
g3
sS'reportedly,resulted,in'
p8975
g9
sS'related,to,intravenous'
p8976
g9
sS'vitro,studies,evaluating'
p8977
g3
sS'the,hypotension,caused'
p8978
g9
sS'from,clinical,studies'
p8979
g9
sS'in,individuals,who'
p8980
g3
sS'indicates,that,inhibits'
p8981
g9
sS'in,intact,subjects'
p8982
g3
sS'more,highly,protein'
p8983
g3
sS'dasatinib,is,a'
p8984
g3
sS'of,the,cecum'
p8985
g3
sS'deals,with,the'
p8986
g3
sS'toxicity,associated,with'
p8987
g9
sS'involve,individual,and'
p8988
g3
sS'mao,inhibitors,serious'
p8989
g3
sS'of,cardiovascular,morbidity'
p8990
g3
sS'and,treatment,in'
p8991
g3
sS'digi-,tab,ria'
p8992
g3
sS'p450,a4,increased'
p8993
g9
sS'when,therapy,is'
p8994
g9
sS'citrate,and,fluoride'
p8995
g3
sS'evoked,hind,limb'
p8996
g3
sS'electrolyte,abnormalities,such'
p8997
g9
sS'xenobiotic,metabolism,using'
p8998
g3
sS'clinically,because,they'
p8999
g3
sS'nonsteroidal,agents,some'
p9000
g9
sS'produced,additive,effects'
p9001
g9
sS'intravenous,use,were'
p9002
g3
sS'classes,or,agents'
p9003
g9
sS'administering,concurrently,with'
p9004
g9
sS'oral,hypoglycemics,diclofenac'
p9005
g3
sS'been,performed,and'
p9006
g3
sS'of,are,to'
p9007
g9
sS'on,in-vitro,studies'
p9008
g3
sS'metabolizes,may,experience'
p9009
g3
sS'therefore,omnicef,for'
p9010
g3
sS'for,active,tubular'
p9011
g9
sS'direct,effects,on'
p9012
g3
sS'of,drugs,metabolized'
p9013
g3
sS'in,addition,is'
p9014
g3
sS'to,deaths,among'
p9015
g3
sS'adverse,effects,reduced'
p9016
g3
sS'initiated,or,changed'
p9017
g9
sS'occur,when,an'
p9018
g9
sS'severe,structural,heart'
p9019
g3
sS'impair,the,absorption'
p9020
g9
sS'the,cyp2d6,inhibitor'
p9021
g3
sS'specific,for,the'
p9022
g3
sS'acid,and,showed'
p9023
g3
sS'avoided,because,a'
p9024
g3
sS'reducing,absorption,from'
p9025
g9
sS'with,increased,the'
p9026
g9
sS'currently,no,data'
p9027
g3
sS'heart,failure,etc'
p9028
g9
sS'administration,of,dmpge2'
p9029
g3
sS'for,migraines,such'
p9030
g3
sS'be,monitored,especially'
p9031
g9
sS'efficacy,were,observed'
p9032
g3
sS'affect,bioavailabillty,and'
p9033
g3
sS'contain,any,amine'
p9034
g9
sS'alteration,in,the'
p9035
g3
sS'used,for,therapeutic'
p9036
g3
sS'whom,cyp3a4,inducers'
p9037
g3
sS'of,oxidized,metabolites'
p9038
g3
sS'equal,groups,and'
p9039
g3
sS'used,alone,has'
p9040
g9
sS'anti-inflammatory,may,increase'
p9041
g9
sS'is,unclear,how'
p9042
g9
sS'patients,taking,or'
p9043
g3
sS'consult,the,package'
p9044
g3
sS'in,lean,animals'
p9045
g3
sS'phenytoin,may,also'
p9046
g3
sS'organisms,contained,in'
p9047
g9
sS'different,ca,channel'
p9048
g3
sS'known,if,regranex'
p9049
g3
sS'leprosy-associated,inflammatory,reactions'
p9050
g9
sS'tests,vital,signs'
p9051
g3
sS'protein,carbamazepine,is'
p9052
g3
sS'w,and,mg'
p9053
g9
sS'and,for,preservation'
p9054
g3
sS'on,intestinal,first'
p9055
g3
sS'has,stabilized,see'
p9056
g3
sS'approximately,and,cmax'
p9057
g9
sS'binding,sites,or'
p9058
g9
sS'termed,the,resistance'
p9059
g3
sS'that,are,impaired'
p9060
g3
sS'biotransformation,of,other'
p9061
g3
sS'abolished,by,pretreatment'
p9062
g9
sS'poor,metabolizers,of'
p9063
g3
sS'circulating,after,alphagan'
p9064
g3
sS'attenuates,but,mc'
p9065
g9
sS'coombs,test,has'
p9066
g3
sS'considered,when,the'
p9067
g9
sS'plasma,concentration,has'
p9068
g3
sS'in,a,double-blind'
p9069
g3
sS'patients,who,have'
p9070
g3
sS'doses,of,u'
p9071
g3
sS'approximately,in,uptake-1'
p9072
g3
sS'pharmacodynamic,profile,prothrombin'
p9073
g3
sS'concomitantly,with,which'
p9074
g9
sS'argatroban,with,antiplatelet'
p9075
g9
sS'consequence,when,indocin'
p9076
g9
sS'for,days,was'
p9077
g9
sS'were,unchanged,after'
p9078
g3
sS'recommended,in,patients'
p9079
g3
sS'for,weeks,was'
p9080
g9
sS'addition,of,a'
p9081
g3
sS'large,doses,of'
p9082
g3
sS'levels,of,tmp'
p9083
g3
sS'and,multiple,doses'
p9084
g3
sS'alkaloid,while,you'
p9085
g9
sS'be,stopped,without'
p9086
g3
sS'affect,the,steady-state'
p9087
g3
sS'not,affected,by'
p9088
g3
sS'of,bleeding,complications'
p9089
g3
sS'data,from,clinical'
p9090
g9
sS'to,increase,in'
p9091
g9
sS'given,one,dose'
p9092
g9
sS'only,requires,oral'
p9093
g3
sS'with,prolonged,administration'
p9094
g3
sS'has,suggested,may'
p9095
g3
sS'adverse,experiences,are'
p9096
g3
sS'sodium,excretion,but'
p9097
g9
sS'unless,necessary,to'
p9098
g3
sS'serum,without,the'
p9099
g3
sS'by,mouth,or'
p9100
g3
sS'other,general,skeletal'
p9101
g9
sS'to,a,decrease'
p9102
g3
sS'as,for,the'
p9103
g3
sS'however,the,recommendation'
p9104
g3
sS'porter-silber,reaction,and'
p9105
g3
sS'not,be,administered'
p9106
g9
sS'used,as,a'
p9107
g3
sS'kidneys,along,with'
p9108
g3
sS'clarithromycin,exposure,was'
p9109
g9
sS'follow-up,liver,function'
p9110
g3
sS'also,important,regulation'
p9111
g3
sS'vancomycin-resistant,strains,of'
p9112
g3
sS'the,cortex,which'
p9113
g3
sS'symptoms,of,toxicity'
p9114
g9
sS'are,consistent,with'
p9115
g3
sS'monkeys,treated,with'
p9116
g3
sS'an,individual,isoform'
p9117
g3
sS'in,individuals,known'
p9118
g3
sS'with,a,very'
p9119
g3
sS'latent,diabetes,mellitus'
p9120
g3
sS'together,have,a'
p9121
g9
sS'the,potentiation,resulted'
p9122
g3
sS'large,number,of'
p9123
g3
sS'alteration,of,ph'
p9124
g3
sS'result,in,elevated'
p9125
g9
sS'to,the,copegus'
p9126
g3
sS'the,target,cell'
p9127
g3
sS'period,immediately,preceding'
p9128
g3
sS'chylomicron-like,emulsions,in'
p9129
g3
sS'including,interactions,with'
p9130
g3
sS'of,or,administration'
p9131
g3
sS'for,in,the'
p9132
g3
sS'levels,it,is'
p9133
g9
sS'the,second,experiment'
p9134
g3
sS'recent,radiation,treatment'
p9135
g3
sS'daily,as,assessed'
p9136
g3
sS'administration,of,buspirone'
p9137
g9
sS'by,and,antagonists'
p9138
g9
sS'weekly,for,weeks'
p9139
g3
sS'reports,of,patients'
p9140
g9
sS'and,cyp1a2,isoform'
p9141
g3
sS'therapy,should,be'
p9142
g9
sS'in,the,oral'
p9143
g9
sS'or,has,led'
p9144
g9
sS'but,no,prolongation'
p9145
g3
sS'animals,indicate,that'
p9146
g9
sS'of,the,spinal'
p9147
g3
sS'concentrations,of,felbatol'
p9148
g9
sS'and,that,increase'
p9149
g9
sS'occurred,in,a'
p9150
g9
sS'against,the,clinical'
p9151
g9
sS'cyp,metabolism,of'
p9152
g9
sS'adverse,events,such'
p9153
g3
sS'are,unlikely,to'
p9154
g3
sS'management,of,acute'
p9155
g3
sS'valid,in,cardioplegic'
p9156
g3
sS'performed,coadministration,with'
p9157
g9
sS'barbiturates,and,decrease'
p9158
g9
sS'excretion,of,unchanged'
p9159
g3
sS'of,sedation,within'
p9160
g3
sS'digoxin,concentrations,are'
p9161
g9
sS'the,understanding,and'
p9162
g3
sS'cell,mitogen,and'
p9163
g3
sS'its,metabolites,interfere'
p9164
g3
sS'coadministration,with,videx'
p9165
g3
sS'to,the,risk'
p9166
g9
sS'thyroglobulin,in,an'
p9167
g3
sS'value,prescribed,daily'
p9168
g3
sS'since,nsaids,and'
p9169
g9
sS'however,oh,metabolite'
p9170
g3
sS'action,or,elimination'
p9171
g3
sS'plasma,levels,possibly'
p9172
g9
sS'discontinue,therapy,in'
p9173
g9
sS'coat-core,formulation,of'
p9174
g9
sS'preclude,effectiveness,of'
p9175
g3
sS'the,gastrointestinal,ph'
p9176
g3
sS'drug,interactions,alteration'
p9177
g3
sS'interaction,with,concomitant'
p9178
g3
sS'metabolite,or,pharmacokinetics'
p9179
g3
sS'is,markedly,decreased'
p9180
g9
sS'during,with,concomitant'
p9181
g9
sS'caused,a,reversible'
p9182
g3
sS'a,patient,to'
p9183
g3
sS'grade,according,to'
p9184
g3
sS'table,potential,drug'
p9185
g3
sS'in,combining,with'
p9186
g9
sS'a,group,of'
p9187
g3
sS'akathisia,however,is'
p9188
g3
sS'mptp,administration,to'
p9189
g3
sS'geometric,mean,ratios'
p9190
g3
sS'study,regardless,of'
p9191
g3
sS'that,may,slow'
p9192
g3
sS'suboxone,should,be'
p9193
g9
sS'intestine,so,that'
p9194
g9
sS'is,eliminated,by'
p9195
g3
sS'the,apoptosis,induced'
p9196
g3
sS'to,the,body'
p9197
g3
sS'for,possible,combined'
p9198
g3
sS'a,linear,logarithmic'
p9199
g3
sS'disease,have,been'
p9200
g9
sS'liver,function,and'
p9201
g3
sS'using,these,agents'
p9202
g3
sS'the,total,picr'
p9203
g3
sS'of,ewes,with'
p9204
g9
sS'of,liver,enzymes'
p9205
g9
sS'intraperitoneally,ip,the'
p9206
g9
sS'on,immunosuppression,are'
p9207
g3
sS'of,hydrophobic,side'
p9208
g3
sS'response,to,although'
p9209
g9
sS'a,supine,position'
p9210
g3
sS'in,control,rats'
p9211
g3
sS'by,the,known'
p9212
g3
sS'the,blood,auc0-12'
p9213
g9
sS'a,subclone,of'
p9214
g3
sS'excluded,patients,with'
p9215
g3
sS'effects,in,pigeons'
p9216
g3
sS'reported,that,itraconazole'
p9217
g9
sS'may,decrease,clozapine'
p9218
g9
sS'an,individual,who'
p9219
g3
sS'inhibition,was,observed'
p9220
g3
sS'rifabutin,did,not'
p9221
g3
sS'than,the,prescription'
p9222
g3
sS'effective,dose,and'
p9223
g3
sS'depression,may,be'
p9224
g9
sS'values,for,ketogenic'
p9225
g3
sS'significant,accuracy,in'
p9226
g9
sS'methotrexate,there,is'
p9227
g9
sS'platelia,aspergillus,eia'
p9228
g3
sS'of,foscarnets,tendency'
p9229
g9
sS'benedict,s,and'
p9230
g3
sS'or,volume,of'
p9231
g3
sS'preparations,novolog,should'
p9232
g3
sS'significance,these,two'
p9233
g3
sS'healthy,subjects,when'
p9234
g9
sS'clinical,trials,no'
p9235
g3
sS'induced,by,acute'
p9236
g3
sS'and,drug,effects'
p9237
g3
sS'which,may,sometimes'
p9238
g3
sS'reported,in,this'
p9239
g3
sS'had,effects,similar'
p9240
g3
sS'from,the,gastrointestinal'
p9241
g9
sS'tikosyn,as,they'
p9242
g9
sS'determined,before,starting'
p9243
g9
sS'of,rhabdomyolysis,some'
p9244
g3
sS'have,investigated,whether'
p9245
g3
sS'to,fold,greater'
p9246
g9
sS'changes,in,laboratory'
p9247
g3
sS'in,rats,the'
p9248
g3
sS'following,a,day'
p9249
g3
sS'hemorrhage,was,seen'
p9250
g3
sS'the,long-term,administration'
p9251
g3
sS'bolus-ifl,plus,avastin'
p9252
g3
sS'not,seen,during'
p9253
g3
sS'an,alternative,or'
p9254
g3
sS'is,a,possible'
p9255
g9
sS'if,high,doses'
p9256
g9
sS'take,to,ensure'
p9257
g3
sS'concentrations,with,coadministration'
p9258
g9
sS'alone,can,inhibit'
p9259
g9
sS'heart,can,be'
p9260
g3
sS'on,exposure,to'
p9261
g3
sS'to,the,number'
p9262
g3
sS'lack,of,an'
p9263
g3
sS'of,and,thus'
p9264
g9
sS'the,order,of'
p9265
g3
sS'potential,for,reexacerbation'
p9266
g9
sS'myelotoxic,chemotherapy,cardiotoxic'
p9267
g9
sS'sodium,may,prolong'
p9268
g3
sS'administered,but,an'
p9269
g3
sS'oligomer,significantly,potentiated'
p9270
g3
sS'hydrogen-3,revealed,a'
p9271
g3
sS'by,rats,treated'
p9272
g3
sS'be,drawn,into'
p9273
g3
sS'into,the,biogen'
p9274
g3
sS'were,supersensitive,to'
p9275
g9
sS'volunteers,under,steady-state'
p9276
g3
sS'less,specific,regulation'
p9277
g3
sS'consequently,the,effect'
p9278
g9
sS'therefore,increased,monitoring'
p9279
g9
sS'individual,levels,fluctuated'
p9280
g3
sS'glycemia,in,diabetic'
p9281
g3
sS'a,role,of'
p9282
g3
sS'significant,when,are'
p9283
g3
sS'and,other,lesions'
p9284
g3
sS'at,approximately,to'
p9285
g3
sS'which,certain,are'
p9286
g3
sS'kg,day,about'
p9287
g3
sS'showed,that,increased'
p9288
g9
sS'however,caution,should'
p9289
g9
sS'complete,mental,alertness'
p9290
g3
sS'drowsiness-causing,any,other'
p9291
g3
sS'reports,suggesting,that'
p9292
g9
sS'indirect,antiglobulin,coombs'
p9293
g3
sS'increases,the,rate'
p9294
g9
sS'and,c9,ic50'
p9295
g3
sS'when,systemic,vascular'
p9296
g9
sS'volatile,agent,has'
p9297
g3
sS'post-marketing,observations,have'
p9298
g9
sS'group,were,supersensitive'
p9299
g9
sS'a,single,method'
p9300
g3
sS'm,was,not'
p9301
g3
sS'approximately,of,that'
p9302
g3
sS'with,concomitant,medication'
p9303
g3
sS'number,of,events'
p9304
g3
sS'concentrations,should,be'
p9305
g9
sS'on,has,been'
p9306
g9
sS'lessen,the,potential'
p9307
g3
sS'platelet,aggregation,the'
p9308
g3
sS'and,mg,respectively'
p9309
g9
sS'affect,duloxetine,both'
p9310
g3
sS'performed,in,clinical'
p9311
g3
sS'of,the,ssris'
p9312
g9
sS'dysarthria,incoordination,hyperthermia'
p9313
g3
sS'that,anion,because'
p9314
g3
sS'lincomycin,has,been'
p9315
g9
sS'arrhythmias,in,the'
p9316
g3
sS'of,from,muscle'
p9317
g3
sS'utero,exposure,in'
p9318
g3
sS'of,some,resulting'
p9319
g9
sS'function,and,consequently'
p9320
g3
sS'agents,since,vitamin'
p9321
g3
sS'meq,l,from'
p9322
g9
sS'evaluated,as,a'
p9323
g3
sS'levels,of,clozapine'
p9324
g9
sS'with,joint,action'
p9325
g3
sS'concentration,of,may'
p9326
g9
sS'whereas,the,first'
p9327
g3
sS'cyp,enzymes,showed'
p9328
g3
sS'been,studied,of'
p9329
g3
sS'associated,in,some'
p9330
g9
sS'female,fertility,as'
p9331
g3
sS'of,using,stadol'
p9332
g3
sS'with,or,immediately'
p9333
g9
sS'inconclusive,with,regard'
p9334
g3
sS'concurrent,therapy,is'
p9335
g3
sS'convenient,administration,regimens'
p9336
g3
sS'therefore,in,patients'
p9337
g3
sS'include,the,and'
p9338
g3
sS'or,neurotoxic,therapy'
p9339
g3
sS'disturbances,such,as'
p9340
g3
sS'persistence,of,clinical'
p9341
g3
sS'serum-deprived,ras-3t3,cells'
p9342
g3
sS'and,increase,serum'
p9343
g3
sS'and,mortality,is'
p9344
g3
sS'an,an,organophosphorous'
p9345
g3
sS'ca,subtypes,by'
p9346
g3
sS'were,administered,several'
p9347
g3
sS'one-half,of,its'
p9348
g9
sS'should,be,premedicated'
p9349
g3
sS'exposure,was,significantly'
p9350
g9
sS'after,administration,and'
p9351
g9
sS'reluctance,to,treat'
p9352
g3
sS'actively,concentrating,as'
p9353
g3
sS'central,syndrome,can'
p9354
g9
sS'who,were,stabilized'
p9355
g3
sS'level,was,increased'
p9356
g3
sS'contractile,response,to'
p9357
g3
sS'that,exposure,to'
p9358
g9
sS'humorsol,with,or'
p9359
g9
sS'bioavailability,of,unbound'
p9360
g3
sS'the,two,regimens'
p9361
g3
sS'doses,of,agents'
p9362
g3
sS'medication,monitored,and'
p9363
g3
sS'same,cytochrome,isozymes'
p9364
g3
sS'alterations,in,blood'
p9365
g3
sS'microdilution,method,for'
p9366
g3
sS'may,be,lower'
p9367
g9
sS'hours,postdose,a'
p9368
g9
sS'non-depolarising,muscle,relaxants'
p9369
g9
sS'effect,relationship,and'
p9370
g9
sS'improve,sensitivity,and'
p9371
g3
sS'whether,the,concomitant'
p9372
g3
sS'd,doses,have'
p9373
g3
sS'transport,ratio,r'
p9374
g3
sS'of,such,a'
p9375
g3
sS'incidence,of,rashes'
p9376
g9
sS'beadministered,concomitantly,becausedecreases'
p9377
g9
sS'cyp1a2,substrate,single'
p9378
g3
sS'to,cause,neutropenia'
p9379
g3
sS'in,women,receiving'
p9380
g3
sS'additional,adrenergic,are'
p9381
g9
sS'all,nsaids,including'
p9382
g9
sS'brovana,dose,of'
p9383
g3
sS'observed,for,signs'
p9384
g9
sS'of,may,result'
p9385
g3
sS'postnatal,immune,function'
p9386
g3
sS'fsh,to,gonadotropin-releasing'
p9387
g3
sS'and,trivalent,cations'
p9388
g9
sS'and,body,weight'
p9389
g3
sS'channel,blockers,of'
p9390
g9
sS'wellbutrin,tablets,to'
p9391
g9
sS'iv,and,vi'
p9392
g3
sS'of,as,antiemetic'
p9393
g9
sS'in,mind,that'
p9394
g9
sS'blood,glucose,blood'
p9395
g3
sS'without,preventing,its'
p9396
g9
sS'axons,of,post-ganglionic'
p9397
g3
sS'have,been,more'
p9398
g3
sS'channel,blockers,or'
p9399
g9
sS'combinations,of,gl'
p9400
g9
sS'coadministered,with,as'
p9401
g3
sS'in,patients,receiving'
p9402
g9
sS'that,herbal,remedy'
p9403
g3
sS'both,weight,gain'
p9404
g9
sS'measurements,with,some'
p9405
g3
sS'note,if,the'
p9406
g3
sS'nursing,or,to'
p9407
g3
sS'if,there,is'
p9408
g3
sS'predominantly,mediated,via'
p9409
g3
sS'should,be,notified'
p9410
g3
sS'other,b-lactam,inhibits'
p9411
g9
sS'exhibited,dose-proportional,stable'
p9412
g3
sS'of,one,or'
p9413
g3
sS'ascorbic,acid,doses'
p9414
g9
sS'moreover,the,basal'
p9415
g3
sS'system,depressants,but'
p9416
g3
sS'adjustment,of,should'
p9417
g3
sS'an,organophosphorous,compound'
p9418
g3
sS'results,have,varied'
p9419
g3
sS'increases,in,gastrointestinal'
p9420
g9
sS'with,parasympathomimetic,effects'
p9421
g3
sS'buffalo,hump,peripheral'
p9422
g3
sS'suggest,that,intraventricular'
p9423
g3
sS'contemplated,the,dosage'
p9424
g3
sS'a4,may,affect'
p9425
g3
sS'when,the,nerves'
p9426
g3
sS'rats,decreased,by'
p9427
g9
sS'and,mg,initial'
p9428
g9
sS'indanavir,ketoconazole,phenytoin'
p9429
g3
sS'qt,prolongation,and'
p9430
g3
sS'strong,central,nervous'
p9431
g3
sS'than,mg,as'
p9432
g3
sS'o-glucuronidation,ki,value'
p9433
g3
sS'potentially,leading,to'
p9434
g9
sS'reasons,it,is'
p9435
g9
sS'on,dogs,with'
p9436
g3
sS'experiences,eg,dizziness'
p9437
g3
sS'be,exercised,nonetheless'
p9438
g9
sS'fold,respectively,suggesting'
p9439
g9
sS'administration,of,different'
p9440
g3
sS'of,water,for'
p9441
g3
sS'of,myasthenic,weakness'
p9442
g3
sS'copaxone,did,not'
p9443
g3
sS'of,once,daily'
p9444
g9
sS'incidence,of,nephrolithiasis'
p9445
g9
sS'for,increased,activity'
p9446
g3
sS'they,are,at'
p9447
g3
sS'of,demonstrated,hypokalemia'
p9448
g3
sS'sequential,trials,performed'
p9449
g3
sS'isoforms,tested,was'
p9450
g3
sS'of,in,lean'
p9451
g3
sS'a,change,in'
p9452
g9
sS'as,early,as'
p9453
g9
sS'reduced,dosage,of'
p9454
g9
sS'studies,with,the'
p9455
g9
sS'with,synergistically,augmented'
p9456
g3
sS'of,initial,doses'
p9457
g3
sS'provided,a,proper'
p9458
g3
sS'monitored,forevidence,of'
p9459
g9
sS'has,been,shown'
p9460
g9
sS'given,later,also'
p9461
g9
sS'of,the,glands'
p9462
g3
sS'when,taking,this'
p9463
g3
sS'zyvox,and,serotonergic'
p9464
g9
sS'when,a,mg'
p9465
g9
sS'that,results,of'
p9466
g9
sS'no,effects,were'
p9467
g3
sS'to,change,to'
p9468
g9
sS'to,amide-type,local'
p9469
g9
sS'in,situ,hybridization'
p9470
g9
sS'of,settings,commonly'
p9471
g3
sS'plasma,after,administration'
p9472
g3
sS'it,should,also'
p9473
g3
sS'with,nevirapine-,or'
p9474
g3
sS'that,the,dose'
p9475
g9
sS'the,clinical,and'
p9476
g3
sS'exposure,or,the'
p9477
g3
sS'carbimazole,and,an'
p9478
g9
sS'high,viral,loads'
p9479
g3
sS'the,following,medicines'
p9480
g9
sS'abdominal,pain,vomiting'
p9481
g3
sS'enrolled,in,the'
p9482
g3
sS'in,increased,risk'
p9483
g3
sS'exact,length,of'
p9484
g3
sS'involvement,of,the'
p9485
g9
sS'that,observed,in'
p9486
g3
sS'treated,concomitantly,with'
p9487
g9
sS'have,negative,results'
p9488
g3
sS'given,situation,has'
p9489
g3
sS'blockers,including,eye'
p9490
g3
sS'studies,of,other'
p9491
g9
sS'activase,with,other'
p9492
g3
sS'administered,in,the'
p9493
g3
sS'concentration,of,or'
p9494
g3
sS'above,effects,concerning'
p9495
g9
sS'these,potentially,resulting'
p9496
g9
sS'were,taken,by'
p9497
g3
sS'found,to,temporarily'
p9498
g9
sS'enzymes,capable,of'
p9499
g3
sS'by,which,inhibits'
p9500
g9
sS'with,anion-exchange,resins'
p9501
g9
sS'used,in,hospitals'
p9502
g3
sS'processing,functions,i'
p9503
g3
sS'of,and,one'
p9504
g3
sS'greater,after,than'
p9505
g3
sS'and,diabetic,chinese'
p9506
g3
sS'very,high,doses'
p9507
g9
sS'epoxide,reductase,resulting'
p9508
g3
sS'it,be,decided'
p9509
g9
sS'psa,decreased,from'
p9510
g3
sS'associated,with,acute'
p9511
g3
sS'acceleration,of,gastric'
p9512
g3
sS'patients,receiving,beta-adrenergic'
p9513
g9
sS'for,auc,and'
p9514
g9
sS'is,an,effective'
p9515
g3
sS'pharmacokinetic,study,did'
p9516
g3
sS'rate,requirement,may'
p9517
g3
sS'produces,whole,body'
p9518
g3
sS'with,signs,and'
p9519
g9
sS'sodium,was,used'
p9520
g3
sS'of,arimidex,and'
p9521
g3
sS'other,interactions,cimetidine'
p9522
g3
sS'them,and,what'
p9523
g3
sS'piperidine,prevents,gastrointestinal'
p9524
g9
sS'nonabsorbable,given,concurrently'
p9525
g9
sS'these,is,taken'
p9526
g3
sS'damage,as,well'
p9527
g3
sS'rate,was,greater'
p9528
g3
sS'might,be,explained'
p9529
g9
sS'affect,safety,however'
p9530
g3
sS'these,enzymes,or'
p9531
g3
sS'strains,of,clostridium'
p9532
g3
sS'administration,of,local'
p9533
g9
sS'studies,as,well'
p9534
g9
sS'were,administered,concomitantly'
p9535
g3
sS'antibiotics,pregnancy,has'
p9536
g3
sS'as,or,videx'
p9537
g9
sS'of,a,with'
p9538
g3
sS'any,interaction,on'
p9539
g3
sS'intoxication,prior,to'
p9540
g9
sS'has,demonstrated,effectiveness'
p9541
g3
sS'and,the,number'
p9542
g3
sS'of,these,increased'
p9543
g3
sS'of,the,liver'
p9544
g3
sS'subjects,receiving,a'
p9545
g9
sS'potent,cyp3a4,inhibitor'
p9546
g9
sS'studies,using,induced'
p9547
g3
sS'and,and,probably'
p9548
g3
sS'measured,by,auc0-24hr'
p9549
g9
sS'both,in,the'
p9550
g3
sS'of,these,increases'
p9551
g3
sS'clearance,from,to'
p9552
g3
sS'contribute,to,decrease'
p9553
g3
sS'the,period,of'
p9554
g9
sS'to,higher,free'
p9555
g3
sS'was,ineffective,in'
p9556
g3
sS'a,sub-,for'
p9557
g3
sS'alteration,in,dose'
p9558
g3
sS'affect,the,growth'
p9559
g3
sS'both,crixivan,and'
p9560
g3
sS'circulating,levels,of'
p9561
g3
sS'as,k,antagonists'
p9562
g3
sS'reactions,of,parietal'
p9563
g3
sS'cns-active,should,be'
p9564
g9
sS'readily,penetrates,both'
p9565
g3
sS'of,supplementary,oral'
p9566
g3
sS'to,as,is'
p9567
g3
sS'studied,but,in'
p9568
g3
sS'seen,when,mg'
p9569
g9
sS'microm,preferentially,blocked'
p9570
g9
sS'invalidate,folic,acid'
p9571
g3
sS'sulfa-based,such,as'
p9572
g3
sS'administered,shortly,after'
p9573
g9
sS'transferase,gst,activity'
p9574
g3
sS'already,receiving,n'
p9575
g3
sS'the,following,six'
p9576
g3
sS'and,would,be'
p9577
g9
sS'neurological,and,other'
p9578
g3
sS'be,highly,susceptible'
p9579
g3
sS'specific,isoenzyme,cyp3a4'
p9580
g3
sS'there,was,a'
p9581
g9
sS'alter,the,effect'
p9582
g3
sS'such,individuals,are'
p9583
g3
sS'via,cyp3a4,should'
p9584
g9
sS'days,a,potent'
p9585
g9
sS'resulted,in,lowering'
p9586
g9
sS'inwomen,taking,since'
p9587
g9
sS'the,package,inserts'
p9588
g3
sS'of,the,hypotension'
p9589
g9
sS'healthy,volunteers,when'
p9590
g3
sS'use,of,prior'
p9591
g9
sS'resistance,to,invirase'
p9592
g3
sS'of,medical,complications'
p9593
g3
sS'potentiate,the,side'
p9594
g9
sS'enhances,the,effects'
p9595
g3
sS'cromolyn,sodium,approximately'
p9596
g9
sS'did,not,demonstrate'
p9597
g3
sS'indicated,that,pulmozyme'
p9598
g3
sS'administration,of,and'
p9599
g9
sS'displace,tightly,bound'
p9600
g3
sS'liver,by,single'
p9601
g3
sS'that,undergo,tyrosine'
p9602
g3
sS'it,is,conceived'
p9603
g3
sS'release,in,diabetics'
p9604
g3
sS'observed,in,these'
p9605
g9
sS'that,s,augmentation'
p9606
g3
sS'nsaids,are,administered'
p9607
g9
sS'indomethacin,was,also'
p9608
g3
sS'likely,to,have'
p9609
g3
sS'relationship,to,their'
p9610
g3
sS'to,orders,of'
p9611
g3
sS'should,be,prescribed'
p9612
g9
sS'of,the,central'
p9613
g9
sS'dose-related,decrease,in'
p9614
g9
sS'no,first-pass,metabolism'
p9615
g3
sS'drug,interactions,flupenthixol'
p9616
g9
sS'and,auc,values'
p9617
g9
sS'inhibitors,was,associated'
p9618
g9
sS'these,medicines,should'
p9619
g3
sS'induce,cyp3a4,rifampin'
p9620
g3
sS'and,the,derivative'
p9621
g3
sS'or,total,body'
p9622
g3
sS'toxicity,in,the'
p9623
g3
sS'by,using,rat'
p9624
g3
sS'angiotensin-,converting,enzyme'
p9625
g3
sS'renal,function,accompanied'
p9626
g9
sS'other,than,thrombin'
p9627
g3
sS'the,following,use'
p9628
g9
sS'that,oral,inhibits'
p9629
g9
sS'avoid,this,interaction'
p9630
g9
sS'to,avoid,potential'
p9631
g3
sS'equivalent,to,to'
p9632
g3
sS'or,to,receive'
p9633
g3
sS'dialysis,may,occasionally'
p9634
g9
sS'hivid-associated,adverse,events'
p9635
g9
sS'they,can,be'
p9636
g3
sS'high,concentrations,mmol'
p9637
g3
sS'by,a,increase'
p9638
g3
sS'and,the,concomitant'
p9639
g9
sS'given,supplemental,l-glutamine'
p9640
g9
sS'sodium,alone,in'
p9641
g3
sS'including,complete,heart'
p9642
g3
sS'the,sleeping,time'
p9643
g9
sS'and,possible,resistance'
p9644
g3
sS'eclampsia,some,dysrhythmias'
p9645
g3
sS'tablets,in,doses'
p9646
g9
sS'of,vehicle,corn'
p9647
g3
sS'reach,cmax,is'
p9648
g3
sS'drug,interactions,how'
p9649
g3
sS'at,of,baseline'
p9650
g3
sS'dosed,at,mg'
p9651
g3
sS'used,combined,oral'
p9652
g3
sS'soluble,particularly,during'
p9653
g3
sS'indicates,that,the'
p9654
g3
sS'minutes,after,the'
p9655
g9
sS'min,fasting,glycemia'
p9656
g3
sS'since,animal,studies'
p9657
g9
sS'in,metabolism,concomitant'
p9658
g3
sS'patients,are,to'
p9659
g9
sS'with,the,anti-glaucoma'
p9660
g9
sS'flucoxacillin,and,demonstrated'
p9661
g3
sS'of,in,a'
p9662
g9
sS'abciximab,may,increase'
p9663
g9
sS'if,and,such'
p9664
g3
sS'novo,renal,transplant'
p9665
g3
sS'rural,health,objectives'
p9666
g3
sS'however,high,doses'
p9667
g9
sS'combination,with,close'
p9668
g9
sS'type,depth,of'
p9669
g3
sS'in,functional,classes'
p9670
g3
sS'dose,of,and'
p9671
g3
sS'on,bioavailability,auc'
p9672
g3
sS'the,human,auc'
p9673
g3
sS'a,similar,study'
p9674
g9
sS'bleeding,time,plasma'
p9675
g3
sS'to,prolong,the'
p9676
g9
sS'of,use,for'
p9677
g3
sS'beta-glucuronidase,are,given'
p9678
g3
sS'as,colostrum,iga'
p9679
g3
sS'analyses,revealed,that'
p9680
g3
sS'when,the,following'
p9681
g3
sS'review,was,to'
p9682
g3
sS'phenobarbital,tegretol,trileptal'
p9683
g9
sS'without,difficulty,once'
p9684
g3
sS'number,of,substances'
p9685
g3
sS'of,co-administration,mean'
p9686
g3
sS'have,more,frequent'
p9687
g3
sS'a,nonfunctioning,gland'
p9688
g9
sS'block,the,therapeutic'
p9689
g9
sS'pharmacokinetics,of,oral'
p9690
g3
sS'withdrawn,from,a'
p9691
g3
sS'cmax,of,averaged'
p9692
g9
sS'with,thiazide,may'
p9693
g9
sS'by,the,was'
p9694
g3
sS'generation,of,three'
p9695
g3
sS'both,and,a'
p9696
g9
sS'the,selective,mao'
p9697
g9
sS'ml,administered,with'
p9698
g9
sS'divided,attention,test'
p9699
g9
sS'both,and,i'
p9700
g3
sS'efficacy,of,xigris'
p9701
g3
sS'of,interactions,of'
p9702
g9
sS'clinical,interaction,studies'
p9703
g3
sS'l,or,kcl'
p9704
g3
sS'minutes,after,administration'
p9705
g3
sS'animals,where,endothelial'
p9706
g3
sS'therefore,prothrombin,time'
p9707
g9
sS'against,sera,from'
p9708
g3
sS'diclofenac,does,not'
p9709
g3
sS'at,greater,risk'
p9710
g3
sS'require,higher,doses'
p9711
g3
sS'naflu,to,and'
p9712
g3
sS'macrolide,and,other'
p9713
g9
sS'trials,concomitant,medications'
p9714
g3
sS'pharmacokinetic,interactions,listed'
p9715
g3
sS'outset,of,such'
p9716
g3
sS'and,of,by'
p9717
g9
sS'in,substantial,increases'
p9718
g9
sS'excretion,of,of'
p9719
g9
sS'other,formal,interaction'
p9720
g3
sS'place,at,the'
p9721
g3
sS'same,age,and'
p9722
g3
sS'moreover,its,activity'
p9723
g3
sS'a,report,of'
p9724
g9
sS'by,cgs21680,was'
p9725
g9
sS'occur,with,benedicts'
p9726
g3
sS'have,been,shown'
p9727
g9
sS'kg,results,in'
p9728
g3
sS'decreases,in,serum'
p9729
g9
sS'a,direct,action'
p9730
g9
sS'in,doses,up'
p9731
g9
sS'have,been,collected'
p9732
g3
sS'system,probably,responsible'
p9733
g3
sS'between,and,other'
p9734
g3
sS'oral,contraceptive,agents'
p9735
g3
sS'loss,or,inactivity'
p9736
g3
sS'may,impair,intestinal'
p9737
g3
sS'way,the,function'
p9738
g9
sS'in,the,male'
p9739
g3
sS'transcriptase,inhibitors,and'
p9740
g3
sS'co-administered,with,it'
p9741
g3
sS'on,equetrotm,and'
p9742
g9
sS'have,noted,that'
p9743
g3
sS'pediatric,patients,to'
p9744
g3
sS'pharmacokinetics,exposure,or'
p9745
g3
sS'when,adjustment,of'
p9746
g3
sS'or,tachycardia,do'
p9747
g3
sS'stopped,to,ensure'
p9748
g9
sS'with,somatic,disease'
p9749
g3
sS'of,both,elements'
p9750
g3
sS'an,intravenous,iv'
p9751
g9
sS'induced,by,aom'
p9752
g3
sS'the,modulation,of'
p9753
g9
sS'probably,at,least'
p9754
g9
sS'of,hansten,into'
p9755
g3
sS'strong,affinity,for'
p9756
g3
sS'incidence,of,reaction'
p9757
g3
sS'brain,memory,system'
p9758
g3
sS'the,lumen,at'
p9759
g3
sS'a,do,not'
p9760
g9
sS'absorption,in,patients'
p9761
g9
sS'shown,to,have'
p9762
g3
sS'of,amevive,administered'
p9763
g3
sS'resulting,increase,in'
p9764
g3
sS'some,and,increase'
p9765
g9
sS'via,the,bile'
p9766
g3
sS'had,plasma,concentrations'
p9767
g9
sS'cyp3a4,and,protease'
p9768
g3
sS'found,but,ki'
p9769
g3
sS'we,carried,out'
p9770
g3
sS'secretion,are,antagonized'
p9771
g3
sS'usually,clear,within'
p9772
g3
sS'urinary,tract,obstruction'
p9773
g3
sS'was,no,difference'
p9774
g3
sS'hours,does,not'
p9775
g9
sS'associated,with,indirect'
p9776
g3
sS'd-gal,binding,lectin'
p9777
g3
sS'and,intravenous,mg'
p9778
g3
sS'take,tricor,at'
p9779
g9
sS's,bioavailability,auc'
p9780
g3
sS'and,as,such'
p9781
g3
sS'state,mg,kg'
p9782
g9
sS'meals,was,administered'
p9783
g3
sS'juice,increases,ethinyl'
p9784
g3
sS'and,or,life-threatening'
p9785
g3
sS'small,when,given'
p9786
g9
sS'weeks,following,completion'
p9787
g3
sS'free,hormone,should'
p9788
g3
sS'physiologic,effects,blood'
p9789
g3
sS'to,healthy,male'
p9790
g3
sS'indicating,an,action'
p9791
g3
sS'and,or,without'
p9792
g3
sS'the,following,immunosuppressives'
p9793
g3
sS'of,toxicity,were'
p9794
g9
sS'suggesting,no,clinically'
p9795
g3
sS'by,hours,or'
p9796
g3
sS'treatment,with,the'
p9797
g3
sS'on,days,through'
p9798
g9
sS'the,pharmacodynamic,consequences'
p9799
g3
sS'with,the,protein'
p9800
g9
sS'on,ecg,taken'
p9801
g3
sS'the,above,behavioral'
p9802
g3
sS'states,and,these'
p9803
g3
sS'nerves,and,was'
p9804
g3
sS'by,hours,of'
p9805
g9
sS'is,primarily,eliminated'
p9806
g3
sS'depression,is,reaching'
p9807
g3
sS'inhalations,than,usual'
p9808
g3
sS'cause,and,effect'
p9809
g9
sS'antagonists,after,repeated'
p9810
g9
sS'phenobarbital,toxicity,has'
p9811
g9
sS'effects,could,potentially'
p9812
g9
sS'pharmacology-related,endocrine,feedback'
p9813
g3
sS'such,as,deltasone'
p9814
g3
sS'exogenous,respiration,becomes'
p9815
g3
sS'is,particularly,important'
p9816
g3
sS'within,a,period'
p9817
g9
sS'residues,on,a'
p9818
g3
sS'with,at,three'
p9819
g3
sS'predicted,interactions,due'
p9820
g3
sS'clinistix,and,glucose'
p9821
g3
sS'on,enzymatic,glucose'
p9822
g3
sS'with,g,kg'
p9823
g3
sS'necessary,during,concomitant'
p9824
g3
sS'interact,altered,hypo-prothrombinemic'
p9825
g3
sS'other,that,act'
p9826
g9
sS'with,anti-neoplastic,agents'
p9827
g3
sS'not,exceed,mg'
p9828
g9
sS'chromatographic,assay,and'
p9829
g3
sS'is,advisable,to'
p9830
g9
sS'to,the,increased'
p9831
g9
sS'is,little,if'
p9832
g3
sS'general,interactions,certain'
p9833
g3
sS'of,etc,but'
p9834
g9
sS'to,induce,hypercalcemia'
p9835
g3
sS'b,antineoplastic,agents'
p9836
g9
sS'asthma,or,copd'
p9837
g3
sS'depressants,including,such'
p9838
g9
sS'sodium,and,channel'
p9839
g9
sS'differences,in,locomotor'
p9840
g3
sS'psychotropic,agents,is'
p9841
g9
sS'strains,of,pointer'
p9842
g3
sS'with,strong,cyp3a4'
p9843
g9
sS'wort,may,decrease'
p9844
g3
sS'with,ibandronate,was'
p9845
g3
sS'drawn,either,before'
p9846
g3
sS'not,an,aed'
p9847
g3
sS'light,dark,test'
p9848
g3
sS'hydroxydesloratadine,were,observed'
p9849
g3
sS'reduced,p450,d6'
p9850
g3
sS'although,the,clinical'
p9851
g9
sS'significantly,decreased,the'
p9852
g9
sS'avoidance,behaviour,of'
p9853
g3
sS'levels,of,has'
p9854
g3
sS'of,serum,creatinine'
p9855
g3
sS'choline,trilisate,disalcid'
p9856
g9
sS'interaction,studies,with'
p9857
g3
sS'was,evaluated,using'
p9858
g3
sS'have,been,characterized'
p9859
g3
sS'parkinsons,disease,have'
p9860
g9
sS'free,cmin,concentrations'
p9861
g3
sS'fruit,juices,fruit'
p9862
g3
sS'albumin,binding,and'
p9863
g3
sS'automated,equipment,for'
p9864
g3
sS'also,shown,that'
p9865
g9
sS'and,genitourinary,symptoms'
p9866
g3
sS'mouse,carcinogenicity,study'
p9867
g3
sS'capsules,mg,with'
p9868
g9
sS'inhibit,cyp2d6,and'
p9869
g3
sS'individuals,treated,with'
p9870
g9
sS'seen,with,or'
p9871
g3
sS'of,a,potentially'
p9872
g9
sS'take,by,mouth'
p9873
g9
sS'status,is,warranted'
p9874
g9
sS'the,can,prevent'
p9875
g3
sS'human,volunteers,co-administration'
p9876
g3
sS'to,the,package'
p9877
g9
sS'be,administered,a'
p9878
g3
sS'do,not,start'
p9879
g3
sS'reversible,increases,in'
p9880
g9
sS'ml,or,dihydroxyflavone'
p9881
g3
sS'phenytoin,serum,levels'
p9882
g9
sS'to,allow,for'
p9883
g3
sS'with,the,reversal'
p9884
g9
sS'be,used,with'
p9885
g9
sS'and,with,frequent'
p9886
g3
sS'otherwise,specified,appropriate'
p9887
g3
sS'of,medication,administered'
p9888
g3
sS'quinidine,immediate,release'
p9889
g9
sS'and,changes,in'
p9890
g3
sS'careful,patient,monitoring'
p9891
g3
sS'amount,absorbed,when'
p9892
g3
sS'whereas,in,pigeons'
p9893
g3
sS'for,therapeutic,advantage'
p9894
g3
sS'receiving,in,combination'
p9895
g9
sS'difference,was,not'
p9896
g3
sS'higher,than,expected'
p9897
g3
sS'calan,sr,by'
p9898
g9
sS'alternative,agents,with'
p9899
g3
sS'be,aggravated,by'
p9900
g9
sS'therapy,although,no'
p9901
g3
sS'glaucoma,or,systemic'
p9902
g9
sS'cells,to,topo'
p9903
g3
sS'received,alone,mg'
p9904
g3
sS'even,experienced,users'
p9905
g9
sS'on,hormonal,contraception'
p9906
g3
sS'of,n-allylnormetazocine,nanm'
p9907
g3
sS'that,inhibited,the'
p9908
g3
sS'be,employed,when'
p9909
g3
sS'performed,at,the'
p9910
g3
sS'atiii,no,interactions'
p9911
g3
sS'be,refractory,to'
p9912
g9
sS'when,cancidas,is'
p9913
g9
sS'when,a,patient'
p9914
g3
sS'this,pharmacodynamic,interaction'
p9915
g3
sS'urine,creatinine,by'
p9916
g3
sS'clear,reproducible,pattern'
p9917
g3
sS'plasma,was,approximately'
p9918
g3
sS'as,or,would'
p9919
g3
sS'induces,or,does'
p9920
g3
sS'from,in,vitro'
p9921
g9
sS'and,or,cardiac'
p9922
g3
sS'significantly,superior,to'
p9923
g3
sS'must,not,conclude'
p9924
g3
sS'normal,levels,when'
p9925
g3
sS'that,same,study'
p9926
g3
sS'omniscan,interferes,with'
p9927
g3
sS'chloral,hydrate,dietary'
p9928
g9
sS'with,similar,properties'
p9929
g9
sS'while,all,the'
p9930
g3
sS'study,examining,mg'
p9931
g9
sS'antihypertensive,medications,other'
p9932
g3
sS'innovar,or,but'
p9933
g9
sS'these,supplements,with'
p9934
g3
sS'with,mg,b'
p9935
g3
sS'in,a,manner'
p9936
g3
sS'with,mg,d'
p9937
g3
sS'reported,association,has'
p9938
g3
sS'of,neurological,toxicity'
p9939
g3
sS'patients,already,on'
p9940
g3
sS'barrier,contraception,should'
p9941
g9
sS'the,minimal,inhibitory'
p9942
g3
sS'replacing,by,therapy'
p9943
g9
sS'with,mg,p'
p9944
g9
sS'not,significantly,interfere'
p9945
g3
sS'method,be,used'
p9946
g3
sS'b6,physiological,doses'
p9947
g3
sS'is,of,importance'
p9948
g3
sS'for,patients,given'
p9949
g9
sS'of,neutrophils,such'
p9950
g3
sS'effects,of,intravenous'
p9951
g9
sS'thus,if,such'
p9952
g3
sS'monitored,and,if'
p9953
g9
sS'concentrations,of,mcg'
p9954
g3
sS'may,prevent,absorption'
p9955
g3
sS'is,not,impaired'
p9956
g3
sS'is,associated,with'
p9957
g3
sS'were,not,observed'
p9958
g3
sS'their,patients,are'
p9959
g3
sS'a,day,for'
p9960
g3
sS'mixed,agonist,antagonist'
p9961
g9
sS'there,also,was'
p9962
g3
sS'injection,concentrate,should'
p9963
g9
sS'drawn,into,the'
p9964
g3
sS'bepridil,with,long-'
p9965
g3
sS'been,used,with'
p9966
g3
sS'infinity,auc,and'
p9967
g3
sS'hormone,levels,and'
p9968
g3
sS'pronounced,though,reversible'
p9969
g9
sS'in,humans,taking'
p9970
g3
sS'volunteers,increased,auc'
p9971
g3
sS'most,potent,inhibitory'
p9972
g3
sS'of,at,the'
p9973
g3
sS'acetate,and,possibly'
p9974
g9
sS'thus,could,lead'
p9975
g3
sS'once,daily,as'
p9976
g9
sS'day,with,a'
p9977
g3
sS'camptosar,the,physician'
p9978
g9
sS'normal,cells,to'
p9979
g3
sS'or,more,when'
p9980
g3
sS'and,dose,reduction'
p9981
g3
sS'to,triple-immunosuppression,regimens'
p9982
g3
sS'mg,t,i'
p9983
g9
sS'when,arava,was'
p9984
g9
sS'enhance,the,neuromuscular'
p9985
g9
sS'tiagabine,has,shown'
p9986
g3
sS'of,sular,with'
p9987
g9
sS'twice,daily,morning'
p9988
g3
sS'both,periods,blood'
p9989
g3
sS'may,enhance,the'
p9990
g9
sS'in,any,changes'
p9991
g3
sS'patients,receiving,antihypertensive'
p9992
g9
sS'advised,to,consult'
p9993
g3
sS'effect,is,not'
p9994
g9
sS'test,interactions,effect'
p9995
g3
sS'as,increasingly,important'
p9996
g3
sS'no,adverse,effects'
p9997
g3
sS'in,significant,increases'
p9998
g3
sS'pcp,in,pigeons'
p9999
g9
sS'a,substrate,and'
p10000
g3
sS'approximately,when,taxol'
p10001
g9
sS'sonata,to,a'
p10002
g3
sS'in,previous,reports'
p10003
g9
sS'clinical,interaction,between'
p10004
g3
sS'doctor,or,pharmacist'
p10005
g3
sS'decreased,serum,levels'
p10006
g9
sS'is,reduced,by'
p10007
g9
sS'ml,min,mean'
p10008
g9
sS'have,been,performed'
p10009
g3
sS'class,antimicrobial,and'
p10010
g9
sS'these,were,given'
p10011
g9
sS'enhanced,and,excretion'
p10012
g9
sS'nacmc,m,v'
p10013
g3
sS'cyp2c19,cyp2d6,cyp2e1'
p10014
g3
sS'and,coronary,oral'
p10015
g3
sS'with,hemostasis,nsaids'
p10016
g3
sS'of,multiple,oral'
p10017
g9
sS'when,vardenafil,mg'
p10018
g3
sS'or,after,ethyl'
p10019
g9
sS'be,increased,with'
p10020
g9
sS'rbc,mice,but'
p10021
g3
sS'because,may,interfere'
p10022
g9
sS'h-triglyceride,fractional,clearance'
p10023
g9
sS'use,especially,of'
p10024
g3
sS'before,injection,produced'
p10025
g3
sS'nsaids,can,reduce'
p10026
g9
sS'renal,nonrenal,and'
p10027
g3
sS'therapy,is,necessary'
p10028
g3
sS'tended,to,be'
p10029
g9
sS'sildenafil,citrate,a'
p10030
g3
sS'isoenzyme,family,may'
p10031
g3
sS'withdrawal,from,dependence'
p10032
g3
sS'healthy,volunteers,hormone'
p10033
g3
sS'dynacirc,and,in'
p10034
g3
sS'these,facts,should'
p10035
g3
sS'mg,doses,of'
p10036
g9
sS'alone,and,because'
p10037
g9
sS'and,and,has'
p10038
g3
sS'addition,neuromuscular,blocking'
p10039
g3
sS'hippocampus,and,to'
p10040
g3
sS'immediate-early,genes,iegs'
p10041
g3
sS'reported,very,rarely'
p10042
g9
sS'defined,physical,dependency'
p10043
g3
sS'subjects,received,alone'
p10044
g3
sS'the,recommended,dose'
p10045
g3
sS'blood,pressure,beyond'
p10046
g3
sS'agents,that,induce'
p10047
g3
sS'administration,of,containing'
p10048
g9
sS'in,time,with'
p10049
g9
sS'you,need,to'
p10050
g9
sS'to,approximate,the'
p10051
g3
sS'and,cautioned,against'
p10052
g3
sS'replacement,may,alter'
p10053
g3
sS'observation,must,be'
p10054
g3
sS'a,interaction,with'
p10055
g3
sS'these,lines,showed'
p10056
g3
sS'the,district,of'
p10057
g3
sS'instances,of,life-'
p10058
g9
sS'possible,adverse,effects'
p10059
g3
sS'small,magnitude,and'
p10060
g3
sS'basis,of,in'
p10061
g9
sS'and,cancer,metastasis'
p10062
g3
sS'a,smaller,initial'
p10063
g9
sS'cared,for,in'
p10064
g3
sS'mg,also,received'
p10065
g3
sS'serum,potassium,enalapril'
p10066
g9
sS'a,slower,gastrointestinal'
p10067
g9
sS'cautiously,and,patients'
p10068
g9
sS'osteoarthritis,when,vioxx'
p10069
g3
sS'and,black,cohosh'
p10070
g3
sS'at,the,higher'
p10071
g3
sS'known,to,interfere'
p10072
g3
sS'on,discrimination,and'
p10073
g3
sS'lst,mice,did'
p10074
g3
sS'role,of,amevive'
p10075
g3
sS'database,three,duloxetine-treated'
p10076
g3
sS'post-marketing,experience,there'
p10077
g9
sS'other,agents,given'
p10078
g3
sS'and,concomitant,use'
p10079
g9
sS'by,and,decreased'
p10080
g9
sS'tumour,the,peak'
p10081
g3
sS'do,not,appear'
p10082
g3
sS'the,ethanolysis,reaction'
p10083
g9
sS'absorption,has,not'
p10084
g3
sS'the,endotoxin-treated,rats'
p10085
g9
sS'bioavailability,auc,or'
p10086
g3
sS'those,of,class'
p10087
g9
sS'cereals,on,absorption'
p10088
g3
sS'receiving,both,as'
p10089
g9
sS'taking,nsaids,concomitantly'
p10090
g9
sS'clearance,or,toxicologic'
p10091
g3
sS'limits,the,dose'
p10092
g3
sS'observed,to,determine'
p10093
g9
sS'isosorbide,mononitrate,may'
p10094
g9
sS'three,clinical,trials'
p10095
g3
sS'also,have,an'
p10096
g9
sS'slight,degree,of'
p10097
g3
sS'urine,for,the'
p10098
g3
sS'and,serotoninergic,central'
p10099
g3
sS'inhibition,of,renal'
p10100
g3
sS'route,may,produce'
p10101
g3
sS'brevibloc,on,the'
p10102
g3
sS'or,dihydroxyflavone,with'
p10103
g3
sS'brain,although,they'
p10104
g3
sS'metastasis,of,intestinal'
p10105
g9
sS'and,or,increased'
p10106
g9
sS'occasional,literature,reports'
p10107
g9
sS'binding,to,avoid'
p10108
g9
sS'in,vivo,it'
p10109
g3
sS'vivo,and,to'
p10110
g9
sS'other,may,affect'
p10111
g3
sS'methylpyrazole,mg,kg'
p10112
g9
sS'the,mean,cmax'
p10113
g9
sS'mortality,in,patients'
p10114
g3
sS'hours,q24h,for'
p10115
g9
sS'indicate,that,keppra'
p10116
g3
sS'onto,the,surface'
p10117
g9
sS'medications,may,decrease'
p10118
g3
sS'humans,have,shown'
p10119
g3
sS'growth,hormone,may'
p10120
g9
sS'also,additive,to'
p10121
g9
sS'trials,that,included'
p10122
g3
sS'on,the,tail-flick'
p10123
g9
sS'to,during,or'
p10124
g9
sS'by,nonsteroidal,anti-inflammatory'
p10125
g9
sS'biocytin,was,included'
p10126
g3
sS'have,demonstrated,an'
p10127
g9
sS'secretion,has,been'
p10128
g9
sS'synthetic,on,placental'
p10129
g3
sS'and,cyp2c8,drugs'
p10130
g3
sS'a,clinically,significant'
p10131
g3
sS'lipid-lowering,that,are'
p10132
g3
sS'to,bovine,thyroglobulin'
p10133
g3
sS'delirium,high,fever'
p10134
g9
sS'level,of,blood'
p10135
g3
sS'of,inspra,to'
p10136
g9
sS'method,and,observations'
p10137
g3
sS'of,the,and'
p10138
g9
sS'difference,in,the'
p10139
g3
sS'administering,celebrex,with'
p10140
g9
sS'contraceptives,coadministration,of'
p10141
g9
sS'by,concomitant,therapies'
p10142
g3
sS'inter-patient,variability,and'
p10143
g3
sS'nucleus,accumbens,but'
p10144
g3
sS'study,patients,with'
p10145
g3
sS'and,should,not'
p10146
g9
sS'cef-120,or,fec-100'
p10147
g3
sS'of,nevirapine,or'
p10148
g3
sS'particularly,the,elderly'
p10149
g9
sS'of,to,normal'
p10150
g9
sS'interactions,because,false'
p10151
g3
sS'patients,receiving,hydrochloride'
p10152
g3
sS'tid,study,of'
p10153
g3
sS'c19,d6,a4'
p10154
g3
sS'a,complex,effect'
p10155
g9
sS'the,supraventricular,arrhythmia'
p10156
g9
sS'patients,on,glycosides'
p10157
g3
sS'an,adjustment,of'
p10158
g3
sS'and,cosmetics,that'
p10159
g3
sS'and,strong,cyp3a4'
p10160
g9
sS'counteract,the,antiepileptic'
p10161
g9
sS'depletion,related,to'
p10162
g3
sS'are,available,for'
p10163
g3
sS'cream,cream,and'
p10164
g3
sS'to,inhibitors,of'
p10165
g3
sS'phenobarbital,the,coadministration'
p10166
g9
sS'metabolism,via,cytochrome'
p10167
g3
sS'no,known,drug'
p10168
g3
sS'administered,during,the'
p10169
g3
sS'although,no,studies'
p10170
g9
sS'on,the,brief'
p10171
g9
sS'choroidal,blood,flow'
p10172
g3
sS'anafranil,is,going'
p10173
g3
sS'to,alter,the'
p10174
g3
sS'dose,of,sodium'
p10175
g9
sS'not,suffer,from'
p10176
g3
sS'of,or,activated'
p10177
g9
sS'mg,taken,and'
p10178
g9
sS'of,fully,formed'
p10179
g3
sS'not,recommended,to'
p10180
g9
sS'following,anti-anxiety,used'
p10181
g3
sS'auc,and,maximum'
p10182
g3
sS'chapter,covers,pharmacology'
p10183
g3
sS'multivitamin,preparations,containing'
p10184
g9
sS'inhibit,this,enzyme'
p10185
g9
sS'was,depressed,in'
p10186
g9
sS'transdermal,system,with'
p10187
g9
sS'in,serum,with'
p10188
g3
sS'levels,were,noted'
p10189
g3
sS'concomitantly,administered,metabolized'
p10190
g3
sS'response,to,accutane'
p10191
g3
sS'permeation,enhancing,effect'
p10192
g3
sS'otherwise,healthy,adults'
p10193
g3
sS'protein,tyrosine,phosphorylation'
p10194
g3
sS'or,resistance,in'
p10195
g3
sS'serum,level,determinations'
p10196
g9
sS'caused,to,fold'
p10197
g9
sS'commonly,in,patients'
p10198
g9
sS'interval,have,an'
p10199
g3
sS'retard,is,used'
p10200
g9
sS'activity,potentiates,the'
p10201
g9
sS'birth,control,should'
p10202
g9
sS'established,steady-state,serum'
p10203
g9
sS'fever,chills,nausea'
p10204
g3
sS'and,positive,test'
p10205
g3
sS'of,vitamin,b12'
p10206
g9
sS'cardiac,and,others'
p10207
g3
sS'may,change,with'
p10208
g3
sS'brief,psychiatric,rating'
p10209
g9
sS'influence,in,vitro'
p10210
g3
sS'similar,concentrations,that'
p10211
g3
sS'jacalin,is,a'
p10212
g3
sS'evening,meal,and'
p10213
g9
sS'or,withdrawn,in'
p10214
g3
sS'this,sample,size'
p10215
g3
sS'of,the,mouth'
p10216
g9
sS'that,is,not'
p10217
g3
sS'but,can,be'
p10218
g3
sS'in,adults,were'
p10219
g3
sS'be,produced,by'
p10220
g3
sS'can,be,affected'
p10221
g9
sS'beta,blocker,and'
p10222
g9
sS'in,increased,central'
p10223
g9
sS'used,with,other'
p10224
g3
sS'concurrently,patients,should'
p10225
g9
sS'enhance,the,metabolism'
p10226
g9
sS'such,as,inotropes'
p10227
g9
sS'derivatives,and,are'
p10228
g9
sS'induce,early,and'
p10229
g3
sS'n,vs,placebo'
p10230
g3
sS'in,the,cytochrome'
p10231
g3
sS'which,themselves,produce'
p10232
g9
sS'oral,dose,even'
p10233
g3
sS'hypoxanthine,and,xanthine'
p10234
g9
sS'degree,of,protein'
p10235
g3
sS'this,suggests,that'
p10236
g3
sS'enzyme,supplements,oral'
p10237
g3
sS'gastrointestinal,tract,where'
p10238
g3
sS'required,when,this'
p10239
g3
sS'who,are,given'
p10240
g3
sS'these,groups,is'
p10241
g3
sS'of,cefditoren,with'
p10242
g9
sS'the,international,literature'
p10243
g3
sS'would,not,be'
p10244
g3
sS'binding,to,plasma'
p10245
g3
sS'when,is,given'
p10246
g3
sS'agent,should,be'
p10247
g9
sS'antipsychotic,with,demonstrated'
p10248
g3
sS'after,nasal,spray'
p10249
g9
sS'cumulative,urinary,excretion'
p10250
g3
sS'less,caspase-3,activity'
p10251
g3
sS'suggest,that,mc'
p10252
g3
sS'and,even,death'
p10253
g3
sS'botox,and,or'
p10254
g9
sS'this,is,especially'
p10255
g3
sS'controlled,study,suggested'
p10256
g3
sS'and,efficacy,data'
p10257
g3
sS'no,adjustment,to'
p10258
g3
sS'hours,were,potentiated'
p10259
g9
sS'system,fentanyl,is'
p10260
g3
sS'of,cyp3a4,may'
p10261
g3
sS'changes,that,occur'
p10262
g3
sS'clearance,of,simulect'
p10263
g9
sS'phasic,contraction,of'
p10264
g3
sS'indicate,that,and'
p10265
g9
sS'hamsters,in,response'
p10266
g3
sS'severity,of,dry'
p10267
g9
sS'of,with,may'
p10268
g9
sS'other,macrolide,such'
p10269
g3
sS'seroquel,is,a'
p10270
g3
sS'plasma,concentrations,may'
p10271
g3
sS'adjustment,required,it'
p10272
g9
sS'on,intact,liver'
p10273
g3
sS'acute,increase,in'
p10274
g3
sS'with,foscavir,and'
p10275
g9
sS'that,several,but'
p10276
g3
sS'n,the,mean'
p10277
g9
sS'coelenterates,of,palythoa'
p10278
g3
sS'be,terminated,the'
p10279
g9
sS'input,impedance,and'
p10280
g3
sS'antianginal,effectiveness,of'
p10281
g3
sS'potentially,serious,adverse'
p10282
g3
sS'administered,mg,starlix'
p10283
g3
sS'hypotensive,response,is'
p10284
g3
sS'hours,or,mg'
p10285
g3
sS'not,expected,in'
p10286
g3
sS'p450,c9,and'
p10287
g3
sS'exposure-response,relationships,and'
p10288
g3
sS'shown,casodex,can'
p10289
g9
sS'and,half,returned'
p10290
g3
sS'inhibitor,being,used'
p10291
g3
sS'anticholinesterase,overdose,cholinergic'
p10292
g3
sS'for,example,and'
p10293
g9
sS'unless,really,needed'
p10294
g3
sS'oxidase,inhibitors,guanethidine'
p10295
g3
sS'tubular,excretion,of'
p10296
g9
sS'of,whom,died'
p10297
g3
sS'other,depressasnts,such'
p10298
g9
sS'or,other,products'
p10299
g9
sS'but,nearly,normal'
p10300
g3
sS'biodistribution,may,provide'
p10301
g3
sS'use,of,pegasys'
p10302
g3
sS'a,considerable,segment'
p10303
g3
sS'or,disposition,of'
p10304
g3
sS'required,since,the'
p10305
g3
sS'milk,ejection,by'
p10306
g3
sS'studies,which,support'
p10307
g3
sS'progression,as,an'
p10308
g3
sS'with,may,cause'
p10309
g3
sS'exact,place,of'
p10310
g3
sS'patients,taking,as'
p10311
g3
sS'ms,patients,including'
p10312
g3
sS'patients,taking,an'
p10313
g9
sS'aureus,a,frequent'
p10314
g9
sS'in,comparison,with'
p10315
g9
sS'acetate,at,about'
p10316
g9
sS'to,hypertensive,nephropathy'
p10317
g3
sS'day,during,adjunctive'
p10318
g9
sS'coadministered,on,day'
p10319
g9
sS'tail-flick,response,to'
p10320
g3
sS'curves,relatively,little'
p10321
g3
sS'associated,with,and'
p10322
g9
sS'a,patient,taking'
p10323
g3
sS'or,depresses,bone'
p10324
g3
sS'out,two,different'
p10325
g3
sS'and,or,epoxide'
p10326
g3
sS'with,respect,to'
p10327
g3
sS'situ,and,in'
p10328
g3
sS'long-,term,therapy'
p10329
g9
sS'be,individualized,when'
p10330
g3
sS'in,human,heart'
p10331
g3
sS'is,a,single'
p10332
g9
sS'have,a,profound'
p10333
g3
sS'arterial,thrombus,formation'
p10334
g9
sS'any,occasion,in'
p10335
g3
sS'if,is,used'
p10336
g9
sS'of,repeat,doses'
p10337
g3
sS'with,practically,only'
p10338
g3
sS'average,of,approximately'
p10339
g9
sS'mg,kg,resulted'
p10340
g3
sS'monitored,in,patients'
p10341
g9
sS'on,such,combined'
p10342
g9
sS'weak,b6,weak'
p10343
g3
sS'to,maintain,barpress'
p10344
g3
sS'of,pcp-induced,behavioral'
p10345
g3
sS'can,be,formed'
p10346
g9
sS'beta-adrenergic,stimulating,properties'
p10347
g3
sS'qd,for,days'
p10348
g9
sS'inhibits,cyp2d6,is'
p10349
g3
sS'diabetics,should,discuss'
p10350
g3
sS'not,shown,consistent'
p10351
g3
sS'of,the,metabolite'
p10352
g3
sS'cyp3a,and,c9'
p10353
g3
sS'ria,kit,may'
p10354
g3
sS'eg,or,cyp2d6'
p10355
g9
sS'potent,inducers,of'
p10356
g9
sS'is,still,valid'
p10357
g3
sS'combines,with,membranes'
p10358
g3
sS'if,vioxx,and'
p10359
g9
sS'causing,no,significant'
p10360
g3
sS'did,not,potentiate'
p10361
g3
sS'was,administered,over'
p10362
g3
sS'concurrently,with,brevibloc'
p10363
g3
sS'facilitation,or,an'
p10364
g3
sS'caution,in,patients'
p10365
g9
sS'reported,with,cefizox'
p10366
g9
sS'cardiac,transplant,recipients'
p10367
g9
sS'the,goal,of'
p10368
g3
sS'day,or,prophylactic'
p10369
g3
sS'increased,potential,of'
p10370
g9
sS'inhibitors,thereby,potentially'
p10371
g9
sS'patient,interferes,with'
p10372
g3
sS'of,panretin,gel'
p10373
g3
sS'm,parenteral,except'
p10374
g3
sS'cause,decreased,serum'
p10375
g9
sS'carefully,considered,and'
p10376
g9
sS'potentiation,occurs,with'
p10377
g3
sS'common,adverse,effects'
p10378
g3
sS'are,pregnant,and'
p10379
g3
sS'cimetidine,cimetidine,can'
p10380
g9
sS'studies,case,reports'
p10381
g3
sS'c,interval,were'
p10382
g3
sS'in,almost,complete'
p10383
g3
sS'apraclonidine,should,not'
p10384
g9
sS'was,administered,intraperitoneally'
p10385
g3
sS'delay,premature,atherosclerotic'
p10386
g3
sS'taken,concomitantly,with'
p10387
g3
sS'evidence,of,a'
p10388
g3
sS'thiazides,may,decrease'
p10389
g9
sS'related,have,been'
p10390
g9
sS'of,the,neuromuscular'
p10391
g9
sS'and,orally,as'
p10392
g9
sS'of,both,first'
p10393
g9
sS'in,combinations,were'
p10394
g3
sS'cyp2d6,many,including'
p10395
g3
sS'clinically,significant,in'
p10396
g9
sS'toxic,effects,such'
p10397
g9
sS'not,significantly,influence'
p10398
g3
sS'inducers,and,such'
p10399
g9
sS'agents,is,generally'
p10400
g9
sS'interactions,certain,could'
p10401
g3
sS'fully,characterized,a'
p10402
g9
sS'of,clozapine,caution'
p10403
g9
sS'hospitals,usually,in'
p10404
g3
sS'propose,these,pharmacokinetic'
p10405
g9
sS'low,temperatures,on'
p10406
g3
sS'in,reference,to'
p10407
g3
sS'produces,an,increase'
p10408
g9
sS'detected,in,ci'
p10409
g3
sS'pharmacodynamics,of,and'
p10410
g3
sS'induce,p-450iie1,a'
p10411
g3
sS'for,proper,interpretation'
p10412
g3
sS'or,if,any'
p10413
g9
sS'tetracyclines,concomitant,treatment'
p10414
g9
sS'primarily,a,substrate'
p10415
g3
sS'specific,substrates,inhibitors'
p10416
g3
sS'six,sudden,cardiac'
p10417
g3
sS'and,understanding,of'
p10418
g3
sS'hallucinations,and,irrational'
p10419
g9
sS'to,study,effects'
p10420
g3
sS'time,scale,of'
p10421
g3
sS'observed,the,concentrations'
p10422
g3
sS'days,of,mg'
p10423
g3
sS'block,following,nimbex'
p10424
g9
sS'ranitidine,produced,smaller'
p10425
g3
sS'the,resolution,of'
p10426
g9
sS'total,gsh,and'
p10427
g3
sS'cause,neutropenia,and'
p10428
g3
sS'clostridium,three,strains'
p10429
g3
sS'blood,coagulation,ketoprofen'
p10430
g3
sS'following,cisplatin,hcl'
p10431
g9
sS'adverse,experiences,and'
p10432
g9
sS'primary,addiction,after'
p10433
g3
sS'and,had,no'
p10434
g3
sS'administered,have,also'
p10435
g3
sS'liquid,impinger,for'
p10436
g3
sS'inhibitor,to,be'
p10437
g3
sS'rare,postmarketing,reports'
p10438
g9
sS'an,experimental,soft-gelatin'
p10439
g9
sS'pharmacokinetic,dosing,has'
p10440
g3
sS'the,molecule,thereby'
p10441
g9
sS'of,months,the'
p10442
g3
sS'with,other,anti-asthma'
p10443
g3
sS'resulted,in,prolongation'
p10444
g9
sS'which,had,a'
p10445
g3
sS'administration,with,other'
p10446
g3
sS'vardenafil,mg,was'
p10447
g3
sS'lowering,their,blood'
p10448
g3
sS'may,sensitize,tissues'
p10449
g3
sS'it,is,difficult'
p10450
g3
sS'concentrations,up,to'
p10451
g3
sS'may,vary,from'
p10452
g3
sS'some,nsaids,has'
p10453
g9
sS'first,test,is'
p10454
g3
sS'data,exist,on'
p10455
g3
sS'concurrent,kineret,and'
p10456
g9
sS'by,cyp,a4'
p10457
g3
sS'in,the,pharmacokinetics'
p10458
g3
sS'levels,of,or'
p10459
g3
sS'in,six,of'
p10460
g9
sS'rashes,with,concomitant'
p10461
g3
sS'anticipated,and,infusion'
p10462
g9
sS'that,could,cause'
p10463
g9
sS'or,prolonged,by'
p10464
g3
sS'be,worsened,by'
p10465
g3
sS'rates,were,similar'
p10466
g3
sS'of,other,nonsteroidal'
p10467
g3
sS'who,are,incompletely'
p10468
g3
sS'reported,during,continuous'
p10469
g3
sS'lean,and,dietary-induced'
p10470
g3
sS'of,albendazole,mg'
p10471
g9
sS'anxiety,associated,with'
p10472
g3
sS'ascorbic,acid,although'
p10473
g3
sS'drinks,may,increase'
p10474
g3
sS'and,careful,titration'
p10475
g3
sS'before,receiving,the'
p10476
g3
sS'activity,of,and'
p10477
g9
sS'of,on,arteries'
p10478
g3
sS'usually,recommended,for'
p10479
g3
sS'toxicity,to,hatching'
p10480
g3
sS'twenty-four,healthy,male'
p10481
g3
sS'patients,are,more'
p10482
g3
sS'until,his,death'
p10483
g3
sS'via,the,organic'
p10484
g3
sS'a,dosage,adjustment'
p10485
g3
sS'ethanol,cause,additive'
p10486
g9
sS'h2-receptor,antagonists,histamine'
p10487
g3
sS'during,initiation,of'
p10488
g3
sS'cyp3a4,and,mg'
p10489
g3
sS'reservoir,function,of'
p10490
g3
sS'as,triazolopyridazines,and'
p10491
g9
sS'suppress,the,immune'
p10492
g3
sS'is,related,to'
p10493
g3
sS'is,seen,in'
p10494
g3
sS'via,the,same'
p10495
g3
sS'and,a,spatial'
p10496
g3
sS'for,the,elimination'
p10497
g3
sS'azole,agents,are'
p10498
g9
sS'in,noradrenaline-precontracted,arteries'
p10499
g3
sS'where,survival,was'
p10500
g3
sS'status,which,requires'
p10501
g3
sS'moderate,inhibitor,of'
p10502
g3
sS'diabetic,individuals,because'
p10503
g3
sS'have,failed,to'
p10504
g3
sS'older,who,were'
p10505
g3
sS'and,lunch,doses'
p10506
g3
sS'via,organic,cationic'
p10507
g9
sS'the,basis,of'
p10508
g3
sS'potential,to,result'
p10509
g9
sS'found,to,produce'
p10510
g3
sS'of,the,maximal'
p10511
g3
sS'in,pediatric,patients'
p10512
g3
sS'industrial,workers,involved'
p10513
g3
sS'mc,decreases,heart'
p10514
g3
sS'is,indicated,because'
p10515
g3
sS'is,recommended,at'
p10516
g3
sS'to,the,underlying'
p10517
g3
sS'no,platelet,aggregation'
p10518
g3
sS'significantly,when,is'
p10519
g9
sS'low-levels,of,exposure'
p10520
g3
sS'hydrochloride,alone,or'
p10521
g3
sS'to,those,prior'
p10522
g3
sS'monitoring,of,methotrexate-related'
p10523
g9
sS'arenot,established,but'
p10524
g3
sS'administered,highly,protein-bound'
p10525
g3
sS'increases,in,cmax'
p10526
g9
sS'kept,in,mind'
p10527
g3
sS'pharmacokinetics,parameters,auc'
p10528
g9
sS'inhibitors,the,effect'
p10529
g3
sS'other,including,preparations'
p10530
g3
sS'concentrations,auc,approximately'
p10531
g9
sS'agents,must,be'
p10532
g3
sS'potentiated,resulting,in'
p10533
g9
sS'or,sodium,a'
p10534
g9
sS'first,phase,of'
p10535
g3
sS'on,endotoxin-induced,changes'
p10536
g3
sS'on,prothrombin,time'
p10537
g3
sS'bradycardia,has,been'
p10538
g3
sS'for,l-glutamine,was'
p10539
g3
sS'because,of,similar'
p10540
g9
sS'of,iiia4,blocks'
p10541
g9
sS'a,only,at'
p10542
g3
sS'clinical,trials,a'
p10543
g3
sS'with,nucleophosmin,b23'
p10544
g3
sS'intraventricular,injection,of'
p10545
g9
sS'assay,xigris,present'
p10546
g3
sS'occurred,in,the'
p10547
g3
sS'as,or,may'
p10548
g9
sS'or,other,metal'
p10549
g9
sS'dosages,may,be'
p10550
g9
sS'including,quinolone,antibiotics'
p10551
g9
sS'days,following,use'
p10552
g9
sS'aldehyde,oxidase,in'
p10553
g9
sS'which,causes,a'
p10554
g9
sS'mechanisms,of,metal'
p10555
g3
sS'significant,interactions,between'
p10556
g3
sS'natrecor,were,conducted'
p10557
g3
sS'adverse,cardiovascular,effects'
p10558
g3
sS'two,mg,sustained-release'
p10559
g3
sS'c,the,non-myelinated'
p10560
g3
sS'and,was,evaluated'
p10561
g3
sS'larger,doses,could'
p10562
g3
sS'disposition,of,the'
p10563
g3
sS'for,days,results'
p10564
g9
sS'agents,only,with'
p10565
g3
sS'with,and,respectively'
p10566
g9
sS'which,has,proven'
p10567
g3
sS'indicate,that,as'
p10568
g3
sS'of,with,mg'
p10569
g9
sS'and,cyp3a4,as'
p10570
g3
sS'administration,even,when'
p10571
g3
sS'indicate,that,at'
p10572
g9
sS'to,be,coadministered'
p10573
g3
sS'see,clinical,pharmacology-pharmacokinetics'
p10574
g3
sS'been,noted,that'
p10575
g3
sS'myoclonus,tremor,hemiballismus'
p10576
g3
sS'and,the,management'
p10577
g3
sS'main,meal,of'
p10578
g3
sS'the,considerable,variability'
p10579
g3
sS'enbrel,and,developed'
p10580
g9
sS'these,medications,are'
p10581
g3
sS'although,one,study'
p10582
g3
sS'pcp,were,observed'
p10583
g3
sS'administered,on,an'
p10584
g3
sS'a,minor,metabolizing'
p10585
g3
sS'on,total,concentrations'
p10586
g9
sS'demonstrated,a,lack'
p10587
g3
sS'glyceryl,trinitrate,isosorbide'
p10588
g3
sS'in,large,well'
p10589
g3
sS'use,of,hctz'
p10590
g3
sS'when,indocin,and'
p10591
g9
sS'was,too,low'
p10592
g3
sS'mm,hg,compared'
p10593
g9
sS'increased,hepatotoxicity,of'
p10594
g9
sS'of,the,two'
p10595
g9
sS'latent,lcv,infection'
p10596
g3
sS'metabolism,of,hmg-coa'
p10597
g9
sS'perhexiline,hydrogen,maleate'
p10598
g9
sS'increases,the,metabolic'
p10599
g9
sS'gritty,substance,to'
p10600
g9
sS'ie,recall,has'
p10601
g3
sS'is,taken,in'
p10602
g3
sS'increasing,metal,concentration'
p10603
g3
sS'cgs21680,was,only'
p10604
g9
sS'or,unusual,taste'
p10605
g3
sS'dose,should,elapse'
p10606
g9
sS'reductase,inhibitors,and'
p10607
g9
sS'with,hepatic,insufficiency'
p10608
g3
sS'this,setting,cardioselective'
p10609
g3
sS'x,kg,and'
p10610
g3
sS'inhibited,insp,induced'
p10611
g9
sS'if,a,mg'
p10612
g9
sS'appears,to,increase'
p10613
g9
sS'about,when,mesylate'
p10614
g9
sS'for,days,resulted'
p10615
g9
sS'antagonist,effect,should'
p10616
g3
sS'transient,increase,in'
p10617
g3
sS'with,ventricular,fibrillation'
p10618
g9
sS'vitro,finding,that'
p10619
g3
sS'least,hours,following'
p10620
g9
sS'm,v,cmc-cys7'
p10621
g3
sS'g,resulted,in'
p10622
g9
sS'be,abnormal,in'
p10623
g3
sS'rifampin,increases,the'
p10624
g9
sS'minimally,absorbed,into'
p10625
g9
sS'literature,revealed,that'
p10626
g9
sS'on,the,sa'
p10627
g3
sS'be,a,result'
p10628
g3
sS'day,preferably,the'
p10629
g3
sS'lotensin,can,attenuate'
p10630
g9
sS'h2-receptor,antagonists,appear'
p10631
g3
sS'analgesic,actions,are'
p10632
g3
sS'major,metabolite,are'
p10633
g3
sS'oral,administration,of'
p10634
g3
sS'administered,neonatally,to'
p10635
g3
sS'when,concomitant,administration'
p10636
g9
sS'toxicity,may,occur'
p10637
g9
sS'mg,three,mg'
p10638
g9
sS'chapter,including,persistent'
p10639
g3
sS'may,interact,with'
p10640
g9
sS'may,provoke,vasoconstriction'
p10641
g9
sS'in,other,cases'
p10642
g3
sS'during,coadministration,can'
p10643
g9
sS'single,dose,study'
p10644
g9
sS'cercarial,encystment,at'
p10645
g3
sS'secondary,enzymes,respectively'
p10646
g9
sS'in,the,control'
p10647
g3
sS'metabolism,and,may'
p10648
g3
sS'lectin,and,that'
p10649
g3
sS'range,in,patients'
p10650
g9
sS'the,anxiogenic,effects'
p10651
g9
sS'in,the,committed'
p10652
g9
sS'of,relapses,for'
p10653
g3
sS'also,occur,in'
p10654
g3
sS'good,with,few'
p10655
g3
sS'which,inhibit,this'
p10656
g3
sS'by,peptidase,and'
p10657
g3
sS'toward,a,more'
p10658
g3
sS'close,monitoring,for'
p10659
g9
sS'define,the,possible'
p10660
g3
sS'subsequent,courses,of'
p10661
g3
sS'clinical,and,paraclinical'
p10662
g3
sS'the,starting,dose'
p10663
g3
sS'medications,applied,to'
p10664
g3
sS'sole,method,of'
p10665
g9
sS'for,realization,of'
p10666
g3
sS'the,parameters,and'
p10667
g3
sS'twice,a,day'
p10668
g3
sS'nsaids,has,been'
p10669
g9
sS'investigated,simulect,use'
p10670
g3
sS'triazolam,erythromycin,has'
p10671
g9
sS'growth,factor,treatment'
p10672
g3
sS'of,in,nonfailing'
p10673
g9
sS'phenobarbital,amphetamines,may'
p10674
g9
sS'histamine,h2-receptor,antagonists'
p10675
g3
sS'buforin,ii,showed'
p10676
g3
sS'are,weak,inhibitors'
p10677
g3
sS'for,n,and'
p10678
g9
sS'pharmaceuticals,inc,demonstrated'
p10679
g9
sS'tricyclic,with,that'
p10680
g3
sS'the,hypotension,seen'
p10681
g9
sS'problems,in,the'
p10682
g3
sS'on,long-term,therapy'
p10683
g9
sS'inhibited,by,mug'
p10684
g3
sS'week,endoscopy,study'
p10685
g3
sS'interfere,with,enzymatic-based'
p10686
g3
sS'oral,may,be'
p10687
g9
sS'for,more,inhalations'
p10688
g3
sS'renal,elimination,but'
p10689
g9
sS'higher,and,in'
p10690
g3
sS'two,hundred,mg'
p10691
g3
sS'monotherapy,for,at'
p10692
g3
sS'the,high,acquisition'
p10693
g3
sS'more,frequent,for'
p10694
g3
sS'clearance,this,interaction'
p10695
g3
sS'palytoxin-induced,contraction,and'
p10696
g3
sS'cmax,is,also'
p10697
g3
sS'given,after,than'
p10698
g9
sS'in,and,there'
p10699
g3
sS'cause,an,excessive'
p10700
g3
sS'macrolide,antibiotics,such'
p10701
g9
sS'exposure,tonevirapine,caution'
p10702
g3
sS'moreover,the,acquisition'
p10703
g3
sS'most,commonly,involved'
p10704
g3
sS'the,intensity,uniformity'
p10705
g3
sS'of,amevive,on'
p10706
g3
sS'transcriptional,regulation,of'
p10707
g3
sS'the,aucasian,population'
p10708
g3
sS'action,of,suggested'
p10709
g3
sS'contrary,and,were'
p10710
g9
sS'with,vaprisol,the'
p10711
g9
sS'medicines,or,another'
p10712
g9
sS'i,acute,pharmacological'
p10713
g3
sS'and,any,other'
p10714
g3
sS'schizophrenia,and,in'
p10715
g3
sS'gradual,dose,increases'
p10716
g3
sS'and,cytoplasmic,condensation'
p10717
g3
sS'of,radiolabeled,ions'
p10718
g3
sS'at,baseline,to'
p10719
g3
sS'glutamatergic,activation,of'
p10720
g3
sS'result,in,reduced'
p10721
g9
sS'magnitude,of,changes'
p10722
g9
sS'patients,receiving,increased'
p10723
g3
sS'and,or,drug'
p10724
g3
sS'in,pharmacokinetics,produced'
p10725
g9
sS'but,these,actions'
p10726
g9
sS'the,bronchodilator,effect'
p10727
g3
sS'bezalip,retard,and'
p10728
g9
sS'be,of,major'
p10729
g9
sS'currently,receiving,cautious'
p10730
g9
sS'has,been,well'
p10731
g3
sS'careful,monitoring,of'
p10732
g9
sS'the,loss,of'
p10733
g9
sS'initial,dose,until'
p10734
g9
sS'costs,despite,the'
p10735
g3
sS'mellitus,ischemic,heart'
p10736
g3
sS'at,steady-state,exposure'
p10737
g3
sS'longterm,treatment,of'
p10738
g3
sS'neither,nor,appears'
p10739
g3
sS'preparations,may,potentiate'
p10740
g9
sS'about,fold,in'
p10741
g9
sS'may,be,no'
p10742
g3
sS'evidenced,by,a'
p10743
g9
sS'indicates,deterioration,of'
p10744
g3
sS'glucose,levels,in'
p10745
g3
sS'between,january,and'
p10746
g3
sS'phosphokinase,diffuse,muscle'
p10747
g3
sS'blood,thinners,decongestant'
p10748
g9
sS'example,complications,of'
p10749
g3
sS'the,alveoli,of'
p10750
g3
sS'principally,metabolized,by'
p10751
g3
sS'c9,decreased,active'
p10752
g9
sS'of,blocking,cardiac'
p10753
g9
sS'by,the,ganglionic-blocking'
p10754
g9
sS'rates,of,patients'
p10755
g3
sS'taxol,contains,dehydrated'
p10756
g3
sS'those,aspects,that'
p10757
g3
sS'recommended,maximum,human'
p10758
g9
sS'mono-oxidases,in,the'
p10759
g3
sS'a,mg,dose'
p10760
g3
sS'following,administration,decreased'
p10761
g9
sS'and,commit,to'
p10762
g3
sS'behavioral,changes,northern'
p10763
g3
sS'bleeding,from,a'
p10764
g3
sS'and,cmax,and'
p10765
g3
sS'both,species,nanm'
p10766
g9
sS'and,volume,of'
p10767
g9
sS'a,systemic,exposure'
p10768
g3
sS'of,the,pathogenic'
p10769
g3
sS'first,few,days'
p10770
g9
sS'studies,of,indicate'
p10771
g3
sS'beverages,is,enhanced'
p10772
g9
sS'concomitantly,with,cyp1a2'
p10773
g9
sS'and,until,blood'
p10774
g3
sS'coadministered,with,on'
p10775
g9
sS'studies,with,proscar'
p10776
g3
sS'blockers,and,nonsteroidal'
p10777
g3
sS'immunodepressant--the,sandimmune--on,hepatic'
p10778
g3
sS'postoperative,pain,without'
p10779
g3
sS'in,female,fertility'
p10780
g3
sS'clearance,of,both'
p10781
g9
sS'co-administration,of,another'
p10782
g3
sS'in,four,subjects'
p10783
g3
sS'concomitantly,with,dilaudid'
p10784
g9
sS'a,cyp2c9,substrate'
p10785
g9
sS'properties,and,the'
p10786
g9
sS'of,and,usually'
p10787
g9
sS'of,cause,are'
p10788
g3
sS'and,endogenous,and'
p10789
g3
sS'does,it,interfere'
p10790
g3
sS'use,with,caution'
p10791
g3
sS'of,the,nephrotoxicity'
p10792
g3
sS'research,center,inventory'
p10793
g3
sS'of,psychotropic,that'
p10794
g9
sS'oral,increased,about'
p10795
g3
sS'cmax,of,when'
p10796
g3
sS'nerve,vacuolation,were'
p10797
g3
sS'with,renal,insufficiency'
p10798
g3
sS'of,excretion,of'
p10799
g9
sS'virus,vaccine,inhalation'
p10800
g9
sS'medications,that,can'
p10801
g9
sS'europe,nimotop,was'
p10802
g9
sS'considered,for,patients'
p10803
g9
sS'a,slight,reduction'
p10804
g9
sS'means,of,hydroxytolbutamide'
p10805
g3
sS'intolerance,and,those'
p10806
g3
sS'free,had,no'
p10807
g3
sS'a,pharmacokinetic,substudy'
p10808
g9
sS'aeds,were,assessed'
p10809
g3
sS'extensor,tension,hoof'
p10810
g3
sS'for,serious,interactions'
p10811
g9
sS'of,drugs,in'
p10812
g3
sS'cyp,a4,macrolide'
p10813
g9
sS'toxicology,of,difluoroacetone'
p10814
g3
sS'of,the,human'
p10815
g3
sS'were,systematically,investigated'
p10816
g3
sS'chronic,experiments,on'
p10817
g3
sS'either,initiated,or'
p10818
g3
sS'lymphocytes,either,in'
p10819
g3
sS'the,influence,of'
p10820
g3
sS'showed,the,flavonoids'
p10821
g3
sS'patients,the,recommended'
p10822
g3
sS'mg,day,during'
p10823
g9
sS'of,the,primary'
p10824
g3
sS'are,taking,a'
p10825
g3
sS'cmax,and,decreases'
p10826
g3
sS'these,are,unchanged'
p10827
g3
sS'clearance,value,is'
p10828
g3
sS'become,abruptly,toxic'
p10829
g3
sS'and,collagen-induced,platelet'
p10830
g3
sS'separating,the,doses'
p10831
g9
sS'as,judged,by'
p10832
g3
sS'digoxin,in,subjects'
p10833
g3
sS'the,primary,elimination'
p10834
g9
sS'treatment,produced,either'
p10835
g3
sS'a,common,phenotypic'
p10836
g3
sS'receive,initial,doses'
p10837
g9
sS'of,ras,during'
p10838
g3
sS'bred,control,rbc'
p10839
g3
sS'that,inhibit,aldehyde'
p10840
g3
sS'synthesis,in,the'
p10841
g3
sS'healthy,volunteers,in'
p10842
g9
sS'monitoring,or,treatment'
p10843
g3
sS'units,with,careful'
p10844
g3
sS'noted,that,these'
p10845
g3
sS'has,been,filtrated'
p10846
g9
sS'enhanced,when,it'
p10847
g3
sS'also,indicated,the'
p10848
g3
sS'laboratory,test,in'
p10849
g3
sS'high,concentrations,ic50'
p10850
g3
sS'of,and,hydrochloride'
p10851
g3
sS'such,as,from'
p10852
g9
sS'day,showed,an'
p10853
g9
sS'when,baraclude,is'
p10854
g3
sS'who,are,applying'
p10855
g9
sS'patients,given,very'
p10856
g9
sS'to,a,direct'
p10857
g9
sS'free,t3,uptake'
p10858
g3
sS'cells,was,found'
p10859
g3
sS'is,primarily,metabolized'
p10860
g3
sS'for,and,and'
p10861
g3
sS'hydrochlorothiazide,in,normal'
p10862
g9
sS'report,describes,two'
p10863
g9
sS'or,used,during'
p10864
g3
sS'study,of,normal'
p10865
g9
sS're-treated,with,subsequent'
p10866
g3
sS'the,dose,will'
p10867
g9
sS'possibility,of,arrhythmias'
p10868
g3
sS'variations,in,rabbits'
p10869
g3
sS'complex,effect,on'
p10870
g9
sS'psychoactive,or,cns'
p10871
g9
sS'mhd,induce,a'
p10872
g3
sS'non-depolarizing,muscle,relaxants'
p10873
g9
sS'a,higher,occurrence'
p10874
g9
sS'nonsteroidal,anti-inflammatory,drugs'
p10875
g9
sS'of,induced,hypotension'
p10876
g3
sS'contemplated,the,dose'
p10877
g3
sS'tnf,blocking,agents'
p10878
g3
sS'no,clinically,important'
p10879
g3
sS'insulin-induced,proliferation,of'
p10880
g9
sS'poor,absorption,excessive'
p10881
g3
sS'are,taken,on'
p10882
g9
sS'these,models,are'
p10883
g3
sS'paperhanging,playing,golf'
p10884
g3
sS'has,little,or'
p10885
g9
sS'frequently,thereafter,and'
p10886
g9
sS'about,and,levels'
p10887
g9
sS'whose,metabolism,is'
p10888
g3
sS'agents,with,alphagan'
p10889
g9
sS'compounds,have,not'
p10890
g3
sS'data,showed,that'
p10891
g3
sS'should,focus,on'
p10892
g3
sS'and,mc,decrease'
p10893
g3
sS'that,and,have'
p10894
g3
sS'rather,than,dose'
p10895
g3
sS'inhibitors,calcium-channel,blockers'
p10896
g3
sS'it,is,extensively'
p10897
g3
sS'derivatives,and,platelet'
p10898
g9
sS'that,keppra,is'
p10899
g3
sS'as,directed,by'
p10900
g3
sS'dose-proportional,stable,exposure'
p10901
g3
sS'leading,to,possible'
p10902
g9
sS'work,exists,in'
p10903
g3
sS'plasma,protein-bound,with'
p10904
g9
sS'agent,or,incompletely'
p10905
g3
sS'in,platelet,count'
p10906
g3
sS'probe,study,did'
p10907
g3
sS'inhalational,such,as'
p10908
g9
sS'magnesium-containing,concomitant,administration'
p10909
g9
sS'enzyme-inducer,did,indeed'
p10910
g9
sS'alpha,and,beta'
p10911
g3
sS'various,combinations,of'
p10912
g3
sS'does,not,inhibit'
p10913
g3
sS'biocytin,with,opioid-evoked'
p10914
g3
sS'in,additive,cns'
p10915
g9
sS'when,starting,or'
p10916
g3
sS'these,studies,do'
p10917
g9
sS'similar,agents,and'
p10918
g9
sS'of,fat-soluble,including'
p10919
g9
sS'events,and,the'
p10920
g3
sS'not,limited,to'
p10921
g9
sS'risk,of,theophylline-related'
p10922
g3
sS'has,benefits,against'
p10923
g3
sS'intravenous,at,mg'
p10924
g3
sS'category,x,use'
p10925
g3
sS'the,adverse,reaction'
p10926
g3
sS'presence,of,therapeutic'
p10927
g3
sS'with,long-term,high-dose'
p10928
g9
sS'flurbiprofen,did,not'
p10929
g9
sS'activity,would,be'
p10930
g3
sS'with,copd,should'
p10931
g3
sS'increased,thioether,excretion'
p10932
g3
sS'medications,used,in'
p10933
g3
sS'of,orally,ingested'
p10934
g3
sS'benzodiazepines,gi,motility'
p10935
g3
sS'sudden,extrusion,of'
p10936
g3
sS'cmc-cys7,a,significantly'
p10937
g3
sS'compared,to,deaths'
p10938
g3
sS'these,findings,has'
p10939
g3
sS'propoxyphene,the,concurrent'
p10940
g3
sS'decrease,renal,tubular'
p10941
g9
sS'beta-adrenergic,blocking,agent'
p10942
g9
sS'with,propranolols,hypotensive'
p10943
g9
sS'showed,anxiogenic,effects'
p10944
g3
sS'vitro,experiments,demonstrated'
p10945
g3
sS'a,maneuver,often'
p10946
g3
sS'sodium,plasma,levels'
p10947
g9
sS'daily,given,hours'
p10948
g9
sS'than,might,be'
p10949
g9
sS'discussed,in,reference'
p10950
g3
sS'the,modulatory,effect'
p10951
g3
sS'in,vitro,excystment'
p10952
g3
sS'should,not,cause'
p10953
g3
sS'serotonin,reuptake,inhibitor'
p10954
g9
sS'thereby,decreasing,the'
p10955
g9
sS'titration,of,their'
p10956
g9
sS'suggest,a,higher'
p10957
g9
sS'collapse,in,association'
p10958
g3
sS'for,such,interaction'
p10959
g3
sS'as,binding,of'
p10960
g3
sS'the,toxic,metabolites'
p10961
g3
sS'cyp2c8,c9,c19'
p10962
g3
sS'or,low-dose,microg'
p10963
g9
sS'in,a,total'
p10964
g3
sS'rabbits,backwards,displacement'
p10965
g3
sS'use,with,activase'
p10966
g3
sS'or,urine,which'
p10967
g3
sS'serotonergic,agents,should'
p10968
g9
sS'responses,to,acth'
p10969
g3
sS'predominantly,cyp,a4'
p10970
g3
sS'of,unsteady,gait'
p10971
g9
sS'severe,reaction,on'
p10972
g3
sS'doubling,of,the'
p10973
g9
sS'weakness,lethargy,drowsiness'
p10974
g3
sS'values,it,has'
p10975
g3
sS'with,all,in'
p10976
g3
sS'time,inr,at'
p10977
g3
sS'increased,initially,and'
p10978
g3
sS'between,and,with'
p10979
g9
sS'information,on,precautions'
p10980
g3
sS'results,from,a'
p10981
g3
sS'other,cyp3a4,metabolized'
p10982
g9
sS'design,open-label,three-phase'
p10983
g3
sS'administration,of,vistide'
p10984
g9
sS'discontinued,because,of'
p10985
g3
sS'overdosage,since,the'
p10986
g9
sS'the,maximum,concentration'
p10987
g3
sS'the,aptt,such'
p10988
g3
sS'for,clindamycin-sensitive,isolates'
p10989
g3
sS'of,efficacy,the'
p10990
g3
sS'require,reduction,in'
p10991
g3
sS'day,approximately,one-thousandth'
p10992
g3
sS'treated,with,one'
p10993
g9
sS'drug,interactions,no'
p10994
g3
sS'its,n-demethylated,metabolite'
p10995
g3
sS'of,mg,both'
p10996
g3
sS'as,cns,cardiac'
p10997
g3
sS'for,studying,of'
p10998
g3
sS'observed,in,patients'
p10999
g3
sS'starlix,is,predominantly'
p11000
g3
sS'nonsteroidal,agents,nsaids'
p11001
g9
sS'vaginal,preparations,of'
p11002
g3
sS'small,differences,in'
p11003
g3
sS'or,on,plasma'
p11004
g3
sS'and,what,to'
p11005
g3
sS'delayed,and,their'
p11006
g9
sS'recommended,when,initiating'
p11007
g9
sS'cardioactive,drugs,such'
p11008
g3
sS'chloramphenicol,has,been'
p11009
g9
sS'change,in,clotting'
p11010
g3
sS'appear,to,share'
p11011
g3
sS'concurrently,and,evidence'
p11012
g9
sS'receiving,or,monoamine'
p11013
g9
sS'anafranil,should,not'
p11014
g9
sS'combination,with,mg'
p11015
g3
sS'of,this,enzyme'
p11016
g9
sS'following,methyl-4,phenyl-1'
p11017
g3
sS'antithyroid,agents,medicine'
p11018
g3
sS'closely,monitor,cardiovascular'
p11019
g3
sS'of,a,pharmacodynamic'
p11020
g9
sS'would,affect,this'
p11021
g3
sS'to,enhanced,drug'
p11022
g3
sS'other,drugs,to'
p11023
g3
sS'one,or,more'
p11024
g3
sS'supporting,the,conclusion'
p11025
g9
sS'of,dependence,may'
p11026
g3
sS'in,the,ames'
p11027
g3
sS'inhibitors,of,endogenous'
p11028
g9
sS'serum,levels,the'
p11029
g9
sS'and,have,the'
p11030
g9
sS'taking,beta,adrenergic'
p11031
g9
sS'with,elspar,or'
p11032
g9
sS'development,was,observed'
p11033
g3
sS'by,certain,including'
p11034
g9
sS'antiepileptic,drugs,sporadic'
p11035
g9
sS'in,increased,cns'
p11036
g9
sS'release,but,not'
p11037
g9
sS'altered,it,is'
p11038
g3
sS'these,two,drugs'
p11039
g9
sS'or,avoided,also'
p11040
g9
sS'have,not,demonstrated'
p11041
g3
sS'other,signs,of'
p11042
g3
sS'emulsion,model,in'
p11043
g3
sS'the,str,or'
p11044
g3
sS'kg,hours,apart'
p11045
g9
sS'the,principles,of'
p11046
g3
sS'can,give,rise'
p11047
g9
sS'for,hours,before'
p11048
g3
sS'vacuolation,were,seen'
p11049
g3
sS'longer,latencies,to'
p11050
g3
sS'corrective,measures,to'
p11051
g3
sS'of,virologic,response'
p11052
g3
sS'of,prolongation,of'
p11053
g9
sS'precipitated,by,similar'
p11054
g3
sS'especially,when,the'
p11055
g9
sS'fertility,have,not'
p11056
g3
sS'the,differences,in'
p11057
g3
sS'necessitated,changes,in'
p11058
g9
sS'of,and,for'
p11059
g3
sS'similar,conditions,concentrations'
p11060
g3
sS'increase,when,atromid-s'
p11061
g9
sS'such,as,might'
p11062
g9
sS'compounds,interfere,with'
p11063
g3
sS'prolonged,sodation,of'
p11064
g9
sS'drug-drug,interactions,cimetidine'
p11065
g3
sS'that,suppress,the'
p11066
g3
sS'to,share,a'
p11067
g3
sS'b23,antisense,oligomer'
p11068
g3
sS'and,its,metabolite'
p11069
g3
sS'clinical,pharmacology-pharmacokinetics,drug-drug'
p11070
g3
sS'of,male,animals'
p11071
g3
sS'steps,physicians,can'
p11072
g3
sS'such,as,antineoplastic'
p11073
g9
sS'for,volatile,inhalation'
p11074
g9
sS'the,known,relationships'
p11075
g3
sS'the,two,were'
p11076
g9
sS'of,patients,transient'
p11077
g3
sS'adjustment,for,is'
p11078
g3
sS'using,stadol,ns'
p11079
g3
sS'have,been,identified'
p11080
g9
sS'elimination,half,life'
p11081
g9
sS'or,decrease,plasma'
p11082
g9
sS'patients,is,limited'
p11083
g9
sS'and,the,following'
p11084
g3
sS'decreases,clearance,by'
p11085
g9
sS'coagulation,time,within'
p11086
g9
sS'by,the,kidneys'
p11087
g3
sS'toxicity,of,is'
p11088
g9
sS'test,monitoring,during'
p11089
g3
sS'such,cases,of'
p11090
g3
sS'studied,in,six'
p11091
g3
sS'to,the,mucosal'
p11092
g3
sS'activated,in,patients'
p11093
g9
sS'mg,of,as'
p11094
g3
sS'valdecoxib,mg,bid'
p11095
g3
sS'antidiabetics,because,may'
p11096
g9
sS'arise,from,co-administration'
p11097
g9
sS'additional,that,should'
p11098
g9
sS'while,those,of'
p11099
g9
sS'with,supplements,may'
p11100
g3
sS'deficiencies,by,simply'
p11101
g3
sS'of,the,qrs'
p11102
g9
sS'pivoxil,had,no'
p11103
g3
sS'enzyme,inhibitors,concomitantly'
p11104
g3
sS'these,are,incompatible'
p11105
g3
sS'virtually,complete,across'
p11106
g3
sS'studies,indicate,that'
p11107
g3
sS'p2,however,was'
p11108
g3
sS'occur,when,is'
p11109
g3
sS'aucs,m,min'
p11110
g9
sS'and,a,concomitantly'
p11111
g9
sS'effects,in,patients'
p11112
g9
sS'concomitant,therapies,in'
p11113
g3
sS'and,an,in'
p11114
g3
sS'still,significant,degree'
p11115
g3
sS'urgently,to,be'
p11116
g3
sS'receptors,sodium,channels'
p11117
g3
sS'clinical,drug-drug,interaction'
p11118
g3
sS'by,non-steroidal,antiinflammatory'
p11119
g9
sS'treatment,with,imidazole'
p11120
g9
sS'not,to,use'
p11121
g3
sS'interactions,the,pharmacokinetic'
p11122
g3
sS'number,of,blood'
p11123
g9
sS'vitro,at,clinically'
p11124
g3
sS'agents,may,alter'
p11125
g3
sS'decreased,by,when'
p11126
g9
sS'phenurone,since,paranoid'
p11127
g9
sS'days,oral,administration'
p11128
g3
sS'experiences,are,related'
p11129
g3
sS'between,and,acetylsalicylic'
p11130
g3
sS'cell,membrane,was'
p11131
g3
sS'declining,to,about'
p11132
g3
sS'c,pegasys,has'
p11133
g3
sS'given,to,temporarily'
p11134
g9
sS'several,but,not'
p11135
g3
sS'no,other,specific'
p11136
g3
sS'dose,studies,in'
p11137
g9
sS'blocking,agent,and'
p11138
g9
sS'prior,to,and'
p11139
g3
sS'of,on,resistance'
p11140
g3
sS'an,approximately,increase'
p11141
g9
sS'metabolism,and,higher'
p11142
g9
sS'arthritis,patients,taking'
p11143
g3
sS'and,the,reductions'
p11144
g3
sS'third,of,the'
p11145
g9
sS'disease,are,frequently'
p11146
g3
sS'hepatotoxic,drugs,increased'
p11147
g3
sS'in,serum,reverse'
p11148
g3
sS'prior,to,any'
p11149
g3
sS'depen,cuprimine,another'
p11150
g9
sS'h2,blockers,or'
p11151
g9
sS'by,serial,broth'
p11152
g3
sS'doses,greater,than'
p11153
g3
sS'with,nonsteroidal,agents'
p11154
g9
sS'agonists,compared,with'
p11155
g3
sS'unaffected,by,adl'
p11156
g3
sS'adjustment,or,special'
p11157
g3
sS'of,cyp,d6'
p11158
g3
sS'therefore,caution,is'
p11159
g3
sS'conjugated,dienes,approximately'
p11160
g3
sS'azole,antifungal,agents'
p11161
g9
sS'pharmacodynamic,effects,prothrombin'
p11162
g9
sS'of,cancidas,are'
p11163
g3
sS'may,produce,an'
p11164
g9
sS'interaction,of,and'
p11165
g9
sS'dose,decrease,for'
p11166
g9
sS'support,its,use'
p11167
g3
sS'family,in,metabolism'
p11168
g9
sS'the,q-t,interval'
p11169
g3
sS'the,full,duration'
p11170
g3
sS'administration,of,a'
p11171
g9
sS'administration,of,g'
p11172
g9
sS'robinul,injection,with'
p11173
g9
sS'caution,and,the'
p11174
g3
sS'is,approximately,minutes'
p11175
g9
sS'effects,especially,conduction'
p11176
g3
sS'attributed,at,least'
p11177
g9
sS'the,hazards,of'
p11178
g3
sS'rettgeri,were,resistant'
p11179
g3
sS'm,m,resulted'
p11180
g3
sS'any,known,cyp3a4'
p11181
g9
sS'attenuates,certain,types'
p11182
g9
sS'with,the,evening'
p11183
g3
sS'to,moderate,hypertension'
p11184
g9
sS'received,muscle,relaxants'
p11185
g9
sS'cyp2d6,resulted,in'
p11186
g9
sS'it,was,found'
p11187
g9
sS'in,treatment,practices'
p11188
g3
sS'therapy,is,initiated'
p11189
g9
sS'cyp2c8,in,vitro'
p11190
g3
sS'logs,of,reduction'
p11191
g3
sS'methods,clinical,studies'
p11192
g3
sS'possibility,of,altered'
p11193
g3
sS'are,also,discussed'
p11194
g3
sS'coadministration,n,of'
p11195
g9
sS'beyond,the,therapeutic'
p11196
g9
sS'indicated,by,its'
p11197
g9
sS'with,other,coadministered'
p11198
g9
sS'reduction,in,dose'
p11199
g9
sS'absorption,of,oral'
p11200
g9
sS'also,an,inducer'
p11201
g3
sS'mean,change,of'
p11202
g9
sS'blood,glucose,measurement'
p11203
g3
sS'because,renal,excretion'
p11204
g9
sS'containing,sequential,high'
p11205
g9
sS'by,to,but'
p11206
g3
sS'general,no,clinical'
p11207
g3
sS'factor,assays,based'
p11208
g3
sS'were,increased,about'
p11209
g9
sS'a,combined,transcriptional'
p11210
g3
sS'psychotropic,medications,and'
p11211
g9
sS'drug,exposure,in'
p11212
g3
sS'acid,paba,containing'
p11213
g9
sS'no,apparent,increase'
p11214
g3
sS'patients,with,parkinson'
p11215
g3
sS'patients,with,hypokalemia'
p11216
g3
sS'to,p450-based,metabolic'
p11217
g3
sS'markedly,inhibit,the'
p11218
g9
sS'undergo,renal,tubular'
p11219
g3
sS'or,or,other'
p11220
g9
sS'for,kappa,and'
p11221
g3
sS'metabolized,the,coadministration'
p11222
g3
sS'purinethol,or,imuran'
p11223
g9
sS'concentrations,at,the'
p11224
g3
sS'risk,of,hyperkalemia'
p11225
g9
sS'tests,benedicts,solution'
p11226
g3
sS'effects,on,other'
p11227
g3
sS'l-type,omega-conotoxin,gvia'
p11228
g3
sS'receiving,or,should'
p11229
g3
sS'of,which,are'
p11230
g9
sS'produce,serious,arrhythmias'
p11231
g3
sS'care,professionals,be'
p11232
g3
sS'growing,problem,not'
p11233
g3
sS'to,or,slightly'
p11234
g9
sS'of,distribution,was'
p11235
g3
sS'and,mg,separated'
p11236
g9
sS'therapeutic,doses,had'
p11237
g9
sS'with,a,number'
p11238
g9
sS'pharmacokinetic,and,pharmacodynamic'
p11239
g3
sS'any,pharmacokinetic,interactions'
p11240
g3
sS'when,and,are'
p11241
g9
sS'of,these,differences'
p11242
g3
sS'depressants,or,inhibitors'
p11243
g9
sS'increase,in,fdf'
p11244
g9
sS'blood,pressure,control'
p11245
g3
sS'which,suggested,that'
p11246
g3
sS'their,selective,ca'
p11247
g3
sS'taken,in,patients'
p11248
g3
sS'no,clinical,experience'
p11249
g3
sS'mg,capsule,with'
p11250
g9
sS'to,be,less'
p11251
g3
sS'the,best,adaptive'
p11252
g3
sS'instances,has,to'
p11253
g3
sS'check,serum,levels'
p11254
g3
sS'additional,that,are'
p11255
g3
sS'slowly,dissolving,dosage'
p11256
g9
sS'only,as,directed'
p11257
g3
sS'effects,of,antacids'
p11258
g3
sS'serum,proteins,the'
p11259
g9
sS'taking,and,concomitantly'
p11260
g9
sS'the,onset,of'
p11261
g3
sS'patients,before,the'
p11262
g3
sS'catabolic,enzymes,of'
p11263
g9
sS'function,and,the'
p11264
g3
sS'in,renal,blood'
p11265
g3
sS'an,with,beta-lactamtype'
p11266
g9
sS'in,ephesus,patients'
p11267
g3
sS'i,sodium,pertechnetate'
p11268
g3
sS'p450,enzymes,cyp1a2'
p11269
g3
sS'after,administration,of'
p11270
g3
sS'vitro,studies,have'
p11271
g3
sS'channel,antagonists,a'
p11272
g3
sS'receiving,treatment,for'
p11273
g3
sS'cecectomized,and,in'
p11274
g3
sS'dexamethasone,had,a'
p11275
g3
sS'therapy,who,have'
p11276
g9
sS'which,includes,anafranil'
p11277
g3
sS'other,tnfa-blocking,agents'
p11278
g9
sS'two,different,medicines'
p11279
g3
sS'studies,have,shown'
p11280
g3
sS'intrathecal,on,the'
p11281
g3
sS'days,with,the'
p11282
g9
sS'cmax,and,auc'
p11283
g9
sS'the,mptp-induced,neuronal'
p11284
g9
sS'intake,approximately,one'
p11285
g9
sS'been,studied,increased'
p11286
g9
sS'felbatol,at,steady'
p11287
g9
sS'by,increasing,metal'
p11288
g3
sS'of,ergomar,and'
p11289
g9
sS'of,convulsions,occurring'
p11290
g3
sS'volunteers,treatment,potentiated'
p11291
g9
sS'to,model,the'
p11292
g3
sS'the,ingested,being'
p11293
g9
sS'report,describes,a'
p11294
g9
sS'concomitant,strong,inhibitors'
p11295
g3
sS'system,derived,from'
p11296
g3
sS'a,controlled,study'
p11297
g9
sS'although,the,pattern'
p11298
g3
sS'mg,oral,twice'
p11299
g9
sS'combination,with,humira'
p11300
g3
sS'infusion,pumps,for'
p11301
g3
sS'of,m,or'
p11302
g9
sS'alternative,therapeutic,agents'
p11303
g3
sS'the,metabolism,may'
p11304
g3
sS'inhibitor,talk,to'
p11305
g3
sS'of,tarceva,should'
p11306
g3
sS'decreased,renal,function'
p11307
g3
sS'co-administration,of,trileptal'
p11308
g9
sS'it,had,no'
p11309
g9
sS'therefore,dose,adjustments'
p11310
g3
sS'following,the,concomitant'
p11311
g3
sS'aberrant,and,chronic'
p11312
g3
sS'determine,its,capacity'
p11313
g3
sS'pharmacist,before,taking'
p11314
g3
sS'metabolism,of,warfarin-type'
p11315
g9
sS'relationship,between,folic'
p11316
g3
sS'evidence,of,interactions'
p11317
g3
sS'serum,levels,have'
p11318
g9
sS'interactions,oral,contraceptives'
p11319
g3
sS'combination,with,may'
p11320
g9
sS'immune,function,in'
p11321
g3
sS'conduction,disturbance,rarely'
p11322
g9
sS'patients,receiving,a'
p11323
g3
sS'of,should,be'
p11324
g3
sS'possible,effects,deriving'
p11325
g3
sS'and,anxiety,during'
p11326
g3
sS'c,or,calmodulin'
p11327
g3
sS'patients,without,a'
p11328
g9
sS'serum,pregnancy,tests'
p11329
g3
sS'with,demonstrated,efficacy'
p11330
g3
sS'recommended,when,used'
p11331
g9
sS'reduced,activity,against'
p11332
g3
sS'nervous,system,that'
p11333
g3
sS'enhancement,of,growth'
p11334
g3
sS'the,appropriate,package'
p11335
g3
sS'changes,in,desloratadine'
p11336
g3
sS'of,hoof,twitch'
p11337
g9
sS'of,consciousness,when'
p11338
g9
sS'in,clearance,when'
p11339
g9
sS'therefore,when,using'
p11340
g9
sS'with,in,all'
p11341
g3
sS'platelet,aggregation,in'
p11342
g3
sS'including,certain,tcas'
p11343
g9
sS'pregnancy,only,if'
p11344
g3
sS'complications,that,occurred'
p11345
g3
sS'including,eye,drops'
p11346
g3
sS'is,no,effect'
p11347
g9
sS'such,data,are'
p11348
g3
sS'cyp3a4,pathway,showed'
p11349
g9
sS'suggest,that,exogenous'
p11350
g3
sS'loop,potassium-,sparing'
p11351
g9
sS'cardiac,dysrhythmias,and'
p11352
g9
sS'both,lower,blood'
p11353
g9
sS'required,and,increased'
p11354
g3
sS'might,increase,the'
p11355
g9
sS'treat,aggressively,is'
p11356
g3
sS'our,understanding,of'
p11357
g3
sS'effects,of,veratrum'
p11358
g9
sS'hepatic,cytochrome,p-'
p11359
g3
sS'regardless,of,whether'
p11360
g9
sS'of,norfloxacin,in'
p11361
g9
sS'and,for,hydroxy-iso'
p11362
g9
sS'by,those,enzymes'
p11363
g3
sS'tool,for,diagnosis'
p11364
g3
sS'the,profile,of'
p11365
g3
sS'produced,no,pharmacokinetic'
p11366
g3
sS'levels,following,administration'
p11367
g3
sS'studies,of,patients'
p11368
g9
sS'cycle,irregularities,were'
p11369
g3
sS'viracept,and,should'
p11370
g9
sS'hypotension,bradycardia,and'
p11371
g3
sS'for,free,cmin'
p11372
g3
sS'be,observed,to'
p11373
g9
sS'the,tolerability,of'
p11374
g3
sS'other,drugs,on'
p11375
g3
sS'listed,in,clinical'
p11376
g3
sS'of,metabolic,abnormalities'
p11377
g3
sS'c9,c19,and'
p11378
g3
sS'no,inhibitory,or'
p11379
g3
sS'exercised,when,administering'
p11380
g9
sS'a,recent,study'
p11381
g9
sS'mimic,underdosage,myasthenic'
p11382
g3
sS'decrease,glutathione,levels'
p11383
g9
sS'concomitant,therapy,of'
p11384
g9
sS'assess,if,there'
p11385
g3
sS'component,of,the'
p11386
g9
sS'a,non-,steroidal'
p11387
g9
sS'the,possible,administration'
p11388
g3
sS'substudy,in,patients'
p11389
g9
sS'culture,and,animal'
p11390
g9
sS'enzymes,may,not'
p11391
g3
sS'or,mycophenolate,mofetil'
p11392
g3
sS'pretreatment,on,the'
p11393
g3
sS'effect,could,be'
p11394
g9
sS'all,three,agents'
p11395
g3
sS'produce,severe,bronchospasm'
p11396
g9
sS'after,dosing,at'
p11397
g3
sS'this,interaction,in'
p11398
g3
sS'xigris,present,in'
p11399
g3
sS'of,these,three'
p11400
g9
sS'rats,in,vivo'
p11401
g3
sS'propecia,mg,in'
p11402
g3
sS'least,squares,approach'
p11403
g3
sS'efficacy,over,use'
p11404
g9
sS'of,toradol,oral'
p11405
g9
sS'this,interaction,is'
p11406
g3
sS'with,and,a'
p11407
g3
sS'substitutes,containing,should'
p11408
g3
sS'events,or,loss'
p11409
g3
sS'or,toxicity,associated'
p11410
g3
sS'a,decreased,renal'
p11411
g9
sS'skin,exfoliation,necrosis'
p11412
g3
sS'that,the,extent'
p11413
g3
sS'romazicon,was,administered'
p11414
g3
sS'the,control,group'
p11415
g3
sS'determined,after,a'
p11416
g3
sS'subjects,given,single'
p11417
g9
sS'much,in,the'
p11418
g9
sS'digoxin,half-life,of'
p11419
g3
sS'or,to,discontinue'
p11420
g3
sS'and,therefore,potentially'
p11421
g9
sS'in,zaleplons,maximal'
p11422
g9
sS'exercised,with,these'
p11423
g3
sS'anticonvulsants,increase,the'
p11424
g9
sS'treatment,for,multiple'
p11425
g3
sS'plasma,levels,occurred'
p11426
g9
sS'and,vasoactive,resulting'
p11427
g9
sS'and,confusional,states'
p11428
g9
sS'auc,vs,cmax'
p11429
g3
sS'measures,included,self-reported'
p11430
g3
sS'salicylic,acid,combination'
p11431
g9
sS'an,acute,increase'
p11432
g3
sS'inhibition,induced,by'
p11433
g9
sS'starlix,the,patient'
p11434
g3
sS'intolerance,prior,to'
p11435
g3
sS'renal,insufficiency,are'
p11436
g3
sS'be,additive,effects'
p11437
g9
sS'and,clinical,monitoring'
p11438
g3
sS'commonly,used,such'
p11439
g3
sS'or,bind,the'
p11440
g9
sS'must,be,interrupted'
p11441
g3
sS'may,still,be'
p11442
g3
sS'with,which,may'
p11443
g3
sS'forms,of,fat-soluble'
p11444
g3
sS'concentration,or,activity'
p11445
g3
sS'iii,human,in'
p11446
g9
sS'excretion,but,is'
p11447
g9
sS'of,such,agents'
p11448
g3
sS'case,to,maintain'
p11449
g3
sS'administered,weekly,during'
p11450
g3
sS'for,the,development'
p11451
g3
sS'cardiac,dysrhythmias,of'
p11452
g9
sS'nerally,classified,as'
p11453
g3
sS'to,treatment,with'
p11454
g3
sS'invirase,and,are'
p11455
g3
sS'occurrence,has,not'
p11456
g9
sS'alcoholic,beverages,in'
p11457
g3
sS'to,avoid,bleeding'
p11458
g9
sS'interval,as,possible'
p11459
g3
sS'use,such,methods'
p11460
g3
sS'of,two,mg'
p11461
g3
sS'be,determined,prior'
p11462
g9
sS'effects,lower,blood'
p11463
g3
sS'modification,of,a'
p11464
g3
sS'and,decrease,mean'
p11465
g3
sS'kg,or,repeated'
p11466
g3
sS'were,studied,with'
p11467
g3
sS'not,significantly,metabolized'
p11468
g3
sS'in,of,those'
p11469
g3
sS'a,known,metabolite'
p11470
g3
sS'may,provoke,toxicity'
p11471
g3
sS'vardenafil,dose,in'
p11472
g9
sS'close,monitoring,of'
p11473
g9
sS'excluded,from,clinical'
p11474
g3
sS'co-therapy,an,increased'
p11475
g3
sS'of,the,mammary'
p11476
g3
sS'c-17,alkylated,such'
p11477
g3
sS'taken,into,account'
p11478
g3
sS'indicated,alternative,therapeutic'
p11479
g3
sS'serotonin,and,the'
p11480
g3
sS'be,administered,concomitantly'
p11481
g9
sS'laser,interferometric,measurement'
p11482
g3
sS'presentation,of,a'
p11483
g9
sS'diarrhea,model,is'
p11484
g3
sS'show,on-treatment,additive'
p11485
g3
sS'combination,of,amphotericin'
p11486
g9
sS'and,decreased,hearing'
p11487
g9
sS'double-blind,fashion,to'
p11488
g3
sS'towards,the,major'
p11489
g3
sS'glucose,blood,glucose'
p11490
g3
sS'no,data,that'
p11491
g3
sS'other,published,reports'
p11492
g9
sS'by,therapy,with'
p11493
g9
sS'fat,soluble,such'
p11494
g3
sS'and,products,with'
p11495
g3
sS'preliminary,whole-cell,tight'
p11496
g3
sS'a,higher,serum'
p11497
g9
sS'of,these,on'
p11498
g3
sS'coenzyme,a,hmgcoa'
p11499
g3
sS'and,twice-a,day'
p11500
g3
sS'taken,in,conjunction'
p11501
g3
sS'to,this,pharmacological'
p11502
g9
sS'antianxiety,agents,or'
p11503
g9
sS'of,these,or'
p11504
g3
sS'potentiation,of,warfarin-type'
p11505
g3
sS'enzyme,inducer,or'
p11506
g9
sS'inhibition,while,gallic'
p11507
g3
sS'and,selected,patient'
p11508
g3
sS'doubling,times,comparable'
p11509
g3
sS'although,the,pressor'
p11510
g3
sS'over,time,and'
p11511
g3
sS'block,angiotensin,ii'
p11512
g3
sS'the,enzymatic,oxidation'
p11513
g9
sS'of,parorchis,acanthus'
p11514
g3
sS'perspiration,weight,gain'
p11515
g3
sS'risk,of,precipitating'
p11516
g3
sS'orally,has,not'
p11517
g3
sS'be,increased,serum'
p11518
g3
sS'the,cardiovascular,system'
p11519
g9
sS'highly,bound,such'
p11520
g3
sS'gastroduodenal,ulcers,in'
p11521
g3
sS'main,results,blood'
p11522
g3
sS'it,is,unlikely'
p11523
g3
sS'agents,such,a'
p11524
g9
sS'indicate,that,administration'
p11525
g3
sS'gaba-ergic,system,and'
p11526
g9
sS'vitro,in,situ'
p11527
g3
sS'in,serum,level'
p11528
g9
sS'and,time,course'
p11529
g3
sS'show,potential,for'
p11530
g3
sS'a,prospective,study'
p11531
g3
sS'not,be,used'
p11532
g9
sS'data,show,that'
p11533
g9
sS'function,is,recommended'
p11534
g3
sS'mm,had,no'
p11535
g3
sS'are,not,available'
p11536
g3
sS'such,as,are'
p11537
g9
sS'used,they,should'
p11538
g3
sS'in,vivo,animal'
p11539
g9
sS'concomitantly,with,a'
p11540
g9
sS'is,the,best'
p11541
g3
sS'neurotoxicity,whereas,none'
p11542
g3
sS'concentration,mean,change'
p11543
g3
sS'cell,cultures,superinduced'
p11544
g3
sS'hypoglycemic,agents,should'
p11545
g9
sS'withdrawal,syndrome,in'
p11546
g9
sS'beta,blockers,cardiac'
p11547
g3
sS'is,administered,before'
p11548
g3
sS'and,may,thereby'
p11549
g3
sS'often,appear,in'
p11550
g3
sS'when,is,withdrawn'
p11551
g9
sS'cyp3a4,or,epoxide'
p11552
g3
sS'studies,using,human'
p11553
g3
sS'and,are,ge'
p11554
g3
sS'gel,until,the'
p11555
g3
sS'the,cytochrome,p450-linked'
p11556
g3
sS'body,clearance,of'
p11557
g9
sS'life-,threatening,cardiac'
p11558
g9
sS'conditions,for,which'
p11559
g3
sS'levels,and,urinary'
p11560
g9
sS'the,last,day'
p11561
g3
sS'to,establish,a'
p11562
g9
sS'hyperlipidaemia,and,obesity'
p11563
g3
sS'of,these,agents'
p11564
g3
sS'of,preparations,such'
p11565
g9
sS'dosage,of,one'
p11566
g3
sS'treatment,of,four'
p11567
g9
sS'are,summarized,in'
p11568
g3
sS'fluid,contents,and'
p11569
g3
sS'mg,tid,were'
p11570
g3
sS'and,cardiac,function'
p11571
g3
sS'doses,of,hydrochloride'
p11572
g9
sS'administration,of,potentially'
p11573
g9
sS'studies,indicated,that'
p11574
g3
sS'sumatriptan,and,d'
p11575
g9
sS'diet,high,in'
p11576
g9
sS'appear,to,cause'
p11577
g3
sS'exercised,in,patients'
p11578
g3
sS'serum,creatinine,have'
p11579
g3
sS'compared,to,these'
p11580
g9
sS'mg,daily,as'
p11581
g9
sS'each,group,took'
p11582
g3
sS'was,not,inhibitory'
p11583
g3
sS'result,in,additive'
p11584
g9
sS'day,and,at'
p11585
g9
sS'cyp,a4,substrate'
p11586
g3
sS'but,colony,stimulating'
p11587
g3
sS'and,to,healthy'
p11588
g3
sS'increased,concentrations,has'
p11589
g3
sS'agents,experience,in'
p11590
g9
sS'coupled,to,activation'
p11591
g3
sS'with,the,levulan'
p11592
g9
sS'been,little,experience'
p11593
g3
sS'strong,in,vitro'
p11594
g3
sS'among,patients,on'
p11595
g3
sS'decrease,in,clearance'
p11596
g9
sS'mg,daily,was'
p11597
g3
sS'blood,liver,or'
p11598
g3
sS'that,undergo,enterohepatic'
p11599
g9
sS'any,other,that'
p11600
g3
sS'the,only,clinically'
p11601
g9
sS'is,truly,hypothyroid'
p11602
g3
sS'produce,a,stimulating'
p11603
g9
sS'tbg,concentrations,are'
p11604
g3
sS'vaccine,inhalation,mefenamic'
p11605
g9
sS'already,receiving,a'
p11606
g3
sS'in,the,free'
p11607
g3
sS'other,drugs,cimetidine'
p11608
g3
sS'excystment,of,parorchis'
p11609
g3
sS'patients,is,advised'
p11610
g3
sS'chronic,concurrent,administration'
p11611
g9
sS'makes,the,clinical'
p11612
g3
sS'presence,of,from'
p11613
g3
sS'can,increase,plasma'
p11614
g3
sS'cytochrome,p-450,enzymes'
p11615
g3
sS'coumarin,anticoagulants,are'
p11616
g9
sS'positive,urine,test'
p11617
g3
sS'placental,vessels,was'
p11618
g3
sS'therapeutic,regimes,against'
p11619
g3
sS'two,retrospective,studies'
p11620
g3
sS'monitored,particularly,in'
p11621
g9
sS'dose,modifying,factors'
p11622
g9
sS'regimen,of,a'
p11623
g9
sS'taking,an,mao'
p11624
g3
sS'decreased,with,and'
p11625
g9
sS'up,to,increase3'
p11626
g3
sS'however,pharmacokinetic,studies'
p11627
g3
sS'with,short,s'
p11628
g3
sS'effect,has,been'
p11629
g3
sS'ethosuximide,amphetamines,may'
p11630
g9
sS'co-administered,with,either'
p11631
g3
sS'to,ng,x'
p11632
g9
sS'out,whether,this'
p11633
g3
sS'in,the,patch'
p11634
g3
sS'short-acting,such,as'
p11635
g3
sS'and,drug,transport'
p11636
g3
sS'to,pressor,activity'
p11637
g3
sS'which,are,capable'
p11638
g3
sS'substrate,for,cyp2d6'
p11639
g9
sS'mg,m2,plus'
p11640
g3
sS'be,followed,and'
p11641
g3
sS'protein,bound,would'
p11642
g3
sS'in,this,formal'
p11643
g3
sS'effects,on,glucose'
p11644
g3
sS'on,the,duration'
p11645
g3
sS'how,safe,sexual'
p11646
g3
sS'did,augment,the'
p11647
g9
sS'a,first-line,option'
p11648
g3
sS'hiv-nhl,who,were'
p11649
g3
sS'mg,of,sodium'
p11650
g9
sS'diabetes,medicine,you'
p11651
g9
sS'risk,for,developing'
p11652
g3
sS'occurred,in,heart'
p11653
g3
sS'other,myelosuppressive,agents'
p11654
g3
sS'doses,of,hmg-coa'
p11655
g3
sS'tricor,there,is'
p11656
g9
sS'effect,of,keppra'
p11657
g3
sS'are,currently,no'
p11658
g3
sS'with,auc,was'
p11659
g3
sS'a,fold,range'
p11660
g3
sS'vitro,data,indicate'
p11661
g9
sS'substantive,effect,on'
p11662
g3
sS'a,patient,is'
p11663
g3
sS'healthy,volunteers,the'
p11664
g9
sS'pregnancy,when,dosed'
p11665
g3
sS'adjustments,of,either'
p11666
g3
sS'daily,mg,total'
p11667
g3
sS'which,may,be'
p11668
g3
sS'aeds,and,that'
p11669
g3
sS'omeprazole,is,a'
p11670
g3
sS'estrogen,increased,levels'
p11671
g3
sS'frequently,been,reported'
p11672
g3
sS'toxicity,was,also'
p11673
g3
sS'amprenavir,plus,was'
p11674
g9
sS'fe,per,kg'
p11675
g9
sS'functional,class,iv'
p11676
g3
sS'in,approximately,half'
p11677
g3
sS'induce,metabolic,enzymes'
p11678
g3
sS'hippocampus,would,play'
p11679
g3
sS'are,important,factors'
p11680
g3
sS'anti-inflammatory,agents,are'
p11681
g9
sS'ca,release,by'
p11682
g3
sS'fe,abstract,truncated'
p11683
g3
sS'of,nimbex,may'
p11684
g9
sS'since,the,effects'
p11685
g9
sS'impairment,particularly,in'
p11686
g3
sS'mao,inhibitors,somatostatin'
p11687
g3
sS'with,bioassay,procedures'
p11688
g3
sS'bioavailability,area,under'
p11689
g3
sS'disintegrin,was,compared'
p11690
g3
sS'agents,by,nonsteroidal'
p11691
g9
sS'cases,the,unbound'
p11692
g3
sS'prevent,the,development'
p11693
g9
sS'known,clinically,significant'
p11694
g3
sS'programs,should,be'
p11695
g3
sS'an,levonorgestrol,oral'
p11696
g3
sS'the,diet,for'
p11697
g9
sS'and,that,polyamines'
p11698
g3
sS'anti-malarial,such,as'
p11699
g9
sS'deet,toxicity,when'
p11700
g3
sS'studies,show,significant'
p11701
g3
sS'have,no,inhibitory'
p11702
g3
sS'even,be,more'
p11703
g9
sS'of,the,level'
p11704
g3
sS'transport,of,noradrenaline'
p11705
g3
sS'tool,for,studying'
p11706
g3
sS'acid,metabolism,are'
p11707
g3
sS'and,auc,from'
p11708
g9
sS'with,hydroxide,containing'
p11709
g9
sS'of,on,endotoxin-induced'
p11710
g3
sS'with,enbrel,and'
p11711
g9
sS'or,more,possibly'
p11712
g9
sS'the,gastrointestinal,absorption'
p11713
g9
sS'and,increases,substantially'
p11714
g9
sS'model,in,patients'
p11715
g3
sS'a,decline,in'
p11716
g3
sS'similar,temporal,patterns'
p11717
g3
sS'thus,appeared,to'
p11718
g9
sS'fluvoxamine,inhibits,the'
p11719
g9
sS'with,at,a'
p11720
g3
sS'not,diminish,fluoride'
p11721
g3
sS'and,lessened,physiologic'
p11722
g9
sS'observed,when,coreg'
p11723
g9
sS'first,few,weeks'
p11724
g9
sS'cause,increased,intracranial'
p11725
g9
sS'activation,in,vitro'
p11726
g3
sS'in,the,elimination'
p11727
g9
sS'other,medications,with'
p11728
g3
sS'route,with,less'
p11729
g3
sS'time,it,has'
p11730
g3
sS'the,vehicle,or'
p11731
g9
sS'of,at,their'
p11732
g3
sS'little,change,in'
p11733
g9
sS'be,catalyzed,by'
p11734
g3
sS'the,ic,was'
p11735
g3
sS'the,patients,in'
p11736
g3
sS'both,and,may'
p11737
g9
sS'do,not,indicate'
p11738
g9
sS'clearance,is,greater'
p11739
g9
sS'results,demonstrate,a'
p11740
g3
sS'the,assay,and'
p11741
g3
sS'relaxant,effect,of'
p11742
g9
sS'antidiabetes,products,ace'
p11743
g3
sS'behavioral,changes,may'
p11744
g3
sS'lst,mice,showed'
p11745
g3
sS'excretion,of,has'
p11746
g9
sS'effects,resulting,from'
p11747
g9
sS'measurement,of,creatinine'
p11748
g3
sS'and,t3,concentrations'
p11749
g3
sS'of,of,the'
p11750
g3
sS'may,partially,counteract'
p11751
g9
sS'patients,taking,while'
p11752
g9
sS'fluoride,levels,and'
p11753
g3
sS'carefully,monitored,in'
p11754
g9
sS'on,cyp1a2,was'
p11755
g3
sS'inhibit,cytochrome,p450iid6'
p11756
g9
sS'anemia,associated,with'
p11757
g3
sS'combined,treatment,with'
p11758
g9
sS'at,three,concentrations'
p11759
g3
sS'and,time,kill'
p11760
g9
sS'but,there,were'
p11761
g3
sS'and,chemotherapy,plus'
p11762
g3
sS'b,intravenous,and'
p11763
g9
sS'and,n1,while'
p11764
g9
sS'production,of,but'
p11765
g3
sS'a,simple,and'
p11766
g3
sS'cases,of,pseudotumor'
p11767
g9
sS'coadministration,of,channel'
p11768
g3
sS'with,in,an'
p11769
g3
sS'reported,in,postmarketing'
p11770
g9
sS'procedures,when,anti-globulin'
p11771
g3
sS'with,high,concentrations'
p11772
g3
sS'discontinuing,to,avoid'
p11773
g9
sS'least,minutes,before'
p11774
g9
sS'metabolized,to,a'
p11775
g3
sS'after,a,one'
p11776
g9
sS'is,moderately,reduced'
p11777
g3
sS'useful,in,combination'
p11778
g9
sS'affecting,the,blood'
p11779
g9
sS'hypertensive,patients,addition'
p11780
g3
sS'ic50,g,ml'
p11781
g3
sS'advanced,or,complete'
p11782
g9
sS'major,enzyme,involved'
p11783
g3
sS'in,an,approximate'
p11784
g9
sS'glomerulonephritis,oculo-bulbar,myasthenia'
p11785
g9
sS'chicks,was,effective'
p11786
g9
sS'was,reached,on'
p11787
g3
sS'the,oral,doses'
p11788
g9
sS'of,ast,sgot'
p11789
g3
sS'extrapolating,these,findings'
p11790
g3
sS'full,dose,range'
p11791
g3
sS'cells,express,the'
p11792
g3
sS'method,or,the'
p11793
g3
sS'flexure,of,the'
p11794
g3
sS'interactions,with,concomitantly'
p11795
g3
sS'therapy,it,is'
p11796
g9
sS'hypotension,because,of'
p11797
g3
sS'of,steady-state,pharmacokinetic'
p11798
g3
sS'may,impair,liver'
p11799
g3
sS'acidic,conditions,similar'
p11800
g9
sS'such,cases,therefore'
p11801
g3
sS'levels,occurred,at'
p11802
g9
sS'reported,to,worsen'
p11803
g3
sS'acetate,in,reducing'
p11804
g9
sS'constituents,of,alcoholic'
p11805
g3
sS'levels,of,serotonin'
p11806
g3
sS'ventricular,arrhythmias,during'
p11807
g9
sS'interactions,between,oh'
p11808
g3
sS'of,the,original'
p11809
g3
sS'humans,and,the'
p11810
g3
sS'and,no,complications'
p11811
g3
sS'however,in,another'
p11812
g9
sS'the,mean,apparent'
p11813
g9
sS'the,detection,of'
p11814
g3
sS'attenuated,by,endothelial'
p11815
g3
sS'signs,of,hypotension'
p11816
g9
sS'microg,l,of'
p11817
g3
sS'concentrations,and,ldl-c'
p11818
g3
sS'nasal,spray,but'
p11819
g9
sS'have,in,some'
p11820
g9
sS'digoxin,enoxacin,may'
p11821
g9
sS'valproate,mg,twice'
p11822
g3
sS'potential,interactions,are'
p11823
g3
sS'we,report,the'
p11824
g9
sS'be,more,pronounced'
p11825
g9
sS'taking,acarbose,was'
p11826
g3
sS'exjade,and,vitamin'
p11827
g3
sS'studies,to,mg'
p11828
g3
sS'hematopoietic,system,should'
p11829
g3
sS'class,of,which'
p11830
g9
sS'monitoring,for,bleeding'
p11831
g3
sS'to,less,than'
p11832
g3
sS'in,clinical,studies'
p11833
g3
sS'the,lst,mice'
p11834
g3
sS'stress,of,the'
p11835
g3
sS'precursor,to,this'
p11836
g3
sS'to,an,altered'
p11837
g9
sS'single-dose,study,with'
p11838
g3
sS'comparable,activity,to'
p11839
g3
sS'give,rise,to'
p11840
g9
sS'basis,of,hippocampal'
p11841
g3
sS'by,and,clotibrate'
p11842
g3
sS'mg,daily,a'
p11843
g9
sS'such,as,liver'
p11844
g9
sS'concomitant,such,as'
p11845
g3
sS'in,dmpge2,mg'
p11846
g3
sS'mc,potentiates,the'
p11847
g9
sS'crossover,design,with'
p11848
g3
sS'drug,class,examples'
p11849
g3
sS'receiving,antihypertensive,medications'
p11850
g9
sS'significant,interaction,with'
p11851
g3
sS'marker,substrates,and'
p11852
g3
sS'bioavailability,of,was'
p11853
g3
sS'of,several,closely'
p11854
g9
sS'the,best,choice'
p11855
g3
sS'the,palytoxin-induced,contraction'
p11856
g3
sS'hormonal,by,inducing'
p11857
g3
sS'treated,with,oral'
p11858
g9
sS'were,randomly,assigned'
p11859
g3
sS'effects,of,other'
p11860
g9
sS'curves,with,enteric'
p11861
g9
sS'cytochrome,p-450,isozymes'
p11862
g9
sS'n-methylthiotetrazole,or,methylthiadiazole'
p11863
g3
sS'with,compared,to'
p11864
g9
sS'species,ros,has'
p11865
g3
sS'compounds,caution,should'
p11866
g3
sS'exposure,to,one'
p11867
g3
sS'stopping,an,mao'
p11868
g9
sS'with,blood,thinners'
p11869
g9
sS'the,cmax,values'
p11870
g3
sS'increase,or,for'
p11871
g3
sS'mg,m2,given'
p11872
g9
sS'reports,of,qtc'
p11873
g3
sS'be,decreased,activity'
p11874
g3
sS'suggests,that,does'
p11875
g3
sS'are,suggested,by'
p11876
g3
sS'interaction,study,co-administration'
p11877
g9
sS'alter,the,optimal'
p11878
g3
sS'were,decreased,by'
p11879
g9
sS'of,therapy,the'
p11880
g3
sS'treatment,studies,evaluating'
p11881
g3
sS'isozymes,a2,a6'
p11882
g3
sS'no,interaction,was'
p11883
g3
sS'p1,and,p2'
p11884
g3
sS'will,occur,in'
p11885
g3
sS'increased,breakthrough,bleeding'
p11886
g3
sS'agents,having,a'
p11887
g3
sS'test,period,will'
p11888
g9
sS'mg,tricor,with'
p11889
g9
sS'tyrosine,phosphorylation,in'
p11890
g3
sS'activity,is,not'
p11891
g3
sS'mg,neurontin,capsule'
p11892
g9
sS'or,pediatric,powder'
p11893
g9
sS'topoisomerases,is,no'
p11894
g3
sS'of,chronic,or'
p11895
g9
sS'valproate,tiagabine,causes'
p11896
g9
sS'with,and,therefore'
p11897
g9
sS'pump,inhibitors,and'
p11898
g9
sS'kemstrotm,was,similar'
p11899
g3
sS'treated,with,difluoro-2'
p11900
g9
sS'for,mania,whereas'
p11901
g3
sS'on,fi,and'
p11902
g9
sS'levels,and,extends'
p11903
g9
sS'of,has,been'
p11904
g9
sS'produced,depletions,of'
p11905
g9
sS'that,because,of'
p11906
g3
sS'well,as,peripheral'
p11907
g3
sS'efficacy,is,reduced'
p11908
g9
sS'altered,by,the'
p11909
g3
sS'observe,the,patient'
p11910
g3
sS'reported,among,patients'
p11911
g9
sS'for,further,kidney'
p11912
g3
sS'a,prolongation,in'
p11913
g9
sS'less,alteration,in'
p11914
g9
sS'these,potential,interactions'
p11915
g3
sS'effect,of,administering'
p11916
g3
sS'the,major,serum'
p11917
g3
sS'hypothyroid,patient,may'
p11918
g9
sS'management,and,progression'
p11919
g3
sS'of,pocs,and'
p11920
g3
sS'hydrochloride,concomitantly,with'
p11921
g9
sS'function,and,host'
p11922
g3
sS'the,types,of'
p11923
g3
sS'rd,th,and'
p11924
g3
sS'potential,inhibitor,of'
p11925
g9
sS'fibroblast,y1,cells'
p11926
g3
sS'interactions,noted,above'
p11927
g3
sS'be,monitored,and'
p11928
g3
sS'not,been,demonstrated'
p11929
g3
sS'wshow,an,effect'
p11930
g3
sS'may,be,especially'
p11931
g3
sS'range,of,plasma'
p11932
g3
sS'in,the,phase'
p11933
g3
sS'gleevec,increases,the'
p11934
g9
sS'that,may,be'
p11935
g3
sS'consciousness,caused,by'
p11936
g9
sS'using,doses,of'
p11937
g9
sS'the,sum,of'
p11938
g3
sS'other,antiretroviral,medications'
p11939
g3
sS'used,only,as'
p11940
g3
sS'results,are,obtained'
p11941
g3
sS'for,days,oral'
p11942
g3
sS'great,potential,in'
p11943
g3
sS'amiodarone,is,metabolized'
p11944
g3
sS'reports,of,both'
p11945
g9
sS'were,randomized,to'
p11946
g3
sS'selectively,prevent,opioid-induced'
p11947
g9
sS'min,p,less'
p11948
g3
sS'of,or,use'
p11949
g3
sS'escalating,doses,from'
p11950
g3
sS'patients,with,blood'
p11951
g3
sS'placed,in,a'
p11952
g3
sS'concentrations,was,dialyzed'
p11953
g3
sS'the,cure,and'
p11954
g9
sS'disulfiram,to,a'
p11955
g9
sS'trimethoprim,alone,or'
p11956
g3
sS'acetaminophen,and,l-methionine'
p11957
g9
sS'm,and,a'
p11958
g3
sS'effects,prothrombin,time'
p11959
g9
sS'whole,blood,area'
p11960
g9
sS'test,findings,asymptomatic'
p11961
g3
sS'partially,counteract,the'
p11962
g9
sS'q,d,doses'
p11963
g3
sS'therefore,periodic,liver'
p11964
g3
sS'xr,may,reduce'
p11965
g9
sS'with,tablets,reduces'
p11966
g9
sS'potassium-sparing,including,midamor'
p11967
g9
sS'that,are,cytochrome'
p11968
g9
sS'temperature,changes,on'
p11969
g3
sS'between,and,is'
p11970
g9
sS'between,and,it'
p11971
g9
sS'lower,respectively,after'
p11972
g3
sS'or,estrogen-containing,oral'
p11973
g9
sS'of,a,thorough'
p11974
g3
sS'after,weeks,of'
p11975
g3
sS'assays,caution,should'
p11976
g3
sS'low,uptakes,which'
p11977
g3
sS'between,and,in'
p11978
g9
sS'involved,in,both'
p11979
g3
sS'growth,in,vitro'
p11980
g9
sS'events,should,be'
p11981
g3
sS'other,affected,by'
p11982
g3
sS'however,somepatients,may'
p11983
g3
sS'subjects,received,in'
p11984
g3
sS'chromatin,and,nuclear'
p11985
g9
sS'pharmacokinetic,effects,seen'
p11986
g9
sS'system,depressants,and'
p11987
g9
sS'should,be,at'
p11988
g9
sS'which,could,increase'
p11989
g9
sS'of,is,potentiated'
p11990
g9
sS'compensate,for,the'
p11991
g9
sS'conducted,for,the'
p11992
g3
sS'addition,the,frequency'
p11993
g3
sS'or,concentrations,when'
p11994
g3
sS'ergocalcitriol,will,be'
p11995
g3
sS'necessary,factor,for'
p11996
g3
sS'oral,agents,may'
p11997
g3
sS'potentiated,and,fatal'
p11998
g9
sS'of,keflex,a'
p11999
g3
sS'as,a,stimulator'
p12000
g9
sS'that,no,significant'
p12001
g9
sS'treatment,of,anticholinesterase'
p12002
g9
sS'laboratory,tests,common'
p12003
g3
sS'may,cause,hypercalcemia'
p12004
g9
sS'adverse,interactions,with'
p12005
g3
sS'pharmacologic,effects,may'
p12006
g3
sS'least,hours,should'
p12007
g9
sS'the,ultimate,effect'
p12008
g3
sS'for,women,of'
p12009
g3
sS'approximately,with,coadministration'
p12010
g9
sS'of,on,the'
p12011
g3
sS'appeared,well,after'
p12012
g3
sS'clinical,studies,have'
p12013
g3
sS'frequency,and,or'
p12014
g9
sS'of,stereoselectivity,in'
p12015
g3
sS'understood,and,depend'
p12016
g3
sS'of,nephrolithiasis,is'
p12017
g9
sS'that,coadministration,with'
p12018
g3
sS'techniques,confirmation,should'
p12019
g3
sS'measurement,of,serum'
p12020
g3
sS'if,are,required'
p12021
g9
sS'iodide,i,and'
p12022
g3
sS'moderately,reduced,approximately'
p12023
g3
sS'a,known,risk'
p12024
g3
sS'after,stopping,fluvoxamine'
p12025
g9
sS'and,the,types'
p12026
g3
sS'other,cns,depressants'
p12027
g9
sS'as,or,is'
p12028
g3
sS'by,the,following'
p12029
g3
sS'of,single,doses'
p12030
g3
sS'randomized,balanced,two-period'
p12031
g3
sS'of,individual,patient'
p12032
g3
sS'etonogestrel,may,interact'
p12033
g9
sS'effects,of,coadministration'
p12034
g9
sS'anafranil,is,highly'
p12035
g9
sS'these,are,used'
p12036
g3
sS'been,safely,tolerated'
p12037
g3
sS'not,inhibit,p-glycoprotein'
p12038
g3
sS'with,hiv-nhl,who'
p12039
g3
sS'represents,an,interaction'
p12040
g3
sS'carbamazepine,overdose,recognized'
p12041
g3
sS'pure,agonist,such'
p12042
g9
sS'is,not,affected'
p12043
g3
sS'concentrations,or,the'
p12044
g3
sS'methylglutaryl,coenzyme,a'
p12045
g3
sS'is,considered,in'
p12046
g3
sS'inhibited,by,added'
p12047
g3
sS'by,cyp2d6,duloxetine'
p12048
g3
sS'who,may,be'
p12049
g3
sS'an,indication,for'
p12050
g3
sS'the,and,effects'
p12051
g9
sS'a,placebo-controlled,crossover'
p12052
g9
sS'used,when,equetrotm'
p12053
g9
sS'did,it,affect'
p12054
g3
sS'mainly,eliminated,by'
p12055
g3
sS'dose,of,may'
p12056
g9
sS'hour,and,then'
p12057
g3
sS'and,administration,to'
p12058
g3
sS'instances,a,slight'
p12059
g9
sS'reactions,when,treated'
p12060
g3
sS'and,decreased,by'
p12061
g9
sS'be,the,cellular'
p12062
g3
sS'abnormalities,such,as'
p12063
g9
sS'compounds,which,inhibit'
p12064
g3
sS'patients,with,symptoms'
p12065
g3
sS'oral,includes,longer'
p12066
g3
sS'hypertension,the,addition'
p12067
g9
sS'prothrombin,test,monitoring'
p12068
g3
sS'selective,serotonin,reuptake'
p12069
g3
sS'interference,may,result'
p12070
g3
sS'volume,and,sodium'
p12071
g9
sS'loss,of,efficacy'
p12072
g3
sS'of,as,compared'
p12073
g9
sS'the,auc,by'
p12074
g9
sS'because,the,geriatric'
p12075
g3
sS'acetazolamide,may,increase'
p12076
g9
sS'whenever,these,agents'
p12077
g3
sS'of,brovana,are'
p12078
g3
sS'ureidopenicillins,including,were'
p12079
g9
sS'levels,of,either'
p12080
g3
sS'breath,test,was'
p12081
g3
sS'interaction,is,a'
p12082
g9
sS'rifampin,an,inducer'
p12083
g9
sS'time,and,platelet'
p12084
g3
sS'increases,will,occur'
p12085
g3
sS'warranted,and,clinical'
p12086
g3
sS'mg,bid,decreased'
p12087
g9
sS'serious,interactions,when'
p12088
g9
sS'of,indocin,can'
p12089
g9
sS'than,months,of'
p12090
g3
sS'cause,a,rise'
p12091
g9
sS'action,of,certain'
p12092
g9
sS'of,desmopressin,tablets'
p12093
g3
sS'also,result,in'
p12094
g9
sS'prothrombin,levels,and'
p12095
g3
sS'in,women,of'
p12096
g3
sS'and,one,at'
p12097
g3
sS'integration,the,interaction'
p12098
g3
sS'by,patients,suffering'
p12099
g9
sS'is,reaching,epidemic'
p12100
g3
sS'of,bepridil,with'
p12101
g3
sS'temporarily,mask,the'
p12102
g9
sS'available,assay,methods'
p12103
g3
sS'including,protease,inhibitors'
p12104
g3
sS'with,videx,chewable'
p12105
g9
sS'significantly,higher,when'
p12106
g9
sS'these,patients,and'
p12107
g3
sS'standard,therapy,includes'
p12108
g3
sS'or,a,antidepressant'
p12109
g9
sS'evidence,suggesting,that'
p12110
g3
sS'vasospastic,effects,may'
p12111
g9
sS'is,not,due'
p12112
g9
sS'either,or,micrograms'
p12113
g3
sS'incompletely,responsive,to'
p12114
g3
sS'a,different,type'
p12115
g9
sS'combination,with,a'
p12116
g3
sS'preparations,such,as'
p12117
g9
sS'of,mefloquine,on'
p12118
g9
sS'in,the,qt0'
p12119
g3
sS'acid,vitamin,c'
p12120
g9
sS'hours,or,concurrent'
p12121
g9
sS'noted,to,possibly'
p12122
g9
sS'may,color,alkaline'
p12123
g3
sS'i,suggesting,a'
p12124
g3
sS'up,to,mg'
p12125
g3
sS'of,trileptal,with'
p12126
g9
sS'physician,should,provide'
p12127
g3
sS'several,well-controlled,studies'
p12128
g3
sS'for,comprehensive,information'
p12129
g3
sS'used,such,as'
p12130
g3
sS'there,was,extensive'
p12131
g3
sS'single,dosage,of'
p12132
g3
sS'agents,when,are'
p12133
g9
sS'drugs,in,vitro'
p12134
g3
sS'is,used,with'
p12135
g9
sS'or,drug,laboratory'
p12136
g3
sS'continued,use,of'
p12137
g3
sS'the,from,protein'
p12138
g9
sS'significantly,affects,prothrombin'
p12139
g3
sS'mtx,nsaids,and'
p12140
g3
sS'patients,receiving,other'
p12141
g9
sS'with,a,reduced'
p12142
g3
sS'levels,were,decreased'
p12143
g9
sS'the,mouse,mammary'
p12144
g3
sS'clinically,significant,differences'
p12145
g3
sS'have,not,established'
p12146
g9
sS'that,are,inhibitors'
p12147
g3
sS'knowledge,of,the'
p12148
g3
sS'neurotransmitter,systems,and'
p12149
g3
sS'served,as,his'
p12150
g3
sS'dose,levels,thereby'
p12151
g3
sS'and,infusion,rate'
p12152
g9
sS'doses,of,were'
p12153
g9
sS'poc,in,the'
p12154
g3
sS'transaminases,have,been'
p12155
g3
sS'likelihood,of,potentially'
p12156
g3
sS'studied,but,cases'
p12157
g9
sS'in,healthy,non-smoking'
p12158
g3
sS'with,that,can'
p12159
g3
sS'volunteers,treatment,with'
p12160
g3
sS'and,suggest,that'
p12161
g9
sS'for,measurement,of'
p12162
g3
sS'onset,of,neuromuscular'
p12163
g9
sS'in,the,ph'
p12164
g9
sS'carried,out,with'
p12165
g3
sS'may,also,influence'
p12166
g3
sS'following,agents,highly'
p12167
g3
sS'suppress,the,dopaminergic'
p12168
g9
sS'arrest,torsades,de'
p12169
g3
sS'no,laboratory,test'
p12170
g3
sS'also,occurs,with'
p12171
g3
sS'by,repeated,challenge'
p12172
g3
sS'cardiac,monitoring,is'
p12173
g3
sS'desethylzaleplon,formed,via'
p12174
g3
sS'than,fold,increase'
p12175
g3
sS'almost,fold,lower'
p12176
g9
sS'or,other,having'
p12177
g9
sS'of,sodium,and'
p12178
g9
sS'minutes,before,using'
p12179
g9
sS'more,severely,depressed'
p12180
g3
sS'should,be,employed'
p12181
g3
sS'greater,antitumour,activity'
p12182
g3
sS'the,terms,viagra'
p12183
g3
sS'largely,unbound,bound'
p12184
g3
sS'porter-silber,test,is'
p12185
g3
sS'were,compared,to'
p12186
g3
sS'amiodarone-treated,patients,who'
p12187
g3
sS'frequency,of,hyperkalemia'
p12188
g9
sS'by,as,measured'
p12189
g9
sS'hydrate,may,cause'
p12190
g9
sS'determined,in,iso-sensitest'
p12191
g3
sS'or,may,diminish'
p12192
g9
sS'serum,concentration,due'
p12193
g9
sS'seem,to,dictate'
p12194
g9
sS'and,its,active'
p12195
g9
sS'mg,on,days'
p12196
g9
sS'i,d,was'
p12197
g9
sS'however,be,administered'
p12198
g3
sS'favorable,effects,on'
p12199
g3
sS'was,higher,when'
p12200
g9
sS'mg,d,of'
p12201
g3
sS'pronounced,when,it'
p12202
g9
sS'blood,glucose,is'
p12203
g3
sS'be,reported,to'
p12204
g3
sS'more,feasible,as'
p12205
g3
sS'exert,additive,ocular'
p12206
g3
sS'may,be,efficacious'
p12207
g3
sS'cyp1a2,c8,c9'
p12208
g3
sS'this,effect,has'
p12209
g3
sS'patients,undergoing,systemic'
p12210
g3
sS'were,also,reported'
p12211
g3
sS'inhibits,metabolism,which'
p12212
g9
sS'test,abnormalities,were'
p12213
g3
sS'laboratory,test,findings'
p12214
g3
sS'agonist,can,give'
p12215
g9
sS'hepatic,enzyme,inhibitors'
p12216
g9
sS'related,compounds,eg'
p12217
g9
sS'liver,enzyme,abnormalities'
p12218
g9
sS'in,the,acute'
p12219
g3
sS'known,to,occasionally'
p12220
g3
sS'feedback,alterations,in'
p12221
g3
sS'been,associated,with'
p12222
g9
sS'with,the,dose'
p12223
g9
sS'differential,actions,of'
p12224
g3
sS'cause,significant,increases'
p12225
g3
sS'proliferates,in,a'
p12226
g3
sS'or,and,that'
p12227
g3
sS'site,reaction,either'
p12228
g3
sS'co-administered,with,fluvoxamine'
p12229
g9
sS'off,before,a'
p12230
g3
sS'toxicity,but,only'
p12231
g3
sS'respectively,suggesting,that'
p12232
g9
sS'and,rats,suggest'
p12233
g9
sS'inducers,eg,are'
p12234
g3
sS'in,or,of'
p12235
g3
sS'prolonged,administration,and'
p12236
g3
sS'hypo-prothrombinemic,effect,and'
p12237
g3
sS'interaction,of,activase'
p12238
g3
sS'in,pharmacokinetics,or'
p12239
g3
sS'been,reported,in'
p12240
g9
sS'because,the,have'
p12241
g9
sS'of,vardenafil,when'
p12242
g3
sS'and,n-oxide,were'
p12243
g3
sS'unchanged,and,its'
p12244
g3
sS'diarrhea,was,analyzed'
p12245
g3
sS'administered,by,patients'
p12246
g3
sS'increase,is,due'
p12247
g9
sS'macrolide,such,as'
p12248
g9
sS'studied,in,combination'
p12249
g3
sS'drug,is,prescribed'
p12250
g3
sS'using,this,medication'
p12251
g3
sS'prescribers,are,advised'
p12252
g3
sS'for,as,well'
p12253
g3
sS'agents,may,also'
p12254
g3
sS'versus,normal,cells'
p12255
g3
sS'time,have,not'
p12256
g3
sS'development,of,not'
p12257
g3
sS'plasma,tca,concentrations'
p12258
g9
sS'monitored,because,nephrotoxicity'
p12259
g9
sS'noted,above,chronic'
p12260
g3
sS'mefloquine,is,taken'
p12261
g9
sS'in,gonadotropin,levels'
p12262
g3
sS'which,inhibit,platelet'
p12263
g9
sS'and,concomitant,serotonergic'
p12264
g9
sS'at,the,outset'
p12265
g3
sS'and,the,pharmacodynamics'
p12266
g3
sS'of,individual,cases'
p12267
g3
sS'nizatidine,does,not'
p12268
g3
sS'best,choice,for'
p12269
g3
sS'of,ph,may'
p12270
g3
sS'theoretically,adversely,influence'
p12271
g9
sS'patients,as,well'
p12272
g3
sS'the,mechanism,underlying'
p12273
g3
sS'from,breast,milk'
p12274
g3
sS'tumor,cell,resistance'
p12275
g3
sS'of,a,group'
p12276
g3
sS'totally,inhibited,at'
p12277
g3
sS'control,in,patients'
p12278
g3
sS'patients,receiving,another'
p12279
g9
sS'mutagenicity,studies,were'
p12280
g3
sS'reduced,about,in'
p12281
g3
sS'minutes,any,such'
p12282
g9
sS'anti-peptic,agents,primarily'
p12283
g3
sS'prolonged,in,the'
p12284
g9
sS'thyroid,hormones,appear'
p12285
g3
sS'toxic,concentrations,decreases'
p12286
g9
sS'of,the,reduction'
p12287
g3
sS'system,is,involved'
p12288
g3
sS'with,other,acting'
p12289
g3
sS'targretin,capsules,and'
p12290
g9
sS'have,potentially,favorable'
p12291
g3
sS'bid,with,celebrex'
p12292
g9
sS'on,the,prothrombin'
p12293
g3
sS'vivo,resulting,in'
p12294
g9
sS'of,the,activity'
p12295
g9
sS'of,cytochrome,cyp'
p12296
g3
sS'was,observed,with'
p12297
g9
sS'potentiating,cns,depressants'
p12298
g9
sS'survival,for,chop-haart'
p12299
g3
sS'is,excreted,via'
p12300
g3
sS'measurements,of,pah'
p12301
g9
sS'role,in,hemostasis'
p12302
g9
sS'contains,reports,of'
p12303
g3
sS'fertility,of,female'
p12304
g3
sS'or,basic,as'
p12305
g9
sS'areas,in,the'
p12306
g3
sS'maintenance,bolus,doses'
p12307
g3
sS'five,normal,volunteers'
p12308
g9
sS'susceptible,to,diethylnitrosamine'
p12309
g3
sS'occur,if,the'
p12310
g3
sS'been,studied,for'
p12311
g3
sS'the,plasma,clearance'
p12312
g9
sS'of,in,states'
p12313
g3
sS'mg,potentiated,the'
p12314
g9
sS'know,how,safe'
p12315
g3
sS'thiazide,use,of'
p12316
g9
sS'gastrointestinal,acidifying,agents'
p12317
g9
sS'in,combination,lies'
p12318
g3
sS'attempt,to,establish'
p12319
g9
sS'for,ototoxicity,is'
p12320
g9
sS'second,contraction,was'
p12321
g3
sS'affect,the,rate'
p12322
g3
sS'patients,receiving,alone'
p12323
g3
sS'of,tracrium,include'
p12324
g9
sS'that,was,detected'
p12325
g3
sS'adverse,reaction,during'
p12326
g3
sS'free,may,be'
p12327
g9
sS'indicate,only,a'
p12328
g9
sS'interest,from,a'
p12329
g3
sS'drug,laboratory,test-interactions'
p12330
g3
sS'decrease,the,overall'
p12331
g3
sS'these,increases,in'
p12332
g3
sS'to,dictate,against'
p12333
g9
sS'mild,to,moderate'
p12334
g9
sS'and,those,used'
p12335
g3
sS'reports,of,fatal'
p12336
g3
sS'or,pcp,produced'
p12337
g3
sS'loop,sparing,thiazide'
p12338
g3
sS'normal,volunteers,the'
p12339
g9
sS'time,partial,thromboplastin'
p12340
g3
sS'pronounced,secretory,diarrhea'
p12341
g3
sS'the,cecum,in'
p12342
g3
sS'palytoxin,ptx,c129h223n3o54'
p12343
g3
sS'of,hydrochloride,concomitantly'
p12344
g9
sS'following,other,drugs'
p12345
g3
sS'amphotericin,b,antineoplastic'
p12346
g9
sS'thyroid,hormonal,replacement'
p12347
g3
sS'phenomenon,was,not'
p12348
g3
sS'the,increase,in'
p12349
g3
sS'when,edecrin,and'
p12350
g9
sS'pharmacodynamic,effects,of'
p12351
g3
sS'added,drug,combinations'
p12352
g3
sS'response,in,the'
p12353
g3
sS'nonbarbiturate,antianxiety,agents'
p12354
g9
sS'in,vivo,as'
p12355
g9
sS'and,non-ossification,of'
p12356
g3
sS'over,the,full'
p12357
g3
sS'phosphorylation,of,this'
p12358
g9
sS'men,n,did'
p12359
g3
sS'of,hcl,was'
p12360
g3
sS'm2,without,indicated'
p12361
g3
sS'inapsine,required,will'
p12362
g3
sS'cmax,were,observed'
p12363
g3
sS'preanesthetic,and,agents'
p12364
g3
sS'a,meal,and'
p12365
g3
sS'tract,by,up'
p12366
g9
sS'member,of,the'
p12367
g9
sS'produced,a,decrease'
p12368
g9
sS'by,as,much'
p12369
g3
sS'patients,on,replacement'
p12370
g3
sS'taken,hours,before'
p12371
g3
sS'antacid,magnesium-aluminum,hydroxide'
p12372
g3
sS'sequence,initiation,is'
p12373
g3
sS'found,to,decrease'
p12374
g9
sS'time,within,the'
p12375
g9
sS'renal,toxicity,of'
p12376
g9
sS'when,administered,with'
p12377
g9
sS'of,increased,steady-state'
p12378
g3
sS'the,individual,compounds'
p12379
g3
sS'patients,predisposing,to'
p12380
g9
sS'of,either,the'
p12381
g3
sS'not,observed,when'
p12382
g3
sS'peripheral,neuropathy,is'
p12383
g3
sS'health,care,professional'
p12384
g9
sS'does,not,have'
p12385
g3
sS'and,the,possibility'
p12386
g3
sS'is,difficult,to'
p12387
g3
sS'to,affect,its'
p12388
g3
sS'supplements,taken,concomitantly'
p12389
g9
sS'are,given,for'
p12390
g3
sS'pharmacokinetics,data,indicate'
p12391
g9
sS'increase,in,renal'
p12392
g3
sS'hot,drinks,may'
p12393
g3
sS'mg,day,doses'
p12394
g3
sS'evaluate,the,effect'
p12395
g3
sS'inflammatory,recall,reaction'
p12396
g3
sS'dealt,with,as'
p12397
g3
sS'given,concurrently,with'
p12398
g9
sS'and,haldol,has'
p12399
g3
sS'of,status,and'
p12400
g3
sS'contraindicated,and,alternative'
p12401
g9
sS'and,coma,have'
p12402
g9
sS'extent,of,plasma'
p12403
g3
sS'its,dosage,reduced'
p12404
g9
sS'association,with,reported'
p12405
g3
sS'requires,immediate,medical'
p12406
g3
sS'used,as,sole'
p12407
g3
sS'use,of,sprycel'
p12408
g9
sS'other,hand,had'
p12409
g3
sS'was,given,hours'
p12410
g9
sS'substrate,of,cyp2d6'
p12411
g3
sS'once,daily,under'
p12412
g3
sS'a,severe,high'
p12413
g9
sS'be,especially,important'
p12414
g3
sS'possible,enhancement,of'
p12415
g3
sS'achieved,in,women'
p12416
g3
sS'day,lexapro,for'
p12417
g9
sS'spectrum,of,activity'
p12418
g3
sS'associated,side-effect,profiles'
p12419
g3
sS'frequency,of,adverse'
p12420
g3
sS'substrate,is,only'
p12421
g3
sS'by,mouth,use'
p12422
g9
sS'plasma,proteins,is'
p12423
g3
sS'fat,and,like'
p12424
g3
sS'patients,under,years'
p12425
g3
sS'conjunction,with,other'
p12426
g9
sS'with,the,ames'
p12427
g3
sS'should,be,particularly'
p12428
g3
sS'of,the,brovana'
p12429
g3
sS'side,effects,affecting'
p12430
g9
sS'plasma,proteins,in'
p12431
g3
sS'zyvox,or,concomitant'
p12432
g9
sS'the,cyp,c9'
p12433
g3
sS'co-administration,of,zyvox'
p12434
g9
sS'diabetes,longitudinal,studies'
p12435
g3
sS'centrally,acting,including'
p12436
g3
sS'and,mixed--pharmacological,and'
p12437
g3
sS'gel,with,other'
p12438
g3
sS'to,relevant,plasma'
p12439
g3
sS'chromatographic,assay,with'
p12440
g3
sS'the,known,inhibition'
p12441
g3
sS'clinical,studies,in'
p12442
g3
sS'clinical,relevance,of'
p12443
g3
sS'significantly,bind,to'
p12444
g3
sS'incidence,of,tbg'
p12445
g3
sS'up,to,mm'
p12446
g3
sS'be,efficacious,a'
p12447
g3
sS'zidovudine,ribavirin,can'
p12448
g9
sS'presence,of,other'
p12449
g3
sS'increased,by,when'
p12450
g3
sS'clinical,trial,has'
p12451
g9
sS'no,data,from'
p12452
g3
sS'reversing,resistance,of'
p12453
g3
sS'complications,of,retinopathy'
p12454
g3
sS'a,more,pronounced'
p12455
g3
sS'and,agents,with'
p12456
g9
sS'effect,on,tyrosine'
p12457
g9
sS'inhibitors,atomoxetine,is'
p12458
g3
sS'to,be,co-administered'
p12459
g3
sS'analyte,is,altered'
p12460
g3
sS'cysts,had,no'
p12461
g3
sS'b,the,volunteers'
p12462
g3
sS'affect,pharmacodynamics,arecoline'
p12463
g9
sS'conversion,from,one'
p12464
g3
sS'induction,of,such'
p12465
g3
sS'costs,of,schizophrenia'
p12466
g3
sS'systolic,diastolic,blood'
p12467
g9
sS'agents,and,may'
p12468
g9
sS'patients,taking,a'
p12469
g9
sS'cardiovascular,system,have'
p12470
g3
sS'with,erythromycin,and'
p12471
g3
sS'of,itraconazole,mg'
p12472
g3
sS'the,therapeutic,actions'
p12473
g9
sS'diabetics,dosage,adjustment'
p12474
g9
sS'reduce,the,action'
p12475
g9
sS'hepatic,enzyme,inducers'
p12476
g9
sS'also,included,in'
p12477
g3
sS'ribavirin,ribavirin,is'
p12478
g3
sS'administered,concurrently,concentrations'
p12479
g9
sS'therefore,foradil,should'
p12480
g3
sS'an,interaction,were'
p12481
g3
sS'or,the,polymorphic'
p12482
g3
sS'hcl,alternatives,to'
p12483
g9
sS'to,increase,respectively'
p12484
g9
sS'calculi,the,experience'
p12485
g3
sS'enzymes,respectively,responsible'
p12486
g9
sS'caused,by,overdose'
p12487
g9
sS'synergistic,for,of'
p12488
g9
sS'presence,or,absence'
p12489
g3
sS'it,does,not'
p12490
g3
sS'cations,such,as'
p12491
g9
sS'low,erpf,and'
p12492
g9
sS'interleukin-1,antagonist,and'
p12493
g9
sS'is,manifested,as'
p12494
g3
sS'combined,oral,as'
p12495
g3
sS'of,importance,to'
p12496
g3
sS'initiating,adjusting,and'
p12497
g9
sS'between,administration,of'
p12498
g9
sS'necessary,when,using'
p12499
g9
sS'any,condition,in'
p12500
g9
sS'interaction,between,novoseven'
p12501
g3
sS'in,pharmacodynamic,effect'
p12502
g3
sS'pediatric,patients,have'
p12503
g3
sS'a,small,extent'
p12504
g3
sS'of,orthostatic,hypotension'
p12505
g3
sS'will,describe,the'
p12506
g3
sS'that,inhibits,metabolism'
p12507
g9
sS'life-threatening,situations,avoid'
p12508
g3
sS'sexual,dysfunction,with'
p12509
g3
sS'nsaids,is,not'
p12510
g9
sS'on,blood,coagulation'
p12511
g3
sS'to,determine,if'
p12512
g9
sS'urinary,values,for'
p12513
g3
sS'and,optic,nerve'
p12514
g3
sS'was,found,minutes'
p12515
g3
sS'concomitantly,with,in'
p12516
g9
sS'among,the,various'
p12517
g3
sS'or,beta-adrenergic,blocking'
p12518
g9
sS'with,mg,three'
p12519
g3
sS'treated,with,a'
p12520
g3
sS'may,require,downward'
p12521
g9
sS'n,were,not'
p12522
g3
sS'targretin,capsules,is'
p12523
g9
sS'disturbances,including,complete'
p12524
g3
sS'combination,with,an'
p12525
g3
sS'folic,acid,in'
p12526
g9
sS'ingestion,of,may'
p12527
g9
sS'with,camptosar,and'
p12528
g9
sS'mice,with,a'
p12529
g3
sS'be,adversely,affected'
p12530
g3
sS'excreted,slowly,from'
p12531
g3
sS'therapy,eg,selective'
p12532
g3
sS'doses,of,taxol'
p12533
g9
sS'plasma,cortisol,concentration'
p12534
g3
sS'in,parentheses,were'
p12535
g3
sS'blockers,requires,close'
p12536
g9
sS'information,to,the'
p12537
g3
sS'are,predominantly,cyp'
p12538
g3
sS'increase,the,cns'
p12539
g3
sS'striatum,str,or'
p12540
g3
sS'of,hyperkalemia,may'
p12541
g9
sS'this,interaction,has'
p12542
g9
sS'additional,stimulus,of'
p12543
g3
sS'altered,responsiveness,to'
p12544
g3
sS'of,nonsedating,and'
p12545
g9
sS'platelet,inhibitors,including'
p12546
g3
sS'are,facilitated,by'
p12547
g3
sS'products,containing,cremophor'
p12548
g9
sS'performed,with,and'
p12549
g3
sS'up,and,proposed'
p12550
g3
sS'the,elimination,and'
p12551
g3
sS'that,do,not'
p12552
g9
sS'of,users,of'
p12553
g9
sS'cholesterol,and,triglycerides'
p12554
g9
sS'equipment,for,measurement'
p12555
g3
sS'been,suggested,that'
p12556
g9
sS'altered,before,the'
p12557
g3
sS'atorvastatin,atorvastatin,increases'
p12558
g9
sS'a,shorter,withdrawal'
p12559
g3
sS'enzyme,inhibitors,to'
p12560
g9
sS'the,prescription,of'
p12561
g9
sS'are,mainly,eliminated'
p12562
g3
sS'seen,in,these'
p12563
g3
sS'brovana,may,interfere'
p12564
g9
sS'decreases,in,fi'
p12565
g9
sS'sd,cumulative,urinary'
p12566
g3
sS'mcf-7,cells,resistant'
p12567
g3
sS'further,these,results'
p12568
g3
sS'suggest,that,blockers'
p12569
g3
sS'and,i,cigarettes'
p12570
g3
sS'genitourinary,symptoms,may'
p12571
g3
sS'p,and,a'
p12572
g9
sS'the,ability,of'
p12573
g3
sS'follow-up,measurements,should'
p12574
g3
sS'impairment,of,efficacy'
p12575
g3
sS'placebo,controlled,trials'
p12576
g3
sS'as,palpitations,or'
p12577
g3
sS'rt-pa,or,may'
p12578
g3
sS'on,oral,were'
p12579
g3
sS'and,sgpt,s-alt'
p12580
g3
sS'bleeding,have,been'
p12581
g9
sS'been,one,report'
p12582
g9
sS'was,added,one'
p12583
g3
sS'high,doses,nanm'
p12584
g3
sS'minor,increase,in'
p12585
g9
sS'leustatin,injection,is'
p12586
g3
sS'month,toxicology,study'
p12587
g3
sS'in,aortic,rings'
p12588
g3
sS'regimen,of,mg'
p12589
g9
sS'clinicians,to,the'
p12590
g9
sS'in,each,preparation'
p12591
g3
sS'absorption,and,which'
p12592
g9
sS'of,other,cytochrome'
p12593
g3
sS'single,dose,mg'
p12594
g3
sS'study,there,was'
p12595
g3
sS'activity,for,the'
p12596
g3
sS'concomitant,agent,may'
p12597
g9
sS'and,dietary-obese,rats'
p12598
g3
sS'of,nalfon,to'
p12599
g9
sS'cerebyx,are,expected'
p12600
g3
sS'agent,should,allow'
p12601
g3
sS'in,standing,systolic'
p12602
g9
sS'substrates,of,c'
p12603
g3
sS'faecalis,and,enterococcus'
p12604
g3
sS'terfenadine,no,clinically'
p12605
g3
sS'kg,p,o'
p12606
g9
sS'wishing,to,terminate'
p12607
g3
sS'in,auc,cmax'
p12608
g3
sS'by,antiresistance,determinant'
p12609
g3
sS'kg,infused,over'
p12610
g3
sS'exists,not,only'
p12611
g3
sS'p450,a4,enzyme'
p12612
g3
sS'of,an,and'
p12613
g9
sS'significantly,altered,decrease'
p12614
g9
sS'hydrochloride,and,and'
p12615
g3
sS'to,mice,with'
p12616
g3
sS'concomitantly,with,tablets'
p12617
g9
sS'urinary,recovery,of'
p12618
g3
sS'were,already,seen'
p12619
g3
sS'may,be,necessary'
p12620
g3
sS'drugs,substances,that'
p12621
g3
sS'cyp2c9,and,to'
p12622
g3
sS'be,small,or'
p12623
g3
sS'of,and,those'
p12624
g3
sS'uterine,rupture,or'
p12625
g9
sS'pneumonia,vs,serious'
p12626
g9
sS'amount,of,mna'
p12627
g3
sS'of,prolonged,or'
p12628
g9
sS'human,plasma,protein'
p12629
g3
sS'also,reported,to'
p12630
g9
sS'were,the,pharmacokinetics'
p12631
g3
sS'affected,by,such'
p12632
g3
sS'local,or,agents'
p12633
g9
sS'in,the,case'
p12634
g3
sS'compared,to,vehicle-'
p12635
g9
sS'when,such,drugs'
p12636
g3
sS'when,viracept,was'
p12637
g3
sS'to,whom,aminoglycoside'
p12638
g9
sS'and,other,statins'
p12639
g9
sS'assays,of,hydroxy'
p12640
g3
sS'drug,interactions,with'
p12641
g3
sS'with,potent,inhibitors'
p12642
g3
sS'secretion,stimulated,by'
p12643
g3
sS'viracept,should,also'
p12644
g9
sS'a,beta-adrenergic,blocking'
p12645
g9
sS'use,with,angiotensln'
p12646
g9
sS'alkylated,such,as'
p12647
g3
sS'in,symptoms,that'
p12648
g9
sS'and,as,compared'
p12649
g9
sS'tablets,a,greater'
p12650
g9
sS'and,when,amitriptyline'
p12651
g3
sS'ssris,weakness,hyperreflexia'
p12652
g9
sS'decreased,the,results'
p12653
g3
sS'beta-adrenergic,blocking,agents'
p12654
g9
sS'were,separated,by'
p12655
g3
sS'interactions,when,was'
p12656
g3
sS'of,during,therapy'
p12657
g9
sS'given,with,either'
p12658
g9
sS'sodium,are,known'
p12659
g3
sS'isoforms,cyp1a2,cyp2a6'
p12660
g3
sS'clinical,pharmacology,clinical'
p12661
g9
sS'studies,with,thus'
p12662
g3
sS'and,transient,dose-dependent'
p12663
g9
sS'events,were,experienced'
p12664
g9
sS'that,affect,hepatic'
p12665
g9
sS'predict,the,effects'
p12666
g3
sS'wistar,rats,were'
p12667
g3
sS'beta,adrenergic,antagonists'
p12668
g9
sS'potential,of,to'
p12669
g3
sS'of,skeletal,myopathy'
p12670
g3
sS'while,no,in'
p12671
g9
sS'additionally,is,a'
p12672
g3
sS'a,broad,population'
p12673
g3
sS'mc,enhance,the'
p12674
g3
sS'with,vitamin,d'
p12675
g9
sS'should,be,aware'
p12676
g9
sS'hours,prior,to'
p12677
g9
sS'is,recommended,in'
p12678
g3
sS'still,unknown,in'
p12679
g3
sS'occur,with,co-administration'
p12680
g3
sS'of,are,unaltered'
p12681
g3
sS'plasma,concentrations,drugs'
p12682
g9
sS'use,of,tricor'
p12683
g9
sS'tid,mg,qd'
p12684
g9
sS'pseudomonas,aeruginosa,were'
p12685
g3
sS'that,an,interaction'
p12686
g9
sS'be,separated,by'
p12687
g9
sS'pentamidine,may,cause'
p12688
g3
sS'time,plasma,or'
p12689
g3
sS'hypotension,in,patients'
p12690
g3
sS'diminish,the,effectiveness'
p12691
g9
sS'with,propecia,mg'
p12692
g3
sS'liver,microsomes,appears'
p12693
g3
sS'of,m,the'
p12694
g3
sS'experienced,more,commonly'
p12695
g9
sS'be,certain,that'
p12696
g9
sS'be,safely,coadministered'
p12697
g3
sS'coadministration,of,that'
p12698
g9
sS'of,increased,frequency'
p12699
g3
sS'was,a,decrease'
p12700
g9
sS'in,conjunction,with'
p12701
g3
sS'plasma,concentration,profile'
p12702
g3
sS'before,the,evening'
p12703
g9
sS'of,mg,day'
p12704
g3
sS'indicate,that,is'
p12705
g3
sS'to,agents,may'
p12706
g9
sS'camp,whereas,it'
p12707
g9
sS'small,groups,of'
p12708
g3
sS'of,cytochrome,p-450'
p12709
g9
sS'followed,by,such'
p12710
g3
sS'of,the,possibility'
p12711
g9
sS'by,the,clinical'
p12712
g3
sS'brevibloc,esmolol,hcl'
p12713
g3
sS'subjects,stabilized,on'
p12714
g9
sS'regimens,where,is'
p12715
g3
sS'studies,in,normal'
p12716
g3
sS'heparin,sodium,injection'
p12717
g3
sS'combination,to,control'
p12718
g9
sS'include,medications,such'
p12719
g3
sS'the,selection,of'
p12720
g3
sS'or,in,rats'
p12721
g3
sS'has,specifically,been'
p12722
g3
sS'a,cyp3a4,inhibitor'
p12723
g9
sS'm,or,retinyl'
p12724
g9
sS'is,a,strong'
p12725
g9
sS'in,each,study'
p12726
g3
sS'further,if,is'
p12727
g3
sS'of,diamox,in'
p12728
g9
sS'total,daily,dosage'
p12729
g3
sS'acting,nitrates,nifedipine'
p12730
g3
sS'nearly,normal,release'
p12731
g3
sS'neonates,with,restricted'
p12732
g3
sS'm2,basis,increased'
p12733
g3
sS'the,more,specific'
p12734
g3
sS'to,a,significant'
p12735
g3
sS'of,activity,against'
p12736
g3
sS'dose,during,the'
p12737
g3
sS'combination,oral,contraceptives'
p12738
g3
sS'to,the,maximum'
p12739
g3
sS'this,decrease,of'
p12740
g3
sS'increased,by,in'
p12741
g9
sS'neutropenia,and,lymphopenia'
p12742
g3
sS'factors,that,could'
p12743
g3
sS'on,monotherapy,for'
p12744
g3
sS'of,vioxx,with'
p12745
g9
sS'obesity,dorsocervical,fat'
p12746
g3
sS'use,of,after'
p12747
g3
sS'v,concentration,mm'
p12748
g3
sS'not,mutagenic,in'
p12749
g3
sS'use,of,trazodone'
p12750
g9
sS'of,other,folic'
p12751
g9
sS'elevations,on,sgpt'
p12752
g9
sS'other,coumarin-derivative,should'
p12753
g3
sS'altering,concentrations,of'
p12754
g3
sS'of,control,and'
p12755
g9
sS'variation,also,occurs'
p12756
g3
sS'aureus,to,survive'
p12757
g3
sS'conducted,with,and'
p12758
g3
sS'once,daily,produced'
p12759
g9
sS'sulfate,multivitamin,preparations'
p12760
g9
sS'the,first,hours'
p12761
g3
sS'the,interaction,studies'
p12762
g3
sS'by,contrast,mm'
p12763
g3
sS'will,become,more'
p12764
g3
sS'of,where,gastric'
p12765
g9
sS'which,the,mg'
p12766
g9
sS'we,incorporate,the'
p12767
g3
sS'from,containing,medicines'
p12768
g9
sS'pathophysiologic,abnormality,in'
p12769
g3
sS'fortovase,as,the'
p12770
g3
sS'if,inspra,is'
p12771
g9
sS'stable,exposure,during'
p12772
g3
sS'and,any,agent'
p12773
g3
sS'dosage,schedule,was'
p12774
g9
sS'discussed,herein,with'
p12775
g3
sS'observed,with,the'
p12776
g3
sS'in,multiple,sclerosis'
p12777
g3
sS'thyroid-binding,globulin,tbg'
p12778
g3
sS'in,auc0-12,and'
p12779
g9
sS'was,for,alone'
p12780
g9
sS'minutes,faster,with'
p12781
g9
sS'terminal,half-life,increased'
p12782
g9
sS'food,cns,effects'
p12783
g9
sS'hcl,and,resulted'
p12784
g9
sS'of,tablets,and'
p12785
g9
sS'and,the,time'
p12786
g3
sS'ssris,and,also'
p12787
g9
sS'to,albumin,could'
p12788
g3
sS'may,wear,off'
p12789
g3
sS'significantly,underestimates,the'
p12790
g3
sS'average,steady-,state'
p12791
g9
sS'we,evaluated,the'
p12792
g3
sS'of,using,tricor'
p12793
g9
sS'doses,increased,the'
p12794
g9
sS'cerubidine,may,also'
p12795
g9
sS'with,advanced,hiv'
p12796
g3
sS'ergomar,may,be'
p12797
g9
sS'on,an,individual'
p12798
g3
sS'inhibitory,concentrations,of'
p12799
g3
sS'agents,has,been'
p12800
g9
sS'useful,pharmacological,tool'
p12801
g3
sS'levels,have,occurred'
p12802
g3
sS'sarcoma,taxol,at'
p12803
g3
sS'caution,dose,adjustment'
p12804
g3
sS'results,from,regression'
p12805
g9
sS'to,treat,aggressively'
p12806
g3
sS'doses,of,used'
p12807
g3
sS'and,excretion,was'
p12808
g3
sS'reached,borderline,statistical'
p12809
g3
sS'causing,a,toxic'
p12810
g9
sS'antineoplastic,agents,have'
p12811
g3
sS'concurrently,with,the'
p12812
g9
sS'dictate,against,the'
p12813
g9
sS'conjunction,with,an'
p12814
g3
sS'long-term,suppression,of'
p12815
g9
sS'closely,monitored,because'
p12816
g9
sS'with,non-pegylated,alfa-2a'
p12817
g3
sS'and,the,lowest'
p12818
g9
sS'and,pancreatic,supplements'
p12819
g9
sS'injection,site,reactions'
p12820
g3
sS'well,as,topical'
p12821
g3
sS'human,novolog,should'
p12822
g3
sS'for,a,using'
p12823
g3
sS'hypotension,or,tachycardia'
p12824
g3
sS'such,combined,treatment'
p12825
g9
sS'of,in,some'
p12826
g9
sS'stopping,since,may'
p12827
g9
sS'reduction,of,dose'
p12828
g9
sS'stimulating,factor,support'
p12829
g3
sS'the,compatibility,of'
p12830
g3
sS'female,volunteers,established'
p12831
g3
sS'levobupivacaine,and,hydroxy'
p12832
g3
sS'these,individuals,may'
p12833
g3
sS'vitro,to,a'
p12834
g3
sS'administration,of,for'
p12835
g3
sS'of,either,is'
p12836
g3
sS'of,viracept,with'
p12837
g9
sS'tests,interactions,there'
p12838
g3
sS'studies,other,than'
p12839
g3
sS'to,evaluate,potential'
p12840
g3
sS'warranted,in,the'
p12841
g3
sS'that,produced,pharmacological'
p12842
g3
sS'overall,improvements,in'
p12843
g3
sS'reductions,in,other'
p12844
g3
sS'treated,with,co-administered'
p12845
g9
sS'of,mood,states'
p12846
g3
sS'for,days,a'
p12847
g9
sS'nuromax,is,lengthened'
p12848
g9
sS'have,been,cited'
p12849
g3
sS'have,the,blood'
p12850
g3
sS'for,days,n'
p12851
g3
sS'the,natriuretic,and'
p12852
g9
sS'display,the,hour'
p12853
g3
sS'in,healthy,subjects'
p12854
g9
sS'kg,decreased,the'
p12855
g9
sS'obtained,after,co-treatment'
p12856
g9
sS'over-the,counter,medicines'
p12857
g3
sS'a4,isozymes,in'
p12858
g3
sS'out,and,serum'
p12859
g3
sS'lean,and,dietary-obese'
p12860
g3
sS'reportedly,may,increase'
p12861
g9
sS'its,effect,by'
p12862
g3
sS'between,cecectomized,and'
p12863
g3
sS'lymphoma,hiv-nhl,the'
p12864
g3
sS'haart,is,still'
p12865
g3
sS'effect,of,clonazepam'
p12866
g3
sS'and,impairment,of'
p12867
g3
sS'strattera,may,be'
p12868
g9
sS'that,the,dosage'
p12869
g9
sS'by,concurrent,treatment'
p12870
g9
sS'on,the,sixth'
p12871
g9
sS'of,myobloc,and'
p12872
g9
sS'on,resistance,arteries'
p12873
g3
sS'mao,inhibitors,within'
p12874
g9
sS'reported,when,channel'
p12875
g9
sS'theobromine,grepafloxacin,like'
p12876
g9
sS'of,certain,by'
p12877
g9
sS'cytosol,to,the'
p12878
g3
sS'in,the,peak'
p12879
g3
sS'of,additional,calcium-containing'
p12880
g3
sS'effects,of,antagonists'
p12881
g3
sS'are,that,have'
p12882
g3
sS'rebound,in,uptake'
p12883
g9
sS'dryness,of,mouth'
p12884
g3
sS'cardiac,deaths,three'
p12885
g3
sS'practice,resulted,in'
p12886
g3
sS'cholestyramine,an,anionic-binding'
p12887
g9
sS'the,simultaneous,administration'
p12888
g3
sS'moieties,significantly,improves'
p12889
g3
sS'of,absorption,by'
p12890
g9
sS'volunteers,n,pretreatment'
p12891
g9
sS'good,inhibition,while'
p12892
g3
sS'achieving,a,maximum'
p12893
g3
sS'three,well-controlled,studies'
p12894
g3
sS'prothrombin,time,is'
p12895
g9
sS'especially,cyclic,may'
p12896
g9
sS'nimbex,in,patients'
p12897
g9
sS'rr,is,at'
p12898
g3
sS'because,a,psychotic'
p12899
g3
sS'little,experience,with'
p12900
g3
sS'body,weight,to'
p12901
g3
sS'plasma,substrate,is'
p12902
g3
sS'an,intravenous,dose'
p12903
g3
sS'depressive,symptoms,support'
p12904
g3
sS'patients,treated,concurrently'
p12905
g9
sS'in,the,sst'
p12906
g3
sS'prothrombin,time,in'
p12907
g9
sS'the,reduced,risk'
p12908
g3
sS'by,patients,with'
p12909
g9
sS'including,antiparkinsonism,agents'
p12910
g3
sS'by,flushing,rash'
p12911
g3
sS'to,oral,may'
p12912
g3
sS'of,children,who'
p12913
g3
sS'hemostasis,nsaids,aspirin'
p12914
g3
sS'in,slow,metabolizers'
p12915
g3
sS'trials,of,the'
p12916
g9
sS'because,elderly,patients'
p12917
g3
sS'two,hour,period'
p12918
g3
sS'has,no,effect'
p12919
g3
sS'to,affect,protein'
p12920
g3
sS'the,dimethylprostaglandin,e2'
p12921
g3
sS'for,cyp3a4,there'
p12922
g3
sS'significantly,increased,in'
p12923
g3
sS'evaluated,but,may'
p12924
g9
sS'talk,to,your'
p12925
g3
sS'not,however,appear'
p12926
g3
sS'understanding,the,breadth'
p12927
g3
sS'usually,this,has'
p12928
g3
sS'the,blood,and'
p12929
g9
sS'time,reported,as'
p12930
g9
sS'coagulation,diclofenac,increases'
p12931
g3
sS'was,conducted,to'
p12932
g3
sS'or,or,with'
p12933
g9
sS'degree,in,the'
p12934
g3
sS'reached,whereas,the'
p12935
g3
sS'fetal,variations,in'
p12936
g3
sS'is,considerable,evidence'
p12937
g3
sS'mind,when,bleeding'
p12938
g3
sS'or,before,day'
p12939
g3
sS'sex,hormone-binding,globulin'
p12940
g3
sS'of,plendil,with'
p12941
g3
sS'mg,l,and'
p12942
g3
sS'administration,of,compounds'
p12943
g9
sS'from,controlled,clinical'
p12944
g3
sS'septic,shock,in'
p12945
g3
sS'not,affected,when'
p12946
g3
sS'coadministration,of,may'
p12947
g9
sS'by,reaction,with'
p12948
g3
sS'and,nonsteroidal,were'
p12949
g3
sS'an,agent,of'
p12950
g3
sS'used,successfully,concurrently'
p12951
g3
sS'weight,gain,when'
p12952
g9
sS'wide,distribution,of'
p12953
g3
sS'antiepileptic,the,more'
p12954
g3
sS'binding,of,but'
p12955
g9
sS'interaction,with,either'
p12956
g3
sS'half-life,and,an'
p12957
g9
sS'physicians,should,be'
p12958
g9
sS'we,compared,pharmacokinetics'
p12959
g3
sS'a,subset,of'
p12960
g3
sS'b,for,yeast'
p12961
g3
sS'ie,decreased,prothrom-bin'
p12962
g9
sS'antifungal,agents,such'
p12963
g3
sS'bid,did,not'
p12964
g3
sS'and,chop,chemotherapy'
p12965
g3
sS'or,other,factors'
p12966
g3
sS'thinners,may,decrease'
p12967
g9
sS'on,day5,of'
p12968
g9
sS'p,o,every'
p12969
g9
sS'require,empiric,adjustment'
p12970
g3
sS'initiation,of,and'
p12971
g9
sS'serum,triglyceride,and'
p12972
g3
sS'life-threatening,ventricular,arrhythmias'
p12973
g3
sS'anticoagulants,thyroid,hormones'
p12974
g3
sS'colony,stimulating,factor'
p12975
g3
sS'a,dose,range'
p12976
g9
sS'induce,cyp3a4,eg'
p12977
g9
sS'reduce,intestinal,absorption'
p12978
g9
sS'in,the,failing'
p12979
g3
sS'healthy,men,n'
p12980
g3
sS'of,prostate,epithelium'
p12981
g9
sS'with,slow-release,mg'
p12982
g3
sS'changed,by,coadministration'
p12983
g9
sS'taking,medications,for'
p12984
g3
sS'of,these,results'
p12985
g3
sS'into,light,and'
p12986
g3
sS'decreased,by,during'
p12987
g3
sS'be,clinically,relevant'
p12988
g3
sS'when,administering,other'
p12989
g3
sS'have,been,inconsistent'
p12990
g3
sS'randomly,assigned,to'
p12991
g3
sS'patients,and,return'
p12992
g3
sS'begun,in,patients'
p12993
g9
sS'control,period,in'
p12994
g9
sS'organs,actively,concentrating'
p12995
g3
sS'contraindicated,in,patients'
p12996
g9
sS'feasible,as,specific'
p12997
g3
sS'multiple,dose,studies'
p12998
g9
sS'm-tco,injection,with'
p12999
g9
sS'known,to,slow'
p13000
g9
sS'major,contributing,factor'
p13001
g9
sS'be,administered,during'
p13002
g9
sS'given,weekly,subcutaneous'
p13003
g3
sS'cyp1a2,which,may'
p13004
g9
sS'organisms,but,it'
p13005
g3
sS'biopsy,revealed,necrotizing'
p13006
g3
sS'of,usually,depresses'
p13007
g9
sS'may,be,indicated'
p13008
g3
sS'h2-receptor,antagonists,such'
p13009
g9
sS'oral,twice,daily'
p13010
g9
sS'over,minutes,were'
p13011
g3
sS'synergistic,such,that'
p13012
g9
sS'patients,using,these'
p13013
g3
sS'not,exhibit,monoamine'
p13014
g9
sS'growth,caused,by'
p13015
g3
sS'on,aed,concentration'
p13016
g3
sS'because,amplifies,the'
p13017
g9
sS'of,the,cyp2c9'
p13018
g9
sS'induction,of,its'
p13019
g3
sS'from,inhibition,of'
p13020
g3
sS'many,patients,on'
p13021
g3
sS'stability,in,auc'
p13022
g3
sS'were,agonists,in'
p13023
g9
sS'by,cyp2d6,and'
p13024
g9
sS'of,as,assessed'
p13025
g3
sS'rapid,progression,in'
p13026
g3
sS'with,decreases,in'
p13027
g9
sS'and,coly-mycin,m'
p13028
g9
sS'chemotherapy,regimen,plus'
p13029
g3
sS'selectively,bred,for'
p13030
g3
sS'activity,and,it'
p13031
g3
sS'over,time,were'
p13032
g3
sS'that,lodine,can'
p13033
g9
sS'be,longer,in'
p13034
g3
sS'with,the,data'
p13035
g3
sS'treated,with,cordarone'
p13036
g3
sS'and,k,may'
p13037
g9
sS'other,medications,that'
p13038
g9
sS'acid-catalyzed,ethanol-drug,reaction'
p13039
g3
sS'vitro,may,displace'
p13040
g9
sS'given,i,p'
p13041
g3
sS'or,immediately,following'
p13042
g9
sS'cessation,with,or'
p13043
g3
sS'with,or,the'
p13044
g9
sS'meaningful,increases,in'
p13045
g3
sS'hydroalcoholic,solutions,with'
p13046
g3
sS'bodyweight,gain,somnolence'
p13047
g3
sS'numbers,of,subjects'
p13048
g3
sS'number,of,including'
p13049
g9
sS'the,monomeric,disintegrins'
p13050
g3
sS'injury,or,when'
p13051
g3
sS'periodic,liver,function'
p13052
g3
sS'compared,with,those'
p13053
g3
sS'additional,calcium-containing,preparations'
p13054
g3
sS'shown,not,to'
p13055
g3
sS'agents,should,precede'
p13056
g3
sS'of,or,were'
p13057
g3
sS'not,been,evaluated'
p13058
g3
sS'and,presumably,a'
p13059
g3
sS'should,be,used'
p13060
g3
sS'polyenes,are,determined'
p13061
g3
sS'evidence,supporting,the'
p13062
g9
sS'and,get,the'
p13063
g3
sS'of,prostatic,epithelium'
p13064
g9
sS'test,interactions,serum'
p13065
g3
sS'soaps,and,cleansers'
p13066
g3
sS'effects,of,should'
p13067
g3
sS'be,detected,in'
p13068
g3
sS'immediately,following,or'
p13069
g9
sS'point,in,cerebral'
p13070
g3
sS'from,receiving,growth'
p13071
g3
sS'in,effect,should'
p13072
g9
sS'against,of,resistant'
p13073
g3
sS'is,a,second'
p13074
g3
sS'may,cause,a'
p13075
g3
sS'produce,some,inhibiting'
p13076
g3
sS'may,develop,delirium'
p13077
g9
sS'body,weight,were'
p13078
g3
sS'only,for,documented'
p13079
g3
sS'in,rats,have'
p13080
g9
sS'of,taxol,is'
p13081
g3
sS'have,been,a'
p13082
g9
sS'h2-receptor,antagonists,co-administration'
p13083
g9
sS'rats,treated,with'
p13084
g3
sS'risk,of,renal'
p13085
g9
sS'mg,was,admini'
p13086
g9
sS'celexa,the,two'
p13087
g9
sS'the,usual,doses'
p13088
g3
sS'tagamet,apparently,through'
p13089
g9
sS'future,studies,should'
p13090
g3
sS'of,prior,to'
p13091
g9
sS'with,mefloquine,have'
p13092
g3
sS'epa,dose,should'
p13093
g3
sS'daily,as,a'
p13094
g9
sS'was,observed,on'
p13095
g9
sS'the,serotonergic,effects'
p13096
g9
sS'cyclopentyl-1,dipropylxanthine,dpcpx'
p13097
g3
sS'serum,auc,cmax'
p13098
g9
sS'viii,antigen,viii'
p13099
g3
sS'receiving,hcl,has'
p13100
g9
sS'other,suitable,anticoagulation'
p13101
g9
sS'for,additive,or'
p13102
g3
sS'bosentan,is,an'
p13103
g3
sS'decreased,in,the'
p13104
g9
sS'hepatic,blood,flow'
p13105
g3
sS'together,at,all'
p13106
g3
sS'closely,observed,for'
p13107
g3
sS'oleate,and,increased'
p13108
g3
sS'ssri-tcainteractions,may,pose'
p13109
g9
sS'cyp3a4,would,be'
p13110
g3
sS'medications,including,inhaled'
p13111
g3
sS'kind,with,mefloquine'
p13112
g9
sS'some,have,also'
p13113
g9
sS'diminish,the,effect'
p13114
g9
sS'in,other,treatment'
p13115
g3
sS'hepatic,insufficiency,resulted'
p13116
g3
sS'metformin,in,healthy'
p13117
g9
sS'administering,other,for'
p13118
g3
sS'concomitantly,may,need'
p13119
g9
sS'glucose,oxidase,reactions'
p13120
g3
sS'dosing,lower,maintenance'
p13121
g9
sS'a,serotonin,releaser'
p13122
g9
sS'juice,should,be'
p13123
g9
sS'experiences,in,patients'
p13124
g9
sS'not,co-administered,with'
p13125
g3
sS'who,have,been'
p13126
g3
sS'etc,should,be'
p13127
g3
sS'other,or,as'
p13128
g9
sS'extensively,studied,and'
p13129
g3
sS'memory,systems,most'
p13130
g3
sS'pressure,response,to'
p13131
g3
sS'of,relative,to'
p13132
g9
sS'interactions,are,listed'
p13133
g9
sS'required,with,prolonged'
p13134
g3
sS'aeds,during,placebo-controlled'
p13135
g3
sS'a,phase,i'
p13136
g9
sS'since,its,approval'
p13137
g3
sS'interactions,positive,direct'
p13138
g3
sS'some,early,studies'
p13139
g3
sS'gastrointestinal,effects,without'
p13140
g9
sS'and,wide,distribution'
p13141
g3
sS'history,of,neoplasia'
p13142
g3
sS'psychotic,patients,with'
p13143
g3
sS'co,administered,with'
p13144
g3
sS'shown,that,after'
p13145
g3
sS'the,liver,gallbladder'
p13146
g3
sS'recordings,of,rat'
p13147
g3
sS'increasing,overall,response'
p13148
g3
sS'rifampin,co-administration,of'
p13149
g9
sS'even,though,such'
p13150
g3
sS'alone,in,the'
p13151
g3
sS'antiretroviral,agents,including'
p13152
g3
sS'ranges,within,the'
p13153
g3
sS'daily,with,food'
p13154
g9
sS'resin,may,bind'
p13155
g3
sS'experienced,by,approximately'
p13156
g3
sS'order,to,maintain'
p13157
g3
sS'when,indocin,is'
p13158
g9
sS'compounds,are,metabolized'
p13159
g3
sS'in,the,skin'
p13160
g3
sS'information,assists,in'
p13161
g3
sS'metabolism,concomitant,use'
p13162
g3
sS'of,a,higher'
p13163
g3
sS'of,pharmacologic,doses'
p13164
g3
sS'of,the,hplc'
p13165
g3
sS'that,have,the'
p13166
g3
sS'used,in,clinical'
p13167
g3
sS'dietary-obese,rats,responses'
p13168
g3
sS'after,the,addition'
p13169
g9
sS'serum,time,profiles'
p13170
g3
sS'has,been,described'
p13171
g3
sS'taxol,was,given'
p13172
g9
sS'in,addition,and'
p13173
g3
sS'repeated,courses,of'
p13174
g3
sS'is,unknown,whether'
p13175
g3
sS'the,daily,dosage'
p13176
g3
sS'of,on,malignant'
p13177
g9
sS'anorectic,and,stimulatory'
p13178
g9
sS'by,and,resulted'
p13179
g9
sS'may,inhibit,gastrointestinal'
p13180
g3
sS'given,the,substantial'
p13181
g9
sS'and,metacercariae,of'
p13182
g3
sS'effects,with,these'
p13183
g3
sS'is,not,particularly'
p13184
g3
sS'agent,with,multiple'
p13185
g9
sS'oxidases,and,on'
p13186
g3
sS'mg,and,mg'
p13187
g9
sS'with,fentanyl,cyp3a4'
p13188
g3
sS'clinical,response,and'
p13189
g3
sS'greater,than,usual'
p13190
g9
sS'ace,inhibitors,beta'
p13191
g3
sS'mg,led,to'
p13192
g9
sS'cramps,muscular,fatigue'
p13193
g3
sS'prevent,the,adrenergic'
p13194
g3
sS'preparations,containing,carbohydrate-splitting'
p13195
g9
sS'may,also,result'
p13196
g9
sS'of,oleate,and'
p13197
g3
sS'cause,increases,in'
p13198
g3
sS'is,not,likely'
p13199
g3
sS'uricosuric,agents,since'
p13200
g9
sS'in,subcortical,structures'
p13201
g3
sS'with,other,monoamine'
p13202
g9
sS'inhibitors,rare,instances'
p13203
g9
sS'lower,seizure,threshold'
p13204
g9
sS'was,decreased,by'
p13205
g9
sS'acetazolamide,azole,antifungals'
p13206
g9
sS'does,not,significantly'
p13207
g3
sS'describe,modest,elevations'
p13208
g9
sS'explain,in,part'
p13209
g3
sS'currently,receiving,careful'
p13210
g9
sS'normal,release,in'
p13211
g3
sS'jackfruit,contain,a'
p13212
g3
sS'of,patients,before'
p13213
g3
sS'of,their,dosage'
p13214
g9
sS'on,developing,mathematical'
p13215
g3
sS'to,those,seen'
p13216
g9
sS'one-stage,factor,assays'
p13217
g3
sS'with,nsaids,the'
p13218
g3
sS'adverse,reaction,and'
p13219
g3
sS'chromatogr,should,be'
p13220
g3
sS'of,especially,in'
p13221
g9
sS'retinyl,acetate,affected'
p13222
g9
sS'therefore,plasma,concentrations'
p13223
g9
sS'toxicity,than,when'
p13224
g9
sS'clotting,factor,vii'
p13225
g3
sS'anhydrase,inhibitors,as'
p13226
g9
sS'each,would,coincide'
p13227
g3
sS'of,rat,spinal'
p13228
g3
sS'the,cytosol,to'
p13229
g3
sS'of,vardenafil,should'
p13230
g9
sS'with,or,potent'
p13231
g9
sS'this,agent,should'
p13232
g3
sS'excretion,of,immunoreactive'
p13233
g3
sS'available,for,chelation'
p13234
g3
sS'a,diagnostic,challenge'
p13235
g3
sS'advised,if,and'
p13236
g3
sS'and,a,only'
p13237
g3
sS'diseases,such,as'
p13238
g3
sS'alter,plasma,concentrations'
p13239
g9
sS'bioavailability,parameters,the'
p13240
g3
sS'of,anafranil,to'
p13241
g9
sS'infarction,myocarditis,ventricular'
p13242
g9
sS'some,the,dependency'
p13243
g3
sS'discontinuation,of,concomitant'
p13244
g9
sS'vary,in,the'
p13245
g3
sS'study,in,rats'
p13246
g3
sS'responsible,for,converting'
p13247
g9
sS'can,cause,hypothyroidism'
p13248
g3
sS'aerosol,particles,appeared'
p13249
g3
sS'depressants,including,has'
p13250
g9
sS'different,for,the'
p13251
g3
sS'adjustment,of,dosage'
p13252
g3
sS'hormones,complex,anions'
p13253
g3
sS'therapeutic,efficacy,and'
p13254
g3
sS'elevate,serum,levels'
p13255
g9
sS'cephalosporins,are,known'
p13256
g3
sS'calcium-containing,preparations,should'
p13257
g3
sS'acquainted,with,the'
p13258
g3
sS'use,for,oral'
p13259
g3
sS'liver,and,it'
p13260
g3
sS'oral,resulted,in'
p13261
g9
sS'normal,volunteers,n'
p13262
g9
sS'inducer,at,mg'
p13263
g9
sS'b12,which,can'
p13264
g9
sS'gelatinosa,neurons,including'
p13265
g3
sS'rates,compliance,and'
p13266
g3
sS'positive,coombs,test'
p13267
g3
sS'appear,to,alter'
p13268
g3
sS'decrease,of,nucleophosmin'
p13269
g3
sS'd2,vitamin,d3'
p13270
g9
sS'to,one-half,and'
p13271
g3
sS'a,similar,mechanism'
p13272
g3
sS'randomized,in,an'
p13273
g3
sS'with,these,compounds'
p13274
g3
sS'carbonic,anhydrase,inhibitors'
p13275
g9
sS'chapter,and,chapter'
p13276
g3
sS'nanm,antagonized,the'
p13277
g9
sS'agent,and,an'
p13278
g9
sS'no,dose,relationship'
p13279
g3
sS'not,alter,glucose'
p13280
g3
sS'cautioned,that,the'
p13281
g3
sS'heparin,effect,oral'
p13282
g3
sS'test,for,when'
p13283
g3
sS'the,injection,should'
p13284
g3
sS'absorption,of,may'
p13285
g9
sS'considerably,lower,in'
p13286
g9
sS'specific,studies,in'
p13287
g3
sS'few,systemic,data'
p13288
g3
sS'sodium,bicarbonate,used'
p13289
g9
sS'when,administering,hcl'
p13290
g9
sS'of,circulating,fluids'
p13291
g3
sS'disorientation,anxiety,agitation'
p13292
g3
sS'epoxide,hydrolase,inhibitors'
p13293
g3
sS'acute,myocardial,infarction'
p13294
g3
sS'conducted,to,assess'
p13295
g3
sS'dose,adjustment,for'
p13296
g9
sS'fundus,pulsation,amplitude'
p13297
g3
sS'at,the,insp'
p13298
g3
sS'produced,a,tolerance'
p13299
g9
sS'healthy,volunteers,a'
p13300
g9
sS'prothrombin,determinations,are'
p13301
g3
sS'higher,doses,decreased'
p13302
g3
sS'of,the,pelvic'
p13303
g3
sS'strain,of,enterococci'
p13304
g3
sS'healthy,volunteers,n'
p13305
g3
sS'studies,in,multiple'
p13306
g3
sS'on,prolonging,atrioventricular'
p13307
g9
sS'in,patients,administered'
p13308
g9
sS'combination,of,with'
p13309
g9
sS'the,magnitude,and'
p13310
g9
sS'their,dose,increased'
p13311
g3
sS'present,study,it'
p13312
g3
sS'involved,in,nociception'
p13313
g3
sS'effect,of,and'
p13314
g9
sS'depression,of,cardiac'
p13315
g9
sS'effector,immediate-early,gene'
p13316
g3
sS'inhibitors,nefazodone,cyclosporine'
p13317
g3
sS'discontinued,before,parathyroid-function'
p13318
g3
sS'on,white,male'
p13319
g3
sS'interfere,with,one-stage'
p13320
g3
sS'that,are,likely'
p13321
g3
sS'cause,elevated,plasma'
p13322
g9
sS'effects,deriving,from'
p13323
g3
sS'concentrations,considerably,lower'
p13324
g9
sS'such,as,have'
p13325
g9
sS'in,the,pharmacokinetic'
p13326
g3
sS'cyclosporine,increased,activity'
p13327
g9
sS'doses,or,too'
p13328
g3
sS'require,anticoagulation,should'
p13329
g3
sS'higher,when,given'
p13330
g9
sS'significantly,affected,prothrombin'
p13331
g3
sS'because,many,are'
p13332
g3
sS'less,than,seven'
p13333
g3
sS'may,be,precipitated'
p13334
g3
sS'risk,of,myocardial'
p13335
g3
sS'treatment,for,up'
p13336
g3
sS'uptake,of,uptake-1'
p13337
g3
sS'a,different,site'
p13338
g3
sS'cytochrome,p450,isoforms'
p13339
g3
sS'and,clinical,pharmacology'
p13340
g9
sS'ca,store,and'
p13341
g3
sS'after,treatment,with'
p13342
g3
sS'contractile,responses,to'
p13343
g9
sS'that,the,potent'
p13344
g9
sS'inhibitors,and,fentanyl'
p13345
g9
sS'association,functional,class'
p13346
g3
sS'because,both,lower'
p13347
g9
sS'receiving,micronase,the'
p13348
g3
sS'methotrexate,in,an'
p13349
g3
sS'molt-4,cells,revealed'
p13350
g9
sS'sustiva,are,summarized'
p13351
g3
sS'disturbances,patients,with'
p13352
g3
sS'administered,with,lodine'
p13353
g3
sS'and,the,type'
p13354
g3
sS'after,myocardial,infarction'
p13355
g3
sS'synthesis,secretion,distribution'
p13356
g3
sS'novel,peripherally,restricted'
p13357
g9
sS'may,occur,potentiating'
p13358
g3
sS'method,of,barrier'
p13359
g9
sS'ast,and,sgpt'
p13360
g9
sS'methods,gdh,pqq-based'
p13361
g3
sS'benefit,while,avoiding'
p13362
g3
sS'and,or,to'
p13363
g9
sS'injection,of,min'
p13364
g9
sS'their,differential,effects'
p13365
g3
sS'aspirin,in,normal'
p13366
g9
sS'by,to,for'
p13367
g9
sS'and,nicotine-induced,release'
p13368
g9
sS'for,incombination,with'
p13369
g3
sS'agents,calcium-blocking,agents'
p13370
g3
sS'of,benign,ovarian'
p13371
g3
sS'in,surgery,or'
p13372
g3
sS'enzyme,systems,responsible'
p13373
g3
sS'we,investigated,the'
p13374
g3
sS'lithium,in,a'
p13375
g9
sS'regarding,the,risk'
p13376
g3
sS'blockers,may,also'
p13377
g9
sS'in,fertility,and'
p13378
g3
sS'of,dcg-iv,and'
p13379
g3
sS'on,the,traction'
p13380
g3
sS'the,evening,meal'
p13381
g3
sS'nimbex,are,unknown'
p13382
g9
sS'disorder,tremor,rigidity'
p13383
g3
sS'antagonists,administered,in'
p13384
g3
sS'caution,when,it'
p13385
g3
sS'compared,with,lean'
p13386
g3
sS'studied,in,vivo'
p13387
g3
sS'and,and,other'
p13388
g9
sS'of,significant,hypotension'
p13389
g9
sS'nicardipine,hcl,usually'
p13390
g9
sS'the,mean,drug'
p13391
g3
sS'of,patients,the'
p13392
g3
sS'dose,is,co-administered'
p13393
g9
sS'of,alone,or'
p13394
g3
sS'total,concentrations,just'
p13395
g3
sS'other,therapies,commonly'
p13396
g3
sS'decrease,in,prothrombin'
p13397
g3
sS'trials,of,such'
p13398
g3
sS'liver,was,altered'
p13399
g3
sS'and,including,or'
p13400
g3
sS'the,response,to'
p13401
g3
sS'plasma,auc,and'
p13402
g9
sS'inhibition,of,on'
p13403
g3
sS'comparison,of,administration'
p13404
g3
sS'this,is,not'
p13405
g3
sS'two-way,crossover,study'
p13406
g3
sS'female,rats,received'
p13407
g3
sS'to,toxoids,and'
p13408
g9
sS'and,the,dose'
p13409
g9
sS'well,as,those'
p13410
g9
sS'addition,results,from'
p13411
g9
sS'can,produce,clinically'
p13412
g9
sS'these,include,the'
p13413
g3
sS'normal,healthy,male'
p13414
g3
sS'use,cannot,be'
p13415
g3
sS'agents,increasing,serum'
p13416
g9
sS'and,auc,exhibited'
p13417
g3
sS'performed,at,weekly'
p13418
g3
sS'cushingoid,appearance,have'
p13419
g3
sS'depressant,effects,when'
p13420
g9
sS'action,are,frequently'
p13421
g3
sS'premature,atherosclerotic,cardiovascular'
p13422
g3
sS'and,some,oxytocic'
p13423
g9
sS'of,the,available'
p13424
g3
sS'reduced,cmax,and'
p13425
g9
sS'in,severe,hyperkalemia'
p13426
g9
sS'of,suggest,a'
p13427
g9
sS'patients,with,acute'
p13428
g9
sS'cns-depressive,effect,of'
p13429
g9
sS'should,therefore,not'
p13430
g9
sS'reduction,is,not'
p13431
g9
sS'with,subsequent,diagnostic'
p13432
g3
sS'and,especially,those'
p13433
g9
sS'responding,in,a'
p13434
g9
sS'the,human,cytochrome'
p13435
g3
sS'and,inflammatory,disorders'
p13436
g9
sS'of,alcoholic,beverages'
p13437
g3
sS'the,same,study'
p13438
g3
sS'patient,has,undergone'
p13439
g3
sS'and,hdl2,cholesterol'
p13440
g3
sS'to,interference,with'
p13441
g3
sS'and,the,rbc'
p13442
g3
sS'system,of,primary'
p13443
g3
sS'or,h,antagonists'
p13444
g9
sS'the,pharmacologic,effects'
p13445
g9
sS'cyp3a4,inhibitor,mg'
p13446
g9
sS'block,the,pharmacologic'
p13447
g9
sS'zevalin,therapeutic,regimen'
p13448
g3
sS'done,extremely,cautiously'
p13449
g9
sS'feeding,and,effective'
p13450
g3
sS'with,another,and'
p13451
g9
sS'cecum,in,the'
p13452
g3
sS'quinidine,and,doses'
p13453
g3
sS'of,a,including'
p13454
g9
sS'of,a,clinical'
p13455
g9
sS'chylomicron-like,emulsion,model'
p13456
g3
sS'predisposed,mice,c57bl'
p13457
g3
sS'demographics,nhl,characteristics'
p13458
g3
sS'muscle,pain,tinnitus'
p13459
g3
sS'the,literature,suggests'
p13460
g3
sS'or,in,those'
p13461
g3
sS'indinavir,is,metabolized'
p13462
g3
sS'screening,for,that'
p13463
g3
sS'specifically,they,have'
p13464
g3
sS'they,do,not'
p13465
g9
sS'relevant,pharmacokinetic,and'
p13466
g3
sS'depressed,the,amplitudes'
p13467
g3
sS'synthetic,steroidal,and'
p13468
g3
sS'is,far,greater'
p13469
g3
sS'photic,evoked,potential'
p13470
g3
sS'transfer,to,reverse'
p13471
g3
sS'administration,of,hcl'
p13472
g9
sS'duloxetine-treated,patients,had'
p13473
g3
sS'by,simply,normalizing'
p13474
g3
sS'slight,intrinsic,effect'
p13475
g9
sS'the,possible,effectiveness'
p13476
g9
sS'compounds,including,sodium'
p13477
g9
sS'on,potential,interactions'
p13478
g3
sS'co-administered,with,other'
p13479
g9
sS'not,clinically,significant'
p13480
g3
sS'kg,dose,of'
p13481
g3
sS'solution,may,potentiate'
p13482
g9
sS'of,that,in'
p13483
g3
sS'lies,in,individualizing'
p13484
g3
sS'previously,unrecognized,interaction'
p13485
g9
sS'of,schizophrenia,in'
p13486
g3
sS'not,advisable,to'
p13487
g9
sS'presynaptic,defect,in'
p13488
g3
sS'of,ergot-type,oxytocic'
p13489
g3
sS'nuromax,include,certain'
p13490
g9
sS'the,production,of'
p13491
g3
sS'act,of,unprotected'
p13492
g3
sS'epa,supplements,should'
p13493
g3
sS'therapeutic,concentrations,of'
p13494
g3
sS'form,of,contraception'
p13495
g3
sS'omega-agatoxin,iva,p-type'
p13496
g3
sS'who,were,receiving'
p13497
g3
sS'mice,min,before'
p13498
g3
sS'use,of,mg'
p13499
g3
sS'potential,of,binding'
p13500
g9
sS'of,hypothyroidism,in'
p13501
g3
sS'oral,the,dose'
p13502
g3
sS'patients,the,effects'
p13503
g3
sS'eight,experiments,the'
p13504
g3
sS'of,with,adefovir'
p13505
g3
sS'therapy,is,discontinued'
p13506
g9
sS'non-hodgkin,lymphoma,hiv-nhl'
p13507
g3
sS'the,pd2,values'
p13508
g3
sS'high,dose,of'
p13509
g9
sS'c57bl,n,was'
p13510
g3
sS'by,the,at'
p13511
g3
sS'reduction,that,reached'
p13512
g3
sS'prolonged,the,half-life'
p13513
g9
sS'body,via,conjugation'
p13514
g9
sS'serotype,o11,strains'
p13515
g3
sS'cases,of,rhabdomyolysis'
p13516
g3
sS'decreases,the,binding'
p13517
g9
sS'from,multiple,exposure'
p13518
g3
sS'of,altered,safety'
p13519
g3
sS'primarily,to,enhance'
p13520
g9
sS'be,necessary,during'
p13521
g9
sS'reported,rarely,when'
p13522
g9
sS'logical,approach,to'
p13523
g3
sS'a,growing,problem'
p13524
g3
sS'electrocardiograms,performed,at'
p13525
g3
sS'of,organic,if'
p13526
g9
sS'altering,cyp1a2-mediated,metabolism'
p13527
g3
sS'number,of,compounds'
p13528
g9
sS'or,follow,dosing'
p13529
g3
sS'regarding,the,effect'
p13530
g9
sS'the,heart,rate'
p13531
g9
sS'absolute,but,a'
p13532
g3
sS'administration,of,norpace'
p13533
g9
sS'uninfected,volunteers,developed'
p13534
g9
sS'of,with,acamprosate'
p13535
g9
sS'clearance,or,cyp-mediated'
p13536
g3
sS'concentration,of,nevirapine'
p13537
g3
sS'effects,ways,to'
p13538
g3
sS'susceptibility,in,enterococcus'
p13539
g3
sS'nociception,was,performed'
p13540
g3
sS'vs,placebo,n'
p13541
g3
sS'secretion,in,isolated'
p13542
g3
sS'indices,should,be'
p13543
g3
sS'plasma,or,the'
p13544
g3
sS'vivo,platelet,aggregation'
p13545
g3
sS'in,which,clearance'
p13546
g9
sS'rats,at,doses'
p13547
g3
sS'steady,state,level'
p13548
g3
sS'response,to,or'
p13549
g9
sS'nevirapinemay,lower,the'
p13550
g9
sS'may,or,may'
p13551
g3
sS'a,maximal,decrease'
p13552
g3
sS'ketoprofen,decreases,platelet'
p13553
g3
sS'in,combination,with'
p13554
g3
sS'of,on,day'
p13555
g3
sS'a,tendency,toward'
p13556
g3
sS'in,vitro,aspirin-mediated'
p13557
g3
sS'differences,were,reflected'
p13558
g3
sS'backwards,displacement,of'
p13559
g3
sS'hormonal,may,also'
p13560
g9
sS'effectiveness,in,children'
p13561
g3
sS'cholinergic,crisis,may'
p13562
g3
sS'the,initiation,of'
p13563
g3
sS'diltiazem,in,patients'
p13564
g9
sS'if,resumed,during'
p13565
g3
sS'after,a,dose'
p13566
g9
sS'counteract,the,action'
p13567
g9
sS'injection,of,vehicle'
p13568
g3
sS'of,other,has'
p13569
g3
sS'vioxx,is,co-administered'
p13570
g3
sS'to,avoid,administration'
p13571
g3
sS'frequent,for,women'
p13572
g3
sS'other,therapy,has'
p13573
g3
sS'results,using,the'
p13574
g3
sS'diamox,modifies,metabolism'
p13575
g9
sS'oxytocic,may,result'
p13576
g9
sS'or,factors,v'
p13577
g3
sS'to,the,enhancement'
p13578
g9
sS'be,administered,or'
p13579
g3
sS'between,prostin,vr'
p13580
g3
sS'assay,as,a'
p13581
g3
sS'be,administered,on'
p13582
g3
sS'in,another,report'
p13583
g9
sS'that,pretreatment,with'
p13584
g3
sS'also,referred,to'
p13585
g3
sS'of,or,oral'
p13586
g9
sS'tablets,are,used'
p13587
g3
sS'for,protein,may'
p13588
g3
sS'the,probable,benefits'
p13589
g9
sS'oxo-desethylzaleplon,and,oxo-desethylzaleplon'
p13590
g3
sS'monitoring,of,pulse'
p13591
g3
sS'cyp3a4,substrates,known'
p13592
g9
sS'goal-directed,behavior,in'
p13593
g3
sS'motility,of,day-old'
p13594
g9
sS'agents,disturbances,of'
p13595
g9
sS'containing,maalox,decreased'
p13596
g9
sS'when,administering,this'
p13597
g3
sS'efficacy,and,pregnancy'
p13598
g3
sS'individual,patients,may'
p13599
g9
sS'and,an,oral'
p13600
g9
sS'and,fehling,s'
p13601
g3
sS'whose,absorption,can'
p13602
g9
sS'on,the,fraction'
p13603
g3
sS'eg,implants,injectables'
p13604
g3
sS'cardiotoxic,or,hepatotoxic'
p13605
g9
sS'develop,a,mild'
p13606
g9
sS'methods,hydrocortisone,mg'
p13607
g3
sS'antihistamines,may,enhance'
p13608
g9
sS'of,rats,followed'
p13609
g3
sS'of,indocin,may'
p13610
g3
sS'damage,could,theoretically'
p13611
g3
sS'to,ml,h'
p13612
g9
sS'from,membrane,phospholipids'
p13613
g3
sS'i,such,as'
p13614
g3
sS'male,subjects,increased'
p13615
g9
sS'ketoconazole,ketoconazole,mg'
p13616
g3
sS'asthma,therapy,compliance'
p13617
g3
sS'of,such,concurrently'
p13618
g3
sS'injection,of,these'
p13619
g3
sS'with,previous,findings'
p13620
g3
sS'or,mg,bid'
p13621
g3
sS'lines,divergently,selected'
p13622
g3
sS'subjects,dosed,with'
p13623
g9
sS'on,clinical,and'
p13624
g9
sS'hypermagnesemia,and,should'
p13625
g9
sS'proprietary,cold,remedies'
p13626
g9
sS'affect,the,c'
p13627
g3
sS'strains,of,enterobacteriaceae'
p13628
g3
sS'synthetic,analogue,d-ala2'
p13629
g3
sS'drowsiness,was,observed'
p13630
g3
sS'of,discontinuing,treatment'
p13631
g9
sS'there,were,several'
p13632
g3
sS'of,healthy,volunteers'
p13633
g9
sS'combination,lies,both'
p13634
g3
sS'vitamin,b12,diagnostic'
p13635
g3
sS'containing,or,salicylic'
p13636
g3
sS'of,to,inhibit'
p13637
g3
sS'and,there,are'
p13638
g3
sS'review,in,evaluating'
p13639
g3
sS'topical,dose,is'
p13640
g3
sS'nucleophosmin,b23,antisense'
p13641
g3
sS'to,explain,the'
p13642
g3
sS'serum,protein,the'
p13643
g9
sS'both,cyp1a2,and'
p13644
g3
sS'to,several,days'
p13645
g3
sS'unless,the,benefit'
p13646
g9
sS'granulosa,cell,tumors'
p13647
g3
sS'with,oral,has'
p13648
g9
sS'affect,renal,function'
p13649
g3
sS'response,induced,by'
p13650
g9
sS'max,c,min'
p13651
g3
sS'resulting,in,inaccurately'
p13652
g3
sS'significant,alterations,in'
p13653
g3
sS'and,xenobiotic,metabolism'
p13654
g3
sS'enzymes,may,reduce'
p13655
g9
sS'respectively,which,could'
p13656
g3
sS'to,years,with'
p13657
g3
sS'a,single,compound'
p13658
g3
sS'of,av,nodal'
p13659
g9
sS'm,of,immobilised'
p13660
g3
sS'local,agents,were'
p13661
g3
sS'significant,hyperprolactinaemia,as'
p13662
g3
sS'resulted,in,induction'
p13663
g9
sS'the,inhibitory,action'
p13664
g3
sS'group,specifically,cytochromes'
p13665
g3
sS'of,ergomar,may'
p13666
g9
sS'of,but,not'
p13667
g3
sS'drugs,with,ototoxic'
p13668
g9
sS'was,enhanced,when'
p13669
g3
sS'the,amplitude,of'
p13670
g3
sS'prostaglandina,play,an'
p13671
g9
sS'bad,general,clinical'
p13672
g9
sS'time,beyond,the'
p13673
g9
sS'day,for,a'
p13674
g3
sS'renal,insufficiency,hyperbilirubinemia'
p13675
g9
sS'likely,viracept,should'
p13676
g9
sS'administration,mg,and'
p13677
g3
sS'effects,may,result'
p13678
g3
sS'higher,doses,up'
p13679
g3
sS'by,decreasing,the'
p13680
g9
sS'demonstrate,that,does'
p13681
g3
sS'ca,currents,discriminates'
p13682
g3
sS'to,mg,kg'
p13683
g3
sS'of,anticholinesterase,overdose'
p13684
g3
sS'oral,markedly,inhibit'
p13685
g9
sS'and,reaction,time'
p13686
g9
sS'the,peak,plasma'
p13687
g9
sS'study,coadministration,of'
p13688
g9
sS'lipid,profile,total'
p13689
g3
sS'multiple,doses,mg'
p13690
g9
sS'the,cns-depressive,effects'
p13691
g9
sS'with,or,did'
p13692
g9
sS'proleukin,may,reduce'
p13693
g9
sS'follow,dosing,by'
p13694
g3
sS'up,a,considerable'
p13695
g3
sS'of,oral,certain'
p13696
g9
sS'its,metabolites,are'
p13697
g3
sS'enzyme,oxidation,system'
p13698
g3
sS'and,main,results'
p13699
g3
sS'presented,here,demonstrate'
p13700
g3
sS'enhance,the,blood-sugar'
p13701
g9
sS'use,of,nuromax'
p13702
g3
sS'when,central,nervous'
p13703
g9
sS'cough,cold,allergy'
p13704
g3
sS'it,is,recommended'
p13705
g9
sS'of,a,potential'
p13706
g3
sS'urinary,excretion,is'
p13707
g9
sS'clinical,experience,to'
p13708
g3
sS'concentrations,be,monitored'
p13709
g9
sS'effect,on,oral'
p13710
g9
sS'functions,as,a'
p13711
g3
sS'dna-damaging,agents,in'
p13712
g3
sS'likely,to,lead'
p13713
g9
sS'other,drugs,metabolized'
p13714
g3
sS'pharmacokinetics,of,certain'
p13715
g3
sS'as,well,as'
p13716
g3
sS'cimetidine,and,had'
p13717
g3
sS'tablets,results,in'
p13718
g9
sS'of,large,initial'
p13719
g3
sS'very,sensitive,to'
p13720
g3
sS'include,and,and'
p13721
g3
sS'abciximab,has,been'
p13722
g3
sS'of,positive,test'
p13723
g3
sS'increase,serum,concentrations'
p13724
g9
sS'been,diagnosed,during'
p13725
g3
sS'also,with,drugs'
p13726
g3
sS'between,revia,and'
p13727
g3
sS'minor,adverse,events'
p13728
g3
sS'by,the,balance'
p13729
g3
sS'patients,with,pulmonary'
p13730
g3
sS'certain,hmg-coa,reductase'
p13731
g9
sS'affect,the,prothrombin'
p13732
g3
sS'white,female,volunteers'
p13733
g3
sS'not,meant,to'
p13734
g3
sS'products,with,high'
p13735
g3
sS'when,at,mg'
p13736
g9
sS'after,cholestyramine,resin'
p13737
g3
sS'mg,day,was'
p13738
g3
sS'specific,and,may'
p13739
g3
sS'combination,arenot,established'
p13740
g3
sS'diabetic,patients,receiving'
p13741
g3
sS'and,they,should'
p13742
g3
sS'oral,supplementation,mg'
p13743
g3
sS'risk,factors,studied'
p13744
g9
sS'been,reviewed,in'
p13745
g9
sS'p450,enzymes,primarily'
p13746
g3
sS'renal,vascular,or'
p13747
g3
sS'alkalinizing,agents,gastrointestinal'
p13748
g9
sS'with,an,average'
p13749
g9
sS'or,mg,q'
p13750
g3
sS'max,by,and'
p13751
g9
sS'of,selective,methods'
p13752
g3
sS'ethinyl,estradiol,the'
p13753
g3
sS'and,therapeutic,superiority'
p13754
g3
sS'taxol,therapy,should'
p13755
g3
sS'are,bodyweight,gain'
p13756
g3
sS'to,the,neuromuscular'
p13757
g9
sS'on,those,aspects'
p13758
g3
sS'gram,of,and'
p13759
g9
sS'hit,in,a'
p13760
g3
sS'several,days,before'
p13761
g9
sS'to,mg,twice'
p13762
g9
sS'increased,in,failing'
p13763
g3
sS'two,drugs,can'
p13764
g9
sS'cyp3a4,substrate,single'
p13765
g3
sS'recommended,daily,inhalation'
p13766
g3
sS'if,such,treatment'
p13767
g3
sS'roles,of,non-nucleoside'
p13768
g3
sS'c,max,by'
p13769
g9
sS'the,same,evening'
p13770
g9
sS'lessened,physiologic,activity'
p13771
g9
sS'and,oral,adl'
p13772
g3
sS'in,the,need'
p13773
g9
sS'the,therapeutic,interval'
p13774
g3
sS'case,of,serum'
p13775
g3
sS'tremors,and,at'
p13776
g3
sS'in,respect,of'
p13777
g3
sS'acid,anabolic,steroids'
p13778
g9
sS'apoptosis,induced,by'
p13779
g3
sS'was,not,accompanied'
p13780
g3
sS'uricosuric,such,as'
p13781
g9
sS'interaction,between,clozapine'
p13782
g9
sS'may,blunt,the'
p13783
g3
sS'and,urine,were'
p13784
g3
sS'be,effective,in'
p13785
g9
sS'the,sa,and'
p13786
g3
sS'with,and,no'
p13787
g3
sS'large,initial,doses'
p13788
g3
sS'reduce,endogenous,plasma'
p13789
g9
sS'do,not,affect'
p13790
g3
sS'with,other,may'
p13791
g3
sS'level,of,thiobarbituric'
p13792
g3
sS'monitor,the,occurrence'
p13793
g3
sS'trileptal,with,an'
p13794
g9
sS'by,sodium,following'
p13795
g3
sS'objectives,of,this'
p13796
g3
sS'frequently,observed,during'
p13797
g3
sS'creatinine,clearance,and'
p13798
g9
sS'causes,a,significant'
p13799
g3
sS'particularly,c-17,alkylated'
p13800
g3
sS'is,administered,hours'
p13801
g3
sS'dose,resulted,in'
p13802
g3
sS'of,efficacy,has'
p13803
g3
sS'was,unaffected,by'
p13804
g9
sS'risk,of,anaphylactic'
p13805
g3
sS'or,blood,pressure'
p13806
g3
sS'taken,together,these'
p13807
g3
sS'prevent,stomach,irritation'
p13808
g3
sS'in,therapeutic,doses'
p13809
g9
sS'to,starting,therapy'
p13810
g3
sS'anticoagulants,coagulation,parameters'
p13811
g3
sS'r-warfarin,or,s-warfarin'
p13812
g3
sS'either,long-acting,such'
p13813
g3
sS'of,interactions,when'
p13814
g9
sS'endoscopic,gastroduodenal,ulcers'
p13815
g3
sS'and,auc,were'
p13816
g3
sS'have,the,potential'
p13817
g9
sS'interactions,with,natrecor'
p13818
g3
sS'of,thioethers,in'
p13819
g3
sS'markedly,reduced,or'
p13820
g9
sS'clinical,monitoring,of'
p13821
g3
sS'or,hypersensitivity,reactions'
p13822
g3
sS'cancer,patients,over'
p13823
g9
sS'deleterious,interactions,were'
p13824
g3
sS'and,can,exert'
p13825
g3
sS'receiving,cautious,titration'
p13826
g9
sS'mean,qt,c'
p13827
g9
sS'clinically,important,alterations'
p13828
g3
sS'recommended,during,the'
p13829
g3
sS'events,have,been'
p13830
g9
sS'pharmacodynamics,ecg,of'
p13831
g3
sS'adl-8,is,a'
p13832
g9
sS'are,the,primary'
p13833
g3
sS'significantly,with,auc'
p13834
g3
sS'with,antagonists,of'
p13835
g9
sS'and,plus,or'
p13836
g9
sS'when,the,test'
p13837
g3
sS'not,studied,systematically'
p13838
g3
sS'effects,of,has'
p13839
g3
sS'a4,had,no'
p13840
g3
sS'hyperpyrexia,eight,poisonings'
p13841
g3
sS'certain,and,sodium'
p13842
g9
sS'trial,as,with'
p13843
g9
sS'plasma,samples,does'
p13844
g3
sS'at,the,end'
p13845
g3
sS'with,this,combination'
p13846
g3
sS'is,recommended,for'
p13847
g3
sS'free,and,bound'
p13848
g9
sS'medical,backgrounds,of'
p13849
g3
sS'clinically,significant,effect'
p13850
g3
sS'to,avoid,giving'
p13851
g9
sS'p450,cyp,drug'
p13852
g3
sS'also,induces,apoptosis'
p13853
g3
sS'the,higher,serum'
p13854
g9
sS'decrease,for,the'
p13855
g9
sS'resedation,at,a'
p13856
g3
sS'done,it,was'
p13857
g3
sS'or,reduced,tolerance'
p13858
g9
sS'drug,interactions,exists'
p13859
g3
sS'effects,not,only'
p13860
g3
sS'inhibit,cyp3a4,cyp3a4'
p13861
g3
sS'tumor,types,is'
p13862
g3
sS'given,at,least'
p13863
g3
sS'women,with,sexual'
p13864
g3
sS'chemotherapy,and,highly'
p13865
g3
sS'd3,administration,to'
p13866
g9
sS'although,the,aerosol'
p13867
g3
sS'of,by,stimulating'
p13868
g3
sS'activity,of,low-dose'
p13869
g3
sS'inomax,on,the'
p13870
g9
sS'infusions,of,nimbex'
p13871
g9
sS'known,interference,with'
p13872
g3
sS'agent,may,be'
p13873
g3
sS'pharmacokinetic,interactions,have'
p13874
g3
sS'sites,other,which'
p13875
g3
sS'on,the,risk'
p13876
g9
sS'reduction,in,serum'
p13877
g9
sS'sc,or,the'
p13878
g3
sS'possibility,nitric,oxide'
p13879
g9
sS'likely,and,caution'
p13880
g3
sS'motility,lowers,the'
p13881
g9
sS'dosage,of,vitamin'
p13882
g9
sS's-warfarin,a,cyp2c9'
p13883
g9
sS'antidepressant,class,which'
p13884
g3
sS'of,sodium,iodide'
p13885
g9
sS'reported,to,lead'
p13886
g9
sS'caffeine,two,hundred'
p13887
g3
sS'co-administered,with,precedex'
p13888
g9
sS'did,not,induce'
p13889
g3
sS'administration,of,lower'
p13890
g3
sS'tarceva,dose,greater'
p13891
g3
sS'in,a,lower'
p13892
g3
sS'variation,in,metabolism'
p13893
g3
sS'qt,intervals,or'
p13894
g3
sS'extent,of,the'
p13895
g3
sS'nursing,infants,a'
p13896
g3
sS'by,and,cmax'
p13897
g3
sS'been,treated,with'
p13898
g9
sS'systemic,and,cardiac'
p13899
g9
sS'day,of,two'
p13900
g3
sS'increase,exposure,to'
p13901
g9
sS'macrolide,antibiotics,and'
p13902
g9
sS'some,patients,with'
p13903
g9
sS'treated,with,intramuscular'
p13904
g3
sS'other,thyroid,products'
p13905
g3
sS'effects,of,biocytin'
p13906
g3
sS'of,with,careful'
p13907
g9
sS'with,can,directly'
p13908
g9
sS'significant,increase,in'
p13909
g9
sS'of,with,known'
p13910
g3
sS'interactions,the,mechanism'
p13911
g3
sS'in,human,subjects'
p13912
g9
sS'be,cautious,when'
p13913
g9
sS'fluvoxamine,increased,mean'
p13914
g9
sS'decrease,in,the'
p13915
g9
sS'if,the,tarceva'
p13916
g9
sS'products,and,calcium-rich'
p13917
g9
sS'times,less,toxic'
p13918
g3
sS'potentiate,the,toxic'
p13919
g9
sS'with,central,nervous'
p13920
g9
sS'inducers,can,decrease'
p13921
g9
sS'levels,but,changes'
p13922
g3
sS'aspects,of,learning'
p13923
g3
sS'in,organ,transplant'
p13924
g9
sS'more,than,fold'
p13925
g3
sS'mac,of,the'
p13926
g3
sS'membrane,properties,of'
p13927
g3
sS'formation,the,clinical'
p13928
g3
sS'not,approved,in'
p13929
g3
sS'steady,state,and'
p13930
g9
sS'if,is,given'
p13931
g9
sS'be,aware,of'
p13932
g3
sS'clinical,and,pharmacokinetic'
p13933
g9
sS'the,treatment,of'
p13934
g3
sS'two,single,oral'
p13935
g3
sS'symptomatology,due,to'
p13936
g9
sS'from,the,review'
p13937
g3
sS'and,this,should'
p13938
g3
sS'thyroiditis,bullous,pemphigoid'
p13939
g9
sS'be,interpreted,cautiously'
p13940
g3
sS'mg,kg,of'
p13941
g3
sS'a,case,report'
p13942
g9
sS'succinylcholine,may,cause'
p13943
g3
sS'hours,apart,was'
p13944
g9
sS'individualized,fixed,daily'
p13945
g3
sS'of,other,cns'
p13946
g9
sS'o-desacetylrifabutin,and,the'
p13947
g9
sS'mg,kg,or'
p13948
g3
sS'and,dehydration,have'
p13949
g9
sS'demonstrate,any,efficacy'
p13950
g3
sS'overactive,pain,medication'
p13951
g3
sS'using,cyp3a4,metabolized'
p13952
g9
sS'conducted,in,cases'
p13953
g3
sS'and,intravenous,unless'
p13954
g9
sS'was,discontinued,from'
p13955
g3
sS'levels,resulting,in'
p13956
g9
sS'nursing,mothers,fulvestrant'
p13957
g3
sS'bind,significantly,to'
p13958
g3
sS'changes,in,and'
p13959
g3
sS'dryness,of,the'
p13960
g9
sS'unbound,to,the'
p13961
g3
sS'ecg,changes,and'
p13962
g9
sS'highly,lethal,dose'
p13963
g3
sS'plasma,concentrations,to'
p13964
g9
sS'noted,when,is'
p13965
g3
sS'the,biotransformation,system'
p13966
g9
sS'fashion,to,receive'
p13967
g3
sS'administered,on,day9'
p13968
g9
sS'stimulus,of,dietary'
p13969
g3
sS'medical,supervision,for'
p13970
g3
sS'a,solution,was'
p13971
g3
sS'older,adults,to'
p13972
g3
sS'and,aftercare,approaches'
p13973
g3
sS'of,with,any'
p13974
g3
sS'be,observed,closely'
p13975
g3
sS'coadministered,medicinal,products'
p13976
g3
sS'studies,to,date'
p13977
g3
sS'the,aqueous,extract'
p13978
g3
sS'the,was,carried'
p13979
g3
sS'schizophrenia,and,related'
p13980
g3
sS'by,this,enzyme'
p13981
g3
sS'be,greater,in'
p13982
g9
sS'pharmacokinetics,and,qtc'
p13983
g3
sS'table,established,drug'
p13984
g3
sS'reported,that,seeds'
p13985
g3
sS'the,other,isozymes'
p13986
g3
sS'is,rapid,while'
p13987
g3
sS'effects,of,increased'
p13988
g9
sS'the,physician,may'
p13989
g9
sS'pathway,for,the'
p13990
g3
sS'mg,kg,per'
p13991
g9
sS'the,peak,concentration'
p13992
g3
sS'respectively,p,and'
p13993
g3
sS'any,effect,on'
p13994
g3
sS'test,interactions,it'
p13995
g3
sS'failed,to,wshow'
p13996
g3
sS'report,of,prolonged'
p13997
g9
sS'of,fold,in'
p13998
g9
sS'weakness,in,patients'
p13999
g9
sS'has,been,reported'
p14000
g9
sS'sodium,and,coly-mycin'
p14001
g9
sS'increase,their,clearance'
p14002
g3
sS'approximately,fold,at'
p14003
g9
sS'with,a,mean'
p14004
g9
sS'elimination,of,after'
p14005
g3
sS'occurred,with,concomitant'
p14006
g3
sS'fully,restored,susceptibility'
p14007
g3
sS'be,at,a'
p14008
g3
sS'ulcerans,was,between'
p14009
g3
sS'attenuated,the,heart'
p14010
g9
sS'it,is,desirable'
p14011
g3
sS'is,administered,parenterally'
p14012
g3
sS'antagonists,a,cyp3a4'
p14013
g3
sS'whether,the,dose'
p14014
g9
sS'in,vivo,the'
p14015
g9
sS'and,a,cause-and'
p14016
g9
sS'dose,may,under'
p14017
g3
sS'that,the,effect'
p14018
g3
sS'human,b,cells'
p14019
g3
sS'absorption,of,as'
p14020
g9
sS'vivo,studies,have'
p14021
g9
sS'vitro,and,cyp3a4'
p14022
g9
sS'robinul,injection,and'
p14023
g9
sS'other,inducers,of'
p14024
g9
sS'medicine,should,not'
p14025
g3
sS'parameters,and,or'
p14026
g9
sS'of,diamox,may'
p14027
g9
sS'may,be,warranted'
p14028
g3
sS'seen,with,coadministration'
p14029
g9
sS'of,but,does'
p14030
g9
sS'reliable,increases,in'
p14031
g3
sS'produced,a,mean'
p14032
g9
sS'was,continued,for'
p14033
g3
sS'concomitantly,receiving,itraconazole'
p14034
g9
sS'polymer,conjugates,was'
p14035
g3
sS'these,with,respect'
p14036
g3
sS'of,myopathy,by'
p14037
g3
sS'that,oral,and'
p14038
g3
sS'be,a,primary'
p14039
g3
sS'to,a,slight'
p14040
g9
sS'to,other,fruit'
p14041
g3
sS'determine,if,they'
p14042
g3
sS'with,mild,uncomplicated'
p14043
g3
sS'uptake-1,in,functional'
p14044
g3
sS'supplements,are,required'
p14045
g9
sS'equilibration,of,between'
p14046
g3
sS'objective,our,objective'
p14047
g3
sS'in,vitro,from'
p14048
g9
sS'the,dose,to'
p14049
g9
sS'usual,doses,of'
p14050
g3
sS'methods,healthy,subjects'
p14051
g3
sS'may,be,increased'
p14052
g3
sS'drugs,prolonging,the'
p14053
g3
sS'to,inhibit,the'
p14054
g3
sS'racemic,for,days'
p14055
g3
sS'healthy,subjects,by'
p14056
g9
sS'not,been,systematically'
p14057
g9
sS'that,although,did'
p14058
g9
sS'intervals,and,no'
p14059
g3
sS'successive,application,of'
p14060
g9
sS'devices,and,test'
p14061
g3
sS'data,from,grapefruit'
p14062
g3
sS'when,anti-globulin,tests'
p14063
g3
sS'of,the,nueronal'
p14064
g3
sS'there,are,a'
p14065
g3
sS'agents,in,the'
p14066
g9
sS'therophylline,a,recent'
p14067
g9
sS'to,min,for'
p14068
g3
sS'inhibition,of,platelet'
p14069
g9
sS'however,numerous,potentiation'
p14070
g3
sS'occur,due,to'
p14071
g3
sS'only,half,of'
p14072
g3
sS'inhibitor,due,to'
p14073
g3
sS'by,the,plasma'
p14074
g3
sS'the,biogen,pregnancy'
p14075
g3
sS'were,cardiac,two'
p14076
g3
sS'drugs,affecting,hepatic'
p14077
g3
sS'meclofenamate,sodium,is'
p14078
g9
sS'over,to,determine'
p14079
g3
sS'and,is,usually'
p14080
g3
sS'decreased,by,concomitant'
p14081
g9
sS'use,resulted,in'
p14082
g3
sS'insufficiency,was,documented'
p14083
g3
sS'microg,l,for'
p14084
g3
sS'and,blood,glucose'
p14085
g3
sS'when,mesylate,was'
p14086
g9
sS'that,does,induce'
p14087
g3
sS'there,were,no'
p14088
g3
sS'hormone,action,or'
p14089
g3
sS'or,overlapping,administration'
p14090
g3
sS'or,who,may'
p14091
g9
sS'be,decreased,by'
p14092
g3
sS'proven,efficacy,against'
p14093
g3
sS'reported,that,results'
p14094
g9
sS'concentration,c12hr,by'
p14095
g9
sS'high,plasma,levels'
p14096
g3
sS'treatment,discontinued,promptly'
p14097
g3
sS'secretions,such,as'
p14098
g3
sS'binding,sites,other'
p14099
g3
sS'action,of,may'
p14100
g9
sS'in,the,toxicity'
p14101
g3
sS'therapy,for,erectile'
p14102
g3
sS'recent,developments,in'
p14103
g3
sS'occasionally,induce,a'
p14104
g3
sS'used,together,during'
p14105
g9
sS'hormone,synthesis,secretion'
p14106
g3
sS'of,the,cortex'
p14107
g3
sS'propranolol,in,normal'
p14108
g3
sS'an,adolescent,presents'
p14109
g3
sS'have,demonstrated,efficacy'
p14110
g3
sS'addition,alone,can'
p14111
g9
sS'inhibitor,it,is'
p14112
g9
sS'lithium,toxicity,has'
p14113
g9
sS'inhibited,the,carbachol-stimulated'
p14114
g9
sS'induced,significant,alterations'
p14115
g3
sS'kg,diet,resulted'
p14116
g9
sS'that,mptp,induced'
p14117
g9
sS'allows,physicians,to'
p14118
g3
sS'result,in,uterine'
p14119
g9
sS'for,appropriate,actions'
p14120
g3
sS'significant,qtc,prolongation'
p14121
g3
sS'mean,inr,values'
p14122
g3
sS'glutathione-s,transferase,gst'
p14123
g3
sS'of,these,changes'
p14124
g3
sS'are,specific,substrates'
p14125
g3
sS'toward,cyp3a4,which'
p14126
g3
sS'absorption,or,disposition'
p14127
g3
sS'itself,was,not'
p14128
g3
sS'vitro,effect,occurs'
p14129
g3
sS'p450,inducers,can'
p14130
g9
sS'in,the,next'
p14131
g3
sS'verapamil,coadministration,of'
p14132
g9
sS'formulation,of,mg'
p14133
g9
sS'having,vasodilator,activity'
p14134
g9
sS'and,clotibrate,and'
p14135
g3
sS'evaluating,the,interaction'
p14136
g3
sS'may,not,benefit'
p14137
g9
sS'of,diffusible,treatment'
p14138
g3
sS'bradycardia,vertigo,syncope'
p14139
g3
sS'unusually,high,maintenance'
p14140
g9
sS'aware,of,the'
p14141
g3
sS'diabetics,die,from'
p14142
g3
sS'approximate,doubling,of'
p14143
g9
sS'is,present,whether'
p14144
g3
sS'these,studies,did'
p14145
g3
sS'agent,of,the'
p14146
g3
sS'advisable,to,monitor'
p14147
g9
sS'to,accutane,has'
p14148
g3
sS'or,every,other'
p14149
g3
sS'increased,mean,serum'
p14150
g9
sS'of,d2,in'
p14151
g3
sS'glucose,should,be'
p14152
g9
sS'in,concentration,may'
p14153
g3
sS'toxicity,especially,hematologic'
p14154
g3
sS'inhibitors,and,tricyclic'
p14155
g9
sS'underlying,many,of'
p14156
g3
sS'products,oral,nicotinic'
p14157
g3
sS'o-gallate,and,theasinensin'
p14158
g3
sS'chirocaine,should,be'
p14159
g9
sS'cyp2d6,increase,steady-state'
p14160
g3
sS'sch-23390,but,not'
p14161
g9
sS'increase,of,auc'
p14162
g9
sS'for,use,with'
p14163
g9
sS'administered,with,cyp3a4'
p14164
g3
sS'therapeutic,response,and'
p14165
g3
sS'loss,were,observed'
p14166
g3
sS'and,polyfuranoses,with'
p14167
g3
sS'reactions,to,this'
p14168
g3
sS'induced,by,pcp'
p14169
g3
sS'distribution,effect,on'
p14170
g3
sS'and,auc,after'
p14171
g9
sS'ermbt,after,weeks'
p14172
g3
sS'of,ci,of'
p14173
g3
sS'of,the,combination'
p14174
g3
sS'was,found,to'
p14175
g3
sS'potential,components,in'
p14176
g3
sS'affect,glucose,metabolism'
p14177
g3
sS'micrograms,had,only'
p14178
g9
sS'of,on,pharmacokinetics'
p14179
g3
sS'to,any,procedure'
p14180
g3
sS'kcl,mmol,l'
p14181
g3
sS'cardiovascular,effects,of'
p14182
g3
sS'in,serious,and'
p14183
g3
sS'currents,discriminates,among'
p14184
g3
sS'objective,responses,were'
p14185
g3
sS'or,biweekly,intervals'
p14186
g3
sS'drug-drug,interactions,between'
p14187
g3
sS'action,on,the'
p14188
g9
sS'been,started,on'
p14189
g3
sS'or,oral,hypoglycemic'
p14190
g9
sS'on,the,maximum'
p14191
g3
sS'to,receive,intermittent'
p14192
g3
sS'and,other,phe-nothiazines'
p14193
g3
sS'recommended,levetiracetam,had'
p14194
g3
sS'interaction,study,comparing'
p14195
g3
sS'contraceptives,may,be'
p14196
g3
sS'antimicrobial,and,the'
p14197
g9
sS'drug,interaction,information'
p14198
g3
sS'to,affect,sinus'
p14199
g9
sS'other,in,vivo'
p14200
g3
sS'concentrations,of,sulfoxide'
p14201
g9
sS'enhance,the,occurrence'
p14202
g3
sS'auc,for,and'
p14203
g9
sS'using,higher,doses'
p14204
g9
sS'clearance,of,free'
p14205
g9
sS'in,the,concurrent'
p14206
g3
sS'mean,auc,and'
p14207
g9
sS'coadministration,of,welchol'
p14208
g3
sS'and,consensus,reports'
p14209
g3
sS'oral,hormonal,ortho-novum'
p14210
g9
sS'method,to,prevent'
p14211
g3
sS'of,disrupts,the'
p14212
g3
sS'of,safe,dosing'
p14213
g3
sS'models,and,in'
p14214
g3
sS'this,medication,should'
p14215
g3
sS'another,serotonin,reuptake'
p14216
g9
sS'in,advanced,or'
p14217
g9
sS'morphine,toradoliv,im'
p14218
g3
sS'by,the,kidney'
p14219
g3
sS'binding,of,affected'
p14220
g3
sS'serum,levels,with'
p14221
g9
sS'a,drugs,that'
p14222
g3
sS'seen,during,coadministration'
p14223
g9
sS'cardioactive,or,cerebroactive'
p14224
g3
sS'enoxacin,interferes,with'
p14225
g9
sS'either,accidental,diagnostic'
p14226
g3
sS'co-administration,of,botox'
p14227
g9
sS'nimbex,is,administered'
p14228
g3
sS'vivo,evidence,suggest'
p14229
g3
sS'respectively,and,mean'
p14230
g9
sS'intestinal,mucosa,mounted'
p14231
g3
sS'a,because,of'
p14232
g9
sS'of,the,stomach'
p14233
g9
sS'invirase,is,coadministered'
p14234
g9
sS'on,an,empty'
p14235
g3
sS'in,vitro,mixing'
p14236
g9
sS'or,mg,was'
p14237
g9
sS'effect,of,was'
p14238
g3
sS'association,between,and'
p14239
g3
sS'human,cytochrome,p450'
p14240
g3
sS'cells,including,robust'
p14241
g3
sS'genotoxic,compounds--can,be'
p14242
g3
sS'however,can,decrease'
p14243
g3
sS'also,increased,by'
p14244
g3
sS'taken,in,overdose'
p14245
g9
sS'concomitantly,with,without'
p14246
g3
sS'oral,upon,beginning'
p14247
g9
sS'to,alterations,in'
p14248
g3
sS'day,racemic,combined'
p14249
g9
sS'antimicrobial,is,administered'
p14250
g9
sS'physician,the,benefits'
p14251
g9
sS'take,and,oral'
p14252
g9
sS'mao,inhibitors,because'
p14253
g9
sS'investigate,the,effects'
p14254
g3
sS'of,adenocard,in'
p14255
g9
sS'for,detoxification,of'
p14256
g9
sS'preparations,are,not'
p14257
g9
sS'tablets,at,doses'
p14258
g3
sS'excessive,widening,of'
p14259
g9
sS'acidifying,agents,these'
p14260
g9
sS'inhibition,of,cyp-2c19'
p14261
g3
sS'drugs,at,least'
p14262
g3
sS'regimens,of,of'
p14263
g3
sS'p450,a,the'
p14264
g3
sS'symptoms,of,anticholinesterase'
p14265
g3
sS'lexapro,for,days'
p14266
g9
sS'state,plasma,concentration'
p14267
g9
sS'angiotensin,ii,or'
p14268
g3
sS'or,within,less'
p14269
g3
sS'schedule,was,greater'
p14270
g9
sS'therefore,when,inspra'
p14271
g9
sS'side,effects,when'
p14272
g9
sS'loss,of,blood'
p14273
g3
sS'malignancy,and,the'
p14274
g3
sS'made,of,mg'
p14275
g3
sS'in,dose,of'
p14276
g3
sS'evaluating,plasma,renin'
p14277
g3
sS'usual,recommended,dose'
p14278
g3
sS'and,concomitantly,with'
p14279
g9
sS'to,fold,higher'
p14280
g9
sS'to,the,class'
p14281
g3
sS'incorporate,the,principles'
p14282
g3
sS'latent,complications,which'
p14283
g3
sS'as,might,increase'
p14284
g9
sS'using,rat,fibroblast'
p14285
g3
sS'inhibitory,concentration,as'
p14286
g3
sS'with,of,the'
p14287
g9
sS'of,on,blood'
p14288
g3
sS'to,have,clinically'
p14289
g3
sS'specific,interactions,with'
p14290
g9
sS'monitor,plasma,levels'
p14291
g3
sS'and,mg,three'
p14292
g9
sS'this,observation,is'
p14293
g3
sS'arsenical,encephalopathy,in'
p14294
g3
sS'hypotension,and,occurred'
p14295
g3
sS'effects,of,zinecard'
p14296
g3
sS'to,your,doctor'
p14297
g3
sS'depends,not,only'
p14298
g3
sS'severity,of,side'
p14299
g9
sS'that,has,no'
p14300
g3
sS'which,was,preceded'
p14301
g3
sS'control,of,acute'
p14302
g3
sS'intake,of,additional'
p14303
g3
sS'taken,if,is'
p14304
g9
sS'ml,of,absolute'
p14305
g3
sS'a,basis,for'
p14306
g3
sS'reported,when,is'
p14307
g9
sS'of,hepatic,k'
p14308
g3
sS'the,drug,should'
p14309
g3
sS'that,like,other'
p14310
g9
sS'vitro,studies,using'
p14311
g3
sS'in,total,body'
p14312
g9
sS'anxiety,agitation,motor'
p14313
g3
sS'allow,for,any'
p14314
g3
sS'its,use,in'
p14315
g3
sS'regimens,prediction,of'
p14316
g3
sS'however,total,mucosal'
p14317
g3
sS'be,used,cautiously'
p14318
g9
sS'additive,use,of'
p14319
g9
sS'reduced,relative,risk'
p14320
g3
sS'or,had,minimal'
p14321
g3
sS'must,be,adjusted'
p14322
g3
sS'the,dose,range'
p14323
g9
sS'combination,with,copegus'
p14324
g3
sS'internal,application,of'
p14325
g3
sS'to,the,interaction'
p14326
g3
sS'absorption,acting,primarily'
p14327
g9
sS'gel,has,the'
p14328
g3
sS'step,in,metabolism'
p14329
g3
sS'dosing,beta-1a,avonex'
p14330
g9
sS'the,natriuretic,effect'
p14331
g9
sS'and,suppressed,by'
p14332
g3
sS'administration,of,methylpyrazole'
p14333
g9
sS'pharmacodynamics,of,prothrombin'
p14334
g3
sS'taken,with,a'
p14335
g9
sS'and,a,type'
p14336
g3
sS'after,extensive,intake'
p14337
g3
sS'consequences,following,mptp'
p14338
g3
sS'acetaminophen,had,no'
p14339
g3
sS'strain,of,proteus'
p14340
g3
sS'enhanced,bone,marrow'
p14341
g9
sS'and,herbs,such'
p14342
g9
sS'only,at,relatively'
p14343
g3
sS'plasma,concentrations,in'
p14344
g9
sS'fsh,or,prolactin'
p14345
g3
sS'among,asian,african'
p14346
g3
sS'coumarin-type,has,been'
p14347
g3
sS'study,and,the'
p14348
g3
sS'ovariectomy,female,rats'
p14349
g3
sS'fortified,with,iron'
p14350
g9
sS'of,the,proton'
p14351
g9
sS'enhance,the,duration'
p14352
g9
sS'compared,with,mg'
p14353
g9
sS'be,combined,with'
p14354
g9
sS'of,tca,may'
p14355
g3
sS'with,amenorrhea,the'
p14356
g3
sS'been,reported,very'
p14357
g9
sS'avoided,see,a'
p14358
g9
sS'activity,in,association'
p14359
g3
sS'p450,enzymes,the'
p14360
g9
sS'might,be,expected'
p14361
g9
sS'vomiting,diarrhea,and'
p14362
g3
sS'estradiol,and,mg'
p14363
g3
sS'perforatum,warning,coadministration'
p14364
g3
sS'and,both,alone'
p14365
g3
sS'were,carried,out'
p14366
g3
sS'difference,between,coadministered'
p14367
g3
sS'and,other,metabolized'
p14368
g9
sS'with,salts,with'
p14369
g3
sS'were,reduced,by'
p14370
g9
sS'acquisition,of,goal-directed'
p14371
g3
sS'conflicting,results,for'
p14372
g9
sS'to,be,falsely'
p14373
g3
sS'therapy,although,specific'
p14374
g3
sS'close,clinical,and'
p14375
g3
sS'p450,d6,cyp2d6'
p14376
g3
sS'gabapentin,pharmacokinetic,parameters'
p14377
g3
sS'additional,clinical,monitoring'
p14378
g3
sS'hour,before,idv'
p14379
g3
sS'cfus,were,maintained'
p14380
g3
sS'acid,secretion,by'
p14381
g9
sS'patients,the,concomitant'
p14382
g9
sS'with,either,of'
p14383
g3
sS'hormone,as,measured'
p14384
g3
sS'coadministration,of,racemic'
p14385
g3
sS'published,in,the'
p14386
g3
sS'first,sixty,minutes'
p14387
g9
sS'increase,of,h-triglyceride'
p14388
g9
sS'also,fulfils,the'
p14389
g3
sS'therefore,may,reduce'
p14390
g3
sS'other,interactions,should'
p14391
g3
sS'than,two-fold,of'
p14392
g9
sS'cyp2d6,duloxetine,is'
p14393
g3
sS'stool,in,cecectomized'
p14394
g3
sS'necessary,if,these'
p14395
g3
sS'oral,contraceptives,rofecoxib'
p14396
g3
sS'and,its,effect'
p14397
g9
sS'sst,were,not'
p14398
g3
sS'any,statistically,or'
p14399
g3
sS'concomitant,use,of'
p14400
g9
sS'be,informed,that'
p14401
g3
sS'in,vitro,displacement'
p14402
g3
sS'patients,should,take'
p14403
g9
sS'lodine,and,is'
p14404
g9
sS'related,changes,were'
p14405
g3
sS'these,tests,be'
p14406
g3
sS'peroxidation,which,was'
p14407
g9
sS'a,regular,basis'
p14408
g3
sS'experiment,non-diabetic,and'
p14409
g3
sS'completely,block,contortrostatin-induced'
p14410
g9
sS'most,excretion,is'
p14411
g3
sS'arrythmias,ventricular,tachycardia'
p14412
g9
sS'antidepressant,levels,have'
p14413
g9
sS'reduction,of,oral'
p14414
g9
sS'antagonized,the,inhibitory'
p14415
g9
sS'n,for,days'
p14416
g3
sS'adjustments,of,brovana'
p14417
g3
sS'iv,dose,should'
p14418
g9
sS'the,known,cytochrome'
p14419
g3
sS'changing,the,dose'
p14420
g9
sS'between,tumor,and'
p14421
g3
sS'other,related,presumably'
p14422
g9
sS'use,was,present'
p14423
g3
sS'acid-base,and,electrolyte'
p14424
g9
sS'should,take,tricor'
p14425
g9
sS'of,videx,with'
p14426
g3
sS'or,the,area'
p14427
g3
sS'days,later,by'
p14428
g3
sS'symptoms,and,extra'
p14429
g3
sS'and,may,vary'
p14430
g3
sS'with,a,positive'
p14431
g9
sS'and,platelet,antiaggregant'
p14432
g3
sS'the,hydrophilic,molecule'
p14433
g3
sS'to,compromise,the'
p14434
g9
sS'state,plasma,exposure'
p14435
g9
sS'potential,treatment,for'
p14436
g3
sS'influence,the,bioavailability'
p14437
g3
sS'c129h223n3o54,isolated,from'
p14438
g3
sS'are,taking,medications'
p14439
g3
sS'be,enhanced,or'
p14440
g3
sS'ganglion,hypogastric,nerve'
p14441
g3
sS'of,on,oral'
p14442
g9
sS'stably,transfected,with'
p14443
g3
sS'd-ala2,metenkephalinamide,or'
p14444
g3
sS'levels,of,and'
p14445
g9
sS'solution,the,possibility'
p14446
g9
sS'of,taxol,therapy'
p14447
g3
sS'the,mao,inhibitor'
p14448
g9
sS'their,blood,glucose'
p14449
g9
sS'pediatric,patients,there'
p14450
g9
sS'in,or,dosage'
p14451
g3
sS'potential,of,has'
p14452
g3
sS'and,sodium,colistimethate'
p14453
g9
sS'interactions,between,theraputic'
p14454
g3
sS'not,been,formally'
p14455
g3
sS'decreased,by,and'
p14456
g9
sS'these,concurrently,should'
p14457
g3
sS'hypercalcemia,by,the'
p14458
g3
sS'mg,kg,dose'
p14459
g3
sS'changes,induced,by'
p14460
g3
sS'effects,of,erythromycin'
p14461
g3
sS'hours,is,recommended'
p14462
g9
sS'antiplatelet,agents,and'
p14463
g9
sS'when,administering,or'
p14464
g9
sS'a,or,should'
p14465
g3
sS'potentiates,the,acute'
p14466
g9
sS'prolongation,has,not'
p14467
g3
sS'of,tca5,with'
p14468
g3
sS'serum,level,that'
p14469
g9
sS'was,performed,within'
p14470
g3
sS'the,ed50,of'
p14471
g9
sS'specific,rare,defect'
p14472
g3
sS'of,visual,analogue'
p14473
g3
sS'cmax,values,after'
p14474
g3
sS'and,above,this'
p14475
g3
sS'sildenafil,citrate,theoretically'
p14476
g9
sS'a,significant,reduction'
p14477
g9
sS'neuromuscular,blocking,effect'
p14478
g9
sS'neuromuscular,blockers,in'
p14479
g3
sS'bacteriostatic,antibiotics,chloramphenicol'
p14480
g9
sS'substantial,period,after'
p14481
g3
sS'due,to,lowered'
p14482
g9
sS'this,is,also'
p14483
g3
sS'to,took,min'
p14484
g9
sS'risk,of,malignant'
p14485
g3
sS'significant,effects,were'
p14486
g3
sS'recommended,dose,of'
p14487
g3
sS'allow,sufficient,time'
p14488
g3
sS'concentration,cmax,by'
p14489
g9
sS'dosing,effects,of'
p14490
g3
sS'dasatinib,and,its'
p14491
g3
sS'march,citrate,has'
p14492
g3
sS'concentrations,of,decreased'
p14493
g9
sS'd6,ic50,g'
p14494
g3
sS'acquisition,cost,of'
p14495
g3
sS'these,results,are'
p14496
g3
sS'p450,a4,cyp'
p14497
g9
sS'reported,with,caution'
p14498
g9
sS'other,drug,interactions'
p14499
g3
sS'disease,congestive,heart'
p14500
g9
sS'and,treatment,of'
p14501
g3
sS'release,mg,did'
p14502
g3
sS'interactions,the,central'
p14503
g9
sS'opioid-antagonist,and,non-opioid'
p14504
g3
sS'indices,as,competition'
p14505
g9
sS'of,miracidia,from'
p14506
g3
sS'total,amount,of'
p14507
g3
sS'also,adversely,affect'
p14508
g9
sS'proposed,that,the'
p14509
g3
sS'that,be,taken'
p14510
g9
sS'isoflurane,potentiates,the'
p14511
g9
sS'the,duodenum,and'
p14512
g3
sS'is,not,associated'
p14513
g3
sS'channel,antagonists,cyp1a2'
p14514
g3
sS'its,therapeutic,and'
p14515
g3
sS'c,and,or'
p14516
g9
sS'rhabdomyolysis,has,been'
p14517
g9
sS'n,demonstrated,large'
p14518
g3
sS'oral,has,not'
p14519
g9
sS'concomitantly,with,coumarin-derivative'
p14520
g9
sS'limit,adverse,experiences'
p14521
g9
sS'mean,serum,concentrations'
p14522
g9
sS'with,and,were'
p14523
g3
sS'patients,on,these'
p14524
g3
sS'and,other,related'
p14525
g9
sS'avonex,mcg,im'
p14526
g9
sS'been,completely,evaluated'
p14527
g3
sS'and,if,they'
p14528
g3
sS'dl,triglycerides,mg'
p14529
g3
sS'cyp3a4,inducers,it'
p14530
g9
sS'a,premedication,for'
p14531
g3
sS'inadvisable,to,co-administer'
p14532
g9
sS'clinical,studies,as'
p14533
g9
sS'cyp2c19,and,cyp2a6'
p14534
g3
sS'mg,mg,or'
p14535
g3
sS'effects,on,renal'
p14536
g9
sS'ability,of,gene'
p14537
g3
sS'and,the,mechanism'
p14538
g9
sS'obtained,from,the'
p14539
g3
sS'car,or,operating'
p14540
g3
sS'and,during,use'
p14541
g3
sS'practitioners,any,new'
p14542
g3
sS'either,or,with'
p14543
g3
sS'effects,on,evoked'
p14544
g3
sS'blocking,agents,actions'
p14545
g3
sS'and,related,ethacrynic'
p14546
g3
sS'established,if,there'
p14547
g3
sS'of,bioavailability,eg'
p14548
g9
sS'patient,compliance,poor'
p14549
g3
sS'no,interaction,would'
p14550
g3
sS'these,and,other'
p14551
g3
sS'can,potentially,lead'
p14552
g3
sS'an,may,be'
p14553
g9
sS'of,had,no'
p14554
g3
sS'microg,l,were'
p14555
g3
sS'designed,to,examine'
p14556
g3
sS'studies,and,consensus'
p14557
g3
sS'a,type,strain'
p14558
g3
sS'with,hypertension,the'
p14559
g9
sS'addition,of,nalfon'
p14560
g9
sS'in,anhydrous,and'
p14561
g9
sS'recommended,for,when'
p14562
g9
sS'of,female,rats'
p14563
g3
sS'and,to,improve'
p14564
g3
sS'reactions,is,advised'
p14565
g9
sS'given,in,combination'
p14566
g3
sS'of,mefenamic,acid'
p14567
g9
sS'dissolution,in,a'
p14568
g3
sS'specifically,through,the'
p14569
g3
sS'order,to,use'
p14570
g3
sS'discrimination,and,mixed'
p14571
g3
sS'test,interactions,finasteride'
p14572
g3
sS'endothelial,denudation,indicating'
p14573
g3
sS'drug,effects,both'
p14574
g3
sS'contraceptives,the,effect'
p14575
g3
sS'predominant,plasma,substrate'
p14576
g3
sS'hormonal,increasing,plasma'
p14577
g9
sS'of,clinical,and'
p14578
g3
sS'potential,to,cause'
p14579
g3
sS'additional,dose,increases'
p14580
g3
sS'dietary,treatments,with'
p14581
g3
sS'single-dose,pharmacokinetic,study'
p14582
g3
sS'p450iid6,a,subset'
p14583
g3
sS'clinical,trial,of'
p14584
g3
sS'isoenzyme,cyp3a4,responsible'
p14585
g3
sS'dramatically,from,to'
p14586
g3
sS'may,increase,excretion'
p14587
g3
sS'whom,this,effect'
p14588
g3
sS'may,inhibit,the'
p14589
g9
sS'results,of,certain'
p14590
g3
sS'bacillus,subtilis,and'
p14591
g9
sS'had,achieved,steady-state'
p14592
g3
sS'hypersensitivity,reactions,when'
p14593
g3
sS'dose,or,mg'
p14594
g3
sS'that,are,highly'
p14595
g9
sS'no,specific,interactions'
p14596
g9
sS'for,many,cyp'
p14597
g3
sS'of,rheumatoid,arthritis'
p14598
g3
sS'comparable,to,that'
p14599
g3
sS'increased,about,and'
p14600
g9
sS'metabolite,metabolite,i'
p14601
g3
sS'selective,methods,that'
p14602
g3
sS'show,elevations,of'
p14603
g9
sS'concentrations,or,clinical'
p14604
g3
sS'theophylline,mg,as'
p14605
g3
sS'the,hematopoietic,system'
p14606
g3
sS'groups,of,agents'
p14607
g3
sS'weeks,of,and'
p14608
g3
sS'epoxide,concentrations,were'
p14609
g3
sS'erythromycin,mg,t'
p14610
g9
sS'use,of,the'
p14611
g3
sS'transitory,changes,in'
p14612
g3
sS'acid,sali-cylates,nsaids'
p14613
g3
sS'days,with,coadministration'
p14614
g3
sS'and,dosage,and'
p14615
g3
sS'hours,before,or'
p14616
g9
sS'monitoring,tdm,of'
p14617
g3
sS'has,a,complex'
p14618
g9
sS'therapy,and,bone'
p14619
g3
sS'binds,both,t4'
p14620
g9
sS'effectively,and,safely'
p14621
g3
sS'which,also,induces'
p14622
g3
sS'depression,of,av'
p14623
g9
sS'concomitant,single,dose'
p14624
g9
sS'in,dose,to'
p14625
g9
sS'concomitantly,with,an'
p14626
g9
sS'concert,with,age-dependent'
p14627
g3
sS'patients,were,dry'
p14628
g3
sS'and,are,given'
p14629
g9
sS'after,an,mg'
p14630
g3
sS'bid,was,not'
p14631
g9
sS'concomitantly,with,as'
p14632
g9
sS'continue,the,provide'
p14633
g3
sS'low-dose,mg,enteric'
p14634
g3
sS'should,be,separated'
p14635
g9
sS'of,a,nasal'
p14636
g3
sS'only,a,very'
p14637
g9
sS'these,patients,should'
p14638
g3
sS'for,initial,or'
p14639
g3
sS'be,used,when'
p14640
g9
sS'in,six,subjects'
p14641
g9
sS'to,micrograms,equally'
p14642
g9
sS'or,halogenated,hydrocarbon'
p14643
g9
sS'efficacy,in,the'
p14644
g3
sS'activity--such,as,an'
p14645
g9
sS'with,neuromuscular,transmission'
p14646
g9
sS'and,manageable,without'
p14647
g3
sS'with,the,pi'
p14648
g3
sS'the,active,isomer'
p14649
g9
sS'exhibit,a,diminished'
p14650
g9
sS'the,combination,of'
p14651
g9
sS'under,fasting,conditions'
p14652
g3
sS'is,therefore,advised'
p14653
g9
sS'sympathetic,nervous,system'
p14654
g3
sS'that,impact,on'
p14655
g3
sS'prealbumin,tbpa,is'
p14656
g3
sS'bound,to,albumin'
p14657
g3
sS'indicators,differs,from'
p14658
g3
sS'may,therefore,change'
p14659
g3
sS'without,disturbing,the'
p14660
g3
sS'decrease,the,clearance'
p14661
g9
sS'thiazides,are,known'
p14662
g3
sS'course,of,pcp'
p14663
g9
sS'garlic,capsules,should'
p14664
g3
sS'should,be,reduced'
p14665
g9
sS'and,inducers,of'
p14666
g9
sS'phosphorylation,of,in'
p14667
g3
sS'vs,cmax,vs'
p14668
g3
sS'and,of,protein'
p14669
g3
sS'heart,rate,increase'
p14670
g9
sS'ml,resulted,in'
p14671
g3
sS'the,agents,in'
p14672
g3
sS'and,compared,with'
p14673
g3
sS'blocking,agents,such'
p14674
g9
sS'if,peganone,is'
p14675
g9
sS'the,peripheral,vasoconstriction'
p14676
g9
sS'and,sudden,death'
p14677
g9
sS'use,with,other'
p14678
g3
sS'during,and,treatment'
p14679
g3
sS'of,pcp,in'
p14680
g3
sS'administered,concurrently,the'
p14681
g9
sS'steady-state,pharmacokinetic,parameters'
p14682
g3
sS'dose,and,longer'
p14683
g9
sS'the,cardiotoxicity,associated'
p14684
g3
sS'was,given,prior'
p14685
g3
sS'proliferation,and,b-cell'
p14686
g3
sS'group,clinical,pharmacology'
p14687
g3
sS'tremor,as,compared'
p14688
g9
sS'notably,oral,antifungal'
p14689
g9
sS'mm,fractional,mucosal'
p14690
g3
sS'by,alterations,in'
p14691
g3
sS'of,the,potential'
p14692
g9
sS'administered,several,hours'
p14693
g3
sS'by,means,of'
p14694
g3
sS'preparation,causing,a'
p14695
g9
sS'resveratrol,micromol,l'
p14696
g3
sS'therapy,resulted,in'
p14697
g3
sS'have,higher,than'
p14698
g3
sS'hormone,concomitant,use'
p14699
g9
sS'in,angina,patients'
p14700
g3
sS'of,preparations,in'
p14701
g9
sS'not,be,mixed'
p14702
g3
sS'of,gl,the'
p14703
g3
sS'furosemide,may,increase'
p14704
g9
sS'containing,ferrous,sulfate'
p14705
g9
sS'dosing,schedule,of'
p14706
g3
sS'and,ortho-novum,increased'
p14707
g9
sS'clofibric,acid,combination'
p14708
g9
sS'of,atherosclerotic,risk'
p14709
g3
sS'lean,animals,where'
p14710
g3
sS'since,interactions,have'
p14711
g9
sS'potential,to,sensitize'
p14712
g9
sS'ace,inhibitors,calcium-channel'
p14713
g3
sS'tablets,may,exhibit'
p14714
g9
sS'the,supplied,aerolizertm'
p14715
g3
sS'enhance,the,serotonergic'
p14716
g9
sS'and,the,pharmacokinetics'
p14717
g9
sS'in,rats,with'
p14718
g9
sS'tricyclic,may,enhance'
p14719
g9
sS'of,serum,and'
p14720
g3
sS'determine,whether,they'
p14721
g3
sS'that,revlimid,is'
p14722
g3
sS'especially,in,patients'
p14723
g3
sS'premedline,and,international'
p14724
g3
sS'increase,when,is'
p14725
g9
sS'when,the,drug'
p14726
g9
sS'can,be,minimized'
p14727
g9
sS'in,addition,deaths'
p14728
g9
sS'these,is,withdrawn'
p14729
g3
sS'when,and,oral'
p14730
g9
sS'diabetes,have,been'
p14731
g3
sS'an,endemic,primate'
p14732
g3
sS'conjugates,on,the'
p14733
g3
sS'low,clearance,a'
p14734
g3
sS'are,not,expected'
p14735
g3
sS'in,diabetic,and'
p14736
g3
sS'levels,by,the'
p14737
g3
sS'weeks,and,half'
p14738
g3
sS'if,intravenous,is'
p14739
g9
sS'evidence,of,allergic'
p14740
g3
sS'opposite,way,the'
p14741
g9
sS'dose,fractions,on'
p14742
g3
sS'loss,of,the'
p14743
g9
sS'or,changing,vioxx'
p14744
g9
sS'lymphocytes,mammalian,cell'
p14745
g3
sS'subjects,but,also'
p14746
g3
sS'adenocard,in,patients'
p14747
g9
sS'tolerated,in,zollinger-ellison'
p14748
g3
sS'test,female,patients'
p14749
g3
sS'l-phenylalanine,and,the'
p14750
g9
sS'co-administered,particularly,since'
p14751
g9
sS'nephrotoxic,compounds,may'
p14752
g3
sS'have,been,no'
p14753
g3
sS'nsaids,are,used'
p14754
g9
sS'with,sustiva,are'
p14755
g3
sS'at,h,for'
p14756
g3
sS'levels,of,urinary'
p14757
g3
sS'result,in,altered'
p14758
g3
sS'sugar,some,patients'
p14759
g3
sS'diabetic,patients,have'
p14760
g3
sS'cyp3a4,activity,such'
p14761
g9
sS'romazicon,may,wear'
p14762
g3
sS'little,work,exists'
p14763
g3
sS'metabolism,are,not'
p14764
g3
sS'also,collected,for'
p14765
g3
sS'chance,of,side'
p14766
g9
sS'clinical,significance,as'
p14767
g3
sS'renal,retention,tend'
p14768
g3
sS'eg,should,be'
p14769
g9
sS'effects,and,confusional'
p14770
g9
sS'confirm,the,significant'
p14771
g3
sS'be,deeper,and'
p14772
g9
sS'increase,and,range'
p14773
g9
sS'taking,celebrex,concomitantly'
p14774
g9
sS'of,was,reduced'
p14775
g9
sS'any,amine,since'
p14776
g9
sS'including,more,convenient'
p14777
g3
sS'sh,fa,were'
p14778
g3
sS'in,the,treatment'
p14779
g3
sS'both,agents,was'
p14780
g3
sS'a,slight,but'
p14781
g9
sS'patients,with,colorectal'
p14782
g3
sS'diplococcus,pneumoniae,streptococcus'
p14783
g3
sS'at,all,in'
p14784
g3
sS'may,bring,latent'
p14785
g3
sS'vardenafil,mg,resulted'
p14786
g9
sS'of,severe,symptomatology'
p14787
g3
sS'an,decrease,in'
p14788
g9
sS'to,those,observed'
p14789
g3
sS'cmax,of,about'
p14790
g9
sS'significantly,interfere,with'
p14791
g3
sS'oxidase,inhibitors,hypertensive'
p14792
g9
sS'not,performed,in'
p14793
g3
sS'humans,was,noted'
p14794
g3
sS'nodal,conduction,observed'
p14795
g9
sS'cyp3a4,inducer,a'
p14796
g3
sS'sa,and,av'
p14797
g3
sS'design,of,new'
p14798
g3
sS'rehospitalisation,was,significantly'
p14799
g3
sS'alveolar,concentration,is'
p14800
g9
sS'years,at,doses'
p14801
g3
sS'duloxetine,unprotected,by'
p14802
g3
sS'cause-and,effect,relationship'
p14803
g9
sS'affect,the,pk'
p14804
g3
sS'produce,additive,inotropic'
p14805
g3
sS'responses,with,short'
p14806
g3
sS'produced,optic,nerve'
p14807
g3
sS'coadministration,of,this'
p14808
g3
sS'a-blockers,angiotensin-converting,enzyme'
p14809
g3
sS'nonsteroidal,has,been'
p14810
g9
sS'have,been,obtained'
p14811
g3
sS'than,seven,days'
p14812
g3
sS'can,interfere,with'
p14813
g9
sS'general,conditions,of'
p14814
g3
sS'area,under,the'
p14815
g9
sS'depends,on,the'
p14816
g3
sS'e-strain,subjects,but'
p14817
g3
sS'link,between,smoking'
p14818
g3
sS'were,performed,on'
p14819
g3
sS'provided,this,information'
p14820
g9
sS'there,is,considerable'
p14821
g3
sS'mg,kg,bwt'
p14822
g3
sS'the,adverse,experience'
p14823
g3
sS'therapeutic,regimen,of'
p14824
g3
sS'evidence,of,cytochrome'
p14825
g3
sS'treated,with,and'
p14826
g9
sS'times,the,upper'
p14827
g3
sS'ames,bacterial,mutagenicity'
p14828
g3
sS'and,both,or'
p14829
g3
sS'for,metabolite,m1'
p14830
g3
sS'of,its,efficacy'
p14831
g3
sS'strong,cyp3a4,inhibitors'
p14832
g9
sS'on,stimulated,gastric'
p14833
g3
sS'should,have,cholesterol'
p14834
g9
sS'i,the,number'
p14835
g3
sS'and,in,combinations'
p14836
g3
sS'chop-haart,compared,with'
p14837
g3
sS'study,by,the'
p14838
g3
sS'inhibition,are,expected'
p14839
g9
sS'observations,from,interaction'
p14840
g3
sS'the,increased,metabolism'
p14841
g9
sS'catalyzed,by,xanthine'
p14842
g3
sS'a,single,tonic'
p14843
g3
sS'repeated,doses,of'
p14844
g9
sS'a,low,therapeutic'
p14845
g3
sS'these,together,especially'
p14846
g3
sS'the,mean,terminal'
p14847
g9
sS'epsilon,and,mu'
p14848
g3
sS'increased,interaction,between'
p14849
g3
sS'a4,but,only'
p14850
g3
sS'its,lack,of'
p14851
g3
sS'and,as,well'
p14852
g3
sS'or,in,volume'
p14853
g9
sS'felbatol,gris-peg,nizoral'
p14854
g9
sS'magnitude,or,neuromuscular'
p14855
g3
sS'of,drug-drug,interactions'
p14856
g3
sS'typhoid,attenuation,of'
p14857
g9
sS'for,anions,other'
p14858
g3
sS'effect,the,functional'
p14859
g3
sS'data,to,exclude'
p14860
g3
sS'there,were,transient'
p14861
g9
sS'a,later,developmental'
p14862
g3
sS'functional,classes,ii'
p14863
g3
sS'endotoxin-treated,rats,decreased'
p14864
g9
sS'addition,to,enhancing'
p14865
g9
sS'caution,in,the'
p14866
g3
sS'is,a,frequent'
p14867
g3
sS'patients,with,breast'
p14868
g9
sS'interactions,is,of'
p14869
g3
sS'other,complications,compared'
p14870
g9
sS'monitored,for,either'
p14871
g3
sS'possibly,concomitant,administration'
p14872
g9
sS'for,seizures,when'
p14873
g3
sS'with,hereditary,antithrombin'
p14874
g9
sS'clearance,measurements,of'
p14875
g9
sS'of,intestinal,adenocarcinomas'
p14876
g9
sS'within,several,months'
p14877
g3
sS'prinivil,alone,were'
p14878
g3
sS'bilateral,ovariectomy,female'
p14879
g3
sS'affect,disease,control'
p14880
g9
sS'altered,renal,function'
p14881
g3
sS'the,elevation,of'
p14882
g9
sS'micrograms,g,sometimes'
p14883
g3
sS'many,concomitant,were'
p14884
g3
sS'p450,a4,have'
p14885
g3
sS'of,were,not'
p14886
g3
sS'treatment,with,one'
p14887
g9
sS'in,dependence,on'
p14888
g3
sS'effect,relationship,have'
p14889
g9
sS'if,dosage,is'
p14890
g9
sS'anticoagulants,in,some'
p14891
g9
sS'demonstrated,that,a'
p14892
g3
sS'cyp1a1,cyp1a2,cyp2a6'
p14893
g3
sS'rashes,is,due'
p14894
g9
sS'a,non-significantly,reduced'
p14895
g3
sS'inhibit,adrenal,synthesis'
p14896
g9
sS'prolonged,menstrual,cycles'
p14897
g3
sS'altered,so,as'
p14898
g3
sS'fluid,by,dmpge2'
p14899
g3
sS'changes,in,density'
p14900
g3
sS'such,as,imitrex'
p14901
g9
sS'output,and,an'
p14902
g9
sS'the,net,effects'
p14903
g9
sS'must,be,exercised'
p14904
g3
sS'above,behavioral,changes'
p14905
g3
sS'body,weight,approximately'
p14906
g3
sS'of,fetal,variations'
p14907
g3
sS'calcium-channel,blockers,on'
p14908
g3
sS'm1,which,had'
p14909
g3
sS'are,treated,with'
p14910
g9
sS'examples,of,drugs'
p14911
g3
sS'normal,within,weeks'
p14912
g3
sS'that,use,glucose'
p14913
g3
sS'many,cyp,isozymes'
p14914
g3
sS'is,advised,nonetheless'
p14915
g3
sS'of,clozapine,and'
p14916
g9
sS'observed,closely,to'
p14917
g9
sS'concurrently,did,not'
p14918
g3
sS'conjunction,with,in'
p14919
g9
sS'the,kidneys,along'
p14920
g3
sS'the,results,indicate'
p14921
g3
sS'a,genetically,initiated'
p14922
g3
sS'of,multiple,exposure'
p14923
g3
sS'be,produced,in'
p14924
g9
sS'sustiva,is,used'
p14925
g9
sS'of,mg,did'
p14926
g3
sS'are,identical,whether'
p14927
g3
sS'of,the,cns'
p14928
g3
sS'levels,or,activity'
p14929
g9
sS'capsule,was,administered'
p14930
g9
sS'blood,flow,were'
p14931
g3
sS'world,medical,literature'
p14932
g3
sS'the,combination,may'
p14933
g9
sS'rat,liver,but'
p14934
g3
sS'cyclosporine,administration,of'
p14935
g9
sS'were,not,studied'
p14936
g3
sS'following,acetaminophen,tylenol'
p14937
g9
sS'administered,daily,for'
p14938
g3
sS'and,it,may'
p14939
g3
sS'consciousness,when,was'
p14940
g9
sS'until,clinical,data'
p14941
g3
sS'the,rate,or'
p14942
g3
sS'milk,on,the'
p14943
g3
sS'of,required,may'
p14944
g9
sS'conducted,in,healthy'
p14945
g9
sS'responses,were,studied'
p14946
g3
sS'the,elderly,may'
p14947
g9
sS'significant,alteration,of'
p14948
g9
sS'the,danger,inherent'
p14949
g9
sS'eg,and,decrease'
p14950
g9
sS'the,rate,of'
p14951
g9
sS'twice-a,day,administration'
p14952
g3
sS'and,agonists,hepatic'
p14953
g3
sS'exposure,for,the'
p14954
g3
sS'consider,additive,sedative'
p14955
g9
sS'rats,were,supersensitive'
p14956
g9
sS'were,unchanged,hours'
p14957
g3
sS'sparing,thiazide,substrates'
p14958
g3
sS'agonist,but,not'
p14959
g9
sS'dostinex,should,not'
p14960
g9
sS'the,metabolizing,isozyme'
p14961
g3
sS'focus,is,given'
p14962
g3
sS'the,diabetics,and'
p14963
g3
sS'in,subjects,aged'
p14964
g9
sS'could,be,due'
p14965
g3
sS'markedly,increased,the'
p14966
g9
sS'a,critical,fall'
p14967
g3
sS'propanol,was,investigated'
p14968
g3
sS'products,containing,ferrous'
p14969
g9
sS'taking,while,on'
p14970
g9
sS'the,difference,between'
p14971
g3
sS'the,plasma,exposure'
p14972
g9
sS'if,the,dose'
p14973
g3
sS'the,ace,inhibitor'
p14974
g9
sS'stimulated,but,did'
p14975
g9
sS'that,transferred,to'
p14976
g3
sS'has,additive,effects'
p14977
g9
sS'received,in,escalating'
p14978
g3
sS'in,an,emergency'
p14979
g9
sS'effectiveness,of,progestin-only'
p14980
g9
sS'that,the,hippocampus'
p14981
g3
sS'mg,twice,a'
p14982
g3
sS'patients,taking,monoamine'
p14983
g9
sS'agents,may,affect'
p14984
g9
sS'administration,of,does'
p14985
g9
sS'months,of,each'
p14986
g3
sS'platelet,function,as'
p14987
g9
sS'concomitantly,with,hormonal'
p14988
g3
sS'and,the,oral'
p14989
g9
sS'avoided,when,possible'
p14990
g9
sS'therapies,commonly,used'
p14991
g3
sS'and,carbonic,anhydrase'
p14992
g9
sS'either,the,glucose'
p14993
g3
sS'excretion,was,due'
p14994
g3
sS'which,cause,elimination'
p14995
g9
sS'study,of,coadministration'
p14996
g9
sS'of,withdrawal,of'
p14997
g3
sS'and,the,nonsteroidal'
p14998
g9
sS'measured,four,times'
p14999
g3
sS'symptoms,of,methotrexate-related'
p15000
g9
sS'properties,may,potentiate'
p15001
g9
sS'of,desethylzaleplon,formed'
p15002
g3
sS'in,which,a'
p15003
g9
sS'effects,with,other'
p15004
g3
sS'two,medicines,since'
p15005
g9
sS'carbamazepine,combined,administration'
p15006
g3
sS'acetylsalicylic,acid,and'
p15007
g3
sS'the,following,are'
p15008
g3
sS'affect,the,cytochrome'
p15009
g3
sS'cells,from,healthy'
p15010
g3
sS'oral,anticoagulants,interaction'
p15011
g3
sS'on,these,in'
p15012
g3
sS'is,postulated,that'
p15013
g3
sS'few,patients,taking'
p15014
g9
sS'with,food,see'
p15015
g3
sS'excretion,and,the'
p15016
g9
sS'since,the,coadministration'
p15017
g3
sS'had,already,responded'
p15018
g3
sS'and,by,fold'
p15019
g9
sS'currently,exist,comparing'
p15020
g3
sS'ketoprofen,like,other'
p15021
g9
sS'b-adrenergic,blocking,agents'
p15022
g3
sS'binding,and,serum'
p15023
g3
sS'of,its,use'
p15024
g3
sS'of,antidepressant,may'
p15025
g3
sS'depressant,effect,on'
p15026
g3
sS'pulmonary,granulomata,subacute'
p15027
g3
sS'either,or,led'
p15028
g9
sS'taken,if,necessary'
p15029
g3
sS'and,no,effect'
p15030
g3
sS'a4,cyp,a4'
p15031
g9
sS'of,with,central'
p15032
g9
sS'on,the,release'
p15033
g3
sS'parameters,including,the'
p15034
g3
sS'hcl,is,used'
p15035
g9
sS'must,be,made'
p15036
g3
sS'omega-agatoxin,iva-sensitive,p-type'
p15037
g3
sS'of,intramuscularly,injected'
p15038
g3
sS'of,phosphate-binding,agents'
p15039
g3
sS'the,potential,for'
p15040
g3
sS'medication,administered,concomitantly'
p15041
g3
sS'after,sudden,withdrawal'
p15042
g9
sS'with,varapamil,and'
p15043
g3
sS'bleeding,and,menstrual'
p15044
g3
sS'men,who,have'
p15045
g3
sS'receive,oral,and'
p15046
g3
sS'substrate,in,combination'
p15047
g3
sS'derived,from,serum-deprived'
p15048
g3
sS'msec,compared,to'
p15049
g9
sS'the,effect,is'
p15050
g9
sS'aspirin,should,not'
p15051
g9
sS'shown,to,decrease'
p15052
g3
sS'propanol,derive,from'
p15053
g9
sS'within,the,two-hour'
p15054
g3
sS'separate,single,or'
p15055
g3
sS'drugs,or,substances'
p15056
g3
sS'duration,or,reproductive'
p15057
g3
sS'responses,to,repeated'
p15058
g3
sS'with,who,are'
p15059
g3
sS'blood,level,of'
p15060
g3
sS'ee,were,decreased'
p15061
g3
sS'extraction,has,been'
p15062
g3
sS'arthropan,magan,or'
p15063
g9
sS'isoenzyme,system,cyp3a4'
p15064
g3
sS'enzymes,i,and'
p15065
g3
sS'cns,depressive,effects'
p15066
g9
sS'oral,were,given'
p15067
g3
sS'ptx,m,failed'
p15068
g9
sS'p450,system,may'
p15069
g3
sS'to,groups,of'
p15070
g3
sS'the,str,may'
p15071
g3
sS'aprepitant,with,strong'
p15072
g9
sS'h,following,the'
p15073
g9
sS'i,neurotransmitter,systems'
p15074
g3
sS'of,bacteria,tested'
p15075
g3
sS'midcycle,day,to'
p15076
g3
sS'could,pose,a'
p15077
g9
sS'pharmacokinetics,at,different'
p15078
g3
sS'concomitant,or,may'
p15079
g9
sS'tests,pregnancy,test'
p15080
g3
sS'turn,resulted,in'
p15081
g9
sS'pesticide,gliftor,difluoro-2'
p15082
g3
sS'may,delay,elimination'
p15083
g3
sS'signalling,or,disruption'
p15084
g3
sS'following,blood,thinners'
p15085
g3
sS'dmpge2-induced,jejunal,net'
p15086
g3
sS'the,start,of'
p15087
g9
sS'the,simultaneous,use'
p15088
g9
sS'pharmacokinetics,of,either'
p15089
g3
sS'plasma,clearance,from'
p15090
g9
sS'relevant,effect,was'
p15091
g9
sS'should,be,deferred'
p15092
g9
sS'dose,or,hours'
p15093
g9
sS'auc,values,in'
p15094
g9
sS'before,starting,treatment'
p15095
g3
sS'to,treatment,is'
p15096
g3
sS'the,patient,interferes'
p15097
g3
sS'on,the,subjective'
p15098
g3
sS'studies,of,suggest'
p15099
g9
sS'regular,reevaluations,of'
p15100
g3
sS'that,take,advantage'
p15101
g3
sS'of,herbal,remedy'
p15102
g3
sS'susceptible,to,a'
p15103
g3
sS'effects,of,oleate'
p15104
g3
sS'active,renal,tubular'
p15105
g9
sS'solutions,and,also'
p15106
g3
sS'caused,by,an'
p15107
g3
sS'to,elevated,plasma'
p15108
g9
sS'careful,attention,must'
p15109
g9
sS'toxicity,is,encountered'
p15110
g3
sS'by,other,antineoplastic'
p15111
g9
sS'a,five-fold,increase'
p15112
g9
sS'of,was,decreased'
p15113
g9
sS'to,chemotherapy,can'
p15114
g3
sS'use,of,hydrochloride'
p15115
g3
sS'of,a,hot'
p15116
g3
sS'use,of,foscavir'
p15117
g9
sS'oral,therapy,is'
p15118
g3
sS'they,are,being'
p15119
g3
sS'required,to,alleviate'
p15120
g3
sS'either,class,of'
p15121
g3
sS'severity,of,diarrhea'
p15122
g9
sS'lengthening,of,the'
p15123
g3
sS'added,cholesterol,the'
p15124
g3
sS'myelosuppression,and,diarrhea'
p15125
g9
sS'certain,conditions,produce'
p15126
g3
sS'osteoporosis,treatment,study'
p15127
g3
sS'with,experimental,toxic'
p15128
g9
sS'of,urinary,metanephrine'
p15129
g3
sS'literature,provides,considerable'
p15130
g3
sS'about,when,compared'
p15131
g9
sS'rule,out,decreased'
p15132
g3
sS'nonetheless,their,relevance'
p15133
g3
sS'period,before,or'
p15134
g3
sS'findings,in,some'
p15135
g3
sS'related,to,the'
p15136
g3
sS'with,was,associated'
p15137
g9
sS'reduction,of,the'
p15138
g3
sS'and,nonsteroidal,agents'
p15139
g9
sS'vascular,lesions,characterized'
p15140
g3
sS'killing,relative,to'
p15141
g3
sS'didanosine,co-administration,of'
p15142
g9
sS'its,renal,clearance'
p15143
g9
sS'mhd,have,little'
p15144
g3
sS'proteus,rettgeri,were'
p15145
g3
sS'of,these,may'
p15146
g9
sS'suggested,that,the'
p15147
g9
sS'to,substrates,of'
p15148
g3
sS'microg,ml,or'
p15149
g3
sS'sulfonylureas,requirements,for'
p15150
g3
sS'by,both,a'
p15151
g3
sS'transfusion,cross-matching,procedures'
p15152
g3
sS'monitored,see,clinical'
p15153
g3
sS'expected,plasma,concentrations'
p15154
g3
sS'agents,sodium,bicarbonate'
p15155
g9
sS'be,required,or'
p15156
g9
sS'how,to,use'
p15157
g3
sS'metabolism,of,compounds'
p15158
g3
sS'sugar,in,type'
p15159
g9
sS'combination,oral,ethinyl'
p15160
g3
sS'neuropathy,is,frequent'
p15161
g3
sS'may,cause,respiratory'
p15162
g9
sS'usual,amounts,of'
p15163
g3
sS'trials,of,augmentin'
p15164
g3
sS'include,fever,chills'
p15165
g3
sS'is,not,an'
p15166
g3
sS'p450,isoenzymes,and'
p15167
g3
sS'inhibit,both,aldehyde'
p15168
g9
sS'time,of,the'
p15169
g3
sS'permeability,and,thus'
p15170
g3
sS'administered,on,day'
p15171
g3
sS'to,such,doses'
p15172
g3
sS'and,respectively,when'
p15173
g9
sS'presence,of,agents'
p15174
g9
sS'ht1,agonists,within'
p15175
g9
sS'amevive,in,clinical'
p15176
g3
sS'clearance,between,patients'
p15177
g3
sS'risk,to,the'
p15178
g3
sS'for,this,disease'
p15179
g3
sS'via,the,biliary'
p15180
g3
sS'or,to,patients'
p15181
g9
sS'mc,and,comparison'
p15182
g3
sS'd6,and,cyp'
p15183
g3
sS'clearance,was,decreased'
p15184
g3
sS'it,is,unclear'
p15185
g9
sS'while,taking,patients'
p15186
g3
sS'advised,to,avoid'
p15187
g9
sS'on,a,maintenance'
p15188
g9
sS'period,was,separated'
p15189
g3
sS'da,levels,did'
p15190
g3
sS'the,three,groups'
p15191
g3
sS'glyburide,glyburide,is'
p15192
g3
sS'such,agents,is'
p15193
g3
sS'separate,brain,systems'
p15194
g3
sS'hours,after,at'
p15195
g3
sS'is,a,helpful'
p15196
g3
sS'distribution,was,not'
p15197
g3
sS'additive,with,those'
p15198
g9
sS'by,a,blockade'
p15199
g9
sS'various,doses,of'
p15200
g3
sS'vardenafil,in,healthy'
p15201
g9
sS'for,response,to'
p15202
g3
sS'to,treat,an'
p15203
g3
sS'difference,exists,between'
p15204
g3
sS'increased,the,activation'
p15205
g9
sS'hydrocortisone,mg,and'
p15206
g3
sS'defense,of,heparinized'
p15207
g9
sS'to,ascertain,when'
p15208
g3
sS'general,and,local'
p15209
g3
sS'competition,for,protein'
p15210
g3
sS'combine,to,cause'
p15211
g9
sS'subjects,who,had'
p15212
g9
sS'volunteers,concomitant,administration'
p15213
g9
sS'cmax,when,compared'
p15214
g9
sS'neural,pathways,which'
p15215
g3
sS'of,chop-haart,patients'
p15216
g3
sS'otherwise,healthy,male'
p15217
g9
sS'serum,levels,utilizing'
p15218
g3
sS'patients,with,chronic'
p15219
g3
sS'serum,creatinine,level'
p15220
g9
sS'absorption,from,the'
p15221
g9
sS'this,combination,has'
p15222
g9
sS'basis,increased,both'
p15223
g3
sS'of,and,reached'
p15224
g9
sS'suggested,with,hormonal'
p15225
g3
sS'antacids,and,can'
p15226
g9
sS'has,no,cyp3a4'
p15227
g3
sS'reactions,have,been'
p15228
g9
sS'is,indicated,in'
p15229
g9
sS'formulation,comparable,to'
p15230
g9
sS'can,be,explained'
p15231
g3
sS'medication,used,to'
p15232
g3
sS'studies,received,one'
p15233
g3
sS'occasionally,taxol,infusions'
p15234
g3
sS'lead,to,several-'
p15235
g3
sS'through,cyp3a4,ingestion'
p15236
g3
sS'with,careful,monitoring'
p15237
g9
sS'to,find,out'
p15238
g3
sS'azole,antifungals,the'
p15239
g3
sS'in,adults,on'
p15240
g3
sS'the,administration,of'
p15241
g9
sS'thiazide,to,hypoparathyroid'
p15242
g9
sS'seven,experiments,reactions'
p15243
g3
sS'in,the,following'
p15244
g3
sS'of,other,medications'
p15245
g3
sS'cytochrome,p450,with'
p15246
g3
sS'and,whether,similar'
p15247
g3
sS'of,any,enzyme'
p15248
g3
sS'concentrations,of,and'
p15249
g3
sS'habituating,potential,prolonged'
p15250
g3
sS'be,titrated,to'
p15251
g3
sS'prostaglandin,synthetase,inhibitor'
p15252
g3
sS'report,that,may'
p15253
g9
sS'the,absence,of'
p15254
g3
sS'limited,therefore,consideration'
p15255
g9
sS'phenobarbitol,rifabutin,rifampin'
p15256
g3
sS'tasks,that,are'
p15257
g3
sS'specific,interaction,studies'
p15258
g3
sS'resulted,in,r-values'
p15259
g3
sS'from,the,currently'
p15260
g3
sS'a,given,dose'
p15261
g3
sS'v,in,the'
p15262
g3
sS'co-administered,with,vardenafil'
p15263
g9
sS'although,no,causal'
p15264
g3
sS'was,assessed,in'
p15265
g3
sS'with,prothrombin,time'
p15266
g9
sS'also,decrease,the'
p15267
g9
sS'per,day,will'
p15268
g9
sS'effects,divalproex,sodium'
p15269
g9
sS'quinolone,antibiotics,videx'
p15270
g9
sS'use,of,barrier'
p15271
g3
sS'increased,stability,of'
p15272
g3
sS'dosing,regimens,of'
p15273
g3
sS'diminished,effect,of'
p15274
g3
sS'kidney,which,was'
p15275
g3
sS'on,therapy,the'
p15276
g9
sS'dogs,one,treated'
p15277
g3
sS'to,lower,the'
p15278
g3
sS'one,week,course'
p15279
g9
sS'carefully,observed,for'
p15280
g9
sS'no,rashes,were'
p15281
g3
sS'concurrently,administered,in'
p15282
g3
sS'nitroglycerin,dynacirc,has'
p15283
g3
sS'with,an,increased'
p15284
g9
sS'with,because,plasma'
p15285
g9
sS'the,contrary,and'
p15286
g9
sS'and,may,inhibit'
p15287
g9
sS'of,concomitant,oral'
p15288
g9
sS'or,multiple,dose'
p15289
g3
sS'mice,did,not'
p15290
g3
sS'the,data,do'
p15291
g3
sS'will,be,reduced'
p15292
g3
sS'in,the,high'
p15293
g3
sS'injections,of,microg'
p15294
g3
sS'each,serum,without'
p15295
g3
sS'of,fat,soluble'
p15296
g3
sS'function,normally,with'
p15297
g3
sS'in,geriatric,subjects'
p15298
g3
sS'require,additional,therapy'
p15299
g3
sS'proquin,xr,should'
p15300
g3
sS'and,css,max'
p15301
g9
sS'between,copaxone,and'
p15302
g3
sS'minutes,following,administration'
p15303
g9
sS'may,predispose,the'
p15304
g9
sS'a,false-negative,result'
p15305
g3
sS'results,are,discussed'
p15306
g3
sS'pretreatment,of,megakaryocytes'
p15307
g9
sS'are,employed,because'
p15308
g9
sS'injection,and,epidural'
p15309
g9
sS'blunts,the,increases'
p15310
g9
sS'inhibit,cyp450s,cyp1a2'
p15311
g3
sS'the,lipid,response'
p15312
g3
sS'oxcarbazepine,can,inhibit'
p15313
g3
sS'non-steroidal,concomitantly,with'
p15314
g9
sS'of,the,spleen'
p15315
g3
sS'displacement,of,in'
p15316
g3
sS'weeks,plasma,concentrations'
p15317
g9
sS'in,gastric,ph'
p15318
g9
sS'threatening,cardiac,dysrhythmias'
p15319
g9
sS'overdosage,cns,stimulation'
p15320
g9
sS'accidents,six,sudden'
p15321
g3
sS'organic,cation,transport'
p15322
g3
sS'recurrence,of,skin'
p15323
g3
sS'number,of,cycles'
p15324
g3
sS'to,in,normovolemic'
p15325
g9
sS'recommended,when,sustiva'
p15326
g9
sS'cyp2d6,cyp2e1,cyp4a9'
p15327
g3
sS'angiotensin,and,angiotensin'
p15328
g3
sS'mg,kg,day'
p15329
g3
sS'is,completely,cleared'
p15330
g3
sS'to,the,vehicle'
p15331
g9
sS'about,and,use'
p15332
g3
sS'patient,is,receiving'
p15333
g9
sS'therefore,mao,inhibitors'
p15334
g9
sS'which,are,usually'
p15335
g9
sS'bowel,and,decrease'
p15336
g3
sS'the,location,histologic'
p15337
g3
sS'cimetidine,cimetidine,increases'
p15338
g9
sS'of,products,with'
p15339
g9
sS'absorbing,materials,amino'
p15340
g3
sS'the,antitumor,effectiveness'
p15341
g9
sS'cyp2d6,cyp1a2,cyp2c9'
p15342
g3
sS'of,microdosed,progestin-containing'
p15343
g9
sS'not,appreciably,metabolized'
p15344
g3
sS'the,pharmacodynamics,prothrombin'
p15345
g3
sS'thus,this,interaction'
p15346
g3
sS'when,administering,peganone'
p15347
g9
sS'such,as,protease'
p15348
g9
sS'by,subsequent,treatment'
p15349
g9
sS'oi,rates,and'
p15350
g3
sS'of,general,the'
p15351
g3
sS'a,higher,risk'
p15352
g3
sS'day,on,weeks'
p15353
g3
sS'the,mentioned,above'
p15354
g3
sS'data,from,a'
p15355
g9
sS'added,concentration,which'
p15356
g3
sS'other,isozymes,evaluated'
p15357
g3
sS'is,unlikely,for'
p15358
g3
sS'relatively,unexplored,area'
p15359
g3
sS'with,one-stage,factor'
p15360
g3
sS'of,nondepolarizing,relaxants'
p15361
g3
sS'stomach,may,effect'
p15362
g9
sS'mesenteric,arteries,preconstricted'
p15363
g3
sS'c,should,be'
p15364
g9
sS'unchanged,or,only'
p15365
g3
sS'patients,either,on'
p15366
g3
sS'levels,could,lessen'
p15367
g3
sS'true,in,patients'
p15368
g3
sS'certain,especially,the'
p15369
g9
sS'of,insp,microm'
p15370
g3
sS'steadystate,trough,cmin'
p15371
g3
sS'plasma,concentrations,and'
p15372
g9
sS'well,as,random'
p15373
g9
sS'by,beta-adrenergic,blocking'
p15374
g9
sS'drug-drug,interactions,with'
p15375
g3
sS'decision,must,be'
p15376
g3
sS'of,combination,hormonal'
p15377
g9
sS'a,single-dose,interaction'
p15378
g3
sS'was,conducted,in'
p15379
g3
sS'parental,mcf-7,cells'
p15380
g3
sS'increase,the,requirements'
p15381
g9
sS'of,the,not'
p15382
g3
sS'arrhythmias,in,patients'
p15383
g3
sS'effective,there,have'
p15384
g3
sS'including,inhaled,and'
p15385
g3
sS'respiratory,failure,cannot'
p15386
g3
sS'heart,disease,is'
p15387
g3
sS'diet,and,more'
p15388
g3
sS'should,be,titrated'
p15389
g9
sS'describes,a,novel'
p15390
g9
sS'the,active,sulfide'
p15391
g9
sS'patients,undergoing,treatment'
p15392
g9
sS'in,parkinsons,disease'
p15393
g9
sS'max,by,confidence'
p15394
g3
sS'employed,because,of'
p15395
g9
sS'and,antagonists,which'
p15396
g9
sS'used,concomitantly,there'
p15397
g9
sS'substrates,of,pgp'
p15398
g3
sS'drug,laboratory,interactions'
p15399
g3
sS'fatty,acids,and'
p15400
g3
sS'qualification,of,the'
p15401
g3
sS'vitro,and,in'
p15402
g3
sS'ribavirin,can,antagonize'
p15403
g9
sS'methods,to,measure'
p15404
g3
sS'increased,severity,and'
p15405
g9
sS'severe,hypotension,has'
p15406
g9
sS'and,long,lasting'
p15407
g3
sS'in,animals,to'
p15408
g3
sS'study,the,effects'
p15409
g3
sS'adjustments,made,when'
p15410
g3
sS'thiazide,for,hypertension'
p15411
g3
sS'a,strong,in'
p15412
g3
sS'are,tricky,using'
p15413
g3
sS'flolan,which,may'
p15414
g9
sS'measured,by,prothrombin'
p15415
g3
sS'and,a,slight'
p15416
g9
sS'neuropathy,should,be'
p15417
g3
sS'selective,cyp3a4,inhibitors'
p15418
g9
sS'cautiously,if,at'
p15419
g3
sS'phenytoin,should,be'
p15420
g3
sS'formulation,with,mg'
p15421
g9
sS'cause,heart,failure'
p15422
g9
sS'inhibits,the,cytochrome'
p15423
g3
sS'was,associated,with'
p15424
g9
sS'elevated,by,and'
p15425
g3
sS'respectively,a,number'
p15426
g9
sS'biotransformation,system,responsible'
p15427
g9
sS'this,adverse,reaction'
p15428
g3
sS'patients,and,greater'
p15429
g3
sS'for,cigarette,smokers'
p15430
g3
sS'vitro,studies,indicated'
p15431
g3
sS'class,of,include'
p15432
g3
sS'including,manic-depressive,illness'
p15433
g9
sS'hmg-coa,reductase,inhibitor'
p15434
g9
sS'index,digoxin,a'
p15435
g3
sS'the,major,ingredient'
p15436
g3
sS'one,survey,of'
p15437
g9
sS'co-administration,of,single'
p15438
g3
sS'of,and,strong'
p15439
g9
sS'withdrawal,period,after'
p15440
g3
sS'also,does,not'
p15441
g3
sS'times,daily,given'
p15442
g9
sS'it,can,prolong'
p15443
g3
sS'the,principles,observed'
p15444
g3
sS'omeprazole,omeprazole,is'
p15445
g3
sS'on,these,components'
p15446
g3
sS'mathematical,functions,to'
p15447
g3
sS'renal,insufficiency,or'
p15448
g3
sS'their,prothrombin,time'
p15449
g9
sS'interaction,sites,between'
p15450
g3
sS'however,because,some'
p15451
g9
sS'estimated,number,of'
p15452
g3
sS'and,pupil,constriction'
p15453
g3
sS'potential,twofold,increase'
p15454
g9
sS'of,the,aucasian'
p15455
g3
sS'greater,than,reduction'
p15456
g9
sS'm2,basis,appears'
p15457
g9
sS'presence,of,metabolites'
p15458
g3
sS'are,advised,to'
p15459
g3
sS'oral,regimen,containing'
p15460
g3
sS'pretreatment,and,follow-up'
p15461
g3
sS'in,tambocor,clinical'
p15462
g3
sS'iron,supplements,and'
p15463
g9
sS'with,coadministration,of'
p15464
g9
sS'neurotoxin,serotypes,at'
p15465
g3
sS'reduction,of,for'
p15466
g3
sS'interaction,because,xigris'
p15467
g3
sS'is,increased,with'
p15468
g3
sS'whose,pulmonary,disease'
p15469
g3
sS'mean,ratios,confidence'
p15470
g3
sS'these,doses,correspond'
p15471
g3
sS'antacid,the,effect'
p15472
g3
sS'was,similar,between'
p15473
g3
sS'contraception,is,suggested'
p15474
g3
sS'nitrous,oxide,with'
p15475
g3
sS'any,of,these'
p15476
g3
sS'antagonists,may,have'
p15477
g9
sS'the,higher,and'
p15478
g3
sS'different,descending,pain'
p15479
g3
sS'results,in,prolongation'
p15480
g9
sS'stable,prothrombin,time'
p15481
g3
sS'frequency,of,skin'
p15482
g9
sS'disease,rather,than'
p15483
g3
sS'cyp2c9,isoenzyme,in'
p15484
g9
sS'characterized,by,perivascular'
p15485
g3
sS'over,those,seen'
p15486
g9
sS'with,other,through'
p15487
g3
sS'the,mean,c'
p15488
g3
sS'induction,or,inhibition'
p15489
g3
sS'toradol,on,plasma'
p15490
g9
sS'co-administered,with,inducers'
p15491
g9
sS'the,day-to,day'
p15492
g3
sS'a,positive,direct'
p15493
g3
sS'must,be,weighed'
p15494
g9
sS'human,dose,based'
p15495
g3
sS'gastric,ph,is'
p15496
g9
sS'gastric,ph,in'
p15497
g3
sS'the,homodimeric,disintegrin'
p15498
g3
sS'uncomplicated,urinary,tract'
p15499
g3
sS'resulted,in,significantly'
p15500
g9
sS'the,mean,t'
p15501
g3
sS'and,type,c'
p15502
g9
sS'when,and,these'
p15503
g3
sS'but,only,increases'
p15504
g3
sS'assessed,on,day'
p15505
g3
sS'by,of,the'
p15506
g9
sS'oral,bioavailability,low'
p15507
g3
sS'are,contraindicated,in'
p15508
g9
sS'pump,inhibitors,with'
p15509
g9
sS'requires,more,than'
p15510
g3
sS'this,finding,to'
p15511
g3
sS'or,with,the'
p15512
g3
sS'and,failed,to'
p15513
g3
sS'symptoms,excitement,hypomania'
p15514
g3
sS'times,more,potent'
p15515
g3
sS'events,by,interfering'
p15516
g9
sS'and,one,with'
p15517
g3
sS'recovery,of,hoof'
p15518
g9
sS'influenced,the,pharmacodynamics'
p15519
g3
sS'an,antiparkinsonian,drug'
p15520
g9
sS'and,demonstrates,the'
p15521
g3
sS'your,bodys,ability'
p15522
g3
sS'clinically,significant,pharmacokinetic'
p15523
g3
sS'renal,toxicity,and'
p15524
g3
sS'of,antizol,mg'
p15525
g9
sS'in,several,dose'
p15526
g3
sS'pharmacokinetits,of,sodium'
p15527
g3
sS'or,other,coumarin-derivative'
p15528
g3
sS'injection,with,a'
p15529
g9
sS'bradycardia,or,hypotension'
p15530
g9
sS'displacement,between,and'
p15531
g3
sS'is,prevented,by'
p15532
g9
sS'concomitantly,with,many'
p15533
g3
sS'n-dodecyl,gallate,showed'
p15534
g3
sS'in,a,phase'
p15535
g9
sS'slight,but,not'
p15536
g9
sS'was,misused,by'
p15537
g3
sS'and,in,limiting'
p15538
g3
sS'from,the,therapeutic'
p15539
g3
sS'blurred,vision,have'
p15540
g9
sS'dose-time,effects,of'
p15541
g3
sS'of,catecholamines,in'
p15542
g3
sS'day,to,prevent'
p15543
g3
sS'potentially,toxic,medications'
p15544
g3
sS'of,drug-induced,cns-related'
p15545
g3
sS'of,needed,to'
p15546
g9
sS'drugs,nsaids,a'
p15547
g3
sS'incidence,of,neurological'
p15548
g3
sS'a,light,dark'
p15549
g3
sS'maxipime,because,of'
p15550
g9
sS'false,positive,test'
p15551
g3
sS'to,maintain,optimum'
p15552
g3
sS'frequent,dosing,may'
p15553
g3
sS'caution,should,be'
p15554
g3
sS'laboratory,test,interactions'
p15555
g3
sS'patient,response,multiple'
p15556
g3
sS'the,combined,data'
p15557
g3
sS'that,the,prothrombin'
p15558
g3
sS'cyp,isoforms,a2'
p15559
g3
sS'be,administered,by'
p15560
g9
sS'as,and,induce'
p15561
g9
sS'intake,of,these'
p15562
g3
sS'of,maximum,block'
p15563
g9
sS'previous,radiation,therapy'
p15564
g3
sS'midamor,and,non-steroidal'
p15565
g9
sS'or,guardian,see'
p15566
g3
sS'tablets,administered,twice'
p15567
g3
sS'that,induce,inhibit'
p15568
g9
sS'free,concentration,may'
p15569
g3
sS'orally,prior,to'
p15570
g9
sS'cmin,concentration,increased'
p15571
g3
sS'auc0-12,and,a'
p15572
g9
sS'decrease,the,response'
p15573
g9
sS'no,relevant,inhibitory'
p15574
g3
sS'half-life,of,sulfoxide'
p15575
g3
sS'a,blocker,of'
p15576
g3
sS'direct,and,indirect'
p15577
g3
sS'the,normal,or'
p15578
g3
sS'not,outweigh,the'
p15579
g9
sS'multiple,effects,on'
p15580
g9
sS'the,negative,symptoms'
p15581
g3
sS'each,of,the'
p15582
g3
sS'mec,values,of'
p15583
g3
sS'closely,related,have'
p15584
g9
sS'two,isoenzymes,will'
p15585
g3
sS'results,that,the'
p15586
g3
sS'levels,by,compared'
p15587
g9
sS'genetically,initiated,cell'
p15588
g3
sS'this,interaction,was'
p15589
g3
sS'of,and,metabolized'
p15590
g3
sS'further,doses,which'
p15591
g3
sS'day,approximately,one-hundredth'
p15592
g3
sS'higher,than,users'
p15593
g9
sS'used,it,may'
p15594
g9
sS'known,interactions,with'
p15595
g3
sS'dose,of,vardenafil'
p15596
g9
sS'therefore,or,other'
p15597
g9
sS'intracranial,hypertension,some'
p15598
g9
sS'mg,bid,with'
p15599
g9
sS'during,simultaneous,administration'
p15600
g3
sS'supplemental,l-glutamine,at'
p15601
g9
sS'these,two,isoenzymes'
p15602
g3
sS'normal,volunteers,it'
p15603
g9
sS'result,from,at'
p15604
g3
sS'reduction,of,approximately'
p15605
g9
sS'levels,of,duloxetine'
p15606
g9
sS'additive,or,potentiating'
p15607
g9
sS'warfarin,in,subjects'
p15608
g3
sS'expected,to,be'
p15609
g3
sS'nervous,system,cns'
p15610
g9
sS'with,its,protein'
p15611
g9
sS'norpace,was,coadministered'
p15612
g3
sS'than,atiii,no'
p15613
g3
sS'ii,to,iii'
p15614
g3
sS'normal,volunteers,resulted'
p15615
g9
sS'of,these,trace'
p15616
g3
sS'be,conducted,in'
p15617
g3
sS'relevance,of,these'
p15618
g3
sS'or,mg,day'
p15619
g3
sS'they,could,enhance'
p15620
g3
sS'procedure,the,possibility'
p15621
g3
sS'hybridization,we,observed'
p15622
g9
sS'strain,c57bl,n'
p15623
g3
sS'acquired,immunodeficiencies,including'
p15624
g3
sS'effects,in,the'
p15625
g3
sS'administered,immediately,following'
p15626
g9
sS'the,specific,toxicities'
p15627
g3
sS'with,biliary,excretion'
p15628
g3
sS'serum,binding,proteins'
p15629
g9
sS'clinical,trials,mesylate'
p15630
g3
sS'p450,a6,or'
p15631
g3
sS'plasma,concentration,of'
p15632
g9
sS'the,permeability,of'
p15633
g3
sS'of,the,type'
p15634
g9
sS'every,hours,does'
p15635
g9
sS'circulars,for,preparations'
p15636
g3
sS'myelopoesis,drugs,which'
p15637
g3
sS'in,order,to'
p15638
g3
sS'glutathione,use,of'
p15639
g9
sS'including,concomitantly,with'
p15640
g9
sS'induction,tool,for'
p15641
g3
sS'blood,pressure,medications'
p15642
g3
sS'pharmacokinetic,captopril-digoxin,interaction'
p15643
g3
sS'use,of,isocarboxazid'
p15644
g9
sS'five,men,levels'
p15645
g3
sS'effects,on,female'
p15646
g3
sS'may,have,an'
p15647
g9
sS'prolonged,thrombocytopenia,the'
p15648
g3
sS'later,changed,to'
p15649
g3
sS'inhaled,and,oral'
p15650
g3
sS'both,a,cyp3a4'
p15651
g3
sS'receiving,treatment,with'
p15652
g3
sS'the,above,data'
p15653
g3
sS'the,first,step'
p15654
g3
sS'pi,with,of'
p15655
g3
sS'nsaids,may,affect'
p15656
g3
sS'absorption,in,those'
p15657
g9
sS'ns,may,be'
p15658
g9
sS'with,nph,human'
p15659
g3
sS'nanm,in,decreasing'
p15660
g3
sS'for,heart,failure'
p15661
g3
sS'concluded,that,may'
p15662
g3
sS'patients,were,treated'
p15663
g3
sS'treatment,is,group'
p15664
g3
sS'identified,in,clinical'
p15665
g9
sS'a4,should,be'
p15666
g3
sS'with,cefamandole,naftate'
p15667
g3
sS'situ,hybridization,we'
p15668
g9
sS'examinations,for,insurances'
p15669
g3
sS'these,drugs,include'
p15670
g3
sS'maintained,in,the'
p15671
g3
sS'determinations,vitamin,c'
p15672
g9
sS'is,present,in'
p15673
g3
sS'a,mild,but'
p15674
g3
sS'little,risk,for'
p15675
g3
sS'of,on,indicates'
p15676
g9
sS'and,antihypertensive,effects'
p15677
g9
sS'therapy,with,interferon'
p15678
g3
sS'p450,metabolism,would'
p15679
g3
sS'significantly,potentiates,the'
p15680
g9
sS'nociception,and,that'
p15681
g3
sS'prinivil,attenuates,loss'
p15682
g9
sS'sexological,psychological,and'
p15683
g3
sS'not,detected,in'
p15684
g3
sS'is,required,if'
p15685
g3
sS'augment,the,activity'
p15686
g9
sS'resolved,within,a'
p15687
g3
sS'current,theories,assume'
p15688
g3
sS'as,common,pathogens'
p15689
g3
sS'of,didanosine-placebo,tablets'
p15690
g9
sS'produced,by,resulting'
p15691
g9
sS'may,enhance,cardiovascular'
p15692
g3
sS'injection,concentrate,and'
p15693
g9
sS'patients,with,organ'
p15694
g3
sS'inhibit,or,are'
p15695
g9
sS'and,cytoprotective,properties'
p15696
g3
sS'microscopy,were,used'
p15697
g3
sS'a4,and,cyp'
p15698
g3
sS'pharmacokinetics,in,subjects'
p15699
g3
sS'cells,at,low'
p15700
g3
sS'torsades,de,pointes'
p15701
g3
sS'when,coadministering,medications'
p15702
g3
sS'associated,with,co-administration'
p15703
g9
sS'no,significant,impact'
p15704
g9
sS'aortic,rings,from'
p15705
g9
sS'is,clinically,significant'
p15706
g3
sS'inducers,it,is'
p15707
g9
sS'increased,nephrotoxicity,has'
p15708
g9
sS'take,place,at'
p15709
g3
sS'demonstrate,very,little'
p15710
g3
sS'a,hypothyroid,patient'
p15711
g3
sS'isoenzymes,tested,cyp1a2'
p15712
g3
sS'is,mildly,reduced'
p15713
g9
sS'not,the,extent'
p15714
g3
sS'mycobacteriumavium-intracellulare,complex,overallactivity'
p15715
g3
sS'alter,the,behavioral'
p15716
g3
sS'the,regulation,of'
p15717
g3
sS'constitutes,the,best'
p15718
g3
sS'of,does,not'
p15719
g3
sS'of,or,was'
p15720
g3
sS'interaction,is,likely'
p15721
g9
sS'exhibited,strong,synergistic'
p15722
g9
sS'established,interactions,there'
p15723
g3
sS'complex,and,can'
p15724
g3
sS'action,of,the'
p15725
g9
sS're-exposure,in,in'
p15726
g3
sS'promoted,significant,decrease'
p15727
g3
sS'a,limited,number'
p15728
g3
sS'increase,in,zaleplons'
p15729
g9
sS'some,associated,with'
p15730
g3
sS'abnormalities,were,identified'
p15731
g3
sS'intact,endothelium,from'
p15732
g9
sS'acetazolamide,reduces,urinary'
p15733
g9
sS'however,a,significantly'
p15734
g3
sS'ace,inhibitors,oral'
p15735
g3
sS'on,concentration,of'
p15736
g3
sS'into,mice,induced'
p15737
g3
sS'for,reduction,in'
p15738
g9
sS'shown,between,and'
p15739
g9
sS'bleeding,when,administered'
p15740
g9
sS'steroidal,anti-,inflammatory'
p15741
g9
sS'effect,was,observed'
p15742
g9
sS'the,may,require'
p15743
g3
sS'in,psoriatic,arthritis'
p15744
g3
sS'human,therapeutic,dose'
p15745
g9
sS'are,provided,to'
p15746
g3
sS'might,reflect,the'
p15747
g3
sS'interval,clinical,laboratory'
p15748
g3
sS'using,in,combination'
p15749
g3
sS'clearance,ml,min'
p15750
g3
sS'use,of,amphotericin'
p15751
g9
sS'of,antagonists,phenyltheophylline'
p15752
g3
sS'monitoring,of,cardiac'
p15753
g9
sS'amino,acids,proteins'
p15754
g3
sS'studies,are,summarized'
p15755
g3
sS'of,dmpge2,in'
p15756
g3
sS'for,auc,infinity'
p15757
g3
sS'no,drug,nutritional'
p15758
g3
sS'when,these,two'
p15759
g3
sS'could,cause,an'
p15760
g9
sS'mg,initial,oral'
p15761
g9
sS'prostate-specific,antigen,psa'
p15762
g3
sS'classes,of,antipsychotic'
p15763
g9
sS'period,following,treatment'
p15764
g3
sS'm,ptx,m'
p15765
g9
sS'are,commonly,found'
p15766
g3
sS'fraction,of,rat'
p15767
g3
sS'markedly,increased,plasma'
p15768
g9
sS'in,these,cases'
p15769
g3
sS'about,to,fold'
p15770
g9
sS'should,be,undertaken'
p15771
g9
sS'of,rat,thoracic'
p15772
g3
sS'with,the,has'
p15773
g9
sS'with,equetrotm,it'
p15774
g3
sS'other,cns,depressant'
p15775
g9
sS'patients,taking,and'
p15776
g9
sS'were,resistant,to'
p15777
g3
sS'in,combination,see'
p15778
g3
sS'is,a,significant'
p15779
g9
sS'and,l-methionine,may'
p15780
g9
sS'performance,was,seen'
p15781
g9
sS'eye,product,containing'
p15782
g9
sS'hydroxide-,and,hydroxide-containing'
p15783
g3
sS'fruit,juices,such'
p15784
g3
sS'channel,blockers,certain'
p15785
g9
sS'resistance,mesenteric,arteries'
p15786
g3
sS'a,common,component'
p15787
g9
sS'in,each,of'
p15788
g3
sS'of,otthostatic,hypotension'
p15789
g3
sS'effect,on,bleeding'
p15790
g3
sS'since,blood,level'
p15791
g3
sS'protein,binding,is'
p15792
g9
sS'been,conducted,the'
p15793
g3
sS'diarrhea,but,did'
p15794
g3
sS'cynomolgus,monkeys,were'
p15795
g3
sS'area,of,the'
p15796
g3
sS'fatal,cardiac,arrests'
p15797
g3
sS'rate,at,which'
p15798
g3
sS'however,current,evidence'
p15799
g3
sS'hyperkalemia,serum,meq'
p15800
g9
sS'to,control,blood'
p15801
g9
sS'inhibitors,of,av'
p15802
g9
sS'reported,interactions,with'
p15803
g3
sS'prevent,opioid-induced,gastrointestinal'
p15804
g9
sS'to,produce,a'
p15805
g9
sS'needed,their,dose'
p15806
g3
sS'blood,pressure,reductions'
p15807
g9
sS'and,titrated,to'
p15808
g3
sS'of,aprepitant,given'
p15809
g9
sS'enbrel,and,therapy'
p15810
g9
sS'seen,in,diabetic'
p15811
g3
sS'monitored,closely,and'
p15812
g9
sS'inhibitors,in,subjects'
p15813
g3
sS'all,the,animals'
p15814
g3
sS'the,neurochemical,and'
p15815
g3
sS'when,has,been'
p15816
g9
sS'function,and,one'
p15817
g3
sS'carbamazepine,is,metabolized'
p15818
g3
sS'it,is,inadvisable'
p15819
g9
sS'a4,but,coadministration'
p15820
g3
sS'when,changing,from'
p15821
g3
sS'myasthenic,weakness,their'
p15822
g3
sS'interactions,benzodiazepines,benzodiazepines'
p15823
g9
sS'reports,of,interactions'
p15824
g9
sS'relaxants,in,postmarketing'
p15825
g3
sS'metabolism,pharmacokinetics,therapeutic'
p15826
g3
sS'cocaine-treated,animals,to'
p15827
g3
sS'model,is,suitable'
p15828
g3
sS'shown,to,displace'
p15829
g9
sS'and,by,inhibiting'
p15830
g9
sS'as,hypotension,requiring'
p15831
g3
sS'occurs,with,other'
p15832
g3
sS'mao,inhibitors,and'
p15833
g9
sS'gvia-sensitive,n-type,channel'
p15834
g3
sS'no,detectable,effect'
p15835
g3
sS'inhibitors,and,beta'
p15836
g9
sS'permeation,of,the'
p15837
g3
sS'some,limited,inhibitory'
p15838
g9
sS'acid,should,not'
p15839
g3
sS'the,adequacy,of'
p15840
g3
sS'and,zidovudine,ribavirin'
p15841
g9
sS'citalopram,citalopram,since'
p15842
g9
sS'eg,for,injection'
p15843
g9
sS'in,basal,small'
p15844
g3
sS'isosorbide,dinitrate,may'
p15845
g9
sS'other,acting,on'
p15846
g3
sS'differences,between,treatment'
p15847
g3
sS'of,human,b'
p15848
g3
sS'capacity,to,function'
p15849
g3
sS'of,felbatol,on'
p15850
g9
sS'functionally,distinguishes,it'
p15851
g3
sS'and,or,in'
p15852
g9
sS'isozyme,activity,among'
p15853
g3
sS'any,intentional,or'
p15854
g9
sS'cns,lesions,have'
p15855
g3
sS'were,determined,by'
p15856
g3
sS'activity,of,desmopressin'
p15857
g3
sS'in,two-lever,discrimination'
p15858
g3
sS'died,compared,to'
p15859
g3
sS'to,the,role'
p15860
g3
sS'ph,h2-receptor,antagonists'
p15861
g9
sS'auc,were,dose'
p15862
g3
sS'im,and,nondepolarizing'
p15863
g3
sS'subsequent,recovery,of'
p15864
g3
sS'not,undergo,renal'
p15865
g3
sS'inhibition,of,cyp3a'
p15866
g9
sS'treatment,of,ewes'
p15867
g9
sS'arc,mrna,in'
p15868
g3
sS'the,hydroxytamoxifen,tam'
p15869
g3
sS'reductase,inhibitors,warning'
p15870
g3
sS'monitoring,particularly,during'
p15871
g3
sS'factrel,may,be'
p15872
g9
sS'exposure,to,was'
p15873
g9
sS'these,two,differ'
p15874
g3
sS'arrhythmia,bradycardia,qt'
p15875
g9
sS'patients,with,serum'
p15876
g3
sS'result,in,insufficient'
p15877
g9
sS'with,other,ergot'
p15878
g9
sS'groups,pd2,values'
p15879
g9
sS'mg,kg,daily'
p15880
g3
sS'nursing,mothers,it'
p15881
g3
sS'oral,on,acth'
p15882
g3
sS'who,has,previously'
p15883
g9
sS'healthy,volunteers,there'
p15884
g3
sS'with,beta-lactamtype,or'
p15885
g9
sS'of,action,of'
p15886
g3
sS'some,patients,if'
p15887
g9
sS'your,doctor,may'
p15888
g3
sS'and,males,dosed'
p15889
g3
sS'theoretical,risk,of'
p15890
g9
sS'sub-,for,in'
p15891
g3
sS'b12,because,they'
p15892
g3
sS'patterns,during,the'
p15893
g3
sS'factors,like,smoking'
p15894
g3
sS'by,the,cytochrome'
p15895
g3
sS'acid,did,not'
p15896
g3
sS'and,malignant,hyperpyrexia'
p15897
g3
sS'time,and,close'
p15898
g3
sS'and,depletion,related'
p15899
g3
sS'the,combined,moieties'
p15900
g3
sS'to,an,improved'
p15901
g3
sS'of,altered,topo'
p15902
g3
sS'mg,x,kg'
p15903
g3
sS'during,concurrent,administration'
p15904
g3
sS'procrit,with,other'
p15905
g3
sS'phenytoin,phenobarbitol,rifabutin'
p15906
g3
sS'dose,of,on'
p15907
g9
sS'automatic,behavior,and'
p15908
g3
sS'pressure,beyond,those'
p15909
g3
sS'on,the,aptt'
p15910
g3
sS'from,male,lean'
p15911
g3
sS'receiving,the,two'
p15912
g3
sS'a,day,qd'
p15913
g3
sS'the,myelotoxicity,of'
p15914
g3
sS'diffraction,differential,scanning'
p15915
g3
sS'wellbutrin,and,that'
p15916
g9
sS'received,rantidine,hydrochloride'
p15917
g3
sS'in,one,study'
p15918
g3
sS'no,doubt,complex'
p15919
g3
sS'taking,both,and'
p15920
g9
sS'have,clinically,relevant'
p15921
g9
sS'of,xigris,have'
p15922
g3
sS'concerning,laboratory,test'
p15923
g3
sS'measurement,of,and'
p15924
g3
sS'when,vioxx,and'
p15925
g9
sS'do,to,help'
p15926
g3
sS'arrhythmias,including,ventricular'
p15927
g3
sS'be,taken,in'
p15928
g3
sS'oral,carbonic,anhydrase'
p15929
g9
sS'reduction,in,clearance'
p15930
g9
sS'because,competitively,displaces'
p15931
g9
sS'heparins,as,indicated'
p15932
g3
sS'animals,to,their'
p15933
g3
sS'antacids,administration,of'
p15934
g9
sS'of,sodium,or'
p15935
g9
sS'nsaids,and,tnf'
p15936
g3
sS'to,when,it'
p15937
g9
sS'and,were,unchanged'
p15938
g3
sS'other,traditional,agents'
p15939
g3
sS'above,chronic,weeks'
p15940
g3
sS'is,no,pharmacokinetic'
p15941
g3
sS'not,all,are'
p15942
g3
sS'single-dose,crossover,study'
p15943
g9
sS'the,first,synthetic'
p15944
g3
sS'of,blood,platelets'
p15945
g9
sS'as,akineton,are'
p15946
g9
sS'with,lymphoma,on'
p15947
g3
sS'presence,of,free'
p15948
g3
sS'p450,with,the'
p15949
g3
sS'in,adequate,numbers'
p15950
g3
sS'coadministration,of,aprepitant'
p15951
g9
sS'one,additional,at'
p15952
g3
sS'effect,was,present'
p15953
g3
sS'inhibits,adp,and'
p15954
g3
sS'interaction,also,occurs'
p15955
g3
sS'inducers,indicate,only'
p15956
g9
sS'when,initiating,and'
p15957
g9
sS'antacids,the,concomitant'
p15958
g3
sS'rifabutin,coadministration,of'
p15959
g9
sS'methyl-4,phenyl-1,tetrahydropyridine'
p15960
g3
sS'plasma,levels,total'
p15961
g9
sS'given,with,compared'
p15962
g9
sS'including,herbal,preparations'
p15963
g3
sS'or,careful,consideration'
p15964
g9
sS'days,of,both'
p15965
g3
sS'of,and,concomitant'
p15966
g3
sS'of,but,increased'
p15967
g3
sS'in,an,open'
p15968
g3
sS'monomeric,disintegrins,and'
p15969
g3
sS'at,and,m'
p15970
g3
sS'mtx,were,nonsteroidal'
p15971
g3
sS'subsequently,treated,with'
p15972
g9
sS'drug,laboratory,test'
p15973
g3
sS'at,the,highest'
p15974
g3
sS'titers,may,have'
p15975
g3
sS'counts,of,less'
p15976
g3
sS'inhibitory,concentration,mic'
p15977
g3
sS'these,interactions,the'
p15978
g3
sS'in,the,transport'
p15979
g3
sS'when,plasma,asparagine'
p15980
g9
sS'bronchodilator,effect,of'
p15981
g3
sS'adverse,effects,of'
p15982
g9
sS'antidepressant,eg,commonly'
p15983
g9
sS'by,such,an'
p15984
g3
sS'the,rate,but'
p15985
g3
sS'minutes,p,this'
p15986
g9
sS'decrease,the,possible'
p15987
g9
sS'in,hiv-infected,subjects'
p15988
g3
sS'platelet,antiaggregant,prostacyclin'
p15989
g3
sS'of,systemic,it'
p15990
g9
sS'higher,concentrations,of'
p15991
g9
sS'be,drawn,either'
p15992
g3
sS'to,a,dose-dependent'
p15993
g9
sS'increase,in,cortisol'
p15994
g3
sS'multiple,dose,pharmacokinetic'
p15995
g3
sS'with,that,either'
p15996
g3
sS'dosage,of,precedex'
p15997
g9
sS'which,may,present'
p15998
g9
sS'influence,through,the'
p15999
g3
sS'ace,inhibitors,in'
p16000
g9
sS'especially,if,these'
p16001
g3
sS'with,more,commonly'
p16002
g9
sS'no,trials,specifically'
p16003
g3
sS'noted,with,other'
p16004
g3
sS'i,and,i'
p16005
g3
sS'concurrently,with,can'
p16006
g3
sS'higher,serum,concentrations'
p16007
g9
sS'addition,there,was'
p16008
g3
sS'and,omega-conotoxin,gvia'
p16009
g3
sS'these,medicines,during'
p16010
g9
sS'training-induced,neurobiological,alterations'
p16011
g3
sS'alcohol,alcohol,g'
p16012
g3
sS'and,c19,are'
p16013
g3
sS'parallel,group,clinical'
p16014
g3
sS'agents,or,adrenergic'
p16015
g3
sS'co-administered,with,maleate'
p16016
g9
sS'initiating,tca,treatment'
p16017
g3
sS'patients,with,copd'
p16018
g3
sS'exception,of,cyp2c19'
p16019
g3
sS'the,and,reduce'
p16020
g9
sS'will,be,augmented'
p16021
g9
sS'a,common,comorbidity'
p16022
g3
sS'initiation,is,considered'
p16023
g3
sS'tumour,and,normal'
p16024
g9
sS'is,coadministered,prescribers'
p16025
g3
sS'and,of,patients'
p16026
g3
sS'reduce,and,retard'
p16027
g3
sS'for,days,increased'
p16028
g9
sS'to,provide,a'
p16029
g3
sS'not,extend,outside'
p16030
g3
sS'intravenous,dose,of'
p16031
g3
sS'progesterone-,and,high-estradiol'
p16032
g9
sS'the,secretion,of'
p16033
g3
sS'were,no,changes'
p16034
g3
sS'seen,in,and'
p16035
g3
sS'intravenous,pentamidine,treatment'
p16036
g3
sS'intravenous,dose,or'
p16037
g9
sS'or,antagonise,the'
p16038
g3
sS'alterations,in,serum'
p16039
g3
sS'of,and,add'
p16040
g9
sS'avoid,the,concomitant'
p16041
g9
sS'hcl,usually,does'
p16042
g9
sS'patients,or,in'
p16043
g3
sS'coumarin-like,should,be'
p16044
g9
sS'and,a,shorter'
p16045
g3
sS'in,parietal,cell'
p16046
g3
sS'treatment,is,associated'
p16047
g3
sS'iv,in,relation'
p16048
g3
sS'inotropes,and,may'
p16049
g9
sS'a,microdilution,method'
p16050
g3
sS'and,were,tested'
p16051
g3
sS'with,specific,neurobiological'
p16052
g3
sS'and,anti,platelet'
p16053
g3
sS'have,not,shown'
p16054
g9
sS'accomplished,through,redundancy'
p16055
g3
sS'non-linear,pharmacokinetics,over'
p16056
g9
sS'analysed,using,two'
p16057
g3
sS'and,rarely,enuresis'
p16058
g3
sS'a6,or,the'
p16059
g3
sS'exogenous,and,endogenous'
p16060
g3
sS'the,urinary,thioether'
p16061
g3
sS'agents,given,concomitantly'
p16062
g3
sS'the,intervals,usually'
p16063
g3
sS'and,consideration,of'
p16064
g3
sS'multiple-dose,study,caused'
p16065
g9
sS'rarely,toxicity,may'
p16066
g9
sS'recovery,of,fade'
p16067
g9
sS'toxicodynamic,interference,between'
p16068
g3
sS'seen,when,arava'
p16069
g9
sS'reduced,the,response'
p16070
g9
sS'after,multiple,dosing'
p16071
g9
sS'chelates,with,alkaline'
p16072
g3
sS'in,moribund,condition'
p16073
g3
sS'as,vertigo,syncope'
p16074
g9
sS'as,and,local'
p16075
g9
sS'are,administered,concomitantly'
p16076
g3
sS'because,of,initial'
p16077
g3
sS'that,the,involvement'
p16078
g3
sS'effects,were,observed'
p16079
g9
sS'forms,of,effective'
p16080
g3
sS'blockers,and,may'
p16081
g9
sS'vitro,tests,with'
p16082
g3
sS'cytochrome,p450iiia4,isozyme'
p16083
g9
sS'in,which,plasma'
p16084
g3
sS'drugs,hallucinations,have'
p16085
g9
sS'a,second,hour'
p16086
g3
sS'prior,to,initiation'
p16087
g9
sS'decreased,in,relation'
p16088
g3
sS'from,cotherapy,an'
p16089
g3
sS'the,intravenous,application'
p16090
g3
sS'after,the,last'
p16091
g3
sS'may,cause,serious'
p16092
g9
sS'is,currently,underway'
p16093
g3
sS'including,with,multivalent'
p16094
g9
sS'in,peak,latency'
p16095
g3
sS'may,be,additive'
p16096
g9
sS'maybe,useful,for'
p16097
g3
sS'receptor,antagonists,the'
p16098
g9
sS'long-acting,or,who'
p16099
g9
sS'taxol,is,catalyzed'
p16100
g3
sS'in,deficits,in'
p16101
g3
sS'detected,after,weeks'
p16102
g3
sS'cyp2c8,cyp2c9,cyp2c19'
p16103
g3
sS'major,are,also'
p16104
g9
sS'concomitantly,with,radiation'
p16105
g3
sS'hypotensive,effects,of'
p16106
g9
sS'acid,a-blockers,angiotensin-converting'
p16107
g3
sS'is,taken,concurrently'
p16108
g9
sS'amounts,of,these'
p16109
g3
sS'n3,for,varying'
p16110
g3
sS'binding,of,may'
p16111
g9
sS'in,eight,hiv-infected'
p16112
g9
sS'an,increased,synaptic'
p16113
g3
sS'of,either,medicine'
p16114
g9
sS'characteristic,apoptotic,morphology'
p16115
g3
sS'in,these,categories'
p16116
g9
sS'd,inhibited,the'
p16117
g9
sS'hospitals,resulting,in'
p16118
g3
sS'test,interactions,as'
p16119
g3
sS'recommended,that,serum'
p16120
g9
sS'method,for,aerobic'
p16121
g3
sS'or,with,suspension'
p16122
g3
sS'mesenteric,vasodilation,induced'
p16123
g9
sS'at,a,median'
p16124
g3
sS'moribund,condition,after'
p16125
g3
sS'general,such,as'
p16126
g9
sS'administered,concurrently,with'
p16127
g9
sS'sleeping,time,after'
p16128
g9
sS'th,and,the'
p16129
g3
sS'diminishes,the,effect'
p16130
g9
sS'be,significantly,more'
p16131
g3
sS'clinical,importance,brevibloc'
p16132
g9
sS'lowers,the,serum'
p16133
g9
sS'this,test,which'
p16134
g3
sS'use,of,pancreatic'
p16135
g9
sS'mg,was,taken'
p16136
g3
sS'vitro,the,plasma'
p16137
g3
sS'but,increased,effects'
p16138
g3
sS'dependence,may,be'
p16139
g3
sS'by,selective,agonists'
p16140
g3
sS'usually,observed,only'
p16141
g3
sS'of,nanm,or'
p16142
g3
sS'or,can,be'
p16143
g9
sS'when,hydrochlorothiazide,and'
p16144
g9
sS'medication,authorization,cards'
p16145
g3
sS'intravenous,sodium,and'
p16146
g9
sS'up,to,hours'
p16147
g9
sS'or,inducers,of'
p16148
g3
sS'discontinued,hours,before'
p16149
g3
sS'using,cardiovascular,concurrently'
p16150
g3
sS'use,caution,when'
p16151
g3
sS'release,of,and'
p16152
g3
sS'of,neurons,displaying'
p16153
g3
sS'many,including,most'
p16154
g3
sS'by,alveoli,of'
p16155
g3
sS'that,inhibit,cytochrome'
p16156
g3
sS'and,a,that'
p16157
g9
sS'of,the,or'
p16158
g9
sS'increases,serum,concentration'
p16159
g3
sS'increase,cmax,by'
p16160
g9
sS'cyp2c9,cyp2c19,and'
p16161
g3
sS'antimicrobial,effect,of'
p16162
g3
sS'by,a,combination'
p16163
g3
sS'increase,in,plasma'
p16164
g9
sS'eg,or,can'
p16165
g9
sS'cardiovascular,agents,enalapril'
p16166
g3
sS'psychotropic,or,even'
p16167
g3
sS'to,be,cyp'
p16168
g9
sS'compatibility,of,novolog'
p16169
g3
sS'of,for,such'
p16170
g3
sS'unlikely,to,cause'
p16171
g3
sS'greater,than,the'
p16172
g3
sS'the,following,situations'
p16173
g3
sS'serious,reaction,to'
p16174
g9
sS'sensipar,is,metabolized'
p16175
g3
sS'chapter,considers,the'
p16176
g3
sS'different,medicines,may'
p16177
g3
sS'discontinued,that,and'
p16178
g3
sS'patients,have,not'
p16179
g3
sS'time,and,by'
p16180
g3
sS'primarily,metabolized,and'
p16181
g3
sS'contrast,media,experienced'
p16182
g9
sS'of,erythema,tenderness'
p16183
g3
sS'with,schizophrenia,and'
p16184
g3
sS'concomitant,useof,a'
p16185
g9
sS'in,serum-supplemented,nih-3t3'
p16186
g3
sS'a,highly,sensitive'
p16187
g3
sS'hours,for,days'
p16188
g3
sS'or,both,agents'
p16189
g3
sS'be,more,reactive'
p16190
g3
sS'ergot-type,oxytocic,may'
p16191
g3
sS'unaffected,following,co-administration'
p16192
g3
sS'of,to,increase'
p16193
g9
sS'whether,they,respond'
p16194
g3
sS'discontinuing,treatment,with'
p16195
g9
sS'nosebleeds,hemoptysis,hematemesis'
p16196
g3
sS'steady-state,serum,antidepressant'
p16197
g9
sS'before,the,analysis'
p16198
g3
sS'history,of,psychiatric'
p16199
g9
sS'of,arimidex,with'
p16200
g3
sS'increase,the,amount'
p16201
g9
sS'monitored,closely,if'
p16202
g9
sS'receiving,hctz,alone'
p16203
g9
sS'were,reported,to'
p16204
g9
sS'of,cyp2d6,such'
p16205
g9
sS'low,serum,levels'
p16206
g3
sS'monitored,closely,in'
p16207
g9
sS'alternating,therapy,for'
p16208
g3
sS'washout,period,was'
p16209
g3
sS'and,other,nsaids'
p16210
g9
sS'effect,of,various'
p16211
g9
sS'acetate,is,a'
p16212
g3
sS'gastrointestinal,tract,by'
p16213
g9
sS'a,trans-3,dimethyl-4'
p16214
g9
sS'with,kerlone,and'
p16215
g3
sS'which,leads,to'
p16216
g3
sS'as,clinistix,or'
p16217
g3
sS'between,neupogen,and'
p16218
g3
sS'order,of,application'
p16219
g3
sS'an,adjustment,in'
p16220
g3
sS'solution,or,clinitest'
p16221
g3
sS'mg,with,mg'
p16222
g9
sS'subsequent,diagnostic,serum'
p16223
g3
sS'of,this,in'
p16224
g3
sS'range,of,individual'
p16225
g3
sS'its,antidiuretic,activity'
p16226
g3
sS'on,renal,tubular'
p16227
g9
sS'furosemide,in,normal'
p16228
g3
sS'tracrium,include,certain'
p16229
g9
sS'inhibits,o-glucuronidation,ki'
p16230
g3
sS'to,microg,ml'
p16231
g3
sS'treatment,of,erection'
p16232
g3
sS'use,both,and'
p16233
g3
sS'especially,central,nervous'
p16234
g3
sS'hepatic,enzyme-inducing,such'
p16235
g9
sS'be,mimicked,by'
p16236
g3
sS'in,general,any'
p16237
g3
sS'on,protein,binding'
p16238
g3
sS'particularly,if,renal'
p16239
g3
sS'immune,system,and'
p16240
g3
sS'levels,was,observed'
p16241
g9
sS'investigate,the,effect'
p16242
g3
sS'lipid,levels,is'
p16243
g9
sS'and,blurred,vision'
p16244
g9
sS'and,or,the'
p16245
g9
sS'levels,of,cortisol'
p16246
g3
sS'as,because,they'
p16247
g9
sS'and,mg,bid'
p16248
g9
sS'and,ketoconazole,ketoconazole'
p16249
g3
sS'including,cefotaxime,sodium'
p16250
g3
sS'diclofenac,decreases,renal'
p16251
g9
sS'iv,compared,with'
p16252
g3
sS'vivo,studies,it'
p16253
g3
sS'patients,following,the'
p16254
g3
sS'with,tuberculosis,andusing'
p16255
g3
sS'blurred,vision,and'
p16256
g9
sS'include,sufficient,numbers'
p16257
g3
sS'and,potassium-sparing,including'
p16258
g9
sS'reported,to,induce'
p16259
g9
sS'patients,the,combined'
p16260
g9
sS'with,all,central'
p16261
g9
sS'to,predict,the'
p16262
g3
sS'increase,in,urinary'
p16263
g9
sS'evidence,of,decreased'
p16264
g9
sS'theophylline,decreased,the'
p16265
g9
sS'of,agents,which'
p16266
g9
sS'diarrhea,induced,by'
p16267
g9
sS'downward,dose,adjustment'
p16268
g9
sS'inhibit,pgp,increased'
p16269
g3
sS'fall,of,the'
p16270
g9
sS'nonsteroidal,antiinflammatories,and'
p16271
g3
sS'measure,plasma,concentrations'
p16272
g3
sS'receiving,concurrent,and'
p16273
g3
sS'by,cyp3a,channel'
p16274
g3
sS'change,in,dose'
p16275
g3
sS'does,not,increase'
p16276
g3
sS'in,etodolac-treated,patients'
p16277
g9
sS'on,a,preparation'
p16278
g9
sS'the,theophylline-induced,anxiogenic'
p16279
g9
sS'to,decreased,plasma'
p16280
g3
sS'reevaluations,of,dosages'
p16281
g3
sS'rifampin,following,concomitant'
p16282
g9
sS'and,from,ml'
p16283
g3
sS'inserted,between,the'
p16284
g3
sS'hepatic,injury,or'
p16285
g3
sS'after,m-tco,injection'
p16286
g9
sS'triphosphate,metabolite,was'
p16287
g3
sS'necessitate,reduction,of'
p16288
g3
sS'plus,catecholamine,depletors'
p16289
g9
sS'most,likely,by'
p16290
g9
sS'hits,are,required'
p16291
g3
sS'review,discusses,the'
p16292
g3
sS'a,preparation,this'
p16293
g9
sS'also,see,warnings'
p16294
g3
sS'frequently,administered,concomitantly'
p16295
g3
sS'decrease,about,in'
p16296
g9
sS'with,other,should'
p16297
g9
sS'a,steady,partner'
p16298
g3
sS'than,one,treatment'
p16299
g3
sS'as,sole,protease'
p16300
g3
sS'positive,inotropic,effects'
p16301
g9
sS'c19,and,a4'
p16302
g3
sS'eszopiclone,is,not'
p16303
g3
sS'all,metabolized,by'
p16304
g9
sS'found,in,rat'
p16305
g3
sS'co-,administration,of'
p16306
g3
sS'patients,receiving,ganglion'
p16307
g3
sS'not,differ,significantly'
p16308
g3
sS'usually,involves,depression'
p16309
g3
sS'lowered,the,plasma'
p16310
g9
sS'to,these,medicinal'
p16311
g9
sS'are,given,in'
p16312
g9
sS'of,active,phosphorylated'
p16313
g9
sS'long,as,plasma'
p16314
g9
sS'suggest,that,nonabsorbable'
p16315
g9
sS'or,quite,large'
p16316
g3
sS'administration,of,difluoroacetone'
p16317
g3
sS'estradiol,concentrations,and'
p16318
g3
sS'using,four,diets'
p16319
g3
sS'but,did,not'
p16320
g9
sS'acting,primarily,to'
p16321
g9
sS'metabolism,carbohydrate,metabolism'
p16322
g3
sS'half-life,the,coadministration'
p16323
g9
sS'window,such,as'
p16324
g9
sS'physicians,query,patients'
p16325
g3
sS'dosage,are,required'
p16326
g9
sS'an,increased,incidence'
p16327
g3
sS'pharmacodynamic,effect,increased'
p16328
g3
sS'you,think,you'
p16329
g3
sS'efficacy,ectopic,pregnancies'
p16330
g3
sS'doses,did,not'
p16331
g3
sS'to,the,regimen'
p16332
g9
sS'by,see,clinical'
p16333
g9
sS'due,to,displacement'
p16334
g3
sS'fatal,adverse,events'
p16335
g3
sS'evaluating,serum,levels'
p16336
g3
sS'albumin,could,increase'
p16337
g3
sS'increased,sedation,when'
p16338
g9
sS'when,compared,with'
p16339
g3
sS'appearance,of,unchanged'
p16340
g3
sS'hypotension,patients,on'
p16341
g9
sS'the,prolonged,survival'
p16342
g3
sS'required,if,or'
p16343
g3
sS'clearance,accelerated,markedly'
p16344
g9
sS'pharmacodynamic,interactions,between'
p16345
g3
sS'reduced,clozapine,dose'
p16346
g3
sS'neither,influenced,the'
p16347
g3
sS'type,c,should'
p16348
g9
sS'either,by,repeated'
p16349
g3
sS'peak,as,being'
p16350
g3
sS'be,related,to'
p16351
g3
sS'm,g,kg'
p16352
g3
sS'extra,doses,should'
p16353
g3
sS'indicate,that,clearance'
p16354
g9
sS'and,then,wait'
p16355
g9
sS'to,the,amount'
p16356
g3
sS'with,norpace,or'
p16357
g9
sS'treatpatients,co-infected,with'
p16358
g3
sS'other,statins,co-administration'
p16359
g9
sS'concentration,of,was'
p16360
g3
sS'taking,low-dose,mg'
p16361
g3
sS'were,not,sufficient'
p16362
g9
sS'all,subjects,and'
p16363
g9
sS'when,the,thioether'
p16364
g3
sS'anti-glaucoma,and,miotic'
p16365
g3
sS'of,the,with'
p16366
g9
sS'approximately,and,respectively'
p16367
g9
sS'involving,metabolized,similarly'
p16368
g9
sS'concentrate,and,for'
p16369
g9
sS'if,or,are'
p16370
g3
sS'weight,w,and'
p16371
g9
sS'the,consequences,of'
p16372
g3
sS'combined,chemotherapy,plus'
p16373
g3
sS'use,of,may'
p16374
g9
sS'enterohepatic,elimination,of'
p16375
g3
sS'involving,adult,volunteers'
p16376
g3
sS'of,an,adolescent'
p16377
g9
sS'blocks,and,receptors'
p16378
g9
sS'metal,mixture,toxicity'
p16379
g3
sS'studies,indicate,cyp3a4'
p16380
g3
sS'then,titrated,according'
p16381
g9
sS'subacute,hepatitis,and'
p16382
g3
sS'glucose,enzymatic,test'
p16383
g3
sS'whenever,one,of'
p16384
g3
sS'somatic,disease,states'
p16385
g3
sS'to,cause,pancreatitis'
p16386
g3
sS'of,nephrotoxic,compounds'
p16387
g3
sS'interactions,have,previously'
p16388
g3
sS'with,concentrations,at'
p16389
g3
sS'taxol,until,neutrophils'
p16390
g3
sS'curve,was,also'
p16391
g3
sS'cyp,a4,may'
p16392
g3
sS'cns,depression,may'
p16393
g9
sS'concomitantly,used,in'
p16394
g3
sS'newly,introduced,atypical'
p16395
g3
sS'during,concomitant,administration'
p16396
g9
sS'and,intensify,the'
p16397
g9
sS'concurrent,treatment,with'
p16398
g3
sS'day,orally,for'
p16399
g9
sS'is,an,inhibitor'
p16400
g3
sS'recommended,twice,daily'
p16401
g3
sS'increased,when,was'
p16402
g9
sS'prolixin,serentil,trilafon'
p16403
g3
sS'with,an,oral'
p16404
g9
sS'seen,with,kemstrotm'
p16405
g3
sS'care,units,with'
p16406
g3
sS'concentration,as,high'
p16407
g3
sS'because,it,is'
p16408
g3
sS'pharmacology,coadministration,of'
p16409
g9
sS'patients,taking,either'
p16410
g9
sS'binding,after,the'
p16411
g3
sS'in,subjects,receiving'
p16412
g3
sS'discontinuing,hydrochloride,could'
p16413
g3
sS'ml,in,the'
p16414
g3
sS'is,clinically,warranted'
p16415
g9
sS'mg,of,the'
p16416
g9
sS'similar,changes,may'
p16417
g3
sS'in,the,synthesis'
p16418
g3
sS'increases,plasma,concentrations'
p16419
g3
sS'decrease,the,hypotensive'
p16420
g9
sS'to,slower,renal'
p16421
g9
sS'enhance,the,curariform'
p16422
g9
sS'available,data,indicate'
p16423
g3
sS'effect,on,psychomotor'
p16424
g9
sS'of,hypotension,will'
p16425
g9
sS'p,in,humans'
p16426
g9
sS'defect,is,not'
p16427
g3
sS'and,n,were'
p16428
g9
sS'caution,as,the'
p16429
g9
sS'optimal,pharmacokinetics,effectiveness'
p16430
g3
sS'at,concentrations,in'
p16431
g3
sS'the,curve,at'
p16432
g9
sS'maintain,levels,limit'
p16433
g9
sS'oral,on,the'
p16434
g3
sS'inhibitors,it,is'
p16435
g3
sS'acid,may,enhance'
p16436
g9
sS'existence,of,pi'
p16437
g3
sS'buforin,ii,alone'
p16438
g3
sS'any,cyp,isoenzymes'
p16439
g3
sS'no,reports,of'
p16440
g3
sS'and,of,on'
p16441
g3
sS'cholestyramine,may,delay'
p16442
g9
sS'to,escalate,the'
p16443
g3
sS'produced,no,statistically'
p16444
g3
sS'response,to,may'
p16445
g3
sS'administration,to,the'
p16446
g3
sS'not,been,fully'
p16447
g9
sS'degree,of,heart'
p16448
g3
sS'to,use,the'
p16449
g3
sS'dosage,of,is'
p16450
g9
sS'with,transdermal,may'
p16451
g9
sS'other,phe-nothiazines,products'
p16452
g3
sS'define,positive,and'
p16453
g3
sS'stimulating,the,synthesis'
p16454
g3
sS'a,patient,being'
p16455
g3
sS'or,the,active'
p16456
g3
sS'plasma,renin,levels'
p16457
g3
sS'in,the,bioavailability'
p16458
g3
sS'folic,acid,should'
p16459
g3
sS'and,mmol,day'
p16460
g3
sS'necessary,when,oral'
p16461
g3
sS'and,the,need'
p16462
g3
sS'in,hypertensive,patients'
p16463
g3
sS'animals,demonstrate,that'
p16464
g9
sS'latencies,to,lose'
p16465
g3
sS'interactions,may,occur'
p16466
g9
sS'systemically-administered,oral,or'
p16467
g9
sS'an,increased,plasma'
p16468
g9
sS'much,higher,changes'
p16469
g3
sS'and,resulting,in'
p16470
g9
sS'chronic,administration,of'
p16471
g9
sS'copd,medications,they'
p16472
g3
sS'theoretically,affect,pharmacodynamics'
p16473
g9
sS'and,some,general'
p16474
g3
sS'of,the,aerosol'
p16475
g3
sS'the,response,rates'
p16476
g3
sS'agents,with,nephrotoxic'
p16477
g9
sS'on,the,intracellular'
p16478
g9
sS'was,lower,and'
p16479
g9
sS'of,preparations,which'
p16480
g3
sS'c19,cyp,d6'
p16481
g3
sS'to,inhibit,cyp3a4'
p16482
g3
sS'ritonavir,significantly,prolonged'
p16483
g9
sS'inhibit,proliferation,in'
p16484
g9
sS'of,ganoderma,lucidum'
p16485
g3
sS'occasional,susceptible,patients'
p16486
g3
sS'not,expected,to'
p16487
g3
sS'not,inhibited,by'
p16488
g3
sS'management,of,angina'
p16489
g9
sS'broad,population,of'
p16490
g3
sS'blood,pressure,carotid'
p16491
g3
sS'cumulative,incidence,of'
p16492
g3
sS'clinical,monitoring,may'
p16493
g3
sS'benefits,of,mefloquine'
p16494
g3
sS'cases,should,be'
p16495
g3
sS'such,as,slowly'
p16496
g9
sS'phosphorylated,concentration,is'
p16497
g3
sS'before,idv,does'
p16498
g3
sS'amphetamines,may,antagonize'
p16499
g9
sS'and,other,similarly'
p16500
g3
sS'was,tested,in'
p16501
g3
sS'of,oral,with'
p16502
g9
sS'and,torsades,de'
p16503
g9
sS'have,specifically,been'
p16504
g3
sS'improved,glucose,utilization'
p16505
g3
sS'alone,in,doses'
p16506
g3
sS'closely,in,patients'
p16507
g9
sS'n-multistix,sg,dipstick'
p16508
g3
sS'antagonists,and,certain'
p16509
g9
sS'produce,additive,effects'
p16510
g9
sS'they,may,be'
p16511
g3
sS'of,the,chronically'
p16512
g3
sS'prior,to,admission'
p16513
g3
sS'on,the,binding'
p16514
g3
sS'with,preparations,may'
p16515
g9
sS'and,urine,creatinine'
p16516
g3
sS'mixed,with,nph'
p16517
g3
sS'both,which,are'
p16518
g3
sS'bsa,during,the'
p16519
g3
sS'man,we,have'
p16520
g3
sS'with,various,containing'
p16521
g9
sS'acidic,or,basic'
p16522
g9
sS'effects,did,not'
p16523
g3
sS'vivo,data,indicate'
p16524
g9
sS'association,of,deep-seated'
p16525
g3
sS'dosing,has,been'
p16526
g3
sS'have,demonstrated,marked'
p16527
g3
sS'displaying,transient,outward'
p16528
g3
sS'relating,to,the'
p16529
g3
sS'during,concomitant,therapy'
p16530
g3
sS'angina,pectoris,additional'
p16531
g9
sS'adrenergic,blockers,including'
p16532
g3
sS'endothelial,dysfunction,and'
p16533
g3
sS'evidence,indicating,that'
p16534
g3
sS'with,repeated,dosing'
p16535
g3
sS'and,a,potent'
p16536
g9
sS'reversed,by,cgs'
p16537
g9
sS'a,contraindication,to'
p16538
g3
sS'used,with,agents'
p16539
g3
sS'of,inhibitor,to'
p16540
g3
sS'of,total,glutathione'
p16541
g3
sS'antiapoptotic,effect,of'
p16542
g3
sS'induced,responses,both'
p16543
g9
sS'in,the,prescribing'
p16544
g3
sS'neutropenia,and,no'
p16545
g9
sS'than,for,nmda'
p16546
g3
sS'parameters,clinical,laboratory'
p16547
g3
sS'tested,to,determine'
p16548
g3
sS'to,elevate,plasma'
p16549
g9
sS'may,occur,between'
p16550
g9
sS'vitro,studies,m1'
p16551
g3
sS'their,physicians,and'
p16552
g3
sS'relation,between,plasma'
p16553
g3
sS'efficacy,of,future'
p16554
g3
sS'effects,of,gabitril'
p16555
g3
sS'angioedema,or,generalized'
p16556
g3
sS'general,population,plasma'
p16557
g3
sS'of,dosages,and'
p16558
g3
sS'asa,and,may'
p16559
g3
sS'for,less,than'
p16560
g3
sS'travelers,receiving,comedication'
p16561
g9
sS'are,often,used'
p16562
g3
sS'increases,the,inhibitory'
p16563
g9
sS'additive,inotropic,and'
p16564
g3
sS'on,should,be'
p16565
g9
sS'when,tested,in'
p16566
g3
sS'poor,metabolizers,and'
p16567
g3
sS'of,medications,for'
p16568
g3
sS'was,made,of'
p16569
g3
sS'using,their,selective'
p16570
g3
sS'experiments,using,the'
p16571
g3
sS'conditions,of,patients'
p16572
g3
sS'paresthesia,and,laboratory'
p16573
g3
sS'change,in,phase'
p16574
g3
sS'of,anticholinesterase,agents'
p16575
g9
sS'effects,on,metabolism'
p16576
g3
sS'prothrombin,test,results'
p16577
g3
sS'ph,of,the'
p16578
g9
sS'be,alert,for'
p16579
g3
sS'adrenal,synthesis,and'
p16580
g9
sS'of,because,of'
p16581
g9
sS'produced,an,inhibition'
p16582
g3
sS'reduce,the,hepatic'
p16583
g9
sS'patients,five,lacking'
p16584
g3
sS'adjustment,of,the'
p16585
g9
sS'patients,years,of'
p16586
g3
sS'dl,dose,adjustment'
p16587
g9
sS'older,patients,some'
p16588
g3
sS'with,sodium,and'
p16589
g3
sS'mg,or,mg'
p16590
g3
sS'sublingual,may,be'
p16591
g3
sS'effects,and,even'
p16592
g3
sS'other,was,observed'
p16593
g3
sS'of,cyp3a4,in'
p16594
g3
sS'the,pharmacodynamic,effects'
p16595
g3
sS'the,persistence,of'
p16596
g3
sS'other,pathways,on'
p16597
g3
sS'nueronal,cell,body'
p16598
g3
sS'class,of,agents'
p16599
g3
sS'dialysis,solutions,blood'
p16600
g3
sS'disturbance,rarely,with'
p16601
g9
sS'in,addition,administration'
p16602
g3
sS'serum,measurements,with'
p16603
g3
sS'be,approached,with'
p16604
g9
sS'determine,blood,plasma'
p16605
g3
sS'literature,reports,indicate'
p16606
g9
sS'to,microg,l'
p16607
g3
sS'isocarboxazid,and,other'
p16608
g9
sS'treatment,costs,inpatient'
p16609
g3
sS'potentially,significant,interactions'
p16610
g9
sS'and,epoxide,concentrations'
p16611
g3
sS'chop-haart,group,than'
p16612
g3
sS'persistent,inhibition,of'
p16613
g9
sS'absorption,of,where'
p16614
g9
sS'blockers,also,increase'
p16615
g3
sS'under,certain,conditions'
p16616
g3
sS'pulmonary,function,or'
p16617
g3
sS'metabolism,of,increasing'
p16618
g9
sS'elements,ethacrynic,acid'
p16619
g9
sS'concentrations,of,these'
p16620
g9
sS'inhalational,muscle,relaxants'
p16621
g3
sS'as,belladonna,alkaloids'
p16622
g9
sS'agents,chloral,hydrate'
p16623
g3
sS'a,small,clinical'
p16624
g3
sS'regimens,consisted,of'
p16625
g3
sS'the,human,liver'
p16626
g3
sS'require,immediate,discontinuation'
p16627
g3
sS'of,oral,on'
p16628
g3
sS'administration,to,a'
p16629
g3
sS'no,controlled,studies'
p16630
g3
sS'function,clinical,studies'
p16631
g3
sS'not,enhance,the'
p16632
g9
sS'prothrombin,activity,patients'
p16633
g9
sS'frequent,condition,in'
p16634
g3
sS'other,protein-bound,from'
p16635
g3
sS'of,decreases,the'
p16636
g9
sS'ratio,or,other'
p16637
g3
sS'also,not,affected'
p16638
g3
sS'fa,were,submitted'
p16639
g3
sS'and,interfere,with'
p16640
g9
sS'or,was,associated'
p16641
g9
sS'concentrations,of,dialyzable'
p16642
g3
sS'mg,dl,were'
p16643
g3
sS'should,be,done'
p16644
g3
sS'groups,receiving,mg'
p16645
g9
sS'of,intestinal,cancers'
p16646
g3
sS'halved,for,the'
p16647
g9
sS'or,delavirdine-based,regimens'
p16648
g3
sS'addition,deaths,have'
p16649
g9
sS'risk,of,hepatitis'
p16650
g9
sS'daily,acquisition,cost'
p16651
g3
sS'pharmacokinetics,of,are'
p16652
g3
sS'susceptibility,to,progression'
p16653
g3
sS'in,the,digitalized'
p16654
g3
sS'individuals,are,referred'
p16655
g3
sS'hormonal,evidence,of'
p16656
g3
sS'continued,serum,levels'
p16657
g3
sS'prostaglandin,f2alpha,and'
p16658
g9
sS'vitro,however,the'
p16659
g3
sS'concentrations,recognition,and'
p16660
g3
sS'in,mice,and'
p16661
g3
sS'suggesting,that,should'
p16662
g9
sS'implantable,forms,may'
p16663
g9
sS'few,patients,receiving'
p16664
g3
sS'use,may,blunt'
p16665
g3
sS'to,be,mediated'
p16666
g3
sS'concentration,increased,and'
p16667
g3
sS'data,from,in'
p16668
g9
sS'that,intracellular,ca'
p16669
g3
sS'monitored,when,or'
p16670
g9
sS'were,generated,from'
p16671
g3
sS'denudation,indicating,an'
p16672
g3
sS'astramorph,kadian,ms'
p16673
g9
sS'the,relation,between'
p16674
g3
sS'closely,for,loss'
p16675
g3
sS'the,implication,that'
p16676
g9
sS'are,metabolized,by'
p16677
g3
sS'relatively,specific,blockade'
p16678
g3
sS'inhibitors,indinavir,mg'
p16679
g9
sS'species,was,totally'
p16680
g3
sS'counteract,the,anticholinesterase'
p16681
g9
sS'interaction,studies,in'
p16682
g3
sS'or,omega-agatoxin,iva'
p16683
g3
sS'in,non-specialist,hospitals'
p16684
g3
sS'valproic,acid,concentrations'
p16685
g3
sS'part,to,their'
p16686
g3
sS'in,humans,that'
p16687
g3
sS'mediated,clearance,or'
p16688
g3
sS'combination,with,produced'
p16689
g3
sS'the,are,used'
p16690
g3
sS'false,increases,of'
p16691
g3
sS'altered,mental,status'
p16692
g3
sS'a,short-acting,and'
p16693
g9
sS'due,to,highintersubject'
p16694
g3
sS'instructions,for,appropriate'
p16695
g3
sS'by,the,addition'
p16696
g9
sS'salt,substitutes,containing'
p16697
g3
sS'orthostatic,hypotension,in'
p16698
g3
sS'to,function,as'
p16699
g3
sS'on,the,breath'
p16700
g3
sS'administration,on,the'
p16701
g3
sS'increase,the,unbound'
p16702
g3
sS'of,using,in'
p16703
g3
sS'changes,in,luteinizing'
p16704
g3
sS'closely,for,several'
p16705
g3
sS'the,plasma,maximum'
p16706
g3
sS'substrates,of,cyp450'
p16707
g3
sS'in,which,was'
p16708
g3
sS'in,the,ferricyanide'
p16709
g3
sS'since,both,and'
p16710
g9
sS'to,the,hospital'
p16711
g3
sS'including,midamor,may'
p16712
g9
sS'with,altered,consciousness'
p16713
g9
sS'for,the,first'
p16714
g9
sS'administration,of,two'
p16715
g3
sS'effects,in,slow'
p16716
g3
sS'healthy,subjects,n'
p16717
g9
sS'cyp3a4,but,has'
p16718
g3
sS'of,the,perfused'
p16719
g3
sS'higher,occurrence,of'
p16720
g9
sS'half-life,and,toxicity'
p16721
g9
sS'medicinal,products,such'
p16722
g3
sS'system,and,brain'
p16723
g9
sS'patients,some,physicians'
p16724
g3
sS'in,mind,in'
p16725
g9
sS'least,weeks,should'
p16726
g9
sS'study,evaluating,the'
p16727
g9
sS'or,in,dmpge2'
p16728
g3
sS'of,cerubidine,in'
p16729
g9
sS'mg,elemental,oz'
p16730
g3
sS'concurrent,dosing,of'
p16731
g3
sS'induction,of,tumors'
p16732
g3
sS'taking,coumarin-derivative,concomitantly'
p16733
g9
sS'be,performed,at'
p16734
g3
sS'overall,exposure,to'
p16735
g9
sS'disease,and,disorder'
p16736
g3
sS'of,low,intrinsic'
p16737
g3
sS'temporal,patterns,during'
p16738
g3
sS'administered,at,doses'
p16739
g3
sS'multiple,cytochrome,p450'
p16740
g3
sS'nonsteroidal,the,co-administration'
p16741
g9
sS'while,a,synergistic'
p16742
g9
sS'same,metabolic,enzymes'
p16743
g3
sS'intestinal,mucosa,caused'
p16744
g9
sS'less,than,optimal'
p16745
g3
sS'established,current,evidence'
p16746
g9
sS'of,interaction,within'
p16747
g3
sS'of,amicar,may'
p16748
g3
sS'to,exposures,similar'
p16749
g3
sS'cyp2d6,activity,at'
p16750
g3
sS'test,in,patients'
p16751
g3
sS'acarbose,did,not'
p16752
g3
sS'similar,in,this'
p16753
g3
sS'survival,and,avoidance'
p16754
g3
sS'precedex,with,and'
p16755
g9
sS'furosemide,may,decrease'
p16756
g9
sS'changes,in,either'
p16757
g3
sS'the,initial,clinical'
p16758
g3
sS'populations,are,not'
p16759
g3
sS'hypotension,oliguria,tachycardia'
p16760
g3
sS'thiazide,substrates,and'
p16761
g3
sS'function,is,normal'
p16762
g9
sS'modify,the,pharmacokinetics'
p16763
g3
sS'treated,with,hours'
p16764
g9
sS'sum,of,desethylzaleplon'
p16765
g3
sS'upon,the,known'
p16766
g9
sS'ie,timi-ii,isis-2'
p16767
g3
sS'given,after,multiple'
p16768
g3
sS'it,is,particularly'
p16769
g3
sS'advised,in,patients'
p16770
g3
sS'digoxin,keppra,mg'
p16771
g3
sS'sharp,fall,of'
p16772
g9
sS'specific,objectives,of'
p16773
g3
sS'available,on,potential'
p16774
g3
sS'monitoring,should,be'
p16775
g3
sS'known,whether,other'
p16776
g3
sS'taking,acarbose,due'
p16777
g9
sS'warnings,and,should'
p16778
g3
sS'influence,serum,concentrations'
p16779
g3
sS'changes,in,corrected'
p16780
g3
sS'taking,ace,inhibitors'
p16781
g3
sS'in,patients,to'
p16782
g9
sS'are,referred,to'
p16783
g3
sS'by,these,two'
p16784
g3
sS'of,naflu,compared'
p16785
g3
sS'receiving,purinethol,or'
p16786
g9
sS'between,and,any'
p16787
g3
sS'either,alpha-,or'
p16788
g3
sS'only,enhances,cocaine-induced'
p16789
g9
sS'other,cns,agents'
p16790
g9
sS'dose,increases,should'
p16791
g3
sS'with,and,tablets'
p16792
g9
sS'involving,either,healthy'
p16793
g3
sS'velcade,treatment,may'
p16794
g9
sS'placebo,with,these'
p16795
g3
sS'naproxen,may,interfere'
p16796
g3
sS'vii,antigen,viii'
p16797
g3
sS'give,you,more'
p16798
g3
sS'the,frequent,occurrence'
p16799
g3
sS'parameters,without,and'
p16800
g3
sS'chop-haart,patients,developed'
p16801
g3
sS'task,considered,the'
p16802
g3
sS'various,antihypertensive,necessitating'
p16803
g9
sS'since,the,pharmacokinetics'
p16804
g9
sS'of,proton,pump'
p16805
g3
sS'ketorolac,is,highly'
p16806
g3
sS'the,case,of'
p16807
g3
sS'carbidopa-levodopa,combination,products'
p16808
g3
sS'about,a,fold'
p16809
g9
sS'data,emphasize,that'
p16810
g3
sS'concurrently,with,does'
p16811
g3
sS'withdrawal,of,the'
p16812
g3
sS'individual,who,is'
p16813
g3
sS'qtc,interval,have'
p16814
g3
sS'reduces,basal,plasma'
p16815
g3
sS'urine,may,interfere'
p16816
g3
sS'receiving,therapy,should'
p16817
g9
sS'of,suggesting,that'
p16818
g3
sS'activation,and,release'
p16819
g3
sS'on,the,dissolution'
p16820
g3
sS'as,g,and'
p16821
g9
sS'human,milk,and'
p16822
g3
sS'sgpt,or,ldh'
p16823
g3
sS'acamprosate,does,not'
p16824
g3
sS'reduction,in,and'
p16825
g9
sS'similar,responses,being'
p16826
g3
sS'pgp,may,modify'
p16827
g3
sS'a,manner,similar'
p16828
g3
sS'prescribing,a,symptomatic'
p16829
g3
sS'and,then,careful'
p16830
g9
sS'the,leukopenic,activity'
p16831
g9
sS'morphological,markers,that'
p16832
g9
sS'reuptake,inhibitors,grapefruit'
p16833
g9
sS'or,supplements,can'
p16834
g3
sS'the,test,sample'
p16835
g3
sS'agents,available,for'
p16836
g3
sS'metabolizers,have,higher'
p16837
g3
sS'its,serum,levels'
p16838
g9
sS'included,mtx,in'
p16839
g3
sS'dysfunction,may,also'
p16840
g3
sS'including,ganglionic,blocking'
p16841
g9
sS'enzymes,responsible,for'
p16842
g3
sS'other,isoforms,cyp2c8'
p16843
g3
sS'affect,its,metabolism'
p16844
g3
sS'whereas,the,colonic'
p16845
g3
sS'is,no,or'
p16846
g3
sS'with,neurons,recorded'
p16847
g3
sS'peak,latency,for'
p16848
g3
sS'pharmacokinetics,of,in'
p16849
g3
sS'was,well,tolerated'
p16850
g3
sS'pharmacokinetics,analysis,of'
p16851
g3
sS'of,natural,and'
p16852
g3
sS'fashion,and,may'
p16853
g3
sS'to,vomiting,and'
p16854
g9
sS'non-comparative,clinical,trial'
p16855
g9
sS'this,could,facilitate'
p16856
g3
sS'oral,overload,of'
p16857
g3
sS'primidone,population,pharmacokinetic'
p16858
g9
sS'but,not,after'
p16859
g9
sS'titrated,to,a'
p16860
g3
sS'use,of,femara'
p16861
g3
sS'competitive,inhibition,of'
p16862
g3
sS'volunteers,who,received'
p16863
g9
sS'the,exact,place'
p16864
g3
sS'lacking,kidney,function'
p16865
g3
sS'by,therapy,can'
p16866
g3
sS'mg,bid,the'
p16867
g9
sS'candida,albicans,one'
p16868
g3
sS'not,known,health'
p16869
g3
sS'on,valproic,acid'
p16870
g9
sS'although,did,augment'
p16871
g9
sS'increase,the,need'
p16872
g3
sS'thioether,excretion,is'
p16873
g3
sS'sgot,alt,sgpt'
p16874
g3
sS'release,tablets,the'
p16875
g9
sS'oral,contraceptives,estrogens'
p16876
g3
sS'be,necessary,eg'
p16877
g9
sS'lifestyle,giving,up'
p16878
g3
sS'reactions,develop,in'
p16879
g9
sS'to,has,a'
p16880
g9
sS'interactions,and,dosage'
p16881
g3
sS'clinical,significance,if'
p16882
g3
sS'benefits,of,medications'
p16883
g3
sS'following,ip,injections'
p16884
g3
sS'erythromycin,in,hypercholesterolemic'
p16885
g9
sS'such,as,amphotericin'
p16886
g9
sS'with,coumarin-derivative,such'
p16887
g9
sS'ex,vivo,platelet'
p16888
g3
sS'increase,in,bioavailability'
p16889
g3
sS'clinical,significance,is'
p16890
g3
sS'particularly,during,the'
p16891
g9
sS'robust,induction,of'
p16892
g3
sS'been,a,few'
p16893
g9
sS'prevent,folic,acid'
p16894
g3
sS'the,high,dose'
p16895
g3
sS'the,hippocampus,would'
p16896
g3
sS'in,his,logical'
p16897
g3
sS'of,m,g'
p16898
g9
sS'and,serious,clinical'
p16899
g9
sS'extent,of,bioavailability'
p16900
g3
sS'must,be,repeated'
p16901
g3
sS'thirst,weakness,lethargy'
p16902
g3
sS'dose,that,produced'
p16903
g3
sS'interaction,with,that'
p16904
g3
sS'in,dosage,will'
p16905
g3
sS'depressant,effects,of'
p16906
g3
sS'mg,dose,of'
p16907
g9
sS'four,hours,after'
p16908
g3
sS'with,other,nsaids'
p16909
g9
sS'influence,on,the'
p16910
g3
sS'av,nodal,conduction'
p16911
g9
sS'n,are,identical'
p16912
g3
sS'moderate,inhibitors,of'
p16913
g3
sS'no,special,precautions'
p16914
g3
sS'a,positive,coombs'
p16915
g3
sS'monitored,in,these'
p16916
g3
sS'data,described,in'
p16917
g3
sS'one,week,prior'
p16918
g9
sS'of,sublingual,mg'
p16919
g9
sS'the,standard,dose'
p16920
g9
sS'the,length,of'
p16921
g3
sS'maximize,the,therapeutic'
p16922
g3
sS'greater,degrees,of'
p16923
g9
sS'aerosol,particles,in'
p16924
g3
sS'alone,or,or'
p16925
g3
sS'to,volunteers,under'
p16926
g3
sS'prior,to,the'
p16927
g9
sS'time,with,or'
p16928
g9
sS'of,aprepitant,mg'
p16929
g9
sS'modification,is,generally'
p16930
g3
sS'must,be,determined'
p16931
g9
sS'necessary,can,continue'
p16932
g3
sS'therapies,including,oral'
p16933
g3
sS'in,extrapolating,these'
p16934
g3
sS'equal,concentrations,of'
p16935
g3
sS'small,extent,by'
p16936
g3
sS'may,produce,false-positive'
p16937
g3
sS'usually,does,not'
p16938
g9
sS'receiving,bolus-ifl,in'
p16939
g3
sS'did,not,antagonize'
p16940
g9
sS'bring,latent,complications'
p16941
g3
sS'taking,other,psychotropic'
p16942
g3
sS'no,long-term,carcinogenicity'
p16943
g3
sS'blood-glucose,lowering,effect'
p16944
g3
sS'hypoprothrombinemic,effect,of'
p16945
g3
sS'tid,the,cmax'
p16946
g9
sS'compromised,in,these'
p16947
g9
sS'c12hr,by,in'
p16948
g9
sS'these,agents,into'
p16949
g3
sS'in,subjects,on'
p16950
g3
sS'or,adrenergic,neuron'
p16951
g3
sS'leucovorin,the,concentration'
p16952
g9
sS'clearance,and,volume'
p16953
g9
sS'enzymatic,oxidation,of'
p16954
g9
sS'with,produces,a'
p16955
g9
sS'cyp-2c19,by,oxc'
p16956
g3
sS'schizophrenic,patients,coadministered'
p16957
g9
sS'hydrochloride,x,mg'
p16958
g9
sS'extent,than,and'
p16959
g3
sS'tcas,with,any'
p16960
g9
sS'and,serum,concentrations'
p16961
g9
sS'healthy,subjects,on'
p16962
g3
sS'prohibited,from,receiving'
p16963
g3
sS'combination,with,very'
p16964
g3
sS'they,are,weak'
p16965
g3
sS'penetrates,both,the'
p16966
g3
sS'which,becomes,complete'
p16967
g3
sS'twice,daily,with'
p16968
g9
sS'inducer,a,dose'
p16969
g3
sS'higher,degrees,of'
p16970
g9
sS'tml,manifested,significantly'
p16971
g3
sS'effects,of,agents'
p16972
g3
sS'frequency,of,seizures'
p16973
g9
sS'reducing,effect,of'
p16974
g9
sS'that,mesylate,has'
p16975
g3
sS'blockers,could,be'
p16976
g9
sS'for,altering,concentrations'
p16977
g3
sS'therapy,were,increased'
p16978
g3
sS'may,have,caused'
p16979
g9
sS'requirements,for,volatile'
p16980
g9
sS'suggest,the,modified'
p16981
g3
sS'advisable,until,it'
p16982
g3
sS'concomitantly,should,be'
p16983
g3
sS'iv,has,been'
p16984
g3
sS'tests,interactions,no'
p16985
g3
sS'is,unknown,amevive'
p16986
g3
sS'users,of,both'
p16987
g9
sS'therefore,necessary,to'
p16988
g3
sS'therapeutic,benefit,of'
p16989
g3
sS'course,of,interference'
p16990
g3
sS'is,co-administered,with'
p16991
g9
sS'are,also,likely'
p16992
g9
sS'attenuate,some,of'
p16993
g3
sS'and,on,days'
p16994
g3
sS'in,patients,the'
p16995
g9
sS'pharmacodynamic,effect,reduction'
p16996
g3
sS'hcl,in,combination'
p16997
g9
sS'in,patients,on'
p16998
g9
sS'ethinyl,estradiol,substrate'
p16999
g3
sS'the,feasibility,and'
p17000
g3
sS'adjustment,to,the'
p17001
g3
sS'with,organ,transplants'
p17002
g3
sS'noted,even,when'
p17003
g9
sS'fold,in,males'
p17004
g3
sS'identify,chromatin,and'
p17005
g9
sS'theophylline,a,single'
p17006
g3
sS'concentration,for,optimal'
p17007
g3
sS'taking,while,taking'
p17008
g9
sS'rash,diarrhea,hypotension'
p17009
g3
sS'stress,in,cerebral'
p17010
g3
sS'depressants,with,habituating'
p17011
g3
sS'or,or,lead'
p17012
g9
sS'on,day,each'
p17013
g3
sS'cholestyramine,cholestyramine,may'
p17014
g9
sS'of,action,including'
p17015
g3
sS'when,was,added'
p17016
g9
sS'inhibitors,of,cyp3a4'
p17017
g3
sS'hallucinations,have,been'
p17018
g9
sS'mg,capsules,every'
p17019
g9
sS'considerable,variability,of'
p17020
g3
sS'consulting,the,appropriate'
p17021
g3
sS'metal,toxicity,but'
p17022
g3
sS'antacids,sucralfate,metal'
p17023
g3
sS'information,concerning,laboratory'
p17024
g3
sS'especially,in,the'
p17025
g9
sS'that,administration,attenuates'
p17026
g9
sS'of,the,benzodiazepine'
p17027
g9
sS'be,avoided,serum'
p17028
g3
sS'studies,caused,no'
p17029
g3
sS'expected,because,is'
p17030
g3
sS'as,grapefruit,orange'
p17031
g3
sS'is,assumed,that'
p17032
g3
sS'oxaloacetate,and,mg2'
p17033
g3
sS'doses,of,b6'
p17034
g3
sS'local,and,some'
p17035
g3
sS'that,patients,on'
p17036
g9
sS'serum,levels,using'
p17037
g3
sS'recurred,when,the'
p17038
g3
sS'ea,was,treated'
p17039
g3
sS'saquinavir,coadministration,of'
p17040
g9
sS'rebound,hypertension,when'
p17041
g9
sS'treatment,practices,in'
p17042
g3
sS'stable,plasma,levels'
p17043
g9
sS'administration,of,precedex'
p17044
g3
sS'decreased,effect,of'
p17045
g3
sS'medication,but,also'
p17046
g3
sS'myoclonus,autonomic,instability'
p17047
g9
sS'mania,whereas,in'
p17048
g3
sS'whom,aminoglycoside,are'
p17049
g9
sS'off,medications,varied'
p17050
g3
sS'by,intrathecal,on'
p17051
g3
sS'reports,of,more'
p17052
g3
sS'binding,entacapone,is'
p17053
g3
sS'of,pancreatic,supplements'
p17054
g9
sS'of,the,mouse'
p17055
g3
sS'confirm,that,the'
p17056
g3
sS'when,tagamet,is'
p17057
g9
sS'given,with,it'
p17058
g3
sS'to,therapy,dose'
p17059
g9
sS'trimethyl,lead,tml'
p17060
g3
sS'with,products,containing'
p17061
g9
sS'encystment,and,in'
p17062
g3
sS'view,of,the'
p17063
g9
sS'cyp3a4,such,as'
p17064
g9
sS'interfere,with,serotonin'
p17065
g9
sS'with,failed,to'
p17066
g3
sS'of,fat-soluble,should'
p17067
g3
sS'if,is,coadministered'
p17068
g9
sS'were,measured,during'
p17069
g3
sS'lodine,like,other'
p17070
g9
sS'to,unique,biopharmaceutical'
p17071
g3
sS'or,agents,structurally'
p17072
g9
sS'reported,in,the'
p17073
g9
sS'tests,of,radio-iodine'
p17074
g3
sS'these,results,that'
p17075
g3
sS'increased,approximately,and'
p17076
g9
sS'platelet,effects,celebrex'
p17077
g3
sS'variety,of,preparations'
p17078
g3
sS'b,patients,should'
p17079
g9
sS'kg,day,or'
p17080
g3
sS'one-third,as,well'
p17081
g9
sS'with,adefovir,dipivoxil'
p17082
g3
sS'bid,with,coadministration'
p17083
g9
sS'least,days,after'
p17084
g3
sS'azoles,are,known'
p17085
g3
sS'tikosyn,and,concomitantly'
p17086
g3
sS'combinations,of,mm'
p17087
g3
sS'show,that,taking'
p17088
g3
sS'kg,day,of'
p17089
g9
sS'inhibit,c9,should'
p17090
g3
sS'of,dizziness,during'
p17091
g3
sS'a,is,administered'
p17092
g9
sS'without,the,need'
p17093
g3
sS'significantly,inhibited,phosphorylation'
p17094
g9
sS'events,was,similar'
p17095
g3
sS'investigation,of,chronic'
p17096
g3
sS'that,have,been'
p17097
g9
sS'a,mean,eight-fold'
p17098
g9
sS'usually,prescribed,for'
p17099
g3
sS'showed,moderate,activity'
p17100
g3
sS'known,enzyme,inducers'
p17101
g9
sS'levels,with,resultant'
p17102
g3
sS'effect,one,study'
p17103
g9
sS'this,mechanism,may'
p17104
g9
sS'to,the,contents'
p17105
g3
sS'and,is,dependent'
p17106
g3
sS'however,is,advised'
p17107
g3
sS'time,have,been'
p17108
g9
sS'were,administered,starlix'
p17109
g3
sS'digitalis,glycosides,patients'
p17110
g3
sS'enflurane,than,when'
p17111
g3
sS'such,as,platelet'
p17112
g3
sS'be,enhanced,when'
p17113
g9
sS'series,of,treatments'
p17114
g3
sS'arrhythmia,and,diamond'
p17115
g9
sS'drug-drug,interactions,and'
p17116
g3
sS'day,have,been'
p17117
g9
sS'either,by,enhanced'
p17118
g3
sS'the,range,reported'
p17119
g3
sS'test,results,using'
p17120
g3
sS'there,are,several'
p17121
g3
sS'tachycardia,dryness,of'
p17122
g9
sS'of,their,antiseizure'
p17123
g3
sS'a,mean,increase'
p17124
g9
sS'important,that,your'
p17125
g9
sS'two,metabolites,hydroxytolbutamide'
p17126
g3
sS'with,chronic,hepatitis'
p17127
g3
sS'inhibitor,may,have'
p17128
g9
sS'number,of,per'
p17129
g3
sS'states,of,disease'
p17130
g3
sS'nor,should,be'
p17131
g9
sS'reported,as,international'
p17132
g9
sS'rate,but,not'
p17133
g3
sS'phosphatase,and,elevation'
p17134
g3
sS'association,with,high'
p17135
g9
sS'in,administering,compounds'
p17136
g3
sS'compazine,sparine,phenergan'
p17137
g3
sS'cells,were,also'
p17138
g3
sS'and,vi,of'
p17139
g3
sS'may,decrease,platelet'
p17140
g3
sS'protease,inhibitors,serotonin'
p17141
g9
sS'ketoconazole,and,are'
p17142
g3
sS'usual,dose,when'
p17143
g9
sS'animal,literature,showing'
p17144
g3
sS'on,the,changes'
p17145
g3
sS'cohort,design,that'
p17146
g9
sS'similarly,inhibit,and'
p17147
g9
sS'interacting,which,leads'
p17148
g3
sS'insulin,requirements,in'
p17149
g3
sS'pyrocarbonate,revealed,concentration'
p17150
g3
sS'requirements,but,also'
p17151
g3
sS'males,who,received'
p17152
g3
sS'initiation,of,soriatane'
p17153
g3
sS'information,on,concomitant'
p17154
g3
sS'in,decreasing,responding'
p17155
g3
sS'observed,but,there'
p17156
g3
sS'were,evaluated,and'
p17157
g3
sS'had,chemotherapy,interrupted'
p17158
g3
sS'however,when,addiction'
p17159
g3
sS'to,cadmium,mixtures'
p17160
g3
sS'effect,on,circulating'
p17161
g3
sS'administration,of,low-dose'
p17162
g9
sS'are,inhibitors,of'
p17163
g3
sS'their,dose,if'
p17164
g9
sS'hazardous,when,taken'
p17165
g3
sS'using,duloxetine,in'
p17166
g3
sS'than,the,mean'
p17167
g3
sS'qt-interval,prolongation,and'
p17168
g3
sS'parnate,using,these'
p17169
g3
sS'weeks,prior,to'
p17170
g3
sS'developed,regarding,interactions'
p17171
g3
sS'are,inhibitors,or'
p17172
g3
sS'rifabutin,and,its'
p17173
g3
sS'analyzed,for,and'
p17174
g3
sS'of,the,components'
p17175
g3
sS'of,mg,per'
p17176
g9
sS'and,cause,renal'
p17177
g3
sS'may,increase,in'
p17178
g3
sS'inclusive,viracept,may'
p17179
g3
sS'but,no,effect'
p17180
g3
sS'the,proportion,of'
p17181
g3
sS'of,femara,with'
p17182
g3
sS'are,given,concomitantly'
p17183
g9
sS'or,on,the'
p17184
g3
sS'years,with,severe'
p17185
g3
sS'of,its,permeation'
p17186
g3
sS'one,with,a'
p17187
g3
sS'of,in,combination'
p17188
g9
sS'tests,if,significant'
p17189
g3
sS'necrosis,and,fibrosis'
p17190
g3
sS'in,utero,serum'
p17191
g3
sS'dihydroxyflavone,with,may'
p17192
g3
sS'by,brevibloc,but'
p17193
g9
sS'lotions,or,skin'
p17194
g3
sS'been,studied,alternative'
p17195
g9
sS'mechanism,for,this'
p17196
g3
sS'by,m,m'
p17197
g9
sS'tablets,and,other'
p17198
g9
sS'interaction,at,other'
p17199
g3
sS'halogenated,hydrocarbon,increase'
p17200
g9
sS'assess,the,carcinogenic'
p17201
g3
sS'of,the,pesticide'
p17202
g3
sS'drugs,that,inhibit'
p17203
g3
sS'days,and,mg'
p17204
g9
sS'the,negative,chronotropic'
p17205
g3
sS'induce,cyp,d6'
p17206
g3
sS'recommended,that,plasma'
p17207
g9
sS'systemic,exposure,to'
p17208
g9
sS'concurrently,with,and'
p17209
g9
sS'by,a,highly'
p17210
g9
sS'and,membrane,properties'
p17211
g3
sS'about,three-fold,compared'
p17212
g3
sS'should,be,monitored'
p17213
g3
sS'of,a,nonsteroidal'
p17214
g9
sS'in,mean,arterial'
p17215
g9
sS'antagonists,hypertension,in'
p17216
g9
sS'hypertension,which,can'
p17217
g9
sS'daily,for,days'
p17218
g3
sS'enhance,the,activity'
p17219
g9
sS'effects,on,hormone'
p17220
g3
sS'picr,could,be'
p17221
g3
sS'exception,of,ssri-associated'
p17222
g3
sS'hydrochlorothiazide,and,non-steroidal'
p17223
g9
sS'and,n1,and'
p17224
g3
sS'nephrotoxicity,frequently,limits'
p17225
g3
sS'competitive,displacement,of'
p17226
g3
sS'potentially,nephrotoxic,such'
p17227
g9
sS'after,clinical,patterns'
p17228
g3
sS'or,has,resulted'
p17229
g9
sS'should,consider,the'
p17230
g9
sS'decreased,the,concentrations'
p17231
g9
sS'of,more,than'
p17232
g9
sS'subtypes,by,in'
p17233
g3
sS'compared,with,that'
p17234
g3
sS'desired,this,combination'
p17235
g3
sS'before,or,at'
p17236
g3
sS'in,vivo,drug-drug'
p17237
g9
sS'consequently,alter,the'
p17238
g3
sS'cause,increased,blood'
p17239
g3
sS'steady-state,blood,levels'
p17240
g9
sS'inhibitors,drugs,such'
p17241
g9
sS'increase,the,clearance'
p17242
g9
sS'gi,bleeding,higher'
p17243
g9
sS'to,a,small'
p17244
g3
sS'conducted,the,most'
p17245
g3
sS'complications,have,specifically'
p17246
g3
sS'it,was,established'
p17247
g3
sS'quinolones,may,enhance'
p17248
g9
sS'may,be,recommended'
p17249
g3
sS'other,cell,lines'
p17250
g9
sS'of,if,used'
p17251
g9
sS'diclofenac,increases,platelet'
p17252
g3
sS'was,increased,when'
p17253
g9
sS'fulvestrant,is,metabolized'
p17254
g3
sS'medical,considerations,are'
p17255
g3
sS'of,non,soluble'
p17256
g3
sS'at,similar,median'
p17257
g3
sS'can,be,dispersed'
p17258
g3
sS'unfractionated,up,to'
p17259
g3
sS'in,table,table'
p17260
g3
sS'enzyme,inhibitors,intravenous'
p17261
g3
sS'by,cyp,d6'
p17262
g3
sS'which,was,administered'
p17263
g3
sS'a,positive,urine'
p17264
g3
sS'to,the,same'
p17265
g9
sS'treatment,with,coadministered'
p17266
g3
sS'carotid,cannulation,decreased'
p17267
g3
sS'and,dosage,levels'
p17268
g9
sS'results,of,preliminary'
p17269
g9
sS'in,postmarketing,experience'
p17270
g9
sS'would,therefore,not'
p17271
g3
sS'sulfa,medicines,thiazide'
p17272
g9
sS'adjunctive,therapy,a'
p17273
g9
sS'this,organism,and'
p17274
g3
sS'systemic,antiretroviral,agents'
p17275
g3
sS'were,comparable,to'
p17276
g9
sS'but,does,not'
p17277
g9
sS'vitro,cytogenetics,study'
p17278
g3
sS'crisis,may,mimic'
p17279
g3
sS'in,renal,retention'
p17280
g3
sS'may,experience,toxicity'
p17281
g9
sS'a,few,spontaneous'
p17282
g9
sS'resulted,in,false-positive'
p17283
g3
sS'possibility,of,adverse'
p17284
g3
sS'by,auc0-24hr,in'
p17285
g9
sS'g,kg,on'
p17286
g9
sS'administration,of,equivalent'
p17287
g9
sS'major,metabolite,beta-naltrexol'
p17288
g3
sS'not,seem,to'
p17289
g3
sS'metabolic,disturbances,have'
p17290
g3
sS'and,interactions,allows'
p17291
g3
sS'digoxin,interaction,studies'
p17292
g3
sS'one,volunteer,reported'
p17293
g3
sS'stadol,ns,were'
p17294
g3
sS'confidence,interval,whole'
p17295
g9
sS'of,a,p-glycoprotein'
p17296
g9
sS'coadministration,of,radiation'
p17297
g3
sS'interaction,may,occur'
p17298
g3
sS'should,allow,for'
p17299
g3
sS'with,are,bodyweight'
p17300
g3
sS'slightly,increased,with'
p17301
g3
sS'controlled,trial,that'
p17302
g3
sS'and,l-ccg,upon'
p17303
g3
sS'when,are,started'
p17304
g9
sS'and,flare,were'
p17305
g3
sS'decision,to,prescribe'
p17306
g3
sS'be,halved,for'
p17307
g9
sS'either,procedure,even'
p17308
g3
sS'be,reduced,upon'
p17309
g9
sS'those,on,severe'
p17310
g9
sS'closely,to,determine'
p17311
g9
sS'to,displacement,of'
p17312
g3
sS'condition,after,weeks'
p17313
g3
sS'to,a,survey'
p17314
g3
sS'sodium,colistimethate,salts'
p17315
g9
sS'lethargy,fever,tremulousness'
p17316
g9
sS'with,glucose,intolerance'
p17317
g3
sS'and,were,systematically'
p17318
g3
sS'topoisomerase,activity,level'
p17319
g3
sS'daily,of,vioxx'
p17320
g9
sS'physical,activity,in'
p17321
g3
sS'proved,to,be'
p17322
g3
sS'topical,injectable,implantable'
p17323
g3
sS'arimidex,and,did'
p17324
g3
sS'may,be,anticipated'
p17325
g9
sS'concentration,altered,by'
p17326
g9
sS'hydrochloride,not,be'
p17327
g9
sS'while,may,also'
p17328
g9
sS'and,transient,asymptomatic'
p17329
g3
sS'treated,with,nonsteroidal'
p17330
g9
sS'ace,inhibitors,and'
p17331
g3
sS'cause,much,more'
p17332
g3
sS'the,risk,of'
p17333
g3
sS'also,prolong,the'
p17334
g3
sS'plasma,concentration,time-curve'
p17335
g9
sS'a,subgroup,of'
p17336
g3
sS'of,this,observation'
p17337
g3
sS'as,tablets,was'
p17338
g3
sS'studied,but,would'
p17339
g3
sS'presumably,to,a'
p17340
g3
sS'rat,stomach,to'
p17341
g9
sS'is,required,since'
p17342
g3
sS'while,the,recognition'
p17343
g3
sS'assay,in,strains'
p17344
g3
sS'over,patients,enrolled'
p17345
g3
sS'of,approximately,times'
p17346
g9
sS'the,course,of'
p17347
g3
sS'or,nor,did'
p17348
g3
sS'program,of,human'
p17349
g3
sS'of,endogenous,prostaglandin'
p17350
g9
sS'm-toluamide,a,common'
p17351
g9
sS'a,non-steroidal,agent'
p17352
g9
sS'blood,loss,results'
p17353
g3
sS'by,measuring,serum'
p17354
g3
sS'cyclosporine,a,during'
p17355
g3
sS'and,raise,the'
p17356
g9
sS'inspra,to,mg'
p17357
g9
sS'kg,weight,w'
p17358
g9
sS'of,sprycel,and'
p17359
g9
sS'may,also,increase'
p17360
g3
sS'produced,a,similar'
p17361
g3
sS'effectiveness,of,polyenes'
p17362
g3
sS'interfere,with,hemostasis'
p17363
g3
sS'as,an,open'
p17364
g3
sS'the,primary,cns'
p17365
g3
sS'clinical,significance,these'
p17366
g3
sS'using,this,technique'
p17367
g3
sS'who,are,hypersensitive'
p17368
g9
sS'practically,only,one'
p17369
g3
sS'toradol,was,used'
p17370
g9
sS'human,subjects,have'
p17371
g3
sS'not,at,min'
p17372
g3
sS'with,and,tenofovir'
p17373
g3
sS'of,oral,form'
p17374
g9
sS'patients,be,accompanied'
p17375
g3
sS'a,single,in'
p17376
g3
sS'elderly,population,in'
p17377
g3
sS'mainly,responsible,for'
p17378
g9
sS'the,cmax,by'
p17379
g9
sS'serious,infections,an'
p17380
g9
sS'and,beta,blockers'
p17381
g3
sS'acid-base,balance,in'
p17382
g3
sS'potentiates,a,cetaminophen'
p17383
g3
sS'monitored,they,should'
p17384
g3
sS'in,general,cognitive'
p17385
g3
sS'even,in,the'
p17386
g9
sS'oral,formulation,the'
p17387
g3
sS'midlands,a,large'
p17388
g3
sS'concentrations,ranging,from'
p17389
g3
sS'both,steady-state,maximum'
p17390
g3
sS'or,pgp,may'
p17391
g3
sS'period,b,the'
p17392
g3
sS'with,sprycel,close'
p17393
g3
sS'of,indications,specific'
p17394
g3
sS'cyp3a,may,decrease'
p17395
g3
sS'combination,with,enhances'
p17396
g9
sS'this,toxicity,see'
p17397
g3
sS'medication,review,in'
p17398
g3
sS'a,decrease,in'
p17399
g9
sS'cardiovascular,concurrently,with'
p17400
g3
sS'short-acting,and,that'
p17401
g9
sS'by,serum,deprivation'
p17402
g3
sS'established,but,physicians'
p17403
g9
sS'in,blood,pressure'
p17404
g9
sS'other,potentially,significant'
p17405
g3
sS'may,increase,exposure'
p17406
g9
sS'of,vasoconstricting,agents'
p17407
g9
sS'patient,is,essential'
p17408
g3
sS'herein,with,emphasis'
p17409
g3
sS'baseline,to,ng'
p17410
g3
sS'noted,with,the'
p17411
g9
sS'confirmed,by,other'
p17412
g3
sS'sedation,times,long-sedation'
p17413
g3
sS'levetiracetam,and,its'
p17414
g3
sS'potential,nephrotoxicity,and'
p17415
g3
sS'the,preceding,lists'
p17416
g3
sS'by,but,not'
p17417
g9
sS'the,interactions,of'
p17418
g3
sS'mind,that,ingestion'
p17419
g9
sS'aerosol,has,been'
p17420
g3
sS'repeated,oral,administration'
p17421
g3
sS'sensipar,on,other'
p17422
g3
sS'however,on,a'
p17423
g3
sS'sites,produced,their'
p17424
g3
sS'across,all,species'
p17425
g3
sS'maintenance,doses,of'
p17426
g9
sS'a,greater,understanding'
p17427
g3
sS'have,shown,that'
p17428
g3
sS'akathisia,in,clinical'
p17429
g9
sS'of,the,cyp'
p17430
g3
sS'the,study,at'
p17431
g3
sS'vitro,against,two'
p17432
g3
sS'diarrhea,but,this'
p17433
g9
sS'of,beta-adrenergic,blocking'
p17434
g9
sS'healthy,volunteers,have'
p17435
g3
sS'of,cyp2d6,in'
p17436
g3
sS'to,be,an'
p17437
g3
sS'a,randomized,crossover'
p17438
g3
sS'muscle,relaxants,and'
p17439
g9
sS'lower,in,patients'
p17440
g9
sS'for,anaphylactic,reaction'
p17441
g3
sS'study,was,given'
p17442
g3
sS'interact,with,other'
p17443
g3
sS'much,as,and'
p17444
g3
sS'of,cyp2d6,is'
p17445
g3
sS'other,including,and'
p17446
g3
sS'raise,the,possibility'
p17447
g9
sS'possible,dosage,modifications'
p17448
g3
sS'cyp3a4,that,mediate'
p17449
g3
sS'and,essentially,completely'
p17450
g3
sS'is,decreased,in'
p17451
g3
sS'or,biocytin,was'
p17452
g3
sS'and,oral,an'
p17453
g3
sS'or,its,metabolite'
p17454
g3
sS'mg,p,o'
p17455
g9
sS'in,vitro,at'
p17456
g3
sS'this,problem,has'
p17457
g3
sS'hydrochloride,is,used'
p17458
g9
sS'two,doses,of'
p17459
g3
sS'exposure,to,mac'
p17460
g3
sS'interactions,because,it'
p17461
g3
sS'once,weekly,for'
p17462
g9
sS'use,of,concurrently'
p17463
g3
sS'inr,or,dose'
p17464
g3
sS'consequently,plasma,concentrations'
p17465
g3
sS'mptp,produced,depletions'
p17466
g9
sS'of,renal,disease'
p17467
g3
sS'phenytoin,keppra,mg'
p17468
g3
sS'patients,using,long-acting'
p17469
g9
sS'concomitantly,with,potent'
p17470
g9
sS'related,to,alpha'
p17471
g3
sS'as,competition,for'
p17472
g9
sS'out,as,an'
p17473
g3
sS'possible,toxicity,from'
p17474
g3
sS'dispersed,in,water'
p17475
g3
sS'protease,inhibitors,agenerase'
p17476
g9
sS'no,reported,laboratory'
p17477
g3
sS'inhibits,the,growth'
p17478
g3
sS'adequate,and,well-controlled'
p17479
g3
sS'taking,a,rauwolfia'
p17480
g9
sS'on,precautions,and'
p17481
g3
sS'may,undergo,hydrolysis'
p17482
g3
sS'situation,when,analgesia'
p17483
g9
sS'drying,effect,and'
p17484
g3
sS'of,were,more'
p17485
g3
sS'potentiation,resulted,from'
p17486
g3
sS'of,congestive,heart'
p17487
g9
sS'effect,of,norfloxacin'
p17488
g9
sS'tested,here,commonly'
p17489
g3
sS'on,these,pharmacokinetic'
p17490
g3
sS'subgroup,of,the'
p17491
g3
sS'in,turn,resulted'
p17492
g9
sS'pigeons,and,squirrel'
p17493
g3
sS'neglect,of,therapy'
p17494
g3
sS'to,fold,elevations'
p17495
g9
sS'are,several,instances'
p17496
g3
sS'cyp2d6,such,as'
p17497
g9
sS'of,sustiva,is'
p17498
g3
sS'without,co-administered,avonex'
p17499
g3
sS'of,these,are'
p17500
g3
sS'influence,of,coadministration'
p17501
g3
sS'with,mg,qd'
p17502
g3
sS'be,given,consideration'
p17503
g9
sS'extreme,agitation,progressing'
p17504
g9
sS'patients,with,cardiac'
p17505
g3
sS'follow-up,opportunistic,infection'
p17506
g3
sS'is,required,when'
p17507
g9
sS'be,taken,concomitantly'
p17508
g3
sS'that,received,mg'
p17509
g3
sS'cerebyx,dosage,may'
p17510
g9
sS'concluded,that,is'
p17511
g9
sS'given,intraluminally,was'
p17512
g3
sS'mg,was,in'
p17513
g3
sS'highly,susceptible,to'
p17514
g3
sS'after,drinking,may'
p17515
g9
sS'dry,mouth,constipation'
p17516
g9
sS'for,the,reduction'
p17517
g9
sS'of,tracleer,and'
p17518
g9
sS'positive,direct,and'
p17519
g3
sS'receiving,inspra,to'
p17520
g3
sS'hydrate,dietary,deficiencies'
p17521
g9
sS'change,the,bioavailabillty'
p17522
g9
sS'if,clearance,is'
p17523
g9
sS'cholestyramine,the,influence'
p17524
g3
sS'morning,doses,on'
p17525
g3
sS'dose,adjustments,of'
p17526
g3
sS'component,p2,however'
p17527
g3
sS'addition,to,bleeding'
p17528
g9
sS'after,oral,administration'
p17529
g3
sS'used,to,chemically'
p17530
g3
sS'to,a,five-fold'
p17531
g9
sS'and,mg,with'
p17532
g3
sS'in,psychiatric,patients'
p17533
g9
sS'with,imidazole,and'
p17534
g9
sS'pretreatment,with,potentiates'
p17535
g3
sS'reported,to,significantly'
p17536
g9
sS'systematically,alter,the'
p17537
g3
sS'chronically,receiving,and'
p17538
g3
sS'decrease,in,ethinyl'
p17539
g9
sS'sodium,given,at'
p17540
g3
sS'ophthalmic,suspension,contains'
p17541
g3
sS'points,after,the'
p17542
g3
sS'mg,bid,did'
p17543
g3
sS'prolong,both,its'
p17544
g3
sS'experience,toxicity,at'
p17545
g9
sS'action,of,after'
p17546
g3
sS'high,or,too'
p17547
g3
sS'furthermore,and,do'
p17548
g3
sS'that,more,than'
p17549
g3
sS'competitive,interaction,at'
p17550
g9
sS'including,may,cause'
p17551
g3
sS'prophylactic,and,antidotal'
p17552
g9
sS'pharmacological,i,without'
p17553
g3
sS'high-estradiol,rats,were'
p17554
g9
sS'initiated,and,repeated'
p17555
g3
sS'therapy,a,reduction'
p17556
g3
sS'deficiency,can,increase'
p17557
g9
sS'prolongs,the,half-life'
p17558
g9
sS'blockers,derivatives,and'
p17559
g9
sS'comparison,of,antiaddictive'
p17560
g3
sS'enhance,the,psychostimulant'
p17561
g3
sS'the,preparation,causing'
p17562
g9
sS'or,mg,once'
p17563
g3
sS'has,recovered,from'
p17564
g9
sS'examples,of,known'
p17565
g9
sS'and,may,subsequently'
p17566
g3
sS'of,this,kind'
p17567
g9
sS'test,for,bacterial'
p17568
g3
sS'regulate,the,proliferation'
p17569
g9
sS'of,labetalol,hcl'
p17570
g3
sS'structurally,distinct,from'
p17571
g3
sS'at,the,dose'
p17572
g3
sS'depth,of,neuromuscular'
p17573
g9
sS'and,bowel,disease'
p17574
g3
sS'evidence,in,animal'
p17575
g3
sS'or,special,monitoring'
p17576
g3
sS'or,skeletal-muscle,relaxants'
p17577
g3
sS'evaluated,in,combination'
p17578
g3
sS'oral,and,inhaled'
p17579
g3
sS'tsh,secretion,p-aminosalicylic'
p17580
g3
sS'thus,the,results'
p17581
g9
sS'aprepitant,to,achieve'
p17582
g9
sS'results,for,urinary'
p17583
g3
sS'changes,in,urinary'
p17584
g3
sS'you,take,by'
p17585
g9
sS'auc,were,seen'
p17586
g3
sS'cyp3a4,is,ordinarily'
p17587
g3
sS'higher,in,the'
p17588
g3
sS'rabbits,dosed,at'
p17589
g3
sS'were,conducted,although'
p17590
g3
sS'immediately,if,any'
p17591
g3
sS'consistent,with,the'
p17592
g3
sS'in,citrate,and'
p17593
g3
sS'mg,a,potent'
p17594
g3
sS'taking,another,that'
p17595
g3
sS'or,salicylic,acid'
p17596
g3
sS'excessive,neuromuscular,weakness'
p17597
g9
sS'or,other,hepatic'
p17598
g9
sS'after,concomitant,administration'
p17599
g3
sS'plasma,concentrations,which'
p17600
g9
sS'maintenance,level,while'
p17601
g9
sS'of,fertility,pegasys'
p17602
g3
sS'acute,pharmacological,i'
p17603
g3
sS'however,higher,plasma'
p17604
g3
sS'increase,respectively,in'
p17605
g9
sS'are,determined,by'
p17606
g3
sS'inhibit,or,induce'
p17607
g3
sS'information,on,efficacy'
p17608
g3
sS'side,effects,in'
p17609
g9
sS'the,following,adrenocorticoids'
p17610
g9
sS'although,not,reported'
p17611
g9
sS'of,probably,at'
p17612
g9
sS'through,searches,of'
p17613
g3
sS'colestipol,plasma,concentrations'
p17614
g9
sS'predictive,of,human'
p17615
g3
sS'serum,amylase,an'
p17616
g3
sS'permit,reductions,in'
p17617
g3
sS'to,three,types'
p17618
g3
sS'hormonal,including,oral'
p17619
g9
sS'recognition,and,understanding'
p17620
g3
sS'are,lower,than'
p17621
g3
sS'treatment,of,depressive'
p17622
g3
sS'been,collected,on'
p17623
g3
sS'than,with,the'
p17624
g9
sS'measurement,of,nociception'
p17625
g3
sS'to,substantially,decrease'
p17626
g3
sS'carbamazepine,tiagabine,had'
p17627
g3
sS'catalyzed,by,cytochromes'
p17628
g3
sS'and,other,had'
p17629
g3
sS'under,the,serum'
p17630
g9
sS'pharmacodynamic-related,interactions,the'
p17631
g3
sS'are,very,potent'
p17632
g9
sS'and,no,significant'
p17633
g3
sS'effects,on,plasma'
p17634
g3
sS'co-administration,of,multiple'
p17635
g3
sS'were,identified,through'
p17636
g3
sS'maximum,plasma,concentrations'
p17637
g9
sS'which,plasma,concentrations'
p17638
g3
sS'hamster,s,alpha'
p17639
g3
sS'high,concentrations,or'
p17640
g9
sS'secondary,to,proleukin'
p17641
g3
sS'likely,to,increase'
p17642
g9
sS'serial,plasma,and'
p17643
g3
sS'interactions,were,detected'
p17644
g3
sS'cyp2a6,cyp2c9,cyp2c19'
p17645
g3
sS'to,be,abnormal'
p17646
g3
sS'or,are,enhanced'
p17647
g9
sS'the,pancreatic,effects'
p17648
g3
sS'atoxic,since,it'
p17649
g3
sS'nonsteroidal,agents,including'
p17650
g9
sS'kg,day,showed'
p17651
g3
sS'cmax,increased,approximately'
p17652
g9
sS'of,keppra,on'
p17653
g3
sS'monitoring,for,adverse'
p17654
g9
sS'virologic,response,and'
p17655
g3
sS'diminished,effects,of'
p17656
g9
sS'elevation,of,the'
p17657
g3
sS'which,may,change'
p17658
g3
sS'esmolol,hcl,and'
p17659
g3
sS'can,occur,when'
p17660
g9
sS'who,use,only'
p17661
g3
sS'have,life-threatening,interactions'
p17662
g9
sS'be,aware,when'
p17663
g9
sS'day,when,was'
p17664
g9
sS'present,in,each'
p17665
g3
sS'to,pooled,human'
p17666
g3
sS'e2,may,augment'
p17667
g9
sS'hcl,cream,cream'
p17668
g3
sS'limited,to,other'
p17669
g9
sS'and,decreases,in'
p17670
g9
sS'be,cautiously,coadministered'
p17671
g9
sS'control,vs,when'
p17672
g9
sS'in,the,duloxetine'
p17673
g3
sS'the,patient,must'
p17674
g3
sS'antihypertensive,action,of'
p17675
g9
sS'potentiate,the,replication'
p17676
g9
sS'observed,at,concentrations'
p17677
g3
sS'patients,the,dose'
p17678
g3
sS'renal,function,in'
p17679
g3
sS'not,proliferation-dependent,but'
p17680
g3
sS'no,alteration,in'
p17681
g3
sS'more,during,a'
p17682
g3
sS'diminish,or,abolish'
p17683
g9
sS'to,have,increased'
p17684
g9
sS'conditions,duloxetine,unprotected'
p17685
g3
sS'indinavir,steady-state,cmax'
p17686
g9
sS'with,concomitant,use'
p17687
g9
sS'with,and,failed'
p17688
g3
sS'dolasetron,mesylate,did'
p17689
g3
sS'without,to,l'
p17690
g9
sS'and,protein,binding'
p17691
g3
sS'agents,amphotericin,b'
p17692
g9
sS'or,outpatient,services'
p17693
g3
sS'parameters,auc,cmax'
p17694
g9
sS'properties,of,these'
p17695
g3
sS'enzyme,ace,inhibitors'
p17696
g3
sS'the,preservative,in'
p17697
g9
sS'antagonized,by,alpha-adrenergic'
p17698
g9
sS'other,nonsteroidal,agents'
p17699
g9
sS'concomitant,use,however'
p17700
g3
sS'anakinra,concurrent,administration'
p17701
g9
sS'with,as,in'
p17702
g9
sS'it,may,also'
p17703
g3
sS'effects,of,l-ccg'
p17704
g3
sS'incoordination,following,the'
p17705
g9
sS'while,transfer,from'
p17706
g3
sS'searches,of,medline'
p17707
g3
sS'micrograms,equally,antagonized'
p17708
g9
sS'with,that,observed'
p17709
g9
sS'the,neuromuscular,blockade'
p17710
g9
sS'if,the,antagonist'
p17711
g3
sS'properties,of,nor'
p17712
g3
sS'mouth,use,of'
p17713
g9
sS'clearance,by,means'
p17714
g3
sS'effect,on,bone'
p17715
g3
sS'occur,the,epa'
p17716
g3
sS'capacity,for,triacylglycerol'
p17717
g3
sS'healthy,volunteers,no'
p17718
g3
sS'to,electrolyte,and'
p17719
g3
sS'probenecid,depresses,tubular'
p17720
g9
sS'of,defecation,episodes'
p17721
g3
sS'are,also,additive'
p17722
g9
sS'inhibits,the,bumetanide-induced'
p17723
g9
sS'using,in,situ'
p17724
g9
sS'may,mimic,underdosage'
p17725
g3
sS'maximum,cumulative,doses'
p17726
g9
sS'other,that,sensitize'
p17727
g9
sS'of,nnrtis,appears'
p17728
g3
sS'per,day,and'
p17729
g9
sS'of,people,who'
p17730
g9
sS'fda,have,involved'
p17731
g3
sS'and,a,clinically'
p17732
g3
sS'potent,effect,of'
p17733
g3
sS'of,a,patient'
p17734
g9
sS'and,sustained,increases'
p17735
g9
sS'bound,would,not'
p17736
g3
sS'substrate,for,cytochrome'
p17737
g3
sS'the,cns,depressant'
p17738
g3
sS'deaths,among,the'
p17739
g3
sS'cns,depressant,and'
p17740
g9
sS'together,with,with'
p17741
g3
sS'reduce,the,blood-glucose'
p17742
g3
sS'patient,had,intoxication'
p17743
g3
sS'metabolites,hydroxytolbutamide,and'
p17744
g3
sS'pharmacokinetic,drug-drug,interactions'
p17745
g3
sS'enzyme,system,notably'
p17746
g9
sS'trough,concentration,accompanied'
p17747
g9
sS'was,given,concomitantly'
p17748
g3
sS'subjects,or,patients'
p17749
g3
sS'studies,involving,otherwise'
p17750
g3
sS'required,infusion,rate'
p17751
g9
sS'may,develop,increased'
p17752
g9
sS'accumulation,that,might'
p17753
g3
sS'other,isoforms,tested'
p17754
g3
sS'or,the,antiprothrombinemic'
p17755
g3
sS'profiles,clinically,significant'
p17756
g3
sS'evidently,the,antinociceptive'
p17757
g9
sS'as,hctz,hydrodiuril'
p17758
g3
sS'function,the,use'
p17759
g9
sS'higher,than,in'
p17760
g9
sS'study,was,carried'
p17761
g3
sS'management,of,infection'
p17762
g3
sS'i,binding,globulin'
p17763
g3
sS'do,not,take'
p17764
g3
sS'inhibitors,to,pms'
p17765
g3
sS'a,third,hour'
p17766
g3
sS'of,cmc-cys,exhibiting'
p17767
g3
sS'receptor,blockers,calcium'
p17768
g3
sS'pharmacokinetic,or,other'
p17769
g3
sS'second,day,of'
p17770
g9
sS'hour,apart,on'
p17771
g9
sS'definitely,indicated,and'
p17772
g9
sS'dose-related,blockade,of'
p17773
g9
sS'treated,with,various'
p17774
g9
sS'antiemetic,prophylaxis,contributed'
p17775
g3
sS'plasma,exposures,of'
p17776
g9
sS'other,oral,formulations'
p17777
g9
sS'in,patients,when'
p17778
g9
sS'than,recommended,doses'
p17779
g9
sS'anticoagulation,test,should'
p17780
g9
sS'anti-inflammatory,agents,may'
p17781
g3
sS'the,active,metabolite'
p17782
g3
sS'the,following,antibiotics'
p17783
g3
sS'hydrochloride,is,also'
p17784
g9
sS'of,when,given'
p17785
g3
sS'of,acute,ischemic'
p17786
g3
sS'oxytocin,or,other'
p17787
g9
sS'both,groups,of'
p17788
g3
sS'adjusted,accordingly,in'
p17789
g9
sS'also,dyslipidemia,hypertension'
p17790
g3
sS'which,is,mediated'
p17791
g9
sS'a,potent,effect'
p17792
g3
sS'and,undetectable,release'
p17793
g3
sS'the,parenteral,route'
p17794
g3
sS'the,intestinal,lumen'
p17795
g3
sS'exposure,to,is'
p17796
g9
sS'reported,by,users'
p17797
g3
sS'for,varying,durations'
p17798
g3
sS'resins,since,bile'
p17799
g9
sS'other,hypotensive,including'
p17800
g9
sS'present,study,the'
p17801
g3
sS'isoenzyme,including,certain'
p17802
g9
sS'interval,certain,including'
p17803
g9
sS'microsomes,the,effects'
p17804
g3
sS'to,topo,in'
p17805
g3
sS'mg,result,in'
p17806
g3
sS'interaction,with,multiple'
p17807
g3
sS'including,blood,pressure'
p17808
g3
sS'volume,of,distribution'
p17809
g3
sS'they,may,interfere'
p17810
g9
sS'may,affect,absorption'
p17811
g3
sS'renin,release,the'
p17812
g9
sS'not,significantly,alter'
p17813
g3
sS'miu,ml,before'
p17814
g3
sS'or,potentiating,effect'
p17815
g9
sS'this,to,patients'
p17816
g3
sS'krm-1648,exhibited,strong'
p17817
g9
sS'other,oxytocic,agents'
p17818
g3
sS'elements,were,determined'
p17819
g3
sS'hours,after,the'
p17820
g9
sS'less,suppression,of'
p17821
g3
sS'cyp,a4,to'
p17822
g3
sS'for,the,association'
p17823
g3
sS'to,such,patients'
p17824
g3
sS'there,are,limited'
p17825
g9
sS'x,mg,capsule'
p17826
g9
sS'normal,subjects,the'
p17827
g3
sS'interfering,with,neuromuscular'
p17828
g9
sS'vitro,and,its'
p17829
g3
sS'increase,the,effect'
p17830
g9
sS'of,these,effects'
p17831
g3
sS'intravenous,and,hivid'
p17832
g9
sS'potentiation,of,the'
p17833
g9
sS'in,no,apparent'
p17834
g3
sS'presented,with,features'
p17835
g3
sS'the,lower,intestine'
p17836
g9
sS'appears,to,decrease'
p17837
g3
sS'differential,diagnosis,of'
p17838
g3
sS'bound,by,reducing'
p17839
g9
sS'with,inomax,on'
p17840
g9
sS'and,from,week'
p17841
g3
sS'interaction,of,the'
p17842
g3
sS'may,be,different'
p17843
g3
sS'increased,volume,of'
p17844
g3
sS'from,midcycle,day'
p17845
g3
sS'agents,prinivil,has'
p17846
g3
sS'vasoconstricting,agents,such'
p17847
g9
sS'dose,may,be'
p17848
g9
sS'interactions,cimetidine,and'
p17849
g3
sS'increase,for,the'
p17850
g3
sS'combination,was,associated'
p17851
g3
sS'clearance,is,changed'
p17852
g9
sS'basal,plasma,renin'
p17853
g3
sS'enhanced,the,translocating'
p17854
g3
sS'clinically,significant,drug-drug'
p17855
g3
sS'cytochrome,p450,enzymes'
p17856
g3
sS'drugs,enhancing,heparin'
p17857
g3
sS'survival,were,evident'
p17858
g3
sS'against,the,possibility'
p17859
g3
sS'to,induce,cytochrome'
p17860
g3
sS'that,act,on'
p17861
g9
sS'carcinogenesis,mutagenesis,impairment'
p17862
g3
sS'similarly,decreased,the'
p17863
g9
sS'an,overactive,pain'
p17864
g3
sS'isozyme,which,metabolizes'
p17865
g3
sS'lower,plasma,concentrations'
p17866
g9
sS'the,phosphohydrolase,becomes'
p17867
g3
sS'because,the,added'
p17868
g9
sS'h,or,mycophenolate'
p17869
g3
sS'kg,day,n'
p17870
g9
sS'either,concomitant,therapy'
p17871
g3
sS'containing,containing,or'
p17872
g9
sS'lipid-lowering,activity,of'
p17873
g3
sS'fourth,group,served'
p17874
g3
sS'than,those,required'
p17875
g9
sS'a,return,to'
p17876
g3
sS'than,users,of'
p17877
g9
sS'diagnosed,during,accutane'
p17878
g3
sS'to,be,above'
p17879
g3
sS'acute,toxicity,tests'
p17880
g3
sS'decongestant,allergy,cold'
p17881
g9
sS'serotonin,syndrome,associated'
p17882
g9
sS'this,report,describes'
p17883
g9
sS'inhibitors,or,angiotensin'
p17884
g3
sS'hyperthyroidism,hypertension,and'
p17885
g3
sS'as,plasma,protein'
p17886
g3
sS'for,either,toxicities'
p17887
g3
sS'coadministered,plasma,concentrations'
p17888
g9
sS'rabbits,failed,to'
p17889
g3
sS'skills,or,stimulus'
p17890
g3
sS'increase,of,the'
p17891
g9
sS'increase,slightly,the'
p17892
g9
sS'whether,these,same'
p17893
g3
sS'haart,was,included'
p17894
g3
sS'of,subjects,taking'
p17895
g3
sS'kadian,ms,contin'
p17896
g9
sS'subjects,to,assess'
p17897
g3
sS'decrease,in,serum'
p17898
g3
sS'interactions,the,following'
p17899
g3
sS'platelet,inhibitors,acetylsalicylic'
p17900
g3
sS'hand,surprisingly,green'
p17901
g3
sS'vitamin,b12,supplement'
p17902
g9
sS'with,concomitant,administration'
p17903
g9
sS'if,indocin,is'
p17904
g9
sS'suggesting,that,the'
p17905
g9
sS'a,facilitates,acquisition'
p17906
g3
sS'a,week,to'
p17907
g3
sS'be,used,for'
p17908
g3
sS'high,threshold,voltage-dependent'
p17909
g3
sS'precautions,should,be'
p17910
g9
sS'this,enzyme,should'
p17911
g9
sS'result,of,specific'
p17912
g3
sS'additional,including,indocin'
p17913
g9
sS'inflammation,associated,with'
p17914
g9
sS'the,c,max'
p17915
g9
sS'the,body,increase'
p17916
g3
sS'apoptosis,assessed,using'
p17917
g9
sS'of,in,sheep'
p17918
g3
sS'when,oral,therapy'
p17919
g3
sS'addition,the,atropine-like'
p17920
g3
sS'epirubicin-containing,cef-120,or'
p17921
g3
sS'metabolism,of,leading'
p17922
g9
sS'considered,when,dosing'
p17923
g3
sS'test,alterations,associated'
p17924
g3
sS'from,concomitant,administration'
p17925
g3
sS'effects,with,lotensin'
p17926
g9
sS'active,therapy,in'
p17927
g3
sS'a,mg,daily'
p17928
g9
sS'combined,exposures,proposed'
p17929
g3
sS'this,situation,special'
p17930
g3
sS'of,depression,in'
p17931
g3
sS'caution,should,also'
p17932
g3
sS'avidities,for,the'
p17933
g3
sS'acid,hcl,ascorbic'
p17934
g9
sS'and,therapy,it'
p17935
g9
sS'intravenous,prodrug,are'
p17936
g3
sS'analysis,and,therefore'
p17937
g3
sS'a,nonlinear,weighted'
p17938
g3
sS'explored,further,in'
p17939
g3
sS'is,enhanced,by'
p17940
g9
sS'mouse,mammary,tumor'
p17941
g3
sS'resemble,poor,metabolizers'
p17942
g3
sS'the,drug,to'
p17943
g3
sS'when,the,cyp3a4'
p17944
g3
sS'a,greater,proportion'
p17945
g9
sS'agents,and,such'
p17946
g9
sS'of,severe,toxicity'
p17947
g9
sS'effects,when,given'
p17948
g9
sS'if,any,clinical'
p17949
g9
sS'and,supplemental,in'
p17950
g9
sS'dosage,on,equetrotm'
p17951
g9
sS'is,metabolized,to'
p17952
g3
sS'history,prior,to'
p17953
g3
sS'carbamazepine,elevated,levels'
p17954
g9
sS'binding,to,human'
p17955
g3
sS'of,exjade,and'
p17956
g3
sS'benefit,of,further'
p17957
g9
sS'i,with,was'
p17958
g3
sS'measure,glucose,levels'
p17959
g3
sS'comparable,to,mg'
p17960
g9
sS'receiving,should,be'
p17961
g3
sS'of,these,have'
p17962
g9
sS'saline,g,kg'
p17963
g3
sS'ml,of,a'
p17964
g3
sS'test,dst,false-negative'
p17965
g3
sS'therapy,can,then'
p17966
g3
sS'weight,to,rats'
p17967
g3
sS'cytochromes,p450,a4'
p17968
g3
sS'of,and,respectively'
p17969
g9
sS'or,for,hours'
p17970
g3
sS'decrease,range,from'
p17971
g9
sS'monitored,regularly,for'
p17972
g3
sS'proteins,is,reduced'
p17973
g3
sS'of,mm,hg'
p17974
g9
sS'about,of,caucasians'
p17975
g3
sS'and,molt-4,cells'
p17976
g9
sS'reduced,if,is'
p17977
g3
sS'enzyme,may,not'
p17978
g3
sS'metabolized,through,the'
p17979
g3
sS'be,initiated,at'
p17980
g9
sS'hypothermia,as,an'
p17981
g3
sS'combination,with,cns-active'
p17982
g3
sS'some,leading,to'
p17983
g9
sS'be,initiated,as'
p17984
g9
sS'cyp3a4,inducers,include'
p17985
g3
sS'in,dogs,the'
p17986
g9
sS'patient,receiving,micronase'
p17987
g3
sS'receiving,concomitant,therapy'
p17988
g3
sS'caution,may,be'
p17989
g3
sS'shown,a,possible'
p17990
g9
sS'and,cyp4a11,with'
p17991
g3
sS'some,general,agents'
p17992
g3
sS'was,administered,intravenously'
p17993
g9
sS'this,defect,in'
p17994
g3
sS'larger,doses,of'
p17995
g3
sS'increase,in,symptoms'
p17996
g9
sS'pigeons,but,did'
p17997
g9
sS'of,carbamazepine,due'
p17998
g3
sS'terminal,half-life,of'
p17999
g9
sS'its,active,metabolites'
p18000
g3
sS'causes,a,marked'
p18001
g9
sS'with,co-administered,avonex'
p18002
g3
sS'this,defect,is'
p18003
g3
sS'channels,and,the'
p18004
g3
sS'vitro,at,total'
p18005
g3
sS'was,more,than'
p18006
g3
sS'mediated,by,the'
p18007
g3
sS'such,as,thiazide'
p18008
g9
sS'doses,of,ascorbic'
p18009
g3
sS'of,oleate,in'
p18010
g3
sS'consequently,interactions,with'
p18011
g3
sS'of,dimethylprostaglandin,e2-induced'
p18012
g3
sS'cyp,c9,cyp'
p18013
g3
sS'depression,and,bradyarrhythmias'
p18014
g3
sS'of,circulating,active'
p18015
g3
sS'there,were,not'
p18016
g3
sS'trivalent,cations,such'
p18017
g9
sS'state,and,therefore'
p18018
g9
sS'and,thus,should'
p18019
g9
sS'be,taken,at'
p18020
g9
sS'that,oral,antagonists'
p18021
g9
sS'atac,trial,should'
p18022
g9
sS'impaired,when,hypothyroid'
p18023
g3
sS'the,fda,have'
p18024
g3
sS'mptp,induced,long'
p18025
g9
sS'bleeding,has,been'
p18026
g9
sS'of,nucleolin,c23'
p18027
g3
sS'cns,including,blood'
p18028
g3
sS'acid,fruit,juices'
p18029
g9
sS'studies,to,determine'
p18030
g3
sS'and,duration,of'
p18031
g9
sS'adults,on,a'
p18032
g3
sS'that,some,of'
p18033
g3
sS'for,peroral,administration'
p18034
g3
sS'potential,to,interact'
p18035
g3
sS'the,long-term,safety'
p18036
g3
sS'on,either,levels'
p18037
g3
sS'if,an,alternative'
p18038
g3
sS'administering,insp,together'
p18039
g9
sS'creatinine,level,has'
p18040
g9
sS'transport,pathway,in'
p18041
g3
sS'other,antiplatelet,agents'
p18042
g9
sS'toxicity,and,possible'
p18043
g9
sS'with,metal,cations'
p18044
g9
sS'motility,may,produce'
p18045
g3
sS'following,concurrent,use'
p18046
g9
sS'are,provided,this'
p18047
g9
sS'be,explained,by'
p18048
g9
sS'recommended,for,patients'
p18049
g3
sS'c23,in,nih-3t3'
p18050
g3
sS'clonazepam,on,the'
p18051
g3
sS'age,range,years'
p18052
g3
sS'acid,prolonged,hot'
p18053
g9
sS'cyp,a4,enzyme'
p18054
g9
sS'effects,following,the'
p18055
g3
sS'these,results,indicate'
p18056
g3
sS'respond,differently,from'
p18057
g3
sS'there,was,no'
p18058
g3
sS'of,addicts,in'
p18059
g3
sS'of,hypoglycemia,may'
p18060
g3
sS'reuptake,thus,inhibiting'
p18061
g9
sS'propanol,mg,kg'
p18062
g9
sS'a,method,for'
p18063
g3
sS'to,be,free'
p18064
g3
sS'decrease,in,binding'
p18065
g9
sS'mg,kg,infused'
p18066
g3
sS'describe,a,simple'
p18067
g3
sS'sensitivity,and,glycemic'
p18068
g3
sS'dose,of,the'
p18069
g9
sS'intervals,usually,recommended'
p18070
g3
sS'curve,of,and'
p18071
g3
sS'mitogenic,effect,of'
p18072
g9
sS'with,resulted,in'
p18073
g9
sS'the,sympathetic,nervous'
p18074
g3
sS'anaphylactic,reaction,while'
p18075
g3
sS'of,factive,had'
p18076
g3
sS'effects,on,p450'
p18077
g3
sS'cyp3a4,below,increase'
p18078
g3
sS'without,a,significant'
p18079
g3
sS'as,and,can'
p18080
g9
sS'capsules,and,tablets'
p18081
g9
sS'and,has,no'
p18082
g3
sS'therapy,with,hcl'
p18083
g9
sS'may,have,to'
p18084
g3
sS'high,maintenance,dose'
p18085
g9
sS'and,need,similar'
p18086
g3
sS'degree,of,apoptosis'
p18087
g9
sS'monitored,for,a'
p18088
g9
sS'they,are,co-administered'
p18089
g9
sS'maintain,pregnancy,when'
p18090
g3
sS'intestinal,cancers,were'
p18091
g3
sS'enzymes,and,drug'
p18092
g3
sS'dose,of,grams'
p18093
g9
sS'repeat,dose,pharmacokinetics'
p18094
g3
sS'interaction,can,potentially'
p18095
g3
sS'that,the,patients'
p18096
g3
sS'ci,were,picr'
p18097
g3
sS'before,use,of'
p18098
g3
sS'least,a,twofold'
p18099
g9
sS'only,improve,sensitivity'
p18100
g3
sS'as,may,have'
p18101
g9
sS'cyp3a4,in,vitro'
p18102
g3
sS'relative,absorption,as'
p18103
g3
sS'pancreatitis,possibly,related'
p18104
g9
sS'and,perhaps,at'
p18105
g3
sS'block,the,antihypertensive'
p18106
g9
sS'concentrations,peak,plasma'
p18107
g9
sS'and,related,anabolic'
p18108
g9
sS'than,and,nonrenal'
p18109
g3
sS'decreased,the,cmax'
p18110
g9
sS'and,cyp,a4'
p18111
g3
sS'for,pharmacokinetic,drug-drug'
p18112
g3
sS'of,tolerance,in'
p18113
g9
sS'maximize,the,effects'
p18114
g3
sS'when,increases,in'
p18115
g3
sS'mg,oral,dose'
p18116
g3
sS'medical,examinations,for'
p18117
g3
sS'a,that,is'
p18118
g3
sS'that,can,progress'
p18119
g3
sS'these,drugs,have'
p18120
g3
sS'probably,accomplished,through'
p18121
g3
sS'the,inhibitory,effect'
p18122
g9
sS'nephrotoxicity,may,cause'
p18123
g9
sS'administration,of,toradol'
p18124
g9
sS'inhibitors,dipyridamole,may'
p18125
g9
sS'metabolism,or,renal'
p18126
g9
sS'pharmacokinetics,of,interactions'
p18127
g3
sS'is,decreased,reflecting'
p18128
g3
sS'with,cardiovascular,disease'
p18129
g3
sS'lipids,in,clinical'
p18130
g3
sS'are,given,concurrently'
p18131
g3
sS'normetanephrine,and,vanillylmandelic'
p18132
g3
sS'with,racemic,mg'
p18133
g9
sS'been,found,to'
p18134
g3
sS'nimodipine,had,no'
p18135
g3
sS'the,cross-reactivity,of'
p18136
g9
sS'the,following,protease'
p18137
g3
sS'contrast,reactions,after'
p18138
g3
sS'thorough,medication,review'
p18139
g3
sS'expected,since,the'
p18140
g3
sS'lowering,effects,of'
p18141
g9
sS'world,health,organization'
p18142
g3
sS'metabolised,therefore,little'
p18143
g3
sS'be,provided,to'
p18144
g3
sS'about,and,half-life'
p18145
g9
sS'neuromuscular,blocking,properties'
p18146
g9
sS'of,by,up'
p18147
g9
sS'effect,of,administered'
p18148
g3
sS'the,clinical,effects'
p18149
g3
sS'av,conduction,disturbances'
p18150
g9
sS'the,two,elements'
p18151
g3
sS'may,suppress,certain'
p18152
g3
sS'inhibitor,on,the'
p18153
g3
sS'of,and,which'
p18154
g9
sS'vitro,data,suggest'
p18155
g9
sS'breast,cancer,recurrence'
p18156
g3
sS'those,of,endotoxin-treated'
p18157
g3
sS'levels,and,cardiac'
p18158
g3
sS'through,pharmacokinetic,screening'
p18159
g3
sS'non-steroidal,anti-inflammatory,agent'
p18160
g9
sS'cyp3a4,inhibitors,that'
p18161
g9
sS'for,using,these'
p18162
g3
sS'after,multiple-dose,administration'
p18163
g3
sS'one,study,or'
p18164
g9
sS'r-warfarin,the,less'
p18165
g9
sS'then,took,mg'
p18166
g3
sS'blood,levels,at'
p18167
g9
sS'cerulein--an,analog,of'
p18168
g3
sS'conditions,had,no'
p18169
g3
sS'observation,of,the'
p18170
g9
sS'whenever,a,tca'
p18171
g3
sS'one,study,of'
p18172
g3
sS'significant,interactions,have'
p18173
g3
sS'cellular,sensitivity,to'
p18174
g3
sS'useof,a,potent'
p18175
g9
sS'there,are,conflicting'
p18176
g9
sS'were,similar,in'
p18177
g3
sS'levels,should,be'
p18178
g3
sS'administration,affects,expression'
p18179
g3
sS'a,role,in'
p18180
g3
sS'in,unexpectedly,low'
p18181
g9
sS'mao,inhibitors,may'
p18182
g9
sS'period,when,used'
p18183
g9
sS'of,peripheral,neuropathy'
p18184
g3
sS'substrates,and,or'
p18185
g3
sS'of,newborns,whose'
p18186
g3
sS'particles,in,saline'
p18187
g3
sS'mg,of,have'
p18188
g3
sS'although,theophylline-induced,anxiogenic'
p18189
g3
sS'some,patients,nor'
p18190
g3
sS'and,transport,were'
p18191
g3
sS'of,arrhythmias,or'
p18192
g3
sS'are,potent,cyp3a'
p18193
g9
sS'skin,rash,particularly'
p18194
g3
sS'the,nephrotoxicity,of'
p18195
g9
sS'the,parent,and'
p18196
g3
sS'diets,no,effect'
p18197
g3
sS'a,study,of'
p18198
g9
sS'from,patients,with'
p18199
g3
sS'had,only,a'
p18200
g9
sS'demonstrated,clinical,evidence'
p18201
g3
sS'a,sprycel,dose'
p18202
g3
sS'as,feso4,or'
p18203
g9
sS'adverse,effects,have'
p18204
g9
sS'neomycin,has,no'
p18205
g3
sS'selective,cyp3a4,inhibitor'
p18206
g9
sS'have,also,been'
p18207
g3
sS'inhibitors,on,the'
p18208
g9
sS'be,performed,when'
p18209
g9
sS'facilitate,the,action'
p18210
g3
sS'related,to,interactions'
p18211
g3
sS'of,men,for'
p18212
g3
sS'tissue,culture,medium'
p18213
g3
sS'significantly,lowered,numbers'
p18214
g3
sS'in,the,presence'
p18215
g3
sS'rbc,mice,in'
p18216
g3
sS'between,trisenox,and'
p18217
g3
sS'similar,regardless,of'
p18218
g3
sS'and,extracellular,application'
p18219
g3
sS'adjustment,of,may'
p18220
g3
sS'significant,inhibitors,of'
p18221
g3
sS'high,oral,doses'
p18222
g3
sS'affects,the,steady-state'
p18223
g9
sS'and,poor-risk,aids-related'
p18224
g3
sS'in,a,broad'
p18225
g3
sS'the,pronounced,intersubject'
p18226
g9
sS'importance,in,the'
p18227
g3
sS'in,dosage,and'
p18228
g3
sS'this,enzyme,eg'
p18229
g9
sS'venlafaxine,coadministration,of'
p18230
g3
sS'co-administration,systemic,levels'
p18231
g3
sS'cyp450,enzyme,would'
p18232
g3
sS'treated,rats,pd2'
p18233
g9
sS'of,either,nanm'
p18234
g9
sS'used,in,treating'
p18235
g3
sS'reported,neuropsychiatric,confusion'
p18236
g3
sS'be,avoided,except'
p18237
g9
sS'enzymes,cyp1a2,cyp2a6'
p18238
g3
sS'the,embryogenesis,of'
p18239
g3
sS'of,acetate,and'
p18240
g3
sS'several,beta-adrenergic,neuroeffector'
p18241
g3
sS'both,therapies,standard'
p18242
g3
sS'lesions,in,rats'
p18243
g9
sS'activity,and,activity'
p18244
g3
sS'none,of,the'
p18245
g3
sS'greater,than,mm'
p18246
g3
sS'affect,renal,prostaglandins'
p18247
g3
sS'such,combinations,has'
p18248
g3
sS'synaptic,concentration,of'
p18249
g3
sS'during,periods,of'
p18250
g9
sS'especially,if,higher'
p18251
g3
sS'greater,than,mg'
p18252
g3
sS'causes,a,decrease'
p18253
g9
sS'certain,antagonists,particularly'
p18254
g9
sS'or,inhibit,this'
p18255
g3
sS'cholecystokinin,octapeptide,is'
p18256
g3
sS'by,a,mg'
p18257
g9
sS'be,given,only'
p18258
g3
sS'gait,or,marked'
p18259
g9
sS'by,co-administration,or'
p18260
g3
sS'shown,no,binding'
p18261
g3
sS'dolasetron,has,been'
p18262
g3
sS'g,bolus,followed'
p18263
g3
sS'l-arginine,may,increase'
p18264
g9
sS'and,angiotensin,on'
p18265
g3
sS'cold,preparations,antidiarrheal'
p18266
g9
sS'of,isocarboxazid,may'
p18267
g3
sS'undergo,tyrosine,phosphorylation'
p18268
g3
sS'a,sudden,increase'
p18269
g9
sS'auc,of,its'
p18270
g9
sS'class,iv,cannot'
p18271
g3
sS'can,be,achieved'
p18272
g3
sS'amplitude,data,from'
p18273
g3
sS'concurrent,administration,of'
p18274
g9
sS'cyp,enzymes,e1'
p18275
g3
sS'strategy,can,result'
p18276
g3
sS'affecting,hepatic,blood'
p18277
g3
sS'of,in,cyp3a4'
p18278
g3
sS'tuberculosa,caused,a'
p18279
g3
sS'a,mg,intravenous'
p18280
g3
sS'decrease,absorption,of'
p18281
g9
sS'of,either,and'
p18282
g9
sS'thiazide,agents,and'
p18283
g3
sS'inhibit,the,hepatic'
p18284
g9
sS'side,effects,of'
p18285
g3
sS'with,in,healthy'
p18286
g9
sS'and,retinyl,acetate'
p18287
g9
sS'dosage,may,need'
p18288
g9
sS'and,vasopressin,was'
p18289
g3
sS'cns,effects,of'
p18290
g9
sS'mellitus,and,may'
p18291
g3
sS'cortical,tissues,of'
p18292
g3
sS'closely,for,early'
p18293
g3
sS'containing,iodine-containing,preparations'
p18294
g3
sS'could,affect,the'
p18295
g3
sS'using,effective,contraception'
p18296
g3
sS'particular,convulsions,have'
p18297
g9
sS'one,hour,after'
p18298
g9
sS'not,correlate,with'
p18299
g3
sS'by,infusion,to'
p18300
g3
sS'or,even,clozapine'
p18301
g3
sS'in,and,two'
p18302
g3
sS'not,lead,to'
p18303
g3
sS'of,the,theophylline-induced'
p18304
g9
sS'days,achieved,in'
p18305
g3
sS'direct,action,on'
p18306
g9
sS'the,pr,interval'
p18307
g9
sS'control,of,their'
p18308
g3
sS'infections,and,no'
p18309
g9
sS'eg,flu-like,effects'
p18310
g3
sS'transits,were,the'
p18311
g3
sS'at,stable,as'
p18312
g3
sS'muscle,relaxants,birth'
p18313
g3
sS'epigallocatechin-3,o-gallate,and'
p18314
g3
sS'absorption,of,while'
p18315
g9
sS'of,sensipar,on'
p18316
g3
sS'drug-specific,interactions,were'
p18317
g3
sS'and,liver,function'
p18318
g3
sS'with,coadministered,with'
p18319
g3
sS'patients,with,lymphoma'
p18320
g3
sS'effects,of,uptake'
p18321
g3
sS'oral,containing,iodine-containing'
p18322
g3
sS'were,divided,into'
p18323
g3
sS'the,two,on'
p18324
g3
sS'mechanism,of,this'
p18325
g3
sS'certain,malignancies,is'
p18326
g3
sS'users,particularly,if'
p18327
g9
sS'intravenously,to,normal'
p18328
g9
sS'significance,as,is'
p18329
g3
sS'components,are,representations'
p18330
g3
sS'on,the,antinociceptive'
p18331
g9
sS'of,with,pivoxil'
p18332
g9
sS'to,mg,three'
p18333
g9
sS'compared,with,conventional'
p18334
g3
sS'be,co-administered,with'
p18335
g3
sS'disintegrating,tablet,was'
p18336
g9
sS'for,the,case'
p18337
g3
sS'was,treated,according'
p18338
g3
sS'tid,was,administered'
p18339
g9
sS'suggested,that,or'
p18340
g9
sS'doubly,labeled,with'
p18341
g3
sS'data,on,metabolic'
p18342
g3
sS'concomitant,treatment,in'
p18343
g3
sS'elderly,may,develop'
p18344
g9
sS'this,sequence,initiation'
p18345
g3
sS'required,the,additional'
p18346
g3
sS'of,animal,source'
p18347
g3
sS'man,and,presumably'
p18348
g3
sS'previously,received,the'
p18349
g9
sS'nonsteroidal,agents,are'
p18350
g9
sS'values,in,the'
p18351
g3
sS'cause,a,clinically'
p18352
g3
sS'of,in,both'
p18353
g9
sS'times,with,or'
p18354
g9
sS'approximately,one-tenth,of'
p18355
g3
sS'or,seen,in'
p18356
g3
sS'valproate,keppra,mg'
p18357
g3
sS'therapy,which,adds'
p18358
g3
sS'other,progestational,such'
p18359
g3
sS'antibiotics,and,azole'
p18360
g3
sS'the,other,hand'
p18361
g3
sS'of,either,protein'
p18362
g3
sS'effects,of,camptosar'
p18363
g9
sS'of,nanm,were'
p18364
g9
sS'symptoms,that,accompany'
p18365
g9
sS'cyp2c19,cyp2e1,or'
p18366
g3
sS'kg,day,are'
p18367
g3
sS'the,bleeding,tendency'
p18368
g9
sS'levels,were,unaffected'
p18369
g9
sS'other,anti-asthma,medications'
p18370
g3
sS'to,and,its'
p18371
g3
sS'occurred,within,hours'
p18372
g3
sS'the,porter-silber,reaction'
p18373
g3
sS'hormonal,are,used'
p18374
g9
sS'can,be,mimicked'
p18375
g3
sS'with,and,an'
p18376
g9
sS'of,is,changed'
p18377
g3
sS'open,randomized,crossover'
p18378
g3
sS'not,studied,in'
p18379
g3
sS'reduces,urinary,excretion'
p18380
g9
sS'in,occasional,susceptible'
p18381
g3
sS'significantly,reduced,by'
p18382
g9
sS'findings,asymptomatic,transitory'
p18383
g3
sS'pressure,has,increased'
p18384
g3
sS'this,effect,should'
p18385
g3
sS'co-administration,with,or'
p18386
g9
sS'concentration,except,at'
p18387
g3
sS'men,with,erectile'
p18388
g3
sS'multiple,in,vitro'
p18389
g3
sS'of,are,the'
p18390
g9
sS'erythro-fluorocitrate,in,vivo'
p18391
g9
sS'for,older,patients'
p18392
g3
sS'and,the,relevance'
p18393
g3
sS'more,or,less'
p18394
g3
sS'first,step,of'
p18395
g3
sS'potentially,fatal,interactions'
p18396
g3
sS'and,serum,txb2'
p18397
g3
sS'drug-drug,interactions,albuterol'
p18398
g9
sS'although,there,may'
p18399
g3
sS'mellitus,is,a'
p18400
g3
sS'to,pre-gentamycin,strength'
p18401
g3
sS'overcoming,tumor,cell'
p18402
g3
sS'risk,of,bleeding'
p18403
g9
sS'garlic,capsules,garlic'
p18404
g3
sS'have,a,delayed'
p18405
g3
sS'this,combination,have'
p18406
g3
sS'for,patients,receiving'
p18407
g3
sS'not,suggest,the'
p18408
g3
sS'elderly,patients,those'
p18409
g3
sS'female,patient,receiving'
p18410
g3
sS'risk,of,arrhythmias'
p18411
g3
sS'decreased,have,been'
p18412
g9
sS'was,administered,on'
p18413
g9
sS'day,in,eight'
p18414
g9
sS'effect,of,mg'
p18415
g3
sS'ml,day,microg'
p18416
g3
sS'in,preventing,erythro-fluorocitrate'
p18417
g3
sS'of,a,four-day'
p18418
g9
sS'belladonna,alkaloids,and'
p18419
g9
sS'instances,resulted,in'
p18420
g9
sS'of,concurrently,with'
p18421
g3
sS'agents,the,time'
p18422
g9
sS'is,concluded,from'
p18423
g3
sS'thioether,concentration,ranges'
p18424
g3
sS'substantially,the,incidence'
p18425
g9
sS'failed,to,maintain'
p18426
g3
sS'taking,acamprosate,concomitantly'
p18427
g9
sS'distribution,of,was'
p18428
g3
sS'whole-cell,recording,technique'
p18429
g3
sS'compounds,that,have'
p18430
g3
sS'of,soriatane,therapy'
p18431
g3
sS'zaleplons,maximal,plasma'
p18432
g9
sS'of,intravenously,or'
p18433
g3
sS'daily,or,placebo'
p18434
g3
sS'have,a,risk'
p18435
g9
sS'of,p450,c9'
p18436
g9
sS'is,recommended,and'
p18437
g9
sS'divalent,or,trivalent'
p18438
g3
sS'of,on,them'
p18439
g3
sS'dissolution,of,administered'
p18440
g3
sS'important,for,older'
p18441
g3
sS'a,selective,serotonin'
p18442
g9
sS'trials,suggest,comparable'
p18443
g3
sS'of,over,patients'
p18444
g3
sS'due,to,decreased'
p18445
g9
sS'with,the,pharmacology-related'
p18446
g3
sS'the,microsomal,metabolizing'
p18447
g3
sS'are,representations,of'
p18448
g3
sS'initiated,in,patients'
p18449
g9
sS'and,may,either'
p18450
g9
sS'hepatic,oxidation,elc'
p18451
g9
sS'blood,samples,also'
p18452
g3
sS'some,and,other'
p18453
g9
sS'total,cholesterol,mg'
p18454
g3
sS'with,other,pressor'
p18455
g3
sS'to,receive,oral'
p18456
g3
sS'notified,immediately,if'
p18457
g3
sS'coupled,to,three'
p18458
g3
sS'c9,d6,e1'
p18459
g3
sS'also,inhibited,insp'
p18460
g9
sS'maalox,on,the'
p18461
g3
sS'ldl,cholesterol,concentration'
p18462
g3
sS'nor,were,there'
p18463
g3
sS'again,neutralized,the'
p18464
g3
sS'and,bioavailability,of'
p18465
g9
sS'adjust,the,dosage'
p18466
g9
sS'in,function,were'
p18467
g3
sS'adjustment,is,necessary'
p18468
g3
sS'extrarenal,mechanisms,of'
p18469
g3
sS'amprenavir,and,low-dose'
p18470
g9
sS'hand,the,density'
p18471
g3
sS'investigated,in,the'
p18472
g3
sS'used,by,millions'
p18473
g3
sS'site,for,possible'
p18474
g3
sS'once,daily,doses'
p18475
g9
sS'using,the,following'
p18476
g9
sS'low,dose,unfractionated'
p18477
g3
sS'studied,in,healthy'
p18478
g3
sS'glucose,concentrations,dosage'
p18479
g9
sS'drugs,with,parasympathomimetic'
p18480
g3
sS'however,in,vivo'
p18481
g3
sS'extensive,intake,of'
p18482
g3
sS'dose,of,aed'
p18483
g3
sS'procedures,for,the'
p18484
g3
sS'adjusting,and,discontinuing'
p18485
g9
sS'epithelium,by,a'
p18486
g9
sS'of,on,plasma'
p18487
g3
sS'digoxin,when,given'
p18488
g3
sS'medication,tell,your'
p18489
g3
sS'creatine,phosphokinase,diffuse'
p18490
g3
sS'have,renal,clearance'
p18491
g3
sS'of,argatroban,g'
p18492
g3
sS'nonlethal,mg,kg'
p18493
g3
sS'tylenol,chloromycetin,local'
p18494
g9
sS'to,their,practitioners'
p18495
g3
sS'by,some,of'
p18496
g3
sS'time,inr,determinations'
p18497
g3
sS'arteries,from,dietary-obese'
p18498
g3
sS'pregnancy,rates,compliance'
p18499
g3
sS'or,other,that'
p18500
g9
sS'charcoal,administration,of'
p18501
g9
sS'of,the,three'
p18502
g3
sS'vitro,data,is'
p18503
g3
sS'single,or,multiple'
p18504
g3
sS'or,generalized,urticaria'
p18505
g3
sS'metabolized,by,the'
p18506
g3
sS'which,clearance,mechanism'
p18507
g3
sS'the,abundance,and'
p18508
g3
sS'mcg,im,once'
p18509
g9
sS'kidneys,and,bones'
p18510
g3
sS'effect,of,natural'
p18511
g3
sS'twice,daily,followed'
p18512
g9
sS'inadequate,method,of'
p18513
g9
sS'or,maximum,concentration'
p18514
g3
sS'of,pt,and'
p18515
g3
sS'patients,currently,taking'
p18516
g3
sS'presence,of,increased'
p18517
g3
sS'concentrations,mics,and'
p18518
g3
sS'anti-inflammatory,activity,with'
p18519
g9
sS'to,their,increased'
p18520
g3
sS'of,approximately,and'
p18521
g9
sS'endogenous,vitamin,d'
p18522
g3
sS'metabolized,through,cyp3a4'
p18523
g3
sS'were,demonstrated,only'
p18524
g3
sS'somnolence,dizziness,effects'
p18525
g3
sS'or,with,with'
p18526
g9
sS'beta,cells,respond'
p18527
g3
sS'with,enhances,the'
p18528
g9
sS'conducted,in,hiv-infected'
p18529
g3
sS'by,to,several'
p18530
g3
sS'exposure,levels,close'
p18531
g3
sS'either,the,antidepressant'
p18532
g3
sS'mefloquineuine,on,the'
p18533
g3
sS'rarely,dry,mouth'
p18534
g3
sS'interactions,by,protein-binding'
p18535
g3
sS'with,activity,such'
p18536
g9
sS'and,mean,c'
p18537
g3
sS'aminosalicylic,acid,nonsteroidal'
p18538
g9
sS'clinically,significant,when'
p18539
g3
sS'highly,plasma,protein-'
p18540
g3
sS'cytogenetics,study,in'
p18541
g3
sS'effect,should,be'
p18542
g9
sS'volume,of,circulating'
p18543
g3
sS'survival,of,miracidia'
p18544
g3
sS'well,as,post'
p18545
g9
sS'and,mean,t'
p18546
g9
sS'with,has,been'
p18547
g9
sS'there,is,however'
p18548
g3
sS'subjects,demonstrated,that'
p18549
g9
sS'lodosyn,and,or'
p18550
g3
sS'in,humans,demonstrated'
p18551
g3
sS'activity,appeared,to'
p18552
g9
sS'phenotypic,subset,of'
p18553
g3
sS'three,cancer,patients'
p18554
g9
sS'addicts,were,completely'
p18555
g9
sS'fell,by,and'
p18556
g9
sS'in,a,temporary'
p18557
g3
sS'not,the,glomerular'
p18558
g3
sS'a,decision,should'
p18559
g3
sS'than,that,in'
p18560
g3
sS'be,unresponsive,to'
p18561
g3
sS'platelet,aggregation,but'
p18562
g9
sS'for,all,subsequentcourses'
p18563
g3
sS'angiomax,and,plasma'
p18564
g3
sS'reduced,upon,discontinuation'
p18565
g9
sS'effects,when,co-administered'
p18566
g9
sS'juice,have,not'
p18567
g3
sS'monitored,and,appropriate'
p18568
g3
sS'synthetic,hydroxy-3,methylglutaryl'
p18569
g3
sS'effect,on,cyp1a2'
p18570
g3
sS'disease,is,intricately'
p18571
g3
sS'pectoris,additional,effects'
p18572
g9
sS'result,from,this'
p18573
g3
sS'concentrations,prior,to'
p18574
g3
sS'decreased,plasma,concentrations'
p18575
g3
sS'or,placebo,and'
p18576
g3
sS'should,be,tested'
p18577
g3
sS'interact,with,tylenol'
p18578
g9
sS'only,hyperglycemia,but'
p18579
g3
sS'greater,eaca,inhibits'
p18580
g3
sS'some,concomitantly,administered'
p18581
g3
sS'of,mg,daily'
p18582
g9
sS'a,interaction,cannot'
p18583
g3
sS'not,produce,a'
p18584
g3
sS's,d,respectively'
p18585
g9
sS'in,lymphocyte,counts'
p18586
g3
sS'causes,an,approximate'
p18587
g9
sS'with,known,to'
p18588
g3
sS'in,auc,of'
p18589
g9
sS'there,is,a'
p18590
g9
sS'pharmacokinetics,in,healthy'
p18591
g3
sS'report,any,serious'
p18592
g3
sS'pharmacokinetic,analyses,indicate'
p18593
g9
sS'the,anemia,associated'
p18594
g3
sS'only,a,weak'
p18595
g3
sS'the,gonadotropin,levels'
p18596
g3
sS'by,acidifying,agents'
p18597
g9
sS'concentration,data,from'
p18598
g3
sS'mg,of,equivalent'
p18599
g3
sS'dysuria,impotence,inability'
p18600
g3
sS'in,niddm,subjects'
p18601
g3
sS'the,function,of'
p18602
g9
sS'may,become,abruptly'
p18603
g3
sS'steady-state,plasma,levels'
p18604
g9
sS'of,patients,already'
p18605
g3
sS'on,specific,patient'
p18606
g3
sS'elevate,plasma,concentrations'
p18607
g9
sS'other,monoamine,oxidase'
p18608
g9
sS'are,more,frequent'
p18609
g3
sS'dysfunction,or,cardiac'
p18610
g3
sS'to,nonopioid,tolerant'
p18611
g3
sS'efficacy,of,oral'
p18612
g9
sS'however,pretreatment,did'
p18613
g3
sS'no,interactions,have'
p18614
g3
sS'temperature,began,within'
p18615
g3
sS'of,agents,derivatives'
p18616
g3
sS'whenever,possible,before'
p18617
g3
sS'leading,to,an'
p18618
g3
sS'cold,preparations,nsaids'
p18619
g3
sS'therapeutic,concentration,monitoring'
p18620
g9
sS'resulted,in,an'
p18621
g9
sS'irinotecan,concentrations,were'
p18622
g3
sS'associated,with,myopathy'
p18623
g3
sS'risk,of,toxicity'
p18624
g9
sS'including,and,such'
p18625
g9
sS'any,excessive,fall'
p18626
g9
sS'antagonists,histamine,h2-receptor'
p18627
g3
sS'doses,up,to'
p18628
g3
sS'not,be,coadministered'
p18629
g3
sS'or,a,variety'
p18630
g3
sS'partner,causes,no'
p18631
g3
sS'ibuprofen,as,well'
p18632
g9
sS'antiretroviral,medications,have'
p18633
g3
sS'the,hatching,of'
p18634
g3
sS'supplements,and,and'
p18635
g9
sS'hepatic,enzyme,induction'
p18636
g9
sS'sc,injections,of'
p18637
g3
sS'metabolism,of,and'
p18638
g9
sS'or,reduced,infusion'
p18639
g9
sS'are,administered,as'
p18640
g3
sS'and,may,possibly'
p18641
g3
sS'concomitant,treatment,of'
p18642
g9
sS'change,of,percentage'
p18643
g9
sS'attenuation,in,the'
p18644
g3
sS'proper,interpretation,of'
p18645
g3
sS'fewer,extrapyramidal,symptoms'
p18646
g3
sS'strong,cyp3a4,inhibitor'
p18647
g9
sS'reduce,the,efficacy'
p18648
g9
sS'and,in,combination'
p18649
g3
sS'substrates,and,human'
p18650
g3
sS'tremor,rigidity,dystonia'
p18651
g3
sS'adolescent,presents,a'
p18652
g3
sS'of,with,resulted'
p18653
g3
sS'vasodilating,effects,of'
p18654
g9
sS'reactions,the,main'
p18655
g9
sS'four,times,weekly'
p18656
g3
sS'between,and,to'
p18657
g3
sS'the,control,mechanisms'
p18658
g3
sS'by,induction,data'
p18659
g3
sS'other,is,withdrawn'
p18660
g3
sS'of,alternate-day,administration'
p18661
g9
sS'in,place,of'
p18662
g9
sS'of,four,patients'
p18663
g9
sS'auc0-120hr,by,and'
p18664
g9
sS'background,the,effects'
p18665
g3
sS'salts,and,may'
p18666
g9
sS'of,reactive,species'
p18667
g3
sS'pharmacokinetics,has,not'
p18668
g3
sS'with,the,highest'
p18669
g3
sS'of,mefloquine,may'
p18670
g9
sS'd,analogues,which'
p18671
g9
sS'expressed,in,terms'
p18672
g3
sS'decreased,approximately,when'
p18673
g9
sS'received,amevive,in'
p18674
g3
sS'oral,has,been'
p18675
g3
sS'specific,interactions,have'
p18676
g3
sS'the,dog,whelk'
p18677
g3
sS'indicate,that,dopamine-induced'
p18678
g9
sS'substrates,of,cyp2d6'
p18679
g9
sS'amount,of,either'
p18680
g9
sS'steady,state,was'
p18681
g3
sS'plendil,with,resulted'
p18682
g3
sS'have,clinically,important'
p18683
g3
sS'may,be,transiently'
p18684
g3
sS'certain,actions,or'
p18685
g3
sS'was,with,alone'
p18686
g9
sS'decreased,prothrom-bin,time'
p18687
g9
sS'calcium-containing,medicines,including'
p18688
g3
sS'specific,sulfosalicylic,acid'
p18689
g3
sS'combined,therapy,should'
p18690
g3
sS'absorption,of,some'
p18691
g9
sS'oh,d3,and'
p18692
g9
sS'not,quantitatively,related'
p18693
g3
sS'omnicef,should,be'
p18694
g9
sS'both,and,retinyl'
p18695
g9
sS'pregnancy,has,been'
p18696
g3
sS'some,patients,combined'
p18697
g9
sS'and,as,low'
p18698
g3
sS'the,tremor,in'
p18699
g3
sS'agents,are,added'
p18700
g3
sS'and,do,not'
p18701
g3
sS'second,test,should'
p18702
g3
sS'reported,to,affect'
p18703
g9
sS'dependent,upon,the'
p18704
g3
sS'equivalent,to,approximately'
p18705
g3
sS'from,prospective,clinical'
p18706
g3
sS'dosing,with,m'
p18707
g3
sS'available,regarding,the'
p18708
g3
sS'with,hcl,an'
p18709
g3
sS'one,study,following'
p18710
g3
sS'conduction,disturbances,left'
p18711
g9
sS'in,ms,patients'
p18712
g9
sS'commonly,used,in'
p18713
g3
sS'be,involved,in'
p18714
g3
sS'unbound,by,hepatic'
p18715
g9
sS'renal,prostaglandin,synthesis'
p18716
g3
sS'a,three-,to'
p18717
g3
sS'of,on,respiration'
p18718
g3
sS'may,be,exacerbated'
p18719
g9
sS'and,loop,and'
p18720
g3
sS'a,cascade,impactor'
p18721
g3
sS'clinically,significant,effects'
p18722
g3
sS'agents,when,used'
p18723
g9
sS'of,and,tablets'
p18724
g9
sS'in,patients,either'
p18725
g3
sS'of,most,components'
p18726
g3
sS'functions,transcription,replication'
p18727
g3
sS'of,sensipar,may'
p18728
g9
sS'albumin,may,displace'
p18729
g3
sS'transmission,should,be'
p18730
g3
sS'of,include,optimal'
p18731
g3
sS'inapsine,the,dose'
p18732
g9
sS'or,with,videx'
p18733
g9
sS'but,not,in'
p18734
g9
sS'with,st,johns'
p18735
g3
sS'the,mean,changes'
p18736
g3
sS'preparations,eg,may'
p18737
g9
sS'day,ig,for'
p18738
g9
sS'human,liver,microsomes'
p18739
g3
sS'effects,and,may'
p18740
g9
sS'acid,binding,may'
p18741
g9
sS'when,given,together'
p18742
g3
sS'pharmacodynamic,interaction,as'
p18743
g3
sS'concurrently,administered,with'
p18744
g3
sS'intensify,electrolyte,imbalance'
p18745
g3
sS'rate,of,metabolism'
p18746
g9
sS'daily,and,mg'
p18747
g3
sS'was,superior,to'
p18748
g3
sS'two,hours,and'
p18749
g3
sS'related,to,during'
p18750
g3
sS'should,be,carefully'
p18751
g9
sS'proof,by,c'
p18752
g3
sS'nucleophosmin,b23,and'
p18753
g3
sS'to,control,symptoms'
p18754
g3
sS'presence,of,equetrotm'
p18755
g9
sS'patient,populations,the'
p18756
g9
sS'at,high,concentration'
p18757
g9
sS'to,healthy,subjects'
p18758
g3
sS'the,initial,step'
p18759
g3
sS'when,administered,concomitantly'
p18760
g9
sS'no,known,interference'
p18761
g3
sS'are,taking,an'
p18762
g3
sS'narrow,serum,levels'
p18763
g3
sS'higher,in,patients'
p18764
g9
sS'cyp3a4,inducers,are'
p18765
g3
sS'potentiate,the,adverse'
p18766
g9
sS'subsequent,adjustment,of'
p18767
g3
sS'aldomet,use,of'
p18768
g9
sS'findings,on,endometrial'
p18769
g3
sS'evidence,of,induction'
p18770
g3
sS'and,epididymides,had'
p18771
g3
sS'inhibitors,of,tubular'
p18772
g9
sS'hypotension,has,been'
p18773
g9
sS'which,can,cause'
p18774
g3
sS'in,a,high'
p18775
g3
sS'of,spermatozoa,from'
p18776
g3
sS'these,studies,are'
p18777
g3
sS'reduced,extent,of'
p18778
g9
sS'neurotoxic,therapy,including'
p18779
g3
sS'and,properties,of'
p18780
g3
sS'should,be,made'
p18781
g3
sS'supplemental,in,a'
p18782
g9
sS'changes,occurred,in'
p18783
g3
sS'interactions,cephalosporins,including'
p18784
g3
sS'polyphenols,as,potent'
p18785
g3
sS'although,many,such'
p18786
g3
sS'high,oral,bioavailability'
p18787
g3
sS'is,no,known'
p18788
g3
sS'and,the,labeling'
p18789
g3
sS'with,symptoms,of'
p18790
g3
sS'concentrations,found,to'
p18791
g3
sS'stimulants,are,commonly'
p18792
g3
sS'groups,achieving,a'
p18793
g3
sS'required,medical,intervention'
p18794
g3
sS'when,concomitant,therapy'
p18795
g9
sS'chiefly,with,the'
p18796
g3
sS'enzymes,inducers,or'
p18797
g3
sS'increase,over,time'
p18798
g3
sS'isolated,reports,of'
p18799
g9
sS'least,six,hours'
p18800
g3
sS'are,given,to'
p18801
g9
sS'lysing,human,red'
p18802
g3
sS'itraconazole,has,led'
p18803
g9
sS'amount,of,absorbed'
p18804
g9
sS'than,for,auc'
p18805
g9
sS'elevation,in,fluoride'
p18806
g3
sS'increase,in,mean'
p18807
g9
sS'quinolones,form,chelates'
p18808
g3
sS'all,central,nervous'
p18809
g9
sS'of,toxicity,resulting'
p18810
g3
sS'levels,or,fasting'
p18811
g3
sS'values,in,a'
p18812
g3
sS'had,a,higher'
p18813
g3
sS'patients,receiving,antabuse'
p18814
g9
sS'human,immunodeficiency,virus-positive'
p18815
g3
sS'those,taking,therapy'
p18816
g9
sS'with,a,luciferase'
p18817
g3
sS'risk,of,agranulocytosis'
p18818
g3
sS'healthy,volunteers,hydrochloride'
p18819
g9
sS'patients,taking,can'
p18820
g3
sS'in,all,subjects'
p18821
g9
sS'have,an,additive'
p18822
g9
sS'as,or,concurrent'
p18823
g3
sS'a,previously,unrecognized'
p18824
g9
sS'result,in,incomplete'
p18825
g3
sS'da,sh,fa'
p18826
g3
sS'to,predict,specific'
p18827
g3
sS'challenge,or,accidental'
p18828
g3
sS'pulse,arterial,pressure'
p18829
g3
sS'manifested,by,alt'
p18830
g3
sS'tubular,secretion,via'
p18831
g9
sS'dosage,of,the'
p18832
g3
sS'correlative,clinical,studies'
p18833
g3
sS'activated,during,photic'
p18834
g3
sS'those,undergoing,strenuous'
p18835
g3
sS'when,using,or'
p18836
g9
sS'arrival,of,oral'
p18837
g3
sS'system,decreased,effect'
p18838
g3
sS'drug,interactions,a'
p18839
g3
sS'as,back,pain'
p18840
g3
sS'were,the,same'
p18841
g3
sS'of,using,an'
p18842
g9
sS'use,by,the'
p18843
g3
sS'of,changed,the'
p18844
g9
sS'in,sprycel,should'
p18845
g3
sS'changes,in,hormone'
p18846
g3
sS'since,cholestyramine,resin'
p18847
g3
sS'monitored,with,dosage'
p18848
g3
sS'also,produce,artifactually'
p18849
g3
sS'co-administration,of,duloxetine'
p18850
g9
sS'the,data,intables'
p18851
g3
sS'and,respectively,after'
p18852
g9
sS'enzyme,inhibitor,the'
p18853
g9
sS'lower,and,exposure'
p18854
g9
sS'initial,clinical,data'
p18855
g3
sS'the,pressor,agent'
p18856
g3
sS'of,to,patients'
p18857
g9
sS'diuretics,lotensin,can'
p18858
g9
sS'although,theoretically,coadministration'
p18859
g9
sS'and,adverse,events'
p18860
g3
sS'developing,renal,failure'
p18861
g3
sS'that,or,co-administration'
p18862
g9
sS'on,body,surface'
p18863
g3
sS'molecule,naflu,and'
p18864
g3
sS'its,metabolites,had'
p18865
g3
sS'elimination,rate,constant'
p18866
g3
sS'coli,in,vitro'
p18867
g3
sS'old,participated,in'
p18868
g3
sS'unknown,neither,nor'
p18869
g9
sS'because,increases,the'
p18870
g9
sS'risk,of,serious'
p18871
g9
sS'in,the,use'
p18872
g3
sS'treated,with,nalfon'
p18873
g9
sS'it,as,much'
p18874
g3
sS'effects,on,discrimination'
p18875
g3
sS'i,insulin-dependent,diabetes'
p18876
g3
sS'therefore,no,adjustment'
p18877
g3
sS'narcotic,general,such'
p18878
g9
sS'inhibit,prostaglandin,synthesis'
p18879
g9
sS'increase,decrease,ci'
p18880
g3
sS'containing,carbohydrate-splitting,enzymes'
p18881
g9
sS'the,menstrual,period'
p18882
g3
sS'severe,hypotension,or'
p18883
g9
sS'effects,celebrex,is'
p18884
g3
sS'reported,in,studies'
p18885
g3
sS'reported,examples,include'
p18886
g3
sS'of,by,cytochrome'
p18887
g9
sS'benefits,outweigh,the'
p18888
g9
sS'superiority,of,over'
p18889
g3
sS'insulin-sensitizing,effects,of'
p18890
g3
sS'of,infection,is'
p18891
g3
sS'duloxetine,did,not'
p18892
g3
sS'toxic,neurological,effects'
p18893
g3
sS'excreted,levels,of'
p18894
g3
sS'and,frequently,enough'
p18895
g9
sS'hypotension,related,to'
p18896
g9
sS'when,compared,to'
p18897
g9
sS'of,infection,in'
p18898
g9
sS'to,either,alone'
p18899
g9
sS'to,one-half,the'
p18900
g9
sS'differs,in,the'
p18901
g3
sS'exposed,histidine,residues'
p18902
g3
sS'ketoconazole,co-administration,of'
p18903
g9
sS'patient,initiates,or'
p18904
g9
sS'was,generally,converted'
p18905
g9
sS'and,of,subjects'
p18906
g9
sS'administration,of,panretin'
p18907
g3
sS'selection,and,it'
p18908
g3
sS'inh,isoniazid,is'
p18909
g9
sS'metabolism,hormone,action'
p18910
g3
sS'l,mmol,mmol'
p18911
g3
sS'paper,we,show'
p18912
g3
sS'that,co-administration,of'
p18913
g9
sS'affects,expression,of'
p18914
g3
sS'result,in,unexpectedly'
p18915
g3
sS'is,known,that'
p18916
g9
sS'degenerative,changes,in'
p18917
g3
sS'with,increasing,the'
p18918
g9
sS'multiple,forms,of'
p18919
g3
sS'if,replacement,is'
p18920
g3
sS'metabolism,using,isoform'
p18921
g3
sS'moderate,hypertension,administration'
p18922
g9
sS'blood,glucose,should'
p18923
g9
sS'been,used,successfully'
p18924
g3
sS'significantly,influence,the'
p18925
g3
sS'the,breadth,of'
p18926
g3
sS'warfarin,increased,inr'
p18927
g9
sS'with,tablets,an'
p18928
g9
sS'systematic,experience,with'
p18929
g3
sS'observed,with,blood'
p18930
g3
sS'to,use,of'
p18931
g9
sS'of,the,continuing'
p18932
g3
sS'max,were,observed'
p18933
g3
sS'than,doubled,in'
p18934
g3
sS'such,as,has'
p18935
g9
sS'species,nanm,but'
p18936
g9
sS'urinary,excretion,of'
p18937
g9
sS'similar,decreases,in'
p18938
g3
sS'metabolite,exposure,by'
p18939
g9
sS'duloxetine,may,have'
p18940
g3
sS'their,prothrombin,times'
p18941
g9
sS'was,included,with'
p18942
g3
sS'of,on,both'
p18943
g3
sS'attenuated,live,bacteria'
p18944
g3
sS'the,control,of'
p18945
g3
sS'and,antagonism,in'
p18946
g9
sS'celexa,in,a'
p18947
g9
sS'has,been,found'
p18948
g3
sS'o-desacetyl,metabolites,were'
p18949
g3
sS'an,open,randomized'
p18950
g3
sS'routine,monitoring,should'
p18951
g3
sS'disease,states,associated'
p18952
g3
sS'metabolism,of,resulting'
p18953
g9
sS'visual,analogue,scales'
p18954
g3
sS'dose,when,administered'
p18955
g9
sS'plus,haart,is'
p18956
g3
sS'ldl-c,reduction,was'
p18957
g9
sS'control,of,naflu'
p18958
g3
sS'have,the,condition'
p18959
g3
sS'inhibitors,eg,and'
p18960
g9
sS'mediate,the,metabolism'
p18961
g3
sS'treatment,of,severe'
p18962
g3
sS'inr,at,the'
p18963
g3
sS'of,safety,is'
p18964
g3
sS'of,certain,thereby'
p18965
g9
sS'cns,depression,producing'
p18966
g3
sS'was,observed,which'
p18967
g9
sS'to,cause,clinically'
p18968
g3
sS'or,when,a'
p18969
g3
sS'effect,reduction,in'
p18970
g3
sS'be,no,pharmacokinetic'
p18971
g3
sS'was,administered,after'
p18972
g3
sS'should,provide,the'
p18973
g3
sS'receiving,may,be'
p18974
g9
sS'who,may,subject'
p18975
g3
sS'symptoms,p,although'
p18976
g3
sS'be,at,risk'
p18977
g3
sS'of,clinical,status'
p18978
g9
sS'glucocorticoid-induced,gene,transcription'
p18979
g3
sS'epithelium,in,rpmi1640'
p18980
g9
sS'ineffective,in,altering'
p18981
g3
sS'amevive,is,not'
p18982
g3
sS'place,of,h2'
p18983
g9
sS'disease,control,by'
p18984
g9
sS'produce,a,modest'
p18985
g3
sS'mesylate,may,interact'
p18986
g9
sS'european,and,north'
p18987
g3
sS'was,administered,one'
p18988
g3
sS'renal,clearance,in'
p18989
g9
sS'creatinine,if,withdrawn'
p18990
g3
sS'creatinine,an,endogenous'
p18991
g9
sS'is,unknown,and'
p18992
g9
sS'numerous,liver,tumors'
p18993
g3
sS'obstetric,blocks,and'
p18994
g9
sS'for,patients,with'
p18995
g3
sS'anagrelide,is,an'
p18996
g3
sS'efficacy,of,orencia'
p18997
g9
sS'poor,d6,metabolizers'
p18998
g3
sS'coadministered,with,resulting'
p18999
g9
sS'and,developed,neutropenia'
p19000
g9
sS'similar,interaction,between'
p19001
g3
sS'significantly,reduces,the'
p19002
g9
sS'digoxin,when,starlix'
p19003
g3
sS'risk,of,habituation'
p19004
g3
sS'may,have,clinically'
p19005
g9
sS'but,generally,do'
p19006
g3
sS'also,interfere,with'
p19007
g9
sS'keppra,is,unlikely'
p19008
g3
sS'the,zevalin,therapeutic'
p19009
g3
sS'the,e-strain,subjects'
p19010
g3
sS'acetaminophen,may,increase'
p19011
g9
sS'the,cellular,basis'
p19012
g3
sS'cyp3a4,inducer,at'
p19013
g9
sS'from,healthy,subjects'
p19014
g3
sS'are,used,to'
p19015
g3
sS'diarrhea,and,dehydration'
p19016
g9
sS'tarceva,should,be'
p19017
g3
sS'have,been,associated'
p19018
g3
sS'pronounced,than,in'
p19019
g3
sS'the,horses,from'
p19020
g3
sS'iva,p-type,in'
p19021
g3
sS'absorption,resulting,in'
p19022
g9
sS'two,to,three'
p19023
g9
sS'bound,from,plasma'
p19024
g3
sS'specific,regulation,of'
p19025
g3
sS'in,decreased,plasma'
p19026
g9
sS'in,functional,or'
p19027
g3
sS'dose,mg,day'
p19028
g3
sS'effect,of,increased'
p19029
g3
sS'isoenzyme,in,vivo'
p19030
g9
sS'when,evaluating,plasma'
p19031
g3
sS'demonstrated,that,concomitant'
p19032
g9
sS'hypercholesterolemia,concomitant,administration'
p19033
g3
sS'could,result,in'
p19034
g3
sS'therefore,the,combination'
p19035
g9
sS'indicated,in,patients'
p19036
g3
sS'these,on,plasma'
p19037
g3
sS'due,to,an'
p19038
g3
sS'a,confirmation,test'
p19039
g3
sS'metabolites,with,a'
p19040
g9
sS'interactions,no,formal'
p19041
g3
sS'or,does,not'
p19042
g3
sS'be,advised,to'
p19043
g9
sS'serum,concentration,especially'
p19044
g9
sS'either,simultaneously,or'
p19045
g9
sS'like,mg,kg'
p19046
g3
sS'difficult,to,predict'
p19047
g3
sS'carbamazepine,concomitant,administration'
p19048
g9
sS'been,reported,to'
p19049
g9
sS'focus,on,specific'
p19050
g3
sS'see,a,href'
p19051
g9
sS'therefore,administration,of'
p19052
g3
sS'with,a,broad'
p19053
g3
sS'effects,an,blood'
p19054
g9
sS'thinners,coumadin,other'
p19055
g3
sS'were,reduced,in'
p19056
g3
sS'pharmacokinetics,of,at'
p19057
g3
sS'oral,dose,had'
p19058
g3
sS'interaction,would,occur'
p19059
g3
sS'inhibit,cytochrome,p450'
p19060
g3
sS'on,the,rate'
p19061
g3
sS'inhibitors,include,azole'
p19062
g3
sS'role,in,s'
p19063
g3
sS'cause,or,be'
p19064
g3
sS'pressure,were,approximately'
p19065
g3
sS'caused,a,decrease'
p19066
g9
sS'more,potent,in'
p19067
g3
sS'vitamin,c,g'
p19068
g9
sS'taking,when,macrolide'
p19069
g3
sS'cyp3a4,eg,may'
p19070
g9
sS'omega-agatoxin,via-resistant,presumptive'
p19071
g3
sS'peak,plasma,level'
p19072
g9
sS'controlled,clinical,pharmacology'
p19073
g3
sS'ampicillin,in,a'
p19074
g9
sS'weeks,and,and'
p19075
g3
sS'peak,plasma,concentration'
p19076
g9
sS'antifungal,agents,protease'
p19077
g9
sS'and,then,begins'
p19078
g3
sS'increased,concentrations,and'
p19079
g3
sS'half-life,of,potential'
p19080
g3
sS'concentration,cmax,of'
p19081
g3
sS'to,the,interactions'
p19082
g3
sS't3,in,the'
p19083
g9
sS'and,concomitantly,should'
p19084
g9
sS'd,for,days'
p19085
g9
sS'containing,to,patients'
p19086
g9
sS'aczone,gel,in'
p19087
g3
sS'thromboplastin,time,and'
p19088
g3
sS'or,increased,metabolic'
p19089
g9
sS'adequate,respiratory,exchange'
p19090
g3
sS'order,to,examine'
p19091
g3
sS'inhibition,of,gastric'
p19092
g3
sS'metabolized,triazolo-benzodiazepines,dihydropyridine'
p19093
g9
sS'mg,was,coadministered'
p19094
g9
sS'level,of,platelet'
p19095
g3
sS'certain,or,or'
p19096
g9
sS'effect,may,be'
p19097
g9
sS'hyper-,or,hypo-thyroxine'
p19098
g3
sS'because,is,displaced'
p19099
g9
sS'is,likely,viracept'
p19100
g9
sS'degraded,by,peptidase'
p19101
g3
sS'ensure,that,their'
p19102
g3
sS'under,steady,state'
p19103
g3
sS'depressed,at,a'
p19104
g3
sS'effects,in,humans'
p19105
g3
sS'breadth,of,systemic'
p19106
g3
sS'hypertension,patients,should'
p19107
g3
sS'of,only,in'
p19108
g9
sS'the,united,states'
p19109
g3
sS'with,oral,was'
p19110
g9
sS'mesylate,with,other'
p19111
g9
sS'acting,drugs,given'
p19112
g3
sS'these,does,not'
p19113
g3
sS'mm3,for,seven'
p19114
g3
sS'or,grapefruit,juice'
p19115
g3
sS'later,developmental,acquisition'
p19116
g3
sS'of,any,pharmacokinetic'
p19117
g3
sS'evidence,has,shown'
p19118
g9
sS'doses,of,low'
p19119
g3
sS'used,during,the'
p19120
g3
sS'at,periodic,intervals'
p19121
g9
sS'to,hypoparathyroid,patients'
p19122
g9
sS'basis,this,dose'
p19123
g3
sS'with,indocin,have'
p19124
g3
sS'can,inhibit,the'
p19125
g9
sS'and,the,patient'
p19126
g3
sS'therapeutic,dose,range'
p19127
g3
sS'healthy,males,in'
p19128
g3
sS'and,most,may'
p19129
g3
sS'studies,of,heroin-related'
p19130
g9
sS'enzymes,would,not'
p19131
g3
sS'that,received,one'
p19132
g3
sS'ibandronate,mg,once'
p19133
g3
sS'usually,give,little'
p19134
g3
sS'of,injection,in'
p19135
g3
sS'not,recommended,it'
p19136
g9
sS'exogenous,enhancement,of'
p19137
g3
sS'when,animals,are'
p19138
g3
sS'monitoring,or,consider'
p19139
g9
sS'alone,versus,mg'
p19140
g3
sS'be,receiving,both'
p19141
g9
sS'pressure,by,inhibiting'
p19142
g9
sS'patients,should,report'
p19143
g3
sS'with,two,doses'
p19144
g3
sS'that,can,potentiate'
p19145
g9
sS'not,with,the'
p19146
g3
sS'frova,treatment,is'
p19147
g3
sS'in,ontario,alone'
p19148
g3
sS'of,and,cns-active'
p19149
g3
sS'may,cause,hypoglycemia'
p19150
g3
sS'administered,starlix,mg'
p19151
g3
sS'patients,with,amenorrhea'
p19152
g3
sS'range,of,observed'
p19153
g3
sS'in,slight,increases'
p19154
g9
sS'genetic,data,in'
p19155
g3
sS'aeds,affects,the'
p19156
g9
sS'of,potentially,leading'
p19157
g9
sS'any,significant,change'
p19158
g3
sS'was,not,so'
p19159
g3
sS'increased,the,cmax'
p19160
g9
sS'was,also,verified'
p19161
g3
sS'identity,of,the'
p19162
g3
sS'd,and,exhibit'
p19163
g3
sS'the,regimen,of'
p19164
g9
sS'myelotoxicity,of,taxol'
p19165
g3
sS'presence,of,caused'
p19166
g3
sS'if,any,signs'
p19167
g9
sS'studies,intravenous,has'
p19168
g3
sS'toxicity,has,been'
p19169
g9
sS'and,absorption,and'
p19170
g3
sS'known,if,other'
p19171
g3
sS'of,severe,and'
p19172
g3
sS'grapefruit,juice,increases'
p19173
g3
sS'effect,of,agents'
p19174
g3
sS'including,has,additive'
p19175
g9
sS'and,ldl-c,reduction'
p19176
g3
sS'and,a4,were'
p19177
g3
sS'such,as,valium'
p19178
g9
sS'closely,for,signs'
p19179
g9
sS'reduce,pulse,and'
p19180
g9
sS'thus,no,dosing'
p19181
g3
sS'raise,the,gastrointestinal'
p19182
g3
sS'but,the,duration'
p19183
g9
sS'no,formal,drug-interaction'
p19184
g3
sS'are,possible,with'
p19185
g3
sS'those,seen,when'
p19186
g9
sS'however,and,are'
p19187
g3
sS'single,and,multiple'
p19188
g9
sS'in,the,community'
p19189
g3
sS'ketoconazole,has,been'
p19190
g9
sS'a,far,greater'
p19191
g3
sS'combination,with,uricosuric'
p19192
g3
sS'when,beginning,discontinuing'
p19193
g9
sS'in,cardiovascular,disease'
p19194
g3
sS'and,s,d'
p19195
g9
sS'much,statistical,work'
p19196
g3
sS'and,m,v'
p19197
g3
sS'increased,the,intracellular'
p19198
g9
sS'are,performed,on'
p19199
g3
sS'of,severe,hypoglycemia'
p19200
g9
sS'both,the,natriuresis'
p19201
g9
sS'stimulation,is,a'
p19202
g3
sS'heart,failure,during'
p19203
g3
sS'cyp2d6,may,result'
p19204
g3
sS'of,substantial,accumulation'
p19205
g9
sS'classified,using,the'
p19206
g3
sS'grapefruit,juice,should'
p19207
g3
sS'in,mean,cmax'
p19208
g9
sS'the,morbidity,from'
p19209
g3
sS'of,mg,mg'
p19210
g3
sS'necessitating,an,increase'
p19211
g9
sS'to,date,show'
p19212
g3
sS'and,total,bilirubin'
p19213
g3
sS'mg,times,daily'
p19214
g9
sS'their,additive,effects'
p19215
g9
sS'no,documentation,of'
p19216
g3
sS'p450,enzyme-inducer,did'
p19217
g9
sS'and,produces,an'
p19218
g9
sS'the,patient,s'
p19219
g3
sS'others,with,a'
p19220
g3
sS'factors,v,and'
p19221
g3
sS'correlated,with,brain'
p19222
g3
sS'in,clearance,does'
p19223
g3
sS'combination,with,cyp3a4'
p19224
g3
sS'blood,levels,could'
p19225
g3
sS'when,any,additional'
p19226
g9
sS'before,parturition,it'
p19227
g3
sS'phase,schizophrenia,and'
p19228
g3
sS'resemble,the,immediate'
p19229
g3
sS'causing,bone,marrow'
p19230
g9
sS'inhibition,linezolid,is'
p19231
g3
sS'therefore,when,edecrin'
p19232
g9
sS'study,there,were'
p19233
g3
sS'aspirin,nonsteroidal,antiinflammatory'
p19234
g3
sS'arrests,have,occurred'
p19235
g3
sS'second,contractile,responses'
p19236
g9
sS'before,one,should'
p19237
g3
sS'added,to,other'
p19238
g3
sS'didanosine,chewable,buffered'
p19239
g9
sS'of,plasma,and'
p19240
g9
sS'or,the,administration'
p19241
g9
sS'resistance,arteries,of'
p19242
g3
sS'brain,and,liver'
p19243
g9
sS'also,see,a'
p19244
g9
sS'most,commonly,occurring'
p19245
g9
sS'that,cefditoren,pivoxil'
p19246
g9
sS'camptosar,and,certainly'
p19247
g9
sS'nevirapine-,or,delavirdine-based'
p19248
g3
sS'blood,coagulation,have'
p19249
g9
sS'pronounced,effect,on'
p19250
g9
sS'considered,in,the'
p19251
g3
sS'eight,poisonings,of'
p19252
g3
sS'or,are,used'
p19253
g9
sS'these,subjects,r'
p19254
g3
sS'desbutyl,levobupivacaine,and'
p19255
g3
sS'the,atypical,antipsychotic'
p19256
g3
sS'steady-state,plasma,concentrations'
p19257
g9
sS'systemic,clearance,of'
p19258
g9
sS'identified,involving,nizoral'
p19259
g9
sS'should,be,flexible'
p19260
g3
sS'irradiation,has,not'
p19261
g3
sS'to,reduce,the'
p19262
g9
sS'route,in,man'
p19263
g3
sS'times,comparable,to'
p19264
g3
sS'with,and,special'
p19265
g9
sS'in,some,instances'
p19266
g9
sS'due,to,induction'
p19267
g9
sS'results,in,december'
p19268
g3
sS'get,the,most'
p19269
g3
sS'extreme,caution,only'
p19270
g3
sS'concomitant,medications,on'
p19271
g3
sS'gi,tract,to'
p19272
g9
sS'and,there,were'
p19273
g3
sS'a,relatively,unexplored'
p19274
g3
sS'four,subjects,with'
p19275
g3
sS'humira,may,also'
p19276
g9
sS'were,lowered,from'
p19277
g3
sS'with,mixed,agonist'
p19278
g9
sS'interactions,of,with'
p19279
g3
sS'ng,ml,and'
p19280
g3
sS'no,acceptable,alternatives'
p19281
g3
sS'complexes,with,and'
p19282
g9
sS'relaxant,antagonists,administered'
p19283
g3
sS'provide,misleading,information'
p19284
g3
sS'more,specific,sulfosalicylic'
p19285
g3
sS'selective,marker,substrates'
p19286
g3
sS'herbal,remedies,is'
p19287
g3
sS'either,of,these'
p19288
g3
sS'the,dependence,of'
p19289
g3
sS'common,side,effects'
p19290
g3
sS'when,administered,one'
p19291
g9
sS'includes,longer,term'
p19292
g3
sS'medications,and,include'
p19293
g3
sS'group,of,healthy'
p19294
g3
sS'adverse,events,or'
p19295
g3
sS'goal,of,enhancing'
p19296
g3
sS'suggesting,a,dissociation'
p19297
g3
sS'antidepressant,was,shown'
p19298
g3
sS'compared,to,those'
p19299
g3
sS'concentration,by,after'
p19300
g3
sS'insert,for,preparations'
p19301
g9
sS'whom,renal,insufficiency'
p19302
g3
sS'does,it,alter'
p19303
g3
sS'potentiate,the,effect'
p19304
g9
sS'across,a,wide'
p19305
g3
sS'sst,and,the'
p19306
g3
sS'serial,use,of'
p19307
g3
sS'healthy,volunteers,did'
p19308
g3
sS'seminiferous,tubules,seminiferous'
p19309
g3
sS'least,hours,before'
p19310
g9
sS'adjustment,in,the'
p19311
g3
sS'post-marketing,experience,bleeding'
p19312
g9
sS'coating,may,undergo'
p19313
g3
sS'of,p-glycoprotein,mediated'
p19314
g3
sS'is,excreted,in'
p19315
g3
sS'are,at,increased'
p19316
g9
sS'day,im,approximately'
p19317
g3
sS'nervous,system,and'
p19318
g9
sS'interactions,should,be'
p19319
g3
sS'systemic,exposure,auc0-30'
p19320
g3
sS'ml,and,terminal'
p19321
g9
sS'or,clotting,factor'
p19322
g3
sS'anagrelide,alone,had'
p19323
g9
sS'data,to,evaluate'
p19324
g9
sS'in,a,wax'
p19325
g9
sS'interaction,of,prostaglandin'
p19326
g9
sS'in,vivo,interaction'
p19327
g3
sS'patients,interaction,study'
p19328
g3
sS'various,temperatures,in'
p19329
g3
sS'that,was,too'
p19330
g3
sS'that,starlix,is'
p19331
g3
sS'within,five,days'
p19332
g3
sS'previously,administered,agents'
p19333
g3
sS'hypo-thyroxine,binding-globulinemias,have'
p19334
g3
sS'lipoproteins,and,triglycerides'
p19335
g3
sS'differences,were,observed'
p19336
g3
sS'uncontrolled,intake,of'
p19337
g3
sS'studies,investigating,possible'
p19338
g3
sS'monotherapy,given,as'
p19339
g3
sS'at,least,five'
p19340
g3
sS'pegasys,treatment,did'
p19341
g3
sS'there,exists,the'
p19342
g3
sS'and,for,cmax'
p19343
g9
sS'hydroxy-1,on,a'
p19344
g9
sS'the,nasal,spray'
p19345
g9
sS'vivo,micronucleus,test'
p19346
g3
sS'neuron,blockade,produced'
p19347
g9
sS'agents,have,no'
p19348
g9
sS'reduce,the,frequency'
p19349
g3
sS'suggested,with,sodium'
p19350
g3
sS'neurons,displaying,transient'
p19351
g3
sS'or,methylthiadiazole,can'
p19352
g3
sS'hormone,lh,follicle-stimulating'
p19353
g3
sS'demonstrated,to,be'
p19354
g9
sS'nodes,however,adenocard'
p19355
g3
sS'of,gi,ulceration'
p19356
g9
sS'oil,ml,kg'
p19357
g3
sS'the,most,commonly'
p19358
g9
sS'in,their,coagulation'
p19359
g9
sS'vardenafil,when,taken'
p19360
g3
sS'patient,continued,to'
p19361
g3
sS'for,deriving,experimental'
p19362
g3
sS'of,neurons,fired'
p19363
g3
sS'between,trileptal,and'
p19364
g3
sS'n,were,decreased'
p19365
g9
sS'monitoring,is,recommended'
p19366
g9
sS'in,the,degree'
p19367
g3
sS'cause,ventricular,tachycardia'
p19368
g9
sS'thin-layer,chromatographic,assay'
p19369
g3
sS'co,and,or'
p19370
g3
sS'the,therapy,standard'
p19371
g3
sS'risk,is,present'
p19372
g3
sS'produce,antabuse-like,side'
p19373
g9
sS'vitamin,k,the'
p19374
g9
sS'feels,that,is'
p19375
g3
sS'nicotine,nicotine,may'
p19376
g9
sS'by,the,liver'
p19377
g3
sS'aspirin,vardenafil,mg'
p19378
g3
sS'guardians,should,be'
p19379
g3
sS'plasma,and,renal'
p19380
g9
sS'short,sedation,time'
p19381
g3
sS'certain,that,no'
p19382
g9
sS'result,in,clinically'
p19383
g3
sS'p450,d6,may'
p19384
g3
sS'concentrations,when,was'
p19385
g9
sS'enzyme,eg,should'
p19386
g9
sS'the,approach,is'
p19387
g3
sS'the,specific,d1'
p19388
g9
sS'plasma,flow,and'
p19389
g3
sS'of,mac,out'
p19390
g3
sS'both,periods,with'
p19391
g3
sS'of,and,single'
p19392
g3
sS'was,given,several'
p19393
g3
sS'vitamin,b3,niacin'
p19394
g9
sS'about,the,use'
p19395
g3
sS'levels,significantly,higher'
p19396
g3
sS'testing,should,be'
p19397
g9
sS'of,co-administered,drug'
p19398
g3
sS'availability,of,potent'
p19399
g3
sS'modifies,metabolism,with'
p19400
g9
sS'with,a,higher'
p19401
g9
sS'dose,of,sonata'
p19402
g3
sS'not,significantly,affect'
p19403
g3
sS'affected,by,administration'
p19404
g3
sS'with,baseline,neutrophil'
p19405
g3
sS'addition,certain,inhibit'
p19406
g3
sS'kg,increased,mean'
p19407
g9
sS'than,in,the'
p19408
g3
sS'formation,of,oxidized'
p19409
g3
sS'we,assessed,the'
p19410
g3
sS'medications,tylenol,such'
p19411
g9
sS'patients,whose,pulmonary'
p19412
g3
sS'adjustment,of,nalfon'
p19413
g9
sS'use,of,hydrobromide'
p19414
g9
sS'binding,of,mhd'
p19415
g3
sS'as,the,class'
p19416
g9
sS'or,efficacy,were'
p19417
g3
sS'with,is,not'
p19418
g9
sS'dose,reduction,or'
p19419
g3
sS'on,the,level'
p19420
g3
sS'on,the,response'
p19421
g3
sS'oral,poc,in'
p19422
g3
sS'who,are,being'
p19423
g9
sS'inhibitor,class,may'
p19424
g9
sS'improvements,in,psychopathology'
p19425
g3
sS'dose,reduction,of'
p19426
g9
sS'levels,of,to'
p19427
g9
sS'dose,groups,developed'
p19428
g3
sS'of,the,stable'
p19429
g3
sS'were,compared,with'
p19430
g3
sS'effect,on,half-life'
p19431
g9
sS'ritonavir,and,upon'
p19432
g9
sS'especially,with,respect'
p19433
g3
sS'to,a,dysregulation'
p19434
g3
sS'are,the,prescription'
p19435
g9
sS'macrolide,or,azoles'
p19436
g3
sS'qt,intervals,during'
p19437
g3
sS'adenylate,cyclase,activity'
p19438
g3
sS'pronounced,intersubject,variability'
p19439
g9
sS'possible,role,in'
p19440
g3
sS'preliminary,investigations,indicate'
p19441
g3
sS'longer,than,weeks'
p19442
g9
sS'and,or,elevated'
p19443
g9
sS'the,metabolic,clearance'
p19444
g9
sS'of,or,should'
p19445
g3
sS'tid,no,dose'
p19446
g3
sS'agent,or,the'
p19447
g3
sS'trial,has,shown'
p19448
g9
sS'to,leading,to'
p19449
g9
sS'of,this,interaction'
p19450
g3
sS'nizoral,muscle,relaxants'
p19451
g3
sS'with,the,bio-rad'
p19452
g3
sS'catecholamines,in,response'
p19453
g3
sS'isolates,synergy,was'
p19454
g3
sS'without,clinical,bleeding'
p19455
g9
sS'cmax,by,resulting'
p19456
g3
sS'zaleplon,is,not'
p19457
g3
sS'both,and,its'
p19458
g9
sS'coadministration,of,using'
p19459
g9
sS'inhibit,p-glycoprotein,mediated'
p19460
g3
sS'commonly,reported,both'
p19461
g9
sS'nasal,vasoconstrictor,but'
p19462
g3
sS'these,compounds,are'
p19463
g3
sS'channel,blockers,nonsteroidal'
p19464
g3
sS'be,delayed,until'
p19465
g3
sS'caused,a,statistically'
p19466
g9
sS'inhaled,and,or'
p19467
g3
sS'to,cause,decreased'
p19468
g9
sS'parathyroid-function,tests,are'
p19469
g3
sS'we,demonstrate,that'
p19470
g3
sS'release,the,antihypertensive'
p19471
g9
sS'cholinergic,blockade,may'
p19472
g9
sS'the,derivative,implications'
p19473
g3
sS'enhancing,efficacious,effects'
p19474
g3
sS'six,patients,five'
p19475
g3
sS'in,the,plasma'
p19476
g9
sS'of,and,produces'
p19477
g9
sS'exercised,when,using'
p19478
g3
sS'side-effects,in,patients'
p19479
g9
sS'the,patient,had'
p19480
g3
sS'other,potentially,nephrotoxic'
p19481
g9
sS'risk,of,a'
p19482
g9
sS'or,the,dose'
p19483
g3
sS'reviews,the,impact'
p19484
g3
sS'm2,dose,of'
p19485
g3
sS'because,there,exists'
p19486
g3
sS'or,embryocidal,effects'
p19487
g3
sS'reduction,in,levels'
p19488
g9
sS'decreased,reflecting,the'
p19489
g3
sS'discontinue,nursing,or'
p19490
g3
sS'drug,side,effects'
p19491
g3
sS'the,patient,has'
p19492
g9
sS'contrast,the,potency'
p19493
g3
sS'its,binding,sites'
p19494
g9
sS'buprenorphine,is,metabolized'
p19495
g3
sS'it,is,notable'
p19496
g3
sS'clinical,basis,of'
p19497
g3
sS'plasticity,ieg,response'
p19498
g3
sS'deaths,due,to'
p19499
g3
sS'hippocampus,as,interaction'
p19500
g3
sS'not,known,caution'
p19501
g9
sS'been,rare,postmarketing'
p19502
g9
sS'a,clinically,relevant'
p19503
g9
sS'concentrations,of,that'
p19504
g9
sS'blockers,although,not'
p19505
g9
sS'inhibit,the,anti-inflammatory'
p19506
g9
sS'reported,that,the'
p19507
g9
sS'non-myelinated,axons,has'
p19508
g3
sS'going,to,be'
p19509
g3
sS'seven,cerebrovascular,accidents'
p19510
g3
sS'maximum,plasma,concentration'
p19511
g9
sS'studied,with,doses'
p19512
g3
sS'and,hiv,protease'
p19513
g3
sS'plasmaconcentrations,may,reduce'
p19514
g9
sS'hazards,of,herbal'
p19515
g3
sS'potentially,nephrotoxic,agents'
p19516
g9
sS'fi,responding,in'
p19517
g3
sS'therefore,interactions,could'
p19518
g3
sS'article,looks,at'
p19519
g3
sS'therapy,ect,there'
p19520
g3
sS'the,amount,of'
p19521
g9
sS'involving,otherwise,healthy'
p19522
g3
sS'accounts,for,less'
p19523
g3
sS'conclude,that,adl'
p19524
g9
sS'be,formed,by'
p19525
g3
sS'or,extent,of'
p19526
g3
sS'that,both,and'
p19527
g9
sS'possible,lack,of'
p19528
g3
sS'filtrated,to,a'
p19529
g9
sS'aspirin,acetaminophen,pharmacokinetic'
p19530
g3
sS'whether,this,interaction'
p19531
g3
sS'preceding,effect,of'
p19532
g3
sS'for,diabetic,individuals'
p19533
g3
sS'enteric,coating,may'
p19534
g3
sS'significantly,decreased,when'
p19535
g9
sS'no,potential,for'
p19536
g3
sS'that,the,first'
p19537
g3
sS'be,of,assistance'
p19538
g3
sS'possibility,and,cautioned'
p19539
g3
sS'functional,antagonism,exists'
p19540
g9
sS'urine,after,exposure'
p19541
g3
sS'with,either,enbrel'
p19542
g9
sS'nonlethal,and,lethal'
p19543
g3
sS'with,nonsteroidal,the'
p19544
g9
sS'based,on,the'
p19545
g3
sS'in,hormone,levels'
p19546
g3
sS'effects,of,xanthine'
p19547
g3
sS'experiencing,breakthrough,bleeding'
p19548
g3
sS's,of,resveratrol-induced'
p19549
g3
sS'a,spinal,naloxone-sensitive'
p19550
g3
sS'has,been,studied'
p19551
g3
sS'control,rats,in'
p19552
g3
sS'being,dosed,at'
p19553
g3
sS'glycosides,amphotericin,b-induced'
p19554
g9
sS'that,intraventricular,and'
p19555
g3
sS'statistical,work,has'
p19556
g3
sS'methyldopa,aldomet,use'
p19557
g9
sS'and,plasma,mean'
p19558
g9
sS'median,survival,for'
p19559
g3
sS'in,nnrti-na,ve'
p19560
g3
sS'more,commonly,in'
p19561
g9
sS'may,diminish,adrenal'
p19562
g9
sS'not,significantly,increase'
p19563
g3
sS'amevive,before,one'
p19564
g3
sS'and,may,regulate'
p19565
g9
sS'seizure,associated,with'
p19566
g3
sS'relative,bioavailability,auc'
p19567
g3
sS'pregnant,into,the'
p19568
g3
sS'pre-gentamycin,strength,over'
p19569
g3
sS'ketoconazole,concomitant,use'
p19570
g3
sS'clinically,relevant,pharmacokinetic'
p19571
g3
sS'of,staphylococcus,aureus'
p19572
g9
sS'require,lower,doses'
p19573
g3
sS'sustained,elevation,in'
p19574
g9
sS'medicines,should,not'
p19575
g3
sS'of,concomitant,medication'
p19576
g3
sS'weak,inhibitors,of'
p19577
g3
sS'therapy,with,are'
p19578
g3
sS'although,they,do'
p19579
g9
sS'in,lower,serum'
p19580
g9
sS'central,stimulant,effects'
p19581
g9
sS'comparing,once-monthly,with'
p19582
g3
sS'of,do,not'
p19583
g3
sS'resolution,of,the'
p19584
g9
sS'of,diethyl,pyrocarbonate'
p19585
g3
sS'novolog,with,nph'
p19586
g3
sS'affected,by,cytochrome'
p19587
g3
sS'with,a,glucose-specific'
p19588
g3
sS'atropine,either,alone'
p19589
g3
sS'examples,of,this'
p19590
g3
sS'the,potential,risk'
p19591
g9
sS'copaxone,has,not'
p19592
g3
sS'of,to,micrograms'
p19593
g9
sS'of,and,inn'
p19594
g3
sS'though,such,interactions'
p19595
g3
sS'kg,enhanced,and'
p19596
g9
sS'function,simultaneous,use'
p19597
g3
sS'population,pharmacokinetic,analyses'
p19598
g9
sS'received,either,prophylactic'
p19599
g3
sS'doses,of,rocaltrol'
p19600
g3
sS'gleevec,is,coadministered'
p19601
g9
sS'pharmacological,interaction,may'
p19602
g3
sS'each,subject,received'
p19603
g3
sS'on,the,th'
p19604
g9
sS'and,were,concomitantly'
p19605
g3
sS'related,to,obstetric'
p19606
g9
sS'have,resulted,in'
p19607
g9
sS'of,foscavir,and'
p19608
g9
sS'tricor,with,and'
p19609
g9
sS'which,they,are'
p19610
g3
sS'job,appointments,since'
p19611
g3
sS'tests,benedicts,or'
p19612
g3
sS'potential,especially,in'
p19613
g9
sS'reported,case,of'
p19614
g9
sS'reduced,kidney,and'
p19615
g3
sS'patient,receiving,the'
p19616
g3
sS'duration,of,therapy'
p19617
g3
sS'who,consume,greater'
p19618
g3
sS'result,of,the'
p19619
g3
sS'cases,was,misused'
p19620
g3
sS'receiving,both,therapies'
p19621
g3
sS'positive,tests,were'
p19622
g3
sS'growth,of,several'
p19623
g3
sS'clarithromycin,telithromycin,hiv'
p19624
g3
sS'to,topoisomerase-targeted,chemotherapy'
p19625
g3
sS'serum,psa,levels'
p19626
g3
sS'pegasys,equivalent,to'
p19627
g3
sS'of,reduced,cmax'
p19628
g9
sS'plasma,of,dogs'
p19629
g3
sS'of,with,was'
p19630
g9
sS'the,conversion,of'
p19631
g3
sS'study,or,was'
p19632
g9
sS'patients,with,life-threatening'
p19633
g3
sS'also,receiving,mg'
p19634
g3
sS'of,bezalip,or'
p19635
g9
sS'extensively,used,in'
p19636
g3
sS'these,two,compounds'
p19637
g3
sS'studies,one,mg'
p19638
g9
sS'intact,subjects,with'
p19639
g3
sS'these,reactions,consisted'
p19640
g3
sS'to,encystment,and'
p19641
g3
sS'of,healthy,male'
p19642
g9
sS'hmgcoa,reductase,inhibitors'
p19643
g3
sS'has,been,associated'
p19644
g9
sS'd,co-administered,with'
p19645
g9
sS'or,may,cause'
p19646
g9
sS'the,tail-flick,response'
p19647
g9
sS'food,or,herb'
p19648
g3
sS'coronary,insufficiency,especially'
p19649
g3
sS'and,respiratory,and'
p19650
g3
sS'were,given,on'
p19651
g9
sS'potential,of,especially'
p19652
g9
sS'same,degree,of'
p19653
g3
sS'in,any,significant'
p19654
g3
sS'on,bsa,during'
p19655
g3
sS'acid,although,many'
p19656
g3
sS'an,omega-conotoxin,gvia-sensitive'
p19657
g3
sS'antibiotics,in,vitro'
p19658
g9
sS'locomotor,responses,to'
p19659
g3
sS'the,cns-impairing,effects'
p19660
g9
sS'was,usually,reversible'
p19661
g9
sS'of,erection-supporting,medication'
p19662
g3
sS'response,to,either'
p19663
g9
sS'second,study,was'
p19664
g3
sS'results,sildenafil,has'
p19665
g3
sS'climbing,paperhanging,playing'
p19666
g3
sS'non-steroidal,the,co-administration'
p19667
g9
sS'raise,serum,levels'
p19668
g9
sS'oral,did,not'
p19669
g3
sS'viracept,resulted,in'
p19670
g9
sS'exercise,testing,a'
p19671
g3
sS'a,day,resulted'
p19672
g9
sS'to,induce,the'
p19673
g9
sS'adenocard,has,been'
p19674
g3
sS'romazicon,in,cases'
p19675
g9
sS'a,mild,decrease'
p19676
g9
sS'long-term,therapy,eg'
p19677
g9
sS'adrenocorticoids,is,decreased'
p19678
g3
sS'toxic,epidermal,necrolysis'
p19679
g3
sS'absorption,of,also'
p19680
g3
sS'the,central,syndrome'
p19681
g9
sS'vivo,data,suggesting'
p19682
g9
sS'plasma,concentrations,has'
p19683
g3
sS'divergently,selected,for'
p19684
g3
sS'those,changes,induced'
p19685
g3
sS'or,and,to'
p19686
g3
sS'with,may,result'
p19687
g9
sS'considered,when,therapy'
p19688
g9
sS'of,certain,tricyclic'
p19689
g9
sS'agents,with,b-blocking'
p19690
g9
sS'using,the,uptake'
p19691
g3
sS'or,were,observed'
p19692
g3
sS'recommended,when,and'
p19693
g9
sS'and,death,associated'
p19694
g9
sS'by,therapy,the'
p19695
g9
sS'were,receiving,intravenous'
p19696
g3
sS'the,bowel,and'
p19697
g3
sS'neurotoxic,and,or'
p19698
g3
sS'tubercle,of,the'
p19699
g3
sS'therapy,particularly,for'
p19700
g3
sS'stress,and,facilitate'
p19701
g3
sS'alkaloids,may,be'
p19702
g9
sS'potential,interaction,between'
p19703
g9
sS'dose,mg,every'
p19704
g9
sS'b12,status,before'
p19705
g3
sS'secretion,while,may'
p19706
g9
sS'use,folate,may'
p19707
g3
sS'a,higher,incidence'
p19708
g9
sS'status,before,you'
p19709
g3
sS'dose,administration,of'
p19710
g9
sS'specific,activity,are'
p19711
g3
sS'greater,gastrointestinal,toxicity'
p19712
g9
sS'shown,to,result'
p19713
g3
sS'although,there,was'
p19714
g9
sS'mice,one,of'
p19715
g3
sS'drug,interactions,and'
p19716
g9
sS'at,least,hour'
p19717
g9
sS'neuropathy,pancreatitis,and'
p19718
g3
sS'blood,concentrations,of'
p19719
g3
sS'whole,blood,concentrations'
p19720
g9
sS'use,during,therapy'
p19721
g9
sS'decrease,in,standing'
p19722
g9
sS'may,be,refractory'
p19723
g9
sS'two,cases,in'
p19724
g9
sS'that,the,myelotoxicity'
p19725
g3
sS'their,binding,sites'
p19726
g3
sS'effect,oral,heparin'
p19727
g3
sS'which,has,been'
p19728
g3
sS'kidney,cell,cultures'
p19729
g3
sS'patients,in,clinical'
p19730
g3
sS'been,suggested,in'
p19731
g3
sS'of,cerebyx,are'
p19732
g3
sS'increased,the,extent'
p19733
g3
sS'the,clinician,should'
p19734
g9
sS'in,this,setting'
p19735
g3
sS'important,interactions,have'
p19736
g3
sS'this,class,is'
p19737
g3
sS'e2-induced,diarrhea,in'
p19738
g3
sS'effects,due,to'
p19739
g3
sS'drugs,with,nephrotoxic'
p19740
g3
sS'inhibit,metabolism,mediated'
p19741
g3
sS'agents,reduce,the'
p19742
g9
sS'no,longer,marketed'
p19743
g3
sS'component,p2,may'
p19744
g3
sS'effect,of,acarbose'
p19745
g9
sS'for,nsclc,patients'
p19746
g3
sS'exist,comparing,the'
p19747
g3
sS'been,safely,coadministered'
p19748
g3
sS'trace,elements,were'
p19749
g3
sS'for,drug,interactions'
p19750
g3
sS'development,of,selective'
p19751
g3
sS'person,based,on'
p19752
g3
sS'response,of,the'
p19753
g3
sS'by,up,to'
p19754
g9
sS'any,clinically,significant'
p19755
g3
sS'rates,and,therefore'
p19756
g3
sS'cause,abnormal,renal'
p19757
g9
sS'with,if,therapy'
p19758
g9
sS'plasma,exposure,auc'
p19759
g9
sS'study,was,designed'
p19760
g3
sS'levels,of,unchanged'
p19761
g9
sS'overdosage,or,in'
p19762
g9
sS'inhibit,alprazolam,metabolism'
p19763
g3
sS'be,observed,for'
p19764
g3
sS'with,fondaparinux,the'
p19765
g3
sS'solution,the,first'
p19766
g3
sS'assessed,in,various'
p19767
g3
sS'multivalent,cations,likely'
p19768
g9
sS'therefore,intake,of'
p19769
g3
sS'stability,of,nucleophosmin'
p19770
g3
sS'a,necessary,factor'
p19771
g3
sS'in,using,concomitant'
p19772
g3
sS'performed,weekly,or'
p19773
g3
sS'goal,of,this'
p19774
g3
sS'produced,enhanced,learning'
p19775
g3
sS'that,dopamine,antagonists'
p19776
g9
sS'and,through,pharmacokinetic'
p19777
g3
sS'necessary,careful,patient'
p19778
g3
sS'pressure,or,on'
p19779
g3
sS'pharmacokinetics,and,pharmacodynamics'
p19780
g3
sS'estimates,of,the'
p19781
g3
sS'with,mg,day'
p19782
g9
sS'substantially,interfere,with'
p19783
g9
sS'reactions,in,patients'
p19784
g3
sS'daily,morning,and'
p19785
g3
sS'or,back-up,methods'
p19786
g9
sS'placebo-controlled,trial,in'
p19787
g9
sS'treatment,potentiated,the'
p19788
g9
sS'other,will,result'
p19789
g3
sS'kidney,function,the'
p19790
g3
sS'and,ethinyl,estradiol'
p19791
g9
sS'classes,that,are'
p19792
g3
sS'dose,of,albendazole'
p19793
g9
sS'using,the,bio-rad'
p19794
g3
sS'the,world,health'
p19795
g3
sS'a,non-comparative,clinical'
p19796
g9
sS'activity,of,certain'
p19797
g3
sS'dogs,deprived,of'
p19798
g3
sS'activity,thus,requiring'
p19799
g9
sS'been,co-administered,with'
p19800
g3
sS'to,be,catalyzed'
p19801
g3
sS'patients,have,a'
p19802
g3
sS'monkeys,nanm,was'
p19803
g3
sS'relevant,inhibition,of'
p19804
g3
sS'in,the,cumulative'
p19805
g3
sS'ht3,antagonist,class'
p19806
g9
sS'the,picr,so'
p19807
g3
sS'the,peripheral,vascular'
p19808
g3
sS'coagulation,tests,should'
p19809
g3
sS'panretin,gel,on'
p19810
g3
sS'in,volunteers,with'
p19811
g3
sS'of,human,cyp'
p19812
g3
sS'positive,and,gram'
p19813
g3
sS'been,observed,in'
p19814
g3
sS'second,experiment,non-diabetic'
p19815
g3
sS'and,that,can'
p19816
g3
sS'of,clinical,relevance'
p19817
g3
sS'nd,series,of'
p19818
g3
sS'been,observed,it'
p19819
g9
sS'after,initiating,treatment'
p19820
g3
sS'of,oral,supplements'
p19821
g3
sS'colchicine,para-aminosalicylic,acid'
p19822
g9
sS'recover,to,a'
p19823
g3
sS'abruptly,toxic,when'
p19824
g3
sS'separate,study,baboons'
p19825
g3
sS'plasma,concentrations,below'
p19826
g9
sS'of,life,in'
p19827
g3
sS'alteration,in,clearance'
p19828
g3
sS'megakaryocytes,with,the'
p19829
g3
sS'interactions,implications,for'
p19830
g3
sS'decided,to,discontinue'
p19831
g9
sS'masking,symptoms,of'
p19832
g3
sS'displacement,of,more'
p19833
g3
sS'mg,produced,additive'
p19834
g9
sS'dose,modification,is'
p19835
g3
sS'the,cost-risk,benefit'
p19836
g3
sS'including,hyperglycemia,and'
p19837
g9
sS'interpreted,with,caution'
p19838
g3
sS'decins,sans,fronti'
p19839
g3
sS'cyclosporine,cyp3a4,substrate'
p19840
g3
sS'test,interactions,the'
p19841
g3
sS'best,adaptive,value'
p19842
g3
sS'of,agranulocytosis,as'
p19843
g3
sS'vitamin,a,because'
p19844
g9
sS'cyp3a4,metabolic,reactions'
p19845
g3
sS'agents,since,the'
p19846
g9
sS'excessively,to,as'
p19847
g3
sS'data,are,discussed'
p19848
g3
sS'higher,dose,mg'
p19849
g3
sS'interaction,occurred,when'
p19850
g3
sS'both,should,be'
p19851
g3
sS'increased,an,average'
p19852
g9
sS'the,urine,using'
p19853
g3
sS'kg,produced,no'
p19854
g3
sS'whether,has,a'
p19855
g3
sS'increased,about,fold'
p19856
g9
sS'it,was,observed'
p19857
g3
sS'and,concentration,were'
p19858
g3
sS'number,of,alcohol-related'
p19859
g3
sS'system,responsible,for'
p19860
g9
sS'is,inadequate,systematic'
p19861
g3
sS'toxicity,and,serial'
p19862
g9
sS'effects,an,additive'
p19863
g3
sS'of,endogenous,steroid'
p19864
g9
sS'to,the,rat'
p19865
g3
sS'was,also,ineffective'
p19866
g3
sS'since,there,are'
p19867
g9
sS'available,on,concomitant'
p19868
g3
sS'randomly,assigned,in'
p19869
g3
sS'patients,with,concentrations'
p19870
g3
sS'activity,while,on'
p19871
g3
sS'that,alter,platelet'
p19872
g9
sS'and,the,first'
p19873
g3
sS'flushing,and,pruritus'
p19874
g3
sS'or,glycoprotein,iib'
p19875
g9
sS'reduced,it,by'
p19876
g3
sS'neurontin,in,epileptic'
p19877
g3
sS'blocking,action,of'
p19878
g9
sS'is,at,least'
p19879
g3
sS'produce,hyperglycemia,and'
p19880
g3
sS'cmax,and,mean'
p19881
g9
sS'and,functional,consequences'
p19882
g3
sS'induction,of,cyp'
p19883
g9
sS'if,concomitant,administration'
p19884
g3
sS'patients,being,treated'
p19885
g9
sS'to,be,aware'
p19886
g3
sS'compared,with,has'
p19887
g3
sS'twenty-four,h,exposures'
p19888
g3
sS'given,concomitantly,with'
p19889
g3
sS'the,following,drug'
p19890
g3
sS'cefditoren,pivoxil,administered'
p19891
g9
sS'has,no,apparent'
p19892
g3
sS'by,different,routes'
p19893
g9
sS'metabolism,in,ms'
p19894
g9
sS'of,herbal,remedies'
p19895
g3
sS'fludara,for,injection'
p19896
g9
sS'alcohol,it,should'
p19897
g9
sS'study,with,and'
p19898
g3
sS'clozapine,is,combined'
p19899
g9
sS'inhibitors,ssris,may'
p19900
g9
sS'such,arrhythmias,may'
p19901
g3
sS'group,of,nonsmoking'
p19902
g3
sS'muscle,was,exposed'
p19903
g3
sS'or,orthostatic,changes'
p19904
g9
sS'in,which,inflammation'
p19905
g3
sS'and,prolonged,the'
p19906
g9
sS'especially,when,therapy'
p19907
g9
sS'a,modest,effect'
p19908
g9
sS'from,alterations,in'
p19909
g3
sS'in,patients,prone'
p19910
g9
sS'or,be,subject'
p19911
g3
sS'and,october,of'
p19912
g3
sS'interactions,with,sustiva'
p19913
g3
sS'of,additive,negative'
p19914
g9
sS'including,gastrointestinal,and'
p19915
g3
sS'digoxin,studies,of'
p19916
g3
sS'should,not,ordinarily'
p19917
g9
sS'concomitantly,careful,monitoring'
p19918
g3
sS'significantly,lowering,their'
p19919
g3
sS'and,editorials,concerning'
p19920
g3
sS'tablet,formulation,comparable'
p19921
g9
sS'intracellular,phosphorylation,of'
p19922
g9
sS'mean,number,of'
p19923
g3
sS'interaction,study,was'
p19924
g3
sS'agents,or,which'
p19925
g9
sS'ng,ml,administered'
p19926
g9
sS'renal,transplant,patients'
p19927
g9
sS'on,pharmacokinetics,if'
p19928
g3
sS'six,hours,following'
p19929
g3
sS'other,nsaids,through'
p19930
g9
sS'cautiously,in,conjunction'
p19931
g9
sS'to,further,doses'
p19932
g3
sS'on,pharmacokinetics,in'
p19933
g3
sS'on,two,strains'
p19934
g3
sS'of,cyp3a4,inhibitors'
p19935
g3
sS'if,systemic,administration'
p19936
g3
sS'and,nuclear,matrix'
p19937
g9
sS'treated,with,an'
p19938
g9
sS'the,treated,animals'
p19939
g3
sS'a,previously,administered'
p19940
g9
sS'be,related,both'
p19941
g3
sS'a,pure,agonist'
p19942
g9
sS'mg,respectively,a'
p19943
g9
sS'topical,products,medicated'
p19944
g3
sS'azole,inhibits,the'
p19945
g9
sS'has,been,proposed'
p19946
g9
sS'anti-inflammatory,nsaids,suggests'
p19947
g9
sS'the,end,fo'
p19948
g3
sS'a,false,low'
p19949
g3
sS'function,have,not'
p19950
g3
sS'left,ventricular,failure'
p19951
g9
sS'turn,out,to'
p19952
g3
sS'absence,of,severe'
p19953
g3
sS'acid,may,interact'
p19954
g9
sS'of,the,broadening'
p19955
g3
sS'combination,hormonal,increasing'
p19956
g9
sS'shown,that,herbal'
p19957
g3
sS'in,the,user'
p19958
g3
sS'pituitary-gonadal,axis,in'
p19959
g3
sS'sickness,medications,muscle'
p19960
g3
sS'alter,the,adverse'
p19961
g3
sS'showed,that,depending'
p19962
g3
sS'medications,especially,central'
p19963
g3
sS'hours,are,recommended'
p19964
g9
sS'interactions,effect,on'
p19965
g3
sS'of,b,for'
p19966
g3
sS'prothrombin,time,has'
p19967
g3
sS'used,alone,because'
p19968
g9
sS'indocin,is,added'
p19969
g9
sS'impairment,reportedly,resulted'
p19970
g9
sS'following,laboratory,tests'
p19971
g3
sS'tolerance,in,dogs'
p19972
g9
sS'coadministration,of,did'
p19973
g3
sS'should,be,cautiously'
p19974
g9
sS'is,a,neutralizing'
p19975
g9
sS'as,imitrex,talk'
p19976
g3
sS'dopamine,antagonists,such'
p19977
g9
sS'the,first,days'
p19978
g3
sS'to,cause,ventricular'
p19979
g9
sS'roegnik,grade,i'
p19980
g3
sS'the,aberrant,and'
p19981
g3
sS'sirolimus-diltiazem,interaction,whole'
p19982
g9
sS'was,shown,that'
p19983
g9
sS'increase,high-density,lipoprotein'
p19984
g3
sS'no,pharmacokinetic-based,drug-drug'
p19985
g3
sS'pulmonary,disease,requires'
p19986
g3
sS'from,working,properly'
p19987
g3
sS'response,duration,suggesting'
p19988
g9
sS'cigarette,smokers,and'
p19989
g3
sS'diagnostic,challenge,and'
p19990
g3
sS'as,this,could'
p19991
g3
sS'ketoconazole,mg,once'
p19992
g9
sS'used,in,older'
p19993
g3
sS'therapy,may,increase'
p19994
g3
sS'doses,of,see'
p19995
g9
sS'changes,were,noted'
p19996
g3
sS'potentiate,the,cognitive'
p19997
g9
sS'to,abnormal,bleeding'
p19998
g3
sS'glibenclamide,in,a'
p19999
g9
sS'amenorrhea,were,observed'
p20000
g3
sS'acute,administration,does'
p20001
g3
sS'liver,disease,and'
p20002
g3
sS'dose,or,any'
p20003
g9
sS'significance,if,any'
p20004
g3
sS'alter,platelet,function'
p20005
g9
sS'other,substances,grapefruit'
p20006
g3
sS'for,pseudomonas,strains'
p20007
g3
sS'appearance,of,a'
p20008
g3
sS'known,microsomal,enzyme'
p20009
g9
sS'of,prophylactic,low'
p20010
g3
sS'rpmi1640,containing,alone'
p20011
g9
sS'therapy,may,be'
p20012
g3
sS'inhibitory,effect,for'
p20013
g9
sS'aprepitant,is,also'
p20014
g3
sS'had,received,days'
p20015
g9
sS'with,hiv-related,systemic'
p20016
g3
sS'about,fold,greater'
p20017
g3
sS'changes,in,prothrombin'
p20018
g3
sS'inhibitors,and,have'
p20019
g9
sS'his,own,pre-'
p20020
g3
sS'results,in,a'
p20021
g9
sS'medical,supervision,after'
p20022
g9
sS'frova,within,hours'
p20023
g9
sS'electron,microscopy,were'
p20024
g3
sS'serentil,trilafon,compazine'
p20025
g3
sS'leading,to,severe'
p20026
g9
sS'or,driving,a'
p20027
g3
sS'of,fludara,for'
p20028
g9
sS'was,controlled,with'
p20029
g9
sS'oxidation,is,the'
p20030
g3
sS'but,not,on'
p20031
g3
sS'amphotericin,b,intravenous'
p20032
g9
sS'such,an,interaction'
p20033
g3
sS'medication,should,not'
p20034
g3
sS'or,consider,hmg-coa'
p20035
g9
sS'to,receive,tablets'
p20036
g3
sS'tolbutamide,in,in'
p20037
g3
sS'important,pharmacokinetic,interactions'
p20038
g3
sS'frequent,laboratory,monitoring'
p20039
g3
sS'doses,which,can'
p20040
g3
sS'oxidase,enzyme,system'
p20041
g3
sS'supports,the,hypothesis'
p20042
g3
sS'although,the,mechanism'
p20043
g9
sS'exposure,of,cefditoren'
p20044
g9
sS'activity,was,enhanced'
p20045
g3
sS'mean,reduction,of'
p20046
g3
sS'alterations,in,hippocampal'
p20047
g3
sS'pressure,usually,within'
p20048
g9
sS'blood,pressure,below'
p20049
g9
sS'mao,inhibitor,talk'
p20050
g3
sS'are,at,an'
p20051
g9
sS'were,and,lower'
p20052
g9
sS'administration,and,patients'
p20053
g3
sS'effect,on,an'
p20054
g3
sS'previous,reports,we'
p20055
g3
sS'types,is,unknown'
p20056
g3
sS'spleen,following,a'
p20057
g3
sS'in,vitro,inhibitor'
p20058
g3
sS'are,being,used'
p20059
g3
sS'and,increase,of'
p20060
g9
sS'presented,of,some'
p20061
g3
sS'toxicity,of,by'
p20062
g9
sS'after,alphagan,p'
p20063
g3
sS'both,agents,should'
p20064
g3
sS'a,a,cyp3a4'
p20065
g9
sS'action,of,alfenta'
p20066
g3
sS'periods,of,active'
p20067
g9
sS'cimetidine,a,study'
p20068
g9
sS'if,co-administration,is'
p20069
g3
sS'without,any,change'
p20070
g3
sS'and,tablets,results'
p20071
g9
sS'observed,and,the'
p20072
g3
sS'agonist,antagonist,may'
p20073
g3
sS'rats,were,fasted'
p20074
g3
sS'nsaid,or,potentiated'
p20075
g9
sS'the,change,in'
p20076
g3
sS'its,synthetic,analogue'
p20077
g3
sS'a,functioning,gland'
p20078
g9
sS'when,it,is'
p20079
g9
sS'the,similarity,of'
p20080
g3
sS'obtained,in,vivo'
p20081
g3
sS'concentration,has,been'
p20082
g9
sS'p450,a4,should'
p20083
g3
sS'digoxin,in,controlled'
p20084
g9
sS'risk,of,dehydration'
p20085
g9
sS'most,who,take'
p20086
g3
sS'doses,of,cefditoren'
p20087
g3
sS'a,marketed,chewable'
p20088
g9
sS'nonabsorbable,complex,between'
p20089
g9
sS'regimen,may,be'
p20090
g3
sS'that,obtained,with'
p20091
g9
sS'inhibitors,of,this'
p20092
g9
sS'agents,some,individuals'
p20093
g9
sS'enhance,the,metabolic'
p20094
g9
sS'oxidase,inhibitors,nalidixic'
p20095
g9
sS'meclofenamate,sodium,enhances'
p20096
g9
sS'selective,peripheral,anitagonism'
p20097
g9
sS'distribution,metabolism,hormone'
p20098
g3
sS'all,the,potential'
p20099
g3
sS'significantly,inhibited,the'
p20100
g9
sS'of,cholino-,and'
p20101
g3
sS'platelet,agents,are'
p20102
g3
sS'reduced,to,maintain'
p20103
g3
sS'lead,to,b-cell'
p20104
g3
sS'every,hours,competes'
p20105
g9
sS'interactions,it,is'
p20106
g3
sS'sufficient,data,to'
p20107
g3
sS'treatment,improves,quality'
p20108
g3
sS'effects,on,immune'
p20109
g3
sS'humans,two,inhibitors'
p20110
g3
sS'hctz,alone,or'
p20111
g3
sS'interact,with,skin'
p20112
g3
sS'within,hours,of'
p20113
g9
sS'these,agents,may'
p20114
g3
sS'and,other,ht1'
p20115
g9
sS'drug,clearance,with'
p20116
g3
sS'in,rats,responding'
p20117
g9
sS'it,may,decrease'
p20118
g3
sS'a,potential,for'
p20119
g3
sS'that,inhibit,this'
p20120
g9
sS'between,and,inducers'
p20121
g9
sS'this,oxidation,which'
p20122
g3
sS'is,metabolized,primarily'
p20123
g3
sS'formal,pharmacokinetic,studies'
p20124
g3
sS'a,mean,template'
p20125
g3
sS'patient,has,recently'
p20126
g9
sS'limited,number,of'
p20127
g3
sS'mesantoin,use,of'
p20128
g3
sS'relevant,inhibitory,effect'
p20129
g3
sS'the,decision,is'
p20130
g3
sS'the,antihypertensive,action'
p20131
g9
sS'life-threatening,reactions,such'
p20132
g3
sS'as,safety,of'
p20133
g3
sS'plasma,exposure,of'
p20134
g9
sS'cannot,be,avoided'
p20135
g3
sS'metabolism,was,tested'
p20136
g3
sS'of,er,extended'
p20137
g3
sS'adjustment,of,either'
p20138
g3
sS'breast,cancer,in'
p20139
g9
sS'toxoids,and,live'
p20140
g9
sS'of,reddish,stools'
p20141
g3
sS'perhaps,other,medications'
p20142
g3
sS'on,steady-state,pharmacokinetics'
p20143
g3
sS'antacids,containing,trisilicate'
p20144
g9
sS'patients,undergoing,ptca'
p20145
g9
sS'levels,and,administration'
p20146
g3
sS'cosmetics,that,have'
p20147
g3
sS'concomitantly,patients,should'
p20148
g9
sS'bioavailability,auc,and'
p20149
g3
sS'population,is,susceptible'
p20150
g3
sS'oil,and,k'
p20151
g9
sS'cyp2d6,isoenzyme,daily'
p20152
g9
sS'of,pcp,for'
p20153
g3
sS'has,been,documented'
p20154
g3
sS'the,polymorphic,p450'
p20155
g3
sS'the,potent,cytochrome'
p20156
g9
sS'administered,with,hexalen'
p20157
g9
sS'altered,for,neurons'
p20158
g3
sS'is,an,interaction'
p20159
g9
sS'been,suggested,with'
p20160
g3
sS'may,produce,electrocardiographic'
p20161
g9
sS'level,of,approximately'
p20162
g3
sS'when,ht1,agonists'
p20163
g9
sS'the,following,table'
p20164
g3
sS'interactions,must,be'
p20165
g9
sS'monitored,for,signs'
p20166
g3
sS'severe,malaria,mefloquine'
p20167
g3
sS'from,treatment,of'
p20168
g3
sS'mg,rat,days'
p20169
g3
sS'assists,in,development'
p20170
g3
sS'rate,but,no'
p20171
g3
sS'products,with,similar'
p20172
g9
sS'been,shown,between'
p20173
g9
sS'everolimus,steady,state'
p20174
g3
sS'nine,patients,with'
p20175
g9
sS'of,profound,hypotension'
p20176
g9
sS'by,the,dependence'
p20177
g3
sS'reported,when,amitriptyline'
p20178
g9
sS'formation,of,a'
p20179
g9
sS'interactions,among,co-administered'
p20180
g3
sS'the,amplitude,data'
p20181
g3
sS'strains,of,escherichia'
p20182
g3
sS'lack,of,correlation'
p20183
g3
sS'administration,to,rachitic'
p20184
g9
sS'potentiation,of,orthostatic'
p20185
g3
sS'the,tysabri,dose'
p20186
g3
sS'pletal,is,extensively'
p20187
g9
sS'interfere,with,chemical'
p20188
g3
sS'of,mixed-function,mono-oxidases'
p20189
g3
sS'interactions,for,include'
p20190
g9
sS'cytochrome,p450,inducers'
p20191
g9
sS'in,man,significantly'
p20192
g9
sS'receiving,concomitant,treatment'
p20193
g3
sS'changes,resulting,from'
p20194
g3
sS'a,supersensitivity,to'
p20195
g9
sS'nevirapine,may,decrease'
p20196
g9
sS'was,not,a'
p20197
g3
sS'significantly,decreased,binding'
p20198
g9
sS'and,enhanced,effects'
p20199
g3
sS'affecting,the,liver'
p20200
g9
sS'nonopioid,tolerant,patients'
p20201
g3
sS'effect,on,phosphate'
p20202
g3
sS'thus,the,interaction'
p20203
g9
sS'of,that,may'
p20204
g9
sS'such,combinations,should'
p20205
g3
sS'use,of,by'
p20206
g9
sS'blockers,calcium-channel,blockers'
p20207
g3
sS'the,characteristics,of'
p20208
g3
sS'anti-inflammatory,nsaids,and'
p20209
g9
sS'bound,drugs,in'
p20210
g3
sS'parametric,dose-response,models'
p20211
g3
sS'placebo-controlled,crossover,study'
p20212
g9
sS'including,based,on'
p20213
g9
sS'which,was,prevented'
p20214
g9
sS'gradual,in,order'
p20215
g9
sS'in,an,decrease'
p20216
g9
sS'enough,to,affect'
p20217
g3
sS'less,than,of'
p20218
g3
sS'by,endothelial,denudation'
p20219
g3
sS'depressant,effects,divalproex'
p20220
g9
sS'nerve,preparations,incubated'
p20221
g3
sS'phosphorylation,in,t24'
p20222
g9
sS'be,delayed,at'
p20223
g3
sS'lead,to,higher'
p20224
g3
sS'combination,with,triamterene'
p20225
g3
sS'varapamil,and,sodium'
p20226
g3
sS'studies,it,is'
p20227
g3
sS'acute,and,repeated'
p20228
g3
sS'do,not,suffer'
p20229
g3
sS'proteins,at,c'
p20230
g3
sS'a,more,rapid'
p20231
g3
sS'sodium,and,may'
p20232
g9
sS'theophylline,following,co-administration'
p20233
g3
sS'rats,probably,due'
p20234
g3
sS'enhance,the,action'
p20235
g9
sS'to,improve,this'
p20236
g3
sS'to,affect,cardiac'
p20237
g3
sS'needed,when,and'
p20238
g3
sS'the,individual,case'
p20239
g3
sS'sodium,thiosulfate,is'
p20240
g9
sS'conducted,with,persantine'
p20241
g3
sS'nine,additional,patients'
p20242
g3
sS'the,medication,authorization'
p20243
g3
sS'granulomata,subacute,hepatitis'
p20244
g3
sS'additional,method,of'
p20245
g3
sS'the,renal,and'
p20246
g3
sS'of,metabolism,decreased'
p20247
g9
sS'in,controlled,clinical'
p20248
g3
sS'the,contribution,of'
p20249
g3
sS'these,were,not'
p20250
g3
sS'the,inulin,method'
p20251
g3
sS'indicates,that,a'
p20252
g3
sS'reductase,inhibitor,to'
p20253
g3
sS'coadministered,with,caution'
p20254
g3
sS'monitoring,of,pancreatitis'
p20255
g3
sS'using,anafranil,in'
p20256
g3
sS'of,by,concomitant'
p20257
g9
sS'cellulitis,induration,skin'
p20258
g3
sS'information,digoxin,studies'
p20259
g3
sS'mental,and,motor'
p20260
g3
sS'consequences,for,drugs'
p20261
g9
sS'may,slow,gastric'
p20262
g3
sS'similarly,the,effects'
p20263
g9
sS'a,balanced,technique'
p20264
g3
sS'severe,obstipation,even'
p20265
g9
sS'of,multiple,doses'
p20266
g3
sS'significant,abnormal,laboratory'
p20267
g3
sS'the,estimated,number'
p20268
g3
sS'time,of,were'
p20269
g3
sS'bid,otc,dose'
p20270
g9
sS'treatment,for,weeks'
p20271
g3
sS'transcriptase,inhibitor,nnrti'
p20272
g3
sS'joint,dose-response,curves'
p20273
g3
sS'of,the,population'
p20274
g3
sS'of,humans,and'
p20275
g3
sS'as,an,agent'
p20276
g3
sS'may,cause,adrenal'
p20277
g9
sS'rises,in,serum'
p20278
g9
sS'compared,with,a'
p20279
g9
sS'are,also,regulated'
p20280
g3
sS'interindividual,pharmacokinetic,variability'
p20281
g3
sS'strong,inducers,of'
p20282
g3
sS'formal,studies,fully'
p20283
g3
sS'endotoxin-induced,changes,in'
p20284
g3
sS'auc,of,sustained-release'
p20285
g9
sS'changed,the,same'
p20286
g3
sS'as,to,provide'
p20287
g3
sS'accutane,has,not'
p20288
g3
sS'on,absorption,from'
p20289
g3
sS'not,impaired,but'
p20290
g3
sS'of,most,evoked'
p20291
g3
sS'in,adverse,events'
p20292
g3
sS'administration,of,these'
p20293
g3
sS'efficacy,data,available'
p20294
g3
sS'blood,levels,in'
p20295
g3
sS'and,requiring,increased'
p20296
g9
sS'about,two,studies'
p20297
g9
sS'characterization,or,by'
p20298
g3
sS'plasma,and,reduction'
p20299
g9
sS'lactating,dams,was'
p20300
g3
sS'determining,synergism,with'
p20301
g3
sS'reduction,in,renal'
p20302
g9
sS'that,are,also'
p20303
g3
sS'assay,system,of'
p20304
g3
sS'with,without,evidence'
p20305
g3
sS'of,the,mucocutaneous'
p20306
g3
sS'positive,test,for'
p20307
g3
sS'in,two,sequential'
p20308
g3
sS'the,introductory,chapter'
p20309
g3
sS'in,antiapoptotic,effect'
p20310
g3
sS'have,some,of'
p20311
g3
sS'increases,in,peak'
p20312
g9
sS'sinus,medicines,diabetic'
p20313
g9
sS'are,available,regarding'
p20314
g3
sS'different,days,for'
p20315
g3
sS'and,cmax,by'
p20316
g9
sS'and,progression,of'
p20317
g3
sS'mg,dose,achieves'
p20318
g3
sS'with,plendil,the'
p20319
g3
sS'm,parenteral,should'
p20320
g9
sS'antiretroviral,agents,no'
p20321
g3
sS'at,receptors,such'
p20322
g9
sS'barbiturates,and,should'
p20323
g9
sS'insertable,hormonal,birth'
p20324
g3
sS'psychiatric,patients,and'
p20325
g9
sS'organic,l-arginine,supplements'
p20326
g9
sS'involved,the,administration'
p20327
g3
sS'it,may,be'
p20328
g3
sS'density,in,functional'
p20329
g3
sS'with,humira,has'
p20330
g3
sS'stimulant,action,on'
p20331
g3
sS'to,be,terminated'
p20332
g9
sS'may,be,potential'
p20333
g3
sS'dosage,is,required'
p20334
g3
sS'a,function,of'
p20335
g3
sS'wellbutrin,should,be'
p20336
g9
sS'a,ki,of'
p20337
g3
sS'a,higher,cardiac'
p20338
g9
sS'of,buspirone,hcl'
p20339
g9
sS'affect,any,of'
p20340
g3
sS'a,high,oral'
p20341
g3
sS'of,aerosolized,has'
p20342
g3
sS'rash,has,been'
p20343
g9
sS'foscavir,and,intravenous'
p20344
g9
sS'trough,plasma,concentrations'
p20345
g3
sS'effect,caution,should'
p20346
g9
sS'p450,enzymes,evaluated'
p20347
g3
sS'dinitrate,may,be'
p20348
g9
sS'n,later,changed'
p20349
g3
sS'and,mc,enhance'
p20350
g3
sS'is,such,a'
p20351
g3
sS'sterol,in,human'
p20352
g3
sS'such,information,assists'
p20353
g3
sS'of,combined,therapy'
p20354
g9
sS'the,development,of'
p20355
g3
sS'not,exhibit,binding'
p20356
g3
sS'level,of,ergocalcitriol'
p20357
g3
sS'the,antidepressant,class'
p20358
g3
sS'supine,position,and'
p20359
g3
sS'when,possible,and'
p20360
g9
sS'agent,that,decreases'
p20361
g3
sS'this,the,dosage'
p20362
g3
sS'the,sirolimus-diltiazem,interaction'
p20363
g9
sS'developed,rash,while'
p20364
g9
sS'and,dry,mouth'
p20365
g3
sS'hydroxytamoxifen,tam,which'
p20366
g3
sS'agents,having,vasodilator'
p20367
g3
sS'in,conditions,for'
p20368
g3
sS'patients,guardians,should'
p20369
g3
sS'level,of,was'
p20370
g9
sS'assay,appears,to'
p20371
g3
sS'choose,particular,low'
p20372
g3
sS'trial,in,which'
p20373
g3
sS'which,the,rate'
p20374
g3
sS'myobloc,and,or'
p20375
g9
sS'of,g,of'
p20376
g9
sS'pharmacokinetic-pharmacodynamic,relationship,measurement'
p20377
g3
sS'reserved,for,patients'
p20378
g3
sS'damage,when,tested'
p20379
g3
sS'in,females,dosed'
p20380
g3
sS'uptake,inhibitors,and'
p20381
g9
sS'circulating,concentrations,and'
p20382
g3
sS'colonic,fluid,by'
p20383
g3
sS'the,applied,to'
p20384
g3
sS'and,prothrombin,time'
p20385
g3
sS'drug-drug,interaction,with'
p20386
g3
sS'by,concurrent,dosing'
p20387
g3
sS'orally,administered,agents'
p20388
g9
sS'of,reports,of'
p20389
g9
sS'healthy,subjects,mean'
p20390
g9
sS'possibility,of,antagonism'
p20391
g3
sS'of,growth,caused'
p20392
g3
sS'zollinger-ellison,ze,patients'
p20393
g3
sS'that,inhibits,cyp2d6'
p20394
g3
sS'muscle,relaxants,in'
p20395
g3
sS'is,a,minor'
p20396
g3
sS'coadministration,of,baraclude'
p20397
g3
sS'prescription,and,nonprescription'
p20398
g3
sS'that,can,prolong'
p20399
g9
sS'well,as,in'
p20400
g3
sS'the,genotypes,of'
p20401
g3
sS'of,normal,subjects'
p20402
g9
sS'use,of,tricyclic'
p20403
g3
sS'of,hydrobromide,may'
p20404
g9
sS'significantly,in,either'
p20405
g3
sS'c-cholesterol,ester,fractional'
p20406
g3
sS'and,one,strain'
p20407
g3
sS'be,performed,with'
p20408
g9
sS'compulsion,loss,of'
p20409
g3
sS'avoided,by,patients'
p20410
g9
sS'co-administration,is,essential'
p20411
g3
sS'therefore,may,interfere'
p20412
g9
sS'substantially,increased,following'
p20413
g9
sS'kg,twice,a'
p20414
g3
sS'a,chronic,toxicity'
p20415
g3
sS'both,agents,with'
p20416
g9
sS'for,which,the'
p20417
g3
sS'such,as,nausea'
p20418
g3
sS'bone,marrow,megakaryocytes'
p20419
g3
sS'levels,then,remained'
p20420
g3
sS'properties,relative,to'
p20421
g3
sS'difference,was,found'
p20422
g3
sS'increases,the,serum'
p20423
g3
sS'hivid,and,zdv'
p20424
g3
sS'tumors,is,consistent'
p20425
g3
sS'and,the,behaviour'
p20426
g3
sS'of,was,observed'
p20427
g9
sS'concentrations,within,the'
p20428
g3
sS'with,acamprosate,produced'
p20429
g9
sS'its,derivatives,or'
p20430
g9
sS'upper,limit,of'
p20431
g3
sS'uptake,producing,low'
p20432
g3
sS'major,ingredient,of'
p20433
g3
sS'therapeutic,action,of'
p20434
g9
sS'whether,the,are'
p20435
g3
sS'in,the,neuronal'
p20436
g3
sS'present,as,vertigo'
p20437
g9
sS'all,in,other'
p20438
g3
sS'suppression,of,gastric'
p20439
g9
sS'symptoms,of,withdrawal'
p20440
g9
sS'than,weeks,may'
p20441
g9
sS'patient,in,how'
p20442
g3
sS'the,mean,values'
p20443
g3
sS'received,chop-haart,compared'
p20444
g3
sS'were,not,excluded'
p20445
g3
sS'treat,an,overactive'
p20446
g3
sS'elixir,was,administered'
p20447
g3
sS'can,inhibit,cytochrome'
p20448
g3
sS'are,required,during'
p20449
g9
sS'when,mg,was'
p20450
g9
sS'count,is,at'
p20451
g3
sS'pentobarbital-induced,sedation,times'
p20452
g3
sS'showed,a,reduction'
p20453
g9
sS'however,because,higher'
p20454
g3
sS'and,fatal,convulsions'
p20455
g9
sS'that,after,the'
p20456
g3
sS'modulation,of,cholinergic'
p20457
g3
sS'given,several,months'
p20458
g3
sS'the,bumetanide-induced,increase'
p20459
g9
sS'tablets,the,including'
p20460
g9
sS'may,increase,metabolism'
p20461
g3
sS'show,a,significant'
p20462
g3
sS'minimise,the,risks'
p20463
g3
sS'not,to,start'
p20464
g3
sS'platelets,and,regulates'
p20465
g3
sS'and,vanillylmandelic,acid'
p20466
g3
sS'bepridil,and,beta-blocking'
p20467
g3
sS'of,beta-adrenergic,antagonists'
p20468
g9
sS'some,patients,by'
p20469
g9
sS'in,areas,where'
p20470
g3
sS'of,an,hydroxide'
p20471
g9
sS'agents,or,radiation'
p20472
g3
sS'patients,receiving,such'
p20473
g3
sS'in,the,median'
p20474
g9
sS'protocol,for,a'
p20475
g3
sS'although,ipratropium,bromide'
p20476
g9
sS'activation,of,arc'
p20477
g3
sS'such,as,videx'
p20478
g9
sS'been,found,with'
p20479
g3
sS'is,thus,an'
p20480
g9
sS'dosage,of,may'
p20481
g9
sS'a,tolerance,to'
p20482
g9
sS'day,provided,significant'
p20483
g9
sS'gastric,acidity,duloxetine'
p20484
g3
sS'm,m,of'
p20485
g3
sS'mg,kg,removes'
p20486
g9
sS'which,increase,the'
p20487
g9
sS'be,avoided,see'
p20488
g9
sS'patients,who,begin'
p20489
g9
sS'to,maintain,pregnancy'
p20490
g3
sS'is,unaltered,impaired'
p20491
g3
sS'of,seizures,in'
p20492
g9
sS'manner,similar,to'
p20493
g3
sS'concentrations,by,as'
p20494
g9
sS'involving,alprazolam,caution'
p20495
g9
sS'effects,of,were'
p20496
g9
sS'dosing,concurrently,with'
p20497
g3
sS'prolactin,secretion,and'
p20498
g3
sS'caution,and,with'
p20499
g3
sS'treated,for,months'
p20500
g3
sS'ability,to,affect'
p20501
g3
sS'no,discernible,changes'
p20502
g3
sS'while,taking,aminosalicylic'
p20503
g9
sS'milk,secretion,by'
p20504
g3
sS'coombs,tests,have'
p20505
g3
sS'or,similar,agents'
p20506
g9
sS'experience,with,co-administration'
p20507
g9
sS'within,the,range'
p20508
g3
sS'l-tryptophan,may,increase'
p20509
g3
sS'induce,cyp3a,may'
p20510
g3
sS'vivo,the,plasma'
p20511
g9
sS'been,no,chemical'
p20512
g3
sS'results,have,been'
p20513
g3
sS'of,to,plasma'
p20514
g9
sS'pig,small,intestinal'
p20515
g3
sS'subjects,the,steady-state'
p20516
g3
sS'of,lean,and'
p20517
g3
sS'times,when,administered'
p20518
g3
sS'and,these,patients'
p20519
g3
sS'the,first,study'
p20520
g9
sS'multivitamins,quinolones,form'
p20521
g3
sS'rifampin,when,a'
p20522
g9
sS'as,compared,with'
p20523
g9
sS'hydatid,cyst,patients'
p20524
g9
sS'explanation,for,the'
p20525
g3
sS'including,myocardial,infarction'
p20526
g9
sS'no,substantive,effect'
p20527
g3
sS'increase,in,cyclosporine-induced'
p20528
g9
sS'mixed,with,any'
p20529
g3
sS'generally,good,with'
p20530
g3
sS'incoordination,hyperthermia,shivering'
p20531
g3
sS'observed,closely,particularly'
p20532
g3
sS'changes,in,inr'
p20533
g3
sS'to,environmental,may'
p20534
g9
sS'taxol,to,such'
p20535
g3
sS'rats,at,intramuscular'
p20536
g3
sS'was,lower,than'
p20537
g9
sS'medroxyprogesterone,acetate,l-histidine'
p20538
g9
sS'further,antihypertensive,effect'
p20539
g9
sS'ganoderma,lucidum,extract'
p20540
g3
sS'nucleotide,release,and'
p20541
g3
sS'actions,certain,narcotic'
p20542
g9
sS'administered,hours,prior'
p20543
g9
sS'blocking,agents,calcium-channel'
p20544
g3
sS'such,as,mg'
p20545
g3
sS'even,if,an'
p20546
g3
sS'because,is,primarily'
p20547
g3
sS'generally,be,given'
p20548
g3
sS'event,of,relevant'
p20549
g3
sS'referred,to,as'
p20550
g3
sS'and,complexes,thereof'
p20551
g3
sS'assist,the,clinician'
p20552
g3
sS'is,comparable,to'
p20553
g3
sS'fluconazole,fluoxetine,indanavir'
p20554
g3
sS'daily,activities,such'
p20555
g3
sS'of,that,induce'
p20556
g3
sS'b23,is,involved'
p20557
g3
sS'recall,reaction,at'
p20558
g3
sS'that,inhibited,high'
p20559
g3
sS'pharmacokinetics,and,or'
p20560
g3
sS'alternatives,to,as'
p20561
g9
sS'synthesis,to,match'
p20562
g3
sS'may,decrease,renal'
p20563
g9
sS'alcohol,there,was'
p20564
g3
sS'in,serum,and'
p20565
g9
sS'that,is,primarily'
p20566
g3
sS'the,safety,of'
p20567
g3
sS'or,impairing,its'
p20568
g9
sS'possibility,of,gastrointestinal'
p20569
g9
sS'incubation,at,degrees'
p20570
g3
sS'evidence,of,any'
p20571
g3
sS'response,to,factrel'
p20572
g9
sS'mg,kg,twice'
p20573
g3
sS'predisposition,for,glucose'
p20574
g3
sS'drugs,within,class'
p20575
g3
sS'indicate,that,m'
p20576
g3
sS'however,no,adverse'
p20577
g3
sS'periodically,in,patients'
p20578
g3
sS'the,safety,or'
p20579
g3
sS'administered,as,stadol'
p20580
g3
sS'or,suspected,to'
p20581
g3
sS'indicate,that,a'
p20582
g3
sS'levels,when,the'
p20583
g3
sS'to,occur,with'
p20584
g3
sS'elderly,basic,science'
p20585
g3
sS'indicate,that,elspar'
p20586
g9
sS'that,in,addition'
p20587
g9
sS'taking,metabolized,by'
p20588
g3
sS'and,volunteers,n'
p20589
g9
sS'receptor,antagonists,congestive'
p20590
g3
sS'the,fraction,containing'
p20591
g3
sS'raptiva,should,not'
p20592
g9
sS'was,discontinued,and'
p20593
g3
sS'study,patients,receiving'
p20594
g3
sS'which,induce,cyp3a4'
p20595
g9
sS'coadministration,may,lead'
p20596
g3
sS'aspirin,animal,studies'
p20597
g9
sS'or,the,hyperuricemia'
p20598
g9
sS'study,who,were'
p20599
g9
sS'extensively,metabolized,in'
p20600
g3
sS'on,clinical,evaluation'
p20601
g3
sS'with,and,in'
p20602
g3
sS'been,observed,during'
p20603
g3
sS'with,and,it'
p20604
g9
sS'of,mg,kg'
p20605
g3
sS'with,and,is'
p20606
g9
sS'kytril,have,all'
p20607
g3
sS'of,the,beta-adrenergic'
p20608
g9
sS'in,the,rat'
p20609
g9
sS'inhibitory,interactions,because'
p20610
g3
sS'diet,did,not'
p20611
g3
sS'substrates,known,to'
p20612
g9
sS'with,arimidex,as'
p20613
g9
sS'to,highintersubject,variability'
p20614
g3
sS'were,elevated,with'
p20615
g3
sS'with,the,implication'
p20616
g9
sS'renal,function,who'
p20617
g9
sS'given,without,the'
p20618
g3
sS'and,in,clinical'
p20619
g9
sS'when,orudis,doses'
p20620
g3
sS'and,or,anticoagulation'
p20621
g3
sS'discussed,especially,with'
p20622
g3
sS'and,requires,close'
p20623
g9
sS'by,prothrombin,time'
p20624
g3
sS'that,interactions,between'
p20625
g3
sS'hepatic,enzymes,such'
p20626
g9
sS'difluoro-2,propanol,was'
p20627
g3
sS'is,limited,experience'
p20628
g3
sS'to,be,provided'
p20629
g3
sS'and,cmax,were'
p20630
g3
sS'administration,of,high'
p20631
g3
sS'ng,ml,with'
p20632
g9
sS'studies,and,time'
p20633
g9
sS'acid,sympathomimet-ics,channel'
p20634
g3
sS'muscle,relaxant,antagonists'
p20635
g3
sS'in,spite,of'
p20636
g3
sS'both,the,oral'
p20637
g9
sS'indocin,given,concomitantly'
p20638
g9
sS'contraceptive,based,on'
p20639
g3
sS'behavior,in,normal'
p20640
g3
sS'done,with,a'
p20641
g3
sS'drug-drug,interaction,was'
p20642
g3
sS'effects,reported,with'
p20643
g3
sS'aminoglutethimide,may,increase'
p20644
g9
sS'caution,because,the'
p20645
g9
sS'b,or,the'
p20646
g3
sS'prescribing,for,older'
p20647
g3
sS'if,prosom,is'
p20648
g3
sS'the,first,post-transplant'
p20649
g3
sS'with,kineret,and'
p20650
g9
sS'dosage,reduction,of'
p20651
g3
sS'inhibit,the,activity'
p20652
g3
sS'in,the,cmax'
p20653
g3
sS'clearance,in,a'
p20654
g9
sS'unprotected,sexual,intercourse'
p20655
g3
sS'considered,to,have'
p20656
g3
sS'effect,of,such'
p20657
g9
sS'or,potentially,result'
p20658
g9
sS'range,of,medications'
p20659
g3
sS'that,prolongs,the'
p20660
g9
sS'is,essential,close'
p20661
g3
sS'one-fourth,of,the'
p20662
g9
sS'then,the,effects'
p20663
g3
sS'to,half,the'
p20664
g9
sS'sulfoxide,by,about'
p20665
g9
sS'intestinal,transits,or'
p20666
g3
sS'tumor,that,results'
p20667
g3
sS'resulting,in,decreased'
p20668
g9
sS'to,maximizing,therapy'
p20669
g3
sS'may,decrease,plasma'
p20670
g3
sS'strongyloidiasis,during,the'
p20671
g9
sS'also,regulated,by'
p20672
g3
sS'effectiveness,of,oral'
p20673
g9
sS'human,bladder,cancer'
p20674
g3
sS'rarely,with,hemodynamic'
p20675
g9
sS'of,learning,and'
p20676
g3
sS'may,cause,synergistic'
p20677
g9
sS'are,suddenly,exceeded'
p20678
g3
sS'correct,the,anemia'
p20679
g3
sS'stabilized,on,oral'
p20680
g9
sS'situation,and,in'
p20681
g3
sS'daily,as,compared'
p20682
g9
sS'gentamycin,reduced,twitch'
p20683
g3
sS'populations,the,concomitant'
p20684
g9
sS'and,calcidiol,cholestyramine'
p20685
g9
sS'and,digestive,enzyme'
p20686
g9
sS'that,increased,the'
p20687
g9
sS'with,uricosuric,agents'
p20688
g3
sS'competing,for,the'
p20689
g9
sS'lesions,as,a'
p20690
g9
sS'studies,on,concomitant'
p20691
g3
sS'route,they,should'
p20692
g9
sS'and,patients,observed'
p20693
g3
sS'patient,was,started'
p20694
g3
sS'either,h2,antagonist'
p20695
g3
sS'action,of,are'
p20696
g3
sS'injection,of,pipracil'
p20697
g9
sS'ii,antagonists,increased'
p20698
g9
sS'specifically,been,described'
p20699
g3
sS'and,magnesium-containing,meq'
p20700
g3
sS'polyfuranoses,with,the'
p20701
g3
sS'antiviral,activity,of'
p20702
g9
sS'relaxants,is,augmented'
p20703
g3
sS'ph,in,human'
p20704
g3
sS'of,these,should'
p20705
g9
sS'mg,tid,no'
p20706
g3
sS'intravenously,over,three'
p20707
g3
sS'some,instances,resulted'
p20708
g9
sS'related,ethacrynic,acid'
p20709
g3
sS'medicine,without,doctor'
p20710
g3
sS'operating,dangerous,machinery'
p20711
g3
sS'and,a,decrease'
p20712
g9
sS'your,doctor,and'
p20713
g3
sS'that,functional,coupling'
p20714
g3
sS'physiological,tolerance,allowing'
p20715
g3
sS'antiparkinsonian,agents,particularly'
p20716
g9
sS'of,or,mg'
p20717
g3
sS'dose,of,elixir'
p20718
g3
sS'those,receiving,tablets'
p20719
g3
sS'together,these,results'
p20720
g3
sS'was,used,concurrently'
p20721
g3
sS'cimetidine,treatment,should'
p20722
g9
sS'a,potential,twofold'
p20723
g9
sS'the,inr,was'
p20724
g3
sS'in,the,nonfailing'
p20725
g3
sS'or,near,mg'
p20726
g9
sS'clearly,show,that'
p20727
g3
sS'minimizing,the,risk'
p20728
g3
sS'beginning,of,the'
p20729
g3
sS'boric,acid,may'
p20730
g9
sS'of,a,daily'
p20731
g9
sS'are,considerably,lower'
p20732
g3
sS'synthesis,of,cyp3a4'
p20733
g3
sS'been,done,it'
p20734
g3
sS'in,establishing,the'
p20735
g3
sS'increased,risk,relative'
p20736
g3
sS'did,not,extend'
p20737
g3
sS'and,can,increase'
p20738
g9
sS'kg,of,metabolite'
p20739
g3
sS'of,may,antagonize'
p20740
g9
sS'and,these,medicines'
p20741
g3
sS'prolonged,by,since'
p20742
g9
sS'and,discrete,responses'
p20743
g3
sS'that,such,doses'
p20744
g3
sS'enhance,the,risk'
p20745
g3
sS'and,disorder,and'
p20746
g3
sS'doses,or,reduced'
p20747
g9
sS'of,other,taken'
p20748
g9
sS'conclusions,in,contrast'
p20749
g3
sS'regimens,lower,tablet'
p20750
g3
sS'potentially,lead,to'
p20751
g3
sS'greater,for,pseudomonas'
p20752
g3
sS'their,pharmacological,actions'
p20753
g3
sS'results,indicate,important'
p20754
g3
sS'oral,therapies,for'
p20755
g3
sS'm,markedly,increased'
p20756
g9
sS'near,mg,dl'
p20757
g9
sS'with,healthy,male'
p20758
g3
sS'has,been,concern'
p20759
g9
sS'decrease,in,effectiveness'
p20760
g9
sS'therefore,when,hydrochlorothiazide'
p20761
g9
sS'health,care,providers'
p20762
g3
sS'such,as,thorazine'
p20763
g3
sS'times,daily,to'
p20764
g3
sS'the,purpose,of'
p20765
g3
sS'may,each,be'
p20766
g9
sS'pegasys,did,not'
p20767
g3
sS'due,to,transport-related'
p20768
g9
sS'drug-metabolizing,enzymes,inducers'
p20769
g3
sS'body,by,the'
p20770
g3
sS'green,as,an'
p20771
g3
sS'antagonized,by,beta-adrenergic'
p20772
g9
sS'not,only,block'
p20773
g9
sS'duloxetine,is,a'
p20774
g3
sS'study,indicates,that'
p20775
g3
sS'the,kidney,by'
p20776
g3
sS'acetylsalicylic,acid,sali-cylates'
p20777
g3
sS'significantly,reduce,and'
p20778
g3
sS'of,administered,orally'
p20779
g3
sS'in,tumor,cells'
p20780
g3
sS'reduce,plasma,clearance'
p20781
g3
sS'and,secondary,enzymes'
p20782
g9
sS'in,divided,doses'
p20783
g3
sS'subnormal,release,and'
p20784
g3
sS'a,major,pathophysiologic'
p20785
g3
sS'retention,was,calculated'
p20786
g3
sS'systemic,corticosteroids,systemic'
p20787
g3
sS'prescribers,should,also'
p20788
g3
sS'depression,stupor,and'
p20789
g9
sS'alone,they,modify'
p20790
g9
sS'mg,every,hours'
p20791
g9
sS'currents,in,a'
p20792
g3
sS'when,hypothyroid,patients'
p20793
g3
sS'may,be,associated'
p20794
g3
sS'q12h,for,days'
p20795
g9
sS'it,is,unknown'
p20796
g3
sS'concentration,and,auc'
p20797
g9
sS'cyp2c9,and,cyp3a4'
p20798
g3
sS'auc,and,of'
p20799
g9
sS'induce,a,subgroup'
p20800
g3
sS'advisable,to,administer'
p20801
g9
sS'therapeutic,value,of'
p20802
g3
sS'stimulation,is,critical'
p20803
g3
sS'the,systemic,administration'
p20804
g9
sS'cytochalasin,d,at'
p20805
g9
sS'against,the,positive'
p20806
g3
sS'or,was,administered'
p20807
g3
sS'in,patients,requiring'
p20808
g3
sS'week,following,mating'
p20809
g3
sS'regularly,results,in'
p20810
g3
sS'may,alter,hormone'
p20811
g3
sS'in,levels,with'
p20812
g9
sS'either,mg,or'
p20813
g3
sS'concentrations,include,vaiproic'
p20814
g9
sS'l,from,on'
p20815
g9
sS'in,a,year'
p20816
g3
sS'monitored,after,tracleer'
p20817
g9
sS'by,the,nonlinear'
p20818
g3
sS'concomitant,medications,may'
p20819
g3
sS'intervals,until,stable'
p20820
g3
sS'during,which,blood'
p20821
g3
sS'but,an,active'
p20822
g3
sS'increased,when,and'
p20823
g9
sS'exposure,in,the'
p20824
g3
sS'cause,a,severe'
p20825
g9
sS'levonorgestrol,oral,product'
p20826
g3
sS'mg,four,times'
p20827
g3
sS'nifedipine,vardenafil,mg'
p20828
g3
sS'concentrations,did,not'
p20829
g3
sS'of,binding,thiazide'
p20830
g9
sS'no,clinical,drug-drug'
p20831
g3
sS'decreased,increased,dosages'
p20832
g9
sS'both,of,these'
p20833
g3
sS'part,to,mechanisms'
p20834
g9
sS'were,also,assessed'
p20835
g3
sS'isoenzymes,may,increase'
p20836
g3
sS'of,and,did'
p20837
g3
sS'diabetic,chinese,hamsters'
p20838
g3
sS'hemiballismus,hyperreflexia,ataxia'
p20839
g3
sS'reduce,the,clearance'
p20840
g9
sS'result,in,decreases'
p20841
g3
sS'factors,may,interact'
p20842
g3
sS'the,sleeping,sickness'
p20843
g3
sS'alter,cardiac,conduction'
p20844
g9
sS'is,also,an'
p20845
g3
sS'precaution,should,be'
p20846
g3
sS'addition,fondaparinux,neither'
p20847
g3
sS'prinivil,can,be'
p20848
g9
sS'the,effect,was'
p20849
g3
sS'for,h,this'
p20850
g3
sS'result,in,decreased'
p20851
g9
sS'capsules,with,the'
p20852
g3
sS'ibuprofen,produced,an'
p20853
g9
sS'what,to,do'
p20854
g3
sS'it,is,believed'
p20855
g9
sS'concomitantly,plasma,levels'
p20856
g3
sS'showed,that,is'
p20857
g3
sS'by,coadministration,of'
p20858
g9
sS'ugt,enzymes,in'
p20859
g3
sS'screening,patients,suspected'
p20860
g3
sS'oxidation,responsible,for'
p20861
g9
sS'alone,at,a'
p20862
g3
sS'adequate,evidence,on'
p20863
g3
sS'but,not,at'
p20864
g3
sS'mg,daily,may'
p20865
g9
sS'resulted,in,erythro-fluorocitrate'
p20866
g3
sS'identical,and,release'
p20867
g3
sS'cardiac,and,coronary'
p20868
g3
sS'elevation,in,liver'
p20869
g9
sS'of,the,pharmacokinetics'
p20870
g3
sS'enzymes,the,interaction'
p20871
g9
sS'a,diabetic,patient'
p20872
g9
sS'and,reliable,affinity'
p20873
g3
sS'by,in,males'
p20874
g9
sS'maintenance,dosing,lower'
p20875
g9
sS'may,produce,a'
p20876
g3
sS'or,was,delayed'
p20877
g3
sS'or,minus,in'
p20878
g9
sS'blood,pressure,caution'
p20879
g9
sS'be,done,extremely'
p20880
g9
sS'maximum,concentration,cmax'
p20881
g3
sS'hot,kidney,on'
p20882
g3
sS'agents,particularly,the'
p20883
g9
sS'fortified,with,elemental'
p20884
g3
sS'the,condition,corrected'
p20885
g3
sS'soriatane,therapy,at'
p20886
g3
sS'of,h2,blockers'
p20887
g9
sS'assay,of,thio'
p20888
g3
sS'orally,ingested,or'
p20889
g3
sS'either,and,the'
p20890
g9
sS'once,daily,with'
p20891
g3
sS'of,these,cyp3a4'
p20892
g9
sS'the,medial,survival'
p20893
g3
sS'abstracts,using,the'
p20894
g3
sS'of,and,inhibitors'
p20895
g3
sS'low,initial,dosing'
p20896
g3
sS'of,several,species'
p20897
g3
sS'use,of,creams'
p20898
g3
sS'acid,oxolinic,acid'
p20899
g9
sS'absorption,decreases,gastrointestinal'
p20900
g9
sS'and,no,dose'
p20901
g3
sS'recommended,that,these'
p20902
g3
sS'to,pressor,amines'
p20903
g3
sS'least,seven,days'
p20904
g3
sS'taking,any,prescription'
p20905
g3
sS'general,have,additive'
p20906
g9
sS'repeat,treatment,studies'
p20907
g3
sS'and,were,indifferent'
p20908
g9
sS'advised,against,taking'
p20909
g9
sS'infusions,of,activase'
p20910
g3
sS'myocardial,injury,including'
p20911
g9
sS'magnitude,of,these'
p20912
g3
sS'package,insert,of'
p20913
g3
sS'of,mg,capsules'
p20914
g9
sS'benedicts,solution,fehlings'
p20915
g3
sS'other,injectable,produces'
p20916
g9
sS'ingredient,of,the'
p20917
g3
sS'resulted,in,the'
p20918
g3
sS'alter,the,mean'
p20919
g3
sS'and,decreased,with'
p20920
g9
sS'at,exposure,levels'
p20921
g3
sS'thus,patients,should'
p20922
g3
sS'affinity,chromatography,procedure'
p20923
g3
sS'at,total,drug'
p20924
g3
sS'failure,post-myocardial,infarction'
p20925
g3
sS'been,proposed,that'
p20926
g9
sS'although,administered,at'
p20927
g3
sS'risk,for,loss'
p20928
g3
sS'the,experience,gained'
p20929
g3
sS'kidney,and,the'
p20930
g3
sS'advised,in,the'
p20931
g9
sS'of,neuronal,uptake'
p20932
g3
sS'sst,mice,showed'
p20933
g3
sS'have,allergic,or'
p20934
g3
sS'in,ra,clinical'
p20935
g3
sS'of,other,neurotoxic'
p20936
g3
sS'to,induce,cyp'
p20937
g3
sS'administration,of,vitamin'
p20938
g9
sS'with,other,by'
p20939
g3
sS'at,and,hours'
p20940
g3
sS'serotonergic,effects,of'
p20941
g9
sS'dose,to,achieve'
p20942
g9
sS'pivoxil,resulted,in'
p20943
g9
sS'itraconazole,with,oral'
p20944
g9
sS'effects,administered,concurrently'
p20945
g3
sS'measured,by,plate'
p20946
g3
sS'antiepileptic,effect,of'
p20947
g9
sS'in,a,significant'
p20948
g9
sS'the,authors,investigated'
p20949
g3
sS'of,use,at'
p20950
g3
sS'forms,of,memory'
p20951
g3
sS'and,or,has'
p20952
g9
sS'recent,case,study'
p20953
g9
sS'congenital,or,acquired'
p20954
g3
sS'of,tablets,containing'
p20955
g3
sS'clinical,studies,were'
p20956
g3
sS'survival,of,chop'
p20957
g3
sS'maoi,could,theoretically'
p20958
g9
sS'demonstrated,widespread,effects'
p20959
g3
sS'or,chronic,administration'
p20960
g3
sS'due,to,their'
p20961
g9
sS'of,body,weight'
p20962
g3
sS'clinically,significant,fluctuations'
p20963
g9
sS'treatment,with,derivatives'
p20964
g3
sS'of,at,therapeutic'
p20965
g3
sS'actions,and,the'
p20966
g3
sS'of,on,milk'
p20967
g3
sS'by,the,jaffe'
p20968
g3
sS'with,lowered,the'
p20969
g9
sS'may,have,higher'
p20970
g3
sS'vitro,studies,with'
p20971
g3
sS'very,rapidly,to'
p20972
g3
sS'other,primarily,being'
p20973
g3
sS'cns,stimulation,is'
p20974
g9
sS'treated,with,pcp'
p20975
g3
sS'limited,data,in'
p20976
g9
sS'treat,anxiety,associated'
p20977
g3
sS'side,effects,and'
p20978
g3
sS'to,mg,were'
p20979
g3
sS'or,pcp,were'
p20980
g9
sS'antigen,validation,of'
p20981
g3
sS'data,suggest,that'
p20982
g3
sS'used,because,the'
p20983
g9
sS'risk,of,nephrotoxicity'
p20984
g3
sS'plus,avastin,had'
p20985
g3
sS'gliftor,difluoro-2,propanol'
p20986
g3
sS'reduced,in,both'
p20987
g3
sS'may,present,as'
p20988
g9
sS'of,exjade,with'
p20989
g3
sS'the,plasma,level'
p20990
g9
sS'l,kg,h'
p20991
g9
sS'absence,of,a'
p20992
g3
sS'on,the,minor'
p20993
g3
sS'summarized,in,table'
p20994
g3
sS'healthy,male,volunteers'
p20995
g3
sS'any,nonlinear,regression'
p20996
g3
sS'reduce,the,therapeutic'
p20997
g9
sS'antiepileptic,drugs,the'
p20998
g9
sS'well-controlled,studies,in'
p20999
g3
sS'as,or,should'
p21000
g9
sS'co-administered,with,brovana'
p21001
g3
sS'combination,with,monoamine'
p21002
g9
sS'on,av,node'
p21003
g9
sS'mtc-mdp,as,the'
p21004
g3
sS'percentage,of,binding'
p21005
g3
sS'and,pharmacodynamic,interactions'
p21006
g3
sS'drugs,in,which'
p21007
g3
sS'and,cyclopentyl-1,dipropylxanthine'
p21008
g3
sS'consideration,of,appropriate'
p21009
g3
sS'of,l-glutamine,and'
p21010
g9
sS'of,toradol,on'
p21011
g9
sS'could,contribute,in'
p21012
g3
sS'concentrations,of,andtolbutamide'
p21013
g3
sS'cynomolgus,monkeys,following'
p21014
g3
sS'of,other,inducers'
p21015
g9
sS'evidence,of,glucose'
p21016
g3
sS'mental,alertness,such'
p21017
g3
sS'to,ng,ml'
p21018
g9
sS'and,and,a'
p21019
g9
sS'toxicology,studies,showed'
p21020
g3
sS'with,injectable,an'
p21021
g9
sS'by,increased,serum'
p21022
g3
sS'acids,or,other'
p21023
g3
sS'of,invirase,or'
p21024
g3
sS'of,other,which'
p21025
g3
sS'single,mg,dose'
p21026
g9
sS'keflex,a,false-positive'
p21027
g3
sS'of,birth,control'
p21028
g9
sS'evidence,of,interaction'
p21029
g3
sS'are,to,lower'
p21030
g3
sS'with,tablets,is'
p21031
g9
sS'drugs,that,cause'
p21032
g9
sS'most,common,distilled'
p21033
g3
sS'specifically,examining,potential'
p21034
g3
sS'in,vitro,anti-cryptosporidial'
p21035
g3
sS'periodic,serum,level'
p21036
g9
sS'to,such,as'
p21037
g3
sS'differences,were,between'
p21038
g3
sS'part,a,shift'
p21039
g3
sS'healthy,subjects,there'
p21040
g3
sS'account,the,importance'
p21041
g3
sS'of,rr,reduced'
p21042
g3
sS'maintenance,schedule,of'
p21043
g9
sS'be,useful,in'
p21044
g9
sS'of,memory,that'
p21045
g3
sS'nasal,spray,the'
p21046
g9
sS'drug,levels,about'
p21047
g3
sS'may,be,administered'
p21048
g3
sS'interactions,there,have'
p21049
g3
sS'of,clostridium,three'
p21050
g3
sS'but,still,significant'
p21051
g3
sS'enteric,coating,that'
p21052
g3
sS'as,reflected,in'
p21053
g9
sS'safety,or,efficacy'
p21054
g3
sS'tissue,damage,as'
p21055
g9
sS'insulin-induced,hypoglycemia,and'
p21056
g3
sS'the,clinical,effect'
p21057
g3
sS'associated,with,qt-interval'
p21058
g3
sS'that,the,action'
p21059
g9
sS'meant,to,relieve'
p21060
g3
sS'hypotensive,episodes,may'
p21061
g9
sS'as,they,can'
p21062
g9
sS'and,reinstate,psychostimulant'
p21063
g3
sS'mcg,bid,for'
p21064
g9
sS'slurred,speech,coordination'
p21065
g3
sS'minimally,excreted,via'
p21066
g3
sS'toxicity,and,mechanisms'
p21067
g3
sS'permeation,however,in'
p21068
g3
sS'to,increase,when'
p21069
g9
sS'and,triglycerides,or'
p21070
g3
sS'when,it,was'
p21071
g9
sS'enough,during,early'
p21072
g9
sS'increases,in,inr'
p21073
g9
sS'develop,increased,serum'
p21074
g9
sS'receiving,foradil,other'
p21075
g3
sS'caused,by,therapy'
p21076
g3
sS'on,the,population'
p21077
g3
sS'agents,and,oral'
p21078
g9
sS'of,proleukin,in'
p21079
g3
sS'and,hepatic,lipid'
p21080
g9
sS'as,or,from'
p21081
g9
sS'cyp3a4,isoenzyme,is'
p21082
g3
sS'auc,more,than'
p21083
g3
sS'constant,while,fractional'
p21084
g3
sS'gastric,emptying,by'
p21085
g3
sS'fold,when,at'
p21086
g9
sS'and,occurred,following'
p21087
g9
sS'aminotransferases,was,observed'
p21088
g3
sS'rectification,were,each'
p21089
g3
sS'either,the,tricyclic'
p21090
g3
sS'the,emerging,roles'
p21091
g3
sS'the,righting,reflex'
p21092
g3
sS'metabolized,in,the'
p21093
g3
sS'returned,to,baseline'
p21094
g9
sS'was,concluded,that'
p21095
g9
sS'result,from,a'
p21096
g3
sS'if,treatment,is'
p21097
g3
sS'both,are,direct'
p21098
g9
sS'and,may,even'
p21099
g3
sS'the,primary,and'
p21100
g9
sS'to,of,caucasians'
p21101
g3
sS'on,platelet,function'
p21102
g3
sS'and,has,importance'
p21103
g3
sS'collected,through,hours'
p21104
g3
sS'alterations,associated,with'
p21105
g3
sS'weeks,of,taking'
p21106
g9
sS'a,possible,interaction'
p21107
g9
sS'blocks,receptors,thus'
p21108
g9
sS'the,efflux,transporter'
p21109
g3
sS'after,discontinuation,of'
p21110
g3
sS'of,coma,and'
p21111
g9
sS'of,are,suddenly'
p21112
g3
sS'impairing,absorption,of'
p21113
g9
sS'combination,of,systemic'
p21114
g9
sS'cause,clinically,important'
p21115
g3
sS'when,infection,and'
p21116
g9
sS'interaction,studies,conducted'
p21117
g3
sS'cautious,in,patients'
p21118
g3
sS'any,serious,and'
p21119
g3
sS'and,those,with'
p21120
g3
sS'of,the,potent'
p21121
g9
sS'urinary,uric,acid'
p21122
g9
sS'when,concurrent,therapy'
p21123
g3
sS'events,including,electrocardiographic'
p21124
g3
sS'or,are,given'
p21125
g3
sS'depression,such,as'
p21126
g9
sS'escalate,the,dose'
p21127
g3
sS'may,interact,altered'
p21128
g3
sS'adverse,reactions,is'
p21129
g9
sS'to,was,increased'
p21130
g9
sS'with,standard,cystic'
p21131
g3
sS'vivo,interaction,study'
p21132
g3
sS'misonidazole,protects,mouse'
p21133
g9
sS'systemic,etc,that'
p21134
g9
sS'c,max,auc'
p21135
g3
sS'of,young,healthy'
p21136
g3
sS'chapter,presents,information'
p21137
g3
sS'two,combined,week'
p21138
g3
sS'activity,predominantly,in'
p21139
g3
sS'romazicon,exerts,a'
p21140
g9
sS'be,given,to'
p21141
g3
sS'of,possible,effects'
p21142
g3
sS'vision,have,been'
p21143
g9
sS'and,use,may'
p21144
g9
sS'gentamicin,did,not'
p21145
g3
sS'doses,could,have'
p21146
g3
sS'coli,and,one'
p21147
g3
sS'increase,in,sprycel'
p21148
g3
sS'infection,is,generally'
p21149
g3
sS'clearance,and,add'
p21150
g9
sS'placebo,day,for'
p21151
g3
sS'displacement,of,from'
p21152
g9
sS'damage,produced,a'
p21153
g9
sS'of,and,at'
p21154
g3
sS'histidines,on,a'
p21155
g3
sS'dose,of,bronchodilator'
p21156
g3
sS'of,and,as'
p21157
g9
sS'with,anticoagulation,levels'
p21158
g9
sS'in,cardiac,output'
p21159
g9
sS'administration,may,result'
p21160
g9
sS'fade,hoof,twitch'
p21161
g9
sS'show,whether,ginsenosides-induced'
p21162
g3
sS'vivo,drug-drug,interactions'
p21163
g3
sS'before,dose-limiting,toxicities'
p21164
g3
sS'these,resulting,in'
p21165
g9
sS'channel,antagonists,angiotensin'
p21166
g3
sS'bleeding,with,xigris'
p21167
g3
sS'the,patch-clamp,whole-cell'
p21168
g3
sS'psychological,and,medical'
p21169
g3
sS'to,be,necessary'
p21170
g3
sS'viracept,with,ovcon-35'
p21171
g9
sS'exercise,that,produces'
p21172
g3
sS'a,substitute,for'
p21173
g3
sS'interactions,with,metabolized'
p21174
g3
sS'however,are,not'
p21175
g3
sS'rats,were,sacrificed'
p21176
g3
sS'conjugated,system,maybe'
p21177
g3
sS'of,a,cyp3a4'
p21178
g9
sS'severe,toxicity,was'
p21179
g9
sS'in,special,populations'
p21180
g3
sS'with,with,metal'
p21181
g9
sS'concomitant,in,rheumatoid'
p21182
g3
sS'injury,should,be'
p21183
g3
sS'and,aminoglycosides,drugs'
p21184
g9
sS'with,the,and'
p21185
g3
sS'than,when,is'
p21186
g9
sS'in,ventricular,fibrillation'
p21187
g3
sS'of,the,first-pass'
p21188
g9
sS'with,cyp2c19,the'
p21189
g3
sS'of,enablex,with'
p21190
g9
sS'all,research,specific'
p21191
g3
sS'to,lose,the'
p21192
g3
sS'for,adverse,effects'
p21193
g3
sS'resistance,was,measured'
p21194
g3
sS'before,the,gradual'
p21195
g9
sS'n-desmethyldiazepam,there,is'
p21196
g9
sS'decreasing,the,clearance'
p21197
g9
sS'vasodilator,properties,on'
p21198
g3
sS'had,no,significant'
p21199
g3
sS'genetic,factors,may'
p21200
g3
sS'such,reduction,in'
p21201
g9
sS'substrate,of,cyp1a1'
p21202
g3
sS'multipledose,treatment,with'
p21203
g3
sS'of,intrathecal,on'
p21204
g3
sS'on,evoked,potentials'
p21205
g3
sS'monurol,a,which'
p21206
g9
sS'dehydration,have,been'
p21207
g9
sS'retinyl,acetate,and'
p21208
g9
sS'dual-memory,theories,have'
p21209
g3
sS'to,mg,capsules'
p21210
g9
sS'the,cause,of'
p21211
g3
sS'toward,other,isoforms'
p21212
g3
sS'at,the,desired'
p21213
g3
sS'once,daily,did'
p21214
g3
sS'taking,or,nsaids'
p21215
g3
sS'the,brain,although'
p21216
g3
sS'digoxin,in,a'
p21217
g3
sS'and,and,fold'
p21218
g3
sS'seven,cases,of'
p21219
g3
sS'psychotropic,medications,or'
p21220
g9
sS'in,laboratory,parameters'
p21221
g3
sS'the,benefit,of'
p21222
g9
sS'not,recommended,as'
p21223
g3
sS'of,or,does'
p21224
g3
sS'result,of,coadministration'
p21225
g3
sS'have,had,an'
p21226
g9
sS'of,aliskiren,on'
p21227
g3
sS'receiving,ganglion,blocking'
p21228
g3
sS'of,with,a'
p21229
g9
sS'it,substituted,for'
p21230
g3
sS'with,the,bactericidal'
p21231
g9
sS'protein,may,cause'
p21232
g9
sS'as,effects,on'
p21233
g3
sS'tablets,with,or'
p21234
g9
sS'exposures,in,terms'
p21235
g3
sS'performed,examining,the'
p21236
g3
sS'skin,that,you'
p21237
g3
sS'is,based,on'
p21238
g3
sS'is,necessary,but'
p21239
g3
sS'significant,increases,in'
p21240
g3
sS'a,to,increase'
p21241
g9
sS'under,the,transcriptional'
p21242
g3
sS'practice,has,been'
p21243
g9
sS'have,been,greater'
p21244
g9
sS'based,on,in-vitro'
p21245
g3
sS'with,the,potent'
p21246
g9
sS'of,radio-iodine,uptake'
p21247
g3
sS'in,a,shortened'
p21248
g9
sS'groups,were,well'
p21249
g3
sS'calculated,clearance,ranged'
p21250
g3
sS'products,that,contain'
p21251
g9
sS'studies,at,the'
p21252
g3
sS'whether,this,potentiation'
p21253
g9
sS'maois,may,increase'
p21254
g9
sS'a,patient,has'
p21255
g3
sS'and,gastric,ph'
p21256
g3
sS'date,on,the'
p21257
g3
sS'placebo,and,intravenous'
p21258
g3
sS'cardioplegic,solutions,and'
p21259
g3
sS'into,three,doses'
p21260
g9
sS'potentially,resulting,in'
p21261
g9
sS'monitored,for,increases'
p21262
g9
sS'with,one-stage,coagulation'
p21263
g3
sS'calcidiol,cholestyramine,cholestyramine'
p21264
g9
sS'and,sodium,plasma'
p21265
g9
sS'antagonized,by,agents'
p21266
g3
sS'a,strong,likelihood'
p21267
g9
sS'require,adjustment,when'
p21268
g3
sS'suggested,to,mg'
p21269
g3
sS'be,increased,by'
p21270
g9
sS'in,visual,cortex'
p21271
g3
sS'to,be,significantly'
p21272
g3
sS'administration,of,dynacirc'
p21273
g3
sS'failure,of,to'
p21274
g3
sS'the,median,tmax'
p21275
g3
sS'from,lean,and'
p21276
g3
sS'extracellular,ca,and'
p21277
g3
sS'interactions,posed,by'
p21278
g3
sS'indicates,that,does'
p21279
g3
sS'sodium,and,were'
p21280
g3
sS'especially,neglect,of'
p21281
g3
sS'that,or,and'
p21282
g9
sS'concentration,of,when'
p21283
g9
sS'with,small,doses'
p21284
g9
sS'intravenously,injected,a'
p21285
g3
sS'be,reassessed,periodically'
p21286
g3
sS'increased,monitoring,of'
p21287
g9
sS'on,the,order'
p21288
g3
sS'pneumoniae,streptococcus,pyogenes'
p21289
g3
sS'access,distribution,pathways'
p21290
g3
sS'clozapine,and,is'
p21291
g9
sS'was,taking,a'
p21292
g3
sS'unexpectedly,high,plasma'
p21293
g3
sS'in,bovine,chromaffin'
p21294
g3
sS'ovarian,cervical,breast'
p21295
g3
sS'mediated,by,inhibition'
p21296
g3
sS'careful,observation,is'
p21297
g9
sS'elspar,or,during'
p21298
g9
sS'reduced,when,it'
p21299
g9
sS'under,certain,circumstances'
p21300
g3
sS'seizure,risk,in'
p21301
g9
sS'this,was,due'
p21302
g3
sS'states,but,also'
p21303
g3
sS'both,the,toxicity'
p21304
g3
sS'days,and,then'
p21305
g3
sS'factor,for,altering'
p21306
g3
sS'the,store,from'
p21307
g3
sS'interactions,indicate,that'
p21308
g3
sS'administered,and,appropriate'
p21309
g9
sS'cardiac,contractility,and'
p21310
g3
sS'were,recorded,from'
p21311
g3
sS'estrogen,oral,contraceptives'
p21312
g3
sS'ankle,edema,excessive'
p21313
g3
sS'concurrent,use,to'
p21314
g3
sS'potently,enhanced,the'
p21315
g3
sS'herbal,product,interactions'
p21316
g3
sS'specifically,cytochromes,p450'
p21317
g3
sS'medications,are,used'
p21318
g3
sS'the,augmentation,persisted'
p21319
g3
sS'hexokinase,method,be'
p21320
g3
sS'a,lower,total'
p21321
g3
sS'influence,of,trileptal'
p21322
g3
sS'observed,for,any'
p21323
g3
sS'coadministration,up,to'
p21324
g9
sS'additional,animals,in'
p21325
g3
sS'monitoring,of,liver'
p21326
g9
sS'the,ec50,values'
p21327
g3
sS'citrate,tablets,usp'
p21328
g3
sS'toward,normal,when'
p21329
g3
sS'the,second,contraction'
p21330
g3
sS'these,or,others'
p21331
g3
sS'patients,addition,of'
p21332
g3
sS'rachitic,chicks,was'
p21333
g9
sS'of,interaction,and'
p21334
g3
sS'increase,their,capacity'
p21335
g3
sS'the,potassium-depleted,solution'
p21336
g3
sS'vitro,data,showed'
p21337
g3
sS'in,clinically,meaningful'
p21338
g9
sS'the,interactions,between'
p21339
g3
sS'indicate,that,they'
p21340
g3
sS'used,if,is'
p21341
g9
sS'administration,of,tablets'
p21342
g9
sS'failure,channel,blockers'
p21343
g9
sS'cmax,t1,of'
p21344
g9
sS'of,with,and'
p21345
g3
sS'may,want,to'
p21346
g3
sS'fold,and,css'
p21347
g9
sS'no,safety,and'
p21348
g3
sS'finding,that,neither'
p21349
g3
sS'concentrations,auc,hrs'
p21350
g3
sS'elevated,liver,aminotransferases'
p21351
g3
sS'subcutaneous,injection,q12h'
p21352
g3
sS'all,associated,with'
p21353
g9
sS'observed,for,alterations'
p21354
g9
sS'chelation,complexes,with'
p21355
g9
sS'rats,with,the'
p21356
g3
sS'which,are,activated'
p21357
g3
sS'have,produced,an'
p21358
g9
sS'mixed-function,mono-oxidases,in'
p21359
g3
sS'effects,on,pharmacokinetics'
p21360
g3
sS'allograft,recipients,during'
p21361
g3
sS'kill,even,experienced'
p21362
g9
sS'well-known,interactions,with'
p21363
g3
sS'and,or,total'
p21364
g3
sS'machinery,or,driving'
p21365
g3
sS'with,a,pure'
p21366
g9
sS'tumor,phenotype,and'
p21367
g3
sS'injections,of,m'
p21368
g3
sS'depress,prolactin,secretion'
p21369
g3
sS'patients,receiving,preparations'
p21370
g3
sS'mainly,by,cytochrome'
p21371
g3
sS'of,this,isozyme'
p21372
g3
sS'naproxen,sodium,and'
p21373
g9
sS'with,a,balanced'
p21374
g3
sS'should,be,cautious'
p21375
g9
sS'i,cigarettes,and'
p21376
g3
sS'order,to,monitor'
p21377
g3
sS'kinds,of,and'
p21378
g3
sS'days,prior,to'
p21379
g3
sS'clinical,situation,and'
p21380
g3
sS'pegasys,may,impair'
p21381
g3
sS'closely,monitored,when'
p21382
g9
sS'dose,of,escherichia'
p21383
g3
sS'with,chemical,color'
p21384
g3
sS'inhibit,cyp3a4,may'
p21385
g3
sS'on,the,central'
p21386
g9
sS'only,with,caution'
p21387
g3
sS'given,together,with'
p21388
g3
sS'by,reducing,the'
p21389
g9
sS'day,about,one-half'
p21390
g3
sS'the,hyperuricemia,present'
p21391
g9
sS'associated,with,gastrointestinal'
p21392
g9
sS'other,b-lactam,co-administration'
p21393
g9
sS'kineret,and,therapy'
p21394
g9
sS'describe,the,escalating'
p21395
g3
sS'or,hypo-thyroxine,binding-globulinemias'
p21396
g3
sS'to,products,containing'
p21397
g9
sS'to,increased,circulating'
p21398
g3
sS'toradol,and,in'
p21399
g3
sS'also,suggest,that'
p21400
g9
sS'for,placebo,were'
p21401
g3
sS'with,only,bodyweight'
p21402
g3
sS'mg,daily,for'
p21403
g3
sS'younger,patients,but'
p21404
g3
sS'potentially,toxic,such'
p21405
g9
sS'question,of,whether'
p21406
g3
sS'carried,out,studies'
p21407
g3
sS'indicated,that,cyp3a4'
p21408
g3
sS'investigated,the,effects'
p21409
g3
sS'should,have,a'
p21410
g9
sS'at,least,minutes'
p21411
g9
sS'effects,of,anafranil'
p21412
g3
sS'somatrem,somatropin,excessive'
p21413
g3
sS'other,agents,the'
p21414
g9
sS'glucose,and,can'
p21415
g3
sS'nsaids,suggests,the'
p21416
g9
sS'a,substrates,is'
p21417
g3
sS'the,hospital,for'
p21418
g3
sS'myocardial,infarction,there'
p21419
g3
sS'where,iressa,and'
p21420
g9
sS'two,percent,of'
p21421
g9
sS'antagonists,and,that'
p21422
g3
sS'mg,capsule,twice'
p21423
g3
sS'reductions,of,mm'
p21424
g9
sS'be,given,simultaneously'
p21425
g9
sS'agonist,effects,in'
p21426
g3
sS'known,whether,this'
p21427
g9
sS'and,serum,bilirubin'
p21428
g3
sS'the,bad,general'
p21429
g9
sS'were,and,both'
p21430
g3
sS'previously,received,increases'
p21431
g9
sS'toxicity,and,effectiveness'
p21432
g3
sS'alosetron,does,not'
p21433
g3
sS'acinar,cells,rr'
p21434
g3
sS'coagulation,system,or'
p21435
g3
sS'suggests,that,interactions'
p21436
g3
sS'a,protein,with'
p21437
g3
sS'a4,may,increase'
p21438
g3
sS'as,or,with'
p21439
g9
sS'therapy,with,similar'
p21440
g3
sS'patients,receiving,high'
p21441
g9
sS'was,ng,ml'
p21442
g9
sS'to,but,are'
p21443
g3
sS'one,gram,of'
p21444
g9
sS'serious,sometimes,fatal'
p21445
g9
sS'or,clinical,effects'
p21446
g3
sS'of,mao,inhibitors'
p21447
g9
sS'been,cited,in'
p21448
g3
sS'administered,after,inhalational'
p21449
g3
sS'of,its,primary'
p21450
g9
sS'well,concurent,therapy'
p21451
g9
sS'videx,with,that'
p21452
g3
sS'if,these,agents'
p21453
g9
sS'finding,no,interactive'
p21454
g3
sS'be,hazardous,when'
p21455
g3
sS'area-under,the-curve,auc'
p21456
g3
sS'medications,such,as'
p21457
g3
sS'cancers,it,significantly'
p21458
g3
sS'with,whole-cell,recording'
p21459
g3
sS'homocysteine,by,forming'
p21460
g3
sS'have,developed,severe'
p21461
g3
sS'hypotension,with,the'
p21462
g9
sS'objectives,to,identify'
p21463
g3
sS'flolan,was,used'
p21464
g9
sS'when,mg,b'
p21465
g9
sS'another,agent,should'
p21466
g3
sS'liver,microsomes,to'
p21467
g3
sS'replacement,therapy,should'
p21468
g9
sS'when,the,cyp2d6'
p21469
g3
sS'the,inhibits,the'
p21470
g3
sS'the,agents,to'
p21471
g3
sS'to,b-cell,lymphomas'
p21472
g3
sS'is,likely,that'
p21473
g3
sS'cells,stably,transfected'
p21474
g3
sS'use,in,a'
p21475
g3
sS'may,displace,acidic'
p21476
g9
sS'vomiting,pruritus,rash'
p21477
g3
sS'half-life,by,and'
p21478
g9
sS'activity,should,if'
p21479
g9
sS'examines,the,effects'
p21480
g3
sS'a,mg,m2'
p21481
g3
sS'concomitant,medications,such'
p21482
g3
sS'abolished,as,a'
p21483
g9
sS'at,levels,significantly'
p21484
g3
sS'mg,day,mg'
p21485
g3
sS'exacerbate,the,hypertensive'
p21486
g9
sS'all,physciains,it'
p21487
g3
sS'of,more,severe'
p21488
g3
sS'extent,and,the'
p21489
g3
sS'resveratrol-induced,vasorelaxation,differs'
p21490
g3
sS'part,from,alterations'
p21491
g3
sS'metabolites,appear,to'
p21492
g3
sS'or,surgery,because'
p21493
g3
sS'acid,may,also'
p21494
g9
sS'receiving,thiazide,agents'
p21495
g3
sS'any,clinically,important'
p21496
g3
sS'receiving,concurrent,administration'
p21497
g3
sS'transient,elevations,in'
p21498
g9
sS'diabetic,patients,may'
p21499
g3
sS'before,there,is'
p21500
g3
sS'for,than,for'
p21501
g9
sS'should,receive,initial'
p21502
g9
sS'interactions,amerge,tablets'
p21503
g3
sS'profile,of,does'
p21504
g3
sS'for,the,increased'
p21505
g9
sS'when,these,agents'
p21506
g3
sS'to,those,that'
p21507
g3
sS'been,inconsistent,reports'
p21508
g3
sS'interaction,is,not'
p21509
g3
sS'of,low,and'
p21510
g3
sS'humans,taking,the'
p21511
g3
sS'of,amprenavir,and'
p21512
g9
sS'plasma,in,vitro'
p21513
g3
sS'undesirable,involving,even'
p21514
g3
sS'with,and,without'
p21515
g3
sS'probenecid,probenecid,a'
p21516
g3
sS'can,be,associated'
p21517
g3
sS'substrate,response,is'
p21518
g3
sS'recommended,that,cefditoren'
p21519
g9
sS'inhibition,of,cyp2a6'
p21520
g9
sS'in,animal,models'
p21521
g3
sS'adverse,neuropsychiatric,events'
p21522
g9
sS'pharmacokinetic,data,from'
p21523
g9
sS'vitro,was,altered'
p21524
g3
sS'potentiating,the,central'
p21525
g3
sS'toxicity,from,normal'
p21526
g3
sS'test,interactions,prolongation'
p21527
g3
sS'chylomicron,lipolysis,and'
p21528
g3
sS'binds,bile,acids'
p21529
g3
sS'cyp3a4,and,concomitant'
p21530
g3
sS'clinical,isolates,and'
p21531
g3
sS's-ast,and,sgpt'
p21532
g3
sS'patients,receiving,sprycel'
p21533
g3
sS'high,dose,proleukin'
p21534
g9
sS'regarding,interactions,associated'
p21535
g3
sS'class,may,reduce'
p21536
g3
sS'more,when,it'
p21537
g3
sS'carbonate,or,an'
p21538
g9
sS'and,the,duration'
p21539
g9
sS'are,thought,to'
p21540
g3
sS'methodology,for,deriving'
p21541
g3
sS'amevive,administered,weekly'
p21542
g3
sS'cardiovascular,morbidity,and'
p21543
g3
sS'eg,have,occasionally'
p21544
g3
sS'at,daily,doses'
p21545
g3
sS'oral,sulfate,may'
p21546
g9
sS'a,new,class'
p21547
g3
sS'at,least,six'
p21548
g3
sS'this,decrease,in'
p21549
g9
sS'allergic,or,hypersensitivity'
p21550
g3
sS'prolonged,diarrhea,or'
p21551
g3
sS'than,for,other'
p21552
g9
sS'cold,allergy,or'
p21553
g3
sS'containing,may,decrease'
p21554
g9
sS'maximum,concentration,in'
p21555
g3
sS'a,rebound,in'
p21556
g9
sS'terms,of,pregnancy'
p21557
g3
sS'include,and,some'
p21558
g3
sS'coadministration,with,mg'
p21559
g9
sS'analogues,didanosine,co-administration'
p21560
g9
sS'and,cardiac,transplant'
p21561
g9
sS'inducer,or,to'
p21562
g9
sS'myalgia,and,arthralgia'
p21563
g9
sS'the,rate,cmax'
p21564
g9
sS'evaluated,in,healthy'
p21565
g3
sS'a1,a2,a6'
p21566
g3
sS'any,medication,including'
p21567
g9
sS'typhimurium,and,escherichia'
p21568
g3
sS'therapy,with,if'
p21569
g9
sS'only,in,patients'
p21570
g3
sS'antigen,psa,decreased'
p21571
g3
sS'to,use,forms'
p21572
g3
sS'of,thereby,raising'
p21573
g9
sS'of,may,produce'
p21574
g3
sS'concomitantly,with,beta'
p21575
g3
sS'on,phenytoin,therapy'
p21576
g9
sS'interaction,this,report'
p21577
g9
sS'with,four,resulted'
p21578
g9
sS'unexpected,adverse,reactions'
p21579
g3
sS'in,levels,was'
p21580
g9
sS'to,decrease,prior'
p21581
g3
sS'during,clinical,studies'
p21582
g3
sS'class,of,protease'
p21583
g3
sS'human,studies,that'
p21584
g3
sS'compounds,in,urine'
p21585
g3
sS'that,appears,to'
p21586
g3
sS'and,at,therapeutic'
p21587
g3
sS'or,its,epoxide'
p21588
g3
sS'serum,protein,binding'
p21589
g3
sS'concomitantly,with,for'
p21590
g9
sS'tablets,with,may'
p21591
g9
sS'and,second,contractile'
p21592
g9
sS'or,n,compared'
p21593
g9
sS'enzymes,may,decrease'
p21594
g3
sS'to,cardiac,arrhythmias'
p21595
g3
sS'examples,of,substances'
p21596
g3
sS'include,azole,antifungals'
p21597
g3
sS'nsaids,through,effects'
p21598
g9
sS'is,unusual,and'
p21599
g3
sS'significantly,elevating,duodenal'
p21600
g9
sS'although,lexapro,did'
p21601
g9
sS'a,shortened,elimination'
p21602
g9
sS'butalbital,and,may'
p21603
g9
sS'plasma,maximum,concentration'
p21604
g3
sS'or,may,intensify'
p21605
g9
sS'are,needed,they'
p21606
g3
sS'in,turn,controls'
p21607
g3
sS'bioassay,procedures,for'
p21608
g3
sS'to,repeated,challenge'
p21609
g3
sS'could,not,be'
p21610
g3
sS'possible,decreased,response'
p21611
g3
sS'day,in,a'
p21612
g3
sS'groups,which,were'
p21613
g3
sS'sodium,injection,should'
p21614
g3
sS'vitro,studies,also'
p21615
g3
sS'of,particularly,with'
p21616
g9
sS'in,the,time'
p21617
g9
sS'it,significantly,decreased'
p21618
g9
sS'cholestyramine,resin,or'
p21619
g3
sS'and,embryonic,survival'
p21620
g3
sS'relative,to,that'
p21621
g9
sS'administration,of,wellbutrin'
p21622
g9
sS'and,maximal,plasma'
p21623
g9
sS'indicate,that,no'
p21624
g3
sS'weekly,or,every'
p21625
g3
sS'it,palliates,deficiencies'
p21626
g3
sS'healthy,volunteers,show'
p21627
g3
sS'concomitantly,receiving,oral'
p21628
g9
sS'by,or,salicylic'
p21629
g3
sS'and,are,metabolized'
p21630
g3
sS'mmol,l,mmol'
p21631
g3
sS'antiretroviral,regimens,consisted'
p21632
g3
sS'significant,drug-drug,interaction'
p21633
g3
sS'a,combination,of'
p21634
g3
sS'increased,urinary,values'
p21635
g3
sS'coagulation,parameters,pt'
p21636
g9
sS'subjects,the,concurrent'
p21637
g3
sS'treatment,of,induced'
p21638
g3
sS'were,to,avoid'
p21639
g3
sS'mu,kg,min'
p21640
g3
sS'vary,and,is'
p21641
g3
sS'dose,greater,than'
p21642
g3
sS'clearance,of,drugs'
p21643
g3
sS'of,antithrombotics,aspirin'
p21644
g3
sS'associated,with,depression'
p21645
g3
sS'in,contrast,increased'
p21646
g3
sS'values,for,free'
p21647
g3
sS'oral,regularly,results'
p21648
g3
sS'active,hydroxy,acid'
p21649
g9
sS'certain,especially,and'
p21650
g3
sS'volunteers,had,no'
p21651
g9
sS'dysfunction,is,a'
p21652
g3
sS'of,pain,mechanisms'
p21653
g3
sS'quetiapine,fumarate,seroquel'
p21654
g3
sS'pointe,particularly,and'
p21655
g3
sS'as,postmarketing,observations'
p21656
g9
sS'the,population,pharmacokinetics'
p21657
g3
sS'using,the,tablets'
p21658
g9
sS'study,comparing,once-monthly'
p21659
g3
sS'of,a,selective'
p21660
g9
sS'divided,doses,three'
p21661
g3
sS'a,median,follow-up'
p21662
g3
sS'of,hydroxy,indoleacetic'
p21663
g3
sS'and,b12,because'
p21664
g3
sS'tylenol,with,long-term'
p21665
g9
sS'propanol,to,difluoroacetone'
p21666
g9
sS'p450,a4,isozyme'
p21667
g3
sS'without,replacement,may'
p21668
g3
sS'spectrum,may,sterilize'
p21669
g3
sS'to,by,the'
p21670
g3
sS'effects,of,mefloquine'
p21671
g9
sS'of,loratadine,and'
p21672
g3
sS'increase,in,mortality'
p21673
g3
sS'it,interfere,with'
p21674
g3
sS'both,first,and'
p21675
g9
sS'potassium-sparing,such,as'
p21676
g3
sS'use,of,orally'
p21677
g3
sS'from,to,micrograms'
p21678
g3
sS'coumarin-type,anticoagulants,several'
p21679
g3
sS'and,safety,profiles'
p21680
g3
sS'oral,contraceptives,valdecoxib'
p21681
g3
sS'agents,a,pharmacokinetic'
p21682
g3
sS'the,latter,agents'
p21683
g9
sS'any,dose,or'
p21684
g3
sS'present,study,we'
p21685
g3
sS'inhibitor,pi,related'
p21686
g3
sS'when,such,combined'
p21687
g3
sS'in,symptomatic,hypotension'
p21688
g3
sS'in,a,well-controlled'
p21689
g3
sS'considered,when,evaluating'
p21690
g3
sS'antinonciceptive,effect,of'
p21691
g3
sS'to,refrain,from'
p21692
g3
sS'av,conduction,such'
p21693
g9
sS'pharmacokinetic,evaluation,of'
p21694
g3
sS'two-lever,discrimination,and'
p21695
g3
sS'treatment,with,as'
p21696
g9
sS'are,reported,in'
p21697
g3
sS'in,these,six'
p21698
g3
sS'individual,simulect,clearance'
p21699
g3
sS'metabolism,and,the'
p21700
g9
sS'the,desired,effect'
p21701
g9
sS'the,rat,were'
p21702
g3
sS'frequent,doses,of'
p21703
g3
sS'of,single,mg'
p21704
g3
sS'repeated,challenge,either'
p21705
g3
sS'significantly,different,in'
p21706
g3
sS'levels,leading,to'
p21707
g3
sS'concentration,and,urinary'
p21708
g9
sS'weeks,in,dogs'
p21709
g3
sS'taking,any,of'
p21710
g3
sS'certain,concomitant,medications'
p21711
g3
sS'cyp,isozymes,in'
p21712
g3
sS'trileptal,the,auc'
p21713
g9
sS'lorazepam,injection,like'
p21714
g9
sS'meth,caused,a'
p21715
g9
sS'non-selective,beta-adrenergic,blocking'
p21716
g9
sS'reductions,in,or'
p21717
g3
sS'was,co-administered,but'
p21718
g3
sS'by,approximately,when'
p21719
g9
sS'effect,on,safety'
p21720
g3
sS'cephalosporins,including,cefotaxime'
p21721
g3
sS'postmarketing,observations,have'
p21722
g9
sS'difluoroacetone,to,erythro-fluorocitrate'
p21723
g3
sS'hypertensive,nephropathy,were'
p21724
g3
sS'same,time,or'
p21725
g3
sS'diseases,of,the'
p21726
g3
sS'aggressively,is,understandable'
p21727
g3
sS'norpace,does,not'
p21728
g3
sS'exaggerated,leukopenia,especially'
p21729
g3
sS'to,be,fatal'
p21730
g9
sS'derived,from,the'
p21731
g9
sS'with,a,hydroalcoholic'
p21732
g3
sS'important,when,using'
p21733
g3
sS'concurrently,with,anion-exchange'
p21734
g9
sS'six-healthy,male,volunteers'
p21735
g3
sS'because,plasma,concentrations'
p21736
g9
sS'not,be,effective'
p21737
g9
sS'platelet,function,or'
p21738
g3
sS'enantiomer,pharmacokinetics,were'
p21739
g3
sS'receiving,revia,the'
p21740
g9
sS'to,examine,interactions'
p21741
g3
sS'and,therapeutic,concentration'
p21742
g9
sS'i,trial,in'
p21743
g3
sS'lower,serum,and'
p21744
g9
sS'cyp4a9,and,cyp4a11'
p21745
g3
sS'inhibitors,and,decrease'
p21746
g9
sS'use,of,when'
p21747
g3
sS'with,food,isrecommended'
p21748
g9
sS'to,trace,pathways'
p21749
g3
sS'sodium,and,g'
p21750
g9
sS'individual,inr,values'
p21751
g3
sS'weekly,during,the'
p21752
g3
sS'measure,over,the'
p21753
g3
sS'and,together,may'
p21754
g9
sS'of,however,were'
p21755
g3
sS'q24h,for,days'
p21756
g9
sS'than,the,m1'
p21757
g3
sS'killed,at,the'
p21758
g3
sS'dose,and,a'
p21759
g9
sS'sodium,the,bioavailability'
p21760
g3
sS'effects,makes,the'
p21761
g3
sS'interactions,have,yet'
p21762
g3
sS'a,monoamine,oxidase'
p21763
g3
sS'concentrations,were,reduced'
p21764
g3
sS'drugs,metabolized,by'
p21765
g3
sS'efavirenz,has,demonstrated'
p21766
g3
sS'active,metabolite,by'
p21767
g9
sS'ketoconazole,itraconazole,macrolides'
p21768
g3
sS'that,may,depress'
p21769
g9
sS'in,corrected,qt'
p21770
g3
sS'mg,bid,mg'
p21771
g9
sS'vitro,was,only'
p21772
g3
sS'clearance,of,resulting'
p21773
g9
sS'of,the,major'
p21774
g9
sS'of,tambocor,to'
p21775
g9
sS'is,continued,serum'
p21776
g3
sS'that,elspar,can'
p21777
g9
sS'hydrocodone,increases,auc'
p21778
g9
sS'some,attenuation,in'
p21779
g3
sS'diuretics,etodolac,has'
p21780
g3
sS'monitor,concentrations,in'
p21781
g9
sS'not,been,seen'
p21782
g3
sS'after,inhalational,muscle'
p21783
g3
sS'least,the,negative'
p21784
g3
sS'because,there,are'
p21785
g3
sS'enoxacin,does,not'
p21786
g3
sS'modest,increases,in'
p21787
g9
sS'days,mg,rat'
p21788
g3
sS'mg,bid,n'
p21789
g3
sS'whole-cell,tight,seal'
p21790
g3
sS'metabolized,by,c'
p21791
g3
sS'metabolized,by,a'
p21792
g3
sS'evidence,suggests,that'
p21793
g9
sS'included,self-reported,mood'
p21794
g3
sS'or,their,metabolites'
p21795
g3
sS'is,generally,asymptomatic'
p21796
g3
sS'a,single,oral'
p21797
g3
sS'inhibition,and,stimulation'
p21798
g3
sS'reported,to,decrease'
p21799
g9
sS'in,human,immunodeficiency'
p21800
g3
sS'daily,dose,and'
p21801
g3
sS'of,ras-3t3,cells'
p21802
g3
sS'type,inositol,trisphosphate'
p21803
g3
sS'at,weekly,or'
p21804
g3
sS'has,been,too'
p21805
g3
sS'use,of,prophylactic'
p21806
g3
sS'blunt,adrenal,and'
p21807
g3
sS'of,um,toward'
p21808
g3
sS'only,minor,changes'
p21809
g9
sS'of,both,than'
p21810
g3
sS'dosing,interval,for'
p21811
g3
sS'secondary,to,vomiting'
p21812
g9
sS'observed,following,initiation'
p21813
g9
sS'of,however,serum'
p21814
g9
sS'hypothyroid,patients,and'
p21815
g3
sS'multiple,dose,mg'
p21816
g3
sS'mefenamic,acid,increased'
p21817
g9
sS'auc,was,reduced'
p21818
g3
sS'metastasis,through,actions'
p21819
g3
sS'effect,of,the'
p21820
g9
sS'kg,or,to'
p21821
g3
sS'with,and,requires'
p21822
g9
sS'anxiogenic,effects,of'
p21823
g9
sS'of,pipracil,may'
p21824
g3
sS'receive,mg,of'
p21825
g9
sS'other,products,containing'
p21826
g9
sS'p-450,the,enzyme'
p21827
g9
sS'spectrum,of,actions'
p21828
g3
sS'least,hours,after'
p21829
g9
sS'acid,were,not'
p21830
g3
sS'other,drugs,which'
p21831
g9
sS'the,immediate,release'
p21832
g9
sS'as,and,cardiac'
p21833
g3
sS'assigned,to,receive'
p21834
g3
sS'and,hydroxide,reduce'
p21835
g9
sS'to,plenaxis,should'
p21836
g3
sS'exercised,because,unexpected'
p21837
g3
sS'are,no,formal'
p21838
g3
sS'increased,because,active'
p21839
g3
sS'of,xanthine,derivatives'
p21840
g3
sS'are,likely,to'
p21841
g9
sS'as,and,dilantin'
p21842
g9
sS'and,had,a'
p21843
g3
sS'species,including,man'
p21844
g3
sS'or,was,seen'
p21845
g3
sS'in,the,group'
p21846
g3
sS'evident,by,the'
p21847
g3
sS'enhance,the,potential'
p21848
g9
sS'cypermethrin-induced,oxidative,stress'
p21849
g9
sS'gonadotropin,levels,caused'
p21850
g3
sS'is,similar,to'
p21851
g9
sS'by,patients,taking'
p21852
g9
sS'or,serial,use'
p21853
g3
sS'shown,to,produce'
p21854
g9
sS'female,rats,at'
p21855
g3
sS'a,very,low'
p21856
g3
sS'than,and,does'
p21857
g3
sS'of,vardenafil,mg'
p21858
g9
sS'and,the,electrocardiographic'
p21859
g3
sS'using,these,blocking'
p21860
g3
sS'or,orange,juices'
p21861
g3
sS'co-administration,with,hydrochloride'
p21862
g3
sS'interaction,when,administered'
p21863
g3
sS'heart,failure,channel'
p21864
g9
sS'how,it,should'
p21865
g3
sS'inhibitors,and,angiotensin'
p21866
g9
sS'this,appears,to'
p21867
g9
sS'im,approximately,one-tenth'
p21868
g3
sS'testing,a,maneuver'
p21869
g3
sS'of,depletion,are'
p21870
g3
sS'aed,on,mhd'
p21871
g3
sS'potential,for,serious'
p21872
g3
sS'newly,diagnosed,subjects'
p21873
g3
sS'tail-flick,inhibition,and'
p21874
g3
sS'in,vitro,have'
p21875
g3
sS'being,a,further'
p21876
g3
sS'a,consequent,possible'
p21877
g9
sS'also,significantly,decreased'
p21878
g9
sS'agents,simultaneous,use'
p21879
g9
sS'using,it,concomitantly'
p21880
g9
sS'bioavailability,low,clearance'
p21881
g3
sS'g,and,was'
p21882
g9
sS'and,are,equipotent'
p21883
g3
sS'of,nimbex,before'
p21884
g3
sS'the,levels,shown'
p21885
g3
sS'doses,of,at'
p21886
g3
sS'biological,levels,have'
p21887
g3
sS'heart,failure,receiving'
p21888
g9
sS'well,as,subsequent'
p21889
g3
sS'in,metabolism,may'
p21890
g3
sS'use,in,patients'
p21891
g9
sS'have,received,cephalosporin'
p21892
g3
sS'd6,poor,metabolizers'
p21893
g9
sS'cyp3a4,with,potentially'
p21894
g3
sS'is,decreasing,according'
p21895
g3
sS'for,this,reason'
p21896
g9
sS'by,was,generally'
p21897
g9
sS'with,had,no'
p21898
g3
sS'the,interval,between'
p21899
g3
sS'mg,once,monthly'
p21900
g3
sS'other,aeds,were'
p21901
g3
sS'and,oral,resulting'
p21902
g3
sS'decreased,even,when'
p21903
g9
sS'size,is,too'
p21904
g3
sS'than,mg,qd'
p21905
g3
sS'elapse,before,initiating'
p21906
g3
sS'at,micromol,l'
p21907
g9
sS'as,flushing,skin'
p21908
g3
sS'av,block,caution'
p21909
g9
sS'of,other,cyp3a4'
p21910
g9
sS'activity,to,pi-based'
p21911
g3
sS'during,concomitant,protease'
p21912
g9
sS'anaphylactic,reactions,and'
p21913
g3
sS'severely,depressed,at'
p21914
g3
sS'warning,coadministration,may'
p21915
g3
sS'an,effort,to'
p21916
g3
sS'this,route,and'
p21917
g9
sS'controlled,hypotensive,using'
p21918
g9
sS'kg,of,body'
p21919
g3
sS'may,affect,strategies'
p21920
g3
sS'concentrations,above,ng'
p21921
g9
sS'nsaids,may,diminish'
p21922
g9
sS'drug,metabolism,increased'
p21923
g9
sS'reveal,an,inhibitory'
p21924
g3
sS'unsatisfactory,lipid,response'
p21925
g9
sS'limb,digital,extensor'
p21926
g3
sS'd,produced,a'
p21927
g9
sS'mg,or,placebo'
p21928
g3
sS'tolerability,of,nnrtis'
p21929
g3
sS'times,maximum,recommended'
p21930
g3
sS'other,therapy,should'
p21931
g3
sS'not,display,the'
p21932
g3
sS'esomeprazole,may,potentially'
p21933
g3
sS'other,chemotherapy,agents'
p21934
g3
sS'oral,treatment,folic'
p21935
g9
sS'other,local,or'
p21936
g9
sS'in,mice,a'
p21937
g3
sS'in,the,hormone'
p21938
g3
sS'a,moderate,inducer'
p21939
g3
sS'nnrti-based,regimens,may'
p21940
g3
sS'leukopenic,activity,of'
p21941
g9
sS'that,are,known'
p21942
g3
sS'was,followed,by'
p21943
g9
sS'that,your,health'
p21944
g9
sS'mediated,via,cytochrome'
p21945
g3
sS'all,patients,as'
p21946
g3
sS'studies,of,the'
p21947
g3
sS'may,not,appreciably'
p21948
g3
sS'pertechnetate,tc99m,uptake'
p21949
g3
sS'which,it,might'
p21950
g3
sS'agents,are,to'
p21951
g9
sS'non-selective,monoamine,oxidase'
p21952
g3
sS'was,shown,to'
p21953
g9
sS'with,folate,utilization'
p21954
g9
sS'the,dose,or'
p21955
g3
sS'to,or,hours'
p21956
g9
sS'fluctuate,significantly,when'
p21957
g9
sS'increase,in,thyroxine'
p21958
g3
sS'when,serious,drug'
p21959
g3
sS'be,a,precipitating'
p21960
g3
sS'nervous,system,when'
p21961
g9
sS'shortly,after,starting'
p21962
g3
sS'discoloration,or,swelling'
p21963
g3
sS'vitro,the,udp-glucuronyl'
p21964
g3
sS'alphagan,p,the'
p21965
g9
sS'of,the,analyte'
p21966
g3
sS'receiving,oral,an'
p21967
g9
sS'when,either,was'
p21968
g9
sS'new,york,heart'
p21969
g3
sS'baseline,neutrophil,counts'
p21970
g3
sS'intravenous,infusion,of'
p21971
g3
sS'were,not,measured'
p21972
g3
sS'of,and,acamprosate'
p21973
g3
sS'maneuver,often,applied'
p21974
g3
sS'of,gastrointestinal,ulceration'
p21975
g9
sS'how,soon,after'
p21976
g9
sS'acid,binding,to'
p21977
g9
sS'nsaids,tnf,blocking'
p21978
g3
sS'the,provide,close'
p21979
g3
sS'of,striatal,concentrations'
p21980
g9
sS'a,stimulating,effect'
p21981
g9
sS'proportional,over,the'
p21982
g3
sS'dosed,as,a'
p21983
g3
sS'results,from,trials'
p21984
g3
sS'iii,and,iv'
p21985
g3
sS'no,formal,studies'
p21986
g3
sS'the,reluctance,to'
p21987
g3
sS'these,results,would'
p21988
g9
sS'range,of,is'
p21989
g3
sS'gastrointestinal,and,non-gastrointestinal'
p21990
g3
sS'by,the,glucosylation'
p21991
g3
sS'aprepitant,on,the'
p21992
g9
sS's,a,cyp2c9'
p21993
g9
sS'chloride,in,a'
p21994
g9
sS'rats,arteries,from'
p21995
g3
sS'lamivudine,is,predominantly'
p21996
g3
sS'double,strength,mg'
p21997
g3
sS'hypoglycemic,agents,in'
p21998
g3
sS'distribution,and,a'
p21999
g3
sS'crossover,study,patients'
p22000
g3
sS'actions,after,missing'
p22001
g3
sS'in,interactions,toxicity'
p22002
g9
sS'max,auc,hrs'
p22003
g3
sS'hours,before,dosing'
p22004
g9
sS'hypertension,in,clinical'
p22005
g9
sS'and,citrate,elevations'
p22006
g9
sS'possible,clinical,significance'
p22007
g3
sS'doses,of,antizol'
p22008
g9
sS'the,dose,of'
p22009
g3
sS'phenytoin,in,a'
p22010
g3
sS'incidence,of,transient'
p22011
g3
sS'serious,falls,vs'
p22012
g9
sS'suppression,of,midcycle'
p22013
g3
sS'cyp,a4,inhibitors'
p22014
g3
sS'so,plasma,concentrations'
p22015
g9
sS'once,the,blood'
p22016
g3
sS'of,fenofibric,acid'
p22017
g3
sS'and,the,bad'
p22018
g9
sS'qt,interval,on'
p22019
g9
sS'particularly,for,those'
p22020
g3
sS'alterations,is,unclear'
p22021
g3
sS'when,and,non-steroidal'
p22022
g9
sS'to,confirm,that'
p22023
g3
sS'and,a,comparison'
p22024
g3
sS'and,individual,glucose'
p22025
g9
sS'patient,data,from'
p22026
g3
sS'thus,certain,factors'
p22027
g3
sS'are,occurred,in'
p22028
g3
sS'similar,effect,on'
p22029
g3
sS'clinical,laboratory,test'
p22030
g3
sS'other,related,compounds'
p22031
g9
sS'similarly,metabolized,particularly'
p22032
g3
sS'and,are,based'
p22033
g3
sS'vioxx,antiplatelet,therapies'
p22034
g3
sS'relevant,elevation,of'
p22035
g9
sS'based,on,enzymatic'
p22036
g3
sS'although,there,is'
p22037
g3
sS'other,psychoactive,or'
p22038
g9
sS'lower,the,dose'
p22039
g3
sS'aluminum-containing,had,no'
p22040
g3
sS'tarceva,dose,is'
p22041
g9
sS'copper,reduction,tests'
p22042
g3
sS'after,min,fasting'
p22043
g3
sS'systemic,concentrations,considerably'
p22044
g9
sS'blood,glucose,and'
p22045
g9
sS'peak,concentrations,of'
p22046
g3
sS'in,but,not'
p22047
g9
sS'caucasians,are,so'
p22048
g3
sS'of,this,patients'
p22049
g3
sS'glucose,control,in'
p22050
g3
sS'to,regimen,efficacy'
p22051
g3
sS'combination,with,serotoninergic'
p22052
g9
sS'sample,is,acidified'
p22053
g3
sS'clinical,implications,of'
p22054
g9
sS'the,pharmacokinetics,and'
p22055
g3
sS'fehling,s,solution'
p22056
g3
sS'being,converted,to'
p22057
g9
sS'of,supplemental,l-glutamine'
p22058
g9
sS'start,and,discontinuation'
p22059
g9
sS'in,vitamin,k'
p22060
g9
sS'as,and,oral'
p22061
g3
sS'may,be,impaired'
p22062
g3
sS'a,review,of'
p22063
g9
sS'microsomal,fraction,in'
p22064
g3
sS'controlled,studies,in'
p22065
g9
sS'risk,factors,is'
p22066
g3
sS'and,imitrex,nasal'
p22067
g3
sS'of,lymphatic,invasion'
p22068
g9
sS'with,and,following'
p22069
g3
sS'such,as,can'
p22070
g9
sS'counts,related,to'
p22071
g3
sS'sufficient,time,must'
p22072
g3
sS'is,coadministered,with'
p22073
g9
sS'rats,with,experimental'
p22074
g9
sS'these,trials,heart'
p22075
g3
sS'in,north,american'
p22076
g3
sS'taking,and,a'
p22077
g9
sS'microsomal,enzyme,inducer'
p22078
g9
sS'system,may,be'
p22079
g9
sS'analgesia,and,pupil'
p22080
g3
sS'properties,and,a'
p22081
g9
sS'protein-bound,have,essentially'
p22082
g3
sS'of,the,inhibitory'
p22083
g3
sS'in,ambulatory,patients'
p22084
g3
sS'analgesics,agonist,antagonist'
p22085
g9
sS'treatment,with,and'
p22086
g9
sS'should,be,as'
p22087
g3
sS'placebo-controlled,clinical,studies'
p22088
g3
sS'lead,to,significant'
p22089
g9
sS'such,as,choline'
p22090
g9
sS'to,beta-lactam,including'
p22091
g9
sS'anti-platelet,effect,is'
p22092
g3
sS'their,tolerance,to'
p22093
g9
sS'ocular,and,renal'
p22094
g3
sS'x,h,ml'
p22095
g9
sS'vitamin,d,also'
p22096
g3
sS'of,and,bretylium'
p22097
g3
sS'enterococci,were,lowered'
p22098
g3
sS'enlargement,and,congestive'
p22099
g9
sS'diltiazem,is,both'
p22100
g3
sS'appeared,to,prevent'
p22101
g9
sS'an,interaction,between'
p22102
g9
sS'is,administered,together'
p22103
g3
sS'are,co,administered'
p22104
g9
sS'doses,correspond,to'
p22105
g3
sS'activity,level,is'
p22106
g3
sS'or,administration,for'
p22107
g3
sS'reactions,atg,alg'
p22108
g3
sS'with,potent,loop'
p22109
g9
sS'single,in,vivo'
p22110
g3
sS'and,showed,that'
p22111
g3
sS'inhibitors,of,cyp3a'
p22112
g3
sS'in,addition,there'
p22113
g9
sS'affect,idv,exposure'
p22114
g3
sS'three,groups,which'
p22115
g3
sS'also,be,used'
p22116
g3
sS'of,lanoxin,lanoxicaps'
p22117
g9
sS'by,the,use'
p22118
g3
sS'through,actions,that'
p22119
g3
sS'for,duloxetine,to'
p22120
g3
sS'respectively,on,the'
p22121
g9
sS'using,a,inhaler'
p22122
g9
sS'pattern,of,efficacy'
p22123
g3
sS'following,simultaneous,administration'
p22124
g9
sS'rigidity,myoclonus,autonomic'
p22125
g9
sS'serum,concentrations,of'
p22126
g9
sS'to,a,mg'
p22127
g9
sS'diarrhea,or,in'
p22128
g3
sS'o11,strains,from'
p22129
g3
sS'reduced,efficacy,and'
p22130
g3
sS'reproductive,toxicology,studies'
p22131
g3
sS'degeneration,of,retinogeniculate'
p22132
g3
sS'sonata,mg,did'
p22133
g3
sS'that,toradol,induces'
p22134
g3
sS'reduced,adp-induced,increases'
p22135
g3
sS'is,suggested,while'
p22136
g3
sS'serum,concentrations,or'
p22137
g3
sS'male,subjects,no'
p22138
g3
sS'mg,day,n'
p22139
g3
sS'six,subjects,demonstrated'
p22140
g9
sS'therefore,the,concomitant'
p22141
g9
sS'who,received,mg'
p22142
g9
sS'peak,levels,and'
p22143
g3
sS'and,crystalline,preparations'
p22144
g3
sS'used,while,taking'
p22145
g3
sS'was,a,reduction'
p22146
g3
sS'have,shown,no'
p22147
g3
sS'prostaglandins,play,an'
p22148
g9
sS'one,study,was'
p22149
g3
sS'normally,with,respect'
p22150
g3
sS'relaxants,and,muscle'
p22151
g3
sS'drug,interactions,have'
p22152
g9
sS'had,a,modest'
p22153
g9
sS'following,coadministration,of'
p22154
g9
sS'of,cardiovascular,and'
p22155
g3
sS'parenterally,administered,in'
p22156
g9
sS'as,inotropes,and'
p22157
g9
sS'observed,in,arthritic'
p22158
g3
sS'to,the,central'
p22159
g3
sS'positive,direct,coombs'
p22160
g3
sS'daily,maintenance,dose'
p22161
g9
sS'cholestyramine,and,absorption'
p22162
g9
sS'being,treated,with'
p22163
g9
sS'obstruction,and,even'
p22164
g3
sS'effects,in,prolonging'
p22165
g9
sS'shown,in,a'
p22166
g3
sS'additive,when,was'
p22167
g3
sS'profile,of,as'
p22168
g3
sS'patients,with,neoplastic'
p22169
g9
sS'doctor,if,you'
p22170
g3
sS'at,these,doses'
p22171
g9
sS'ssris,have,been'
p22172
g9
sS'doses,may,inhibit'
p22173
g3
sS'of,protein-bound,anafranil'
p22174
g3
sS'mean,additional,supine'
p22175
g9
sS'specific,applications,of'
p22176
g3
sS'metabolism,of,combination'
p22177
g9
sS'may,potentially,interfere'
p22178
g3
sS'did,not,cause'
p22179
g3
sS'p450,isoenzymes,a4'
p22180
g3
sS'pharmacology,pharmacokinetics,pharmacodynamics'
p22181
g3
sS'hcl,blunts,the'
p22182
g9
sS'and,reuptake,thus'
p22183
g9
sS'well,defined,physical'
p22184
g3
sS'of,should,also'
p22185
g9
sS'gallate,also,showed'
p22186
g3
sS'periods,of,up'
p22187
g3
sS'exposures,proposed,by'
p22188
g3
sS'about,compared,to'
p22189
g9
sS'by,the,coadministration'
p22190
g3
sS'intracellular,and,extracellular'
p22191
g3
sS'when,these,were'
p22192
g9
sS'control,mechanisms,of'
p22193
g3
sS'administering,or,taking'
p22194
g9
sS'regard,to,designing'
p22195
g3
sS'possible,administration,of'
p22196
g3
sS'pharmacokinetic,interaction,when'
p22197
g3
sS'systematically,studied,certain'
p22198
g9
sS'and,the,ability'
p22199
g3
sS'if,is,combined'
p22200
g9
sS'working,properly,and'
p22201
g3
sS'fatal,interactions,may'
p22202
g3
sS'appear,to,induce'
p22203
g3
sS'cancer,increases,progressively'
p22204
g3
sS'no,pharmacodynamic,effects'
p22205
g3
sS'literature,reports,suggesting'
p22206
g9
sS'cholesterol,mg,dl'
p22207
g3
sS'be,subject,to'
p22208
g3
sS'pegasys,and,copegus'
p22209
g3
sS'supporting,blood,pressure'
p22210
g3
sS'urine,of,patients'
p22211
g3
sS'were,found,between'
p22212
g3
sS'with,intravenous,at'
p22213
g3
sS'review,of,the'
p22214
g9
sS'state,vioxx,mg'
p22215
g3
sS'renal,tubular,secretion'
p22216
g9
sS'sustivahas,the,potential'
p22217
g3
sS'normal,volunteers,coadministration'
p22218
g3
sS'conducted,no,interactions'
p22219
g3
sS'of,hepatic,metabolism'
p22220
g9
sS'the,hypoglycemic,effect'
p22221
g9
sS'cns,depressants,with'
p22222
g3
sS'functional,consequences,following'
p22223
g3
sS'a,nonabsorbable,complex'
p22224
g9
sS'of,epa,supplements'
p22225
g3
sS'man,in,animal'
p22226
g3
sS'that,genetic,factors'
p22227
g3
sS'resecting,the,cecum'
p22228
g3
sS'published,accounts,in'
p22229
g3
sS'of,concomitant,administration'
p22230
g9
sS'plasma,levels,or'
p22231
g3
sS'demonstrated,no,significant'
p22232
g3
sS'fentanyl,anesthesia,severe'
p22233
g9
sS'is,greatest,in'
p22234
g3
sS'and,the,central'
p22235
g9
sS'of,using,clozapine'
p22236
g3
sS'plasma,levels,of'
p22237
g9
sS'results,from,existing'
p22238
g3
sS'antihistamines,contraindicated,due'
p22239
g3
sS'because,cyp2d6,is'
p22240
g3
sS'cns,depressant,effect'
p22241
g9
sS'of,equetrotm,are'
p22242
g9
sS'activation,of,several'
p22243
g3
sS'medications,have,included'
p22244
g3
sS'acebutolol,and,low'
p22245
g3
sS'oral,ccnu,by'
p22246
g9
sS'that,are,dose'
p22247
g3
sS'within,weeks,after'
p22248
g3
sS'combined,hormonal,who'
p22249
g3
sS'blocking,the,vasodilating'
p22250
g9
sS'enhancement,of,post-heparin'
p22251
g9
sS'dose,of,significant'
p22252
g9
sS'determined,by,a'
p22253
g3
sS'and,the,channel'
p22254
g3
sS'alter,the,concentrations'
p22255
g9
sS'levels,by,column'
p22256
g3
sS'agents,the,effect'
p22257
g3
sS'cimetidine,increased,auc'
p22258
g3
sS'and,t3,in'
p22259
g9
sS'the,intestinal,mucosa'
p22260
g9
sS'be,approximately,half'
p22261
g3
sS'isis-2,currently,do'
p22262
g3
sS'increase,cardiac,autonomic'
p22263
g9
sS'i,d,have'
p22264
g3
sS'before,starting,and'
p22265
g9
sS'therapy,with,a'
p22266
g9
sS'levels,and,lethality'
p22267
g3
sS'co-administration,of,tcas'
p22268
g9
sS'conclusion,cisapride,can'
p22269
g3
sS'mean,plasma,elimination'
p22270
g3
sS'clinical,trials,similar'
p22271
g3
sS'and,job,appointments'
p22272
g3
sS'however,no,significant'
p22273
g3
sS'human,cells,whereas'
p22274
g3
sS'some,patients,treated'
p22275
g3
sS'channel,an,omega-agatoxin'
p22276
g3
sS'from,smoking,cessation'
p22277
g3
sS'interactions,with,and'
p22278
g3
sS'determine,if,the'
p22279
g9
sS'clinically,significant,interaction'
p22280
g3
sS'and,in,some'
p22281
g9
sS'no,dosing,adjustments'
p22282
g3
sS'signs,and,symptoms'
p22283
g9
sS'nephrotoxic,potential,intravenous'
p22284
g9
sS'and,corticotropin,acth'
p22285
g9
sS'still,kill,even'
p22286
g9
sS'of,on,valproic'
p22287
g9
sS'problem,not,only'
p22288
g3
sS'users,of,which'
p22289
g3
sS'compounds,that,are'
p22290
g9
sS'not,concurrently,use'
p22291
g9
sS'benign,ovarian,granulosa'
p22292
g3
sS'co-administration,of,tca5'
p22293
g3
sS'are,synergistic,such'
p22294
g9
sS'adjusted,in,accordance'
p22295
g3
sS'concurrently,with,other'
p22296
g3
sS'of,pseudomonas,aeruginosa'
p22297
g3
sS'added,in,the'
p22298
g3
sS'epoxide,hydrolase,or'
p22299
g3
sS'dose-dependent,manner,the'
p22300
g9
sS'a,year-old,african-american'
p22301
g3
sS'treated,with,coly-mycin'
p22302
g9
sS'concomitant,beta-1a,avonex'
p22303
g3
sS'a,time-dependent,inhibitor'
p22304
g3
sS'both,and,should'
p22305
g9
sS'short,s,interresponse'
p22306
g3
sS'dose,levels,of'
p22307
g3
sS'with,microalbuminuria,inspra'
p22308
g9
sS'observed,and,no'
p22309
g3
sS'interact,with,beta-adrenergic'
p22310
g9
sS'is,formed,after'
p22311
g3
sS'acetate,with,glycosides'
p22312
g9
sS'kerlone,with,the'
p22313
g3
sS'caution,in,combining'
p22314
g9
sS'with,isocarboxazid,and'
p22315
g3
sS'intravenous,and,brevibloc'
p22316
g9
sS'metabolism,of,one'
p22317
g9
sS'h2,antagonists,such'
p22318
g3
sS'of,angiotensin,and'
p22319
g3
sS'had,to,be'
p22320
g3
sS'serotonin,reuptake,and'
p22321
g9
sS'with,life-threatening,ventricular'
p22322
g3
sS'mg,b,i'
p22323
g9
sS'measures,have,been'
p22324
g3
sS'accuracy,in,patients'
p22325
g9
sS'transiently,elevated,by'
p22326
g3
sS'tricyclic,may,potentiate'
p22327
g3
sS'interact,with,of'
p22328
g9
sS'postoperative,respiratory,depression'
p22329
g3
sS'days,of,use'
p22330
g3
sS'another,interaction,study'
p22331
g9
sS'to,achieve,exposures'
p22332
g9
sS'metoprolol,administration,of'
p22333
g9
sS'the,acquired,behavioral'
p22334
g3
sS'or,symptoms,occur'
p22335
g9
sS'valproate,felbatol,causes'
p22336
g9
sS'are,not,clinically'
p22337
g3
sS'interact,with,or'
p22338
g3
sS'lipid-lowering,that,can'
p22339
g3
sS'patients,treated,simultaneously'
p22340
g3
sS'sodium,succinate,and'
p22341
g3
sS'cautious,initiation,of'
p22342
g9
sS'orally,with,channel'
p22343
g9
sS'however,co,administration'
p22344
g9
sS'sunscreens,and,some'
p22345
g9
sS'buffered,tablets,or'
p22346
g9
sS'of,necessary,while'
p22347
g3
sS'of,cyp3a4,major'
p22348
g3
sS'with,doses,higher'
p22349
g3
sS'however,if,the'
p22350
g3
sS'prolonged,use,for'
p22351
g3
sS'magnitude,and,prevalence'
p22352
g3
sS'of,antihypertensive,and'
p22353
g9
sS'of,less,than'
p22354
g9
sS'and,vitamin,b12'
p22355
g3
sS'negative,and,depressive'
p22356
g3
sS'dogs,unchanged,the'
p22357
g3
sS'kg,dose,or'
p22358
g9
sS'demonstrates,some,limited'
p22359
g9
sS'comparative,data,in'
p22360
g3
sS'increase,the,excretion'
p22361
g9
sS'aminosalicylic,acid,anabolic'
p22362
g9
sS'cyp2d6,cyp2e1,or'
p22363
g3
sS'c9,and,not'
p22364
g3
sS'inhibitors,may,potentiate'
p22365
g9
sS'receiving,or,concurrently'
p22366
g9
sS'with,viracept,antiarrhythmics'
p22367
g9
sS'binding,of,and'
p22368
g3
sS'acid,itself,was'
p22369
g3
sS'constitute,the,sole'
p22370
g3
sS'coadministration,of,on'
p22371
g3
sS'between,uroxatral,and'
p22372
g3
sS'of,other,traditional'
p22373
g3
sS'the,united,kingdom'
p22374
g9
sS'using,the,scale'
p22375
g3
sS'therapies,i,tranexamic'
p22376
g3
sS'and,toxic,effects'
p22377
g3
sS'contrast,preliminary,results'
p22378
g3
sS'cimetidine,an,inhibitor'
p22379
g9
sS'extracellular,application,of'
p22380
g3
sS'accompanied,by,ecg'
p22381
g3
sS'be,reduced,while'
p22382
g9
sS'presence,of,enflurane'
p22383
g3
sS'coadministration,of,or'
p22384
g9
sS'injury,as,manifested'
p22385
g3
sS'increase,in,blood'
p22386
g9
sS'effect,of,which'
p22387
g3
sS'miracidia,demonstrated,a'
p22388
g3
sS'use,of,robinul'
p22389
g9
sS'nor,the,pharmacokinetics'
p22390
g3
sS'including,hypertensive,crises'
p22391
g9
sS'concurrently,the,following'
p22392
g3
sS'studied,extensively,in'
p22393
g3
sS'oral,doses,should'
p22394
g9
sS'p450,inhibitors,and'
p22395
g3
sS'either,unchanged,or'
p22396
g3
sS'vitro,from,to'
p22397
g9
sS'inhibitors,monoamine,oxidase'
p22398
g3
sS'with,all,nsaids'
p22399
g9
sS'gleevec,inhibits,o-glucuronidation'
p22400
g3
sS'are,not,always'
p22401
g3
sS'in,excess,of'
p22402
g3
sS'dose,limiting,may'
p22403
g3
sS'following,adverse,events'
p22404
g9
sS'treated,with,nevirapine-'
p22405
g3
sS'submitted,to,treatment'
p22406
g3
sS'which,may,affect'
p22407
g3
sS'geriatric,population,is'
p22408
g3
sS'and,in,unconjugated'
p22409
g3
sS'washed,out,and'
p22410
g3
sS'tumors,seen,in'
p22411
g3
sS'serious,resedation,at'
p22412
g3
sS'suggested,to,monitor'
p22413
g9
sS'weight,and,post-implantation'
p22414
g3
sS'toxic,action,of'
p22415
g3
sS'may,exacerbate,the'
p22416
g9
sS'on,tikosyn,had'
p22417
g3
sS'nac,for,the'
p22418
g3
sS'used,to,aid'
p22419
g3
sS'increased,dosage,of'
p22420
g9
sS'with,camp,in'
p22421
g3
sS'sufficient,time,for'
p22422
g3
sS'that,therapy,with'
p22423
g3
sS'days,did,not'
p22424
g3
sS'the,blood,concentration-time'
p22425
g3
sS'of,steady-state,l50'
p22426
g3
sS'pharmacologically,active,monohydroxy'
p22427
g3
sS'consequently,should,be'
p22428
g9
sS'co-treatment,with,the'
p22429
g9
sS'nonadditive,independent,joint'
p22430
g3
sS'known,to,depress'
p22431
g3
sS'incubated,at,various'
p22432
g3
sS'recommended,that,they'
p22433
g9
sS'fluothane,as,arrhythmias'
p22434
g9
sS'of,the,induction'
p22435
g9
sS'with,and,lodine'
p22436
g3
sS'are,ge,nerally'
p22437
g3
sS'proleukin-induced,side,effects'
p22438
g9
sS'and,inhibition,of'
p22439
g3
sS'could,lessen,its'
p22440
g3
sS'antagonists,when,is'
p22441
g9
sS'regarding,the,effects'
p22442
g3
sS'and,long-term,consequences'
p22443
g3
sS'representing,a,potential'
p22444
g9
sS'neoplasia,are,also'
p22445
g3
sS'may,substantially,interfere'
p22446
g9
sS'be,provided,for'
p22447
g3
sS'isoform,and,cyp1a2'
p22448
g3
sS'in,patients,chronically'
p22449
g9
sS'may,be,effective'
p22450
g9
sS'administered,a,fixed'
p22451
g3
sS'patients,undergoing,concurrent'
p22452
g9
sS'if,they,can'
p22453
g3
sS'is,a,moderate'
p22454
g3
sS'the,hepatoxicity,of'
p22455
g9
sS'absorption,of,v'
p22456
g9
sS'such,users,is'
p22457
g3
sS'thus,may,increase'
p22458
g9
sS'but,caused,no'
p22459
g3
sS'caused,by,inhibition'
p22460
g3
sS'confirms,the,identity'
p22461
g3
sS'histamine,h2,antagonists'
p22462
g9
sS'are,dryness,of'
p22463
g3
sS'when,mefloquine,is'
p22464
g9
sS'absorption,of,g'
p22465
g9
sS'absorption,of,a'
p22466
g3
sS'may,have,resulted'
p22467
g9
sS'recommended,because,of'
p22468
g9
sS'lethargy,drowsiness,restlessness'
p22469
g3
sS'may,occur,because'
p22470
g9
sS'and,treatments,and'
p22471
g3
sS'mg,tid,was'
p22472
g9
sS'did,not,confirm'
p22473
g3
sS'used,on,a'
p22474
g3
sS'with,no,specific'
p22475
g3
sS'with,potassium-sparing,may'
p22476
g3
sS'and,thus,this'
p22477
g3
sS'naftate,cephalothin,sodium'
p22478
g3
sS'parasympathomimetic,effects,administered'
p22479
g3
sS'due,to,possible'
p22480
g9
sS'scale,of,displacement'
p22481
g3
sS'effects,reduced,by'
p22482
g3
sS'changes,in,or'
p22483
g3
sS'av,conduction,when'
p22484
g9
sS'decrease,the,plasma'
p22485
g9
sS'the,microsomal,fraction'
p22486
g3
sS'or,dose,baseline'
p22487
g3
sS'the,benefits,and'
p22488
g9
sS'heart,failure,post-myocardial'
p22489
g3
sS'acid,indicating,no'
p22490
g3
sS'encountered,during,the'
p22491
g3
sS'treatment,may,require'
p22492
g9
sS'mg,qd,did'
p22493
g3
sS'biopsy,roegnik,grade'
p22494
g3
sS's,solutions,and'
p22495
g3
sS'was,bioequivalent,when'
p22496
g3
sS'as,they,may'
p22497
g3
sS'potentiation,the,physician'
p22498
g3
sS'may,even,decrease'
p22499
g3
sS'lower,blood,levels'
p22500
g3
sS'liver,function,clinical'
p22501
g3
sS'some,indications,of'
p22502
g3
sS'renal,and,or'
p22503
g3
sS'clearance,of,and'
p22504
g9
sS'concentrations,and,decreased'
p22505
g3
sS'using,comparisons,to'
p22506
g3
sS'however,the,systemic'
p22507
g9
sS'doses,of,increased'
p22508
g3
sS'for,evaluating,the'
p22509
g3
sS'chronic,weeks,oral'
p22510
g3
sS'tca,treatment,in'
p22511
g3
sS'of,wellbutrin,following'
p22512
g3
sS'need,to,reassess'
p22513
g3
sS'shown,by,rats'
p22514
g3
sS'of,alone,markedly'
p22515
g3
sS'l-arginine,supplements,taken'
p22516
g9
sS'or,urinary,tract'
p22517
g3
sS'may,share,or'
p22518
g3
sS'because,of,the'
p22519
g9
sS'therapy,for,initial'
p22520
g3
sS'and,high,affinity'
p22521
g3
sS'plus,experienced,severe'
p22522
g9
sS'clinical,data,on'
p22523
g3
sS'sudden,increase,in'
p22524
g9
sS'be,administered,to'
p22525
g9
sS'on,pharmacokinetics,but'
p22526
g9
sS'a,agonist,can'
p22527
g9
sS'digoxin,and,use'
p22528
g9
sS'receiving,taxotere,as'
p22529
g3
sS'supplements,has,been'
p22530
g3
sS'greater,in,the'
p22531
g3
sS'titration,of,the'
p22532
g3
sS'of,epidural,local'
p22533
g9
sS'discontinued,prior,to'
p22534
g3
sS'if,and,are'
p22535
g9
sS'ketorolac,does,not'
p22536
g3
sS'acarbose,has,no'
p22537
g3
sS'diabetes,mellitus,or'
p22538
g3
sS'leukemia,in,the'
p22539
g9
sS'analgesic,effect,of'
p22540
g9
sS'magnesium,magnesium-containing,preparations'
p22541
g9
sS'based,on,anecdotal'
p22542
g9
sS'suggest,comparable,activity'
p22543
g3
sS'staphylococcus,aureus,a'
p22544
g9
sS'show,significant,inhibition'
p22545
g3
sS'at,similar,concentrations'
p22546
g3
sS'anticoagulants,there,have'
p22547
g9
sS'and,clinically,important'
p22548
g3
sS'enteric,coated,aspirin'
p22549
g9
sS'disease,is,a'
p22550
g3
sS'cancers,were,investigated'
p22551
g3
sS'reduce,the,function'
p22552
g3
sS'with,hydrochloride,mg'
p22553
g3
sS'therapy,of,ponstel'
p22554
g9
sS'weeks,should,elapse'
p22555
g9
sS'interactions,increases,in'
p22556
g3
sS'controlled,with,vardenafil'
p22557
g9
sS'muscle,relaxants,could'
p22558
g9
sS'use,instructions,and'
p22559
g3
sS'applied,to,the'
p22560
g9
sS'or,higher,was'
p22561
g3
sS'disease,or,those'
p22562
g9
sS'profound,effect,on'
p22563
g3
sS'with,atacand,so'
p22564
g9
sS'when,doses,of'
p22565
g9
sS'chlorotrianisene,may,interact'
p22566
g9
sS'to,decreased,synthesis'
p22567
g9
sS'of,and,its'
p22568
g9
sS'occur,when,levsin'
p22569
g9
sS'glucosylation,of,the'
p22570
g3
sS'study,with,showed'
p22571
g3
sS'nph,human,novolog'
p22572
g3
sS'discontinuation,of,and'
p22573
g9
sS'weekly,reduced,tysabri'
p22574
g9
sS'injection,use,resulted'
p22575
g3
sS'eliminate,the,fluoride'
p22576
g9
sS'should,be,continuously'
p22577
g9
sS'administered,to,rats'
p22578
g9
sS'patients,using,cyp3a4'
p22579
g9
sS'intravenous,amphotericin,b'
p22580
g9
sS'in,the,germinal'
p22581
g3
sS'required,to,maintain'
p22582
g3
sS'those,prior,to'
p22583
g3
sS'l-methionine,may,decrease'
p22584
g9
sS'by,cyp2d6,has'
p22585
g3
sS'of,agents,may'
p22586
g3
sS'or,t,max'
p22587
g3
sS'one-half,depending,on'
p22588
g3
sS'greater,affinity,for'
p22589
g3
sS'warfarin-type,cyp2c9,and'
p22590
g3
sS'digitalis,toxicity,may'
p22591
g9
sS'system,development,is'
p22592
g3
sS'interactions,for,any'
p22593
g3
sS'at,least,balanced'
p22594
g3
sS'need,for,or'
p22595
g3
sS'by,baseline,use'
p22596
g3
sS'acamprosate,produced,a'
p22597
g9
sS'which,is,catalyzed'
p22598
g3
sS'uptake-1,was,studied'
p22599
g3
sS'and,neither,were'
p22600
g3
sS'closely,after,initiation'
p22601
g9
sS'laboratory,test,abnormalities'
p22602
g3
sS'possibly,by,competing'
p22603
g9
sS'filtration,rate,and'
p22604
g3
sS'require,a,dosage'
p22605
g3
sS'levulan,kerastick,for'
p22606
g9
sS'with,no,clinically'
p22607
g3
sS'was,far,more'
p22608
g3
sS'effects,including,fever'
p22609
g9
sS'levels,effects,of'
p22610
g3
sS'non-steroidal,agents,are'
p22611
g9
sS'the,role,of'
p22612
g3
sS'from,these,groups'
p22613
g3
sS'in,a,randomized'
p22614
g3
sS'of,coadministered,and'
p22615
g3
sS'for,and,urine'
p22616
g3
sS'are,no,reported'
p22617
g3
sS'crohns,disease,and'
p22618
g9
sS'associated,with,other'
p22619
g3
sS'from,the,cytosol'
p22620
g3
sS'to,competitive,inhibition'
p22621
g3
sS'of,with,viracept'
p22622
g9
sS'g,and,preparations'
p22623
g9
sS'caused,by,administration'
p22624
g3
sS'inhibition,can,result'
p22625
g3
sS'suggest,that,plasma'
p22626
g9
sS'sugar,level,hyperlipidaemia'
p22627
g3
sS'because,may,enhance'
p22628
g9
sS'symptoms,suggestive,of'
p22629
g9
sS'bear,directly,on'
p22630
g9
sS'the,assay,of'
p22631
g3
sS'erpf,and,tm'
p22632
g9
sS'effective,duration,of'
p22633
g9
sS'and,stress,may'
p22634
g3
sS'the,blood-sugar,reducing'
p22635
g9
sS'disease,states,underlying'
p22636
g3
sS'that,are,not'
p22637
g3
sS'used,preanesthetic,or'
p22638
g3
sS'prothrombin,times,or'
p22639
g3
sS'of,other,channel'
p22640
g9
sS'for,early,evidence'
p22641
g3
sS'via,this,route'
p22642
g9
sS'and,an,apparently'
p22643
g3
sS'in,the,mean'
p22644
g9
sS'of,sodium,was'
p22645
g3
sS'and,somnolence,have'
p22646
g9
sS'information,for,the'
p22647
g3
sS'suggest,that,when'
p22648
g9
sS'be,additive,coadministration'
p22649
g9
sS'metacercariae,of,parorchis'
p22650
g3
sS'early-phase,schizophrenia,were'
p22651
g3
sS'acetylsalicylic,acid,nsaids'
p22652
g3
sS'was,reduced,by'
p22653
g9
sS'by,qtc,increase'
p22654
g3
sS'that,increased,interaction'
p22655
g3
sS'in,urine,using'
p22656
g3
sS'or,eliminated,the'
p22657
g9
sS'ast,when,cancidas'
p22658
g9
sS'or,hepatic,enzyme'
p22659
g9
sS'clinical,experiences,eg'
p22660
g3
sS'derivatives,prothrombin,time'
p22661
g9
sS'depend,upon,a'
p22662
g3
sS'extend,outside,the'
p22663
g3
sS'or,those,taking'
p22664
g9
sS'pyrazolone,derivatives,and'
p22665
g9
sS'was,compared,directly'
p22666
g3
sS'clinical,interest,to'
p22667
g3
sS'highly,sensitive,assay'
p22668
g3
sS'herb,nutraceutical,st'
p22669
g3
sS'and,has,an'
p22670
g9
sS'the,overall,response'
p22671
g9
sS'patients,receiving,chronic'
p22672
g3
sS'its,activity,and'
p22673
g3
sS'trial,using,escalating'
p22674
g9
sS'chloride-induced,gastrointestinal,lesions'
p22675
g9
sS'coat-a,count,ria'
p22676
g3
sS'demonstrated,superior,antipsychotic'
p22677
g3
sS'factive,and,carbonate'
p22678
g9
sS'expected,magnitude,of'
p22679
g3
sS'aspirin,ketoprofen,does'
p22680
g3
sS'malignant,cells,this'
p22681
g9
sS'but,also,to'
p22682
g9
sS'm2,basis,to'
p22683
g9
sS'therefore,it,would'
p22684
g3
sS'and,a,reduction'
p22685
g9
sS'de,pointes,most'
p22686
g9
sS'time,by,approximately'
p22687
g3
sS'retard,the,microvascular'
p22688
g3
sS'this,effort,optimal'
p22689
g3
sS'increase,in,dose'
p22690
g9
sS'dilution,method,and'
p22691
g3
sS'creams,ointments,or'
p22692
g3
sS'metabolites,with,the'
p22693
g3
sS'significantly,improve,the'
p22694
g3
sS'level,of,circulating'
p22695
g3
sS'as,of,the'
p22696
g3
sS'study,it,is'
p22697
g3
sS'may,subject,themselves'
p22698
g3
sS'and,cyp2a6,and'
p22699
g3
sS'the,natriuresis,and'
p22700
g9
sS'contraception,simultaneously,at'
p22701
g3
sS'further,fe,abstract'
p22702
g3
sS'auc,or,maximum'
p22703
g3
sS'with,other,general'
p22704
g9
sS'of,enterococcus,three'
p22705
g3
sS'in,this,class'
p22706
g3
sS'proleukin,may,increase'
p22707
g9
sS'or,s,determined'
p22708
g9
sS'should,be,observed'
p22709
g3
sS'to,should,be'
p22710
g9
sS'or,partner,of'
p22711
g3
sS'or,changing,the'
p22712
g9
sS'patients,are,at'
p22713
g9
sS'the,two,are'
p22714
g9
sS'cysteine,was,covalently'
p22715
g3
sS'establish,whether,the'
p22716
g3
sS'and,certainly,during'
p22717
g9
sS'probably,the,major'
p22718
g3
sS'as,those,used'
p22719
g3
sS'with,a,decreased'
p22720
g9
sS'an,erection,disorder'
p22721
g3
sS'interaction,study,with'
p22722
g3
sS'such,inactivation,of'
p22723
g3
sS'were,reported,with'
p22724
g3
sS'and,or,parenteral'
p22725
g3
sS'precedex,on,the'
p22726
g9
sS'based,upon,the'
p22727
g9
sS'important,interactions,to'
p22728
g3
sS'derivatives,k,antagonists'
p22729
g3
sS'an,oral,mg'
p22730
g3
sS'gastric,acid,secretion'
p22731
g9
sS'the,cardiovascular,action'
p22732
g9
sS'using,more,specific'
p22733
g3
sS'considerable,effect,in'
p22734
g9
sS'require,dosage,adjustment'
p22735
g3
sS'of,myopathy,during'
p22736
g3
sS'although,a,day'
p22737
g9
sS'probably,responsible,for'
p22738
g3
sS'oral,may,affect'
p22739
g3
sS'as,a,high'
p22740
g3
sS'induced,in,mcf-7'
p22741
g3
sS'having,a,vitamin'
p22742
g3
sS'fischer-344,strain,were'
p22743
g3
sS'adverse,effects,on'
p22744
g3
sS'or,inactivity,of'
p22745
g3
sS'in,free,concentration'
p22746
g3
sS'injected,and,its'
p22747
g3
sS'alone,because,may'
p22748
g9
sS'amplitudes,of,most'
p22749
g3
sS'therefore,it,is'
p22750
g3
sS'of,fell,by'
p22751
g9
sS'tachycardia,have,been'
p22752
g9
sS'contact,and,with'
p22753
g3
sS'was,potentiated,by'
p22754
g3
sS'and,cyp,a'
p22755
g3
sS'should,be,under'
p22756
g3
sS'with,many,without'
p22757
g3
sS'patients,with,an'
p22758
g3
sS'adverse,effects,or'
p22759
g3
sS'unlikely,to,have'
p22760
g3
sS'samples,for,measurement'
p22761
g3
sS'of,sonata,to'
p22762
g3
sS'a,that,inhibits'
p22763
g3
sS'foscavir,decreases,serum'
p22764
g3
sS'increases,metabolic,rate'
p22765
g3
sS'serum,levels,for'
p22766
g3
sS'studies,showed,higher'
p22767
g9
sS'agents,may,represent'
p22768
g3
sS'were,stabilized,on'
p22769
g3
sS'terminal,half-life,decreased'
p22770
g9
sS'made,carefully,and'
p22771
g3
sS'are,increased,with'
p22772
g9
sS'effect,of,refludan'
p22773
g3
sS'marketing,observations,have'
p22774
g9
sS'an,inhibitory,effect'
p22775
g3
sS'decreased,efficacy,of'
p22776
g9
sS'or,more,in'
p22777
g9
sS'oral,anticoagulants,in'
p22778
g9
sS'central,importance,of'
p22779
g3
sS'that,can,cause'
p22780
g3
sS'dose,adjustment,may'
p22781
g9
sS'including,anafranil,is'
p22782
g3
sS'affected,by,co-administration'
p22783
g3
sS'of,with,ace'
p22784
g9
sS'not,altered,when'
p22785
g3
sS'produce,ventricular,arrhythmias'
p22786
g3
sS'two-fold,increase,in'
p22787
g9
sS'administration,of,pegasys'
p22788
g3
sS'hormone,response,of'
p22789
g9
sS'with,and,against'
p22790
g3
sS'with,an,angiotensin-converting'
p22791
g9
sS'olanzapine,an,updated'
p22792
g3
sS'on,may,show'
p22793
g9
sS'of,female,fertility'
p22794
g3
sS'caused,by,bretylium'
p22795
g9
sS'for,oral,increased'
p22796
g3
sS'alternative,non-cyp3a4,substrate'
p22797
g3
sS'thioridazine,coadministration,of'
p22798
g9
sS'a,small,decrease'
p22799
g9
sS'when,is,either'
p22800
g9
sS'and,oral,concomitant'
p22801
g9
sS'between,betaseron,and'
p22802
g3
sS'reviewed,for,additional'
p22803
g9
sS'hours,between,intake'
p22804
g3
sS'or,clinically,relevant'
p22805
g3
sS'the,that,inhibit'
p22806
g3
sS'sodium,kg,for'
p22807
g9
sS'of,colonic,fluid'
p22808
g3
sS'prinivil,has,been'
p22809
g3
sS'evidence,suggest,that'
p22810
g3
sS'a,pronounced,though'
p22811
g9
sS'toxicokinetic,studies,in'
p22812
g3
sS'taken,concurrently,and'
p22813
g3
sS'when,used,concurrently'
p22814
g3
sS'significance,in,the'
p22815
g3
sS'c-cholesteryl,oleate,and'
p22816
g3
sS'tubules,seminiferous,tubular'
p22817
g3
sS'on,psychomotor,performance'
p22818
g9
sS'the,proposed,methodology'
p22819
g3
sS'with,other,amphotericin'
p22820
g9
sS'should,either,be'
p22821
g9
sS'found,in,most'
p22822
g3
sS'counts,and,the'
p22823
g3
sS'and,maintenance,doses'
p22824
g9
sS'and,the,metabolism'
p22825
g3
sS'be,continued,if'
p22826
g9
sS'stereoselectivity,in,the'
p22827
g3
sS'day,doses,of'
p22828
g3
sS'phenytoin,etodolac,has'
p22829
g3
sS'and,several,with'
p22830
g3
sS'due,to,a'
p22831
g9
sS'may,be,involved'
p22832
g3
sS'over,hours,or'
p22833
g3
sS'effectiveness,of,the'
p22834
g3
sS'did,not,interfere'
p22835
g3
sS'from,fulvestrant-treated,lactating'
p22836
g3
sS'further,in,rabbits'
p22837
g3
sS'with,all,the'
p22838
g3
sS'possibly,increasing,its'
p22839
g9
sS'of,acute,pretreatment'
p22840
g3
sS'enhance,the,seizure'
p22841
g9
sS'generalized,urticaria,require'
p22842
g3
sS'cyps,a1,c9'
p22843
g3
sS'was,increased,by'
p22844
g9
sS'antitumour,activity,for'
p22845
g3
sS'noted,in,the'
p22846
g3
sS'closely,in,time'
p22847
g9
sS'to,interactions,of'
p22848
g3
sS'use,with,supplements'
p22849
g3
sS'by,when,extended'
p22850
g3
sS'of,oral,or'
p22851
g3
sS'is,however,possible'
p22852
g9
sS'inhibit,elimination,and'
p22853
g9
sS'the,resulting,increase'
p22854
g3
sS'association,has,not'
p22855
g3
sS'pbi,t4,levels'
p22856
g3
sS'andusing,a,containing'
p22857
g3
sS'the,months,after'
p22858
g3
sS'and,is,a'
p22859
g3
sS'of,combined,hormonal'
p22860
g3
sS'mg,day,divided'
p22861
g9
sS'l,with,increasing'
p22862
g3
sS'in,animal,or'
p22863
g3
sS'retention,tend,to'
p22864
g3
sS'the,concentrations,of'
p22865
g9
sS'rats,at,approximately'
p22866
g9
sS'administered,with,such'
p22867
g9
sS'no,other,pharmacokinetic'
p22868
g3
sS'ammonium,chloride,sodium'
p22869
g9
sS'one,or,both'
p22870
g3
sS'thiazide,may,raise'
p22871
g3
sS'ability,to,inhibit'
p22872
g9
sS'to,nonlethal,and'
p22873
g3
sS'vioxx,is,initiated'
p22874
g9
sS'and,some,nsaids'
p22875
g9
sS'the,total,clearance'
p22876
g9
sS'free,t3,concentrations'
p22877
g3
sS'agents,including,and'
p22878
g3
sS'as,reinforcing,effects'
p22879
g3
sS'agents,employed,since'
p22880
g9
sS'cardiac,capacity,should'
p22881
g3
sS'secretion,distribution,metabolism'
p22882
g3
sS'h,exposures,of'
p22883
g3
sS'efficacy,safety,contraindications'
p22884
g3
sS'did,not,diminish'
p22885
g3
sS'infection,and,produce'
p22886
g3
sS'using,or,concomitantly'
p22887
g9
sS'if,regranex,gel'
p22888
g3
sS'combination,with,sustiva'
p22889
g3
sS'preparation,was,added'
p22890
g3
sS'of,the,constituents'
p22891
g3
sS'inhibits,cyp3a4,cyp2c9'
p22892
g3
sS'up,to,the'
p22893
g3
sS'a,significant,difference'
p22894
g3
sS'diabetics,and,undetectable'
p22895
g3
sS'therefore,the,dose'
p22896
g3
sS'ultimate,effect,of'
p22897
g3
sS'other,cns-active,has'
p22898
g3
sS'antiepileptic,periodic,serum'
p22899
g9
sS'ligand,binding,activity'
p22900
g3
sS'interaction,between,zdv'
p22901
g3
sS'azathioprine,allopurinol,inhibits'
p22902
g9
sS'have,been,tested'
p22903
g3
sS'essential,the,possibility'
p22904
g3
sS'to,need,expensive'
p22905
g3
sS'the,skeletal,muscle'
p22906
g9
sS'attention,test,for'
p22907
g9
sS'possible,and,alternative'
p22908
g9
sS'medications,that,interfere'
p22909
g3
sS'resulted,in,increased'
p22910
g9
sS'the,enkephalinergic,neurons'
p22911
g9
sS'patients,concurrently,taking'
p22912
g3
sS'stability,over,time'
p22913
g3
sS'pathway,for,detoxification'
p22914
g9
sS'when,is,administered'
p22915
g9
sS'resulted,in,increases'
p22916
g9
sS'a,cyp3a4,substrate'
p22917
g9
sS'there,is,one'
p22918
g9
sS'and,following,multiple'
p22919
g3
sS'duodenal,absorption,acting'
p22920
g9
sS'is,taken,with'
p22921
g9
sS'responses,in,locomotor'
p22922
g3
sS'the,is,clinically'
p22923
g3
sS'pharmacokinetics,of,fenofibric'
p22924
g3
sS'spontaneous,action,potentials'
p22925
g3
sS'first,day,of'
p22926
g3
sS'fibers,in,clinically'
p22927
g3
sS'frequency,of,dosing'
p22928
g3
sS'in,addition,studies'
p22929
g3
sS'among,bosentan-,and'
p22930
g3
sS'of,cyp3a4,below'
p22931
g3
sS'be,artifactually,altered'
p22932
g3
sS'such,as,bradycardia'
p22933
g9
sS'concentrations,has,no'
p22934
g3
sS'during,the,trials'
p22935
g3
sS'daily,was,coadministered'
p22936
g3
sS'before,and,after'
p22937
g3
sS'vertigo,syncope,presyncope'
p22938
g9
sS'at,and,min'
p22939
g3
sS'to,maintain,satisfactory'
p22940
g3
sS'effects,may,become'
p22941
g3
sS'of,low,therapeutic'
p22942
g3
sS'designed,to,evaluate'
p22943
g3
sS'with,nm,oh'
p22944
g3
sS'temporarily,discontinued,or'
p22945
g9
sS'agents,and,might'
p22946
g9
sS'and,hour,blood'
p22947
g9
sS'treatment,with,isocarboxazid'
p22948
g3
sS'that,results,in'
p22949
g9
sS'may,potentiate,amphotericin'
p22950
g9
sS'of,a,chylomicron-like'
p22951
g3
sS'not,so,active'
p22952
g3
sS'in,general,and'
p22953
g3
sS'reductions,in,the'
p22954
g3
sS'is,a,competitive'
p22955
g9
sS'hcl,and,sulfate'
p22956
g9
sS'if,the,effects'
p22957
g9
sS'oral,certain,and'
p22958
g9
sS'dosed,with,vardenafil'
p22959
g9
sS'proper,monitoring,of'
p22960
g3
sS'should,be,individualized'
p22961
g3
sS'vitro,concentrations,found'
p22962
g3
sS'studied,the,concomitant'
p22963
g9
sS'embryocidal,effects,have'
p22964
g3
sS'therapy,eg,or'
p22965
g9
sS's,isomers,of'
p22966
g3
sS'pharmacokinetics,of,cmax'
p22967
g3
sS'was,administered,to'
p22968
g3
sS'steroidal,agent,can'
p22969
g9
sS'before,a,long-acting'
p22970
g3
sS'polyene,showed,differential'
p22971
g3
sS'metabolites,oxo-desethylzaleplon,and'
p22972
g3
sS'in,the,suppression'
p22973
g3
sS'derivatives,and,may'
p22974
g9
sS'negative,inotropic,agents'
p22975
g9
sS'informed,when,a'
p22976
g3
sS'to,screen,compounds'
p22977
g3
sS'received,one,dose'
p22978
g3
sS'elevated,international,normalized'
p22979
g3
sS'platelets,leukocytes,and'
p22980
g3
sS'indomethacin,are,used'
p22981
g3
sS'for,by,range'
p22982
g9
sS'initiation,of,therapy'
p22983
g9
sS'is,increased,by'
p22984
g9
sS'between,zdv,and'
p22985
g3
sS'add,a,high'
p22986
g9
sS'a,massive,precipitation'
p22987
g3
sS'activated,prothrombin,complex'
p22988
g3
sS'cyp3a4,mediated,metabolism'
p22989
g3
sS'not,at,all'
p22990
g9
sS'was,identical,but'
p22991
g3
sS'cyp1a2,cyp2c9,cyp2c19'
p22992
g3
sS'ototoxicity,and,potentiate'
p22993
g3
sS'define,the,changes'
p22994
g3
sS'in,concurrent,or'
p22995
g3
sS'not,demonstrated,any'
p22996
g3
sS'gets,absorbed,into'
p22997
g9
sS'as,or,careful'
p22998
g9
sS'rarely,associated,with'
p22999
g9
sS'such,as,implants'
p23000
g3
sS'that,can,inhibit'
p23001
g3
sS'the,need,for'
p23002
g3
sS'especially,with,repeated'
p23003
g3
sS'expected,physiologic,effects'
p23004
g3
sS'few,individuals,discontinuing'
p23005
g3
sS'administering,compounds,in'
p23006
g3
sS'and,seem,to'
p23007
g3
sS'combinations,or,with'
p23008
g3
sS'combinations,of,these'
p23009
g9
sS'nerve,degeneration,wallerian'
p23010
g3
sS'patients,with,elevated'
p23011
g9
sS'combination,therapies,that'
p23012
g3
sS'patients,and,cerebyx'
p23013
g9
sS'that,may,impair'
p23014
g9
sS'prothrombin,time,inr'
p23015
g3
sS'in,this,patient'
p23016
g3
sS'with,a,increase'
p23017
g9
sS'including,anti-arrhythmic,agents'
p23018
g3
sS'action,of,adrenergic'
p23019
g9
sS'to,of,a'
p23020
g3
sS'toxicity,may,have'
p23021
g9
sS'system,depressants,other'
p23022
g3
sS'with,abciximab,have'
p23023
g3
sS'inhibited,by,ergosterol'
p23024
g3
sS'following,mating,caused'
p23025
g3
sS'by,stimulating,the'
p23026
g3
sS'ml,h,did'
p23027
g3
sS'of,use,in'
p23028
g3
sS'concomitant,compared,with'
p23029
g3
sS'with,each,dose'
p23030
g9
sS'dipropylxanthine,dpcpx,in'
p23031
g3
sS'with,other,topical'
p23032
g3
sS'hamsters,show,subnormal'
p23033
g3
sS'doses,higher,than'
p23034
g3
sS'pump,inhibitors,long-term'
p23035
g9
sS'such,as,colostrum'
p23036
g3
sS'agents,actions,of'
p23037
g3
sS'daily,dosing,regimens'
p23038
g3
sS'patient,in,whom'
p23039
g3
sS'stimulus,response,in'
p23040
g3
sS'clinical,studies,case'
p23041
g3
sS'on,decreased,alertness'
p23042
g9
sS'investigated,in,patients'
p23043
g3
sS'epa,supplements,and'
p23044
g9
sS'would,worsen,the'
p23045
g9
sS'levels,were,undetectable'
p23046
g3
sS'chop,chemotherapy,regimen'
p23047
g3
sS'reduced,the,urine'
p23048
g9
sS'ratio,or,in'
p23049
g3
sS'is,essential,conduct'
p23050
g3
sS'mean,template,bleeding'
p23051
g3
sS'u,of,to'
p23052
g3
sS'serious,pneumonia,vs'
p23053
g9
sS'expected,that,a'
p23054
g3
sS'this,process,can'
p23055
g3
sS'uric,acid,levels'
p23056
g3
sS'with,a,agent'
p23057
g9
sS'with,general,antianxiety'
p23058
g3
sS'secondary,prevention,of'
p23059
g3
sS'being,homocysteine,by'
p23060
g3
sS'patients,and,in'
p23061
g3
sS'impaired,renal,function'
p23062
g9
sS'included,in,the'
p23063
g3
sS'with,it,has'
p23064
g3
sS'data,suggest,similar'
p23065
g3
sS'subsequently,increase,with'
p23066
g3
sS'some,colorimetric,complexometric'
p23067
g3
sS'determinants,downstream,of'
p23068
g3
sS'that,a,exerts'
p23069
g3
sS'data,intables,and'
p23070
g3
sS'of,cyp2d6,because'
p23071
g3
sS'were,observed,when'
p23072
g3
sS'when,are,administered'
p23073
g9
sS'considered,when,selecting'
p23074
g9
sS'long,acting,nitrates'
p23075
g3
sS'when,amines,have'
p23076
g9
sS'fluoroquinolones,macrolide,and'
p23077
g3
sS'a,minor,contribution'
p23078
g3
sS'of,clinical,significance'
p23079
g3
sS'these,strategies,will'
p23080
g3
sS'and,non-selective,mao'
p23081
g9
sS'study,tambocor,and'
p23082
g3
sS'of,levulan,kerastick'
p23083
g3
sS'for,days,there'
p23084
g3
sS'shuttle,vectors,containing'
p23085
g3
sS'similarity,of,the'
p23086
g3
sS'strongly,induce,cyp3a4'
p23087
g9
sS'for,example,complications'
p23088
g3
sS'when,heart,function'
p23089
g9
sS'para-aminobenzoic,acid,metabolite'
p23090
g3
sS'sixth,day,showed'
p23091
g9
sS'together,with,that'
p23092
g3
sS'have,resulted,from'
p23093
g9
sS'the,bactericidal,action'
p23094
g9
sS'prefrontal,cortical,tissues'
p23095
g3
sS'values,for,by'
p23096
g9
sS'immune,function,and'
p23097
g3
sS'or,micrograms,kg'
p23098
g3
sS'racemic,were,not'
p23099
g3
sS'needed,to,cause'
p23100
g9
sS'shown,to,interfere'
p23101
g9
sS'day,in,the'
p23102
g3
sS'of,the,presence'
p23103
g3
sS'which,contain,any'
p23104
g9
sS'effects,of,aliskiren'
p23105
g3
sS'have,occasionally,been'
p23106
g3
sS'in,accordance,with'
p23107
g3
sS'enhanced,clearance,secondary'
p23108
g9
sS'to,which,ssri-tca'
p23109
g9
sS'episodes,and,induced'
p23110
g3
sS'with,ganglionic,peripheral'
p23111
g3
sS'of,but,no'
p23112
g9
sS'with,particularly,during'
p23113
g9
sS'patients,with,renal'
p23114
g3
sS'oxidase,reactions,such'
p23115
g3
sS'patients,receiving,acarbose'
p23116
g3
sS'prednisolone,sodium,succinate'
p23117
g3
sS'creatinine,in,patients'
p23118
g9
sS'must,be,administered'
p23119
g9
sS'safety,have,not'
p23120
g3
sS'undertaken,only,with'
p23121
g9
sS'clearance,and,renal'
p23122
g9
sS'liver,is,prevented'
p23123
g9
sS'group,interaction,study'
p23124
g3
sS'by,but,decreased'
p23125
g9
sS'hours,most,commonly'
p23126
g3
sS'precipitated,by,the'
p23127
g3
sS'alteration,of,prothrombin'
p23128
g9
sS'probenecid,a,renal'
p23129
g3
sS'likely,to,inhibit'
p23130
g3
sS'has,on,rare'
p23131
g9
sS'by,to,in'
p23132
g9
sS'which,are,highly'
p23133
g3
sS'since,drowsiness,may'
p23134
g3
sS'ketones,in,the'
p23135
g3
sS'underlying,renal,insufficiency'
p23136
g3
sS'to,a,theoretical'
p23137
g9
sS'vitro,excystment,of'
p23138
g3
sS'probenecid,given,concurrently'
p23139
g9
sS'massive,seizures,may'
p23140
g3
sS'of,plasma,levels'
p23141
g3
sS'malignant,hyperthermia,crisis'
p23142
g9
sS'agents,may,become'
p23143
g9
sS'treated,with,hcl'
p23144
g3
sS'observed,for,increased'
p23145
g3
sS'of,the,fetal'
p23146
g3
sS'estrogenic,component,in'
p23147
g3
sS'at,a,different'
p23148
g3
sS'and,renal,vasodilator'
p23149
g3
sS'against,gram,positive'
p23150
g3
sS'switched,from,therapy'
p23151
g3
sS'other,have,not'
p23152
g3
sS'adverse,events,was'
p23153
g3
sS'the,thioxanthene,and'
p23154
g9
sS'an,improved,glucose'
p23155
g3
sS'different,times,after'
p23156
g3
sS'agents,when,heart'
p23157
g9
sS'inducible,vana,antisense'
p23158
g3
sS'zdv,and,which'
p23159
g3
sS'condition,worse,and'
p23160
g3
sS'in,poor,metabolizers'
p23161
g3
sS'with,the,determination'
p23162
g3
sS'of,ethinyl,estradiol'
p23163
g9
sS'given,alone,or'
p23164
g3
sS'related,metabolic,disturbances'
p23165
g3
sS'considerably,enhance,the'
p23166
g3
sS'the,color,reverses'
p23167
g3
sS'therapy,did,not'
p23168
g3
sS'risk,of,elevated'
p23169
g3
sS'substrate,with,oral'
p23170
g9
sS'to,the,frequent'
p23171
g3
sS'a,which,increases'
p23172
g9
sS'pressure,and,increased'
p23173
g3
sS'behaviour,of,the'
p23174
g3
sS'or,closely,monitor'
p23175
g3
sS'administered,prior,to'
p23176
g9
sS'your,b12,status'
p23177
g3
sS'supplemented,with,mg'
p23178
g9
sS'unlike,mc,does'
p23179
g3
sS'wort,theo-dur,and'
p23180
g9
sS'the,volunteers,who'
p23181
g9
sS'responded,to,the'
p23182
g3
sS'mice,in,the'
p23183
g3
sS'return,toward,normal'
p23184
g3
sS'antimycobacterial,agents,benzodiazepines'
p23185
g9
sS'impairment,of,renal'
p23186
g9
sS'such,as,phlebitis'
p23187
g3
sS'of,theophylline-related,side-effects'
p23188
g9
sS'potentiated,when,used'
p23189
g3
sS'that,are,renally'
p23190
g3
sS'oral,dose,followed'
p23191
g9
sS'if,diminished,renal'
p23192
g9
sS'cns,depressants,such'
p23193
g9
sS'two,studies,were'
p23194
g3
sS'increased,fold,by'
p23195
g9
sS'studied,in,patients'
p23196
g9
sS'generated,from,an'
p23197
g3
sS'blocking,agents,by'
p23198
g9
sS'other,on,sensipar'
p23199
g3
sS'was,a,statistically'
p23200
g9
sS'of,either,age'
p23201
g3
sS'completely,antagonized,the'
p23202
g9
sS'evaluating,the,administration'
p23203
g9
sS'arthritis,n,as'
p23204
g3
sS'concentrations,or,above'
p23205
g9
sS'proquin,xr,was'
p23206
g3
sS'increased,renal,plasma'
p23207
g3
sS'administered,hours,before'
p23208
g9
sS'patients,with,compromised'
p23209
g9
sS'studies,to,evaluate'
p23210
g3
sS'other,hand,surprisingly'
p23211
g3
sS'with,agents,with'
p23212
g9
sS'hypercholesterolemia,was,and'
p23213
g3
sS'dosing,of,the'
p23214
g3
sS'in,the,parameters'
p23215
g3
sS'requires,close,monitoring'
p23216
g9
sS'from,high-estradiol,rats'
p23217
g9
sS'closely,associated,with'
p23218
g3
sS'thus,results,of'
p23219
g3
sS'led,to,a'
p23220
g9
sS'kg,daily,for'
p23221
g3
sS'or,to,those'
p23222
g9
sS'in,vivo,to'
p23223
g3
sS'both,its,activity'
p23224
g3
sS'ccnu,either,alone'
p23225
g3
sS'a,number,of'
p23226
g9
sS'mean,renal,clearance'
p23227
g9
sS'the,problems,encountered'
p23228
g3
sS'inr,was,not'
p23229
g3
sS'level,determinations,of'
p23230
g9
sS'models,are,typically'
p23231
g3
sS'weeks,oral,cordarone'
p23232
g3
sS'effects,such,as'
p23233
g9
sS'subjects,r,b'
p23234
g3
sS'of,and,iv'
p23235
g9
sS'not,indicate,a'
p23236
g9
sS'marrow,function,will'
p23237
g3
sS'of,and,is'
p23238
g9
sS'hrs,of,loratadine'
p23239
g3
sS'of,and,in'
p23240
g9
sS'epinephrine,also,should'
p23241
g9
sS'food,on,the'
p23242
g3
sS'to,those,of'
p23243
g3
sS'any,enzyme,in'
p23244
g3
sS'copegus,should,not'
p23245
g3
sS'in,vitro,showed'
p23246
g3
sS'study,volunteers,mg'
p23247
g3
sS'taking,with,or'
p23248
g9
sS'once,daily,was'
p23249
g3
sS'ethacrynic,acid,have'
p23250
g9
sS'activity,of,krm-1648'
p23251
g3
sS'pregnancy,from,women'
p23252
g3
sS'of,this,isoenzyme'
p23253
g9
sS'be,encountered,with'
p23254
g3
sS'adequate,degree,of'
p23255
g3
sS'familial,hyper-,or'
p23256
g3
sS'coadministration,of,tambocor'
p23257
g3
sS'results,we,present'
p23258
g3
sS'hyperglycemia,and,hypoglycemia'
p23259
g9
sS'metabolite,beta-naltrexol,were'
p23260
g3
sS'of,perivascular,spaces'
p23261
g3
sS'would,occur,when'
p23262
g3
sS'warned,of,the'
p23263
g9
sS'doses,decreased,fi'
p23264
g3
sS'between,taxol,a'
p23265
g3
sS'to,additive,potentiation'
p23266
g3
sS'proportions,as,those'
p23267
g3
sS'a,h,period'
p23268
g3
sS'interactions,a,drugs'
p23269
g3
sS'warfarin,the,effect'
p23270
g3
sS'a,reduction,in'
p23271
g9
sS'dispersible,buffered,tablets'
p23272
g9
sS'mixed,with,or'
p23273
g3
sS'days,because,severe'
p23274
g9
sS'led,to,significant'
p23275
g3
sS'reduction,in,cardiac'
p23276
g9
sS'systematically,evaluated,but'
p23277
g9
sS'characterized,a,reliable'
p23278
g9
sS'an,updated,review'
p23279
g3
sS'a,possible,hypokalemic'
p23280
g9
sS'are,usually,administered'
p23281
g9
sS'from,treatment,dosage'
p23282
g9
sS'tetracyclines,since,both'
p23283
g9
sS'variables,for,were'
p23284
g3
sS'not,measured,toxicity'
p23285
g3
sS'revealed,concentration,dependent'
p23286
g3
sS'g,ml,or'
p23287
g3
sS'increased,bun,serum'
p23288
g9
sS'folic,acid,from'
p23289
g3
sS'salicylate,and,heparin'
p23290
g9
sS'with,significantly,decreased'
p23291
g9
sS'release,capsules,there'
p23292
g9
sS'agents,and,vasoactive'
p23293
g9
sS'this,interaction,occurs'
p23294
g3
sS'cyp1a2,cyp3a,a'
p23295
g9
sS'block,caution,is'
p23296
g9
sS'to,the,receptor-binding'
p23297
g3
sS'prolong,the,qtc'
p23298
g9
sS'male,sprague-dawley,rats'
p23299
g3
sS'amiodarone,should,be'
p23300
g3
sS'while,the,effects'
p23301
g9
sS'a,regimen,of'
p23302
g9
sS'to,platelet,activation'
p23303
g3
sS'increased,the,steadystate'
p23304
g9
sS'patients,taking,acamprosate'
p23305
g9
sS'another,is,structurally'
p23306
g3
sS'of,the,literature'
p23307
g9
sS'or,mg,of'
p23308
g3
sS'lovastatin,therapy,has'
p23309
g3
sS'and,automaticity,as'
p23310
g9
sS'since,it,creates'
p23311
g3
sS'iiia4,blocks,the'
p23312
g9
sS'and,and,their'
p23313
g3
sS'like,due,to'
p23314
g9
sS'with,no,alteration'
p23315
g3
sS'cyp,d6,and'
p23316
g3
sS'thienobenzodiazepine,derivative,is'
p23317
g3
sS'been,evaluated,these'
p23318
g3
sS'potential,to,increase'
p23319
g9
sS'by,compared,to'
p23320
g9
sS'different,on,glycemia'
p23321
g3
sS'their,condition,may'
p23322
g3
sS'absorbed,from,the'
p23323
g3
sS'transfer,to,the'
p23324
g3
sS'expected,with,larger'
p23325
g3
sS'mammalian,liver,metabolic'
p23326
g3
sS'and,without,the'
p23327
g3
sS'be,enhanced,by'
p23328
g9
sS'underlying,mechanism,for'
p23329
g9
sS'a,single-dose,pharmacokinetic'
p23330
g3
sS'to,triple,therapy'
p23331
g3
sS'competitively,inhibit,accumulation'
p23332
g9
sS'oa,patients,there'
p23333
g3
sS'and,enterococcus,faecium'
p23334
g3
sS'an,intravenous,injection'
p23335
g9
sS'combined,with,either'
p23336
g3
sS'days,or,more'
p23337
g3
sS'increased,half-life,by'
p23338
g9
sS'of,drugs,possessing'
p23339
g9
sS'for,other,oral'
p23340
g9
sS'antidiuretic,activity,large'
p23341
g3
sS'the,th,and'
p23342
g3
sS'to,affect,bleeding'
p23343
g9
sS'between,and,the'
p23344
g3
sS'of,retinal,tamponades'
p23345
g3
sS'both,to,pressor'
p23346
g3
sS'the,auc,for'
p23347
g9
sS'observed,when,colestid'
p23348
g9
sS'severe,anaphylactic,reaction'
p23349
g3
sS'with,than,those'
p23350
g9
sS'of,vitamin-d,mediated'
p23351
g3
sS'tests,since,elevations'
p23352
g3
sS'reductase,resulting,in'
p23353
g3
sS'was,a,increase'
p23354
g9
sS'the,insp,or'
p23355
g3
sS'by,approx,because'
p23356
g9
sS'increasing,from,a'
p23357
g3
sS'mainly,metabolized,by'
p23358
g9
sS'with,hcl,a'
p23359
g3
sS'of,anafranil,caution'
p23360
g3
sS'oxidative,stress,induction'
p23361
g3
sS'the,duration,of'
p23362
g3
sS'between,keppra,and'
p23363
g3
sS'tracleer,and,is'
p23364
g9
sS'concomitantly,with,mao'
p23365
g9
sS'residual,effects,of'
p23366
g9
sS'events,in,patients'
p23367
g3
sS'aprepitant,was,administered'
p23368
g9
sS'is,mmol,l'
p23369
g3
sS'to,do,if'
p23370
g3
sS'nerves,and,their'
p23371
g3
sS'or,serum,pregnancy'
p23372
g3
sS'initiated,apparent,oral'
p23373
g9
sS'vivo,studies,suggest'
p23374
g3
sS'influence,recovery,time'
p23375
g3
sS'interval,were,less'
p23376
g9
sS'that,reduce,the'
p23377
g9
sS'investigated,in,male'
p23378
g3
sS'may,displace,from'
p23379
g3
sS'of,antagonism,in'
p23380
g3
sS'when,coadministered,in'
p23381
g3
sS'has,not,demonstrated'
p23382
g3
sS'plasma,thrombin,clotting'
p23383
g3
sS'time,may,vary'
p23384
g3
sS'that,are,mainly'
p23385
g3
sS'vaprisol,the,clinician'
p23386
g9
sS'allergic,or,anaphylactic'
p23387
g3
sS'on,male,fertility'
p23388
g3
sS'be,decided,to'
p23389
g9
sS'is,a,more'
p23390
g3
sS'pi,related,metabolic'
p23391
g3
sS'fivefold,increase,in'
p23392
g3
sS'toradol,oral,and'
p23393
g9
sS'be,discontinued,before'
p23394
g3
sS'of,deficiency,and'
p23395
g3
sS'clozapine,should,not'
p23396
g3
sS'not,mc,decreases'
p23397
g3
sS'with,blood,liver'
p23398
g3
sS'second,in,both'
p23399
g3
sS'increased,cns,depressant'
p23400
g9
sS'of,oral,may'
p23401
g3
sS'the,commercially,available'
p23402
g3
sS'of,arachidonic,acid'
p23403
g3
sS'distribution,of,concentrations'
p23404
g3
sS'have,not,been'
p23405
g3
sS'while,only,additive'
p23406
g9
sS'the,plasma,and'
p23407
g9
sS'reduced,to,one-half'
p23408
g9
sS'the,coat-core,formulation'
p23409
g9
sS'gvia,n-type,or'
p23410
g3
sS'presence,of,microg'
p23411
g3
sS'greater,in,patients'
p23412
g9
sS'post-implantation,loss,were'
p23413
g3
sS'were,administered,a'
p23414
g9
sS'prevented,by,and'
p23415
g9
sS'marked,has,been'
p23416
g3
sS'of,male,dogs'
p23417
g3
sS'in,female,and'
p23418
g3
sS'and,or,aluminum-containing'
p23419
g9
sS'cells,or,in'
p23420
g9
sS'iodometric,titration,of'
p23421
g3
sS'not,cause,dna'
p23422
g3
sS'parameters,the,degree'
p23423
g3
sS'doctor,and,pharmacist'
p23424
g3
sS'not,have,any'
p23425
g3
sS'could,cause,heart'
p23426
g9
sS'of,to,treat'
p23427
g9
sS'concomitantly,with,potassium-depleting'
p23428
g9
sS'd,or,mg'
p23429
g9
sS'and,intravenously,administered'
p23430
g9
sS'other,strong,cyp3a4'
p23431
g9
sS'occurs,when,eye'
p23432
g3
sS'is,unknown,but'
p23433
g3
sS'or,no,change'
p23434
g3
sS'action,in,reversing'
p23435
g3
sS'drugs,whose,absorption'
p23436
g9
sS'and,avoidance,behaviour'
p23437
g3
sS'concentrations,of,astringents'
p23438
g3
sS'the,myocardium,to'
p23439
g9
sS'and,complications,compared'
p23440
g9
sS'to,diethylnitrosamine,during'
p23441
g3
sS'acetaminophen,in,normal'
p23442
g9
sS'in,a,single-dose'
p23443
g3
sS'been,reported,among'
p23444
g9
sS'in,anti-apoptotic,effect'
p23445
g3
sS'selective,survival,in'
p23446
g3
sS'characterized,by,severe'
p23447
g9
sS'by,gleevec,gleevec'
p23448
g9
sS'serious,toxicity,may'
p23449
g9
sS'level,of,their'
p23450
g3
sS'metabolite,mhd,have'
p23451
g3
sS'the,perfused,pancreas'
p23452
g3
sS'they,can,potentially'
p23453
g9
sS'patients,receiving,proleukin'
p23454
g9
sS'to,the,induction'
p23455
g9
sS'week,study,has'
p23456
g3
sS'male,rats,at'
p23457
g3
sS'trend,to,increase'
p23458
g3
sS'neither,nor,should'
p23459
g9
sS'normal,volunteers,a'
p23460
g9
sS'the,luteinizing,hormone'
p23461
g3
sS'when,these,are'
p23462
g3
sS'used,concomitantly,within14'
p23463
g9
sS'hunger,can,be'
p23464
g3
sS'well,as,complications'
p23465
g3
sS'and,special,care'
p23466
g9
sS'potassium-sparing,or,supplements'
p23467
g9
sS'administered,with,a'
p23468
g3
sS'the,minimum,inhibitory'
p23469
g3
sS'an,interleukin-1,antagonist'
p23470
g9
sS'to,the,zevalin'
p23471
g3
sS'think,you,are'
p23472
g3
sS'administered,with,g'
p23473
g3
sS'for,periods,of'
p23474
g3
sS'other,kits,such'
p23475
g3
sS'known,that,there'
p23476
g3
sS'and,c19,inhibitors'
p23477
g3
sS'following,situations,occur'
p23478
g3
sS'the,urine,as'
p23479
g3
sS'common,medications,used'
p23480
g3
sS'loop,such,as'
p23481
g9
sS'ritonavir,mg,b'
p23482
g9
sS'degrees,c,for'
p23483
g3
sS'and,sometimes,prescribed'
p23484
g9
sS'dose,of,administered'
p23485
g3
sS'replication,of,some'
p23486
g9
sS'rats,and,the'
p23487
g3
sS'ventricular,tachycardia,induced'
p23488
g9
sS'flavonoids,alone,significantly'
p23489
g3
sS'to,produce,persistently'
p23490
g3
sS'therapy,were,treated'
p23491
g3
sS'in,hazardous,activities'
p23492
g3
sS'first,and,second'
p23493
g9
sS'this,dose,was'
p23494
g3
sS'currently,receiving,therapy'
p23495
g9
sS'member,have,been'
p23496
g9
sS'of,as,measured'
p23497
g3
sS'brevibloc,steady-state,blood'
p23498
g9
sS'markedly,inhibits,the'
p23499
g9
sS'efficacy,of,proleukin'
p23500
g3
sS'addition,of,causes'
p23501
g9
sS'channel,subtypes,in'
p23502
g3
sS'mechanisms,of,pcp-induced'
p23503
g3
sS'bradycardia,and,av'
p23504
g9
sS'and,the,antimicrobial'
p23505
g3
sS'and,incoordination,following'
p23506
g9
sS'should,be,treated'
p23507
g3
sS'the,incidence,or'
p23508
g9
sS'with,or,and'
p23509
g9
sS'include,regular,reevaluations'
p23510
g3
sS'once-daily,dose,was'
p23511
g3
sS'at,the,intervals'
p23512
g3
sS'who,were,drinking'
p23513
g9
sS'as,etc,is'
p23514
g9
sS'agents,the,possibility'
p23515
g3
sS'with,or,any'
p23516
g9
sS'release,of,neutrophils'
p23517
g3
sS'that,were,in'
p23518
g9
sS'are,on,therapy'
p23519
g9
sS'the,incidence,of'
p23520
g3
sS'the,tarceva,dose'
p23521
g9
sS'trials,patients,who'
p23522
g3
sS'considered,when,coadministering'
p23523
g9
sS'of,other,such'
p23524
g9
sS'dst,in,patients'
p23525
g3
sS'hypertension,did,not'
p23526
g3
sS'effect,of,may'
p23527
g9
sS'p450,isoenzyme,cyp2d6'
p23528
g3
sS'mg,when,given'
p23529
g3
sS'the,testes,and'
p23530
g3
sS'release,from,the'
p23531
g9
sS'volunteers,hydrochloride,either'
p23532
g9
sS'studies,with,aprepitant'
p23533
g9
sS'activity,of,oral'
p23534
g9
sS'was,applied,to'
p23535
g9
sS'not,benefit,from'
p23536
g9
sS'medicinal,products,including'
p23537
g9
sS'been,safely,used'
p23538
g3
sS'absorption,of,diamox'
p23539
g9
sS'either,too,high'
p23540
g3
sS'and,medical,backgrounds'
p23541
g3
sS'anticipated,due,to'
p23542
g3
sS'considered,to,result'
p23543
g3
sS'interactions,between,taxol'
p23544
g3
sS'a,min,interval'
p23545
g9
sS'stable,and,thereafter'
p23546
g3
sS'are,reports,of'
p23547
g9
sS'randomized,double-blind,study'
p23548
g3
sS'the,primary,enzymes'
p23549
g3
sS'of,patients,used'
p23550
g3
sS'if,a,valid'
p23551
g9
sS'rarely,in,patients'
p23552
g9
sS'thiazide,may,contribute'
p23553
g9
sS'but,regular,users'
p23554
g3
sS'sympathetic,effects,of'
p23555
g9
sS'derivatives,nicotinic,acid'
p23556
g3
sS'of,interaction,depends'
p23557
g3
sS'and,make,normal'
p23558
g3
sS'drugs,include,the'
p23559
g3
sS'hour,observation,period'
p23560
g3
sS'stabilized,on,should'
p23561
g9
sS'in,six,patients'
p23562
g3
sS'this,hit,may'
p23563
g3
sS'was,analyzed,in'
p23564
g3
sS'coadministered,with,aprepitant'
p23565
g9
sS'phase,of,this'
p23566
g3
sS'adverse,reactions,in'
p23567
g3
sS'now,clear,that'
p23568
g3
sS'warfarin,the,effects'
p23569
g9
sS'pregnancy,and,estrogen-containing'
p23570
g3
sS'agents,have,been'
p23571
g9
sS'lithium,lithium,toxicity'
p23572
g9
sS'enterobacteriaceae,and,pseudomonas'
p23573
g3
sS'saw,palmetto,red'
p23574
g3
sS'question,the,utility'
p23575
g3
sS'therapeutic,regimen,be'
p23576
g3
sS'enzyme,inhibitors,and'
p23577
g9
sS'needed,when,is'
p23578
g9
sS'limited,clinical,data'
p23579
g9
sS'capsules,with,ml'
p23580
g9
sS'closely,when,clozapine'
p23581
g9
sS'were,between,given'
p23582
g3
sS'five,or,mg'
p23583
g3
sS'effect,of,ras'
p23584
g3
sS'fatal,when,used'
p23585
g9
sS'area,bsa,caused'
p23586
g3
sS'the,concomitant,substrate'
p23587
g3
sS'the,risks,arising'
p23588
g3
sS'with,the,preservative'
p23589
g9
sS'and,cmax,was'
p23590
g3
sS'the,wild-type,alleles'
p23591
g3
sS'decreases,in,the'
p23592
g9
sS'has,been,coadministered'
p23593
g3
sS'the,two,agents'
p23594
g9
sS'patients,were,intravenously'
p23595
g3
sS'kill,curves,with'
p23596
g9
sS'enzyme,induction,and'
p23597
g9
sS'listed,here,may'
p23598
g3
sS'a,temporary,decrease'
p23599
g3
sS'of,relevant,significant'
p23600
g3
sS'reports,of,a'
p23601
g3
sS'those,taking,mg'
p23602
g3
sS'urine,has,resulted'
p23603
g3
sS'liver,but,its'
p23604
g3
sS'or,toxicologic,profile'
p23605
g3
sS'upon,administration,of'
p23606
g9
sS'although,no,specific'
p23607
g9
sS'to,significantly,alter'
p23608
g9
sS'in,a,schedule'
p23609
g9
sS'administration,of,morning'
p23610
g3
sS'interaction,may,precipitate'
p23611
g9
sS'steady,state,therefore'
p23612
g3
sS'aminoglutethimide,aminoglutethimide,may'
p23613
g9
sS'to,mechanisms,involving'
p23614
g9
sS'of,a,slower'
p23615
g9
sS'physiological,supplementation,and'
p23616
g3
sS'and,very,little'
p23617
g9
sS'may,be,blunted'
p23618
g9
sS'higher,increases,in'
p23619
g9
sS'revealed,that,range'
p23620
g9
sS'or,weaken,the'
p23621
g9
sS'pi,was,related'
p23622
g3
sS'substitution,test,dsst'
p23623
g9
sS'drugs,to,affect'
p23624
g3
sS'the,prothrombin,level'
p23625
g3
sS'both,dose,groups'
p23626
g3
sS'antipsychotic,agents,monoamine'
p23627
g9
sS'of,the,cell'
p23628
g3
sS'olanzapine,coadministration,of'
p23629
g9
sS'and,organoleads,are'
p23630
g3
sS'for,preparations,before'
p23631
g3
sS'occur,if,b12'
p23632
g3
sS'these,data,indicate'
p23633
g3
sS'thus,may,make'
p23634
g3
sS'decreased,significantly,without'
p23635
g3
sS'eg,may,cause'
p23636
g9
sS'vital,sign,monitoring'
p23637
g3
sS'either,enbrel,ci'
p23638
g9
sS'and,produced,a'
p23639
g9
sS'hydrochloride,mg,twice'
p23640
g3
sS'gene,expression,that'
p23641
g3
sS'from,l,kg'
p23642
g9
sS'monitor,tcaplasma,levels'
p23643
g3
sS'concentration,profile,or'
p23644
g3
sS'of,interactions,have'
p23645
g9
sS'therapies,in,clinical'
p23646
g3
sS'to,inhibitory,interactions'
p23647
g3
sS'variability,and,individual'
p23648
g9
sS'mg,m,basis'
p23649
g3
sS'salt,restriction,or'
p23650
g9
sS'or,are,known'
p23651
g3
sS'ketoconazole,ketoconazole,has'
p23652
g9
sS'not,in,rats'
p23653
g9
sS'has,been,little'
p23654
g3
sS'study,evaluated,the'
p23655
g3
sS'the,optimal,therapeutic'
p23656
g3
sS'is,recommended,to'
p23657
g9
sS'produced,a,marked'
p23658
g3
sS'd,and,mg'
p23659
g3
sS'suspension,were,coadministered'
p23660
g9
sS'pointes,and,other'
p23661
g3
sS'of,adverse,neuropsychiatric'
p23662
g9
sS'in,fdf,at'
p23663
g9
sS'since,the,nrtis'
p23664
g3
sS'a,broad,range'
p23665
g3
sS'the,lack,of'
p23666
g3
sS'experience,on,the'
p23667
g3
sS'taken,orally,imidazole'
p23668
g9
sS'for,oral,includes'
p23669
g3
sS'levels,close,to'
p23670
g3
sS'of,the,can'
p23671
g3
sS'is,probably,the'
p23672
g3
sS'also,be,monitored'
p23673
g9
sS'grapefruit,or,orange'
p23674
g3
sS'the,cellular,and'
p23675
g3
sS'exhibited,no,platelet'
p23676
g3
sS'after,a,second'
p23677
g3
sS'in,the,same'
p23678
g3
sS'combinations,should,be'
p23679
g3
sS'when,hydrochloride,was'
p23680
g3
sS'reduced,and,titrated'
p23681
g3
sS'used,at,doses'
p23682
g9
sS'metabolite,of,chloroprocaine'
p23683
g3
sS'a2,and,a'
p23684
g9
sS'doses,of,as'
p23685
g9
sS'neuromuscular,block,following'
p23686
g3
sS'out,possible,increases'
p23687
g3
sS'when,are,given'
p23688
g9
sS'appreciably,metabolized,nor'
p23689
g3
sS'and,greater,degrees'
p23690
g9
sS'that,the,metabolism'
p23691
g9
sS'refractory,to,in'
p23692
g9
sS'this,increased,bioavailability'
p23693
g3
sS'saline,values,all'
p23694
g3
sS'on,the,results'
p23695
g3
sS'randomized,trial,of'
p23696
g9
sS'doses,of,an'
p23697
g9
sS'activation,of,an'
p23698
g3
sS'as,antiparkinson,or'
p23699
g9
sS'toxicity,and,a'
p23700
g3
sS'concomitantly,to,patients'
p23701
g9
sS'relaxing,effect,of'
p23702
g9
sS'age,the,mean'
p23703
g3
sS'that,induce,cyp3a'
p23704
g3
sS'two,differ,and'
p23705
g3
sS'with,moderate,to'
p23706
g9
sS'treatment,of,relapses'
p23707
g3
sS'tablets,may,reduce'
p23708
g9
sS'with,concomitant,augmentin'
p23709
g3
sS'with,or,can'
p23710
g9
sS'relaxants,are,used'
p23711
g3
sS'the,dosing,of'
p23712
g9
sS'of,apoptosis,assessed'
p23713
g9
sS'that,nsaids,may'
p23714
g9
sS'in,clearance,and'
p23715
g9
sS'hepatotoxic,potential,must'
p23716
g9
sS'of,mefloquine,and'
p23717
g9
sS'agents,increase,blood'
p23718
g3
sS'nephrotoxic,agents,concomitant'
p23719
g9
sS'cortisol,does,not'
p23720
g3
sS'was,administered,minute'
p23721
g9
sS'reveal,frequent,involvement'
p23722
g9
sS'of,doubled,the'
p23723
g9
sS'when,cyp3a4,inhibitors'
p23724
g3
sS'additive,potentiation,synergistic'
p23725
g3
sS'animal,or,human'
p23726
g3
sS'maoi,within,days'
p23727
g9
sS'of,absorption,of'
p23728
g3
sS'dependent,upon,cytochrome'
p23729
g3
sS'of,reducing,hunger'
p23730
g3
sS'acetate,is,not'
p23731
g3
sS'pharmacologic,mechanism,of'
p23732
g3
sS'with,xigris,have'
p23733
g3
sS'vasorelaxation,differs,in'
p23734
g3
sS'loss,of,consciousness'
p23735
g9
sS'mg,day,a'
p23736
g9
sS'to,reach,cmax'
p23737
g3
sS'wort,because,of'
p23738
g3
sS'following,dosing,of'
p23739
g3
sS'of,absorption,or'
p23740
g3
sS'noted,that,discontinuation'
p23741
g9
sS'on,glucocorticoid-induced,gene'
p23742
g3
sS'coumadin,other,tegretol'
p23743
g3
sS'concurrently,taking,antiseizure'
p23744
g3
sS'of,the,should'
p23745
g3
sS'standard,dose,and'
p23746
g9
sS'important,for,women'
p23747
g3
sS'showing,that,hippocampal'
p23748
g3
sS'in,the,steady-state'
p23749
g9
sS'alters,hormone,synthesis'
p23750
g3
sS'tolerated,but,there'
p23751
g9
sS'amantadine,limited,clinical'
p23752
g9
sS'with,another,drug'
p23753
g3
sS'that,may,increase'
p23754
g3
sS'treatment,with,is'
p23755
g3
sS'times,daily,for'
p23756
g9
sS't4,and,free'
p23757
g3
sS'the,reaction,after'
p23758
g3
sS'in,a,systemic'
p23759
g3
sS'will,require,a'
p23760
g9
sS'years,weight,range'
p23761
g3
sS'and,tricyclic,antidepressants'
p23762
g9
sS'substrates,for,cyp1a2'
p23763
g3
sS'combination,with,was'
p23764
g3
sS'mg,when,coadministered'
p23765
g9
sS'to,the,usual'
p23766
g3
sS'multiple,enzyme,systems'
p23767
g3
sS'effects,of,epidural'
p23768
g9
sS'studies,with,or'
p23769
g9
sS'than,episodes,of'
p23770
g3
sS'plasma,concentrations,were'
p23771
g3
sS'or,to,the'
p23772
g3
sS'and,then,analysing'
p23773
g3
sS'prostatectomy,radiation,therapy'
p23774
g3
sS'may,temporarily,mask'
p23775
g9
sS'leukocytosis,elevated,serum'
p23776
g9
sS'intensity,uniformity,and'
p23777
g3
sS'gst,activity,however'
p23778
g3
sS'renal,function,since'
p23779
g3
sS'with,simultaneous,use'
p23780
g3
sS'methods,we,carried'
p23781
g3
sS'hz,degrees,c'
p23782
g3
sS'should,not,exceed'
p23783
g9
sS'prothrombin,time,following'
p23784
g3
sS'enzymes,in,vitro'
p23785
g3
sS'an,nad,dependent'
p23786
g3
sS'gene,which,may'
p23787
g3
sS'us,a,comprehensive'
p23788
g3
sS'but,may,produce'
p23789
g9
sS'is,now,difficult'
p23790
g3
sS'and,bone,scintigraphy'
p23791
g3
sS'systolic,blood,pressure'
p23792
g9
sS'n1,and,produced'
p23793
g3
sS'hydrochloride,and,is'
p23794
g3
sS'physiology,the,following'
p23795
g3
sS'argatroban,and,concomitantly'
p23796
g3
sS'blockers,or,channel'
p23797
g9
sS'controlled,and,uncontrolled'
p23798
g3
sS'the,ibandronate,osteoporosis'
p23799
g3
sS'on,phosphate,transport'
p23800
g3
sS'limited,as,is'
p23801
g3
sS'mao-b,inhibitor,in'
p23802
g3
sS'that,observed,with'
p23803
g9
sS'no,effect,was'
p23804
g3
sS'certain,and,type'
p23805
g9
sS'to,the,pharmacokinetics'
p23806
g3
sS'associated,with,strenuous'
p23807
g3
sS'who,also,used'
p23808
g3
sS'studies,in,female'
p23809
g3
sS'was,no,significant'
p23810
g3
sS'supplemental,l-glutamine,for'
p23811
g9
sS'monitoring,of,their'
p23812
g9
sS'inhibitors,and,various'
p23813
g3
sS'possible,interaction,with'
p23814
g3
sS'concentration,of,as'
p23815
g3
sS'the,anti-inflammatory,activity'
p23816
g9
sS'a,primary,form'
p23817
g3
sS'does,not,reduce'
p23818
g3
sS'interference,has,resulted'
p23819
g3
sS'activity,of,cytochrome'
p23820
g3
sS'exposure,auc,to'
p23821
g9
sS'day,and,orally'
p23822
g9
sS'inhibitors,with,sprycel'
p23823
g9
sS'anticholinesterase,agents,should'
p23824
g9
sS'cimetidine,ranitidine,in'
p23825
g9
sS'ester,fractional,clearance'
p23826
g3
sS'such,tumors,is'
p23827
g3
sS'renal,function,and'
p23828
g3
sS'or,concurrent,use'
p23829
g3
sS'baraclude,is,coadministered'
p23830
g3
sS'of,and,mean'
p23831
g9
sS'in,vitro,studies'
p23832
g3
sS'on,the,individual'
p23833
g3
sS'and,these,compounds'
p23834
g3
sS'simultaneous,administration,of'
p23835
g9
sS'minutes,at,a'
p23836
g3
sS'subjects,mean,steady-state'
p23837
g9
sS'and,the,possible'
p23838
g3
sS'a,tarceva,dose'
p23839
g3
sS'not,require,exogenous'
p23840
g3
sS'to,an,increased'
p23841
g9
sS'international,literature,between'
p23842
g3
sS'of,factive,with'
p23843
g9
sS'therefore,and,should'
p23844
g9
sS'other,plasma,proteins'
p23845
g3
sS'sucralfate,and,containing'
p23846
g9
sS'of,treatment,in'
p23847
g9
sS'treatment-experienced,patients,have'
p23848
g3
sS'it,from,other'
p23849
g3
sS'with,aprepitant,reflects'
p23850
g9
sS'a,potent,inducer'
p23851
g9
sS'neoplastic,disease,except'
p23852
g9
sS'for,known,side'
p23853
g9
sS'effect,and,should'
p23854
g9
sS'no,significant,change'
p23855
g3
sS'when,duloxetine,and'
p23856
g3
sS'as,compared,to'
p23857
g9
sS'recipients,during,the'
p23858
g3
sS'used,in,dentistry'
p23859
g3
sS'administration,of,concomitantly'
p23860
g9
sS'a4,isoenzyme,system'
p23861
g3
sS'certain,could,increase'
p23862
g3
sS'oral,parenteral,or'
p23863
g3
sS'the,tricyclic,when'
p23864
g9
sS'day,with,coadministered'
p23865
g9
sS'if,combination,hormonal'
p23866
g9
sS'multiple,occupational,exposure'
p23867
g3
sS'of,combined,administration'
p23868
g3
sS'arc,activity-regulated,cytoskeleton-associated'
p23869
g3
sS'an,regimen,reduces'
p23870
g3
sS'been,exploited,in'
p23871
g3
sS'upon,discontinuation,of'
p23872
g9
sS'primarily,by,p450'
p23873
g3
sS'and,mental,status'
p23874
g9
sS'dose,increased,as'
p23875
g3
sS'the,active,epoxide'
p23876
g3
sS'of,the,template'
p23877
g3
sS'hypertension,were,examined'
p23878
g3
sS'disorder,including,manic-depressive'
p23879
g9
sS'five,different,ca'
p23880
g3
sS'starlix,mg,three'
p23881
g3
sS'of,cholinesterase,inhibitors'
p23882
g9
sS'mucosa,mounted,in'
p23883
g3
sS'the,greatest,value'
p23884
g3
sS'approved,prescription,dose'
p23885
g9
sS'x,c3h,hen'
p23886
g3
sS'interactions,between,trileptal'
p23887
g3
sS'such,as,akineton'
p23888
g9
sS'reduction,in,cell'
p23889
g9
sS'in,mean,auc'
p23890
g9
sS'or,side,effects'
p23891
g3
sS'their,effects,by'
p23892
g3
sS'of,preliminary,studies'
p23893
g9
sS'protein,with,homology'
p23894
g3
sS'infiltration,of,perivascular'
p23895
g3
sS'cortex,that,was'
p23896
g9
sS'receiving,infusions,of'
p23897
g3
sS'indicated,alternative,agents'
p23898
g3
sS'who,are,concomitantly'
p23899
g3
sS'alcohol,in,post-marketing'
p23900
g9
sS'therefore,positive,test'
p23901
g3
sS'noted,when,was'
p23902
g3
sS'min,and,copegus'
p23903
g3
sS'depressive,effects,of'
p23904
g9
sS'been,identified,involving'
p23905
g9
sS'pulmonary,wedge,pressure'
p23906
g9
sS'steady-state,exposure,to'
p23907
g3
sS'valproic,acid,with'
p23908
g9
sS'patient,is,truly'
p23909
g3
sS'stomach,to,form'
p23910
g9
sS'active,dose,of'
p23911
g3
sS'about,of,that'
p23912
g3
sS'therapy,the,prothrombin'
p23913
g9
sS'of,are,tolerated'
p23914
g3
sS'are,highly,protein'
p23915
g9
sS'and,interact,pharmacologically'
p23916
g9
sS'mercaptopurine,azathioprine,allopurinol'
p23917
g9
sS'non-matched,historicalcontrol,group'
p23918
g9
sS'major,membrane,sterol'
p23919
g3
sS'of,gly-buride,and'
p23920
g3
sS'mtx,have,not'
p23921
g3
sS'reversal,of,the'
p23922
g9
sS'treated,with,have'
p23923
g3
sS'has,occurred,in'
p23924
g9
sS'with,likely,to'
p23925
g3
sS'between,older,and'
p23926
g3
sS'cyp2a6,cyp2c9,cyp2d6'
p23927
g3
sS'elimination,of,antizol'
p23928
g9
sS'levels,of,anti-factor'
p23929
g3
sS'of,proportionate,responses'
p23930
g3
sS'loratadine,mg,in'
p23931
g3
sS'pharmacology-pharmacokinetics,drug-drug,interactions'
p23932
g3
sS'pulmonary,emboli,rises'
p23933
g3
sS'iso-sensitest,broth,using'
p23934
g3
sS'not,be,reliable'
p23935
g9
sS'different,route,than'
p23936
g3
sS'above,the,usual'
p23937
g3
sS'the,release,but'
p23938
g3
sS'of,increased,by'
p23939
g9
sS'and,can,inhibit'
p23940
g9
sS'therefore,be,completed'
p23941
g3
sS'histidine,residues,may'
p23942
g3
sS'inhibitors,mg,bid'
p23943
g9
sS'strength,of,their'
p23944
g9
sS'of,serum,concentrations'
p23945
g9
sS'however,these,studies'
p23946
g3
sS'no,teratogenic,effects'
p23947
g3
sS'levels,of,if'
p23948
g9
sS'the,potential,to'
p23949
g3
sS'the,efficacy,of'
p23950
g9
sS'and,in,normal'
p23951
g9
sS'antimicrobial,combinations,of'
p23952
g9
sS'ki,of,um'
p23953
g3
sS'bone,marrow,suppression'
p23954
g9
sS'levels,of,in'
p23955
g3
sS'of,contraception,and'
p23956
g3
sS'when,sodium,is'
p23957
g9
sS'interference,with,urine'
p23958
g3
sS'without,alterations,of'
p23959
g3
sS'this,was,expected'
p23960
g3
sS'plasma,concentration-time,curve'
p23961
g3
sS'novolog,were,not'
p23962
g3
sS'and,showed,no'
p23963
g3
sS'produced,an,approximate'
p23964
g9
sS'such,combined,therapy'
p23965
g3
sS'partial,thromboplastin,times'
p23966
g3
sS'are,used,concurrently'
p23967
g9
sS'nimbex,and,decrease'
p23968
g9
sS'well,as,minimal'
p23969
g3
sS'an,increased,severity'
p23970
g9
sS'fortovase,invirase,kaletra'
p23971
g9
sS'running,a,control'
p23972
g3
sS'for,injection,in'
p23973
g9
sS'inhibitors,long-term,suppression'
p23974
g9
sS'increased,plasma,concentration'
p23975
g9
sS'were,kept,in'
p23976
g3
sS'effects,and,need'
p23977
g3
sS'be,needed,following'
p23978
g9
sS'subjects,receiving,either'
p23979
g9
sS'bmax,in,either'
p23980
g3
sS'of,metabotropic,glutamate'
p23981
g3
sS'of,are,antagonized'
p23982
g9
sS'the,following,may'
p23983
g3
sS'phosphatases,in,the'
p23984
g3
sS'or,partly,share'
p23985
g3
sS'an,association,between'
p23986
g9
sS'in,vitro,does'
p23987
g3
sS'during,studies,involving'
p23988
g9
sS'effector,ieg,arc'
p23989
g3
sS'profiles,in,young'
p23990
g3
sS'one-tenth,of,the'
p23991
g9
sS'was,greater,after'
p23992
g3
sS'contain,deet,n'
p23993
g9
sS'regimen,of,oral'
p23994
g9
sS'patients,receiving,should'
p23995
g3
sS'less,active,isomer'
p23996
g9
sS'or,were,added'
p23997
g3
sS'cause,adrenal,insufficiency'
p23998
g9
sS'can,increase,the'
p23999
g3
sS'as,with,most'
p24000
g9
sS'the,cmax,of'
p24001
g9
sS'treatment,may,delay'
p24002
g3
sS'increases,anion,plasma'
p24003
g9
sS'oral,decreased,prothrombin'
p24004
g3
sS'and,av,block'
p24005
g9
sS'magnesium-,and,or'
p24006
g9
sS'two,were,cardiac'
p24007
g3
sS'and,amantadine,limited'
p24008
g9
sS'of,arava,with'
p24009
g9
sS'hypersensitive,to,nonsteroidal'
p24010
g9
sS'administered,alone,suggesting'
p24011
g9
sS'sprycel,dose,reduction'
p24012
g3
sS'dose,of,changed'
p24013
g9
sS'zalcitabine,inhibited,phosphorylation'
p24014
g9
sS'thus,should,not'
p24015
g9
sS'paba,containing,preparations'
p24016
g9
sS'enhanced,as,well'
p24017
g9
sS'was,designed,to'
p24018
g3
sS'of,b,were'
p24019
g3
sS'gout,and,renal'
p24020
g3
sS'anticipated,alternative,therapy'
p24021
g3
sS'anticholinesterase,poisoning,although'
p24022
g9
sS'presents,findings,on'
p24023
g3
sS'both,a,substrate'
p24024
g3
sS'tests,common,side'
p24025
g3
sS'suggested,by,induction'
p24026
g3
sS'coadministered,with,nonselective'
p24027
g9
sS'the,rats,were'
p24028
g3
sS'angiotensin,converting,enzyme'
p24029
g9
sS'received,mg,once'
p24030
g3
sS'in,the,str'
p24031
g3
sS'may,be,hazardous'
p24032
g3
sS'reproduction,studies,however'
p24033
g3
sS'transits,or,in'
p24034
g3
sS'cytochrome,p450,cyp'
p24035
g3
sS'acid,metabolite,of'
p24036
g3
sS'by,either,mg'
p24037
g3
sS'on,metabolism,in'
p24038
g9
sS'intravenous,mg,x'
p24039
g3
sS'experienced,a,decrease'
p24040
g9
sS'potassium-containing,salt,substitutes'
p24041
g9
sS'or,more,during'
p24042
g3
sS'to,the,cautious'
p24043
g9
sS'animals,than,in'
p24044
g3
sS'on,the,antinonciceptive'
p24045
g3
sS'be,an,interaction'
p24046
g9
sS'prophylaxis,after,myocardial'
p24047
g3
sS'occurs,while,taking'
p24048
g3
sS'coumarin-type,the,addition'
p24049
g9
sS'specific,neurobiological,alterations'
p24050
g3
sS'of,any,of'
p24051
g3
sS'bilirubin,and,alkaline'
p24052
g3
sS'cardiovascular,are,also'
p24053
g3
sS'accentuate,the,electrolyte'
p24054
g9
sS'used,with,peripheral'
p24055
g9
sS'then,hoof,twitch'
p24056
g3
sS'up,to,weeks'
p24057
g9
sS'for,urinary,protein'
p24058
g3
sS'more,with,activity--such'
p24059
g9
sS'binding,sites,during'
p24060
g9
sS'a,small,yet'
p24061
g3
sS'associated,with,hepatic'
p24062
g3
sS'the,combination,therapy'
p24063
g3
sS'current,study,the'
p24064
g3
sS'tumor,and,normal'
p24065
g3
sS'days,of,a'
p24066
g9
sS'were,transient,increases'
p24067
g9
sS'to,take,a'
p24068
g9
sS'concomitantly,with,oral'
p24069
g9
sS'number,of,patients'
p24070
g3
sS'evidence,of,hypotension'
p24071
g3
sS'produce,a,less'
p24072
g9
sS'the,recommended,twice'
p24073
g3
sS'substitute,for,for'
p24074
g3
sS'with,angiotensin-,converting'
p24075
g3
sS'and,dose,should'
p24076
g9
sS'for,both,cyp2d6'
p24077
g3
sS'the,stereoisomers,of'
p24078
g3
sS'by,dose,modifying'
p24079
g9
sS'days,in,a'
p24080
g3
sS'the,metabolic,effects'
p24081
g9
sS'over,pi-based,therapy'
p24082
g3
sS'protease,inhibitors,protease'
p24083
g3
sS'is,not,advisable'
p24084
g9
sS'high-dose,mg,kg'
p24085
g9
sS'given,the,following'
p24086
g3
sS'tract,where,the'
p24087
g3
sS'levels,were,seen'
p24088
g9
sS'certain,weak,acids'
p24089
g9
sS'responses,associated,with'
p24090
g3
sS'cortex,of,the'
p24091
g3
sS'com,cgi,generic3'
p24092
g3
sS'taking,medications,associated'
p24093
g3
sS'using,the,intravenous'
p24094
g3
sS'be,monitored,forevidence'
p24095
g9
sS'misonidazole,reduced,the'
p24096
g9
sS'dose,of,tricyclic'
p24097
g3
sS'conversion,could,be'
p24098
g3
sS'treatments,and,no'
p24099
g3
sS'monoamines,from,adrenergic'
p24100
g3
sS'factor,concentrates,has'
p24101
g3
sS'the,liver,by'
p24102
g3
sS'with,should,generally'
p24103
g9
sS'from,prefrontal,cortical'
p24104
g3
sS'a,double,blind'
p24105
g3
sS'agents,such,as'
p24106
g3
sS'and,other,populations'
p24107
g3
sS'events,involving,levo-dromoran'
p24108
g3
sS'produced,less,than'
p24109
g3
sS'to,a,non-matched'
p24110
g9
sS'investigation,was,undertaken'
p24111
g3
sS'and,background,the'
p24112
g3
sS'were,not,considered'
p24113
g3
sS'non-opioid,analgesics,was'
p24114
g3
sS'hypotension,will,be'
p24115
g9
sS'in,view,of'
p24116
g9
sS'associated,with,peripheral'
p24117
g3
sS'of,the,specific'
p24118
g3
sS'domain,decoy,and'
p24119
g3
sS'pegasys,has,not'
p24120
g3
sS'limb,injury,or'
p24121
g3
sS'least,two,hours'
p24122
g3
sS'of,hydroxyzine,must'
p24123
g9
sS'effects,of,caution'
p24124
g9
sS'differences,in,the'
p24125
g3
sS'in,isolated,cases'
p24126
g9
sS'complex,ii-vii,x'
p24127
g3
sS'phenobarbital,it,appears'
p24128
g9
sS'clinical,studies,beta-receptor'
p24129
g3
sS'receiving,catecholamine-depleting,such'
p24130
g9
sS'heparin,effect,digitalis'
p24131
g9
sS'inhibitor,of,aldehyde'
p24132
g3
sS'reactions,include,fever'
p24133
g3
sS'net,fluid,transfers'
p24134
g3
sS'to,date,in'
p24135
g3
sS'proportion,of,neurons'
p24136
g3
sS'inducer,mg,every'
p24137
g9
sS'decreases,platelet,adhesion'
p24138
g3
sS'also,higher,when'
p24139
g9
sS'methotrexate,ketoprofen,like'
p24140
g9
sS'transient,asymptomatic,liver'
p24141
g3
sS'complex,and,multifaceted'
p24142
g3
sS'combined,exposure,to'
p24143
g3
sS'fulfils,the,function'
p24144
g3
sS'really,needed,agents'
p24145
g3
sS'a,dose-dependent,modification'
p24146
g9
sS'norpace,cr,lower'
p24147
g9
sS'in,regimens,where'
p24148
g3
sS'compounds,for,antipsychotic'
p24149
g3
sS'of,gl,was'
p24150
g3
sS'juice,co-administration,of'
p24151
g3
sS'habituation,or,cns'
p24152
g3
sS'on,should,have'
p24153
g3
sS'the,mg,orally'
p24154
g9
sS'nephropathy,were,not'
p24155
g3
sS'the,antihypertensive,effect'
p24156
g9
sS'function,and,arachidonic'
p24157
g3
sS'interaction,with,monoamine'
p24158
g3
sS'bleeding,time,of'
p24159
g3
sS'pharmacokinetic,studies,oral'
p24160
g3
sS's,d,and'
p24161
g9
sS'in,external,subcutaneous'
p24162
g3
sS'were,increased,fold'
p24163
g3
sS'enzyme,activities,and'
p24164
g3
sS'b,and,suggest'
p24165
g9
sS'no,differences,between'
p24166
g3
sS'but,an,increase'
p24167
g3
sS'p450,a4,enzymes'
p24168
g3
sS'action,it,is'
p24169
g9
sS'should,have,their'
p24170
g3
sS'these,cases,was'
p24171
g3
sS'available,and,except'
p24172
g3
sS'agents,structurally,related'
p24173
g9
sS'of,tricor,and'
p24174
g9
sS'month,washout,period'
p24175
g3
sS'to,iii,and'
p24176
g3
sS'the,odontoid,and'
p24177
g3
sS'nor,did,it'
p24178
g3
sS'in,glycemia,after'
p24179
g3
sS'interaction,when,is'
p24180
g3
sS'the,carcinogenic,potential'
p24181
g3
sS'd,also,has'
p24182
g3
sS'below,a,sub-'
p24183
g3
sS'and,compared,to'
p24184
g3
sS'about,higher,when'
p24185
g9
sS'analyses,of,this'
p24186
g3
sS'both,or,its'
p24187
g3
sS'enhanced,by,concurrent'
p24188
g9
sS'nonselective,inhibitor,of'
p24189
g9
sS'p53,mouse,carcinogenicity'
p24190
g3
sS'indocin,should,not'
p24191
g9
sS'and,active,metabolite'
p24192
g3
sS'volunteer,reported,intermenstrual'
p24193
g3
sS'with,impaired,liver'
p24194
g3
sS'metabolite,formation,the'
p24195
g3
sS'derivative,while,left'
p24196
g3
sS'performed,at,specified'
p24197
g3
sS'on,mhd,concentration'
p24198
g3
sS'development,of,safe'
p24199
g3
sS'microsomes,suggest,that'
p24200
g3
sS't4,levels,by'
p24201
g3
sS'metal,toxicity,where'
p24202
g3
sS'glutathione,total,gsh'
p24203
g3
sS'thiazide,and,might'
p24204
g9
sS'and,a,penicillin-type'
p24205
g9
sS'when,such,are'
p24206
g3
sS'also,reduced,to'
p24207
g3
sS'combined,week,placebo'
p24208
g3
sS'reactions,including,anaphylaxis'
p24209
g3
sS'with,citrate,may'
p24210
g9
sS'primary,sources,for'
p24211
g3
sS'titration,should,be'
p24212
g3
sS'mechanism,involved,in'
p24213
g3
sS'on,the,availability'
p24214
g9
sS'nursing,infant,has'
p24215
g3
sS'the,proposed,topical'
p24216
g3
sS'mice,showed,behavioral'
p24217
g3
sS'cimetidine,in,the'
p24218
g9
sS'the,toxic,effects'
p24219
g9
sS'on,days,and'
p24220
g3
sS'warfarin,in,a'
p24221
g3
sS'c,p,a'
p24222
g3
sS'beta-adrenergic,receptor,blockers'
p24223
g3
sS'to,produce,some'
p24224
g3
sS'patients,with,depressed'
p24225
g9
sS'prothrombin,level,has'
p24226
g3
sS'medications,motion,sickness'
p24227
g3
sS'either,occurred,during'
p24228
g3
sS'risk,for,potentially'
p24229
g9
sS'care,providers,are'
p24230
g3
sS'was,no,effect'
p24231
g3
sS'nsaids,like,aleve'
p24232
g9
sS'by,meth,has'
p24233
g3
sS'aspirin,should,be'
p24234
g9
sS'profile,of,in'
p24235
g3
sS'indicates,that,this'
p24236
g3
sS'four,patients,in'
p24237
g9
sS'been,reported,chiefly'
p24238
g3
sS'two-fold,of,and'
p24239
g9
sS'by,cyp3a4,may'
p24240
g3
sS'nausea,vomiting,pruritus'
p24241
g3
sS'of,the,relationship'
p24242
g9
sS'inhibition,of,elimination'
p24243
g9
sS'can,be,detected'
p24244
g3
sS'well,studied,than'
p24245
g3
sS'cyp,c9,human'
p24246
g3
sS'such,a,case'
p24247
g3
sS'muscle,relaxants,most'
p24248
g9
sS'pharmacodynamic,profile,of'
p24249
g3
sS'or,with,preparations'
p24250
g9
sS'trials,a,total'
p24251
g3
sS'on,coumarin-type,the'
p24252
g9
sS'at,least,months'
p24253
g3
sS'were,studied,in'
p24254
g3
sS'overdose,recognized,by'
p24255
g3
sS'weeks,of,escalating'
p24256
g3
sS'cardiac,function,simultaneous'
p24257
g3
sS'patients,taking,with'
p24258
g9
sS'nor,of,other'
p24259
g3
sS'family,may,potentially'
p24260
g3
sS'syndrome,cognitive,dysfunction'
p24261
g9
sS'rate,or,blood'
p24262
g3
sS'with,anaesthesia,for'
p24263
g3
sS'studies,with,and'
p24264
g3
sS'usage,of,and'
p24265
g3
sS'antagonists,in,clinical'
p24266
g3
sS'ratio,or,enantiomer'
p24267
g3
sS'exposure,to,solvents'
p24268
g3
sS'in,individual,inr'
p24269
g3
sS'avoid,use,if'
p24270
g3
sS'hydroxide,and,hydroxide'
p24271
g9
sS'conclusively,establish,whether'
p24272
g3
sS'fractional,mucosal,cell'
p24273
g3
sS'the,current,theories'
p24274
g3
sS'diuretics,the,reports'
p24275
g9
sS'effects,of,mixing'
p24276
g3
sS'taken,concurrently,with'
p24277
g9
sS'this,study,and'
p24278
g3
sS'regulation,of,blood'
p24279
g3
sS'mg,of,administered'
p24280
g3
sS'd6,debrisoquin,hydroxylase'
p24281
g3
sS'amounts,of,nondepolarizing'
p24282
g3
sS'because,of,competitive'
p24283
g9
sS'membrane,phospholipids,as'
p24284
g3
sS'used,some,form'
p24285
g3
sS'peak,blood,concentration'
p24286
g9
sS'and,an,agent'
p24287
g3
sS'in,vitro,data'
p24288
g3
sS'desloratadine,and,hydroxydesloratadine'
p24289
g3
sS'arachidonic,acid,metabolism'
p24290
g3
sS'use,of,was'
p24291
g3
sS'bpm,and,mm'
p24292
g3
sS'live,typhoid,attenuation'
p24293
g9
sS'is,known,to'
p24294
g3
sS'administration,of,strong'
p24295
g3
sS'supplements,and,l-lysine'
p24296
g9
sS'and,hours,subsequent'
p24297
g3
sS'reference,to,possible'
p24298
g3
sS'selective,ca,channel'
p24299
g3
sS'occurrence,of,myelotoxicity'
p24300
g3
sS'derive,from,its'
p24301
g9
sS'de,novo,kidney'
p24302
g3
sS'oral,as,well'
p24303
g3
sS'in,rpmi1640,containing'
p24304
g9
sS'of,with,agents'
p24305
g9
sS'as,camptosar,than'
p24306
g9
sS'until,the,lipid'
p24307
g3
sS'ect,there,are'
p24308
g3
sS'the,steady-state,auc'
p24309
g9
sS'as,alternatives,to'
p24310
g9
sS'eaca,inhibits,adp'
p24311
g3
sS'and,other,commonly'
p24312
g3
sS'recent,studies,of'
p24313
g3
sS'of,stress,and'
p24314
g3
sS'the,a-v,node'
p24315
g9
sS'and,discontinuing,to'
p24316
g9
sS'drug-drug,interaction,studies'
p24317
g3
sS'medications,and,increase'
p24318
g3
sS'daily,and,provide'
p24319
g9
sS'mg,kg,such'
p24320
g3
sS'attributed,to,inhibition'
p24321
g3
sS'ellence,with,other'
p24322
g9
sS'effect,of,only'
p24323
g9
sS'in,a,multiple-dose'
p24324
g9
sS'maintained,on,gm'
p24325
g9
sS'of,serotonin,syndrome'
p24326
g9
sS'clinically,in,patients'
p24327
g3
sS'interfere,with,cyp2c19'
p24328
g3
sS'of,aczone,gel'
p24329
g3
sS'animals,studies,on'
p24330
g3
sS'with,the,same'
p24331
g3
sS'time,as,other'
p24332
g9
sS'current,evidence,suggests'
p24333
g9
sS'including,acetylsalicylic,acid'
p24334
g3
sS'concentration-time,curve,and'
p24335
g9
sS'be,greater,than'
p24336
g9
sS'orally,because,of'
p24337
g9
sS'furosemide,has,a'
p24338
g9
sS'doses,had,a'
p24339
g9
sS'patient,who,has'
p24340
g9
sS'study,demonstrated,that'
p24341
g9
sS'performed,in,cynomolgus'
p24342
g3
sS'the,oral,formulation'
p24343
g3
sS'three,weeks,prior'
p24344
g9
sS'well-controlled,study,of'
p24345
g3
sS'and,is,to'
p24346
g9
sS'volume,of,an'
p24347
g3
sS'given,dose,of'
p24348
g3
sS'production,of,tail-flick'
p24349
g3
sS'transport,systems,lapatinib'
p24350
g3
sS'mean,sodium,and'
p24351
g9
sS'interactions,may,pose'
p24352
g9
sS'in,such,users'
p24353
g3
sS'only,when,they'
p24354
g3
sS'treatment,of,crohn'
p24355
g3
sS'dietary,deficiencies,affecting'
p24356
g9
sS'to,be,sensitive'
p24357
g3
sS'reduce,the,tubular'
p24358
g9
sS'blood,pressure,and'
p24359
g3
sS'total,peak,concentrations'
p24360
g3
sS'inhibit,this,metabolic'
p24361
g3
sS'and,by,maximum'
p24362
g3
sS'eye,drops,containing'
p24363
g3
sS'of,these,studies'
p24364
g3
sS'ml,may,interfere'
p24365
g3
sS'undetectable,release,in'
p24366
g3
sS'receiving,hmg-coa,reductase'
p24367
g9
sS'the,antinociceptive,effect'
p24368
g9
sS'a,stimulator,of'
p24369
g9
sS'conjunction,with,a'
p24370
g9
sS'to,avoid,intoxication'
p24371
g3
sS'treated,with,chop'
p24372
g3
sS'injection,site,reaction'
p24373
g3
sS'studies,of,drug'
p24374
g3
sS'interfere,with,blood'
p24375
g9
sS'sali-cylates,nsaids,including'
p24376
g3
sS'dose,of,subutex'
p24377
g3
sS'factor,iegs,has'
p24378
g3
sS'any,such,reduction'
p24379
g9
sS'concomitantly,prothrombin,time'
p24380
g3
sS'methodology,used,to'
p24381
g3
sS'emerging,roles,of'
p24382
g3
sS'degrees,of,locomotor'
p24383
g3
sS'x,mg,tablets'
p24384
g9
sS'with,aprepitant,to'
p24385
g9
sS'laboratory,tests,if'
p24386
g3
sS'studies,and,nonclinical'
p24387
g3
sS'a-v,node,higher'
p24388
g9
sS'than,patients,were'
p24389
g3
sS'effects,of,epa'
p24390
g3
sS'of,the,period'
p24391
g3
sS'significant,protection,against'
p24392
g9
sS'monitoring,and,follow-up'
p24393
g3
sS'data,from,prospective'
p24394
g3
sS'liver,tumors,seen'
p24395
g3
sS'chemical,i,neurotransmitter'
p24396
g3
sS'and,efficacy,has'
p24397
g3
sS'nicotinic,acid,may'
p24398
g9
sS'dependent,hypertension,including'
p24399
g9
sS'no,potentiation,of'
p24400
g3
sS'is,administered,concurrently'
p24401
g9
sS'decrease,first,pass'
p24402
g3
sS'is,added,to'
p24403
g9
sS'or,to,recommend'
p24404
g3
sS'vitamin,d,concentrations'
p24405
g3
sS'alone,mg,twice'
p24406
g3
sS'metabolism,and,increase'
p24407
g9
sS'mg,were,administered'
p24408
g3
sS'in,well-controlled,patients'
p24409
g9
sS'disorder,and,anticipation'
p24410
g3
sS'diflunisal,decreased,the'
p24411
g9
sS'days,as,a'
p24412
g9
sS'to,have,no'
p24413
g3
sS'concentrations,were,collected'
p24414
g3
sS'the,last,two'
p24415
g3
sS'degree,of,hypotension'
p24416
g9
sS'produced,in,the'
p24417
g9
sS'and,must,be'
p24418
g3
sS'cephalosporin,before,parturition'
p24419
g3
sS'allowed,before,starting'
p24420
g9
sS'procedure,even,when'
p24421
g3
sS'levels,by,displacement'
p24422
g3
sS'been,performed,coadministration'
p24423
g9
sS'substantially,decrease,plasma'
p24424
g3
sS'compounds,was,assessed'
p24425
g3
sS'sporanox,nizoral,muscle'
p24426
g3
sS'mg,single,oral'
p24427
g3
sS'or,activated,in'
p24428
g9
sS'ordinarily,recommended,unless'
p24429
g9
sS'a,urine,or'
p24430
g3
sS'electrolyte,and,acid-base'
p24431
g3
sS'the,hydroalcoholic,solutions'
p24432
g3
sS'femara,and,mg'
p24433
g9
sS'psychiatric,disorder,including'
p24434
g9
sS'and,except,for'
p24435
g3
sS'useful,to,monitor'
p24436
g3
sS'interfere,with,measurement'
p24437
g3
sS'v,to,m'
p24438
g3
sS'patients,careful,tapering'
p24439
g3
sS'observed,following,coadministration'
p24440
g3
sS'were,sampled,at'
p24441
g3
sS'calcium-rich,foods,or'
p24442
g9
sS'for,diagnosis,or'
p24443
g3
sS'the,cecum,and'
p24444
g3
sS'prolongation,and,an'
p24445
g3
sS'considered,for,nsclc'
p24446
g3
sS'of,levo-dromoran,with'
p24447
g9
sS'and,medication,must'
p24448
g9
sS'can,cause,k'
p24449
g3
sS'for,other,that'
p24450
g3
sS'serum,psa,when'
p24451
g3
sS'no,more,cardiovascular'
p24452
g3
sS'tablets,in,epileptic'
p24453
g9
sS'control,rats,at'
p24454
g3
sS'restoration,of,female'
p24455
g3
sS'misleading,information,that'
p24456
g3
sS'coupling,between,the'
p24457
g3
sS'for,one,month'
p24458
g3
sS'was,not,detected'
p24459
g3
sS'inhibiting,parts,of'
p24460
g9
sS'trials,flolan,was'
p24461
g9
sS'physiological,changes,resulting'
p24462
g3
sS'crucial,to,the'
p24463
g3
sS'of,bleeding,if'
p24464
g9
sS'increase,the,impairment'
p24465
g3
sS'in,clinical,interaction'
p24466
g3
sS'a,net,change'
p24467
g9
sS'or,teratogenic,effects'
p24468
g3
sS'that,ingestion,may'
p24469
g9
sS'for,flolan,to'
p24470
g9
sS'receiving,either,or'
p24471
g9
sS'however,caution,must'
p24472
g3
sS'of,drugs,affecting'
p24473
g3
sS'investigated,the,possibility'
p24474
g3
sS'this,particular,sulphydryl-containing'
p24475
g3
sS'these,events,were'
p24476
g3
sS'status,at,the'
p24477
g3
sS'include,one,or'
p24478
g3
sS'argatroban,and,is'
p24479
g3
sS'prolixin,permitil,compazine'
p24480
g3
sS'patients,are,not'
p24481
g3
sS'agents,interfering,with'
p24482
g9
sS'delay,or,reduce'
p24483
g9
sS'were,coadministered,with'
p24484
g3
sS'tablets,inhibit,the'
p24485
g9
sS'excessive,bradycardia,vertigo'
p24486
g3
sS'auc0-12,of,by'
p24487
g9
sS'a,catecholamine,depletor'
p24488
g3
sS'under,a,multiple'
p24489
g3
sS'by,when,co-administered'
p24490
g9
sS'repeated,mg,kg'
p24491
g3
sS'be,informed,when'
p24492
g3
sS'nsaids,including,and'
p24493
g9
sS'this,loss,of'
p24494
g3
sS'by,combination,hormonal'
p24495
g9
sS'and,nonrenal,clearance'
p24496
g3
sS'unbound,free,hormone'
p24497
g3
sS'in,rat,liver'
p24498
g3
sS'intervals,or,if'
p24499
g9
sS'supplemented,with,coenzyme'
p24500
g3
sS'or,other,medications'
p24501
g3
sS'treated,with,alone'
p24502
g9
sS'potentiates,the,effect'
p24503
g9
sS'given,with,two'
p24504
g3
sS'i,these,polyene'
p24505
g3
sS'confusion,and,dyspnea'
p24506
g9
sS'such,medicinal,products'
p24507
g9
sS'symptoms,appear,before'
p24508
g3
sS'when,initiating,a'
p24509
g9
sS'bacteria,tested,the'
p24510
g3
sS'antagonists,because,of'
p24511
g9
sS'of,mg,times'
p24512
g3
sS'highly,active,therapy'
p24513
g3
sS'inhibitors,eg,grapefruit'
p24514
g3
sS'and,no,potentiation'
p24515
g3
sS'there,are,rare'
p24516
g9
sS'that,was,responsible'
p24517
g9
sS'iga,glomerulonephritis,oculo-bulbar'
p24518
g9
sS'in,a,greater'
p24519
g9
sS'for,ketogenic,because'
p24520
g3
sS'shortened,elimination,half-life'
p24521
g9
sS'cancer,in,the'
p24522
g3
sS'the,study,and'
p24523
g3
sS'of,ml,h'
p24524
g3
sS'facial,wasting,breast'
p24525
g3
sS'established,and,other'
p24526
g3
sS'concentrations,of,may'
p24527
g3
sS'metabolism,studies,have'
p24528
g3
sS'of,mhd,to'
p24529
g3
sS'the,patient,continued'
p24530
g3
sS'cyp4a11,with,the'
p24531
g3
sS'concentration,increased,to'
p24532
g3
sS'enterococci,vre,is'
p24533
g3
sS'agent,on,intact'
p24534
g3
sS'isomer,had,opioid-antagonist'
p24535
g3
sS'mealtime,dosing,and'
p24536
g3
sS'bradycardia,which,may'
p24537
g3
sS'treatment,for,a'
p24538
g3
sS'indocin,with,other'
p24539
g9
sS'non-steroidal,anti-inflammatory,may'
p24540
g9
sS'serotonin,ht2a,than'
p24541
g3
sS'if,the,treatment'
p24542
g3
sS'reaction,to,any'
p24543
g9
sS'day,monotherapy,did'
p24544
g3
sS'dosages,and,plasma'
p24545
g3
sS'risk,and,or'
p24546
g3
sS'of,surface,histidine'
p24547
g3
sS'breast,cancer,cell'
p24548
g3
sS'administered,antiepileptic,periodic'
p24549
g9
sS'to,affect,conversion'
p24550
g3
sS'more,reactive,to'
p24551
g3
sS'or,potassium-containing,salt'
p24552
g9
sS'nonsteroidal,given,with'
p24553
g3
sS'to,ml,min'
p24554
g9
sS'activities,similar,to'
p24555
g3
sS'decreasing,responding,whereas'
p24556
g3
sS'effects,noted,below'
p24557
g3
sS'enhance,the,cns'
p24558
g9
sS'control,and,levonorgestrel-treated'
p24559
g3
sS'mg,reduced,the'
p24560
g9
sS'any,time,point'
p24561
g3
sS'nonfailing,myocardium,p'
p24562
g9
sS'in,female,cynomolgus'
p24563
g3
sS'indocin,and,are'
p24564
g9
sS'male,and,female'
p24565
g9
sS'this,study,were'
p24566
g3
sS'study,did,not'
p24567
g3
sS'glucose,measurement,must'
p24568
g3
sS'when,trileptal,was'
p24569
g9
sS'were,observed,for'
p24570
g3
sS'gleevec,gleevec,increases'
p24571
g9
sS'the,lymphoid,malignancy'
p24572
g3
sS'clinically,meaningful,changes'
p24573
g3
sS'because,can,produce'
p24574
g9
sS'pharmacodynamic,with,no'
p24575
g3
sS'of,antiaddictive,efficacy'
p24576
g3
sS'sporadic,cases,of'
p24577
g9
sS'avoid,the,use'
p24578
g9
sS'to,was,necessary'
p24579
g9
sS'effect,and,other'
p24580
g3
sS'which,indicate,that'
p24581
g3
sS'interactions,food,cns'
p24582
g9
sS'coagulation,assays,based'
p24583
g3
sS'may,occur,up'
p24584
g9
sS'of,with,products'
p24585
g9
sS'by,while,those'
p24586
g9
sS'possible,that,larger'
p24587
g3
sS'oh,metabolite,concentrations'
p24588
g3
sS'anxiogenic,effects,were'
p24589
g9
sS'the,human,plasma'
p24590
g3
sS'in,increased,levels'
p24591
g9
sS'concentration,of,the'
p24592
g9
sS'system,and,cardiovascular'
p24593
g9
sS'of,the,diets'
p24594
g3
sS'agents,or,with'
p24595
g9
sS'and,decrease,its'
p24596
g3
sS'is,the,chosen'
p24597
g3
sS'stress,in,rat'
p24598
g9
sS'amines,have,been'
p24599
g9
sS'and,to,beta-adrenergic'
p24600
g3
sS'to,be,concomitantly'
p24601
g3
sS'in,prothrombin,and'
p24602
g3
sS'n,was,also'
p24603
g3
sS'risks,of,severe'
p24604
g9
sS'has,reduced,or'
p24605
g9
sS'disorder,requires,more'
p24606
g3
sS'dose,of,resulted'
p24607
g9
sS'is,ordinarily,a'
p24608
g3
sS'high,in,vitamin'
p24609
g9
sS'spite,of,the'
p24610
g3
sS'ventricular,hypokinesia,and'
p24611
g9
sS'significant,changes,to'
p24612
g3
sS'healthy,white,female'
p24613
g3
sS'by,gradually,decreasing'
p24614
g3
sS'use,of,injection'
p24615
g9
sS'inhibitors,of,cyp2c9'
p24616
g9
sS'sequestrants,may,bind'
p24617
g9
sS'findings,to,humans'
p24618
g9
sS'equetrotm,due,to'
p24619
g9
sS'patients,on,chronic'
p24620
g9
sS'in,steady-state,serum'
p24621
g9
sS'and,then,with'
p24622
g3
sS'abolished,the,cold'
p24623
g3
sS'regranex,gel,with'
p24624
g3
sS'relaxants,amphotericin,b-induced'
p24625
g9
sS'other,coadministered,medicinal'
p24626
g9
sS'by,following,administration'
p24627
g9
sS'are,strong,central'
p24628
g3
sS'prolonging,the,qt'
p24629
g3
sS'necessary,receive,an'
p24630
g3
sS'to,establish,corrective'
p24631
g3
sS'inflammatory,agents,are'
p24632
g9
sS'of,phosphorylated,concentration'
p24633
g3
sS'results,of,a'
p24634
g9
sS'disease,clinical,studies'
p24635
g3
sS'on,alone,or'
p24636
g3
sS'a,inhaler,take'
p24637
g9
sS'increase,of,level'
p24638
g9
sS'the,pharmacokinetic,basis'
p24639
g3
sS'may,cause,bleeding'
p24640
g3
sS'from,combined,use'
p24641
g9
sS'dosing,should,be'
p24642
g3
sS'when,using,these'
p24643
g3
sS'patients,serum,protein-bound'
p24644
g3
sS'the,substantial,interaction'
p24645
g9
sS'in,an,uncontrolled'
p24646
g3
sS'regimen,containing,mg'
p24647
g3
sS'felbatol,on,other'
p24648
g9
sS'is,advised,when'
p24649
g9
sS'on,the,major'
p24650
g3
sS'rofecoxib,mg,once'
p24651
g3
sS'with,a,corresponding'
p24652
g9
sS'lead,to,decreased'
p24653
g9
sS'is,recommended,that'
p24654
g9
sS'secondary,to,this'
p24655
g9
sS'true,interaction,may'
p24656
g9
sS'any,patient,in'
p24657
g3
sS'require,that,the'
p24658
g9
sS'by,after,to'
p24659
g3
sS'allergic,reaction,and'
p24660
g9
sS'any,clinical,interaction'
p24661
g3
sS'in,the,diabectics'
p24662
g3
sS'of,actinic,keratoses'
p24663
g9
sS'also,produces,a'
p24664
g9
sS'applicable,across,a'
p24665
g3
sS'human,trials,have'
p24666
g9
sS'taken,in,concurrent'
p24667
g3
sS'approximately,minutes,faster'
p24668
g9
sS'others,medrol,others'
p24669
g3
sS'been,receiving,treatment'
p24670
g3
sS'review,was,made'
p24671
g3
sS'observed,when,a'
p24672
g3
sS'wasting,breast,enlargement'
p24673
g3
sS'rapidly,identified,and'
p24674
g3
sS'reduces,the,plasma'
p24675
g3
sS'administering,gleevec,with'
p24676
g9
sS'lower,tablet,volume'
p24677
g3
sS'dose,was,times'
p24678
g3
sS'compounds,have,cns'
p24679
g3
sS'were,usually,mild'
p24680
g3
sS'death,potentially,associated'
p24681
g9
sS'enhanced,by,interaction'
p24682
g9
sS'study,involving,adult'
p24683
g3
sS'artery,disease,and'
p24684
g3
sS'the,stomach,does'
p24685
g3
sS'secretory,effect,of'
p24686
g9
sS'be,as,long'
p24687
g3
sS'some,patients,a'
p24688
g3
sS's,of,altered'
p24689
g3
sS'of,busulfex,were'
p24690
g9
sS'behaviors,most,closely'
p24691
g3
sS'phenytoin,steady,state'
p24692
g9
sS'to,patient,demographics'
p24693
g3
sS'have,congenital,or'
p24694
g3
sS'the,clinical,course'
p24695
g3
sS'not,effected,by'
p24696
g3
sS'mg,day,increased'
p24697
g9
sS'potential,for,a'
p24698
g3
sS'receiving,or,similar'
p24699
g9
sS'effects,of,n-allylnormetazocine'
p24700
g3
sS'which,increased,with'
p24701
g3
sS'in,relation,to'
p24702
g3
sS'c,interval,msec'
p24703
g9
sS'products,with,and'
p24704
g9
sS'human,plasma,is'
p24705
g3
sS'toxicity,when,deet'
p24706
g3
sS'ultracentrifugation,indicated,that'
p24707
g3
sS'die,from,macrovascular'
p24708
g3
sS'and,the,th'
p24709
g3
sS'following,the,administration'
p24710
g3
sS'of,barrier,form'
p24711
g3
sS'metabolism,with,increased'
p24712
g9
sS'detrimental,effects,on'
p24713
g3
sS'of,modest,degree'
p24714
g3
sS'of,activase,with'
p24715
g3
sS'racemic,did,not'
p24716
g3
sS'and,extra,doses'
p24717
g3
sS'peroral,administration,of'
p24718
g3
sS'with,mg,followed'
p24719
g3
sS'the,enzyme-inducing,properties'
p24720
g9
sS'may,increase,slightly'
p24721
g9
sS'range,are,neither'
p24722
g3
sS'oxidase,enzyme,that'
p24723
g3
sS'by,the,intravenous'
p24724
g3
sS'block,following,initial'
p24725
g3
sS'with,amprenavir,and'
p24726
g9
sS'maleate,mg,tid'
p24727
g9
sS'and,the,occurrence'
p24728
g9
sS'metabolite,of,were'
p24729
g3
sS'disease,and,ulcerative'
p24730
g9
sS'or,the,auc'
p24731
g9
sS'differences,in,prothrombin'
p24732
g3
sS'as,three,weeks'
p24733
g9
sS'enhance,the,inhibition'
p24734
g9
sS'exposure,to,environmental'
p24735
g9
sS'and,cystic,fluid'
p24736
g9
sS'rigidity,dystonia,ataxia'
p24737
g3
sS'expected,to,decrease'
p24738
g9
sS'patients,coadministered,oral'
p24739
g9
sS'of,with,celebrex'
p24740
g9
sS'of,were,and'
p24741
g9
sS'pulsatile,choroidal,blood'
p24742
g3
sS'receive,adl,mg'
p24743
g3
sS'grapefruit,or,grapefruit'
p24744
g3
sS'and,can,reduce'
p24745
g9
sS'repeat,doses,of'
p24746
g3
sS'inhibitor,produced,a'
p24747
g9
sS'effects,on,steady-state'
p24748
g3
sS'to,the,muscle'
p24749
g9
sS'is,expected,based'
p24750
g3
sS'majority,of,patients'
p24751
g3
sS'study,of,rheumatoid'
p24752
g3
sS'take,lodine,can'
p24753
g3
sS'constriction,were,unaffected'
p24754
g3
sS'a,month,controlled'
p24755
g3
sS'assay,and,the'
p24756
g3
sS'mg,bid,were'
p24757
g3
sS'and,pharmacological,interactions'
p24758
g3
sS'with,taxol,should'
p24759
g3
sS'of,agents,simultaneous'
p24760
g9
sS'between,ssris,and'
p24761
g3
sS'i,d,produced'
p24762
g9
sS'reported,to,reduce'
p24763
g9
sS'generally,by,effects'
p24764
g3
sS'system,notably,oral'
p24765
g9
sS'patients,with,angina'
p24766
g9
sS'of,before,intramuscular'
p24767
g9
sS'mg,kg,weight'
p24768
g9
sS'therapy,may,not'
p24769
g3
sS'properties,of,is'
p24770
g3
sS'the,modified,histidine'
p24771
g3
sS'activation,of,spontaneous'
p24772
g9
sS'predisposing,to,adenylyl'
p24773
g3
sS'concomitantly,administered,with'
p24774
g3
sS'in,pcp,discrimination'
p24775
g3
sS'vitro,have,shown'
p24776
g3
sS'overdose,especially,cyclic'
p24777
g9
sS'reported,when,and'
p24778
g9
sS'in,decreased,effectiveness'
p24779
g9
sS'a,reduced,antihypertensive'
p24780
g3
sS'and,two,outbreaks'
p24781
g3
sS'the,conjugates,so'
p24782
g3
sS'with,potassium-sparing,or'
p24783
g9
sS'patients,in,whom'
p24784
g3
sS'and,thiazide,may'
p24785
g9
sS'was,taken,in'
p24786
g3
sS'persist,for,a'
p24787
g3
sS'and,following,single'
p24788
g3
sS'be,carefully,considered'
p24789
g9
sS'as,or,large'
p24790
g3
sS'k,antagonists,and'
p24791
g3
sS'aim,and,background'
p24792
g3
sS'treatment-experienced,patients,available'
p24793
g3
sS'mg,with,multiple'
p24794
g9
sS'use,the,pharmacological'
p24795
g3
sS'than,nanm,in'
p24796
g3
sS'whether,abnormal,topoisomerase'
p24797
g3
sS'im,reduced,the'
p24798
g9
sS'effects,of,antihypertensive'
p24799
g9
sS'atg,alg,mycophenolate'
p24800
g3
sS'the,maintenance,dose'
p24801
g9
sS'oral,azole,inhibits'
p24802
g9
sS'of,tricyclic,and'
p24803
g9
sS'interactions,given,the'
p24804
g9
sS'rate,and,systolic'
p24805
g3
sS'weakness,their,condition'
p24806
g3
sS'for,is,recommended'
p24807
g3
sS'be,antagonistic,to'
p24808
g9
sS'this,acid-catalyzed,ethanolysis'
p24809
g3
sS'fibrillation,their,additive'
p24810
g9
sS'compensatory,increase,in'
p24811
g3
sS'effective,but,can'
p24812
g3
sS'patients,and,dosage'
p24813
g9
sS'research,has,shown'
p24814
g3
sS'increases,the,plasma'
p24815
g9
sS'definite,nondepolarizing,blocking'
p24816
g3
sS'no,known,interactions'
p24817
g3
sS'concurrently,administered,antiepileptic'
p24818
g9
sS'of,hemorrhage,should'
p24819
g3
sS'potential,for,renal'
p24820
g9
sS'of,retinogeniculate,fibers'
p24821
g3
sS'daily,may,result'
p24822
g9
sS'a,nonsteroidal,anti'
p24823
g9
sS'to,cause,increases'
p24824
g3
sS'cholestyramine,has,been'
p24825
g9
sS'caused,by,sodium'
p24826
g3
sS'mesylate,tablets,have'
p24827
g3
sS'ototoxicity,is,enhanced'
p24828
g9
sS'need,expensive,or'
p24829
g3
sS'to,cause,increased'
p24830
g3
sS'mg,if,is'
p24831
g9
sS'test,was,measured'
p24832
g3
sS'and,have,revealed'
p24833
g3
sS'cyp3a4,is,a'
p24834
g3
sS'biocytin,compared,to'
p24835
g3
sS'conditions,or,was'
p24836
g3
sS'in,plasma,and'
p24837
g9
sS'systematic,changes,in'
p24838
g3
sS'who,are,found'
p24839
g9
sS'two-second,increase,in'
p24840
g9
sS'increase,in,systemic'
p24841
g9
sS'episodes,of,concomitant'
p24842
g3
sS'bleeding,time,has'
p24843
g3
sS'about,times,the'
p24844
g3
sS'beginning,discontinuing,or'
p24845
g9
sS'isozymes,may,result'
p24846
g3
sS'effect,of,strong'
p24847
g3
sS'induce,the,metabolism'
p24848
g9
sS'needed,they,should'
p24849
g3
sS'used,concomitantly,careful'
p24850
g3
sS'beta-adrenergic,blockers,presumably'
p24851
g9
sS'concentration,of,krm-1648'
p24852
g3
sS'reduced,the,number'
p24853
g3
sS'statistical,significance,in'
p24854
g3
sS'etc,in,vitro'
p24855
g9
sS'mimicked,by,the'
p24856
g3
sS'patients,on,warfarin-type'
p24857
g9
sS'efficacy,in,patients'
p24858
g3
sS'when,is,co'
p24859
g3
sS'because,the,small'
p24860
g3
sS'other,metabolized,via'
p24861
g9
sS'a,standing,systolic'
p24862
g9
sS'cellular,basis,of'
p24863
g3
sS'vardenafil,mg,in'
p24864
g9
sS'acid,when,measured'
p24865
g3
sS'determined,by,consulting'
p24866
g3
sS'demonstrated,that,inhibits'
p24867
g3
sS'of,oral,hypoglycemic'
p24868
g3
sS'interactions,between,copaxone'
p24869
g3
sS'not,alter,the'
p24870
g3
sS'additive,cns,depression'
p24871
g9
sS'nanm,were,more'
p24872
g9
sS'is,not,meant'
p24873
g3
sS'tnf-blocking,agents,including'
p24874
g9
sS'the,immune,system'
p24875
g3
sS'toxic,medications,that'
p24876
g3
sS'globulin,tbg,leading'
p24877
g3
sS'felbatol,the,coadministration'
p24878
g3
sS'is,a,novel'
p24879
g9
sS'pursue,qualification,of'
p24880
g3
sS'be,a,sign'
p24881
g3
sS'patients,experiencing,severe'
p24882
g3
sS'with,non-steroidal,the'
p24883
g9
sS'clinical,studies,sodium'
p24884
g3
sS'fraction,in,a'
p24885
g3
sS'patients,this,may'
p24886
g3
sS'the,main,indications'
p24887
g3
sS'frequently,enough,during'
p24888
g9
sS'for,when,coadministered'
p24889
g9
sS'progestational,such,as'
p24890
g3
sS'regularly,for,changes'
p24891
g3
sS'highly,bound,to'
p24892
g3
sS'appears,to,generate'
p24893
g3
sS'with,or,substituted'
p24894
g3
sS'pupillary,dilation,diaphoresis'
p24895
g3
sS'higher,changes,were'
p24896
g3
sS'circulars,for,preparation'
p24897
g3
sS'the,patients,were'
p24898
g3
sS'bleeding,international,normalized'
p24899
g3
sS'cerubidine,should,not'
p24900
g9
sS'this,may,have'
p24901
g3
sS'these,effects,not'
p24902
g3
sS'or,inhibit,cytochrome'
p24903
g3
sS'of,by,increasing'
p24904
g9
sS'which,support,these'
p24905
g3
sS'and,or,hepatic'
p24906
g3
sS'conditions,to,healthy'
p24907
g3
sS'cause,too,much'
p24908
g3
sS'diphenhydramine,hydrochloride,has'
p24909
g9
sS'concomitant,therapy,in'
p24910
g3
sS'reports,describing,patients'
p24911
g9
sS'to,its,potential'
p24912
g3
sS'causing,renin,release'
p24913
g9
sS'severe,cardiovascular,disease'
p24914
g9
sS'that,may,arise'
p24915
g3
sS'therapeutic,effect,and'
p24916
g3
sS'considerably,lower,than'
p24917
g3
sS'maximum,recommended,daily'
p24918
g3
sS'increase,was,seen'
p24919
g3
sS'although,a,causal'
p24920
g9
sS'a,false-positive,direct'
p24921
g3
sS'all,the,selective'
p24922
g3
sS'the,various,ca'
p24923
g3
sS'excretion,is,markedly'
p24924
g9
sS'with,those,in'
p24925
g3
sS'be,potentiated,when'
p24926
g3
sS'liver,microsomes,indicate'
p24927
g3
sS'both,and,prothrombin'
p24928
g9
sS'days,of,discontinuing'
p24929
g9
sS'inhibitors,of,hepatic'
p24930
g9
sS'concentration,should,be'
p24931
g3
sS'preparations,since,there'
p24932
g9
sS'gleevec,increased,gleevec'
p24933
g9
sS'before,these,determinations'
p24934
g3
sS'and,dose,adjustment'
p24935
g9
sS'fold,higher,than'
p24936
g9
sS'on,rare,occasions'
p24937
g9
sS'some,increase,the'
p24938
g9
sS'amphotericin,b,or'
p24939
g3
sS'possibility,of,additive'
p24940
g9
sS'of,medications,which'
p24941
g3
sS'mean,arterial,pressure'
p24942
g9
sS'cells,with,nucleophosmin'
p24943
g3
sS'h2-antagonists,and,proton'
p24944
g3
sS'during,the,administration'
p24945
g9
sS'schizophrenia,in,the'
p24946
g3
sS'approximately,in,subjects'
p24947
g9
sS'to,two,patients'
p24948
g9
sS'concentrations,reach,to10'
p24949
g9
sS'of,compounds,that'
p24950
g9
sS'of,arava,to'
p24951
g9
sS'responsiveness,of,an'
p24952
g9
sS'and,a,should'
p24953
g9
sS'clindamycin-sensitive,isolates,synergy'
p24954
g3
sS'cns,depression,when'
p24955
g9
sS'human,lymphocytes,either'
p24956
g3
sS'concomitantly,with,other'
p24957
g9
sS'animals,dosed,with'
p24958
g3
sS'exceed,a,maximum'
p24959
g9
sS'during,a,prolonged'
p24960
g3
sS'and,chronic,activation'
p24961
g3
sS'matched,with,regard'
p24962
g3
sS'human,dose,had'
p24963
g3
sS'antacid,products,absorption'
p24964
g3
sS'inhibiting,their,metabolism'
p24965
g9
sS'closely,and,appropriate'
p24966
g9
sS'bosentan,had,no'
p24967
g3
sS'on,other,components'
p24968
g3
sS'is,not,sufficient'
p24969
g3
sS'behavioral,responsiveness,of'
p24970
g9
sS'a,cause-and,effect'
p24971
g9
sS'established,on,an'
p24972
g3
sS'sprycel,and,that'
p24973
g9
sS'diclofenac,and,other'
p24974
g9
sS'on,the,management'
p24975
g3
sS'metabolism,by,cyp2d6'
p24976
g3
sS'during,videx,therapy'
p24977
g3
sS'magnitude,and,duration'
p24978
g9
sS'cholestyramine,cholestyramine,binds'
p24979
g9
sS'interferes,with,renal'
p24980
g9
sS'of,sodium,carboxymethylcellulose'
p24981
g3
sS'absorption,metabolism,and'
p24982
g3
sS'the,underlying,disease'
p24983
g3
sS'solvents,have,generally'
p24984
g3
sS'anecdotal,reports,there'
p24985
g9
sS'to,affect,other'
p24986
g3
sS'effect,was,noted'
p24987
g9
sS'for,one,day'
p24988
g3
sS'to,hours,should'
p24989
g9
sS'thromboxane,a2,are'
p24990
g3
sS'enzyme,preparations,containing'
p24991
g9
sS'of,and,mepron'
p24992
g9
sS'received,or,is'
p24993
g9
sS'plasma,levels,have'
p24994
g3
sS'have,been,conducted'
p24995
g3
sS'appeared,to,influence'
p24996
g9
sS'perioperative,period,has'
p24997
g9
sS'high,dose,group'
p24998
g3
sS'with,difluoro-2,propanol'
p24999
g9
sS'values,were,in'
p25000
g3
sS'used,in,external'
p25001
g3
sS'epileptic,patients,n'
p25002
g3
sS'mitogen,and,an'
p25003
g3
sS'important,for,the'
p25004
g3
sS'following,interactions,have'
p25005
g3
sS'during,the,same'
p25006
g3
sS'mg,should,be'
p25007
g3
sS'abilify,aripiprazole,is'
p25008
g3
sS'of,on,clonidines'
p25009
g3
sS'probably,for,as'
p25010
g3
sS'measured,by,the'
p25011
g3
sS'that,significantly,bind'
p25012
g3
sS'and,pharmacokinetic,results'
p25013
g9
sS'data,have,been'
p25014
g3
sS'patients,administered,prior'
p25015
g9
sS'rxlist,com,cgi'
p25016
g3
sS'induction,of,phosphorylation'
p25017
g3
sS'in,a,group'
p25018
g3
sS'evaluating,the,minimum'
p25019
g3
sS'small,volume,of'
p25020
g3
sS'for,ketones,in'
p25021
g3
sS'changed,and,they'
p25022
g3
sS'and,a,fluoroquinolone'
p25023
g9
sS'on,especially,those'
p25024
g9
sS'high,trileptal,doses'
p25025
g9
sS'column,or,by'
p25026
g3
sS'report,which,suggests'
p25027
g9
sS'cardiac,two,hepatic'
p25028
g3
sS'units,day,or'
p25029
g3
sS'oral,hypoglycemics,initiating'
p25030
g3
sS'the,effect,should'
p25031
g9
sS'orally,imidazole,compounds'
p25032
g9
sS'blockade,may,occur'
p25033
g9
sS'blocking,agents,these'
p25034
g3
sS'only,with,careful'
p25035
g3
sS'mineral,oil,interferes'
p25036
g9
sS'in,a,decreased'
p25037
g9
sS'acetate,similarly,inhibit'
p25038
g9
sS'incoordination,when,coadministered'
p25039
g9
sS'i,tranexamic,acid'
p25040
g3
sS'of,are,altered'
p25041
g9
sS'psychotropic,have,not'
p25042
g9
sS'to,observations,which'
p25043
g3
sS'not,particularly,dangerous'
p25044
g3
sS'mg,a,substrate'
p25045
g9
sS'of,required,to'
p25046
g9
sS'when,coreg,is'
p25047
g9
sS'be,envisaged,in'
p25048
g3
sS'auc,of,the'
p25049
g9
sS'increase,in,area'
p25050
g9
sS'designs,for,the'
p25051
g3
sS'hours,should,elapse'
p25052
g9
sS'of,sprycel,with'
p25053
g9
sS'be,reviewed,for'
p25054
g9
sS'demonstrate,that,and'
p25055
g3
sS'cmin,are,summarized'
p25056
g3
sS'with,of,animal'
p25057
g3
sS'treatment,arm,was'
p25058
g3
sS'serum,potassium,levels'
p25059
g3
sS'are,concomitantly,receiving'
p25060
g3
sS'the,side,effects'
p25061
g3
sS'a,day,did'
p25062
g3
sS'or,other,hivid-associated'
p25063
g9
sS'treatment,of,a'
p25064
g3
sS'long-term,studies,on'
p25065
g3
sS'ethopropazine,can,interact'
p25066
g9
sS'reduced,by,acidifying'
p25067
g9
sS'that,in,serum-supplemented'
p25068
g3
sS'significantly,increased,vasoconstriction'
p25069
g9
sS'taking,therapy,are'
p25070
g9
sS'inhibiting,activity,against'
p25071
g3
sS'comparison,to,groups'
p25072
g9
sS'inositol,trisphosphate-induced,responses'
p25073
g3
sS'one,report,l-glutamine'
p25074
g9
sS'a,change,of'
p25075
g3
sS'been,conflicting,results'
p25076
g9
sS'critical,for,determining'
p25077
g3
sS'patients,receiving,coumarin-type'
p25078
g9
sS'respectively,and,did'
p25079
g9
sS'should,be,halved'
p25080
g9
sS'a,cyp2c19,substrate'
p25081
g9
sS'possible,dose,of'
p25082
g9
sS'the,nature,of'
p25083
g3
sS'of,interactions,in'
p25084
g3
sS'metabolism,and,diabetes'
p25085
g3
sS'ix,x,xii'
p25086
g3
sS'observed,in,man'
p25087
g3
sS'crixivan,and,other'
p25088
g3
sS'in,animals,treated'
p25089
g9
sS'interval,were,measured'
p25090
g3
sS'because,may,increase'
p25091
g9
sS'assessed,by,evaluating'
p25092
g3
sS'serum,levels,were'
p25093
g9
sS'to,days,after'
p25094
g9
sS'small,gradual,dose'
p25095
g3
sS'concentration,of,mg'
p25096
g9
sS'associated,with,prostatectomy'
p25097
g3
sS'orally,administered,by'
p25098
g3
sS'inhibited,by,concentrations'
p25099
g3
sS'with,other,cardioactive'
p25100
g9
sS'plasma,clearance,of'
p25101
g9
sS'prolonged,or,delayed'
p25102
g9
sS'protects,mouse,tumour'
p25103
g9
sS'injection,q12h,for'
p25104
g3
sS'the,major,cyp'
p25105
g3
sS'cyp3a4,responsible,for'
p25106
g3
sS'plasma,clearance,or'
p25107
g3
sS'blocking,action,which'
p25108
g3
sS'indifferent,for,strains'
p25109
g9
sS'res,is,running'
p25110
g3
sS'ingesting,the,steady-state'
p25111
g3
sS'cholesterol,concentration,increased'
p25112
g3
sS'pressure,may,be'
p25113
g3
sS'is,given,concomitantly'
p25114
g3
sS'tissues,metabolism,or'
p25115
g3
sS'of,changes,in'
p25116
g9
sS'by,conjugation,through'
p25117
g3
sS'and,the,resulting'
p25118
g9
sS'lymphomas,when,animals'
p25119
g3
sS'glucose,alone,and'
p25120
g3
sS'haloperidol,reduced,or'
p25121
g9
sS'crossover,clinical,pharmacology'
p25122
g3
sS'interval,between,administration'
p25123
g3
sS'factors,in,hemostasis'
p25124
g3
sS'therapy,with,betagan'
p25125
g9
sS'bowel,disease,in'
p25126
g3
sS'patients,in,a'
p25127
g9
sS'patients,receiving,foradil'
p25128
g3
sS'two,different,way'
p25129
g3
sS'and,bezalip,retard'
p25130
g9
sS'given,the,enzyme-inducing'
p25131
g9
sS'redundancy,at,many'
p25132
g3
sS'of,active,vomiting'
p25133
g9
sS'these,observations,are'
p25134
g3
sS'the,electrocardiographic,qt'
p25135
g3
sS'ca,currents,in'
p25136
g3
sS'heroin-related,deaths,reveal'
p25137
g9
sS'double-blind,randomized,balanced'
p25138
g3
sS'in,subjects,who'
p25139
g3
sS'i,and,activated'
p25140
g3
sS'effects,on,either'
p25141
g3
sS'with,antihypertensive,agents'
p25142
g9
sS'supplementation,mg,kg'
p25143
g3
sS'effects,caution,and'
p25144
g3
sS'excretion,of,is'
p25145
g9
sS'observed,to,be'
p25146
g3
sS'preceding,the,beginning'
p25147
g3
sS'curve,of,sulfoxide'
p25148
g9
sS'by,and,respectively'
p25149
g9
sS'only,a,single'
p25150
g3
sS'who,have,discontinued'
p25151
g3
sS'amphetamines,may,decrease'
p25152
g9
sS'ms,contin,prelone'
p25153
g9
sS'a,patient,on'
p25154
g9
sS'which,can,lead'
p25155
g9
sS'on,other,progestational'
p25156
g3
sS'not,induce,cyp1a2'
p25157
g3
sS'preparations,of,is'
p25158
g3
sS'administered,concomitantly,without'
p25159
g3
sS'package,inserts,of'
p25160
g3
sS'be,administered,until'
p25161
g9
sS'given,to,possible'
p25162
g3
sS'of,is,inhibited'
p25163
g9
sS'might,have,the'
p25164
g3
sS'quantities,of,grapefruit'
p25165
g3
sS'and,the,proportion'
p25166
g3
sS'a,patient,or'
p25167
g3
sS'outweigh,the,risks'
p25168
g9
sS'sn38,the,active'
p25169
g3
sS'as,systemic,levels'
p25170
g3
sS'as,which,sensitize'
p25171
g9
sS'more,severe,structural'
p25172
g3
sS'mg,kg,once'
p25173
g3
sS'shown,that,because'
p25174
g3
sS'trials,similar,changes'
p25175
g3
sS'in,vivo,tests'
p25176
g3
sS'effectiveness,against,multidrug-resistant'
p25177
g3
sS'administered,orally,to'
p25178
g3
sS'the,bioavailability,of'
p25179
g3
sS'been,no,reported'
p25180
g3
sS'in,oa,patients'
p25181
g3
sS'is,lengthened,and'
p25182
g9
sS'in,addition,to'
p25183
g9
sS'other,medication,should'
p25184
g3
sS'keppra,on,was'
p25185
g3
sS'on,drug,metabolizing'
p25186
g3
sS'study,administration,of'
p25187
g9
sS'to,to,mg'
p25188
g3
sS'to,but,not'
p25189
g9
sS'g,m2,dose'
p25190
g3
sS'levels,and,weight'
p25191
g9
sS'profile,prothrombin,time'
p25192
g3
sS'including,nonsteroidal,agents'
p25193
g9
sS'of,symptoms,termed'
p25194
g9
sS'with,that,may'
p25195
g9
sS'derivative,of,this'
p25196
g3
sS'from,in,the'
p25197
g3
sS'due,to,potential'
p25198
g3
sS'liver,injury,as'
p25199
g3
sS'when,treatment,is'
p25200
g3
sS'buspirone,hydrochloride,not'
p25201
g9
sS'to,fivefold,increase'
p25202
g3
sS'an,anionic-binding,has'
p25203
g9
sS'ed95,nimbex,at'
p25204
g9
sS'back-up,methods,of'
p25205
g9
sS'vitro,glucuronidation,of'
p25206
g3
sS'arava,and,were'
p25207
g9
sS'or,substances,the'
p25208
g9
sS'other,possible,interactions'
p25209
g3
sS'controlled,clinical,trials'
p25210
g3
sS'to,prevent,excessive'
p25211
g9
sS'supplements,and,the'
p25212
g3
sS'appropriate,actions,after'
p25213
g3
sS'cells,whereas,the'
p25214
g3
sS'decrease,blood,glucose'
p25215
g9
sS'the,male,partners'
p25216
g3
sS'so,careful,monitoring'
p25217
g9
sS'predictable,sympathetic,effects'
p25218
g9
sS'potently,inhibits,the'
p25219
g9
sS'and,may,lead'
p25220
g3
sS'hepatic,microsomal,enzyme'
p25221
g3
sS'rings,from,high-estradiol'
p25222
g9
sS'be,at,least'
p25223
g9
sS'during,treatment,with'
p25224
g3
sS'with,quantitative,and'
p25225
g3
sS'in,interpreting,the'
p25226
g3
sS'increased,the,c'
p25227
g9
sS'iodide,i131,a'
p25228
g9
sS'produce,a,satisfactory'
p25229
g3
sS'a,dose,of'
p25230
g9
sS'relevant,plasma,levels'
p25231
g3
sS'and,infants,which'
p25232
g3
sS'or,or,supplements'
p25233
g3
sS'with,other,such'
p25234
g9
sS'the,recommended,human'
p25235
g3
sS'glucosyl,transferase,enzyme'
p25236
g3
sS'in,vitro,human'
p25237
g3
sS'investigations,indicate,that'
p25238
g3
sS'all,with,the'
p25239
g9
sS'a,host,of'
p25240
g3
sS'are,receiving,or'
p25241
g9
sS'type,it,is'
p25242
g9
sS'in,healthy,individuals'
p25243
g9
sS'studies,demonstrated,no'
p25244
g3
sS'be,significantly,affected'
p25245
g3
sS'reaction,to,have'
p25246
g3
sS'least,miu,ml'
p25247
g3
sS'neither,subject,demonstrated'
p25248
g3
sS'serum,creatinine,in'
p25249
g9
sS'were,precise,and'
p25250
g3
sS'the,introduction,of'
p25251
g9
sS'with,may,increase'
p25252
g9
sS'returned,to,pre-gentamycin'
p25253
g3
sS'a,cyp3a4,inducer'
p25254
g3
sS'depressants,using,these'
p25255
g9
sS'chylomicron-like,emulsion,doubly'
p25256
g3
sS'therapy,is,needed'
p25257
g9
sS'from,ng,ml'
p25258
g3
sS'and,apple,may'
p25259
g3
sS'were,receiving,beta'
p25260
g3
sS'either,inhibitors,or'
p25261
g3
sS'may,lead,to'
p25262
g3
sS'toradoliv,im,has'
p25263
g3
sS'considered,for,pancreatic'
p25264
g3
sS'were,seen,after'
p25265
g3
sS'informed,that,the'
p25266
g3
sS'have,erroneously,low'
p25267
g9
sS'affinity,for,serotonin'
p25268
g3
sS'reported,with,this'
p25269
g3
sS'induction,thus,leading'
p25270
g9
sS'with,the,hour'
p25271
g3
sS'expected,lasma,concentrations'
p25272
g3
sS'hyperthermia,shivering,pupillary'
p25273
g3
sS'to,dosing,should'
p25274
g3
sS'either,due,to'
p25275
g3
sS'with,or,placebo'
p25276
g3
sS'groups,of,patients'
p25277
g3
sS'additive,effect,in'
p25278
g9
sS'the,mechanisms,of'
p25279
g3
sS'aggregation,time,but'
p25280
g3
sS'initial,dosage,should'
p25281
g9
sS'since,does,not'
p25282
g3
sS'of,its,lack'
p25283
g3
sS'with,such,the'
p25284
g3
sS'and,renal,function'
p25285
g9
sS'can,inhibit,adrenal'
p25286
g9
sS'with,metabolism,very'
p25287
g3
sS'agents,pharmacokinetic,drug-drug'
p25288
g3
sS'quinolones,including,nalidixic'
p25289
g9
sS'toxicity,at,lower'
p25290
g9
sS'the,peritoneal,cavity'
p25291
g3
sS'and,also,increased'
p25292
g9
sS'an,angiotensin-converting,enzyme'
p25293
g9
sS'spontaneous,reports,of'
p25294
g9
sS'of,is,enhanced'
p25295
g9
sS'who,is,stable'
p25296
g3
sS'the,divided,attention'
p25297
g9
sS'is,important,that'
p25298
g3
sS'of,by,possibly'
p25299
g9
sS'muscle,pain,and'
p25300
g3
sS'consideration,in,patients'
p25301
g9
sS'four,male,wistar'
p25302
g3
sS'drugs,given,the'
p25303
g3
sS'inhibitors,result,in'
p25304
g9
sS'decrease,in,mean'
p25305
g9
sS'the,functional,integrity'
p25306
g3
sS'reduced,as,much'
p25307
g3
sS'potential,for,interactions'
p25308
g3
sS'occur,with,concomitant'
p25309
g9
sS'treated,with,either'
p25310
g9
sS'these,compounds,interfere'
p25311
g3
sS'absorption,of,administered'
p25312
g3
sS'exposure,presumably,by'
p25313
g9
sS'and,any,mechanism'
p25314
g3
sS'pt,such,as'
p25315
g3
sS'lithium,generally,should'
p25316
g9
sS'phosphorylation,in,tumor'
p25317
g3
sS'be,avoided,at'
p25318
g3
sS'only,n3,showing'
p25319
g3
sS'between,these,and'
p25320
g3
sS'been,used,by'
p25321
g3
sS'a,novel,purification'
p25322
g3
sS'active,metabolite,averaged'
p25323
g3
sS'meal,and,the'
p25324
g3
sS'ci,in,one'
p25325
g3
sS'design,that,have'
p25326
g9
sS'the,oral,self-administration'
p25327
g3
sS'the,renal,elimination'
p25328
g3
sS'the,cautious,initiation'
p25329
g9
sS'duloxetine,it,should'
p25330
g3
sS't,i,d'
p25331
g9
sS'of,with,hydroxide'
p25332
g9
sS'with,pulmonary,arterial'
p25333
g3
sS'of,enhancing,selective'
p25334
g3
sS'desyrel,and,buspirone'
p25335
g9
sS'doses,of,factive'
p25336
g3
sS'incidence,of,atherosclerotic'
p25337
g3
sS'concluded,that,oral'
p25338
g3
sS'gene,cassette,fully'
p25339
g3
sS'were,several,factors'
p25340
g3
sS'and,rarely,euphoria'
p25341
g3
sS'literature,reports,the'
p25342
g3
sS'argatroban,is,to'
p25343
g3
sS'stimulation,is,potentiated'
p25344
g9
sS'poor,metabolizers,with'
p25345
g3
sS'are,unknown,slightly'
p25346
g9
sS'thyroid,physiology,the'
p25347
g3
sS'mechanisms,involving,inhibition'
p25348
g9
sS'in,dose,or'
p25349
g3
sS'luteinizing,hormone,and'
p25350
g3
sS'one,mg,capsule'
p25351
g3
sS'as,methyltetrahydro-folate,and'
p25352
g3
sS'alert,clinicians,to'
p25353
g9
sS'beyond,those,changes'
p25354
g3
sS'hcl,is,administered'
p25355
g9
sS'antidepressants,amphetamines,may'
p25356
g9
sS'of,on,exjade'
p25357
g3
sS'cancer,indicated,that'
p25358
g9
sS'thiazides,should,be'
p25359
g3
sS'clinically,relevant,consequences'
p25360
g9
sS'sympathetic,activity,ganglionic'
p25361
g3
sS'an,interaction,can'
p25362
g3
sS'like,does,not'
p25363
g3
sS'the,and,increased'
p25364
g9
sS'effects,of,but'
p25365
g9
sS'hours,following,an'
p25366
g3
sS'for,to,interact'
p25367
g3
sS'plasma,lipid,profile'
p25368
g3
sS'of,to,its'
p25369
g3
sS'was,tested,by'
p25370
g3
sS'individuals,plasma,concentrations'
p25371
g9
sS'pathway,suggesting,that'
p25372
g3
sS'and,nonclinical,studies'
p25373
g3
sS'heart,block,produced'
p25374
g3
sS'heart,disease,spinal'
p25375
g3
sS'receiving,both,agents'
p25376
g3
sS'studies,with,propecia'
p25377
g3
sS'and,symptoms,suggestive'
p25378
g9
sS'vitro,anti-cryptosporidial,activity'
p25379
g3
sS'in,the,steady'
p25380
g3
sS'that,reached,borderline'
p25381
g3
sS'of,the,glucocorticoid-induced'
p25382
g3
sS'nonsteroidal,probably,reduces'
p25383
g9
sS'the,patient,was'
p25384
g3
sS'or,moieties,are'
p25385
g3
sS'p2,while,decreasing'
p25386
g3
sS'th,week,of'
p25387
g3
sS'least,two,weeks'
p25388
g9
sS'a,marked,inhibition'
p25389
g3
sS'for,the,effect'
p25390
g9
sS'vs,respectively,p'
p25391
g3
sS'with,your,bodys'
p25392
g3
sS'and,minutes,to'
p25393
g3
sS'quai,and,black'
p25394
g3
sS'coronary,oral,cough'
p25395
g3
sS'through,the,cyp3a'
p25396
g3
sS'concurrently,with,since'
p25397
g9
sS'the,have,been'
p25398
g9
sS'from,plasma,albumin'
p25399
g9
sS'could,theoretically,adversely'
p25400
g9
sS'fluoroquinolone,has,been'
p25401
g9
sS'on,certain,microsomal'
p25402
g9
sS'normal,subjects,with'
p25403
g9
sS'induration,skin,exfoliation'
p25404
g3
sS'reports,regarding,the'
p25405
g3
sS'pcp,in,either'
p25406
g3
sS'genetically,predisposed,mice'
p25407
g3
sS'a,agent,has'
p25408
g9
sS'supplement,that,contains'
p25409
g3
sS'assessments,of,drug-drug'
p25410
g3
sS'even,so,plasma'
p25411
g9
sS'the,oral,combination'
p25412
g9
sS'were,prohibited,from'
p25413
g3
sS'high,intraperitoneal,doses'
p25414
g9
sS'intrinsic,effect,its'
p25415
g9
sS'under,steady-state,conditions'
p25416
g3
sS'a,period,of'
p25417
g9
sS'be,useful,for'
p25418
g3
sS'reported,that,may'
p25419
g9
sS'for,days,while'
p25420
g9
sS'testing,and,reaction'
p25421
g9
sS'vasospasm,and,its'
p25422
g9
sS'becomes,sensitive,to'
p25423
g3
sS'response,and,adverse'
p25424
g3
sS'cure,rates,and'
p25425
g3
sS'enzymes,bun,and'
p25426
g9
sS'approach,is,applicable'
p25427
g3
sS'possible,additive,effects'
p25428
g3
sS'after,previous,radiation'
p25429
g3
sS'overall,direct,treatment'
p25430
g3
sS'adrenergic,antagonists,because'
p25431
g9
sS'envisaged,in,intensive'
p25432
g3
sS'with,colorectal,cancer'
p25433
g3
sS'however,possible,that'
p25434
g9
sS'be,exercised,during'
p25435
g9
sS'constant,was,significantly'
p25436
g3
sS'pelvic,girdle,and'
p25437
g3
sS'as,nsaids,and'
p25438
g3
sS'of,probenecid,probenecid'
p25439
g3
sS'last,two,hours'
p25440
g3
sS'are,not,receiving'
p25441
g9
sS'retard,and,then'
p25442
g9
sS'dose-related,increase,in'
p25443
g9
sS'were,increased,in'
p25444
g3
sS'solutions,until,clinical'
p25445
g3
sS'in,this,strain'
p25446
g3
sS'and,formulations,containing'
p25447
g9
sS'the,management,and'
p25448
g3
sS'since,the,arrival'
p25449
g3
sS'ketoconazole,increased,mean'
p25450
g9
sS'needed,agents,which'
p25451
g3
sS'enzyme,system,may'
p25452
g3
sS'plasma,auc,was'
p25453
g3
sS'toxicity,of,various'
p25454
g3
sS'and,the,selective'
p25455
g9
sS'length,of,time'
p25456
g9
sS'avoidance,behaviour,when'
p25457
g3
sS'co-administered,to,steady'
p25458
g9
sS'currently,available,and'
p25459
g3
sS'drugs,highly,bound'
p25460
g3
sS'when,bezalip,or'
p25461
g9
sS'individualizing,it,as'
p25462
g3
sS'in,the,duodenum'
p25463
g3
sS'pattern,of,deficit'
p25464
g3
sS'disorders,has,been'
p25465
g9
sS'therefore,a,starting'
p25466
g3
sS'a,has,been'
p25467
g9
sS'inhalation,device,and'
p25468
g3
sS'as,a,metabolite'
p25469
g9
sS'been,conducted,with'
p25470
g9
sS'in,the,preparation'
p25471
g9
sS'the,herbal,supplement'
p25472
g3
sS'toxicity,investigation,was'
p25473
g3
sS'the,patients,liver'
p25474
g9
sS'interfere,with,biliary'
p25475
g3
sS'increased,if,and'
p25476
g9
sS'with,did,not'
p25477
g3
sS'these,reports,concerned'
p25478
g3
sS'with,habituating,potential'
p25479
g3
sS'response,to,toxoids'
p25480
g9
sS'of,anti-platelet,effect'
p25481
g3
sS'the,ames,n-multistix'
p25482
g3
sS'nor,retinyl,acetate'
p25483
g9
sS'of,deoxy,to'
p25484
g3
sS'pregnancy,and,fetal'
p25485
g3
sS'administration,of,several'
p25486
g3
sS'elevated,serum,levels'
p25487
g9
sS'table,effects,on'
p25488
g3
sS'either,or,kineret'
p25489
g3
sS'weeks,should,be'
p25490
g9
sS'encodes,a,protein'
p25491
g3
sS'a,mixed-function,oxidase'
p25492
g3
sS'increased,blood,levels'
p25493
g9
sS'and,or,pgp'
p25494
g3
sS'and,by,decreasing'
p25495
g9
sS'cyp2d6,has,not'
p25496
g3
sS'activity,persists,as'
p25497
g9
sS'tambocor,clinical,trials'
p25498
g3
sS'the,oral,and'
p25499
g9
sS'immune,response,suggest'
p25500
g3
sS'bradycardia,and,hypertension'
p25501
g3
sS'co-administration,of,did'
p25502
g3
sS'the-curve,after,a'
p25503
g9
sS'agents,in,a'
p25504
g3
sS'the,fraction,of'
p25505
g3
sS'interactions,a,false-positive'
p25506
g3
sS'antigout,oral,and'
p25507
g3
sS'the,thioether,assay'
p25508
g3
sS'reversible,upon,discontinuation'
p25509
g9
sS'to,fold,and'
p25510
g9
sS'of,this,oral'
p25511
g3
sS'the,reported,association'
p25512
g3
sS'and,l-ccg,on'
p25513
g3
sS'usp,has,not'
p25514
g3
sS'via,the,activation'
p25515
g3
sS'as,from,their'
p25516
g9
sS'after,incubation,at'
p25517
g3
sS'synthesis,it,has'
p25518
g9
sS'ages,to,years'
p25519
g9
sS'cyp3a4,substrate,administered'
p25520
g3
sS'that,inhibit,both'
p25521
g9
sS'of,caused,subnormal'
p25522
g3
sS'not,noted,when'
p25523
g3
sS'one,mechanism,of'
p25524
g3
sS'in,enhancing,efficacious'
p25525
g3
sS'patients,demonstrated,a'
p25526
g9
sS'of,release,in'
p25527
g3
sS'regimen,plus,haart'
p25528
g3
sS'when,given,i'
p25529
g3
sS'at,the,same'
p25530
g3
sS'were,used,to'
p25531
g3
sS'because,is,metabolized'
p25532
g3
sS'recent,studies,and'
p25533
g3
sS'approximately,equal,to'
p25534
g3
sS'reported,with,some'
p25535
g3
sS'in,plasma,concentrations'
p25536
g9
sS'than,the,cytochrome'
p25537
g3
sS'adverse,effects,reported'
p25538
g3
sS'to,be,discontinued'
p25539
g9
sS'a,sensitive,cyp3a4'
p25540
g9
sS'effects,of,nonbenzodiazepine'
p25541
g9
sS'neither,case,were'
p25542
g3
sS'it,was,noted'
p25543
g3
sS'reactions,from,faslodex'
p25544
g3
sS'in,an,increase'
p25545
g9
sS'of,and,cause'
p25546
g3
sS'with,occurs,dose'
p25547
g9
sS'cultures,superinduced,by'
p25548
g3
sS'to,prevent,stomach'
p25549
g3
sS'tambocor,with,or'
p25550
g3
sS'that,prolonged,administration'
p25551
g3
sS'renal,impairment,the'
p25552
g9
sS'of,gross,motor'
p25553
g3
sS'reuptake,inhibitors,and'
p25554
g3
sS'undergoing,systemic,anticholinesterase'
p25555
g3
sS'as,garlic,allium'
p25556
g9
sS'use,of,for'
p25557
g3
sS'undergoing,concurrent,therapy'
p25558
g9
sS'and,mild-to,moderate'
p25559
g3
sS'available,and,only'
p25560
g3
sS'increased,clearance,of'
p25561
g3
sS'urine,as,mercapturic'
p25562
g3
sS'not,inhibit,cyp'
p25563
g3
sS'such,as,dose'
p25564
g3
sS'at,to,days'
p25565
g9
sS'platelets,by,causing'
p25566
g9
sS'was,added,in'
p25567
g3
sS'in,these,studies'
p25568
g9
sS'brain,systems,and'
p25569
g3
sS'caution,however,is'
p25570
g3
sS'to,patients,along'
p25571
g3
sS'cases,is,warranted'
p25572
g3
sS'much,as,possible'
p25573
g3
sS'we,noted,a'
p25574
g3
sS'be,monitored,for'
p25575
g3
sS'of,vital,signs'
p25576
g9
sS'discontinued,if,such'
p25577
g3
sS'if,prinivil,is'
p25578
g9
sS'mg,of,or'
p25579
g3
sS'alone,and,subsequently'
p25580
g9
sS'hypersensitivity,reactions,all'
p25581
g3
sS'taken,with,other'
p25582
g9
sS'with,most,other'
p25583
g9
sS'associated,with,fatal'
p25584
g9
sS'some,normal,volunteers'
p25585
g9
sS'three,times,a'
p25586
g9
sS'retinyl,acetate,x'
p25587
g9
sS'result,from,inhibition'
p25588
g3
sS'of,not,only'
p25589
g3
sS'clinical,studies,did'
p25590
g3
sS'day9,of,a'
p25591
g9
sS'either,potentiate,or'
p25592
g9
sS'importance,of,topoisomerases'
p25593
g3
sS'such,doses,of'
p25594
g3
sS'weak,acids,such'
p25595
g9
sS'patient,has,been'
p25596
g3
sS'interaction,studies,intravenous'
p25597
g3
sS'in,the,prevention'
p25598
g3
sS'ii,or,its'
p25599
g3
sS'both,renal,clearance'
p25600
g3
sS'contraindicated,due,to'
p25601
g3
sS'maintained,on,the'
p25602
g9
sS'a4,has,no'
p25603
g3
sS'cell,from,the'
p25604
g3
sS'used,together,caution'
p25605
g3
sS'an,ssri,is'
p25606
g9
sS'known,it,is'
p25607
g9
sS'several,months,of'
p25608
g3
sS'of,hivid,and'
p25609
g3
sS'with,maximum,levels'
p25610
g3
sS'converted,difluoroacetone,to'
p25611
g3
sS'the,effect,seen'
p25612
g3
sS'the,are,administered'
p25613
g3
sS'number,of,defecation'
p25614
g3
sS'and,pseudomonas,aeruginosa'
p25615
g3
sS'of,hydroxylamine,dha'
p25616
g3
sS'carbamazepine,levels,should'
p25617
g9
sS'the,medications,most'
p25618
g3
sS'its,congeners,and'
p25619
g3
sS'midazolam,aprepitant,increased'
p25620
g9
sS'pharmacokinetics,exposure-response,relationships'
p25621
g3
sS'may,increase,blood'
p25622
g9
sS'known,to,induce'
p25623
g3
sS'of,given,as'
p25624
g3
sS'co-administration,of,argatroban'
p25625
g3
sS'treatment,resulted,in'
p25626
g9
sS'a,rare,but'
p25627
g9
sS'a,single,daily'
p25628
g3
sS'into,account,for'
p25629
g3
sS'mucosa,the,systemic'
p25630
g3
sS'discontinue,nursing,while'
p25631
g3
sS'be,determined,with'
p25632
g9
sS'decrease,of,the'
p25633
g3
sS'and,mean,renal'
p25634
g9
sS'oxidase,or,hexokinase'
p25635
g3
sS'evidence,of,fetal'
p25636
g3
sS'limited,in,vivo'
p25637
g9
sS'rebound,hypertension,which'
p25638
g9
sS'may,protect,against'
p25639
g9
sS'isozyme,cytochrome,p450'
p25640
g3
sS'receiving,the,recommended'
p25641
g3
sS'compared,to,the'
p25642
g9
sS'of,fluvoxamine,tablets'
p25643
g9
sS'requirements,in,diabetic'
p25644
g3
sS'concomitantly,may,develop'
p25645
g9
sS'exposure,of,mg'
p25646
g9
sS'an,eight-fold,increase'
p25647
g9
sS'on,histamine-,or'
p25648
g9
sS'be,negatively,impacted'
p25649
g3
sS'intraperitoneal,injections,of'
p25650
g3
sS'oral,estrogens,may'
p25651
g9
sS'should,be,conducted'
p25652
g3
sS'least,in,part'
p25653
g3
sS'subjects,with,mg'
p25654
g3
sS'n,under,steady'
p25655
g3
sS'liver,function,testing'
p25656
g3
sS'therefore,careful,monitoring'
p25657
g3
sS'shown,to,increase'
p25658
g9
sS'agents,by,non-steroidal'
p25659
g9
sS'rates,over,a'
p25660
g3
sS'did,not,have'
p25661
g3
sS'with,combination,therapy'
p25662
g3
sS'increased,levels,of'
p25663
g3
sS'should,be,maintained'
p25664
g9
sS'to,an,earlier'
p25665
g3
sS'of,vitamin,a'
p25666
g9
sS'of,vitamin,c'
p25667
g3
sS'and,concerns,regarding'
p25668
g3
sS'to,the,considerable'
p25669
g3
sS'of,sulfoxide,by'
p25670
g9
sS'bioavailability,and,whether'
p25671
g3
sS'efficacious,a,second'
p25672
g3
sS'may,displace,less'
p25673
g9
sS'when,lotensin,was'
p25674
g3
sS'and,sustiva,mg'
p25675
g3
sS'of,blood,concentrations'
p25676
g3
sS'other,beta2,agonists'
p25677
g9
sS'these,monkeys,were'
p25678
g3
sS'onset,were,prohibited'
p25679
g3
sS'cost-risk,benefit,balance'
p25680
g3
sS'through,various,cytochrome'
p25681
g3
sS'myocardium,to,the'
p25682
g9
sS'changes,in,liver'
p25683
g3
sS'differ,significantly,in'
p25684
g3
sS'strategies,will,become'
p25685
g3
sS'of,serious,or'
p25686
g3
sS'in,the,sleeping'
p25687
g3
sS'thalidomide,co-administration,with'
p25688
g3
sS'decrease,platelet,nucleotide'
p25689
g3
sS'use,of,intravenously'
p25690
g3
sS'phenytoin,is,metabolized'
p25691
g3
sS'certain,factors,such'
p25692
g3
sS'were,not,affected'
p25693
g3
sS'and,but,may'
p25694
g9
sS'minimal,experimental,designs'
p25695
g3
sS'diagnosed,schizophrenia,schizoaffective'
p25696
g9
sS'l-glutamine,was,grams'
p25697
g3
sS'in,vivo,micronucleus'
p25698
g3
sS'while,you,are'
p25699
g9
sS'an,isoform,also'
p25700
g9
sS'but,are,not'
p25701
g3
sS'other,may,show'
p25702
g3
sS'is,administered,with'
p25703
g9
sS'mononuclear,cells,or'
p25704
g9
sS'the,significantly,affects'
p25705
g3
sS'due,to,nonlethal'
p25706
g3
sS'increases,the,risk'
p25707
g9
sS'systemic,are,known'
p25708
g3
sS'to,progression,as'
p25709
g3
sS'above,findings,are'
p25710
g3
sS'presence,of,these'
p25711
g9
sS'in,some,patients'
p25712
g9
sS'interval,were,observed'
p25713
g3
sS'based,on,some'
p25714
g3
sS'trials,patients,were'
p25715
g3
sS'not,recommended,because'
p25716
g9
sS'blockers,and,organic'
p25717
g9
sS'or,reverse,the'
p25718
g9
sS'time,or,within'
p25719
g3
sS'used,in,diabetic'
p25720
g3
sS'glucose,concentrations,with'
p25721
g9
sS'lower,when,the'
p25722
g9
sS'euphoria,excitement,depression'
p25723
g3
sS'inhibitor,the,auc'
p25724
g9
sS'rifampin,significantly,decreased'
p25725
g9
sS'with,and,vitamin'
p25726
g9
sS'serum,samples,from'
p25727
g3
sS'combination,of,hivid'
p25728
g3
sS'and,lymphopenia,proper'
p25729
g3
sS'increased,approximately,fold'
p25730
g9
sS'of,dissolution,of'
p25731
g3
sS'changed,the,serum'
p25732
g9
sS'with,a,predisposition'
p25733
g3
sS'inflammatory,reactions,develop'
p25734
g9
sS'formed,often,appear'
p25735
g3
sS'blood,thinners,coumadin'
p25736
g3
sS'have,centroblast,proliferation'
p25737
g3
sS'a,stable,dosage'
p25738
g3
sS'statistically,significant,decrease'
p25739
g9
sS'which,requires,an'
p25740
g3
sS'no,clinical,data'
p25741
g3
sS'administered,with,and'
p25742
g9
sS'neuropsychiatric,events,or'
p25743
g9
sS'report,of,one'
p25744
g9
sS'administered,with,any'
p25745
g3
sS'or,sensitivity,to'
p25746
g3
sS'be,used,together'
p25747
g9
sS'globulin,thereby,increasing'
p25748
g3
sS'renal,failure,secondary'
p25749
g3
sS'alternate,treatments,lacking'
p25750
g3
sS'perivascular,hemorrhages,edema'
p25751
g3
sS'sn38,levels,in'
p25752
g3
sS'studies,demonstrated,that'
p25753
g3
sS'to,difluoroacetone,mg'
p25754
g3
sS'cefamandole,naftate,cephalothin'
p25755
g3
sS'has,greater,affinity'
p25756
g3
sS'of,and,agents'
p25757
g9
sS'should,include,such'
p25758
g3
sS'metabolism,of,taxol'
p25759
g3
sS'orudis,kt,oruvail'
p25760
g3
sS'toxicity,when,given'
p25761
g9
sS'tested,up,to'
p25762
g3
sS'time,but,does'
p25763
g3
sS'deaths,in,users'
p25764
g3
sS'or,milk,there'
p25765
g3
sS'caution,and,be'
p25766
g3
sS'high,as,in'
p25767
g3
sS'system,depression,produced'
p25768
g3
sS'such,medication,and'
p25769
g3
sS'medications,with,activity'
p25770
g9
sS'be,initiated,after'
p25771
g3
sS'use,of,hmg-coa'
p25772
g9
sS'therefore,it,should'
p25773
g3
sS'and,cmax,increased'
p25774
g9
sS'medicines,thiazide,use'
p25775
g9
sS'to,wshow,that'
p25776
g3
sS'sixty-two,of,strains'
p25777
g3
sS'a,day,washout'
p25778
g3
sS'type,diabetes,used'
p25779
g9
sS'these,have,not'
p25780
g9
sS'host,of,other'
p25781
g3
sS'population,pharmacokinetic,studies'
p25782
g9
sS'reduced,in,hypothyroid'
p25783
g3
sS'interactions,prolongation,of'
p25784
g3
sS'the,dose,at'
p25785
g3
sS'cholesterol,the,major'
p25786
g3
sS'on,measures,of'
p25787
g3
sS'decrease,the,ed50'
p25788
g9
sS'of,all,prescription'
p25789
g3
sS'co-administered,with,anticoagulation'
p25790
g9
sS'administered,mg,reduced'
p25791
g9
sS'glands,with,cytochalasin'
p25792
g3
sS'technique,in,combination'
p25793
g3
sS'ribavirin,see,contraindications'
p25794
g3
sS'taking,concomitantly,with'
p25795
g9
sS'temporarily,reduced,creatinine'
p25796
g9
sS'also,suggest,an'
p25797
g3
sS'mg2,converted,difluoroacetone'
p25798
g3
sS'with,in,clinical'
p25799
g3
sS'weekly,doses,of'
p25800
g3
sS'mg,of,decreased'
p25801
g9
sS'leading,to,a'
p25802
g9
sS'change,significantly,while'
p25803
g3
sS'to,copaxone,did'
p25804
g3
sS'this,parenteral,may'
p25805
g9
sS'fluoxetine,and,its'
p25806
g3
sS'interaction,between,b12'
p25807
g9
sS'hoof,twitch,was'
p25808
g3
sS'that,alcoholic,beverages'
p25809
g3
sS'inhibited,the,dmpge2'
p25810
g9
sS'involved,in,its'
p25811
g3
sS'k,epoxide,reductase'
p25812
g3
sS'been,noted,to'
p25813
g9
sS'relevant,consequences,for'
p25814
g9
sS'by,cyp2d6,the'
p25815
g3
sS'slight,decrease,about'
p25816
g9
sS'the,peak,b'
p25817
g3
sS'any,mechanism,of'
p25818
g3
sS'the,urine,remained'
p25819
g3
sS'cox-2,inhibitor,at'
p25820
g3
sS'were,significantly,lower'
p25821
g3
sS'prolonged,or,increased'
p25822
g3
sS'information,on,the'
p25823
g3
sS'trials,mesylate,tablets'
p25824
g3
sS'the,first,contractile'
p25825
g3
sS'orange,and,apple'
p25826
g3
sS'of,have,also'
p25827
g3
sS'dose,may,need'
p25828
g3
sS'that,inhibit,or'
p25829
g3
sS'to,a,randomized'
p25830
g3
sS'are,advisable,until'
p25831
g3
sS'should,be,cautioned'
p25832
g3
sS'specific,clinical,interaction'
p25833
g3
sS'coumarin,type,revealed'
p25834
g3
sS'along,with,an'
p25835
g3
sS'shown,to,induce'
p25836
g9
sS'to,maintain,an'
p25837
g3
sS'concomitantly,with,coly-mycin'
p25838
g3
sS'of,a,non-'
p25839
g9
sS'agents,it,should'
p25840
g9
sS'gl,the,aqueous'
p25841
g3
sS'tca,is,co-administered'
p25842
g9
sS'such,as,but'
p25843
g9
sS'enzyme,activity,may'
p25844
g9
sS'and,therefore,may'
p25845
g3
sS'weight,was,found'
p25846
g3
sS'almost,complete,loss'
p25847
g3
sS'plasma,concentrations,reach'
p25848
g9
sS'from,one,to'
p25849
g3
sS'fi,responding,produced'
p25850
g9
sS'male,subjects,were'
p25851
g3
sS'hypotensite,effects,due'
p25852
g9
sS'and,susceptibility,to'
p25853
g3
sS'endocrine,feedback,alterations'
p25854
g3
sS'half-life,leading,to'
p25855
g3
sS'nicotinic,acid,channel'
p25856
g3
sS'in,vitro,antiviral'
p25857
g9
sS'on,excystment,rates'
p25858
g3
sS'shown,to,depress'
p25859
g9
sS'in,about,of'
p25860
g3
sS'myopathy,which,is'
p25861
g3
sS'or,cimetidine,concomitant'
p25862
g9
sS'recommended,when,these'
p25863
g3
sS'ortho-novum,produced,average'
p25864
g9
sS'hour,period,before'
p25865
g3
sS'at,lower,concentrations'
p25866
g3
sS'of,compounds,metabolized'
p25867
g3
sS'chapter,discusses,the'
p25868
g3
sS'genomes,have,been'
p25869
g3
sS'or,too,frequent'
p25870
g3
sS'effect,of,exogenous'
p25871
g3
sS'a,similar,metabolism'
p25872
g3
sS'color,reverses,when'
p25873
g3
sS'with,the,initiation'
p25874
g3
sS'impaired,ventricular,function'
p25875
g3
sS'and,identifications,of'
p25876
g3
sS'data,suggest,a'
p25877
g9
sS'when,either,is'
p25878
g9
sS'as,directed,and'
p25879
g3
sS'agents,in,general'
p25880
g3
sS'daily,dosage,of'
p25881
g3
sS'vital,signs,salivary'
p25882
g3
sS'may,cause,hypertension'
p25883
g9
sS'urinary,metanephrine,normetanephrine'
p25884
g3
sS'situate,the,exact'
p25885
g3
sS'salt,intake,approximately'
p25886
g9
sS'reduced,although,the'
p25887
g9
sS'of,was,not'
p25888
g3
sS'used,in,surgery'
p25889
g3
sS'dose,proleukin,and'
p25890
g9
sS'similar,increases,will'
p25891
g3
sS'products,that,are'
p25892
g3
sS'on,the,relation'
p25893
g3
sS'hyperuricemia,present,in'
p25894
g9
sS'possible,interaction,between'
p25895
g9
sS'of,serotonin,in'
p25896
g3
sS'following,intravenous,bolus'
p25897
g3
sS'inhibitory,effects,of'
p25898
g3
sS'interpreted,cautiously,and'
p25899
g3
sS'day,of,from'
p25900
g3
sS'apparent,increase,in'
p25901
g3
sS'for,minutes,at'
p25902
g3
sS'welfare,of,those'
p25903
g3
sS'study,male,rats'
p25904
g3
sS'use,of,a'
p25905
g3
sS'absorption,after,administration'
p25906
g3
sS'hydroxylation,catalyzed,by'
p25907
g3
sS'intensify,the,effect'
p25908
g9
sS'of,decreased,probably'
p25909
g3
sS'there,may,be'
p25910
g3
sS'the,same,procedure'
p25911
g3
sS'ptx,caused,the'
p25912
g3
sS'maoi,as,well'
p25913
g9
sS'systemic,it,is'
p25914
g9
sS'sensipar,is,a'
p25915
g3
sS'indicated,and,then'
p25916
g9
sS'not,recommended,since'
p25917
g9
sS'significant,differences,between'
p25918
g3
sS'testicular,axis,was'
p25919
g3
sS'in,such,a'
p25920
g3
sS'culture,the,effect'
p25921
g9
sS'all,been,used'
p25922
g3
sS'decrease,the,levels'
p25923
g9
sS'chains,of,n-methylthiotetrazole'
p25924
g3
sS'increase,of,glycemia'
p25925
g3
sS'methods,of,contraception'
p25926
g3
sS'interaction,will,lead'
p25927
g9
sS'that,clorazepate,dipotassium'
p25928
g9
sS'botulinum,neurotoxin,serotypes'
p25929
g3
sS'zyvox,and,concomitant'
p25930
g9
sS'caution,when,giving'
p25931
g3
sS'in,either,the'
p25932
g3
sS'was,combined,with'
p25933
g9
sS'of,a,krm-1648'
p25934
g3
sS'studies,with,have'
p25935
g3
sS'in,vivo,metabolic'
p25936
g3
sS'and,hours,prior'
p25937
g3
sS'of,medical,examinations'
p25938
g3
sS'inducer,of,hepatic'
p25939
g9
sS'little,if,any'
p25940
g3
sS'the,orally,disintegrating'
p25941
g9
sS'time,in,all'
p25942
g9
sS'n,did,not'
p25943
g3
sS'stopped,during,treatment'
p25944
g9
sS'mean,of,minutes'
p25945
g3
sS'recommended,in,epileptic'
p25946
g3
sS'antacids,concomitant,administration'
p25947
g9
sS'and,female,volunteers'
p25948
g9
sS'busulfex,were,studied'
p25949
g9
sS'substrate,for,uptake-1'
p25950
g3
sS'in,liver,alt'
p25951
g9
sS'at,high,doses'
p25952
g3
sS'and,mg,decreased'
p25953
g9
sS'of,bepridil,and'
p25954
g3
sS'fetal,abnormalities,in'
p25955
g3
sS'and,a,lesser'
p25956
g9
sS'in,cmax,leading'
p25957
g9
sS'commit,to,use'
p25958
g3
sS'of,or,other'
p25959
g9
sS'patient,populations,prostate'
p25960
g3
sS'unchanged,the,secretion'
p25961
g3
sS'isozymes,including,cyp1a2'
p25962
g3
sS'agents,in,this'
p25963
g3
sS'the,escalating,use'
p25964
g3
sS'the,most,out'
p25965
g3
sS'of,cyp3a4,alter'
p25966
g3
sS'the,following,precautions'
p25967
g9
sS'the,glucocorticoid-induced,gene'
p25968
g3
sS'satisfactory,hypotensive,effect'
p25969
g9
sS'least,of,which'
p25970
g3
sS'cyp1a2,and,cyp2d6'
p25971
g3
sS'tc,suspension,reduces'
p25972
g9
sS'are,years,of'
p25973
g3
sS'johns,wort,because'
p25974
g3
sS'eliminated,the,increases'
p25975
g9
sS'day,and,above'
p25976
g3
sS'suggests,that,more'
p25977
g3
sS'fraction,suggesting,a'
p25978
g3
sS'rats,giving,superimposed'
p25979
g3
sS'with,the,effect'
p25980
g9
sS'bile,acid,sequestrants'
p25981
g9
sS'weight,was,shown'
p25982
g9
sS'information,for,regarding'
p25983
g3
sS'and,a,weak'
p25984
g3
sS'and,are,administered'
p25985
g9
sS'of,anaphylactic,reaction'
p25986
g3
sS'psychoactive,medications,patients'
p25987
g9
sS'arsenical,reactive,encephalopathy'
p25988
g3
sS'or,without,tdp'
p25989
g3
sS'effect,of,as'
p25990
g3
sS'cardiac,patients,does'
p25991
g3
sS'pathway,in,the'
p25992
g3
sS'they,are,begun'
p25993
g9
sS'indications,are,eclampsia'
p25994
g3
sS'not,by,cytochrome'
p25995
g3
sS'not,tested,to'
p25996
g3
sS'prolonged,prothrombin,time'
p25997
g9
sS'c9,human,hepatic'
p25998
g3
sS'therefore,not,be'
p25999
g9
sS'help,to,trace'
p26000
g3
sS'may,remain,some'
p26001
g3
sS'ethanol,clinical,evidence'
p26002
g9
sS'are,case,reports'
p26003
g9
sS'debrisoquin,hydroxylase,is'
p26004
g3
sS'co-administration,leading,to'
p26005
g9
sS'same,effects,may'
p26006
g3
sS'completely,depressed,the'
p26007
g9
sS'non-ossification,of,the'
p26008
g3
sS'for,management,and'
p26009
g3
sS'caffeine,theobromine,grepafloxacin'
p26010
g9
sS'combinations,has,not'
p26011
g3
sS'angina,or,other'
p26012
g9
sS'low-density,lipoproteins,high-density'
p26013
g3
sS'reflex,tachycardia,produced'
p26014
g9
sS'parenteral,enzyme,supplements'
p26015
g3
sS'enhancing,heparin,effect'
p26016
g3
sS'enteric,coating,of'
p26017
g9
sS'including,were,concurrently'
p26018
g3
sS'of,enhancing,the'
p26019
g9
sS'antihypertensive,effect,and'
p26020
g9
sS'are,effective,but'
p26021
g3
sS'it,is,concluded'
p26022
g3
sS'to,adjust,the'
p26023
g9
sS'and,other,nondepolarizing'
p26024
g3
sS'clearance,of,metabolized'
p26025
g3
sS'ii,receptor,antagonists'
p26026
g9
sS'felbatol,as,compared'
p26027
g9
sS'in,a,basic'
p26028
g3
sS'and,the,appearance'
p26029
g3
sS'any,conclusions,to'
p26030
g3
sS'auc,hrs,of'
p26031
g3
sS'taken,during,treatment'
p26032
g3
sS'proteins,is,only'
p26033
g9
sS'active,metabolites,or'
p26034
g3
sS'therapy,may,require'
p26035
g9
sS'inositol,trisphosphate,insp'
p26036
g3
sS'this,medicine,should'
p26037
g3
sS'sodium,and,urinary'
p26038
g9
sS'expected,changes,in'
p26039
g3
sS'period,of,days'
p26040
g3
sS'reported,following,doses'
p26041
g9
sS'rhabdomyolysis,secondary,to'
p26042
g9
sS'healthy,male,subjects'
p26043
g3
sS'in,dogs,treated'
p26044
g3
sS'group,of,patients'
p26045
g3
sS'to,hours,p'
p26046
g3
sS'pharmacokinetic,analyses,were'
p26047
g3
sS'required,when,hydrochloride'
p26048
g9
sS'either,or,concurrently'
p26049
g9
sS'may,prevent,the'
p26050
g9
sS'patients,not,receiving'
p26051
g9
sS'evidence,that,and'
p26052
g3
sS'is,one,report'
p26053
g9
sS'obtained,either,dosage'
p26054
g3
sS'inhibitors,was,delayed'
p26055
g9
sS'would,not,result'
p26056
g3
sS'patients,receiving,long-'
p26057
g9
sS'number,of,microtubules'
p26058
g3
sS'or,has,been'
p26059
g9
sS'appropriate,dosage,adjustments'
p26060
g3
sS'to,pursue,qualification'
p26061
g3
sS'is,via,the'
p26062
g3
sS'for,preservation,of'
p26063
g3
sS'parenterally,special,precaution'
p26064
g3
sS'example,sparing,pharmacological'
p26065
g3
sS'loperamide,and,and'
p26066
g9
sS'we,have,carried'
p26067
g3
sS'therapy,with,the'
p26068
g3
sS'types,of,liver'
p26069
g3
sS'blood,concentration,cmax'
p26070
g9
sS'hydrochloride,a,channel'
p26071
g3
sS'until,the,volatile'
p26072
g3
sS'aminosalicylic,acid,higher'
p26073
g9
sS'or,accidental,contact'
p26074
g3
sS'a,dose-dependent,manner'
p26075
g9
sS'concentrations,it,is'
p26076
g3
sS'in,the,medication'
p26077
g3
sS'percentage,of,endotoxin-induced'
p26078
g9
sS'and,other,including'
p26079
g9
sS'had,an,unsatisfactory'
p26080
g9
sS'with,the,patients'
p26081
g3
sS'patients,receiving,inspra'
p26082
g3
sS'which,enbrel,was'
p26083
g9
sS'in,proof,by'
p26084
g3
sS'agents,and,without'
p26085
g3
sS'coagulation,parameters,should'
p26086
g3
sS'is,therefore,advisable'
p26087
g9
sS'of,a,pulmonary'
p26088
g3
sS'capacity,to,inhibit'
p26089
g9
sS'intestinal,mucosa,the'
p26090
g3
sS'measurements,porter-silber,test'
p26091
g3
sS'seven,days,or'
p26092
g3
sS'be,free,of'
p26093
g3
sS'embryonic,survival,were'
p26094
g3
sS'in,exposure,were'
p26095
g3
sS'one,week,plasma'
p26096
g9
sS'interactions,phenytoin,may'
p26097
g3
sS'indomethacin,may,also'
p26098
g3
sS'str,was,significantly'
p26099
g3
sS'trecator,has,been'
p26100
g9
sS'treatment,in,some'
p26101
g3
sS'was,grams,daily'
p26102
g3
sS'proliferation,in,b-cell'
p26103
g3
sS'other,added,as'
p26104
g3
sS'male,volunteers,did'
p26105
g3
sS'liver,microsomes,demonstrated'
p26106
g3
sS'of,with,of'
p26107
g9
sS'ophthalmic,solution,should'
p26108
g3
sS'a,disulfiram-like,reaction'
p26109
g3
sS'or,salt,substitutes'
p26110
g3
sS'cardiac,arrest,torsades'
p26111
g3
sS'does,not,interfere'
p26112
g3
sS'model,peptide,and'
p26113
g3
sS'and,kappa-selective,was'
p26114
g3
sS'drug,interaction,studies'
p26115
g3
sS'of,with,or'
p26116
g9
sS'aware,when,is'
p26117
g9
sS'trough,cmin,plasma'
p26118
g3
sS'a,week,leaving'
p26119
g3
sS'the,large,placebo-controlled'
p26120
g3
sS'far,more,potent'
p26121
g3
sS'depressants,but,regular'
p26122
g3
sS'cancidas,are,not'
p26123
g3
sS'of,adequate,dosage'
p26124
g3
sS'influence,of,angiotensin'
p26125
g3
sS'a,follow-up,study'
p26126
g3
sS'combined,hyperglycaemia,and'
p26127
g3
sS'with,the,growth'
p26128
g3
sS'the,administrative,arrangements'
p26129
g3
sS'interactions,between,ellence'
p26130
g3
sS'mycophenolate,mofetil,respectively'
p26131
g9
sS'from,amevive,a'
p26132
g3
sS'reinforcing,effects,conditioning'
p26133
g3
sS'of,its,structural'
p26134
g9
sS'potentially,increased,or'
p26135
g3
sS'and,butyrophenone,classes'
p26136
g9
sS'cells,u937,and'
p26137
g9
sS'protein-bound,would,not'
p26138
g3
sS'pharmacokinetics,effectiveness,against'
p26139
g3
sS'days,of,the'
p26140
g3
sS'or,operating,dangerous'
p26141
g3
sS'may,change,the'
p26142
g3
sS'studies,in,which'
p26143
g3
sS'agents,into,patients'
p26144
g3
sS'lapatinib,on,drug'
p26145
g3
sS'induced,a,watery'
p26146
g3
sS'hypoglycemia,and,mask'
p26147
g3
sS'simultaneous,use,should'
p26148
g3
sS'during,multiple-dose,suggesting'
p26149
g3
sS'to,depress,plasma'
p26150
g9
sS'the,frequency,of'
p26151
g3
sS'increasing,blood,levels'
p26152
g9
sS'rheumatoid,arthritis,or'
p26153
g3
sS'formulation,the,potential'
p26154
g3
sS'anesthesiologist,should,be'
p26155
g3
sS'in,the,intestine'
p26156
g3
sS'course,of,at'
p26157
g9
sS'and,degree,of'
p26158
g3
sS'aminoglycoside,are,also'
p26159
g9
sS'protease,inhibitors,are'
p26160
g3
sS'treatment,with,incisive'
p26161
g3
sS'are,often,administered'
p26162
g3
sS'renal,function,have'
p26163
g3
sS'the,results,we'
p26164
g3
sS'single,weekly,doses'
p26165
g3
sS'a,moderate,inhibitor'
p26166
g3
sS'pharmacokinetic,studies,of'
p26167
g3
sS'with,reduces,both'
p26168
g9
sS'in,the,level'
p26169
g9
sS'been,noted,in'
p26170
g9
sS'degeneration,wallerian,degeneration'
p26171
g3
sS'used,with,arimidex'
p26172
g9
sS'began,within,five'
p26173
g3
sS'inhibits,cancer,metastasis'
p26174
g3
sS'found,in,interaction'
p26175
g3
sS'amenorrhea,the,second'
p26176
g3
sS'rapid,equilibration,of'
p26177
g3
sS'system,depressants,the'
p26178
g9
sS'when,duragesic,is'
p26179
g3
sS'may,increase,oral'
p26180
g9
sS'the,additional,stimulus'
p26181
g3
sS'addition,to,this'
p26182
g9
sS'the,pharmacokinetic,interactions'
p26183
g3
sS'exposures,of,r-warfarin'
p26184
g9
sS'of,cefditoren,pivoxil'
p26185
g9
sS'not,after,administration'
p26186
g9
sS'range,while,in'
p26187
g3
sS'as,retention,in'
p26188
g3
sS'or,biocytin,compared'
p26189
g3
sS'significant,metabolism,by'
p26190
g9
sS'of,it,has'
p26191
g3
sS'with,gram,absorption'
p26192
g9
sS'use,of,duragesic'
p26193
g9
sS'clotting,time,have'
p26194
g3
sS'amphetamines,inhibit,the'
p26195
g9
sS'conduction,abnormalities,also'
p26196
g3
sS'interaction,with,and'
p26197
g9
sS'ip,the,effect'
p26198
g9
sS'produced,distinctive,effects'
p26199
g3
sS'inhibitors,reports,suggest'
p26200
g9
sS'rate,of,aerosol'
p26201
g3
sS'in,human,liver'
p26202
g3
sS'levetiracetam,circulates,largely'
p26203
g3
sS'result,in,the'
p26204
g9
sS'coadministration,leads,to'
p26205
g9
sS'discontinued,several,days'
p26206
g3
sS'miosis,mydriasis,diplopia'
p26207
g3
sS'on,some,reports'
p26208
g3
sS'wear,off,before'
p26209
g3
sS'some,disorders,unrelated'
p26210
g3
sS'of,cholinesterase,activity'
p26211
g9
sS'including,ether,and'
p26212
g9
sS'primarily,metabolized,to'
p26213
g3
sS'therefore,based,on'
p26214
g3
sS'methotrexate,valdecoxib,mg'
p26215
g3
sS'that,are,associated'
p26216
g3
sS'after,administration,was'
p26217
g9
sS'in,regard,to'
p26218
g3
sS'that,inhibit,high'
p26219
g3
sS'of,doses,of'
p26220
g3
sS'avoided,at,the'
p26221
g3
sS'c,for,h'
p26222
g3
sS'of,hypoglycemic,agents'
p26223
g9
sS'effect,on,target'
p26224
g3
sS'of,toxicity,in'
p26225
g9
sS'group,served,as'
p26226
g3
sS'this,inhibition,can'
p26227
g3
sS'period,followed,by'
p26228
g3
sS'observed,after,concomitant'
p26229
g3
sS'patients,without,significantly'
p26230
g3
sS'liver,enzymes,is'
p26231
g9
sS'hypokalemia,which,may'
p26232
g9
sS'hypotensive,including,ganglionic'
p26233
g9
sS'since,pletal,is'
p26234
g9
sS'of,an,effect'
p26235
g3
sS'studies,with,plenaxis'
p26236
g3
sS'of,pediatric,patients'
p26237
g3
sS'bromide,is,minimally'
p26238
g9
sS'development,of,myalgia'
p26239
g9
sS'in,additive,central'
p26240
g9
sS'emerge,if,is'
p26241
g9
sS'collapse,in,patients'
p26242
g3
sS'the,reduction,depending'
p26243
g3
sS'an,area,of'
p26244
g3
sS'had,no,relevant'
p26245
g3
sS'lack,of,interaction'
p26246
g3
sS'elderly,patients,with'
p26247
g3
sS'simplest,inference,is'
p26248
g3
sS'mediated,transport,of'
p26249
g3
sS'blockers,and,proton'
p26250
g3
sS'patients,treated,by'
p26251
g3
sS'used,concomitantly,the'
p26252
g9
sS'the,rate,at'
p26253
g3
sS'urine,using,clinitest'
p26254
g3
sS'patients,receiving,either'
p26255
g9
sS'initiating,adjusting,or'
p26256
g9
sS'the,tmax,by'
p26257
g9
sS'effect,in,lowering'
p26258
g9
sS'shown,that,like'
p26259
g9
sS'with,at,least'
p26260
g3
sS'structure,of,functionally'
p26261
g3
sS'spray,during,the'
p26262
g3
sS'hippocampus,is,involved'
p26263
g3
sS'of,chronic,dosing'
p26264
g3
sS'consciousness,confusion,disorientation'
p26265
g3
sS'one,contra-indication,overt'
p26266
g3
sS'marrow,depression,or'
p26267
g3
sS'of,kg,of'
p26268
g3
sS'the,possible,complications'
p26269
g9
sS'as,in,rheumatic'
p26270
g9
sS'of,an,increase'
p26271
g9
sS'basis,of,clinical'
p26272
g9
sS'drugs,drugs,such'
p26273
g3
sS'nrtis,are,metabolized'
p26274
g3
sS'or,its,derivatives'
p26275
g9
sS'taking,aminosalicylic,acid'
p26276
g9
sS'the,risks,to'
p26277
g9
sS'interaction,between,wellbutrin'
p26278
g9
sS'start,or,stop'
p26279
g3
sS'cyp3a4,which,is'
p26280
g3
sS'in,most,subjects'
p26281
g9
sS'and,with,transdermal'
p26282
g9
sS'cyclosporine,doses,trough'
p26283
g3
sS'uptake,blocking,agents'
p26284
g3
sS'observed,which,was'
p26285
g9
sS'cyp3a4,inhibitor,which'
p26286
g9
sS'the,literature,revealed'
p26287
g9
sS'a,major,cause'
p26288
g3
sS'urinary,thioether,assay'
p26289
g3
sS'effects,on,prolonging'
p26290
g9
sS'elimination,half-life,was'
p26291
g3
sS'effect,seen,in'
p26292
g3
sS'with,elemental,primarily'
p26293
g3
sS'experiencing,increases,in'
p26294
g9
sS'adl,and,differed'
p26295
g3
sS'has,slight,effects'
p26296
g3
sS'and,concomitant,beta-1a'
p26297
g3
sS'isoforms,cyp2c8,c9'
p26298
g3
sS'lithium,valdecoxib,mg'
p26299
g9
sS'cause,elimination,of'
p26300
g9
sS'other,drug,at'
p26301
g3
sS'observations,on,hepatotoxicity'
p26302
g9
sS'ketamine,is,clinically'
p26303
g3
sS'prothrombin,time,or'
p26304
g3
sS'used,when,and'
p26305
g9
sS'concurrent,use,with'
p26306
g3
sS'to,erythro-fluorocitrate,in'
p26307
g9
sS'pharmacokinetic-based,drug-drug,interaction'
p26308
g3
sS'in,the,nervous'
p26309
g3
sS'baseline,phenytoin,serum'
p26310
g9
sS'exposure,to,electrophilic'
p26311
g3
sS'possible,extrarenal,mechanisms'
p26312
g3
sS'was,similar,among'
p26313
g3
sS'clearance,of,ucb'
p26314
g3
sS'effects,of,organic'
p26315
g9
sS'of,non-depolarising,muscle'
p26316
g9
sS'suffer,from,these'
p26317
g3
sS'treatment,of,chronic'
p26318
g3
sS'day,or,mg'
p26319
g3
sS'increased,metabolism,of'
p26320
g9
sS'alcohol,or,potentiation'
p26321
g3
sS'life,of,and'
p26322
g9
sS'fetal,toxicity,including'
p26323
g3
sS'k,aquamephyton,synkayvite'
p26324
g3
sS'through,increased,metabolism'
p26325
g9
sS'been,receiving,for'
p26326
g3
sS'and,commentaries,and'
p26327
g3
sS'vitro,and,to'
p26328
g3
sS'for,the,calcium-entry'
p26329
g3
sS'titrated,according,to'
p26330
g9
sS'supplements,and,foods'
p26331
g9
sS'disorders,treated,with'
p26332
g9
sS'in,rodent,studies'
p26333
g3
sS'of,mesenteric,arteries'
p26334
g3
sS'risk,of,using'
p26335
g9
sS'idv,exposure,despite'
p26336
g3
sS'not,induce,metabolic'
p26337
g3
sS'their,increased,renal'
p26338
g3
sS'sonata,mg,potentiated'
p26339
g9
sS'results,of,serum'
p26340
g3
sS'reached,after,administration'
p26341
g9
sS'may,produce,malabsorption'
p26342
g9
sS'curve,and,maximal'
p26343
g9
sS'combination,see,drug'
p26344
g3
sS'involves,depression,anxiety'
p26345
g3
sS'been,administered,safely'
p26346
g3
sS'between,vidaza,and'
p26347
g3
sS'susceptibility,through,a'
p26348
g3
sS'of,antizol,by'
p26349
g9
sS'were,pi,with'
p26350
g3
sS'four,days,in'
p26351
g3
sS'steady-state,cmin,concentration'
p26352
g3
sS'modify,acth,induced'
p26353
g3
sS'reduced,in,order'
p26354
g3
sS'tension,hoof,twitch'
p26355
g3
sS'many,other,and'
p26356
g3
sS'salicylic,acid,in'
p26357
g3
sS'associated,dental,complications'
p26358
g9
sS'such,as,grapefruit'
p26359
g3
sS'mg,d,but'
p26360
g3
sS'when,healthy,subjects'
p26361
g3
sS'of,astringents,spices'
p26362
g3
sS'within,hours,before'
p26363
g9
sS'an,oral,containing'
p26364
g9
sS'is,now,strong'
p26365
g3
sS'therapy,lies,in'
p26366
g3
sS'spite,of,adequate'
p26367
g3
sS'with,some,colorimetric'
p26368
g3
sS'corticotropin,acth,may'
p26369
g9
sS'of,trypanosomiasis,uganda'
p26370
g3
sS'early,components,p1'
p26371
g9
sS'and,dilantin,phenobarbital'
p26372
g9
sS'information,processing,functions'
p26373
g3
sS'potassium,levels,the'
p26374
g9
sS'for,an,interval'
p26375
g3
sS'urine,by,active'
p26376
g3
sS'the,b-blocking,agent'
p26377
g9
sS'reduced,by,hepatic'
p26378
g9
sS'for,days,received'
p26379
g3
sS'with,drugs,administered'
p26380
g3
sS'of,the,dosage'
p26381
g9
sS'iii,decreased,antithrombin'
p26382
g3
sS'of,toxicity,and'
p26383
g9
sS'days,and,titrated'
p26384
g3
sS'and,or,resulted'
p26385
g9
sS'produced,approximately,the'
p26386
g3
sS'to,be,maximal'
p26387
g9
sS'the,digit,symbol'
p26388
g9
sS'decrease,in,auc'
p26389
g9
sS'headaches,and,other'
p26390
g3
sS'hazard,to,health'
p26391
g9
sS'possible,that,the'
p26392
g9
sS'data,vardenafil,should'
p26393
g9
sS'exerts,a,slight'
p26394
g9
sS'are,due,not'
p26395
g9
sS'not,been,explored'
p26396
g3
sS'contains,a,carbonic'
p26397
g3
sS'coadministering,medications,that'
p26398
g3
sS'disulfiram,alone,in'
p26399
g3
sS'the,calcium-entry,blocking'
p26400
g3
sS'binding,studies,with'
p26401
g3
sS'either,medicine,that'
p26402
g9
sS'of,angina,myocardial'
p26403
g3
sS'apparent,oral,clearance'
p26404
g9
sS'treatment,with,synthetic'
p26405
g3
sS'coadministration,with,increased'
p26406
g9
sS'enzyme,inducer,although'
p26407
g3
sS'clonazepam,literature,reports'
p26408
g3
sS'or,evidence,of'
p26409
g3
sS'falls,vs,and'
p26410
g9
sS'anticoagulents,may,be'
p26411
g3
sS'a,that,can'
p26412
g9
sS'be,deferred,until'
p26413
g9
sS'new,acute,episode'
p26414
g3
sS'were,not,significant'
p26415
g3
sS'ra,were,treated'
p26416
g9
sS'the,force,of'
p26417
g3
sS'with,cyp1a2,and'
p26418
g3
sS'renal,effects,of'
p26419
g3
sS'the,channel,blocker'
p26420
g3
sS'rhesus,monkeys,at'
p26421
g3
sS'registered,trademark,of'
p26422
g3
sS'and,intestinal,beta-glucuronidase'
p26423
g3
sS'the,acute,toxicity'
p26424
g9
sS'has,been,effectively'
p26425
g3
sS'weakness,who,are'
p26426
g3
sS'four-day,regimen,of'
p26427
g9
sS'on,bar-press,behavior'
p26428
g3
sS'and,randomly,bred'
p26429
g3
sS'interaction,with,other'
p26430
g3
sS'of,l-ccg,were'
p26431
g3
sS'in,laboratory,assessments'
p26432
g3
sS'consensus,reports,have'
p26433
g3
sS'clearance,and,significantly'
p26434
g9
sS'with,an,indication'
p26435
g3
sS'route,of,elimination'
p26436
g3
sS'patients,than,in'
p26437
g3
sS'a,mammalian,liver'
p26438
g3
sS'verapamil,also,significantly'
p26439
g9
sS'beta-adrenergic,blocking,add'
p26440
g9
sS'of,low,temperatures'
p26441
g3
sS'mean,terminal,half-life'
p26442
g9
sS'in,period,a'
p26443
g3
sS'offset,by,reductions'
p26444
g3
sS'their,similar,mechanism'
p26445
g9
sS'significant,interactions,of'
p26446
g3
sS'but,not,sufficient'
p26447
g3
sS'treatment,groups,were'
p26448
g3
sS'that,the,use'
p26449
g3
sS'auc,of,ethinyl'
p26450
g9
sS'encountered,such,arrhythmias'
p26451
g3
sS'phase,extraction,j'
p26452
g3
sS'ethanol,an,additive'
p26453
g9
sS'adequate,dosage,replacement'
p26454
g3
sS'pegasys,in,combination'
p26455
g3
sS'in,absorption,results'
p26456
g3
sS'dose,bioavailability,studies'
p26457
g3
sS'to,eliminate,the'
p26458
g9
sS'reported,between,zoladex'
p26459
g3
sS'c57bl,n,demonstrated'
p26460
g3
sS'concurrently,treated,with'
p26461
g9
sS'the,infusion,site'
p26462
g3
sS'psychotomimetic,effects,in'
p26463
g3
sS'experiments,on,dogs'
p26464
g3
sS'adverse,clinical,experiences'
p26465
g3
sS'admissions,for,mania'
p26466
g3
sS'methotrexate,vioxx,and'
p26467
g3
sS'does,not,undergo'
p26468
g3
sS'of,the,cyp3a4'
p26469
g9
sS'single,mg,doses'
p26470
g9
sS'requirement,of,our'
p26471
g9
sS'january,and,august'
p26472
g3
sS'medications,besides,mtx'
p26473
g3
sS'to,terminate,treatment'
p26474
g3
sS'effective,use,of'
p26475
g3
sS'that,apoptosis,can'
p26476
g3
sS'broad,range,of'
p26477
g3
sS'theoretically,could,likewise'
p26478
g3
sS'tolbutamide,aprepitant,when'
p26479
g9
sS'reports,of,an'
p26480
g9
sS'was,times,less'
p26481
g3
sS'hivid,should,be'
p26482
g3
sS'lithium,carbonate,mg'
p26483
g3
sS'cyp3a4,eg,channel'
p26484
g9
sS'mouse,bone,marrow'
p26485
g3
sS'patients,taking,labetalol'
p26486
g9
sS'other,nonsteroidal,given'
p26487
g3
sS'theophylline,vioxx,and'
p26488
g9
sS'neuromuscular,blocking,agents'
p26489
g9
sS'urinary,retention,blurred'
p26490
g9
sS'cholinergic,stimulation,is'
p26491
g3
sS'disodium,interferes,with'
p26492
g9
sS'kt,oruvail,voltaren'
p26493
g3
sS'adverse,reactions,to'
p26494
g9
sS'substitutes,may,lead'
p26495
g9
sS'to,be,formed'
p26496
g3
sS'karst,was,tested'
p26497
g3
sS'risk,of,this'
p26498
g3
sS'it,is,considered'
p26499
g3
sS'to,be,deficient'
p26500
g3
sS'benzyl,has,been'
p26501
g3
sS'did,not,produce'
p26502
g3
sS'beta,to,copaxone'
p26503
g3
sS'lean,rats,arteries'
p26504
g3
sS'contrast,media,a'
p26505
g9
sS'thyroid,hormone,activity'
p26506
g3
sS'since,invirase,is'
p26507
g9
sS'for,medications,to'
p26508
g3
sS'concomitantly,receiving,velcade'
p26509
g3
sS'pharmacotherapy,of,cardiovascular'
p26510
g3
sS'studied,and,have'
p26511
g3
sS'oral,contraception,a'
p26512
g3
sS'l,induced,concentration-dependent'
p26513
g3
sS'chemotherapies,breast,irradiation'
p26514
g3
sS'sodium,blood,levels'
p26515
g9
sS'signs,and,mental'
p26516
g9
sS'for,i,coadministration'
p26517
g9
sS'consideration,should,be'
p26518
g3
sS'vasodilation,is,not'
p26519
g3
sS'is,not,antagonized'
p26520
g3
sS'hormonal,may,increase'
p26521
g9
sS'exposure,was,decreased'
p26522
g9
sS'the,renal,plasma'
p26523
g3
sS'intensify,the,drying'
p26524
g9
sS'changes,in,cervical'
p26525
g3
sS'because,reduces,the'
p26526
g9
sS'effect,of,in'
p26527
g9
sS'and,were,not'
p26528
g3
sS'a,hot,kidney'
p26529
g3
sS'the,resistance,or'
p26530
g3
sS'uptake-1,were,reduced'
p26531
g3
sS'been,administered,concurrently'
p26532
g3
sS'by,or,more'
p26533
g9
sS'with,concurrent,administration'
p26534
g3
sS'p450,enzymes,i'
p26535
g3
sS'and,flares,coupled'
p26536
g3
sS'significant,interactions,are'
p26537
g3
sS'interaction,occurs,with'
p26538
g3
sS'abuse,of,this'
p26539
g3
sS'of,a,blunting'
p26540
g3
sS'intensive,care,units'
p26541
g3
sS'with,bleeding,or'
p26542
g3
sS'levels,using,an'
p26543
g3
sS'intervals,or,in'
p26544
g3
sS'than,usual,dose'
p26545
g3
sS'levodopa,and,amantadine'
p26546
g9
sS'of,microg,l'
p26547
g3
sS'and,north,american'
p26548
g3
sS'resulting,in,toxicity'
p26549
g9
sS'of,asthma,control'
p26550
g3
sS'these,data,suggest'
p26551
g3
sS'should,elapse,before'
p26552
g9
sS'metabolized,by,cyp1a2'
p26553
g3
sS'or,intravenous,or'
p26554
g9
sS'drowsiness,may,occur'
p26555
g3
sS'dose,of,did'
p26556
g3
sS'this,might,be'
p26557
g9
sS'administered,simultaneously,because'
p26558
g9
sS'a,such,as'
p26559
g3
sS'nonlinear,kinetic,characteristics'
p26560
g3
sS'to,the,identification'
p26561
g3
sS'that,d1,receptors'
p26562
g3
sS'steady-state,trough,plasma'
p26563
g3
sS'products,concurrent,administration'
p26564
g9
sS'as,evidenced,by'
p26565
g9
sS'reaction,with,glutathione'
p26566
g3
sS'that,the,combination'
p26567
g9
sS'in,circulating,concentrations'
p26568
g3
sS'gland,who,are'
p26569
g9
sS'treatment,age,sex'
p26570
g3
sS'close,observation,of'
p26571
g9
sS'saline,was,low'
p26572
g3
sS'its,three,metabolites'
p26573
g3
sS'than,and,a'
p26574
g9
sS'sparing,agents,should'
p26575
g3
sS'of,faslodex,in'
p26576
g3
sS'gl,was,the'
p26577
g3
sS'patients,receiving,nonselective'
p26578
g9
sS'secretion,by,alveoli'
p26579
g3
sS'measured,from,the'
p26580
g3
sS'known,whether,might'
p26581
g3
sS'blood,levels,was'
p26582
g9
sS'and,indirect,antiglobulin'
p26583
g3
sS'into,the,systemic'
p26584
g9
sS'of,serious,reaction'
p26585
g9
sS'agents,including,humira'
p26586
g9
sS'controlled,studies,to'
p26587
g3
sS'since,the,therapeutic'
p26588
g3
sS'the,second,response'
p26589
g3
sS'it,is,of'
p26590
g3
sS'medications,on,clearance'
p26591
g3
sS'mg,causing,no'
p26592
g3
sS'already,seen,with'
p26593
g3
sS'for,hypertension,and'
p26594
g3
sS'levels,of,diabetic'
p26595
g3
sS'of,equetrotm,due'
p26596
g9
sS'combination,with,patients'
p26597
g9
sS'the,problems,that'
p26598
g3
sS'as,subsequent,synthesis'
p26599
g3
sS'excretion,too,was'
p26600
g3
sS'thiazide,may,increase'
p26601
g9
sS'by,interfering,with'
p26602
g9
sS'the,authors,examined'
p26603
g3
sS'recovery,in,a'
p26604
g3
sS'of,an,additive'
p26605
g9
sS'of,bar-press,response'
p26606
g3
sS'artery,disease,aged'
p26607
g3
sS'in,patients,with'
p26608
g3
sS'healthy,subjects,administered'
p26609
g9
sS'dynacirc,an,increased'
p26610
g3
sS'significant,only,in'
p26611
g3
sS'who,had,depleting'
p26612
g3
sS'therapy,could,prolong'
p26613
g9
sS'amevive,underwent,trans-placental'
p26614
g3
sS'approximately,of,the'
p26615
g3
sS'decision,should,be'
p26616
g3
sS'introductory,chapter,discusses'
p26617
g3
sS'until,it,has'
p26618
g3
sS'increases,excretion,and'
p26619
g9
sS'on,aspects,of'
p26620
g3
sS'extent,of,absorption'
p26621
g3
sS'brevibloc,and,does'
p26622
g3
sS'administered,and,the'
p26623
g3
sS'some,studies,and'
p26624
g9
sS'administered,with,maxipime'
p26625
g9
sS'the,excreted,levels'
p26626
g3
sS'state,serum,levels'
p26627
g3
sS'symptoms,such,as'
p26628
g3
sS'cyp3a,may,increase'
p26629
g3
sS'toxicology,studies,have'
p26630
g3
sS'increase,the,side'
p26631
g3
sS'sensitive,to,ph'
p26632
g3
sS'qd,resulted,in'
p26633
g9
sS'and,concentrations,and'
p26634
g3
sS'use,of,hormone'
p26635
g3
sS'neutrophil,counts,in'
p26636
g9
sS'of,warfarin-type,cyp2c9'
p26637
g3
sS'the,affinity,kd'
p26638
g3
sS'particularly,in,hyperuricemic'
p26639
g3
sS'researchers,have,investigated'
p26640
g3
sS'observed,in,the'
p26641
g3
sS'to,either,was'
p26642
g3
sS'deleted,from,a'
p26643
g9
sS'pose,clinical,problems'
p26644
g9
sS'a,total,of'
p26645
g3
sS'a,renal,tubular'
p26646
g3
sS'cytokines,have,been'
p26647
g3
sS'unaltered,by,concomitant'
p26648
g3
sS'an,in,vitro'
p26649
g9
sS'known,to,inhibit'
p26650
g3
sS'microsomal,enzyme,system'
p26651
g9
sS'metabolites,dfur,fu'
p26652
g3
sS'other,muscle,relaxants'
p26653
g3
sS'cervical,mucus,the'
p26654
g3
sS'suspected,of,having'
p26655
g3
sS'were,done,at'
p26656
g3
sS'anti-neoplastic,agents,have'
p26657
g3
sS'prepared,by,resecting'
p26658
g3
sS'be,highly,unstable'
p26659
g3
sS'people,who,consume'
p26660
g9
sS'the,secretory,effect'
p26661
g9
sS'characteristics,hiv,status'
p26662
g3
sS'dorsocervical,fat,enlargement'
p26663
g3
sS'with,but,this'
p26664
g9
sS'of,depressive,and'
p26665
g3
sS'i131,a,rebound'
p26666
g9
sS'mesylate,has,been'
p26667
g3
sS'dependence,usually,involves'
p26668
g3
sS'megakaryocytes,with,extracellular'
p26669
g9
sS'be,expected,that'
p26670
g9
sS'may,have,their'
p26671
g9
sS'and,or,excessive'
p26672
g3
sS'risk,of,neurotoxic'
p26673
g9
sS'rpmi1640,containing,microgram'
p26674
g3
sS'also,affect,plasma'
p26675
g3
sS'of,clonazepam,literature'
p26676
g3
sS'phosphatidate,phosphohydrolase,from'
p26677
g3
sS'information,that,can'
p26678
g3
sS'and,a,mechanism'
p26679
g9
sS'it,is,likely'
p26680
g3
sS'median,follow-up,opportunistic'
p26681
g3
sS'dosage,may,be'
p26682
g3
sS'decreased,the,antinociceptive'
p26683
g9
sS'index,and,most'
p26684
g3
sS'b,and,was'
p26685
g9
sS'esomeprazole,inhibits,gastric'
p26686
g3
sS'surgical,procedures,during'
p26687
g9
sS'day,of,incubation'
p26688
g3
sS'pharmacokinetic,interaction,occurred'
p26689
g3
sS'at,to,week'
p26690
g3
sS'index,of,hepatic'
p26691
g3
sS'is,bound,to'
p26692
g3
sS'emulsion,doubly,labeled'
p26693
g3
sS'to,change,the'
p26694
g3
sS'biological,and,behavioral'
p26695
g9
sS'flushing,rash,peripheral'
p26696
g3
sS'and,the,dosage'
p26697
g3
sS'the,steadystate,trough'
p26698
g3
sS'mean,sem,to'
p26699
g3
sS'dosed,with,mg'
p26700
g3
sS'demonstrated,by,the'
p26701
g3
sS'the,oral,absorption'
p26702
g9
sS'an,deficiency,can'
p26703
g9
sS'drugs,have,been'
p26704
g3
sS'physician,should,be'
p26705
g3
sS'be,acutely,worsened'
p26706
g9
sS'mortality,rate,in'
p26707
g3
sS'the,gradual,withdrawal'
p26708
g3
sS'serum,salicylate,assays'
p26709
g3
sS'renal,vasodilator,effects'
p26710
g3
sS'following,co-administration,of'
p26711
g3
sS'cause,are,dryness'
p26712
g3
sS'agents,ethinyl,estradiol'
p26713
g3
sS'elemental,reduced,extent'
p26714
g9
sS'signs,of,hypoglycemia'
p26715
g3
sS'class,which,includes'
p26716
g3
sS'hormonal,who,also'
p26717
g3
sS'those,seen,prior'
p26718
g9
sS'inhibitors,to,control'
p26719
g9
sS'monitored,especially,if'
p26720
g3
sS'for,blood,pressure'
p26721
g3
sS'in,states,of'
p26722
g3
sS'of,enterococcus,faecalis'
p26723
g3
sS'fentanyl,cyp3a4,substrate'
p26724
g3
sS'animals,were,not'
p26725
g3
sS'adjustment,of,co-administered'
p26726
g3
sS'neonates,whose,mothers'
p26727
g3
sS'either,the,str'
p26728
g3
sS'electrocardiographic,qt,c'
p26729
g3
sS'proposed,topical,dose'
p26730
g3
sS'tricor,with,mg'
p26731
g9
sS'the,absorption,or'
p26732
g3
sS'events,were,also'
p26733
g3
sS'prothrombin,or,other'
p26734
g3
sS'one,at,mg'
p26735
g3
sS'an,adequate,respiratory'
p26736
g3
sS'velcade,and,that'
p26737
g3
sS'zyvox,may,experience'
p26738
g9
sS'hormones,appear,to'
p26739
g3
sS'of,systemically,administered'
p26740
g3
sS'toxicity,to,miracidia'
p26741
g3
sS'disease,may,experience'
p26742
g9
sS'bismuth,subsalicylate,given'
p26743
g9
sS'nsaids,without,evidence'
p26744
g3
sS'supplements,may,give'
p26745
g9
sS'the,body,via'
p26746
g9
sS'the,study,dosed'
p26747
g3
sS'of,these,potentially'
p26748
g9
sS'of,the,ermbt'
p26749
g3
sS'clinician,should,be'
p26750
g9
sS'administration,with,racemic'
p26751
g9
sS'to,doses,that'
p26752
g3
sS'and,drug,administration'
p26753
g3
sS'observed,when,multiple'
p26754
g9
sS'during,the,hour'
p26755
g3
sS'inactivate,by,bacterial'
p26756
g9
sS'of,indocin,and'
p26757
g9
sS'magnitude,of,response'
p26758
g3
sS'concomitantly,taking,or'
p26759
g3
sS'aldehyde,oxidase,and'
p26760
g9
sS'beta,blockers,should'
p26761
g9
sS'effects,kemstro,the'
p26762
g3
sS'infusion,in,horses'
p26763
g3
sS'revia,and,other'
p26764
g3
sS'was,analyzed,for'
p26765
g3
sS'of,and,subsalicylate'
p26766
g9
sS'bolus,of,amicar'
p26767
g3
sS'vitro,does,not'
p26768
g3
sS'a2-selective,agonist,but'
p26769
g9
sS'compatible,with,the'
p26770
g3
sS'muscle,pains,or'
p26771
g3
sS'is,highly,bound'
p26772
g3
sS'change,the,dose'
p26773
g3
sS'excretion,ibuprofen,ibuprofen'
p26774
g3
sS'warfarin,administration,of'
p26775
g3
sS'binding,of,hcl'
p26776
g3
sS'receiving,a,potent'
p26777
g3
sS'to,avoid,the'
p26778
g9
sS'restriction,or,dialysis'
p26779
g9
sS'myasthenic,weakness,who'
p26780
g3
sS'establish,corrective,measures'
p26781
g3
sS'nephrotoxicity,and,the'
p26782
g3
sS'pqq,based,methods'
p26783
g3
sS'feasible,and,may'
p26784
g3
sS'with,does,not'
p26785
g3
sS'of,an,effector'
p26786
g3
sS'listed,below,drugs'
p26787
g9
sS'the,manufacturer,or'
p26788
g3
sS'compounds,and,beta-adrenergic'
p26789
g9
sS'of,both,s-warfarin'
p26790
g9
sS'men,levels,were'
p26791
g3
sS'between,plasma,levels'
p26792
g3
sS'maintained,on,monotherapy'
p26793
g3
sS'that,in,control'
p26794
g3
sS'however,appear,to'
p26795
g3
sS'drug,eg,and'
p26796
g9
sS'these,same,interactions'
p26797
g3
sS'or,other,as'
p26798
g9
sS'by,and,hour'
p26799
g9
sS'should,be,watched'
p26800
g9
sS'adverse,events,associated'
p26801
g9
sS'least,balanced,by'
p26802
g3
sS'decreased,when,administered'
p26803
g9
sS'negative,chronotropic,effects'
p26804
g3
sS'maximum,of,mg'
p26805
g9
sS'objective,to,report'
p26806
g3
sS'an,attempt,to'
p26807
g9
sS'adverse,reactions,are'
p26808
g3
sS'undergo,hydrolysis,to'
p26809
g3
sS'from,clinical,trials'
p26810
g3
sS'is,reasonable,to'
p26811
g3
sS'that,frequent,peripheral'
p26812
g3
sS'who,are,treated'
p26813
g9
sS'occur,in,neonates'
p26814
g3
sS'to,an,enhancement'
p26815
g9
sS'levels,in,humans'
p26816
g3
sS'since,and,potassium-sparing'
p26817
g9
sS'interferences,between,solvents'
p26818
g3
sS'to,published,accounts'
p26819
g3
sS'block,pcp-induced,behaviors'
p26820
g3
sS'interactions,between,apokyn'
p26821
g3
sS'and,cleansers,soaps'
p26822
g3
sS'data,from,patients'
p26823
g3
sS'various,dual-memory,theories'
p26824
g3
sS'doses,than,usually'
p26825
g3
sS'vitro,studies,cytochrome'
p26826
g3
sS'haemodynamic,effects,of'
p26827
g3
sS'due,to,increased'
p26828
g3
sS'lymphoma,on,combination'
p26829
g3
sS'by,the,lectin'
p26830
g3
sS'a,hmg-coa,reductase'
p26831
g9
sS'of,which,is'
p26832
g3
sS'tcas,such,as'
p26833
g9
sS'the,myasthenic,patient'
p26834
g9
sS'in,urinary,and'
p26835
g9
sS'ia,such,as'
p26836
g9
sS'fi,fr,schedule'
p26837
g3
sS'molecular,basis,for'
p26838
g9
sS'dexamethasone,at,m'
p26839
g9
sS'cyp2d6,is,unlikely'
p26840
g3
sS'or,life-threatening,reactions'
p26841
g3
sS'noted,to,develop'
p26842
g9
sS'cyp3a4,inducer,the'
p26843
g9
sS'first,hour,after'
p26844
g9
sS'for,type,diabetes'
p26845
g3
sS'radioimmunoassay,or,t3'
p26846
g3
sS'consequently,with,a'
p26847
g3
sS'period,a,all'
p26848
g3
sS'to,high,temperature'
p26849
g9
sS'bound,to,serum'
p26850
g9
sS'since,an,increase'
p26851
g9
sS'ingestion,of,an'
p26852
g9
sS'href,bupropz_od,htm'
p26853
g9
sS'the,results,generated'
p26854
g3
sS'of,diabetes,mellitus'
p26855
g3
sS'or,abolished,as'
p26856
g9
sS'in,serum-deprived,ras-transformed'
p26857
g3
sS'metabolite,and,the'
p26858
g3
sS'and,hydroxides,does'
p26859
g3
sS'to,or,oral'
p26860
g9
sS'reduces,the,clearance'
p26861
g9
sS'and,reduced,subjects'
p26862
g3
sS'biocytin,with,whole-cell'
p26863
g3
sS'inhibitor,resulted,in'
p26864
g3
sS'challenged,with,a'
p26865
g3
sS'attenuation,of,immunization'
p26866
g9
sS'that,identify,chromatin'
p26867
g9
sS'at,mg,qid'
p26868
g9
sS'with,other,cyp3a4'
p26869
g9
sS'given,with,nonsteroidal'
p26870
g9
sS'sites,for,increased'
p26871
g3
sS'in,the,sympathetic'
p26872
g3
sS'inhibitors,mao,inhibitors'
p26873
g3
sS'surfaces,of,the'
p26874
g3
sS'concentration,mm,is'
p26875
g3
sS'with,neurontin,mg'
p26876
g9
sS'and,monoamine,oxidase'
p26877
g9
sS'although,the,results'
p26878
g9
sS'dose,of,tml'
p26879
g3
sS'cardiac,channel,blockers'
p26880
g3
sS'only,take,place'
p26881
g3
sS'the,antiedematous,action'
p26882
g9
sS'and,other,may'
p26883
g9
sS'angiotensin,ii,receptor'
p26884
g9
sS'decrease,to,increase'
p26885
g9
sS'anticholinesterase,effect,of'
p26886
g9
sS'recommended,that,be'
p26887
g9
sS'of,hypotension,related'
p26888
g9
sS'skin,tests,corticosteroids'
p26889
g3
sS'than,usual,and'
p26890
g9
sS'lowering,effect,of'
p26891
g9
sS'beta-blockers,and,other'
p26892
g9
sS'a,kda,adapter'
p26893
g3
sS'ulceration,and,complications'
p26894
g9
sS'other,potent,a4'
p26895
g9
sS'thus,it,is'
p26896
g3
sS'notably,nondepolarizing,muscle'
p26897
g9
sS'therapy,should,not'
p26898
g3
sS'interaction,of,foscavir'
p26899
g9
sS'of,postoperative,pain'
p26900
g3
sS'agents,negative,inotropic'
p26901
g9
sS'absolute,number,of'
p26902
g3
sS'antacids,aluminum-,or'
p26903
g9
sS'therefore,when,midamor'
p26904
g9
sS'cancer,cell,growth'
p26905
g3
sS'does,not,change'
p26906
g3
sS'patients,taking,since'
p26907
g9
sS'cause,changes,in'
p26908
g9
sS'optimal,dosing,interval'
p26909
g3
sS'antagonist,opioid,analgesics'
p26910
g9
sS'is,administered,immediately'
p26911
g9
sS'nsaids,a,interaction'
p26912
g3
sS'derived,from,a'
p26913
g9
sS'dactinomycin,may,interfere'
p26914
g3
sS'taking,that,inhibit'
p26915
g3
sS'other,that,block'
p26916
g3
sS'blockers,including,were'
p26917
g3
sS'transient,thrombocytopenia,or'
p26918
g3
sS'probenecid,probenecid,increases'
p26919
g9
sS'kineret,and,developed'
p26920
g9
sS'electrocardiographic,qt,qtc'
p26921
g3
sS'combination,with,against'
p26922
g3
sS'inhibition,significantly,reduced'
p26923
g9
sS'should,consider,discontinuation'
p26924
g9
sS'likely,to,be'
p26925
g3
sS'adolescent,with,altered'
p26926
g9
sS'serum,nih-3t3,cells'
p26927
g3
sS'the,concurrent,administration'
p26928
g3
sS'or,monitoring,of'
p26929
g3
sS'more,efficiently,inhibited'
p26930
g3
sS'with,similar,responses'
p26931
g3
sS'studies,conducted,in'
p26932
g3
sS's,and,fehling'
p26933
g3
sS'q12h,for,four'
p26934
g3
sS'in,plasma,exposures'
p26935
g9
sS'as,indicated,by'
p26936
g9
sS'was,a,slight'
p26937
g9
sS'agents,are,used'
p26938
g9
sS'conducted,it,is'
p26939
g9
sS'not,due,to'
p26940
g9
sS'and,a,new'
p26941
g3
sS'between,treatments,with'
p26942
g3
sS'concentrations,of,micrograms'
p26943
g3
sS'd6,c9,c19'
p26944
g3
sS'carefully,monitored,for'
p26945
g9
sS'the,mucocutaneous,and'
p26946
g3
sS'upon,the,reaction'
p26947
g9
sS'that,and,its'
p26948
g3
sS'reactions,including,hypertensive'
p26949
g9
sS'evaluating,the,effect'
p26950
g9
sS'can,cause,myopathy'
p26951
g3
sS'intermediate,doses,of'
p26952
g9
sS'in,a,clinical'
p26953
g3
sS'been,reported,predominantly'
p26954
g9
sS'mg,administered,daily'
p26955
g3
sS'side,effects,kemstro'
p26956
g3
sS'usually,depresses,activity'
p26957
g9
sS'and,g,resulted'
p26958
g9
sS'enbrel,was,unaltered'
p26959
g3
sS'ketoconazole,phenytoin,phenobarbitol'
p26960
g3
sS'prior,to,administration'
p26961
g3
sS'been,found,in'
p26962
g3
sS'with,other,antiepileptic'
p26963
g9
sS'in,immune,function'
p26964
g3
sS'anti,platelet,agents'
p26965
g3
sS'last,intravenous,dose'
p26966
g9
sS'soluble,to,the'
p26967
g3
sS'made,they,should'
p26968
g3
sS'discontinued,or,decreased'
p26969
g9
sS'in,saline,was'
p26970
g3
sS'not,potentiate,the'
p26971
g3
sS'adverse,events,when'
p26972
g3
sS'were,not,co-administered'
p26973
g3
sS'the,ratio,between'
p26974
g3
sS'pharmacokinetics,in,patients'
p26975
g3
sS'should,be,exercised'
p26976
g3
sS'perfused,pancreases,of'
p26977
g3
sS'caution,to,patients'
p26978
g9
sS'hydroxytolbutamide,and,by'
p26979
g3
sS'for,older,adults'
p26980
g3
sS'dose,for,subsequent'
p26981
g3
sS'of,breakthrough,symptoms'
p26982
g3
sS'aliskiren,on,other'
p26983
g3
sS'are,enhanced,by'
p26984
g9
sS'experimental,soft-gelatin,capsule'
p26985
g9
sS'several,transcription,factor'
p26986
g3
sS'to,a,regimen'
p26987
g9
sS'nonetheless,they,have'
p26988
g3
sS'ig,for,days'
p26989
g9
sS'affecting,patients,ci'
p26990
g3
sS'response,to,agents'
p26991
g9
sS'metabolizers,which,is'
p26992
g3
sS'that,are,potent'
p26993
g9
sS'trials,with,these'
p26994
g9
sS'to,be,receiving'
p26995
g9
sS'facultative,and,anaerobic'
p26996
g3
sS'effect,of,aeds'
p26997
g9
sS'the,effects,noted'
p26998
g3
sS'and,coexisting,in'
p26999
g3
sS'were,added,to'
p27000
g3
sS'and,cmax,of'
p27001
g9
sS'have,an,acceptable'
p27002
g3
sS'increase,blood,levels'
p27003
g3
sS'depression,or,may'
p27004
g9
sS'to,mg,m2'
p27005
g3
sS'therefore,patients,concurrently'
p27006
g3
sS'the,cns-depressant,action'
p27007
g9
sS'hours,after,injection'
p27008
g9
sS'impairment,the,use'
p27009
g9
sS'a,antidepressant,eg'
p27010
g9
sS'pathophysiologic,consequences,could'
p27011
g3
sS'is,negligible,interactions'
p27012
g3
sS'use,of,certain'
p27013
g3
sS'of,the,righting'
p27014
g3
sS'advisable,to,continue'
p27015
g9
sS'of,two,of'
p27016
g3
sS'given,the,long'
p27017
g3
sS'a,clinical,pharmacology'
p27018
g9
sS'in,most,instances'
p27019
g9
sS'to,minutes,p'
p27020
g9
sS'indocin,mg,t'
p27021
g9
sS'with,tikosyn,as'
p27022
g9
sS'included,brovana,doses'
p27023
g3
sS'de,pointes,and'
p27024
g3
sS'shown,a,significant'
p27025
g9
sS'in,decreases,in'
p27026
g3
sS'chemical,reaction,between'
p27027
g9
sS'the,study,had'
p27028
g3
sS'for,chop-haart,patients'
p27029
g3
sS'a,metabolized,by'
p27030
g3
sS'when,sustiva,is'
p27031
g9
sS'taking,labetalol,hcl'
p27032
g9
sS'and,unexpected,adverse'
p27033
g3
sS'used,in,addition'
p27034
g9
sS'that,either,are'
p27035
g3
sS'ra,clinical,studies'
p27036
g3
sS'and,other,inducers'
p27037
g9
sS'actions,and,will'
p27038
g3
sS'other,than,suggest'
p27039
g9
sS'alt,sgpt,or'
p27040
g3
sS'a,lower,affinity'
p27041
g9
sS'prostaglandins,and,increase'
p27042
g3
sS'has,an,enteric'
p27043
g3
sS'withdrawn,at,least'
p27044
g9
sS'the,model,peptide'
p27045
g3
sS'with,a,narrow'
p27046
g3
sS'interaction,and,potential'
p27047
g3
sS'with,other,oral'
p27048
g3
sS'a,control,period'
p27049
g9
sS'should,be,increased'
p27050
g3
sS'with,other,drugs'
p27051
g3
sS'since,the,toxic'
p27052
g9
sS'with,concomitant,agents'
p27053
g3
sS'mg,single,dose'
p27054
g9
sS't,max,increased'
p27055
g9
sS'ketone,bodies,in'
p27056
g3
sS'than,mg,of'
p27057
g3
sS'reported,in,seriously'
p27058
g3
sS'qtc,intervals,and'
p27059
g3
sS'concentrations,were,found'
p27060
g3
sS'these,compounds,caution'
p27061
g3
sS'and,levo-dromoran,has'
p27062
g9
sS'to,years,at'
p27063
g3
sS'become,more,pronounced'
p27064
g3
sS'the,time,of'
p27065
g9
sS'showed,hormonal,evidence'
p27066
g3
sS'rats,the,human'
p27067
g3
sS'general,population,of'
p27068
g3
sS'or,stopping,concomitantly'
p27069
g3
sS'to,saline,values'
p27070
g3
sS'monitor,cardiovascular,status'
p27071
g3
sS'hg,compared,to'
p27072
g9
sS'agents,known,to'
p27073
g9
sS'interaction,with,its'
p27074
g9
sS'agents,and,has'
p27075
g9
sS'with,an,intravenous'
p27076
g9
sS'it,has,recently'
p27077
g3
sS'clinical,studies,adjuvant'
p27078
g9
sS'of,on,high'
p27079
g3
sS'chronic,indications,and'
p27080
g3
sS'with,some,the'
p27081
g3
sS'under,years,of'
p27082
g3
sS'a4,increased,the'
p27083
g9
sS'a,vitamin,b12'
p27084
g9
sS'co-administration,of,tikosyn'
p27085
g9
sS'of,other,on'
p27086
g3
sS'from,this,hit'
p27087
g3
sS'metabolized,by,catechol-o'
p27088
g3
sS'be,applied,to'
p27089
g3
sS'griseofulvin,may,induce'
p27090
g9
sS'ventricular,fibrulation,and'
p27091
g9
sS'of,approximately,um'
p27092
g3
sS'wort,hypericum,perforatum'
p27093
g3
sS'human,immunodeficiency,virus'
p27094
g3
sS'increase,awareness,of'
p27095
g9
sS'compared,with,administered'
p27096
g9
sS'be,affected,by'
p27097
g3
sS'nicotine,may,provoke'
p27098
g9
sS'from,the,dog'
p27099
g3
sS'mefloquine,administration,should'
p27100
g3
sS'patients,must,take'
p27101
g3
sS'should,be,introduced'
p27102
g9
sS'and,electrolyte,disturbances'
p27103
g9
sS'for,metabolism,were'
p27104
g3
sS'days,and,for'
p27105
g3
sS'these,techniques,confirmation'
p27106
g3
sS'and,creatinine,clearance'
p27107
g9
sS'edema,and,mononuclear'
p27108
g3
sS'with,non-aspergillus,polysaccharides'
p27109
g3
sS'absolute,in,a'
p27110
g3
sS'or,camp-stimulated,acid'
p27111
g9
sS'aggregation,and,prolong'
p27112
g3
sS'in,eight,healthy'
p27113
g9
sS'patients,suspected,of'
p27114
g3
sS'with,on,the'
p27115
g9
sS'regression,model,primary'
p27116
g3
sS'concentrations,of,or'
p27117
g3
sS'human,dose,on'
p27118
g3
sS'commonly,found,in'
p27119
g3
sS'their,serum,half-life'
p27120
g3
sS'the,above,effects'
p27121
g9
sS'were,reported,in'
p27122
g3
sS'that,has,been'
p27123
g9
sS'theophylline,grepafloxacin,is'
p27124
g9
sS'caused,by,high'
p27125
g9
sS'and,the,bioavailability'
p27126
g3
sS'and,calcium-rich,foods'
p27127
g9
sS'or,in,two'
p27128
g9
sS'the,concomitant,intravenous'
p27129
g9
sS'given,the,increased'
p27130
g3
sS'reduced,or,the'
p27131
g9
sS'verapamil,the,risk'
p27132
g9
sS'relaxants,birth,control'
p27133
g3
sS'clinician,depends,on'
p27134
g3
sS'primary,rabbit,kidney'
p27135
g3
sS'that,experience,significantly'
p27136
g3
sS'cytochrome,cyp,c9'
p27137
g3
sS'both,increases,and'
p27138
g9
sS'gastrointestinal,toxicity,with'
p27139
g9
sS'the,only,protein'
p27140
g3
sS'added,to,triple-immunosuppression'
p27141
g3
sS'rifampin,is,a'
p27142
g3
sS'hepatic,toxicity,in'
p27143
g9
sS'the,time,for'
p27144
g3
sS'blood,is,drawn'
p27145
g9
sS'affect,responding,for'
p27146
g3
sS'supervision,for,at'
p27147
g3
sS'in,anti-inflammatory,activity'
p27148
g9
sS'disoproxil,fumarate,did'
p27149
g3
sS'injection,and,should'
p27150
g9
sS'presence,of,food'
p27151
g3
sS'of,leading,to'
p27152
g9
sS'other,which,could'
p27153
g3
sS'since,this,could'
p27154
g3
sS'at,increased,risk'
p27155
g3
sS'low,dose,and'
p27156
g3
sS'on,the,potential'
p27157
g3
sS'were,there,any'
p27158
g3
sS'to,accelerate,the'
p27159
g3
sS'administration,of,nonsteroial'
p27160
g9
sS'eight,healthy,volunteers'
p27161
g9
sS'amerge,tablets,are'
p27162
g3
sS'than,when,or'
p27163
g3
sS'been,tested,and'
p27164
g3
sS'be,prolonged,in'
p27165
g9
sS'here,commonly,showed'
p27166
g3
sS'drugs,alcohol,when'
p27167
g3
sS'is,accelerated,when'
p27168
g9
sS'normal,daily,activities'
p27169
g3
sS'tricyclic,metabolism,may'
p27170
g9
sS'therefore,that,affect'
p27171
g3
sS'in,a,cell-free'
p27172
g3
sS'lead,to,an'
p27173
g9
sS'concomitant,medications,that'
p27174
g9
sS'the,physician,wishing'
p27175
g3
sS'optimal,care,in'
p27176
g3
sS'maintenance,dose,should'
p27177
g9
sS'simulect,is,added'
p27178
g3
sS'through,competition,for'
p27179
g3
sS'similar,effects,and'
p27180
g3
sS'study,healthy,female'
p27181
g3
sS'prolongation,and,increase'
p27182
g3
sS'labetalol,hcl,blunts'
p27183
g9
sS'in,the,blood'
p27184
g9
sS'should,precede,dosing'
p27185
g3
sS'ruthenium,red,on'
p27186
g3
sS'taking,vioxx,concomitantly'
p27187
g9
sS'tbars,levels,in'
p27188
g9
sS'gain,and,increased'
p27189
g3
sS'observations,are,discussed'
p27190
g3
sS'imipramine,and,did'
p27191
g3
sS'a,with,c'
p27192
g3
sS'or,other,cns'
p27193
g9
sS'of,oral,agents'
p27194
g3
sS'live,bacteria,should'
p27195
g3
sS'as,mg,twice'
p27196
g9
sS'increased,effects,of'
p27197
g3
sS'proleukin,and,thus'
p27198
g9
sS'p,although,consistent'
p27199
g3
sS'etc,that,lower'
p27200
g9
sS'fe,instead,of'
p27201
g9
sS'three,agents,produced'
p27202
g3
sS'or,prolong,adverse'
p27203
g9
sS'given,as,sequential'
p27204
g9
sS'of,pgp,increased'
p27205
g3
sS'is,only,about'
p27206
g3
sS'without,significantly,lowering'
p27207
g3
sS'likewise,further,reduced'
p27208
g3
sS'tuberculosis,showed,a'
p27209
g9
sS'doses,of,these'
p27210
g3
sS'less,than,and'
p27211
g9
sS'clonidine,therapy,can'
p27212
g3
sS'fold,increases,in'
p27213
g9
sS'weak,c19,weak'
p27214
g3
sS'is,very,low'
p27215
g3
sS'trials,the,concomitant'
p27216
g3
sS'decrease,of,total'
p27217
g3
sS'increased,binding,globulin'
p27218
g3
sS'extensive,metabolizers,of'
p27219
g9
sS'with,serious,toxicity'
p27220
g3
sS'was,seen,on'
p27221
g3
sS'however,l-name,and'
p27222
g3
sS'or,hits,are'
p27223
g3
sS'use,in,combination'
p27224
g3
sS'between,and,pharmacokinetics'
p27225
g3
sS'clozapine,dose,should'
p27226
g3
sS'system,or,the'
p27227
g3
sS'decrease,in,absorption'
p27228
g3
sS'altered,to,a'
p27229
g3
sS'with,hard,gelatin'
p27230
g3
sS'six,cases,it'
p27231
g3
sS'cyp3a4,enzyme,inducer'
p27232
g3
sS'reported,musculoskeletal,adverse'
p27233
g3
sS'administered,in,patients'
p27234
g9
sS'and,can,produce'
p27235
g9
sS'increased,indicating,induction'
p27236
g3
sS'experiments,for,assessing'
p27237
g3
sS'nsclc,patients,and'
p27238
g3
sS'is,predominantly,eliminated'
p27239
g3
sS'on,diuretic,therapy'
p27240
g9
sS'and,other,non-steroidal'
p27241
g9
sS'of,withdrawal,syndrome'
p27242
g9
sS'clinical,acumen,but'
p27243
g3
sS'such,as,belladonna'
p27244
g9
sS'degree,of,qtc'
p27245
g3
sS'of,cyp2d6,minor'
p27246
g3
sS'covers,pharmacology,pharmacokinetics'
p27247
g3
sS'are,at,a'
p27248
g3
sS'cause,myopathy,when'
p27249
g3
sS'marrow,megakaryocytes,with'
p27250
g3
sS'the,various,dual-memory'
p27251
g3
sS'is,a,growing'
p27252
g3
sS'received,concomitant,at'
p27253
g3
sS'from,bovine,lung'
p27254
g3
sS'have,enhanced,the'
p27255
g9
sS'cmax,of,were'
p27256
g9
sS'a,mean,of'
p27257
g3
sS'increase,in,bleeding'
p27258
g3
sS'fade,recovery,took'
p27259
g9
sS'isoform,mediate,the'
p27260
g3
sS'are,begun,in'
p27261
g9
sS'may,induce,an'
p27262
g3
sS'of,and,sodium'
p27263
g3
sS'therapeutic,monitoring,can'
p27264
g9
sS'supplements,affect,their'
p27265
g3
sS'potentiate,the,therapeutic'
p27266
g9
sS'local,factor,for'
p27267
g3
sS'approximately,given,to'
p27268
g9
sS'coadministration,of,single'
p27269
g9
sS'several,hours,for'
p27270
g9
sS'could,be,ascertained'
p27271
g3
sS'on,the,milk'
p27272
g3
sS'or,stopping,since'
p27273
g9
sS'other,which,are'
p27274
g3
sS'advanced,hiv,disease'
p27275
g3
sS'the,majority,of'
p27276
g3
sS'inhibits,cyp1a2,weak'
p27277
g3
sS'of,various,doses'
p27278
g3
sS'showed,a,loss'
p27279
g3
sS'cyp3a4,inhibitors,and'
p27280
g9
sS'reported,for,other'
p27281
g3
sS'is,that,the'
p27282
g3
sS'enhance,the,mitogenic'
p27283
g9
sS'including,cyp1a2,cyp2c9'
p27284
g3
sS'some,patients,have'
p27285
g9
sS'interaction,of,exjade'
p27286
g3
sS'than,of,the'
p27287
g3
sS'digitalis,or,may'
p27288
g9
sS'concentration,of,following'
p27289
g3
sS'order,to,produce'
p27290
g9
sS'adverse,consequences,hunger'
p27291
g3
sS'l-histidine,was,observed'
p27292
g9
sS'dihydroxycholecalciferol,d3,oh'
p27293
g3
sS'risk,of,cardiac'
p27294
g3
sS'has,the,potential'
p27295
g3
sS'ng,ml,throughout'
p27296
g3
sS'start,therapy,with'
p27297
g3
sS'its,derivatives,and'
p27298
g9
sS'agents,or,other'
p27299
g9
sS'day,a,dose'
p27300
g9
sS'potential,to,prolong'
p27301
g3
sS'oral,and,resulted'
p27302
g9
sS'in,healthy,volunteers'
p27303
g3
sS'histidine,residues,abolishes'
p27304
g3
sS'types,of,studies'
p27305
g3
sS'platelet,aggregation,response'
p27306
g3
sS'of,or,a'
p27307
g3
sS'and,other,similar'
p27308
g3
sS'inhibitors,has,been'
p27309
g9
sS'including,for,example'
p27310
g9
sS'of,hepatic,cytochrome'
p27311
g9
sS'of,b,can'
p27312
g3
sS'neither,metabolized,by'
p27313
g3
sS'underlies,the,antipsychotic'
p27314
g3
sS'daily,to,patients'
p27315
g3
sS'known,to,prolong'
p27316
g9
sS'of,treatment,did'
p27317
g3
sS'agents,and,hypoglycemia'
p27318
g3
sS'may,affect,metabolism'
p27319
g3
sS'of,ect,and'
p27320
g3
sS'even,after,was'
p27321
g3
sS'therefore,should,not'
p27322
g9
sS'tests,for,glycosuria'
p27323
g3
sS'ii,showed,moderate'
p27324
g3
sS'for,weeks,following'
p27325
g3
sS'after,and,increases'
p27326
g9
sS'match,an,increased'
p27327
g3
sS'synthesis,of,the'
p27328
g3
sS'and,without,evidence'
p27329
g3
sS'in,gene,expression'
p27330
g3
sS'by,the,presence'
p27331
g3
sS'of,is,mg'
p27332
g3
sS'although,no,interaction'
p27333
g9
sS'procedure,is,recommended'
p27334
g3
sS'than,mg,should'
p27335
g3
sS'metabolizers,after,multiple-dose'
p27336
g3
sS'of,significant,respiratory'
p27337
g9
sS'significant,interactions,for'
p27338
g3
sS'was,again,allowed'
p27339
g3
sS'studies,involving,renal'
p27340
g9
sS'milk,milk,products'
p27341
g9
sS'multiple,exposure,in'
p27342
g3
sS'and,differed,from'
p27343
g3
sS'receiving,nonselective,monoamine'
p27344
g9
sS'patients,taking,should'
p27345
g3
sS'change,the,pharmacokinetic'
p27346
g3
sS'direct,coombs,tests'
p27347
g3
sS'safe,problem,associated'
p27348
g9
sS'pra,as,well'
p27349
g3
sS'cause,myopathy,which'
p27350
g3
sS'exercised,because,there'
p27351
g9
sS'and,other,complications'
p27352
g3
sS'interactions,are,not'
p27353
g3
sS'curves,derived,from'
p27354
g9
sS'inhibit,the,hypotensive'
p27355
g9
sS'demonstrated,any,effect'
p27356
g3
sS'agents,that,may'
p27357
g3
sS'that,is,metabolized'
p27358
g3
sS'observed,when,this'
p27359
g9
sS'following,a,meal'
p27360
g9
sS'incidence,of,endoscopic'
p27361
g3
sS'cyp2c19,the,major'
p27362
g3
sS'steroidal,and,progestogen'
p27363
g3
sS'nefazodone,cyclosporine,large'
p27364
g3
sS'of,rejection,episodes'
p27365
g3
sS'groups,fed,further'
p27366
g3
sS'carpophores,of,ganoderma'
p27367
g3
sS'comparison,of,pharmacokinetics'
p27368
g3
sS'potential,to,produce'
p27369
g3
sS'gemfibrozil,other,niacin'
p27370
g3
sS'these,cases,and'
p27371
g3
sS'cisapride,can,be'
p27372
g3
sS'test,strips,that'
p27373
g3
sS'given,the,abundance'
p27374
g3
sS'increase,of,apparent'
p27375
g9
sS'decreasing,the,concentration'
p27376
g3
sS'mg,on,day'
p27377
g9
sS'of,initial,or'
p27378
g3
sS'taking,amevive,continued'
p27379
g3
sS'to,normal,healthy'
p27380
g3
sS'induced,by,serum'
p27381
g3
sS'in,an,eight-fold'
p27382
g9
sS'interaction,depends,on'
p27383
g3
sS'people,are,becoming'
p27384
g3
sS'have,indicated,that'
p27385
g3
sS'maximum,calculated,clearance'
p27386
g3
sS'however,neither,nor'
p27387
g3
sS'to,closely,monitor'
p27388
g3
sS'danger,of,blocking'
p27389
g9
sS'that,this,alteration'
p27390
g3
sS'the,mixing,of'
p27391
g9
sS'test,interactions,increases'
p27392
g3
sS'be,compromised,in'
p27393
g9
sS'but,the,effect'
p27394
g9
sS'reduced,by,factors'
p27395
g3
sS'the,acute,locomotor'
p27396
g9
sS'have,reported,that'
p27397
g3
sS'increased,serum,concentrations'
p27398
g3
sS'the,depth,of'
p27399
g9
sS'adverse,events,should'
p27400
g3
sS'of,the,a-blocking'
p27401
g3
sS'the,mean,reduction'
p27402
g3
sS'randomized,multiple-dose,crossover'
p27403
g3
sS'concurrent,use,may'
p27404
g3
sS'decreased,when,used'
p27405
g3
sS'from,grapefruit,and'
p27406
g3
sS'glucose,concentrations,were'
p27407
g9
sS'observed,increase,in'
p27408
g9
sS'the,inhibitory,potential'
p27409
g3
sS'levels,generally,by'
p27410
g3
sS'but,these,would'
p27411
g9
sS'unaffected,by,baseline'
p27412
g3
sS'the,results,suggest'
p27413
g9
sS'rats,hydrochloride,was'
p27414
g9
sS'to,administering,disulfiram'
p27415
g9
sS'effects,may,occur'
p27416
g3
sS'clearance,and,increases'
p27417
g9
sS'insure,that,no'
p27418
g9
sS'wistar,rats,in'
p27419
g3
sS'or,systolic,blood'
p27420
g3
sS'evidence,of,marked'
p27421
g9
sS'with,some,agents'
p27422
g3
sS'expected,to,affect'
p27423
g3
sS'in,pigeons,but'
p27424
g9
sS'efficacy,of,used'
p27425
g3
sS'not,to,exceed'
p27426
g9
sS'of,after,being'
p27427
g3
sS'cyp1a2,inducers,and'
p27428
g3
sS'infections,and,increased'
p27429
g9
sS'doses,of,pcp'
p27430
g9
sS'between,toradoliv,im'
p27431
g3
sS'furthermore,it,has'
p27432
g9
sS'cefotaxime,sodium,are'
p27433
g3
sS'with,other,dialysis'
p27434
g3
sS'first,month,and'
p27435
g3
sS'due,to,interactions'
p27436
g3
sS'media,was,given'
p27437
g3
sS'doses,trough,concentrations'
p27438
g3
sS'the,limits,of'
p27439
g3
sS'that,concomitan,administration'
p27440
g9
sS'effects,of,low'
p27441
g3
sS'disrupts,the,behavioral'
p27442
g3
sS'of,contraception,during'
p27443
g9
sS'interact,with,concurrently'
p27444
g9
sS'studies,these,results'
p27445
g3
sS'with,ethacrynic,acid'
p27446
g9
sS'to,and,was'
p27447
g3
sS'and,auc,of'
p27448
g9
sS'substrate,single,dose'
p27449
g3
sS'botulinum,prior,to'
p27450
g9
sS'first,study,both'
p27451
g3
sS'be,prepared,to'
p27452
g3
sS'evaluating,the,use'
p27453
g3
sS'little,or,no'
p27454
g9
sS'of,hypertriglyceridemia,is'
p27455
g3
sS'substrate,and,a'
p27456
g3
sS'diabetic,patient,s'
p27457
g9
sS'pah,cannot,be'
p27458
g9
sS'that,users,of'
p27459
g9
sS'between,and,or'
p27460
g3
sS'as,possible,when'
p27461
g3
sS'a,two-fold,increase'
p27462
g9
sS'of,drug,side'
p27463
g3
sS'max,or,t'
p27464
g3
sS'and,therefore,the'
p27465
g9
sS'potential,for,abilify'
p27466
g3
sS'administration,of,large'
p27467
g3
sS'effects,are,likely'
p27468
g9
sS'of,mefloquineuine,and'
p27469
g3
sS'co-administration,of,hmg-coa'
p27470
g9
sS'in,addition,the'
p27471
g3
sS'of,and,significantly'
p27472
g9
sS'the,link,between'
p27473
g3
sS'other,medications,used'
p27474
g3
sS'pharmacokinetic,interactions,were'
p27475
g3
sS'medicines,although,certain'
p27476
g3
sS'of,oral,regularly'
p27477
g3
sS'activity,in,the'
p27478
g9
sS'number,fell,to'
p27479
g3
sS'amiodarone,amiodarone,therapy'
p27480
g3
sS'the,increased,possibility'
p27481
g9
sS'long,lasting,depletions'
p27482
g9
sS'fibrinogen,to,the'
p27483
g3
sS'plasma,proteins,at'
p27484
g3
sS'potential,to,reduce'
p27485
g3
sS'administered,due,to'
p27486
g3
sS'no,significant,difference'
p27487
g3
sS'by,cyp3a,results'
p27488
g3
sS'enrolled,in,two'
p27489
g3
sS'hypoglycemics,bepridil,has'
p27490
g3
sS'not,generally,recommended'
p27491
g9
sS'hypotension,cimetidine,an'
p27492
g9
sS'prothrombin,time,when'
p27493
g9
sS'concomitantly,with,increases'
p27494
g3
sS'with,diethyl,pyrocarbonate'
p27495
g3
sS'interact,significantly,with'
p27496
g3
sS'absorption,when,it'
p27497
g9
sS'recorded,at,and'
p27498
g3
sS'vehicle-controlled,studies,of'
p27499
g3
sS'in,the,lower'
p27500
g9
sS'in,hydatid,cyst'
p27501
g9
sS'followed,by,determination'
p27502
g3
sS'in,average,steady-'
p27503
g9
sS'inhibitors,of,the'
p27504
g3
sS'with,since,interactions'
p27505
g9
sS'blocking,agent,orally'
p27506
g9
sS'and,hyperglycemic,effects'
p27507
g3
sS'cause,transient,increase'
p27508
g3
sS'with,a,therapeutic'
p27509
g9
sS'for,insurances,and'
p27510
g3
sS'additive,or,synergistic'
p27511
g3
sS'compared,to,of'
p27512
g3
sS'kg,with,an'
p27513
g9
sS'cyclosporin,reports,indicate'
p27514
g9
sS'discussion,clarithromycin,is'
p27515
g9
sS'the,biological,and'
p27516
g9
sS'of,adverse,clinical'
p27517
g3
sS'not,be,predictive'
p27518
g3
sS'closely,monitor,serum'
p27519
g3
sS'with,in,patients'
p27520
g9
sS'trials,no,clinically'
p27521
g3
sS'antacid,when,and'
p27522
g9
sS'greater,extent,than'
p27523
g3
sS'when,cefotan,was'
p27524
g3
sS'potentially,hepatotoxic,medications'
p27525
g9
sS'with,serum,creatinine'
p27526
g3
sS'decreased,on,average'
p27527
g9
sS'kg,dose,resulted'
p27528
g3
sS'elevated,by,minimally'
p27529
g3
sS'avoided,and,alternative'
p27530
g9
sS'the,cyp1a2,substrate'
p27531
g3
sS'increase,the,metabolism'
p27532
g9
sS'not,inhibit,the'
p27533
g3
sS'auc,hrs,c'
p27534
g3
sS'suppression,of,organs'
p27535
g3
sS'on,cyp450,isoenzymes'
p27536
g3
sS'animals,were,challenged'
p27537
g3
sS'inhibition,of,cyp'
p27538
g3
sS'recommended,that,glucose'
p27539
g3
sS'since,paranoid,symptoms'
p27540
g9
sS'inhibit,the,intracellular'
p27541
g9
sS'but,not,by'
p27542
g9
sS'arteries,of,lean'
p27543
g3
sS'necessary,when,coadministered'
p27544
g9
sS'the,are,to'
p27545
g3
sS'has,an,effect'
p27546
g3
sS'pretreatment,with,or'
p27547
g9
sS'be,altered,so'
p27548
g3
sS'an,in,vivo'
p27549
g3
sS'if,at,all'
p27550
g9
sS'profile,or,renal'
p27551
g3
sS'studies,also,indicate'
p27552
g3
sS'valproic,acid,depakene'
p27553
g3
sS'microg,kg,body'
p27554
g3
sS'disintegrins,and,for'
p27555
g3
sS'possibly,have,some'
p27556
g3
sS'their,combined,use'
p27557
g9
sS'submitted,to,daily'
p27558
g3
sS'gold,salts,medicine'
p27559
g3
sS'fluoxetine,and,increased'
p27560
g3
sS'other,antiretroviral,drugs'
p27561
g9
sS'can,be,rationalized'
p27562
g3
sS'in,vitro,study'
p27563
g9
sS'proteins,in,the'
p27564
g3
sS'not,influence,recovery'
p27565
g3
sS'concentrations,of,mmol'
p27566
g3
sS'a,patients,should'
p27567
g9
sS'with,grapefruit,juice'
p27568
g3
sS'bind,and,decrease'
p27569
g9
sS'increase,the,mean'
p27570
g9
sS'noted,below,a'
p27571
g3
sS'though,has,been'
p27572
g3
sS'parent,and,active'
p27573
g3
sS'with,severe,bradycardia'
p27574
g3
sS'mydriasis,tachycardia,dryness'
p27575
g9
sS'achieved,with,biocytin'
p27576
g3
sS'the,tail-flick,inhibition'
p27577
g9
sS'any,added,drug'
p27578
g3
sS'decreased,the,hyperuricemic'
p27579
g9
sS'inhibitors,or,may'
p27580
g9
sS'adrenocortical,steroids,chloral'
p27581
g9
sS'affinity,kd,of'
p27582
g3
sS'isolated,cases,a'
p27583
g9
sS'a,novel,peripherally'
p27584
g9
sS'vitro,can,result'
p27585
g9
sS'copegus,pegasys,treatment'
p27586
g3
sS'panretin,gel,and'
p27587
g3
sS'with,co-administered,with'
p27588
g9
sS'were,more,pronounced'
p27589
g3
sS'co-administration,of,cyp3a4'
p27590
g3
sS'similar,effects,of'
p27591
g3
sS'clearance,of,from'
p27592
g9
sS'is,followed,by'
p27593
g3
sS'followed,by,irreversible'
p27594
g9
sS'scales,and,in'
p27595
g3
sS'representative,metabolized,by'
p27596
g3
sS'performance,of,gross'
p27597
g3
sS'in,proprietary,cold'
p27598
g9
sS'enantiomer,nanm,failed'
p27599
g3
sS'of,ergocalcitriol,by'
p27600
g9
sS'alteration,in,steady-state'
p27601
g9
sS'agents,with,increased'
p27602
g9
sS'including,nalidixic,acid'
p27603
g9
sS'is,the,potential'
p27604
g9
sS'coadministration,with,available'
p27605
g9
sS'in,temperature,began'
p27606
g3
sS'vs,myocardial,infarction'
p27607
g9
sS'these,data,emphasize'
p27608
g3
sS'for,equetrotm,may'
p27609
g9
sS'i,expression,in'
p27610
g3
sS'memory,system,that'
p27611
g3
sS'multiple-dose,crossover,study'
p27612
g3
sS'related,to,platelet'
p27613
g3
sS'therefore,when,central'
p27614
g9
sS'the,rabbit,following'
p27615
g3
sS'with,simultaneous,reduction'
p27616
g3
sS'may,contribute,to'
p27617
g9
sS'was,delayed,and'
p27618
g9
sS'these,would,include'
p27619
g3
sS'pharmacokinetic,interactions,with'
p27620
g3
sS'adds,to,the'
p27621
g3
sS'in,separate,studies'
p27622
g3
sS'and,antithrombin,iii'
p27623
g3
sS'abnormalities,related,to'
p27624
g3
sS'continued,use,in'
p27625
g3
sS'same,proportions,as'
p27626
g3
sS'development,is,not'
p27627
g3
sS'monitoring,with,dosage'
p27628
g3
sS'with,other,will'
p27629
g3
sS'alter,a,diabetic'
p27630
g9
sS'following,concomitant,use'
p27631
g3
sS'several,factors,that'
p27632
g3
sS'use,of,enablex'
p27633
g9
sS'as,renal,vascular'
p27634
g3
sS'or,t3,levels'
p27635
g3
sS'in,no,difference'
p27636
g3
sS'agents,were,reported'
p27637
g3
sS'and,sodium,bicarbonate'
p27638
g9
sS'approximately,to,representing'
p27639
g9
sS'appear,to,overlap'
p27640
g3
sS'as,and,see'
p27641
g9
sS'younger,patients,have'
p27642
g3
sS'interferes,with,serum'
p27643
g3
sS'met,acr,criteria'
p27644
g3
sS'maintained,at,of'
p27645
g3
sS'itraconazole,and,or'
p27646
g9
sS'incomplete,depletion,which'
p27647
g3
sS'the,within,a'
p27648
g9
sS'be,withdrawn,several'
p27649
g9
sS'as,manifested,by'
p27650
g3
sS'pancreatic,content,after'
p27651
g3
sS'hydroxides,and,did'
p27652
g3
sS'to,maintain,trough'
p27653
g9
sS'in,the,levels'
p27654
g3
sS'mac,minimum,alveolar'
p27655
g9
sS'following,antibiotics,rifampin'
p27656
g3
sS'sclerosis,patients,taking'
p27657
g3
sS'of,mg,sodium'
p27658
g9
sS'be,fatal,when'
p27659
g9
sS'these,with,lodosyn'
p27660
g3
sS'status,and,treatment'
p27661
g3
sS'such,as,sulfamethoxazole-trimethoprim'
p27662
g3
sS'proposed,mechanism,for'
p27663
g3
sS'elevations,returned,to'
p27664
g3
sS'of,fludrocortisone,acetate'
p27665
g9
sS'medical,complications,of'
p27666
g3
sS'or,compounds,which'
p27667
g3
sS'sodium,following,oral'
p27668
g3
sS'these,agents,and'
p27669
g3
sS'levetiracetam,had,no'
p27670
g3
sS'of,method,and'
p27671
g3
sS'lithium,reversible,increases'
p27672
g9
sS'in,part,a'
p27673
g3
sS'for,a,substantial'
p27674
g3
sS'is,characterised,by'
p27675
g3
sS'patients,understand,how'
p27676
g3
sS'it,reduced,the'
p27677
g3
sS'healthy,subjects,the'
p27678
g3
sS'on,acth,induced'
p27679
g3
sS'of,antipsychotic,agents'
p27680
g9
sS'compromise,the,limbic'
p27681
g3
sS'of,cardiovascular,in'
p27682
g3
sS'duloxetine,both,cyp1a2'
p27683
g3
sS'barpress,response,in'
p27684
g3
sS'pupil,constriction,were'
p27685
g3
sS'when,patients,take'
p27686
g9
sS'levels,were,also'
p27687
g9
sS'be,interpreted,with'
p27688
g3
sS'of,various,antihypertensive'
p27689
g9
sS'have,demonstrated,a'
p27690
g9
sS'revia,and,is'
p27691
g9
sS'done,to,see'
p27692
g9
sS'time-curve,increased,from'
p27693
g9
sS'because,of,lessened'
p27694
g3
sS'showed,that,oral'
p27695
g3
sS'rheumatoid,arthritis,concomitant'
p27696
g3
sS'generally,been,suggested'
p27697
g3
sS'steady-state,trough,concentrations'
p27698
g9
sS'and,fluvoxamine,tablets'
p27699
g9
sS'fell,to,plus'
p27700
g3
sS'of,the,parent'
p27701
g3
sS'observations,which,indicate'
p27702
g3
sS'entacapone,is,highly'
p27703
g3
sS'to,that,observed'
p27704
g9
sS'diagnostic,dip-stick,methodology'
p27705
g3
sS'reduction,in,blood'
p27706
g9
sS'intubating,dose,of'
p27707
g9
sS'of,such,preparations'
p27708
g3
sS'during,clinical,trials'
p27709
g3
sS'are,unknown,neither'
p27710
g9
sS'ca,i,increase'
p27711
g9
sS'that,neither,nor'
p27712
g3
sS'routine,administration,of'
p27713
g9
sS'between,and,following'
p27714
g3
sS'antinociception,was,measured'
p27715
g3
sS'an,increasing,incidence'
p27716
g3
sS'as,marplan,nardil'
p27717
g3
sS'active,metabolite,has'
p27718
g3
sS'when,these,medications'
p27719
g3
sS'identification,of,interactions'
p27720
g3
sS'may,regulate,the'
p27721
g9
sS'of,decreased,by'
p27722
g9
sS'concentrations,cyp3a4,inhibitors'
p27723
g3
sS'for,at,least'
p27724
g3
sS'the,dose,levels'
p27725
g3
sS'pharmacologically,with,orally'
p27726
g9
sS'kidney,diseases,recent'
p27727
g3
sS'human,plasma,in'
p27728
g3
sS'after,days,with'
p27729
g9
sS'prevent,the,urinary'
p27730
g9
sS'the,two,medicines'
p27731
g9
sS'observed,following,the'
p27732
g3
sS'the,trials,of'
p27733
g3
sS'with,a,nonfunctioning'
p27734
g9
sS'if,a,tca'
p27735
g9
sS'transfected,with,a'
p27736
g3
sS'concurrently,concentrations,should'
p27737
g9
sS'administration,of,taxol'
p27738
g3
sS'retention,blurred,vision'
p27739
g9
sS'male,rats,hydrochloride'
p27740
g9
sS'of,extravasation,it'
p27741
g3
sS'healthy,volunteers,resulted'
p27742
g9
sS'red,blood,cells'
p27743
g3
sS'may,displace,other'
p27744
g3
sS'patients,and,may'
p27745
g3
sS'and,the,serum'
p27746
g3
sS'at,three,different'
p27747
g3
sS'arachidonic,acid,from'
p27748
g3
sS'between,ellence,and'
p27749
g3
sS'patients,receiving,injection'
p27750
g3
sS'and,adrenoreceptors,on'
p27751
g3
sS'dosing,is,required'
p27752
g3
sS'months,at,doses'
p27753
g3
sS'procedure,for,the'
p27754
g3
sS'by,mug,or'
p27755
g3
sS'prothrombin,time,reported'
p27756
g9
sS'activity,of,four'
p27757
g3
sS'doses,or,infusions'
p27758
g3
sS'a,type,ii'
p27759
g9
sS'may,potentiate,a'
p27760
g9
sS'on,the,advice'
p27761
g9
sS'cimetidine,cimetidine,inhibits'
p27762
g9
sS'animals,in,the'
p27763
g3
sS'amantadine,and,maois'
p27764
g9
sS'plasma,concentrations,resulted'
p27765
g3
sS'trace,pathways,which'
p27766
g3
sS'of,prothrombin,time'
p27767
g9
sS'also,modify,the'
p27768
g3
sS'decreased,plasma,levels'
p27769
g9
sS'taking,on,a'
p27770
g3
sS'time,for,heparins'
p27771
g3
sS'the,potential,that'
p27772
g3
sS'rats,responses,to'
p27773
g3
sS'complexometric,methods,commonly'
p27774
g3
sS'reported,when,was'
p27775
g9
sS'reported,to,have'
p27776
g9
sS'diphenoxylate,hcl,and'
p27777
g9
sS'tests,have,been'
p27778
g3
sS'd2,binding,sites'
p27779
g3
sS'serious,and,or'
p27780
g3
sS'significant,changes,occurred'
p27781
g3
sS'multiple,exposure,be'
p27782
g3
sS'in,the,area'
p27783
g9
sS'mediated,signalling,or'
p27784
g3
sS'followed,by,in'
p27785
g3
sS'the,volume,of'
p27786
g3
sS'bruising,nosebleeds,hemoptysis'
p27787
g3
sS'potent,non-nucleoside,reverse'
p27788
g3
sS'concurrently,plasma,levels'
p27789
g9
sS'anabolic,anabolin,anavar'
p27790
g3
sS'metabolized,by,multiple'
p27791
g3
sS'rash,while,receiving'
p27792
g9
sS'not,demonstrate,any'
p27793
g3
sS'of,while,minimizing'
p27794
g3
sS'day,will,require'
p27795
g9
sS'of,contraception,inwomen'
p27796
g9
sS'one,hyperglycaemic,clamps'
p27797
g3
sS'falsely,elevated,levels'
p27798
g3
sS'and,the,aberrant'
p27799
g3
sS'the,and,this'
p27800
g3
sS'suppress,reactions,to'
p27801
g3
sS'cardiac,arrythmias,ventricular'
p27802
g9
sS'the,amount,absorbed'
p27803
g3
sS'was,and,that'
p27804
g3
sS'microalbuminuria,inspra,mg'
p27805
g9
sS'other,that,are'
p27806
g3
sS'reactions,in,vitro'
p27807
g3
sS'd,and,s'
p27808
g9
sS'isoenzymes,may,decrease'
p27809
g3
sS'have,revealed,no'
p27810
g3
sS'not,reported,in'
p27811
g9
sS'and,one,mg'
p27812
g9
sS'vary,from,those'
p27813
g3
sS'to,an,insufficient'
p27814
g3
sS'events,and,therapeutic'
p27815
g3
sS'agents,that,cause'
p27816
g9
sS'sodium,it,is'
p27817
g9
sS'cause,synergistic,elevation'
p27818
g9
sS'in,overall,improvements'
p27819
g3
sS'for,example,may'
p27820
g3
sS'may,be,affected'
p27821
g3
sS'receiving,the,initial'
p27822
g9
sS'addition,of,given'
p27823
g3
sS'that,and,markedly'
p27824
g9
sS'in,vitro,activity'
p27825
g3
sS'on,the,day'
p27826
g9
sS'death,have,occurred'
p27827
g9
sS'rare,occasions,resulted'
p27828
g9
sS'alternate,sequence,ie'
p27829
g9
sS'using,the,terms'
p27830
g3
sS'control,rats,probably'
p27831
g3
sS'lodine,can,reduce'
p27832
g9
sS'or,recovery,following'
p27833
g9
sS'primary,effect,of'
p27834
g9
sS'neuromuscular,blockade,produced'
p27835
g9
sS'preparations,glyceryl,trinitrate'
p27836
g3
sS'in,myocardium,in'
p27837
g3
sS'at,intervals,as'
p27838
g3
sS'the,coagulation,times'
p27839
g3
sS'alfenta,can,significantly'
p27840
g9
sS'other,manufacturers,have'
p27841
g3
sS'anticoagulants,increased,prothrombin'
p27842
g9
sS'trough,concentrations,were'
p27843
g9
sS'the,increase,of'
p27844
g9
sS'courses,of,therapy'
p27845
g3
sS'administration,trough,concentrations'
p27846
g3
sS'human,serum,and'
p27847
g3
sS'unlikely,that,would'
p27848
g3
sS'found,with,at'
p27849
g3
sS'treatment,did,not'
p27850
g3
sS'however,is,useful'
p27851
g3
sS'the,pharmacologic,effect'
p27852
g9
sS'when,any,of'
p27853
g3
sS'changes,to,the'
p27854
g3
sS'when,given,concomitantly'
p27855
g3
sS'cancer,res,have'
p27856
g3
sS'to,treatment,for'
p27857
g3
sS'use,with,ribavirin'
p27858
g3
sS'muscular,fatigue,hypotension'
p27859
g3
sS'the,therapeutic,range'
p27860
g3
sS'may,also,potentiate'
p27861
g9
sS'increase,the,therapeutic'
p27862
g3
sS'mu-,delta,and'
p27863
g3
sS'depress,plasma,prothrombin'
p27864
g9
sS'in,an,additive'
p27865
g9
sS'to,serum,plasma'
p27866
g3
sS'a,pharmacological,interaction'
p27867
g3
sS'extended,release,tablets'
p27868
g9
sS'neurontin,mg,appears'
p27869
g9
sS'indicate,that,there'
p27870
g9
sS'with,and,monoamine'
p27871
g9
sS'a,narrower,spectrum'
p27872
g3
sS'of,administered,alone'
p27873
g3
sS'prepared,in,water'
p27874
g3
sS'attenuated,the,hypotensive'
p27875
g9
sS'of,and,partly'
p27876
g9
sS'alterations,of,the'
p27877
g9
sS'increase,the,plasma'
p27878
g9
sS'of,the,toxic'
p27879
g3
sS'should,report,to'
p27880
g3
sS'and,that,affect'
p27881
g9
sS'interaction,has,been'
p27882
g3
sS'slightly,enhance,the'
p27883
g9
sS'of,your,skin'
p27884
g3
sS'of,organs,actively'
p27885
g3
sS'day,decreases,blood'
p27886
g9
sS'experience,an,increased'
p27887
g3
sS'be,kept,in'
p27888
g3
sS'conjugated,and,and'
p27889
g3
sS'experience,in,the'
p27890
g3
sS'such,interaction,should'
p27891
g3
sS'induce,cyp,enzymes'
p27892
g3
sS'clinically,relevant,changes'
p27893
g3
sS'mefenamic,acid,by'
p27894
g9
sS'if,these,products'
p27895
g3
sS'demonstrated,in,a'
p27896
g9
sS'with,ganglionic,or'
p27897
g3
sS'including,an,omega-conotoxin'
p27898
g3
sS'topoisomerase,quantity,and'
p27899
g3
sS'rat,kidney,homogenates'
p27900
g3
sS'effects,of,isocarboxazid'
p27901
g3
sS'and,lead,electrocardiograms'
p27902
g3
sS'individual,cases,is'
p27903
g3
sS'patients,with,early-phase'
p27904
g3
sS'inhibitors,aminosalicylic,acid'
p27905
g9
sS'is,withdrawn,from'
p27906
g3
sS'which,may,predispose'
p27907
g9
sS'collected,for,quantitation'
p27908
g3
sS'platelet,function,to'
p27909
g3
sS'cytochrome,p-450,linked'
p27910
g3
sS'of,the,agents'
p27911
g3
sS'been,no,controlled'
p27912
g3
sS'with,mild,to'
p27913
g9
sS'antidepressant,agent,or'
p27914
g3
sS'partial,thromboplastin,time'
p27915
g3
sS'drugs,and,other'
p27916
g9
sS'no,effect,on'
p27917
g3
sS'drugs,that,reportedly'
p27918
g9
sS'and,caution,should'
p27919
g3
sS'kidney,function,and'
p27920
g3
sS'lipids,were,explored'
p27921
g3
sS'spectrophotometrically,determined,urinary'
p27922
g3
sS'no,effect,of'
p27923
g3
sS'a,dose,adjustment'
p27924
g9
sS'data,are,not'
p27925
g3
sS'such,a,nonlinear'
p27926
g3
sS'administration,hour,before'
p27927
g3
sS'carbonate,the,stimulatory'
p27928
g9
sS'in,the,parietal'
p27929
g3
sS'in,blood,sugar'
p27930
g9
sS'been,observed,following'
p27931
g3
sS'and,safely,used'
p27932
g3
sS'of,hivid,with'
p27933
g9
sS'synthesis,or,in'
p27934
g3
sS'gastrointestinal,adverse,experiences'
p27935
g3
sS'of,the,lymphoid'
p27936
g3
sS'corticosteroid,binding,globulin'
p27937
g3
sS'for,serious,adverse'
p27938
g3
sS'reported,in,organ'
p27939
g9
sS'has,been,used'
p27940
g3
sS'griseofulvin,griseofulvin,may'
p27941
g9
sS'seizures,may,be'
p27942
g3
sS'such,as,prolonged'
p27943
g3
sS'patients,with,congestive'
p27944
g3
sS'reduced,significantly,when'
p27945
g3
sS'administration,however,the'
p27946
g3
sS'diamond,trials,the'
p27947
g3
sS'doses,of,tmp'
p27948
g3
sS'be,safely,co-administered'
p27949
g3
sS'administration,at,doses'
p27950
g3
sS'sgot,elevated,alkaline'
p27951
g3
sS'anticoagulants,several,short-term'
p27952
g3
sS'co,administered,and'
p27953
g9
sS'occasionally,experience,an'
p27954
g9
sS'between,apokyn,and'
p27955
g3
sS'certain,inhibit,the'
p27956
g3
sS'effect,of,cholinesterase'
p27957
g9
sS'alternative,treatment,is'
p27958
g3
sS'dosage,adjustments,patients'
p27959
g9
sS'during,or,less'
p27960
g9
sS'aqueous,extract,from'
p27961
g3
sS'increase,in,steady-state'
p27962
g9
sS'half-life,or,serum'
p27963
g9
sS'monitored,frequently,to'
p27964
g3
sS'to,hormone,is'
p27965
g3
sS'sites,between,cerebral'
p27966
g3
sS'mellitus,or,evidence'
p27967
g3
sS'to,increase,high-density'
p27968
g3
sS'reports,and,commentaries'
p27969
g3
sS'is,frequently,co-administered'
p27970
g3
sS'the,serum,concentration'
p27971
g9
sS'tricyclic,antidepressants,foradil'
p27972
g9
sS'with,strong,inhibitors'
p27973
g9
sS'of,may,render'
p27974
g9
sS'dams,was,estimated'
p27975
g3
sS'to,one,or'
p27976
g3
sS'tests,showed,that'
p27977
g3
sS'each,be,associated'
p27978
g9
sS'males,in,separate'
p27979
g3
sS'm2,plus,to'
p27980
g3
sS'as,and,should'
p27981
g9
sS'responses,being,observed'
p27982
g3
sS'excystment,in,vitro'
p27983
g3
sS'gastric,hydrochloric,acid'
p27984
g3
sS'oral,who,are'
p27985
g9
sS'qt,qtc,interval'
p27986
g3
sS'healthy,male,n'
p27987
g3
sS'agents,receiving,velcade'
p27988
g9
sS'c,max,c'
p27989
g3
sS'when,clozapine,is'
p27990
g9
sS'and,respectively,by'
p27991
g9
sS'or,maintenance,bolus'
p27992
g3
sS'function,induced,by'
p27993
g3
sS'constant,values,being'
p27994
g3
sS'decreased,approximately,fold'
p27995
g9
sS'action,is,enhanced'
p27996
g3
sS'kg,min,over'
p27997
g3
sS'caution,using,small'
p27998
g9
sS'plasma,concentrations,substances'
p27999
g3
sS'and,viracept,resulted'
p28000
g9
sS'evaluation,and,laboratory'
p28001
g3
sS'not,be,expected'
p28002
g3
sS'augment,the,neuromuscular'
p28003
g9
sS'ninth,day,the'
p28004
g3
sS'of,genetically,predisposed'
p28005
g3
sS'constellation,of,symptoms'
p28006
g9
sS'xigris,caution,should'
p28007
g3
sS'of,other,known'
p28008
g9
sS'receptors,in,the'
p28009
g3
sS'consequently,tracleer,is'
p28010
g3
sS'been,evaluated,and'
p28011
g9
sS'period,of,concurrent'
p28012
g9
sS'transplant,patients,receiving'
p28013
g9
sS'downstream,of,cleavable'
p28014
g3
sS'with,maois,or'
p28015
g9
sS'and,confusion,extrapyramidal'
p28016
g9
sS'steady-state,pharmacokinetic,variables'
p28017
g3
sS'disease,erectile,dysfunction'
p28018
g3
sS'interactions,the,urine'
p28019
g3
sS'intervals,during,administration'
p28020
g3
sS'p450,c9,have'
p28021
g3
sS'acetaminophen,diminished,the'
p28022
g9
sS'sumatriptan,sumatriptan,has'
p28023
g9
sS'high,acquisition,cost'
p28024
g3
sS'lower,rate,of'
p28025
g9
sS'concentrations,in,serum'
p28026
g3
sS'or,potassium-depleting,and'
p28027
g3
sS'a,possible,drug'
p28028
g9
sS'level,in,humans'
p28029
g3
sS'normal,metabolizers,resemble'
p28030
g3
sS'used,when,nsaids'
p28031
g9
sS'concomitantly,with,or'
p28032
g9
sS'subcutaneous,injections,in'
p28033
g3
sS'is,not,appreciably'
p28034
g3
sS'levels,are,decreased'
p28035
g3
sS'cell,or,to'
p28036
g3
sS'str,or,nucleus'
p28037
g3
sS'is,advised,and'
p28038
g9
sS'cell,killing,relative'
p28039
g3
sS'vitamin,k,oral'
p28040
g9
sS'rate,of,absorption'
p28041
g9
sS'transient,increases,in'
p28042
g3
sS'and,signs,of'
p28043
g9
sS'or,metabolite,i'
p28044
g3
sS'p450,d6,many'
p28045
g3
sS'recommended,to,be'
p28046
g9
sS'possible,that,its'
p28047
g3
sS'reduced,by,one-third'
p28048
g3
sS'data,which,suggest'
p28049
g9
sS'concentrations,fo,these'
p28050
g3
sS'electrolyte,loss,associated'
p28051
g9
sS'for,coadministration,with'
p28052
g3
sS'and,when,administered'
p28053
g9
sS'hydrate,and,interact'
p28054
g9
sS'renin,activity,in'
p28055
g3
sS'prevent,or,delay'
p28056
g3
sS'mouth,urinary,retention'
p28057
g9
sS'to,groups,treated'
p28058
g9
sS'hours,for,cmax'
p28059
g3
sS'treatment,there,was'
p28060
g3
sS'affect,the,mediated'
p28061
g3
sS'the,dst,should'
p28062
g3
sS'stabilized,on,a'
p28063
g9
sS'however,increasing,use'
p28064
g3
sS'definitively,demonstrated,that'
p28065
g9
sS'taking,revia,may'
p28066
g9
sS'vomiting,and,or'
p28067
g9
sS'elimination,of,leading'
p28068
g9
sS'the,platelets,in'
p28069
g3
sS'of,azole,agents'
p28070
g9
sS'uroxatral,and,other'
p28071
g3
sS'of,the,enzyme'
p28072
g3
sS'which,may,induce'
p28073
g3
sS'trials,were,maintained'
p28074
g3
sS'close,monitoring,allows'
p28075
g3
sS'oral,dose,should'
p28076
g9
sS'enhanced,by,general'
p28077
g3
sS'cyclooxygenase-2,cox-2,inhibitor'
p28078
g3
sS'of,aldehyde,oxidase'
p28079
g3
sS'inhibitors,nnrtis,nevirapine'
p28080
g9
sS'other,instances,of'
p28081
g3
sS'following,or,h'
p28082
g9
sS'ecg,heart,rate'
p28083
g3
sS'herbal,remedy,use'
p28084
g3
sS'of,pcp,or'
p28085
g9
sS'be,performed,prior'
p28086
g3
sS'oral,and,supplemental'
p28087
g9
sS'in,area,under'
p28088
g9
sS'avoid,bleeding,reduced'
p28089
g9
sS'of,rocaltrol,may'
p28090
g3
sS'benzthiazide,may,interact'
p28091
g9
sS'therapy,is,begun'
p28092
g3
sS'are,not,inhibitors'
p28093
g3
sS'this,period,of'
p28094
g3
sS'long-sedation,time,lst'
p28095
g3
sS'may,enhance,nutrient'
p28096
g9
sS'these,factors,in'
p28097
g3
sS'system,depressants,eg'
p28098
g9
sS'as,sequential,infusions'
p28099
g9
sS'this,effect,did'
p28100
g3
sS'and,systemic,eg'
p28101
g3
sS'oral,are,also'
p28102
g3
sS'preconstricted,with,micromol'
p28103
g3
sS'by,an,average'
p28104
g9
sS'treatment,and,aftercare'
p28105
g3
sS'when,starlix,mg'
p28106
g3
sS'decreased,in,hypothyroid'
p28107
g3
sS'metabolism,or,elimination'
p28108
g3
sS'increased,activity,of'
p28109
g9
sS'no,drug,interactions'
p28110
g3
sS'ssri,is,clinically'
p28111
g9
sS'been,obtained,in'
p28112
g3
sS'interval,between,the'
p28113
g3
sS'surprisingly,green,tea'
p28114
g3
sS'predominantly,metabolized,by'
p28115
g9
sS'and,or,ast'
p28116
g3
sS'levo-dromoran,reported,to'
p28117
g3
sS'no,pharmacodynamic,interaction'
p28118
g3
sS'should,refer,to'
p28119
g3
sS'and,should,have'
p28120
g3
sS'of,with,with'
p28121
g9
sS'clinical,studies,the'
p28122
g3
sS'be,discontinued,for'
p28123
g9
sS'reduce,the,number'
p28124
g9
sS'to,provide,information'
p28125
g3
sS'amitriptyline,concurrent,administration'
p28126
g9
sS'lst,short,sedation'
p28127
g3
sS'hours,and,as'
p28128
g9
sS'toradoliv,im,was'
p28129
g3
sS'extracellular,rr,microm'
p28130
g9
sS'the,are,also'
p28131
g3
sS'furthermore,no,significant'
p28132
g3
sS'interfere,with,commonly'
p28133
g3
sS'tablets,an,can'
p28134
g9
sS'carbamazepine,coadministration,of'
p28135
g9
sS'pressure,their,combined'
p28136
g9
sS'to,increase,their'
p28137
g9
sS'are,capable,of'
p28138
g3
sS'some,are,analgesic'
p28139
g3
sS'both,control,and'
p28140
g3
sS'regarding,interactions,with'
p28141
g3
sS'whom,therapy,with'
p28142
g9
sS'of,phosphatidate,phosphohydrolase'
p28143
g3
sS'in,an,opposite'
p28144
g9
sS'followed,by,the'
p28145
g3
sS'that,are,extensively'
p28146
g9
sS'on,hormone,synthesis'
p28147
g3
sS'and,are,predominantly'
p28148
g3
sS'of,the,patient'
p28149
g9
sS'hydrocortisone,elevated,salivary'
p28150
g3
sS'and,produce,false'
p28151
g3
sS'produces,depression,of'
p28152
g9
sS'be,expected,and'
p28153
g9
sS'for,renal,toxicity'
p28154
g9
sS'however,were,increased'
p28155
g3
sS'the,auc0-120hr,by'
p28156
g9
sS'hypoglycemic,action,of'
p28157
g9
sS'hyperglycaemia,increased,all'
p28158
g3
sS'amiodarone,caused,a'
p28159
g3
sS'in,a,c'
p28160
g9
sS'acute,episode,despite'
p28161
g3
sS'cautious,and,this'
p28162
g3
sS'and,anti-depressants,could'
p28163
g9
sS'celebrex,mg,bid'
p28164
g9
sS'day,on,day'
p28165
g9
sS'hypoglycemia,and,hyperglycemia'
p28166
g3
sS'which,we,call'
p28167
g3
sS'task,induced,significant'
p28168
g3
sS'subject,given,one'
p28169
g9
sS'juice,which,inhibits'
p28170
g3
sS'oral,clearance,and'
p28171
g9
sS'in,patients,below'
p28172
g3
sS'small,changes,are'
p28173
g3
sS'recommended,unless,the'
p28174
g9
sS'non-pegylated,alfa-2a,for'
p28175
g3
sS'by,approximately,by'
p28176
g9
sS'necrolysis,has,been'
p28177
g3
sS'and,safety,have'
p28178
g3
sS'release,in,either'
p28179
g3
sS'ph,may,affect'
p28180
g3
sS'test,interactions,phenytoin'
p28181
g3
sS'amphotericin,b,has'
p28182
g9
sS'using,small,initial'
p28183
g9
sS'to,compete,for'
p28184
g3
sS'is,recommended,not'
p28185
g9
sS'in,effectiveness,of'
p28186
g9
sS'of,and,metabolite'
p28187
g9
sS'a,light,meal'
p28188
g9
sS'in,a,further'
p28189
g9
sS'with,an,interval'
p28190
g3
sS'introduction,of,beta'
p28191
g9
sS'hypotension,or,exacerbation'
p28192
g9
sS'mg,to,ace'
p28193
g9
sS'diabetic,patients,the'
p28194
g9
sS'only,be,envisaged'
p28195
g3
sS'was,coadministered,with'
p28196
g9
sS'patients,who,inactivate'
p28197
g9
sS'thus,the,selective'
p28198
g3
sS'corticosteroids,and,corticotropin'
p28199
g9
sS'cardiopulmonary,arrest,with'
p28200
g3
sS'which,increases,gastrointestinal'
p28201
g9
sS'lithium,coadministration,of'
p28202
g3
sS'the,dmpge2,mg'
p28203
g9
sS'cyp1a2,in,vitro'
p28204
g3
sS'a,watery,stool'
p28205
g3
sS'patients,receiving,hctz'
p28206
g9
sS'narrow,therapeutic,windows'
p28207
g3
sS'for,a,kg'
p28208
g3
sS'of,interference,of'
p28209
g3
sS'inhibits,platelet,function'
p28210
g9
sS'prolong,its,therapeutic'
p28211
g3
sS'weight,for,days'
p28212
g3
sS'via,dehydrogenase,inhibition'
p28213
g9
sS'clearance,and,rises'
p28214
g9
sS'a,cell-free,system'
p28215
g3
sS'efficacy,and,increased'
p28216
g3
sS'know,if,you'
p28217
g9
sS'a4,inhibitors,such'
p28218
g9
sS'glucose,is,recommended'
p28219
g3
sS'sensitivity,to,topoisomerase-targeted'
p28220
g3
sS'renal,insufficiency,and'
p28221
g3
sS'of,foods,highly'
p28222
g3
sS'diminished,urinary,excretion'
p28223
g9
sS'have,any,effect'
p28224
g3
sS'also,been,shown'
p28225
g9
sS'poor-risk,aids-related,kaposi'
p28226
g3
sS'alternately,when,the'
p28227
g3
sS'before,meals,was'
p28228
g3
sS'synergistically,augmented,the'
p28229
g3
sS'specific,pharmacokinetic,changes'
p28230
g3
sS'enzyme,inducers,and'
p28231
g9
sS'management,of,cutaneous'
p28232
g3
sS'not,be,discontinued'
p28233
g3
sS'should,be,delayed'
p28234
g3
sS'powder,for,oral'
p28235
g9
sS'produced,an,increase'
p28236
g9
sS'recombinant,shuttle,vectors'
p28237
g3
sS'antagonists,may,be'
p28238
g9
sS'test,dsst,symbol'
p28239
g9
sS'confidence,interval,decrease'
p28240
g3
sS'reversible,reduction,in'
p28241
g3
sS'the,release,of'
p28242
g3
sS'dysrhythmias,of,other'
p28243
g9
sS'should,not,take'
p28244
g3
sS'activity,transient,cardiac'
p28245
g9
sS'the,components,with'
p28246
g3
sS'course,of,in'
p28247
g9
sS'the,harmonic,mean'
p28248
g3
sS't4,by,column'
p28249
g3
sS'radiation,therapy,but'
p28250
g3
sS'lamivudine,in,vitro'
p28251
g9
sS'concomitantly,with,lodosyn'
p28252
g3
sS'a,novel,chemical'
p28253
g9
sS'the,and,cns'
p28254
g9
sS'significant,inhibitory,effect'
p28255
g3
sS'pharmacological,properties,of'
p28256
g3
sS'phenytoin,felbatol,causes'
p28257
g9
sS'avoided,serum,levels'
p28258
g3
sS'and,thereafter,at'
p28259
g3
sS'drawn,at,and'
p28260
g3
sS'not,sufficient,data'
p28261
g3
sS'antagonists,cimetidine,inhibits'
p28262
g9
sS'of,other,neuromuscular'
p28263
g9
sS'and,channel,blockers'
p28264
g9
sS'incidence,of,grade'
p28265
g3
sS'tbg,concentration,should'
p28266
g3
sS'with,plenaxis,and'
p28267
g3
sS'of,peritoneal,metastasis'
p28268
g3
sS'pharmacokinetic,analyses,revealed'
p28269
g3
sS'be,used,concomitantly'
p28270
g9
sS'to,monitor,tcaplasma'
p28271
g3
sS'studies,in,healthy'
p28272
g3
sS'isoforms,cyp3a4,cyp2d6'
p28273
g3
sS'potent,a4,inhibitors'
p28274
g9
sS'carbonate,mg,bid'
p28275
g3
sS'with,elevations,of'
p28276
g9
sS'on,the,repeat'
p28277
g3
sS'antidepressant,class,including'
p28278
g3
sS'cardiovascular,collapse,in'
p28279
g3
sS'and,hyperglycemia,were'
p28280
g3
sS'mc,does,not'
p28281
g3
sS'and,completely,depressed'
p28282
g9
sS'of,cromolyn,sodium'
p28283
g9
sS'the,pancreatic,alpha'
p28284
g3
sS'elemental,as,feso4'
p28285
g9
sS'inhibitor,of,cyp'
p28286
g3
sS'mixed,with,infusion'
p28287
g3
sS'patients,with,severe'
p28288
g3
sS'ascorbic,acid,may'
p28289
g3
sS'inhibitors,and,which'
p28290
g3
sS'reduce,the,gastrointestinal'
p28291
g9
sS'ng,ml,resulted'
p28292
g3
sS'three,mg,capsules'
p28293
g9
sS'drugs,which,impair'
p28294
g3
sS'although,it,significantly'
p28295
g9
sS'density,bmax,in'
p28296
g3
sS'cmax,and,a'
p28297
g9
sS'body,fat,including'
p28298
g3
sS'in,monkeys,nanm'
p28299
g3
sS'this,is,based'
p28300
g3
sS'to,its,antidiuretic'
p28301
g3
sS'of,following,ultracentrifugation'
p28302
g3
sS'relationship,between,these'
p28303
g3
sS'an,elisa,and'
p28304
g3
sS'capsules,or,ml'
p28305
g9
sS'suggest,that,nsaids'
p28306
g9
sS'its,activity,was'
p28307
g3
sS'and,is,prone'
p28308
g3
sS'antihypertensive,medications,or'
p28309
g9
sS'of,these,medications'
p28310
g3
sS'take,first,and'
p28311
g9
sS'state,was,reached'
p28312
g3
sS'of,adverse,effects'
p28313
g3
sS'plasma,was,analyzed'
p28314
g3
sS'to,influence,limbic'
p28315
g3
sS'involvement,of,reactive'
p28316
g3
sS'encouraged,to,enroll'
p28317
g3
sS'other,members,of'
p28318
g9
sS'block,is,shortened'
p28319
g9
sS'serum,proteins,indicate'
p28320
g3
sS'and,thus,may'
p28321
g3
sS'at,dosages,exceeding'
p28322
g3
sS'blood,pressure,were'
p28323
g3
sS'cause,a,sharp'
p28324
g9
sS'novolog,should,be'
p28325
g3
sS'at,a,greater'
p28326
g3
sS'a,similar,effect'
p28327
g3
sS'altered,by,coadministration'
p28328
g3
sS'serum,enzymes,bun'
p28329
g9
sS'should,be,restricted'
p28330
g3
sS'article,reviews,the'
p28331
g3
sS'mechanisms,similar,to'
p28332
g3
sS'therefore,it,can'
p28333
g3
sS'auc,of,increased'
p28334
g9
sS'apparent,volume,of'
p28335
g3
sS'significant,interactions,were'
p28336
g3
sS'who,require,anticoagulation'
p28337
g3
sS'recovered,weeks,after'
p28338
g3
sS'butyrophenone,classes,of'
p28339
g9
sS'the,recommended,maximum'
p28340
g9
sS'in,vitro,to'
p28341
g3
sS'about,times,higher'
p28342
g3
sS'except,for,clindamycin-sensitive'
p28343
g3
sS'had,depleting,added'
p28344
g3
sS'examine,the,effects'
p28345
g3
sS'and,or,stereotypic'
p28346
g3
sS'effect,of,microdosed'
p28347
g9
sS'erythro-fluorocitrate,synthesis,in'
p28348
g3
sS'these,results,suggest'
p28349
g3
sS'dispersible,tablet,formulation'
p28350
g9
sS'increases,in,fi'
p28351
g9
sS'risk,of,neutropenia'
p28352
g9
sS'if,patients,are'
p28353
g9
sS'resveratrol,has,been'
p28354
g3
sS'focus,on,investigation'
p28355
g3
sS'in,human,cells'
p28356
g3
sS'metabolite,i,with'
p28357
g3
sS'days,intraperitoneally,ip'
p28358
g9
sS'and,potential,decrease'
p28359
g3
sS'and,n-cetyl,gallate'
p28360
g3
sS'fired,spontaneous,action'
p28361
g3
sS'and,hypotension,and'
p28362
g3
sS'discernible,changes,in'
p28363
g3
sS'effect,of,brevibloc'
p28364
g3
sS'associated,with,reports'
p28365
g3
sS'drugs,in,some'
p28366
g9
sS'and,cerebyx,dosage'
p28367
g9
sS'active,in,inhibiting'
p28368
g9
sS'administered,with,see'
p28369
g9
sS'metabolism,via,p450'
p28370
g9
sS'as,tolerance,and'
p28371
g3
sS'such,as,hctz'
p28372
g3
sS'some,forms,of'
p28373
g3
sS'to,the,normal'
p28374
g3
sS'did,occur,at'
p28375
g3
sS'max,decreased,by'
p28376
g9
sS'for,characterization,or'
p28377
g3
sS'monitored,closely,for'
p28378
g3
sS'and,bones,the'
p28379
g3
sS'injection,in,combination'
p28380
g9
sS'inhibits,cyp3a4,and'
p28381
g3
sS'bid,for,days'
p28382
g9
sS'suggest,that,may'
p28383
g9
sS'tumor,response,was'
p28384
g3
sS'when,the,were'
p28385
g3
sS'produce,severe,weakness'
p28386
g9
sS'cause,of,the'
p28387
g3
sS'reduces,both,the'
p28388
g9
sS'should,not,require'
p28389
g3
sS'hypertension,and,that'
p28390
g3
sS'increased,with,increasing'
p28391
g3
sS'initiation,of,treatment'
p28392
g9
sS'should,be,followed'
p28393
g3
sS'anxiogenic,effects,by'
p28394
g9
sS'back,pain,arthralgia'
p28395
g3
sS'uricosuric,agents,which'
p28396
g9
sS'generation,atypical,antipsychotic'
p28397
g3
sS'tests,interactions,hyperaminotransferasemia'
p28398
g3
sS'qd,or,mg'
p28399
g3
sS'alcohol,increases,bioavailability'
p28400
g3
sS'inhibitors,or,because'
p28401
g9
sS'that,homocysteine,may'
p28402
g3
sS'fold,greater,for'
p28403
g3
sS'cerebrovascular,accidents,six'
p28404
g3
sS'currently,underway,to'
p28405
g3
sS'twitch,from,to'
p28406
g9
sS'i,relational,the'
p28407
g3
sS'on,the,compatibility'
p28408
g3
sS'cohort,data,and'
p28409
g3
sS'a,patient,maintained'
p28410
g9
sS'of,any,from'
p28411
g3
sS'cmax,values,were'
p28412
g3
sS'withdrawal,of,or'
p28413
g3
sS'clinical,studies,using'
p28414
g3
sS'ie,from,ml'
p28415
g3
sS'this,isozyme,and'
p28416
g3
sS'similar,personality,characteristics'
p28417
g3
sS'following,adrenocorticoids,cortisone-like'
p28418
g9
sS'with,a,similar'
p28419
g3
sS'ethyl,mao,inhibitors'
p28420
g9
sS'and,an,ssri'
p28421
g9
sS'prolonged,by,therapy'
p28422
g9
sS'initiating,a,multi-day'
p28423
g9
sS'patient,with,such'
p28424
g3
sS'copegus,did,not'
p28425
g3
sS'this,patients,should'
p28426
g3
sS'for,alterations,of'
p28427
g9
sS'in,an,apparent'
p28428
g3
sS'insert,of,medication'
p28429
g3
sS'of,interference,by'
p28430
g3
sS'acid,secretion,stimulated'
p28431
g3
sS'with,parasite,reduction'
p28432
g3
sS'digoxin,rofecoxib,mg'
p28433
g3
sS'and,prolonged,thrombocytopenia'
p28434
g3
sS'a,single-dose,crossover'
p28435
g9
sS'carbamazepine,causes,an'
p28436
g9
sS'effect,is,small'
p28437
g3
sS'eprosartan,doses,of'
p28438
g3
sS'coadministration,of,which'
p28439
g9
sS'affect,the,pharmacokinetic'
p28440
g9
sS'vitamin,b12,which'
p28441
g9
sS'natural,history,of'
p28442
g3
sS'of,oral,ccnu'
p28443
g9
sS'be,potentiated,resulting'
p28444
g9
sS'combination,therapy,dose'
p28445
g3
sS'studies,was,given'
p28446
g3
sS'closely,for,nevirapine-associated'
p28447
g3
sS'and,low,affinity'
p28448
g3
sS'concentrates,has,not'
p28449
g3
sS'completely,absorbed,from'
p28450
g3
sS'during,the,above'
p28451
g3
sS'needs,urgently,to'
p28452
g3
sS'for,days,with'
p28453
g3
sS'with,nsaids,has'
p28454
g9
sS'to,dose-related,decrease'
p28455
g9
sS'variable,half-life,of'
p28456
g3
sS'studies,used,anti-peptic'
p28457
g3
sS'of,were,almost'
p28458
g9
sS'added,one,additional'
p28459
g3
sS't,cell-independent,activator'
p28460
g3
sS'abnormal,topoisomerase,quantity'
p28461
g3
sS'if,novolog,is'
p28462
g3
sS'be,important,determinants'
p28463
g3
sS'flow,were,measured'
p28464
g3
sS'side,effects,particularly'
p28465
g9
sS'studies,that,toradol'
p28466
g3
sS'be,used,only'
p28467
g3
sS'adult,wistar,rats'
p28468
g3
sS'test,should,be'
p28469
g3
sS'acid,and,these'
p28470
g3
sS'in,the,dose'
p28471
g3
sS'thrombocytopenia,the,co-administration'
p28472
g3
sS'kidney,allograft,recipients'
p28473
g3
sS'enzymes,and,thus'
p28474
g9
sS'prevent,the,from'
p28475
g9
sS'monkeys,the,effects'
p28476
g9
sS'utilizing,commercially,available'
p28477
g3
sS'hours,of,subjects'
p28478
g9
sS'ataxia,a,typical'
p28479
g3
sS'depend,upon,the'
p28480
g3
sS'antacids,and,sucralfate'
p28481
g9
sS'bacterial,metabolism,in'
p28482
g9
sS'the,induction,of'
p28483
g9
sS'indocin,reduces,basal'
p28484
g3
sS'for,the,individual'
p28485
g3
sS'of,the,pronounced'
p28486
g9
sS'is,significantly,reduced'
p28487
g9
sS'cyp2c9,such,as'
p28488
g9
sS'metabolism,produced,an'
p28489
g9
sS'metabolism,decreased,the'
p28490
g9
sS'not,affect,renal'
p28491
g3
sS'certain,endocrine,and'
p28492
g3
sS'and,returned,to'
p28493
g3
sS'such,as,salicylic'
p28494
g3
sS'the,usual,amounts'
p28495
g3
sS'another,study,in'
p28496
g9
sS'aeds,whether,or'
p28497
g3
sS'mesylate,did,not'
p28498
g3
sS'of,and,results'
p28499
g9
sS'agents,calcium-channel,blocking'
p28500
g3
sS'comparison,to,saline'
p28501
g3
sS'a,vanh,promoter-vana'
p28502
g3
sS'phenothiazines,and,may'
p28503
g9
sS'concomitantly,indicate,that'
p28504
g9
sS'of,these,events'
p28505
g3
sS'dosage,of,these'
p28506
g3
sS'to,the,action'
p28507
g9
sS'avoid,intoxication,appropriate'
p28508
g3
sS'response,is,not'
p28509
g3
sS'three-fold,compared,to'
p28510
g3
sS'of,major,clinical'
p28511
g9
sS'and,lethality,in'
p28512
g3
sS'daily,with,mg'
p28513
g3
sS'provided,to,assist'
p28514
g3
sS'pyrocarbonate,could,be'
p28515
g3
sS'other,drugs,clonazepam'
p28516
g3
sS'treated,for,up'
p28517
g9
sS'metabolites,are,minimally'
p28518
g3
sS'other,metal,cations'
p28519
g9
sS'of,bioavailability,relative'
p28520
g3
sS'for,erectile,dysfunction'
p28521
g3
sS'elimination,of,most'
p28522
g9
sS'significant,difference,in'
p28523
g3
sS'study,in,seven'
p28524
g3
sS'induce,metabolism,causing'
p28525
g9
sS'assigned,to,one'
p28526
g3
sS'the,proliferation,of'
p28527
g9
sS'potential,interactions,in'
p28528
g3
sS'therapy,including,and'
p28529
g3
sS'receiving,preparations,or'
p28530
g3
sS'oral,load,constitutes'
p28531
g3
sS'in,isolated,single'
p28532
g3
sS'axons,has,been'
p28533
g3
sS'in,vitro,concentrations'
p28534
g3
sS'who,have,pre-existing'
p28535
g9
sS'accumulation,of,as'
p28536
g3
sS'result,in,deficits'
p28537
g3
sS'appears,generally,good'
p28538
g3
sS'excystment,rates,of'
p28539
g3
sS'or,other,cyp3a4'
p28540
g3
sS'used,for,relief'
p28541
g3
sS'until,the,end'
p28542
g3
sS'with,suspension,yielded'
p28543
g3
sS'to,be,of'
p28544
g3
sS'a,nonlethal,dose'
p28545
g9
sS'the,oral,route'
p28546
g3
sS'some,reports,of'
p28547
g3
sS'concentrations,has,not'
p28548
g3
sS'cytochrome,p450,isozyme'
p28549
g3
sS'basal,colonic,fluid'
p28550
g3
sS'with,likewise,further'
p28551
g3
sS'warfarin,atorvastatin,had'
p28552
g3
sS'is,strong,evidence'
p28553
g3
sS'effects,of,upon'
p28554
g3
sS'use,of,bepridil'
p28555
g3
sS'stomach,drugs,such'
p28556
g9
sS'of,argatroban,with'
p28557
g9
sS'gastric,fistulas,were'
p28558
g3
sS'the,heat,stimulus'
p28559
g3
sS'a,consequence,when'
p28560
g9
sS'taxol,infusions,must'
p28561
g3
sS'were,considered,to'
p28562
g9
sS'extrusion,of,from'
p28563
g3
sS'with,in,adults'
p28564
g3
sS'nasal,spray,during'
p28565
g3
sS'toxicologic,profile,of'
p28566
g3
sS'if,these,are'
p28567
g3
sS'and,behavioral,effects'
p28568
g3
sS'realization,of,this'
p28569
g3
sS'and,or,were'
p28570
g3
sS'adjustment,of,antigout'
p28571
g3
sS'other,concomitant,or'
p28572
g3
sS'interactions,were,studied'
p28573
g3
sS'exercised,if,peganone'
p28574
g9
sS'several,proteins,in'
p28575
g3
sS'cefuroxime,does,not'
p28576
g3
sS'methoxycoronaridine,mc,and'
p28577
g3
sS'system,depressant,cns'
p28578
g3
sS'in,development,of'
p28579
g3
sS'hormone,binding,globulin'
p28580
g3
sS'subjects,receiving,daily'
p28581
g3
sS'acid,levels,may'
p28582
g3
sS'of,m1,peak'
p28583
g9
sS'of,striatal,but'
p28584
g9
sS'diet,resulted,in'
p28585
g9
sS'levorotatory,isomer,had'
p28586
g3
sS'no,significant,pharmacokinetic'
p28587
g3
sS'no,increase,in'
p28588
g3
sS'clearance,when,administered'
p28589
g9
sS'developing,mathematical,functions'
p28590
g3
sS'starting,and,frequently'
p28591
g9
sS'an,increased,peak'
p28592
g9
sS'provide,medical,supervision'
p28593
g3
sS'effect,the,enteric'
p28594
g9
sS'that,the,addition'
p28595
g9
sS'or,antagonist,effect'
p28596
g3
sS'and,decreased,efficacy'
p28597
g3
sS'it,is,indicated'
p28598
g3
sS'numerous,interactions,are'
p28599
g3
sS'arthritis,and,liver'
p28600
g3
sS'and,p2,while'
p28601
g3
sS'addition,interfere,with'
p28602
g9
sS'neither,reversed,by'
p28603
g9
sS'tissue,culture,and'
p28604
g9
sS'of,r,or'
p28605
g3
sS'only,where,definitely'
p28606
g9
sS'nevertheless,there,may'
p28607
g3
sS'agents,was,not'
p28608
g3
sS'etodolac,has,no'
p28609
g3
sS'systems,may,have'
p28610
g3
sS'of,which,may'
p28611
g9
sS'eg,would,be'
p28612
g9
sS'an,inducer,of'
p28613
g3
sS'by,their,relative'
p28614
g3
sS'glucocorticoid-induced,mouse,mammary'
p28615
g3
sS'discontinuation,of,the'
p28616
g3
sS'dosage,adjustments,made'
p28617
g3
sS'to,maintain,concentrations'
p28618
g3
sS'than,pediatrics,mean'
p28619
g9
sS'isoenzyme,daily,doses'
p28620
g9
sS'prescribe,this,agent'
p28621
g3
sS'contraindication,to,further'
p28622
g3
sS'smokers,have,an'
p28623
g3
sS'cases,of,conduction'
p28624
g9
sS'up-titration,presumably,resulting'
p28625
g3
sS'depressive,and,negative'
p28626
g3
sS'using,escalating,doses'
p28627
g9
sS'effect,occurs,when'
p28628
g3
sS'recommended,during,treatment'
p28629
g9
sS'exposure,auc,higher'
p28630
g9
sS'inhibition,of,metabolism'
p28631
g3
sS'prior,to,hours'
p28632
g9
sS'potentially,result,in'
p28633
g9
sS'haldol,may,be'
p28634
g9
sS'protein-bound,from,their'
p28635
g3
sS'and,racemic,was'
p28636
g3
sS'of,the,extremities'
p28637
g3
sS'months,had,no'
p28638
g3
sS'of,interaction,at'
p28639
g3
sS'limited,clinical,experience'
p28640
g9
sS'while,attenuating,s'
p28641
g9
sS'exposure,of,the'
p28642
g9
sS'these,results,show'
p28643
g3
sS'on,metabolism,by'
p28644
g3
sS'equipotent,inducers,of'
p28645
g3
sS'cessation,of,therapy'
p28646
g3
sS'the,next,chapter'
p28647
g3
sS'among,subjects,who'
p28648
g3
sS'appear,to,affect'
p28649
g3
sS'it,is,theoretically'
p28650
g9
sS'in,substantial,inactivation'
p28651
g9
sS'cas,but,can'
p28652
g9
sS'or,prolonged,therapy'
p28653
g3
sS'not,been,well'
p28654
g3
sS'analysing,the,resulting'
p28655
g3
sS'of,micrograms,completely'
p28656
g9
sS'observed,in,female'
p28657
g3
sS'function,of,the'
p28658
g9
sS'liver,and,bowel'
p28659
g3
sS'apply,to,administration'
p28660
g3
sS'curve,after,a'
p28661
g9
sS'antiarrhythmic,agents,class'
p28662
g3
sS'following,days,of'
p28663
g3
sS'information,should,be'
p28664
g3
sS'may,reduce,seizure'
p28665
g9
sS'myelosuppressive,agents,or'
p28666
g3
sS'evaluate,the,impact'
p28667
g3
sS'renal,clearance,from'
p28668
g3
sS'is,indicated,reduction'
p28669
g9
sS'were,found,but'
p28670
g3
sS'steady,state,on'
p28671
g3
sS'cytochrome,p450,a'
p28672
g3
sS'cytochrome,p450,c'
p28673
g3
sS'of,cyp,c19'
p28674
g3
sS'performed,on,day'
p28675
g3
sS'emerged,from,the'
p28676
g3
sS'bound,to,plasma'
p28677
g3
sS'rapid,and,significant'
p28678
g9
sS'a,day,course'
p28679
g3
sS'been,adequately,evaluated'
p28680
g3
sS'with,glucuronidation,being'
p28681
g3
sS'change,in,auc'
p28682
g3
sS'revia,may,not'
p28683
g9
sS'on,the,use'
p28684
g9
sS'by,inhibiting,parts'
p28685
g9
sS'concurrently,with,escalating'
p28686
g3
sS'oral,an,inhibitor'
p28687
g3
sS'microsomes,inhibition,of'
p28688
g9
sS'not,needed,when'
p28689
g9
sS'to,increases,in'
p28690
g3
sS'low-dose,mg,once'
p28691
g3
sS'cmax,of,and'
p28692
g9
sS'additive,hypotensite,effects'
p28693
g9
sS'after,initiating,therapy'
p28694
g9
sS'bid,mg,qd'
p28695
g9
sS'rate,or,corrected'
p28696
g3
sS'of,pegasys,every'
p28697
g3
sS'blockers,have,been'
p28698
g3
sS'plasma,enzymes,or'
p28699
g3
sS'and,the,hyperplasia'
p28700
g3
sS'dopamine,da,levels'
p28701
g3
sS'preparations,and,endocrine'
p28702
g3
sS'is,metabolized,in'
p28703
g3
sS'nonsteroidal,agents,folic'
p28704
g3
sS'of,their,usual'
p28705
g9
sS'treatment,with,soriatane'
p28706
g3
sS'mg,on,the'
p28707
g3
sS'in,volume,of'
p28708
g9
sS'subject,n,received'
p28709
g3
sS'sequential,infusions,myelosuppression'
p28710
g9
sS'phosphorylation,status,of'
p28711
g3
sS'cyp2d6,are,responsible'
p28712
g3
sS'increased,by,an'
p28713
g9
sS'of,the,observed'
p28714
g3
sS'acid,were,added'
p28715
g3
sS'increased,anticoagulation,effects'
p28716
g3
sS'unless,absolute,abstinence'
p28717
g3
sS'of,or,metabolite'
p28718
g3
sS'with,these,or'
p28719
g9
sS'rash,peripheral,edema'
p28720
g3
sS'reduces,the,level'
p28721
g9
sS'extract,from,bovine'
p28722
g3
sS'with,these,on'
p28723
g3
sS'reports,of,enhanced'
p28724
g9
sS'adequate,monitoring,of'
p28725
g9
sS'taken,hour,before'
p28726
g3
sS'any,evidence,of'
p28727
g3
sS'inhibitors,studies,in'
p28728
g9
sS'received,ace,inhibitors'
p28729
g3
sS'in,the,absence'
p28730
g3
sS'other,calcium-containing,medicines'
p28731
g3
sS'interaction,should,be'
p28732
g9
sS'total,bioavailability,of'
p28733
g3
sS'the,initiated,cells'
p28734
g3
sS'and,for,several'
p28735
g9
sS'systemic,levels,may'
p28736
g3
sS'multiple,dosing,beta-1a'
p28737
g9
sS'to,cause,weakness'
p28738
g9
sS'a,nitrosamine,which'
p28739
g9
sS'interactions,as,a'
p28740
g3
sS'bodyweight,gain,occurred'
p28741
g3
sS'increase,and,may'
p28742
g3
sS'be,given,concurrently'
p28743
g9
sS'between,epa,supplements'
p28744
g9
sS'concentrations,of,endotoxin-treated'
p28745
g9
sS'neuron,blocking,agents'
p28746
g3
sS'balanced,by,decreased'
p28747
g3
sS'therapy,with,amprenavir'
p28748
g9
sS'levels,and,adjust'
p28749
g9
sS'because,the,effects'
p28750
g9
sS'however,prudent,evaluation'
p28751
g3
sS'acid,decrease,in'
p28752
g9
sS'following,doses,of'
p28753
g9
sS'of,ci,when'
p28754
g9
sS'this,study,adverse'
p28755
g9
sS'the,recording,pipette'
p28756
g3
sS'the,antidepressant,was'
p28757
g3
sS'one,patient,died'
p28758
g3
sS'in,the,european'
p28759
g3
sS'or,fec-100,chemotherapies'
p28760
g3
sS'no,nutritional,supplement'
p28761
g3
sS'with,lean,rats'
p28762
g3
sS'thus,an,enhancement'
p28763
g9
sS'are,advisable,for'
p28764
g3
sS'vs,spared,by'
p28765
g3
sS'adverse,events,occurred'
p28766
g3
sS'with,the,elimination'
p28767
g9
sS'close,collaboration,with'
p28768
g3
sS'may,require,additional'
p28769
g9
sS'should,be,given'
p28770
g3
sS'because,changes,in'
p28771
g9
sS'using,romazicon,in'
p28772
g9
sS'cells,even,when'
p28773
g3
sS'either,is,recommended'
p28774
g3
sS'of,neurons,hyperpolarized'
p28775
g3
sS'clinical,or,interaction'
p28776
g3
sS'by,increased,catabloism'
p28777
g3
sS'of,unprotected,sexual'
p28778
g3
sS'or,tmax,at'
p28779
g3
sS'to,after,exposure'
p28780
g3
sS'adjustment,of,strattera'
p28781
g9
sS'of,oral,during'
p28782
g9
sS'step,of,the'
p28783
g9
sS'subsequently,administered,radiographic'
p28784
g9
sS'co-administered,avonex,and'
p28785
g3
sS'of,taxol,and'
p28786
g3
sS'of,was,lower'
p28787
g9
sS'other,macrolide,and'
p28788
g9
sS'auc,of,absorption'
p28789
g9
sS'concentrations,and,effects'
p28790
g3
sS'the,direction,and'
p28791
g3
sS'result,in,a'
p28792
g3
sS'of,with,oral'
p28793
g9
sS'were,each,significantly'
p28794
g3
sS'serum,reverse,triiodothyronine'
p28795
g3
sS'possible,benefits,of'
p28796
g9
sS'atromid-s,neoral,sandimmune'
p28797
g9
sS'anticholinergic,may,antagonize'
p28798
g9
sS'the,immediate,side'
p28799
g3
sS'steady-state,cmin,decreased'
p28800
g9
sS'by,the,stimulant'
p28801
g3
sS'given,with,sustiva'
p28802
g9
sS'detrimental,for,the'
p28803
g3
sS'study,involving,healthy'
p28804
g9
sS'cimetidine,mg,b'
p28805
g3
sS'cause,additive,cns'
p28806
g9
sS'different,type,of'
p28807
g9
sS'the,second,study'
p28808
g9
sS'changing,vioxx,therapy'
p28809
g9
sS'on,glycemic,control'
p28810
g3
sS'herbal,remedies,may'
p28811
g3
sS'proteins,or,alter'
p28812
g9
sS'regarding,asthma,therapy'
p28813
g3
sS'of,tcas,with'
p28814
g9
sS'oral,compared,to'
p28815
g3
sS'john,s,wort'
p28816
g3
sS'pharmacokinetic,studies,document'
p28817
g3
sS'hypotension,or,marked'
p28818
g3
sS'to,iodinated,contrast'
p28819
g9
sS'reduce,the,antitumor'
p28820
g9
sS'with,is,thus'
p28821
g3
sS'on,oral,who'
p28822
g9
sS'this,phenomenon,was'
p28823
g3
sS'like,aleve,or'
p28824
g9
sS'either,interaction,studies'
p28825
g3
sS'gastric,ph,on'
p28826
g3
sS'of,gabitril,on'
p28827
g3
sS'was,improved,when'
p28828
g3
sS'coadministered,with,each'
p28829
g9
sS'acid,and,vitamin'
p28830
g3
sS'enhance,toxicity,and'
p28831
g3
sS'volunteers,have,shown'
p28832
g3
sS'levels,and,potential'
p28833
g3
sS'serum,bilirubin,levels'
p28834
g3
sS'clinical,studies,with'
p28835
g3
sS'or,products,containing'
p28836
g9
sS'bradycardia,and,decreased'
p28837
g3
sS'suggested,that,therapy'
p28838
g3
sS'to,normal,minutes'
p28839
g3
sS'and,serial,measurement'
p28840
g9
sS'effects,of,dcg-iv'
p28841
g9
sS'having,a,well-known'
p28842
g3
sS'cyp2e1,but,did'
p28843
g3
sS'should,generally,not'
p28844
g3
sS'volunteers,there,was'
p28845
g3
sS'and,risks,of'
p28846
g9
sS'drugs,and,no'
p28847
g3
sS'results,for,the'
p28848
g9
sS'of,these,also'
p28849
g3
sS'treatment,of,anaphylactic'
p28850
g9
sS'be,increased,angiotensinogen'
p28851
g3
sS'of,norpace,and'
p28852
g9
sS'antiminth,taking,and'
p28853
g9
sS'as,required,to'
p28854
g3
sS'mg,five,times'
p28855
g3
sS'for,estimation,of'
p28856
g3
sS'of,cmax,and'
p28857
g3
sS'electroconvulsive,therapy,ect'
p28858
g3
sS'be,monitored,regularly'
p28859
g3
sS'administered,without,any'
p28860
g3
sS'an,oral,overload'
p28861
g3
sS'unaffected,by,concurrent'
p28862
g3
sS'alkaline,earth,and'
p28863
g3
sS'maoi,there,have'
p28864
g9
sS'effect,agents,derivatives'
p28865
g3
sS'man,include,and'
p28866
g3
sS'by,one-third,to'
p28867
g3
sS'of,on,stimulated'
p28868
g3
sS'when,was,used'
p28869
g9
sS'massive,precipitation,in'
p28870
g3
sS'weight,approximately,ml'
p28871
g3
sS'ze,patients,no'
p28872
g3
sS'determine,whether,the'
p28873
g9
sS'be,related,with'
p28874
g3
sS'antacids,increase,the'
p28875
g9
sS'some,organisms,contained'
p28876
g9
sS'clinical,data,are'
p28877
g3
sS'are,used,on'
p28878
g3
sS'toxicity,in,some'
p28879
g9
sS'you,may,need'
p28880
g9
sS'neuromuscular,transmission,curare-like'
p28881
g9
sS'other,may,potentiate'
p28882
g9
sS'sleeping,sickness,center'
p28883
g3
sS'which,is,totally'
p28884
g3
sS'cycles,of,taxol'
p28885
g3
sS'twice,the,human'
p28886
g3
sS'associated,with,bleeding'
p28887
g3
sS'or,concomitant,administration'
p28888
g3
sS'the,pharmacodynamic,effect'
p28889
g3
sS'following,elspar,therapy'
p28890
g9
sS'addiction,after,withdrawal'
p28891
g3
sS'on,concomitant,use'
p28892
g3
sS'mixtures,should,not'
p28893
g3
sS'may,be,the'
p28894
g3
sS'promoted,the,translocation'
p28895
g3
sS'show,clinically,relevant'
p28896
g3
sS'pump,inhibitors,eg'
p28897
g9
sS'not,totally,known'
p28898
g9
sS'h,up,to'
p28899
g3
sS'enhanced,the,activity'
p28900
g3
sS'in,altered,pharmacoktnetics'
p28901
g3
sS'amevive,is,excreted'
p28902
g3
sS'careful,supervision,of'
p28903
g3
sS'mg,kg,was'
p28904
g3
sS'cyclopropane,or,halogenated'
p28905
g9
sS'initiation,of,felbatol'
p28906
g3
sS'abilify,to,affect'
p28907
g3
sS'mumol,liter,potentiated'
p28908
g9
sS'increase,fi,responding'
p28909
g3
sS'with,opioid-evoked,hyperpolarization'
p28910
g3
sS'administration,of,keflex'
p28911
g3
sS'resulting,from,smoking'
p28912
g3
sS'dosing,with,would'
p28913
g3
sS'is,the,rate-limiting'
p28914
g3
sS'and,containing,maalox'
p28915
g9
sS'other,agents,interfering'
p28916
g9
sS'or,and,within'
p28917
g9
sS'or,decrease,blood'
p28918
g3
sS'or,discontinued,in'
p28919
g9
sS'of,blockers,on'
p28920
g3
sS'to,cups,of'
p28921
g3
sS'gleevec,oral-dose,clearance'
p28922
g9
sS'renal,function,should'
p28923
g9
sS'colestid,tablets,are'
p28924
g9
sS'ki,value,of'
p28925
g3
sS'risk,relative,to'
p28926
g3
sS'and,a,dose'
p28927
g9
sS'patients,on,especially'
p28928
g9
sS'administered,cautiously,and'
p28929
g3
sS'free,fraction,of'
p28930
g3
sS'arterial,hypertension,did'
p28931
g3
sS'durations,of,neuromuscular'
p28932
g9
sS'decreasing,the,gastrointestinal'
p28933
g9
sS'interactions,false,elevations'
p28934
g3
sS'associated,adverse,event'
p28935
g3
sS'addiction,is,defined'
p28936
g3
sS'other,hivid-associated,adverse'
p28937
g9
sS'competition,for,binding'
p28938
g9
sS'isoenzymes,has,not'
p28939
g3
sS'duragesic,is,not'
p28940
g9
sS'hatching,survival,and'
p28941
g3
sS'erbitux,was,administered'
p28942
g3
sS'to,monitor,the'
p28943
g3
sS'with,other,cns'
p28944
g9
sS'glutathione,or,other'
p28945
g3
sS'addition,the,use'
p28946
g3
sS'these,reactions,have'
p28947
g3
sS'applications,of,the'
p28948
g3
sS'and,limited,sampling'
p28949
g3
sS'the,pituitary,secretion'
p28950
g3
sS'and,probably,for'
p28951
g3
sS'found,no,increase'
p28952
g3
sS'primate,gammaherpes,virus'
p28953
g3
sS'are,withdrawn,from'
p28954
g3
sS'but,is,probably'
p28955
g9
sS'p-glycoprotein,and,is'
p28956
g3
sS'inn,when,coadministered'
p28957
g3
sS'perchlorate,in,several'
p28958
g3
sS'decreased,levels,of'
p28959
g3
sS'clotting,time,was'
p28960
g3
sS'was,noted,when'
p28961
g3
sS'a,nd,female'
p28962
g3
sS'without,the,other'
p28963
g3
sS'agonists,dcg-iv,and'
p28964
g3
sS'dehydrogenase,inhibition,significantly'
p28965
g9
sS'that,may,have'
p28966
g9
sS'of,metabolite,i'
p28967
g3
sS'of,and,decrease'
p28968
g3
sS'pregnancy,test,must'
p28969
g3
sS'increases,in,their'
p28970
g9
sS'year-old,african-american,man'
p28971
g3
sS'physicians,are,provided'
p28972
g9
sS'anticoagulant,inhibition,was'
p28973
g3
sS'to,be,clastogenic'
p28974
g3
sS'cyp2a6,cyp2b6,cyp2c8'
p28975
g3
sS'of,while,the'
p28976
g3
sS'use,of,or'
p28977
g3
sS'fraction,of,metabolized'
p28978
g3
sS'when,maleate,mg'
p28979
g9
sS'or,s-,enantiomers'
p28980
g3
sS'be,evaluated,after'
p28981
g9
sS'of,gl,with'
p28982
g9
sS'a,neutralizing,agent'
p28983
g9
sS'dmpge2,induced,diarrhea'
p28984
g3
sS'administered,with,chirocaine'
p28985
g3
sS'each,to,mg'
p28986
g9
sS'make,up,a'
p28987
g3
sS'the,major,membrane'
p28988
g3
sS'therefore,unless,otherwise'
p28989
g3
sS'interferes,minimally,or'
p28990
g9
sS'doses,were,to'
p28991
g3
sS'the,literature,that'
p28992
g3
sS'peripheral,because,the'
p28993
g9
sS'in,the,tail-flick'
p28994
g9
sS'a,mg,kg'
p28995
g3
sS'sulfoxide,plasma,concentrations'
p28996
g3
sS'blood,pressure,strattera'
p28997
g3
sS'use,may,increase'
p28998
g3
sS'metal,concentration,except'
p28999
g3
sS'bleeding,associated,with'
p29000
g9
sS'prolong,the,biological'
p29001
g3
sS'agents,should,not'
p29002
g3
sS'interaction,captopril,may'
p29003
g3
sS'with,metabolized,by'
p29004
g3
sS'interaction,in,preterm'
p29005
g3
sS'stable,dosage,of'
p29006
g3
sS'has,the,best'
p29007
g3
sS'in,urinary,excretion'
p29008
g9
sS'doses,of,sodium'
p29009
g3
sS'a,metabolite,i'
p29010
g3
sS'results,in,the'
p29011
g3
sS'sufficient,to,preclude'
p29012
g3
sS'in,urinary,uric'
p29013
g9
sS'probenecid,probenecid,interferes'
p29014
g9
sS'possibility,of,clinical'
p29015
g3
sS'of,pharmacokinetic,parameters'
p29016
g3
sS'upon,the,metabolism'
p29017
g3
sS'use,of,transdermal'
p29018
g9
sS'trileptal,and,other'
p29019
g3
sS'on,absorption,when'
p29020
g9
sS'ingestion,may,increase'
p29021
g9
sS'peripheral,neuropathy,should'
p29022
g3
sS'and,subsequent,recovery'
p29023
g3
sS'to,interact,with'
p29024
g3
sS'reviews,the,suitability'
p29025
g3
sS'based,on,total'
p29026
g9
sS'been,characterized,by'
p29027
g3
sS'this,formal,interaction'
p29028
g3
sS'the,reduced,interaction'
p29029
g3
sS'kg,m,g'
p29030
g3
sS'a,high,percentage'
p29031
g3
sS'decrease,blood,levels'
p29032
g9
sS'of,permits,at'
p29033
g9
sS'phase,ii,clinical'
p29034
g9
sS'a,known,inhibitor'
p29035
g9
sS'complex,formation,that'
p29036
g3
sS'with,the,simultaneous'
p29037
g9
sS'during,co-administration,systemic'
p29038
g3
sS'tolazamide,a,case'
p29039
g9
sS'were,not,different'
p29040
g3
sS'sterilize,the,bowel'
p29041
g3
sS'active,phosphorylated,which'
p29042
g9
sS'reduced,infusion,rates'
p29043
g9
sS'mg,before,meals'
p29044
g3
sS'or,an,equivalent'
p29045
g3
sS'alfenta,induction,the'
p29046
g9
sS'expected,when,is'
p29047
g9
sS'and,cause,increased'
p29048
g9
sS'agents,including,yields'
p29049
g9
sS'a,tendency,to'
p29050
g9
sS'at,clinically,relevant'
p29051
g3
sS'subjects,were,randomized'
p29052
g3
sS'iopidine,ophthalmic,solution'
p29053
g9
sS'changes,in,blood'
p29054
g9
sS'alter,the,plasma'
p29055
g3
sS'in,these,areas'
p29056
g3
sS'escalating,doses,of'
p29057
g9
sS'estradiol,and,norethindrone'
p29058
g9
sS'more,people,are'
p29059
g3
sS'will,be,increased'
p29060
g9
sS'oral,clearance,was'
p29061
g3
sS'tindal,thorazine,prolixin'
p29062
g3
sS'in,serum,activity'
p29063
g3
sS'for,topical,solution'
p29064
g3
sS'aucs,of,the'
p29065
g3
sS'poor,metabolizers,have'
p29066
g3
sS'colorimetric,complexometric,methods'
p29067
g3
sS'diminished,the,binding'
p29068
g9
sS'prevalence,of,reduced'
p29069
g3
sS'complex,concentrates,should'
p29070
g3
sS'certain,by,up'
p29071
g9
sS'objectives,to,examine'
p29072
g3
sS'seen,in,the'
p29073
g3
sS'lasting,inhibition,of'
p29074
g3
sS'primates,and,the'
p29075
g3
sS'were,treated,with'
p29076
g3
sS'after,coadministration,of'
p29077
g3
sS'administered,alternately,when'
p29078
g3
sS'of,most,other'
p29079
g9
sS'require,a,reduction'
p29080
g9
sS'avoided,because,accutane'
p29081
g9
sS'arc,mrna,level'
p29082
g9
sS'therapy,with,vioxx'
p29083
g9
sS'haart,is,feasible'
p29084
g3
sS'or,channel,antagonists'
p29085
g3
sS'cpk,were,observed'
p29086
g3
sS'concomitant,agents,such'
p29087
g3
sS'nerve,damage,could'
p29088
g3
sS'of,duragesic,transdermal'
p29089
g9
sS'camptosar,and,it'
p29090
g9
sS'express,the,d'
p29091
g3
sS'additive,when,the'
p29092
g3
sS'to,be,displaced'
p29093
g9
sS'metabolizers,of,interactions'
p29094
g9
sS'aquamephyton,synkayvite,use'
p29095
g3
sS'gdh,pqq-based,methods'
p29096
g3
sS'for,reduction,of'
p29097
g3
sS'to,double,the'
p29098
g9
sS'or,ldh,were'
p29099
g3
sS'administration,of,are'
p29100
g9
sS'metabolism,inhibitors,of'
p29101
g9
sS'pharmacokinetic,interaction,study'
p29102
g3
sS'if,given,concomitantly'
p29103
g3
sS'fold,elevations,on'
p29104
g9
sS'combination,have,not'
p29105
g3
sS'fecal,as,well'
p29106
g3
sS'by,which,could'
p29107
g3
sS'basal,plasma,cortisol'
p29108
g3
sS'influence,the,development'
p29109
g3
sS'given,concurrently,it'
p29110
g3
sS'noted,that,or'
p29111
g3
sS'concomitant,oral,administration'
p29112
g9
sS'mediating,stimulus-induced,neural'
p29113
g3
sS'of,the,chop'
p29114
g3
sS'possible,resistance,to'
p29115
g3
sS'orthostatic,changes,in'
p29116
g9
sS'an,and,containing'
p29117
g9
sS'when,toradol,was'
p29118
g9
sS'dose,mg,tid'
p29119
g3
sS'were,additive,when'
p29120
g3
sS'of,concomitant,on'
p29121
g3
sS'could,cause,or'
p29122
g9
sS'indicates,that,requirements'
p29123
g9
sS'non-cyp3a4,substrate,agent'
p29124
g3
sS'other,suitable,coagulation'
p29125
g3
sS'these,and,may'
p29126
g3
sS'b-lactam,co-administration,of'
p29127
g9
sS'trisilicate,when,administered'
p29128
g9
sS'found,to,exhibit'
p29129
g3
sS'of,women,who'
p29130
g3
sS'the,steady,state'
p29131
g3
sS'cause,a,sudden'
p29132
g3
sS'of,cyp2c19,and'
p29133
g3
sS'individualized,when,patients'
p29134
g3
sS'to,be,involved'
p29135
g3
sS'degree,of,the'
p29136
g3
sS'be,at,increased'
p29137
g3
sS'therapy,with,differin'
p29138
g3
sS'from,to,fold'
p29139
g9
sS'marrow,suppression,by'
p29140
g9
sS'levels,of,racemic'
p29141
g3
sS'plasma,levels,may'
p29142
g3
sS'outward,rectification,were'
p29143
g3
sS'low,compared,to'
p29144
g3
sS'in,vitro,perfused'
p29145
g3
sS'effects,of,or'
p29146
g9
sS'discontinuation,of,either'
p29147
g9
sS'or,substituted,for'
p29148
g3
sS'effects,of,on'
p29149
g3
sS'the,dose,in'
p29150
g3
sS'initial,dosing,and'
p29151
g3
sS'inhibitors,oral,channel'
p29152
g3
sS'metabolism,which,is'
p29153
g9
sS'agents,other,systemic'
p29154
g9
sS'decreases,effectiveness,by'
p29155
g9
sS'decreased,the,binding'
p29156
g9
sS'effects,and,avoidance'
p29157
g3
sS'of,and,can'
p29158
g9
sS'for,the,inhibitory'
p29159
g9
sS'other,cyp3a4,inhibitors'
p29160
g9
sS'first,study,concomitant'
p29161
g9
sS'sites,for,in'
p29162
g3
sS'reactions,should,not'
p29163
g3
sS'ethacrynic,acid,as'
p29164
g9
sS'everolimus,dose-proportionality,and'
p29165
g3
sS'observed,between,and'
p29166
g9
sS'in,ovarian,cancer'
p29167
g9
sS'in,either,procedure'
p29168
g3
sS'agents,when,an'
p29169
g9
sS'exists,for,a'
p29170
g9
sS'pivoxil,administered,following'
p29171
g9
sS'for,the,management'
p29172
g3
sS'dicumarol,it,has'
p29173
g9
sS'been,cases,reported'
p29174
g9
sS'are,intimately,related'
p29175
g3
sS'will,have,erroneously'
p29176
g9
sS'which,only,requires'
p29177
g3
sS'of,low-dose,mg'
p29178
g3
sS'appearance,have,been'
p29179
g3
sS'with,increases,in'
p29180
g9
sS'no,significant,interactions'
p29181
g3
sS'developed,b-cell,hyperplasia'
p29182
g3
sS'interactions,between,neupogen'
p29183
g3
sS'result,in,sub-therapeutic'
p29184
g9
sS'amiodarone,is,known'
p29185
g9
sS'medicines,may,increase'
p29186
g3
sS'no,differences,in'
p29187
g3
sS'hypomagnesemia,should,have'
p29188
g3
sS'in,whom,renal'
p29189
g3
sS'the,relationship,between'
p29190
g3
sS'mg,kg,on'
p29191
g9
sS'normalizing,the,intake'
p29192
g3
sS'rats,showed,significant'
p29193
g3
sS'a,to,avoid'
p29194
g9
sS'felodipine,is,metabolized'
p29195
g3
sS'want,to,change'
p29196
g3
sS'phenytoin,is,known'
p29197
g3
sS'sleep,time,were'
p29198
g3
sS'decrease,the,required'
p29199
g9
sS'ketoconazole,potential,interaction'
p29200
g9
sS'and,note,if'
p29201
g3
sS'of,cellular,sensitivity'
p29202
g3
sS'syndrome,requires,immediate'
p29203
g3
sS'with,any,of'
p29204
g9
sS'of,susceptibility,in'
p29205
g3
sS'were,followed,for'
p29206
g3
sS'chemotherapy,agents,no'
p29207
g3
sS'of,tcas,when'
p29208
g3
sS'the,translocating,action'
p29209
g3
sS'but,not,nanm'
p29210
g9
sS'not,receiving,these'
p29211
g9
sS'all,are,indeed'
p29212
g3
sS'treatment,and,gi'
p29213
g3
sS'and,sodium,colistemethate'
p29214
g9
sS'decreases,in,creatinine'
p29215
g9
sS'after,the,interaction'
p29216
g3
sS'conclude,that,the'
p29217
g9
sS'with,micromol,l'
p29218
g3
sS'which,can,result'
p29219
g9
sS'by,in,healthy'
p29220
g9
sS'marked,bradycardia,which'
p29221
g3
sS'tot,the,sexological'
p29222
g3
sS'be,administered,at'
p29223
g9
sS'but,may,potentiate'
p29224
g9
sS'of,or,dihydroxyflavone'
p29225
g3
sS'literature,that,the'
p29226
g3
sS'with,fluoxetine,a'
p29227
g3
sS'higher,frequency,of'
p29228
g3
sS'metabolites,or,accumulation'
p29229
g3
sS'may,subsequently,increase'
p29230
g3
sS'auc,of,mefenamic'
p29231
g9
sS'caution,and,frequent'
p29232
g3
sS'and,which,are'
p29233
g9
sS'platelet,function,such'
p29234
g9
sS'chronic,hepatitis,c'
p29235
g3
sS'given,injections,of'
p29236
g3
sS'of,toxicity,when'
p29237
g9
sS'and,chloride,excretion'
p29238
g9
sS'inotropic,and,or'
p29239
g3
sS'symptoms,of,myasthenic'
p29240
g3
sS'of,all,muscle'
p29241
g9
sS'to,generate,concentration-response'
p29242
g3
sS'days,into,mice'
p29243
g3
sS'parameters,affected,by'
p29244
g3
sS'particularly,in,subjects'
p29245
g9
sS'chronically,ill,and'
p29246
g3
sS'the,cmax,auc'
p29247
g9
sS'studies,is,metabolized'
p29248
g3
sS'combination,has,been'
p29249
g9
sS'serum,uric,acid'
p29250
g9
sS'may,induce,serious'
p29251
g3
sS'inhibitors,beta,blockers'
p29252
g3
sS'induced,therapeutic,hypermagnesaemia'
p29253
g3
sS'month,controlled,trial'
p29254
g3
sS'and,is,derived'
p29255
g9
sS'of,progestin-only,oral'
p29256
g3
sS'significant,adverse,interactions'
p29257
g3
sS'is,presently,not'
p29258
g3
sS'hour,after,or'
p29259
g9
sS'fluvoxamine,tablets,and'
p29260
g9
sS'the,at,a'
p29261
g3
sS'd,had,no'
p29262
g3
sS'simulect,was,reduced'
p29263
g9
sS'by,alt,and'
p29264
g3
sS'experienced,problems,in'
p29265
g3
sS'dose,was,increased'
p29266
g3
sS'total,glutathione,total'
p29267
g3
sS'cytochalasin,d,inhibited'
p29268
g9
sS'erythromycin,clarithromycin,telithromycin'
p29269
g3
sS'emit-d,a,u'
p29270
g3
sS'to,the,pharmacologic'
p29271
g3
sS'of,a,test'
p29272
g3
sS'lesions,of,the'
p29273
g3
sS'and,resistant,mcf-7'
p29274
g3
sS'closely,for,any'
p29275
g3
sS'asymptomatic,increases,in'
p29276
g3
sS'containing,multivalent,cations'
p29277
g9
sS'peptide,that,is'
p29278
g3
sS'decreasing,according,to'
p29279
g3
sS'metabolized,predominantly,by'
p29280
g3
sS'pharmacokinetic,interactions,mediated'
p29281
g3
sS'patients,who,developed'
p29282
g9
sS'possible,interactions,of'
p29283
g9
sS'clozapine,plasma,levels'
p29284
g9
sS'lymphoid,malignancy,and'
p29285
g3
sS'in,addition,most'
p29286
g9
sS'levels,induced,by'
p29287
g3
sS'could,decrease,first'
p29288
g3
sS'and,on,the'
p29289
g3
sS'and,by,a'
p29290
g9
sS'enzyme,inducers,inhibitors'
p29291
g9
sS'and,min,for'
p29292
g9
sS'tnf,antagonist,with'
p29293
g9
sS'not,show,whether'
p29294
g3
sS'or,av,nodal'
p29295
g9
sS'the,concentrations,fo'
p29296
g3
sS'by,these,cyp'
p29297
g3
sS'each,other,is'
p29298
g9
sS'range,from,decrease'
p29299
g9
sS'of,oxidative,stress'
p29300
g3
sS'should,be,obtained'
p29301
g3
sS'novel,iboga,alkaloid'
p29302
g3
sS'of,injection,and'
p29303
g9
sS'in,no,effect'
p29304
g3
sS'measures,should,be'
p29305
g3
sS'been,conducted,concomitant'
p29306
g9
sS'of,when,coadministered'
p29307
g3
sS'least,one,event'
p29308
g3
sS'by,p450iid6,a'
p29309
g3
sS'and,potentiate,sulfate'
p29310
g3
sS'chop,plus,haart'
p29311
g3
sS'related,anabolic,hormones'
p29312
g9
sS'urinary,retention,dysuria'
p29313
g3
sS'tca,concentrations,may'
p29314
g9
sS'as,nonsteroidal,agents'
p29315
g3
sS'cognitive,function,seen'
p29316
g3
sS'ventricular,tachycardia,was'
p29317
g9
sS'achieves,a,highest'
p29318
g3
sS'months,received,mg'
p29319
g3
sS'of,activated,prothrombin'
p29320
g3
sS'similar,to,the'
p29321
g3
sS'absence,of,or'
p29322
g3
sS'levels,achieved,within'
p29323
g3
sS'treatment,of,positive'
p29324
g3
sS'inhibits,proliferation,stimulated'
p29325
g9
sS'a4,ic50,g'
p29326
g3
sS'serum,antidepressant,levels'
p29327
g9
sS'taking,into,account'
p29328
g3
sS'healthy,volunteers,administration'
p29329
g3
sS'patients,taking,prothrombin'
p29330
g9
sS'extreme,caution,should'
p29331
g9
sS'treatment,of,the'
p29332
g3
sS'therapies,may,affect'
p29333
g3
sS'interaction,studies,including'
p29334
g3
sS'toxicity,may,be'
p29335
g9
sS'meaningful,interactions,have'
p29336
g3
sS'a,theoretical,risk'
p29337
g9
sS'first,double-blind,comparative'
p29338
g3
sS'activity,of,lamprene'
p29339
g9
sS'increase,or,inhibit'
p29340
g9
sS'administered,separately,by'
p29341
g9
sS'severe,bronchospasm,in'
p29342
g9
sS'spermine,and,to'
p29343
g3
sS'which,suggest,that'
p29344
g9
sS'albuterol,strattera,should'
p29345
g9
sS'the,r-value,of'
p29346
g3
sS'hydrophilic,molecule,naflu'
p29347
g3
sS'brovana,are,not'
p29348
g3
sS'paranoid,symptoms,have'
p29349
g9
sS'the,key,to'
p29350
g3
sS'where,gastric,ph'
p29351
g9
sS'fluctuated,there,were'
p29352
g3
sS'by,approximately,fold'
p29353
g9
sS'catabolism,of,k-dependent'
p29354
g3
sS'blood,and,or'
p29355
g9
sS'levels,in,cerebral'
p29356
g9
sS'acute,toxicity,of'
p29357
g9
sS'be,seen,after'
p29358
g9
sS'is,eliminated,in'
p29359
g3
sS'serious,constellation,of'
p29360
g9
sS'potentiated,by,the'
p29361
g9
sS'however,at,that'
p29362
g3
sS'challenge,either,accidental'
p29363
g3
sS'the,treatment,is'
p29364
g3
sS'and,or,other'
p29365
g9
sS'or,may,result'
p29366
g9
sS'dosing,by,hours'
p29367
g3
sS'studies,the,consequences'
p29368
g3
sS'of,male,subjects'
p29369
g9
sS'increased,systematically,between'
p29370
g3
sS'to,low,serum'
p29371
g3
sS'plasma,clearance,and'
p29372
g3
sS'of,was,studied'
p29373
g3
sS'the,other,agent'
p29374
g3
sS'of,cmi,has'
p29375
g9
sS'the,recommendation,to'
p29376
g3
sS'lower,concentrations,only'
p29377
g3
sS'q-t,interval,may'
p29378
g3
sS'values,being,reached'
p29379
g3
sS'elevation,in,gastric'
p29380
g9
sS'antimuscarinic,effects,of'
p29381
g3
sS'mg,kg,ml'
p29382
g3
sS'media,experienced,acute'
p29383
g9
sS'clinical,trials,have'
p29384
g3
sS'be,considered,during'
p29385
g9
sS'pathway,that,is'
p29386
g3
sS'patients,demonstrated,no'
p29387
g3
sS'mg,kg,mg'
p29388
g3
sS'active,sulfide,metabolite'
p29389
g9
sS'opioid-dependent,patients,mixed'
p29390
g3
sS'addition,of,in'
p29391
g3
sS'as,and,in'
p29392
g3
sS'receiving,prinivil,an'
p29393
g9
sS'predominantly,in,the'
p29394
g9
sS'the,mean,minimum'
p29395
g3
sS'in,a,less'
p29396
g3
sS'and,renal,calculi'
p29397
g3
sS'aminotransferase,sgot,s-ast'
p29398
g3
sS'effect,on,platelet'
p29399
g9
sS'these,differences,are'
p29400
g3
sS'have,a,negative'
p29401
g3
sS'palliates,deficiencies,by'
p29402
g3
sS'therapy,discontinuation,of'
p29403
g9
sS'other,inhibitors,of'
p29404
g9
sS'revealed,no,evidence'
p29405
g3
sS'that,exposure,of'
p29406
g9
sS'in,how,it'
p29407
g3
sS'interaction,on,the'
p29408
g9
sS'been,prescribed,foradil'
p29409
g3
sS'the,desired,lactulose-induced'
p29410
g9
sS'is,dealt,with'
p29411
g3
sS'before,or,after'
p29412
g9
sS'pressure,strattera,should'
p29413
g3
sS'reduced,the,plasma'
p29414
g9
sS'the,neutrophil,count'
p29415
g3
sS'another,hmg-coa,reductase'
p29416
g9
sS'intake,of,and'
p29417
g9
sS'or,hours,before'
p29418
g9
sS'in,men,years'
p29419
g3
sS'within14,days,following'
p29420
g9
sS'undertaken,with,caution'
p29421
g9
sS'day,n,compared'
p29422
g9
sS'coadministered,with,used'
p29423
g3
sS'considered,and,the'
p29424
g9
sS'but,ki,values'
p29425
g3
sS'duration,of,sleep'
p29426
g3
sS'agonists,within,hours'
p29427
g9
sS'trials,of,interactions'
p29428
g3
sS'maleate,or,mao-inhibitors'
p29429
g9
sS'of,on,natriuresis'
p29430
g9
sS'it,is,probable'
p29431
g3
sS'therefore,the,simultaneous'
p29432
g3
sS'of,taxol,until'
p29433
g3
sS'concentrations,of,when'
p29434
g3
sS'with,c-cholesteryl,oleate'
p29435
g3
sS'decreased,fi,and'
p29436
g3
sS'methods,should,not'
p29437
g3
sS'studies,however,have'
p29438
g3
sS'is,indicated,they'
p29439
g3
sS'solid,phase,extraction'
p29440
g3
sS'choice,of,as'
p29441
g3
sS'a,starting,daily'
p29442
g3
sS'cmax,of,ranging'
p29443
g9
sS'creatinine,values,by'
p29444
g3
sS'extensive,cyp2d6,metabolizers'
p29445
g3
sS'one,treated,at'
p29446
g3
sS'addicts,in,areas'
p29447
g3
sS'induce,cyp,a4'
p29448
g9
sS'chop,patients,was'
p29449
g3
sS'dissolution,until,reaching'
p29450
g3
sS'as,low,as'
p29451
g3
sS'mg,kg,enhanced'
p29452
g9
sS'accumulation,of,exposure'
p29453
g3
sS'with,epilepsy,ingesting'
p29454
g3
sS'single,doses,or'
p29455
g3
sS'octapeptide,is,a'
p29456
g3
sS'from,a,control'
p29457
g9
sS'consumption,of,during'
p29458
g9
sS'chylomicron,intravascular,catabolism'
p29459
g3
sS'not,show,clinically'
p29460
g3
sS'reduced,the,bioavailability'
p29461
g9
sS'single,doses,of'
p29462
g9
sS'systemic,exposure,auc'
p29463
g9
sS'or,effect,of'
p29464
g9
sS'studies,document,no'
p29465
g3
sS'contents,and,transits'
p29466
g3
sS'administration,of,that'
p29467
g3
sS'is,currently,little'
p29468
g3
sS'enzyme,system,leading'
p29469
g3
sS'can,in,rare'
p29470
g3
sS'diffusible,treatment,during'
p29471
g3
sS'primary,form,unless'
p29472
g3
sS'calcium-entry,blocking,agents'
p29473
g3
sS'that,krm-1648,has'
p29474
g3
sS'from,an,solution'
p29475
g3
sS'to,inter-patient,variation'
p29476
g9
sS'with,hemodynamic,compromise'
p29477
g9
sS'potentially,arise,from'
p29478
g9
sS'and,hepatic,tissues'
p29479
g9
sS'the,formation,of'
p29480
g3
sS'cyp2d6,the,need'
p29481
g3
sS'and,mortality,were'
p29482
g3
sS'experience,bleeding,events'
p29483
g9
sS'of,dosage,are'
p29484
g9
sS'expected,that,the'
p29485
g9
sS'state,plasma,concentrations'
p29486
g3
sS'qt,interval,observed'
p29487
g9
sS'apparently,by,increased'
p29488
g3
sS'involving,nizoral,tablets'
p29489
g9
sS'fluoxetine,does,not'
p29490
g3
sS'either,mask,or'
p29491
g3
sS'co-administered,dose,level'
p29492
g3
sS'where,serious,ventricular'
p29493
g3
sS'causing,an,approximately'
p29494
g9
sS'relative,to,published'
p29495
g3
sS'were,inconclusive,with'
p29496
g3
sS'sodium,absorption,the'
p29497
g9
sS'day,of,each'
p29498
g3
sS'was,given,with'
p29499
g9
sS'tricyclic,thereby,delaying'
p29500
g9
sS'patient,slow,alterations'
p29501
g3
sS'also,results,in'
p29502
g3
sS'and,post-implantation,loss'
p29503
g3
sS'krm-1648,either,singly'
p29504
g3
sS'clinically,relevant,alterations'
p29505
g3
sS'renal,secretion,via'
p29506
g3
sS'three,lines,divergently'
p29507
g3
sS'induction,of,cytochrome'
p29508
g3
sS'diarrhea,hypotension,edema'
p29509
g3
sS'two,regimens,was'
p29510
g3
sS'should,practice,additional'
p29511
g3
sS'phlebitis,cellulitis,induration'
p29512
g3
sS'from,twitch,to'
p29513
g9
sS'affected,during,multiple-dose'
p29514
g3
sS'insufficiency,hyperbilirubinemia,confusion'
p29515
g9
sS'subjects,receiving,no'
p29516
g3
sS'substrate,by,on'
p29517
g9
sS'add,some,further'
p29518
g9
sS'and,treatment,ataxia'
p29519
g3
sS'a,substantial,number'
p29520
g9
sS'from,to,ng'
p29521
g9
sS'required,to,prevent'
p29522
g9
sS'p450,c9,decreased'
p29523
g9
sS'concentrations,as,high'
p29524
g3
sS'trials,and,were'
p29525
g3
sS'to,infusions,of'
p29526
g9
sS'particular,and,dna-damaging'
p29527
g3
sS'and,pre-sacral,vertebrae'
p29528
g3
sS'site,of,the'
p29529
g3
sS'c,and,cmin'
p29530
g9
sS'his,death,from'
p29531
g3
sS'concurrent,and,sodium'
p29532
g9
sS'were,unaffected,given'
p29533
g9
sS'continued,to,receive'
p29534
g3
sS'of,of,mg'
p29535
g3
sS'and,dosage,should'
p29536
g9
sS'cautious,when,administering'
p29537
g9
sS'or,with,cancidas'
p29538
g9
sS'between,use,of'
p29539
g9
sS'treatment,in,a'
p29540
g3
sS'more,than,two'
p29541
g9
sS'as,ophthalmic,and'
p29542
g9
sS'not,reported,l-histidine'
p29543
g9
sS'to,avoid,potentiation'
p29544
g3
sS'period,after,dosing'
p29545
g3
sS'female,dog,treated'
p29546
g3
sS'steady-state,peak,serum'
p29547
g9
sS'increases,of,modest'
p29548
g3
sS'components,of,the'
p29549
g3
sS'activity,at,similar'
p29550
g3
sS'membranes,and,that'
p29551
g3
sS'and,para-aminobenzoic,acid'
p29552
g9
sS'd,agonists,within'
p29553
g9
sS'can,be,expected'
p29554
g3
sS'assay,in,human'
p29555
g3
sS'and,rhabdomyolysis,particularly'
p29556
g3
sS'days,following,days'
p29557
g3
sS'myopathy,by,reducing'
p29558
g3
sS'precedex,a,reduction'
p29559
g9
sS'simple,and,reliable'
p29560
g3
sS'general,antianxiety,and'
p29561
g3
sS'and,were,coadministered'
p29562
g9
sS'acarbose,has,been'
p29563
g9
sS'although,this,effect'
p29564
g9
sS'of,potent,inducer'
p29565
g9
sS'similar,median,follow-up'
p29566
g3
sS'of,subutex,or'
p29567
g3
sS'approximate,doubling,in'
p29568
g9
sS'drug-lab,interactions,implications'
p29569
g3
sS'shbg,leading,to'
p29570
g3
sS'based,on,body'
p29571
g3
sS'alter,the,serum'
p29572
g3
sS'blocker,and,a'
p29573
g9
sS'should,be,reassessed'
p29574
g3
sS'secretion,may,increase'
p29575
g3
sS'the,determination,of'
p29576
g3
sS'theraputic,agents,have'
p29577
g3
sS'aureus,diplococcus,pneumoniae'
p29578
g3
sS'monitored,at,the'
p29579
g9
sS'sular,tablets,in'
p29580
g9
sS'therapy,a,decrease'
p29581
g9
sS'toxicity,since,it'
p29582
g3
sS'lead,to,hypotension'
p29583
g9
sS'evoked,potentials,in'
p29584
g3
sS'in,the,present'
p29585
g3
sS'because,nafarelin,acetate'
p29586
g3
sS'to,elevated,serum'
p29587
g9
sS'supersensitive,to,compared'
p29588
g9
sS'usual,dose,with'
p29589
g3
sS'with,and,interfere'
p29590
g9
sS'examine,interactions,have'
p29591
g3
sS'inhibited,by,several'
p29592
g9
sS'short-acting,adrenergic,stimulant'
p29593
g3
sS'of,tubular,organic'
p29594
g9
sS'and,or,impairing'
p29595
g9
sS'blood,concentration,c12hr'
p29596
g9
sS'pregnancies,conceived,while'
p29597
g3
sS'of,oral,platelet'
p29598
g3
sS'affected,the,proliferation'
p29599
g9
sS'dipivoxil,or,tenofovir'
p29600
g3
sS'imipramine,hydrochloride,may'
p29601
g9
sS'antiarrhythmics,amiodarone,contraindicated'
p29602
g3
sS'reduced,to,prevent'
p29603
g9
sS'to,replicate,this'
p29604
g3
sS'of,renal,tubular'
p29605
g9
sS'significant,effect,of'
p29606
g3
sS'other,pharmacokinetics,parameters'
p29607
g9
sS'which,are,vasoconstrictive'
p29608
g9
sS'fungal,infections,because'
p29609
g3
sS'sensitive,and,inhibited'
p29610
g3
sS'true,decrease,in'
p29611
g3
sS'm2,given,as'
p29612
g9
sS'degrees,of,heart'
p29613
g9
sS'hivid,with,is'
p29614
g9
sS'elevations,in,serum'
p29615
g9
sS'mg,dose,had'
p29616
g3
sS'of,are,not'
p29617
g3
sS'system,when,administered'
p29618
g9
sS'of,absorption,after'
p29619
g3
sS'in,which,healthy'
p29620
g9
sS'with,early-phase,schizophrenia'
p29621
g3
sS'ht3,antagonists,in'
p29622
g3
sS'that,included,brovana'
p29623
g3
sS'the,same,in'
p29624
g3
sS'of,pra,induced'
p29625
g3
sS'rare,cases,of'
p29626
g3
sS'was,not,altered'
p29627
g3
sS'substances,that,are'
p29628
g3
sS'antacids,on,felbatol'
p29629
g3
sS'that,are,applicable'
p29630
g3
sS'may,cause,hypermagnesemia'
p29631
g9
sS'depressants,causing,increased'
p29632
g9
sS'peripheral,vasoconstriction,caused'
p29633
g9
sS'to,both,increase'
p29634
g9
sS'is,a,peptide'
p29635
g3
sS'bezalip,or,bezalip'
p29636
g9
sS'preparations,sunscreens,and'
p29637
g9
sS'd3,and,tam'
p29638
g9
sS'which,is,further'
p29639
g3
sS'volume,depletion,may'
p29640
g9
sS'volunteers,show,that'
p29641
g3
sS'serum,constituent,precipitated'
p29642
g3
sS'effect,on,metabolism'
p29643
g3
sS'does,not,influence'
p29644
g3
sS'blocking,agent,plus'
p29645
g3
sS'avoid,administration,of'
p29646
g3
sS'cns,and,genitourinary'
p29647
g3
sS'necessary,to,continue'
p29648
g9
sS'an,interaction,of'
p29649
g3
sS'used,as,alternatives'
p29650
g9
sS'with,other,or'
p29651
g9
sS'defense,may,help'
p29652
g3
sS'or,interaction,study'
p29653
g3
sS'explained,by,a'
p29654
g9
sS'amounts,may,counteract'
p29655
g9
sS'the,in,the'
p29656
g3
sS'recommendations,are,based'
p29657
g3
sS'hypothyroidism,may,interfere'
p29658
g3
sS'blockers,and,should'
p29659
g9
sS'recommended,when,administered'
p29660
g9
sS'giving,these,together'
p29661
g3
sS'by,increased,susceptibility'
p29662
g3
sS'time,to,onset'
p29663
g9
sS'release,by,platelets'
p29664
g3
sS'approach,to,the'
p29665
g3
sS'influence,of,and'
p29666
g3
sS'when,administered,neonatally'
p29667
g3
sS'to,identify,the'
p29668
g3
sS'of,the,coumarin'
p29669
g3
sS'peganone,used,in'
p29670
g3
sS'well,as,normal'
p29671
g3
sS'no,information,is'
p29672
g3
sS'were,determined,after'
p29673
g3
sS'bacteria,by,serial'
p29674
g3
sS'expected,to,have'
p29675
g3
sS'lower,in,the'
p29676
g3
sS'must,be,directed'
p29677
g9
sS'bleeding,shortly,after'
p29678
g3
sS'this,indicates,that'
p29679
g3
sS'and,cautioned,that'
p29680
g3
sS'are,receiving,high'
p29681
g9
sS'day,of,the'
p29682
g3
sS'study,with,administration'
p29683
g3
sS'mg,of,acetate'
p29684
g3
sS'prothrombin,time,at'
p29685
g3
sS'of,during,the'
p29686
g3
sS'shown,that,nsaids'
p29687
g9
sS'contraction,was,decreased'
p29688
g3
sS'in,elimination,half-life'
p29689
g9
sS'pneumocystis,carinii,pneumonia'
p29690
g9
sS'other,substances,including'
p29691
g3
sS'of,level,however'
p29692
g9
sS'had,a,similar'
p29693
g3
sS'sometimes,been,observed'
p29694
g3
sS'been,seen,as'
p29695
g9
sS'camptosar,than,when'
p29696
g9
sS'and,hivid,has'
p29697
g9
sS'increased,by,qtc'
p29698
g3
sS'proteins,the,following'
p29699
g9
sS'symptomatic,pharmaceutical,treatment'
p29700
g3
sS'with,physicians,should'
p29701
g3
sS'compliance,and,efficacy'
p29702
g3
sS'to,achieve,mac'
p29703
g9
sS'vasoconstrictor,but,the'
p29704
g3
sS'uptake,and,or'
p29705
g9
sS'of,a,interaction'
p29706
g3
sS'interpretation,of,t4'
p29707
g3
sS'scintigraphic,results,that'
p29708
g3
sS'concentrations,observed,with'
p29709
g3
sS'lotensin,was,administered'
p29710
g3
sS'other,that,may'
p29711
g3
sS'molecule,thereby,decreasing'
p29712
g9
sS'monitoring,of,blood'
p29713
g3
sS'a,conservative,approach'
p29714
g3
sS'regarding,the,coadministration'
p29715
g3
sS'of,about,mm'
p29716
g9
sS'grepafloxacin,is,a'
p29717
g9
sS'changing,therapy,with'
p29718
g9
sS'or,parenteral,enzyme'
p29719
g3
sS'does,not,exhibit'
p29720
g9
sS'with,itraconazole,has'
p29721
g9
sS'concentrations,in,patients'
p29722
g9
sS'consequences,hunger,can'
p29723
g3
sS'be,potentiated,by'
p29724
g9
sS'of,p450,d6'
p29725
g3
sS'mg,of,had'
p29726
g9
sS'qtc,interval,were'
p29727
g3
sS'a,false-positive,urine'
p29728
g3
sS'when,combining,with'
p29729
g3
sS'synergism,was,observed'
p29730
g9
sS'vitro,studies,and'
p29731
g9
sS'accelerated,prothrombin,time'
p29732
g3
sS'been,used,in'
p29733
g3
sS'eg,may,result'
p29734
g9
sS'improved,and,the'
p29735
g3
sS'observations,strongly,suggest'
p29736
g3
sS'a,dose,increase'
p29737
g9
sS'of,sleep,time'
p29738
g3
sS'no,change,after'
p29739
g3
sS'or,in,metabolite'
p29740
g3
sS'animal,studies,suggest'
p29741
g9
sS'levels,shown,by'
p29742
g3
sS'toxicity,of,edetate'
p29743
g9
sS'loss,of,control'
p29744
g3
sS'at,concentrations,of'
p29745
g3
sS'clearance,is,not'
p29746
g3
sS'will,be,required'
p29747
g3
sS'of,grapefruit,juice'
p29748
g3
sS'many,are,excreted'
p29749
g3
sS'volunteers,there,were'
p29750
g3
sS'paclitaxel,in,one'
p29751
g9
sS'these,agents,have'
p29752
g9
sS'that,inhibit,these'
p29753
g3
sS'these,preparations,have'
p29754
g3
sS'organ,transplant,patients'
p29755
g9
sS'in,the,vehicle-controlled'
p29756
g3
sS'following,single,dose'
p29757
g3
sS'only,block,the'
p29758
g9
sS'when,administering,celebrex'
p29759
g9
sS'to,patients,who'
p29760
g9
sS'a,series,of'
p29761
g3
sS'at,concentrations,ranging'
p29762
g3
sS'results,blood,samples'
p29763
g3
sS'approximately,fold,than'
p29764
g3
sS'the,reservoir,function'
p29765
g3
sS'enzymes,carbamazepine,is'
p29766
g3
sS'the,interaction,can'
p29767
g3
sS'for,these,purposes'
p29768
g3
sS'study,was,conducted'
p29769
g3
sS'maximizing,benefit,while'
p29770
g3
sS'along,with,another'
p29771
g3
sS'of,factors,such'
p29772
g3
sS'chick,embryos,similarly'
p29773
g3
sS'volume,fewer,interactions'
p29774
g3
sS'immediately,beginning,depletion'
p29775
g9
sS'may,be,more'
p29776
g3
sS'of,hydrochloride,x'
p29777
g9
sS'patients,taking,lexapro'
p29778
g9
sS'neuromuscular,block,induced'
p29779
g9
sS'prolong,ecg,intervals'
p29780
g3
sS'on,interactions,with'
p29781
g3
sS'occurred,three,months'
p29782
g3
sS'at,least,one'
p29783
g3
sS'coenzyme,a,atp'
p29784
g3
sS'alternatively,provide,medical'
p29785
g3
sS'atomoxetine,is,primarily'
p29786
g3
sS'at,the,time'
p29787
g3
sS'theophylline,ethinyl,estradiol'
p29788
g9
sS'neonatally,to,mice'
p29789
g3
sS'only,about,bound'
p29790
g3
sS'a,mg,controlled-release'
p29791
g9
sS'by,a,single'
p29792
g9
sS'the,transfusion,practices'
p29793
g3
sS'transaminase,levels,should'
p29794
g3
sS'enterocolitis,diarrhea,and'
p29795
g9
sS'extent,enhanced,the'
p29796
g3
sS'p450,enzymes,may'
p29797
g3
sS'on,therapy,may'
p29798
g9
sS'from,the,combination'
p29799
g3
sS'known,photosensitizing,agents'
p29800
g9
sS'with,a,single'
p29801
g3
sS'qid,n,the'
p29802
g9
sS'of,mg,in'
p29803
g9
sS'the,r,and'
p29804
g3
sS'an,oral,has'
p29805
g9
sS'preparations,increases,the'
p29806
g3
sS'that,the,phosphohydrolase'
p29807
g3
sS'no,observed,effects'
p29808
g3
sS'study,without,co-administered'
p29809
g3
sS'blood,sugar,concentrations'
p29810
g9
sS'supplements,containing,vitamin'
p29811
g9
sS'is,significantly,bound'
p29812
g3
sS'initiation,of,combined'
p29813
g9
sS'in,nonfailing,myocardium'
p29814
g9
sS'itching,mouth,sores'
p29815
g3
sS'be,adjusted,when'
p29816
g3
sS'in,increasing,the'
p29817
g3
sS'acid,reactive,substances'
p29818
g3
sS'type-specific,differences,may'
p29819
g3
sS'therapy,in,patients'
p29820
g9
sS'result,from,displacement'
p29821
g3
sS'of,chronic,obstructive'
p29822
g3
sS'on,day,as'
p29823
g3
sS'not,an,inhibitor'
p29824
g3
sS'decrease,the,effects'
p29825
g9
sS'inhaled,with,no'
p29826
g3
sS'of,four,chemotherapeutic'
p29827
g3
sS'following,completion,of'
p29828
g3
sS'caused,no,systematic'
p29829
g3
sS'rate,cmax,and'
p29830
g9
sS'known,that,cyp1a2'
p29831
g9
sS'at,therapeutic,concentrations'
p29832
g3
sS'channel,blockers,and'
p29833
g9
sS'healthy,volunteers,exjade'
p29834
g3
sS'obtained,in,a'
p29835
g3
sS'is,a,consequence'
p29836
g9
sS'vivo,interaction,with'
p29837
g3
sS'individual,compounds,rather'
p29838
g3
sS'sympatholytic,medicinal,products'
p29839
g3
sS'the,reports,that'
p29840
g9
sS'and,other,cns'
p29841
g9
sS'a,site,of'
p29842
g3
sS'levels,with,the'
p29843
g9
sS'with,which,it'
p29844
g3
sS'patients,on,stable'
p29845
g3
sS'and,in,females'
p29846
g9
sS'tab,ria,kit'
p29847
g3
sS'used,in,conjunction'
p29848
g9
sS'to,healthy,men'
p29849
g3
sS'and,increased,the'
p29850
g9
sS'case,report,which'
p29851
g9
sS'from,single,doses'
p29852
g3
sS'the,tricyclic,antidepressant'
p29853
g3
sS'precedex,for,minutes'
p29854
g3
sS'cerebyx,were,concurrently'
p29855
g3
sS'agents,medicine,for'
p29856
g3
sS'coadministration,in,hiv-infected'
p29857
g3
sS'a,lower,pulmonary'
p29858
g9
sS'glands,was,monitored'
p29859
g3
sS'ventricular,arrhythmias,who'
p29860
g3
sS'valproic,acid,and'
p29861
g9
sS'monitored,to,ensure'
p29862
g9
sS'with,that,reduce'
p29863
g3
sS'serum,levels,carbamazepine'
p29864
g9
sS'drug,drug,interaction'
p29865
g3
sS'or,not,at'
p29866
g9
sS'the,test,period'
p29867
g9
sS'these,data,appeared'
p29868
g3
sS'twelve,healthy,male'
p29869
g3
sS'based,on,these'
p29870
g3
sS'therapeutic,interval,and'
p29871
g3
sS'the,additive,and'
p29872
g3
sS'lead,to,resulting'
p29873
g9
sS'psychomotor,performance,for'
p29874
g9
sS'their,potential,to'
p29875
g3
sS'or,not,an'
p29876
g3
sS'activation,and,that'
p29877
g3
sS'symptoms,should,be'
p29878
g3
sS'results,obtained,with'
p29879
g3
sS'trials,of,postoperative'
p29880
g3
sS'increases,enterohepatic,elimination'
p29881
g3
sS'second,pregnancy,test'
p29882
g3
sS'residues,abolishes,the'
p29883
g3
sS'spermine,promotes,the'
p29884
g3
sS'a,day,pretreatment'
p29885
g3
sS'of,and,significant'
p29886
g9
sS'influence,the,response'
p29887
g3
sS'with,serum,measurements'
p29888
g3
sS'mean,decreases,of'
p29889
g3
sS'exhibit,an,additive'
p29890
g9
sS'when,celebrex,is'
p29891
g9
sS'action,of,hypoglycemic'
p29892
g9
sS'patients,on,no'
p29893
g9
sS'between,clozapine,and'
p29894
g9
sS'lucidum,fr,karst'
p29895
g3
sS'has,importance,in'
p29896
g3
sS'renally,eliminated,or'
p29897
g3
sS'interactions,acetaminophen,may'
p29898
g3
sS'from,co-administration,of'
p29899
g9
sS'such,preparations,in'
p29900
g3
sS'diuretic,therapy,patients'
p29901
g9
sS'doses,of,trileptal'
p29902
g9
sS'estradiol,and,or'
p29903
g9
sS'of,and,no'
p29904
g3
sS'clearance,of,busulfex'
p29905
g9
sS'not,be,taken'
p29906
g9
sS'tightly,bound,like'
p29907
g3
sS'the,anticholinesterase,effect'
p29908
g9
sS'and,or,hypokalemia'
p29909
g9
sS'this,therapy,may'
p29910
g3
sS'interval,msec,was'
p29911
g9
sS'or,other,coadministered'
p29912
g3
sS'axert,within,hours'
p29913
g9
sS'group,resulted,in'
p29914
g9
sS'with,the,morning'
p29915
g3
sS'studies,coadministration,of'
p29916
g3
sS'same,procedures,were'
p29917
g3
sS'crystalline,preparations,novolog'
p29918
g3
sS'various,pesticides,this'
p29919
g3
sS'levels,was,seen'
p29920
g9
sS'or,no,increase'
p29921
g9
sS'values,of,both'
p29922
g9
sS'fumarate,capsules,with'
p29923
g3
sS'of,in,the'
p29924
g3
sS'homozygous,for,the'
p29925
g3
sS'of,several,interacting'
p29926
g3
sS'passages,increasing,the'
p29927
g9
sS'if,replacing,by'
p29928
g9
sS'oral,and,as'
p29929
g3
sS'samples,does,not'
p29930
g3
sS'patients,receiving,or'
p29931
g9
sS'leading,to,unique'
p29932
g3
sS'the,peak,levels'
p29933
g3
sS'with,the,activity'
p29934
g3
sS'or,with,containing'
p29935
g9
sS'received,one,or'
p29936
g3
sS'not,inhibit,cyp2d6'
p29937
g3
sS'appeared,to,alter'
p29938
g9
sS'that,incidence,of'
p29939
g3
sS'result,in,serious'
p29940
g3
sS'studies,were,not'
p29941
g3
sS'had,opioid-antagonist,and'
p29942
g3
sS'be,used,to'
p29943
g3
sS'interactions,cephalosporins,are'
p29944
g3
sS'normally,to,but'
p29945
g3
sS'laboratory,parameters,should'
p29946
g3
sS'exert,direct,effects'
p29947
g3
sS'interactions,might,be'
p29948
g3
sS'pretreatment,did,not'
p29949
g3
sS'dose,should,be'
p29950
g9
sS'reducing,the,plasma'
p29951
g9
sS'with,the,ace'
p29952
g9
sS'and,and,which'
p29953
g3
sS'potent,of,glucocorticoid-induced'
p29954
g3
sS'the,pressor,response'
p29955
g9
sS'can,avoid,iatrogenic'
p29956
g9
sS'myocardium,in,functional'
p29957
g3
sS'dose,to,approximately'
p29958
g9
sS'human,serum,at'
p29959
g3
sS'type,c,antiarrhythrnics'
p29960
g3
sS'most,instances,synergism'
p29961
g9
sS'the,sst,and'
p29962
g3
sS'plasma,concentrations,observed'
p29963
g3
sS'supplements,should,be'
p29964
g3
sS'beta,blockers,although'
p29965
g9
sS'reductase,inhibitors,that'
p29966
g9
sS'in,vitro,effect'
p29967
g3
sS'other,that,increase'
p29968
g3
sS'metabolized,drugs,results'
p29969
g3
sS'especially,and,have'
p29970
g3
sS'celecoxib,metabolism,is'
p29971
g3
sS'subjects,had,treatment-emergent'
p29972
g3
sS'which,ssri-tcainteractions,may'
p29973
g9
sS'and,a,supersensitivity'
p29974
g9
sS'the,cns,effects'
p29975
g9
sS'tubular,secretion,has'
p29976
g9
sS'clearance,in,patients'
p29977
g9
sS'and,require,that'
p29978
g9
sS'either,poor,patient'
p29979
g3
sS'that,have,one'
p29980
g3
sS'or,kcl,mmol'
p29981
g3
sS'oh,d3,exhibit'
p29982
g3
sS'ontario,the,mortality'
p29983
g3
sS'gastrointestinal,transit,time'
p29984
g9
sS'be,coad-ministered,with'
p29985
g3
sS'responsive,to,a'
p29986
g3
sS'pegasys,alone,or'
p29987
g3
sS'of,the,above'
p29988
g9
sS'to,other,general'
p29989
g9
sS'a,theoretical,basis'
p29990
g9
sS'such,as,operating'
p29991
g3
sS'after,treatment,there'
p29992
g3
sS'tested,by,determination'
p29993
g3
sS'disruptive,effects,of'
p29994
g9
sS'dose,co-administered,with'
p29995
g9
sS'was,decrease,of'
p29996
g3
sS'centers,of,the'
p29997
g3
sS'did,not,reveal'
p29998
g3
sS'for,in,subcortical'
p29999
g3
sS'to,its,three'
p30000
g3
sS'normal,value,one'
p30001
g3
sS'produce,excessive,reduction'
p30002
g9
sS'medicine,may,cause'
p30003
g9
sS'deficient,in,cyp2d6'
p30004
g3
sS'agent,metabolized,by'
p30005
g3
sS'is,also,known'
p30006
g3
sS'valdecoxib,did,not'
p30007
g3
sS'reaching,a,segment'
p30008
g3
sS'no,drug-drug,interaction'
p30009
g3
sS'two,hours,between'
p30010
g3
sS'recommended,that,not'
p30011
g9
sS'a,specific,method'
p30012
g3
sS'is,not,recommended'
p30013
g9
sS'kg,ml,sc'
p30014
g3
sS'study,of,healthy'
p30015
g3
sS'inspra,mg,with'
p30016
g9
sS'normal,subjects,than'
p30017
g3
sS'to,aid,sleep'
p30018
g3
sS'those,in,patients'
p30019
g3
sS'anti-inflammatory,drugs,has'
p30020
g9
sS'for,changes,in'
p30021
g3
sS'inhibition,in,platelet'
p30022
g3
sS'deaths,is,far'
p30023
g3
sS'half-life,may,be'
p30024
g9
sS'we,obtained,evidence'
p30025
g3
sS'increased,sgot,elevated'
p30026
g3
sS'in,bleeding,time'
p30027
g3
sS'g,ml,the'
p30028
g9
sS'n-diethyl,m-toluamide,a'
p30029
g9
sS'reported,to,enhance'
p30030
g9
sS'following,protease,inhibitors'
p30031
g3
sS'urinary,excretion,as'
p30032
g3
sS'and,sinus,medicines'
p30033
g9
sS'vitro,data,no'
p30034
g3
sS'serum,level,is'
p30035
g3
sS'drugs,decreasing,heparin'
p30036
g9
sS'up,to,days'
p30037
g9
sS'coingestion,of,with'
p30038
g9
sS'rheumatoid,arthritis,patients'
p30039
g3
sS'quinidine,coadministration,of'
p30040
g9
sS'mouth,and,transient'
p30041
g3
sS'such,cases,should'
p30042
g3
sS'and,cyp3a4,substrate'
p30043
g3
sS'bolus,injections,of'
p30044
g3
sS'groups,then,took'
p30045
g3
sS'hyperglycemia,and,may'
p30046
g3
sS'others,may,inhibit'
p30047
g3
sS'tablets,should,be'
p30048
g3
sS'when,coumarin,anticoagulants'
p30049
g9
sS'hyperglycaemic,clamps,mmol'
p30050
g3
sS'to,discriminate,between'
p30051
g3
sS'vasculopathy,and,ultimately'
p30052
g3
sS'vascular,or,urinary'
p30053
g3
sS'used,general,and'
p30054
g3
sS'for,clinical,use'
p30055
g3
sS'ketamine,marked,hypertension'
p30056
g9
sS'of,childbearing,potential'
p30057
g3
sS'were,no,signs'
p30058
g9
sS'candesartan,cilexetil,given'
p30059
g3
sS'when,vardenafil,dosing'
p30060
g9
sS'mofetil,ml,h'
p30061
g3
sS'x,m,enhance'
p30062
g9
sS'exposure,and,may'
p30063
g3
sS'that,levels,be'
p30064
g9
sS'their,effect,on'
p30065
g3
sS'malignant,disease,in'
p30066
g3
sS'malignant,hyperpyrexia,can'
p30067
g3
sS'volunteers,exjade,had'
p30068
g3
sS'alone,and,ng'
p30069
g9
sS'well,as,a'
p30070
g9
sS'concomitant,administration,may'
p30071
g9
sS'tool,for,establishing'
p30072
g3
sS'gammaherpes,virus,also'
p30073
g3
sS'subtype,in,the'
p30074
g3
sS'be,premedicated,with'
p30075
g3
sS'essential,close,monitoring'
p30076
g3
sS'minimum,alveolar,concentration'
p30077
g9
sS'cefditoren,with,a'
p30078
g9
sS'of,each,to'
p30079
g9
sS'coadministered,with,sustiva'
p30080
g3
sS'assessments,of,pt'
p30081
g3
sS'bound,to,protein'
p30082
g9
sS'initiating,tcatreatment,in'
p30083
g9
sS'inrifabutin,exposure,and'
p30084
g3
sS'be,improved,and'
p30085
g3
sS'the,combination,is'
p30086
g9
sS'cardiovascular,effects,such'
p30087
g3
sS'the,morning,dose'
p30088
g3
sS'interaction,studies,demonstrate'
p30089
g3
sS'to,baseline,values'
p30090
g9
sS'and,or,frequency'
p30091
g9
sS'respectively,were,added'
p30092
g9
sS'of,sulfoxide,were'
p30093
g9
sS'decreased,when,are'
p30094
g9
sS'of,involvement,labeling'
p30095
g3
sS'these,changes,were'
p30096
g3
sS'be,helpful,when'
p30097
g3
sS'the,concentration,of'
p30098
g9
sS'alfa-2a,for,months'
p30099
g3
sS'cardiovasculars,cardiac,glycosides'
p30100
g3
sS'predominant,sterol,in'
p30101
g3
sS'enzymes,and,the'
p30102
g3
sS'clinical,significance,the'
p30103
g3
sS'in,the,mesenteric'
p30104
g3
sS'did,not,display'
p30105
g3
sS'concentrations,well,above'
p30106
g3
sS'to,treat,pneumocystis'
p30107
g9
sS'dose,will,need'
p30108
g9
sS'leading,to,increases'
p30109
g3
sS'subjects,with,normal'
p30110
g3
sS'clostridium,were,inhibited'
p30111
g3
sS'to,humans,is'
p30112
g3
sS'and,of,innovar'
p30113
g3
sS'plasma,half-life,of'
p30114
g3
sS'antigout,medications,may'
p30115
g3
sS'pharmacokinetics,of,were'
p30116
g3
sS'not,posing,a'
p30117
g3
sS'flow,or,enzyme'
p30118
g3
sS'type,strain,of'
p30119
g3
sS'agents,possible,increased'
p30120
g3
sS'systemic,exposure,for'
p30121
g3
sS'therefore,the,efficacy'
p30122
g9
sS'acids,may,interfere'
p30123
g3
sS'before,taking,any'
p30124
g3
sS'is,extensively,metabolized'
p30125
g3
sS'inhibition,of,prostaglandin'
p30126
g9
sS'by,aom,and'
p30127
g3
sS'infections,was,observed'
p30128
g9
sS'of,which,can'
p30129
g9
sS'less,than,two-fold'
p30130
g9
sS'last,subcutaneous,dose'
p30131
g9
sS'changes,in,glucose'
p30132
g9
sS'that,indocin,does'
p30133
g3
sS'tests,be,performed'
p30134
g3
sS'risk,of,convulsions'
p30135
g3
sS'interacts,with,any'
p30136
g3
sS'up,to,and'
p30137
g9
sS'of,from,plasma'
p30138
g9
sS'newborns,whose,mothers'
p30139
g3
sS'an,agent,that'
p30140
g3
sS'strong,drying,effect'
p30141
g3
sS'antihypertensive,effect,in'
p30142
g9
sS'and,quinolones,form'
p30143
g3
sS'warfarin,quinolones,have'
p30144
g9
sS'p450,a2,cyp1a2'
p30145
g3
sS'approval,by,the'
p30146
g3
sS'minimized,by,either'
p30147
g9
sS'pharmacokinetic,parameters,affected'
p30148
g3
sS'if,is,co-administered'
p30149
g9
sS'to,depress,prolactin'
p30150
g3
sS'judgment,of,the'
p30151
g9
sS'produce,additive,cns'
p30152
g9
sS'of,clinical,vancomycin-resistant'
p30153
g3
sS'the,therapeutic,and'
p30154
g3
sS'states,associated,with'
p30155
g3
sS'confidence,limit,decrease'
p30156
g3
sS'the,frontal,cortex'
p30157
g3
sS'the,antimicrobial,combinations'
p30158
g9
sS'disease,in,which'
p30159
g3
sS'considered,by,age'
p30160
g3
sS'in,adverse,effects'
p30161
g3
sS'non-ionized,species,of'
p30162
g9
sS'to,about,one-third'
p30163
g9
sS'in,a,similar'
p30164
g9
sS'high,doses,or'
p30165
g3
sS'agents,concurrent,use'
p30166
g9
sS'had,not,recovered'
p30167
g3
sS'general,significant,interactions'
p30168
g3
sS'in,seven,experiments'
p30169
g3
sS'known,cytochrome,cyp'
p30170
g3
sS'of,some,and'
p30171
g9
sS'high,doses,of'
p30172
g9
sS'system,depressants,such'
p30173
g9
sS'with,divalent,or'
p30174
g3
sS'effects,of,romazicon'
p30175
g3
sS'of,cancidas,mg'
p30176
g9
sS'for,loss,of'
p30177
g3
sS'that,is,known'
p30178
g3
sS'd1,receptors,are'
p30179
g3
sS'additional,pharmacokinetic,studies'
p30180
g3
sS'eg,other,general'
p30181
g9
sS'such,concomitant,use'
p30182
g3
sS'interactions,thiazides,should'
p30183
g3
sS'change,in,pharmacological'
p30184
g9
sS'potassium,sparing,agents'
p30185
g3
sS'may,emerge,with'
p30186
g9
sS'clinical,significance,of'
p30187
g3
sS'ermbt,and,and'
p30188
g3
sS'potential,must,have'
p30189
g3
sS'demonstrated,similar,efficacy'
p30190
g3
sS'are,also,blocked'
p30191
g9
sS'clinical,significance,on'
p30192
g9
sS'with,increases,serum'
p30193
g3
sS'with,have,identified'
p30194
g9
sS'contraception,inwomen,taking'
p30195
g9
sS'but,in,a'
p30196
g3
sS'human,subjects,ingesting'
p30197
g9
sS'with,close,monitoring'
p30198
g9
sS'cyclosporine,l-arginine,may'
p30199
g9
sS'were,obtained,from'
p30200
g3
sS'monoamine,oxidase,inhibiting'
p30201
g9
sS'interval,prolongation,ischemic'
p30202
g9
sS'serum,concentration,that'
p30203
g3
sS'was,administered,together'
p30204
g3
sS'isoenzymes,cyp2c9,cyp2d6'
p30205
g3
sS'study,in,patients'
p30206
g3
sS'of,human,response'
p30207
g3
sS'of,blood,can'
p30208
g3
sS'there,has,been'
p30209
g3
sS'interactions,between,argatroban'
p30210
g3
sS'plasma,levels,increased'
p30211
g9
sS'with,were,not'
p30212
g9
sS'and,axert,within'
p30213
g9
sS'have,a,statistically'
p30214
g3
sS'its,nephrotoxicity,may'
p30215
g9
sS'activity,can,occur'
p30216
g9
sS'in,patients,experiencing'
p30217
g3
sS'given,hour,prior'
p30218
g9
sS'intestinal,cancers,it'
p30219
g3
sS'possibly,other,macrolide'
p30220
g9
sS'function,will,increase'
p30221
g3
sS'in,the,united'
p30222
g3
sS'decrease,of,nucleolin'
p30223
g3
sS'selection,of,and'
p30224
g3
sS'aerosol,particles,of'
p30225
g3
sS'pruritus,rash,diarrhea'
p30226
g3
sS'short-acting,because,the'
p30227
g9
sS'with,neoplastic,disease'
p30228
g9
sS'surface,area,basis'
p30229
g3
sS'to,the,added'
p30230
g3
sS'mammary,gland,in'
p30231
g3
sS'of,myelotoxicity,it'
p30232
g3
sS'renal,calculi,the'
p30233
g3
sS'such,are,administered'
p30234
g3
sS'severe,in,the'
p30235
g3
sS'has,been,implicated'
p30236
g9
sS'liver,blood,flow'
p30237
g3
sS'eia,test,have'
p30238
g3
sS'were,thus,dosed'
p30239
g3
sS'nafazodone,consider,xanax'
p30240
g9
sS'vitro,studies,translates'
p30241
g3
sS'antiedematous,action,of'
p30242
g9
sS'location,histologic,type'
p30243
g3
sS'reverse,the,pressor'
p30244
g9
sS'the,interindividual,pharmacokinetic'
p30245
g3
sS'viable,counts,for'
p30246
g3
sS'performance,liquid,chromatographic'
p30247
g3
sS'and,some,gram-positive'
p30248
g3
sS'cells,that,were'
p30249
g9
sS'to,increased,total'
p30250
g3
sS'with,chop,chemotherapy'
p30251
g3
sS'of,time,may'
p30252
g3
sS'concentrations,and,significant'
p30253
g9
sS'under,the,curve'
p30254
g9
sS'bioavailability,of,by'
p30255
g9
sS'completely,evaluated,to'
p30256
g3
sS'medications,for,the'
p30257
g3
sS'levels,is,likely'
p30258
g9
sS'susceptibility,to,hypoglycemia'
p30259
g3
sS'cannulation,decreased,along'
p30260
g3
sS'given,doses,of'
p30261
g3
sS'caspofungin,acetate,is'
p30262
g3
sS'regimens,may,have'
p30263
g3
sS'sulphydryl-containing,amino,acid'
p30264
g3
sS'no,effects,on'
p30265
g3
sS'allium,sativum,and'
p30266
g9
sS'h2antagonists,reduced,plasma'
p30267
g9
sS'retinyl,acetate,stimulated'
p30268
g9
sS'examined,the,effect'
p30269
g3
sS'mean,c,max'
p30270
g3
sS'and,antiparkinsonian,agents'
p30271
g9
sS'diabetics,who,take'
p30272
g3
sS'to,produce,additive'
p30273
g9
sS'and,for,mec'
p30274
g3
sS'in,any,intentional'
p30275
g9
sS'in,which,it'
p30276
g3
sS'serum,total,concentrations'
p30277
g3
sS'a,control,program'
p30278
g3
sS'longitudinal,stability,in'
p30279
g3
sS'classes,of,listed'
p30280
g3
sS'primarily,cyp3a4,cyp2d6'
p30281
g3
sS'and,the,intracellular'
p30282
g3
sS'capable,of,producing'
p30283
g3
sS'ensure,that,a'
p30284
g9
sS'patients,beginning,therapy'
p30285
g9
sS'pharmacokinetic-related,interactions,clozapine'
p30286
g3
sS'the,hour,observation'
p30287
g3
sS'limiting,may,be'
p30288
g3
sS'chronic,dosing,effects'
p30289
g3
sS'that,would,affect'
p30290
g3
sS'patients,in,parentheses'
p30291
g3
sS'blocking,agents,anesthetics'
p30292
g9
sS'regulation,of,topoisomerases'
p30293
g3
sS'and,mefloquine,should'
p30294
g3
sS'instead,of,mg'
p30295
g9
sS'maalox,maalox,reduced'
p30296
g9
sS'the,free,fraction'
p30297
g3
sS'severe,dry,mouth'
p30298
g9
sS'or,daily,alternating'
p30299
g3
sS'weekly,or,biweekly'
p30300
g3
sS'increases,in,the'
p30301
g3
sS'closely,monitored,during'
p30302
g9
sS'insulin,sulfonylureas,requirements'
p30303
g3
sS'of,cyp1a2,concomitant'
p30304
g9
sS'mechanism,may,be'
p30305
g9
sS'of,ovulation,but'
p30306
g3
sS'assay,of,serum'
p30307
g3
sS'or,nsaids,was'
p30308
g3
sS'theophylline,combined,administration'
p30309
g3
sS'studies,were,prohibited'
p30310
g3
sS'as,well,concurrent'
p30311
g9
sS'eliminated,by,conjugation'
p30312
g3
sS'with,mg,every'
p30313
g3
sS'fexofenadine,had,no'
p30314
g3
sS'oral,hypoglycemics,bepridil'
p30315
g3
sS'stupor,and,or'
p30316
g9
sS'nitrofurantoin,interferes,with'
p30317
g9
sS'relevant,laboratory,test'
p30318
g3
sS'phenytoin,in,post-marketing'
p30319
g9
sS'bone,scintigraphy,employing'
p30320
g3
sS'parenteral,forms,of'
p30321
g3
sS'can,inhibit,renal'
p30322
g9
sS'tc,suspension,were'
p30323
g9
sS'bleedings,have,been'
p30324
g3
sS'glycosides,could,exaggerate'
p30325
g9
sS'after,the,effects'
p30326
g3
sS'by,cgs,nor'
p30327
g9
sS'its,action,on'
p30328
g9
sS'combination,of,intravenous'
p30329
g9
sS'weakness,lethargy,fever'
p30330
g9
sS'of,by,patients'
p30331
g9
sS'other,than,myopathy'
p30332
g3
sS'alter,hormone,or'
p30333
g3
sS'hypoglycemia,may,be'
p30334
g3
sS'is,mixed,with'
p30335
g3
sS'studies,were,conducted'
p30336
g3
sS'imipramine,coadministration,of'
p30337
g9
sS'pt,and,international'
p30338
g9
sS'that,can,speed-up'
p30339
g3
sS'exercised,when,coumarin'
p30340
g9
sS'assays,based,on'
p30341
g3
sS'addition,patients,taking'
p30342
g3
sS'm,v,nacmc'
p30343
g3
sS'clinical,data,relating'
p30344
g3
sS'rashes,were,reported'
p30345
g3
sS'steady,state,in'
p30346
g3
sS'intrathecal,injection,of'
p30347
g9
sS'adenocarcinomas,which,was'
p30348
g9
sS'that,these,effects'
p30349
g9
sS'vitamin,d3,calcitriol'
p30350
g9
sS'profiles,and,interactions'
p30351
g3
sS'available,kits,with'
p30352
g3
sS'reactions,in,nursing'
p30353
g3
sS'cyp1a2,was,explored'
p30354
g3
sS'and,upon,concomitant'
p30355
g9
sS'proposed,specific,information'
p30356
g3
sS'initiates,or,discontinues'
p30357
g9
sS'or,bezalip,retard'
p30358
g9
sS'at,other,doses'
p30359
g3
sS'treatment,with,daily'
p30360
g3
sS'values,of,ee'
p30361
g3
sS'other,having,vasodilator'
p30362
g9
sS'interferometric,measurement,of'
p30363
g3
sS'as,random,observations'
p30364
g9
sS'potentiated,by,co-administration'
p30365
g3
sS'among,or,nsaid'
p30366
g3
sS'absorption,of,sodium'
p30367
g9
sS'on,bsa,when'
p30368
g3
sS'aberration,assay,in'
p30369
g3
sS'mesylate,has,no'
p30370
g3
sS'optimal,and,minimal'
p30371
g3
sS'in,monkeys,the'
p30372
g9
sS'pharmacology,pharmacokinetics,and'
p30373
g3
sS'were,no,reports'
p30374
g3
sS'was,to,investigate'
p30375
g3
sS'at,a,higher'
p30376
g3
sS'macrolide,and,may'
p30377
g9
sS'renin,substrate,alpha-1'
p30378
g3
sS'had,increased,systematically'
p30379
g3
sS'aminosalicylic,acid,may'
p30380
g9
sS'adults,to,be'
p30381
g3
sS'ratios,of,the'
p30382
g3
sS'continue,to,increase'
p30383
g9
sS'to,the,complete'
p30384
g3
sS'antihypertensive,effect,although'
p30385
g3
sS'the,physician,even'
p30386
g3
sS'rapidly,to,fully'
p30387
g3
sS'did,not,experience'
p30388
g3
sS'wshow,that,significantly'
p30389
g3
sS'higher,doses,of'
p30390
g3
sS'were,about,fold'
p30391
g3
sS'likely,that,experience'
p30392
g3
sS'with,moieties,significantly'
p30393
g3
sS'agents,should,generally'
p30394
g3
sS'homocysteine,in,the'
p30395
g3
sS'necessary,when,patient'
p30396
g3
sS'acidity,duloxetine,has'
p30397
g3
sS'mg,of,daily'
p30398
g9
sS'unchanged,when,they'
p30399
g3
sS'trial,a,reduction'
p30400
g3
sS'that,the,prophylactic'
p30401
g9
sS'this,neurotoxic,effect'
p30402
g9
sS'microsomal,enzymes,and'
p30403
g9
sS'mechanism,and,seven'
p30404
g3
sS'warranted,in,patients'
p30405
g9
sS'transport,of,or'
p30406
g3
sS'the,basal,colonic'
p30407
g3
sS'therapy,with,other'
p30408
g3
sS'unbound,bound,to'
p30409
g3
sS'activity,against,mycobacteriumavium-intracellulare'
p30410
g3
sS'oral,including,or'
p30411
g9
sS'were,only,slightly'
p30412
g3
sS'and,may,produce'
p30413
g9
sS'studies,with,sustiva'
p30414
g3
sS'mice,c57bl,n'
p30415
g3
sS'intake,of,grapefruit'
p30416
g3
sS'be,avoided,and'
p30417
g9
sS'smaller,week,study'
p30418
g3
sS'cns,depressants,using'
p30419
g9
sS'disulfiram,appears,to'
p30420
g3
sS'rheumatic,disease,may'
p30421
g9
sS'increased,clinical,effects'
p30422
g9
sS'must,not,be'
p30423
g9
sS'additive,effects,on'
p30424
g9
sS'k,may,reduce'
p30425
g9
sS'nonsteroidal,that,inhibit'
p30426
g9
sS'of,the,metabolizing'
p30427
g3
sS'mg,once-daily,dose'
p30428
g3
sS'since,bacteriostatic,may'
p30429
g9
sS'of,various,pesticides'
p30430
g3
sS'recommended,that,levels'
p30431
g9
sS'rat,milk,at'
p30432
g3
sS'anti-hiv,protease,inhibitors'
p30433
g3
sS'guanethidine,or,similarly'
p30434
g3
sS'utero,serum,levels'
p30435
g3
sS'the,welfare,of'
p30436
g3
sS'concentrations,similar,to'
p30437
g9
sS'administration,of,diffusible'
p30438
g3
sS'their,dose,of'
p30439
g3
sS'to,be,approved'
p30440
g3
sS'second,study,by'
p30441
g3
sS'step,in,the'
p30442
g3
sS'in,healthy,males'
p30443
g3
sS'cyp2a6,hydroxylation,of'
p30444
g9
sS'effect,on,insp'
p30445
g3
sS'taking,these,with'
p30446
g3
sS'of,mean,serum'
p30447
g9
sS'vs,serious,falls'
p30448
g9
sS'a,half-life,less'
p30449
g3
sS'their,dose,or'
p30450
g9
sS'data,in,these'
p30451
g3
sS'valdecoxib,steady,state'
p30452
g3
sS'times,were,measured'
p30453
g3
sS'activator,of,human'
p30454
g3
sS'of,the,total'
p30455
g3
sS'and,results,in'
p30456
g9
sS'could,have,increased'
p30457
g3
sS'irritation,in,some'
p30458
g3
sS'low-dose,plus,were'
p30459
g3
sS'to,similar,effects'
p30460
g3
sS'an,blood,coagulation'
p30461
g9
sS'non-gastrointestinal,bleedings,have'
p30462
g3
sS'patient,died,with'
p30463
g3
sS'baboons,given,doses'
p30464
g3
sS'kg,injected,with'
p30465
g9
sS'there,is,more'
p30466
g3
sS'preservation,of,the'
p30467
g3
sS'exposed,to,the'
p30468
g3
sS'detection,of,exposure'
p30469
g3
sS'if,or,estrogen-containing'
p30470
g9
sS'although,combinations,are'
p30471
g3
sS'in,a,defined'
p30472
g3
sS'decarboxylase,inhibitor,does'
p30473
g3
sS'response,and,possible'
p30474
g3
sS'basis,of,therapeutic'
p30475
g3
sS'are,listed,below'
p30476
g9
sS'such,an,action'
p30477
g3
sS'and,beta,adrenergic'
p30478
g9
sS'metabolite,i,suggesting'
p30479
g3
sS'reflexes,hourly,diuresis'
p30480
g3
sS'when,the,muscle'
p30481
g3
sS'for,and,respectively'
p30482
g3
sS'of,this,acid-catalyzed'
p30483
g3
sS'and,patients,with'
p30484
g3
sS'gabapentin,is,not'
p30485
g3
sS'a,recently,identified'
p30486
g3
sS'both,hypo-,and'
p30487
g3
sS'range,years,weight'
p30488
g3
sS'of,both,possibly'
p30489
g3
sS'avoid,the,possible'
p30490
g9
sS'distribution,of,phosphatases'
p30491
g3
sS'or,swelling,at'
p30492
g3
sS'stimulated,by,but'
p30493
g3
sS'instituted,may,occasionally'
p30494
g9
sS'kg,mc,mg'
p30495
g3
sS'three,times,daily'
p30496
g3
sS'to,effects,on'
p30497
g3
sS'baseline,for,h'
p30498
g3
sS'affect,the,sensitivity'
p30499
g3
sS'at,low,as'
p30500
g3
sS'our,patient,appeared'
p30501
g9
sS'fat,digestion,and'
p30502
g3
sS'acid,secretion,are'
p30503
g3
sS'of,lexapro,and'
p30504
g3
sS'carefully,in,order'
p30505
g3
sS'suggests,that,renal'
p30506
g9
sS'dextrorotatory,isomer,on'
p30507
g3
sS'reduce,the,natriuretic'
p30508
g9
sS'cercariae,exposed,to'
p30509
g3
sS'osteomalacia,in,some'
p30510
g3
sS'the,original,medication'
p30511
g3
sS'at,recommended,dosages'
p30512
g9
sS'induce,toxicity,since'
p30513
g3
sS'is,desirable,to'
p30514
g3
sS'anticipated,if,stadol'
p30515
g9
sS'however,other,published'
p30516
g9
sS'a,potent,t'
p30517
g3
sS'of,and,initiation'
p30518
g9
sS'clinically,important,pharmacokinetic'
p30519
g3
sS'shorter,durations,of'
p30520
g9
sS'the,synthesis,of'
p30521
g3
sS'be,taken,for'
p30522
g3
sS'maintain,barpress,response'
p30523
g3
sS'doses,of,required'
p30524
g9
sS'sodium,and,in'
p30525
g3
sS'amprenavir,does,not'
p30526
g3
sS'caution,is,therefore'
p30527
g9
sS'to,evaluate,the'
p30528
g3
sS'and,urinary,excretion'
p30529
g9
sS'mg,clo-4,simultaneously'
p30530
g3
sS'neuromuscular,paralysis,may'
p30531
g3
sS'have,been,rare'
p30532
g9
sS'relaxants,eg,and'
p30533
g9
sS'the,brief,psychiatric'
p30534
g9
sS'sex,number,of'
p30535
g3
sS'with,as,hypercalcemia'
p30536
g9
sS'well-controlled,studies,caused'
p30537
g3
sS'co-administration,of,mg'
p30538
g9
sS'reaction,at,concentrations'
p30539
g3
sS'with,serotonin,reuptake'
p30540
g9
sS'in,enterococcus,faecalis'
p30541
g3
sS'the,mean,auc'
p30542
g3
sS'its,primary,cns'
p30543
g9
sS'tablets,or,pediatric'
p30544
g9
sS'increased,both,resorptions'
p30545
g3
sS'or,are,expected'
p30546
g9
sS'that,produces,cardiopulmonary'
p30547
g3
sS'within,the,first'
p30548
g9
sS'in,users,causes'
p30549
g3
sS'majority,of,adverse'
p30550
g3
sS'cyp2d6,or,ugt'
p30551
g3
sS'upon,beginning,or'
p30552
g9
sS'are,extensively,metabolized'
p30553
g9
sS'of,its,action'
p30554
g9
sS'inhibitor,of,p450'
p30555
g9
sS'celebrex,did,not'
p30556
g3
sS'cataflam,lodine,indocin'
p30557
g3
sS'response,to,and'
p30558
g3
sS'may,if,abruptly'
p30559
g3
sS'metabolic,responses,to'
p30560
g3
sS'normal,dose,when'
p30561
g9
sS'an,anion,exchange'
p30562
g3
sS'precede,dosing,by'
p30563
g3
sS'of,taking,mao'
p30564
g9
sS'without,other,enzyme-'
p30565
g9
sS'active,s-isomer,and'
p30566
g3
sS'highly,protein-bound,have'
p30567
g3
sS'because,of,alkalinization'
p30568
g3
sS'an,a2-selective,agonist'
p30569
g9
sS'ml,twice,daily'
p30570
g9
sS'coadministered,the,beta'
p30571
g9
sS'human,ventricular,cardiac'
p30572
g3
sS'also,be,taken'
p30573
g3
sS'indicating,that,impairment'
p30574
g3
sS'and,that,induce'
p30575
g3
sS'intestinal,carcinogenesis,by'
p30576
g3
sS'sensitivity,to,the'
p30577
g9
sS's,c,completely'
p30578
g9
sS'produced,transient,increases'
p30579
g3
sS'or,supplements,or'
p30580
g9
sS'sodium,can,attenuate'
p30581
g9
sS'when,or,were'
p30582
g3
sS'from,a,level'
p30583
g3
sS'diabetic,patients,demonstrated'
p30584
g3
sS'reduce,the,antihypertensive'
p30585
g9
sS'not,require,dosage'
p30586
g3
sS'agents,in,pharmacokinetic'
p30587
g3
sS'or,fehlings,solution'
p30588
g3
sS'metabolite,ucb,l057'
p30589
g3
sS'blocking,agents,calcium'
p30590
g3
sS'concentrations,of,should'
p30591
g9
sS'ingesting,the,steadystate'
p30592
g3
sS'to,the,disruptive'
p30593
g9
sS'used,during,pregnancy'
p30594
g3
sS'schizophrenic,patients,who'
p30595
g3
sS'have,been,demonstrated'
p30596
g3
sS'in,neonates,whose'
p30597
g3
sS'n,resulted,in'
p30598
g9
sS'the,therapeutic,action'
p30599
g9
sS'no,igg,or'
p30600
g3
sS'augmented,the,depressant'
p30601
g9
sS'the,may,occur'
p30602
g9
sS'depressants,or,should'
p30603
g9
sS'of,g,hour'
p30604
g9
sS'be,reduced,when'
p30605
g9
sS'avastin,when,compared'
p30606
g3
sS'are,not,sufficient'
p30607
g3
sS'less,than,the'
p30608
g3
sS'times,have,been'
p30609
g3
sS'as,a,substitute'
p30610
g3
sS'for,toxicity,and'
p30611
g9
sS'the,steady-state,plasma'
p30612
g3
sS'agents,leading,to'
p30613
g9
sS'drugs,significant,decreases'
p30614
g9
sS'substances,the,following'
p30615
g9
sS'toxicity,possibly,due'
p30616
g9
sS'known,hence,is'
p30617
g9
sS'in,a,higher'
p30618
g9
sS'therapy,free,may'
p30619
g9
sS'mic,of,flucoxacillin'
p30620
g3
sS'to,a,interaction'
p30621
g9
sS'concomitant,use,cannot'
p30622
g3
sS'the,aim,of'
p30623
g3
sS'effectiveness,may,be'
p30624
g3
sS'special,precautions,appear'
p30625
g3
sS'revealed,a,significant'
p30626
g3
sS'and,with,coadministration'
p30627
g3
sS'with,an,active'
p30628
g3
sS'lorazepam,coadministration,of'
p30629
g3
sS'effects,of,during'
p30630
g3
sS'of,m,ptx'
p30631
g9
sS'inulin,method,and'
p30632
g3
sS'weeks,after,initiating'
p30633
g9
sS'failure,may,be'
p30634
g3
sS'by,the,they'
p30635
g9
sS'could,be,the'
p30636
g3
sS'treatment,with,inhibitors'
p30637
g9
sS'as,was,evident'
p30638
g3
sS'depleting,added,to'
p30639
g3
sS'given,as,tablets'
p30640
g3
sS'as,myelosuppression,and'
p30641
g9
sS'diabetes,there,were'
p30642
g3
sS'and,pruritus,and'
p30643
g3
sS'was,observed,at'
p30644
g3
sS'concomitantly,should,have'
p30645
g9
sS'with,there,was'
p30646
g9
sS'was,to,determine'
p30647
g3
sS'detoxification,of,is'
p30648
g9
sS'with,prinivil,at'
p30649
g9
sS'of,st,john'
p30650
g3
sS'have,long,half-lives'
p30651
g3
sS'to,bleeding,associated'
p30652
g9
sS'lodine,can,give'
p30653
g3
sS'long-term,studies,are'
p30654
g3
sS'creatinine,and,serum'
p30655
g9
sS'care,in,patients'
p30656
g9
sS'levels,possibly,by'
p30657
g9
sS'products,associated,with'
p30658
g3
sS'reported,in,patients'
p30659
g9
sS'bexarotene,oxidative,metabolites'
p30660
g3
sS'because,pregnancy,could'
p30661
g3
sS'did,not,differ'
p30662
g3
sS'compared,retrospectively,a'
p30663
g3
sS'of,other,than'
p30664
g9
sS'levels,in,all'
p30665
g9
sS'with,food,or'
p30666
g3
sS'technique,and,by'
p30667
g3
sS'of,other,that'
p30668
g9
sS'study,in,normal'
p30669
g3
sS'system,cns,depressants'
p30670
g9
sS'monitor,closely,for'
p30671
g3
sS'a,interaction,between'
p30672
g9
sS'that,can,reduce'
p30673
g9
sS'in,a,to'
p30674
g9
sS'neural,plasticity,triggered'
p30675
g3
sS'anticholinesterases,concomitant,use'
p30676
g9
sS'tbg,levels,leading'
p30677
g3
sS'in,liver,enzymes'
p30678
g9
sS'twice,daily,mg'
p30679
g3
sS'or,in,coombs'
p30680
g3
sS'oral,or,have'
p30681
g3
sS'for,use,by'
p30682
g3
sS'associated,with,serious'
p30683
g3
sS'that,caspofungin,acetate'
p30684
g3
sS'cancer,recurrence,relative'
p30685
g3
sS'clinical,trials,currently'
p30686
g3
sS'authors,investigated,the'
p30687
g3
sS'who,were,randomly'
p30688
g3
sS'these,medicines,may'
p30689
g3
sS'decreased,slightly,from'
p30690
g9
sS'however,the,peak'
p30691
g9
sS'concomitant,strong,inducers'
p30692
g3
sS'erythrocyte,acetylcholinesterase,ache'
p30693
g9
sS'theo-dur,key,pharmaceuticals'
p30694
g9
sS'with,nalfon,may'
p30695
g9
sS'in,the,adverse'
p30696
g3
sS'of,parietal,cells'
p30697
g3
sS'hypokalemia,may,enhance'
p30698
g9
sS'easy,and,can'
p30699
g3
sS'effective,in,women'
p30700
g3
sS'myelotoxicity,it,is'
p30701
g3
sS'and,effects,of'
p30702
g9
sS'or,m,and'
p30703
g3
sS'a,decrease,of'
p30704
g3
sS'and,effects,on'
p30705
g3
sS'nuromax,before,to'
p30706
g3
sS'demonstrate,that,with'
p30707
g3
sS'faslodex,in,the'
p30708
g3
sS'orally,as,mg'
p30709
g9
sS'using,such,as'
p30710
g9
sS'inhibitor,in,combination'
p30711
g9
sS'inducers,are,taken'
p30712
g9
sS'and,the,lack'
p30713
g3
sS'added,or,deleted'
p30714
g9
sS'vs,and,tmax'
p30715
g3
sS'take,advantage,of'
p30716
g3
sS'from,severe,enterocolitis'
p30717
g9
sS'effect,of,angiotensin'
p30718
g9
sS'been,reported,concomitant'
p30719
g9
sS'mefloquine,on,travelers'
p30720
g9
sS'of,pancreatitis,in'
p30721
g3
sS'decrease,in,phosphorylation'
p30722
g9
sS'prescription,of,to'
p30723
g9
sS'pharmacokinetic,studies,were'
p30724
g3
sS'and,to,groups'
p30725
g3
sS'although,inhibition,of'
p30726
g3
sS'metabolizers,had,a'
p30727
g3
sS'anti-inflammatory,agents,in'
p30728
g9
sS'on,exjade,pharmacokinetics'
p30729
g3
sS'the,adverse,events'
p30730
g3
sS'a,pulse,of'
p30731
g3
sS'microg,ml,when'
p30732
g3
sS'which,blood,levels'
p30733
g3
sS'however,serum,levels'
p30734
g9
sS'was,administered,with'
p30735
g3
sS'mg,of,vardenafil'
p30736
g9
sS'with,multivalent,cation-containing'
p30737
g9
sS'in,an,interaction'
p30738
g3
sS'first,response,was'
p30739
g3
sS'this,study,the'
p30740
g3
sS'that,depending,on'
p30741
g3
sS'exists,between,the'
p30742
g3
sS'interactions,between,homopolyribonucleotides'
p30743
g3
sS'corticosteroid-binding,globulin,thereby'
p30744
g3
sS'cns,acting,drugs'
p30745
g3
sS'containing,mg,of'
p30746
g9
sS'administration,with,the'
p30747
g3
sS'administering,with,since'
p30748
g9
sS'another,study,showed'
p30749
g3
sS'cyp,a4,or'
p30750
g9
sS'or,maintain,the'
p30751
g3
sS'studies,with,highly'
p30752
g3
sS'reversal,in,enterococci'
p30753
g3
sS'increase,excretion,of'
p30754
g3
sS'other,doses,is'
p30755
g3
sS'laboratory,interactions,no'
p30756
g3
sS'plasma,auc,of'
p30757
g3
sS'efficacy,has,not'
p30758
g3
sS'matulane,eldepryl,and'
p30759
g3
sS'during,photic,stimulation'
p30760
g3
sS'to,avoid,this'
p30761
g9
sS'in,terms,of'
p30762
g3
sS'careful,observations,on'
p30763
g9
sS'increase,the,blood-glucose'
p30764
g3
sS'test,interaction,because'
p30765
g3
sS'with,tambocor,are'
p30766
g9
sS'of,and,k'
p30767
g9
sS'did,not,seem'
p30768
g3
sS'of,and,g'
p30769
g9
sS'is,required,to'
p30770
g9
sS'of,and,a'
p30771
g9
sS'in,clotting,time'
p30772
g3
sS'the,body,occurs'
p30773
g3
sS'bind,other,drugs'
p30774
g3
sS'are,examples,of'
p30775
g3
sS'human,lymphocytes,mammalian'
p30776
g3
sS'appears,to,have'
p30777
g9
sS'including,dry,mouth'
p30778
g9
sS'logarithmic,fashion,from'
p30779
g3
sS'no,formal,laboratory'
p30780
g3
sS'describes,a,recently'
p30781
g3
sS'in,detecting,alterations'
p30782
g3
sS'not,studied,with'
p30783
g9
sS'products,are,capable'
p30784
g3
sS'the,intake,of'
p30785
g9
sS'transplants,malignancy,and'
p30786
g3
sS'unlikely,to,affect'
p30787
g3
sS'formed,via,cyp3a4'
p30788
g3
sS'shown,in,vivo'
p30789
g3
sS'remainder,were,of'
p30790
g3
sS'that,acarbose,has'
p30791
g3
sS'and,therapy,a'
p30792
g9
sS'similar,serum,time'
p30793
g3
sS'the,management,of'
p30794
g3
sS'eg,and,by'
p30795
g9
sS'has,a,less'
p30796
g9
sS'other,narcotic,general'
p30797
g9
sS'maximal,hypotension,was'
p30798
g3
sS'function,and,increase'
p30799
g3
sS'on,fetal,development'
p30800
g3
sS'persists,as,long'
p30801
g9
sS'of,hydroxylamine,a'
p30802
g3
sS'or,known,to'
p30803
g9
sS'key,pharmaceuticals,inc'
p30804
g9
sS'had,little,or'
p30805
g3
sS'most,automated,equipment'
p30806
g3
sS'patients,with,serious'
p30807
g3
sS'as,a,tool'
p30808
g3
sS'heparins,effect,on'
p30809
g3
sS'rashes,itching,mouth'
p30810
g3
sS'and,did,not'
p30811
g3
sS'the,mediation,of'
p30812
g3
sS'administered,with,vaprisol'
p30813
g9
sS'nanm,failed,to'
p30814
g3
sS'doses,of,may'
p30815
g9
sS'pharmacokinetics,except,that'
p30816
g9
sS'carbamazepine,equetrotm,increases'
p30817
g9
sS'producing,transient,increases'
p30818
g3
sS'clarithromycin,is,a'
p30819
g9
sS'unique,biopharmaceutical,properties'
p30820
g3
sS'and,diuretics,concomitant'
p30821
g9
sS'same,dose,of'
p30822
g9
sS'little,progression,in'
p30823
g3
sS'then,be,discontinued'
p30824
g3
sS'between,given,singly'
p30825
g3
sS'or,increasing,salt'
p30826
g9
sS'in,the,chop'
p30827
g3
sS'no,capacity,to'
p30828
g3
sS'p450iiia4,isozyme,and'
p30829
g9
sS'as,a,local'
p30830
g3
sS'evaluated,using,comparisons'
p30831
g3
sS'of,and,hydroxides'
p30832
g3
sS'atacand,so,careful'
p30833
g9
sS'secretion,via,organic'
p30834
g9
sS'rings,with,intact'
p30835
g9
sS'under,the,concentration-time'
p30836
g3
sS'the,receptor-binding,activity'
p30837
g3
sS'vitro,and,or'
p30838
g9
sS'of,and,plasma'
p30839
g9
sS'for,drug-drug,interaction'
p30840
g3
sS'over,patients,with'
p30841
g3
sS'activity,of,liver'
p30842
g3
sS'to,induce,both'
p30843
g3
sS'amevive,in,the'
p30844
g3
sS'not,have,clinically'
p30845
g3
sS'volunteers,taking,mg'
p30846
g9
sS'a,with,any'
p30847
g9
sS'pharmacokinetic,effects,did'
p30848
g3
sS'such,are,withdrawn'
p30849
g3
sS'aspirin,concomitant,administration'
p30850
g9
sS'noted,that,both'
p30851
g3
sS'activation,of,vitamin-d'
p30852
g3
sS'too,frequent,doses'
p30853
g3
sS'was,documented,however'
p30854
g3
sS'nervous,system,although'
p30855
g3
sS'panretin,gel,should'
p30856
g9
sS'antithyroid,b-adrenergic,blocking'
p30857
g3
sS'however,a,comparison'
p30858
g3
sS'drugs,that,should'
p30859
g3
sS'and,other,medicinal'
p30860
g3
sS'separated,by,hours'
p30861
g9
sS'receiving,concomitant,antihypertensive'
p30862
g9
sS'a,multicenter,randomized'
p30863
g3
sS'given,tot,the'
p30864
g3
sS'the,are,a'
p30865
g3
sS'for,longitudinal,stability'
p30866
g3
sS'plasma,levels,be'
p30867
g9
sS'the,relationship,to'
p30868
g3
sS'signs,or,symptoms'
p30869
g9
sS'monitoring,for,known'
p30870
g9
sS'thio,compounds,in'
p30871
g3
sS'peganone,is,administered'
p30872
g9
sS'toxic,product,erythro-fluorocitrate'
p30873
g3
sS'renal,uptake,to'
p30874
g9
sS'dosage,should,be'
p30875
g9
sS'attenuating,s,influence'
p30876
g9
sS'risks,of,cns'
p30877
g9
sS'oral,solution,may'
p30878
g9
sS'use,of,parenterally'
p30879
g9
sS'and,current,responses'
p30880
g9
sS'inpatient,and,or'
p30881
g3
sS'their,dosage,when'
p30882
g9
sS'treatment,which,causes'
p30883
g9
sS'epinephrine,should,be'
p30884
g3
sS'to,concurrent,administration'
p30885
g9
sS'oral-dose,clearance,by'
p30886
g9
sS'to,mac,or'
p30887
g3
sS'concentrations,lower,than'
p30888
g3
sS'submitted,to,a'
p30889
g3
sS'slight,reduction,in'
p30890
g9
sS'rate,compared,with'
p30891
g9
sS'beta-naltrexol,were,unaffected'
p30892
g3
sS'the,relevance,of'
p30893
g3
sS'thromboplastin,time,or'
p30894
g3
sS'with,these,medicines'
p30895
g3
sS'patients,with,coronary'
p30896
g3
sS'outcome,of,pregnancies'
p30897
g3
sS'these,agents,including'
p30898
g3
sS'with,thrombolytic,agents'
p30899
g3
sS'intestinal,permeation,of'
p30900
g3
sS'on,clonidines,analgesic'
p30901
g3
sS'this,response,has'
p30902
g3
sS'of,lapatinib,on'
p30903
g3
sS'human,liver,are'
p30904
g3
sS'been,reports,that'
p30905
g9
sS'of,nmda,receptors'
p30906
g3
sS'other,agents,affecting'
p30907
g3
sS'are,overly,cautious'
p30908
g3
sS'metabolite,of,the'
p30909
g3
sS'oxidase,inhibitors,should'
p30910
g9
sS'is,metabolized,at'
p30911
g3
sS'preparations,produced,by'
p30912
g3
sS'make,normal,metabolizers'
p30913
g3
sS'prescribed,to,control'
p30914
g9
sS'inr,determinations,are'
p30915
g3
sS'preparations,minipills,that'
p30916
g9
sS'renin,levels,aldosterone'
p30917
g3
sS'of,argatroban,and'
p30918
g9
sS'and,infrequent,reports'
p30919
g3
sS'by,a,corresponding'
p30920
g9
sS'coadministered,with,the'
p30921
g9
sS'exhibits,non-linear,pharmacokinetics'
p30922
g9
sS'of,both,increases'
p30923
g9
sS'evidence,of,incompatibility'
p30924
g3
sS'concurrently,taking,medications'
p30925
g3
sS'of,precedex,with'
p30926
g9
sS'microsomes,to,determine'
p30927
g3
sS'area,of,rural'
p30928
g3
sS'the,replication,of'
p30929
g9
sS'possible,with,some'
p30930
g3
sS'potentiated,apparently,by'
p30931
g3
sS'being,metabolized,through'
p30932
g3
sS'be,exercised,when'
p30933
g3
sS'have,additive,effects'
p30934
g9
sS'period,particularly,at'
p30935
g9
sS'including,and,have'
p30936
g3
sS'a,level,cells'
p30937
g3
sS'were,prohibited,in'
p30938
g3
sS'humans,metabolism,is'
p30939
g3
sS'not,affected,during'
p30940
g3
sS'to,first-pass,metabolism'
p30941
g3
sS'acid,concentrations,prior'
p30942
g3
sS'not,extensively,bound'
p30943
g3
sS'this,medicine,certain'
p30944
g3
sS'fertility,pegasys,may'
p30945
g3
sS'in,those,receiving'
p30946
g3
sS'low-density,lipoprotein,cholesterol'
p30947
g3
sS'on,the,clinical'
p30948
g3
sS'a,may,increase'
p30949
g9
sS'dosing,with,because'
p30950
g9
sS'has,been,extensively'
p30951
g3
sS'twice-daily,with,resulted'
p30952
g9
sS'of,upon,the'
p30953
g3
sS'a,low,dose'
p30954
g3
sS'hormonal,differ,in'
p30955
g3
sS'other,and,anti'
p30956
g3
sS'nmda,receptors,in'
p30957
g3
sS'tnf-blocking,agent,has'
p30958
g9
sS'the,following,cisplatin'
p30959
g9
sS'isoenzymes,caution,should'
p30960
g9
sS'mao,inhibitor,may'
p30961
g9
sS'of,when,used'
p30962
g9
sS'is,not,possible'
p30963
g3
sS'times,rat,the'
p30964
g3
sS'pharmacokinetics,auc,c'
p30965
g3
sS'albendazole,mg,kg'
p30966
g9
sS'may,alter,a'
p30967
g9
sS'for,vitamin,d'
p30968
g9
sS'are,no,clinical'
p30969
g3
sS'than,in,patients'
p30970
g9
sS'a,useful,pharmacological'
p30971
g3
sS'such,as,narcotics'
p30972
g9
sS'bid,in,conjunction'
p30973
g9
sS'interaction,may,result'
p30974
g3
sS'gastrointestinal,motility,may'
p30975
g3
sS'inhibitors,or,with'
p30976
g9
sS'cytochrome,p-450,inducers'
p30977
g9
sS'circulates,largely,unbound'
p30978
g3
sS'revealed,necrotizing,myopathy'
p30979
g3
sS'only,of,the'
p30980
g3
sS'absorption,and,result'
p30981
g9
sS'of,starlix,and'
p30982
g9
sS'many,used,in'
p30983
g3
sS'anti-inflammatory,concomitantly,with'
p30984
g9
sS'and,invalidate,folic'
p30985
g3
sS'and,decreased,measured'
p30986
g9
sS'and,the,signs'
p30987
g3
sS'and,other,signs'
p30988
g3
sS'ucb,l057,in'
p30989
g3
sS'h,without,to'
p30990
g9
sS'insp,or,its'
p30991
g3
sS'itraconazole,plasma,concentrations'
p30992
g9
sS'that,serum,levels'
p30993
g9
sS'concentration,as,well'
p30994
g3
sS'and,could,have'
p30995
g3
sS'p450,enzymes,interactions'
p30996
g3
sS'however,modification,abolished'
p30997
g3
sS'and,copegus,are'
p30998
g3
sS'a,greater,extent'
p30999
g3
sS'relaxation,of,mesenteric'
p31000
g3
sS'pharmacokinetics,of,affected'
p31001
g3
sS'dofetilide,is,metabolized'
p31002
g3
sS'the,ototoxic,potential'
p31003
g9
sS'since,higher,doses'
p31004
g9
sS'significantly,greater,than'
p31005
g3
sS'blood,glucose,was'
p31006
g3
sS'vivo,particularly,when'
p31007
g3
sS'this,combinational,action'
p31008
g3
sS'with,be,temporarily'
p31009
g3
sS'minutes,to,min'
p31010
g3
sS'mefloquine,and,other'
p31011
g9
sS'trileptal,doses,in'
p31012
g9
sS'additive,negative,inotropic'
p31013
g9
sS'offer,patients,optimal'
p31014
g3
sS'and,with,diagnostic'
p31015
g3
sS'a,prostaglandin,synthetase'
p31016
g3
sS'cure,and,the'
p31017
g9
sS'of,renal,failure'
p31018
g9
sS'levels,of,previously'
p31019
g3
sS'p,a,such'
p31020
g9
sS'of,interferences,and'
p31021
g3
sS'these,and,perhaps'
p31022
g3
sS'of,pulmonary,symptomatology'
p31023
g9
sS'cancer,were,given'
p31024
g3
sS'care,when,myocardial'
p31025
g9
sS'agent,plus,a'
p31026
g3
sS'alter,the,effects'
p31027
g3
sS'of,mice,treated'
p31028
g3
sS'the,intravenous,topical'
p31029
g3
sS'combined,with,against'
p31030
g9
sS'reported,during,therapy'
p31031
g9
sS'significant,effect,in'
p31032
g3
sS'effects,with,and'
p31033
g9
sS'are,generally,believed'
p31034
g3
sS'twice,daily,dose'
p31035
g3
sS'of,the,supraventricular'
p31036
g9
sS'treated,with,monoamine'
p31037
g9
sS'co-administration,with,antifungal'
p31038
g3
sS'or,by,protecting'
p31039
g3
sS'inhibitor,has,been'
p31040
g9
sS'antagonists,drugs,that'
p31041
g9
sS'and,dosage,of'
p31042
g3
sS'a,pulmonary,extract'
p31043
g3
sS'alterations,might,reflect'
p31044
g3
sS'and,antineoplastic,agents'
p31045
g9
sS'on,clinical,acumen'
p31046
g3
sS'a,pharmacodynamic,interaction'
p31047
g9
sS'of,also,appears'
p31048
g3
sS'drugs,the,addition'
p31049
g9
sS'was,markedly,sensitive'
p31050
g3
sS'of,hypotensive,effects'
p31051
g9
sS'potential,differences,in'
p31052
g3
sS'be,administered,concurrently'
p31053
g9
sS'tendency,toward,a'
p31054
g3
sS'indicate,important,relationships'
p31055
g3
sS'increase,the,serum'
p31056
g9
sS'maximal,effects,of'
p31057
g3
sS'of,exposure,to'
p31058
g3
sS'is,co,administered'
p31059
g3
sS'patients,with,heparin-induced'
p31060
g3
sS'occurring,interactions,are'
p31061
g9
sS'medium,blocked,the'
p31062
g3
sS'zdv,as,shown'
p31063
g9
sS'a,single,study'
p31064
g9
sS'auc,of,cyp3a4'
p31065
g9
sS'that,the,analgesic'
p31066
g9
sS'data,from,studies'
p31067
g3
sS'to,have,an'
p31068
g3
sS'hepatic,tissues,induced'
p31069
g9
sS'eia,test,in'
p31070
g3
sS'take,a,vitamin'
p31071
g9
sS'grapefruit,juice,co-administration'
p31072
g3
sS'hydrochloride,ferrous,sulfate'
p31073
g9
sS'electrocardiograms,were,done'
p31074
g3
sS'lamivudine,and,may'
p31075
g9
sS'effects,of,beta'
p31076
g9
sS'i,trial,using'
p31077
g9
sS'of,a,nonabsorbable'
p31078
g9
sS'initial,treatment,occurred'
p31079
g3
sS'plasma,levels,are'
p31080
g3
sS'normal,subjects,concurrent'
p31081
g9
sS'on,over,of'
p31082
g3
sS'this,might,increase'
p31083
g3
sS'and,higher,doses'
p31084
g9
sS'such,as,palpitations'
p31085
g3
sS'the,clinical,use'
p31086
g9
sS'an,additive,cns'
p31087
g9
sS'nystagmus,strabismus,miosis'
p31088
g3
sS'such,as,nuromax'
p31089
g9
sS'evidence,of,circulating'
p31090
g3
sS'result,in,fatal'
p31091
g9
sS'on,hormone,therapy'
p31092
g3
sS'given,concurrently,patients'
p31093
g9
sS'auc,after,a'
p31094
g9
sS'underdosage,myasthenic,weakness'
p31095
g3
sS'tagamet,prozac,sporanox'
p31096
g3
sS'inhibit,phosphatase,activities'
p31097
g9
sS'pancreatic,supplements,use'
p31098
g9
sS'depressants,such,as'
p31099
g9
sS'heart,medicine,may'
p31100
g9
sS'situations,in,which'
p31101
g3
sS'increase,toxicity,and'
p31102
g3
sS'levels,at,different'
p31103
g3
sS'novel,targets,and'
p31104
g3
sS'binding,and,increased'
p31105
g9
sS'be,seen,on'
p31106
g9
sS'brovana,at,steady-state'
p31107
g3
sS'based,on,known'
p31108
g3
sS'should,be,guided'
p31109
g3
sS'were,neither,reversed'
p31110
g9
sS'co-administered,but,not'
p31111
g3
sS'concentration,especially,in'
p31112
g9
sS'suppressed,by,synthetic'
p31113
g3
sS'conclusions,single-dose,coadministration'
p31114
g9
sS'two,compounds,was'
p31115
g3
sS'his,her,and'
p31116
g3
sS'epileptic,patients,lowered'
p31117
g9
sS'marked,bradycardia,or'
p31118
g9
sS'behaviors,which,are'
p31119
g3
sS'of,as,determined'
p31120
g3
sS'administration,of,was'
p31121
g3
sS'considered,although,they'
p31122
g3
sS'and,may,interfere'
p31123
g9
sS'recommended,that,patients'
p31124
g3
sS'or,over-the,counter'
p31125
g3
sS'applied,to,supraspinal'
p31126
g3
sS'rebif,is,given'
p31127
g3
sS'when,cancidas,and'
p31128
g9
sS'in,determining,the'
p31129
g3
sS'not,administered,but'
p31130
g3
sS'in,gastrointestinal,transit'
p31131
g9
sS'simulect,with,no'
p31132
g3
sS'be,further,increased'
p31133
g3
sS'bid,day,and'
p31134
g9
sS'isosorbide,dinitrate,chloride'
p31135
g3
sS'patients,whose,hypertension'
p31136
g9
sS'following,drug,interactions'
p31137
g3
sS'kidney,homogenates,supplemented'
p31138
g3
sS'not,alter,tromethamine'
p31139
g3
sS'the,ccnu,is'
p31140
g3
sS'cimetidine,increased,the'
p31141
g9
sS'onset,of,action'
p31142
g3
sS'dose,of,reduced'
p31143
g3
sS'secretion,may,result'
p31144
g9
sS'may,exhibit,an'
p31145
g9
sS'severe,recalcitrant,nodular'
p31146
g3
sS'of,and,their'
p31147
g3
sS'liver,weight,and'
p31148
g3
sS'ergotamine-containing,or,ergot-type'
p31149
g9
sS'of,ergotamine-containing,or'
p31150
g9
sS'with,and,and'
p31151
g3
sS'been,as,effective'
p31152
g3
sS'measured,by,high-performance'
p31153
g3
sS'x,l,with'
p31154
g3
sS'and,blood,pressure'
p31155
g9
sS'in,males,and'
p31156
g9
sS'on,glycosides,may'
p31157
g3
sS'pharmacokinetic,interaction,between'
p31158
g3
sS'indocin,can,reduce'
p31159
g9
sS'used,the,length'
p31160
g3
sS'mg,was,given'
p31161
g9
sS'of,inhibition,and'
p31162
g9
sS'vitro,against,gram'
p31163
g3
sS'effect,compared,with'
p31164
g3
sS'are,negatively,coupled'
p31165
g3
sS'in,approximately,fold'
p31166
g3
sS'therapy,administration,of'
p31167
g3
sS'neupogen,and,other'
p31168
g3
sS'the,renal,toxicity'
p31169
g9
sS'observed,with,prolongation'
p31170
g3
sS'epidemiological,studies,of'
p31171
g9
sS'effects,with,beta-adrenergic'
p31172
g9
sS'of,aprepitant,may'
p31173
g9
sS'with,significantly,fewer'
p31174
g3
sS'recommended,in,dosage'
p31175
g3
sS'to,week,intervals'
p31176
g3
sS'complications,related,to'
p31177
g3
sS'or,inhibition,of'
p31178
g3
sS'those,enzymes,would'
p31179
g3
sS'in,subjects,treated'
p31180
g3
sS'affect,plasma,concentrations'
p31181
g9
sS'concentrations,and,urinary'
p31182
g9
sS'enzymes,in,human'
p31183
g3
sS'inhibitors,and,inducers'
p31184
g3
sS'dysfunction,and,b'
p31185
g3
sS'reported,during,treatment'
p31186
g3
sS'glycemia,after,overload'
p31187
g3
sS'and,possible,toxicity'
p31188
g3
sS'for,normal,rates'
p31189
g3
sS'test,interactions,no'
p31190
g3
sS'skin,reactions,at'
p31191
g3
sS'as,v,readily'
p31192
g3
sS'indeed,agents,and'
p31193
g3
sS'antibiotics,and,agents'
p31194
g9
sS'inhibitors,and,has'
p31195
g9
sS'maalox,decreased,auc'
p31196
g9
sS'other,by,a'
p31197
g3
sS'affect,gastric,acidity'
p31198
g3
sS'levels,to,below'
p31199
g9
sS'such,cases,the'
p31200
g3
sS'observed,more,frequently'
p31201
g3
sS'glucose,utilization,with'
p31202
g3
sS'particularly,serotype,o11'
p31203
g3
sS'must,be,done'
p31204
g3
sS'termed,serotonin,syndrome'
p31205
g9
sS'aprepitant,mg,on'
p31206
g9
sS'm1,cmax,values'
p31207
g3
sS'toxicity,should,be'
p31208
g9
sS'inhibitors,of,cyp2d6'
p31209
g3
sS'arise,in,association'
p31210
g3
sS'of,camp-mediated,acid'
p31211
g3
sS'excretion,and,renal'
p31212
g3
sS'of,are,reported'
p31213
g9
sS'dose,reduction,for'
p31214
g3
sS'hand,the,enhanced'
p31215
g3
sS'cyp3a4,cimetidine,cimetidine'
p31216
g9
sS'oral,or,did'
p31217
g3
sS'the,were,administered'
p31218
g3
sS'd3,calcitriol,and'
p31219
g9
sS'study,and,nonsteroidal'
p31220
g3
sS'due,to,fulminant'
p31221
g9
sS'day,n,for'
p31222
g3
sS'coadministration,of,tcas'
p31223
g9
sS'who,have,congenital'
p31224
g3
sS'cimetidine,can,inhibit'
p31225
g9
sS'indocin,may,produce'
p31226
g3
sS'the,individual,and'
p31227
g3
sS'using,tricor,with'
p31228
g9
sS'co-administered,which,may'
p31229
g9
sS'cisapride,is,metabolized'
p31230
g3
sS'rats,have,shown'
p31231
g9
sS'least,four,times'
p31232
g3
sS'reduced,and,signs'
p31233
g9
sS'glucose,levels,or'
p31234
g9
sS'different,routes,a'
p31235
g9
sS'trials,specifically,examining'
p31236
g3
sS'ketoprofen,does,not'
p31237
g3
sS'an,adolescent,with'
p31238
g9
sS'and,an,deficiency'
p31239
g9
sS'of,sodium,perchlorate'
p31240
g3
sS'patients,taking,celebrex'
p31241
g9
sS'sign,monitoring,particularly'
p31242
g3
sS'is,not,approved'
p31243
g3
sS'in,diabetics,with'
p31244
g9
sS'to,be,susceptible'
p31245
g3
sS'subjects,n,there'
p31246
g3
sS'ergot,alkaloids,should'
p31247
g9
sS'general,agents,and'
p31248
g3
sS'by,pbi,t4'
p31249
g3
sS'isozyme,and,which'
p31250
g9
sS'or,mg,twice'
p31251
g3
sS'three,concentrations,ranging'
p31252
g3
sS'of,were,increased'
p31253
g3
sS'in,nucleoside-experienced,patients'
p31254
g3
sS'oral,contraceptives,multiple'
p31255
g3
sS'well,above,cmax'
p31256
g3
sS'of,agents,increase'
p31257
g3
sS'of,neuropathy,or'
p31258
g3
sS'oral,adl,mg'
p31259
g3
sS'anafranil,with,that'
p31260
g3
sS'an,and,a'
p31261
g9
sS'be,avoided,in'
p31262
g9
sS'forming,a,radioactive'
p31263
g3
sS'on,balance,testing'
p31264
g9
sS'a,nd,series'
p31265
g3
sS'occur,when,duragesic'
p31266
g3
sS'the,alkaloid,class'
p31267
g9
sS'cns,depressant,effects'
p31268
g9
sS'reduction,in,fertility'
p31269
g3
sS'potential,interaction,of'
p31270
g9
sS'rats,fasted,for'
p31271
g3
sS'agents,used,in'
p31272
g3
sS'interactions,allows,the'
p31273
g3
sS'of,total,formation'
p31274
g9
sS'required,for,the'
p31275
g3
sS'vitro,sodium,is'
p31276
g3
sS'vitamin,e,mg'
p31277
g9
sS'or,verapamil,the'
p31278
g9
sS'or,fr,responding'
p31279
g9
sS'toxi-lab,a,thin-layer'
p31280
g3
sS'minimal,effects,on'
p31281
g3
sS'development,of,dependence'
p31282
g3
sS'with,the,contraceptive'
p31283
g9
sS'with,racemic,citalopram'
p31284
g9
sS'indicating,that,this'
p31285
g3
sS'to,micrograms,caused'
p31286
g9
sS'a,profound,and'
p31287
g3
sS'time,ratio,or'
p31288
g3
sS'in,coffee,and'
p31289
g3
sS'treated,with,non-steroidal'
p31290
g9
sS'appropriate,adjustment,of'
p31291
g9
sS'disease,except,leukemia'
p31292
g9
sS'and,sgpt,alt'
p31293
g9
sS'to,continue,treatment'
p31294
g9
sS'pharmacokinetic,variables,of'
p31295
g3
sS'should,be,considered'
p31296
g3
sS'in,this,category'
p31297
g3
sS'to,continue,to'
p31298
g9
sS'identified,potentially,significant'
p31299
g9
sS'cell,permeability,of'
p31300
g3
sS'receiving,gm,daily'
p31301
g9
sS'especially,important,for'
p31302
g3
sS'findings,and,no'
p31303
g3
sS'mg,bid,resulted'
p31304
g9
sS'days,with,co-administration'
p31305
g9
sS'for,and,were'
p31306
g3
sS'to,the,administration'
p31307
g9
sS'with,tablets,usp'
p31308
g9
sS'cyp3a,the,metabolism'
p31309
g3
sS'relationship,with,amphotericin'
p31310
g9
sS'was,to,evaluate'
p31311
g3
sS'used,with,described'
p31312
g3
sS'significantly,eliminated,by'
p31313
g9
sS'seen,in,cyp'
p31314
g9
sS'to,patients,receiving'
p31315
g9
sS'by,approximately,given'
p31316
g9
sS'the,scale,of'
p31317
g3
sS'of,mg,qhs'
p31318
g3
sS'containing,side,chains'
p31319
g3
sS'of,isocarboxazid,and'
p31320
g9
sS'adverse,events,are'
p31321
g3
sS'daily,dose,in'
p31322
g3
sS'as,prophylaxis,after'
p31323
g3
sS'decrease,extracellular,levels'
p31324
g3
sS'transient,peak,plasma'
p31325
g3
sS'it,may,impair'
p31326
g3
sS'dose,of,mg'
p31327
g3
sS'hepatic,cytochrome,p-450'
p31328
g9
sS'concomitant,treatment,with'
p31329
g9
sS'mucosal,cell,accumulation'
p31330
g3
sS'to,withhold,during'
p31331
g9
sS'compounds,taken,concomitantly'
p31332
g9
sS'or,mg,per'
p31333
g3
sS'cells,this,effect'
p31334
g9
sS'effectiveness,when,used'
p31335
g3
sS'attenuates,loss,caused'
p31336
g9
sS'metabolized,by,cytochrome'
p31337
g3
sS'avoid,dong,quai'
p31338
g3
sS'patients,with,cardiovascular'
p31339
g3
sS'brevibloc,should,not'
p31340
g9
sS'doses,in,vivo'
p31341
g9
sS'precautions,and,contraindications'
p31342
g3
sS'and,was,resistant'
p31343
g3
sS'doses,of,either'
p31344
g9
sS'co-administration,with,other'
p31345
g3
sS'been,definitely,determined'
p31346
g3
sS'emerge,with,the'
p31347
g9
sS'any,new,rashes'
p31348
g3
sS'value,abstract,truncated'
p31349
g3
sS'a,less,pronounced'
p31350
g9
sS'intravenous,or,other'
p31351
g9
sS'whether,or,or'
p31352
g3
sS'may,reduce,pulse'
p31353
g9
sS'single,dose,bioavailability'
p31354
g3
sS'cell,and,was'
p31355
g3
sS'increase,the,dose'
p31356
g9
sS'nor,other,possible'
p31357
g3
sS'of,sodium,is'
p31358
g9
sS'lithium,nonsteroidal,agents'
p31359
g9
sS'parameters,of,either'
p31360
g3
sS'trilisate,disalcid,others'
p31361
g9
sS'd1,antagonist,sch-23390'
p31362
g9
sS'pharmacodynamic,interaction,with'
p31363
g3
sS'considered,prior,to'
p31364
g9
sS'blood,glucose,levels'
p31365
g9
sS'the,hippocampus,is'
p31366
g3
sS'these,reports,and'
p31367
g3
sS'to,proleukin,treatment'
p31368
g3
sS'avoid,giving,in'
p31369
g9
sS'provoke,vasoconstriction,in'
p31370
g9
sS'of,other,clotting'
p31371
g3
sS'plasma,protein,is'
p31372
g3
sS'other,tnf-blocking,agents'
p31373
g9
sS'relevant,interactions,with'
p31374
g3
sS'erectile,dysfunction,associated'
p31375
g3
sS'lowering,effect,agents'
p31376
g3
sS'in,adequate,and'
p31377
g3
sS'in,nociception,and'
p31378
g3
sS'been,reported,regarding'
p31379
g3
sS'brevibloc,concentrations,were'
p31380
g9
sS'influence,of,calcium-channel'
p31381
g3
sS'injection,clonidine,may'
p31382
g9
sS'exceed,micrograms,g'
p31383
g3
sS'no,clinically,meaningful'
p31384
g3
sS'been,administered,with'
p31385
g3
sS'clinical,trials,in'
p31386
g9
sS'of,acetate,in'
p31387
g9
sS'until,a,patient'
p31388
g9
sS'for,up,to'
p31389
g9
sS'in,cell,cultures'
p31390
g3
sS'anti-depressants,could,exaggerate'
p31391
g9
sS'yet,statistically,significant'
p31392
g3
sS'rapidly,hydrolyzed,intravenous'
p31393
g3
sS'describes,two,cases'
p31394
g9
sS'the,that,alter'
p31395
g9
sS'approximately,increase,in'
p31396
g9
sS'the,event,of'
p31397
g3
sS'blockade,produced,by'
p31398
g9
sS'resistance,or,sensitivity'
p31399
g3
sS'are,substrates,inhibitors'
p31400
g3
sS'with,channel,blockers'
p31401
g9
sS'a,very,weak'
p31402
g9
sS'tablets,reduces,the'
p31403
g9
sS'to,crixivan,or'
p31404
g3
sS'and,pregnancy,outcomes'
p31405
g3
sS'absence,of,serious'
p31406
g3
sS'bradycardia,qt,c'
p31407
g9
sS'increases,bioavailability,by'
p31408
g3
sS'with,renal,and'
p31409
g3
sS'to,be,associated'
p31410
g3
sS'of,intestinal,tumors'
p31411
g3
sS'medicine,with,thioridizine'
p31412
g3
sS'the,kidneys,coadministration'
p31413
g3
sS'with,the,urine'
p31414
g3
sS'but,the,overall'
p31415
g9
sS'of,developing,an'
p31416
g9
sS'in,a,first'
p31417
g3
sS'an,average,and'
p31418
g9
sS'also,resolved,with'
p31419
g3
sS'suggest,the,need'
p31420
g3
sS'number,of,intrinsic'
p31421
g3
sS'and,other,thyroid'
p31422
g3
sS'exists,the,potential'
p31423
g3
sS'agents,which,increase'
p31424
g9
sS'dose,of,indocin'
p31425
g3
sS'with,incisive,by'
p31426
g3
sS'reaction,is,unknown'
p31427
g3
sS'were,co-administered,to'
p31428
g9
sS'of,with,blood'
p31429
g3
sS'reported,following,concomitant'
p31430
g9
sS'administered,with,ethyl'
p31431
g9
sS'prolonged,by,concurrent'
p31432
g9
sS'same,pharmacological,treatment'
p31433
g3
sS'patients,who,are'
p31434
g9
sS'oral,combination,of'
p31435
g9
sS'administered,with,other'
p31436
g9
sS'use,in,the'
p31437
g3
sS'were,observed,there'
p31438
g3
sS'increase,the,danger'
p31439
g9
sS'improved,the,transport'
p31440
g3
sS'to,rats,hours'
p31441
g3
sS'every,mac,with'
p31442
g3
sS'sodium,and,other'
p31443
g9
sS'x,use,with'
p31444
g3
sS'longitudinal,assessment,of'
p31445
g3
sS'therapeutic,doses,of'
p31446
g3
sS'differin,gel,until'
p31447
g3
sS'childbearing,potential,only'
p31448
g3
sS'revealed,that,mtx'
p31449
g3
sS'exposure,by,approximately'
p31450
g9
sS'potential,for,duloxetine'
p31451
g3
sS'dose,achieves,a'
p31452
g3
sS'cations,or,videx'
p31453
g9
sS'and,other,pharmacokinetics'
p31454
g9
sS'by,the,auc0-120hr'
p31455
g9
sS'when,prescribing,concomitantly'
p31456
g3
sS'a,role,for'
p31457
g3
sS'with,hepatic,enzyme'
p31458
g9
sS'additional,clinical,experience'
p31459
g3
sS'the,parental,mcf-7'
p31460
g3
sS'vardenafil,dosing,was'
p31461
g9
sS'micrograms,ml,may'
p31462
g3
sS'and,administered,with'
p31463
g3
sS'decreased,by,a'
p31464
g9
sS'over,a,dose'
p31465
g9
sS'initiated,as,a'
p31466
g9
sS'large,fold,increase'
p31467
g3
sS'prostate,cancer,diabetes'
p31468
g3
sS'and,comparison,of'
p31469
g3
sS'and,under,acidic'
p31470
g9
sS'monitoring,of,anticoagulation'
p31471
g3
sS'at,different,levels'
p31472
g3
sS'no,binding,displacement'
p31473
g3
sS'altered,by,cyp3a4'
p31474
g3
sS'moderate,to,severe'
p31475
g9
sS'with,fluvoxamine,tablets'
p31476
g9
sS'release,was,measured'
p31477
g3
sS'exposures,of,and'
p31478
g9
sS'agents,monoamine,oxidase'
p31479
g9
sS'in,vitro,in'
p31480
g9
sS'evidence,for,longitudinal'
p31481
g3
sS'in,cyp2d6,activity'
p31482
g3
sS'decreases,in,plasma'
p31483
g9
sS'to,c,p'
p31484
g3
sS'infant,has,not'
p31485
g3
sS'with,a,short-acting'
p31486
g3
sS'active,metabolite,formation'
p31487
g3
sS'orders,of,magnitude'
p31488
g3
sS'states,careful,attention'
p31489
g3
sS'that,if,casodex'
p31490
g9
sS'each,study,there'
p31491
g3
sS'because,the,incidence'
p31492
g3
sS'other,high,concentrations'
p31493
g3
sS'mustard,etc,should'
p31494
g3
sS'the,average,for'
p31495
g3
sS'data,including,continuous'
p31496
g3
sS'appropriate,interval,between'
p31497
g3
sS'analogues,vitamin,d2'
p31498
g9
sS'prinivil,was,used'
p31499
g3
sS'lipoproteins,high-density,lipoproteins'
p31500
g3
sS'number,of,prescribed'
p31501
g3
sS'in,plasma,exposure'
p31502
g9
sS'have,been,administered'
p31503
g3
sS'liver,via,the'
p31504
g3
sS'epoxide,which,is'
p31505
g3
sS'containing,or,as'
p31506
g9
sS'and,therapy,were'
p31507
g3
sS'and,parnate,using'
p31508
g3
sS'of,an,aluminum'
p31509
g3
sS'effective,as,intravenous'
p31510
g3
sS'hcl,and,a'
p31511
g3
sS'this,interaction,include'
p31512
g3
sS'isoenzyme,and,are'
p31513
g3
sS'for,an,interaction'
p31514
g3
sS'sustain,plasma,levels'
p31515
g3
sS'also,been,assessed'
p31516
g3
sS'blood,platelets,by'
p31517
g9
sS'carefully,about,and'
p31518
g3
sS'from,dietary-obese,rats'
p31519
g3
sS'patients,receiving,purinethol'
p31520
g9
sS'inositol,trisphosphate,the'
p31521
g3
sS'adverse,experiences,in'
p31522
g3
sS'less,effective,and'
p31523
g3
sS'these,medicines,central'
p31524
g9
sS'any,from,the'
p31525
g3
sS'chronic,or,therapy'
p31526
g9
sS'use,of,potassium-sparing'
p31527
g3
sS'antifungals,in,vitro'
p31528
g9
sS'observed,when,and'
p31529
g3
sS'hmgcoa,reductase,inhibitor'
p31530
g3
sS'no,statistically,significant'
p31531
g3
sS'and,n-acetyl,by'
p31532
g3
sS'if,necessary,receive'
p31533
g3
sS'hypotensive,effects,can'
p31534
g9
sS'or,bleeding,have'
p31535
g9
sS'to,the,pharmacology'
p31536
g3
sS'bleeding,time,by'
p31537
g3
sS'was,withdrawn,and'
p31538
g3
sS'plus,to,those'
p31539
g3
sS'vioxx,and,mg'
p31540
g9
sS'has,been,co-administered'
p31541
g3
sS'occasionally,intensify,the'
p31542
g9
sS'least,days,before'
p31543
g3
sS'and,hours,after'
p31544
g9
sS'risk,of,severe'
p31545
g9
sS'within,minutes,of'
p31546
g9
sS'oral,clearance,of'
p31547
g9
sS'biological,half-lives,of'
p31548
g3
sS'dosing,and,small'
p31549
g3
sS'has,not,been'
p31550
g3
sS'vitamin,c,has'
p31551
g3
sS'vasoconstrictor,can,combine'
p31552
g9
sS'formulation,of,was'
p31553
g3
sS'incidence,or,severity'
p31554
g9
sS'inhibitor,nnrti,based'
p31555
g3
sS'antifungal,agents,should'
p31556
g9
sS'interaction,was,pharmacodynamic'
p31557
g3
sS'reduced,clearance,based'
p31558
g9
sS'arrhythmias,may,mask'
p31559
g3
sS'predisposed,mice,one'
p31560
g3
sS'type,i,insulin-dependent'
p31561
g3
sS'may,be,substrates'
p31562
g3
sS'shown,that,inhibit'
p31563
g3
sS'by,the,initial'
p31564
g9
sS'the,dose,may'
p31565
g9
sS'days,n,or'
p31566
g3
sS'of,tasks,that'
p31567
g3
sS'safe,dosing,regimens'
p31568
g3
sS'autonomic,neurotoxicity,whereas'
p31569
g3
sS'oral,cordarone,administration'
p31570
g3
sS'combined,with,other'
p31571
g9
sS'levels,may,change'
p31572
g3
sS'depending,on,the'
p31573
g3
sS'discontinuation,of,or'
p31574
g9
sS'that,does,not'
p31575
g3
sS'chromatography,procedure,for'
p31576
g3
sS's-warfarin,with,the'
p31577
g3
sS'with,combined,use'
p31578
g9
sS'potentially,fatal,prolongation'
p31579
g9
sS'tca5,with,any'
p31580
g3
sS'when,given,in'
p31581
g3
sS'rate,of,gi'
p31582
g9
sS'and,may,reduce'
p31583
g9
sS'of,with,other'
p31584
g9
sS'receiving,such,combined'
p31585
g3
sS'authors,compared,retrospectively'
p31586
g3
sS'with,larger,doses'
p31587
g3
sS'not,be,rechallenged'
p31588
g3
sS'microsomal,fraction,suggesting'
p31589
g3
sS'increased,its,effectiveness'
p31590
g3
sS'drugs,which,require'
p31591
g9
sS'are,administered,to'
p31592
g3
sS'potential,must,not'
p31593
g9
sS'may,require,dosage'
p31594
g9
sS'via,conjugation,with'
p31595
g9
sS'activity,is,desired'
p31596
g3
sS'of,microtubules,in'
p31597
g3
sS'the,octapeptide,cholecystokinin--of'
p31598
g3
sS'provide,information,for'
p31599
g3
sS'indicate,no,discernible'
p31600
g3
sS'increases,substantially,the'
p31601
g9
sS'also,known,as'
p31602
g3
sS'blurred,vision,nystagmus'
p31603
g3
sS'when,channel,blockers'
p31604
g9
sS'of,aeds,in'
p31605
g9
sS'clearance,and,concentration'
p31606
g3
sS'required,for,therapeutic'
p31607
g3
sS'cannot,be,made'
p31608
g9
sS'hydroxide,reduce,the'
p31609
g9
sS'the,variability,component'
p31610
g9
sS'strength,over,the'
p31611
g3
sS'of,mg,twice-daily'
p31612
g9
sS'potentiation,of,rashes'
p31613
g9
sS'a,lower,than'
p31614
g3
sS'agents,in,some'
p31615
g9
sS'monitoring,of,prothrombin'
p31616
g9
sS'therapy,and,the'
p31617
g3
sS'likely,that,use'
p31618
g3
sS'acetaminophen,pharmacokinetic,or'
p31619
g3
sS'models,for,individual'
p31620
g3
sS'vivo,tests,of'
p31621
g3
sS'since,chronic,dosing'
p31622
g3
sS'fluctuations,in,steady-state'
p31623
g9
sS'additional,measures,should'
p31624
g3
sS'nutrition,or,depresses'
p31625
g3
sS'helpful,when,possible'
p31626
g3
sS'aim,of,this'
p31627
g3
sS'with,mg,once'
p31628
g9
sS'that,oral,ccnu'
p31629
g3
sS'although,it,is'
p31630
g3
sS'urine,using,a'
p31631
g3
sS'minor,metabolic,pathway'
p31632
g3
sS'the,prescriber,when'
p31633
g3
sS'there,are,other'
p31634
g3
sS'impedance,and,the'
p31635
g3
sS'given,alone,in'
p31636
g3
sS'n,with,n'
p31637
g3
sS'asymptomatic,but,can'
p31638
g3
sS'possible,pharmacokinetic,interactions'
p31639
g9
sS'suggested,that,in'
p31640
g9
sS'isomers,of,were'
p31641
g3
sS'hansten,into,light'
p31642
g3
sS'channel,blockers,should'
p31643
g9
sS'not,take,this'
p31644
g3
sS'qrs,complex,and'
p31645
g9
sS'muscle,in,the'
p31646
g9
sS'secretion,by,the'
p31647
g3
sS'clearance,a,small'
p31648
g3
sS'suggested,that,is'
p31649
g3
sS'myocardial,depressants,or'
p31650
g9
sS'for,migraine,therapy'
p31651
g9
sS'regard,to,concomitant'
p31652
g3
sS'and,cortex,that'
p31653
g9
sS'demonstrated,in,patients'
p31654
g9
sS'of,serious,infections'
p31655
g9
sS'nephrotoxic,medications,agents'
p31656
g3
sS'suggests,the,potential'
p31657
g9
sS'and,hypoglycemic,agents'
p31658
g9
sS'in,addressing,information'
p31659
g3
sS'exposure,from,the'
p31660
g3
sS'whole,body,tremors'
p31661
g3
sS'fifteen,species,of'
p31662
g3
sS'not,shown,to'
p31663
g9
sS'for,additional,that'
p31664
g9
sS'sheep,interactions,of'
p31665
g3
sS'and,range,from'
p31666
g9
sS'to,possible,interaction'
p31667
g3
sS'pharmacokinetic,profiles,of'
p31668
g3
sS'intracellular,exposure,to'
p31669
g9
sS'ras-3t3,cells,compared'
p31670
g3
sS'non-aspergillus,polysaccharides,and'
p31671
g3
sS'volunteers,resulted,in'
p31672
g9
sS'site,fecal,and'
p31673
g3
sS'medications,or,or'
p31674
g9
sS'patient,has,recovered'
p31675
g9
sS'mc,has,much'
p31676
g3
sS'studies,with,other'
p31677
g3
sS'class,of,with'
p31678
g3
sS'daily,increases,in'
p31679
g9
sS'agents,affecting,sympathetic'
p31680
g3
sS'on,the,various'
p31681
g3
sS'meth,induced,arc'
p31682
g3
sS'of,diarrhea,but'
p31683
g9
sS'blockers,antagonists,and'
p31684
g3
sS'subjects,and,bioavailability'
p31685
g9
sS'increased,serum,and'
p31686
g3
sS'auc,approximately,fold'
p31687
g9
sS'novolog,but,that'
p31688
g3
sS'been,conducted,at'
p31689
g3
sS'within,the,normal'
p31690
g9
sS'reaction,between,a'
p31691
g9
sS'between,intake,of'
p31692
g3
sS'either,be,temporarily'
p31693
g9
sS'the,most,potent'
p31694
g3
sS'administration,the,effect'
p31695
g3
sS'race,intercurrent,illnesses'
p31696
g3
sS'may,experience,enhanced'
p31697
g9
sS'very,unlikely,to'
p31698
g3
sS'by,and,reduced'
p31699
g9
sS'be,recognized,that'
p31700
g3
sS'rats,responding,in'
p31701
g9
sS'developed,neutropenia,anc'
p31702
g9
sS'below,the,age'
p31703
g3
sS'of,phenytoin,should'
p31704
g3
sS'with,congestive,heart'
p31705
g3
sS'and,or,embryocidal'
p31706
g3
sS'of,by,decreased'
p31707
g9
sS'to,suppression,of'
p31708
g3
sS'conditions,kinetics,equilibrium'
p31709
g3
sS'with,brain,levels'
p31710
g3
sS'or,within,weeks'
p31711
g9
sS'prevention,of,atherosclerotic'
p31712
g3
sS'likewise,pharmacokinetics,were'
p31713
g3
sS'tolerance,secretion,or'
p31714
g3
sS'that,these,are'
p31715
g3
sS'following,lipid-lowering,that'
p31716
g3
sS'in,chronic,treatments'
p31717
g3
sS'of,disease,and'
p31718
g3
sS'or,hepatic,impairment'
p31719
g3
sS'and,tmax,vs'
p31720
g3
sS'interaction,studies,however'
p31721
g3
sS'bumetanide,may,potentiate'
p31722
g9
sS'the,toxicity,of'
p31723
g3
sS'depressants,eg,other'
p31724
g9
sS'are,not,necessary'
p31725
g3
sS'must,be,avoided'
p31726
g9
sS'dihydroergotamine,contraindicated,due'
p31727
g3
sS'resveratrol-induced,vasorelaxation,in'
p31728
g3
sS'reduced,to,one'
p31729
g9
sS'possibility,of,worsened'
p31730
g3
sS'which,also,lowers'
p31731
g3
sS'astringents,spices,or'
p31732
g3
sS'of,the,formation'
p31733
g3
sS'through,the,a-v'
p31734
g9
sS'symptoms,of,serotonin'
p31735
g9
sS'and,the,plasma'
p31736
g3
sS'a,case,of'
p31737
g9
sS'through,hours,following'
p31738
g3
sS'response,has,been'
p31739
g3
sS'as,increasing,overall'
p31740
g3
sS'should,achieve,and'
p31741
g3
sS'days,produced,no'
p31742
g3
sS'been,observed,and'
p31743
g3
sS'vardenafil,with,has'
p31744
g3
sS'smoking,adapting,of'
p31745
g3
sS'the,following,eight'
p31746
g3
sS'mg,orally,given'
p31747
g3
sS'with,acute,delirium'
p31748
g9
sS'an,oral,produced'
p31749
g9
sS'induction,data,obtained'
p31750
g3
sS'agents,with,decreased'
p31751
g3
sS'the,hepatic,metabolism'
p31752
g9
sS'many,like,cannot'
p31753
g3
sS'could,facilitate,the'
p31754
g3
sS'comparing,the,intravenous'
p31755
g3
sS'temperature,in,female'
p31756
g3
sS'reports,of,changes'
p31757
g3
sS'mutagenic,or,clastogenic'
p31758
g3
sS'decreased,by,co-administration'
p31759
g3
sS'are,available,it'
p31760
g3
sS'tnf,blocking,agent'
p31761
g9
sS'and,effects,especially'
p31762
g3
sS'hydrochlorothiazide,given,concomitantly'
p31763
g9
sS'diabetes,were,administered'
p31764
g3
sS'ions,in,platelets'
p31765
g3
sS'the,d,and'
p31766
g3
sS'gastric,secretion,chronic'
p31767
g3
sS'a,potential,treatment'
p31768
g3
sS'with,increased,exposure'
p31769
g9
sS'adrenergic-blocking,agents,calcium-blocking'
p31770
g3
sS'the,possible,additive'
p31771
g9
sS'to,inhibit,c9'
p31772
g3
sS'increased,rate,of'
p31773
g9
sS'important,role,in'
p31774
g9
sS'best,approach,in'
p31775
g3
sS'and,have,not'
p31776
g3
sS'volunteers,no,significant'
p31777
g3
sS'angiotensin,ii,antagonists'
p31778
g9
sS'udp-glucuronyl,transferase,it'
p31779
g3
sS'of,neuropathy,during'
p31780
g3
sS'alphagan,p,in'
p31781
g9
sS'more,pharmacologic,activities'
p31782
g3
sS'in,the,striatum'
p31783
g9
sS'against,cryptosporidium,parvum'
p31784
g3
sS'of,pregnancies,conceived'
p31785
g3
sS'starting,daily,dose'
p31786
g3
sS'mhd,concentration,mean'
p31787
g3
sS'a,large,decrease'
p31788
g3
sS'also,occurs,in'
p31789
g3
sS'deviation,to,ml'
p31790
g9
sS'within,days,because'
p31791
g9
sS'the,nucleus,accumbens'
p31792
g3
sS'preparations,containing,or'
p31793
g9
sS'decreased,by,the'
p31794
g9
sS'renal,clearances,by'
p31795
g9
sS'in,the,in'
p31796
g3
sS'kd,and,bmax'
p31797
g3
sS'to,in-creased,circulating'
p31798
g3
sS'isoenzyme,of,the'
p31799
g3
sS'urine,may,result'
p31800
g3
sS'competitively,displaces,from'
p31801
g9
sS'micrococcus,luteus,mic'
p31802
g3
sS'dosage,adjustments,of'
p31803
g9
sS'for,the,determination'
p31804
g3
sS'administered,alternately,provided'
p31805
g3
sS'association,with,anaesthesia'
p31806
g3
sS'of,the,diabetic'
p31807
g3
sS'such,as,reinforcing'
p31808
g3
sS'major,metabolite,at'
p31809
g3
sS'of,previous,extravasation'
p31810
g3
sS'coenzyme,a,hmg-coa'
p31811
g9
sS'clearance,from,l'
p31812
g9
sS'enalapril,iv,has'
p31813
g3
sS'nonsteroidal,anti,inflammatory'
p31814
g9
sS'rofecoxib,did,not'
p31815
g3
sS'subjects,no,significant'
p31816
g3
sS'increased,by,compared'
p31817
g9
sS'other,medicines,or'
p31818
g9
sS'hours,experienced,a'
p31819
g9
sS'the,antidepressant,or'
p31820
g3
sS'indocin,and,should'
p31821
g9
sS'this,could,be'
p31822
g3
sS'the,half-life,of'
p31823
g9
sS'this,phenomenon,has'
p31824
g3
sS'and,are,unlikely'
p31825
g3
sS'factors,may,play'
p31826
g3
sS'tissues,induced,by'
p31827
g9
sS'negatively,coupled,to'
p31828
g3
sS'felbatol,on,low-dose'
p31829
g3
sS'exercised,with,simultaneous'
p31830
g3
sS'in,sn38,levels'
p31831
g3
sS'receiving,concomitantly,with'
p31832
g9
sS'samples,may,interfere'
p31833
g3
sS'addition,we,have'
p31834
g3
sS'metabolic,reactions,catalyzed'
p31835
g3
sS'reports,have,shown'
p31836
g9
sS'and,hypoglycemia,have'
p31837
g9
sS'include,optimal,pharmacokinetics'
p31838
g3
sS'in,one,controlled'
p31839
g9
sS'containing,or,may'
p31840
g9
sS'p,less,than'
p31841
g3
sS'effective,contraception,simultaneously'
p31842
g3
sS'by,sodium,should'
p31843
g3
sS'and,the,decreased'
p31844
g3
sS'possible,decrease,in'
p31845
g9
sS'blood,flow,seen'
p31846
g3
sS'patients,exposed,to'
p31847
g9
sS'l-glutamine,and,human'
p31848
g9
sS'each,found,to'
p31849
g3
sS'is,contraindicated,in'
p31850
g9
sS'been,observed,between'
p31851
g3
sS'day,pretreatment,period'
p31852
g3
sS'given,singly,and'
p31853
g3
sS'and,induced,a'
p31854
g3
sS'treatments,lacking,cyp3a4'
p31855
g3
sS'modulatory,effect,of'
p31856
g3
sS'ketoconazole,when,a'
p31857
g9
sS'concluded,that,chloral'
p31858
g3
sS'effect,of,toradol'
p31859
g9
sS'when,initiating,extraneal'
p31860
g9
sS'closely,particularly,if'
p31861
g3
sS'at,doses,above'
p31862
g9
sS'lead,to,abnormal'
p31863
g3
sS'daily,has,been'
p31864
g3
sS'no,clinically,relevant'
p31865
g3
sS'nih-3t3,cells,was'
p31866
g3
sS'used,with,care'
p31867
g9
sS'the,pharmacokinetics,exposure'
p31868
g3
sS'direct,pharmacokinetic,captopril-digoxin'
p31869
g3
sS'for,drugs,such'
p31870
g9
sS'also,be,applied'
p31871
g3
sS'of,mg,to'
p31872
g9
sS'only,in,genetically'
p31873
g3
sS'other,than,have'
p31874
g3
sS'the,literature,suggest'
p31875
g9
sS'jejunal,net,fluid'
p31876
g3
sS'amplitudes,of,components'
p31877
g3
sS'in,male,rhesus'
p31878
g3
sS'facilitated,by,hippocampal'
p31879
g3
sS'product,can,affect'
p31880
g3
sS'cases,of,hyperpyrexia'
p31881
g3
sS'nor,does,it'
p31882
g3
sS'reaction,since,ancobon'
p31883
g3
sS'which,can,affect'
p31884
g3
sS'patients,taking,which'
p31885
g3
sS'administration,of,kerlone'
p31886
g3
sS'with,crohns,disease'
p31887
g9
sS'with,those,achieved'
p31888
g9
sS'evidence,of,impaired'
p31889
g3
sS'cell,number,induced'
p31890
g9
sS'with,an,appropriate'
p31891
g9
sS'the,treatment,regimen'
p31892
g9
sS'recognized,as,increasingly'
p31893
g3
sS'single,intravenous,infusion'
p31894
g3
sS'the,first,few'
p31895
g9
sS'is,principally,metabolized'
p31896
g3
sS'should,be,based'
p31897
g3
sS'well-controlled,patients,receiving'
p31898
g9
sS'method,to,maximize'
p31899
g3
sS'agents,on,the'
p31900
g3
sS'a,concomitantly,any'
p31901
g9
sS'review,of,all'
p31902
g3
sS'bioavailability,of,the'
p31903
g3
sS'patients,with,schizophrenia'
p31904
g3
sS'interval,has,elapsed'
p31905
g3
sS'systems,and,have'
p31906
g3
sS'in,older,men'
p31907
g3
sS'ventral,tubercle,of'
p31908
g3
sS'a,small,increase'
p31909
g3
sS'administered,orally,has'
p31910
g3
sS'seminiferous,tubular,atrophy'
p31911
g3
sS'pentamidine,treatment,with'
p31912
g3
sS'small,or,quite'
p31913
g3
sS'p450-mediated,interactions,that'
p31914
g3
sS'therapy,have,experienced'
p31915
g3
sS'pancreatic,acinar,cells'
p31916
g3
sS'relationships,among,ras'
p31917
g3
sS'volunteers,either,simultaneously'
p31918
g9
sS'these,in,normal'
p31919
g3
sS'increased,to,micrograms'
p31920
g3
sS'and,the,prolonged'
p31921
g3
sS'ketoconazole,is,a'
p31922
g3
sS'there,is,little'
p31923
g3
sS'antitumor,activity,of'
p31924
g3
sS'interfere,with,any'
p31925
g3
sS'limited,renal,excretion'
p31926
g3
sS'other,central,nervous'
p31927
g9
sS'microg,l,or'
p31928
g3
sS'has,sometimes,been'
p31929
g3
sS'and,oral,hypoglycemic'
p31930
g9
sS'half-life,of,thereby'
p31931
g9
sS'produce,scintigraphic,results'
p31932
g3
sS'effort,to,screen'
p31933
g3
sS'these,results,do'
p31934
g9
sS'may,potentially,interact'
p31935
g3
sS'receiving,these,concurrently'
p31936
g3
sS'for,and,the'
p31937
g3
sS'the,and,and'
p31938
g9
sS'mg,bid,day'
p31939
g9
sS'interpreting,the,results'
p31940
g3
sS'e2,dmpge2,induced'
p31941
g3
sS'to,select,and'
p31942
g3
sS'effects,with,can'
p31943
g9
sS'of,glycemia,induced'
p31944
g3
sS'pharmacologic,studies,indicate'
p31945
g9
sS'alter,gastrointestinal,motility'
p31946
g9
sS'dantrium,is,metabolized'
p31947
g3
sS'patients,who,switched'
p31948
g3
sS'c,human,ventricular'
p31949
g3
sS'preparation,before,use'
p31950
g3
sS'are,taking,or'
p31951
g9
sS'of,tail-flick,inhibition'
p31952
g3
sS'are,renally,eliminated'
p31953
g3
sS'it,enhances,the'
p31954
g3
sS'smaller,alfenta,doses'
p31955
g3
sS'vivo,interaction,studies'
p31956
g3
sS'of,developing,renal'
p31957
g3
sS'theoretical,potential,for'
p31958
g9
sS'a4,and,to'
p31959
g3
sS'as,v,remains'
p31960
g3
sS'ototoxic,potential,of'
p31961
g9
sS'however,the,total'
p31962
g3
sS'medications,muscle,relaxants'
p31963
g3
sS'where,the,effects'
p31964
g3
sS'therefore,if,concomitant'
p31965
g3
sS'similar,properties,such'
p31966
g9
sS'angiomax,does,not'
p31967
g3
sS'to,alter,behaviors'
p31968
g3
sS'decreased,the,plasma'
p31969
g9
sS'particular,caution,should'
p31970
g9
sS'usually,severe,abdominal'
p31971
g3
sS'affect,the,relative'
p31972
g3
sS'exaggeration,of,the'
p31973
g9
sS'on,the,pharmacodynamics'
p31974
g3
sS'mg,kg,every'
p31975
g3
sS'substrates,dasatinib,is'
p31976
g3
sS'a,well-defined,pharmacokinetic-pharmacodynamic'
p31977
g3
sS'of,decreased,with'
p31978
g9
sS'currently,do,not'
p31979
g3
sS'at,low,levels'
p31980
g3
sS'excretion,is,observed'
p31981
g3
sS'recommended,dose,ranges'
p31982
g3
sS'to,have,negative'
p31983
g3
sS'the,week,period'
p31984
g9
sS'diazepam,diazepam,valium'
p31985
g3
sS'macrolide,have,been'
p31986
g9
sS'mean,half-life,and'
p31987
g9
sS'administered,to,normal'
p31988
g3
sS'dose,when,concomitant'
p31989
g9
sS'for,possible,infiltration'
p31990
g3
sS'proposed,as,a'
p31991
g3
sS'clotting,time,plasma'
p31992
g3
sS'oral,was,associated'
p31993
g9
sS'unrecognized,interactions,between'
p31994
g3
sS'tract,to,healthy'
p31995
g9
sS'treated,at,mg'
p31996
g3
sS'muscle,relaxants,sleeping'
p31997
g3
sS'this,interaction,which'
p31998
g9
sS'an,uncontrolled,study'
p31999
g3
sS'reduced,by,an'
p32000
g9
sS'no,in,vitro'
p32001
g3
sS'hypoglycemia,have,been'
p32002
g9
sS'reduced,by,at'
p32003
g9
sS'nsaids,and,did'
p32004
g3
sS'on,the,neuromuscular'
p32005
g3
sS'and,the,rest'
p32006
g3
sS'diagnosed,during,therapy'
p32007
g3
sS'k,can,antagonize'
p32008
g9
sS'to,benefits,should'
p32009
g3
sS'of,fibric,acid'
p32010
g3
sS'nsaids,should,be'
p32011
g9
sS'b-cell,dependent,areas'
p32012
g3
sS'monitoring,of,serum'
p32013
g3
sS'can,completely,block'
p32014
g9
sS'decrease,in,hypothyroid'
p32015
g3
sS'suggest,similar,effects'
p32016
g3
sS'ephedrine,ephedrine,may'
p32017
g9
sS'of,patients,years'
p32018
g3
sS'is,important,to'
p32019
g3
sS'mg,produced,a'
p32020
g9
sS'crixivan,and,are'
p32021
g3
sS'implicated,in,the'
p32022
g9
sS'decrease,between,and'
p32023
g3
sS'were,performed,with'
p32024
g3
sS'the,therapeutic,value'
p32025
g3
sS'used,with,general'
p32026
g3
sS'in,the,body'
p32027
g3
sS'of,autoimmune,and'
p32028
g9
sS'and,release,was'
p32029
g3
sS'of,kg,for'
p32030
g3
sS'of,the,ionized'
p32031
g9
sS'a,blunting,of'
p32032
g3
sS'adrenal,and,or'
p32033
g3
sS'metabolic,pathway,may'
p32034
g3
sS'micro-dosed,progesterone,preparations'
p32035
g9
sS'volunteers,received,alone'
p32036
g3
sS'response,was,not'
p32037
g3
sS'in,part,from'
p32038
g3
sS'studies,angiomax,exhibited'
p32039
g3
sS'with,other,centrally'
p32040
g9
sS'reduced,the,blood'
p32041
g9
sS'been,postmarketing,reports'
p32042
g9
sS'and,agents,is'
p32043
g9
sS'therapy,indicate,no'
p32044
g3
sS'a,patient,who'
p32045
g9
sS'potent,inhalational,such'
p32046
g9
sS'human,serum,in'
p32047
g3
sS'interactions,were,seen'
p32048
g3
sS'important,effects,on'
p32049
g3
sS'prothrombin,time,partial'
p32050
g3
sS'fluoride,or,citrate'
p32051
g3
sS'concomitantly,with,ethacrynic'
p32052
g9
sS'these,included,seven'
p32053
g3
sS'was,admini,stered'
p32054
g9
sS'locomotor,activities,of'
p32055
g3
sS'common,distilled,and'
p32056
g3
sS'if,administered,prior'
p32057
g9
sS'cyp2d6,cyp2c9,cyp2c19'
p32058
g3
sS'in,steady-state,peak'
p32059
g9
sS'of,was,found'
p32060
g3
sS'meal,and,mg'
p32061
g9
sS'hours,concurrently,with'
p32062
g3
sS'be,the,potential'
p32063
g3
sS'a,reversible,enhancement'
p32064
g9
sS'exposure,during,the'
p32065
g3
sS'support,the,choice'
p32066
g3
sS'supraventricular,arrhythmias,may'
p32067
g3
sS'and,follow-up,measurements'
p32068
g3
sS'taking,placebo,with'
p32069
g3
sS'nonsteroidal,antiinflammatory,agents'
p32070
g9
sS'the,smallest,effective'
p32071
g3
sS'to,existing,therapy'
p32072
g3
sS'study,in,eight'
p32073
g9
sS'on,the,nursing'
p32074
g3
sS'of,cyp2d6,increased'
p32075
g9
sS'interactions,hyperaminotransferasemia,significant'
p32076
g3
sS'circulating,catecholamines,after'
p32077
g3
sS'affect,bleeding,parameters'
p32078
g9
sS'according,to,the'
p32079
g3
sS'with,moderate,renal'
p32080
g3
sS'for,which,they'
p32081
g3
sS'and,th,days'
p32082
g3
sS'triamterene,concomitant,use'
p32083
g3
sS'urinary,and,chloride'
p32084
g9
sS'ipratropium,bromide,is'
p32085
g9
sS'is,probable,that'
p32086
g3
sS'r-value,of,naflu'
p32087
g3
sS'fulminant,pancreatitis,possibly'
p32088
g9
sS'known,whether,amevive'
p32089
g3
sS'in,coombs,testing'
p32090
g3
sS'days,following,initiation'
p32091
g9
sS'anabolic,hormones,complex'
p32092
g3
sS'adrenergic,stimulant,type'
p32093
g3
sS'partially,impaired,renal'
p32094
g3
sS'interaction,studies,or'
p32095
g3
sS'of,when,both'
p32096
g9
sS'such,patients,may'
p32097
g3
sS'a4,would,be'
p32098
g9
sS'the,clearance,by'
p32099
g3
sS'mesenteric,resistance,arteries'
p32100
g3
sS'among,the,risk'
p32101
g9
sS'on,the,chemical'
p32102
g9
sS'respectively,after,administration'
p32103
g3
sS'results,confirm,that'
p32104
g3
sS'interaction,studies,of'
p32105
g3
sS'maximizing,therapy,lies'
p32106
g3
sS'interfere,with,folate'
p32107
g9
sS'inhibitors,the,use'
p32108
g9
sS'need,for,dose'
p32109
g3
sS'cyp1a2,results,in'
p32110
g9
sS'levels,may,also'
p32111
g3
sS'of,may,be'
p32112
g9
sS'thioether,assay,appears'
p32113
g3
sS'to,inhibit,cyps'
p32114
g3
sS't4,and,t3'
p32115
g9
sS'is,a,decrease'
p32116
g3
sS'or,other,complications'
p32117
g9
sS'these,doses,were'
p32118
g3
sS'serum,concentration,has'
p32119
g9
sS'the,two,hormonal'
p32120
g9
sS'and,that,is'
p32121
g3
sS'kg,was,significantly'
p32122
g9
sS'with,the,oral'
p32123
g3
sS'glycosides,in,patients'
p32124
g3
sS'this,kind,with'
p32125
g9
sS'relevance,continues,to'
p32126
g3
sS'insufficiency,or,those'
p32127
g3
sS'oxidase,mao,inhibition'
p32128
g3
sS'beta-blockers,in,controlled'
p32129
g3
sS'endometrial,ovarian,cervical'
p32130
g3
sS'it,is,now'
p32131
g3
sS'unlikely,to,be'
p32132
g3
sS'it,is,not'
p32133
g3
sS'mg,day,against'
p32134
g3
sS'sumatriptan,has,been'
p32135
g9
sS'used,with,the'
p32136
g3
sS'laboratory,abnormalities,elevated'
p32137
g3
sS'when,their,main'
p32138
g3
sS'excretion,of,many'
p32139
g9
sS'globulin,tbg,levels'
p32140
g3
sS'interfere,with,normal'
p32141
g3
sS'with,of,a'
p32142
g3
sS'ml,before,receiving'
p32143
g3
sS'therapy,with,flolan'
p32144
g9
sS'epa,supplements,on'
p32145
g3
sS'with,dual,therapy'
p32146
g3
sS'that,a,dose'
p32147
g3
sS'on,bsa,and'
p32148
g3
sS'observed,that,meth'
p32149
g9
sS'effect,on,protein'
p32150
g3
sS'rats,prepared,by'
p32151
g3
sS'avoid,potentiation,the'
p32152
g3
sS'changes,are,not'
p32153
g3
sS'of,this,being'
p32154
g3
sS'and,repeat,testing'
p32155
g3
sS'may,produce,ventricular'
p32156
g3
sS'seen,in,difluoro-2'
p32157
g9
sS'coadministration,of,resulted'
p32158
g9
sS'be,administered,safely'
p32159
g3
sS'magnitude,of,interaction'
p32160
g3
sS'and,incoordination,when'
p32161
g9
sS'glycemic,control,with'
p32162
g3
sS'who,have,used'
p32163
g3
sS'in,their,prothrombin'
p32164
g9
sS'procedures,in,animals'
p32165
g3
sS'interactions,clozapine,is'
p32166
g3
sS'is,a,high'
p32167
g3
sS'with,fruit,juices'
p32168
g3
sS'of,and,prolongation'
p32169
g9
sS'female,animals,dosed'
p32170
g3
sS'of,parametric,dose-response'
p32171
g3
sS'bentiromide,may,interact'
p32172
g9
sS'whose,absorption,is'
p32173
g3
sS'at,least,hours'
p32174
g9
sS'accordingly,and,should'
p32175
g9
sS'yields,a,net'
p32176
g9
sS'and,was,followed'
p32177
g9
sS'the,digitalized,patient'
p32178
g3
sS'the,current,study'
p32179
g3
sS'effects,on,potassium'
p32180
g9
sS'obtained,for,any'
p32181
g3
sS'article,will,describe'
p32182
g3
sS'to,loss,of'
p32183
g3
sS'strong,inhibitor,of'
p32184
g9
sS'efficacy,although,these'
p32185
g3
sS'are,either,added'
p32186
g9
sS'trial,there,have'
p32187
g3
sS'oral,and,oral'
p32188
g9
sS'as,being,homocysteine'
p32189
g3
sS'basis,that,these'
p32190
g9
sS'antagonists,and,may'
p32191
g9
sS'by,evaluating,the'
p32192
g3
sS'symptoms,i,severe'
p32193
g9
sS'a,first,rapid'
p32194
g3
sS'levels,of,exposure'
p32195
g3
sS'blocking,agents,to'
p32196
g3
sS'with,hepatotoxicity,concomitant'
p32197
g9
sS'susceptible,to,the'
p32198
g3
sS'ordinarily,a,minor'
p32199
g3
sS'must,be,a'
p32200
g3
sS'doxil,may,interact'
p32201
g3
sS'and,their,bioavailability'
p32202
g9
sS'increased,by,a'
p32203
g3
sS'regimen,of,aprepitant'
p32204
g9
sS'by,endothelial,dysfunction'
p32205
g3
sS'patch,pipette,yielded'
p32206
g3
sS'have,also,shown'
p32207
g9
sS'to,therapy,could'
p32208
g9
sS'because,severe,and'
p32209
g9
sS'be,cyp,a'
p32210
g9
sS'vasospastic,reactions,have'
p32211
g9
sS'occur,earlier,than'
p32212
g9
sS'systems,lapatinib,inhibits'
p32213
g3
sS'in,no,significant'
p32214
g3
sS'little,consideration,to'
p32215
g3
sS'of,the,problems'
p32216
g3
sS'of,fertility,a'
p32217
g3
sS'with,tylenol,chloromycetin'
p32218
g9
sS'of,or,during'
p32219
g3
sS'presence,of,ml'
p32220
g3
sS'of,minutes,to'
p32221
g3
sS'interactions,vardenafil,had'
p32222
g3
sS'after,administration,but'
p32223
g3
sS'foradil,is,not'
p32224
g3
sS'nalfon,and,a'
p32225
g9
sS'have,been,case'
p32226
g3
sS'or,orally,administered'
p32227
g3
sS'more,conservatively,adjusted'
p32228
g9
sS'can,only,be'
p32229
g3
sS'high,intraluminal,concentrations'
p32230
g3
sS'components,with,only'
p32231
g3
sS'trademark,of,ames'
p32232
g3
sS'activity,but,given'
p32233
g3
sS'with,drugs,that'
p32234
g3
sS'the,extremities,and'
p32235
g3
sS'of,the,sympathetic'
p32236
g3
sS'transcriptional,activator,binding'
p32237
g3
sS'medicinal,products,that'
p32238
g3
sS'teratogenic,and,or'
p32239
g3
sS'especially,those,with'
p32240
g9
sS'of,and,veratrum'
p32241
g9
sS'who,were,to'
p32242
g3
sS'induce,cytochrome,p450'
p32243
g3
sS'the,therapeutic,effect'
p32244
g9
sS'in,any,of'
p32245
g3
sS'haloperidol,haloperidol,blocks'
p32246
g9
sS'because,or,activase'
p32247
g3
sS'probably,should,apply'
p32248
g3
sS'is,predominantly,metabolized'
p32249
g3
sS'pressure,of,less'
p32250
g9
sS'the,mean,half-life'
p32251
g9
sS'for,or,oral'
p32252
g3
sS'cure,and,to'
p32253
g3
sS'effects,specifically,lipid'
p32254
g3
sS'medicinal,or,dietary'
p32255
g3
sS'on,the,involvement'
p32256
g9
sS'the,association,of'
p32257
g3
sS'in,rats,did'
p32258
g3
sS'concentrations,to,exposures'
p32259
g3
sS'after,injection,of'
p32260
g9
sS'clear,within,a'
p32261
g3
sS'auc,of,during'
p32262
g3
sS'mg,qd,and'
p32263
g9
sS'which,metabolizes,may'
p32264
g3
sS'or,vaginal,preparations'
p32265
g3
sS'counter,medicines,including'
p32266
g3
sS'the,response,of'
p32267
g3
sS'of,patients,and'
p32268
g3
sS'hypercalcemia,too,much'
p32269
g9
sS'mg,m2,without'
p32270
g3
sS'patients,with,impaired'
p32271
g3
sS'oral,with,may'
p32272
g9
sS'and,to,alter'
p32273
g3
sS'on,dopamine2-,and'
p32274
g3
sS'app,polymer,p'
p32275
g3
sS'test,interactions,amphetamines'
p32276
g9
sS'because,moderate,cyp3a4'
p32277
g9
sS'confirmed,interactions,have'
p32278
g3
sS'clinical,problems,will'
p32279
g9
sS'were,measured,using'
p32280
g3
sS'decrease,thyroidal,uptake'
p32281
g9
sS'separate,studies,hydrochloride'
p32282
g3
sS'phenytoin,amphetamines,may'
p32283
g9
sS'be,minimized,or'
p32284
g9
sS'corticosteroids,concomitant,administration'
p32285
g9
sS'exist,on,interactions'
p32286
g3
sS'to,the,formation'
p32287
g9
sS'following,concomitant,administration'
p32288
g9
sS'and,distribution,of'
p32289
g3
sS'pr,interval,were'
p32290
g9
sS'relaxants,has,not'
p32291
g3
sS'interaction,during,pregnancy'
p32292
g3
sS'metabolism,in,normal'
p32293
g3
sS'given,intravenously,over'
p32294
g3
sS'acanthus,obtained,from'
p32295
g3
sS'drug,is,used'
p32296
g9
sS'the,stomach,drugs'
p32297
g9
sS'two,sequential,trials'
p32298
g3
sS'of,the,usual'
p32299
g9
sS'as,acetylsalicylic,acid'
p32300
g9
sS'was,used,to'
p32301
g3
sS'in,urinary,homocysteine'
p32302
g3
sS'prostatic,epithelium,in'
p32303
g9
sS'treatment,of,psychotic'
p32304
g3
sS'and,reduced,the'
p32305
g9
sS'presently,not,known'
p32306
g3
sS'of,have,not'
p32307
g3
sS'conversely,the,administration'
p32308
g3
sS'period,mg,kg'
p32309
g3
sS'inhibition,of,erythrocyte'
p32310
g9
sS'that,allegra,should'
p32311
g3
sS'when,and,crixivan'
p32312
g9
sS'p450,system,though'
p32313
g9
sS'collected,by,a'
p32314
g3
sS'does,not,bind'
p32315
g3
sS'of,the,controlled'
p32316
g3
sS'use,of,indocin'
p32317
g9
sS'apparent,effect,on'
p32318
g3
sS'inhibit,the,antitumor'
p32319
g3
sS'date,levosimendan,does'
p32320
g3
sS'the,remainder,were'
p32321
g3
sS'those,obtained,after'
p32322
g9
sS'fraction,of,and'
p32323
g3
sS'tegretol,trileptal,topamax'
p32324
g9
sS'effect,of,aprepitant'
p32325
g9
sS'clearance,of,caused'
p32326
g9
sS'artery,vasospasm,and'
p32327
g9
sS'b,or,corticosteroids'
p32328
g3
sS'of,fe,over'
p32329
g3
sS'used,when,cyp3a4'
p32330
g3
sS'in,serum,concentration'
p32331
g9
sS'interact,with,addictive'
p32332
g3
sS'and,l-lysine,may'
p32333
g9
sS'with,either,or'
p32334
g3
sS'resistance,which,is'
p32335
g3
sS'route,is,suitable'
p32336
g3
sS'hypothesis,that,such'
p32337
g3
sS'response,multiple,interacting'
p32338
g3
sS'abnormalities,in,platelet'
p32339
g3
sS'probably,is,adsorption'
p32340
g9
sS'patient,in,on'
p32341
g3
sS'mg,qd,was'
p32342
g3
sS'alone,or,in'
p32343
g3
sS'moderate,cyp1a2,inhibitors'
p32344
g9
sS'given,or,times'
p32345
g3
sS'sular,with,or'
p32346
g9
sS'inc,demonstrated,less'
p32347
g9
sS'rats,at,but'
p32348
g3
sS'the,hypothalamic-pituitary,testicular'
p32349
g3
sS'gut,motility,may'
p32350
g9
sS'and,increased,its'
p32351
g3
sS'decrease,anti-inflammatory,action'
p32352
g9
sS'other,pressor,agents'
p32353
g3
sS'of,flucoxacillin,and'
p32354
g3
sS'of,theophylline-related,side'
p32355
g9
sS'stopping,fluvoxamine,tablets'
p32356
g9
sS'three-,to,fivefold'
p32357
g3
sS'effect,did,not'
p32358
g3
sS'and,bone,and'
p32359
g9
sS'and,may,require'
p32360
g3
sS'of,renal,prostaglandin'
p32361
g3
sS'option,in,the'
p32362
g3
sS'therapeutic,dose,of'
p32363
g9
sS'avoided,beta-blockers,and'
p32364
g9
sS'female,rats,appear'
p32365
g3
sS'article,review,papers'
p32366
g3
sS'taking,antiseizure,medication'
p32367
g3
sS'patients,taking,tricyclic'
p32368
g9
sS'females,and,auc'
p32369
g9
sS'the,two,groups'
p32370
g3
sS'of,more,malignant'
p32371
g3
sS'application,of,insp'
p32372
g3
sS'to,although,there'
p32373
g9
sS'also,due,to'
p32374
g9
sS'serum,prostate-specific,antigen'
p32375
g3
sS'than,that,observed'
p32376
g9
sS'activity,but,in'
p32377
g3
sS'cytochrome,p450,enzyme-inducer'
p32378
g9
sS'to,increase,blood'
p32379
g9
sS'such,as,cns'
p32380
g3
sS'other,and,have'
p32381
g3
sS'is,a,agonist'
p32382
g9
sS'considered,for,the'
p32383
g3
sS'known,to,cause'
p32384
g3
sS'exception,of,there'
p32385
g3
sS'and,prolong,and'
p32386
g3
sS'blocking,the,tail-flick'
p32387
g3
sS'once,weekly,or'
p32388
g3
sS'administered,once,daily'
p32389
g9
sS'and,behavioral,inhibition'
p32390
g3
sS'the,same,day'
p32391
g9
sS'and,is,generally'
p32392
g9
sS'qid,did,not'
p32393
g3
sS'with,simultaneous,dosing'
p32394
g9
sS'in,patients,is'
p32395
g9
sS'level,is,recommended'
p32396
g3
sS'be,used,in'
p32397
g3
sS'account,when,evaluating'
p32398
g3
sS'in,patients,in'
p32399
g3
sS'folate,utilization,including'
p32400
g9
sS'be,used,if'
p32401
g9
sS'acid,aminocaproic,acid'
p32402
g3
sS'or,the,initial'
p32403
g9
sS'of,neural,pathways'
p32404
g3
sS'training,dose,in'
p32405
g3
sS'only,on,clinical'
p32406
g3
sS'than,dose,levels'
p32407
g3
sS'since,is,frequently'
p32408
g3
sS'levels,total,auc'
p32409
g9
sS'and,fr,responding'
p32410
g3
sS'both,and,coreg'
p32411
g9
sS'include,increased,sedation'
p32412
g9
sS'effects,of,ruthenium'
p32413
g3
sS'be,applied,for'
p32414
g3
sS'to,fold,elevation'
p32415
g9
sS'of,increased,dramatically'
p32416
g3
sS'intracranial,pressure,their'
p32417
g9
sS'in,users,of'
p32418
g3
sS'by,a,nonlethal'
p32419
g3
sS'levels,considerably,lower'
p32420
g9
sS'modification,is,recommended'
p32421
g3
sS'given,single,mg'
p32422
g9
sS'be,explained,either'
p32423
g3
sS'interactions,with,in'
p32424
g3
sS'compromised,cardiovascular,system'
p32425
g3
sS'test,results,and'
p32426
g9
sS'other,given,concurrently'
p32427
g9
sS'p450,d6,and'
p32428
g3
sS'structures,whereas,h-spiroperidol'
p32429
g3
sS'in,thyroxine,output'
p32430
g3
sS'continued,admistration,of'
p32431
g3
sS'other,vasoconstrictor,can'
p32432
g9
sS'hydrochloride,mg,every'
p32433
g3
sS'concentrations,in,otherwise'
p32434
g9
sS'l-arginine,supplements,theoretically'
p32435
g9
sS'inr,or,due'
p32436
g3
sS'is,consistent,with'
p32437
g3
sS'fr,responding,in'
p32438
g3
sS'or,increased,prothrombin'
p32439
g9
sS'erythro-fluorocitrate,synthesis,or'
p32440
g3
sS'or,other,formal'
p32441
g3
sS'and,include,but'
p32442
g3
sS'displace,other,protein-bound'
p32443
g3
sS'basic,as,well'
p32444
g9
sS'been,observed,with'
p32445
g3
sS'doses,has,been'
p32446
g9
sS'or,corrected,qt'
p32447
g3
sS'depressant,effect,of'
p32448
g9
sS'majority,of,these'
p32449
g3
sS'the,animals,were'
p32450
g3
sS'of,hours,after'
p32451
g9
sS'caused,a,dose-related'
p32452
g9
sS'potential,on,the'
p32453
g3
sS'interfere,with,bioassay'
p32454
g3
sS'mg,vardenafil,dose'
p32455
g9
sS'patients,given,oral'
p32456
g3
sS'study,data,to'
p32457
g9
sS'of,metabolism,via'
p32458
g9
sS'and,effects,potentially'
p32459
g3
sS'on,hepatic,cytochrome'
p32460
g3
sS'is,of,clinical'
p32461
g3
sS'in,all,animal'
p32462
g3
sS'with,that,potentiate'
p32463
g3
sS'four-session,placebo-controlled,within-subject'
p32464
g3
sS'of,robinul,injection'
p32465
g9
sS'm1,the,active'
p32466
g9
sS'hydroxylamine,a,metabolite'
p32467
g3
sS'responsiveness,to,the'
p32468
g3
sS'and,mg,each'
p32469
g9
sS'major,psychotic,disorders'
p32470
g9
sS'safety,of,pharmacologic'
p32471
g3
sS'unchanged,alkaloids,and'
p32472
g9
sS'means,of,the'
p32473
g3
sS'kg,day,is'
p32474
g3
sS'antidepressants,or,other'
p32475
g3
sS'of,and,lodine'
p32476
g9
sS'patients,with,type'
p32477
g3
sS'adverse,events,in'
p32478
g3
sS'drugs,that,affect'
p32479
g3
sS'supervision,and,careful'
p32480
g3
sS'tablets,but,not'
p32481
g3
sS'kg,day,in'
p32482
g9
sS'in,a,study'
p32483
g9
sS'kg,day,im'
p32484
g3
sS'should,not,beadministered'
p32485
g9
sS'that,are,actively'
p32486
g9
sS'case-control,and,cohort'
p32487
g9
sS'least,one,hour'
p32488
g3
sS'or,dose,mu'
p32489
g3
sS'interactions,with,commonly'
p32490
g3
sS'particular,a2,d6'
p32491
g3
sS'were,administered,one'
p32492
g3
sS'from,urine,or'
p32493
g3
sS'these,patients,the'
p32494
g3
sS'reflected,in,urinary'
p32495
g9
sS'use,of,two'
p32496
g9
sS'vision,and,other'
p32497
g9
sS'whether,this,was'
p32498
g3
sS'given,in,a'
p32499
g9
sS'to,midcycle,day'
p32500
g3
sS'whose,plasma,levels'
p32501
g3
sS'of,was,associated'
p32502
g3
sS'on,a,mg'
p32503
g3
sS'administered,with,food'
p32504
g9
sS'may,produce,severe'
p32505
g9
sS'of,desmopressin,is'
p32506
g3
sS'resistance,to,the'
p32507
g9
sS'enhanced,by,the'
p32508
g9
sS'beginning,depletion,of'
p32509
g9
sS'control,should,not'
p32510
g9
sS'effect,on,cas'
p32511
g9
sS'antagonists,phenyltheophylline,and'
p32512
g3
sS'eg,may,increase'
p32513
g9
sS'formulations,containing,buffer'
p32514
g9
sS'evaluate,the,interactions'
p32515
g3
sS'individual,and,family'
p32516
g3
sS'not,detect,an'
p32517
g3
sS'given,to,patients'
p32518
g3
sS'concomitant,and,chemotherapy'
p32519
g3
sS'if,the,are'
p32520
g3
sS'of,competitive,displacement'
p32521
g3
sS'increase,the,absorption'
p32522
g9
sS'recently,identified,case'
p32523
g3
sS'stimulate,egf-,or'
p32524
g9
sS'proteins,in,vitro'
p32525
g3
sS'hyperreflexia,and,incoordination'
p32526
g9
sS'to,cause,a'
p32527
g9
sS'nsaids,was,similar'
p32528
g3
sS'therefore,patients,with'
p32529
g3
sS'average,by,and'
p32530
g9
sS'patients,with,human'
p32531
g3
sS'effectiveness,of,combination'
p32532
g3
sS'if,combination,therapy'
p32533
g3
sS'local,use,of'
p32534
g3
sS'patients,already,stabilized'
p32535
g9
sS'lower,affinity,for'
p32536
g9
sS'approximately,one-hundredth,of'
p32537
g3
sS'administration,of,hydroxide'
p32538
g3
sS'to,oral,the'
p32539
g3
sS'therapeutic,ratio,or'
p32540
g3
sS'interactions,were,not'
p32541
g3
sS'days,after,administration'
p32542
g9
sS'similar,to,and'
p32543
g3
sS'topo,i,expression'
p32544
g3
sS'a,times,increase'
p32545
g9
sS'antagonist,that,may'
p32546
g9
sS'significantly,improved,permeation'
p32547
g3
sS'increased,the,incidence'
p32548
g9
sS'to,the,combination'
p32549
g3
sS'may,sensitize,the'
p32550
g9
sS'essential,tissue,culture'
p32551
g3
sS'then,mg,kg'
p32552
g3
sS'with,resistance,which'
p32553
g3
sS'in,the,course'
p32554
g3
sS'urinary,bilirubin,urobilin'
p32555
g3
sS'vivo,the,primary'
p32556
g9
sS'a,narrow,therapeutic'
p32557
g9
sS'of,class,ia'
p32558
g9
sS'causes,of,at'
p32559
g3
sS'enhance,the,cns-depressive'
p32560
g9
sS'the,classes,of'
p32561
g3
sS'that,its,metabolism'
p32562
g3
sS'of,a,mg'
p32563
g3
sS'so,active,suggesting'
p32564
g3
sS'a,maintenance,schedule'
p32565
g9
sS'whereas,the,mean'
p32566
g9
sS'who,take,epa'
p32567
g3
sS'these,are,that'
p32568
g3
sS'the,initiate,therapy'
p32569
g9
sS'on,previous,experience'
p32570
g3
sS'if,additional,adrenergic'
p32571
g9
sS'should,have,the'
p32572
g3
sS'bring,into,question'
p32573
g3
sS'by,measuring,locomotor'
p32574
g3
sS'agents,gastrointestinal,acidifying'
p32575
g9
sS'that,time,the'
p32576
g3
sS'effect,of,concomitant'
p32577
g3
sS'volatile,inhalation,are'
p32578
g9
sS'at,doses,mg'
p32579
g3
sS'cardiovascular,system,may'
p32580
g9
sS'topoisomerase-targeted,chemotherapy,in'
p32581
g3
sS'as,have,the'
p32582
g9
sS'on,glucose,tolerance'
p32583
g3
sS'the,corrected,qt'
p32584
g3
sS'patients,with,high'
p32585
g3
sS'beta-blockers,not,only'
p32586
g9
sS'most,out,of'
p32587
g3
sS'system,mainly,responsible'
p32588
g9
sS'blunts,the,reflex'
p32589
g9
sS'coadministration,of,itraconazole'
p32590
g9
sS's,effects,on'
p32591
g3
sS'the,potential,of'
p32592
g9
sS'noted,that,incidence'
p32593
g3
sS'hyperprolactinaemia,as,seen'
p32594
g3
sS'ventricular,tachycardia,and'
p32595
g3
sS'potent,inhibition,inhibition'
p32596
g3
sS'alprazolam,when,maleate'
p32597
g9
sS'p450,d6,isozyme'
p32598
g3
sS'at,the,cardiac'
p32599
g3
sS'x,kg,in'
p32600
g3
sS'the,chop-haart,patients'
p32601
g3
sS'to,see,whether'
p32602
g9
sS'cautioned,regarding,potential'
p32603
g3
sS'conversion,to,inactive'
p32604
g3
sS'adrenal,function,tests'
p32605
g3
sS'by,the,accumulation'
p32606
g3
sS'as,and,inhibit'
p32607
g3
sS'bactericidal,activity,is'
p32608
g3
sS'antacids,may,interfere'
p32609
g9
sS'blockers,may,result'
p32610
g3
sS'vasospasm,and,ischemia'
p32611
g3
sS'in,cortisol,does'
p32612
g3
sS'using,labetalol,hcl'
p32613
g9
sS'advised,especially,at'
p32614
g3
sS'studies,show,that'
p32615
g3
sS'th,day,provided'
p32616
g9
sS'a,focus,on'
p32617
g3
sS'for,cyp3a4,and'
p32618
g3
sS'active,metabolite,of'
p32619
g3
sS'and,mesenteric,vasodilation'
p32620
g9
sS'sodium,valproic,acid'
p32621
g9
sS'have,resulted,when'
p32622
g9
sS'patients,who,had'
p32623
g3
sS'is,administered,shortly'
p32624
g9
sS'potent,cyp3a4,enzyme'
p32625
g3
sS'concurrent,administration,with'
p32626
g9
sS'mg,dl,submitted'
p32627
g3
sS'except,for,patients'
p32628
g3
sS'when,k,antagonists'
p32629
g9
sS'or,related,psychoses'
p32630
g3
sS'unaffected,given,the'
p32631
g9
sS'has,focused,on'
p32632
g3
sS'of,cyp450,a4'
p32633
g3
sS'therapy,includes,such'
p32634
g3
sS'patients,with,severely'
p32635
g3
sS'therapy,standard,in'
p32636
g3
sS'amplitude,of,most'
p32637
g3
sS'eproxindine,ethanol,flupenthixol'
p32638
g9
sS'by,millions,of'
p32639
g3
sS'been,termed,the'
p32640
g3
sS'was,used,in'
p32641
g9
sS'hour,after,receiving'
p32642
g9
sS'studying,of,serum'
p32643
g3
sS'half-life,increased,from'
p32644
g3
sS'or,implant,have'
p32645
g3
sS'studies,with,human'
p32646
g3
sS'glucuronide,account,for'
p32647
g3
sS'two,weeks,prior'
p32648
g9
sS'locomotor,activity,and'
p32649
g3
sS'leading,to,inter-patient'
p32650
g9
sS'on,a,patient'
p32651
g3
sS'elimination,half-life,and'
p32652
g9
sS'were,subsequently,administered'
p32653
g9
sS'treatment,is,followed'
p32654
g3
sS'serial,measurement,of'
p32655
g9
sS'which,are,not'
p32656
g3
sS'required,during,omnicef'
p32657
g9
sS'of,other,with'
p32658
g9
sS'volunteers,who,had'
p32659
g3
sS'in,addition,fondaparinux'
p32660
g3
sS'and,a,known'
p32661
g9
sS'this,interference,has'
p32662
g3
sS'zinecard,does,not'
p32663
g3
sS'significant,interactions,may'
p32664
g3
sS'vitro,binding,of'
p32665
g9
sS'g,kg,mg'
p32666
g3
sS'infusion,or,was'
p32667
g3
sS'establish,strategies,to'
p32668
g3
sS'consideration,to,the'
p32669
g3
sS'mao,inhibitors,studies'
p32670
g9
sS'avoided,unless,clinically'
p32671
g9
sS'diabetes,mellitus,and'
p32672
g3
sS'for,excretion,in'
p32673
g9
sS'b,the,effects'
p32674
g3
sS'some,patients,undergoing'
p32675
g3
sS'develop,toxicity,characteristics'
p32676
g9
sS'for,women,who'
p32677
g3
sS'if,any,on'
p32678
g3
sS'if,any,of'
p32679
g3
sS'of,components,p1'
p32680
g3
sS'types,of,channels'
p32681
g3
sS'decrease,the,peak'
p32682
g3
sS'were,experienced,more'
p32683
g9
sS'analogue,d-ala2,metenkephalinamide'
p32684
g3
sS'the,proposed,mechanisms'
p32685
g3
sS'continuing,surveillance,of'
p32686
g3
sS'by,these,enzyme'
p32687
g3
sS'because,a,similar'
p32688
g9
sS'clearance,and,a'
p32689
g9
sS'according,to,a'
p32690
g3
sS'average,of,fold'
p32691
g9
sS'started,in,patients'
p32692
g9
sS'may,vary,and'
p32693
g3
sS'antacids,kaolin-pectin,certain'
p32694
g9
sS'tablets,as,well'
p32695
g9
sS'mg,ml,and'
p32696
g3
sS'among,patients,with'
p32697
g9
sS'pressure,and,blood'
p32698
g3
sS'with,amevive,before'
p32699
g3
sS'mg,increased,the'
p32700
g9
sS'to,insulin-induced,hypoglycemia'
p32701
g3
sS'rr,had,no'
p32702
g3
sS'hours,after,or'
p32703
g9
sS'was,no,pharmacodynamic'
p32704
g3
sS'herbal,remedies,nephropathies'
p32705
g3
sS'required,when,administering'
p32706
g3
sS'serious,and,life-threatening'
p32707
g3
sS'or,primidone,no'
p32708
g3
sS'a,clinically,important'
p32709
g3
sS'of,was,lowered'
p32710
g9
sS'renal,excretion,is'
p32711
g9
sS'be,monitored,in'
p32712
g9
sS'oxidase,inhibitors,or'
p32713
g9
sS'the,csf,primarily'
p32714
g3
sS'nc,denotes,a'
p32715
g9
sS'increase,of,approximately'
p32716
g9
sS'human,immediately,before'
p32717
g3
sS'the,elderly,and'
p32718
g3
sS'that,interacts,with'
p32719
g3
sS'vasculature,without,disturbing'
p32720
g3
sS'toxoids,should,be'
p32721
g9
sS'can,progress,very'
p32722
g3
sS'by,added,cholesterol'
p32723
g3
sS'effects,of,brovana'
p32724
g9
sS'relevant,concentrations,in'
p32725
g3
sS'disturbances,were,not'
p32726
g9
sS'treatment,of,negative'
p32727
g3
sS'prolonged,survival,in'
p32728
g3
sS'emergency,situation,when'
p32729
g9
sS'were,reflected,in'
p32730
g3
sS'order,to,lessen'
p32731
g3
sS'increased,as,required'
p32732
g3
sS'studies,ie,timi-ii'
p32733
g3
sS'is,available,about'
p32734
g3
sS'and,relative,importance'
p32735
g3
sS'or,hypokalemia,that'
p32736
g9
sS'decrease,the,amount'
p32737
g9
sS'cardiovascular,and,identifies'
p32738
g3
sS'omeprazole,should,be'
p32739
g3
sS'intravenously,administered,mg'
p32740
g9
sS'withdrawn,within,hours'
p32741
g3
sS'of,methylpyrazole,seen'
p32742
g9
sS'patient,pharmacokinetic,data'
p32743
g9
sS'triazole,have,not'
p32744
g3
sS'were,picr,detected'
p32745
g3
sS'including,humira,may'
p32746
g9
sS'volunteers,of,subjects'
p32747
g9
sS'cmax,leading,to'
p32748
g9
sS'mice,from,the'
p32749
g3
sS'prodrug,form,of'
p32750
g3
sS'occurrence,of,osteomalacia'
p32751
g3
sS'by,an,alteration'
p32752
g3
sS'and,pharmacist,before'
p32753
g3
sS'changes,in,platelets'
p32754
g3
sS'significant,degree,should'
p32755
g3
sS'erythromycin,in,healthy'
p32756
g9
sS'the,relevance,to'
p32757
g3
sS'when,myocardial,depressants'
p32758
g9
sS'phenyl-butazone,sodium,and'
p32759
g3
sS'using,it,is'
p32760
g9
sS'depressants,are,administered'
p32761
g9
sS'have,a,narrow'
p32762
g9
sS'or,cyp3a4,in'
p32763
g3
sS'or,synergistic,depressant'
p32764
g3
sS'that,exogenous,co-factors'
p32765
g3
sS'patients,the,steroidal'
p32766
g9
sS'daily,produced,a'
p32767
g9
sS'to,produce,local'
p32768
g3
sS'of,for,up'
p32769
g3
sS'to,the,concentrations'
p32770
g3
sS'hdl,and,hdl2'
p32771
g3
sS'simply,normalizing,the'
p32772
g3
sS'substantial,intercurrent,use'
p32773
g3
sS'because,is,a'
p32774
g9
sS'salivary,cortisol,levels'
p32775
g3
sS'effect,with,in'
p32776
g9
sS'lowest,recommended,dose'
p32777
g9
sS'of,cyp3a4,have'
p32778
g3
sS'pharmacokinetic,substudy,in'
p32779
g9
sS'mg,kg,with'
p32780
g9
sS'concomitant,substrate,should'
p32781
g3
sS'enzyme,involved,in'
p32782
g3
sS'evaluation,of,the'
p32783
g3
sS'it,may,increase'
p32784
g9
sS'digitalized,hypothyroid,patient'
p32785
g9
sS'a,broad,spectrum'
p32786
g3
sS'behavioral,sensitization,similar'
p32787
g3
sS'effect,of,these'
p32788
g3
sS'the,same,dose'
p32789
g9
sS'was,obtained,for'
p32790
g3
sS'on,an,oral'
p32791
g3
sS'or,less,frequent'
p32792
g9
sS'inactivate,the,activity'
p32793
g9
sS'baraclude,with,that'
p32794
g3
sS'increased,plasminogen,antigen'
p32795
g3
sS'of,these,leading'
p32796
g9
sS'concern,regarding,asthma'
p32797
g3
sS'of,contraception,should'
p32798
g9
sS'function,tests,are'
p32799
g3
sS'used,in,establishing'
p32800
g3
sS'acid,have,been'
p32801
g9
sS'than,for,exjade'
p32802
g9
sS'hypotensive,using,labetalol'
p32803
g9
sS'dialyzed,were,and'
p32804
g3
sS'subject,before,and'
p32805
g3
sS'mac,with,more'
p32806
g3
sS'to,and,st'
p32807
g3
sS'doubled,in,the'
p32808
g3
sS'measurement,must,be'
p32809
g3
sS'im,was,given'
p32810
g3
sS'other,that,require'
p32811
g3
sS'of,single,oral'
p32812
g9
sS'adverse,effects,may'
p32813
g3
sS'with,some,other'
p32814
g9
sS'percentage,increase,in'
p32815
g9
sS'large,quantities,of'
p32816
g3
sS'protein-bound,with,narrow'
p32817
g9
sS'agents,channel,blockers'
p32818
g9
sS'interactions,have,not'
p32819
g3
sS'to,its,proposed'
p32820
g3
sS'impairment,in,vitro'
p32821
g3
sS'days,a,decrease'
p32822
g9
sS'and,hours,were'
p32823
g9
sS'effects,seen,are'
p32824
g3
sS'affinity,for,than'
p32825
g9
sS'blocker,was,studied'
p32826
g3
sS'site,ie,recall'
p32827
g3
sS'defect,in,cytochrome'
p32828
g3
sS'up,to,x'
p32829
g3
sS'foods,highly,fortified'
p32830
g3
sS'to,approximately,of'
p32831
g3
sS'and,adjustment,of'
p32832
g9
sS'period,of,min'
p32833
g9
sS'upon,the,particular'
p32834
g3
sS'or,in,conjunction'
p32835
g3
sS'population,pharmacokinetics,analysis'
p32836
g3
sS'their,bioavailability,was'
p32837
g9
sS'inter-patient,variation,in'
p32838
g9
sS'microsomes,cyp1a2,cyp2c9'
p32839
g3
sS'may,be,similar'
p32840
g3
sS'either,discontinuing,the'
p32841
g9
sS'diltiazem,plasma,levels'
p32842
g3
sS'cns,depressants,causing'
p32843
g9
sS'and,tnf,antagonists'
p32844
g9
sS'therapy,with,nsaids'
p32845
g3
sS'neither,were,pharmacokinetic'
p32846
g3
sS'or,nsaid,users'
p32847
g3
sS'nearly,times,the'
p32848
g3
sS'drawn,if,a'
p32849
g9
sS'of,erythema,pruritus'
p32850
g3
sS'range,of,patients'
p32851
g9
sS'with,beta-adrenergic,blocking'
p32852
g9
sS'and,intravenous,placebo'
p32853
g3
sS'contraceptives,valdecoxib,mg'
p32854
g3
sS'or,pcp,in'
p32855
g9
sS'extraneal,on,absorption'
p32856
g3
sS'fo,the,experiment'
p32857
g3
sS'that,the,time'
p32858
g3
sS'acid-catalyzed,ethanolysis,of'
p32859
g9
sS'increase,the,frequency'
p32860
g9
sS'is,to,be'
p32861
g9
sS'gain,and,weight'
p32862
g9
sS'kg,min,dose'
p32863
g3
sS'to,but,it'
p32864
g9
sS'the,community,or'
p32865
g3
sS'with,systemically-administered,oral'
p32866
g9
sS'pancreases,of,normal'
p32867
g3
sS'than,peak,plasma'
p32868
g3
sS'on,the,rd'
p32869
g3
sS'a,substrate,a'
p32870
g3
sS'important,effect,on'
p32871
g3
sS'the,digi-,tab'
p32872
g3
sS'to,their,differential'
p32873
g3
sS'hypertension,in,patients'
p32874
g9
sS'possible,deleterious,effects'
p32875
g3
sS'at,the,aviano'
p32876
g3
sS's,wort,hypericum'
p32877
g3
sS'dissolution,of,aerosol'
p32878
g3
sS'thiazide,can,be'
p32879
g9
sS'data,lower,doses'
p32880
g9
sS'hmg-coa,reductase,may'
p32881
g3
sS'reduce,its,serum'
p32882
g3
sS'differin,gel,has'
p32883
g3
sS'hours,competes,for'
p32884
g9
sS'the,lysate,of'
p32885
g3
sS'deaths,three,cases'
p32886
g3
sS'a,relatively,specific'
p32887
g3
sS'studies,with,ace'
p32888
g9
sS'can,produce,nephrotoxicity'
p32889
g9
sS'co-administration,of,angiomax'
p32890
g9
sS'cells,mm3,for'
p32891
g3
sS'of,the,bile-acidsequestering'
p32892
g3
sS'by,nonlethal,mg'
p32893
g3
sS'triazolo-benzodiazepines,dihydropyridine,channel'
p32894
g9
sS'when,the,two'
p32895
g9
sS'must,be,provided'
p32896
g3
sS'of,age,the'
p32897
g3
sS'auc,of,there'
p32898
g9
sS'to,the,stress'
p32899
g3
sS'and,mycophenolate,mofetil'
p32900
g9
sS'toxicokinetic,interferences,between'
p32901
g3
sS'of,the,effects'
p32902
g3
sS'a,drug-drug,interaction'
p32903
g9
sS'known,to,be'
p32904
g3
sS'squares,approach,can'
p32905
g3
sS'non-myelinated,axons,contained'
p32906
g3
sS'with,one,gram'
p32907
g9
sS'hyperthermia,rigidity,myoclonus'
p32908
g9
sS'cause,severe,orthostatic'
p32909
g9
sS'cohort,or,mg'
p32910
g3
sS'of,representative,metabolized'
p32911
g3
sS'livers,of,genetically'
p32912
g3
sS'hour,blood,concentration'
p32913
g9
sS'role,in,determining'
p32914
g3
sS'studies,are,needed'
p32915
g3
sS'day-old,embryos,was'
p32916
g3
sS'sodium,approximately,hours'
p32917
g9
sS'the,environment,and'
p32918
g3
sS'which,are,thought'
p32919
g3
sS'and,dmpge2-induced,jejunal'
p32920
g3
sS'increased,the,amplitudes'
p32921
g3
sS'in,one,report'
p32922
g9
sS'triglycerides,or,bone'
p32923
g3
sS'taking,an,eg'
p32924
g9
sS'renal,and,mesenteric'
p32925
g9
sS'infusion,site,for'
p32926
g3
sS'reports,of,oral'
p32927
g3
sS'strains,from,addicts'
p32928
g3
sS'of,each,year'
p32929
g3
sS'as,mg,kg'
p32930
g3
sS'and,or,amenorrhea'
p32931
g3
sS'following,specific,interactions'
p32932
g3
sS'low,cardiac,capacity'
p32933
g3
sS'c9,and,cyp'
p32934
g3
sS'fibric,acid,derivatives'
p32935
g3
sS'kg,of,co'
p32936
g3
sS'the,direction,of'
p32937
g3
sS'events,when,was'
p32938
g3
sS'interact,with,medication'
p32939
g3
sS'meperidine,amphetamines,potentiate'
p32940
g9
sS'oral,self-administration,of'
p32941
g3
sS'the,proton,pump'
p32942
g9
sS'are,present,in'
p32943
g3
sS'were,cardiac,and'
p32944
g3
sS'can,diminish,or'
p32945
g9
sS'exposure,of,and'
p32946
g9
sS'nafarelin,acetate,is'
p32947
g3
sS'creatinine,clearance,in'
p32948
g9
sS'elevated,glucose,levels'
p32949
g3
sS'needed,the,dose'
p32950
g9
sS'constant,volume,of'
p32951
g3
sS'sensitive,assay,system'
p32952
g3
sS'as,hours,and'
p32953
g9
sS'pharmacological,tool,with'
p32954
g3
sS'glyburide,is,a'
p32955
g3
sS'of,by,sodium'
p32956
g3
sS'of,elixir,was'
p32957
g3
sS'patients,who,received'
p32958
g3
sS'within,days,of'
p32959
g9
sS'in,the,urine'
p32960
g3
sS'd2,in,the'
p32961
g3
sS'renal,cationic,secretion'
p32962
g3
sS'with,has,not'
p32963
g3
sS'peak,plasma,levels'
p32964
g9
sS'most,genotoxic,compounds--can'
p32965
g3
sS'only,observed,in'
p32966
g9
sS'to,be,more'
p32967
g3
sS'demonstrated,for,cigarette'
p32968
g3
sS'this,oral,did'
p32969
g3
sS'mg,resulted,in'
p32970
g9
sS'converted,to,the'
p32971
g9
sS'severe,and,unpredictable'
p32972
g9
sS'levels,increased,approximately'
p32973
g9
sS'from,serum-deprived,ras-3t3'
p32974
g3
sS'on,the,mechanism'
p32975
g3
sS'time,concomitant,supplementation'
p32976
g3
sS'warfarin-type,certain,and'
p32977
g9
sS'may,be,an'
p32978
g9
sS'to,as,poor'
p32979
g3
sS'vardenafil,mg,produced'
p32980
g9
sS'of,patients,including'
p32981
g3
sS'mg,once,a'
p32982
g3
sS'group,developed,a'
p32983
g3
sS'and,certain,nonsteroidal'
p32984
g9
sS'dosage,of,needed'
p32985
g9
sS'recommended,maximum,cumulative'
p32986
g9
sS'hcl,with,most'
p32987
g9
sS'may,be,at'
p32988
g3
sS'compared,to,subjects'
p32989
g9
sS'effect,on,exposure'
p32990
g3
sS'it,is,assumed'
p32991
g3
sS'short-term,pharmacokinetic,studies'
p32992
g9
sS'monthly,comparison,study'
p32993
g3
sS'exceeded,when,used'
p32994
g9
sS'day,washout,period'
p32995
g3
sS'exerts,its,effect'
p32996
g3
sS'body,weight,and'
p32997
g3
sS'ways,of,improving'
p32998
g3
sS'group,is,currently'
p32999
g3
sS'if,you,think'
p33000
g3
sS'the,results,raise'
p33001
g9
sS'hepatic,there,is'
p33002
g3
sS'results,would,seem'
p33003
g9
sS'ethanolysis,of,in'
p33004
g9
sS'hypericum,perforatum,may'
p33005
g3
sS'metanephrine,normetanephrine,and'
p33006
g3
sS'level,hyperlipidaemia,and'
p33007
g3
sS'sex,men,and'
p33008
g3
sS'scale,were,increased'
p33009
g9
sS'other,cns-active,should'
p33010
g9
sS'in,platelets,and'
p33011
g3
sS'in,humans,and'
p33012
g9
sS'involving,concomitant,administration'
p33013
g3
sS'may,have,life-threatening'
p33014
g9
sS'in,liver,by'
p33015
g3
sS'anafranil,in,combination'
p33016
g3
sS'itraconazole,and,oral'
p33017
g9
sS'mean,value,of'
p33018
g3
sS'biliary,excretion,glucuronidation'
p33019
g3
sS'added,to,pooled'
p33020
g3
sS'administration,decreased,bioavailability'
p33021
g9
sS'facilitates,acquisition,of'
p33022
g3
sS'concentrations,were,equivocally'
p33023
g9
sS'fatal,hepatic,failure'
p33024
g3
sS'perfusion,did,not'
p33025
g3
sS'increase,in,clearance'
p33026
g9
sS'bleeding,in,etodolac-treated'
p33027
g9
sS'for,therapy,and'
p33028
g3
sS'at,very,high'
p33029
g3
sS'a,cetaminophen,hepatoxicity'
p33030
g3
sS'for,a,change'
p33031
g9
sS'the,in,nursing'
p33032
g3
sS'pulse,of,carcinogen'
p33033
g3
sS'with,four,kinds'
p33034
g3
sS'polyamines,might,help'
p33035
g3
sS'who,were,already'
p33036
g3
sS'were,unaffected,following'
p33037
g3
sS'release,in,the'
p33038
g3
sS'antiretroviral,drugs,significant'
p33039
g9
sS'a2,a6,c9'
p33040
g3
sS'drugs,which,induce'
p33041
g9
sS'the,decision,to'
p33042
g3
sS'a,synergistic,or'
p33043
g3
sS'the,dextrorotatory,isomer'
p33044
g3
sS'with,knowledge,of'
p33045
g3
sS'administered,or,if'
p33046
g3
sS'older,ask,your'
p33047
g3
sS'indocin,is,administered'
p33048
g9
sS'during,the,longterm'
p33049
g3
sS'of,brevibloc,and'
p33050
g9
sS'of,hyperpyrexia,eight'
p33051
g3
sS'with,have,a'
p33052
g3
sS'balance,patient,access'
p33053
g3
sS'used,if,patients'
p33054
g9
sS'hepatitis,has,been'
p33055
g9
sS'that,are,metabolized'
p33056
g3
sS'even,when,tested'
p33057
g3
sS'instituted,as,well'
p33058
g9
sS'may,be,negatively'
p33059
g3
sS'mcg,twice,daily'
p33060
g3
sS'to,treat,a'
p33061
g3
sS'administration,on,a'
p33062
g3
sS'of,racemic,celexa'
p33063
g9
sS'pharmacoeconomic,analyses,indicate'
p33064
g3
sS'and,or,hypotension'
p33065
g9
sS'during,can,be'
p33066
g9
sS'be,taken,with'
p33067
g3
sS'been,frequently,administered'
p33068
g3
sS'were,completely,inhibited'
p33069
g9
sS'ways,to,avoid'
p33070
g3
sS'inhibitory,towards,the'
p33071
g3
sS'while,no,formal'
p33072
g3
sS'days,of,daily'
p33073
g3
sS'interaction,studies,did'
p33074
g3
sS'mesenteric,arteries,from'
p33075
g3
sS'the,diets,no'
p33076
g3
sS'levels,are,being'
p33077
g3
sS'reduced,by,the'
p33078
g9
sS'intercourse,with,a'
p33079
g3
sS'higher,than,that'
p33080
g9
sS'and,instruct,the'
p33081
g3
sS'the,or,type'
p33082
g9
sS'test,interactions,blood'
p33083
g3
sS'a,more,efficient'
p33084
g3
sS'comparable,to,those'
p33085
g3
sS'beta-1a,avonex,mcg'
p33086
g9
sS'effective,in,significantly'
p33087
g9
sS'reduce,the,effects'
p33088
g9
sS'inhibitors,of,p450'
p33089
g3
sS'these,in,combination'
p33090
g3
sS'minimum,inhibitory,concentration'
p33091
g3
sS'day,regimen,of'
p33092
g9
sS'follow-up,blood,lipids'
p33093
g3
sS'inhibitors,intravenous,and'
p33094
g3
sS'n,pretreatment,with'
p33095
g9
sS'function,or,coagulation'
p33096
g3
sS'indicated,by,the'
p33097
g3
sS'with,drugs,or'
p33098
g3
sS'to,have,decreased'
p33099
g9
sS'the,same,pharmacological'
p33100
g3
sS'intravenous,in,ontario'
p33101
g3
sS'agents,enalapril,and'
p33102
g3
sS'but,its,inhibitory'
p33103
g3
sS'appear,before,there'
p33104
g3
sS'to,match,an'
p33105
g3
sS'reduce,the,bioavailability'
p33106
g9
sS'unexplored,area,and'
p33107
g3
sS'vasorelaxation,in,resistance'
p33108
g3
sS'compelling,reasons,for'
p33109
g3
sS'of,pointer,dogs'
p33110
g3
sS'important,potentiation,of'
p33111
g3
sS'interaction,is,unlikely'
p33112
g3
sS'both,the,and'
p33113
g9
sS'tricyclic,when,used'
p33114
g9
sS'dose,to,mg'
p33115
g9
sS'importance,of,the'
p33116
g3
sS'the,may,be'
p33117
g9
sS'the,anti-glaucoma,action'
p33118
g9
sS'relationship,have,not'
p33119
g9
sS'of,other,aeds'
p33120
g3
sS'animals,edetate,disodium'
p33121
g9
sS'ethinyl,estradiol,by'
p33122
g9
sS'by,mg,day'
p33123
g9
sS'the,uptake,inhibitor'
p33124
g3
sS'be,precipitated,by'
p33125
g3
sS'time,for,hour'
p33126
g9
sS'with,bextra,in'
p33127
g9
sS'a,day,before'
p33128
g3
sS'the,carbachol-stimulated,intracellular'
p33129
g9
sS'with,bextra,is'
p33130
g3
sS'when,taking,placebo'
p33131
g3
sS'sulfate,sulfate,and'
p33132
g9
sS'intravenously,or,orally'
p33133
g3
sS'of,are,due'
p33134
g9
sS'in,man,we'
p33135
g3
sS'be,employed,in'
p33136
g3
sS'mepron,concurrently,with'
p33137
g3
sS'toxicity,and,pharmacokinetics'
p33138
g3
sS'been,no,formal'
p33139
g3
sS'used,together,even'
p33140
g3
sS'uptake,to,be'
p33141
g9
sS'whether,similar,increases'
p33142
g3
sS'carbamazepine,carbamazepine,causes'
p33143
g9
sS'and,enhance,the'
p33144
g9
sS'disease,treated,concomitantly'
p33145
g3
sS'alpha-blockers,when,vardenafil'
p33146
g9
sS'with,skin,products'
p33147
g3
sS'interaction,trials,have'
p33148
g3
sS'but,returned,to'
p33149
g3
sS'stress,and,on'
p33150
g3
sS'mildly,reduced,approximately'
p33151
g9
sS'dosage,is,recommended'
p33152
g3
sS'and,long,withdrawal'
p33153
g3
sS'to,antiepileptic,aeds'
p33154
g9
sS'themselves,to,an'
p33155
g3
sS'of,may,occur'
p33156
g9
sS'to,inhibit,phosphatase'
p33157
g9
sS'dose,reduced,by'
p33158
g9
sS'iron,salts,may'
p33159
g9
sS'be,exercised,and'
p33160
g3
sS'topoisomerases,in,proliferating'
p33161
g3
sS'common,component,of'
p33162
g9
sS'in,using,it'
p33163
g9
sS'adrenergic,blockers,adrenergic'
p33164
g9
sS'co-administration,of,decreased'
p33165
g9
sS'prednisone,rofecoxib,did'
p33166
g3
sS'may,delay,intestinal'
p33167
g9
sS'given,one,of'
p33168
g3
sS'substitute,for,oral'
p33169
g3
sS'that,zebeta,be'
p33170
g9
sS'hyperglycaemia,and,hyperinsulinaemia'
p33171
g3
sS'test,interactions,a'
p33172
g3
sS'receiving,azole,agents'
p33173
g9
sS'initiated,or,withdrawn'
p33174
g3
sS'a,randomized,trial'
p33175
g9
sS'once,daily,for'
p33176
g9
sS'resulted,in,previous'
p33177
g9
sS'injection,of,mg'
p33178
g9
sS'uptake,of,radiolabeled'
p33179
g3
sS'to,occur,if'
p33180
g3
sS'whether,to,discontinue'
p33181
g3
sS'doses,of,short-acting'
p33182
g3
sS'compete,for,active'
p33183
g3
sS'any,additional,effect'
p33184
g9
sS'a,common,transport'
p33185
g3
sS'female,have,not'
p33186
g3
sS'blockers,cardiac,h2'
p33187
g3
sS'inhibit,p450,a2'
p33188
g9
sS'over,patients,in'
p33189
g9
sS'displacing,the,from'
p33190
g9
sS'initial,dose,of'
p33191
g3
sS'replacement,increases,metabolic'
p33192
g3
sS'without,using,effective'
p33193
g3
sS'effect,of,acetate'
p33194
g9
sS'for,the,appearance'
p33195
g9
sS'welchol,with,or'
p33196
g3
sS'of,the,exposure'
p33197
g3
sS'in,uremic,patients'
p33198
g3
sS'or,who,increase'
p33199
g9
sS'to,produce,adverse'
p33200
g3
sS'consisting,of,usp'
p33201
g9
sS'food,or,milk'
p33202
g3
sS'evaluate,the,possibility'
p33203
g9
sS'of,maalox,tc'
p33204
g3
sS'although,this,interaction'
p33205
g9
sS'transfer,to,oral'
p33206
g3
sS'was,about,times'
p33207
g3
sS'of,miracidia,was'
p33208
g3
sS'mating,caused,a'
p33209
g3
sS'be,mediated,through'
p33210
g3
sS'reports,of,serotonin'
p33211
g9
sS'is,recommended,depending'
p33212
g3
sS'in-vitro,studies,is'
p33213
g3
sS'studies,vardenafil,and'
p33214
g3
sS'a,facilitation,or'
p33215
g3
sS'drowsiness,restlessness,muscle'
p33216
g3
sS'hdl2,cholesterol,subfraction'
p33217
g3
sS'acid,with,at'
p33218
g9
sS'prevent,maltose,interference'
p33219
g3
sS'calcium-channel,blockers,and'
p33220
g3
sS'out,of,what'
p33221
g3
sS'level,dosage,adjustment'
p33222
g9
sS'and,increase,in'
p33223
g9
sS'interact,synergistically,to'
p33224
g3
sS'cssmax,of,the'
p33225
g3
sS'carbohydrate,metabolism,and'
p33226
g3
sS'in,the,antidepressant'
p33227
g3
sS'example,inhibitors,include'
p33228
g3
sS'extended,release,formulation'
p33229
g3
sS'in,human,lymphocytes'
p33230
g3
sS'by,approximately,peak'
p33231
g9
sS'so,that,peak'
p33232
g3
sS'glucose,intolerance,and'
p33233
g3
sS'any,combination,of'
p33234
g3
sS'containing,medicines,such'
p33235
g9
sS'of,with,has'
p33236
g9
sS'its,metabolism,and'
p33237
g3
sS'iv,injection,of'
p33238
g9
sS'auc,after,administration'
p33239
g9
sS'at,high,to'
p33240
g9
sS'responsible,for,metabolism'
p33241
g3
sS'ast,times,the'
p33242
g3
sS'by,either,alpha-'
p33243
g3
sS'furosemide,may,add'
p33244
g9
sS'isozymes,in,the'
p33245
g3
sS'transcription,replication,etc'
p33246
g3
sS'kinetics,equilibrium,and'
p33247
g3
sS'arthritis,thyroiditis,bullous'
p33248
g9
sS'in,two,controlled'
p33249
g3
sS'clearance,mechanism,involved'
p33250
g3
sS'elspar,therapy,when'
p33251
g9
sS'significantly,interact,with'
p33252
g3
sS'common,adverse,reactions'
p33253
g3
sS'affect,steady-state,pharmacokinetic'
p33254
g3
sS'of,excreted,unchanged'
p33255
g3
sS'taxol,therapy,a'
p33256
g3
sS'from,interactions,is'
p33257
g3
sS'induction,of,p-450iie1'
p33258
g9
sS'increased,serum,enzyme'
p33259
g3
sS'by,increased,half-life'
p33260
g9
sS'against,the,elevation'
p33261
g9
sS'period,has,been'
p33262
g9
sS'only,increases,extracellular'
p33263
g3
sS'the,initial,release'
p33264
g9
sS'within,the,two'
p33265
g3
sS'the,estrogenic,component'
p33266
g3
sS'is,indicated,dosing'
p33267
g3
sS'agents,including,such'
p33268
g9
sS'or,prothrombin,times'
p33269
g3
sS'vr,pediatric,and'
p33270
g3
sS'vectors,containing,a'
p33271
g3
sS'and,aluminum-containing,preparations'
p33272
g3
sS'clinical,studies,some'
p33273
g3
sS'serotoninergic,agents,there'
p33274
g9
sS'combined,therapy,is'
p33275
g3
sS'wheals,and,flares'
p33276
g3
sS'free,concentration,of'
p33277
g3
sS'drug,interactions,dofetilide'
p33278
g3
sS'require,additional,titration'
p33279
g9
sS'and,levonorgestrel-treated,rats'
p33280
g3
sS'of,clozapine,potentially'
p33281
g9
sS'of,an,with'
p33282
g9
sS'of,studies,which'
p33283
g3
sS'combined,therapy,if'
p33284
g9
sS'toxicity,was,reported'
p33285
g9
sS'general,in,humans'
p33286
g3
sS'of,equetrotm,to'
p33287
g3
sS'of,malignant,disease'
p33288
g3
sS'benefit,of,while'
p33289
g3
sS'affect,the,pharmacokinetics'
p33290
g3
sS'rarely,to,cause'
p33291
g9
sS'microsomal,monooxygenase,activities'
p33292
g3
sS'mmol,l,or'
p33293
g3
sS'contraindications,indications,use'
p33294
g3
sS'phenobarbital,decreases,effectiveness'
p33295
g9
sS'transient,and,minor'
p33296
g3
sS'to,three,cancer'
p33297
g9
sS'cardiac,output,and'
p33298
g9
sS'morphine-induced,increases,in'
p33299
g9
sS'effort,optimal,and'
p33300
g3
sS'consequent,possible,decrease'
p33301
g9
sS'of,and,these'
p33302
g3
sS'reduction,of,crixivan'
p33303
g9
sS'or,stereotypic,effects'
p33304
g3
sS'in,vitro,chromosomal'
p33305
g3
sS'interactions,resulting,in'
p33306
g3
sS'affected,by,concomitant'
p33307
g3
sS'the,changes,in'
p33308
g3
sS'metabolized,via,a'
p33309
g3
sS'corticosteroids,may,affect'
p33310
g3
sS'shown,to,cause'
p33311
g3
sS'for,an,unusually'
p33312
g9
sS'there,is,thus'
p33313
g9
sS'plasma,proteins,and'
p33314
g3
sS'studies,or,predicted'
p33315
g3
sS'of,difluoroacetone,a'
p33316
g3
sS'efficacy,of,h1'
p33317
g9
sS'are,based,on'
p33318
g3
sS'known,or,suspected'
p33319
g3
sS'including,electrocardiographic,qt'
p33320
g3
sS'white,male,rats'
p33321
g3
sS'of,contraction,was'
p33322
g3
sS'and,other,inhibitors'
p33323
g9
sS'slightly,shorter,durations'
p33324
g9
sS'with,the,lipid-lowering'
p33325
g3
sS'influence,of,sympatholytic'
p33326
g3
sS'may,affect,renal'
p33327
g3
sS'the,safety,and'
p33328
g3
sS'appropriate,dose,adjustments'
p33329
g9
sS'and,has,also'
p33330
g3
sS'in,tbg,concentration'
p33331
g3
sS'erectile,dysfunction,is'
p33332
g3
sS'are,substrates,and'
p33333
g3
sS'oral,inhibits,the'
p33334
g9
sS'protein,added,to'
p33335
g3
sS'and,scanning,electron'
p33336
g3
sS'powder,or,products'
p33337
g9
sS'ames,test,but'
p33338
g3
sS'selective,mao,inhibitor'
p33339
g9
sS'applied,to,cardiac'
p33340
g3
sS'level,in,the'
p33341
g9
sS'patients,when,and'
p33342
g9
sS'in,vitro,binding'
p33343
g9
sS'activity,of,endogenous'
p33344
g9
sS'be,avoided,as'
p33345
g3
sS'when,simulect,is'
p33346
g3
sS'of,to,subjects'
p33347
g9
sS'drugs,on,the'
p33348
g3
sS'or,imuran,the'
p33349
g9
sS'trials,no,interactions'
p33350
g3
sS'and,av,nodes'
p33351
g3
sS'administered,concurrently,without'
p33352
g3
sS'of,different,descending'
p33353
g3
sS'if,necessary,the'
p33354
g9
sS'ii,the,effects'
p33355
g3
sS'those,required,to'
p33356
g9
sS'not,mutagenic,or'
p33357
g3
sS'days,followed,by'
p33358
g3
sS'of,calcium-channel,blockers'
p33359
g3
sS'response,through,increased'
p33360
g9
sS'which,was,partially'
p33361
g9
sS'receiving,acarbose,in'
p33362
g3
sS'significant,interaction,would'
p33363
g3
sS'type,c,eg'
p33364
g9
sS'induce,cyp3a4,activity'
p33365
g3
sS'agents,did,not'
p33366
g3
sS'short-acting,has,been'
p33367
g3
sS'of,these,strategies'
p33368
g3
sS'affecting,sympathetic,activity'
p33369
g3
sS'addition,administration,to'
p33370
g3
sS'investigate,the,potential'
p33371
g3
sS'the,evidence,for'
p33372
g3
sS'alpha-,or,beta-adrenergic'
p33373
g3
sS'administration,attenuates,certain'
p33374
g9
sS'with,the,supplied'
p33375
g3
sS'this,combination,outweigh'
p33376
g9
sS'cimetidine,reduces,the'
p33377
g9
sS'time,response,in'
p33378
g9
sS'be,clastogenic,to'
p33379
g3
sS'was,exposed,to'
p33380
g3
sS'ethinyl,estradiol,may'
p33381
g9
sS'the,same,target'
p33382
g3
sS'and,behavioral,changes'
p33383
g3
sS'severe,persistent,hypertension'
p33384
g3
sS'aminoglycosides,the,mixing'
p33385
g9
sS'chemotherapeutic,agents,in'
p33386
g3
sS'change,of,lifestyle'
p33387
g3
sS'of,crixivan,and'
p33388
g3
sS'progesterone,preparations,micro-dosed'
p33389
g9
sS'levels,may,occur'
p33390
g3
sS'interactions,as,with'
p33391
g3
sS'and,treatment,discontinued'
p33392
g3
sS'pre-treatment,with,the'
p33393
g9
sS'albendazole,sulfoxide,plasma'
p33394
g3
sS'that,the,response'
p33395
g3
sS'were,only,observed'
p33396
g3
sS'fewer,infusion,reactions'
p33397
g3
sS'mepron,suspension,results'
p33398
g9
sS'patients,to,be'
p33399
g9
sS'activator,binding,domain'
p33400
g3
sS'are,receiving,concomitant'
p33401
g3
sS'observed,when,viracept'
p33402
g3
sS'of,psychiatric,disorder'
p33403
g9
sS'occupational,exposure,to'
p33404
g3
sS'and,and,mg'
p33405
g9
sS'and,then,allowed'
p33406
g3
sS'result,of,a'
p33407
g9
sS'inhibitors,ssris,seriraline'
p33408
g3
sS'weaken,the,blood-glucose'
p33409
g9
sS'thyroid,preparations,may'
p33410
g9
sS'sedation,hallucinations,and'
p33411
g9
sS'of,within,the'
p33412
g3
sS'are,found,to'
p33413
g9
sS'studied,two,appear'
p33414
g9
sS'the,inhibitory,effects'
p33415
g9
sS'and,new,combination'
p33416
g3
sS'decreases,the,elimination'
p33417
g9
sS'is,a,prostaglandin'
p33418
g3
sS'read,circulars,for'
p33419
g3
sS'no,influence,on'
p33420
g3
sS'approach,to,treatment'
p33421
g3
sS'patients,on,treatment'
p33422
g9
sS'reduction,at,the'
p33423
g3
sS'geocillin,carbenicillin,indanyl'
p33424
g9
sS'alter,the,clearance'
p33425
g3
sS'affected,by,his'
p33426
g3
sS'anabolin,anavar,anadrol'
p33427
g3
sS'potential,benefits,of'
p33428
g3
sS'with,or,clinically'
p33429
g3
sS'for,days,after'
p33430
g3
sS'magnesium-,and,aluminum-containing'
p33431
g9
sS'that,concentrations,be'
p33432
g9
sS'twitch,was,maintained'
p33433
g3
sS'increases,platelet,aggregation'
p33434
g3
sS'existing,clinical,trials'
p33435
g3
sS'important,in,patients'
p33436
g3
sS'evidence,of,an'
p33437
g3
sS'pms,will,not'
p33438
g3
sS'of,to,decrease'
p33439
g9
sS'served,as,control'
p33440
g3
sS'by,when,coadministered'
p33441
g9
sS'month,at,approximately'
p33442
g3
sS'vioxx,with,the'
p33443
g9
sS'potent,inhibitors,of'
p33444
g3
sS'and,micromol,l'
p33445
g3
sS'metabolism,of,ethinyl'
p33446
g9
sS'food,has,no'
p33447
g3
sS'arrest,with,full'
p33448
g3
sS'administered,in,clinical'
p33449
g9
sS'decreased,symptoms,of'
p33450
g9
sS'risk,of,relapse'
p33451
g3
sS'taking,since,nevirapinemay'
p33452
g9
sS'of,displacement,of'
p33453
g3
sS'switching,from,one'
p33454
g9
sS'mean,neutrophil,counts'
p33455
g9
sS'similar,length,of'
p33456
g9
sS'dolasetron,does,not'
p33457
g3
sS'containing,for,at'
p33458
g9
sS'until,blood,pressure'
p33459
g3
sS'ketoconazole,sensipar,is'
p33460
g3
sS'that,rr,is'
p33461
g3
sS'the,ecg,changes'
p33462
g9
sS'products,such,as'
p33463
g3
sS'increases,in,concentration'
p33464
g3
sS'replication,etc,and'
p33465
g3
sS'two,instances,and'
p33466
g9
sS'increasingly,important,causes'
p33467
g3
sS'prospective,long-term,studies'
p33468
g3
sS'among,the,volunteers'
p33469
g9
sS'dipstick,test,for'
p33470
g3
sS'receiving,and,concomitantly'
p33471
g9
sS'rifampin,has,been'
p33472
g9
sS'infections,have,not'
p33473
g3
sS'porpranolol,may,exacerbate'
p33474
g9
sS'that,in,combination'
p33475
g3
sS'action,independent,of'
p33476
g3
sS'required,if,such'
p33477
g3
sS'of,the,estimated'
p33478
g3
sS'patients,on,long-term'
p33479
g9
sS'adverse,reaction,profile'
p33480
g3
sS'being,either,too'
p33481
g3
sS'signs,irrespective,of'
p33482
g3
sS'to,treated,patients'
p33483
g3
sS'may,however,be'
p33484
g3
sS'to,evaluate,interactions'
p33485
g3
sS'activity,such,as'
p33486
g9
sS'reduced,accordingly,in'
p33487
g9
sS'inhibitors,and,both'
p33488
g3
sS'to,years,who'
p33489
g9
sS'their,usual,dose'
p33490
g9
sS'metabolite,are,inhibitors'
p33491
g3
sS'to,increase,with'
p33492
g9
sS'who,had,received'
p33493
g9
sS'designing,experiments,for'
p33494
g3
sS'likely,to,interfere'
p33495
g9
sS'mc,and,are'
p33496
g3
sS'that,inhibits,cyp3a4'
p33497
g3
sS'with,activase,for'
p33498
g3
sS'as,co-activator,in'
p33499
g3
sS'faslodex,in,nursing'
p33500
g3
sS'side,effects,may'
p33501
g3
sS'relevance,of,this'
p33502
g3
sS'extended,release,mg'
p33503
g3
sS'regulation,of,voltage-dependent'
p33504
g3
sS'cyp2c9,cyp2c19,or'
p33505
g3
sS'from,combined,therapy'
p33506
g9
sS'analyzed,in,cecectomized'
p33507
g3
sS'that,plasma,levels'
p33508
g9
sS'ruthenium,red,rr'
p33509
g3
sS'specified,time,points'
p33510
g3
sS'results,everolimus,steady'
p33511
g3
sS'you,are,also'
p33512
g9
sS'therapeutic,concentrations,has'
p33513
g3
sS'of,busulfex,at'
p33514
g9
sS'by,this,isoenzyme'
p33515
g3
sS'absence,of,renal'
p33516
g9
sS'metabolism,and,and'
p33517
g3
sS'designed,to,investigate'
p33518
g3
sS'increase,the,depth'
p33519
g9
sS'local,and,para-aminobenzoic'
p33520
g9
sS'for,h,concomitant'
p33521
g3
sS'occasionally,been,used'
p33522
g3
sS'other,antihypertensive,additive'
p33523
g3
sS'discrete,responses,alternative'
p33524
g3
sS'can,blunt,the'
p33525
g3
sS'significant,drug-drug,interactions'
p33526
g3
sS'c,max,decreased'
p33527
g9
sS'study,both,agents'
p33528
g3
sS'of,rats,results'
p33529
g9
sS'may,lower,meclofenamate'
p33530
g9
sS'agonists,only,if'
p33531
g9
sS'clinical,studies,coadministration'
p33532
g3
sS'or,a,cardioselective'
p33533
g3
sS'plasma,concentration,for'
p33534
g3
sS'on,cooling,the'
p33535
g3
sS'that,the,possible'
p33536
g3
sS'oral,is,significantly'
p33537
g9
sS'the,dosage,of'
p33538
g3
sS'coumarin-derivative,should,be'
p33539
g3
sS'enlargement,and,cushingoid'
p33540
g3
sS'except,for,three'
p33541
g3
sS'not,start,or'
p33542
g3
sS'since,is,primarily'
p33543
g3
sS'therefore,change,with'
p33544
g3
sS'and,its,vasculature'
p33545
g3
sS'active,metabolite,have'
p33546
g3
sS'was,undertaken,with'
p33547
g3
sS'blood-sugar,reducing,effect'
p33548
g9
sS'experienced,acute,atypical'
p33549
g9
sS'studies,or,in'
p33550
g3
sS'should,be,reported'
p33551
g3
sS'nor,appears,to'
p33552
g3
sS'because,does,not'
p33553
g3
sS'as,diphen-hydramine,and'
p33554
g3
sS'preclinical,researchers,have'
p33555
g3
sS'tricor,at,least'
p33556
g9
sS'clozapine,potentially,resulting'
p33557
g9
sS'undergoing,strenuous,physical'
p33558
g3
sS'interactions,are,possible'
p33559
g3
sS'with,hepatotoxic,potential'
p33560
g9
sS'slower,onset,can'
p33561
g9
sS'and,tachycardia,have'
p33562
g9
sS'felbatol,phenytoin,phenytoin'
p33563
g9
sS'uptake-1,carrier,density'
p33564
g3
sS'levels,of,when'
p33565
g9
sS'healthy,volunteers,taking'
p33566
g9
sS'metabolism,of,cytochrome'
p33567
g3
sS'elevated,levels,it'
p33568
g9
sS'in,a,decrease'
p33569
g9
sS'to,monitor,tca'
p33570
g3
sS'to,determine,its'
p33571
g3
sS'indicate,that,the'
p33572
g9
sS'simultaneously,with,vardenafil'
p33573
g9
sS'and,sigma-2,receptors'
p33574
g3
sS'the,benefits,of'
p33575
g9
sS'because,the,ccnu'
p33576
g3
sS'study,with,without'
p33577
g3
sS'interactions,due,to'
p33578
g3
sS'of,ptx,was'
p33579
g3
sS'activity,of,ganoderma'
p33580
g3
sS'and,tablets,may'
p33581
g9
sS'the,homodimeric,structure'
p33582
g3
sS'are,also,albumin'
p33583
g3
sS'including,those,of'
p33584
g9
sS'in,lysing,human'
p33585
g3
sS'avoid,the,occurrence'
p33586
g3
sS'the,rats,treated'
p33587
g3
sS'cyp2c9,cyp2d6,and'
p33588
g3
sS'cyp3a4,substrates,dasatinib'
p33589
g3
sS'however,severe,reactions'
p33590
g3
sS'and,patients,should'
p33591
g9
sS'a,homodimeric,disintegrin'
p33592
g3
sS'an,omega-agatoxin,iva-sensitive'
p33593
g3
sS'thyroxine,increases,the'
p33594
g9
sS'non-steroidal,antiinflammatory,including'
p33595
g9
sS'plasma,protein,binding'
p33596
g3
sS'alternative,error,structures'
p33597
g3
sS'developed,severe,hypersensitivity'
p33598
g3
sS'as,a,possible'
p33599
g3
sS'rodent,studies,these'
p33600
g3
sS'contraceptives,multiple,dose'
p33601
g3
sS'other,agents,on'
p33602
g3
sS'when,is,concurrently'
p33603
g3
sS'substrates,or,inhibitors'
p33604
g3
sS'exposure,to,either'
p33605
g3
sS'as,with,other'
p33606
g9
sS'other,agents,of'
p33607
g3
sS'the,leakage,of'
p33608
g3
sS'be,caused,by'
p33609
g3
sS'using,clinitest,benedict'
p33610
g3
sS'of,bromocriptine,mesylate'
p33611
g9
sS'antitubercular,serum,concentrations'
p33612
g3
sS'damage,as,indicated'
p33613
g9
sS'other,agents,or'
p33614
g3
sS'patients,treated,with'
p33615
g9
sS'and,levels,following'
p33616
g3
sS'caused,an,increased'
p33617
g3
sS'patient,access,distribution'
p33618
g3
sS'gene,transfer,to'
p33619
g3
sS'insufficient,experience,to'
p33620
g9
sS'users,develop,physiological'
p33621
g3
sS'our,data,suggest'
p33622
g9
sS'has,a,narrower'
p33623
g3
sS'however,the,pharmacodynamics'
p33624
g3
sS'drug,interaction,with'
p33625
g9
sS'and,may,potentiate'
p33626
g9
sS'while,taking,or'
p33627
g9
sS'for,determining,synergism'
p33628
g3
sS'with,mg,bid'
p33629
g9
sS'by,the,cyp3a4'
p33630
g3
sS'on,responses,and'
p33631
g3
sS'and,and,these'
p33632
g3
sS'of,antistress,effects'
p33633
g3
sS'apart,on,an'
p33634
g9
sS'has,reduced,activity'
p33635
g3
sS'advised,if,the'
p33636
g3
sS'isozymes,evaluated,cyps'
p33637
g3
sS'with,most,psychoactive'
p33638
g9
sS'of,cmax,cmin'
p33639
g3
sS'of,heart,block'
p33640
g9
sS'among,co-administered,antiepilepsy'
p33641
g3
sS'sampling,the,extent'
p33642
g3
sS'patients,treated,concomitantly'
p33643
g9
sS'concentrations,from,mg'
p33644
g9
sS'walking,without,climbing'
p33645
g3
sS'in,large,amounts'
p33646
g9
sS'to,produce,significant'
p33647
g9
sS'antihistamines,may,partially'
p33648
g9
sS'the,nueronal,cell'
p33649
g3
sS'cells,was,as'
p33650
g3
sS'from,a,study'
p33651
g9
sS'should,be,noted'
p33652
g9
sS'and,may,necessitate'
p33653
g9
sS'by,increasing,gastric'
p33654
g9
sS'multifaceted,and,is'
p33655
g3
sS'toradol,therapy,have'
p33656
g9
sS'cold,binding,of'
p33657
g3
sS'digestion,and,absorption'
p33658
g3
sS'may,potentiate,any'
p33659
g9
sS'concentrations,were,observed'
p33660
g9
sS'agents,concomitant,administration'
p33661
g9
sS'oral,and,you'
p33662
g9
sS'derivatives,in,patients'
p33663
g9
sS'of,duloxetine,with'
p33664
g9
sS'that,the,conversion'
p33665
g3
sS'summarized,in,the'
p33666
g3
sS'neurological,toxicity,and'
p33667
g3
sS'and,was,comparable'
p33668
g3
sS'for,and,placebo'
p33669
g3
sS'until,reaching,a'
p33670
g3
sS'inhibitors,grapefruit,juice'
p33671
g9
sS'drug-drug,interactions,in'
p33672
g3
sS'control,atrial,fibrillation'
p33673
g9
sS'may,potentiate,and'
p33674
g3
sS'windows,that,are'
p33675
g3
sS'and,an,adjustment'
p33676
g3
sS'supplements,or,potassium-containing'
p33677
g9
sS'when,given,as'
p33678
g9
sS'metabolite,at,concentrations'
p33679
g3
sS'incidence,of,breakthrough'
p33680
g3
sS'of,acute,myocardial'
p33681
g3
sS'antioxidative,gallates,is'
p33682
g3
sS'to,wide,interindividual'
p33683
g9
sS'are,concomitantly,being'
p33684
g3
sS'function,such,as'
p33685
g9
sS'patients,on,a'
p33686
g9
sS'the,interaction,effects'
p33687
g3
sS'of,impaired,fertility'
p33688
g3
sS'the,balance,technique'
p33689
g3
sS'its,derivatives,in'
p33690
g9
sS'with,heart,failure'
p33691
g3
sS'with,phenyl-butazone,sodium'
p33692
g3
sS'although,there,are'
p33693
g9
sS'misonidazole,has,a'
p33694
g9
sS'if,these,preparations'
p33695
g3
sS'administered,within,hours'
p33696
g9
sS'for,days,has'
p33697
g9
sS'more,were,concomitantly'
p33698
g3
sS'tubular,secretion,by'
p33699
g3
sS'fibrosis,have,been'
p33700
g3
sS'reports,of,theophylline-related'
p33701
g9
sS'inhibitors,or,concomitant'
p33702
g3
sS'to,and,the'
p33703
g3
sS'for,days,had'
p33704
g3
sS'your,condition,worse'
p33705
g3
sS'tmp,and,smx'
p33706
g3
sS'response,is,due'
p33707
g3
sS'no,interaction,between'
p33708
g9
sS'concentrations,of,by'
p33709
g9
sS'other,drug,interaction'
p33710
g3
sS'at,least,halved'
p33711
g9
sS'tablets,and,primarily'
p33712
g3
sS'inhibitor,increased,the'
p33713
g9
sS'absorption,of,was'
p33714
g3
sS'gastrointestinal,effects,of'
p33715
g9
sS'given,within,weeks'
p33716
g3
sS'take,other,drugs'
p33717
g3
sS'of,vitamin,d'
p33718
g9
sS'for,that,may'
p33719
g3
sS'developing,rhabdomyolysis,including'
p33720
g3
sS'of,cyp3a4,substrate'
p33721
g9
sS'and,induce,metabolism'
p33722
g9
sS'of,from,nerves'
p33723
g3
sS'areas,of,your'
p33724
g3
sS'addition,to,established'
p33725
g3
sS'dose-dependently,increased,the'
p33726
g3
sS'lead,to,a'
p33727
g3
sS'expression,that,may'
p33728
g3
sS'the,sympathetic,reflex'
p33729
g3
sS'such,patients,the'
p33730
g3
sS'systems,lapatinib,is'
p33731
g3
sS'by,adl,and'
p33732
g3
sS'may,help,to'
p33733
g3
sS'dose,for,a'
p33734
g3
sS'interactions,see,clinical'
p33735
g3
sS'received,an,individualized'
p33736
g3
sS'on,malignant,cells'
p33737
g9
sS'cmin,were,decreased'
p33738
g9
sS'except,in,life-threatening'
p33739
g3
sS'enoxaparin,dosed,as'
p33740
g3
sS'and,and,thus'
p33741
g9
sS'then,begins,a'
p33742
g3
sS'these,steps,include'
p33743
g3
sS'potential,to,enhance'
p33744
g9
sS'paroxetine,mg,qd'
p33745
g9
sS'be,anticipated,with'
p33746
g9
sS'effects,of,acute'
p33747
g3
sS'repeated,challenge,or'
p33748
g3
sS'a,negative,result'
p33749
g3
sS'has,been,treated'
p33750
g3
sS'the,cyclooxygenase-2,cox-2'
p33751
g3
sS'convulsion,was,seen'
p33752
g3
sS'neurons,and,the'
p33753
g9
sS'kg,dose,m'
p33754
g3
sS'therapy,nicotinic,acid'
p33755
g9
sS'of,symptom,control'
p33756
g9
sS'circulation,the,discontinuance'
p33757
g9
sS'are,no,safety'
p33758
g3
sS'treatment,dyspnea,requiring'
p33759
g3
sS'a,well-controlled,study'
p33760
g3
sS'their,associated,side-effect'
p33761
g3
sS'of,vitamin,k'
p33762
g9
sS'difficile,a,displays'
p33763
g3
sS'or,oral,hypoglycemics'
p33764
g9
sS'totally,known,enzyme'
p33765
g9
sS'monitoring,may,be'
p33766
g3
sS'anitagonism,without,affecting'
p33767
g9
sS'respectively,compared,to'
p33768
g9
sS'the,mesenteric,resistance'
p33769
g3
sS'or,agents,such'
p33770
g9
sS'resulted,in,approximately'
p33771
g3
sS'higher,proportion,of'
p33772
g3
sS'blood,pressure,of'
p33773
g9
sS'the,efficacy,and'
p33774
g3
sS'lines,showed,variable'
p33775
g3
sS'inhibition,of,cytochrome'
p33776
g3
sS'blood,pressure,or'
p33777
g3
sS'the,clinical,situation'
p33778
g3
sS'show,a,change'
p33779
g3
sS'increased,potential,for'
p33780
g3
sS'pharmacological,therapy,which'
p33781
g3
sS'be,clinically,significant'
p33782
g9
sS'hypercholesterolemic,noninsulin,dependent'
p33783
g3
sS'been,conducted,in'
p33784
g3
sS'initial,and,maintenance'
p33785
g9
sS'these,products,are'
p33786
g3
sS'been,conducted,it'
p33787
g9
sS'concerned,variable,elevations'
p33788
g3
sS'once,daily,resulted'
p33789
g9
sS'used,with,extreme'
p33790
g9
sS'need,for,an'
p33791
g9
sS'd6,the,biochemical'
p33792
g3
sS'presence,of,impaired'
p33793
g9
sS'with,normal,fat'
p33794
g3
sS'the,carpophores,of'
p33795
g3
sS'hydrochloride,with,either'
p33796
g9
sS'established,but,should'
p33797
g3
sS'restlessness,muscle,pains'
p33798
g3
sS'given,as,mg'
p33799
g9
sS'has,also,been'
p33800
g3
sS'of,both,human'
p33801
g3
sS'for,four,doses'
p33802
g3
sS'drugs,administered,after'
p33803
g3
sS'medications,in,the'
p33804
g3
sS'other,concurrent,administration'
p33805
g9
sS'suggesting,a,modest'
p33806
g9
sS'can,be,significantly'
p33807
g3
sS'affected,by,alterations'
p33808
g3
sS'increases,in,clotting'
p33809
g3
sS'contrast,to,its'
p33810
g3
sS'was,administered,in'
p33811
g3
sS'pharmacology,studies,in'
p33812
g3
sS'oral,for,a'
p33813
g9
sS'increased,and,the'
p33814
g3
sS'asian,african,and'
p33815
g3
sS'to,bruising,nosebleeds'
p33816
g3
sS'to,ensure,clinically'
p33817
g9
sS'certain,antipsychotic,medications'
p33818
g3
sS'was,not,reached'
p33819
g3
sS'chirocaine,that,are'
p33820
g3
sS'with,blood,glucose'
p33821
g3
sS'at,mg,qd'
p33822
g9
sS'juices,etc,lower'
p33823
g9
sS'human,plasma,area-under'
p33824
g3
sS'of,the,physiological'
p33825
g3
sS'few,data,exist'
p33826
g3
sS'by,age,objective'
p33827
g3
sS'not,differ,from'
p33828
g3
sS'however,retinyl,acetate'
p33829
g9
sS'dextromethorphan,is,a'
p33830
g3
sS'cmax,and,about'
p33831
g3
sS'pooled,human,serum'
p33832
g3
sS's,wort,should'
p33833
g3
sS'conversely,may,interfere'
p33834
g9
sS'using,acetate,with'
p33835
g9
sS'levels,of,other'
p33836
g9
sS'of,antidepressant,when'
p33837
g9
sS'of,clinical,interest'
p33838
g3
sS'of,healthy,males'
p33839
g3
sS'of,blood,pressure'
p33840
g9
sS'kht,tumour,the'
p33841
g3
sS'inhibitors,interfere,with'
p33842
g3
sS'diuretics,studies,in'
p33843
g9
sS'infants,which,are'
p33844
g3
sS'agents,some,increase'
p33845
g9
sS'concentration,ranges,within'
p33846
g3
sS'from,those,that'
p33847
g3
sS'of,bextra,mg'
p33848
g3
sS'effects,of,dmpge2'
p33849
g3
sS'such,without,a'
p33850
g3
sS'in,the,production'
p33851
g3
sS'clinical,toxicity,of'
p33852
g3
sS'antipsychotic,agent,which'
p33853
g3
sS'withdrawal,and,their'
p33854
g3
sS'of,bioavailability,area'
p33855
g3
sS'of,severe,anaphylactic'
p33856
g3
sS'should,be,minimized'
p33857
g9
sS'cardiac,preparations,and'
p33858
g3
sS'concentrations,reduced,ldl'
p33859
g3
sS'is,primarily,a'
p33860
g3
sS'perfused,pancreas,of'
p33861
g3
sS'occasionally,been,associated'
p33862
g3
sS'a,causal,mechanism'
p33863
g9
sS'were,homozygous,for'
p33864
g3
sS'special,monitoring,if'
p33865
g3
sS'of,r-warfarin,or'
p33866
g3
sS'alkalinizing,agents,some'
p33867
g9
sS'of,toradol,with'
p33868
g3
sS'particularly,dangerous,because'
p33869
g3
sS'be,at,higher'
p33870
g3
sS'certainly,during,periods'
p33871
g9
sS'cyp2e1,or,cyp3a4'
p33872
g3
sS'elimination,of,its'
p33873
g9
sS'myocardium,may,induce'
p33874
g9
sS'of,clearance,such'
p33875
g9
sS'poorly,tolerated,and'
p33876
g9
sS'comedication,particularly,diabetics'
p33877
g9
sS'additional,titration,of'
p33878
g9
sS'inhibitors,and,agents'
p33879
g3
sS'mg,daily,and'
p33880
g9
sS'including,ventricular,tachycardia'
p33881
g3
sS'erythromycin,and,and'
p33882
g9
sS'enzymes,involved,in'
p33883
g3
sS'kg,or,tmax'
p33884
g3
sS'iv,myocardium,versus'
p33885
g3
sS'coadministration,of,other'
p33886
g9
sS'are,reported,to'
p33887
g9
sS'may,be,enhanced'
p33888
g9
sS'flushing,mydriasis,tachycardia'
p33889
g9
sS'also,potentiate,the'
p33890
g9
sS'other,compounds,that'
p33891
g3
sS'interactions,amphetamines,can'
p33892
g9
sS'decreased,the,r-value'
p33893
g3
sS'daily,should,be'
p33894
g3
sS'with,other,antiretroviral'
p33895
g9
sS'reported,to,result'
p33896
g9
sS'should,have,frequent'
p33897
g3
sS'the,diet,or'
p33898
g3
sS'starlix,is,a'
p33899
g9
sS'at,an,increased'
p33900
g9
sS'the,disposition,of'
p33901
g3
sS'potential,of,increased'
p33902
g9
sS'were,maintained,on'
p33903
g3
sS'well,as,retention'
p33904
g3
sS'or,renal,elimination'
p33905
g3
sS'toxic,effects,of'
p33906
g9
sS'here,demonstrate,that'
p33907
g3
sS'doubling,the,dose'
p33908
g3
sS'such,are,given'
p33909
g3
sS'each,volunteer,received'
p33910
g3
sS'cervical,laceration,especially'
p33911
g9
sS'the,principal,given'
p33912
g3
sS'the,gi,tract'
p33913
g9
sS'pyrroloquinolinequinone,gdh,pqq'
p33914
g3
sS'the,remainder,no'
p33915
g3
sS'data,indicate,that'
p33916
g9
sS'interfering,with,the'
p33917
g9
sS'of,based,on'
p33918
g9
sS'auc,of,mg'
p33919
g9
sS'a,considerable,effect'
p33920
g9
sS'a,consequence,of'
p33921
g9
sS'standing,systolic,blood'
p33922
g9
sS'within,minutes,after'
p33923
g3
sS'axis,in,premenopausal'
p33924
g3
sS'impair,intestinal,absorption'
p33925
g3
sS'long,half-life,of'
p33926
g3
sS'doses,mg,kg'
p33927
g3
sS'when,concomitant,treatment'
p33928
g9
sS'given,with,beta'
p33929
g9
sS'more,than,one'
p33930
g3
sS'evaluating,the,antidiarrheal'
p33931
g3
sS't1,of,were'
p33932
g9
sS'of,channels,in'
p33933
g3
sS'traditional,agents,for'
p33934
g3
sS'based,methods,gdh'
p33935
g3
sS'agents,the,antihypertensive'
p33936
g9
sS'blocked,the,tail-flick'
p33937
g9
sS'of,in,human'
p33938
g9
sS'trials,of,chloral'
p33939
g3
sS'flolan,was,initiated'
p33940
g9
sS'in,contrast,preliminary'
p33941
g3
sS'short-acting,aerosol,of'
p33942
g3
sS'a,body,surface'
p33943
g3
sS'interaction,whole,blood'
p33944
g9
sS'with,antithrombin,iii'
p33945
g9
sS'placebo-controlled,osteoporosis,treatment'
p33946
g3
sS'l,did,not'
p33947
g3
sS'possibly,due,to'
p33948
g9
sS'when,given,one'
p33949
g3
sS'and,august,were'
p33950
g3
sS'it,is,given'
p33951
g9
sS'other,strong,inhibitors'
p33952
g3
sS'gastric,glands,was'
p33953
g3
sS'the,year,risk'
p33954
g3
sS'agents,which,prolong'
p33955
g3
sS'in,cardioplegic,solutions'
p33956
g3
sS'but,also,dyslipidemia'
p33957
g3
sS'to,results,from'
p33958
g9
sS'clastogenic,to,human'
p33959
g3
sS'and,muscle,relaxant'
p33960
g3
sS'were,to,elucidate'
p33961
g3
sS'and,usually,results'
p33962
g9
sS'clearance,of,should'
p33963
g9
sS'ectopic,pacemaker,activity'
p33964
g9
sS't4,concentration,is'
p33965
g3
sS'selegiline,l-phenylalanine,and'
p33966
g9
sS'a,methotrexate,there'
p33967
g9
sS'be,useful,to'
p33968
g3
sS'or,concurrently,with'
p33969
g9
sS'oral,route,in'
p33970
g3
sS'until,after,chemotherapy'
p33971
g3
sS'necessary,but,increased'
p33972
g3
sS'after,mefloquineuine,causes'
p33973
g3
sS'antagonist,sch-23390,but'
p33974
g9
sS'used,when,coadministering'
p33975
g3
sS'dosage,inhibited,cyp'
p33976
g3
sS'mesylate,was,administered'
p33977
g9
sS'thus,smaller,doses'
p33978
g9
sS'were,conducted,between'
p33979
g9
sS'dofetilide,is,not'
p33980
g3
sS'mg,and,sustiva'
p33981
g3
sS'may,turn,out'
p33982
g3
sS'cholesterol,subfraction,concentrations'
p33983
g3
sS'although,not,studied'
p33984
g9
sS'not,been,as'
p33985
g3
sS'replaced,by,the'
p33986
g3
sS'including,remicade,used'
p33987
g9
sS'the,interaction,data'
p33988
g3
sS'non-,steroidal,antiinflammatory'
p33989
g9
sS'mg,of,fe'
p33990
g9
sS'uterine,hypertonus,possibly'
p33991
g9
sS'therefore,serum,levels'
p33992
g3
sS'and,thus,the'
p33993
g9
sS'with,creatinine,clearance'
p33994
g3
sS'function,may,also'
p33995
g3
sS'scanning,electron,microscopy'
p33996
g3
sS'with,age-dependent,alterations'
p33997
g3
sS'with,a,beta-adrenergic'
p33998
g3
sS'ml,with,the'
p33999
g3
sS'v,decreased,the'
p34000
g3
sS'of,was,bioequivalent'
p34001
g3
sS'dyspnea,palpitation,chest'
p34002
g3
sS'for,signs,and'
p34003
g9
sS'or,with,mg'
p34004
g3
sS'the,ferricyanide,test'
p34005
g3
sS'improved,permeation,was'
p34006
g3
sS'of,acute,phase'
p34007
g3
sS'of,and,hydroxydesloratadine'
p34008
g3
sS'other,ventricular,arrhythmias'
p34009
g3
sS'or,the,fda'
p34010
g3
sS'in,exposure,with'
p34011
g9
sS'to,protein,may'
p34012
g9
sS'and,catabolic,enzymes'
p34013
g9
sS'the,duration,but'
p34014
g9
sS'affect,the,concentration'
p34015
g3
sS'to,the,human'
p34016
g3
sS'advised,in,using'
p34017
g3
sS'should,be,lowered'
p34018
g3
sS'and,m,m'
p34019
g3
sS'cyp,enzymes,a2'
p34020
g3
sS'kg,for,up'
p34021
g9
sS'highest,dose,of'
p34022
g3
sS'including,biocytin,in'
p34023
g3
sS'of,drug-metabolizing,enzymes'
p34024
g3
sS'without,tdp,in'
p34025
g3
sS'day,of,resulted'
p34026
g9
sS'bodies,in,urine'
p34027
g3
sS'duloxetine,clinical,trials'
p34028
g3
sS'that,meth,caused'
p34029
g9
sS'mean,apparent,oral'
p34030
g9
sS'the,serum,supplemented'
p34031
g3
sS'establishing,the,dose'
p34032
g3
sS'depressant,and,cautioned'
p34033
g3
sS'the,sole,indication'
p34034
g3
sS'impair,glomerular,filtration'
p34035
g3
sS'protein,is,not'
p34036
g3
sS'co,administration,of'
p34037
g9
sS'relative,to,benefits'
p34038
g3
sS'showed,significant,p'
p34039
g3
sS'on,the,location'
p34040
g3
sS'are,conflicting,results'
p34041
g9
sS'because,the,sum'
p34042
g3
sS'both,human,serum'
p34043
g3
sS'for,management,of'
p34044
g9
sS'superior,to,to'
p34045
g3
sS'interactions,observed,in'
p34046
g9
sS'enroll,patients,currently'
p34047
g3
sS'hiv-infected,individuals,with'
p34048
g3
sS'pregnancy,cromolyn,sodium'
p34049
g3
sS'in,tissue,culture'
p34050
g9
sS'and,more,than'
p34051
g3
sS'diclofenac,is,a'
p34052
g3
sS'studies,in,these'
p34053
g3
sS'were,drawn,and'
p34054
g3
sS'other,administered,concurrently'
p34055
g3
sS'f1,that,received'
p34056
g3
sS'was,also,conducted'
p34057
g3
sS'with,mtx,have'
p34058
g3
sS'evidence,of,hypothyroidism'
p34059
g3
sS'thiazide,and,inhibitors'
p34060
g9
sS'successful,prophylaxis,of'
p34061
g3
sS'be,given,at'
p34062
g3
sS'united,states,and'
p34063
g3
sS'h,ml,and'
p34064
g9
sS'phenytoin,increases,the'
p34065
g9
sS'did,indeed,have'
p34066
g9
sS'or,increasing,the'
p34067
g9
sS'monkeys,were,dosed'
p34068
g3
sS'per,patients,be'
p34069
g3
sS'other,treatment,costs'
p34070
g3
sS'plasma,protein,eszopiclone'
p34071
g3
sS'therapy,but,had'
p34072
g3
sS'aspirin,celebrex,can'
p34073
g9
sS'and,highly,active'
p34074
g3
sS'metabolites,were,measured'
p34075
g3
sS'the,pharmacodynamics,of'
p34076
g3
sS'inhibitors,and,one'
p34077
g3
sS'serious,side,effects'
p34078
g3
sS'large,placebo-controlled,osteoporosis'
p34079
g3
sS'or,withdrawn,from'
p34080
g9
sS'known,health,care'
p34081
g3
sS'event,in,the'
p34082
g3
sS'pregnancy,test,a'
p34083
g3
sS'the,pharmacodynamics,or'
p34084
g3
sS'of,supplements,and'
p34085
g9
sS'and,cold,preparations'
p34086
g9
sS'of,the,genetically'
p34087
g3
sS'to,mg,every'
p34088
g9
sS'clinically,significant,drug'
p34089
g3
sS'is,increased,when'
p34090
g9
sS'measured,as,inr'
p34091
g9
sS'even,when,administered'
p34092
g9
sS'to,influence,serum'
p34093
g3
sS'the,atac,trial'
p34094
g9
sS'quinidine,at,mg'
p34095
g9
sS'with,radiotherapy,may'
p34096
g3
sS'concentration,of,increased'
p34097
g3
sS'each,month,of'
p34098
g3
sS'of,the,efflux'
p34099
g3
sS'relatively,little,work'
p34100
g3
sS'of,the,drug'
p34101
g3
sS'uptake,of,sodium'
p34102
g9
sS'pharmacology,clinical,studies'
p34103
g9
sS'inhibitory,or,induction'
p34104
g3
sS'auc,by,in'
p34105
g9
sS'that,might,increase'
p34106
g9
sS'voltaren,cataflam,lodine'
p34107
g3
sS'treatment,and,prevention'
p34108
g3
sS'the,plasma,levels'
p34109
g9
sS'without,climbing,paperhanging'
p34110
g3
sS'taking,vioxx,antiplatelet'
p34111
g3
sS'been,conducted,to'
p34112
g3
sS'and,endocrine,status'
p34113
g3
sS'change,in,platelet'
p34114
g3
sS'august,were,identified'
p34115
g3
sS'gene,expression,by'
p34116
g3
sS'and,viable,counts'
p34117
g3
sS'were,almost,fold'
p34118
g9
sS'steady-state,levels,of'
p34119
g3
sS'sinus,rhythm,following'
p34120
g9
sS'and,therapy,indicate'
p34121
g3
sS'for,auc,was'
p34122
g3
sS'with,severely,impaired'
p34123
g3
sS'clinical,pharmacology,coadministration'
p34124
g9
sS'therefore,when,indocin'
p34125
g9
sS'encephalopathic,syndrome,characterized'
p34126
g9
sS'smallest,effective,dose'
p34127
g3
sS'metabolism,studies,indicate'
p34128
g3
sS'cases,two,were'
p34129
g3
sS'direction,of,the'
p34130
g3
sS'any,reduction,in'
p34131
g9
sS'objective,of,this'
p34132
g3
sS'as,monotherapy,given'
p34133
g3
sS'if,therapy,is'
p34134
g9
sS'nonclinical,studies,show'
p34135
g3
sS'aspirin,concomitant,may'
p34136
g9
sS'a,synergistic,relationship'
p34137
g9
sS'd,but,may'
p34138
g9
sS'other,pathways,have'
p34139
g3
sS'regimens,for,therapy'
p34140
g3
sS'for,subjects,had'
p34141
g3
sS'should,be,stopped'
p34142
g9
sS'may,decrease,the'
p34143
g9
sS'significant,decrease,by'
p34144
g3
sS'inhibiting,cyp3a,to'
p34145
g3
sS'their,o-desacetyl,metabolites'
p34146
g3
sS'and,hoof,twitch'
p34147
g3
sS'immunodeficiencies,including,those'
p34148
g3
sS'of,recovery,from'
p34149
g3
sS'sympathetic,activity,the'
p34150
g3
sS'count,prothrombin,time'
p34151
g3
sS'inhibit,platelet,activation'
p34152
g3
sS'and,on,day'
p34153
g9
sS'been,recognized,as'
p34154
g3
sS'medications,can,cause'
p34155
g3
sS'with,decreased,levels'
p34156
g3
sS'further,they,bring'
p34157
g3
sS'metoclopramide,when,coadministered'
p34158
g9
sS'interactions,between,vidaza'
p34159
g3
sS'metabolism,of,to'
p34160
g3
sS'after,remained,the'
p34161
g3
sS'of,had,plasma'
p34162
g9
sS'requiring,increased,dosage'
p34163
g9
sS'unfortunately,folic,acid'
p34164
g3
sS'is,a,time-dependent'
p34165
g3
sS'of,allergic,or'
p34166
g3
sS'enzymes,and,is'
p34167
g3
sS'withdrawn,from,given'
p34168
g3
sS'decrease,effectiveness,by'
p34169
g3
sS'taking,or,other'
p34170
g3
sS'be,a,non-enzyme'
p34171
g3
sS'and,implications,for'
p34172
g3
sS'ponstel,is,used'
p34173
g3
sS'testing,transaminases,bilirubin'
p34174
g3
sS'three,metabolites,including'
p34175
g3
sS'two,agents,were'
p34176
g3
sS'cyp3a4,inducer,decreased'
p34177
g9
sS'no,formal,pharmacokinetic'
p34178
g3
sS'subtle,cell,type-specific'
p34179
g3
sS'given,high,intraperitoneal'
p34180
g9
sS'p450,system,specifically'
p34181
g3
sS'frequency,of,admissions'
p34182
g3
sS'dosage,replacement,indicates'
p34183
g3
sS'impaired,in,the'
p34184
g9
sS'medications,or,n'
p34185
g9
sS'a,compensatory,increase'
p34186
g3
sS'be,important,also'
p34187
g3
sS'whose,mothers,have'
p34188
g3
sS'relationship,has,not'
p34189
g9
sS'they,may,diminish'
p34190
g9
sS'agents,zyvox,or'
p34191
g9
sS'reported,from,the'
p34192
g9
sS'comparing,the,approved'
p34193
g3
sS'their,dosage,should'
p34194
g9
sS'of,nimbex,in'
p34195
g9
sS'earlier,than,might'
p34196
g9
sS'theoretically,interfere,with'
p34197
g3
sS'lasma,concentrations,of'
p34198
g3
sS'oral,solution,should'
p34199
g9
sS'makes,use,of'
p34200
g3
sS'with,any,other'
p34201
g3
sS'serum,should,be'
p34202
g3
sS'serious,cardiovascular,adverse'
p34203
g9
sS'failure,nyha,class'
p34204
g3
sS'similar,to,that'
p34205
g3
sS'carcinogenicity,studies,have'
p34206
g3
sS'single-dose,nature,of'
p34207
g3
sS'were,on,average'
p34208
g3
sS'in,renal,clearance'
p34209
g9
sS'receiving,mg,fe'
p34210
g9
sS'of,the,additive'
p34211
g3
sS'other,drugs,aliskiren'
p34212
g3
sS'antipsychotic,agents,it'
p34213
g9
sS'oral,contraceptive,based'
p34214
g3
sS'becoming,more,severely'
p34215
g3
sS'hippocampal,lesions,actually'
p34216
g3
sS'frequent,clinical,and'
p34217
g3
sS'it,is,administered'
p34218
g9
sS'hcl,an,increased'
p34219
g3
sS'provide,close,medical'
p34220
g9
sS'cancer,in,postmenopausal'
p34221
g9
sS'two,mg,kg'
p34222
g9
sS'studied,alternative,or'
p34223
g9
sS'aspects,that,impact'
p34224
g3
sS'dose,have,not'
p34225
g3
sS'agents,contribute,to'
p34226
g3
sS'very,weak,effect'
p34227
g9
sS'in,cecectomized,rats'
p34228
g3
sS'conducted,in,female'
p34229
g3
sS'neuropathy,has,occurred'
p34230
g3
sS'tikosyn,with,resulted'
p34231
g9
sS'were,due,to'
p34232
g3
sS'is,essential,to'
p34233
g3
sS'and,effectiveness,of'
p34234
g3
sS'are,not,altered'
p34235
g3
sS'brevibloc,and,in'
p34236
g9
sS'substrate,for,the'
p34237
g3
sS'galloyl,esters,on'
p34238
g3
sS'male,rats,and'
p34239
g3
sS'alone,and,minutes'
p34240
g3
sS'the,intestine,kidneys'
p34241
g3
sS'not,clear,whether'
p34242
g3
sS'ml,h,in'
p34243
g3
sS'a,greater,ischemic'
p34244
g9
sS'in,plasma,concentration'
p34245
g3
sS'formal,studies,to'
p34246
g3
sS'pharmacokinetic,study,maximum'
p34247
g9
sS'from,these,results'
p34248
g3
sS'plasma,proteins,may'
p34249
g3
sS'chemotherapy,or,a'
p34250
g3
sS'as,pure,powders'
p34251
g9
sS'alosetron,also,does'
p34252
g3
sS'that,their,patients'
p34253
g3
sS'dose,of,gleevec'
p34254
g9
sS'did,not,meaningfully'
p34255
g3
sS'or,st,john'
p34256
g9
sS'formal,drug-drug,interaction'
p34257
g3
sS'monitored,to,maintain'
p34258
g3
sS'have,been,reviewed'
p34259
g9
sS'mao,inhibitors,should'
p34260
g9
sS'such,as,cough'
p34261
g9
sS'no,changes,in'
p34262
g3
sS'of,in,dependence'
p34263
g3
sS'vivo,studies,nitrates'
p34264
g9
sS'of,pharmacologic,effects'
p34265
g9
sS'or,pharmacist,of'
p34266
g3
sS'd,is,a'
p34267
g3
sS'of,pgf2alpha,upon'
p34268
g9
sS'to,inhibition,of'
p34269
g3
sS'were,not,seen'
p34270
g3
sS'is,less,well'
p34271
g3
sS'of,assays,using'
p34272
g3
sS'from,marine,coelenterates'
p34273
g3
sS'not,to,potentiate'
p34274
g3
sS'using,human,liver'
p34275
g3
sS'ns,and,imitrex'
p34276
g3
sS'effects,can,be'
p34277
g9
sS'for,information,on'
p34278
g3
sS'insufficient,plasma,and'
p34279
g9
sS'only,clinically,relevant'
p34280
g9
sS'of,kg,was'
p34281
g9
sS'such,as,clinistix'
p34282
g3
sS'reduced,serum,levels'
p34283
g9
sS'both,and,organoleads'
p34284
g3
sS'demonstrated,between,and'
p34285
g9
sS'with,a,genetic'
p34286
g3
sS'rats,results,in'
p34287
g9
sS'on,day,there'
p34288
g9
sS'cleavable,complex,formation'
p34289
g3
sS'digital,extensor,tension'
p34290
g3
sS'which,the,effects'
p34291
g3
sS'potentially,important,drug'
p34292
g9
sS'subjects,than,for'
p34293
g3
sS'for,the,control'
p34294
g3
sS'but,changes,in'
p34295
g3
sS'categories,result,in'
p34296
g9
sS'receiving,oral,may'
p34297
g3
sS'this,disease,can'
p34298
g3
sS'is,dependent,upon'
p34299
g3
sS'of,mg,was'
p34300
g9
sS'wellbutrin,and,agents'
p34301
g9
sS'developments,in,these'
p34302
g3
sS'bromocriptine,mesylate,with'
p34303
g9
sS'be,borne,in'
p34304
g9
sS'antagonists,decreased,the'
p34305
g3
sS'indicate,that,oral'
p34306
g9
sS'due,to,accident'
p34307
g3
sS'cyp,c9,and'
p34308
g3
sS'amiodarone,therapy,alone'
p34309
g3
sS'adjusted,when,these'
p34310
g3
sS'in,mice,selectively'
p34311
g3
sS'estradiol,following,administration'
p34312
g3
sS'it,appears,that'
p34313
g9
sS'in,auc,vs'
p34314
g3
sS'and,may,enhance'
p34315
g9
sS'products,you,may'
p34316
g3
sS'with,the,negative'
p34317
g3
sS'of,the,q-t'
p34318
g3
sS'intoxication,appropriate,adjustment'
p34319
g3
sS'with,erectile,dysfunction'
p34320
g3
sS'agents,along,with'
p34321
g9
sS'be,reduced,thus'
p34322
g9
sS'pharmacokinetics,of,see'
p34323
g3
sS'did,not,show'
p34324
g3
sS'plasma,mean,cmax'
p34325
g9
sS'vitro,showed,no'
p34326
g3
sS'study,in,six'
p34327
g9
sS'use,only,a'
p34328
g3
sS'normal,cells,are'
p34329
g3
sS'interactions,with,that'
p34330
g3
sS'clinitest,benedict,s'
p34331
g3
sS'of,mg,with'
p34332
g9
sS'indinavir,may,be'
p34333
g9
sS'generation,more,people'
p34334
g3
sS'effects,by,cgs21680'
p34335
g9
sS'of,adverse,consequences'
p34336
g3
sS'compromised,renal,function'
p34337
g9
sS'folic,acid,will'
p34338
g3
sS'eg,may,decrease'
p34339
g9
sS'be,achieved,either'
p34340
g3
sS'cause,headaches,and'
p34341
g3
sS'potential,for,arrhythmias'
p34342
g3
sS'to,interfere,with'
p34343
g3
sS'considered,particularly,for'
p34344
g3
sS'cyclopentolate,may,interfere'
p34345
g9
sS'is,not,indicated'
p34346
g3
sS'of,when,has'
p34347
g9
sS'poor,patient,compliance'
p34348
g3
sS'agents,protease,inhibitors'
p34349
g9
sS'increasing,the,salt'
p34350
g9
sS'more,malignant,phenotype'
p34351
g3
sS'mean,steady-state,trough'
p34352
g3
sS'of,blood,glucose'
p34353
g3
sS'the,therapeutic,dose'
p34354
g3
sS'did,not,detect'
p34355
g3
sS'some,blockers,may'
p34356
g9
sS'with,flolan,was'
p34357
g9
sS'to,avoid,impeding'
p34358
g9
sS'and,significant,increases'
p34359
g9
sS'and,can,cause'
p34360
g9
sS'enhancing,the,rate'
p34361
g3
sS'toxic,and,traumatic'
p34362
g9
sS'as,a,regimen'
p34363
g9
sS'levels,whenever,an'
p34364
g3
sS'and,blood,pressures'
p34365
g3
sS'oral,in,patients'
p34366
g3
sS'to,be,lower'
p34367
g3
sS'renal,clearance,of'
p34368
g9
sS'chance,of,developing'
p34369
g9
sS'normal,renal,function'
p34370
g3
sS'patients,on,such'
p34371
g9
sS'and,given,before'
p34372
g3
sS'cyp3a4,inducers,eg'
p34373
g3
sS'crescentic,iga,glomerulonephritis'
p34374
g9
sS'reports,of,positive'
p34375
g3
sS'volunteers,in,the'
p34376
g3
sS'agents,these,agents'
p34377
g9
sS'effect,on,plasma'
p34378
g3
sS'is,no,clinical'
p34379
g3
sS'with,other,have'
p34380
g3
sS'steady-state,l50,mg'
p34381
g3
sS'toxicologic,and,toxicokinetic'
p34382
g3
sS'hydrochloride,binds,a'
p34383
g3
sS'responsiveness,to,after'
p34384
g3
sS'modification,abolished,the'
p34385
g3
sS'in,an,animal'
p34386
g9
sS'in,water,orange'
p34387
g3
sS'activity,was,observed'
p34388
g3
sS'studies,was,administered'
p34389
g3
sS'with,constant,values'
p34390
g3
sS'mediated,by,any'
p34391
g3
sS'reduce,its,renal'
p34392
g9
sS'systemic,antimicrobial,agents'
p34393
g3
sS'manifestation,of,corneal'
p34394
g9
sS'is,presented,of'
p34395
g3
sS'shivering,pupillary,dilation'
p34396
g3
sS'peripheral,anitagonism,without'
p34397
g9
sS'co-administered,with,racemic'
p34398
g9
sS'the,binding,is'
p34399
g3
sS'release,captopril,s'
p34400
g9
sS'the,absorption,of'
p34401
g9
sS'protein,binding,in'
p34402
g9
sS'pcp,produces,psychotomimetic'
p34403
g3
sS'including,man,and'
p34404
g3
sS'formed,with,concurrent'
p34405
g9
sS'similar,to,in'
p34406
g9
sS'like,may,enhance'
p34407
g9
sS'cystic,fibrosis,therapies'
p34408
g3
sS'rely,on,hormonal'
p34409
g3
sS'fexofenadine,has,been'
p34410
g3
sS'non-significantly,reduced,relative'
p34411
g3
sS'in,humans,was'
p34412
g3
sS'the,concomitant,agent'
p34413
g9
sS'were,no,differential'
p34414
g3
sS'can,be,induced'
p34415
g3
sS'as,those,found'
p34416
g3
sS'were,similar,with'
p34417
g3
sS'carbamazepine,due,to'
p34418
g3
sS'of,was,investigated'
p34419
g3
sS'weight,every,other'
p34420
g3
sS'vivo,it,is'
p34421
g3
sS'be,induced,resulting'
p34422
g3
sS'commentaries,and,editorials'
p34423
g3
sS'been,reported,pretreatment'
p34424
g3
sS'sulfamethoxazole-trimethoprim,bactrim,septra'
p34425
g3
sS'the,has,been'
p34426
g3
sS'could,be,prolonged'
p34427
g9
sS'therapy,urinary,excretion'
p34428
g9
sS'fashion,at,a'
p34429
g3
sS'also,increased,rate'
p34430
g3
sS'may,provide,misleading'
p34431
g3
sS'contraindications,significant,teratogenic'
p34432
g3
sS'of,the,hypoglycemic'
p34433
g9
sS'under,the,plasma'
p34434
g9
sS'protein,the,administration'
p34435
g9
sS'creams,lotions,or'
p34436
g3
sS'intensify,the,antimuscarinic'
p34437
g9
sS'periods,with,alone'
p34438
g3
sS'combination,hormonal,by'
p34439
g3
sS'hepatic,cytochrome,p450'
p34440
g3
sS'should,be,adjusted'
p34441
g9
sS'strong,synergistic,activity'
p34442
g9
sS'unconjugated,nacmc,m'
p34443
g3
sS'has,been,tested'
p34444
g3
sS'also,occur,with'
p34445
g3
sS'followed,for,estimation'
p34446
g3
sS'have,their,dose'
p34447
g3
sS'bacterial,infection,and'
p34448
g3
sS'rats,epidural,injection'
p34449
g9
sS'need,for,therapy'
p34450
g9
sS'the,rate-decreasing,effects'
p34451
g9
sS'therapy,allow,sufficient'
p34452
g3
sS'be,maintained,in'
p34453
g3
sS'treatment,with,can'
p34454
g9
sS'oral,and,to'
p34455
g9
sS'many,selective,serotonin'
p34456
g3
sS'been,shown,not'
p34457
g3
sS'of,decreased,slightly'
p34458
g9
sS'day,of,therapy'
p34459
g9
sS'subjects,who,do'
p34460
g3
sS'system,though,this'
p34461
g9
sS'considered,if,systemic'
p34462
g3
sS'of,for,all'
p34463
g3
sS'in,s,effects'
p34464
g3
sS'warfarin-vitamin,k,can'
p34465
g9
sS'may,augment,the'
p34466
g9
sS'actions,desirable,or'
p34467
g3
sS'take,a,supplement'
p34468
g3
sS'patients,receiving,itraconazole'
p34469
g9
sS'the,most,effective'
p34470
g3
sS'be,used,as'
p34471
g3
sS'to,established,interactions'
p34472
g3
sS'of,serious,ventricular'
p34473
g9
sS'and,av,conduction'
p34474
g3
sS'this,interference,may'
p34475
g3
sS'or,equal,to'
p34476
g3
sS'of,immunoreactive,after'
p34477
g3
sS'cell,permeable,caspase-3'
p34478
g3
sS'of,developing,peripheral'
p34479
g9
sS'elevated,salivary,cortisol'
p34480
g3
sS'of,at,h'
p34481
g3
sS'each,of,male'
p34482
g3
sS'the,clinical,studies'
p34483
g3
sS'followed,by,to'
p34484
g3
sS'bleeding,events,including'
p34485
g3
sS'hiv-infected,patients,the'
p34486
g9
sS'metabolites,have,been'
p34487
g3
sS'effects,of,are'
p34488
g9
sS'approximately,times,the'
p34489
g3
sS'from,both,lean'
p34490
g3
sS'of,chloroprocaine,inhibits'
p34491
g3
sS'high-estradiol,treated,rats'
p34492
g9
sS'variably,increased,when'
p34493
g3
sS'when,the,preceding'
p34494
g3
sS'of,its,adverse'
p34495
g3
sS'prospective,clinical,trials'
p34496
g3
sS'target,added,drug'
p34497
g3
sS'of,on,fi'
p34498
g9
sS'clinical,practice,has'
p34499
g9
sS'inappropriate,being,either'
p34500
g3
sS'initiated,to,see'
p34501
g9
sS'celebrex,should,be'
p34502
g9
sS'by,cytochromes,p450'
p34503
g3
sS'and,intravenous,administration'
p34504
g3
sS'subjects,nor,does'
p34505
g3
sS'of,the,current'
p34506
g3
sS'may,render,these'
p34507
g9
sS'from,ml,h'
p34508
g9
sS'hormone,or,tsh'
p34509
g3
sS'the,package,insert'
p34510
g9
sS'induce,cyp3a4,rifampicin'
p34511
g9
sS'and,no,reports'
p34512
g3
sS'th,and,th'
p34513
g3
sS'be,warned,of'
p34514
g3
sS'sodium,fluorescein,naflu'
p34515
g3
sS'of,uptake,sites'
p34516
g3
sS'measures,for,its'
p34517
g3
sS'release,or,the'
p34518
g3
sS'xr,should,be'
p34519
g3
sS'factrel,test,should'
p34520
g3
sS'and,oral,administration'
p34521
g3
sS'have,secondary,actions'
p34522
g9
sS'for,in,combination'
p34523
g3
sS'before,or,to'
p34524
g3
sS'coadministered,with,a'
p34525
g3
sS'there,may,remain'
p34526
g3
sS'in,pharmacokinetics,auc'
p34527
g3
sS'to,difluoroacetone,by'
p34528
g3
sS'condensation,nuclear,matrix'
p34529
g3
sS'were,administered,mg'
p34530
g3
sS'however,at,lower'
p34531
g3
sS'a,containing,regimen'
p34532
g3
sS'activity,eg,and'
p34533
g9
sS'short-acting,inhaled,such'
p34534
g3
sS'muscle,relaxants,has'
p34535
g3
sS'saquinavir,steady-state,cmax'
p34536
g9
sS'grapefruit,orange,and'
p34537
g3
sS'catecholamine-depleting,drugs,such'
p34538
g9
sS'stop,any,medicine'
p34539
g3
sS'with,mg,sular'
p34540
g9
sS'in,each,subject'
p34541
g3
sS'in,study,one'
p34542
g3
sS'added,to,therapy'
p34543
g9
sS'the,mucosal,cells'
p34544
g3
sS'pressure,may,occur'
p34545
g9
sS'combination,study,of'
p34546
g9
sS'reactions,secondary,to'
p34547
g3
sS'concentration,as,compared'
p34548
g3
sS'after,the,start'
p34549
g9
sS'of,sodium,fluorescein'
p34550
g3
sS'disposition,of,and'
p34551
g3
sS'ten,patients,who'
p34552
g3
sS'clozapine,and,or'
p34553
g9
sS'that,mcf-7,cells'
p34554
g3
sS'as,stable,as'
p34555
g3
sS'of,concomitant,treatment'
p34556
g3
sS'of,an,analog'
p34557
g3
sS'mg,bid,for'
p34558
g9
sS'of,overdosage,cns'
p34559
g9
sS'for,the,patient'
p34560
g3
sS'any,procedure,in'
p34561
g3
sS'diamond,patient,populations'
p34562
g9
sS'on,recovery,and'
p34563
g3
sS'on,the,enhancement'
p34564
g3
sS'necessary,during,and'
p34565
g9
sS'for,to,hours'
p34566
g9
sS'had,returned,to'
p34567
g9
sS'by,bacterial,metabolism'
p34568
g9
sS'initial,therapy,with'
p34569
g3
sS'patients,with,tuberculosis'
p34570
g9
sS'and,these,imidazole'
p34571
g3
sS'with,the,rate'
p34572
g3
sS'binding,proteins,may'
p34573
g3
sS'although,the,difference'
p34574
g3
sS'anticoagulant,therapy,should'
p34575
g9
sS'paralytic,ileus,may'
p34576
g9
sS'of,may,decrease'
p34577
g9
sS'variety,of,factors'
p34578
g3
sS'with,subsequent,cycles'
p34579
g3
sS'produce,any,additional'
p34580
g9
sS'last,chapters,cover'
p34581
g3
sS'similar,between,the'
p34582
g3
sS'effect,of,other'
p34583
g3
sS'depression,producing,medications'
p34584
g3
sS'on,either,the'
p34585
g3
sS'such,as,flushing'
p34586
g3
sS'healthy,normal,volunteers'
p34587
g3
sS'neuropathy,or,other'
p34588
g9
sS'more,than,patients'
p34589
g3
sS'and,adult,patients'
p34590
g3
sS'hyperplasia,polymorphic,proliferation'
p34591
g3
sS'absence,of,formal'
p34592
g3
sS'drug,may,be'
p34593
g3
sS'which,healthy,volunteers'
p34594
g9
sS'with,vioxx,may'
p34595
g9
sS'with,and,when'
p34596
g9
sS'corticosteroids,may,suppress'
p34597
g3
sS'for,which,is'
p34598
g3
sS'to,be,demonstrated'
p34599
g3
sS'regarding,protease,inhibitor'
p34600
g3
sS'dosed,weekly,for'
p34601
g3
sS'increased,metabolism,and'
p34602
g9
sS'strains,of,staphylococcus'
p34603
g9
sS'has,increased,after'
p34604
g3
sS'could,be,considered'
p34605
g3
sS'bepridil,has,been'
p34606
g3
sS'metabolized,nor,does'
p34607
g3
sS'in,a,patient'
p34608
g9
sS'available,for,use'
p34609
g3
sS'and,cyp2c8,in'
p34610
g3
sS'a,poor,substrate'
p34611
g3
sS'actions,via,the'
p34612
g3
sS'concentrations,and,reduce'
p34613
g3
sS'administration,of,mefloquine'
p34614
g9
sS'their,metabolism,in'
p34615
g9
sS'has,been,noted'
p34616
g3
sS'these,medicines,with'
p34617
g9
sS'be,advocated,on'
p34618
g3
sS'assay,and,emit-d'
p34619
g3
sS'when,known,to'
p34620
g3
sS'addition,is,not'
p34621
g3
sS'will,interfere,with'
p34622
g9
sS'or,with,formulations'
p34623
g9
sS'was,extensive,concomitant'
p34624
g3
sS'secretion,blocking,agent'
p34625
g3
sS'test,for,using'
p34626
g3
sS'for,mg,qd'
p34627
g9
sS'when,lodine,is'
p34628
g9
sS'when,administering,cyp3a4'
p34629
g3
sS'use,of,trileptal'
p34630
g9
sS'potentiating,effect,on'
p34631
g9
sS'predispose,the,patient'
p34632
g9
sS'substrates,inhibitors,or'
p34633
g3
sS'drugs,fibric,acid'
p34634
g3
sS'individuals,may,develop'
p34635
g3
sS'after,oral,mg'
p34636
g3
sS'involving,inhibition,of'
p34637
g9
sS'control,at,h'
p34638
g3
sS'of,such,combinations'
p34639
g3
sS'have,a,strong'
p34640
g3
sS'flow,glomerular,filtration'
p34641
g3
sS'be,avoided,beta-blockers'
p34642
g9
sS'that,may,selectively'
p34643
g9
sS'at,either,dose'
p34644
g3
sS'minimum,concentration,increased'
p34645
g3
sS'and,mg,of'
p34646
g9
sS'that,is,both'
p34647
g3
sS'effects,were,short-lasting'
p34648
g3
sS'by,about,but'
p34649
g3
sS'become,pregnant,into'
p34650
g3
sS'clinic,is,now'
p34651
g3
sS'impaired,psychomotor,performance'
p34652
g9
sS'been,reported,upon'
p34653
g9
sS'the,rbc,mice'
p34654
g3
sS'and,mg,or'
p34655
g3
sS'propranolol,may,decrease'
p34656
g9
sS'two-year,carcinogenesis,study'
p34657
g3
sS'once,a,stable'
p34658
g3
sS'this,table,is'
p34659
g3
sS'agents,there,were'
p34660
g9
sS'careful,tapering,of'
p34661
g3
sS'a,nonhormonal,product'
p34662
g3
sS'a,two-year,carcinogenesis'
p34663
g3
sS'patients,does,not'
p34664
g3
sS'literature,contains,reports'
p34665
g3
sS'inhibit,the,biotransformation'
p34666
g3
sS'window,is,different'
p34667
g9
sS'exposed,to,a'
p34668
g3
sS'bioavailability,of,is'
p34669
g9
sS'be,considered,although'
p34670
g3
sS'basis,of,the'
p34671
g3
sS'several,cardiovascular,directly'
p34672
g3
sS'at,doses,up'
p34673
g3
sS'and,may,ameliorate'
p34674
g9
sS'in,vitro,metabolism'
p34675
g3
sS'day,for,days'
p34676
g3
sS'most,are,contraindicated'
p34677
g9
sS'flurbiprofen,pretreatment,attenuated'
p34678
g9
sS'acid,and,others'
p34679
g9
sS'solution,should,have'
p34680
g3
sS'not,influence,the'
p34681
g3
sS'we,describe,a'
p34682
g3
sS'and,respectively,on'
p34683
g9
sS'possible,effectiveness,of'
p34684
g9
sS'either,or,h'
p34685
g3
sS'to,possible,deleterious'
p34686
g3
sS'carboxymethylcellulose,in,vitro'
p34687
g3
sS'of,morning,and'
p34688
g3
sS'with,that,inhibit'
p34689
g3
sS'elimination,route,of'
p34690
g9
sS'and,absorption,of'
p34691
g9
sS'of,lifestyle,giving'
p34692
g3
sS'patients,should,not'
p34693
g3
sS'maximum,concentration,and'
p34694
g3
sS'daily,and,mcg'
p34695
g3
sS'understanding,of,pain'
p34696
g3
sS'proteins,other,than'
p34697
g3
sS'similar,in,patients'
p34698
g3
sS'in,vitro,gleevec'
p34699
g3
sS'or,preanesthetic,and'
p34700
g3
sS'variability,component,of'
p34701
g9
sS'body,weight,for'
p34702
g3
sS'be,necessary,to'
p34703
g9
sS'transport,of,may'
p34704
g9
sS'been,administered,without'
p34705
g3
sS'result,in,prolonged'
p34706
g3
sS'evaluated,the,interference'
p34707
g3
sS'up,to,years'
p34708
g3
sS'should,be,interrupted'
p34709
g3
sS'of,these,case'
p34710
g3
sS'pharmacokinetic,parameters,without'
p34711
g3
sS'during,any,of'
p34712
g3
sS'clearance,of,adrenocorticoids'
p34713
g3
sS'p450,inhibitors,to'
p34714
g3
sS'gentamicin,methionine,may'
p34715
g9
sS'dosage,or,monitoring'
p34716
g3
sS'dexamethasone,aprepitant,when'
p34717
g9
sS'significantly,higher,than'
p34718
g3
sS'uroxatral,should,not'
p34719
g9
sS'initial,dose,should'
p34720
g3
sS'drug,interactions,benzodiazepines'
p34721
g9
sS'abnormalities,and,hearing'
p34722
g9
sS'may,reduce,serum'
p34723
g9
sS'either,agent,additional'
p34724
g3
sS'and,provide,close'
p34725
g9
sS'was,no,clinically'
p34726
g3
sS'synthesis,have,been'
p34727
g9
sS'concomitantly,with,plendil'
p34728
g3
sS'systemic,exposure,auc0-12'
p34729
g3
sS'other,precautions,may'
p34730
g3
sS'adjustment,of,uricosuric'
p34731
g9
sS'patients,concurrently,treated'
p34732
g9
sS'and,celexa,in'
p34733
g9
sS'fashion,from,to'
p34734
g3
sS'ecg,and,blood'
p34735
g9
sS'with,an,adjustment'
p34736
g3
sS'with,the,potential'
p34737
g3
sS'include,certain,and'
p34738
g9
sS'membrane,potential,input'
p34739
g3
sS'dosage,adjustment,when'
p34740
g3
sS'mg,ml,approximately'
p34741
g3
sS'therapeutic,monitoring,the'
p34742
g3
sS'plasma,half-life,may'
p34743
g9
sS'in,treatment-experienced,patients'
p34744
g3
sS'therefore,the,potential'
p34745
g3
sS'of,naflu,to'
p34746
g3
sS'cite,primary,sources'
p34747
g3
sS'or,carbidopa-levodopa,combination'
p34748
g3
sS'hypertension,where,the'
p34749
g3
sS'have,used,combined'
p34750
g3
sS'blocker,given,in'
p34751
g9
sS'the,effectiveness,of'
p34752
g3
sS'screening,urine,for'
p34753
g3
sS'or,accumulation,during'
p34754
g3
sS'with,mg,daily'
p34755
g9
sS'controlled,clinical,study'
p34756
g9
sS'slow,alterations,in'
p34757
g3
sS'hcl,is,given'
p34758
g3
sS'decreased,in,hyperthyroidism'
p34759
g3
sS'metabolism,or,qt'
p34760
g3
sS'and,others,plasma'
p34761
g3
sS'similar,to,hydrochloride'
p34762
g3
sS'time,were,recorded'
p34763
g3
sS'p450,c9,by'
p34764
g9
sS'days,has,been'
p34765
g9
sS'was,effective,in'
p34766
g9
sS'maximum,block,following'
p34767
g9
sS'reduced,tolerance,in'
p34768
g9
sS'therapy,the,initial'
p34769
g3
sS'rates,in,the'
p34770
g3
sS'at,the,site'
p34771
g3
sS'of,hctz,alone'
p34772
g3
sS'shown,that,at'
p34773
g3
sS'with,measurement,of'
p34774
g3
sS'reduced,thus,necessitating'
p34775
g9
sS'administration,of,camptosar'
p34776
g3
sS'as,and,sometimes'
p34777
g9
sS'following,administration,of'
p34778
g3
sS'can,exert,additive'
p34779
g3
sS'concentrations,may,need'
p34780
g9
sS'regranex,gel,interacts'
p34781
g3
sS'the,systemic,circulation'
p34782
g9
sS'either,protein,kinase'
p34783
g3
sS'ortho-novum,increased,the'
p34784
g9
sS'been,demonstrated,between'
p34785
g9
sS'patients,and,result'
p34786
g9
sS'of,tambocor,with'
p34787
g3
sS'in,an,regimen'
p34788
g3
sS'medications,were,grouped'
p34789
g3
sS'reduction,in,urinary'
p34790
g9
sS'of,the,aucs'
p34791
g3
sS'and,non-opioid,agonist'
p34792
g3
sS'warfarin,co-,administration'
p34793
g3
sS'other,fruit,juices'
p34794
g3
sS'carefully,for,signs'
p34795
g9
sS'the,intravenous,route'
p34796
g3
sS'excessive,effects,including'
p34797
g9
sS'failure,have,been'
p34798
g9
sS'effects,of,stimulation'
p34799
g3
sS'is,metabolized,through'
p34800
g3
sS'to,acute,release'
p34801
g3
sS'profound,when,taxol'
p34802
g9
sS'effects,addiction,research'
p34803
g3
sS'concentrations,of,one'
p34804
g3
sS'equetrotm,increases,the'
p34805
g9
sS'like,monoamine,oxidase'
p34806
g9
sS'kda,adapter,protein'
p34807
g3
sS'were,below,the'
p34808
g3
sS'p,endothelial,dysfunction'
p34809
g3
sS'revlimid,is,neither'
p34810
g3
sS'that,strongly,induce'
p34811
g9
sS'induce,cyp1a2,activity'
p34812
g3
sS'have,been,noted'
p34813
g9
sS'requires,oral,physiological'
p34814
g3
sS'a,potentially,fatal'
p34815
g9
sS'g,bolus,of'
p34816
g3
sS'therapy,oral,containing'
p34817
g3
sS'from,ois,in'
p34818
g3
sS'well,as,effects'
p34819
g3
sS'that,in,a'
p34820
g3
sS'effects,vioxx,is'
p34821
g3
sS'not,recommended,levetiracetam'
p34822
g3
sS'topical,or,vaginal'
p34823
g3
sS'interaction,between,oral'
p34824
g9
sS'bsa,and,non-ossification'
p34825
g3
sS'antidiabetic,requirements,i'
p34826
g3
sS'receiving,velcade,treatment'
p34827
g9
sS'captopril-digoxin,interaction,could'
p34828
g3
sS'conjugates,so,formed'
p34829
g3
sS'medication,should,be'
p34830
g3
sS'increasing,the,non-renal'
p34831
g9
sS'inference,is,that'
p34832
g3
sS'each,subject,was'
p34833
g3
sS'within,hours,after'
p34834
g3
sS'concentration,of,novolog'
p34835
g3
sS'endocrine,and,liver'
p34836
g3
sS'determined,by,the'
p34837
g3
sS'is,no,significant'
p34838
g3
sS'primary,enzymes,involved'
p34839
g3
sS'as,the,potential'
p34840
g9
sS'reaction,either,occurred'
p34841
g3
sS'interactions,interactions,between'
p34842
g3
sS'channel,blockers,sustained-release'
p34843
g3
sS'large,doses,may'
p34844
g3
sS'the,levels,effects'
p34845
g3
sS'administered,together,the'
p34846
g3
sS'of,is,excreted'
p34847
g3
sS'studied,in,a'
p34848
g3
sS'and,increasing,steady-state'
p34849
g9
sS'to,in,the'
p34850
g9
sS'p450,enzymes,and'
p34851
g3
sS'plasma,half-life,and'
p34852
g9
sS'potential,for,such'
p34853
g3
sS'days,with,mg'
p34854
g3
sS'monitoring,serum,concentration'
p34855
g3
sS'this,section,as'
p34856
g3
sS'erythromycin,co-administration,of'
p34857
g3
sS'thus,dosed,to'
p34858
g3
sS'remains,constant,while'
p34859
g3
sS'are,administered,dilute'
p34860
g3
sS'tca,may,become'
p34861
g3
sS'of,studies,in'
p34862
g9
sS'between,and,racemic'
p34863
g3
sS'therapies,as,safety'
p34864
g3
sS'above,data,from'
p34865
g3
sS'also,receiving,a'
p34866
g3
sS'or,without,replacement'
p34867
g3
sS'gsh,and,elevation'
p34868
g3
sS'reduced,from,approximately'
p34869
g9
sS'therapeutic,agents,with'
p34870
g3
sS'some,clinicians,have'
p34871
g3
sS'general,or,other'
p34872
g9
sS'either,agent,or'
p34873
g3
sS'in,diabetes,longitudinal'
p34874
g3
sS'isoenzyme,and,thus'
p34875
g3
sS'mesenteric,vasodilation,is'
p34876
g3
sS'mellitus,certain,neurologic'
p34877
g3
sS'at,least,miu'
p34878
g3
sS'mao,inhibitors,in'
p34879
g9
sS'given,oral,h2-antagonists'
p34880
g3
sS'that,discontinuation,of'
p34881
g9
sS'and,other,potentially'
p34882
g9
sS'risk,of,depression'
p34883
g3
sS'supported,by,separate'
p34884
g3
sS'to,decrease,overall'
p34885
g3
sS'especially,resistant,to'
p34886
g3
sS'outbreaks,of,arsenical'
p34887
g3
sS'to,this,adverse'
p34888
g3
sS'the,clinical,presentation'
p34889
g3
sS'suggest,that,d1'
p34890
g3
sS'trial,of,pediatric'
p34891
g3
sS'lymphocytes,in,vitro'
p34892
g3
sS'a,simultaneous,fold'
p34893
g9
sS'in,case,of'
p34894
g9
sS'if,they,occur'
p34895
g3
sS'resin,or,at'
p34896
g3
sS'the,alters,the'
p34897
g3
sS'appeared,to,produce'
p34898
g9
sS'trial,should,not'
p34899
g9
sS'as,age,gender'
p34900
g3
sS'commercially,available,kits'
p34901
g3
sS'incidence,of,upper'
p34902
g3
sS'taken,concomitantly,by'
p34903
g9
sS'the,first,phase'
p34904
g3
sS'treat,a,wide'
p34905
g3
sS'studies,studies,in'
p34906
g3
sS'potential,of,nephrotoxicity'
p34907
g9
sS'interval,caution,should'
p34908
g3
sS'over,a,h'
p34909
g3
sS'initial,or,maintenance'
p34910
g3
sS'the,task,considered'
p34911
g3
sS'with,impaired,renal'
p34912
g9
sS'blocking,agents,channel'
p34913
g9
sS'effects,on,arterial'
p34914
g9
sS'hcl,ascorbic,acid'
p34915
g9
sS'analysis,of,total'
p34916
g3
sS'in,contrast,the'
p34917
g3
sS'development,including,immune'
p34918
g3
sS'and,low,hepatic'
p34919
g3
sS'immediately,preceding,the'
p34920
g3
sS'warfarin,multiple,oral'
p34921
g3
sS'blockers,may,increase'
p34922
g9
sS'lymphopenia,proper,monitoring'
p34923
g3
sS'and,hydroxydesloratadine,pharmacokinetics'
p34924
g3
sS'of,the,caucasian'
p34925
g3
sS'viracept,and,that'
p34926
g3
sS'interaction,fosinopril,may'
p34927
g3
sS'agents,nsaids,concomitant'
p34928
g9
sS'of,cefotan,may'
p34929
g3
sS'that,affect,platelet'
p34930
g3
sS'capsule,formulation,with'
p34931
g9
sS'of,more,highly'
p34932
g3
sS'and,nondepolarizing,muscle'
p34933
g3
sS'an,insufficient,intake'
p34934
g3
sS'with,xanthine,derivatives'
p34935
g9
sS'up,smoking,adapting'
p34936
g3
sS'and,cyp2d6,are'
p34937
g3
sS'of,itraconazole,with'
p34938
g9
sS'co-administration,of,copegus'
p34939
g9
sS'cardiopulmonary,stimulation,is'
p34940
g3
sS'the,intestinal,absorption'
p34941
g3
sS'and,ethacrynic,acid'
p34942
g9
sS'control,program,of'
p34943
g3
sS'develop,in,patients'
p34944
g9
sS'acid,sequestrants,have'
p34945
g3
sS'recommended,human,hour'
p34946
g3
sS'hyperpolarized,by,selective'
p34947
g3
sS'if,taken,hour'
p34948
g3
sS'caused,by,a'
p34949
g9
sS'index,such,as'
p34950
g9
sS'compared,with,patients'
p34951
g9
sS'present,in,the'
p34952
g3
sS'both,dietary,concentrations'
p34953
g3
sS'up,to,year'
p34954
g3
sS'necessary,when,tagamet'
p34955
g9
sS'digoxin,the,concomitant'
p34956
g3
sS'without,endothelium,were'
p34957
g3
sS'coadministration,whereas,the'
p34958
g9
sS'the,to,bind'
p34959
g3
sS'other,and,may'
p34960
g9
sS'be,exercised,with'
p34961
g3
sS'administered,alone,and'
p34962
g9
sS'patients,receiving,for'
p34963
g3
sS'when,mg,every'
p34964
g9
sS'that,cyp1a2,is'
p34965
g9
sS'with,type,diabetes'
p34966
g3
sS'which,have,been'
p34967
g3
sS'hydantoin,antiepileptic,and'
p34968
g9
sS'exacerbated,by,administration'
p34969
g9
sS'ca,channels,in'
p34970
g3
sS'concomitantly,the,patient'
p34971
g9
sS'seizures,in,susceptible'
p34972
g9
sS'injection,should,not'
p34973
g3
sS'by,coadministration,with'
p34974
g3
sS'and,phase,days'
p34975
g3
sS'effects,of,this'
p34976
g3
sS'mediated,reduction,in'
p34977
g3
sS'cause,increased,serum'
p34978
g3
sS'haloperidol,blocks,and'
p34979
g9
sS'performed,and,caution'
p34980
g3
sS'based,on,this'
p34981
g3
sS'with,flolan,which'
p34982
g9
sS'and,monitored,regularly'
p34983
g3
sS'the,mean,qt'
p34984
g9
sS'modify,the,mitogenic'
p34985
g9
sS'of,either,h2'
p34986
g3
sS'aids-related,kaposi,s'
p34987
g3
sS'also,has,an'
p34988
g3
sS'fractional,clearance,rate'
p34989
g9
sS'patients,serum,should'
p34990
g3
sS'of,nimbex,are'
p34991
g9
sS'of,gastrointestinal,toxicity'
p34992
g9
sS'with,membranes,and'
p34993
g3
sS'herbal,products,st'
p34994
g3
sS'concentrations,tested,to'
p34995
g3
sS'remedies,is,becoming'
p34996
g3
sS'defecation,episodes,and'
p34997
g3
sS'aeds,in,pediatric'
p34998
g9
sS'elevation,of,tbars'
p34999
g9
sS'age,of,years'
p35000
g3
sS'have,frequently,been'
p35001
g3
sS'few,data,regarding'
p35002
g3
sS'abnormal,laboratory,results'
p35003
g3
sS'suppress,certain,cyp450'
p35004
g3
sS'that,have,renal'
p35005
g3
sS'is,limited,as'
p35006
g3
sS'three,strains,of'
p35007
g3
sS'the,dose,adjustment'
p35008
g9
sS'response,to,campath'
p35009
g3
sS'vitro,displacement,studies'
p35010
g3
sS'the,hippocampus,and'
p35011
g3
sS'stress,induction,by'
p35012
g3
sS'of,levels,and'
p35013
g3
sS'such,as,because'
p35014
g9
sS'the,ph,of'
p35015
g9
sS'exposure,general,logistic'
p35016
g3
sS'metabolized,by,monoamine'
p35017
g3
sS'subjects,single-dose,administration'
p35018
g3
sS'patients,with,are'
p35019
g3
sS'increased,phenytoin,levels'
p35020
g3
sS'valproic,acid,were'
p35021
g3
sS'serious,toxicity,such'
p35022
g3
sS'absorption,of,fat'
p35023
g9
sS'channel,subtypes,using'
p35024
g3
sS'was,established,that'
p35025
g3
sS'reduce,the,metabolism'
p35026
g3
sS'metabolism,by,is'
p35027
g3
sS'of,vasopressor,and'
p35028
g3
sS'characteristics,of,the'
p35029
g3
sS'studied,in,rat'
p35030
g3
sS'liver,biopsy,roegnik'
p35031
g3
sS'reactions,have,also'
p35032
g3
sS'p-450,isoenzymes,caution'
p35033
g9
sS'local,close,supervision'
p35034
g3
sS'and,concomitantly,administered'
p35035
g3
sS'seen,in,clinical'
p35036
g3
sS'least,hours,prior'
p35037
g9
sS'felbatol,the,rate'
p35038
g3
sS'cefditoren,pivoxil,had'
p35039
g3
sS'mg,q24h,for'
p35040
g3
sS'concentrations,after,initiation'
p35041
g9
sS'the,result,of'
p35042
g3
sS'some,patients,and'
p35043
g9
sS'and,produced,in'
p35044
g3
sS'inducers,such,as'
p35045
g9
sS'the,and,properties'
p35046
g3
sS'increased,by,chronic'
p35047
g9
sS'two,mg,tablets'
p35048
g3
sS'shown,to,be'
p35049
g3
sS'dong,quai,and'
p35050
g3
sS'prolonged,prothrombin,times'
p35051
g9
sS'a,sign,of'
p35052
g3
sS'for,glucose,in'
p35053
g3
sS'of,starlix,mg'
p35054
g3
sS'with,plus,catecholamine'
p35055
g9
sS'for,binding,sites'
p35056
g9
sS'tmax,at,daily'
p35057
g3
sS'dose,administration,mg'
p35058
g3
sS'when,given,supplemental'
p35059
g9
sS'acid,erythromycin,azole'
p35060
g3
sS'with,treatment,in'
p35061
g3
sS'radiographic,iodinated,contrast'
p35062
g9
sS'effects,and,these'
p35063
g3
sS'excessive,increase,in'
p35064
g3
sS'are,a,rapidly'
p35065
g3
sS'following,initial,or'
p35066
g3
sS'an,analysis,of'
p35067
g9
sS'for,one,week'
p35068
g9
sS'occurs,dose,should'
p35069
g9
sS'suppression,of,release'
p35070
g3
sS'those,with,severe'
p35071
g9
sS'the,cyp2c9,catalyzed'
p35072
g9
sS'increased,sedation,with'
p35073
g3
sS'potassium-sparing,on,kinetics'
p35074
g9
sS'physiological,oral,supplementation'
p35075
g3
sS'impairment,may,require'
p35076
g3
sS'camp,in,parietal'
p35077
g3
sS'and,without,an'
p35078
g9
sS'amevive,who,become'
p35079
g3
sS'since,bile,acid'
p35080
g9
sS'the,reaction,of'
p35081
g9
sS'purification,of,both'
p35082
g3
sS'actions,of,the'
p35083
g9
sS'gain,occurred,significantly'
p35084
g3
sS'as,the,coat-a'
p35085
g3
sS'to,cause,tumors'
p35086
g9
sS'to,prevent,maltose'
p35087
g3
sS'a,female,dog'
p35088
g3
sS'hormone,may,enhance'
p35089
g9
sS'several,dose,fractions'
p35090
g3
sS'because,have,been'
p35091
g9
sS'rewarming,was,a'
p35092
g3
sS'with,dynacirc,an'
p35093
g3
sS'serial,pharmacokinetic,dosing'
p35094
g3
sS'fi,responding,significantly'
p35095
g3
sS'if,changes,in'
p35096
g3
sS'may,decrease,sprycel'
p35097
g3
sS'together,these,findings'
p35098
g3
sS'during,coadministration,with'
p35099
g9
sS'hatching,of,miracidia'
p35100
g3
sS'at,mg,daily'
p35101
g9
sS'loss,of,bar-press'
p35102
g3
sS'other,including,ether'
p35103
g9
sS'results,in,patients'
p35104
g3
sS'secretion,of,and'
p35105
g9
sS'days,after,initiating'
p35106
g9
sS'p450,isoforms,cyp1a2'
p35107
g3
sS'a,hmgcoa,reductase'
p35108
g3
sS'and,hydrochloride,a'
p35109
g3
sS'tissue,culture,the'
p35110
g9
sS'on,the,incidence'
p35111
g3
sS'a2,c8,and'
p35112
g3
sS'observed,with,another'
p35113
g3
sS'serotonin,releaser,and'
p35114
g9
sS'life,in,patients'
p35115
g3
sS'prothrombin,measures,have'
p35116
g3
sS'available,data,are'
p35117
g3
sS'time,course,of'
p35118
g3
sS'the,desired,level'
p35119
g3
sS'metabolism,and,elimination'
p35120
g3
sS'observed,when,norpace'
p35121
g3
sS'exercised,when,these'
p35122
g3
sS'several,studies,indicate'
p35123
g3
sS'be,the,underlying'
p35124
g9
sS'other,antiepileptic,drugs'
p35125
g9
sS'shown,a,increase'
p35126
g9
sS'those,patients,reveiving'
p35127
g9
sS'd6,they,may'
p35128
g3
sS'a,mcg,once'
p35129
g3
sS'to,assist,the'
p35130
g3
sS'qd,cohort,or'
p35131
g3
sS'progressing,to,delirium'
p35132
g9
sS'studies,translates,into'
p35133
g3
sS'animal,data,indicated'
p35134
g3
sS'oral,antifungal,agents'
p35135
g9
sS'clo-4,simultaneously,or'
p35136
g3
sS'gonadotropin-releasing,hormone,indicating'
p35137
g3
sS'rifampicin,in,a'
p35138
g9
sS'when,both,are'
p35139
g9
sS'be,used,inconcomitant'
p35140
g3
sS'was,not,associated'
p35141
g3
sS'to,emerge,if'
p35142
g9
sS'in,a,increase'
p35143
g9
sS'liver,microsomes,the'
p35144
g3
sS'control,rbc,were'
p35145
g3
sS'artifactually,low,results'
p35146
g3
sS'inhalation,aerosol,with'
p35147
g9
sS'changes,are,listed'
p35148
g3
sS'study,in,this'
p35149
g3
sS'one-thousandth,of,the'
p35150
g3
sS'to,x,iu'
p35151
g3
sS'preparations,micro-dosed,preparations'
p35152
g9
sS'of,with,containing'
p35153
g9
sS'concomitantly,administered,due'
p35154
g3
sS'with,medication,iodine-containing'
p35155
g3
sS'core,temperature,was'
p35156
g9
sS'fat,including,central'
p35157
g3
sS'any,interaction,between'
p35158
g3
sS'mg,increased,exposure'
p35159
g9
sS'with,sprycel,is'
p35160
g9
sS'clearance,by,and'
p35161
g9
sS'with,sprycel,in'
p35162
g3
sS'an,interacting,which'
p35163
g3
sS'microsomal,enzyme,oxidation'
p35164
g3
sS'hiv,classified,as'
p35165
g9
sS'with,dilaudid,may'
p35166
g9
sS'which,was,also'
p35167
g3
sS'are,receiving,ace'
p35168
g9
sS'evidence,that,the'
p35169
g3
sS'ergomar,and,other'
p35170
g9
sS'pupil,size,mydriasis'
p35171
g9
sS'of,and,serotonergic'
p35172
g3
sS'treatment,in,patients'
p35173
g3
sS'with,has,also'
p35174
g3
sS'by,or,inhibit'
p35175
g3
sS'conclude,that,an'
p35176
g3
sS'the,single-dose,nature'
p35177
g3
sS'administered,or,discontinued'
p35178
g9
sS'clomipramine,hcl,phenytoin'
p35179
g9
sS'clonazepam,does,not'
p35180
g3
sS'approximately,decrease,range'
p35181
g9
sS'interactions,a,false'
p35182
g3
sS'is,feasible,and'
p35183
g3
sS'study,cytochrome,p450'
p35184
g3
sS'negative,inotropic,properties'
p35185
g9
sS'mao,inhibitor,being'
p35186
g3
sS'metabolism,of,the'
p35187
g9
sS'or,or,its'
p35188
g3
sS'patient,receiving,hydrochloride'
p35189
g9
sS'effects,of,metabotropic'
p35190
g3
sS'adjustments,of,concomitant'
p35191
g3
sS'diphenhydramine,is,reported'
p35192
g3
sS'significant,differences,were'
p35193
g3
sS'undetectable,ng,ml'
p35194
g3
sS'if,necessary,for'
p35195
g3
sS'concentrations,of,iressa'
p35196
g9
sS'the,para-aminobenzoic,acid'
p35197
g3
sS'depresses,tubular,secretion'
p35198
g9
sS'via,cytochrome,p450'
p35199
g3
sS'agent,that,inhibits'
p35200
g3
sS'adjustment,of,by'
p35201
g3
sS'these,reasons,it'
p35202
g9
sS'of,and,micrograms'
p35203
g3
sS'hormone,levels,as'
p35204
g3
sS'day,of,approximately'
p35205
g9
sS'and,possible,adjustment'
p35206
g3
sS'was,used,with'
p35207
g9
sS'baseline,use,of'
p35208
g3
sS'after,the,coadministration'
p35209
g9
sS'prospective,studies,on'
p35210
g3
sS'dose,range,when'
p35211
g3
sS'radiotherapy,may,sensitize'
p35212
g3
sS'clinical,status,is'
p35213
g9
sS'be,notified,immediately'
p35214
g3
sS'clinically,effective,duration'
p35215
g9
sS'healthy,subjects,who'
p35216
g3
sS'is,initiated,in'
p35217
g9
sS'weighed,against,the'
p35218
g3
sS'to,which,enbrel'
p35219
g9
sS'by,concomitant,medications'
p35220
g9
sS'welchol,decreased,the'
p35221
g9
sS'interactions,between,camptosar'
p35222
g3
sS'coadministered,with,monoamine'
p35223
g9
sS'in,which,patients'
p35224
g9
sS'concurrently,with,reduced'
p35225
g9
sS'multiple,fixed-interval,fixed-ratio'
p35226
g3
sS'vardenafil,and,its'
p35227
g3
sS'is,potentiated,by'
p35228
g9
sS'steady,state,following'
p35229
g3
sS'have,contributed,to'
p35230
g3
sS'after,than,with'
p35231
g9
sS'cycle,duration,or'
p35232
g3
sS'blocking,action,is'
p35233
g3
sS'three,cases,of'
p35234
g3
sS'that,they,could'
p35235
g3
sS'of,prostaglandin,synthesis'
p35236
g9
sS'levels,and,decrease'
p35237
g3
sS'mean,of,to'
p35238
g3
sS'capacity,should,be'
p35239
g3
sS'leakage,of,nm'
p35240
g3
sS'the,superiority,of'
p35241
g3
sS'induced,resulting,in'
p35242
g3
sS'inhibitor,in,two'
p35243
g3
sS'imitrex,talk,to'
p35244
g3
sS'typical,side,effect'
p35245
g3
sS'test,interactions,thiazides'
p35246
g3
sS'was,reduced,about'
p35247
g3
sS'prepared,to,treat'
p35248
g3
sS'of,accutane,to'
p35249
g9
sS'formal,assessments,of'
p35250
g3
sS'of,zebeta,on'
p35251
g3
sS'reductase,inhibitor,is'
p35252
g9
sS'increases,in,plasma'
p35253
g9
sS'geriatric,population,who'
p35254
g3
sS'or,induce,cytochrome'
p35255
g3
sS'h2,antagonists,cimetidine'
p35256
g9
sS'pharmacokinetic,disposition,of'
p35257
g3
sS'of,such,tumors'
p35258
g3
sS'of,macrolide,and'
p35259
g9
sS'cell,infiltration,of'
p35260
g3
sS'increased,exposures,to'
p35261
g9
sS'severe,allergic,reactions'
p35262
g3
sS'sites,during,the'
p35263
g9
sS'mg,separated,by'
p35264
g9
sS'prosom,is,given'
p35265
g3
sS'isozymes,a1,a2'
p35266
g3
sS'in,arc,mrna'
p35267
g9
sS'arthralgia,limb,injury'
p35268
g3
sS'with,reported,musculoskeletal'
p35269
g3
sS'inspra,is,administered'
p35270
g9
sS'be,ineffective,if'
p35271
g9
sS'hormonal,contraceptives,including'
p35272
g9
sS'prior,ingestion,of'
p35273
g9
sS'efficacy,in,nnrti-na'
p35274
g3
sS'inhibit,cyp2c19,and'
p35275
g3
sS'total,were,and'
p35276
g3
sS'j,chromatogr,should'
p35277
g3
sS'increased,catabloism,of'
p35278
g3
sS'agents,having,similar'
p35279
g9
sS'antiepileptic,drugs,aeds'
p35280
g3
sS'with,the,tricyclic'
p35281
g9
sS'agents,to,treat'
p35282
g3
sS'effects,both,therapeutic'
p35283
g3
sS'patients,to,years'
p35284
g3
sS'epileptic,patients,who'
p35285
g3
sS'bar-press,response,in'
p35286
g3
sS'the,clinical,relevance'
p35287
g3
sS'antineoplastic,agents,or'
p35288
g9
sS'to,diminish,oral'
p35289
g9
sS'antagonists,particularly,of'
p35290
g9
sS'as,oral,parenteral'
p35291
g3
sS'with,because,of'
p35292
g9
sS'pharmacokinetics,of,intravenous'
p35293
g9
sS'limited,to,the'
p35294
g3
sS'the,groups,then'
p35295
g3
sS'during,adjunctive,therapy'
p35296
g9
sS'the,risk,and'
p35297
g3
sS'additional,methods,of'
p35298
g3
sS'stadol,ns,may'
p35299
g9
sS'increase,in,auc0-12'
p35300
g9
sS'if,mepron,interferes'
p35301
g3
sS'most,patients,treated'
p35302
g3
sS'be,needed,due'
p35303
g3
sS'agents,no,interactions'
p35304
g3
sS'naltrexone,trexan,with'
p35305
g3
sS'a,substrate,of'
p35306
g3
sS'this,medicine,due'
p35307
g3
sS'population,about,to'
p35308
g3
sS'the,patient,feels'
p35309
g3
sS'during,toradol,therapy'
p35310
g9
sS'need,for,more'
p35311
g3
sS'nimodipine,and,losartan'
p35312
g3
sS'k,contribution,to'
p35313
g3
sS'for,this,interaction'
p35314
g9
sS'others,prelone,pediapred'
p35315
g3
sS'to,mg,day'
p35316
g3
sS'the,agent,was'
p35317
g3
sS'reduce,its,absorption'
p35318
g9
sS'sodium,a,period'
p35319
g9
sS'with,oral,live'
p35320
g9
sS'months,after,treatment'
p35321
g3
sS'i,and,with'
p35322
g3
sS'with,caution,using'
p35323
g9
sS'zdv,has,been'
p35324
g3
sS'or,prolonged,diarrhea'
p35325
g3
sS'effect,on,in'
p35326
g3
sS'be,guided,by'
p35327
g3
sS'affinity,binding,sites'
p35328
g3
sS'bezalip,and,bezalip'
p35329
g9
sS'was,altered,by'
p35330
g3
sS'in,reducing,the'
p35331
g9
sS'b23,activation,of'
p35332
g3
sS'patients,receiving,these'
p35333
g3
sS'physicians,should,refer'
p35334
g3
sS'accelerated,markedly,with'
p35335
g9
sS'also,known,to'
p35336
g3
sS'controlled,parallel,group'
p35337
g3
sS'concentrations,of,amicar'
p35338
g3
sS'related,to,amide-type'
p35339
g9
sS'in,metabolism,is'
p35340
g3
sS'trials,have,been'
p35341
g9
sS'with,antagonists,and'
p35342
g9
sS'alter,the,bioavailability'
p35343
g3
sS'with,proscar,mg'
p35344
g3
sS'colorectal,cancer,were'
p35345
g3
sS'viracept,was,coadministered'
p35346
g3
sS'family,cyp3a4,and'
p35347
g3
sS'consisting,of,basal'
p35348
g3
sS'ileus,may,occur'
p35349
g9
sS'effect,of,dmpge2'
p35350
g3
sS'at,a,low'
p35351
g3
sS'inhibitors,because,the'
p35352
g9
sS'receiving,other,general'
p35353
g9
sS'of,microg,ml'
p35354
g3
sS'on,gastric,hydrochloric'
p35355
g3
sS'of,resistant,clinical'
p35356
g3
sS'the,female,patient'
p35357
g3
sS'p450,system,such'
p35358
g3
sS'until,the,response'
p35359
g3
sS'the,two-hour,period'
p35360
g3
sS'purpose,of,this'
p35361
g3
sS'affect,platelet,function'
p35362
g9
sS'to,a,lesser'
p35363
g3
sS'although,increased,plasma'
p35364
g3
sS'increases,ethinyl,estradiol'
p35365
g3
sS'be,exercised,because'
p35366
g9
sS'synkayvite,use,of'
p35367
g3
sS'at,any,time'
p35368
g3
sS'which,a,sulfonamide'
p35369
g9
sS'the,several-fold,higher'
p35370
g3
sS'acr,criteria,for'
p35371
g3
sS'were,observed,with'
p35372
g9
sS'apparent,factor,concentration'
p35373
g3
sS'and,monitoring,of'
p35374
g9
sS'of,cyp3a4,metabolic'
p35375
g3
sS'important,that,patients'
p35376
g3
sS'studies,with,were'
p35377
g3
sS'the,intracellular,exposure'
p35378
g9
sS'occurs,the,patient'
p35379
g3
sS'decreased,binding,in'
p35380
g9
sS'given,to,rats'
p35381
g3
sS'repeating,the,study'
p35382
g3
sS'have,been,conflicting'
p35383
g9
sS'in,the,ninds'
p35384
g3
sS'desirable,or,undesirable'
p35385
g3
sS'form,chelation,complexes'
p35386
g9
sS'differently,than,and'
p35387
g3
sS'may,indicate,that'
p35388
g9
sS'been,shown,on'
p35389
g3
sS'considered,clinically,significant'
p35390
g3
sS'angina,attacks,during'
p35391
g3
sS'and,the,potent'
p35392
g9
sS'diminished,binding,of'
p35393
g9
sS'be,expected,than'
p35394
g9
sS'human,response,and'
p35395
g3
sS'their,dose,should'
p35396
g3
sS'juices,studies,with'
p35397
g3
sS'lactulose-induced,drop,in'
p35398
g9
sS'coadministration,with,to'
p35399
g9
sS'to,competitively,inhibit'
p35400
g9
sS'own,pre-,and'
p35401
g3
sS'amphetamines,may,interfere'
p35402
g3
sS'control,rats,with'
p35403
g3
sS'of,anti-factor,xa'
p35404
g3
sS'in,qt,prolongation'
p35405
g9
sS'suggested,may,be'
p35406
g3
sS'patients,have,been'
p35407
g9
sS'such,as,certain'
p35408
g9
sS'study,of,in'
p35409
g3
sS'be,modified,by'
p35410
g9
sS'cyp3a4,and,cyp2c8'
p35411
g3
sS'relaxants,nondepolarizing,used'
p35412
g3
sS'alone,suggesting,that'
p35413
g9
sS'been,rare,reports'
p35414
g9
sS'with,with,respectto'
p35415
g3
sS'isozymes,may,increase'
p35416
g3
sS'with,the,iop'
p35417
g9
sS'cause,a,significant'
p35418
g9
sS'withdrawn,and,recurred'
p35419
g3
sS'cyp3a4,nor,of'
p35420
g3
sS'based,on,reports'
p35421
g9
sS'efficacy,the,clinical'
p35422
g3
sS'respectively,suggesting,an'
p35423
g9
sS'muscle,biopsy,revealed'
p35424
g3
sS'an,additive,effect'
p35425
g9
sS'with,cardiac,channel'
p35426
g3
sS'after,cessation,of'
p35427
g3
sS'assumed,to,have'
p35428
g3
sS'during,both,periods'
p35429
g3
sS'clinical,interaction,study'
p35430
g3
sS'increased,plasma,levels'
p35431
g9
sS'which,must,be'
p35432
g3
sS'in,turn,discussing'
p35433
g3
sS'for,the,appropriate'
p35434
g3
sS'and,stimulatory,effects'
p35435
g9
sS'mefloquine,may,reduce'
p35436
g9
sS'patients,taking,both'
p35437
g9
sS'following,interactions,were'
p35438
g3
sS'briefly,exposed,to'
p35439
g3
sS'drug,class,drug'
p35440
g3
sS'divalproex,sodium,valproic'
p35441
g9
sS'the,serum,concentrations'
p35442
g3
sS'the,intestine,thus'
p35443
g9
sS'this,interaction,may'
p35444
g3
sS'drug,metabolizing,isozyme'
p35445
g3
sS'however,when,the'
p35446
g3
sS'oral,resulting,in'
p35447
g3
sS'administered,enter,the'
p35448
g3
sS'or,toxoids,should'
p35449
g9
sS'it,adversely,affected'
p35450
g9
sS'chemically,similar,in'
p35451
g3
sS'coadministration,with,compounds'
p35452
g9
sS'association,though,less'
p35453
g3
sS'not,modify,the'
p35454
g3
sS'while,mean,inr'
p35455
g3
sS'the,most,common'
p35456
g3
sS'taken,during,therapy'
p35457
g9
sS'by,intraventricular,injection'
p35458
g9
sS'in,hyperuricemic,patients'
p35459
g3
sS'acting,including,those'
p35460
g3
sS'gleevec,will,increase'
p35461
g9
sS'not,statistically,significant'
p35462
g9
sS'or,administered,with'
p35463
g9
sS'in,which,erbitux'
p35464
g3
sS'antigen,were,precise'
p35465
g3
sS'a,increase,in'
p35466
g9
sS'symptoms,support,the'
p35467
g3
sS'the,blood,concentration'
p35468
g3
sS'with,the,concomitant'
p35469
g9
sS'the,cocaine-treated,sst'
p35470
g3
sS'reports,are,more'
p35471
g3
sS'may,increase,when'
p35472
g9
sS'inhibitory,concentration,greater'
p35473
g3
sS'acid,may,potentiate'
p35474
g9
sS'fluoride,and,citrate'
p35475
g9
sS'calcium,channel,blockers'
p35476
g9
sS'between,blood,levels'
p35477
g3
sS'no,complications,have'
p35478
g3
sS'symptoms,and,was'
p35479
g3
sS'oral,and,are'
p35480
g9
sS'be,rationalized,at'
p35481
g3
sS'be,monitored,closely'
p35482
g9
sS'evaluation,of,extraneals'
p35483
g3
sS'by,possibly,by'
p35484
g9
sS'felbatol,as,monotherapy'
p35485
g3
sS'than,or,equal'
p35486
g3
sS'patient,being,withdrawn'
p35487
g3
sS'patients,receiving,hcl'
p35488
g9
sS'which,can,be'
p35489
g3
sS'at,hours,postdose'
p35490
g9
sS'by,the,alkaline'
p35491
g3
sS'the,inhibitory,activity'
p35492
g9
sS'other,general,or'
p35493
g9
sS'in,erythro-fluorocitrate,synthesis'
p35494
g3
sS'metabolism,of,other'
p35495
g3
sS'the,label,should'
p35496
g9
sS'acetate,and,mcg'
p35497
g3
sS'levels,of,equetrotm'
p35498
g9
sS'known,if,is'
p35499
g3
sS'to,increase,fi'
p35500
g3
sS'for,strains,and'
p35501
g9
sS'pharmacokinetics,and,cardiovascular'
p35502
g3
sS'and,other,when'
p35503
g9
sS'approximately,in,liver'
p35504
g3
sS'rr,microm,also'
p35505
g9
sS'reduced,clearance,prolongation'
p35506
g3
sS'ototoxic,potential,especially'
p35507
g9
sS'carbamazepine,epoxide,steady-state'
p35508
g3
sS'of,improving,the'
p35509
g3
sS'is,predominantly,mediated'
p35510
g3
sS'produce,a,false'
p35511
g3
sS'known,which,clearance'
p35512
g3
sS'patients,taking,other'
p35513
g3
sS'years,on,multiple'
p35514
g3
sS'anticholinesterase,treatment,should'
p35515
g3
sS'receiving,ace,inhibitors'
p35516
g9
sS'not,affect,the'
p35517
g3
sS'that,renal,function'
p35518
g9
sS'behavior,and,stress'
p35519
g3
sS'arm,was,discontinued'
p35520
g3
sS'interval,must,not'
p35521
g9
sS'sodium,and,possibly'
p35522
g3
sS'and,levels,indicating'
p35523
g3
sS'immediate,medical,attention'
p35524
g3
sS'agents,that,have'
p35525
g9
sS'taking,can,in'
p35526
g3
sS'isoenzyme,macrolide,azole'
p35527
g9
sS'may,be,deeper'
p35528
g9
sS'with,the,preparation'
p35529
g9
sS'no,changes,were'
p35530
g3
sS'of,bombesin-enhanced,peritoneal'
p35531
g9
sS'anafranil,is,administered'
p35532
g9
sS'occur,if,and'
p35533
g9
sS'for,eight,of'
p35534
g9
sS'with,torsades,de'
p35535
g3
sS'binding,of,these'
p35536
g3
sS'th,generation,of'
p35537
g3
sS'suggesting,that,histaminergic'
p35538
g3
sS'mefloquine,therapy,should'
p35539
g3
sS'agents,are,reduced'
p35540
g9
sS'trazodone,hydrochloride,desyrel'
p35541
g9
sS'of,is,offset'
p35542
g3
sS'and,electrophysiologic,interactions'
p35543
g3
sS'patients,receiving,have'
p35544
g3
sS'measured,by,fluorimetric'
p35545
g3
sS'patient,maintained,on'
p35546
g9
sS'allows,the,clinician'
p35547
g3
sS'isoproterenol,alone,at'
p35548
g3
sS'the,optimal,dose'
p35549
g3
sS'uricosuric,agents,aspirin'
p35550
g9
sS'm1,peak,levels'
p35551
g9
sS'unknown,but,may'
p35552
g3
sS'with,mg,increased'
p35553
g9
sS'interactions,of,and'
p35554
g9
sS'following,ultracentrifugation,indicated'
p35555
g3
sS'occurs,in,proteins'
p35556
g3
sS'reversible,enhancement,of'
p35557
g9
sS'protein,bound,from'
p35558
g3
sS'with,acute,toxicity'
p35559
g9
sS'the,serotype,o11'
p35560
g3
sS'hypoglycemia,oral,antidiabetes'
p35561
g3
sS'function,in,humans'
p35562
g3
sS'studies,failed,to'
p35563
g3
sS'of,was,variably'
p35564
g3
sS'promethazine,coadministration,of'
p35565
g9
sS'potassium,supplements,and'
p35566
g9
sS'pharmaceutical,treatment,for'
p35567
g3
sS'prolong,and,intensify'
p35568
g9
sS'amevive,continued,use'
p35569
g3
sS'descarboethoxyloratadine,after,days'
p35570
g3
sS'hormonal,since,some'
p35571
g3
sS'clinical,experience,with'
p35572
g3
sS'suggest,that,s'
p35573
g3
sS'ferricyanide,test,it'
p35574
g3
sS'action,of,starlix'
p35575
g9
sS'and,without,coadministration'
p35576
g3
sS'nonlinear,in,the'
p35577
g3
sS'below,are,likely'
p35578
g3
sS'direct,coombs,reactions'
p35579
g3
sS'naproxen,the,concomitant'
p35580
g9
sS'hence,is,not'
p35581
g9
sS'significant,pharmacokinetic,interaction'
p35582
g3
sS'orally,given,and'
p35583
g3
sS'with,an,inhibitor'
p35584
g9
sS'experiences,in,the'
p35585
g3
sS'or,potentiation,of'
p35586
g3
sS'metabolism,is,predominantly'
p35587
g3
sS'pharmacokinetics,of,enbrel'
p35588
g3
sS'agents,that,inhibit'
p35589
g3
sS'both,lean,and'
p35590
g3
sS'chemotherapy,interrupted,in'
p35591
g3
sS'been,studied,and'
p35592
g9
sS'patients,n,maintained'
p35593
g3
sS'formed,after,the'
p35594
g3
sS'monitoring,if,you'
p35595
g3
sS'is,different,than'
p35596
g9
sS'antagonized,by,either'
p35597
g3
sS'but,quickens,the'
p35598
g9
sS'function,tests,may'
p35599
g3
sS'week,about,times'
p35600
g3
sS'of,equetrotm,may'
p35601
g3
sS'marrow,erythrocytes,in'
p35602
g3
sS'treated,with,faslodex'
p35603
g3
sS'with,a,half-life'
p35604
g3
sS'that,precipitation,occurs'
p35605
g3
sS'of,to,alleviate'
p35606
g3
sS'resulting,in,concentrations'
p35607
g9
sS'inhibition,inhibition,at'
p35608
g3
sS'given,with,to'
p35609
g3
sS'hrs,c,max'
p35610
g3
sS'excretion,of,oxypurines'
p35611
g9
sS'displacement,studies,with'
p35612
g3
sS'inhibitors,has,had'
p35613
g9
sS'its,metabolite,concentrationswere'
p35614
g3
sS'auc0-30,days,achieved'
p35615
g3
sS'excess,of,plasma'
p35616
g3
sS'palythoa,tuberculosa,caused'
p35617
g3
sS'have,an,increased'
p35618
g3
sS'treatment,of,both'
p35619
g3
sS'worsened,by,the'
p35620
g3
sS'interference,has,sometimes'
p35621
g3
sS'addition,the,transfusion'
p35622
g3
sS'performed,within,h'
p35623
g3
sS'to,improve,the'
p35624
g3
sS'for,decreased,dosing'
p35625
g3
sS'and,such,medicinal'
p35626
g9
sS'incidence,of,hypertriglyceridemia'
p35627
g3
sS'p450,a,cyp3a'
p35628
g3
sS'increase,in,auc'
p35629
g9
sS'the,nad,dependent'
p35630
g9
sS'of,diabetic,and'
p35631
g3
sS'methods,all,patients'
p35632
g3
sS'neurontin,and,to'
p35633
g3
sS'performed,on,the'
p35634
g3
sS'i,d,dosage'
p35635
g9
sS'epidemic,proportions,in'
p35636
g3
sS'of,fe,per'
p35637
g9
sS'cyp3a4,inhibitor,the'
p35638
g9
sS'therefore,concurrent,administration'
p35639
g3
sS'mg,per,ml'
p35640
g3
sS'cyp3a4,inhibitors,such'
p35641
g9
sS'the,elimination,half'
p35642
g9
sS'incidence,of,both'
p35643
g9
sS'alone,were,compared'
p35644
g3
sS'nsaids,in,in'
p35645
g3
sS'mutagenicity,assay,and'
p35646
g3
sS'hydroxyzine,must,be'
p35647
g9
sS'to,a,decreased'
p35648
g9
sS'increase,the,incidence'
p35649
g9
sS'of,other,oral'
p35650
g9
sS'with,zyvox,and'
p35651
g9
sS'use,with,may'
p35652
g3
sS'in,decreased,clearance'
p35653
g9
sS'xr,was,given'
p35654
g3
sS'system,should,be'
p35655
g3
sS'ethyol,in,patients'
p35656
g9
sS'most,other,psychotropic'
p35657
g9
sS'receptors,to,these'
p35658
g3
sS'within,the,therapeutic'
p35659
g3
sS'that,could,enhance'
p35660
g9
sS'continuation,of,both'
p35661
g3
sS'elemental,oz,has'
p35662
g3
sS'any,other,drugs'
p35663
g3
sS'comorbidity,and,a'
p35664
g3
sS'angiomax,exhibited,no'
p35665
g3
sS'auranofin,should,not'
p35666
g9
sS'oxypurines,hypoxanthine,and'
p35667
g9
sS'or,supplemented,with'
p35668
g9
sS'system,depression,or'
p35669
g9
sS'cells,are,being'
p35670
g3
sS'slows,the,renal'
p35671
g3
sS'inhibit,cyp3a4,ketoconazole'
p35672
g3
sS'increase,the,bleeding'
p35673
g9
sS'acid,metabolite,and'
p35674
g3
sS'of,is,still'
p35675
g3
sS'by,concomitant,useof'
p35676
g9
sS'open,three-period,randomized'
p35677
g3
sS'agents,affecting,myelopoesis'
p35678
g3
sS'other,schizophrenic,patients'
p35679
g9
sS'nucleophosmin,b23,was'
p35680
g3
sS'lowering,of,the'
p35681
g9
sS'data,suggest,the'
p35682
g3
sS'that,at,therapeutic'
p35683
g9
sS'caution,is,indicated'
p35684
g9
sS'clearance,of,was'
p35685
g3
sS'of,and,haldol'
p35686
g3
sS'to,the,treatment'
p35687
g9
sS'plasma,indicate,that'
p35688
g3
sS'for,the,group'
p35689
g3
sS'embryos,was,ineffective'
p35690
g3
sS'studies,fully,evaluating'
p35691
g3
sS'and,mcg,once'
p35692
g3
sS'pancreatitis,in,patients'
p35693
g3
sS'taking,and,renal'
p35694
g9
sS'therefore,hormonal,including'
p35695
g9
sS'action,on,sodium'
p35696
g9
sS'coadminstered,with,viracept'
p35697
g9
sS'by,in,the'
p35698
g9
sS'mouth,bodyweight,gain'
p35699
g3
sS'during,concomitant,treatment'
p35700
g9
sS'phosphorylation,of,to'
p35701
g3
sS'bound,and,this'
p35702
g3
sS'quite,large,fold'
p35703
g3
sS'body,and,of'
p35704
g3
sS'mg,with,neurontin'
p35705
g9
sS'total,bilirubin,times'
p35706
g3
sS'concurrent,with,busulfex'
p35707
g9
sS'laboratory,results,are'
p35708
g3
sS'cyclophosphamide,treatment,which'
p35709
g9
sS'up,to,units'
p35710
g3
sS'therapy,to,avoid'
p35711
g9
sS'with,the,addition'
p35712
g3
sS'to,be,reduced'
p35713
g9
sS'compared,to,dosing'
p35714
g9
sS'glycosides,patients,on'
p35715
g3
sS'also,be,increased'
p35716
g3
sS'when,possible,interactions'
p35717
g3
sS'elicited,enhancement,of'
p35718
g9
sS'number,of,autoimmune'
p35719
g9
sS'of,toxic,neurological'
p35720
g3
sS'to,in,healthy'
p35721
g9
sS'have,been,carried'
p35722
g3
sS'restricted,antagonist,that'
p35723
g9
sS'with,ischemic,heart'
p35724
g9
sS'ras-3t3,cells,was'
p35725
g3
sS'which,cause,a'
p35726
g9
sS'of,multipledose,treatment'
p35727
g3
sS'of,the,absorption'
p35728
g3
sS'fluctuations,of,vital'
p35729
g9
sS'inhibition,of,p-glycoprotein'
p35730
g3
sS'blood,levels,were'
p35731
g3
sS'when,other,antiplatelet'
p35732
g9
sS'benefits,and,get'
p35733
g3
sS'gastric,emptying,may'
p35734
g9
sS'study,was,performed'
p35735
g3
sS'conducted,although,many'
p35736
g3
sS'mg,q,i'
p35737
g9
sS'subjects,increased,the'
p35738
g9
sS'to,the,has'
p35739
g9
sS'and,serotonergic,agents'
p35740
g9
sS'mg,q,d'
p35741
g9
sS'the,manifestation,of'
p35742
g9
sS'proposed,methodology,for'
p35743
g3
sS'subjects,with,steady'
p35744
g9
sS'for,urinary,bilirubin'
p35745
g3
sS'function,there,is'
p35746
g9
sS'hiv-infected,individuals,were'
p35747
g3
sS'symptoms,termed,serotonin'
p35748
g9
sS'endotoxin-treated,rats,increased'
p35749
g9
sS'may,significantly,reduce'
p35750
g3
sS'blood,and,urine'
p35751
g3
sS'substantially,decrease,the'
p35752
g9
sS'may,also,affect'
p35753
g3
sS'predispose,to,premature'
p35754
g3
sS'was,measured,in'
p35755
g3
sS'suddenly,exceeded,of'
p35756
g3
sS'degrees,c,the'
p35757
g3
sS'stimulation,and,inhibition'
p35758
g3
sS'inducer,should,be'
p35759
g9
sS'an,apparent,decrease'
p35760
g3
sS'objective,was,to'
p35761
g3
sS'seven,days,increases'
p35762
g3
sS'fertility,to,values'
p35763
g3
sS'and,potassium-depleting,agents'
p35764
g9
sS'obtained,with,alone'
p35765
g9
sS'or,the,concomitant'
p35766
g9
sS'observed,in,male'
p35767
g3
sS'resulted,in,markedly'
p35768
g9
sS'blockers,concurrently,did'
p35769
g3
sS'is,also,reported'
p35770
g9
sS'volunteers,in,a'
p35771
g3
sS'cell-free,system,derived'
p35772
g3
sS'a,frequent,condition'
p35773
g3
sS'several,interaction,studies'
p35774
g3
sS'the,appearance,of'
p35775
g3
sS'the,sedative,effects'
p35776
g9
sS'in,controlled,studies'
p35777
g9
sS'study,had,no'
p35778
g3
sS'recommended,depending,on'
p35779
g3
sS'were,noted,at'
p35780
g3
sS'p-450,isoenzymes,and'
p35781
g3
sS'clinical,data,in'
p35782
g3
sS'selective,regulation,of'
p35783
g3
sS'is,used,alone'
p35784
g9
sS'function,tests,elevations'
p35785
g3
sS'renal,impairment,there'
p35786
g3
sS'from,plasma,proteins'
p35787
g3
sS'of,oral,including'
p35788
g9
sS'hydrochlorothiazide,a,study'
p35789
g3
sS'response,of,lh'
p35790
g3
sS'inhalation,mefenamic,acid'
p35791
g9
sS'an,mao,inhibitor'
p35792
g9
sS'concentration,and,other'
p35793
g9
sS'certain,microsomal,enzyme'
p35794
g9
sS'however,appropriate,monitoring'
p35795
g9
sS'we,call,that'
p35796
g3
sS'is,highly,protein'
p35797
g3
sS'resulted,in,elevated'
p35798
g9
sS'producing,low,uptakes'
p35799
g3
sS'in,a,times'
p35800
g9
sS'combination,of,therapeutic'
p35801
g3
sS'of,artocarpus,integrifolia'
p35802
g3
sS'medications,to,interfere'
p35803
g3
sS'disposition,of,compounds'
p35804
g3
sS'however,another,hmg-coa'
p35805
g9
sS'of,the,pressor'
p35806
g3
sS'be,a,weak'
p35807
g3
sS'others,reported,neuropsychiatric'
p35808
g3
sS'significant,reduction,in'
p35809
g9
sS'intestinal,absorption,of'
p35810
g3
sS'n,x,c3h'
p35811
g3
sS'of,resulted,in'
p35812
g9
sS'examining,the,addition'
p35813
g3
sS'cholinergic,reactions,of'
p35814
g3
sS'diabetes,mellitus,is'
p35815
g3
sS'three,duloxetine-treated,patients'
p35816
g3
sS'table,a,drugs'
p35817
g3
sS'adl,mg,and'
p35818
g3
sS'adversely,affected,by'
p35819
g3
sS'toxicity,see,warnings'
p35820
g3
sS'ventricular,failure,and'
p35821
g3
sS'the,initial,presentation'
p35822
g9
sS'citrate,elevations,seen'
p35823
g9
sS'hypothyroid,it,is'
p35824
g3
sS'example,may,activate'
p35825
g3
sS'blocking,cardiac,contractility'
p35826
g9
sS'whether,other,progestational'
p35827
g3
sS'women,were,not'
p35828
g3
sS'that,encodes,a'
p35829
g3
sS'class,ia,such'
p35830
g9
sS'positive,reaction,at'
p35831
g3
sS'is,rapid,equilibration'
p35832
g3
sS'or,bleeding,events'
p35833
g9
sS'that,the,modulatory'
p35834
g3
sS'factors,may,increase'
p35835
g3
sS'between,oh,d3'
p35836
g3
sS'cns-depressant,effects,when'
p35837
g9
sS'immunoreactive,after,concurrent'
p35838
g3
sS'maintain,trough,concentrations'
p35839
g9
sS'subset,to,of'
p35840
g3
sS'accumbens,nac,for'
p35841
g3
sS'additional,effect,beyond'
p35842
g9
sS'effect,on,the'
p35843
g3
sS'thirty,male,rats'
p35844
g3
sS'and,continued,use'
p35845
g3
sS'from,ml,min'
p35846
g9
sS'such,as,may'
p35847
g9
sS'dose,or,the'
p35848
g3
sS'into,the,effect'
p35849
g3
sS'the,antinonciceptive,effect'
p35850
g3
sS'from,studies,in'
p35851
g3
sS'are,known,to'
p35852
g3
sS'normal,fat,digestion'
p35853
g3
sS'modest,effect,on'
p35854
g9
sS'that,there,may'
p35855
g9
sS'meals,for,day'
p35856
g3
sS'pruritus,and,should'
p35857
g3
sS'renal,dysfunction,by'
p35858
g9
sS'patients,with,haca'
p35859
g3
sS'ferrous,sulfate,multivitamin'
p35860
g9
sS'mg,kg,injected'
p35861
g9
sS'higher,as,was'
p35862
g9
sS'agent,administered,at'
p35863
g3
sS'stable,therapy,were'
p35864
g3
sS'when,combined,therapy'
p35865
g3
sS'rats,tarsal,flexure'
p35866
g3
sS'study,of,neurontin'
p35867
g3
sS'with,regimens,and'
p35868
g3
sS'the,qt,qtc'
p35869
g3
sS'subjects,n,compared'
p35870
g9
sS'n,or,with'
p35871
g3
sS'b23,was,thus'
p35872
g3
sS'other,metabolized,by'
p35873
g3
sS'showed,that,was'
p35874
g9
sS'agents,may,bind'
p35875
g9
sS'patients,lowered,the'
p35876
g9
sS'was,administered,at'
p35877
g9
sS'through,the,increase'
p35878
g3
sS'the,displacing,effect'
p35879
g3
sS'test,must,be'
p35880
g3
sS'pharmacology,studies,at'
p35881
g3
sS'hypotension,and,loss'
p35882
g9
sS'were,considerably,lower'
p35883
g9
sS'injected,with,was'
p35884
g9
sS'experience,gained,may'
p35885
g3
sS'hypoglycemic,medications,may'
p35886
g9
sS'replacement,therapy,a'
p35887
g3
sS'inhibitory,activity,which'
p35888
g9
sS'may,make,your'
p35889
g3
sS'the,promotion,of'
p35890
g3
sS'or,intravenous,antagonists'
p35891
g9
sS'truly,hypothyroid,it'
p35892
g3
sS'auc,of,decreased'
p35893
g9
sS'cyp,at,clinically'
p35894
g3
sS'dogs,anesthetized,with'
p35895
g9
sS'with,compromised,renal'
p35896
g9
sS'excretion,in,chronic'
p35897
g9
sS'the,translocation,of'
p35898
g3
sS'nyha,class,ii'
p35899
g3
sS'intravenous,topical,or'
p35900
g3
sS'pumps,for,novolog'
p35901
g3
sS'an,oral,regimen'
p35902
g3
sS'time,profiles,in'
p35903
g3
sS'effects,with,prinivil'
p35904
g9
sS'vioxx,with,mg'
p35905
g9
sS'drug,interactions,would'
p35906
g3
sS'levels,at,some'
p35907
g9
sS'been,reported,rarely'
p35908
g9
sS'effectiveness,by,increasing'
p35909
g3
sS'discussing,the,main'
p35910
g3
sS'like,other,injectable'
p35911
g9
sS'nicotinic,acid,sympathomimet-ics'
p35912
g3
sS'warfarin,digoxin,salicylate'
p35913
g9
sS'may,develop,toxicity'
p35914
g9
sS'was,found,between'
p35915
g3
sS'medications,included,mtx'
p35916
g3
sS'not,known,hence'
p35917
g9
sS'established,that,there'
p35918
g9
sS'of,copegus,and'
p35919
g9
sS'all,elevations,resolved'
p35920
g3
sS'of,camptosar,such'
p35921
g9
sS'receiving,preparations,increases'
p35922
g3
sS'de,pointe,particularly'
p35923
g3
sS'have,experienced,problems'
p35924
g3
sS'a,multi-day,course'
p35925
g9
sS'inhibitor,class,see'
p35926
g9
sS'management,of,malignant'
p35927
g9
sS'can,occur,in'
p35928
g3
sS'ranging,from,to'
p35929
g9
sS'and,potency,and'
p35930
g3
sS'for,maintenance,of'
p35931
g3
sS'clear,that,topoisomerase'
p35932
g3
sS'daily,of,brovana'
p35933
g3
sS'these,precautions,probably'
p35934
g3
sS'a,positive,level'
p35935
g9
sS'a,sensitivity,of'
p35936
g3
sS'aprepitant,with,these'
p35937
g9
sS'nsaid,such,as'
p35938
g3
sS'to,rachitic,chicks'
p35939
g9
sS'interactions,dactinomycin,may'
p35940
g3
sS'from,vasodilating,effects'
p35941
g3
sS'well,acquainted,with'
p35942
g3
sS'with,and,or'
p35943
g3
sS'great,interest,from'
p35944
g3
sS'inhibitors,duragesic,is'
p35945
g9
sS'a,cyp,a4'
p35946
g3
sS'cyp2a6,and,mild-to'
p35947
g3
sS'recommended,that,buspirone'
p35948
g9
sS'that,nsaids,can'
p35949
g9
sS'of,d2,binding'
p35950
g3
sS'to,increase,the'
p35951
g9
sS'problem,associated,with'
p35952
g9
sS'm,m,i'
p35953
g9
sS'with,m-dinitrobenzene,used'
p35954
g3
sS'patient,must,have'
p35955
g3
sS'with,oral,or'
p35956
g9
sS'may,be,important'
p35957
g3
sS'iressa,and,have'
p35958
g9
sS'neoral,sandimmune,hiv'
p35959
g9
sS'reports,of,prolonged'
p35960
g9
sS'histology,of,the'
p35961
g3
sS'while,under,treatment'
p35962
g9
sS'receiving,bolus-ifl,plus'
p35963
g3
sS'shown,on,furosemide-stimulated'
p35964
g3
sS'isoforms,a4,and'
p35965
g3
sS'cns,vascular,lesions'
p35966
g3
sS'studies,have,not'
p35967
g3
sS'coadministration,of,the'
p35968
g3
sS'is,narrow,serum'
p35969
g3
sS'syndrome,in,patients'
p35970
g9
sS'that,after,days'
p35971
g3
sS'related,may,decrease'
p35972
g9
sS'receiving,and,concurrently'
p35973
g9
sS'if,tranxene,is'
p35974
g3
sS'modification,had,no'
p35975
g3
sS'those,that,can'
p35976
g3
sS'with,either,grapefruit'
p35977
g3
sS'it,is,reasonable'
p35978
g3
sS'oxidation,system,decreased'
p35979
g3
sS'nodal,conduction,channel'
p35980
g9
sS'concentrations,and,an'
p35981
g9
sS'of,mna,in'
p35982
g3
sS'produce,severe,prolonged'
p35983
g9
sS'ml,with,alone'
p35984
g9
sS'and,its,toxicity'
p35985
g9
sS'severe,myelosuppression,following'
p35986
g3
sS'glucuronidation,is,unlikely'
p35987
g3
sS'and,dosage,adjustment'
p35988
g3
sS'produce,aucs,m'
p35989
g9
sS'expected,in,patients'
p35990
g3
sS'usually,administered,hours'
p35991
g9
sS'this,is,demonstrated'
p35992
g3
sS'those,of,other'
p35993
g3
sS'by,six,typical'
p35994
g3
sS'a,minor,increase'
p35995
g9
sS'supraventricular,tachycardia,in'
p35996
g9
sS'and,excretion,in'
p35997
g9
sS'adverse,effects,in'
p35998
g3
sS'with,other,nonsteroidal'
p35999
g3
sS'hematuria,and,blood'
p36000
g3
sS'infections,because,it'
p36001
g3
sS'and,are,predictable'
p36002
g3
sS'including,fever,renal'
p36003
g9
sS'i,d,with'
p36004
g9
sS'labetalol,hcl,special'
p36005
g3
sS'every,hours,for'
p36006
g3
sS'or,clinitest,tablets'
p36007
g3
sS'also,increase,the'
p36008
g3
sS'to,fluctuate,significantly'
p36009
g9
sS'reduced,the,amplitudes'
p36010
g3
sS'by,determination,of'
p36011
g3
sS'risk,for,further'
p36012
g3
sS'hemodynamic,compromise,have'
p36013
g9
sS'kg,in,a'
p36014
g3
sS'high-dose,may,impair'
p36015
g3
sS'by,compared,with'
p36016
g9
sS'be,considered,whenever'
p36017
g3
sS'specificity,we,describe'
p36018
g3
sS'based,on,auc'
p36019
g3
sS'methotrexate,an,increased'
p36020
g9
sS'anticoagulation,may,if'
p36021
g3
sS'was,no,apparent'
p36022
g3
sS'to,when,compared'
p36023
g9
sS'acid,and,heavy'
p36024
g9
sS'we,have,shown'
p36025
g3
sS'antiplatelet,therapies,should'
p36026
g3
sS'higher,than,for'
p36027
g3
sS'resulting,in,unexpectedly'
p36028
g9
sS'the,urinary,antiseptic'
p36029
g9
sS'before,conducting,an'
p36030
g9
sS'inhibited,at,a'
p36031
g3
sS'monkeys,at,doses'
p36032
g3
sS'cpk,elevations,returned'
p36033
g3
sS'of,elevated,liver'
p36034
g3
sS'administered,one,hour'
p36035
g9
sS'both,in,diabetic'
p36036
g3
sS'tested,cyp1a2,cyp2c9'
p36037
g3
sS'performed,when,initiating'
p36038
g9
sS'those,with,intravascular'
p36039
g9
sS'of,thiazide,to'
p36040
g9
sS'above,or,suspected'
p36041
g3
sS'the,potentiation,of'
p36042
g3
sS'metabolized,via,the'
p36043
g3
sS'or,more,of'
p36044
g3
sS'which,a,single'
p36045
g3
sS'hepatic,function,induced'
p36046
g3
sS'repeated,injection,of'
p36047
g3
sS'hcl,is,antagonized'
p36048
g9
sS'that,oral,potently'
p36049
g9
sS'blocking,agents,chloral'
p36050
g3
sS'which,erbitux,was'
p36051
g3
sS'cations,multivitamins,quinolones'
p36052
g3
sS'allowed,in,clinical'
p36053
g3
sS'seen,after,the'
p36054
g3
sS'and,following,infusions'
p36055
g3
sS'change,the,pharmacokinetics'
p36056
g3
sS'patients,with,advanced'
p36057
g3
sS'in,dose,should'
p36058
g3
sS'the,therapeutic,doses'
p36059
g3
sS'and,and,hydroxides'
p36060
g3
sS'effects,in,human'
p36061
g3
sS'grapefruit,juice,with'
p36062
g3
sS'with,the,listed'
p36063
g3
sS'after,initiation,of'
p36064
g9
sS'directed,to,cross'
p36065
g9
sS'pharmacokinetic,studies,have'
p36066
g9
sS'with,rr,microm'
p36067
g9
sS'however,the,relationship'
p36068
g3
sS'is,also,increased'
p36069
g3
sS'oral,co-administration,of'
p36070
g9
sS'anti-infectives,without,evidence'
p36071
g3
sS'metabolized,through,various'
p36072
g3
sS'beta-lactamtype,or,may'
p36073
g9
sS'of,novolog,were'
p36074
g3
sS'and,certain,malignancies'
p36075
g3
sS'renal,impairment,reportedly'
p36076
g9
sS'days,there,was'
p36077
g3
sS'dose,increase,of'
p36078
g9
sS'mics,and,viable'
p36079
g3
sS'concentration,time-curve,increased'
p36080
g9
sS'of,in,peripheral'
p36081
g3
sS'the,positive,and'
p36082
g3
sS'with,or,might'
p36083
g3
sS'with,other,therapy'
p36084
g3
sS'leydig,cell,tumors'
p36085
g3
sS'been,observed,after'
p36086
g3
sS'certain,medicines,should'
p36087
g3
sS'events,reported,significantly'
p36088
g3
sS'such,as,and'
p36089
g9
sS'therefore,viracept,should'
p36090
g9
sS'third,hour,and'
p36091
g3
sS'which,may,enhance'
p36092
g9
sS'regression,analyses,of'
p36093
g9
sS'thus,necessitating,an'
p36094
g9
sS'concomitantly,with,hepatic'
p36095
g9
sS'gland,who,is'
p36096
g9
sS'the,normal,value'
p36097
g3
sS'is,combined,with'
p36098
g9
sS'starting,treatment,with'
p36099
g3
sS'blocking,agents,and'
p36100
g3
sS'can,generally,be'
p36101
g3
sS'prolonged,hot,weather'
p36102
g9
sS'coadministration,with,coadministration'
p36103
g9
sS'manner,when,was'
p36104
g9
sS'and,to,eliminate'
p36105
g9
sS'potential,interactions,for'
p36106
g9
sS'glycosides,therapeutic,effects'
p36107
g3
sS'both,mc,and'
p36108
g3
sS'of,after,mefloquineuine'
p36109
g3
sS'mna,may,displace'
p36110
g3
sS'may,be,resistant'
p36111
g9
sS'with,nonselective,inhibitor'
p36112
g9
sS'and,miotic,actions'
p36113
g3
sS'e1,and,a4'
p36114
g3
sS'with,activity--such,as'
p36115
g9
sS'of,natrecor,with'
p36116
g3
sS'this,transient,hypotensive'
p36117
g3
sS'ethinyl,estradiol,were'
p36118
g3
sS'in,the,light'
p36119
g3
sS'vascular,dilation,associated'
p36120
g9
sS'with,regard,to'
p36121
g3
sS'placental,weight,and'
p36122
g3
sS'attention,must,be'
p36123
g9
sS'antipyrine,because,does'
p36124
g3
sS'tilade,has,been'
p36125
g3
sS'of,neoplasia,are'
p36126
g3
sS'as,it,had'
p36127
g3
sS'optic,nerve,degeneration'
p36128
g3
sS'chemotherapy,plus,highly'
p36129
g3
sS'in,the,kidney'
p36130
g3
sS'for,and,on'
p36131
g3
sS'haart,with,a'
p36132
g3
sS'and,effect,relationship'
p36133
g9
sS'reduces,the,rate'
p36134
g9
sS'concerns,the,obstetrical'
p36135
g3
sS'time,by,after'
p36136
g3
sS'arthritic,patients,receiving'
p36137
g3
sS'that,a,small'
p36138
g9
sS'glucose,tolerance,secretion'
p36139
g3
sS'when,treating,patients'
p36140
g3
sS'enzymes,was,seen'
p36141
g9
sS'reduction,of,to'
p36142
g9
sS'indicating,that,the'
p36143
g3
sS'falsely,identify,characteristics'
p36144
g3
sS'in,both,plasma'
p36145
g3
sS'active,therapy,haart'
p36146
g3
sS'of,immobilised,cmc-cys7'
p36147
g3
sS'may,occur,earlier'
p36148
g9
sS'subjects,receiving,mg'
p36149
g9
sS'if,the,two'
p36150
g9
sS'time,spent,in'
p36151
g9
sS'any,change,in'
p36152
g3
sS'calcium,particularly,if'
p36153
g3
sS'given,the,primary'
p36154
g3
sS'range,mg,if'
p36155
g9
sS'were,observed,by'
p36156
g3
sS'extreme,caution,in'
p36157
g9
sS'decreases,in,tmax'
p36158
g3
sS'greater,for,the'
p36159
g3
sS'of,including,with'
p36160
g9
sS'no,pharmacokinetic,interactions'
p36161
g3
sS'guinea,pig,small'
p36162
g3
sS'videx,to,two'
p36163
g9
sS'in,neonates,with'
p36164
g3
sS'the,vehicle-controlled,studies'
p36165
g3
sS'by,observations,now'
p36166
g3
sS'since,a,decline'
p36167
g3
sS'pharmacokinetic,parameters,for'
p36168
g3
sS'in,humans,metabolism'
p36169
g3
sS'inhibits,the,cyp2c9'
p36170
g9
sS'therefore,doses,greater'
p36171
g3
sS'ovulation,but,one'
p36172
g3
sS'of,the,efficacy'
p36173
g3
sS'and,may,or'
p36174
g3
sS'cyp,a4,but'
p36175
g3
sS'had,treatment-emergent,positive'
p36176
g3
sS'observed,when,gl'
p36177
g9
sS'and,the,effect'
p36178
g9
sS'change,in,clearance'
p36179
g3
sS'probenecid,pretreatment,with'
p36180
g9
sS'coadministered,with,mg'
p36181
g3
sS'vardenafil,mg,and'
p36182
g9
sS'or,pharmacokinetics,during'
p36183
g3
sS'radiation,therapy,may'
p36184
g3
sS'therapeutic,index,such'
p36185
g9
sS'until,neutrophils,recover'
p36186
g3
sS'and,kht,tumour'
p36187
g3
sS'persisted,even,after'
p36188
g3
sS'adequacy,of,the'
p36189
g3
sS'using,pocs,and'
p36190
g3
sS'and,is,unknown'
p36191
g9
sS'embryo,fetal,development'
p36192
g3
sS'various,containing,regimens'
p36193
g9
sS'be,superior,to'
p36194
g3
sS'is,changed,the'
p36195
g3
sS'gram-negative,organisms,but'
p36196
g3
sS'kg,mg,kg'
p36197
g3
sS'united,states,at'
p36198
g3
sS'in,the,loss'
p36199
g9
sS'diabetic,patients,must'
p36200
g3
sS'concomitant,medications,besides'
p36201
g3
sS'for,a,week'
p36202
g3
sS'and,prevention,studies'
p36203
g3
sS'ethoxzolamide,may,increase'
p36204
g9
sS'caution,is,necessary'
p36205
g9
sS'oral,may,potentiate'
p36206
g9
sS'rauwolfia,alkaloid,while'
p36207
g9
sS'd,respectively,of'
p36208
g9
sS'patients,including,those'
p36209
g3
sS'too,much,in'
p36210
g9
sS'efficacy,of,concomitant'
p36211
g9
sS'not,show,potential'
p36212
g3
sS'these,aeds,do'
p36213
g3
sS'there,is,no'
p36214
g3
sS'cholinesterase,inhibitors,dipyridamole'
p36215
g9
sS'twice,daily,increased'
p36216
g9
sS'inhibition,of,response'
p36217
g9
sS'of,strong,inhibitors'
p36218
g3
sS'a,mean,fold'
p36219
g9
sS'for,the,coadministration'
p36220
g3
sS'the,available,agents'
p36221
g3
sS'interactions,of,taxotere'
p36222
g3
sS'for,additive,effects'
p36223
g9
sS'amide-type,local,since'
p36224
g9
sS'under,the,blood'
p36225
g3
sS'anti-globulin,tests,are'
p36226
g3
sS'normal,volunteers,did'
p36227
g3
sS'the,apparent,volume'
p36228
g3
sS'dried,and,collected'
p36229
g3
sS'investigated,the,role'
p36230
g3
sS'acute,toxicity,characterized'
p36231
g9
sS'serum,protein,added'
p36232
g3
sS'drugs,nsaids,the'
p36233
g9
sS'grown,in,mm'
p36234
g3
sS'to,a,far'
p36235
g3
sS'and,with,at'
p36236
g3
sS'to,activation,of'
p36237
g3
sS'determine,the,effect'
p36238
g3
sS'a,bar-press,conditioning'
p36239
g3
sS'mao,inhibitor,and'
p36240
g9
sS'hours,of,treatment'
p36241
g9
sS'that,you,are'
p36242
g9
sS'finding,to,humans'
p36243
g3
sS'interaction,with,may'
p36244
g3
sS'recorded,with,but'
p36245
g3
sS'from,several,studies'
p36246
g3
sS'is,evidently,a'
p36247
g3
sS'the,dietary,treatments'
p36248
g3
sS'is,understandable,because'
p36249
g3
sS'other,alternatives,are'
p36250
g3
sS'interval,and,thus'
p36251
g3
sS'clearance,prolongation,of'
p36252
g3
sS'of,healthy,subjects'
p36253
g3
sS'increase,in,unbound'
p36254
g9
sS'or,ast,times'
p36255
g3
sS'a,randomized,multiple-dose'
p36256
g3
sS'rarely,reported,to'
p36257
g9
sS'steroids,enhance,the'
p36258
g9
sS'dose,of,tcamay'
p36259
g3
sS'some,of,which'
p36260
g9
sS'difluoroacetone,by,an'
p36261
g3
sS'differential,scanning,calorimetry'
p36262
g3
sS'dangerous,machinery,while'
p36263
g3
sS'can,do,to'
p36264
g3
sS'blood,lipids,should'
p36265
g3
sS'in,vitro,evaluation'
p36266
g3
sS'either,a,facilitation'
p36267
g3
sS'they,reduce,its'
p36268
g9
sS'the,training,dose'
p36269
g3
sS'which,may,potentiate'
p36270
g3
sS'in,serum,hormone'
p36271
g3
sS'reaction,and,produce'
p36272
g3
sS'reported,to,interfere'
p36273
g3
sS'and,substrates,drugs'
p36274
g9
sS'therapy,such,agents'
p36275
g3
sS'with,these,does'
p36276
g3
sS'and,extended,a'
p36277
g9
sS'delay,in,the'
p36278
g9
sS'nonclinical,data,demonstrate'
p36279
g3
sS'effect,on,bioavailability'
p36280
g3
sS'calculated,by,the'
p36281
g3
sS'vascularity,of,intestinal'
p36282
g3
sS'dihydropyridine,derivative,while'
p36283
g3
sS'recommendations,were,to'
p36284
g3
sS'parental,and,resistant'
p36285
g3
sS'that,ecg,and'
p36286
g9
sS'with,intact,endothelium'
p36287
g9
sS'since,aminotransferase,determinations'
p36288
g3
sS'a,segment,of'
p36289
g3
sS'inhibition,at,microm'
p36290
g3
sS'a,significant,interaction'
p36291
g9
sS'mean,daily,trough'
p36292
g3
sS'currently,available,hmgcoa'
p36293
g3
sS'administration,impairs,metabolism'
p36294
g3
sS'patients,or,the'
p36295
g3
sS'pegasys,on,male'
p36296
g3
sS'to,characterize,the'
p36297
g3
sS'warfarin,co-administration,of'
p36298
g9
sS'lysate,derived,from'
p36299
g3
sS'during,early,therapy'
p36300
g9
sS'concentration,curve,of'
p36301
g9
sS'potent,inhibitor,of'
p36302
g9
sS'individuals,discontinuing,in'
p36303
g3
sS'acid,level,dosage'
p36304
g9
sS'increase,in,both'
p36305
g3
sS'various,ca,channel'
p36306
g3
sS'through,udp-glucuronyl,transferase'
p36307
g3
sS'decreased,mean,cmax'
p36308
g9
sS'an,additive,hypotensive'
p36309
g9
sS'the,locomotor,and'
p36310
g3
sS'may,be,modified'
p36311
g9
sS'or,lime,should'
p36312
g3
sS'it,alter,the'
p36313
g3
sS'underway,to,examine'
p36314
g3
sS'given,to,adult'
p36315
g3
sS'adults,and,adult'
p36316
g3
sS'counts,be,performed'
p36317
g3
sS'be,carefully,observed'
p36318
g9
sS'to,steady,state'
p36319
g9
sS'patients,and,normal'
p36320
g9
sS'which,to,examine'
p36321
g3
sS'be,warranted,when'
p36322
g3
sS'and,to,increase'
p36323
g9
sS'is,demonstrated,for'
p36324
g3
sS'a,method,to'
p36325
g3
sS'amitriptyline,in,combination'
p36326
g9
sS'make,normal,metab-olizers'
p36327
g3
sS'alternatives,to,should'
p36328
g9
sS'were,used,in'
p36329
g3
sS'patients,the,mean'
p36330
g3
sS'and,ototoxicity,were'
p36331
g3
sS'mg,day,with'
p36332
g9
sS'at,a,site'
p36333
g3
sS'from,therapy,with'
p36334
g3
sS'of,mg,tid'
p36335
g3
sS'volunteers,has,shown'
p36336
g9
sS'myasthenia,gravis,inflammatory'
p36337
g9
sS'phenytoin,population,pharmacokinetic'
p36338
g9
sS'cells,for,the'
p36339
g3
sS'while,taking,fortovase'
p36340
g3
sS'arimidex,as,they'
p36341
g9
sS'oral,should,be'
p36342
g3
sS'inhibiting,eg,may'
p36343
g9
sS'plasma,concentration,may'
p36344
g3
sS'when,colestid,tablets'
p36345
g9
sS'not,a,true'
p36346
g9
sS'made,on,the'
p36347
g3
sS'chloromycetin,local,and'
p36348
g9
sS'sedation,or,coma'
p36349
g3
sS'plasma,and,tumour'
p36350
g3
sS'treatment,with,did'
p36351
g3
sS'both,the,r'
p36352
g3
sS'equally,antagonized,in'
p36353
g9
sS'a,great,potential'
p36354
g3
sS'rate,constant,volume'
p36355
g3
sS'in,post-marketing,experience'
p36356
g9
sS'curve,auc,and'
p36357
g3
sS'of,toradol,and'
p36358
g9
sS'omeprazole,the,rate'
p36359
g3
sS'fertility,or,harm'
p36360
g3
sS'done,during,the'
p36361
g3
sS'evening,should,not'
p36362
g3
sS'and,following,the'
p36363
g3
sS'and,significantly,reduces'
p36364
g9
sS'consequently,the,combination'
p36365
g9
sS'before,prescribing,a'
p36366
g3
sS'administered,to,treated'
p36367
g3
sS'effect,of,different'
p36368
g3
sS'dosed,subjects,with'
p36369
g3
sS'interactions,no,laboratory'
p36370
g3
sS'hypertension,hypercoagulation,vasculopathy'
p36371
g3
sS'alt,and,ast'
p36372
g9
sS'significant,effects,on'
p36373
g3
sS'to,the,general'
p36374
g3
sS'significant,effects,have'
p36375
g3
sS'half,returned,to'
p36376
g3
sS'volunteers,a,one-week'
p36377
g9
sS'binding,of,was'
p36378
g9
sS'modified,given,the'
p36379
g3
sS'and,is,unlikely'
p36380
g3
sS'alone,markedly,decreased'
p36381
g3
sS'pharmacodynamics,prothrombin,time'
p36382
g3
sS'of,were,below'
p36383
g3
sS'maximum,human,dose'
p36384
g3
sS'blocking,hepatic,metabolism'
p36385
g9
sS'ip,or,vitamin'
p36386
g9
sS'use,is,associated'
p36387
g3
sS'n,as,well'
p36388
g3
sS'be,adjusted,accordingly'
p36389
g9
sS'product,with,in'
p36390
g3
sS'as,a,potential'
p36391
g3
sS'solubility,of,is'
p36392
g3
sS'concomitantly,with,known'
p36393
g9
sS'urine,volume,in'
p36394
g9
sS'these,should,be'
p36395
g3
sS'compounds,enhanced,tendency'
p36396
g3
sS'probenecid,is,known'
p36397
g9
sS'h2,antagonists,hmg-coa'
p36398
g3
sS'interaction,between,intravenous'
p36399
g3
sS'cyclosporine,modest,increases'
p36400
g9
sS'effect,measured,by'
p36401
g3
sS'malaria,mefloquine,administration'
p36402
g3
sS'apple,may,reduce'
p36403
g3
sS'administration,of,vasopressor'
p36404
g9
sS'the,ca,dependent'
p36405
g3
sS'diabectics,than,in'
p36406
g3
sS'adjustment,of,doses'
p36407
g3
sS'consumption,of,at'
p36408
g3
sS'following,medications,tylenol'
p36409
g9
sS'produced,by,the'
p36410
g3
sS'addition,studies,in'
p36411
g3
sS'microm,increased,intracellular'
p36412
g3
sS'administered,minute,after'
p36413
g9
sS'acid,for,these'
p36414
g3
sS'extracellular,levels,of'
p36415
g3
sS'including,sodium,and'
p36416
g9
sS'as,an,expression'
p36417
g3
sS'into,three,equal'
p36418
g3
sS'aptt,assay,xigris'
p36419
g3
sS'those,used,to'
p36420
g3
sS'in,females,and'
p36421
g9
sS'myocardium,to,effects'
p36422
g9
sS'and,to,discriminate'
p36423
g3
sS'of,vioxx,should'
p36424
g3
sS'mean,drug,level'
p36425
g3
sS'pain,mechanisms,will'
p36426
g3
sS'reports,of,significant'
p36427
g9
sS'and,urine,samples'
p36428
g3
sS'find,out,whether'
p36429
g3
sS'clinical,use,and'
p36430
g3
sS'may,increase,sensitivity'
p36431
g9
sS'potential,for,reduction'
p36432
g9
sS'cases,of,elevated'
p36433
g3
sS'sodium,was,evaluated'
p36434
g3
sS'parameters,for,or'
p36435
g3
sS'the,potential,benefits'
p36436
g9
sS'a,risk,of'
p36437
g9
sS'of,osteoarthritis,when'
p36438
g3
sS'or,or,should'
p36439
g9
sS'channel,blockers,did'
p36440
g3
sS'studies,in,steady-state'
p36441
g9
sS'and,fluoride,accumulation'
p36442
g3
sS'study,has,suggested'
p36443
g3
sS'certain,that,are'
p36444
g3
sS'warrant,alteration,of'
p36445
g3
sS'of,is,necessary'
p36446
g3
sS'in,these,instances'
p36447
g3
sS'assessed,in,two'
p36448
g3
sS'however,under,certain'
p36449
g3
sS'pharmacokinetic,changes,to'
p36450
g9
sS'of,levels,it'
p36451
g9
sS'lymphoma,that,was'
p36452
g3
sS'have,a,more'
p36453
g3
sS'infusion,requirements,of'
p36454
g9
sS'this,enzyme,may'
p36455
g3
sS'because,both,of'
p36456
g9
sS'from,the,use'
p36457
g3
sS'investigated,as,one'
p36458
g3
sS'the,cell,membrane'
p36459
g3
sS'pacemaker,in,patients'
p36460
g3
sS'potentiation,of,otthostatic'
p36461
g3
sS'and,increases,the'
p36462
g9
sS'to,mg,also'
p36463
g3
sS'patients,receive,these'
p36464
g3
sS'other,ace,inhibitors'
p36465
g9
sS'nalidixic,acid,may'
p36466
g9
sS'antacids,nonclinical,data'
p36467
g3
sS'concentration,in,plasma'
p36468
g3
sS'in,a,slower'
p36469
g9
sS'of,cyp3a4,the'
p36470
g9
sS'system,and,at'
p36471
g3
sS'neither,sodium,nor'
p36472
g3
sS'for,regarding,interactions'
p36473
g3
sS'a6,b6,d6'
p36474
g3
sS'the,human,weekly'
p36475
g3
sS'to,the,additive'
p36476
g3
sS'concurrently,with,mg'
p36477
g3
sS'dose,of,prostigmin'
p36478
g3
sS'sigma-2,receptors,sodium'
p36479
g3
sS'of,a,novel'
p36480
g3
sS'with,and,subsequent'
p36481
g3
sS'been,reported,by'
p36482
g3
sS'trough,concentrations,similar'
p36483
g9
sS'cortisone-like,medicine,blood'
p36484
g9
sS'definitely,determined,that'
p36485
g3
sS'elevation,of,serum'
p36486
g3
sS'a,well,defined'
p36487
g3
sS'food,isrecommended,in'
p36488
g9
sS'treated,with,appropriate'
p36489
g3
sS'of,the,clearance'
p36490
g9
sS'with,may,intensify'
p36491
g3
sS'myocarditis,ventricular,hypokinesia'
p36492
g9
sS'not,be,combined'
p36493
g9
sS'studies,have,indicated'
p36494
g3
sS'healthy,subjects,stabilized'
p36495
g9
sS'and,can,decrease'
p36496
g9
sS'higher,than,the'
p36497
g3
sS'reduced,by,to'
p36498
g9
sS'of,tablets,with'
p36499
g9
sS'active,metabolites,were'
p36500
g3
sS'findings,are,summarized'
p36501
g3
sS'protein,bound,drugs'
p36502
g3
sS'principles,of,recovery'
p36503
g3
sS'removes,the,antiedematous'
p36504
g9
sS'were,more,than'
p36505
g9
sS'volunteers,receiving,decreased'
p36506
g9
sS'the,ermbt,and'
p36507
g3
sS'were,not,inhibited'
p36508
g3
sS'reliable,when,tracleer'
p36509
g9
sS'temperature,was,decreased'
p36510
g9
sS'mg,dosage,inhibited'
p36511
g3
sS'the,spleen,following'
p36512
g3
sS'an,interactive,effect'
p36513
g3
sS'water-miscible,or,parenteral'
p36514
g3
sS'used,in,relation'
p36515
g3
sS'dizziness,during,up-titration'
p36516
g3
sS'response,to,indirect-acting'
p36517
g9
sS'are,actively,secreted'
p36518
g9
sS'be,observed,when'
p36519
g9
sS'cyp3a4,isoenzyme,of'
p36520
g3
sS'could,result,from'
p36521
g3
sS'anti-apoptotic,effect,of'
p36522
g3
sS'arrhythmias,and,sudden'
p36523
g9
sS'solutions,blood,concentrations'
p36524
g3
sS'use,younger,patients'
p36525
g3
sS'and,exert,additive'
p36526
g3
sS'risk,of,hypoglycemia'
p36527
g9
sS'in,nih-3t3,cells'
p36528
g3
sS'effects,caused,by'
p36529
g9
sS'that,potentiate,the'
p36530
g3
sS'then,received,plus'
p36531
g3
sS'on,the,pituitary-gonadal'
p36532
g3
sS'therefore,patients,who'
p36533
g3
sS'retention,dysuria,impotence'
p36534
g3
sS'number,of,regular'
p36535
g3
sS'of,alkalinization,of'
p36536
g3
sS'assays,using,red'
p36537
g3
sS'summary,a,year-old'
p36538
g3
sS'prolonged,recovery,time'
p36539
g9
sS'additive,vasodilator,properties'
p36540
g3
sS'baraclude,with,other'
p36541
g3
sS'induced,hypertension,were'
p36542
g3
sS'limit,values,it'
p36543
g3
sS'intracellular,mobilization,of'
p36544
g3
sS'patients,receiving,concurrently'
p36545
g9
sS'without,bleeding,in'
p36546
g9
sS'many,without,evidence'
p36547
g3
sS'be,given,when'
p36548
g3
sS'if,the,supplements'
p36549
g3
sS'permeation,studies,were'
p36550
g3
sS'vitamin,c,up'
p36551
g3
sS'mainly,receiving,thiazide'
p36552
g3
sS'p4502d6,in,vitro'
p36553
g3
sS'may,decrease,serum'
p36554
g9
sS'difluoroacetone,did,not'
p36555
g3
sS'was,longer,in'
p36556
g9
sS'the,following,blood'
p36557
g3
sS'associated,with,joint'
p36558
g3
sS'symptoms,resolved,when'
p36559
g3
sS'other,studies,strongly'
p36560
g3
sS'layers,iv,and'
p36561
g3
sS'the,study,was'
p36562
g3
sS'under,lying,the'
p36563
g9
sS'when,using,clinitest'
p36564
g3
sS'metabolism,may,need'
p36565
g3
sS'as,prolonged,or'
p36566
g3
sS'transplant,recipients,a'
p36567
g9
sS'all,species,including'
p36568
g3
sS'a,lesser,degree'
p36569
g3
sS'studies,showed,increased'
p36570
g3
sS'injection,of,insufficient'
p36571
g9
sS'accordingly,in,patients'
p36572
g9
sS'to,the,dosing'
p36573
g9
sS'are,suggested,when'
p36574
g9
sS'well,tolerated,in'
p36575
g3
sS'max,is,about'
p36576
g9
sS'induced,by,oh'
p36577
g9
sS'with,or,h2antagonists'
p36578
g9
sS'cross-matching,procedures,when'
p36579
g3
sS'interaction,with,the'
p36580
g3
sS'cyp2c19,substrate,resulted'
p36581
g9
sS'used,in,chemotherapy'
p36582
g3
sS'be,modified,given'
p36583
g3
sS'from,intravenous,use'
p36584
g3
sS'opioid-evoked,hyperpolarization,and'
p36585
g3
sS'to,warrant,dosage'
p36586
g9
sS'normal,variability,and'
p36587
g9
sS'with,crohn,s'
p36588
g3
sS'g,kg,body'
p36589
g3
sS'c,inhibited,the'
p36590
g9
sS'doses,of,the'
p36591
g3
sS'liver,tumors,when'
p36592
g3
sS'observed,in,comparative'
p36593
g3
sS'to,increase,serum'
p36594
g3
sS'furthermore,and,other'
p36595
g9
sS'flupenthixol,increases,the'
p36596
g9
sS'monitored,for,possible'
p36597
g9
sS'of,migraine,has'
p36598
g3
sS'action,or,dosing'
p36599
g3
sS'co-administered,with,that'
p36600
g3
sS'phenytoin,phenobarbital,the'
p36601
g9
sS'discontinue,the,use'
p36602
g3
sS'healthy,subjects,with'
p36603
g3
sS'a,to,fold'
p36604
g9
sS'arava,to,subjects'
p36605
g9
sS'roughly,twofold,greater'
p36606
g3
sS'or,elimination,may'
p36607
g3
sS'isolates,and,a'
p36608
g3
sS'differences,in,balance'
p36609
g3
sS'dose,at,the'
p36610
g3
sS'doses,of,to'
p36611
g9
sS'antagonists,which,cause'
p36612
g9
sS'kg,resulted,in'
p36613
g3
sS'dose,reduction,should'
p36614
g3
sS'the,remaining,cases'
p36615
g3
sS'of,other,ht1b'
p36616
g9
sS'of,mcg,twice'
p36617
g3
sS'using,pcp,combination'
p36618
g3
sS'of,sleep,than'
p36619
g3
sS'consequently,concomitant,administration'
p36620
g9
sS'needing,to,treatpatients'
p36621
g3
sS'be,decreased,thiazides'
p36622
g3
sS'with,the,action'
p36623
g9
sS'reduced,from,ml'
p36624
g9
sS'with,experienced,tremor'
p36625
g9
sS'cisapride,was,well'
p36626
g3
sS'urine,were,sampled'
p36627
g3
sS'in,escalating,doses'
p36628
g3
sS'v,concentrations,greater'
p36629
g3
sS'with,differin,gel'
p36630
g3
sS'anti-platelet,activity,of'
p36631
g3
sS'to,a,level'
p36632
g3
sS'pressure,deep,tendon'
p36633
g3
sS'some,inhibiting,activity'
p36634
g3
sS'have,been,rarely'
p36635
g9
sS'metabolite,after,intravenous'
p36636
g3
sS'for,serious,reactions'
p36637
g3
sS'mac,or,had'
p36638
g3
sS'sites,may,be'
p36639
g3
sS'on,the,pharmacokinetics'
p36640
g3
sS'in,monkeys,and'
p36641
g3
sS'vitro,study,in'
p36642
g9
sS'dogs,have,demonstrated'
p36643
g3
sS'false,positive,reaction'
p36644
g3
sS'the,plasma,lipid'
p36645
g3
sS'healthy,volunteers,who'
p36646
g3
sS'difluoro-2,propanol,derive'
p36647
g9
sS'response,rates,than'
p36648
g3
sS'maintenance,dose,and'
p36649
g9
sS'or,by,injection'
p36650
g3
sS'healthy,women,of'
p36651
g3
sS'oral,the,need'
p36652
g9
sS'sensitive,to,c'
p36653
g3
sS'tumor,versus,normal'
p36654
g3
sS'by,during,this'
p36655
g3
sS'without,evidence,of'
p36656
g3
sS'reaction,although,it'
p36657
g9
sS'blockers,l-type,omega-conotoxin'
p36658
g3
sS'toxicity,study,cynomolgus'
p36659
g3
sS'the,frequency,and'
p36660
g9
sS'but,not,with'
p36661
g3
sS'p450,d6,they'
p36662
g3
sS'have,received,muscle'
p36663
g9
sS'other,medications,to'
p36664
g3
sS'respectively,and,for'
p36665
g9
sS'peripheral,neuropathy,include'
p36666
g3
sS'been,conducted,no'
p36667
g3
sS'clearance,such,as'
p36668
g9
sS'mental,status,changes'
p36669
g9
sS'of,the,pharmacological'
p36670
g3
sS'pre-existing,cardiac,abnormalities'
p36671
g9
sS'm,failed,to'
p36672
g9
sS'interferences,and,the'
p36673
g3
sS'range,kg,and'
p36674
g3
sS'markedly,decreased,the'
p36675
g3
sS'in,which,the'
p36676
g3
sS'tricyclic,have,been'
p36677
g9
sS'undergoing,treatment,with'
p36678
g9
sS'hundred,mg,of'
p36679
g3
sS'blood,coagulation,system'
p36680
g3
sS'the,stadol,ns'
p36681
g9
sS'with,the,digi-'
p36682
g3
sS'with,cefizox,nephrotoxicity'
p36683
g9
sS'receiving,or,oral'
p36684
g3
sS'ischemic,heart,disease'
p36685
g9
sS'voltage-dependent,ca,channel'
p36686
g3
sS'york,heart,association'
p36687
g3
sS'pharmacodynamic,interactions,when'
p36688
g9
sS'average,of,and'
p36689
g9
sS'given,for,each'
p36690
g3
sS'that,of,urate'
p36691
g9
sS'no,greater,than'
p36692
g9
sS'increased,the,systemic'
p36693
g9
sS'the,patients,serum'
p36694
g3
sS'an,increased,rate'
p36695
g9
sS'terfenadine,and,are'
p36696
g9
sS'and,receptors,thus'
p36697
g9
sS'those,produced,by'
p36698
g9
sS'nutrition,herb,interactions'
p36699
g9
sS'addition,reduced,kidney'
p36700
g3
sS'the,additive,effects'
p36701
g3
sS'medicine,certain,such'
p36702
g3
sS'days,and,the'
p36703
g3
sS'for,patients,taking'
p36704
g3
sS'esters,on,glucocorticoid-induced'
p36705
g3
sS'repeated,each,month'
p36706
g3
sS'novel,purification,protocol'
p36707
g3
sS'with,a,small'
p36708
g3
sS'vehicle,corn,oil'
p36709
g3
sS'nalfon,to,therapy'
p36710
g9
sS'this,isoenzyme,and'
p36711
g3
sS'platelet,activation,in'
p36712
g3
sS'isoforms,epoxide,hydrolase'
p36713
g3
sS'inhibits,the,enzymatic'
p36714
g9
sS'proleukin,treatment,may'
p36715
g3
sS'the,treatment,with'
p36716
g9
sS'immediate,release,capsules'
p36717
g9
sS'an,immune,response'
p36718
g3
sS'complications,careful,monitoring'
p36719
g3
sS'the,effects,seen'
p36720
g3
sS'a,rapid,and'
p36721
g9
sS'binding,in,each'
p36722
g3
sS'nmda,and,sigma-2'
p36723
g3
sS'b,has,been'
p36724
g9
sS'reaction,for,ketones'
p36725
g3
sS'cognitive,dysfunction,hyperpyrexia'
p36726
g9
sS'molecular,mechanisms,of'
p36727
g3
sS'for,antipsychotic,activity'
p36728
g3
sS'of,the,mentioned'
p36729
g3
sS'are,discussed,in'
p36730
g3
sS'is,not,metabolized'
p36731
g3
sS'pegasys,is,recommended'
p36732
g3
sS'increased,exposure,following'
p36733
g9
sS'is,believed,that'
p36734
g9
sS'with,coadministration,were'
p36735
g9
sS'still,advisable,to'
p36736
g9
sS'insufficiency,are,anticipated'
p36737
g3
sS'states,underlying,conditions'
p36738
g3
sS'reported,to,both'
p36739
g9
sS'l,and,by'
p36740
g9
sS'and,h2,blockers'
p36741
g9
sS'patients,who,were'
p36742
g3
sS'concentration,of,and'
p36743
g9
sS'toradol,and,or'
p36744
g9
sS'as,the,geriatric'
p36745
g3
sS'doubt,complex,and'
p36746
g3
sS'monitored,closely,after'
p36747
g9
sS'faecium,to,the'
p36748
g3
sS'to,supraspinal,brain'
p36749
g3
sS'discrimination,and,behavioral'
p36750
g3
sS'in,epileptic,patients'
p36751
g9
sS'or,pharmacist,can'
p36752
g3
sS'of,chloride-induced,gastrointestinal'
p36753
g9
sS'with,for,two'
p36754
g9
sS'fold,increase,in'
p36755
g9
sS'beginning,therapy,should'
p36756
g9
sS'of,did,not'
p36757
g3
sS'nuclei,chromatin,and'
p36758
g3
sS'meal,as,evidenced'
p36759
g9
sS'produces,psychotomimetic,effects'
p36760
g3
sS'reports,concerned,variable'
p36761
g3
sS'show,that,lung'
p36762
g3
sS'nalfon,and,is'
p36763
g9
sS'bound,with,narrow'
p36764
g3
sS'is,defined,as'
p36765
g3
sS'interactions,there,are'
p36766
g3
sS'significant,interaction,may'
p36767
g3
sS'ht1b,d,agonists'
p36768
g9
sS'will,not,increase'
p36769
g3
sS'man,was,admitted'
p36770
g3
sS'receiving,or,halogenated'
p36771
g9
sS'physicians,can,take'
p36772
g3
sS'axons,contained,plus'
p36773
g3
sS'similar,changes,in'
p36774
g3
sS'with,standard,clinical'
p36775
g3
sS'binding,with,high'
p36776
g3
sS'analysis,and,scanning'
p36777
g3
sS'at,mg,per'
p36778
g9
sS'in,clinically,normal'
p36779
g3
sS'symptoms,may,be'
p36780
g3
sS'between,solvents,can'
p36781
g3
sS'with,high,affinity'
p36782
g3
sS'drugs,can,lead'
p36783
g9
sS'the,behavioral,changes'
p36784
g3
sS'between,brevibloc,and'
p36785
g3
sS'with,containing,or'
p36786
g9
sS'dmpge2,in,cecectomized'
p36787
g3
sS'when,administered,during'
p36788
g3
sS'metabolism,and,has'
p36789
g9
sS'of,which,d'
p36790
g9
sS'because,of,an'
p36791
g9
sS'that,induce,hepatic'
p36792
g9
sS'commercially,available,assay'
p36793
g3
sS'plasma,levels,were'
p36794
g9
sS'mechanism,and,long-term'
p36795
g3
sS'conjugated,with,further'
p36796
g3
sS'tolerance,and,sensitization'
p36797
g3
sS'mglur,agonists,dcg-iv'
p36798
g3
sS'in,patients,suffering'
p36799
g9
sS'supervision,of,diabetic'
p36800
g3
sS'to,might,decrease'
p36801
g9
sS'that,poor,d6'
p36802
g3
sS'tolerated,dose,of'
p36803
g3
sS'after,at,the'
p36804
g3
sS'or,excessive,bradycardia'
p36805
g3
sS'in,the,fed'
p36806
g9
sS'or,more,were'
p36807
g3
sS'verapamil,concomitant,use'
p36808
g3
sS'of,were,noted'
p36809
g3
sS'it,is,subject'
p36810
g3
sS'and,postnatal,immune'
p36811
g3
sS'in,insufficient,plasma'
p36812
g9
sS'once-monthly,with,daily'
p36813
g3
sS'insp,microm,increased'
p36814
g3
sS'the,experiment,rats'
p36815
g3
sS'in,these,trials'
p36816
g3
sS'protease,inhibitor,due'
p36817
g3
sS'female,volunteers,in'
p36818
g3
sS'a,supplement,that'
p36819
g3
sS'there,is,the'
p36820
g3
sS'p450,a4,grapefruit'
p36821
g9
sS'returned,to,normal'
p36822
g3
sS'and,the,same'
p36823
g3
sS'and,less,suppression'
p36824
g3
sS'was,to,examine'
p36825
g3
sS'enablex,is,used'
p36826
g9
sS'monitoring,of,clinical'
p36827
g9
sS'be,the,major'
p36828
g3
sS'progestational,eg,implants'
p36829
g3
sS'caution,in,using'
p36830
g9
sS'nursing,while,taking'
p36831
g3
sS'the,liver,via'
p36832
g3
sS'if,used,concomitantly'
p36833
g9
sS'metabolic,pathway,for'
p36834
g3
sS'oral,diabetes,medicine'
p36835
g9
sS'against,driving,a'
p36836
g3
sS'supplements,uncontrolled,intake'
p36837
g3
sS'oleate,and,h-triolein'
p36838
g3
sS'mg,bid,was'
p36839
g9
sS'maois,which,may'
p36840
g3
sS'multiple,oral,doses'
p36841
g9
sS'concentrations,and,auc'
p36842
g3
sS'others,that,interfere'
p36843
g9
sS'mediated,by,cimetidines'
p36844
g9
sS'known,whether,the'
p36845
g9
sS'of,than,when'
p36846
g9
sS'dose,mu,kg'
p36847
g3
sS'studies,where,patients'
p36848
g3
sS'metabolism,is,hydroxylation'
p36849
g3
sS'shown,that,is'
p36850
g3
sS'may,elevate,serum'
p36851
g9
sS'subjects,no,evidence'
p36852
g3
sS'cell,tumors,and'
p36853
g3
sS'that,the,binding'
p36854
g3
sS'in,the,myasthenic'
p36855
g9
sS'these,conclusions,are'
p36856
g3
sS'pharmacokinetics,of,amphotericin'
p36857
g3
sS'therapy,may,exhibit'
p36858
g9
sS'metabolized,by,these'
p36859
g3
sS'of,and,some'
p36860
g9
sS'has,a,tendency'
p36861
g9
sS'dose,reduction,as'
p36862
g3
sS'system,particularly,the'
p36863
g3
sS'serum,concentrations,and'
p36864
g9
sS'from,human,in'
p36865
g3
sS'and,brain,was'
p36866
g9
sS'epidermal,necrolysis,has'
p36867
g3
sS'dimenhydrinate,may,decrease'
p36868
g9
sS'with,human,immunodeficiency'
p36869
g3
sS'vasodilator,activity,should'
p36870
g9
sS'maintain,inhibition,of'
p36871
g3
sS'worsened,by,especially'
p36872
g9
sS'proliferating,cell,functions'
p36873
g3
sS'components,in,comparison'
p36874
g3
sS'dosage,when,is'
p36875
g9
sS'aggregation,but,did'
p36876
g9
sS'cyp3a4,rifampin,cyp3a4'
p36877
g3
sS'for,mec,values'
p36878
g3
sS'study,following,chronic'
p36879
g3
sS'increased,frequency,of'
p36880
g3
sS'transfusions,acute,pulmonary'
p36881
g9
sS'must,receive,concomitant'
p36882
g3
sS'for,the,potentiation'
p36883
g3
sS'diagnostic,or,therapeutic'
p36884
g3
sS'has,no,clinically'
p36885
g3
sS'expected,with,higher'
p36886
g9
sS'survival,in,and'
p36887
g3
sS'the,serum,creatinine'
p36888
g9
sS'a,proper,interval'
p36889
g3
sS'be,exceeded,when'
p36890
g9
sS'antibiotics,macrolide,have'
p36891
g9
sS'auc,values,of'
p36892
g3
sS'primarily,iron-fortified,breakfast'
p36893
g3
sS'respectively,in,the'
p36894
g3
sS'affect,the,aptt'
p36895
g3
sS'matrix,may,increase'
p36896
g9
sS'core,temperature,in'
p36897
g3
sS'and,the,excretion'
p36898
g3
sS'caffeine,administered,concurrently'
p36899
g9
sS'the,steadystate,cmin'
p36900
g9
sS'the,qrs,complex'
p36901
g9
sS'if,the,neutrophil'
p36902
g3
sS'release,of,vasoconstrictor'
p36903
g3
sS'an,endogenous,marker'
p36904
g9
sS'antizol,and,that'
p36905
g9
sS'been,administered,concomitantly'
p36906
g3
sS'impairment,of,fertility'
p36907
g3
sS'approximately,threefold,from'
p36908
g9
sS'coadministration,with,of'
p36909
g3
sS'kinase,c,or'
p36910
g3
sS'of,either,agent'
p36911
g3
sS'micrograms,ml,when'
p36912
g3
sS'significant,difference,p'
p36913
g3
sS'weak,inhibitor,of'
p36914
g3
sS'are,compelling,reasons'
p36915
g3
sS'respect,to,efficacy'
p36916
g3
sS'as,diminished,effects'
p36917
g9
sS'interaction,for,the'
p36918
g9
sS'benign,prostatic,hyperplasia'
p36919
g3
sS'reassess,the,patient'
p36920
g3
sS'may,experience,increased'
p36921
g3
sS'dose,of,stadol'
p36922
g9
sS'not,necessary,when'
p36923
g3
sS'clinical,studies,without'
p36924
g3
sS'affect,cyp3a4,and'
p36925
g3
sS'schedule,of,indocin'
p36926
g9
sS'antagonize,the,effect'
p36927
g9
sS'usual,and,the'
p36928
g9
sS'may,also,occur'
p36929
g3
sS'mutagenesis,and,impairment'
p36930
g3
sS'alprazolam,caution,is'
p36931
g9
sS'action,should,be'
p36932
g3
sS'higher,when,mg'
p36933
g9
sS'healthy,subjects,were'
p36934
g3
sS'p450,isoforms,epoxide'
p36935
g3
sS'product,erythro-fluorocitrate,from'
p36936
g3
sS'mg,qhs,after'
p36937
g3
sS'to,assess,the'
p36938
g3
sS'the,biological,half-lives'
p36939
g3
sS'patients,received,epirubicin-based'
p36940
g3
sS'as,and,similar'
p36941
g3
sS'with,systemic,antiretroviral'
p36942
g3
sS'wallerian,degeneration,of'
p36943
g3
sS'experience,in,over'
p36944
g9
sS'available,about,the'
p36945
g3
sS'healthy,volunteers,receiving'
p36946
g9
sS'medications,concurrent,use'
p36947
g3
sS'or,triazolam,no'
p36948
g3
sS'us,food,and'
p36949
g3
sS'from,the,proposed'
p36950
g3
sS'potential,interaction,involving'
p36951
g9
sS'patients,taking,mg'
p36952
g3
sS'normal,subjects,nor'
p36953
g3
sS'pletal,is,coadministered'
p36954
g9
sS'acromegaly,and,after'
p36955
g3
sS'reported,in,clinical'
p36956
g3
sS'acts,as,a'
p36957
g9
sS'female,volunteers,suggests'
p36958
g9
sS'findings,should,be'
p36959
g3
sS'occur,with,labetalol'
p36960
g9
sS'the,lectin,and'
p36961
g3
sS'subject,received,an'
p36962
g3
sS'test,may,be'
p36963
g3
sS'such,methods,for'
p36964
g3
sS'enhancing,effects,of'
p36965
g3
sS'and,mhd,however'
p36966
g3
sS'it,is,still'
p36967
g9
sS'pseudomonas,strains,from'
p36968
g3
sS'in,women,who'
p36969
g3
sS'differences,in,dosing'
p36970
g3
sS'of,some,patients'
p36971
g3
sS'toxic,such,as'
p36972
g9
sS'cerebroactive,drugs,has'
p36973
g3
sS'hyperpolarized,by,mu-'
p36974
g3
sS'high,inter-patient,variability'
p36975
g3
sS'values,similar,to'
p36976
g3
sS'the,iv,dose'
p36977
g9
sS'while,levels,of'
p36978
g9
sS'is,necessary,careful'
p36979
g3
sS'by,severe,peripheral'
p36980
g9
sS'than,when,was'
p36981
g9
sS'itraconazole,ketoconazole,erythromycin'
p36982
g3
sS'minutes,of,exposure'
p36983
g3
sS'by,administration,however'
p36984
g3
sS'known,to,raise'
p36985
g9
sS'toradol,with,muscle'
p36986
g3
sS'control,hypertension,in'
p36987
g9
sS'without,changes,in'
p36988
g3
sS'increased,approximately,twofold'
p36989
g9
sS'observed,in,mice'
p36990
g3
sS'volunteers,when,administered'
p36991
g3
sS'receiving,high,doses'
p36992
g9
sS'starting,the,or'
p36993
g3
sS'ketoconazole,fexofenadine,has'
p36994
g3
sS'study,showed,that'
p36995
g3
sS'bullous,pemphigoid,and'
p36996
g9
sS'history,of,severe'
p36997
g3
sS'the,clinical,dose'
p36998
g3
sS'possessing,properties,can'
p36999
g3
sS'evaluated,and,compared'
p37000
g3
sS'hypersensitivity,reactions,have'
p37001
g9
sS'patients,on,concomitant'
p37002
g9
sS'bred,for,differential'
p37003
g3
sS'use,of,alone'
p37004
g3
sS'state,levels,of'
p37005
g3
sS'in,serum,levels'
p37006
g3
sS'following,varying,degrees'
p37007
g3
sS'in,a,separate'
p37008
g3
sS'use,as,part'
p37009
g3
sS'evaluation,of,individual'
p37010
g3
sS'one,or,two'
p37011
g3
sS'a,rate,of'
p37012
g9
sS'by,use,of'
p37013
g3
sS'loss,of,virologic'
p37014
g3
sS'gl,was,combined'
p37015
g9
sS'maximum,levels,meq'
p37016
g3
sS'and,iv,compared'
p37017
g3
sS'and,g,kg'
p37018
g9
sS'studies,with,in'
p37019
g3
sS'and,and,no'
p37020
g3
sS'patients,available,uncontrolled'
p37021
g3
sS'however,the,cause'
p37022
g3
sS'bar-press,conditioning,and'
p37023
g3
sS'with,sustiva,in'
p37024
g3
sS'therapy,are,at'
p37025
g9
sS'of,these,cases'
p37026
g3
sS'ethacrynic,acid,because'
p37027
g9
sS'of,elimination,was'
p37028
g3
sS'certain,tcas,such'
p37029
g9
sS'supplements,can,increase'
p37030
g3
sS'post,and,returned'
p37031
g3
sS'administration,of,hepatic'
p37032
g9
sS'of,patients,treated'
p37033
g9
sS'homocysteine,may,be'
p37034
g3
sS'mg,qd,is'
p37035
g9
sS'and,consequently,alter'
p37036
g3
sS'could,be,affected'
p37037
g3
sS'other,currently,available'
p37038
g3
sS'factors,is,also'
p37039
g3
sS'adrenergic,agonists,on'
p37040
g9
sS'of,an,mao'
p37041
g9
sS'experience,indicates,that'
p37042
g9
sS'blockers,proton,pump'
p37043
g9
sS'responding,under,a'
p37044
g3
sS'neither,nor,its'
p37045
g3
sS'bolus-ifl,with,or'
p37046
g3
sS'in,lower,plasma'
p37047
g9
sS'conditions,that,may'
p37048
g3
sS'concurrent,or,serial'
p37049
g3
sS'of,results,in'
p37050
g9
sS'mg,qd,in'
p37051
g3
sS'caution,and,consideration'
p37052
g3
sS'similar,compounds,enhanced'
p37053
g3
sS'n,and,n'
p37054
g9
sS'with,several,which'
p37055
g3
sS'changes,in,the'
p37056
g3
sS'the,doses,of'
p37057
g9
sS'may,be,small'
p37058
g3
sS'is,especially,true'
p37059
g3
sS'using,an,i-labelled'
p37060
g3
sS'combination,may,cause'
p37061
g9
sS'neuronal,damage,produced'
p37062
g9
sS'or,mg,orally'
p37063
g3
sS'half-life,of,because'
p37064
g9
sS'in,animals,demonstrate'
p37065
g9
sS'higher,when,and'
p37066
g9
sS'depresses,bone,marrow'
p37067
g3
sS'insufficiency,in,patients'
p37068
g3
sS'ultimately,however,up'
p37069
g3
sS'cryptosporidium,parvum,in'
p37070
g3
sS'phenomenon,has,not'
p37071
g3
sS's,nor,were'
p37072
g3
sS'each,successive,generation'
p37073
g3
sS'concurrent,with,oral'
p37074
g9
sS'substrate,the,auc'
p37075
g9
sS'anti-coagulant,effect,of'
p37076
g3
sS'of,to,be'
p37077
g3
sS'drug,transport,systems'
p37078
g3
sS'in,decreased,antihypertensive'
p37079
g9
sS'aged,or,over'
p37080
g3
sS'do,not,bear'
p37081
g9
sS'non-selective,mao,inhibitors'
p37082
g9
sS'patients,with,moderate'
p37083
g9
sS'of,ergotamine-containing,when'
p37084
g9
sS'q,i,d'
p37085
g9
sS'isoniazid,should,not'
p37086
g3
sS'to,check,coagulation'
p37087
g9
sS'zidovudine,there,is'
p37088
g3
sS'these,agents,include'
p37089
g3
sS'days,and,to'
p37090
g3
sS'at,the,cellular'
p37091
g3
sS'early,therapy,to'
p37092
g9
sS'inhibitor,at,mg'
p37093
g9
sS'pressor,agents,because'
p37094
g3
sS'nephrotoxic,myelotoxic,chemotherapy'
p37095
g9
sS'genetic,variation,in'
p37096
g3
sS'individual,case,to'
p37097
g3
sS'drug,at,the'
p37098
g3
sS'association,between,use'
p37099
g9
sS'res,have,reported'
p37100
g3
sS'sinus,node,function'
p37101
g9
sS'the,dose,required'
p37102
g3
sS's-isomer,and,changes'
p37103
g3
sS'dose,relationship,has'
p37104
g3
sS'the,findings,suggest'
p37105
g3
sS'kg,day,was'
p37106
g3
sS'l,were,similar'
p37107
g3
sS'not,affect,pharmacokinetics'
p37108
g9
sS'coadministration,can,result'
p37109
g9
sS'receiving,the,and'
p37110
g3
sS'particularly,of,the'
p37111
g9
sS'interval,because,the'
p37112
g9
sS'or,other,caution'
p37113
g9
sS'are,used,during'
p37114
g3
sS'a,sulfa-based,such'
p37115
g3
sS'of,using,anafranil'
p37116
g3
sS'study,of,the'
p37117
g3
sS'were,recorded,while'
p37118
g3
sS'statistically,significant,changes'
p37119
g3
sS't24,human,bladder'
p37120
g3
sS'methaemoglobinaemia,particularly,in'
p37121
g3
sS'on,its,rate'
p37122
g3
sS'when,and,maalox'
p37123
g9
sS'it,is,postulated'
p37124
g3
sS'anaesthetised,with,fluothane'
p37125
g9
sS'increases,the,prothrombin'
p37126
g3
sS'cyp,enzymes,are'
p37127
g9
sS'effects,affecting,the'
p37128
g9
sS'or,mg,rat'
p37129
g3
sS'of,akathisia,however'
p37130
g3
sS'cmi,has,been'
p37131
g9
sS'ascorbic,acid,in'
p37132
g3
sS'of,treatment,and'
p37133
g3
sS'patients,liver,which'
p37134
g9
sS'derivative,is,a'
p37135
g3
sS'concluded,from,these'
p37136
g3
sS'half-lives,to,days'
p37137
g3
sS'and,produced,an'
p37138
g3
sS'together,the,signs'
p37139
g9
sS'major,pathophysiologic,abnormality'
p37140
g3
sS'products,sharing,that'
p37141
g9
sS'prothrombin,time,be'
p37142
g9
sS'receiving,therapy,who'
p37143
g9
sS'and,abciximab,may'
p37144
g9
sS'sensitize,tissues,to'
p37145
g3
sS'narrow,therapeutic,indices'
p37146
g9
sS'liver,microsomes,inhibition'
p37147
g9
sS'about,when,and'
p37148
g9
sS'with,cmi,because'
p37149
g9
sS'been,drawn,up'
p37150
g3
sS'precipitation,procedure,is'
p37151
g3
sS'prothrombin,time,by'
p37152
g3
sS'is,a,serotonin'
p37153
g9
sS'partner,of,a'
p37154
g3
sS'studies,have,excluded'
p37155
g3
sS'in,cerebral,and'
p37156
g3
sS'mc,has,a'
p37157
g3
sS'oral,to,maintain'
p37158
g3
sS'use,of,mefloquine'
p37159
g9
sS'effects,of,that'
p37160
g9
sS'effective,while,you'
p37161
g9
sS'such,as,impulsivity'
p37162
g3
sS'may,depend,upon'
p37163
g3
sS'falsely,elevated,with'
p37164
g3
sS'suggest,that,intracellular'
p37165
g3
sS'of,approximately,was'
p37166
g9
sS'human,heart,failure'
p37167
g3
sS'and,sodium,levels'
p37168
g3
sS'no,apparent,effect'
p37169
g3
sS'exert,additive,vasodilator'
p37170
g3
sS'elimination,and,increases'
p37171
g3
sS'conclude,that,there'
p37172
g3
sS'therefore,use,of'
p37173
g9
sS'about,fold,when'
p37174
g9
sS'the,solubility,of'
p37175
g3
sS'increased,in,cocaine-treated'
p37176
g3
sS'sensitive,cyp3a4,substrate'
p37177
g9
sS'body,weight,every'
p37178
g3
sS'insulin,increased,renal'
p37179
g3
sS'uptake,sites,in'
p37180
g3
sS'prolong,the,serum'
p37181
g9
sS'of,fertility,no'
p37182
g3
sS'nsaids,and,anti-infectives'
p37183
g3
sS'physiological,doses,of'
p37184
g3
sS'levels,and,area-under'
p37185
g9
sS'other,hepatic,enzyme'
p37186
g9
sS'reactions,was,not'
p37187
g3
sS'racemic,mg,day'
p37188
g3
sS'evidenced,by,the'
p37189
g3
sS'probable,benefits,outweigh'
p37190
g9
sS'may,occasionally,experience'
p37191
g9
sS'and,behavioral,responsiveness'
p37192
g9
sS'excretion,and,renin'
p37193
g3
sS'the,marrow,toxicity'
p37194
g3
sS'active,renal,secretion'
p37195
g3
sS'a,subset,to'
p37196
g3
sS'a,hazard,to'
p37197
g9
sS'interaction,between,a'
p37198
g3
sS'these,categories,result'
p37199
g9
sS'metabolized,to,by'
p37200
g3
sS'had,no,substantive'
p37201
g3
sS'they,also,suggest'
p37202
g3
sS'p450,d6,hydroxylase'
p37203
g3
sS'when,and,viracept'
p37204
g3
sS'in,blood,levels'
p37205
g9
sS'an,and,oral'
p37206
g9
sS'there,are,currently'
p37207
g3
sS'levels,after,oral'
p37208
g3
sS'nature,of,this'
p37209
g3
sS'to,date,levosimendan'
p37210
g3
sS'taking,low-dose,plus'
p37211
g3
sS'such,as,marplan'
p37212
g3
sS'been,no,experience'
p37213
g3
sS'on,should,receive'
p37214
g9
sS'as,choline,trilisate'
p37215
g9
sS'mg,controlled-release,capsule'
p37216
g9
sS'treatment,on,patient'
p37217
g3
sS'mg,bid,on'
p37218
g3
sS'concentrating,as,effective'
p37219
g3
sS'strips,that,use'
p37220
g3
sS'concentration,that,may'
p37221
g3
sS'avoided,while,taking'
p37222
g3
sS'an,important,role'
p37223
g9
sS'benign,intracranial,hypertension'
p37224
g9
sS'dosage,and,permit'
p37225
g3
sS'for,a,interaction'
p37226
g9
sS'subjects,received,rantidine'
p37227
g3
sS'cardiac,arrests,have'
p37228
g3
sS'conducted,on,plasma'
p37229
g3
sS'neuropathy,the,concomitant'
p37230
g3
sS'gaba-positive,be,included'
p37231
g3
sS'both,synthetic,and'
p37232
g9
sS'clearance,has,not'
p37233
g3
sS'the,duloxetine,clinical'
p37234
g3
sS'in,altering,activity'
p37235
g3
sS'day,of,cromolyn'
p37236
g9
sS'of,these,larger'
p37237
g9
sS'of,thereby,decreasing'
p37238
g9
sS'as,liver,enzyme'
p37239
g9
sS'materially,different,from'
p37240
g3
sS'december,the,following'
p37241
g3
sS'any,agent,metabolized'
p37242
g3
sS'motion,sickness,medications'
p37243
g3
sS'stopping,before,starting'
p37244
g9
sS'other,potent,parental'
p37245
g9
sS'it,has,not'
p37246
g9
sS'of,and,viracept'
p37247
g9
sS'with,mg,kg'
p37248
g3
sS'in,general,if'
p37249
g3
sS'five,commonly,used'
p37250
g3
sS'phenothiazines,taking,and'
p37251
g9
sS'p-450,is,not'
p37252
g3
sS'pharmacokinetic,parameters,of'
p37253
g3
sS'distribution,pathways,and'
p37254
g3
sS'based,regimens,for'
p37255
g3
sS'feels,better,after'
p37256
g3
sS'with,or,subsequent'
p37257
g9
sS'n,compared,to'
p37258
g9
sS'of,fundus,pulsation'
p37259
g3
sS'mg,ml,have'
p37260
g3
sS'enhanced,drug,effect'
p37261
g3
sS'renal,clearance,with'
p37262
g9
sS'to,produce,scintigraphic'
p37263
g3
sS'azole,agents,and'
p37264
g9
sS'vasodilator,effects,on'
p37265
g3
sS'impairment,of,mental'
p37266
g3
sS'male,subjects,ages'
p37267
g9
sS'varied,from,study'
p37268
g3
sS'occurrence,of,severe'
p37269
g3
sS'improving,the,adequacy'
p37270
g3
sS'day,and,aprepitant'
p37271
g9
sS'from,the,in'
p37272
g3
sS'be,evaluated,in'
p37273
g3
sS'other,nsaid,while'
p37274
g9
sS'likely,by,inhibition'
p37275
g9
sS'your,physician,to'
p37276
g3
sS'remedies,and,vasoconstrictive'
p37277
g9
sS'administered,at,a'
p37278
g9
sS'acceptable,alternatives,to'
p37279
g3
sS'or,fatal,adverse'
p37280
g3
sS'maintaining,a,given'
p37281
g3
sS'delayed,for,several'
p37282
g9
sS'serious,symptoms,i'
p37283
g9
sS'could,potentially,arise'
p37284
g9
sS'settings,commonly,associated'
p37285
g3
sS'dose,and,plasma'
p37286
g9
sS'number,of,reports'
p37287
g9
sS'vivo,studies,to'
p37288
g3
sS'in,the,clearance'
p37289
g9
sS'increase,resulting,in'
p37290
g9
sS'should,apply,to'
p37291
g3
sS'skin,products,or'
p37292
g3
sS'on,metabolism,or'
p37293
g3
sS'the,roughly,twofold'
p37294
g3
sS'of,exposure,were'
p37295
g3
sS'pharmacokinetics,if,the'
p37296
g3
sS'antidiabetic,agents,disturbances'
p37297
g9
sS'the,urine,volume'
p37298
g9
sS'constipation,and,dry'
p37299
g3
sS'of,the,gastrointestinal'
p37300
g3
sS'high,concentrations,it'
p37301
g3
sS'with,oral,the'
p37302
g9
sS'volunteers,receiving,the'
p37303
g9
sS'nsaids,and,may'
p37304
g9
sS'inhibitors,and,concomitantly'
p37305
g9
sS'clidinium,may,decrease'
p37306
g9
sS'sirolimus,works,differently'
p37307
g3
sS'taken,as,directed'
p37308
g3
sS'who,have,received'
p37309
g9
sS'hunger,and,anxiety'
p37310
g3
sS'expression,of,subpopulations'
p37311
g3
sS'receiving,blocking,agents'
p37312
g3
sS'patients,receiving,low'
p37313
g3
sS'both,tissues,either'
p37314
g3
sS'and,and,increase'
p37315
g9
sS'with,lipid-lowering,that'
p37316
g3
sS'that,includes,most'
p37317
g3
sS'of,certain,compounds'
p37318
g9
sS'mg,enteric,coated'
p37319
g3
sS'in,vitro,results'
p37320
g3
sS'ml,whereas,exogenous'
p37321
g3
sS'that,intensive,control'
p37322
g3
sS'minutes,before,any'
p37323
g9
sS'such,as,nonsteroidal'
p37324
g9
sS'to,its,nephrotoxicity'
p37325
g9
sS'not,established,a'
p37326
g9
sS'trileptal,greater,than'
p37327
g9
sS'effects,breast,feeding'
p37328
g3
sS'not,different,and'
p37329
g3
sS'changes,to,be'
p37330
g9
sS'phenobarbital,primidone,population'
p37331
g9
sS'm,and,c9'
p37332
g3
sS'amplifies,the,therapeutic'
p37333
g9
sS'organ,may,be'
p37334
g3
sS'by,perivascular,hemorrhages'
p37335
g3
sS'proportion,to,the'
p37336
g3
sS'p450,isoen-zymes,cyp2c8'
p37337
g3
sS'administered,iron-fortified,infant'
p37338
g3
sS'a,study,with'
p37339
g3
sS'were,experienced,by'
p37340
g3
sS'or,by,a'
p37341
g3
sS'a,marked,effect'
p37342
g9
sS'that,the,administration'
p37343
g9
sS'even,when,co-administered'
p37344
g3
sS'however,reports,suggest'
p37345
g9
sS'began,within,minutes'
p37346
g3
sS'mg,neurontin,and'
p37347
g3
sS'used,many,patients'
p37348
g3
sS'wort,may,increase'
p37349
g3
sS'of,which,also'
p37350
g3
sS'approximate,increase,in'
p37351
g9
sS'the,sensitivity,of'
p37352
g3
sS'protective,effect,of'
p37353
g9
sS'neurobiological,alterations,might'
p37354
g3
sS'cyp,a4,by'
p37355
g3
sS'blood,sugar,level'
p37356
g3
sS'result,from,the'
p37357
g9
sS'increase,metabolism,and'
p37358
g3
sS'such,agents,must'
p37359
g3
sS'not,in,and'
p37360
g9
sS'sodium,is,given'
p37361
g9
sS'acetazolamide,and,sodium'
p37362
g9
sS'agents,may,have'
p37363
g9
sS'optimal,conditions,kinetics'
p37364
g3
sS'in,whom,therapy'
p37365
g9
sS'of,whether,is'
p37366
g3
sS'necessary,for,eight'
p37367
g9
sS'either,or,biocytin'
p37368
g3
sS'were,grouped,as'
p37369
g3
sS'drugs,the,administration'
p37370
g9
sS'vitro,gleevec,inhibits'
p37371
g3
sS'that,the,histidine'
p37372
g3
sS'storage,vesicles,along'
p37373
g3
sS'the,plasma,concentration-time'
p37374
g3
sS'exposure,following,a'
p37375
g9
sS'differences,in,effect'
p37376
g3
sS'tolerated,in,patients'
p37377
g3
sS'therapy,is,contemplated'
p37378
g3
sS'may,vary,by'
p37379
g3
sS'modifications,in,special'
p37380
g3
sS'in,fi,or'
p37381
g9
sS'on,bone,loss'
p37382
g3
sS'by,displacing,the'
p37383
g9
sS'p-type,in,bovine'
p37384
g3
sS'concentrations,of,active'
p37385
g9
sS'from,nerves,and'
p37386
g3
sS'exaggerate,the,degree'
p37387
g3
sS'in,the,acquired'
p37388
g3
sS'taxol,but,generally'
p37389
g3
sS'inhibited,by,concomitant'
p37390
g9
sS'days,to,healthy'
p37391
g3
sS'sparine,phenergan,mellaril'
p37392
g3
sS'other,than,with'
p37393
g3
sS'containing,microgram,ml'
p37394
g3
sS'esomeprazole,is,extensively'
p37395
g3
sS'be,susceptible,to'
p37396
g3
sS'low-dose,combination,oral'
p37397
g3
sS'and,has,been'
p37398
g9
sS'transit,time,by'
p37399
g9
sS'the,interactions,observed'
p37400
g9
sS'clearance,of,r-warfarin'
p37401
g9
sS'used,during,muscle'
p37402
g3
sS'be,used,during'
p37403
g3
sS'including,tricor,there'
p37404
g9
sS'acetate,because,of'
p37405
g9
sS'microsomal,fraction,of'
p37406
g3
sS'to,its,inhibitory'
p37407
g9
sS'mice,treated,with'
p37408
g3
sS'female,patients,of'
p37409
g3
sS'each,subject,before'
p37410
g3
sS'potentiates,the,reduction'
p37411
g9
sS'in,a,rapid'
p37412
g9
sS'inhibitors,and,the'
p37413
g9
sS'alter,the,response'
p37414
g3
sS'uncertain,mechanism,and'
p37415
g3
sS'precipitation,of,oxypurines'
p37416
g3
sS'effects,and,malignant'
p37417
g3
sS'slow,gastric,emptying'
p37418
g3
sS'these,with,hivid'
p37419
g3
sS'as,can,also'
p37420
g9
sS'was,the,ld50'
p37421
g9
sS'including,but,not'
p37422
g9
sS'also,being,given'
p37423
g9
sS'no,information,regarding'
p37424
g3
sS'not,necessitate,an'
p37425
g3
sS'of,a,cyp2d6'
p37426
g9
sS'and,other,substances'
p37427
g9
sS'in,water,from'
p37428
g3
sS'levsin,is,administered'
p37429
g9
sS'l,were,carried'
p37430
g3
sS'levels,utilizing,commercially'
p37431
g3
sS'time,be,monitored'
p37432
g9
sS'and,are,all'
p37433
g9
sS'sixty,minutes,following'
p37434
g9
sS'to,of,total'
p37435
g3
sS'kg,was,investigated'
p37436
g3
sS'show,that,caspofungin'
p37437
g3
sS'after,concurrent,treatment'
p37438
g3
sS'serum,by,a'
p37439
g9
sS'photic,stimulation,study'
p37440
g3
sS'be,substrates,inhibitors'
p37441
g3
sS'withdrawal,the,lst'
p37442
g3
sS'altered,distribution,in'
p37443
g9
sS'of,at,a'
p37444
g3
sS'an,alternative,non-cyp3a4'
p37445
g3
sS'there,was,evidence'
p37446
g3
sS'at,as,v'
p37447
g3
sS'popular,in,the'
p37448
g3
sS'to,approximately,to'
p37449
g9
sS'cell,counts,be'
p37450
g3
sS'cecum,and,its'
p37451
g3
sS'to,plasma,protein'
p37452
g3
sS'anticoagulants,oral,the'
p37453
g3
sS'account,bezalip,and'
p37454
g9
sS'within,two,to'
p37455
g9
sS'into,account,bezalip'
p37456
g9
sS'cyp3a,compounds,that'
p37457
g9
sS'can,also,be'
p37458
g9
sS'cisplatin,hcl,phenytoin'
p37459
g9
sS'in,the,contents'
p37460
g3
sS'prolong,the,clinically'
p37461
g9
sS'be,deficient,in'
p37462
g3
sS'guardian,see,illustrated'
p37463
g3
sS'and,short-acting,has'
p37464
g3
sS'auc,based,on'
p37465
g3
sS'sodium,is,not'
p37466
g3
sS'motility,in,chick'
p37467
g3
sS'be,ascertained,between'
p37468
g3
sS'impaired,liver,function'
p37469
g3
sS'accompanied,by,both'
p37470
g3
sS'for,strains,from'
p37471
g3
sS'buffer,should,be'
p37472
g9
sS'serum,concentration,during'
p37473
g9
sS'administration,of,with'
p37474
g9
sS'oral,increased,auc'
p37475
g9
sS'or,shampoos,for'
p37476
g3
sS'is,either,unchanged'
p37477
g3
sS'of,pharmacokinetic,drug-drug'
p37478
g3
sS'ergotamine,or,acute'
p37479
g3
sS'multiple,dose,administration'
p37480
g3
sS'by,one-half,depending'
p37481
g3
sS'this,represents,an'
p37482
g3
sS'symptoms,may,also'
p37483
g3
sS'agents,derivatives,hormones'
p37484
g3
sS'with,were,performed'
p37485
g3
sS'taxotere,as,there'
p37486
g3
sS'increase,due,to'
p37487
g9
sS'additive,coadministration,of'
p37488
g9
sS'that,when,a'
p37489
g9
sS'any,medicine,without'
p37490
g3
sS'may,effect,the'
p37491
g9
sS'previously,stable,plasma'
p37492
g9
sS'therefore,advisable,to'
p37493
g9
sS'certain,tumor,types'
p37494
g3
sS'anesthetized,with,innovar'
p37495
g9
sS'treatment,with,plenaxis'
p37496
g3
sS'up,to,doses'
p37497
g3
sS'present,in,plasma'
p37498
g3
sS'for,day,in'
p37499
g3
sS'with,the,serum'
p37500
g3
sS'effect,to,but'
p37501
g9
sS'there,is,such'
p37502
g3
sS'liver,transaminases,have'
p37503
g3
sS'meq,or,duloxetine'
p37504
g3
sS'with,nutrition,or'
p37505
g3
sS'are,no,significant'
p37506
g3
sS'hour,infusion,than'
p37507
g3
sS'if,these,patients'
p37508
g3
sS'than,myopathy,and'
p37509
g3
sS'through,redundancy,at'
p37510
g3
sS'serum,and,with'
p37511
g3
sS'by,the,ability'
p37512
g9
sS'of,uricosuric,agents'
p37513
g9
sS'patients,mixed,agonist'
p37514
g3
sS'exaggerate,the,prolongation'
p37515
g9
sS'be,watched,very'
p37516
g9
sS'substrates,of,cyp3a4'
p37517
g3
sS'when,alfenta,is'
p37518
g9
sS'patients,receiving,oral'
p37519
g3
sS'specific,studies,have'
p37520
g3
sS'hepatotoxic,influenza,virus'
p37521
g9
sS'bleeding,or,with'
p37522
g3
sS'once,every,hours'
p37523
g3
sS'attempting,to,replicate'
p37524
g3
sS'the,light,dark'
p37525
g3
sS'the,coadministration,with'
p37526
g9
sS'interaction,would,be'
p37527
g3
sS'were,already,receiving'
p37528
g3
sS'with,tikosyn,and'
p37529
g3
sS'variety,of,toxic'
p37530
g3
sS'on,day,of'
p37531
g9
sS'and,discontinuation,ordinarily'
p37532
g3
sS'risk,for,death'
p37533
g3
sS'already,on,cyp'
p37534
g3
sS'the,muscle,to'
p37535
g9
sS'on,day,on'
p37536
g9
sS'or,treatment,discontinuation'
p37537
g3
sS'and,the,two'
p37538
g3
sS'of,relapse,rehospitalisation'
p37539
g3
sS'is,only,slightly'
p37540
g9
sS'such,as,inderal'
p37541
g3
sS'long-acting,is,completely'
p37542
g3
sS'considering,that,the'
p37543
g3
sS'tentatively,supports,the'
p37544
g3
sS'tricyclic,flupenthixol,increases'
p37545
g9
sS'locomotion,and,behavioral'
p37546
g3
sS'be,used,because'
p37547
g9
sS'trials,were,administered'
p37548
g3
sS'found,to,accompany'
p37549
g3
sS'is,a,relatively'
p37550
g3
sS'of,absorption,mean'
p37551
g9
sS'reports,of,sedation'
p37552
g3
sS'of,novolog,but'
p37553
g3
sS'be,particularly,cautious'
p37554
g3
sS'the,context,of'
p37555
g3
sS'interactions,dofetilide,is'
p37556
g3
sS'but,coadministration,of'
p37557
g3
sS'extravasation,it,is'
p37558
g3
sS'because,a,critical'
p37559
g3
sS'and,decrease,absorption'
p37560
g9
sS'eulexin,capsules,are'
p37561
g9
sS'absorption,excessive,fecal'
p37562
g3
sS'observed,with,dual'
p37563
g3
sS'development,of,the'
p37564
g3
sS'with,conditions,such'
p37565
g3
sS'cases,therefore,more'
p37566
g3
sS'administration,reaching,a'
p37567
g3
sS'conclusions,are,given'
p37568
g3
sS'was,included,in'
p37569
g3
sS'principal,given,number'
p37570
g3
sS'n,hypotension,vs'
p37571
g9
sS'on,potassium,kinetics'
p37572
g9
sS'in,isolated,rabbit'
p37573
g3
sS'products,or,shampoos'
p37574
g3
sS'was,also,chronically'
p37575
g3
sS'clozapine,is,a'
p37576
g3
sS'of,targretin,capsules'
p37577
g9
sS'hormonal,components,ee'
p37578
g9
sS'these,cells,express'
p37579
g3
sS'resulting,in,excessive'
p37580
g9
sS'reactions,from,the'
p37581
g3
sS'increased,mean,maximum'
p37582
g9
sS'dihydropyridine,channel,blockers'
p37583
g9
sS'n-octyl,and,n-cetyl'
p37584
g3
sS'with,orencia,has'
p37585
g9
sS'with,addictive,medications'
p37586
g3
sS'minus,in,ovarian'
p37587
g9
sS'of,and,treatment'
p37588
g3
sS'exercised,when,is'
p37589
g9
sS'a,level,that'
p37590
g3
sS'up,to,nearly'
p37591
g3
sS'clozapine,in,combination'
p37592
g3
sS'not,excluded,from'
p37593
g3
sS'desired,level,to'
p37594
g3
sS'infrequent,reports,of'
p37595
g3
sS'may,use,especially'
p37596
g3
sS'aminoglutethimide,diminishes,the'
p37597
g9
sS'an,adequate,degree'
p37598
g3
sS'serum,clearance,and'
p37599
g9
sS'cpk,some,patients'
p37600
g3
sS'consuming,while,on'
p37601
g9
sS'by,hepatic,oxidation'
p37602
g9
sS'interruption,of,tarceva'
p37603
g3
sS'a,complex,of'
p37604
g3
sS'by,a,day'
p37605
g3
sS'week,until,the'
p37606
g3
sS'to,be,due'
p37607
g3
sS'needed,due,to'
p37608
g3
sS'lowest,possible,dose'
p37609
g9
sS'shifts,in,treatment'
p37610
g3
sS'effects,seen,during'
p37611
g9
sS'action,which,may'
p37612
g3
sS'of,pah,cannot'
p37613
g9
sS'several,interacting,simultaneously'
p37614
g3
sS'and,proquin,xr'
p37615
g3
sS'related,to,dose'
p37616
g3
sS'whereas,b,was'
p37617
g3
sS'orally,administered,could'
p37618
g3
sS'unexpected,hypotension,could'
p37619
g3
sS'c,max,of'
p37620
g9
sS'this,article,review'
p37621
g3
sS'and,many,that'
p37622
g3
sS'interval,of,at'
p37623
g3
sS'agent,has,been'
p37624
g9
sS'c,max,or'
p37625
g3
sS'occurring,in,susceptible'
p37626
g3
sS'corrected,qt,interval'
p37627
g3
sS'sildenafil,is,an'
p37628
g3
sS'reported,that,can'
p37629
g9
sS'since,the,absorption'
p37630
g9
sS'these,doses,is'
p37631
g9
sS'amprenavir,is,an'
p37632
g3
sS'therefore,advised,when'
p37633
g9
sS'heart,failure,there'
p37634
g3
sS'commonly,occurring,interactions'
p37635
g9
sS'we,show,that'
p37636
g3
sS'conditions,or,with'
p37637
g3
sS'rats,with,mg'
p37638
g9
sS'normal,healthy,volunteers'
p37639
g3
sS'as,effective,as'
p37640
g3
sS'and,hydroxy-1,on'
p37641
g9
sS'through,effects,on'
p37642
g9
sS'the,literature,provides'
p37643
g3
sS'increased,by,and'
p37644
g9
sS'elevations,of,ast'
p37645
g3
sS'testicular,atrophy,was'
p37646
g3
sS'not,reveal,an'
p37647
g3
sS'disturbances,of,blood'
p37648
g9
sS'however,cohort,data'
p37649
g3
sS'studied,as,triple'
p37650
g3
sS'of,the,small'
p37651
g9
sS'of,the,sst'
p37652
g3
sS'secretion,p-aminosalicylic,acid'
p37653
g3
sS'where,definitely,indicated'
p37654
g9
sS'by,increasing,the'
p37655
g9
sS'or,at,any'
p37656
g3
sS'and,may,explain'
p37657
g3
sS'low,results,in'
p37658
g3
sS'of,procrit,with'
p37659
g3
sS'or,stop,any'
p37660
g3
sS'many,that,are'
p37661
g3
sS'the,mean,concentrations'
p37662
g3
sS'were,found,to'
p37663
g3
sS'l-phenylalanine,may,potentiate'
p37664
g9
sS'disease,aged,years'
p37665
g3
sS'recovered,from,succinylcholine-induced'
p37666
g9
sS'synthesis,and,may'
p37667
g9
sS'of,angiomax,with'
p37668
g9
sS'be,the,only'
p37669
g9
sS'over,the,course'
p37670
g3
sS'tests,interactions,because'
p37671
g3
sS'taking,other,psychoactive'
p37672
g9
sS'observed,with,regimens'
p37673
g3
sS'receiving,combination,regimens'
p37674
g9
sS'ethinyl,estradiol,should'
p37675
g9
sS'of,itraconazole,and'
p37676
g9
sS'cyp3a4,there,is'
p37677
g3
sS'of,by,and'
p37678
g9
sS'carbamazepine,has,been'
p37679
g3
sS'standard,in,neonates'
p37680
g3
sS'of,that,necessitated'
p37681
g9
sS'cortisol,levels,produced'
p37682
g3
sS'on,the,steady-state'
p37683
g3
sS'reddish,stools,in'
p37684
g3
sS'of,onto,the'
p37685
g9
sS'i,coadministration,of'
p37686
g9
sS'apoptotic,index,or'
p37687
g3
sS'of,the,variability'
p37688
g3
sS'one,class,to'
p37689
g9
sS'no,volunteer,showed'
p37690
g3
sS'with,these,when'
p37691
g3
sS'duration,of,neuromuscular'
p37692
g9
sS'drugs,that,induce'
p37693
g3
sS'response,to,in'
p37694
g9
sS'effect,on,a'
p37695
g3
sS'concentration,was,delayed'
p37696
g3
sS'they,should,be'
p37697
g3
sS'is,administered,or'
p37698
g9
sS'of,breast,cancer'
p37699
g9
sS'conclusions,it,is'
p37700
g3
sS'the,first,day'
p37701
g3
sS'digoxin,sonata,mg'
p37702
g3
sS'coadministration,of,mg'
p37703
g9
sS'system,at,a'
p37704
g9
sS'elevations,with,evidence'
p37705
g3
sS'given,with,other'
p37706
g9
sS'potency,of,was'
p37707
g3
sS'care,and,observation'
p37708
g3
sS'in,an,adolescent'
p37709
g3
sS'inhibiting,effects,of'
p37710
g3
sS'use,of,other'
p37711
g3
sS'included,into,a'
p37712
g3
sS'sulfate,sodium,polystyrene'
p37713
g9
sS'from,patients,treated'
p37714
g3
sS'on,hepatotoxicity,are'
p37715
g9
sS'next,chapter,presents'
p37716
g3
sS'by,cercariae,exposed'
p37717
g3
sS'week,intraperitoneal,injections'
p37718
g3
sS'susceptible,patients,or'
p37719
g3
sS'including,may,enhance'
p37720
g9
sS'administration,of,exjade'
p37721
g3
sS'severe,or,prolonged'
p37722
g3
sS'potentiate,the,action'
p37723
g9
sS'l-arginine,may,counteract'
p37724
g9
sS'known,to,adversely'
p37725
g3
sS'intravenous,placebo,oral'
p37726
g3
sS'induces,or,inhibits'
p37727
g3
sS'of,the,day'
p37728
g9
sS'metabolic,clearance,that'
p37729
g9
sS'increase,in,adverse'
p37730
g3
sS'pharmacological,treatment,of'
p37731
g3
sS'biochemical,toxicology,of'
p37732
g3
sS'day,relative,to'
p37733
g9
sS'sinus,bradycardia,has'
p37734
g3
sS'regularly,during,simultaneous'
p37735
g3
sS'are,required,for'
p37736
g3
sS'however,in,a'
p37737
g3
sS'initiate,therapy,with'
p37738
g9
sS'hydrocarbon,general,such'
p37739
g9
sS'a4,substrate,and'
p37740
g3
sS'tests,are,performed'
p37741
g3
sS'the,in,situ'
p37742
g3
sS'in,an,approximately'
p37743
g9
sS'on,cyp,a4'
p37744
g3
sS'be,taken,when'
p37745
g3
sS'oral,dose,for'
p37746
g3
sS'had,a,new'
p37747
g3
sS'decreasing,gut,motility'
p37748
g9
sS'interference,with,propranolols'
p37749
g9
sS'kg,day,approximately'
p37750
g3
sS'other,medications,may'
p37751
g3
sS'concomitant,use,with'
p37752
g3
sS'the,salt,intake'
p37753
g9
sS'increase,daily,dose'
p37754
g3
sS'enzymatic,glucose,oxidase'
p37755
g3
sS'of,possible,clinical'
p37756
g3
sS'daypro,and,anaprox'
p37757
g3
sS'potentially,toxic,to'
p37758
g3
sS'with,and,antagonists'
p37759
g9
sS'plate,counts,and'
p37760
g3
sS'cyp3a4-eplerenone,metabolism,is'
p37761
g3
sS'and,bretylium,tosylate'
p37762
g3
sS'in,healthy,normal'
p37763
g3
sS'transdermal,may,also'
p37764
g9
sS'blood,pressure,may'
p37765
g9
sS'in,clinical,pharmacokinetic'
p37766
g3
sS'regimens,who,were'
p37767
g9
sS'may,be,required'
p37768
g3
sS'to,blunt,the'
p37769
g9
sS'extent,of,binding'
p37770
g3
sS'development,of,withdrawal'
p37771
g3
sS'by,several,medicinal'
p37772
g9
sS'of,aggression,and'
p37773
g3
sS'administration,of,alone'
p37774
g9
sS'sensitize,resistant,strains'
p37775
g3
sS'including,medications,such'
p37776
g9
sS'before,resulted,in'
p37777
g9
sS'with,potent,cyp3a4'
p37778
g9
sS'the,coat-a,count'
p37779
g3
sS'iv,im,reduced'
p37780
g9
sS'substrate,is,an'
p37781
g3
sS'hyperlipidemia,or,elevated'
p37782
g9
sS'mg,daily,resulted'
p37783
g9
sS'with,may,have'
p37784
g3
sS'be,patient,specific'
p37785
g3
sS'reported,with,are'
p37786
g3
sS'women,of,childbearing'
p37787
g3
sS'other,psychotropic,medications'
p37788
g9
sS'disadvantages,of,pocs'
p37789
g3
sS'tambocor,to,healthy'
p37790
g9
sS'or,duloxetine,with'
p37791
g3
sS'known,if,the'
p37792
g9
sS'specific,interaction,was'
p37793
g3
sS'the,cns,and'
p37794
g3
sS'unknown,amevive,should'
p37795
g3
sS'recommended,because,is'
p37796
g9
sS'increased,responsiveness,to'
p37797
g3
sS'not,these,in'
p37798
g3
sS'to,the,need'
p37799
g3
sS'of,and,occurred'
p37800
g9
sS'with,highly,protein'
p37801
g3
sS'of,skin,reactions'
p37802
g3
sS'general,utilizing,a'
p37803
g3
sS'that,nonabsorbable,given'
p37804
g9
sS'injections,of,amevive'
p37805
g3
sS'cyp2c9,substrate,and'
p37806
g9
sS'receiving,bolus-ifl,alone'
p37807
g3
sS'human,in,patients'
p37808
g9
sS'recipients,suggest,that'
p37809
g3
sS'concentrations,of,have'
p37810
g9
sS'direct,causal,relationship'
p37811
g9
sS'microsomes,showed,that'
p37812
g3
sS'titrated,with,caution'
p37813
g9
sS'large,reduction,in'
p37814
g9
sS'caution,in,those'
p37815
g9
sS'in,free,fraction'
p37816
g9
sS'compared,to,reported'
p37817
g9
sS'elderly,and,implications'
p37818
g3
sS'differences,are,being'
p37819
g3
sS'wax,matrix,may'
p37820
g9
sS'in,livers,of'
p37821
g3
sS'effects,of,by'
p37822
g9
sS'commonly,used,general'
p37823
g3
sS'difference,p,in'
p37824
g3
sS'hydroxymethylglutaryl,coenzyme,a'
p37825
g9
sS'patients,receiving,combination'
p37826
g9
sS'on,hepatic,transaminases'
p37827
g3
sS'iga,is,probably'
p37828
g3
sS'mg,orally,min'
p37829
g3
sS'effectiveness,of,pegasys'
p37830
g3
sS'seen,are,poorly'
p37831
g3
sS'in,an,analysis'
p37832
g9
sS'used,if,therapy'
p37833
g9
sS'to,changes,in'
p37834
g3
sS'in,a,multiple'
p37835
g9
sS'years,who,were'
p37836
g9
sS'therapy,with,another'
p37837
g9
sS'the,plasma,pharmacokinetics'
p37838
g3
sS'cause,qt,prolongation'
p37839
g3
sS'and,coreg,slow'
p37840
g9
sS'cns,depressants,including'
p37841
g9
sS'salicylic,acid,indicating'
p37842
g3
sS'by,and,mean'
p37843
g9
sS'were,noted,in'
p37844
g3
sS'cynomolgus,monkeys,given'
p37845
g3
sS'pharmacodynamics,of,acetylsalicylic'
p37846
g3
sS'thedosage,of,may'
p37847
g3
sS'male,rats,treated'
p37848
g3
sS'of,age,or'
p37849
g3
sS'in,supporting,blood'
p37850
g3
sS'oral,contraceptives,coadministration'
p37851
g9
sS'of,locomotor,activities'
p37852
g3
sS'death,due,to'
p37853
g9
sS'possibility,of,a'
p37854
g3
sS'with,oh,d3'
p37855
g9
sS'a,proposed,mechanism'
p37856
g3
sS'as,thiazide,and'
p37857
g9
sS'g,hr,should'
p37858
g3
sS'prothrombin,time,with'
p37859
g9
sS'the,effects,if'
p37860
g3
sS'b-blocking,properties,may'
p37861
g9
sS'is,suggested,that'
p37862
g9
sS'supplementation,and,depletion'
p37863
g3
sS'mg,as,mg'
p37864
g3
sS'initial,positive,tests'
p37865
g3
sS'alone,significantly,lowered'
p37866
g3
sS'in,high,doses'
p37867
g9
sS'the,glands,with'
p37868
g3
sS'the,cyp2c9,isoenzyme'
p37869
g9
sS'received,a,single'
p37870
g3
sS'times,as,well'
p37871
g3
sS'anti-inflammatory,have,been'
p37872
g9
sS'conservatively,adjusted,in'
p37873
g9
sS'distribution,have,been'
p37874
g3
sS'on,the,dosage'
p37875
g3
sS'and,occurred,within'
p37876
g3
sS'demonstrated,any,significant'
p37877
g3
sS'impact,of,chemotherapy'
p37878
g3
sS'phenobarbital,estimates,of'
p37879
g3
sS'activity,based,on'
p37880
g3
sS'agents,and,increases'
p37881
g9
sS'chemotherapy,in,the'
p37882
g3
sS'reductase,inhibitors,interfere'
p37883
g3
sS'alcohol,has,a'
p37884
g9
sS'measured,during,both'
p37885
g3
sS'dosage,must,be'
p37886
g9
sS'to,the,locomotor'
p37887
g3
sS'pharmacological,therapy,mainly'
p37888
g3
sS'generation,of,vasodilator'
p37889
g3
sS'factor,in,the'
p37890
g3
sS'but,not,these'
p37891
g3
sS'and,secondary,deficiencies'
p37892
g3
sS'neuronal,uptake,of'
p37893
g3
sS'may,still,kill'
p37894
g9
sS'solution,can,form'
p37895
g9
sS'exogenous,respiration,was'
p37896
g3
sS'similarly,of,over'
p37897
g3
sS'of,increased,effects'
p37898
g9
sS'the,occurrence,of'
p37899
g3
sS'chromaffin,cell,could'
p37900
g3
sS'or,over,to'
p37901
g3
sS'studies,of,with'
p37902
g3
sS'total,formation,in'
p37903
g9
sS'each,volunteer,was'
p37904
g3
sS'dosage,on,one'
p37905
g3
sS'and,auc,hrs'
p37906
g3
sS'is,critical,for'
p37907
g3
sS'socioeconomic,factors,involved'
p37908
g3
sS'epa,supplements,might'
p37909
g3
sS'penicillin-type,are,administered'
p37910
g9
sS'been,described,in'
p37911
g3
sS'acquired,behavioral,response'
p37912
g3
sS'reduction,of,uptake'
p37913
g3
sS'actions,that,do'
p37914
g3
sS'morning,and,lunch'
p37915
g3
sS'for,include,increased'
p37916
g9
sS'in,hypothyroid,patients'
p37917
g3
sS'and,aortic,rings'
p37918
g3
sS'elements,had,already'
p37919
g3
sS'their,concurrent,use'
p37920
g3
sS'and,it,increased'
p37921
g3
sS'exercised,if,an'
p37922
g9
sS'used,cautiously,with'
p37923
g9
sS'simultaneously,or,mg'
p37924
g3
sS'problem,has,been'
p37925
g3
sS'patients,with,left'
p37926
g3
sS'a,high,degree'
p37927
g3
sS'shown,to,interact'
p37928
g9
sS'i-labelled,antigen,were'
p37929
g3
sS'highlights,novel,targets'
p37930
g3
sS'trisphosphate,insp,induced'
p37931
g3
sS'cell,cultures,stimulated'
p37932
g3
sS'reported,pretreatment,and'
p37933
g3
sS'synthesis,and,release'
p37934
g3
sS'blot,analysis,of'
p37935
g3
sS'ratio,and,potential'
p37936
g3
sS'johns,wort,theo-dur'
p37937
g9
sS'class,resulting,in'
p37938
g9
sS'lead,to,reduced'
p37939
g3
sS'breast,enlargement,and'
p37940
g3
sS'of,other,highly'
p37941
g3
sS'the,possibility,that'
p37942
g9
sS'first,cervical,vertebra'
p37943
g3
sS'such,as,motrin'
p37944
g3
sS'study,rats,given'
p37945
g9
sS'assays,resulting,in'
p37946
g3
sS'detrimental,effects,in'
p37947
g3
sS'its,efficacy,safety'
p37948
g3
sS'of,at,mg'
p37949
g9
sS'modest,inhibition,of'
p37950
g3
sS'and,efficacy,is'
p37951
g9
sS'affect,abilify,aripiprazole'
p37952
g3
sS'with,concurrent,enbrel'
p37953
g9
sS'failure,who,are'
p37954
g3
sS'overdose,with,a'
p37955
g9
sS'platelet,count,prothrombin'
p37956
g3
sS'dha,was,more'
p37957
g3
sS'deriving,experimental,designs'
p37958
g3
sS'patients,receiving,blocking'
p37959
g3
sS'mg,decreased,the'
p37960
g9
sS'not,beadministered,concomitantly'
p37961
g9
sS'day,and,fold'
p37962
g9
sS'of,is,virtually'
p37963
g3
sS'with,desirable,antimuscarinic'
p37964
g3
sS'formal,drug-interaction,studies'
p37965
g3
sS'conflicting,results,have'
p37966
g3
sS'metabolize,to,active'
p37967
g3
sS'psychotic,disorders,treated'
p37968
g9
sS'in,safety,or'
p37969
g3
sS'of,offers,advantages'
p37970
g3
sS't,max,were'
p37971
g3
sS'antiplatelet,agents,or'
p37972
g9
sS'because,they,are'
p37973
g3
sS'arrhythmias,qt,prolongation'
p37974
g3
sS'derivatives,and,has'
p37975
g9
sS'acid,calcium,channel-blocking'
p37976
g3
sS'inhibitor,is,withdrawn'
p37977
g3
sS'or,without,endothelium'
p37978
g3
sS'the,polyene,many'
p37979
g3
sS'volunteers,mg,times'
p37980
g3
sS'reduction,in,female'
p37981
g3
sS'in,transfusion,cross-matching'
p37982
g3
sS'serum,i,binding'
p37983
g3
sS'controlled,trials,in'
p37984
g3
sS'increased,exposure,and'
p37985
g9
sS'when,measured,by'
p37986
g3
sS'and,frequent,monitoring'
p37987
g3
sS'was,also,reduced'
p37988
g3
sS'drugs,that,reduce'
p37989
g9
sS'bosentan,has,no'
p37990
g3
sS'to,the,initial'
p37991
g3
sS'when,you,are'
p37992
g9
sS'concomitantly,with,reduce'
p37993
g9
sS'or,to,hours'
p37994
g3
sS'with,cytochalasin,d'
p37995
g3
sS'which,adds,to'
p37996
g3
sS'was,necessary,for'
p37997
g9
sS'like,other,may'
p37998
g9
sS'naproxen,had,no'
p37999
g3
sS'theophylline,theophylline,clearance'
p38000
g3
sS'in,hyperthyroidism,or'
p38001
g3
sS'not,substantially,increased'
p38002
g9
sS'or,at,as'
p38003
g3
sS'action,of,ptx'
p38004
g3
sS'remainder,no,adjustment'
p38005
g3
sS'equetrotm,are,the'
p38006
g9
sS'nevertheless,the,prothrombin'
p38007
g9
sS'that,clearance,is'
p38008
g9
sS'the,following,other'
p38009
g3
sS'the,behavioral,effects'
p38010
g3
sS'out,and,was'
p38011
g3
sS'may,require,lower'
p38012
g3
sS'studies,with,fortovase'
p38013
g3
sS'levels,were,within'
p38014
g3
sS'by,hepatic,cytochrome'
p38015
g3
sS'histidine,residues,on'
p38016
g3
sS'identify,characteristics,related'
p38017
g3
sS'reducing,hunger,and'
p38018
g3
sS'combination,with,any'
p38019
g3
sS'controlled,crossover,clinical'
p38020
g3
sS'oral,cough,and'
p38021
g3
sS'no,significant,changes'
p38022
g3
sS'or,for,a'
p38023
g3
sS'the,following,have'
p38024
g3
sS'either,or,is'
p38025
g9
sS'nimbex,is,approximately'
p38026
g9
sS'proteins,and,is'
p38027
g3
sS'other,potentially,clinically'
p38028
g3
sS'lansoprazole,has,also'
p38029
g3
sS'may,precipitate,seizures'
p38030
g9
sS'bound,like,and'
p38031
g3
sS'be,done,at'
p38032
g3
sS'products,st,john'
p38033
g3
sS'occur,when,are'
p38034
g9
sS'no,interactive,effect'
p38035
g3
sS'may,be,needed'
p38036
g9
sS'myopathy,during,treatment'
p38037
g3
sS'further,the,duration'
p38038
g9
sS'biological,indicators,differs'
p38039
g3
sS'vioxx,and,are'
p38040
g9
sS'fold,increase,was'
p38041
g3
sS'preventing,erythro-fluorocitrate,synthesis'
p38042
g3
sS'animal,and,human'
p38043
g3
sS'buforin,ii,may'
p38044
g9
sS'subjects,with,epilepsy'
p38045
g3
sS'reductase,inhibitors,on'
p38046
g3
sS'to,is,catalyzed'
p38047
g3
sS'in,by,decreasing'
p38048
g9
sS'agents,in,addition'
p38049
g3
sS'not,with,enzyme'
p38050
g3
sS'we,previously,reported'
p38051
g3
sS'with,any,one'
p38052
g3
sS'placebo,as,indicated'
p38053
g3
sS'being,developed,as'
p38054
g3
sS'clearance,ranged,from'
p38055
g3
sS'scales,vital,signs'
p38056
g3
sS'potent,t,cell'
p38057
g3
sS'in,three,well-controlled'
p38058
g3
sS'and,ulcerative,colitis'
p38059
g9
sS'study,at,doses'
p38060
g3
sS'ml,and,minimal'
p38061
g3
sS'patients,with,a'
p38062
g3
sS'concentrations,greater,than'
p38063
g3
sS'as,potent,of'
p38064
g3
sS'wasting,facial,wasting'
p38065
g3
sS'others,are,also'
p38066
g9
sS'obesity,as,well'
p38067
g3
sS'serum,concentration,curve'
p38068
g9
sS'potassium-depleting,are,a'
p38069
g9
sS'shown,that,the'
p38070
g9
sS'may,represent,the'
p38071
g3
sS'mg,kg,results'
p38072
g3
sS'glucose,levels,usually'
p38073
g3
sS'the,reddish,color'
p38074
g9
sS'the,hour,infusion'
p38075
g3
sS'indinavir,coadministration,of'
p38076
g9
sS'different,times,and'
p38077
g3
sS'in,the,relation'
p38078
g3
sS'discontinue,pegasys,and'
p38079
g3
sS'coadministered,with,monurol'
p38080
g9
sS'trials,with,simulect'
p38081
g3
sS'progestin-only,oral,poc'
p38082
g3
sS'more,effective,than'
p38083
g3
sS'spermine,mm,promoted'
p38084
g3
sS'they,are,part'
p38085
g3
sS'longer,intervals,between'
p38086
g9
sS'including,may,lead'
p38087
g3
sS'secretion,are,contraindicated'
p38088
g3
sS'require,increases,in'
p38089
g9
sS'have,been,reports'
p38090
g9
sS'calcium,supplements,uncontrolled'
p38091
g3
sS'reassessed,periodically,in'
p38092
g3
sS'coronary,artery,disease'
p38093
g3
sS'the,user,such'
p38094
g3
sS'to,suppress,bone'
p38095
g3
sS'oxidation,which,is'
p38096
g3
sS'to,hydrochloride,including'
p38097
g3
sS'an,emergency,situation'
p38098
g9
sS'unmodified,nacmc,m'
p38099
g3
sS'in,the,stomach'
p38100
g9
sS'prior,to,initiating'
p38101
g9
sS'rare,reports,of'
p38102
g9
sS'after,receiving,the'
p38103
g9
sS'aeruginosa,as,common'
p38104
g3
sS'therefore,patients,without'
p38105
g9
sS'release,of,from'
p38106
g3
sS'psoriatic,arthritis,clinical'
p38107
g3
sS'tikosyn,and,therapy'
p38108
g9
sS'efficacy,of,amevive'
p38109
g3
sS'is,a,reversible'
p38110
g3
sS'the,macrolide,class'
p38111
g9
sS'of,infections,and'
p38112
g3
sS'of,steps,physicians'
p38113
g3
sS'already,stabilized,on'
p38114
g9
sS'transferase,enzyme,activity'
p38115
g3
sS'equivalent,to,mg'
p38116
g9
sS'solution,or,fehling'
p38117
g3
sS'trexan,with,long-term'
p38118
g3
sS'used,concomitantly,patients'
p38119
g9
sS'odontoid,and,ventral'
p38120
g3
sS'breakthrough,bleeding,and'
p38121
g3
sS'inhibitors,as,systemic'
p38122
g3
sS'alter,the,pharmacological'
p38123
g3
sS'the,elderly,population'
p38124
g3
sS'either,or,bind'
p38125
g9
sS'include,vaiproic,acid'
p38126
g9
sS'by,to,g'
p38127
g3
sS'or,other,coumarin-like'
p38128
g9
sS'administering,this,to'
p38129
g3
sS'closely,watched,during'
p38130
g3
sS'inhibitors,have,resulted'
p38131
g9
sS'against,gram-negative,and'
p38132
g3
sS'therapy,including,more'
p38133
g3
sS'subutex,and,suboxone'
p38134
g9
sS'if,used,in'
p38135
g3
sS'neuromuscular,blockade,will'
p38136
g3
sS'when,used,with'
p38137
g3
sS'another,tnf,blocking'
p38138
g9
sS'beyond,days,are'
p38139
g3
sS'including,derivatives,indandione'
p38140
g9
sS'the,or,mg'
p38141
g3
sS'of,action,are'
p38142
g3
sS'less,than,pediatrics'
p38143
g9
sS'pqq-based,methods,should'
p38144
g3
sS'as,an,antipsychotic'
p38145
g9
sS'due,to,exposure'
p38146
g3
sS'to,administration,on'
p38147
g3
sS'pump,inhibitors,was'
p38148
g9
sS'dose,of,had'
p38149
g3
sS'and,classes,or'
p38150
g9
sS'safety,studies,was'
p38151
g3
sS'other,drugs,that'
p38152
g9
sS'with,antiplatelet,agents'
p38153
g9
sS'three,patients,met'
p38154
g3
sS'noradrenaline,storage,vesicles'
p38155
g3
sS'administering,cyp3a4,inhibitors'
p38156
g3
sS'and,decreased,respectively'
p38157
g9
sS'polystyrene,sulfonate,soybean'
p38158
g9
sS'inhibitors,such,as'
p38159
g9
sS'demonstrated,effectiveness,in'
p38160
g3
sS'initiation,of,argatroban'
p38161
g3
sS'on,the,protein'
p38162
g3
sS'aptt,to,decrease'
p38163
g3
sS'by,one,or'
p38164
g3
sS'hyperthyroidism,or,when'
p38165
g3
sS'that,concomitant,use'
p38166
g9
sS'shown,that,can'
p38167
g9
sS'an,excessive,increase'
p38168
g3
sS'mm,declining,to'
p38169
g3
sS'of,the,effect'
p38170
g3
sS'particularly,important,that'
p38171
g3
sS'the,groups,fed'
p38172
g3
sS'recommended,and,adjustment'
p38173
g9
sS'abciximab,have,not'
p38174
g3
sS'certain,tricyclic,thereby'
p38175
g9
sS'therefore,the,assay'
p38176
g3
sS'mercapturic,acids,or'
p38177
g3
sS'of,oral,in'
p38178
g3
sS'later,all,animals'
p38179
g3
sS'changes,has,not'
p38180
g3
sS'rats,that,prolonged'
p38181
g3
sS'however,there,has'
p38182
g9
sS'arrest,during,initial'
p38183
g3
sS'administration,of,oral'
p38184
g9
sS'therapeutic,window,such'
p38185
g9
sS'ginsenosides-induced,inhibition,of'
p38186
g3
sS'that,inhibits,the'
p38187
g9
sS'prolonged,from,to'
p38188
g3
sS'excreted,by,the'
p38189
g3
sS'of,meclofenamate,sodium'
p38190
g3
sS'studies,when,was'
p38191
g3
sS'respect,to,their'
p38192
g3
sS'side-effect,profiles,and'
p38193
g3
sS'sufficient,to,predict'
p38194
g3
sS'test,interaction,fosinopril'
p38195
g3
sS'serious,symptoms,severe'
p38196
g9
sS'course,of,patients'
p38197
g3
sS'discontinue,after,concurrent'
p38198
g9
sS'used,in,therapeutic'
p38199
g9
sS'apparent,decrease,in'
p38200
g3
sS'was,given,to'
p38201
g3
sS'administered,concomitantly,showed'
p38202
g3
sS'respectto,safety,and'
p38203
g3
sS'and,cerebyx,were'
p38204
g3
sS'muscle,relaxants,amphotericin'
p38205
g9
sS'for,and,its'
p38206
g3
sS'all,strains,of'
p38207
g3
sS'antagonise,the,effect'
p38208
g3
sS'disintegrin,and,monomeric'
p38209
g3
sS'reddish,color,is'
p38210
g9
sS'of,severe,hypersensitivity'
p38211
g9
sS'vessels,was,studied'
p38212
g3
sS'medications,should,be'
p38213
g3
sS'usual,dosage,may'
p38214
g3
sS'niacin,antihypertensive,therapy'
p38215
g9
sS'well,tolerated,but'
p38216
g9
sS'dopamine,d2,antagonists'
p38217
g9
sS'practices,for,such'
p38218
g3
sS'extended,sodium,capsules'
p38219
g3
sS'tambocor,and,concurrently'
p38220
g9
sS'aviano,cancer,center'
p38221
g3
sS'the,mucosal,and'
p38222
g3
sS'of,nalfon,may'
p38223
g9
sS'by,minimally,elevated'
p38224
g3
sS'investigator,found,no'
p38225
g3
sS'pi,over,weeks'
p38226
g3
sS'occur,when,cime-tidine'
p38227
g9
sS'vitro,excystment,rates'
p38228
g3
sS'interaction,as,a'
p38229
g3
sS'antagonism,exists,between'
p38230
g9
sS'nsaids,affect,platelet'
p38231
g9
sS'patients,receiving,thiazide'
p38232
g3
sS'serum,transaminase,levels'
p38233
g3
sS'studied,in,rheumatoid'
p38234
g3
sS'atypical,antipsychotic,with'
p38235
g3
sS'is,impaired,by'
p38236
g9
sS'doses,of,hcl'
p38237
g9
sS'that,inhibit,cyp3a'
p38238
g3
sS'and,heparin,the'
p38239
g9
sS'vre,is,a'
p38240
g3
sS'metabolism,studies,and'
p38241
g3
sS'adrenergic,from,working'
p38242
g3
sS'of,and,hypoglycemic'
p38243
g9
sS'of,both,the'
p38244
g9
sS'observed,when,or'
p38245
g3
sS'mechanisms,of,status'
p38246
g3
sS'x,ed95,nimbex'
p38247
g9
sS'iron,concomitant,administration'
p38248
g9
sS'that,iga,is'
p38249
g3
sS'in,dose,and'
p38250
g9
sS'renal,clearance,measurements'
p38251
g9
sS'with,vardenafil,mg'
p38252
g9
sS'compounds,are,inhibitors'
p38253
g9
sS'with,reduced,serum'
p38254
g9
sS'to,avoid,while'
p38255
g9
sS'the,interaction,on'
p38256
g3
sS'concentration,of,predisposing'
p38257
g3
sS'randomized,to,one'
p38258
g3
sS'the,interaction,of'
p38259
g3
sS'these,isozymes,may'
p38260
g3
sS'action,by,competing'
p38261
g9
sS'effect,its,abrupt'
p38262
g9
sS'ca,channel,blockers'
p38263
g3
sS'you,may,use'
p38264
g3
sS'to,initiating,combination'
p38265
g9
sS'aed,concentration,mean'
p38266
g3
sS'mg,dl,dose'
p38267
g9
sS'increases,in,auc'
p38268
g3
sS'prolongation,of,its'
p38269
g3
sS'digoxin,studies,in'
p38270
g3
sS'high,as,mug'
p38271
g3
sS'this,is,administered'
p38272
g3
sS'dose,in,a'
p38273
g9
sS'determined,by,using'
p38274
g3
sS'several,clinically,important'
p38275
g3
sS'anhydrase,inhibitors,rare'
p38276
g9
sS'when,was,given'
p38277
g3
sS'a,reduced,clearance'
p38278
g9
sS'from,studies,to'
p38279
g3
sS'coagulant,activity,ix'
p38280
g3
sS'females,dosed,at'
p38281
g3
sS'inhibits,the,metabolism'
p38282
g9
sS'days,after,a'
p38283
g3
sS'digoxin,digoxin,concentrations'
p38284
g9
sS'receiving,beta-adrenergic,blocking'
p38285
g9
sS'disorder,abdominal,pain'
p38286
g3
sS'depletion,may,occasionally'
p38287
g9
sS'when,a,is'
p38288
g9
sS'the,ssris,and'
p38289
g9
sS'in,either,pharmacokinetics'
p38290
g3
sS'its,adverse,effects'
p38291
g3
sS'of,selective,serotonin'
p38292
g9
sS'neither,nor,retinyl'
p38293
g9
sS'awareness,of,the'
p38294
g9
sS'about,in,healthy'
p38295
g9
sS'not,studied,but'
p38296
g3
sS'of,on,absorption'
p38297
g3
sS'similarly,patients,receiving'
p38298
g3
sS'twitch,strength,from'
p38299
g3
sS'table,table,summary'
p38300
g3
sS'either,added,or'
p38301
g9
sS'pre-sacral,vertebrae,at'
p38302
g3
sS'lowering,the,rate'
p38303
g9
sS'certain,neurologic,disorders'
p38304
g3
sS'affinity,substrates,for'
p38305
g3
sS'which,inhibits,the'
p38306
g9
sS'the,need,to'
p38307
g3
sS'in,dosing,and'
p38308
g3
sS'related,to,cytochrome'
p38309
g9
sS'oral,or,intravenous'
p38310
g9
sS'vasodilation,induced,with'
p38311
g9
sS'clinical,study,did'
p38312
g9
sS'the,test,results'
p38313
g9
sS'and,where,appropriate'
p38314
g3
sS'no,studies,have'
p38315
g3
sS'does,not,markedly'
p38316
g3
sS'morphology,pyknotic,nuclei'
p38317
g3
sS'of,the,displacing'
p38318
g3
sS'on,antinociceptive,effect'
p38319
g3
sS'spite,of,adverse'
p38320
g3
sS'crohn,s,disease'
p38321
g3
sS'the,general,conditions'
p38322
g3
sS'only,be,performed'
p38323
g9
sS'relevant,pharmacokinetic,interactions'
p38324
g3
sS'time,to,peak'
p38325
g3
sS'righting,reflex,and'
p38326
g3
sS'tests,have,not'
p38327
g3
sS'time,after,or'
p38328
g9
sS'potassium,prinivil,attenuates'
p38329
g9
sS'doses,will,be'
p38330
g3
sS'receive,an,intravenous'
p38331
g3
sS'and,their,dose'
p38332
g9
sS'after,administration,may'
p38333
g9
sS'of,sodium,given'
p38334
g3
sS'to,the,world'
p38335
g3
sS'showed,a,fold'
p38336
g9
sS'mao,inhibitors,maoi'
p38337
g9
sS'the,biochemical,toxicology'
p38338
g3
sS'lipitor,atromid-s,neoral'
p38339
g9
sS'blockade,of,diverse'
p38340
g3
sS'studies,strongly,support'
p38341
g3
sS'core,temperature,returned'
p38342
g3
sS'effects,of,sublingual'
p38343
g9
sS'urinary,assays,of'
p38344
g3
sS'eg,and,should'
p38345
g9
sS'in,some,cases'
p38346
g3
sS'of,immunization,cannot'
p38347
g9
sS'older,men,who'
p38348
g3
sS'which,affect,hepatic'
p38349
g3
sS'and,azole,antifungals'
p38350
g3
sS'in,the,week'
p38351
g9
sS'taking,prothrombin,time'
p38352
g9
sS'aminoglycosides,drugs,such'
p38353
g9
sS'cefotan,may,result'
p38354
g3
sS'data,regarding,the'
p38355
g3
sS'cooling,the,nerves'
p38356
g3
sS'of,these,birth'
p38357
g3
sS'little,is,known'
p38358
g3
sS'exemestane,is,extensively'
p38359
g3
sS'and,antacids,and'
p38360
g9
sS'approximately,in,patients'
p38361
g3
sS'observed,with,concomitant'
p38362
g9
sS'on,and,especially'
p38363
g9
sS'myocardial,infarction,or'
p38364
g3
sS'studies,of,candesartan'
p38365
g3
sS'a,similar,to'
p38366
g9
sS'relaxants,nondepolarizing,possible'
p38367
g3
sS'from,time,zero'
p38368
g3
sS'data,in,human'
p38369
g3
sS'novolog,and,crystalline'
p38370
g3
sS'health,objectives,to'
p38371
g3
sS'a,small,volume'
p38372
g3
sS'decrease,and,delay'
p38373
g3
sS'heart,block,were'
p38374
g3
sS'day,after,weeks'
p38375
g3
sS'over,indinavir-based,regimens'
p38376
g3
sS'and,cholestytamine,and'
p38377
g9
sS'preparations,may,increase'
p38378
g9
sS'blood,pressure,by'
p38379
g9
sS'thus,should,be'
p38380
g9
sS'concomitant,intake,of'
p38381
g3
sS'levels,and,drug'
p38382
g3
sS'the,plasma-level,of'
p38383
g9
sS'should,only,be'
p38384
g9
sS'colonic,fluid,contents'
p38385
g3
sS'decreases,of,to'
p38386
g3
sS'should,not,be'
p38387
g9
sS'some,cases,presented'
p38388
g3
sS'of,its,normal'
p38389
g9
sS'additive,effect,on'
p38390
g9
sS'norpace,or,norpace'
p38391
g9
sS'heparin,no,human'
p38392
g3
sS'that,inhibits,c9'
p38393
g3
sS'result,in,prolongation'
p38394
g9
sS'the,particular,mao'
p38395
g3
sS'mg,daily,should'
p38396
g3
sS'blockers,may,weaken'
p38397
g3
sS'male,volunteers,for'
p38398
g3
sS'steady,partner,causes'
p38399
g3
sS'of,distribution,and'
p38400
g3
sS'of,sonata,reflecting'
p38401
g3
sS'before,day,with'
p38402
g3
sS'ewes,given,mg'
p38403
g9
sS'or,with,had'
p38404
g3
sS'food,see,clinical'
p38405
g3
sS'place,of,the'
p38406
g3
sS'potent,than,nanm'
p38407
g3
sS'd6,hydroxylase,is'
p38408
g3
sS'last,day,of'
p38409
g3
sS'in,the,offspring'
p38410
g3
sS'it,is,important'
p38411
g3
sS'caution,is,advised'
p38412
g3
sS'v,patients,should'
p38413
g3
sS'abased,on,reports'
p38414
g9
sS'reported,rarely,to'
p38415
g9
sS'this,study,demonstrates'
p38416
g9
sS'episodes,permit,reductions'
p38417
g3
sS'the,paraaminohippurate,method'
p38418
g3
sS'different,from,results'
p38419
g3
sS'during,the,first'
p38420
g3
sS'respiration,becomes,sensitive'
p38421
g3
sS'involving,levo-dromoran,reported'
p38422
g3
sS'although,concomitant,use'
p38423
g9
sS'the,is,given'
p38424
g9
sS'antacids,and,antacids'
p38425
g9
sS'may,induce,toxicity'
p38426
g3
sS'strains,from,normal'
p38427
g3
sS'closely,if,a'
p38428
g9
sS'conditions,similar,to'
p38429
g9
sS'live-attenuated,should,not'
p38430
g9
sS'use,of,oral'
p38431
g9
sS'these,patients,have'
p38432
g3
sS'with,the,clinical'
p38433
g3
sS'of,cyp450,enzyme'
p38434
g3
sS'endothelial,dysfunction,as'
p38435
g3
sS'both,in,enhancing'
p38436
g3
sS'one-hundredth,of,the'
p38437
g3
sS'compounds,tested,in'
p38438
g3
sS'reduced,ligand,binding'
p38439
g3
sS'effect,on,histamine-'
p38440
g9
sS'to,designing,experiments'
p38441
g3
sS'with,n,or'
p38442
g3
sS'in,two,clinical'
p38443
g9
sS'was,not,observed'
p38444
g3
sS'neurontin,capsule,n'
p38445
g9
sS'current,therapies,are'
p38446
g3
sS'oral,concomitant,administration'
p38447
g9
sS'antagonized,in,a'
p38448
g9
sS'condition,may,be'
p38449
g3
sS'has,had,less'
p38450
g9
sS'enhanced,by,bezalip'
p38451
g9
sS'inhibitors,in,combination'
p38452
g9
sS'a,channel,blocker'
p38453
g3
sS'not,only,re-results'
p38454
g3
sS'dose,of,pegasys'
p38455
g3
sS'individuals,with,a'
p38456
g3
sS'diagnostic,interference,with'
p38457
g3
sS'other,that,interfere'
p38458
g3
sS'interfere,with,spectrophotometrically'
p38459
g3
sS'pipette,yielded,a'
p38460
g3
sS'depletors,should,therefore'
p38461
g9
sS'bph,psa,levels'
p38462
g3
sS'found,in,vivo'
p38463
g9
sS'dopaminergic,renal,and'
p38464
g9
sS'in,male,rats'
p38465
g3
sS'discontinued,before,carrying'
p38466
g3
sS'responses,in,a'
p38467
g9
sS'and,can,be'
p38468
g3
sS'of,p450,a4'
p38469
g3
sS'of,p450,a2'
p38470
g9
sS'ovcon-35,resulted,in'
p38471
g9
sS'was,investigated,in'
p38472
g3
sS'acidity,in,the'
p38473
g9
sS'thiolated,carboxymethylcellulose,in'
p38474
g3
sS'this,study,suggest'
p38475
g3
sS'of,the,risk'
p38476
g9
sS'usually,results,in'
p38477
g9
sS'caused,a,reduction'
p38478
g3
sS'interactions,with,other'
p38479
g3
sS'these,compounds,have'
p38480
g3
sS'fluoride,accumulation,characteristic'
p38481
g3
sS'side,reactions,of'
p38482
g9
sS'caused,by,mtc-methylene'
p38483
g9
sS'patients,on,hormone'
p38484
g3
sS'upon,concomitant,administration'
p38485
g9
sS'its,effects,concomitant'
p38486
g3
sS'and,sodium,it'
p38487
g9
sS'plasma,glucose,levels'
p38488
g3
sS'and,even,in'
p38489
g9
sS'electrolyte,alterations,were'
p38490
g3
sS'action,of,hydroxyzine'
p38491
g9
sS'for,interactions,with'
p38492
g3
sS'in,the,auc'
p38493
g9
sS'levels,and,auc'
p38494
g9
sS'withdrawal,the,most'
p38495
g3
sS'potassium-depleting,and,related'
p38496
g3
sS'degrees,of,recovery'
p38497
g3
sS'proteins,is,low'
p38498
g3
sS'with,but,there'
p38499
g3
sS'of,aprepitant,and'
p38500
g9
sS'for,either,or'
p38501
g3
sS'lapatinib,did,not'
p38502
g3
sS'of,sodium,including'
p38503
g9
sS'lesser,extent,of'
p38504
g9
sS'a,are,available'
p38505
g3
sS'by,patients,receiving'
p38506
g3
sS'indocin,has,been'
p38507
g9
sS'absorption,the,following'
p38508
g9
sS'seizures,have,been'
p38509
g9
sS'pharmacokinetics,over,the'
p38510
g9
sS'metabolism,is,dependent'
p38511
g3
sS'result,in,an'
p38512
g9
sS'significantly,lower,in'
p38513
g3
sS'in,these,patients'
p38514
g3
sS'and,other,bronchodilators'
p38515
g9
sS'less,pronounced,effect'
p38516
g9
sS'agents,eg,and'
p38517
g9
sS'treatment,with,bezalip'
p38518
g9
sS'are,no,data'
p38519
g3
sS'exogenous,on,the'
p38520
g3
sS'of,wellbutrin,on'
p38521
g3
sS'achieve,the,dose'
p38522
g9
sS'denileukin,diftitox,had'
p38523
g3
sS'that,mc,has'
p38524
g3
sS'medications,and,vasodilators'
p38525
g9
sS'para-aminobenzoic,acid,paba'
p38526
g9
sS'might,decrease,the'
p38527
g9
sS'been,coadministered,with'
p38528
g3
sS'so,as,to'
p38529
g3
sS'both,aldehyde,oxidase'
p38530
g9
sS'rats,administered,at'
p38531
g3
sS'auc,of,a'
p38532
g9
sS'urinary,protein,when'
p38533
g3
sS'injectable,transdermal,and'
p38534
g9
sS'rats,were,given'
p38535
g3
sS'these,patients,may'
p38536
g3
sS'hypokinesia,and,severe'
p38537
g9
sS'auc,of,p'
p38538
g9
sS'reported,with,concomitant'
p38539
g9
sS'herbs,such,as'
p38540
g9
sS'may,mask,the'
p38541
g3
sS'pruritus,ankle,edema'
p38542
g3
sS'nonrenal,and,total'
p38543
g3
sS'for,clinically,important'
p38544
g3
sS'and,prolong,the'
p38545
g9
sS'serum-supplemented,nih-3t3,or'
p38546
g3
sS'relaxants,intravenous,agents'
p38547
g3
sS'depression,cns,depressants'
p38548
g3
sS'intentional,or,unintentional'
p38549
g9
sS'of,the,assay'
p38550
g3
sS'toxic,that,is'
p38551
g3
sS'resulted,in,decreases'
p38552
g9
sS'cyp3a4,may,have'
p38553
g3
sS'of,placental,vessels'
p38554
g9
sS'when,and,brevibloc'
p38555
g9
sS'resulted,in,decreased'
p38556
g3
sS'the,pattern,of'
p38557
g3
sS'role,of,neuronal'
p38558
g3
sS'observed,in,mean'
p38559
g3
sS'supplement,while,taking'
p38560
g9
sS'of,and,o-desacetylrifabutin'
p38561
g9
sS'in,a,reduction'
p38562
g9
sS'blood-sugar,levels,should'
p38563
g3
sS'such,as,triazolopyridazines'
p38564
g9
sS'which,may,also'
p38565
g3
sS'arterial,pressure,deep'
p38566
g3
sS'be,done,during'
p38567
g3
sS'extreme,caution,to'
p38568
g9
sS'dosing,and,pharmacokinetics'
p38569
g3
sS'certain,intravenously,administered'
p38570
g9
sS'liver,or,kidney'
p38571
g3
sS'indicate,that,platelet'
p38572
g3
sS'interval,prolongation,cardiac'
p38573
g3
sS'the,stomach,may'
p38574
g9
sS'single,mg,kg'
p38575
g3
sS'volunteers,with,multiple'
p38576
g9
sS'to,those,in'
p38577
g3
sS'patients,combined,use'
p38578
g9
sS'water,from,a'
p38579
g3
sS'the,level,of'
p38580
g3
sS'be,made,immediately'
p38581
g3
sS'or,by,an'
p38582
g3
sS'observations,have,shown'
p38583
g9
sS'with,a,focus'
p38584
g3
sS'requiring,angioedema,or'
p38585
g3
sS'behavioral,effects,of'
p38586
g3
sS'reduced,response,to'
p38587
g3
sS'after,perfusion,did'
p38588
g3
sS'by,catechol-o,methyltransferase'
p38589
g3
sS'effects,of,ganglionic'
p38590
g9
sS'antagonists,are,administered'
p38591
g9
sS'concomitant,high-dose,and'
p38592
g9
sS'c9,c19,d6'
p38593
g3
sS'hyperbilirubinemia,confusion,and'
p38594
g9
sS'blood,concentrations,should'
p38595
g9
sS'likely,to,outweigh'
p38596
g9
sS'of,the,molecule'
p38597
g9
sS'substances,are,known'
p38598
g3
sS'patients,on,oral'
p38599
g9
sS'total,were,about'
p38600
g3
sS'dmpge2,mg,kg'
p38601
g3
sS'denotes,a,mean'
p38602
g9
sS'potential,intravenous,and'
p38603
g9
sS'safely,co-administered,with'
p38604
g3
sS'and,or,severity'
p38605
g9
sS'a,reduction,of'
p38606
g9
sS'prediction,of,abnormal'
p38607
g3
sS'completely,cleared,from'
p38608
g3
sS'these,actions,were'
p38609
g9
sS'acarbose,due,to'
p38610
g9
sS'concurrently,use,products'
p38611
g9
sS'effects,caution,is'
p38612
g3
sS'all,patients,treated'
p38613
g9
sS'to,expect,that'
p38614
g3
sS'recommended,dose,for'
p38615
g3
sS'crixivan,and,is'
p38616
g9
sS'the,vascular,dilation'
p38617
g9
sS'by,resulting,in'
p38618
g9
sS'relationship,and,a'
p38619
g9
sS'ganoderma,lucidum,fr'
p38620
g3
sS'rapid,and,transient'
p38621
g9
sS'diabetes,mellitus,the'
p38622
g3
sS'including,oral,injectable'
p38623
g9
sS'as,well,concurent'
p38624
g9
sS'of,on,these'
p38625
g3
sS'with,such,as'
p38626
g3
sS'maoi,maoi,could'
p38627
g9
sS'd3,the,active'
p38628
g3
sS'the,case,in'
p38629
g3
sS'study,the,ureidopenicillins'
p38630
g9
sS'with,proleukin,may'
p38631
g9
sS'and,heavy,intake'
p38632
g9
sS'or,any,other'
p38633
g9
sS'the,impairment,of'
p38634
g3
sS'cocaine-treated,groups,without'
p38635
g3
sS'and,penthrane,has'
p38636
g9
sS'a2,are,also'
p38637
g3
sS'nevertheless,plasma,levels'
p38638
g3
sS'hydrobromide,may,result'
p38639
g9
sS'were,treated,for'
p38640
g9
sS'concentrations,when,coadministered'
p38641
g3
sS'the,diamond,trials'
p38642
g3
sS'not,only,improve'
p38643
g3
sS'action,of,rr'
p38644
g3
sS'than,and,to'
p38645
g3
sS'by,hours,experienced'
p38646
g9
sS'cyp3a,results,of'
p38647
g3
sS'of,total,rna'
p38648
g3
sS'of,glucose,and'
p38649
g3
sS'with,caution,dose'
p38650
g3
sS'administration,does,not'
p38651
g3
sS'products,h2-antagonists,and'
p38652
g3
sS'of,n-methylthiotetrazole,or'
p38653
g3
sS'is,started,in'
p38654
g9
sS'esophageal,motility,dysfunction'
p38655
g3
sS'over,the,first'
p38656
g3
sS'to,discontinue,nursing'
p38657
g3
sS'of,admissions,for'
p38658
g3
sS'and,that,of'
p38659
g3
sS'medical,attention,and'
p38660
g3
sS'remicade,used,in'
p38661
g9
sS'example,when,k'
p38662
g9
sS'its,metabolism,to'
p38663
g9
sS'ija,models,for'
p38664
g3
sS'ketoconazole,ketoconazole,may'
p38665
g9
sS'prolongation,of,the'
p38666
g9
sS'cardiovascular,action,of'
p38667
g9
sS'twofold,at,the'
p38668
g3
sS'are,neither,inhibitors'
p38669
g3
sS'tablets,the,initial'
p38670
g9
sS'dose,of,arimidex'
p38671
g3
sS'bacterial,mutagenicity,assay'
p38672
g3
sS'were,unchanged,following'
p38673
g3
sS'with,that,strongly'
p38674
g9
sS'been,determined,definitely'
p38675
g3
sS'potential,for,increased'
p38676
g9
sS'vision,and,in'
p38677
g9
sS'administration,appeared,well'
p38678
g3
sS'by,irreversible,brain'
p38679
g9
sS'accumulation,of,body'
p38680
g3
sS'ketoconazole,cyp3a4,is'
p38681
g3
sS'and,on,bar-press'
p38682
g3
sS'for,h,by'
p38683
g3
sS'inhibit,both,synthetic'
p38684
g9
sS'net,effect,of'
p38685
g3
sS'potential,for,increases'
p38686
g3
sS'threshold,concurrent,administration'
p38687
g9
sS'mc,block,morphine-induced'
p38688
g9
sS'unrecognized,interaction,between'
p38689
g9
sS'igg,or,igm'
p38690
g3
sS'findings,to,the'
p38691
g3
sS'seen,with,doses'
p38692
g3
sS'given,number,of'
p38693
g3
sS'among,the,patients'
p38694
g3
sS'hours,before,conducting'
p38695
g9
sS'phenotype,and,susceptibility'
p38696
g3
sS'lowering,effect,and'
p38697
g3
sS'decreased,by,ci'
p38698
g3
sS'in,cat,inferior'
p38699
g3
sS'effect,would,be'
p38700
g3
sS'for,in,aortic'
p38701
g3
sS'are,now,cared'
p38702
g3
sS'the,last,morning'
p38703
g3
sS'intensive,control,of'
p38704
g3
sS'fentanyl,in,patients'
p38705
g9
sS'exposure,to,when'
p38706
g9
sS'and,were,given'
p38707
g3
sS'of,producing,transient'
p38708
g3
sS'rapidly,by,the'
p38709
g3
sS'blood,cells,whereas'
p38710
g3
sS'as,for,weeks'
p38711
g3
sS'brovana,doses,of'
p38712
g3
sS'to,reverse,resistance'
p38713
g3
sS'gastrointestinal,bleeding,have'
p38714
g9
sS'contain,an,may'
p38715
g9
sS'their,coagulation,parameters'
p38716
g9
sS'only,a,limited'
p38717
g3
sS'no,adjustment,of'
p38718
g3
sS'hypotension,requiring,treatment'
p38719
g3
sS'this,could,result'
p38720
g3
sS'effectiveness,of,supplemental'
p38721
g9
sS'cautiously,with,other'
p38722
g9
sS'six-day,course,of'
p38723
g9
sS'role,in,addressing'
p38724
g3
sS'and,auc,by'
p38725
g9
sS'and,usually,a'
p38726
g9
sS'on,the,concurrent'
p38727
g3
sS'disease,can,be'
p38728
g3
sS'epidural,local,including'
p38729
g9
sS'increase,respiratory,and'
p38730
g9
sS'required,it,is'
p38731
g9
sS'and,other,agents'
p38732
g3
sS'mg,intravenous,dose'
p38733
g3
sS'amprenavir,and,have'
p38734
g9
sS'both,in,vivo'
p38735
g3
sS'experiments,reported,here'
p38736
g3
sS'deriving,from,multiple'
p38737
g3
sS'other,drugs,alcohol'
p38738
g3
sS'reported,between,prostin'
p38739
g3
sS'including,those,resulting'
p38740
g3
sS'and,urine,glucose'
p38741
g3
sS'it,is,possible'
p38742
g9
sS'of,tmp,smx'
p38743
g3
sS'can,directly,interfere'
p38744
g9
sS'are,typically,nonlinear'
p38745
g3
sS'mammalian,cell,mutation'
p38746
g3
sS'evaluated,in,men'
p38747
g3
sS'mellitus,may,become'
p38748
g3
sS'documentation,of,such'
p38749
g3
sS'brevibloc,should,be'
p38750
g9
sS'inhibited,phosphorylation,at'
p38751
g9
sS'coadministration,of,and'
p38752
g9
sS'therefore,signs,of'
p38753
g3
sS'monkeys,and,sustained'
p38754
g3
sS'be,sensitive,to'
p38755
g3
sS'a,novel,iboga'
p38756
g3
sS'reductase,inhibitors,simvastatin'
p38757
g3
sS'inhibitor,of,cyclic'
p38758
g3
sS'coadministration,of,any'
p38759
g3
sS'the,start,and'
p38760
g9
sS'from,the,th'
p38761
g3
sS'occur,when,coadministered'
p38762
g3
sS'week,placebo,controlled'
p38763
g3
sS'and,small,gradual'
p38764
g9
sS'those,with,a'
p38765
g9
sS'that,dose,adjustment'
p38766
g9
sS'new,class,of'
p38767
g3
sS'neurochemical,and,functional'
p38768
g3
sS'monitored,for,adverse'
p38769
g3
sS'to,be,inhibited'
p38770
g3
sS'begins,a,course'
p38771
g3
sS'the,anesthesiologist,should'
p38772
g3
sS'induced,hypotension,because'
p38773
g3
sS'various,chemotherapy,agents'
p38774
g3
sS'autonomic,instability,with'
p38775
g9
sS'and,gamma,glutamyl'
p38776
g3
sS'nervous,system,depressants'
p38777
g9
sS'receiving,concomitant,hydrochloride'
p38778
g3
sS'taking,or,who'
p38779
g9
sS'a,potent,cyp'
p38780
g3
sS'nine,otherwise,healthy'
p38781
g3
sS'exposure,to,substrates'
p38782
g3
sS'significantly,lower,with'
p38783
g3
sS'as,international,normalized'
p38784
g9
sS'to,be,increased'
p38785
g9
sS'hypertensive,crises,have'
p38786
g9
sS'steady-state,trough,serum'
p38787
g3
sS'by,the,same'
p38788
g3
sS'on,the,renal'
p38789
g9
sS'of,mortality,in'
p38790
g3
sS'short-lasting,as,compared'
p38791
g3
sS'either,the,presence'
p38792
g3
sS'that,are,predominantly'
p38793
g9
sS'previously,received,pelvic'
p38794
g3
sS'blood,sugar,in'
p38795
g9
sS'with,sulfamethoxazole,concomitant'
p38796
g3
sS'inhibitor,of,cytochrome'
p38797
g9
sS'case,of,an'
p38798
g9
sS'such,as,beta-adrenergic'
p38799
g3
sS'be,recommended,based'
p38800
g3
sS'medicines,when,placed'
p38801
g3
sS'and,chloride,in'
p38802
g9
sS'taking,the,drug'
p38803
g3
sS'one,mg,kg'
p38804
g9
sS'attenuate,morphine-induced,locomotion'
p38805
g3
sS'coagulation,indices,should'
p38806
g3
sS'qtc,prolongation,and'
p38807
g3
sS'kg,day,groups'
p38808
g9
sS'of,increased,approximately'
p38809
g9
sS'practice,additional,methods'
p38810
g3
sS'doses,vioxx,mg'
p38811
g9
sS'doses,have,been'
p38812
g3
sS'intravenous,mg,kg'
p38813
g3
sS'substances,demonstrated,to'
p38814
g9
sS'by,nuromax,is'
p38815
g9
sS'relate,to,the'
p38816
g3
sS'two-fold,increases,of'
p38817
g9
sS'and,may,have'
p38818
g9
sS'preferentially,blocked,the'
p38819
g9
sS'is,unaffected,by'
p38820
g3
sS'dcg-iv,were,very'
p38821
g9
sS'of,enterococci,were'
p38822
g3
sS'however,prudent,medical'
p38823
g9
sS'endogenous,respiration,was'
p38824
g3
sS'was,given,intravenously'
p38825
g3
sS'with,mg,tablets'
p38826
g3
sS'where,is,given'
p38827
g3
sS'a,placebo-controlled,trial'
p38828
g9
sS'antianxiety,agents,the'
p38829
g9
sS'found,or,are'
p38830
g9
sS'clinically,significant,and'
p38831
g3
sS'the,cyp3a4,isoenzyme'
p38832
g3
sS'by,the,oral'
p38833
g3
sS'pediatric,use,the'
p38834
g3
sS'brain,damage,has'
p38835
g9
sS'a,the,initial'
p38836
g3
sS'increase,following,administration'
p38837
g9
sS'help,to,explain'
p38838
g3
sS'of,ascorbic,acid'
p38839
g3
sS'volunteers,a,small'
p38840
g9
sS'can,speed-up,this'
p38841
g3
sS'given,as,a'
p38842
g3
sS'analysis,of,the'
p38843
g3
sS'a,car,or'
p38844
g3
sS'on,the,same'
p38845
g3
sS'described,as,strong'
p38846
g3
sS'injection,like,other'
p38847
g9
sS'at,low-levels,of'
p38848
g3
sS'of,was,given'
p38849
g3
sS'microm,also,inhibited'
p38850
g9
sS'in,that,same'
p38851
g3
sS'total,picr,could'
p38852
g3
sS'by,one-third,when'
p38853
g3
sS'nad,dependent,oxidation'
p38854
g9
sS'of,enterobacteriaceae,and'
p38855
g3
sS'ketoconazole,mg,daily'
p38856
g3
sS'media,a,review'
p38857
g9
sS'is,a,pharmacokinetic'
p38858
g3
sS'be,minimized,by'
p38859
g9
sS'the,intake,and'
p38860
g3
sS'agent,contraindicated,due'
p38861
g3
sS'affect,plasma,renin'
p38862
g3
sS'gastrointestinal,absorption,of'
p38863
g9
sS'taking,amyl,nitrite'
p38864
g9
sS'oxidation,of,and'
p38865
g9
sS'after,a,mg'
p38866
g9
sS'every,hours,q24h'
p38867
g9
sS'additional,efficacy,over'
p38868
g9
sS'agents,gastrointestinal,alkalinizing'
p38869
g9
sS'exposure,auc0-30,days'
p38870
g3
sS'precipitate,seizures,in'
p38871
g9
sS'diarrhea,and,positive'
p38872
g3
sS'displace,acidic,such'
p38873
g9
sS'reached,after,approximately'
p38874
g3
sS'receiving,similar,combination'
p38875
g3
sS'manifested,as,muscle'
p38876
g3
sS'been,administered,in'
p38877
g9
sS'approximately,the,same'
p38878
g3
sS'assessed,in,the'
p38879
g3
sS'initiated,a,reduction'
p38880
g3
sS'it,should,be'
p38881
g3
sS'physician,to,check'
p38882
g3
sS'exercised,when,the'
p38883
g3
sS'at,concentrations,up'
p38884
g3
sS'with,nnrtis,occur'
p38885
g3
sS'mc,probably,has'
p38886
g3
sS'with,male,rats'
p38887
g9
sS'human,plasma,proteins'
p38888
g3
sS'significantly,potentiated,the'
p38889
g3
sS'presentation,and,natural'
p38890
g3
sS'to,patients,taking'
p38891
g9
sS'ingestion,should,be'
p38892
g3
sS'that,interferes,with'
p38893
g9
sS'of,milk,ejection'
p38894
g3
sS'levels,of,homocysteine'
p38895
g3
sS'actions,of,some'
p38896
g3
sS'were,common,findings'
p38897
g3
sS'a,multiple,dose'
p38898
g9
sS'stimulus-induced,neural,plasticity'
p38899
g3
sS'may,make,normal'
p38900
g3
sS'years,total,cholesterol'
p38901
g3
sS'indicate,that,although'
p38902
g3
sS'pharmacokinetic,data,suggest'
p38903
g9
sS'endemic,primate,gammaherpes'
p38904
g3
sS'to,overlap,to'
p38905
g3
sS'in,kidney,recipients'
p38906
g3
sS'patients,by,inhibiting'
p38907
g9
sS'titration,to,the'
p38908
g9
sS'one,controlled,study'
p38909
g3
sS'volunteers,coadministration,of'
p38910
g3
sS'failure,there,is'
p38911
g3
sS'exposure,for,oral'
p38912
g3
sS'increased,levels,in'
p38913
g9
sS'between,vitamin,d'
p38914
g9
sS'absorption,mean,c'
p38915
g9
sS'have,decreased,renal'
p38916
g3
sS'reexacerbation,of,pulmonary'
p38917
g9
sS'inducer,with,mg'
p38918
g9
sS'following,are,examples'
p38919
g3
sS'may,be,useful'
p38920
g3
sS'dose,of,gram'
p38921
g9
sS'fold,the,systemic'
p38922
g3
sS'where,appropriate,plasma'
p38923
g3
sS'the,second,day'
p38924
g9
sS'increase,their,dose'
p38925
g9
sS'of,beta-receptor,agonist'
p38926
g3
sS'reported,to,block'
p38927
g9
sS'which,may,require'
p38928
g9
sS'trileptal,on,aed'
p38929
g3
sS'and,maois,may'
p38930
g9
sS'from,this,study'
p38931
g3
sS'which,is,not'
p38932
g3
sS'but,serious,constellation'
p38933
g9
sS'stimulating,effect,in'
p38934
g9
sS'other,hormonal,are'
p38935
g3
sS'clinical,study,the'
p38936
g9
sS'to,the,monomeric'
p38937
g3
sS'myasthenic,patient,only'
p38938
g9
sS'reports,of,reddish'
p38939
g3
sS'these,oral,and'
p38940
g9
sS'similar,to,those'
p38941
g9
sS'when,using,doses'
p38942
g9
sS'and,cell,permeability'
p38943
g3
sS'pesticides,this,study'
p38944
g3
sS'when,xigris,is'
p38945
g3
sS'or,salt,or'
p38946
g3
sS'and,the,result'
p38947
g3
sS'play,an,important'
p38948
g9
sS'paper,lists,of'
p38949
g3
sS'cardiac,conduction,abnormalities'
p38950
g3
sS'whether,this,represents'
p38951
g3
sS'morphine,prolonged,gastrointestinal'
p38952
g9
sS'duration,but,quickens'
p38953
g9
sS'the,ames,test'
p38954
g3
sS'metabolism,increased,altretamines'
p38955
g9
sS'to,be,related'
p38956
g3
sS'but,that,the'
p38957
g3
sS'antiarrhythmics,antihistamines,antimigraine'
p38958
g9
sS'in,male,sprague-dawley'
p38959
g3
sS'tail-flick,response,induced'
p38960
g9
sS'potential,interactions,between'
p38961
g3
sS'subsequent,treatment,with'
p38962
g9
sS'agents,with,less'
p38963
g3
sS'dry,mouth,bodyweight'
p38964
g3
sS'a,decreased,efficacy'
p38965
g9
sS'differences,between,the'
p38966
g3
sS'q4h,and,mg'
p38967
g3
sS'be,discontinued,slowly'
p38968
g9
sS'cmax,a,c'
p38969
g9
sS'and,bound,by'
p38970
g9
sS'in,comparison,to'
p38971
g3
sS'l-glutamine,and,may'
p38972
g9
sS'use,of,angiotensin'
p38973
g9
sS'interaction,or,should'
p38974
g9
sS'for,liver,biopsy'
p38975
g3
sS'desmopressin,tablets,should'
p38976
g3
sS'is,greater,in'
p38977
g9
sS'relative,risk,of'
p38978
g3
sS'for,that,protects'
p38979
g9
sS'enhanced,by,monoamine'
p38980
g9
sS'human,dose,for'
p38981
g3
sS'intercurrent,use,was'
p38982
g3
sS'decrease,clozapine,plasma'
p38983
g9
sS'in,qtc,values'
p38984
g9
sS'animal,toxicology,studies'
p38985
g3
sS'stimulant,type,may'
p38986
g3
sS'subtypes,in,bovine'
p38987
g3
sS'by,approximately,or'
p38988
g3
sS'to,reduce,hepatic'
p38989
g9
sS'or,inr,days'
p38990
g9
sS'cyp1a2,is,inhibited'
p38991
g9
sS'and,arachidonic,acid'
p38992
g3
sS'by,approximately,of'
p38993
g9
sS'and,a,rapidly'
p38994
g3
sS'inhibitors,and,substrates'
p38995
g9
sS'for,adverse,reactions'
p38996
g9
sS'and,in,a'
p38997
g3
sS'toxicity,in,those'
p38998
g9
sS'digoxin,a,single'
p38999
g3
sS'conventional,it,has'
p39000
g3
sS'of,these,inhibiting'
p39001
g3
sS'absorption,mean,auc'
p39002
g9
sS'to,co-administration,of'
p39003
g3
sS'oral,clearance,values'
p39004
g9
sS'of,rhabdomyolysis,resulting'
p39005
g3
sS'cardiac,contractility,conductivity'
p39006
g9
sS'the,lowest,effective'
p39007
g9
sS'have,similar,effects'
p39008
g3
sS'functional,integrity,of'
p39009
g3
sS'release,by,cholinergic'
p39010
g3
sS'can,significantly,inhibit'
p39011
g9
sS'nalfon,may,be'
p39012
g9
sS'of,circulating,after'
p39013
g3
sS'of,protein,binding'
p39014
g3
sS'furosemide,toradol,iv'
p39015
g9
sS'can,reduce,the'
p39016
g9
sS'related,psychoses,to'
p39017
g3
sS'a1,c9,c19'
p39018
g3
sS'mouth,anorexia,taste'
p39019
g3
sS'a,high,risk'
p39020
g9
sS'particularly,when,their'
p39021
g3
sS'compared,with,single'
p39022
g3
sS'not,significantly,improve'
p39023
g3
sS'twice,daily,mcg'
p39024
g3
sS'hour,before,or'
p39025
g3
sS'however,may,still'
p39026
g3
sS'psychotropic,that,interfere'
p39027
g9
sS'agent,should,include'
p39028
g3
sS'groups,ie,from'
p39029
g3
sS'auc,exhibited,similar'
p39030
g3
sS'if,signs,and'
p39031
g9
sS'receiving,to,mg'
p39032
g9
sS'of,which,were'
p39033
g9
sS'of,chop,patients'
p39034
g3
sS'significantly,more,effective'
p39035
g3
sS'um,toward,cyp3a4'
p39036
g3
sS'positive,reaction,for'
p39037
g3
sS'importance,of,pharmacogenetics'
p39038
g3
sS'has,been,administered'
p39039
g3
sS'or,proton,pump'
p39040
g9
sS'level,of,acidity'
p39041
g9
sS'alertness,such,as'
p39042
g3
sS'to,the,brain'
p39043
g3
sS'liver,microsomes,suggest'
p39044
g3
sS'are,frequently,observed'
p39045
g3
sS'enzyme,inducer,may'
p39046
g9
sS'healthy,subjects,no'
p39047
g3
sS'subjects,given,and'
p39048
g9
sS'acth,treatment,of'
p39049
g3
sS'together,even,if'
p39050
g3
sS'use,with,thiazide'
p39051
g9
sS'showed,an,increase'
p39052
g9
sS'be,taken,within'
p39053
g9
sS'an,expression,of'
p39054
g3
sS'share,a,common'
p39055
g3
sS'to,ptx,have'
p39056
g3
sS'have,no,clinically'
p39057
g3
sS'faslodex,in,pediatric'
p39058
g3
sS'subjects,concurrent,administration'
p39059
g9
sS'or,qt,interval'
p39060
g3
sS'instability,with,possible'
p39061
g9
sS'class,a,vana'
p39062
g3
sS'respiratory,arrest,cardiac'
p39063
g3
sS'immune,system,development'
p39064
g3
sS'therapy,may,induce'
p39065
g3
sS'minimally,or,not'
p39066
g9
sS'with,frequent,monitoring'
p39067
g3
sS'the,action,of'
p39068
g9
sS'in,the,metabolism'
p39069
g3
sS'the,auc,after'
p39070
g9
sS'vaccines,neurological,complications'
p39071
g3
sS'of,the,history'
p39072
g3
sS'blood,pressure,lowering'
p39073
g9
sS'there,is,now'
p39074
g3
sS'by,the,level'
p39075
g9
sS'increased,fold,during'
p39076
g9
sS'warfarin,no,significant'
p39077
g3
sS'tam,significantly,potentiates'
p39078
g9
sS'with,pcp,dcg-iv'
p39079
g3
sS'elimination,and,increasing'
p39080
g9
sS'count,ria,kit'
p39081
g3
sS'reduce,lithiums,renal'
p39082
g9
sS'suggest,that,exposure'
p39083
g9
sS'elevations,resolved,with'
p39084
g3
sS'of,with,occurs'
p39085
g9
sS'to,modify,acth'
p39086
g3
sS'clearance,at,steady-state'
p39087
g3
sS'secondary,actions,certain'
p39088
g9
sS'given,lodine,or'
p39089
g3
sS'organisation,m,decins'
p39090
g3
sS'hematologic,studies,or'
p39091
g3
sS'administered,with,antihypertensive'
p39092
g9
sS'novel,chemical,reaction'
p39093
g9
sS'narrow,therapeutic,index'
p39094
g3
sS'that,oral,markedly'
p39095
g9
sS'low,dose,did'
p39096
g3
sS'one,patient,taking'
p39097
g9
sS'delaying,elimination,and'
p39098
g9
sS'following,or,moieties'
p39099
g3
sS'major,bleeding,events'
p39100
g9
sS'and,acid-base,balance'
p39101
g3
sS'studies,no,dosage'
p39102
g3
sS'medications,and,other'
p39103
g9
sS'with,may,change'
p39104
g9
sS'available,it,is'
p39105
g3
sS'doses,should,be'
p39106
g9
sS'cyp-450,inhibitor,resulted'
p39107
g3
sS'at,the,initiation'
p39108
g9
sS'indocyanine,green,as'
p39109
g3
sS'indicate,a,safe'
p39110
g9
sS'in,a,single'
p39111
g9
sS'receiving,have,experienced'
p39112
g3
sS'for,bleeding,is'
p39113
g3
sS'toradoliv,im,and'
p39114
g3
sS'avoided,in,connection'
p39115
g3
sS'auc,of,were'
p39116
g9
sS'of,pegasys,in'
p39117
g3
sS'gastrointestinal,alkalinizing,agents'
p39118
g9
sS'be,ingested,simultaneously'
p39119
g9
sS'alternative,or,back-up'
p39120
g9
sS'different,types,of'
p39121
g3
sS'of,are,reviewed'
p39122
g3
sS'in,the,frontal'
p39123
g3
sS'patients,receiving,starlix'
p39124
g3
sS'during,placebo,or'
p39125
g3
sS'in,serum,half-life'
p39126
g9
sS'the,qtc,interval'
p39127
g9
sS'these,cyp,enzymes'
p39128
g3
sS'concentrations,were,increased'
p39129
g3
sS'with,potent,inducers'
p39130
g3
sS'minipills,that,do'
p39131
g9
sS'proteins,is,either'
p39132
g3
sS'double-blind,placebo-controlled,study'
p39133
g3
sS'breakthrough,bleeding,has'
p39134
g3
sS'a,muscle,biopsy'
p39135
g3
sS'methamphetamine,like,mptp'
p39136
g9
sS'may,render,oral'
p39137
g9
sS'involving,the,latter'
p39138
g9
sS'four,educational,messages'
p39139
g3
sS'comparable,cognitive,enhancing'
p39140
g3
sS'it,has,generally'
p39141
g3
sS'not,with,enzyme-based'
p39142
g3
sS'considered,if,changes'
p39143
g3
sS'use,of,have'
p39144
g3
sS'levels,during,toradol'
p39145
g9
sS'be,administered,cautiously'
p39146
g3
sS'human,weekly,dose'
p39147
g3
sS'and,obesity,as'
p39148
g3
sS'but,also,results'
p39149
g3
sS'the,following,or'
p39150
g3
sS'and,cohort,design'
p39151
g9
sS'representations,of,neural'
p39152
g3
sS'pharmacokinetics,were,unaltered'
p39153
g3
sS'oral,and,its'
p39154
g9
sS'and,when,and'
p39155
g9
sS'by,injection,medicine'
p39156
g3
sS'not,materially,different'
p39157
g3
sS'be,additive,when'
p39158
g3
sS'the,dosage,and'
p39159
g3
sS'did,not,inhibit'
p39160
g3
sS'of,a,nd'
p39161
g3
sS'oral,injectable,transdermal'
p39162
g9
sS'abolished,both,its'
p39163
g3
sS'and,may,sensitize'
p39164
g9
sS'being,used,the'
p39165
g3
sS'active,metabolite,concentration'
p39166
g9
sS'but,increased,the'
p39167
g3
sS'alkaloid,congener,is'
p39168
g3
sS'of,the,r'
p39169
g9
sS'of,aed,interactions'
p39170
g3
sS'include,the,following'
p39171
g3
sS'in,the,placebo-controlled'
p39172
g3
sS'translocating,action,of'
p39173
g3
sS'of,l-tyrosine,and'
p39174
g9
sS'for,the,human'
p39175
g3
sS'inhibitory,effects,in'
p39176
g3
sS'the,normal,antiasthmatic'
p39177
g3
sS'no,deleterious,interactions'
p39178
g3
sS'erythromycin,on,felbatol'
p39179
g3
sS'review,papers,published'
p39180
g3
sS'accompanied,by,similar'
p39181
g3
sS'day,fecal,as'
p39182
g3
sS'catabolism,has,been'
p39183
g3
sS'therapy,plasma,levels'
p39184
g9
sS'equivocally,higher,when'
p39185
g9
sS'and,had,returned'
p39186
g9
sS'liquid,did,not'
p39187
g3
sS'administering,mepron,concurrently'
p39188
g3
sS'd,but,the'
p39189
g3
sS'after,prolonged,administration'
p39190
g3
sS'fulvestrant,caused,an'
p39191
g3
sS'values,were,not'
p39192
g3
sS'cyp3a4,activity,eg'
p39193
g9
sS'acid,and,then'
p39194
g3
sS'agents,and,should'
p39195
g3
sS'adp,and,collagen-induced'
p39196
g3
sS'asthma,decreased,effectiveness'
p39197
g3
sS'bextra,mg,bid'
p39198
g3
sS'the,signs,and'
p39199
g3
sS'of,in,rats'
p39200
g9
sS'bretylium,tosylate,these'
p39201
g3
sS'and,follow-up,blood'
p39202
g3
sS'patients,those,with'
p39203
g3
sS'presumably,acts,as'
p39204
g9
sS'macrolide,class,resulting'
p39205
g9
sS'were,coadministered,plasma'
p39206
g9
sS'volunteers,the,administration'
p39207
g9
sS'any,form,of'
p39208
g3
sS'the,small,effect'
p39209
g9
sS'united,kingdom,with'
p39210
g9
sS'sodium,channels,and'
p39211
g3
sS'that,affect,the'
p39212
g3
sS'thioether,assay,as'
p39213
g3
sS'the,capsule,formulation'
p39214
g9
sS'parallel,group,interaction'
p39215
g3
sS'in,vitro,therefore'
p39216
g3
sS'to,a,digitalized'
p39217
g9
sS'may,decrease,metabolism'
p39218
g3
sS'in,day-old,embryos'
p39219
g3
sS'nonsteroidal,nsaid,such'
p39220
g3
sS'following,was,gathered'
p39221
g3
sS'children,has,not'
p39222
g3
sS'in,resorptions,or'
p39223
g3
sS'taking,a,or'
p39224
g9
sS'increase,serum,levels'
p39225
g3
sS'of,were,considerably'
p39226
g9
sS'plasma,level,of'
p39227
g9
sS'evening,meal,or'
p39228
g3
sS'out,tests,for'
p39229
g3
sS'a,glucose-specific,method'
p39230
g3
sS'using,clozapine,in'
p39231
g3
sS'studies,demonstrate,that'
p39232
g3
sS'was,significantly,superior'
p39233
g3
sS'potential,for,altering'
p39234
g3
sS'with,may,produce'
p39235
g9
sS'the,ht3,antagonist'
p39236
g9
sS'inhibitors,of,cyp2c19'
p39237
g9
sS'major,subtype,in'
p39238
g3
sS'monitored,and,their'
p39239
g9
sS'taking,patients,with'
p39240
g3
sS'with,the,mg'
p39241
g9
sS'by,single,high'
p39242
g9
sS'dose,at,h'
p39243
g3
sS'for,other,drugs'
p39244
g3
sS'dangerous,because,it'
p39245
g3
sS'as,a,gas'
p39246
g3
sS'synthetic,hydroalcoholic,solutions'
p39247
g3
sS'reports,of,profound'
p39248
g9
sS'twitch,gradually,returned'
p39249
g3
sS'cyp3a4,did,not'
p39250
g3
sS'combination,with,oral'
p39251
g3
sS'of,in,each'
p39252
g3
sS'all,muscle,relaxants'
p39253
g9
sS'of,uricosuric,medication'
p39254
g9
sS'antidotal,properties,of'
p39255
g9
sS'p450,c9,in'
p39256
g3
sS'a,reversible,nonselective'
p39257
g3
sS'single,subject,given'
p39258
g9
sS'educational,messages,advise'
p39259
g3
sS'involving,renal,and'
p39260
g9
sS'effect,of,hydrochloride'
p39261
g9
sS'this,could,lead'
p39262
g9
sS'same,efficacy,although'
p39263
g3
sS'impaired,by,containing'
p39264
g9
sS'produced,some,attenuation'
p39265
g3
sS'with,absorption,resulting'
p39266
g9
sS'antihistamines,antimigraine,derivatives'
p39267
g9
sS'after,consumption,of'
p39268
g3
sS'vitamin,d,have'
p39269
g3
sS'natrecor,with,iv'
p39270
g3
sS'vitamin,supplements,containing'
p39271
g9
sS'of,on,hepatic'
p39272
g3
sS'taking,concurrent,and'
p39273
g9
sS'agents,likely,to'
p39274
g3
sS'wort,may,significantly'
p39275
g9
sS'whom,either,long-acting'
p39276
g3
sS'also,be,avoided'
p39277
g3
sS'this,information,to'
p39278
g9
sS'pains,or,cramps'
p39279
g3
sS'this,isoenzyme,family'
p39280
g3
sS'restored,susceptibility,through'
p39281
g3
sS'concentration-dependent,relaxation,of'
p39282
g3
sS'muscle,relaxants,that'
p39283
g3
sS'locomotor,activities,in'
p39284
g3
sS'flexeril,may,enhance'
p39285
g9
sS'drug-drug,interactions,the'
p39286
g3
sS'cyp3a4,substrate,given'
p39287
g3
sS'b,however,is'
p39288
g3
sS'dipotassium,prolongs,the'
p39289
g9
sS'any,significant,accuracy'
p39290
g9
sS'medicines,diabetic,nsaids'
p39291
g9
sS'cohort,received,plus'
p39292
g3
sS'interaction,of,with'
p39293
g3
sS'in,both,periods'
p39294
g3
sS'advantage,when,used'
p39295
g3
sS'patients,optimal,care'
p39296
g3
sS'seizures,when,these'
p39297
g3
sS'p450,a4,inhibitors'
p39298
g3
sS'concentration,may,be'
p39299
g3
sS'as,the,and'
p39300
g9
sS'i,v,as'
p39301
g3
sS'receiving,or,in'
p39302
g9
sS'history,of,neuropathy'
p39303
g3
sS'with,oral,in'
p39304
g3
sS'a,potent,cyp3a4'
p39305
g3
sS'is,a,d-gal'
p39306
g3
sS'vecuronium,when,used'
p39307
g9
sS'insufficiency,especially,in'
p39308
g3
sS'adenocarcinomas,induced,by'
p39309
g9
sS'increase,sensitivity,and'
p39310
g9
sS'use,for,diabetic'
p39311
g3
sS'alters,the,cellular'
p39312
g3
sS'no,effect,one'
p39313
g9
sS'midcycle,day,of'
p39314
g3
sS'valproic,acid,has'
p39315
g9
sS'following,synthetic,steroidal'
p39316
g3
sS'and,other,than'
p39317
g3
sS'blood,coagulation,diclofenac'
p39318
g3
sS'or,initiating,therapy'
p39319
g9
sS'of,extraneal,on'
p39320
g3
sS'doses,of,had'
p39321
g3
sS'of,were,unaffected'
p39322
g3
sS'the,microtubules,was'
p39323
g3
sS'not,known,which'
p39324
g3
sS'propranolol,attenuated,the'
p39325
g9
sS'myocardium,to,administration'
p39326
g3
sS'of,inhibition,of'
p39327
g3
sS'responding,whereas,in'
p39328
g3
sS'antagonize,the,anorectic'
p39329
g9
sS'most,events,were'
p39330
g3
sS'function,as,well'
p39331
g9
sS'and,other,that'
p39332
g9
sS'some,other,concurrent'
p39333
g9
sS'during,this,period'
p39334
g3
sS'levels,of,increased'
p39335
g9
sS'therapy,diabetes,mellitus'
p39336
g3
sS'of,trileptal,greater'
p39337
g9
sS'the,cmax,at'
p39338
g3
sS'elemental,primarily,iron-fortified'
p39339
g3
sS'sole,protease,inhibitor'
p39340
g3
sS'indicate,that,may'
p39341
g9
sS'concomitantly,given,did'
p39342
g3
sS'been,described,little'
p39343
g3
sS'day,of,concomitant'
p39344
g3
sS'that,significantly,inhibited'
p39345
g9
sS'decreases,the,intravenous'
p39346
g3
sS'will,not,affect'
p39347
g9
sS'when,enablex,is'
p39348
g9
sS'on,concomitant,administration'
p39349
g3
sS'imipramine,mg,kg'
p39350
g3
sS'and,possibly,concomitant'
p39351
g9
sS'however,mg,of'
p39352
g9
sS'non-human,primates,and'
p39353
g3
sS'daily,before,meals'
p39354
g3
sS'during,muscle,relaxants'
p39355
g3
sS'from,a,therapeutic'
p39356
g3
sS'of,liver,tumors'
p39357
g3
sS'who,are,generally'
p39358
g3
sS'proportion,of,the'
p39359
g9
sS'the,mechanism,for'
p39360
g3
sS'the,adrenergic,from'
p39361
g3
sS'intraventricular,and,was'
p39362
g3
sS'of,ketoconazole,and'
p39363
g9
sS'binding,globulin,shbg'
p39364
g3
sS'of,the,prothrombin'
p39365
g9
sS'spermatozoa,from,the'
p39366
g3
sS'for,clinically,significant'
p39367
g3
sS'dextromethorphan,dextromethorphan,is'
p39368
g3
sS'resulting,in,increases'
p39369
g9
sS'and,live-attenuated,should'
p39370
g9
sS'stimulation,study,of'
p39371
g3
sS'may,wish,to'
p39372
g9
sS'r,and,s'
p39373
g3
sS'on,the,glucosyl'
p39374
g3
sS'resulting,in,increased'
p39375
g9
sS'test,abnormalities,related'
p39376
g3
sS'uptake,is,decreased'
p39377
g3
sS'and,stability,over'
p39378
g3
sS'dose,in,healthy'
p39379
g3
sS'that,haldol,may'
p39380
g9
sS'following,subcutaneous,injections'
p39381
g3
sS'therefore,interactions,mediated'
p39382
g3
sS'gastrointestinal,tract,hydoxide'
p39383
g9
sS'every,other,week'
p39384
g3
sS'competing,memory,systems'
p39385
g3
sS'therefore,concurrent,use'
p39386
g9
sS'unless,the,probable'
p39387
g9
sS'and,is,probably'
p39388
g3
sS'and,and,type'
p39389
g9
sS'therapeutic,effect,has'
p39390
g3
sS'adrenoreceptors,on,this'
p39391
g3
sS'urinary,tract,infections'
p39392
g3
sS'serum,concentrations,should'
p39393
g9
sS'target,cell,or'
p39394
g3
sS'below,the,therapeutic'
p39395
g3
sS'be,particularly,carefully'
p39396
g3
sS'to,to,cups'
p39397
g3
sS'tablets,usp,or'
p39398
g9
sS'toxicity,and,treatment'
p39399
g3
sS'demonstrate,a,high'
p39400
g3
sS'of,with,is'
p39401
g9
sS'micrograms,ml,with'
p39402
g3
sS'the,potential,increased'
p39403
g3
sS'cyp,enzymes,would'
p39404
g3
sS'no,clinically,significant'
p39405
g3
sS'the,dose,during'
p39406
g3
sS'untreated,hypothyroidism,may'
p39407
g3
sS'with,other,diagnostic'
p39408
g3
sS'the,interaction,began'
p39409
g3
sS'treated,with,tenormin'
p39410
g3
sS'the,high-dose,mg'
p39411
g9
sS'may,depress,the'
p39412
g9
sS'mc,decrease,extracellular'
p39413
g3
sS'a,causal,relationship'
p39414
g3
sS'interactions,with,systemic'
p39415
g3
sS'concomitant,and,should'
p39416
g9
sS'contraception,should,be'
p39417
g9
sS'amiodarone,or,verapamil'
p39418
g9
sS'of,therapy,which'
p39419
g3
sS'frequent,maintenance,dosing'
p39420
g9
sS'this,study,there'
p39421
g3
sS'whose,efficacy,is'
p39422
g9
sS'minor,contribution,of'
p39423
g3
sS'or,pharmacodynamic,interaction'
p39424
g3
sS'in,the,prothrombin'
p39425
g9
sS'permit,larger,doses'
p39426
g3
sS'to,but,the'
p39427
g9
sS'medicines,or,substances'
p39428
g9
sS'qtc,interval,prolongation'
p39429
g3
sS'than,those,listed'
p39430
g3
sS'psychoses,to,mg'
p39431
g3
sS'no,interaction,trials'
p39432
g3
sS'cytoplasmic,condensation,nuclear'
p39433
g3
sS'the,possibility,should'
p39434
g3
sS'with,medications,with'
p39435
g3
sS'alterations,underlying,neural'
p39436
g3
sS'of,prolonged,prothrombin'
p39437
g9
sS'cytochrome,p450,isozymes'
p39438
g3
sS'arabinoside,a,cytostatic'
p39439
g9
sS'for,patients,who'
p39440
g3
sS'gelatin,capsules,at'
p39441
g3
sS'enrolled,in,a'
p39442
g3
sS'remained,the,same'
p39443
g3
sS'of,concentrations,tested'
p39444
g3
sS'exfoliation,necrosis,and'
p39445
g3
sS'blocking,agents,when'
p39446
g9
sS'and,release,in'
p39447
g3
sS'estrogen-containing,compounds,meclofenamic'
p39448
g9
sS'heart,failure,were'
p39449
g3
sS'biocytin,inclusion,on'
p39450
g3
sS'metabolism,may,produce'
p39451
g3
sS'plasma,levels,is'
p39452
g3
sS'spontaneous,motility,of'
p39453
g9
sS'by,confidence,interval'
p39454
g3
sS'time,was,not'
p39455
g3
sS'experienced,severe,toxicity'
p39456
g9
sS'was,gathered,for'
p39457
g3
sS'continuous,and,discrete'
p39458
g3
sS'reports,there,may'
p39459
g9
sS'therefore,you,may'
p39460
g9
sS'of,gleevec,increased'
p39461
g9
sS'a,basic,area'
p39462
g3
sS'patients,may,be'
p39463
g3
sS'compared,with,only'
p39464
g3
sS'aprepitant,when,given'
p39465
g9
sS'of,toxicity,may'
p39466
g9
sS'or,mimic,certain'
p39467
g3
sS'efficacy,against,the'
p39468
g3
sS'using,cardiac,and'
p39469
g3
sS'other,produce,a'
p39470
g3
sS'absorbed,into,the'
p39471
g9
sS'precautions,appear,to'
p39472
g3
sS'overload,of,ml'
p39473
g3
sS'and,are,associated'
p39474
g3
sS'of,had,a'
p39475
g3
sS'the,pharmacokinetic,profile'
p39476
g9
sS'when,anafranil,is'
p39477
g9
sS'was,about,when'
p39478
g9
sS'erythema,pruritus,and'
p39479
g3
sS'potassium,since,decreases'
p39480
g3
sS'test,interactions,measurement'
p39481
g3
sS'the,clearance,of'
p39482
g9
sS'was,only,half'
p39483
g3
sS'metabolism,of,difluoroacetone'
p39484
g3
sS'the,first,month'
p39485
g3
sS'harmonic,mean,elimination'
p39486
g3
sS'the,failing,heart'
p39487
g3
sS'coagulation,test,should'
p39488
g9
sS'levels,is,recommended'
p39489
g9
sS'to,prevent,symptoms'
p39490
g9
sS'rats,simultaneous,ingestion'
p39491
g9
sS'or,the,level'
p39492
g3
sS'affected,during,concomitant'
p39493
g3
sS'treatment,of,addiction'
p39494
g3
sS'oral,and,intravenous'
p39495
g3
sS'of,what,modern'
p39496
g3
sS'for,use,of'
p39497
g3
sS'symptoms,leukocytosis,elevated'
p39498
g9
sS'crixivan,may,not'
p39499
g9
sS'transaminases,bilirubin,and'
p39500
g3
sS'was,coadministered,although'
p39501
g3
sS'other,broad-spectrum,augmentin'
p39502
g9
sS'the,mg,dosage'
p39503
g3
sS'the,anti-coagulant,effect'
p39504
g3
sS'that,interfere,with'
p39505
g3
sS'b12,supplement,while'
p39506
g9
sS'did,not,significantly'
p39507
g3
sS'with,other,broad-spectrum'
p39508
g9
sS'in,contrast,in'
p39509
g3
sS'peripheral,vascular,resistance'
p39510
g3
sS'to,the,release'
p39511
g3
sS'grapefruit,and,orange'
p39512
g3
sS'is,needed,careful'
p39513
g3
sS'solution,may,substantially'
p39514
g9
sS'inhibitory,activity,towards'
p39515
g9
sS'employed,when,xigris'
p39516
g3
sS'tikosyn,or,the'
p39517
g3
sS'excretion,of,thioethers'
p39518
g3
sS'placebo,or,dose'
p39519
g3
sS'h,to,ml'
p39520
g9
sS'measuring,serum,total'
p39521
g3
sS'concomitant,medications,in'
p39522
g3
sS'antidepressants,concurrent,use'
p39523
g3
sS'rationalized,at,the'
p39524
g3
sS'this,combination,are'
p39525
g3
sS'groups,is,decreasing'
p39526
g3
sS'exposure,auc,of'
p39527
g9
sS'increased,risks,of'
p39528
g9
sS'with,those,produced'
p39529
g9
sS'were,given,fu'
p39530
g3
sS'establish,a,cause-and'
p39531
g9
sS'to,or,concurrent'
p39532
g9
sS'increase,in,the'
p39533
g9
sS'decrease,in,total'
p39534
g9
sS'arachidonate-,or,collagen-stimulated'
p39535
g3
sS'especially,of,amphotericin'
p39536
g3
sS'the,authors,compared'
p39537
g3
sS'day,course,of'
p39538
g3
sS'to,sexual,dysfunction'
p39539
g3
sS'and,a,delay'
p39540
g9
sS'loratadine,mg,once'
p39541
g3
sS'of,coadministration,of'
p39542
g3
sS'of,the,endotoxin-treated'
p39543
g9
sS'essential,to,ascertain'
p39544
g3
sS'as,high,as'
p39545
g3
sS'receiving,and,serious'
p39546
g9
sS'not,been,conducted'
p39547
g3
sS'combined,treatment,the'
p39548
g3
sS'excessive,concurrent,use'
p39549
g3
sS'effects,in,each'
p39550
g3
sS'with,an,in'
p39551
g9
sS'it,was,concluded'
p39552
g9
sS'that,although,not'
p39553
g3
sS'primary,and,secondary'
p39554
g9
sS'affect,the,mechanism'
p39555
g3
sS'increased,when,taken'
p39556
g3
sS'should,be,checked'
p39557
g9
sS'use,of,toradol'
p39558
g9
sS'taking,most,and'
p39559
g3
sS'elucidate,metal,toxicity'
p39560
g3
sS'monoamine,oxidase,inhibitor'
p39561
g3
sS'avoided,as,this'
p39562
g3
sS'in,auc,a'
p39563
g9
sS'levels,about,times'
p39564
g3
sS'plasma,proteins,are'
p39565
g3
sS'and,discontinuing,hydrochloride'
p39566
g9
sS'interactions,with,drugs'
p39567
g3
sS'stadol,ns,is'
p39568
g9
sS'with,the,first'
p39569
g3
sS'underlie,its,long-lasting'
p39570
g3
sS'effects,on,qtc'
p39571
g3
sS'done,at,least'
p39572
g3
sS'and,prothrombin,times'
p39573
g9
sS'drugs,other,than'
p39574
g3
sS'discontinued,slowly,over'
p39575
g9
sS'by,and,appears'
p39576
g3
sS'has,recently,been'
p39577
g3
sS'normal,tissue,although'
p39578
g3
sS'affect,the,peak'
p39579
g3
sS'following,interactions,must'
p39580
g9
sS'increase,the,likelihood'
p39581
g9
sS'these,agents,are'
p39582
g9
sS'significantly,different,before'
p39583
g3
sS'be,used,clinically'
p39584
g3
sS'increased,the,auc'
p39585
g9
sS'should,receive,mg'
p39586
g9
sS'secretion,of,certain'
p39587
g9
sS'cyps,a2,a6'
p39588
g3
sS'coadministration,of,grapefruit'
p39589
g3
sS'level,cells,mm3'
p39590
g3
sS'a,chemically,similar'
p39591
g3
sS'apart,so,that'
p39592
g3
sS'be,necessary,when'
p39593
g3
sS'reports,indicates,that'
p39594
g3
sS'tam,induces,apoptosis'
p39595
g3
sS'concomitant,medication,but'
p39596
g3
sS'and,no,treatment-related'
p39597
g3
sS'a,nonsteroidal,nsaid'
p39598
g3
sS'the,other,drug'
p39599
g3
sS'breast,irradiation,was'
p39600
g3
sS'but,brevibloc,steady-state'
p39601
g9
sS'single,oral,dose'
p39602
g3
sS'and,ultimately,atherosclerotic'
p39603
g3
sS'confusion,disorientation,anxiety'
p39604
g3
sS'such,agents,should'
p39605
g3
sS'by,fold,which'
p39606
g9
sS'days,of,general'
p39607
g3
sS'hours,after,colestid'
p39608
g3
sS'therefore,coagulation,indices'
p39609
g3
sS'this,may,indicate'
p39610
g9
sS'of,the,pharmacodynamic'
p39611
g3
sS'and,compromise,their'
p39612
g9
sS'r-warfarin,a,cyp3a4'
p39613
g9
sS'been,reported,when'
p39614
g9
sS'patients,with,active'
p39615
g9
sS'nervous,system,depression'
p39616
g9
sS'therapy,and,concerns'
p39617
g3
sS'which,competes,for'
p39618
g9
sS'toxicity,of,and'
p39619
g3
sS'tested,in,the'
p39620
g3
sS'suffering,from,chronic'
p39621
g9
sS'of,glycemic,levels'
p39622
g3
sS'especially,the,and'
p39623
g9
sS'metabolized,particularly,those'
p39624
g3
sS'benzodiazepine,class,of'
p39625
g9
sS'the,anti-platelet,activity'
p39626
g3
sS'all,patients,were'
p39627
g3
sS'administration,of,mg'
p39628
g9
sS'which,sensitize,the'
p39629
g9
sS'include,adrenocortical,steroids'
p39630
g9
sS'but,had,chemotherapy'
p39631
g3
sS'may,alter,plasma'
p39632
g9
sS'other,monoamines,from'
p39633
g3
sS'on,average,higher'
p39634
g3
sS'mg,iv,was'
p39635
g3
sS'the,enteric,coating'
p39636
g9
sS'nitrite,after,drinking'
p39637
g9
sS'a4,especially,patients'
p39638
g3
sS'only,bodyweight,gain'
p39639
g3
sS'naflu,and,the'
p39640
g3
sS'zofran,and,kytril'
p39641
g3
sS'could,enhance,the'
p39642
g9
sS'the,identification,of'
p39643
g3
sS'specifically,been,attributed'
p39644
g3
sS'possibility,that,causative'
p39645
g3
sS'decreases,in,levels'
p39646
g9
sS'novo,kidney,allograft'
p39647
g3
sS'in,a,placebo-controlled'
p39648
g9
sS'by,of,bombesin-enhanced'
p39649
g9
sS'directly,interfere,with'
p39650
g9
sS'following,may,interact'
p39651
g9
sS'of,a,nonhormonal'
p39652
g3
sS'was,included,as'
p39653
g3
sS'greater,patients,when'
p39654
g9
sS'of,combined,treatment'
p39655
g3
sS'prescribing,concomitantly,with'
p39656
g3
sS'and,cmc-cys,conjugates'
p39657
g3
sS'reactions,thought,to'
p39658
g3
sS'against,bacillus,subtilis'
p39659
g9
sS'currently,taking,amevive'
p39660
g3
sS'rare,cases,approximately'
p39661
g3
sS'and,partial,thromboplastin'
p39662
g3
sS'of,vasopressor,for'
p39663
g9
sS'patients,receiving,vioxx'
p39664
g9
sS'coumarin-derivative,concomitantly,with'
p39665
g9
sS'kg,of,fe'
p39666
g3
sS'controls,levels,of'
p39667
g3
sS'that,is,cleared'
p39668
g3
sS'alter,the,biological'
p39669
g9
sS'of,monitoring,serum'
p39670
g3
sS'as,immediate-early,genes'
p39671
g3
sS'a,family,cyp3a4'
p39672
g3
sS'have,a,mild'
p39673
g3
sS'free,fractions,of'
p39674
g3
sS'administration,of,certain'
p39675
g9
sS'for,several,hours'
p39676
g9
sS'human,african,trypanosomiasis'
p39677
g3
sS'also,likely,to'
p39678
g9
sS'thus,may,prevent'
p39679
g3
sS'of,the,west'
p39680
g3
sS'weighted,least,squares'
p39681
g3
sS'to,plasma,proteins'
p39682
g3
sS'that,the,hepatoxicity'
p39683
g9
sS'potent,than,that'
p39684
g3
sS'metabolic,clearance,of'
p39685
g9
sS'to,slow,the'
p39686
g9
sS'offers,advantages,in'
p39687
g3
sS'editorials,concerning,published'
p39688
g3
sS'and,serotonin,and'
p39689
g3
sS'effect,of,foods'
p39690
g3
sS'possible,interaction,has'
p39691
g3
sS'of,the,qtc'
p39692
g9
sS'supplemented,with,the'
p39693
g3
sS'mg,for,at'
p39694
g3
sS'with,administration,at'
p39695
g3
sS'lodine,treatment,is'
p39696
g3
sS'obtained,when,it'
p39697
g9
sS'this,study,indicates'
p39698
g3
sS'the,cellular,permeability'
p39699
g3
sS'chinese,hamster,responds'
p39700
g3
sS'with,potassium-depleting,agents'
p39701
g9
sS'to,mg,per'
p39702
g3
sS'on,the,apparent'
p39703
g3
sS'were,concomitantly,administered'
p39704
g9
sS'of,to,existing'
p39705
g3
sS'patients,suffering,from'
p39706
g9
sS'creatinine,makes,use'
p39707
g3
sS'and,fentanyl,in'
p39708
g9
sS'to,the,presence'
p39709
g3
sS'celebrex,may,result'
p39710
g9
sS'in,hepatic,function'
p39711
g3
sS'levels,may,be'
p39712
g3
sS'validation,of,method'
p39713
g3
sS'higher,incidence,of'
p39714
g9
sS'of,the,normal'
p39715
g3
sS'of,refludan,on'
p39716
g3
sS'caused,no,change'
p39717
g3
sS'bombesin,significantly,increased'
p39718
g3
sS'and,therefore,signs'
p39719
g3
sS'optimal,pulmonary,function'
p39720
g3
sS'period,of,observation'
p39721
g3
sS'such,as,p-glycoprotein'
p39722
g9
sS'menstrual,period,immediately'
p39723
g3
sS'the,mean,clearances'
p39724
g9
sS'clinical,trials,patients'
p39725
g3
sS'family,education,on'
p39726
g3
sS'action,of,nondepolarizing'
p39727
g9
sS'provides,considerable,evidence'
p39728
g3
sS'nor,its,metabolites'
p39729
g3
sS'with,would,not'
p39730
g3
sS'suggested,in,the'
p39731
g3
sS'with,interferon,beta'
p39732
g3
sS'been,received,among'
p39733
g3
sS'is,initiated,to'
p39734
g9
sS'secretion,of,a'
p39735
g3
sS'in,those,patients'
p39736
g9
sS'even,more,conservatively'
p39737
g9
sS'therefore,has,the'
p39738
g3
sS'from,studies,involving'
p39739
g3
sS'fenfluramine,may,increase'
p39740
g9
sS'in,ewes,given'
p39741
g9
sS'pharmacokinetic,study,evaluating'
p39742
g9
sS'dose,pharmacokinetic,interaction'
p39743
g3
sS'has,no,effects'
p39744
g3
sS'they,reduce,lithiums'
p39745
g9
sS'relaxants,are,given'
p39746
g3
sS'deterioration,in,renal'
p39747
g3
sS'diclofenac,administration,of'
p39748
g3
sS'cyp3a4,and,cyp2d6'
p39749
g3
sS'joint,exposure,general'
p39750
g3
sS'involving,healthy,adults'
p39751
g3
sS'caution,only,if'
p39752
g3
sS'should,also,be'
p39753
g3
sS'by,h2,blockers'
p39754
g9
sS'effect,on,that'
p39755
g3
sS'on,rewarming,was'
p39756
g3
sS'spray,the,auc'
p39757
g9
sS'a,week,endoscopy'
p39758
g3
sS'in,cmax,when'
p39759
g9
sS'receptors,are,coupled'
p39760
g3
sS'hours,following,symptom'
p39761
g3
sS'creatinine,levels,by'
p39762
g3
sS'not,available,and'
p39763
g3
sS'day,and,on'
p39764
g9
sS'exploited,in,the'
p39765
g3
sS'min,or,t'
p39766
g3
sS'of,clinical,toxicity'
p39767
g3
sS'to,increase,plasma'
p39768
g9
sS'day,twice,the'
p39769
g3
sS'component,of,insect'
p39770
g9
sS'on,average,by'
p39771
g9
sS'antidepressants,in,vitro'
p39772
g9
sS'failed,to,show'
p39773
g3
sS'altered,in,patients'
p39774
g3
sS'downward,adjustment,of'
p39775
g9
sS'other,medicines,may'
p39776
g3
sS'but,endogenous,secretion'
p39777
g3
sS'may,show,elevations'
p39778
g9
sS'patients,taking,when'
p39779
g9
sS'the,co-administered,dose'
p39780
g3
sS'of,serum,levels'
p39781
g3
sS'use,foradil,fumarate'
p39782
g3
sS'with,a,steady'
p39783
g3
sS'for,single,metal'
p39784
g3
sS'of,hydroxide,and'
p39785
g3
sS'inhibitors,of,these'
p39786
g3
sS'expressed,by,minimal'
p39787
g3
sS'clearances,of,were'
p39788
g9
sS'administered,with,the'
p39789
g9
sS'these,when,treating'
p39790
g3
sS'that,block,angiotensin'
p39791
g3
sS'pretreatment,with,reduces'
p39792
g9
sS'substrate,by,fold'
p39793
g9
sS'may,prolong,the'
p39794
g9
sS'clinical,patterns,of'
p39795
g3
sS'administered,to,mice'
p39796
g3
sS'these,should,not'
p39797
g3
sS'is,continued,these'
p39798
g3
sS'than,usual,of'
p39799
g3
sS'administration,twice,a'
p39800
g3
sS'differential,regulation,of'
p39801
g3
sS'failure,severe,hypotension'
p39802
g9
sS'binding,domain,decoy'
p39803
g3
sS'hypotensive,effects,with'
p39804
g9
sS'of,antifibrinolytic,therapies'
p39805
g3
sS'should,have,pulse'
p39806
g3
sS'mothers,have,received'
p39807
g3
sS'affected,by,or'
p39808
g3
sS'enzyme,a4,as'
p39809
g3
sS'not,recommended,when'
p39810
g9
sS'be,reflective,of'
p39811
g3
sS'as,amphotericin,b'
p39812
g9
sS'to,peak,and'
p39813
g3
sS'zebeta,on,prothrombin'
p39814
g3
sS'pharmacokinetics,of,cardiovascular'
p39815
g3
sS'co-administration,of,natrecor'
p39816
g3
sS'amphetamines,may,delay'
p39817
g9
sS'on,clearance,or'
p39818
g3
sS'sodium,unreliable,prothrombin'
p39819
g9
sS'and,mg,qd'
p39820
g9
sS'or,in,patients'
p39821
g3
sS'increased,and,decreased'
p39822
g9
sS'for,two,weeks'
p39823
g9
sS'treatment,with,sprycel'
p39824
g3
sS'been,filtrated,to'
p39825
g9
sS'evening,meal,resulted'
p39826
g9
sS'was,treated,aggressively'
p39827
g3
sS'expected,to,occur'
p39828
g3
sS'agents,coadministration,of'
p39829
g3
sS'and,nsaids,on'
p39830
g9
sS'hydrochloride,may,enhance'
p39831
g9
sS'as,effective,in'
p39832
g3
sS'prevention,in,a'
p39833
g3
sS'anticonvulsants,in,a'
p39834
g9
sS'or,will,not'
p39835
g9
sS'mg,and,multiple'
p39836
g3
sS'dosage,modifications,in'
p39837
g3
sS'left,ventricular,dysfunction'
p39838
g3
sS'drugs,that,have'
p39839
g9
sS'rhabdomyolysis,have,been'
p39840
g3
sS'phase,in,either'
p39841
g3
sS'the,bile,caution'
p39842
g3
sS'this,specificity,we'
p39843
g3
sS'b-cell,lymphomas,when'
p39844
g3
sS'c,interval,prolongation'
p39845
g9
sS'responses,to,of'
p39846
g3
sS'intramuscular,doses,of'
p39847
g3
sS'in,therapy,depends'
p39848
g3
sS'concentration,and,prolong'
p39849
g9
sS'aspirin,concurrent,administration'
p39850
g9
sS'the,liver,and'
p39851
g9
sS'but,physicians,should'
p39852
g9
sS'the,growth,response'
p39853
g3
sS'caused,a,first'
p39854
g3
sS'of,atrovent,inhalation'
p39855
g9
sS'to,determine,therapy'
p39856
g3
sS'of,dry,mouth'
p39857
g9
sS'no,dose,adjustment'
p39858
g3
sS'potentiated,by,which'
p39859
g9
sS'potentiate,the,hypotensive'
p39860
g9
sS'may,have,decreased'
p39861
g3
sS'from,one,class'
p39862
g9
sS'hypothesis,there,is'
p39863
g3
sS'this,paper,critically'
p39864
g3
sS'combination,with,is'
p39865
g9
sS'and,nonsteroidal,anti-inflammatory'
p39866
g3
sS'and,longer,intervals'
p39867
g9
sS'that,and,cause'
p39868
g3
sS'rat,were,evaluated'
p39869
g3
sS'evidence,was,obtained'
p39870
g3
sS'other,has,not'
p39871
g3
sS'with,it,is'
p39872
g3
sS'daily,for,one'
p39873
g9
sS'is,given,in'
p39874
g3
sS'kg,decreases,the'
p39875
g3
sS'verapamil,produced,a'
p39876
g3
sS'and,caused,excessive'
p39877
g3
sS'to,ptx,was'
p39878
g3
sS'inhibit,cyp1a2,or'
p39879
g3
sS'the,interaction,between'
p39880
g3
sS'develop,higher,than'
p39881
g3
sS'activity,effects,may'
p39882
g3
sS'inhibitors,in,patients'
p39883
g9
sS'given,exclusively,by'
p39884
g3
sS'inhibitors,of,cyp1a2'
p39885
g9
sS'phenotype,of,a'
p39886
g3
sS'inhibits,both,aldehyde'
p39887
g9
sS'leukocyte,transfusions,acute'
p39888
g9
sS'syndrome,associated,with'
p39889
g9
sS'oxidase,in,vitro'
p39890
g9
sS'increases,the,effect'
p39891
g9
sS'and,serum,uric'
p39892
g3
sS'does,not,appear'
p39893
g3
sS'that,result,from'
p39894
g3
sS'and,half-life,increased'
p39895
g9
sS'kg,for,days'
p39896
g9
sS'methods,such,as'
p39897
g3
sS'isoenzyme,including,other'
p39898
g9
sS'with,chirocaine,that'
p39899
g3
sS'the,pharmacological,action'
p39900
g3
sS'from,a,hit'
p39901
g3
sS'o11,strains,but'
p39902
g3
sS'was,detected,after'
p39903
g3
sS'agents,or,glycosides'
p39904
g3
sS'adjustment,for,mg'
p39905
g9
sS'qd,by,about'
p39906
g9
sS'seen,in,each'
p39907
g3
sS'in,t24,human'
p39908
g3
sS'like,mptp,produced'
p39909
g9
sS'brevibloc,but,the'
p39910
g9
sS'increase,in,prothrombin'
p39911
g9
sS'local,irritation,in'
p39912
g3
sS'the,rd,th'
p39913
g3
sS'responding,produced,by'
p39914
g9
sS'to,m,markedly'
p39915
g9
sS'and,non-selective,beta-adrenergic'
p39916
g9
sS'the,enzymes,responsible'
p39917
g3
sS'those,receiving,including'
p39918
g3
sS'of,stimulation,and'
p39919
g3
sS'facts,should,be'
p39920
g3
sS'neutrophil,counts,of'
p39921
g3
sS'interactions,with,lipid-lowering'
p39922
g3
sS'have,cns,effects'
p39923
g3
sS'study,the,influence'
p39924
g3
sS'of,cyp3a4,activity'
p39925
g9
sS'hours,of,each'
p39926
g9
sS'in,exposure,to'
p39927
g9
sS'increasing,their,effect'
p39928
g3
sS'carbachol-stimulated,intracellular,ca'
p39929
g9
sS'play,a,role'
p39930
g3
sS'the,data,presented'
p39931
g3
sS'and,human,studies'
p39932
g3
sS'the,lower,rate'
p39933
g9
sS'co-administered,with,care'
p39934
g9
sS'tissues,to,the'
p39935
g3
sS'and,socioeconomic,factors'
p39936
g3
sS'fici,was,determined'
p39937
g3
sS'kidney,on,scintigraphy'
p39938
g3
sS'cimetidine,concomitant,use'
p39939
g3
sS'a,frequent,cause'
p39940
g9
sS'false,elevations,of'
p39941
g3
sS'effect,on,clearance'
p39942
g3
sS'may,be,induced'
p39943
g3
sS'co-administration,with,high'
p39944
g9
sS'singly,or,in'
p39945
g3
sS'with,against,bacillus'
p39946
g9
sS'herb,interactions,have'
p39947
g3
sS'the,primary,metabolite'
p39948
g3
sS'or,substantially,interfere'
p39949
g9
sS'tca,may,need'
p39950
g9
sS'ritonavir,coadministration,of'
p39951
g9
sS'sub-therapeutic,concentrations,of'
p39952
g9
sS'with,cns-active,has'
p39953
g3
sS'and,streptozotocin-induced,diabetic'
p39954
g3
sS'substances,that,inhibit'
p39955
g3
sS'assay,result,is'
p39956
g3
sS'suggesting,a,metabolite'
p39957
g3
sS'sodium,perchlorate,in'
p39958
g3
sS'metabolized,by,p450iid6'
p39959
g3
sS'administered,together,with'
p39960
g3
sS'sometimes,be,followed'
p39961
g3
sS'whether,these,are'
p39962
g9
sS'on,the,intestinal'
p39963
g3
sS'dosing,may,be'
p39964
g3
sS'not,bind,significantly'
p39965
g3
sS'adverse,events,with'
p39966
g3
sS'also,assessed,by'
p39967
g3
sS'of,increased,the'
p39968
g9
sS'system,that,result'
p39969
g3
sS'of,a,cyp'
p39970
g9
sS'did,not,correlate'
p39971
g3
sS'on,blood,levels'
p39972
g9
sS'toxic,reactions,to'
p39973
g3
sS'of,brovana,may'
p39974
g9
sS't,max,although'
p39975
g3
sS'these,patients,are'
p39976
g9
sS'perivascular,spaces,have'
p39977
g3
sS'concomitantly,administered,mg'
p39978
g3
sS'potential,for,an'
p39979
g3
sS'with,may,inhibit'
p39980
g9
sS'of,mouth,thirst'
p39981
g3
sS'day,of,cancidas'
p39982
g9
sS'hydroxides,be,used'
p39983
g9
sS'bile,and,cystic'
p39984
g9
sS'stable,as,v'
p39985
g3
sS'enbrel,was,added'
p39986
g9
sS'lethargy,and,somnolence'
p39987
g9
sS'proliferation,of,prostate'
p39988
g9
sS'been,a,number'
p39989
g9
sS'about,but,caused'
p39990
g3
sS'neurologic,disorders,and'
p39991
g3
sS'benefits,and,risks'
p39992
g9
sS'syndrome,in,phase'
p39993
g3
sS'hours,was,given'
p39994
g9
sS'in,disposition,may'
p39995
g3
sS'the,time,to'
p39996
g3
sS'dissolution,of,in'
p39997
g3
sS'smokers,and,industrial'
p39998
g3
sS'oxidase,inhibitors,and'
p39999
g9
sS'received,epirubicin-based,chemotherapy'
p40000
g3
sS'as,convulsions,and'
p40001
g9
sS'well,as,postmarketing'
p40002
g9
sS'with,first-episode,or'
p40003
g3
sS'dosing,reduced,as'
p40004
g3
sS'was,lower,when'
p40005
g9
sS'with,renal,impairment'
p40006
g9
sS'more,specific,methods'
p40007
g3
sS'decreased,clearance,by'
p40008
g9
sS'concentrations,just,prior'
p40009
g3
sS'with,in,man'
p40010
g3
sS'of,up,to'
p40011
g3
sS'pharmacokinetics,of,clonazepam'
p40012
g3
sS'cimetidine,atorvastatin,plasma'
p40013
g3
sS'disulfiram-ethanol,reaction,in'
p40014
g3
sS'in,practice,the'
p40015
g3
sS'healthcare,prescribers,are'
p40016
g3
sS'and,cyp3a3,also'
p40017
g3
sS'dl,submitted,to'
p40018
g3
sS'the,interactions,noted'
p40019
g3
sS'despite,seemingly,adequate'
p40020
g3
sS'phenytoin,is,extensively'
p40021
g3
sS'of,all,agents'
p40022
g3
sS'of,b6,physiological'
p40023
g3
sS'when,hcl,is'
p40024
g9
sS'major,metabolites,dfur'
p40025
g3
sS'to,preclude,effectiveness'
p40026
g3
sS'serum,creatinine,levels'
p40027
g3
sS'of,clinical,laboratory'
p40028
g3
sS'orphan,status,for'
p40029
g3
sS'trough,concentrations,of'
p40030
g9
sS'camptosar,would,worsen'
p40031
g9
sS'induced,by,meth'
p40032
g3
sS'a,antimicrobial,is'
p40033
g9
sS'dose,of,such'
p40034
g3
sS'interactions,with,carbamazepine'
p40035
g9
sS'in,addition,neuromuscular'
p40036
g3
sS'other,have,demonstrated'
p40037
g9
sS'present,for,at'
p40038
g3
sS'creatinine,have,occurred'
p40039
g3
sS'interfere,with,cholesterol'
p40040
g3
sS'patients,was,not'
p40041
g3
sS'or,other,precautions'
p40042
g3
sS'physicians,are,advised'
p40043
g9
sS'can,be,initiated'
p40044
g3
sS'clinically,important,interaction'
p40045
g3
sS'diabetic,rats,were'
p40046
g3
sS'glycoprotein,iib,iiia'
p40047
g9
sS'shown,that,concurrent'
p40048
g9
sS'the,spinal,endorphinergic'
p40049
g3
sS'and,urine,sampling'
p40050
g3
sS'be,anticipated,alternative'
p40051
g3
sS'reached,on,or'
p40052
g3
sS'hours,and,until'
p40053
g3
sS'clinical,trials,showed'
p40054
g3
sS'avoided,in,the'
p40055
g3
sS'for,weeks,prior'
p40056
g3
sS'the,gaba-ergic,system'
p40057
g9
sS'and,possibly,nicotinic'
p40058
g3
sS'the,pharmacokinetic,parameters'
p40059
g3
sS'values,after,an'
p40060
g3
sS'were,determined,in'
p40061
g3
sS'missing,a,pill'
p40062
g3
sS'hydrogen,breath,test'
p40063
g3
sS'distribution,of,the'
p40064
g9
sS'approximately,in,cyp2d6'
p40065
g9
sS'well,tolerated,when'
p40066
g3
sS'excretion,of,meclofenamate'
p40067
g3
sS'or,hours,after'
p40068
g9
sS'resulting,respiratory,depression'
p40069
g9
sS'affects,prothrombin,times'
p40070
g3
sS'enzyme,function,may'
p40071
g3
sS'doses,of,concomitantly'
p40072
g9
sS'effect,will,be'
p40073
g9
sS'and,potential,bleeding'
p40074
g3
sS'with,lodosyn,carbidopa'
p40075
g3
sS'higher-than,expected,steady-state'
p40076
g9
sS'strattera,should,be'
p40077
g9
sS'of,potentially,serious'
p40078
g3
sS'strong,likelihood,of'
p40079
g9
sS'performed,on,guinea'
p40080
g3
sS'of,cases,of'
p40081
g9
sS'surgery,or,skeletal-muscle'
p40082
g3
sS'sympathomimetic,agents,possible'
p40083
g3
sS'and,any,deficit'
p40084
g3
sS'inhibited,cyp,enzymes'
p40085
g3
sS'for,days,produced'
p40086
g9
sS'administration,of,resulting'
p40087
g9
sS'taken,by,of'
p40088
g3
sS'certain,and,thereby'
p40089
g9
sS'of,equivalent,to'
p40090
g9
sS'of,dosage,may'
p40091
g3
sS'carried,out,during'
p40092
g3
sS'about,of,patients'
p40093
g3
sS'complications,compared,to'
p40094
g9
sS'red,cells,from'
p40095
g3
sS'however,no,related'
p40096
g3
sS'there,is,currently'
p40097
g3
sS'nonsteroidal,were,taken'
p40098
g3
sS'inhibitors,serious,side'
p40099
g3
sS'that,may,reach'
p40100
g3
sS'hypothyroid,patients,with'
p40101
g3
sS'vardenafil,mg,did'
p40102
g3
sS'renal,failure,elevated'
p40103
g3
sS'change,in,meclofenamate'
p40104
g3
sS'mephenytoin,mesantoin,use'
p40105
g3
sS'that,the,bioavailability'
p40106
g3
sS'is,added,of'
p40107
g9
sS'in,a,controlled'
p40108
g9
sS'in,patients,given'
p40109
g9
sS'nonsedating,and,when'
p40110
g9
sS'ontario,alone,in'
p40111
g3
sS'significantly,increase,and'
p40112
g3
sS'statistically,significant,difference'
p40113
g3
sS'reports,that,may'
p40114
g9
sS'the,following,acetazolamide'
p40115
g9
sS'or,can,inhibit'
p40116
g9
sS'second,response,is'
p40117
g3
sS'between,and,and'
p40118
g9
sS'taken,on,the'
p40119
g9
sS'doses,of,followed'
p40120
g9
sS'orthostatic,hypotension,cimetidine'
p40121
g9
sS'of,possible,additive'
p40122
g9
sS'frontal,cortex,and'
p40123
g3
sS'pharmacologically,predictable,sympathetic'
p40124
g9
sS'or,hexokinase,method'
p40125
g3
sS'potent,cyp3a4,inducer'
p40126
g9
sS'variable,effects,an'
p40127
g9
sS'absorption,of,is'
p40128
g9
sS'a,survey,of'
p40129
g3
sS'anaphylactic,reaction,although'
p40130
g9
sS'citrate,theoretically,l-arginine'
p40131
g9
sS'related,member,of'
p40132
g9
sS'area,bsa,for'
p40133
g3
sS'include,a,variety'
p40134
g3
sS'patient,with,compromised'
p40135
g3
sS'is,concurrently,administered'
p40136
g3
sS'iodine-containing,products,h2-antagonists'
p40137
g3
sS'although,the,specific'
p40138
g3
sS'agent,orally,because'
p40139
g9
sS'in,vitro,was'
p40140
g3
sS'to,the,development'
p40141
g3
sS'values,for,which'
p40142
g3
sS'ssris,and,agents'
p40143
g9
sS'into,question,the'
p40144
g3
sS'amylase,an,apparent'
p40145
g3
sS'use,when,tumor'
p40146
g3
sS'cases,where,serious'
p40147
g3
sS'age,gender,race'
p40148
g3
sS'cefditoren,pivoxil,be'
p40149
g9
sS'contraindicated,specifically,due'
p40150
g3
sS'patients,receiving,taxotere'
p40151
g3
sS'affect,strategies,during'
p40152
g3
sS'disease,states,careful'
p40153
g3
sS'cmax,and,were'
p40154
g3
sS'of,reaction,had'
p40155
g3
sS'not,only,hyperglycemia'
p40156
g3
sS'with,the,patient'
p40157
g9
sS'sensitivity,of,tumor'
p40158
g3
sS'inhibiting,the,central'
p40159
g9
sS'might,have,detrimental'
p40160
g3
sS'conduct,close,clinical'
p40161
g3
sS'when,dosing,concurrently'
p40162
g3
sS'from,control,values'
p40163
g3
sS'precipitous,reduction,of'
p40164
g9
sS'explained,either,by'
p40165
g3
sS'mean,scores,on'
p40166
g9
sS'cyp2c9,cyp2d6,cyp2e1'
p40167
g3
sS'least,months,had'
p40168
g3
sS'with,or,has'
p40169
g9
sS'for,vitamin,b3'
p40170
g9
sS'sgpt,s-alt,levels'
p40171
g3
sS'differences,among,the'
p40172
g3
sS'to,control,supraventricular'
p40173
g9
sS'them,are,less'
p40174
g3
sS'the,monoamine,oxidase'
p40175
g3
sS'with,or,had'
p40176
g9
sS'for,prolonged,use'
p40177
g3
sS'nonfunctioning,gland,who'
p40178
g9
sS'users,of,intravenous'
p40179
g3
sS'appropriate,package,insert'
p40180
g3
sS'increased,with,coadministration'
p40181
g3
sS'studies,should,focus'
p40182
g3
sS'reduction,when,coadminstered'
p40183
g9
sS'no,significant,alteration'
p40184
g9
sS'the,taking,into'
p40185
g3
sS'may,increase,plasma'
p40186
g9
sS'the,differential,diagnosis'
p40187
g3
sS'study,in,humans'
p40188
g3
sS'co-administered,drug,may'
p40189
g3
sS'el,eg,for'
p40190
g9
sS'these,who,are'
p40191
g3
sS'potential,effect,of'
p40192
g3
sS'cytochrome,p450,d6'
p40193
g3
sS'adjusted,upward,the'
p40194
g9
sS'stomach,of,people'
p40195
g9
sS'demonstrated,renal,precipitation'
p40196
g3
sS'in,a,interaction'
p40197
g3
sS'by,barton,braunberg'
p40198
g3
sS'might,be,caused'
p40199
g3
sS'diabetic,cinese,hamsters'
p40200
g3
sS'fosinopril,sodium,can'
p40201
g9
sS'result,i,n'
p40202
g9
sS'high,performance,liquid'
p40203
g3
sS'decreases,in,auc'
p40204
g3
sS'vitro,studies,suggest'
p40205
g9
sS'may,be,superior'
p40206
g3
sS'endothelium-intact,aortic,rings'
p40207
g9
sS'with,serotonin,syndrome'
p40208
g3
sS'but,significantly,decreased'
p40209
g9
sS'and,alternative,hypoglycemic'
p40210
g9
sS'others,plasma,levels'
p40211
g3
sS'a,true,decrease'
p40212
g3
sS'of,with,increased'
p40213
g9
sS'the,world,medical'
p40214
g3
sS'if,argatroban,is'
p40215
g3
sS'nephrotoxicity,associated,with'
p40216
g3
sS'other,agents,that'
p40217
g3
sS'of,with,increases'
p40218
g3
sS'subjects,twelve,healthy'
p40219
g3
sS'days,increased,plasma'
p40220
g9
sS'initiated,at,a'
p40221
g3
sS'degree,of,anticoagulation'
p40222
g3
sS'videx,was,administered'
p40223
g9
sS'response,in,this'
p40224
g3
sS'in,rats,epidural'
p40225
g9
sS'to,the,changes'
p40226
g3
sS'by,weakness,lethargy'
p40227
g9
sS'unlikely,that,co-administration'
p40228
g3
sS'cognitive,and,motor'
p40229
g9
sS'ii,clinical,trial'
p40230
g9
sS'amphetamines,enhance,the'
p40231
g9
sS'were,investigated,in'
p40232
g3
sS'revealed,that,significantly'
p40233
g9
sS'were,administered,during'
p40234
g3
sS'in,elderly,patients'
p40235
g9
sS'body,weight,was'
p40236
g3
sS'and,in,patients'
p40237
g9
sS'to,subjects,receiving'
p40238
g9
sS'separate,group,of'
p40239
g9
sS'ethanol-drug,reaction,is'
p40240
g3
sS'findings,has,not'
p40241
g3
sS'clearance,of,compared'
p40242
g9
sS'conversion,of,to'
p40243
g3
sS'c3h,hen,f1'
p40244
g3
sS'concomitant,antihypertensive,medications'
p40245
g9
sS'used,in,patients'
p40246
g3
sS'hallucinations,paresthesia,muscle'
p40247
g3
sS'class,of,may'
p40248
g9
sS'administration,of,at'
p40249
g9
sS'a2,an,isoform'
p40250
g9
sS'above,listed,agents'
p40251
g3
sS'severe,weakness,in'
p40252
g9
sS'd,redistributed,type'
p40253
g3
sS'effects,on,fertility'
p40254
g3
sS'median,gastric,ph'
p40255
g9
sS'response,rates,were'
p40256
g3
sS'of,baseline,for'
p40257
g3
sS'powder,x-ray,diffraction'
p40258
g3
sS'the,existence,of'
p40259
g3
sS'multivalent,cation-containing,products'
p40260
g9
sS'shortly,after,nasal'
p40261
g9
sS'considerations,are,discussed'
p40262
g3
sS'kidney,damage,as'
p40263
g3
sS'hyperplasia,observed,in'
p40264
g3
sS'significant,decrease,in'
p40265
g9
sS'are,taking,any'
p40266
g3
sS'at,ph,was'
p40267
g3
sS'increased,vasoconstriction,after'
p40268
g9
sS'enzymes,is,recommended'
p40269
g9
sS'with,those,of'
p40270
g3
sS'antithrombotics,aspirin,and'
p40271
g3
sS'studies,and,the'
p40272
g3
sS'antihypertensive,additive,effect'
p40273
g3
sS'been,effectively,administered'
p40274
g3
sS'amphotericin,b,patients'
p40275
g9
sS'childbearing,potential,must'
p40276
g3
sS'for,seven,days'
p40277
g3
sS'the,blood,glucose'
p40278
g9
sS'and,cardiovascular,safety'
p40279
g3
sS'dmpge2,given,intraluminally'
p40280
g3
sS'an,ability,of'
p40281
g3
sS'concentration,times,the'
p40282
g3
sS'a,course,of'
p40283
g3
sS'properties,of,induced'
p40284
g3
sS'elevations,of,urinary'
p40285
g3
sS'evaluate,the,antianginal'
p40286
g3
sS'accelerated,when,they'
p40287
g9
sS'magnesium-containing,meq,or'
p40288
g3
sS'the,cytochrome,p450iiia4'
p40289
g9
sS'is,however,currently'
p40290
g3
sS'combination,of,the'
p40291
g3
sS'frequently,with,in'
p40292
g3
sS'of,another,tnf'
p40293
g9
sS'uricosuric,agents,and'
p40294
g9
sS'after,being,dosed'
p40295
g3
sS'prolonged,from,minutes'
p40296
g9
sS'supplementation,which,is'
p40297
g3
sS'other,agents,known'
p40298
g3
sS'of,renal,impairment'
p40299
g3
sS'prodrug,are,reported'
p40300
g3
sS'as,the,retention'
p40301
g3
sS'with,commonly,employed'
p40302
g3
sS'day,showed,that'
p40303
g3
sS'of,bone,marrow'
p40304
g3
sS'interfere,with,absorption'
p40305
g9
sS'or,as,well'
p40306
g9
sS'the,pathophysiologic,consequences'
p40307
g3
sS'inhibits,the,effects'
p40308
g9
sS'of,prostaglandin,synthase'
p40309
g9
sS'from,to,was'
p40310
g9
sS'a,lack,of'
p40311
g3
sS'continue,to,be'
p40312
g3
sS'co-administration,of,other'
p40313
g9
sS'additive,effect,when'
p40314
g9
sS'the,reduction,in'
p40315
g9
sS'enantiomers,or,the'
p40316
g3
sS'vitro,antiviral,activity'
p40317
g9
sS'levels,of,several'
p40318
g9
sS'sh,da,sh'
p40319
g3
sS'out,of,a'
p40320
g3
sS'h1,and,h2'
p40321
g9
sS'discontinues,therapy,with'
p40322
g9
sS'patients,had,liver'
p40323
g3
sS'have,synergistic,activity'
p40324
g9
sS'to,be,initiated'
p40325
g3
sS'cyp,c19,substrate'
p40326
g3
sS'result,from,combined'
p40327
g9
sS'with,caution,should'
p40328
g9
sS'humans,show,that'
p40329
g9
sS'enhanced,possibility,of'
p40330
g3
sS'as,assessed,by'
p40331
g3
sS'fold,lower,than'
p40332
g9
sS'and,in,dogs'
p40333
g9
sS'low,therapeutic,margin'
p40334
g3
sS'study,were,to'
p40335
g3
sS'dry,mouth,urinary'
p40336
g9
sS'to,other,antiepileptic'
p40337
g3
sS'double,the,bioavailability'
p40338
g9
sS'absorbed,when,taking'
p40339
g3
sS'concomitant,use,may'
p40340
g9
sS'biopharmaceutical,properties,relative'
p40341
g3
sS'reduced,higher,doses'
p40342
g3
sS'dosing,was,separated'
p40343
g9
sS'of,the,urinary'
p40344
g3
sS'arc,gene,which'
p40345
g3
sS'no,positive,reaction'
p40346
g3
sS'at,five,commonly'
p40347
g3
sS'this,may,enhance'
p40348
g3
sS'ml,sc,or'
p40349
g3
sS'arterial,pressure,of'
p40350
g9
sS'of,metabolized,by'
p40351
g3
sS'as,selective,serotonin'
p40352
g9
sS'in,the,environment'
p40353
g3
sS'in,free,radical-mediated'
p40354
g9
sS'after,a,bile'
p40355
g9
sS'clinically,meaningful,interactions'
p40356
g3
sS'maximum,concentration,was'
p40357
g3
sS'in,inhibition,of'
p40358
g9
sS'life-threatening,interactions,with'
p40359
g9
sS'lead,to,electrolyte'
p40360
g9
sS'experience,as,they'
p40361
g3
sS'for,the,treatment'
p40362
g3
sS'invasion,of,adenocarcinomas'
p40363
g9
sS'potential,of,on'
p40364
g3
sS'depression,hypotension,and'
p40365
g9
sS'direct,coombs,test'
p40366
g3
sS'to,and,for'
p40367
g3
sS'some,that,are'
p40368
g3
sS'reduce,both,the'
p40369
g9
sS'bioavailability,of,novolog'
p40370
g3
sS'homodimeric,disintegrin,and'
p40371
g3
sS'the,diabectics,than'
p40372
g3
sS'm,g,h'
p40373
g9
sS'plasma,concentrations,achieved'
p40374
g3
sS'concurrently,increases,anion'
p40375
g9
sS'published,information,on'
p40376
g3
sS'considered,when,taking'
p40377
g9
sS'that,inhibit,drug'
p40378
g3
sS'pharmacokinetic,drug-drug,interaction'
p40379
g3
sS'with,absorption,and'
p40380
g9
sS'observed,between,older'
p40381
g3
sS'alkaloids,should,be'
p40382
g9
sS'tablets,are,not'
p40383
g3
sS'of,a,beta'
p40384
g9
sS'effect,on,felbatol'
p40385
g3
sS'twitch,for,a'
p40386
g3
sS'cocaine,sometimes,proves'
p40387
g9
sS'hepatic,impairment,may'
p40388
g3
sS'every,hours,was'
p40389
g9
sS'transient,cardiac,arrhythmias'
p40390
g9
sS'of,unchanged,and'
p40391
g3
sS'dosage,of,phosphate-binding'
p40392
g3
sS'impacted,by,concomitant'
p40393
g3
sS'with,or,with'
p40394
g9
sS'systemic,anticholinesterase,treatment'
p40395
g3
sS'increases,about,two'
p40396
g9
sS'suggest,that,acute'
p40397
g3
sS'plus,was,poorly'
p40398
g9
sS'time,should,be'
p40399
g9
sS'the,v,v'
p40400
g3
sS'are,types,of'
p40401
g3
sS'sustiva,and,these'
p40402
g3
sS'they,have,been'
p40403
g3
sS'have,one,or'
p40404
g3
sS'concentrations,of,at'
p40405
g3
sS'on,weeks,and'
p40406
g3
sS'each,task,it'
p40407
g3
sS'bsa,increases,in'
p40408
g3
sS'because,nephrotoxicity,may'
p40409
g9
sS'hoof,twitch,from'
p40410
g9
sS'b,injection,and'
p40411
g9
sS'mean,distribution,of'
p40412
g3
sS's,effect,will'
p40413
g9
sS'is,also,prolonged'
p40414
g3
sS'on,plasma,concentration'
p40415
g3
sS'decreased,synthesis,of'
p40416
g9
sS'other,no,clinically'
p40417
g3
sS'or,diarrhea,induced'
p40418
g9
sS'plasma,concentrations,decreased'
p40419
g3
sS'joint,action,ija'
p40420
g3
sS'and,an,are'
p40421
g9
sS'injection,who,were'
p40422
g3
sS'observed,with,preparations'
p40423
g9
sS'other,may,be'
p40424
g3
sS'that,and,significantly'
p40425
g9
sS'aprepitant,was,given'
p40426
g3
sS'limits,of,the'
p40427
g3
sS'steady,state,serum'
p40428
g3
sS'the,upper,limit'
p40429
g3
sS'of,dosage,or'
p40430
g3
sS'who,were,subsequently'
p40431
g9
sS'occurs,when,the'
p40432
g3
sS'signs,of,renal'
p40433
g3
sS'benefits,of,combined'
p40434
g9
sS'non-steroidal,anti-inflammatory,drugs'
p40435
g9
sS'smooth,muscle,cell'
p40436
g3
sS'less,than,second'
p40437
g3
sS'of,each,other'
p40438
g9
sS'patient,should,be'
p40439
g3
sS'studies,do,not'
p40440
g9
sS'of,was,prepared'
p40441
g3
sS'receiving,known,enzyme'
p40442
g9
sS'doses,of,but'
p40443
g3
sS'treatment,for,anaphylactic'
p40444
g3
sS'variety,of,allergens'
p40445
g3
sS'or,a,diminished'
p40446
g9
sS'usp,to,subjects'
p40447
g9
sS'tendency,to,cause'
p40448
g9
sS'be,observed,with'
p40449
g9
sS'concurrent,and,avastin'
p40450
g3
sS'solutions,should,be'
p40451
g3
sS'levels,and,pharmaco-dynamic'
p40452
g3
sS'aleve,or,ibuprofen'
p40453
g9
sS'showed,increased,deet'
p40454
g3
sS'this,reduction,is'
p40455
g9
sS'to,for,the'
p40456
g9
sS'and,the,muscle'
p40457
g9
sS'since,the,effect'
p40458
g3
sS'or,abrasive,soaps'
p40459
g3
sS'diets,containing,either'
p40460
g3
sS'in,certain,tumor'
p40461
g3
sS'months,at,mg'
p40462
g3
sS'phase,i,trial'
p40463
g9
sS'or,within,hours'
p40464
g9
sS'the,tablets,as'
p40465
g9
sS'than,expected,lasma'
p40466
g3
sS'recommendation,to,lower'
p40467
g3
sS'k,oral,unreliable'
p40468
g9
sS'were,not,attenuated'
p40469
g3
sS'the,washout,period'
p40470
g3
sS'drugs,on,felbatol'
p40471
g9
sS'of,these,could'
p40472
g9
sS'recovery,following,an'
p40473
g9
sS'basis,of,this'
p40474
g3
sS'achieved,within,the'
p40475
g3
sS'johns,wort,hypericum'
p40476
g3
sS'ph,was,used'
p40477
g3
sS'to,a,reduction'
p40478
g9
sS'drug-drug,interactions,given'
p40479
g9
sS'time,must,elapse'
p40480
g3
sS'the,utilization,of'
p40481
g3
sS'trial,data,where'
p40482
g9
sS'concentration,of,one'
p40483
g3
sS'kerlone,and,have'
p40484
g3
sS'uncontrolled,domestic,studies'
p40485
g3
sS'there,is,rapid'
p40486
g3
sS's,that,are'
p40487
g9
sS'circulating,metabolite,hydroxy-estazolam'
p40488
g3
sS'particles,of,in'
p40489
g3
sS'was,also,shown'
p40490
g3
sS'cells,in,response'
p40491
g3
sS'only,additive,effects'
p40492
g9
sS'weeks,in,healthy'
p40493
g9
sS'of,a,mammalian'
p40494
g3
sS'cases,it,was'
p40495
g3
sS'studies,of,mevacor'
p40496
g3
sS'study,and,those'
p40497
g3
sS'half-life,of,elimination'
p40498
g3
sS'of,by,is'
p40499
g9
sS'of,the,menstrual'
p40500
g3
sS'cadmium,and,cadmium'
p40501
g3
sS'inhibited,phosphorylation,in'
p40502
g9
sS'but,did,produce'
p40503
g3
sS'anti-inflammatory,agents,and'
p40504
g9
sS'known,interactions,between'
p40505
g3
sS'allergens,either,by'
p40506
g3
sS'above,cmax,levels'
p40507
g3
sS'contributed,to,hyperglycemia'
p40508
g3
sS'both,ca,and'
p40509
g9
sS'in,plasma,auc'
p40510
g3
sS'elevated,liver,function'
p40511
g9
sS'on,the,fertility'
p40512
g3
sS'crossover,study,to'
p40513
g3
sS'some,patients,receiving'
p40514
g3
sS'or,acth,treatment'
p40515
g3
sS'sustiva,and,nrtis'
p40516
g3
sS'ci,when,was'
p40517
g9
sS'patients,were,diagnosed'
p40518
g3
sS'symptomatology,is,unusual'
p40519
g3
sS'cytochrome,p450iid6,such'
p40520
g9
sS'and,related,may'
p40521
g9
sS'reduced,to,approximately'
p40522
g3
sS'occasions,resulted,in'
p40523
g9
sS'alone,auc,increased'
p40524
g9
sS'that,are,cyp3a4'
p40525
g9
sS'and,oral,a'
p40526
g9
sS'the,data,from'
p40527
g3
sS'following,precautions,should'
p40528
g9
sS'ic50,from,to'
p40529
g3
sS'metabolic,rate,which'
p40530
g3
sS'therapeutic,range,in'
p40531
g9
sS'psychiatric,rating,scale'
p40532
g9
sS'treatment,of,hypotension'
p40533
g9
sS'that,are,substrates'
p40534
g3
sS'other,membrane,properties'
p40535
g3
sS'cautioned,against,driving'
p40536
g3
sS'had,had,a'
p40537
g3
sS'have,experienced,elevated'
p40538
g3
sS'control,and,continued'
p40539
g3
sS'in,serum,auc'
p40540
g9
sS'can,be,administered'
p40541
g3
sS'administered,with,extreme'
p40542
g9
sS'protein,mna,may'
p40543
g3
sS'as,adverse,experiences'
p40544
g3
sS'is,not,highly'
p40545
g3
sS'of,serum,assays'
p40546
g3
sS'collected,on,the'
p40547
g3
sS'and,oral,in'
p40548
g3
sS'changes,in,pharmacokinetics'
p40549
g3
sS'much,less,caspase-3'
p40550
g3
sS'although,the,relevance'
p40551
g3
sS'ability,of,the'
p40552
g3
sS'phenytoin,if,is'
p40553
g9
sS'all,subjects,received'
p40554
g3
sS'pancreatic,alpha,cell'
p40555
g3
sS'a,slight,degree'
p40556
g3
sS'tricyclic,tcas,when'
p40557
g3
sS'animal,studies,indicate'
p40558
g9
sS'that,are,negatively'
p40559
g3
sS'no,evidence,that'
p40560
g3
sS'to,be,produced'
p40561
g3
sS'are,indicated,alternative'
p40562
g3
sS'or,tumor,vascularity'
p40563
g3
sS'and,subsalicylate,should'
p40564
g9
sS'increased,the,exposure'
p40565
g9
sS'avoid,concurrent,administration'
p40566
g9
sS'enzyme-based,tests,such'
p40567
g3
sS'and,dna-damaging,agents'
p40568
g3
sS'single,or,repeated'
p40569
g3
sS'intravenous,misuse,of'
p40570
g9
sS'tranxene,tablets,are'
p40571
g3
sS'abnormal,handling,of'
p40572
g3
sS'was,investigated,as'
p40573
g3
sS'by,overdose,with'
p40574
g9
sS'inhibit,sodium,binding'
p40575
g9
sS'cytochrome,p450iid6,cyp2d6'
p40576
g3
sS'renal,prostaglandins,may'
p40577
g9
sS'low-dose,has,been'
p40578
g9
sS'was,a,multicenter'
p40579
g3
sS'the,diuretic,natriuretic'
p40580
g9
sS'amphotericin,b,injection'
p40581
g9
sS'by,the,hepatic'
p40582
g3
sS'increase,in,sn38'
p40583
g3
sS'synthesis,and,theoretically'
p40584
g3
sS'the,fetus,due'
p40585
g3
sS'that,the,solubility'
p40586
g3
sS'was,higher,than'
p40587
g9
sS'hypoglycemia,secondary,to'
p40588
g9
sS'coadministered,with,another'
p40589
g3
sS'the,extent,to'
p40590
g9
sS'have,occurred,in'
p40591
g9
sS'haca,titers,may'
p40592
g3
sS'renal,precipitation,of'
p40593
g3
sS'of,zdv,as'
p40594
g9
sS'of,the,anticoagulants'
p40595
g3
sS'least,hour,before'
p40596
g9
sS'simvastatin,cyp3a4,substrate'
p40597
g3
sS'release,capsules,since'
p40598
g9
sS'negative,inotropic,effects'
p40599
g9
sS'alphagan,p,administration'
p40600
g3
sS'mmol,mmol,l'
p40601
g3
sS'also,on,the'
p40602
g3
sS'age-dependent,alterations,in'
p40603
g3
sS'itraconazole,mg,b'
p40604
g3
sS'dose,of,serious'
p40605
g3
sS'appearance,of,unsteady'
p40606
g9
sS'interactions,between,keppra'
p40607
g3
sS'reflected,in,the'
p40608
g3
sS'index,of,the'
p40609
g3
sS'have,cholesterol,levels'
p40610
g9
sS'include,some,that'
p40611
g3
sS'episode,of,migraine'
p40612
g3
sS'on,absorption,has'
p40613
g3
sS'decreasing,heparin,effect'
p40614
g9
sS'as,or,iv'
p40615
g3
sS'there,are,case'
p40616
g9
sS'day,did,not'
p40617
g3
sS'lansoprazole,causes,a'
p40618
g3
sS'studies,nitrates,the'
p40619
g9
sS'hypotensive,effect,has'
p40620
g9
sS'therapy,the,introduction'
p40621
g9
sS'enzyme,in,the'
p40622
g3
sS'fr,responding,produced'
p40623
g9
sS'unlikely,to,inhibit'
p40624
g3
sS'by,an,elevation'
p40625
g3
sS'patients,on,may'
p40626
g9
sS'steady-state,pharmacokinetics,after'
p40627
g3
sS'which,were,submitted'
p40628
g3
sS'given,and,hours'
p40629
g3
sS'of,taxol,at'
p40630
g3
sS'bisphosphonates,are,known'
p40631
g3
sS'either,single,or'
p40632
g3
sS'on,concurrent,usage'
p40633
g3
sS'may,decrease,hepatic'
p40634
g9
sS'on,felbatol,the'
p40635
g3
sS'self-administration,of,and'
p40636
g3
sS'striatal,concentrations,and'
p40637
g9
sS'be,interrupted,when'
p40638
g3
sS'cation-containing,products,concurrent'
p40639
g9
sS'in,switching,from'
p40640
g9
sS'infants,has,specifically'
p40641
g3
sS'warfarin,a,single'
p40642
g3
sS'as,nonsteroidal,anti-inflammatory'
p40643
g9
sS'analyses,indicate,that'
p40644
g9
sS'indinavir,and,formulations'
p40645
g9
sS'the,other,that'
p40646
g3
sS'concomitant,administration,on'
p40647
g3
sS'a,substantially,greater'
p40648
g3
sS'of,atp,and'
p40649
g3
sS'concomitant,administration,of'
p40650
g9
sS'this,enzyme,prolongs'
p40651
g3
sS'initial,dose,for'
p40652
g3
sS'antihypertensive,medications,and'
p40653
g9
sS'between,the,liver'
p40654
g3
sS'be,taken,closely'
p40655
g9
sS'by,hepatic,enzyme'
p40656
g9
sS'that,an,agent'
p40657
g3
sS'potentials,in,visual'
p40658
g3
sS'cyp1a2,cyp2a6,cyp2b6'
p40659
g3
sS'deet,n,n-diethyl'
p40660
g9
sS'inconsistent,reports,regarding'
p40661
g3
sS'sodium,colistemethate,salts'
p40662
g9
sS'inducer,the,auc'
p40663
g9
sS'be,approved,for'
p40664
g3
sS'bleeding,and,should'
p40665
g9
sS'kingdom,with,foscavir'
p40666
g9
sS'and,serum,levels'
p40667
g9
sS'such,preparations,to'
p40668
g3
sS'sexual,activity,is'
p40669
g3
sS'substances,the,types'
p40670
g3
sS'co-administered,with,mg'
p40671
g9
sS'reports,of,serious'
p40672
g9
sS'of,this,agent'
p40673
g3
sS'frequency,on,placebo'
p40674
g3
sS'divalent,and,trivalent'
p40675
g9
sS'irradiation,was,delayed'
p40676
g3
sS'cyp,enzymes,d6'
p40677
g3
sS'immediate,release,but'
p40678
g9
sS'at,high,trileptal'
p40679
g9
sS'additional,supine,systolic'
p40680
g9
sS'to,any,medication'
p40681
g9
sS'more,pronounced,secretory'
p40682
g3
sS'of,patients,experiencing'
p40683
g9
sS'drugs,ethanol,an'
p40684
g9
sS'from,what,would'
p40685
g3
sS'given,mg,of'
p40686
g9
sS'significant,in,patients'
p40687
g9
sS'patients,receiving,nalfon'
p40688
g9
sS'adverse,events,including'
p40689
g3
sS'differences,in,sensitivity'
p40690
g3
sS'however,and,all'
p40691
g3
sS'decrease,the,efficacy'
p40692
g9
sS'hypomania,restlessness,loss'
p40693
g3
sS'hyperlactatemia,lactic,acidosis'
p40694
g3
sS'affinity,for,anions'
p40695
g3
sS'activity,which,was'
p40696
g9
sS'loss,of,symptom'
p40697
g9
sS'clinical,studies,involving'
p40698
g9
sS'growth,of,pseudomonas'
p40699
g3
sS'metabolite,has,reduced'
p40700
g3
sS'non-pegylated,alfa-2a,treatment'
p40701
g3
sS'after,or,after'
p40702
g9
sS'transferase,it,is'
p40703
g3
sS'affect,the,pituitary'
p40704
g3
sS'is,structurally,distinct'
p40705
g3
sS'fractional,inhibitory,concentration'
p40706
g3
sS'typically,nonlinear,in'
p40707
g3
sS'alkalinizing,agents,sodium'
p40708
g9
sS'taking,mg,day'
p40709
g9
sS'since,nevirapinemay,lower'
p40710
g9
sS'example,the,plasma'
p40711
g3
sS'may,interfere,with'
p40712
g9
sS'against,hepatic,microsomal'
p40713
g3
sS'potential,benefits,outweigh'
p40714
g9
sS'lacking,cyp3a4,inducing'
p40715
g3
sS'pharmacodynamic,interaction,use'
p40716
g9
sS'by,radioimmunoassay,or'
p40717
g3
sS'withdrawal,methadone,maintained'
p40718
g9
sS'day,qd,cohort'
p40719
g3
sS'inducer,although,not'
p40720
g3
sS'adrenergic,blockers,may'
p40721
g3
sS'can,correct,the'
p40722
g3
sS'within,class,not'
p40723
g3
sS'of,tricyclic,tcas'
p40724
g3
sS'treatment,occurred,in'
p40725
g3
sS'effects,blood,and'
p40726
g3
sS'adjustments,of,should'
p40727
g9
sS'coadministration,of,lexapro'
p40728
g3
sS'chlorpromazine,chlorpromazine,blocks'
p40729
g9
sS'specific,d1,antagonist'
p40730
g9
sS'in,approximately,decrease'
p40731
g9
sS'and,antidotal,properties'
p40732
g9
sS'for,three,strains'
p40733
g3
sS'bromocriptine,mesylate,in'
p40734
g9
sS'cotherapy,an,increased'
p40735
g3
sS'indicated,reduction,of'
p40736
g9
sS'kg,removes,the'
p40737
g9
sS'maximum,concentration,increased'
p40738
g9
sS'alfenta,clearance,and'
p40739
g9
sS'or,other,beta2'
p40740
g9
sS'the,factrel,test'
p40741
g3
sS'that,epa,supplements'
p40742
g3
sS'in,those,such'
p40743
g3
sS'seen,in,non-specialist'
p40744
g3
sS'changes,in,serum'
p40745
g3
sS'when,an,and'
p40746
g9
sS'was,more,likely'
p40747
g3
sS'if,such,drugs'
p40748
g3
sS'alterations,of,clearance'
p40749
g3
sS'alternatives,to,the'
p40750
g3
sS'with,other,the'
p40751
g9
sS'oral,in,combination'
p40752
g3
sS'of,genomes,have'
p40753
g3
sS'day,was,coadministered'
p40754
g9
sS'northern,blot,analysis'
p40755
g3
sS'the,total,amount'
p40756
g3
sS'aminoglutethimide,may,diminish'
p40757
g9
sS'for,in,patients'
p40758
g3
sS'receiving,these,concomitant'
p40759
g9
sS'from,other,monomeric'
p40760
g3
sS'administration,in,march'
p40761
g3
sS'pipracil,may,result'
p40762
g3
sS'by,interaction,with'
p40763
g9
sS'subjects,received,mg'
p40764
g3
sS'cytadren,accelerates,the'
p40765
g9
sS'lipids,should,be'
p40766
g3
sS'because,bleeding,has'
p40767
g9
sS'literature,reports,suggest'
p40768
g9
sS'by,ex,vivo'
p40769
g3
sS'separated,by,at'
p40770
g9
sS'cytochrome,p450iid6,may'
p40771
g3
sS'with,other,antipsychotic'
p40772
g9
sS'our,laboratory,preliminary'
p40773
g3
sS'study,received,either'
p40774
g3
sS'block,with,and'
p40775
g3
sS'compounds,meclofenamic,acid'
p40776
g9
sS'the,physiological,behavioral'
p40777
g3
sS'use,of,anticholinesterase'
p40778
g9
sS'praziquantel,in,the'
p40779
g9
sS'other,lesions,resulting'
p40780
g3
sS'the,following,nicotinic'
p40781
g3
sS'since,bacteriostatic,such'
p40782
g9
sS'immediate,discontinuation,of'
p40783
g3
sS'these,may,be'
p40784
g9
sS'the,blockade,of'
p40785
g3
sS'to,potentiate,the'
p40786
g3
sS'tendon,reflexes,hourly'
p40787
g3
sS'treated,by,during'
p40788
g3
sS'of,was,ng'
p40789
g9
sS'valium,is,a'
p40790
g3
sS'in,survanta,a'
p40791
g3
sS'pyogenes,and,anaerobic'
p40792
g3
sS'cases,approximately,case'
p40793
g3
sS'trial,that,included'
p40794
g3
sS'of,the,during'
p40795
g9
sS'zmax,have,not'
p40796
g3
sS'may,even,be'
p40797
g9
sS'mrna,level,in'
p40798
g9
sS'amyl,nitrite,after'
p40799
g9
sS'of,tbars,levels'
p40800
g9
sS'stimulating,properties,of'
p40801
g3
sS'twitch,was,for'
p40802
g9
sS'small,with,occasional'
p40803
g3
sS'significant,lengthening,of'
p40804
g3
sS'effect,is,at'
p40805
g3
sS'angiotensin,on,pentagastrin-'
p40806
g3
sS'suppression,test,dst'
p40807
g3
sS'administration,of,ponstel'
p40808
g9
sS'specific,and,aspecific'
p40809
g3
sS'cas,a,kda'
p40810
g3
sS'significant,elevations,of'
p40811
g3
sS'neuropathy,include,nucleoside'
p40812
g3
sS'one,controlled,clinical'
p40813
g9
sS'or,marked,changes'
p40814
g9
sS'oral,during,administration'
p40815
g9
sS'significant,deterioration,in'
p40816
g3
sS'when,extended,sodium'
p40817
g3
sS'effects,were,evident'
p40818
g3
sS'administration,with,may'
p40819
g9
sS'elevating,duodenal,absorption'
p40820
g9
sS'oral,antidiabetes,products'
p40821
g3
sS'of,positive,and'
p40822
g3
sS'theoretically,occur,if'
p40823
g3
sS'mg,vardenafil,in'
p40824
g3
sS'immunoreactive,concentrations,were'
p40825
g3
sS'b-blocking,agent,should'
p40826
g9
sS'to,chelated,extracellular'
p40827
g3
sS'cyclase,activity,but'
p40828
g3
sS'or,its,components'
p40829
g3
sS'and,increase,its'
p40830
g9
sS'used,concomitantly,and'
p40831
g9
sS'areas,examines,the'
p40832
g3
sS'the,stimulant,action'
p40833
g3
sS'single,study,rats'
p40834
g9
sS'or,potentially,toxic'
p40835
g3
sS'dose,study,in'
p40836
g3
sS'ovarian,granulosa,cell'
p40837
g3
sS'glyburide,an,increased'
p40838
g3
sS'addition,or,deletion'
p40839
g3
sS'a,twofold,increase'
p40840
g9
sS'protein,when,was'
p40841
g3
sS'was,a,small'
p40842
g9
sS'overlapping,administration,of'
p40843
g3
sS'altered,tsh,secretion'
p40844
g3
sS'approximately,to,times'
p40845
g3
sS'pegasys,once,weekly'
p40846
g9
sS'nsaids,may,cause'
p40847
g9
sS'prior,administration,of'
p40848
g9
sS'may,cause,hypotension'
p40849
g3
sS'clotting,factors,when'
p40850
g3
sS'inducers,are,indicated'
p40851
g3
sS'of,with,elspar'
p40852
g9
sS'v,did,not'
p40853
g3
sS'pronestyl,sulfa,medicines'
p40854
g9
sS'as,factor,ii'
p40855
g3
sS'use,of,romazicon'
p40856
g3
sS'whether,ginsenosides-induced,inhibition'
p40857
g3
sS'occur,with,use'
p40858
g3
sS'to,adversely,affect'
p40859
g3
sS'formulation,of,fluorescence'
p40860
g3
sS'there,any,changes'
p40861
g3
sS'opportunistic,infection,oi'
p40862
g3
sS'open-label,two-way,crossover'
p40863
g3
sS'men,for,the'
p40864
g3
sS'warranted,when,is'
p40865
g9
sS'depressant,effects,on'
p40866
g3
sS'considered,particularly,when'
p40867
g3
sS'or,laboratory,test'
p40868
g3
sS'more,pronounced,in'
p40869
g3
sS'approximately,twofold,at'
p40870
g3
sS'animals,treated,with'
p40871
g9
sS'known,property,of'
p40872
g9
sS'more,pronounced,if'
p40873
g9
sS'whether,an,alteration'
p40874
g3
sS'once,monthly,was'
p40875
g3
sS'receive,low-molecular,weight'
p40876
g3
sS'bleeding,and,or'
p40877
g9
sS'rate,increased,initially'
p40878
g3
sS'copegus,in,patients'
p40879
g3
sS'several-fold,higher,daily'
p40880
g3
sS'observed,during,the'
p40881
g3
sS'other,asthma,or'
p40882
g3
sS'rifampicin,racemic,exposure'
p40883
g9
sS'a,dihydropyridine,derivative'
p40884
g3
sS'median,fold,accumulation'
p40885
g3
sS'possible,pharmacodynamic,interactions'
p40886
g9
sS'in,therapy,of'
p40887
g3
sS'absorption,or,by'
p40888
g3
sS'metabolism,of,is'
p40889
g3
sS'over,use,of'
p40890
g9
sS'completely,inhibited,by'
p40891
g9
sS'reassessed,and,where'
p40892
g3
sS'and,therefore,has'
p40893
g3
sS'the,intracellular,phosphorylation'
p40894
g9
sS'affect,the,extent'
p40895
g3
sS'results,insulin,increased'
p40896
g3
sS'increase,is,greatest'
p40897
g3
sS'observed,during,studies'
p40898
g9
sS'ml,min,p'
p40899
g9
sS'remedies,may,be'
p40900
g3
sS'an,approximate,doubling'
p40901
g9
sS'as,they,might'
p40902
g9
sS'felbamate,treatment,resulted'
p40903
g9
sS'membrane,and,intracellular'
p40904
g3
sS'the,plasma,protein'
p40905
g3
sS'its,normal,dose'
p40906
g9
sS'cns,drugs,given'
p40907
g3
sS'these,increases,should'
p40908
g9
sS'metabolized,should,have'
p40909
g9
sS'coadministered,although,the'
p40910
g3
sS'major,clinical,importance'
p40911
g9
sS'the,steady-state,pharmacokinetics'
p40912
g3
sS'moderate,inducer,of'
p40913
g3
sS'were,very,strong'
p40914
g9
sS'monthly,was,similar'
p40915
g3
sS'may,present,a'
p40916
g9
sS'oral,administration,even'
p40917
g3
sS'and,anticoagulants,increased'
p40918
g9
sS'avonex,indicates,that'
p40919
g3
sS'increased,intraocular,pressure'
p40920
g3
sS'recommended,that,concentrations'
p40921
g9
sS'indinavir,concentrations,may'
p40922
g9
sS'have,a,significant'
p40923
g3
sS'substrate,of,cyp3a4'
p40924
g3
sS'especially,at,arterial'
p40925
g3
sS'may,be,decreased'
p40926
g3
sS'be,made,by'
p40927
g3
sS'an,hmg-coa,reductase'
p40928
g9
sS'concentrations,and,a'
p40929
g9
sS'the,survanta,and'
p40930
g3
sS'characteristics,related,to'
p40931
g3
sS'mcf-7,cells,either'
p40932
g3
sS'and,increase,growth'
p40933
g3
sS'mechanism,and,a'
p40934
g9
sS'given,fu,bolus-ifl'
p40935
g3
sS'before,a,nonlethal'
p40936
g9
sS'enhance,the,effects'
p40937
g9
sS'medial,survival,of'
p40938
g3
sS'spaces,have,been'
p40939
g3
sS'weeks,in,rats'
p40940
g3
sS'study,involving,six-healthy'
p40941
g3
sS'use,of,regranex'
p40942
g3
sS'thyroid,products,oral'
p40943
g3
sS'with,and,has'
p40944
g3
sS'may,be,produced'
p40945
g9
sS'when,parenteral,are'
p40946
g3
sS'parameters,should,if'
p40947
g3
sS'chemical,resemblance,of'
p40948
g9
sS'inhalation,aerosol,has'
p40949
g3
sS'than,and,would'
p40950
g3
sS'aerosol,and,these'
p40951
g3
sS'enzyme,systems,may'
p40952
g3
sS'cyp3a,inducers,such'
p40953
g9
sS'the,dopaminergic,renal'
p40954
g9
sS'regular,users,develop'
p40955
g3
sS'providers,are,encouraged'
p40956
g3
sS'cmax,the,geometric'
p40957
g3
sS'serum,levels,of'
p40958
g9
sS'felbatol,therapy,resulted'
p40959
g3
sS'significant,impact,on'
p40960
g9
sS'a,or,induce'
p40961
g3
sS'serum,levels,or'
p40962
g9
sS'with,appropriate,adjustment'
p40963
g3
sS'both,and,after'
p40964
g3
sS'the,not,only'
p40965
g3
sS'of,desired,effect'
p40966
g3
sS'between,solvents,have'
p40967
g3
sS'chick,by,means'
p40968
g3
sS'alpha,interferons,such'
p40969
g3
sS'specific,treatment,for'
p40970
g3
sS'is,given,with'
p40971
g3
sS'even,when,an'
p40972
g9
sS'and,by,observations'
p40973
g3
sS'as,and,may'
p40974
g9
sS'possible,before,being'
p40975
g3
sS'initial,step,in'
p40976
g3
sS'organization,criteria,was'
p40977
g3
sS'on,the,basis'
p40978
g3
sS'bolus,followed,by'
p40979
g3
sS'these,events,are'
p40980
g3
sS'for,uptake-1,were'
p40981
g3
sS'acetaminophen,oral,phenytoin'
p40982
g9
sS'isolated,single,pancreatic'
p40983
g3
sS'handling,of,in'
p40984
g3
sS'extent,of,interaction'
p40985
g3
sS'eliminated,by,the'
p40986
g3
sS'cefizox,nephrotoxicity,has'
p40987
g9
sS'levels,could,be'
p40988
g3
sS'metabolic,enzymes,is'
p40989
g3
sS'act,on,the'
p40990
g9
sS'opioids,are,strong'
p40991
g3
sS'in,a,double'
p40992
g3
sS'estradiol,and,some'
p40993
g9
sS'propanolol,the,pharmacokinetics'
p40994
g3
sS'may,have,contributed'
p40995
g3
sS'cilexetil,given,with'
p40996
g3
sS'should,also,refer'
p40997
g3
sS'marked,effect,on'
p40998
g9
sS'clinical,vancomycin-resistant,strains'
p40999
g3
sS'the,elimination,rate'
p41000
g3
sS'tegretol,tagamet,prozac'
p41001
g3
sS'such,interactions,might'
p41002
g3
sS'years,have,not'
p41003
g3
sS'by,concomitant,administration'
p41004
g9
sS'increased,in,hyperthyroid'
p41005
g3
sS'not,been,completely'
p41006
g3
sS'basal,small,intestinal'
p41007
g3
sS'tcas,when,given'
p41008
g3
sS'urinary,excretion,and'
p41009
g3
sS'on,application,mode'
p41010
g3
sS'two,hours,of'
p41011
g3
sS'synthesis,and,did'
p41012
g3
sS'prinivil,with,potassium-sparing'
p41013
g9
sS'on,the,biotransformation'
p41014
g9
sS'need,to,use'
p41015
g9
sS'as,possible,to'
p41016
g3
sS'chronic,activation,of'
p41017
g3
sS'to,a,patients'
p41018
g9
sS'etofibrate,elicited,enhancement'
p41019
g9
sS'most,effective,treatment'
p41020
g3
sS'fenofibric,acid,were'
p41021
g3
sS'restlessness,loss,of'
p41022
g3
sS'initiation,of,the'
p41023
g9
sS'did,not,include'
p41024
g3
sS'plays,an,important'
p41025
g3
sS'with,some,urinary'
p41026
g3
sS'for,multiple,forms'
p41027
g3
sS'the,pharmacokinetits,of'
p41028
g3
sS'depletions,of,striatal'
p41029
g9
sS'since,some,patients'
p41030
g3
sS'of,the,cyclooxygenase-2'
p41031
g3
sS'unknown,whether,this'
p41032
g3
sS'study,were,positive'
p41033
g3
sS'increase,for,equetrotm'
p41034
g9
sS'reductase,inhibitors,have'
p41035
g9
sS'although,c,max'
p41036
g3
sS'with,other,highly'
p41037
g3
sS'italy,from,april'
p41038
g3
sS'decreases,in,tbg'
p41039
g3
sS'within,weeks,of'
p41040
g9
sS'of,myocardial,infarction'
p41041
g3
sS'efficacy,toxicity,and'
p41042
g3
sS'patients,a,disulfiram-like'
p41043
g3
sS'were,approximately,bpm'
p41044
g3
sS'thereby,providing,for'
p41045
g3
sS'a,corresponding,increase'
p41046
g9
sS'hivid,with,that'
p41047
g3
sS'of,treatment,measures'
p41048
g3
sS'of,the,are'
p41049
g3
sS'reduced,by,concomitant'
p41050
g9
sS'that,inhibit,pgp'
p41051
g3
sS'ranges,of,either'
p41052
g3
sS'the,coadministration,of'
p41053
g3
sS'fungal,resistance,to'
p41054
g9
sS'c19,d6,e1'
p41055
g3
sS'strategies,during,conversion'
p41056
g3
sS'd,analogues,should'
p41057
g3
sS'plasma,concentrations,c'
p41058
g3
sS'mixed,signalled-unsignalled,differential-reinforcement'
p41059
g3
sS'not,recommended,for'
p41060
g9
sS'well,as,formulations'
p41061
g9
sS'patients,with,rheumatoid'
p41062
g3
sS'area-under,the-curve,after'
p41063
g9
sS'among,ras,nucleophosmin'
p41064
g3
sS'given,the,time'
p41065
g3
sS'accidental,contact,and'
p41066
g3
sS'ii,may,be'
p41067
g9
sS'oral,contraceptives,a'
p41068
g3
sS'result,of,administration'
p41069
g3
sS'and,organic,were'
p41070
g9
sS'of,tablets,in'
p41071
g9
sS'therefore,a,possible'
p41072
g3
sS'g,h,ml'
p41073
g9
sS'tests,such,as'
p41074
g3
sS'metabolism,were,homozygous'
p41075
g3
sS'with,or,glycoprotein'
p41076
g9
sS'below,have,not'
p41077
g3
sS'therapy,with,prinivil'
p41078
g9
sS'such,as,antiparkinson'
p41079
g9
sS'cyp3a3,also,inhibit'
p41080
g3
sS'of,other,pathways'
p41081
g3
sS'been,too,little'
p41082
g3
sS'antagonists,congestive,heart'
p41083
g3
sS'of,pseudotumor,cerebri'
p41084
g9
sS'were,performed,both'
p41085
g3
sS'have,several,advantages'
p41086
g3
sS'mhd,and,with'
p41087
g3
sS'drug,monitoring,may'
p41088
g3
sS'the,exception,of'
p41089
g3
sS'not,in,functional'
p41090
g9
sS'reported,upon,discontinuation'
p41091
g9
sS'oliguria,tachycardia,and'
p41092
g3
sS'benzodiazepines,were,administered'
p41093
g3
sS'and,dpcpx-induced,anxiogenic'
p41094
g9
sS'added,to,or'
p41095
g9
sS'use,of,selective'
p41096
g9
sS'cardiac,dysrhythmias,some'
p41097
g9
sS'commonly,associated,with'
p41098
g3
sS'was,no,clinical'
p41099
g3
sS'the,last,act'
p41100
g3
sS'a,higher,rate'
p41101
g3
sS'minipill,preparations,are'
p41102
g9
sS'table,changes,in'
p41103
g3
sS'hydroxy,acid,metabolite'
p41104
g9
sS'because,prostaglandina,play'
p41105
g9
sS'studies,in,peripheral'
p41106
g9
sS'in,cynomolgus,monkeys'
p41107
g3
sS'have,been,recognized'
p41108
g3
sS'vivo,and,clinically'
p41109
g3
sS'margin,such,as'
p41110
g3
sS'indicated,by,a'
p41111
g3
sS'they,may,lead'
p41112
g3
sS'hours,for,any'
p41113
g9
sS'concentrations,which,could'
p41114
g9
sS'of,the,increased'
p41115
g9
sS'each,of,these'
p41116
g3
sS'patient,for,possible'
p41117
g3
sS'with,concomitant,treatment'
p41118
g3
sS'warning,potential,for'
p41119
g3
sS'with,other,and'
p41120
g9
sS'tetracycline,a,bacteriostatic'
p41121
g9
sS'with,long-,and'
p41122
g3
sS'or,inactivated,due'
p41123
g9
sS'glucose,in,the'
p41124
g3
sS'major,serum,constituent'
p41125
g3
sS'inducer,of,drug-metabolizing'
p41126
g3
sS'time,lst,short'
p41127
g3
sS'to,the,microsomal'
p41128
g3
sS'withdrawn,from,patients'
p41129
g3
sS'and,effectiveness,in'
p41130
g3
sS'produce,cns-depressant,effects'
p41131
g9
sS'and,inhibitors,of'
p41132
g9
sS'normalized,ratio,when'
p41133
g9
sS'acid,the,mean'
p41134
g3
sS'such,as,ironing'
p41135
g3
sS'the,trials,due'
p41136
g3
sS'levels,could,have'
p41137
g3
sS'of,was,coadministered'
p41138
g3
sS'receiving,therapy,administration'
p41139
g3
sS'pharmacology,and,pharmacotherapy'
p41140
g3
sS'the,interaction,study'
p41141
g9
sS'the,nervous,system'
p41142
g9
sS'to,a,release'
p41143
g3
sS'and,were,administered'
p41144
g3
sS'n,ingestion,of'
p41145
g9
sS'onset,of,the'
p41146
g3
sS'theophylline,the,pharmacokinetics'
p41147
g3
sS'suggested,that,there'
p41148
g3
sS'to,mg,dl'
p41149
g3
sS'ph,may,be'
p41150
g3
sS'function,tests,since'
p41151
g3
sS'markedly,decreased,even'
p41152
g9
sS'of,interfere,with'
p41153
g9
sS'and,a,together'
p41154
g9
sS'and,coagulation,factor'
p41155
g3
sS'complex,overallactivity,against'
p41156
g3
sS'at,concentrations,well'
p41157
g3
sS'are,unchanged,when'
p41158
g3
sS'delayed,elimination,and'
p41159
g3
sS'the,translocation,when'
p41160
g3
sS'rash,pruritus,ankle'
p41161
g3
sS'release,of,atp'
p41162
g3
sS'at,mg,day'
p41163
g9
sS'all,animals,were'
p41164
g3
sS'low,to,measure'
p41165
g3
sS'have,been,found'
p41166
g3
sS'tbg,leading,to'
p41167
g3
sS'h,e,mesylate'
p41168
g9
sS'concentrations,and,therapeutic'
p41169
g9
sS'on,chronic,therapy'
p41170
g9
sS'clinically,relevant,effect'
p41171
g9
sS'treatment,with,xanthine'
p41172
g9
sS'concentrations,of,but'
p41173
g9
sS'dose,of,pcp'
p41174
g3
sS'with,the,auc'
p41175
g9
sS'reduced,if,a'
p41176
g9
sS'exposures,similar,to'
p41177
g3
sS'healthy,subjects,or'
p41178
g3
sS'mg,as,a'
p41179
g3
sS'which,may,interfere'
p41180
g3
sS'oral,the,prothrombin'
p41181
g9
sS'in,both,species'
p41182
g9
sS'and,a,high'
p41183
g9
sS'suggest,that,in'
p41184
g9
sS'are,potent,inducers'
p41185
g9
sS'no,significant,interaction'
p41186
g3
sS'thus,in,addition'
p41187
g3
sS'because,is,eliminated'
p41188
g9
sS'trough,plasma,and'
p41189
g3
sS'ratio,between,the'
p41190
g3
sS'racemic,titrated,to'
p41191
g3
sS'concern,about,the'
p41192
g9
sS'especially,in,cases'
p41193
g9
sS'curve,from,time'
p41194
g3
sS'behavioral,responses,to'
p41195
g3
sS'of,given,later'
p41196
g9
sS'resulting,from,concomitant'
p41197
g9
sS'does,not,displace'
p41198
g3
sS'estradiol,by,and'
p41199
g9
sS'relaxants,may,temporarily'
p41200
g9
sS'greater,amount,of'
p41201
g9
sS'of,rhabdomyolysis,were'
p41202
g3
sS'antihypertensive,effect,to'
p41203
g9
sS'greater,than,mug'
p41204
g3
sS'was,and,micrograms'
p41205
g3
sS'reported,to,competitively'
p41206
g9
sS'to,increased,risk'
p41207
g9
sS'delirium,associated,with'
p41208
g9
sS'taste,disorder,abdominal'
p41209
g3
sS'following,multiple,doses'
p41210
g3
sS'and,metabolite,concentrations'
p41211
g9
sS'microsomal,enzymes,cytochrome'
p41212
g3
sS'increased,in,patients'
p41213
g9
sS'with,targretin,capsules'
p41214
g9
sS'particularly,those,patients'
p41215
g3
sS'added,to,a'
p41216
g9
sS'mao,inhibitors,or'
p41217
g9
sS'was,correlated,with'
p41218
g3
sS'tonevirapine,caution,should'
p41219
g3
sS'increased,to,approximately'
p41220
g9
sS'metabolic,interference,has'
p41221
g3
sS'broadening,indications,for'
p41222
g3
sS'is,reduced,significantly'
p41223
g3
sS'pulmonary,or,systemic'
p41224
g3
sS'was,necessary,to'
p41225
g9
sS'between,discontinuation,of'
p41226
g9
sS'theories,assume,that'
p41227
g3
sS'with,or,sodium'
p41228
g9
sS'resulting,in,low'
p41229
g9
sS'of,rat,liver'
p41230
g3
sS'the,sixth,day'
p41231
g9
sS'and,extent,of'
p41232
g3
sS'was,a,tendency'
p41233
g3
sS'was,pharmacodynamic,with'
p41234
g3
sS'safely,used,in'
p41235
g3
sS'ethanol,depressed,the'
p41236
g3
sS'therefore,the,use'
p41237
g3
sS'against,micrococcus,luteus'
p41238
g3
sS'therapy,alone,can'
p41239
g3
sS'medication,on,patients'
p41240
g3
sS'multiple,dose,study'
p41241
g9
sS'antibiotics,videx,should'
p41242
g9
sS'also,used,it'
p41243
g9
sS'after,tracleer,is'
p41244
g9
sS'study,of,interaction'
p41245
g3
sS'speech,coordination,disorder'
p41246
g3
sS'general,and,during'
p41247
g3
sS'for,were,determined'
p41248
g3
sS'more,cardiovascular,risk'
p41249
g3
sS'lapatinib,inhibits,cyp3a4'
p41250
g3
sS'to,their,similar'
p41251
g9
sS'emptying,may,also'
p41252
g9
sS'c19,are,the'
p41253
g3
sS'approximately,case,per'
p41254
g3
sS'that,this,decrease'
p41255
g3
sS'in,a,short-term'
p41256
g3
sS'in,altered,plasma'
p41257
g3
sS'psychotic,reaction,has'
p41258
g3
sS'interacting,simultaneously,it'
p41259
g3
sS'p450,isozymes,a2'
p41260
g3
sS'interactions,may,be'
p41261
g9
sS'is,observed,it'
p41262
g3
sS'administration,of,both'
p41263
g3
sS'in,mouse,lymphoma'
p41264
g3
sS'antipsychotic,eg,an'
p41265
g9
sS'faecalis,by,antiresistance'
p41266
g3
sS'ethacrynic,acid,and'
p41267
g3
sS'infections,an,increased'
p41268
g9
sS'decreased,prothrombin,time'
p41269
g3
sS'present,in,both'
p41270
g3
sS'was,usually,observed'
p41271
g3
sS'is,not,extensively'
p41272
g3
sS'cfu,ml,for'
p41273
g3
sS'on,the,pt'
p41274
g3
sS'alterations,were,not'
p41275
g3
sS'cyp3a4,may,decrease'
p41276
g3
sS'as,post,marketing'
p41277
g9
sS'controlled,on,receiving'
p41278
g9
sS'the,core,temperature'
p41279
g3
sS'in,other,schizophrenic'
p41280
g9
sS'to,normal,menstrual'
p41281
g3
sS'therapy,with,all'
p41282
g9
sS'a,significantly,smaller'
p41283
g3
sS'by,checkerboard,assay'
p41284
g3
sS'been,observed,when'
p41285
g9
sS'substrate,should,be'
p41286
g3
sS'ventricular,arrhythmias,qt'
p41287
g3
sS'oral,solution,one'
p41288
g9
sS'of,because,they'
p41289
g9
sS'may,become,subtherapeutic'
p41290
g9
sS'an,apparently,t'
p41291
g3
sS'effect,of,induction'
p41292
g3
sS'to,hours,following'
p41293
g3
sS'in,and,epoxide'
p41294
g3
sS'motor,weakness,myoclonus'
p41295
g3
sS'mg,qd,cohort'
p41296
g3
sS'following,symptoms,excitement'
p41297
g3
sS'used,to,treat'
p41298
g3
sS'that,the,precipitate'
p41299
g3
sS'therapy,with,be'
p41300
g3
sS'measured,by,pbi'
p41301
g3
sS'fetal,development,consistent'
p41302
g3
sS'new,agents,are'
p41303
g3
sS'for,increased,both'
p41304
g3
sS'agents,is,indicated'
p41305
g3
sS'was,noted,even'
p41306
g9
sS'renin,release,captopril'
p41307
g9
sS'renal,and,ocular'
p41308
g3
sS'labeling,can,be'
p41309
g3
sS'when,bleeding,times'
p41310
g3
sS'to,a,mean'
p41311
g3
sS'coagulation,have,been'
p41312
g9
sS'oxidase,inhibitor,maoi'
p41313
g3
sS'whether,or,not'
p41314
g3
sS'chapter,focuses,on'
p41315
g3
sS'possible,to,avoid'
p41316
g3
sS'to,possible,pharmacodynamic'
p41317
g9
sS'an,altered,distribution'
p41318
g9
sS'but,not,when'
p41319
g9
sS'potentiated,by,through'
p41320
g3
sS'the,unbound,free'
p41321
g3
sS'of,three,lines'
p41322
g3
sS'the,small,gtp-binding'
p41323
g3
sS'involving,healthy,subjects'
p41324
g9
sS'clinically,relevant,effects'
p41325
g3
sS'per,day,for'
p41326
g3
sS'liver,enzymes,have'
p41327
g3
sS'were,dry,mouth'
p41328
g3
sS'loop,diuretics,furosemide'
p41329
g3
sS'concomitantly,with,beta-adrenergic'
p41330
g3
sS'in,two,combined'
p41331
g3
sS'reduction,were,not'
p41332
g3
sS'immunodeficiency,virus,hiv'
p41333
g3
sS'single,dose,pharmacokinetics'
p41334
g3
sS'the,pathway,that'
p41335
g3
sS'aripiprazole,is,not'
p41336
g3
sS'a,mg,capsule'
p41337
g9
sS'potential,that,the'
p41338
g3
sS'against,the,concurrent'
p41339
g9
sS'metabolite,n-desmethyldiazepam,there'
p41340
g9
sS'nanm,decreased,fi'
p41341
g3
sS'bile,caution,should'
p41342
g3
sS'effects,by,the'
p41343
g3
sS'of,a,agonist'
p41344
g9
sS'of,nucleophosmin,b23'
p41345
g3
sS'preliminary,studies,in'
p41346
g9
sS'ptx,have,entirely'
p41347
g3
sS'anticoagulation,should,receive'
p41348
g3
sS'allow,development,of'
p41349
g3
sS'a,delayed,elimination'
p41350
g3
sS'when,is,used'
p41351
g9
sS'fecal,loss,or'
p41352
g3
sS'demonstrates,the,importance'
p41353
g3
sS'concerning,published,in'
p41354
g3
sS'patients,on,thiazide'
p41355
g9
sS'interfere,with,desirable'
p41356
g3
sS'recommended,dose,may'
p41357
g9
sS'were,seen,on'
p41358
g3
sS'single,dose,at'
p41359
g3
sS'of,subjects,experienced'
p41360
g9
sS'of,neurological,toxic'
p41361
g3
sS'and,tumour,total'
p41362
g3
sS'is,increased,and'
p41363
g9
sS'at,or,recovery'
p41364
g9
sS'nonpredisposed,strain,c57bl'
p41365
g3
sS'both,t4,and'
p41366
g9
sS'reduction,of,plasma'
p41367
g9
sS'voltage-dependent,ca,subtypes'
p41368
g3
sS'secretion,and,reduces'
p41369
g9
sS'exercised,nonetheless,since'
p41370
g9
sS'although,minimal,alterations'
p41371
g3
sS'enzymes,d6,c9'
p41372
g3
sS'receiving,and,no'
p41373
g3
sS'one-third,when,either'
p41374
g3
sS'synthase,inhibiting,eg'
p41375
g9
sS'd6,a4,were'
p41376
g3
sS'cns,effects,an'
p41377
g3
sS'when,videx,was'
p41378
g9
sS'of,other,cardioactive'
p41379
g3
sS'with,other,known'
p41380
g3
sS'suggested,when,is'
p41381
g9
sS'for,days,and'
p41382
g3
sS'beta,blockers,calcium-channel'
p41383
g3
sS'beta,blockers,in'
p41384
g3
sS'k,the,net'
p41385
g9
sS'mg,respectively,resulted'
p41386
g9
sS'injection,there,is'
p41387
g3
sS'cholestyramine-concomitant,intake,of'
p41388
g9
sS'conduction,eg,or'
p41389
g9
sS'special,consideration,should'
p41390
g9
sS'have,discontinued,that'
p41391
g3
sS'antitumour,activity,acute'
p41392
g3
sS'or,cerebroactive,drugs'
p41393
g3
sS'activase,may,cause'
p41394
g3
sS'in,the,management'
p41395
g3
sS'ejection,by,vasopressin'
p41396
g3
sS'potassium-sparing,each,may'
p41397
g3
sS'ldh,were,experienced'
p41398
g3
sS'ames,company,division'
p41399
g3
sS'binding,activity,in'
p41400
g3
sS'to,decrease,the'
p41401
g9
sS'or,cyp2d6,eg'
p41402
g9
sS'degree,should,be'
p41403
g3
sS'also,should,be'
p41404
g9
sS'most,common,adverse'
p41405
g3
sS'increased,regional,perfusion'
p41406
g3
sS'clearance,rate,compared'
p41407
g9
sS'is,higher,in'
p41408
g9
sS'narcotic,may,potentiate'
p41409
g9
sS'conditions,such,as'
p41410
g3
sS'a,marked,and'
p41411
g9
sS'isoenzymes,will,be'
p41412
g3
sS'antiepileptic,drugs,on'
p41413
g9
sS'least,hours,between'
p41414
g3
sS'patients,observed,for'
p41415
g3
sS'of,potential,for'
p41416
g3
sS'statistically,significant,effect'
p41417
g3
sS'administration,of,tracleer'
p41418
g9
sS'on,plasma,levels'
p41419
g3
sS'begin,therapy,with'
p41420
g3
sS'cases,reported,in'
p41421
g9
sS'the,expected,magnitude'
p41422
g3
sS'of,and,thiazide'
p41423
g9
sS'body,it,is'
p41424
g3
sS'of,a,that'
p41425
g3
sS'study,objective,to'
p41426
g3
sS'above,experiments,we'
p41427
g3
sS'properties,that,may'
p41428
g9
sS'used,when,abilify'
p41429
g9
sS'doxazosin,mesylate,has'
p41430
g3
sS'phosphorylation,inhibition,of'
p41431
g9
sS'seen,as,early'
p41432
g9
sS'enalapril,and,iv'
p41433
g9
sS'total,body,clearance'
p41434
g9
sS'ca,i,and'
p41435
g3
sS'to,reduce,plasma'
p41436
g9
sS'type,ii,diabetic'
p41437
g9
sS'advantages,and,disadvantages'
p41438
g3
sS'cns-impairing,effects,of'
p41439
g9
sS'in,vitro,metabolic'
p41440
g3
sS'an,active,dose'
p41441
g3
sS'administration,of,suggesting'
p41442
g3
sS'these,also,resolved'
p41443
g3
sS'kg,doses,increased'
p41444
g9
sS'practice,dictates,careful'
p41445
g9
sS'of,treatment,with'
p41446
g9
sS'in,the,range'
p41447
g3
sS'complex,concentrates,or'
p41448
g3
sS'note,all,patients'
p41449
g3
sS'if,abruptly,discontinued'
p41450
g3
sS'at,mg,twice'
p41451
g9
sS'acarbose,in,combination'
p41452
g3
sS'of,binding,in'
p41453
g3
sS'pregnancy,could,not'
p41454
g3
sS'close,medical,supervision'
p41455
g9
sS'of,fluorescence,labelled'
p41456
g3
sS'decrease,in,renal'
p41457
g3
sS'both,elements,had'
p41458
g3
sS'other,cardioactive,compounds'
p41459
g9
sS'hyperplasia,of,the'
p41460
g3
sS'optimal,dose,of'
p41461
g3
sS'women,who,are'
p41462
g3
sS'drug,interactions,general'
p41463
g3
sS'interleukin-1,antagonist,has'
p41464
g9
sS'may,decrease,anti-inflammatory'
p41465
g9
sS'of,listed,in'
p41466
g3
sS'concentrations,dosage,adjustments'
p41467
g9
sS'no,pharmacokinetic,drug-drug'
p41468
g3
sS'although,not,a'
p41469
g9
sS'study,to,receive'
p41470
g3
sS'of,with,an'
p41471
g9
sS'does,not,affect'
p41472
g3
sS'antihistamines,may,have'
p41473
g9
sS'with,a,that'
p41474
g3
sS'control,blood,glucose'
p41475
g3
sS'eagles,minimal,essential'
p41476
g3
sS'agents,there,have'
p41477
g9
sS'staphylococcus,aureus,diplococcus'
p41478
g3
sS'in,any,condition'
p41479
g9
sS'and,cyp3a4,patients'
p41480
g3
sS'elevated,levels,and'
p41481
g9
sS'the,clinic,is'
p41482
g3
sS'administration,of,hexalen'
p41483
g9
sS'other,drugs,based'
p41484
g3
sS'if,supplements,are'
p41485
g9
sS'glycemic,levels,at'
p41486
g3
sS'including,certain,and'
p41487
g9
sS'acids,and,enable'
p41488
g3
sS'pregnancies,the,outcome'
p41489
g3
sS'applied,to,any'
p41490
g3
sS'upon,chylomicron,metabolism'
p41491
g3
sS'reduction,or,interruption'
p41492
g3
sS'agents,and,other'
p41493
g9
sS'have,elevated,plasma'
p41494
g9
sS'acid,may,decrease'
p41495
g9
sS'irritating,topical,products'
p41496
g3
sS'of,such,as'
p41497
g9
sS'in,genetically,predisposed'
p41498
g3
sS'in,locomotor,activity'
p41499
g3
sS'with,absorption,of'
p41500
g3
sS'the,nerves,and'
p41501
g3
sS'plasma,concentration,data'
p41502
g3
sS'half,the,standard'
p41503
g9
sS'reliable,estimates,of'
p41504
g3
sS'increased,by,up'
p41505
g9
sS'followed,by,either'
p41506
g3
sS'cyp-mediated,drug,clearance'
p41507
g3
sS'traumatic,edemas,that'
p41508
g9
sS'concomitant,protease,inhibitor'
p41509
g9
sS'of,a,true'
p41510
g3
sS'by,since,and'
p41511
g9
sS'mothers,fulvestrant,is'
p41512
g3
sS'have,lower,than'
p41513
g3
sS'was,observed,to'
p41514
g9
sS'the,activation,of'
p41515
g3
sS'the,agents,employed'
p41516
g9
sS'lists,of,are'
p41517
g3
sS'number,induced,by'
p41518
g9
sS'binding,globulin,cbg'
p41519
g3
sS'heart,disease,treated'
p41520
g3
sS'if,a,is'
p41521
g9
sS'insulin,a,clinical'
p41522
g3
sS'utilization,with,simultaneous'
p41523
g3
sS'agents,co-administration,of'
p41524
g3
sS'heart,failure,are'
p41525
g3
sS'have,increased,his'
p41526
g3
sS'appropriate,in,patients'
p41527
g3
sS'hormone,may,accelerate'
p41528
g3
sS'interact,with,antagonists'
p41529
g9
sS'of,during,treatment'
p41530
g9
sS'such,treatment,is'
p41531
g3
sS'cyp3a4,inhibitors,should'
p41532
g9
sS'may,affect,its'
p41533
g3
sS'digoxin,plasma,levels'
p41534
g3
sS'that,given,with'
p41535
g9
sS'or,may,substantially'
p41536
g9
sS'of,the,horses'
p41537
g3
sS'enzymes,or,the'
p41538
g3
sS'other,known,to'
p41539
g3
sS'chinese,hamsters,in'
p41540
g3
sS'medications,were,identified'
p41541
g9
sS'an,important,determinant'
p41542
g9
sS'itraconazole,therapy,and'
p41543
g9
sS'of,a,similar'
p41544
g9
sS'order,to,approximate'
p41545
g3
sS'counts,were,determined'
p41546
g3
sS'and,mhd,induce'
p41547
g3
sS'the,possible,potentiation'
p41548
g3
sS'but,it,is'
p41549
g3
sS'in,non-diabetics,with'
p41550
g3
sS'mononuclear,cells,were'
p41551
g3
sS'heparin,the,in'
p41552
g9
sS'also,chronically,receiving'
p41553
g3
sS'vs,serious,pneumonia'
p41554
g9
sS'work,involved,the'
p41555
g3
sS'in,cecectomized,and'
p41556
g3
sS'inhibitors,and,non-selective'
p41557
g9
sS'to,maintain,the'
p41558
g3
sS'subjects,aged,years'
p41559
g9
sS'isoenzyme,cyp3a4,activity'
p41560
g3
sS'studies,beta-receptor,blockers'
p41561
g3
sS'a,second,generation'
p41562
g3
sS'with,single,metal'
p41563
g3
sS'one,month,at'
p41564
g3
sS'days,increased,the'
p41565
g9
sS'when,was,applied'
p41566
g9
sS'or,may,partially'
p41567
g9
sS'other,significant,inhibitors'
p41568
g3
sS'with,other,high'
p41569
g3
sS'both,together,have'
p41570
g9
sS'approximately,one-thousandth,of'
p41571
g3
sS'with,its,congeners'
p41572
g3
sS'resins,an,interval'
p41573
g9
sS'coadministration,of,crixivan'
p41574
g3
sS'the,chop,patients'
p41575
g3
sS'are,supported,by'
p41576
g3
sS'change,with,the'
p41577
g3
sS'the,metabolite,ucb'
p41578
g3
sS'during,whole-cell,tight'
p41579
g3
sS'oral,or,other'
p41580
g3
sS'one-half,the,human'
p41581
g3
sS'or,dosing,requirements'
p41582
g3
sS'no,formal,drug-drug'
p41583
g3
sS'taking,the,significantly'
p41584
g3
sS'reports,indicate,that'
p41585
g9
sS'adefovir,dipivoxil,or'
p41586
g3
sS'plasma,levels,suggesting'
p41587
g9
sS'agent,on,the'
p41588
g3
sS'it,combines,with'
p41589
g3
sS'a,short-acting,inhaled'
p41590
g3
sS'characterised,by,a'
p41591
g3
sS'with,reports,of'
p41592
g3
sS'and,increased,in'
p41593
g3
sS'being,rapidly,identified'
p41594
g3
sS'confusion,extrapyramidal,symptoms'
p41595
g9
sS'the,animal,literature'
p41596
g3
sS'from,the,mucosal'
p41597
g3
sS'after,starting,st'
p41598
g3
sS'route,than,and'
p41599
g3
sS'including,oral,inhaled'
p41600
g3
sS'h,antagonists,when'
p41601
g9
sS'considering,the,use'
p41602
g9
sS'that,requirements,for'
p41603
g9
sS'the,is,administered'
p41604
g3
sS'ethanol,nutrition,herb'
p41605
g9
sS'for,hour,after'
p41606
g9
sS'b,can,be'
p41607
g3
sS'mg,of,elemental'
p41608
g9
sS'moderate,activity,which'
p41609
g3
sS'day5,of,a'
p41610
g9
sS'spinal,naloxone-sensitive,endorphinergic'
p41611
g3
sS'systems,inhibition,of'
p41612
g3
sS'the,requirement,of'
p41613
g9
sS'and,glucose,enzymatic'
p41614
g3
sS'not,higher,among'
p41615
g3
sS'eg,or,beta-adrenergic'
p41616
g9
sS'levels,limit,adverse'
p41617
g9
sS'that,the,alters'
p41618
g3
sS'limbic,integration,the'
p41619
g3
sS'significant,findings,and'
p41620
g3
sS'non-infection,unwanted,effects'
p41621
g3
sS'both,alone,at'
p41622
g3
sS'normal,volunteers,receiving'
p41623
g9
sS'of,conduction,disturbance'
p41624
g9
sS'to,mg,ml'
p41625
g3
sS'as,narcotics,non-narcotic'
p41626
g9
sS'level,however,is'
p41627
g9
sS'day,to,patients'
p41628
g3
sS'to,be,markedly'
p41629
g9
sS'treatment,i,the'
p41630
g3
sS'of,those,receiving'
p41631
g3
sS'these,aeds,during'
p41632
g3
sS'their,combined,effects'
p41633
g9
sS'of,elemental,as'
p41634
g9
sS'tablets,and,is'
p41635
g9
sS'adrenergic,agents,some'
p41636
g9
sS'patients,receiving,monoamine'
p41637
g9
sS'of,in,survanta'
p41638
g3
sS'consider,starting,other'
p41639
g3
sS'not,affect,responding'
p41640
g3
sS'and,diarrhea,would'
p41641
g9
sS'the,pharmacokinetic,or'
p41642
g3
sS'criteria,was,significantly'
p41643
g3
sS'have,been,prescribed'
p41644
g3
sS'interactions,how,to'
p41645
g3
sS'by,and,creatinine'
p41646
g9
sS'presence,of,high'
p41647
g9
sS'kg,or,mg'
p41648
g3
sS'was,added,were'
p41649
g9
sS'inr,were,observed'
p41650
g3
sS'total,hormone,as'
p41651
g3
sS'serum,levels,should'
p41652
g3
sS'is,unknown,how'
p41653
g3
sS'additionally,and,did'
p41654
g3
sS'crossover,study,examining'
p41655
g9
sS'or,elimination,or'
p41656
g3
sS'doses,of,vardenafil'
p41657
g3
sS'they,occur,they'
p41658
g3
sS'system,leading,to'
p41659
g3
sS'of,oral,users'
p41660
g3
sS'associated,with,ventricular'
p41661
g9
sS'single,oral,doses'
p41662
g9
sS'does,not,cause'
p41663
g3
sS'acne,transient,elevations'
p41664
g3
sS'pancreatitis,may,increase'
p41665
g3
sS'and,are,used'
p41666
g9
sS'increases,should,be'
p41667
g9
sS'tricyclic,which,can'
p41668
g3
sS'rodent,study,denileukin'
p41669
g3
sS'by,in,bovine'
p41670
g3
sS'first,and,then'
p41671
g9
sS'medication,including,solganal'
p41672
g9
sS'is,of,great'
p41673
g3
sS'an,excessive,reduction'
p41674
g9
sS'ca,channel,subtypes'
p41675
g3
sS'solution,was,given'
p41676
g3
sS'of,sites,may'
p41677
g3
sS'and,other,hydroxymethylglutaryl'
p41678
g9
sS'renal,impairment,particularly'
p41679
g3
sS'ibogaine,but,not'
p41680
g3
sS'a,significant,lengthening'
p41681
g3
sS'where,or,other'
p41682
g3
sS'selegiline,combination,hormonal'
p41683
g9
sS'to,determine,whether'
p41684
g3
sS'of,each,would'
p41685
g3
sS'breakthrough,bleeding,shortly'
p41686
g3
sS'q,d,for'
p41687
g9
sS'in,lowered,plasma'
p41688
g3
sS'use,were,common'
p41689
g3
sS'mice,but,the'
p41690
g3
sS'parturition,it,should'
p41691
g3
sS'to,develop,a'
p41692
g9
sS'respect,of,competitive'
p41693
g3
sS'depressants,including,but'
p41694
g9
sS'than,in,control'
p41695
g3
sS'increase,the,action'
p41696
g9
sS'pharmacokinetics,of,that'
p41697
g9
sS'plasma,m1,the'
p41698
g9
sS'cns,depressants,should'
p41699
g9
sS'bicarbonate,etc,increase'
p41700
g9
sS'agents,may,increase'
p41701
g9
sS'clinical,signs,or'
p41702
g9
sS'the,possible,benefits'
p41703
g9
sS'uptakes,which,may'
p41704
g3
sS'oh,d3,the'
p41705
g3
sS'methadone,levels,may'
p41706
g9
sS'beneficial,effects,on'
p41707
g9
sS'effects,were,already'
p41708
g3
sS'weekly,dosage,schedule'
p41709
g9
sS'women,who,have'
p41710
g3
sS'furthermore,whenever,one'
p41711
g3
sS'beneficial,effects,of'
p41712
g9
sS'consistent,with,its'
p41713
g3
sS'needed,following,coadministration'
p41714
g9
sS'up,to,when'
p41715
g9
sS'been,assessed,in'
p41716
g3
sS'pain,without,evidence'
p41717
g3
sS'concentrations,and,enhance'
p41718
g3
sS'to,fade,recovery'
p41719
g9
sS'an,average,increase'
p41720
g9
sS'of,racemic,titrated'
p41721
g3
sS'substitutes,containing,may'
p41722
g3
sS'may,affect,leukocyte'
p41723
g3
sS'with,gastrointestinal,irritation'
p41724
g9
sS'such,as,the'
p41725
g3
sS'sensitize,the,myocardium'
p41726
g9
sS'other,agent,should'
p41727
g3
sS'and,return,toward'
p41728
g3
sS'studies,with,male'
p41729
g9
sS'for,when,screening'
p41730
g3
sS'are,becoming,more'
p41731
g3
sS'level,to,prevent'
p41732
g3
sS'cases,with,potential'
p41733
g3
sS'concentration-time,curve,auc'
p41734
g3
sS'hepatic,enzymes,capable'
p41735
g3
sS'plasma,concentrations,include'
p41736
g9
sS'iodine-containing,preparations,and'
p41737
g3
sS'frequent,prothrombin,time'
p41738
g3
sS'interactions,to,date'
p41739
g3
sS'to,the,aucs'
p41740
g3
sS'of,this,medication'
p41741
g3
sS'of,both,ethynyl'
p41742
g3
sS'possibility,of,toxicity'
p41743
g9
sS'conversely,decreases,in'
p41744
g9
sS'action,data,including'
p41745
g3
sS'that,increase,gastrointestinal'
p41746
g3
sS'preanesthetic,or,used'
p41747
g3
sS'use,of,fludara'
p41748
g9
sS'potentiated,the,risk'
p41749
g9
sS'to,efficacy,and'
p41750
g3
sS'steroids,chloral,hydrate'
p41751
g9
sS'withdrawal,period,mg'
p41752
g3
sS'frequent,prothrombin,determinations'
p41753
g3
sS'no,formal,drug'
p41754
g3
sS'potential,for,protein'
p41755
g3
sS'displacing,effect,of'
p41756
g3
sS'with,diabetes,mellitus'
p41757
g3
sS'of,strattera,may'
p41758
g9
sS'physostigmine,pretreatment,augmented'
p41759
g9
sS'withdrawn,from,the'
p41760
g3
sS'tysabri,associated,adverse'
p41761
g3
sS'mouse,tumour,and'
p41762
g9
sS'disturbances,have,been'
p41763
g9
sS'included,as,proof'
p41764
g3
sS'obtained,from,studies'
p41765
g3
sS'immunogenicity,re-exposure,in'
p41766
g3
sS'as,nimbex,include'
p41767
g9
sS'exposed,to,cadmium'
p41768
g3
sS'for,serotonin,ht2a'
p41769
g3
sS'menstrual,rhythm,followed'
p41770
g3
sS'with,mg,and'
p41771
g9
sS'there,are,no'
p41772
g3
sS'regular,monitoring,of'
p41773
g3
sS'containing,or,videx'
p41774
g9
sS'treatment,period,was'
p41775
g3
sS'in,their,potential'
p41776
g3
sS'mg,for,weeks'
p41777
g9
sS'implantable,insertable,hormonal'
p41778
g3
sS'bioavailability,was,reduced'
p41779
g9
sS'an,approximate,increase'
p41780
g9
sS'after,the,nasal'
p41781
g9
sS'and,on,intestinal'
p41782
g3
sS'with,renal,tubular'
p41783
g9
sS'with,the,coadministration'
p41784
g3
sS'microsomes,indicate,that'
p41785
g3
sS'possible,potentiation,of'
p41786
g3
sS'significant,changes,in'
p41787
g3
sS'conversely,adverse,effects'
p41788
g3
sS'more,frequently,in'
p41789
g3
sS'of,the,weekly'
p41790
g9
sS'be,additive,use'
p41791
g9
sS'available,for,the'
p41792
g3
sS'that,oral,administration'
p41793
g3
sS'case,reports,indicates'
p41794
g3
sS'day,resulted,in'
p41795
g9
sS'and,mg,b'
p41796
g3
sS'safety,of,using'
p41797
g3
sS'preceding,lists,of'
p41798
g3
sS'medication,may,antagonise'
p41799
g3
sS'v,and,that'
p41800
g3
sS'red,rr,on'
p41801
g3
sS'derivatives,or,may'
p41802
g9
sS'and,transits,were'
p41803
g3
sS'about,the,interaction'
p41804
g9
sS'of,conjugated,dienes'
p41805
g3
sS'should,be,taken'
p41806
g3
sS'hearing,have,been'
p41807
g9
sS'following,use,of'
p41808
g9
sS'crossover,studies,in'
p41809
g3
sS'co-administered,with,but'
p41810
g3
sS'use,of,does'
p41811
g3
sS'among,the,proteins'
p41812
g3
sS'fecal,excretion,too'
p41813
g3
sS'including,produce,additive'
p41814
g9
sS'reduce,the,absorption'
p41815
g9
sS'the,ermbt,after'
p41816
g3
sS'of,interaction,of'
p41817
g3
sS'concentration,of,approximately'
p41818
g3
sS'alone,and,min'
p41819
g9
sS'n6-cyclopentyladenosine,cpa,an'
p41820
g9
sS'i,corticosteroid,binding'
p41821
g3
sS'mu,systems,for'
p41822
g3
sS'pretreatment,with,the'
p41823
g9
sS'as,with,all'
p41824
g3
sS'urine,allow,development'
p41825
g3
sS'of,the,extent'
p41826
g3
sS'class,of,oral'
p41827
g3
sS'is,mediated,by'
p41828
g3
sS'no,adequate,and'
p41829
g3
sS'together,with,adrenergic'
p41830
g3
sS'laboratory,monitoring,with'
p41831
g3
sS'one,dose,of'
p41832
g9
sS'whereas,urinary,excretion'
p41833
g3
sS'these,or,other'
p41834
g9
sS'with,described,as'
p41835
g3
sS'with,copegus,pegasys'
p41836
g3
sS'with,that,associated'
p41837
g3
sS'whether,this,could'
p41838
g3
sS'and,markedly,inhibit'
p41839
g9
sS'regimen,consisting,of'
p41840
g9
sS'if,an,hmg-coa'
p41841
g9
sS'period,following,elspar'
p41842
g9
sS'achlorhydria,and,those'
p41843
g3
sS'other,nsaids,is'
p41844
g9
sS'elevated,with,some'
p41845
g3
sS'for,optimal,pulmonary'
p41846
g3
sS'should,be,drawn'
p41847
g3
sS'and,its,clinical'
p41848
g3
sS'with,and,indicated'
p41849
g3
sS'a,macrolide,immunosuppressant'
p41850
g3
sS'an,inadequate,method'
p41851
g9
sS'bioequivalent,when,proquin'
p41852
g3
sS'including,both,sensory'
p41853
g9
sS'other,agents,prinivil'
p41854
g3
sS'including,and,either'
p41855
g3
sS'is,suitable,for'
p41856
g3
sS'possibly,other,and'
p41857
g9
sS'clinically,meaningful,increases'
p41858
g3
sS'and,intravenous,has'
p41859
g9
sS'and,or,pharmacodynamics'
p41860
g3
sS'recent,better,designed'
p41861
g3
sS'approach,can,be'
p41862
g3
sS'prothrombin,time,should'
p41863
g9
sS'were,detected,except'
p41864
g3
sS'weeks,has,been'
p41865
g9
sS'of,which,involved'
p41866
g9
sS'auc,of,although'
p41867
g9
sS'irritation,caution,should'
p41868
g9
sS'by,co-administration,of'
p41869
g3
sS'addicts,was,especially'
p41870
g3
sS'upper,gastrointestinal,bleeding'
p41871
g9
sS'therapy,had,no'
p41872
g3
sS'response,to,oral'
p41873
g3
sS'haart,on,the'
p41874
g3
sS'kd,of,d2'
p41875
g3
sS'formal,clinical,interaction'
p41876
g3
sS'anagrelide,demonstrates,some'
p41877
g9
sS'suspension,contains,a'
p41878
g3
sS'proteins,that,undergo'
p41879
g3
sS'observations,i,these'
p41880
g3
sS'both,were,thus'
p41881
g3
sS'upper,gastrointestinal,adverse'
p41882
g3
sS'treated,with,nm'
p41883
g3
sS'any,signs,or'
p41884
g9
sS'end,of,the'
p41885
g3
sS'dose,or,regimen'
p41886
g3
sS'interaction,of,gabitril'
p41887
g3
sS'study,n,ingestion'
p41888
g9
sS'observed,when,therapy'
p41889
g9
sS'deoxy,to,is'
p41890
g3
sS'vasoactive,resulting,in'
p41891
g9
sS'responsible,for,of'
p41892
g3
sS'of,increased,metabolism'
p41893
g9
sS'is,not,ordinarily'
p41894
g9
sS'decrease,vascular,response'
p41895
g9
sS'migraine,has,not'
p41896
g3
sS'may,vary,in'
p41897
g3
sS'tests,to,rule'
p41898
g3
sS'thus,inhibiting,the'
p41899
g9
sS'orudis,doses,greater'
p41900
g3
sS'properties,and,is'
p41901
g9
sS'hypotensive,effect,of'
p41902
g9
sS'by,these,isozymes'
p41903
g3
sS'or,uncomplicated,urinary'
p41904
g3
sS'therefore,if,replacement'
p41905
g3
sS'anafranil,to,patients'
p41906
g9
sS'when,vioxx,is'
p41907
g3
sS'orencia,mtx,nsaids'
p41908
g3
sS'of,exposure,in'
p41909
g3
sS'also,interact,with'
p41910
g3
sS'although,clinical,evidence'
p41911
g3
sS'reaction,may,be'
p41912
g3
sS'hypogastric,nerve,preparations'
p41913
g3
sS'a,median,fold'
p41914
g3
sS'to,pms,will'
p41915
g3
sS'co-administration,or,overlapping'
p41916
g3
sS'for,triacylglycerol,synthesis'
p41917
g3
sS'reactions,compared,to'
p41918
g3
sS'studies,have,confirmed'
p41919
g3
sS'management,of,chronic'
p41920
g3
sS'qd,or,hctz'
p41921
g3
sS'it,was,possible'
p41922
g3
sS'mofetil,respectively,were'
p41923
g9
sS'cyp,c19,ic50'
p41924
g3
sS'binding,thiazide,and'
p41925
g9
sS'be,excluded,based'
p41926
g3
sS'blocking,effect,and'
p41927
g9
sS'cause,hypercalcemia,too'
p41928
g9
sS'enhancement,of,the'
p41929
g9
sS'to,this,regimen'
p41930
g9
sS'increase,certain,actions'
p41931
g3
sS'term,therapy,particularly'
p41932
g3
sS'for,arrhythmias,including'
p41933
g3
sS'when,taken,with'
p41934
g3
sS'renal,function,secondary'
p41935
g3
sS'daily,increased,the'
p41936
g9
sS'duloxetine,in,patients'
p41937
g3
sS'patients,the,prothrombin'
p41938
g9
sS'and,the,prolongation'
p41939
g3
sS'monitored,particularly,during'
p41940
g9
sS'be,noted,when'
p41941
g3
sS'of,augmentin,xr'
p41942
g3
sS'study,toradoliv,im'
p41943
g3
sS'dose,in,pcp'
p41944
g3
sS'the,recommended,dosage'
p41945
g3
sS'several,advantages,over'
p41946
g3
sS'compete,for,excretion'
p41947
g9
sS'addition,of,results'
p41948
g9
sS'impaired,but,not'
p41949
g3
sS'among,patients,receiving'
p41950
g9
sS'as,a,change'
p41951
g3
sS'used,physiological,oral'
p41952
g3
sS'and,delay,in'
p41953
g3
sS'in,a,comparison'
p41954
g9
sS'evaluation,of,its'
p41955
g3
sS'not,required,except'
p41956
g3
sS'two,potentially,hepatotoxic'
p41957
g9
sS'because,they,may'
p41958
g9
sS'suggest,that,is'
p41959
g3
sS'and,area,under'
p41960
g9
sS'inr,was,increased'
p41961
g9
sS'small,initial,doses'
p41962
g9
sS'clinical,trials,was'
p41963
g3
sS'post-myocardial,infarction,in'
p41964
g3
sS'interactions,finasteride,had'
p41965
g3
sS'instances,of,rash'
p41966
g3
sS'potential,to,suppress'
p41967
g3
sS'exhibit,binding,to'
p41968
g3
sS'decreased,when,tracleer'
p41969
g3
sS'be,mediated,by'
p41970
g9
sS'and,hyperinsulinaemia,on'
p41971
g3
sS'contractility,when,systemic'
p41972
g9
sS'days,before,the'
p41973
g9
sS'and,containing,or'
p41974
g9
sS'dienes,approximately,in'
p41975
g3
sS'dilation,diaphoresis,emesis'
p41976
g3
sS'ros,has,been'
p41977
g3
sS'and,brovana,may'
p41978
g9
sS'in,falsely,elevated'
p41979
g3
sS'total,hormone,levels'
p41980
g3
sS'doses,of,nimbex'
p41981
g9
sS'of,be,adjusted'
p41982
g9
sS'aprepitant,reflects,an'
p41983
g9
sS'or,the,dosage'
p41984
g9
sS'both,therapeutic,and'
p41985
g3
sS'a,true,interaction'
p41986
g9
sS'and,thus,if'
p41987
g9
sS'subject,was,treated'
p41988
g3
sS'administration,of,lodine'
p41989
g9
sS'interactions,that,are'
p41990
g3
sS'are,also,affected'
p41991
g3
sS'prostaglandin,synthesis,by'
p41992
g3
sS'metabolism,of,wellbutrin'
p41993
g3
sS'have,occurred,when'
p41994
g3
sS'and,therefore,should'
p41995
g3
sS'effects,of,medicinal'
p41996
g9
sS'characteristics,for,and'
p41997
g3
sS'pth,and,serum'
p41998
g9
sS'this,effect,may'
p41999
g9
sS'administration,of,or'
p42000
g9
sS'been,administered,and'
p42001
g3
sS'cells,respond,normally'
p42002
g3
sS'be,reassessed,and'
p42003
g3
sS'required,if,this'
p42004
g3
sS'substrates,for,p450'
p42005
g3
sS'reported,that,these'
p42006
g3
sS'oxide,to,achieve'
p42007
g9
sS'hypertonus,possibly,causing'
p42008
g9
sS'ca,and,to'
p42009
g3
sS'administration,of,on'
p42010
g3
sS'two,treatment,groups'
p42011
g3
sS'ergot-containing,drugs,these'
p42012
g3
sS'was,comparable,in'
p42013
g3
sS'the,preservation,of'
p42014
g3
sS's,wort,may'
p42015
g9
sS'have,previously,received'
p42016
g9
sS'of,treatments,given'
p42017
g3
sS'potassium-sparing,diuretics,lotensin'
p42018
g9
sS'probably,reduces,the'
p42019
g9
sS'the,atropine-like,effects'
p42020
g3
sS'minimized,or,avoided'
p42021
g9
sS'and,depressive,symptoms'
p42022
g3
sS'study,the,atypical'
p42023
g3
sS'administration,of,mefloquineuine'
p42024
g3
sS'must,be,discontinued'
p42025
g3
sS'produces,a,complete'
p42026
g9
sS'patient,with,acute'
p42027
g9
sS'l-glutamine,has,orphan'
p42028
g3
sS'consider,discontinuation,of'
p42029
g9
sS'this,may,result'
p42030
g3
sS'nevertheless,the,possibility'
p42031
g9
sS'oral,response,ie'
p42032
g9
sS'the,they,should'
p42033
g9
sS'metabolite,m1,which'
p42034
g3
sS'smoking,cessation,with'
p42035
g3
sS'showed,no,clinically'
p42036
g3
sS'of,to,human'
p42037
g9
sS'or,prolong,its'
p42038
g3
sS'effect,in,the'
p42039
g3
sS'of,the,short-acting'
p42040
g3
sS'the,or,increasing'
p42041
g9
sS'regimen,as,well'
p42042
g3
sS'substrate,resulted,in'
p42043
g9
sS'therapeutic,range,while'
p42044
g3
sS'cyp2e1,cyp4a9,and'
p42045
g3
sS'the,clinical,significance'
p42046
g3
sS'of,other,central'
p42047
g9
sS'this,may,be'
p42048
g3
sS'effect,of,alternate-day'
p42049
g9
sS'studies,of,pegasys'
p42050
g3
sS'by,at,least'
p42051
g9
sS'of,serious,gi'
p42052
g9
sS'was,more,profound'
p42053
g9
sS'patients,on,should'
p42054
g9
sS'the,different,responses'
p42055
g3
sS'are,no,adequate'
p42056
g3
sS'treatment,is,unavailable'
p42057
g3
sS'doses,from,to'
p42058
g3
sS'epileptic,patients,on'
p42059
g9
sS'signs,of,withdrawal'
p42060
g3
sS'those,seen,in'
p42061
g9
sS'viracept,should,not'
p42062
g9
sS'from,study,to'
p42063
g3
sS'those,patients,in'
p42064
g3
sS'patients,with,hyperthyroidism'
p42065
g3
sS'of,ca,currents'
p42066
g3
sS'subjects,to,determine'
p42067
g3
sS'and,persistent,inhibition'
p42068
g9
sS'hind,limb,digital'
p42069
g3
sS'of,videx,hours'
p42070
g9
sS'and,such,are'
p42071
g3
sS'of,such,concomitant'
p42072
g3
sS'cevimeline,should,be'
p42073
g9
sS'the,last,chapters'
p42074
g3
sS'w,in,a'
p42075
g9
sS'cyp3a4,ketoconazole,cyp3a4'
p42076
g3
sS'in,liver,transaminases'
p42077
g3
sS'binding,is,reduced'
p42078
g9
sS'physical,dependency,and'
p42079
g3
sS'recently,instituted,as'
p42080
g9
sS'while,no,clinical'
p42081
g3
sS'evaluated,in,preclinical'
p42082
g3
sS'lower,locomotor,activity'
p42083
g3
sS'enhancing,absorption,decreases'
p42084
g9
sS'the,activity,and'
p42085
g3
sS'exercised,when,treating'
p42086
g3
sS'itself,could,likewise'
p42087
g3
sS'patients,n,and'
p42088
g9
sS'congeners,and,coexisting'
p42089
g3
sS'to,the,degree'
p42090
g3
sS'in,the,chick'
p42091
g3
sS'containing,or,with'
p42092
g9
sS'vivo,drug-drug,interaction'
p42093
g9
sS'that,is,bound'
p42094
g3
sS'decreased,alertness,and'
p42095
g9
sS'potassium-depleted,solution,the'
p42096
g3
sS'in,sheep,interactions'
p42097
g3
sS'mesylate,in,combination'
p42098
g9
sS'remedies,with,complex'
p42099
g3
sS'half,of,the'
p42100
g3
sS'clearance,of,felbatol'
p42101
g9
sS'recording,technique,in'
p42102
g3
sS'has,demonstrated,superiority'
p42103
g3
sS'quantitative,and,qualitative'
p42104
g3
sS'metabolized,by,p450'
p42105
g3
sS'antagonist,were,a'
p42106
g3
sS'in,a-chloralose,anesthetized'
p42107
g3
sS'response,by,displacing'
p42108
g9
sS'were,seen,when'
p42109
g9
sS'valid,prothrombin,time'
p42110
g9
sS'studies,in,rabbit'
p42111
g9
sS'on,the,blood'
p42112
g3
sS'the,patient,with'
p42113
g3
sS'magnitude,and,the'
p42114
g3
sS'blood,glucose,concentrations'
p42115
g9
sS'provide,a,basis'
p42116
g3
sS'general,public,feels'
p42117
g3
sS'increased,synaptic,concentration'
p42118
g3
sS'concurrently,increases,the'
p42119
g9
sS'time,from,to'
p42120
g9
sS'an,alteration,of'
p42121
g3
sS'of,other,metabolized'
p42122
g3
sS'cyp3a4,inhibitor,at'
p42123
g9
sS'and,seven,cases'
p42124
g3
sS'time,determinations,vitamin'
p42125
g9
sS'that,variable,effects'
p42126
g9
sS'unchanged,after,coadministration'
p42127
g3
sS'the,phenotype,of'
p42128
g3
sS'treatment,with,amevive'
p42129
g3
sS'or,acute,ergot'
p42130
g3
sS'in,a,reduced'
p42131
g9
sS'of,cyp2c9,and'
p42132
g3
sS'propoxyphene,in,cases'
p42133
g9
sS'microsomal,enzyme,systems'
p42134
g9
sS'effects,would,be'
p42135
g3
sS'especially,conduction,disturbances'
p42136
g3
sS'complications,considerably,enhance'
p42137
g3
sS'shown,that,anion'
p42138
g3
sS'dosage,range,mg'
p42139
g9
sS'now,appearing,on'
p42140
g3
sS'c,max,t'
p42141
g3
sS'and,without,and'
p42142
g3
sS'concentrations,substances,that'
p42143
g3
sS'pretreatment,with,likewise'
p42144
g3
sS'the,pesticide,gliftor'
p42145
g3
sS'its,structural,similarity'
p42146
g9
sS'for,other,centrally'
p42147
g3
sS'stable,on,a'
p42148
g3
sS'enhances,the,effect'
p42149
g9
sS'period,after,nalidixic'
p42150
g3
sS'pharmacogenetics,deals,with'
p42151
g3
sS'of,to,approximately'
p42152
g9
sS'administration,for,days'
p42153
g3
sS'inhibitory,concentrations,mics'
p42154
g3
sS'rises,that,might'
p42155
g3
sS'elimination,of,because'
p42156
g3
sS'support,the,effectiveness'
p42157
g3
sS'parameters,should,be'
p42158
g3
sS'sodium,an,inducer'
p42159
g3
sS'agents,used,to'
p42160
g3
sS'dose,is,adjusted'
p42161
g9
sS'form,of,st'
p42162
g3
sS'concomitant,administration,should'
p42163
g9
sS'and,in,controlled'
p42164
g3
sS'via,the,cytochrome'
p42165
g3
sS'drug-interaction,studies,have'
p42166
g3
sS'metabolites,with,m-dinitrobenzene'
p42167
g3
sS'in,systemic,concentrations'
p42168
g9
sS'achieved,steady-state,blood'
p42169
g3
sS'with,avastin,when'
p42170
g3
sS'to,the,level'
p42171
g3
sS'with,multiple,doses'
p42172
g9
sS'other,similarly,metabolized'
p42173
g3
sS'continued,need,for'
p42174
g3
sS'as,to,establish'
p42175
g3
sS'most,psychoactive,medications'
p42176
g9
sS'm,v,significantly'
p42177
g3
sS'caused,a,three-'
p42178
g3
sS'the,combined,chemotherapy'
p42179
g3
sS'of,urinary,hydroxy-corticosteroids'
p42180
g3
sS'literature,showing,that'
p42181
g3
sS'from,the,administration'
p42182
g9
sS'important,also,in'
p42183
g3
sS'p450,isoenzymes,cyp2c9'
p42184
g3
sS'on,smooth,muscle'
p42185
g3
sS'be,induced,in'
p42186
g3
sS'tablets,for,oral'
p42187
g3
sS'cholinergic,role,in'
p42188
g3
sS'and,also,with'
p42189
g3
sS'would,play,a'
p42190
g3
sS'anticoagulants,predispose,a'
p42191
g3
sS'is,a,substrate'
p42192
g3
sS'adverse,reactions,atg'
p42193
g3
sS'better,designed,studies'
p42194
g3
sS'ketogenic,because,of'
p42195
g3
sS'event,profile,between'
p42196
g3
sS'exposure,despite,persistent'
p42197
g3
sS'or,iv,ace'
p42198
g3
sS'a,higher,frequency'
p42199
g3
sS'a,g,bolus'
p42200
g3
sS'with,may,prolong'
p42201
g9
sS'their,concomitant,medications'
p42202
g3
sS'or,cns,depressants'
p42203
g9
sS'to,normal,volunteers'
p42204
g9
sS'gastric,ph,h2-receptor'
p42205
g9
sS'treatment,of,hypoxic'
p42206
g3
sS'to,high,intraluminal'
p42207
g3
sS'a,one-week,course'
p42208
g9
sS'imidazole,and,the'
p42209
g9
sS'be,monitored,with'
p42210
g3
sS'doses,or,mg'
p42211
g3
sS'a,decreased,plasma'
p42212
g9
sS'mg,co-administered,with'
p42213
g9
sS'slow-release,mg,or'
p42214
g3
sS'at,approximately,times'
p42215
g9
sS'immediately,following,a'
p42216
g9
sS'or,maois,which'
p42217
g3
sS'mean,sd,cumulative'
p42218
g3
sS'coagulation,alterations,is'
p42219
g3
sS'to,factrel,may'
p42220
g9
sS'tizoxanide,is,highly'
p42221
g3
sS'in,peak,serum'
p42222
g9
sS'danger,inherent,in'
p42223
g9
sS'exercised,when,prescribing'
p42224
g3
sS'as,a,false-negative'
p42225
g3
sS'transfers,were,the'
p42226
g3
sS'with,the,hepatic'
p42227
g9
sS'of,proteus,rettgeri'
p42228
g3
sS'elimination,is,dependent'
p42229
g3
sS'rats,of,the'
p42230
g3
sS'to,that,of'
p42231
g9
sS'interfere,with,laboratory'
p42232
g3
sS'when,an,adequate'
p42233
g3
sS'avoid,them,and'
p42234
g3
sS'h,this,number'
p42235
g3
sS'acidified,in,vitro'
p42236
g3
sS'the,pk,properties'
p42237
g3
sS'time,or,other'
p42238
g3
sS'treatment,the,dose'
p42239
g3
sS'of,a,large'
p42240
g9
sS'for,these,reasons'
p42241
g9
sS'in,auc,values'
p42242
g9
sS'weeks,may,produce'
p42243
g9
sS'and,these,with'
p42244
g3
sS'there,have,been'
p42245
g9
sS'this,being,the'
p42246
g3
sS'combined,therapy,with'
p42247
g9
sS'and,mg,did'
p42248
g3
sS'particularly,carefully,monitored'
p42249
g3
sS'of,metabolism,by'
p42250
g3
sS'bile-acidsequestering,agent,on'
p42251
g3
sS'ascorbic,acid,fruit'
p42252
g9
sS'the,impact,of'
p42253
g3
sS'and,also,inhibits'
p42254
g3
sS'population,is,considered'
p42255
g3
sS'occurred,following,simultaneous'
p42256
g9
sS'false,positive,readings'
p42257
g3
sS'if,possible,or'
p42258
g3
sS'involved,in,chemical'
p42259
g3
sS'may,antagonize,the'
p42260
g9
sS'studies,were,carried'
p42261
g3
sS'dose,until,blood'
p42262
g9
sS'were,to,fold'
p42263
g9
sS'in,interaction,studies'
p42264
g3
sS'to,be,modified'
p42265
g3
sS'of,severe,neutropenia'
p42266
g3
sS'maximum,approved,prescription'
p42267
g9
sS'was,taken,hours'
p42268
g3
sS'medical,literature,contains'
p42269
g3
sS'of,and,must'
p42270
g3
sS'use,of,an'
p42271
g9
sS'cyp,a4,and'
p42272
g3
sS'an,i-labelled,antigen'
p42273
g3
sS'have,demonstrated,that'
p42274
g3
sS'and,a,laser'
p42275
g3
sS'administration,of,indigestion'
p42276
g9
sS'been,established,in'
p42277
g3
sS'bosentan,is,metabolized'
p42278
g3
sS'associated,with,hepatotoxicity'
p42279
g9
sS'of,substrates,of'
p42280
g3
sS'both,cyp3a4,and'
p42281
g3
sS'counts,for,type'
p42282
g3
sS'acetylcysteine,interference,with'
p42283
g3
sS'from,to,which'
p42284
g9
sS'if,the,desired'
p42285
g9
sS'for,oral,suspension'
p42286
g3
sS'different,levels,of'
p42287
g3
sS'potentially,irritating,topical'
p42288
g3
sS'followed,by,a'
p42289
g9
sS'patients,with,hiv-related'
p42290
g3
sS'of,the,remaining'
p42291
g3
sS'functions,to,model'
p42292
g3
sS'however,concomitant,administration'
p42293
g9
sS'but,there,was'
p42294
g9
sS'month,and,are'
p42295
g3
sS'a,small,effect'
p42296
g3
sS'related,to,acute'
p42297
g3
sS'examined,the,interactions'
p42298
g3
sS'occur,with,that'
p42299
g3
sS'citrate,potentiate,the'
p42300
g9
sS'levels,and,efficacy'
p42301
g9
sS'response,ie,increased'
p42302
g9
sS'administered,before,after'
p42303
g3
sS'displace,such,as'
p42304
g9
sS'hypertension,and,tachycardia'
p42305
g9
sS'a,strong,affinity'
p42306
g3
sS'cyp2d6,activity,based'
p42307
g3
sS'to,affect,the'
p42308
g3
sS'state,conditions,or'
p42309
g3
sS'in,man,and'
p42310
g3
sS'nimotop,was,observed'
p42311
g9
sS'that,tikosyn,does'
p42312
g3
sS'other,cardioactive,or'
p42313
g3
sS'system,can,be'
p42314
g9
sS'pyrocarbonate,abolished,both'
p42315
g3
sS'review,of,these'
p42316
g3
sS'the,lowest,recommended'
p42317
g9
sS'postoperatively,patients,were'
p42318
g3
sS'adequately,evaluated,in'
p42319
g3
sS'recommended,that,ecg'
p42320
g9
sS'of,with,tablets'
p42321
g9
sS'of,vasodilator,and'
p42322
g3
sS'nsaids,monoamine,oxidase'
p42323
g9
sS'each,dose,of'
p42324
g9
sS'effect,with,inomax'
p42325
g9
sS'drugs,phenytoin,felbatol'
p42326
g9
sS'rate,of,dizziness'
p42327
g3
sS'methods,for,hours'
p42328
g3
sS'effectively,administered,in'
p42329
g3
sS'which,inhibit,neuronal'
p42330
g3
sS'with,orencia,mtx'
p42331
g3
sS'been,found,or'
p42332
g9
sS'vitro,mixing,of'
p42333
g9
sS'b-induced,hypokalemia,may'
p42334
g9
sS'hydrochloride,was,found'
p42335
g9
sS'administration,of,some'
p42336
g9
sS'no,significant,effects'
p42337
g3
sS'in,mice,on'
p42338
g3
sS'on,pentagastrin-,and'
p42339
g3
sS'steady,state,auc'
p42340
g9
sS'injection,of,and'
p42341
g9
sS'male,or,female'
p42342
g3
sS'instructions,and,instructions'
p42343
g3
sS'with,the,combination'
p42344
g9
sS'c19,ic50,g'
p42345
g3
sS'increased,toxicity,cns'
p42346
g3
sS'occurrence,of,upper'
p42347
g9
sS'these,cases,your'
p42348
g3
sS'creatinine,by,the'
p42349
g3
sS'to,mg,or'
p42350
g9
sS'reduced,plasma,concentrations'
p42351
g9
sS'serotypes,at,the'
p42352
g3
sS'treatment,following,the'
p42353
g9
sS'no,interaction,with'
p42354
g3
sS'without,any,evidence'
p42355
g3
sS'to,mg,of'
p42356
g9
sS'of,the,adverse'
p42357
g3
sS'possessing,nephrotoxic,myelotoxic'
p42358
g9
sS'and,mg,when'
p42359
g3
sS'weeks,with,intravenous'
p42360
g3
sS'may,be,compromised'
p42361
g9
sS'confidence,interval,and'
p42362
g3
sS'and,a,cyp2c19'
p42363
g9
sS'inhibit,high,threshold'
p42364
g3
sS'micromol,l,and'
p42365
g9
sS'ponstel,with,the'
p42366
g9
sS'those,that,demonstrate'
p42367
g3
sS'for,five,days'
p42368
g3
sS'of,the,tnf'
p42369
g9
sS'cyp2d6,inhibitor,is'
p42370
g3
sS'addictive,medications,especially'
p42371
g3
sS'the,reflex,tachycardia'
p42372
g9
sS'dose-proportionality,and,stability'
p42373
g3
sS'blocking,agents,should'
p42374
g9
sS'ribavirin,is,genotoxic'
p42375
g3
sS'effective,treatment,is'
p42376
g3
sS'on,the,average'
p42377
g3
sS'containing,or,to'
p42378
g9
sS'light,meal,h'
p42379
g9
sS'intake,of,mineral'
p42380
g9
sS'agents,these,medicines'
p42381
g3
sS'injection,of,given'
p42382
g9
sS'reported,regarding,the'
p42383
g3
sS'immediately,before,injection'
p42384
g3
sS'day,in,six'
p42385
g9
sS'and,these,have'
p42386
g3
sS'pups,from,fulvestrant-treated'
p42387
g3
sS'two,concomitantly,should'
p42388
g3
sS'data,suggesting,a'
p42389
g9
sS'the,two,at'
p42390
g3
sS'including,central,obesity'
p42391
g3
sS'identify,the,pharmacological'
p42392
g3
sS'and,agents,of'
p42393
g9
sS'activity,in,arteries'
p42394
g3
sS'production,of,hypotension'
p42395
g9
sS'can,potentiate,the'
p42396
g9
sS'of,rashes,with'
p42397
g3
sS'caused,excessive,release'
p42398
g3
sS'interference,of,with'
p42399
g3
sS'plasma,levels,should'
p42400
g3
sS'from,marketing,experiences'
p42401
g9
sS'drug,should,be'
p42402
g3
sS'low,hepatic,clearance'
p42403
g3
sS'including,or,its'
p42404
g9
sS'soluble,such,as'
p42405
g3
sS'employed,since,the'
p42406
g9
sS'kg,day,group'
p42407
g9
sS'recommended,in,such'
p42408
g3
sS'fluconazole,an,inhibitor'
p42409
g9
sS'spent,in,the'
p42410
g9
sS'interaction,study,demonstrated'
p42411
g9
sS'no,significant,differences'
p42412
g3
sS'and,hydroxydesloratadine,were'
p42413
g3
sS'employed,cautiously,as'
p42414
g3
sS'enzymes,may,change'
p42415
g3
sS'certain,tend,to'
p42416
g3
sS'seem,to,influence'
p42417
g3
sS'with,reduced,the'
p42418
g9
sS'at,intramuscular,doses'
p42419
g3
sS'mao,inhibitors,including'
p42420
g9
sS'its,metabolism,may'
p42421
g3
sS'excessive,fecal,loss'
p42422
g3
sS'patients,with,crohn'
p42423
g3
sS'in,otherwise,healthy'
p42424
g3
sS'levels,to,continue'
p42425
g9
sS'by,peripheral,vasospasm'
p42426
g3
sS'cancer,were,reported'
p42427
g9
sS'and,aetiopathogenic--,for'
p42428
g3
sS'on,the,task'
p42429
g3
sS'recommended,human,dose'
p42430
g3
sS'im,twice,the'
p42431
g3
sS'conversely,the,have'
p42432
g9
sS'receiving,there,have'
p42433
g9
sS'concentrations,has,been'
p42434
g3
sS'pharmacokinetic,study,of'
p42435
g3
sS'little,adequate,evidence'
p42436
g3
sS'therapies,for,type'
p42437
g3
sS'n-allylnormetazocine,in,pigeons'
p42438
g3
sS'to,the,following'
p42439
g3
sS'a,penicillin-type,are'
p42440
g9
sS'aspirin,as,with'
p42441
g9
sS'basic,science,and'
p42442
g3
sS'uncompromised,elderly,patients'
p42443
g3
sS'non-specific,cyp-450,inhibitor'
p42444
g3
sS'the,biliary,route'
p42445
g3
sS'general,population,is'
p42446
g3
sS'other,drugs,aripiprazole'
p42447
g3
sS'of,peptide,in'
p42448
g3
sS'and,because,they'
p42449
g3
sS'exhibited,similar,temporal'
p42450
g3
sS'remained,stable,for'
p42451
g3
sS'insulin-dependent,diabetic,patients'
p42452
g3
sS'can,in,addition'
p42453
g9
sS'effects,of,in'
p42454
g9
sS'cyp,isoforms,a4'
p42455
g3
sS'interactions,between,the'
p42456
g3
sS'phenothiazines,tindal,thorazine'
p42457
g3
sS'study,effects,have'
p42458
g3
sS'hitherto,unrecognized,interactions'
p42459
g3
sS'altretamines,half-life,and'
p42460
g9
sS'and,exposure,auc'
p42461
g9
sS'subjects,dosed,simultaneously'
p42462
g9
sS'serotonin,syndrome,cognitive'
p42463
g9
sS'estazolam,interaction,with'
p42464
g3
sS'effects,of,it'
p42465
g3
sS'lead,tml,or'
p42466
g3
sS'when,prinivil,was'
p42467
g3
sS'embryos,in,comparison'
p42468
g9
sS'adult,diabetics,who'
p42469
g3
sS'stopped,without,consulting'
p42470
g3
sS'of,other,is'
p42471
g3
sS'ranitidine,in,normal'
p42472
g9
sS'is,too,small'
p42473
g3
sS'the,levulan,kerastick'
p42474
g9
sS'the,glucose,oxidase'
p42475
g3
sS't,a,with'
p42476
g9
sS'of,other,in'
p42477
g3
sS'renal,toxicity,bronchospasm'
p42478
g9
sS'substrate,administered,in'
p42479
g3
sS'caused,by,two'
p42480
g3
sS'and,significant,increase'
p42481
g9
sS'electrolyte,disturbances,were'
p42482
g9
sS'iboga,alkaloid,congener'
p42483
g3
sS'determined,with,care'
p42484
g9
sS'levels,whenever,a'
p42485
g3
sS'fold,prolongation,in'
p42486
g3
sS'your,doctor,if'
p42487
g3
sS'and,another,tnf-blocking'
p42488
g9
sS'the,following,macrolide'
p42489
g9
sS'production,elevation,of'
p42490
g3
sS'specified,appropriate,dosage'
p42491
g3
sS'clearance,of,by'
p42492
g9
sS'tcaplasma,levels,whenever'
p42493
g3
sS'may,interact,synergistically'
p42494
g3
sS'increase,susceptibility,to'
p42495
g3
sS'olanzapine,is,associated'
p42496
g3
sS'concentrations,of,in'
p42497
g3
sS'cause,an,increased'
p42498
g9
sS'tenormin,sectral,lopressor'
p42499
g3
sS'topical,has,not'
p42500
g3
sS'populations,prostate,cancer'
p42501
g3
sS'as,risk,of'
p42502
g3
sS'cerubidine,may,be'
p42503
g3
sS'on,the,number'
p42504
g3
sS'risk,that,an'
p42505
g9
sS'h-spiroperidol,binding,with'
p42506
g3
sS'indicate,that,could'
p42507
g9
sS'mg,kg,p'
p42508
g9
sS'reduction,was,greater'
p42509
g9
sS'pituitary,secretion,of'
p42510
g3
sS'of,dosing,reduced'
p42511
g3
sS'reported,with,oral'
p42512
g9
sS'neuromuscular,transmission,should'
p42513
g3
sS'latency,to,loss'
p42514
g3
sS'of,symptoms,usually'
p42515
g3
sS'erroneously,low,erpf'
p42516
g9
sS'of,the,concomitant'
p42517
g3
sS'in,addition,several'
p42518
g9
sS'on,embryo,fetal'
p42519
g3
sS'behavioral,changes,of'
p42520
g3
sS'physostigmine,briefly,reduced'
p42521
g3
sS'of,preparations,and'
p42522
g3
sS'of,clozapine,induced'
p42523
g3
sS'derivatives,indandione,derivatives'
p42524
g9
sS'metabolized,by,this'
p42525
g3
sS'for,four,days'
p42526
g3
sS'greater,understanding,of'
p42527
g3
sS'was,sacrificed,in'
p42528
g3
sS'however,did,not'
p42529
g3
sS'exceed,mg,when'
p42530
g9
sS'patients,taking,ace'
p42531
g3
sS'with,ribavirin,ribavirin'
p42532
g3
sS'auc,and,decrease'
p42533
g9
sS'after,days,of'
p42534
g3
sS'ventricular,dysfunction,or'
p42535
g3
sS'discontinuing,hydrochloride,therapy'
p42536
g9
sS'intravenous,self-administration,of'
p42537
g9
sS'agents,the,concomitant'
p42538
g3
sS'as,cough,and'
p42539
g9
sS'administering,disulfiram,to'
p42540
g9
sS'was,measured,by'
p42541
g3
sS'of,ucb,l057'
p42542
g3
sS'that,increase,or'
p42543
g9
sS'a,study,comparing'
p42544
g3
sS'in,both,instances'
p42545
g3
sS'conclusions,sildenafil,is'
p42546
g3
sS'reuptake,inhibitor,should'
p42547
g9
sS'and,uncontrolled,domestic'
p42548
g3
sS'and,induce,cyp3a4'
p42549
g3
sS'exposure,in,which'
p42550
g3
sS'weighed,against,an'
p42551
g9
sS'receiving,diabinese,the'
p42552
g3
sS'events,associated,with'
p42553
g9
sS'sh,ea,was'
p42554
g3
sS'daily,inhalation,dose'
p42555
g3
sS'effect,increased,by'
p42556
g3
sS'the,mouth,and'
p42557
g9
sS'drugs,are,administered'
p42558
g3
sS'a,and,under'
p42559
g9
sS'excretion,of,resulting'
p42560
g9
sS'treated,with,agonists'
p42561
g9
sS'to,the,possibility'
p42562
g9
sS'calcium-channel,blocking,agents'
p42563
g3
sS'blockers,did,not'
p42564
g3
sS'as,or,other'
p42565
g9
sS'to,when,gleevec'
p42566
g9
sS'both,increase,and'
p42567
g9
sS'and,other,highly'
p42568
g3
sS'close,supervision,and'
p42569
g3
sS'hyperglycemic,effects,have'
p42570
g3
sS'antiaggregant,prostacyclin,which'
p42571
g3
sS'dose,adjustment,required'
p42572
g9
sS'a,comprehensive,review'
p42573
g3
sS'carefully,monitored,especially'
p42574
g3
sS'as,initial,therapy'
p42575
g3
sS'pharmacokinetics,during,concurrent'
p42576
g3
sS'significantly,p,decreased'
p42577
g9
sS'reliable,method,of'
p42578
g9
sS'or,anaphylactic,reactions'
p42579
g3
sS'interactions,is,summarized'
p42580
g3
sS'occurs,with,the'
p42581
g3
sS'hour,prior,to'
p42582
g9
sS'not,all,inclusive'
p42583
g3
sS'who,are,also'
p42584
g3
sS'during,pregnancy,cromolyn'
p42585
g3
sS'with,some,like'
p42586
g9
sS'to,induce,hepatic'
p42587
g3
sS'of,intrinsic,value'
p42588
g3
sS'echistatin,alone,had'
p42589
g9
sS'a,greater,risk'
p42590
g3
sS'and,cmax,differences'
p42591
g3
sS'treatment,of,depression'
p42592
g3
sS'increases,in,urine'
p42593
g9
sS'at,mg,rat'
p42594
g3
sS'the,half-life,by'
p42595
g9
sS'to,human,plasma'
p42596
g3
sS'as,other,nonsteroidal'
p42597
g9
sS'of,and,penthrane'
p42598
g9
sS'eg,may,elevate'
p42599
g9
sS'produced,a,increase'
p42600
g9
sS'no,pharmacokinetic,interaction'
p42601
g3
sS'in,rats,simultaneous'
p42602
g9
sS'of,histidine,residues'
p42603
g3
sS'significant,interactions,with'
p42604
g3
sS'of,after,their'
p42605
g3
sS'ace,inhibitor,to'
p42606
g9
sS'also,ineffective,in'
p42607
g3
sS'cmin,concentrations,were'
p42608
g3
sS'when,taking,mg'
p42609
g9
sS'ph,was,significantly'
p42610
g9
sS'dose,in,regimens'
p42611
g3
sS'some,oxytocic,may'
p42612
g9
sS'the,non-depolarizing,muscle'
p42613
g9
sS'added,in,and'
p42614
g3
sS'been,performed,based'
p42615
g9
sS'to,or,on'
p42616
g9
sS'the,full,dose'
p42617
g3
sS'the,genetically,diabetic'
p42618
g3
sS'interfere,with,some'
p42619
g3
sS'plasma,concentrations,when'
p42620
g9
sS'effect,in,most'
p42621
g9
sS'and,subsequently,treated'
p42622
g9
sS'effects,were,seen'
p42623
g3
sS'such,concurrent,use'
p42624
g3
sS'adult,data,lower'
p42625
g9
sS'and,not,materially'
p42626
g3
sS'the,cases,of'
p42627
g3
sS'or,videx,chewable'
p42628
g9
sS'administration,may,be'
p42629
g9
sS'and,disadvantages,of'
p42630
g3
sS'injected,a,chylomicron-like'
p42631
g3
sS'inhibitor,the,risk'
p42632
g9
sS'the,should,be'
p42633
g3
sS'serotonin,in,the'
p42634
g3
sS'physical,activity,while'
p42635
g3
sS'of,growth,to'
p42636
g3
sS'ss,of,o-desacetylrifabutin'
p42637
g9
sS'amicar,necessary,to'
p42638
g3
sS'the,mechanism,and'
p42639
g3
sS'affect,the,test'
p42640
g9
sS'with,coadministered,orally'
p42641
g9
sS'or,substances,that'
p42642
g3
sS'similar,efficacy,on'
p42643
g3
sS'and,mg,were'
p42644
g3
sS'with,sustiva,is'
p42645
g3
sS'finasteride,had,no'
p42646
g3
sS'with,intravascular,volume'
p42647
g9
sS'reported,here,we'
p42648
g3
sS'when,given,concurrently'
p42649
g3
sS'a,href,frova_od'
p42650
g9
sS'specific,information,processing'
p42651
g3
sS'required,for,blood'
p42652
g3
sS'highly,unstable,with'
p42653
g3
sS'least,partially,related'
p42654
g9
sS'metabolizers,and,extensive'
p42655
g3
sS'soaps,and,cosmetics'
p42656
g3
sS'in,a,mean'
p42657
g9
sS'this,protein,in'
p42658
g9
sS'the,second,test'
p42659
g3
sS'various,oral,anticoagulents'
p42660
g3
sS'as,the,cost-risk'
p42661
g3
sS'and,were,agonists'
p42662
g9
sS'these,patients,when'
p42663
g9
sS'metabolite,concentrations,were'
p42664
g3
sS'that,use,during'
p42665
g9
sS'volunteers,were,administered'
p42666
g3
sS'of,intravenous,sodium'
p42667
g9
sS'administration,of,proton'
p42668
g3
sS'levels,and,compromise'
p42669
g9
sS'in,arteries,from'
p42670
g3
sS'discontinuance,of,could'
p42671
g9
sS'in,the,coadministration'
p42672
g9
sS'maintain,optimum,therapeutic'
p42673
g3
sS'l50,mg,bid'
p42674
g3
sS'require,downward,adjustment'
p42675
g9
sS'ii,alone,and'
p42676
g3
sS'response,against,sera'
p42677
g3
sS'of,upper,gastrointestinal'
p42678
g3
sS'and,oral,and'
p42679
g3
sS'to,the,patient'
p42680
g3
sS'urinary,levels,could'
p42681
g3
sS'tablets,are,either'
p42682
g9
sS'patients,steady-state,auc'
p42683
g9
sS'available,in,the'
p42684
g3
sS'physicians,to,minimize'
p42685
g3
sS'estrogens,may,decrease'
p42686
g9
sS'these,case,reports'
p42687
g3
sS'given,compensatory,increases'
p42688
g3
sS'of,by,an'
p42689
g9
sS'and,mepron,suspension'
p42690
g9
sS'percent,of,patients'
p42691
g9
sS'or,reduce,the'
p42692
g9
sS'induced,by,camptosar'
p42693
g9
sS'to,all,physciains'
p42694
g3
sS'dialyzable,may,be'
p42695
g3
sS'e1,and,cyp'
p42696
g3
sS'phenotype,were,demonstrated'
p42697
g3
sS'the,concomitant,administration'
p42698
g9
sS'probably,due,to'
p42699
g3
sS'as,and,the'
p42700
g3
sS'ci,kg,or'
p42701
g3
sS'on,monoamine,oxidases'
p42702
g3
sS'the,jaff,reaction'
p42703
g3
sS'no,reported,drug-laboratory'
p42704
g3
sS'patients,take,other'
p42705
g3
sS'studies,showed,that'
p42706
g9
sS'one,treatment,age'
p42707
g3
sS'control,in,non-diabetics'
p42708
g3
sS'a,tumor,that'
p42709
g3
sS'are,administered,separately'
p42710
g9
sS'half-life,multiple-dose,pharmacokinetic'
p42711
g3
sS'of,increased,risk'
p42712
g3
sS'be,resistant,to'
p42713
g9
sS'or,than,in'
p42714
g9
sS'fold,and,prolonged'
p42715
g9
sS'of,therapeutic,doses'
p42716
g3
sS'blockade,by,was'
p42717
g9
sS'transporter,as,demonstrated'
p42718
g3
sS'of,oral,to'
p42719
g3
sS'the,cyp,enzymes'
p42720
g3
sS'retard,may,enhance'
p42721
g9
sS'antithrombin,iii,decreased'
p42722
g3
sS'of,g,per'
p42723
g3
sS'ace,inhibitors,concomitant'
p42724
g3
sS'rats,are,mediated'
p42725
g3
sS'increases,qt,prolongation'
p42726
g3
sS'vitro,upon,combination'
p42727
g9
sS'times,the,control'
p42728
g3
sS'serum,slightly,about'
p42729
g9
sS'hypothesis,of,gibaldi'
p42730
g3
sS'spared,by,lesions'
p42731
g3
sS'have,increased,the'
p42732
g9
sS'efficacy,compared,with'
p42733
g3
sS'involved,in,disposition'
p42734
g3
sS'agents,may,potentially'
p42735
g3
sS'test,results,for'
p42736
g3
sS'coadministered,prescribers,should'
p42737
g3
sS'and,veratrum,alkaloids'
p42738
g9
sS'steady-state,auc,and'
p42739
g9
sS'and,may,also'
p42740
g3
sS'as,mercapturic,acids'
p42741
g3
sS'of,cycles,and'
p42742
g3
sS'camptosar,such,as'
p42743
g9
sS'of,the,dose'
p42744
g9
sS'effects,of,pegasys'
p42745
g3
sS'dose,of,other'
p42746
g9
sS'depression,may,occur'
p42747
g9
sS'or,given,with'
p42748
g3
sS'or,logistic,probability'
p42749
g3
sS'from,interaction,studies'
p42750
g3
sS'suggest,that,there'
p42751
g3
sS'the,nursing,infant'
p42752
g3
sS'less,marked,has'
p42753
g3
sS'hemodynamic,and,electrophysiologic'
p42754
g3
sS'test,results,during'
p42755
g3
sS'treated,patients,no'
p42756
g3
sS'the,combination,oral'
p42757
g3
sS'or,crohn,s'
p42758
g3
sS'generally,not,recommended'
p42759
g9
sS'andtolbutamide,did,not'
p42760
g3
sS'identified,that,would'
p42761
g3
sS'alpha,cell,of'
p42762
g3
sS'cyp3a4,inducer,with'
p42763
g9
sS'prophylaxis,contributed,to'
p42764
g3
sS'that,induce,cytochrome'
p42765
g3
sS'agonist,it,is'
p42766
g9
sS'however,its,effects'
p42767
g3
sS'less,than,minutes'
p42768
g3
sS'and,the,contribution'
p42769
g3
sS'of,the,that'
p42770
g3
sS'aripiprazole,dose,should'
p42771
g9
sS'levels,or,increase'
p42772
g9
sS'increasing,serum,potassium'
p42773
g9
sS'binding,of,in'
p42774
g3
sS'lipid,levels,the'
p42775
g3
sS'bleeding,time,pt'
p42776
g3
sS'patients,whose,plasma'
p42777
g3
sS'time,in,healthy'
p42778
g9
sS'is,shortened,in'
p42779
g9
sS'for,cmax,tmax'
p42780
g3
sS'employing,mtc-mdp,as'
p42781
g3
sS'into,consideration,when'
p42782
g9
sS'tenderness,skin,discoloration'
p42783
g3
sS'shown,to,reduce'
p42784
g9
sS'examined,whether,meth'
p42785
g3
sS'investigating,possible,interactions'
p42786
g3
sS'use,and,has'
p42787
g3
sS'hcl,phenytoin,and'
p42788
g9
sS'male,dogs,one'
p42789
g3
sS'with,wthionamide,trecator-sc'
p42790
g3
sS'binding,of,is'
p42791
g3
sS'but,did,slightly'
p42792
g9
sS'mg,kg,body'
p42793
g3
sS'stable,for,up'
p42794
g3
sS'next,chapter,and'
p42795
g3
sS'additive,effect,with'
p42796
g9
sS'a4,activity,may'
p42797
g3
sS'the,ht3,zofran'
p42798
g3
sS'resulted,in,no'
p42799
g3
sS'effect,of,orally'
p42800
g3
sS'and,plasma,levels'
p42801
g9
sS'compared,to,triple'
p42802
g3
sS'results,raise,the'
p42803
g9
sS'concomitantly,renal,function'
p42804
g9
sS'their,efficacy,in'
p42805
g3
sS'experiments,the,perfusion'
p42806
g3
sS'clinically,significant,degree'
p42807
g3
sS'commonly,to,hours'
p42808
g3
sS'of,on,diastolic'
p42809
g3
sS'to,be,monitored'
p42810
g9
sS'as,causally,related'
p42811
g3
sS'and,the,binding'
p42812
g3
sS'not,demonstrated,renal'
p42813
g3
sS'by,was,unaffected'
p42814
g9
sS'of,erythromycin,on'
p42815
g3
sS'pigeons,did,not'
p42816
g3
sS'been,isolated,reports'
p42817
g9
sS'treatment,costs,despite'
p42818
g3
sS'in,dosage,may'
p42819
g3
sS'use,of,vasoconstricting'
p42820
g9
sS'prevent,excessive,prolongation'
p42821
g9
sS'although,the,interaction'
p42822
g9
sS'blood,flow,or'
p42823
g3
sS'produce,or,be'
p42824
g3
sS'are,related,to'
p42825
g3
sS'of,following,a'
p42826
g3
sS'the,hypothesis,of'
p42827
g3
sS'ranitidine,also,has'
p42828
g3
sS'is,antagonized,by'
p42829
g9
sS'case,of,severe'
p42830
g9
sS'nsaids,in,patients'
p42831
g9
sS'within,hours,most'
p42832
g3
sS'of,to,desbutyl'
p42833
g3
sS'and,agents,for'
p42834
g9
sS'administered,on,day5'
p42835
g9
sS'study,involving,concomitant'
p42836
g3
sS'in,the,event'
p42837
g3
sS'information,regarding,the'
p42838
g3
sS'iva-sensitive,p-type,channel'
p42839
g3
sS'hepatic,metabolism,produced'
p42840
g9
sS'the,range,observed'
p42841
g3
sS'administered,over,the'
p42842
g3
sS'xanthine,derivatives,in'
p42843
g3
sS'are,used,they'
p42844
g3
sS'between,and,mg'
p42845
g3
sS'cyp3a4,the,major'
p42846
g9
sS'anaerobic,bacteria,except'
p42847
g3
sS'who,had,initial'
p42848
g3
sS'worsen,side,effects'
p42849
g9
sS'prolong,further,the'
p42850
g9
sS'designed,studies,have'
p42851
g3
sS'type,diabetes,there'
p42852
g3
sS'reaction,is,a'
p42853
g3
sS'viracept,astramorph,kadian'
p42854
g9
sS'the,analyte,is'
p42855
g3
sS'elicit,their,pharmacological'
p42856
g3
sS'several,hours,following'
p42857
g3
sS'caused,by,gram-negative'
p42858
g3
sS'mg,produced,mean'
p42859
g9
sS'related,presumably,through'
p42860
g9
sS'inventory,the,profile'
p42861
g3
sS'in,functional,class'
p42862
g9
sS'are,being,treated'
p42863
g9
sS'ht3,antagonists,based'
p42864
g9
sS'medications,can,interfere'
p42865
g9
sS'the,long,and'
p42866
g3
sS'to,onset,of'
p42867
g9
sS'the,first,hour'
p42868
g9
sS'administration,regimens,lower'
p42869
g3
sS'with,greater,than'
p42870
g3
sS'of,carbamazepine,equetrotm'
p42871
g9
sS'stadol,ns,absorbed'
p42872
g3
sS'same,time,as'
p42873
g9
sS'the,histidine,residues'
p42874
g3
sS'subjects,receiving,the'
p42875
g9
sS'or,supplements,should'
p42876
g3
sS'is,also,expected'
p42877
g9
sS'day,there,was'
p42878
g9
sS'respectively,after,days'
p42879
g9
sS'and,theoretically,might'
p42880
g3
sS'eg,rt-pa,or'
p42881
g3
sS'remaining,cases,two'
p42882
g3
sS'or,any,known'
p42883
g9
sS'doses,of,starlix'
p42884
g3
sS'by,activation,of'
p42885
g3
sS'occur,when,contrast'
p42886
g3
sS'by,fold,compared'
p42887
g9
sS'of,negative,and'
p42888
g3
sS'ectopic,pregnancies,the'
p42889
g3
sS'in,any,statistically'
p42890
g3
sS'the,hypoprothrombinemic,effect'
p42891
g3
sS'vivo,data,show'
p42892
g9
sS'above,ng,ml'
p42893
g9
sS'nuclear,matrix,protein'
p42894
g3
sS'of,this,study'
p42895
g3
sS'may,also,produce'
p42896
g3
sS'or,co-administration,enhances'
p42897
g9
sS'the,transport,of'
p42898
g3
sS'insulins,ability,to'
p42899
g3
sS'anti-inflammatory,drugs,nsaids'
p42900
g9
sS'with,other,creams'
p42901
g3
sS'or,as,these'
p42902
g9
sS'cups,of,american'
p42903
g3
sS'from,the,carpophores'
p42904
g3
sS'and,fibrosis,have'
p42905
g3
sS'this,sequence,however'
p42906
g3
sS'recommended,when,administering'
p42907
g9
sS'reaction,had,increased'
p42908
g3
sS'and,have,a'
p42909
g3
sS'was,evaluated,by'
p42910
g3
sS'patients,receiving,to'
p42911
g9
sS'be,blunted,by'
p42912
g9
sS'tricyclic,and,in'
p42913
g9
sS'steady-state,were,not'
p42914
g3
sS'of,nizoral,tablets'
p42915
g9
sS'generally,should,not'
p42916
g9
sS'patients,developed,severe'
p42917
g3
sS'coagulation,ketoprofen,decreases'
p42918
g3
sS'of,the,higher'
p42919
g3
sS'amphetamines,can,cause'
p42920
g9
sS'occur,at,high'
p42921
g3
sS'with,camptosar,would'
p42922
g9
sS'these,agents,with'
p42923
g9
sS'be,metabolized,by'
p42924
g9
sS'progestin-only,oral,contraception'
p42925
g3
sS'same,enzyme,and'
p42926
g3
sS'was,not,considered'
p42927
g3
sS'beta-blocking,agents,a'
p42928
g3
sS'interactions,exists,not'
p42929
g3
sS'significant,pharmacokinetic,interactions'
p42930
g3
sS'action,of,tracrium'
p42931
g9
sS'the,ninth,day'
p42932
g3
sS'may,raise,serum'
p42933
g9
sS'with,irradiation,has'
p42934
g3
sS'necessary,the,dosage'
p42935
g9
sS'as,have,not'
p42936
g3
sS'the,oral,contraceptive'
p42937
g3
sS'h,in,the'
p42938
g3
sS'hormone,levels,induced'
p42939
g3
sS'of,decreased,approximately'
p42940
g9
sS'it,is,however'
p42941
g9
sS'carbamazepine,steady-state,trough'
p42942
g3
sS'been,fully,characterized'
p42943
g9
sS'fluoxetine,ocs,macrolide'
p42944
g3
sS'qtc,interval,caution'
p42945
g3
sS'the,in,vitro'
p42946
g3
sS'and,increases,in'
p42947
g3
sS'msec,was,with'
p42948
g9
sS'on,gm,day'
p42949
g9
sS'and,synthetic,galloyl'
p42950
g3
sS'required,will,be'
p42951
g3
sS'the,insp,mediated'
p42952
g3
sS'coadministration,with,tambocor'
p42953
g9
sS'heart,disease,congestive'
p42954
g9
sS'while,in,the'
p42955
g3
sS'on,possible,interactions'
p42956
g9
sS'may,also,have'
p42957
g9
sS'both,with,and'
p42958
g3
sS'blood,pressure,without'
p42959
g9
sS'suppression,by,of'
p42960
g9
sS'concentrations,that,affect'
p42961
g3
sS'the,slow,phasic'
p42962
g3
sS'patients,on,immunosuppression'
p42963
g3
sS'these,drugs,is'
p42964
g3
sS'human,studies,have'
p42965
g3
sS'potential,prolonged,concurrent'
p42966
g3
sS'agents,for,the'
p42967
g3
sS'at,mg,kg'
p42968
g3
sS'has,sufficient,function'
p42969
g3
sS'clearance,values,in'
p42970
g3
sS'higher,serum,exposure'
p42971
g9
sS'receiving,a,cyp3a4'
p42972
g9
sS'rifampin,rifampin,increases'
p42973
g9
sS'cases,occurred,between'
p42974
g3
sS'dose,reduction,when'
p42975
g9
sS'like,or,and'
p42976
g9
sS'from,mean,sem'
p42977
g3
sS'for,drug-induced,renal'
p42978
g3
sS'patients,receiving,therapy'
p42979
g9
sS'cyp3a4,and,cyp3a5'
p42980
g3
sS'monitored,frequently,if'
p42981
g9
sS'increased,both,in'
p42982
g3
sS'for,every,mac'
p42983
g3
sS'epidural,may,prolong'
p42984
g9
sS'of,cyp2d6,was'
p42985
g3
sS'estrogens,including,oral'
p42986
g9
sS'concentrations,decreases,the'
p42987
g9
sS'that,occur,with'
p42988
g3
sS'are,not,primarily'
p42989
g9
sS'health,organization,criteria'
p42990
g3
sS'of,metabolizing,itself'
p42991
g3
sS'function,or,in'
p42992
g3
sS'not,antagonize,the'
p42993
g9
sS'treat,strongyloidiasis,during'
p42994
g9
sS'c9,respectively,have'
p42995
g3
sS'a,patient,receiving'
p42996
g3
sS'subfraction,concentrations,reduced'
p42997
g3
sS'a,medicine,such'
p42998
g3
sS'plasma,and,brain'
p42999
g9
sS'or,at,least'
p43000
g3
sS'inducer,of,cytochrome'
p43001
g9
sS'do,not,influence'
p43002
g3
sS'cholestyramine,cholestyramine,has'
p43003
g9
sS'ranged,from,to'
p43004
g3
sS'dose,and,long'
p43005
g3
sS'affect,the,course'
p43006
g3
sS'two-way,interaction,between'
p43007
g9
sS'since,foscavir,decreases'
p43008
g3
sS'are,limited,in'
p43009
g9
sS'inhibitors,also,referred'
p43010
g3
sS'with,in,some'
p43011
g9
sS'racemic,exposure,was'
p43012
g9
sS'dosage,accordingly,if'
p43013
g3
sS'while,it,is'
p43014
g3
sS'subjects,treated,with'
p43015
g3
sS'administered,with,oral'
p43016
g9
sS'retinogeniculate,fibers,in'
p43017
g3
sS'important,in,the'
p43018
g3
sS'rarely,enuresis,urinary'
p43019
g3
sS'induction,and,displacement'
p43020
g9
sS'is,going,to'
p43021
g3
sS'patients,but,there'
p43022
g3
sS'vioxx,and,have'
p43023
g3
sS'intercourse,without,using'
p43024
g3
sS'for,days,decreased'
p43025
g9
sS'the,dissolution,rate'
p43026
g3
sS'the,simplest,inference'
p43027
g3
sS'compared,with,recordings'
p43028
g3
sS'blockers,in,the'
p43029
g3
sS'however,since,nsaids'
p43030
g9
sS'increased,intracranial,pressure'
p43031
g9
sS'mg,qid,did'
p43032
g3
sS'poisonings,of,uncertain'
p43033
g3
sS'increases,the,metabolism'
p43034
g9
sS'coadministration,of,bextra'
p43035
g3
sS'and,repeated,if'
p43036
g3
sS'ability,to,use'
p43037
g3
sS'observed,in,north'
p43038
g3
sS'a,mg,m'
p43039
g3
sS'the,single,dose'
p43040
g3
sS'receiving,daily,doses'
p43041
g3
sS'of,the,side'
p43042
g3
sS'suggests,that,may'
p43043
g9
sS'cyp3a4,inducing,activity'
p43044
g3
sS'of,the,divided'
p43045
g9
sS'a,mg,b'
p43046
g9
sS'to,have,occurred'
p43047
g9
sS'no,differential,effect'
p43048
g3
sS'conducted,with,alphagan'
p43049
g9
sS'specific,compatibility,data'
p43050
g3
sS'monkeys,at,approximately'
p43051
g3
sS'another,drug,known'
p43052
g3
sS'results,from,urine'
p43053
g3
sS'decreased,the,auc'
p43054
g9
sS'other,topical,has'
p43055
g3
sS'or,in,combination'
p43056
g3
sS'days,of,treatment'
p43057
g3
sS'clinical,trials,concomitant'
p43058
g3
sS'performed,with,sustiva'
p43059
g3
sS'in,mac,was'
p43060
g3
sS'patients,receiving,maintenance'
p43061
g3
sS'sparing,pharmacological,doses'
p43062
g3
sS'a,reduced,clozapine'
p43063
g3
sS'ventricular,fibrillation,when'
p43064
g9
sS'should,discuss,the'
p43065
g3
sS'of,stadol,ns'
p43066
g9
sS'azole,antifungals,grapefruit'
p43067
g9
sS'in,a,small'
p43068
g3
sS'of,certain,with'
p43069
g3
sS'with,acamprosate,concomitantly'
p43070
g3
sS'that,itraconazole,enhances'
p43071
g9
sS'unchanged,in,the'
p43072
g3
sS'enzymes,have,been'
p43073
g3
sS'the,clinical,basis'
p43074
g3
sS'authors,examined,the'
p43075
g3
sS'nephrotoxic,such,as'
p43076
g9
sS'pocs,and,the'
p43077
g3
sS'acute,asthma,or'
p43078
g3
sS'elimination,of,these'
p43079
g9
sS'and,a,single'
p43080
g9
sS'either,or,compounds'
p43081
g3
sS'of,other,narcotic'
p43082
g9
sS'caution,and,careful'
p43083
g3
sS'of,trileptal,on'
p43084
g3
sS'increased,by,concomitant'
p43085
g9
sS'that,given,as'
p43086
g3
sS'pathogens,of,addicts'
p43087
g3
sS'may,require,close'
p43088
g9
sS'doses,mg,qd'
p43089
g9
sS'to,be,used'
p43090
g3
sS'about,bound,to'
p43091
g3
sS'to,temporarily,suspending'
p43092
g9
sS'tolerance,in,patients'
p43093
g9
sS'cancidas,is,co-administered'
p43094
g9
sS'and,increased,blood'
p43095
g3
sS'conduction,disturbances,and'
p43096
g9
sS'of,may,interfere'
p43097
g9
sS'or,an,impairment'
p43098
g3
sS'associated,with,crohns'
p43099
g9
sS'of,is,minimized'
p43100
g3
sS'complicated,or,uncomplicated'
p43101
g3
sS'cyp3a4,activity,would'
p43102
g3
sS'administered,could,theoretically'
p43103
g3
sS'compared,with,in'
p43104
g3
sS'sirolimus,mammalian,target'
p43105
g3
sS'av,nodes,however'
p43106
g3
sS'glutamate,mglur,agonists'
p43107
g3
sS'concentrations,has,also'
p43108
g3
sS'rats,are,not'
p43109
g3
sS'addition,does,not'
p43110
g3
sS'in,vivo,rodent'
p43111
g3
sS'in,in,vivo'
p43112
g3
sS'alterations,caused,by'
p43113
g9
sS'the,cpk,elevations'
p43114
g3
sS'examining,mg,and'
p43115
g9
sS'identify,the,medications'
p43116
g3
sS'pseudomonas,aeruginosa,serotype'
p43117
g3
sS'the,amplitudes,of'
p43118
g3
sS'reactions,and,repeat'
p43119
g3
sS'development,at,clinically'
p43120
g3
sS'drugs,aripiprazole,is'
p43121
g3
sS'agents,benzodiazepines,gi'
p43122
g9
sS'do,occur,the'
p43123
g3
sS'of,from,these'
p43124
g3
sS'with,co-administration,of'
p43125
g9
sS'other,hand,promoted'
p43126
g3
sS'observed,with,beta-receptor'
p43127
g3
sS'might,interfere,with'
p43128
g3
sS'retinyl,acetate,at'
p43129
g9
sS'of,atherosclerotic,disease'
p43130
g3
sS'but,decreased,the'
p43131
g9
sS'substrate,and,an'
p43132
g3
sS'were,in,the'
p43133
g9
sS'drugs,which,may'
p43134
g9
sS'determined,on,different'
p43135
g3
sS'metabolism,and,uptake'
p43136
g3
sS'hypotension,caused,by'
p43137
g9
sS'clonidine,concomitant,administration'
p43138
g9
sS'the,question,of'
p43139
g3
sS'function,who,are'
p43140
g9
sS'the,m1,cmax'
p43141
g3
sS'bodys,ability,to'
p43142
g3
sS'single,mg,subcutaneous'
p43143
g3
sS'c9,cyp,c19'
p43144
g3
sS'qd,was,co-administered'
p43145
g3
sS'was,about,a'
p43146
g9
sS'stimulated,gastric,secretion'
p43147
g3
sS'mild,but,definite'
p43148
g3
sS'observed,in,a'
p43149
g3
sS'molecular,differences,between'
p43150
g3
sS'to,compared,to'
p43151
g9
sS'anion,exchange,it'
p43152
g3
sS'with,derivatives,k'
p43153
g3
sS'or,minus,s'
p43154
g3
sS'dose,m,g'
p43155
g3
sS'natriuresis,is,not'
p43156
g9
sS'both,agents,did'
p43157
g3
sS'loss,of,microtubules'
p43158
g3
sS'and,may,antagonize'
p43159
g9
sS'have,received,general'
p43160
g3
sS'at,any,occasion'
p43161
g3
sS'induce,the,cyp3a4'
p43162
g3
sS'was,as,stable'
p43163
g3
sS'immediate,and,extended'
p43164
g9
sS'glucose-specific,method,to'
p43165
g3
sS'cardiac,autonomic,irritability'
p43166
g9
sS'thiosulfate,is,a'
p43167
g9
sS'beta,blockers,including'
p43168
g3
sS'the,discontinuance,of'
p43169
g9
sS'combination,hormonal,causing'
p43170
g9
sS'of,increased,exposure'
p43171
g3
sS'following,macrolide,antibiotics'
p43172
g9
sS'were,given,weekly'
p43173
g3
sS'by,cyp3a4,but'
p43174
g3
sS'pharmacokinetics,of,and'
p43175
g3
sS'secondary,deficiencies,constitute'
p43176
g3
sS'with,hypokalemia,or'
p43177
g3
sS'drug,interaction,for'
p43178
g9
sS'p450,system,and'
p43179
g3
sS'is,a,weak'
p43180
g9
sS'aetiopathogenic--,for,example'
p43181
g3
sS'fold,by,coadministration'
p43182
g9
sS'levels,and,there'
p43183
g9
sS'received,as,part'
p43184
g3
sS'weight,loss,compared'
p43185
g9
sS'discontinuation,of,has'
p43186
g9
sS'given,when,administering'
p43187
g3
sS'with,amphotericin,b'
p43188
g9
sS'exercised,when,taking'
p43189
g3
sS'level,to,alert'
p43190
g9
sS'orally,disintegrating,tablet'
p43191
g9
sS'h1-blocking,agents,and'
p43192
g9
sS'trials,mean,decreases'
p43193
g3
sS'significant,inhibition,of'
p43194
g3
sS'recommended,when,is'
p43195
g3
sS'clinical,studies,tilade'
p43196
g3
sS'conclusion,that,it'
p43197
g9
sS'inomax,has,been'
p43198
g3
sS'with,that,in'
p43199
g3
sS'and,mac,minimum'
p43200
g9
sS'when,pletal,is'
p43201
g9
sS'theophylline,in,three'
p43202
g3
sS'anaphylaxis,have,been'
p43203
g3
sS'oxo-desethylzaleplon,glucuronide,account'
p43204
g3
sS'therapeutic,supplement,containing'
p43205
g9
sS'alcoholic,beverages,are'
p43206
g3
sS'is,mg,with'
p43207
g3
sS'a,concentration,as'
p43208
g3
sS'established,that,interferes'
p43209
g9
sS'from,a,stock'
p43210
g3
sS'glucose,alkaline,phosphatase'
p43211
g3
sS'h,s,concomitantly'
p43212
g9
sS'and,glycemic,control'
p43213
g3
sS'and,reached,after'
p43214
g9
sS'cmax,vs,and'
p43215
g3
sS'and,foods,fortified'
p43216
g9
sS'an,inhibition,of'
p43217
g9
sS'trials,to,examine'
p43218
g3
sS'the,clinical,trials'
p43219
g9
sS'cmax,was,observed'
p43220
g3
sS'were,each,found'
p43221
g3
sS'a,more,severe'
p43222
g3
sS'of,the,have'
p43223
g9
sS'is,hydroxylation,catalyzed'
p43224
g3
sS'of,transdermal,with'
p43225
g9
sS'in,the,excretion'
p43226
g9
sS'celebrex,can,be'
p43227
g9
sS'foods,fortified,with'
p43228
g9
sS'of,the,day-to'
p43229
g3
sS'acid,supplements,can'
p43230
g3
sS'altered,in,the'
p43231
g3
sS'occur,within,the'
p43232
g3
sS'duration,of,its'
p43233
g9
sS'with,axert,and'
p43234
g9
sS'when,nsaids,and'
p43235
g9
sS'hydrochloride,in,combination'
p43236
g9
sS'mm3,and,platelets'
p43237
g3
sS'should,be,continued'
p43238
g9
sS'elevated,creatinine,despite'
p43239
g3
sS'increases,in,heart'
p43240
g9
sS'ieg,response,induced'
p43241
g3
sS'urine,or,serum'
p43242
g3
sS'and,incoordination,have'
p43243
g9
sS'yeast,and,for'
p43244
g3
sS'myelosuppression,following,the'
p43245
g3
sS'methotrexate,there,has'
p43246
g9
sS'stimulants,and,their'
p43247
g9
sS'or,hepatotoxic,effects'
p43248
g9
sS'of,aprepitant,was'
p43249
g3
sS'on,how,age'
p43250
g3
sS'blockers,presumably,because'
p43251
g9
sS'that,disease,states'
p43252
g3
sS'channel,blocking,agents'
p43253
g3
sS'especially,hematologic,and'
p43254
g3
sS'synergistic,activity,if'
p43255
g9
sS'plasma,levels,when'
p43256
g3
sS'elevation,of,plasma'
p43257
g9
sS'may,inhibit,both'
p43258
g9
sS'on,p450,enzymes'
p43259
g3
sS'patients,receiving,in'
p43260
g9
sS'however,is,within'
p43261
g3
sS'patients,anaesthetised,with'
p43262
g9
sS'not,metabolized,by'
p43263
g3
sS'cells,that,are'
p43264
g3
sS'of,heroin-related,deaths'
p43265
g9
sS'or,ototoxicity,and'
p43266
g3
sS'several,instances,in'
p43267
g3
sS'the,initial,dosage'
p43268
g9
sS'moreover,additional,interaction'
p43269
g3
sS'variables,of,compared'
p43270
g3
sS'symbol,copying,test'
p43271
g9
sS'statistically,significant,increase'
p43272
g9
sS'to,be,patient'
p43273
g3
sS'excreted,in,order'
p43274
g3
sS'to,ace,inhibitors'
p43275
g9
sS'use,of,antifibrinolytic'
p43276
g3
sS'included,with,combination'
p43277
g3
sS'more,pronounced,inhibition'
p43278
g3
sS'and,or,carbidopa-levodopa'
p43279
g3
sS'no,interactions,with'
p43280
g3
sS'is,a,common'
p43281
g3
sS'cyp2c9,substrate,trough'
p43282
g9
sS'not,cause,increased'
p43283
g3
sS'electrocardiographic,parameters,including'
p43284
g3
sS'advisable,to,closely'
p43285
g3
sS'oral,ethinyl,estradiol'
p43286
g3
sS'hiv-nhl,the,authors'
p43287
g3
sS'color,development,essential'
p43288
g3
sS'endothelium,were,used'
p43289
g3
sS'also,there,were'
p43290
g3
sS'dose,on,a'
p43291
g3
sS'co-administered,with,tikosyn'
p43292
g9
sS'of,oral,the'
p43293
g9
sS'on,female,fertility'
p43294
g3
sS'and,the,patients'
p43295
g3
sS'for,an,endemic'
p43296
g3
sS'agents,and,some'
p43297
g3
sS'stimulation,by,cerulein--an'
p43298
g3
sS'was,the,most'
p43299
g3
sS'those,who,are'
p43300
g3
sS'although,the,interactions'
p43301
g9
sS'the,potential,nephrotoxicity'
p43302
g3
sS'we,conclude,that'
p43303
g9
sS'treatment,with,hivid'
p43304
g9
sS'longer,term,therapy'
p43305
g3
sS'additive,sedative,effects'
p43306
g9
sS'shown,to,exhibit'
p43307
g3
sS'were,also,decreased'
p43308
g3
sS'anti-inflammatory,agent,can'
p43309
g9
sS'although,additional,interaction'
p43310
g3
sS'tracleer,is,initiated'
p43311
g9
sS'anticoagulants,flurbiprofen,like'
p43312
g9
sS'result,in,increased'
p43313
g3
sS'reduction,in,order'
p43314
g3
sS'median,follow-up,of'
p43315
g3
sS'performed,to,evaluate'
p43316
g3
sS'subject,themselves,to'
p43317
g3
sS'of,that,from'
p43318
g3
sS'in,treatment-naive,patients'
p43319
g3
sS'antihypertensive,and,the'
p43320
g9
sS'was,significantly,higher'
p43321
g9
sS'clinitest,tablets,but'
p43322
g3
sS'results,from,human'
p43323
g3
sS'of,two,potentially'
p43324
g9
sS'of,using,bromocriptine'
p43325
g9
sS'allergens,may,be'
p43326
g3
sS'stomach,acidity,does'
p43327
g3
sS'leading,to,elevated'
p43328
g9
sS'significantly,decreases,clearance'
p43329
g9
sS'modest,increases,about'
p43330
g9
sS'measured,toxicity,was'
p43331
g3
sS'when,the,patient'
p43332
g3
sS'an,equivalent,volume'
p43333
g3
sS'deprived,of,water'
p43334
g3
sS'brevibloc,were,concomitantly'
p43335
g9
sS'more,information,on'
p43336
g3
sS'for,and,ethinyl'
p43337
g9
sS'to,cause,the'
p43338
g9
sS'be,prescribed,with'
p43339
g9
sS'or,alter,the'
p43340
g9
sS'dose,or,at'
p43341
g3
sS'change,of,less'
p43342
g9
sS'with,demonstrated,no'
p43343
g3
sS'that,the,toxicity'
p43344
g9
sS'digoxin,methotrexate,cyclosporine'
p43345
g3
sS'biotransformation,system,mainly'
p43346
g9
sS'does,not,produce'
p43347
g3
sS'pegasys,should,be'
p43348
g3
sS'day,and,one'
p43349
g3
sS'affect,cardiac,contractility'
p43350
g3
sS'of,videx,to'
p43351
g9
sS'been,established,that'
p43352
g9
sS'efficient,substrate,for'
p43353
g3
sS'increased,availability,of'
p43354
g3
sS'oral,physiological,supplementation'
p43355
g3
sS'involved,in,antiapoptotic'
p43356
g3
sS'of,p-glycoprotein,loop'
p43357
g3
sS'of,averaged,s'
p43358
g9
sS'the,higher,end'
p43359
g3
sS'are,reduced,when'
p43360
g9
sS'toxicity,where,survival'
p43361
g3
sS'false-positive,test,results'
p43362
g3
sS'other,agents,dynamic'
p43363
g3
sS'vision,nystagmus,strabismus'
p43364
g3
sS'its,breakdown,products'
p43365
g9
sS'enhanced,learning,and'
p43366
g3
sS'prescribed,to,each'
p43367
g3
sS'peripheral,edema,nausea'
p43368
g3
sS'as,channel-blockers,ace'
p43369
g3
sS'copaxone,and,other'
p43370
g3
sS'a,symptomatic,pharmaceutical'
p43371
g3
sS'week,intervals,until'
p43372
g3
sS'ml,and,micrograms'
p43373
g3
sS'consequences,could,be'
p43374
g3
sS'in,diabetic,patients'
p43375
g3
sS'effect,of,each'
p43376
g9
sS'be,impaired,when'
p43377
g3
sS'from,the,high-dose'
p43378
g9
sS'observed,between,both'
p43379
g3
sS'affecting,myelopoesis,drugs'
p43380
g3
sS'route,of,including'
p43381
g9
sS'bid,the,cmax'
p43382
g9
sS'the,rebound,hypertension'
p43383
g9
sS'for,most,of'
p43384
g3
sS'treated,with,systemically-administered'
p43385
g9
sS'cytochrome,p450,cyp450'
p43386
g3
sS'angina,myocardial,infarction'
p43387
g3
sS'other,have,been'
p43388
g9
sS'of,assistance,in'
p43389
g3
sS'agonist,antagonist,eg'
p43390
g9
sS'due,to,release'
p43391
g9
sS'app,control,of'
p43392
g3
sS'ketones,and,demonstrates'
p43393
g3
sS'individual,isoform,is'
p43394
g3
sS'particular,has,been'
p43395
g3
sS'not,affect,either'
p43396
g3
sS'subcutaneous,injections,of'
p43397
g3
sS'that,sensitize,the'
p43398
g9
sS'with,daily,dosing'
p43399
g3
sS'or,induce,cyp'
p43400
g3
sS'and,o-desacetylrifabutin,and'
p43401
g9
sS'with,complex,renal'
p43402
g3
sS'ejection,by,the'
p43403
g3
sS'in,december,the'
p43404
g3
sS'exposure-response,relationships,between'
p43405
g3
sS'clinical,trials,were'
p43406
g3
sS'the,photosensitivity,reaction'
p43407
g9
sS'increase,sensitivity,to'
p43408
g3
sS'oral,containing,mcg'
p43409
g9
sS'objective,to,evaluate'
p43410
g3
sS'and,a,do'
p43411
g9
sS'mode,of,toxic'
p43412
g3
sS'out,to,study'
p43413
g3
sS'tcas,decrease,the'
p43414
g9
sS'by,containing,or'
p43415
g9
sS'with,an,i-labelled'
p43416
g3
sS'inhibitors,protease,inhibitors'
p43417
g3
sS'the,analysis,and'
p43418
g3
sS'anxiogenic,effects,in'
p43419
g3
sS'reverse,transcriptase,inhibitor'
p43420
g3
sS'after,or,hours'
p43421
g9
sS'until,the,relevance'
p43422
g9
sS'combined,with,these'
p43423
g9
sS'the,blood,levels'
p43424
g9
sS'dose,level,p'
p43425
g3
sS'may,require,dose'
p43426
g3
sS'for,neurons,recorded'
p43427
g3
sS'plasma,flow,glomerular'
p43428
g3
sS'increase,increase,decrease'
p43429
g3
sS'response,was,considered'
p43430
g3
sS'either,striatum,str'
p43431
g3
sS'phosphorylation,in,response'
p43432
g3
sS'but,can,lead'
p43433
g3
sS'original,medication,should'
p43434
g3
sS'before,using,this'
p43435
g3
sS'was,more,pronounced'
p43436
g3
sS'streptozotocin-induced,diabetic,rats'
p43437
g3
sS'enzyme,based,tests'
p43438
g3
sS'the,transport,ratio'
p43439
g3
sS'of,pharmacogenetics,pharmacogenetics'
p43440
g3
sS'relationships,between,and'
p43441
g3
sS'necessary,when,eulexin'
p43442
g9
sS'cimetidine,is,reported'
p43443
g9
sS'events,in,subjects'
p43444
g3
sS'or,the,pharmacodynamics'
p43445
g3
sS'on,any,cyp'
p43446
g3
sS'in,the,concomitant'
p43447
g9
sS'significantly,reduced,in'
p43448
g3
sS'these,two,should'
p43449
g3
sS'some,patients,the'
p43450
g9
sS'does,not,necessitate'
p43451
g3
sS'although,many,concomitant'
p43452
g3
sS'vitamin,k,aquamephyton'
p43453
g3
sS'on,administration,of'
p43454
g9
sS'not,mix,toradol'
p43455
g3
sS'studies,caution,should'
p43456
g3
sS'experiments,we,noted'
p43457
g3
sS'of,marked,bradycardia'
p43458
g9
sS'the,light,zone'
p43459
g9
sS'should,be,evaluated'
p43460
g9
sS'fractional,transfer,to'
p43461
g3
sS'bones,the,dosage'
p43462
g3
sS'trials,was,used'
p43463
g3
sS'mg,day,followed'
p43464
g9
sS'as,an,index'
p43465
g3
sS'nsaid,users,the'
p43466
g3
sS'a,sudden,extrusion'
p43467
g3
sS'therefore,consideration,should'
p43468
g9
sS'hormone,replacement,therapy'
p43469
g3
sS'increase,in,cmax'
p43470
g9
sS'anticholinesterase,agents,and'
p43471
g9
sS'single,dose,in'
p43472
g3
sS'and,clearance,at'
p43473
g3
sS'affect,the,bioavailability'
p43474
g3
sS'reported,for,use'
p43475
g3
sS'incidence,of,peritoneal'
p43476
g3
sS'and,a4,isozymes'
p43477
g3
sS'sex,hormone,response'
p43478
g9
sS'physician,is,advised'
p43479
g3
sS'however,it,has'
p43480
g9
sS'of,ee,were'
p43481
g3
sS'mm,hg,higher'
p43482
g3
sS'recommended,that,either'
p43483
g3
sS'if,necessary,should'
p43484
g3
sS'no,treatment-related,pattern'
p43485
g3
sS'anti-arrhythmic,agents,such'
p43486
g3
sS'with,radiation,therapy'
p43487
g3
sS'in,prolongation,of'
p43488
g9
sS'addition,several,aed'
p43489
g9
sS'cinese,hamsters,show'
p43490
g3
sS'from,eggs,was'
p43491
g3
sS'vitro,on,the'
p43492
g3
sS'have,no,influence'
p43493
g3
sS'supplemental,folic,acid'
p43494
g3
sS'not,be,confirmed'
p43495
g3
sS'lipoprotein,cholesterol,levels'
p43496
g3
sS'to,mm,declining'
p43497
g3
sS'dose-limiting,organ,may'
p43498
g3
sS'was,responsible,for'
p43499
g9
sS'higher,daily,acquisition'
p43500
g3
sS'by,cyp2d6,isoenzyme'
p43501
g9
sS'that,the,site'
p43502
g3
sS'the,therapeutic,benefit'
p43503
g3
sS'secretion,distribution,effect'
p43504
g3
sS'the,cyp3a4,pathway'
p43505
g9
sS'monitor,for,symptoms'
p43506
g3
sS'in,vitro,appears'
p43507
g9
sS'zebeta,resulting,in'
p43508
g9
sS'pharmacological,doses,of'
p43509
g3
sS'nondepolarizing,neuromuscular,blocking'
p43510
g9
sS'given,for,long'
p43511
g3
sS'effect,of,zebeta'
p43512
g3
sS'will,not,correct'
p43513
g3
sS'between,treatment,groups'
p43514
g3
sS'of,the,antidepressant'
p43515
g3
sS'local,agents,when'
p43516
g3
sS'in,all,patients'
p43517
g9
sS'glucose,and,exert'
p43518
g3
sS'was,expected,because'
p43519
g3
sS'medications,is,not'
p43520
g9
sS'or,may,interfere'
p43521
g9
sS'of,platelet,aggregation'
p43522
g3
sS'mna,in,the'
p43523
g3
sS'share,or,partly'
p43524
g3
sS'is,acidified,in'
p43525
g3
sS'are,taking,other'
p43526
g9
sS'with,oral,resulted'
p43527
g9
sS'active,metabolite,exposure'
p43528
g9
sS'as,triple,combination'
p43529
g3
sS'to,control,inflammation'
p43530
g9
sS'times,when,was'
p43531
g9
sS'agents,of,the'
p43532
g9
sS'in,plasmaconcentrations,may'
p43533
g9
sS'hepatic,clearance,or'
p43534
g3
sS'inhibitors,may,cause'
p43535
g3
sS'for,days,systemic'
p43536
g9
sS'daily,brovana,dose'
p43537
g3
sS'very,little,change'
p43538
g9
sS'day,administration,for'
p43539
g3
sS'low-dose,microg,kg'
p43540
g9
sS'tachypnea,lethargy,and'
p43541
g9
sS'gram,of,hydroxide'
p43542
g9
sS'approximate,decrease,in'
p43543
g9
sS'd,the,coadministration'
p43544
g3
sS'of,that,increase'
p43545
g9
sS'beta-blockers,concomitant,use'
p43546
g9
sS'can,decrease,plasma'
p43547
g9
sS'g,of,per'
p43548
g9
sS'and,traumatic,edemas'
p43549
g9
sS'and,mask,the'
p43550
g3
sS'observation,period,in'
p43551
g3
sS'that,lung,has'
p43552
g3
sS'agents,glutamic,acid'
p43553
g9
sS'administration,of,innovar'
p43554
g9
sS'or,use,of'
p43555
g9
sS'as,antiemetic,prophylaxis'
p43556
g9
sS'by,nonbarbiturate,antianxiety'
p43557
g9
sS'changes,in,hepatic'
p43558
g3
sS'kits,with,an'
p43559
g3
sS'with,alt,and'
p43560
g3
sS'for,adverse,events'
p43561
g3
sS'a,physician,or'
p43562
g9
sS'accutane,use,is'
p43563
g3
sS'axert,and,an'
p43564
g9
sS'itraconazole,decreases,clearance'
p43565
g9
sS'lithium,inhibition,of'
p43566
g3
sS'interaction,between,the'
p43567
g3
sS'and,its,acid'
p43568
g3
sS'of,these,drugs'
p43569
g3
sS'necessary,when,nimbex'
p43570
g3
sS'no,evidence,of'
p43571
g3
sS'co-administration,concomitant,use'
p43572
g9
sS'being,withdrawn,from'
p43573
g3
sS'metabolism,of,chylomicron-like'
p43574
g3
sS'factor,viii,ix'
p43575
g3
sS'using,morphological,markers'
p43576
g9
sS'by,bezalip,or'
p43577
g9
sS'be,analyzed,for'
p43578
g3
sS'towards,cyp1a2,which'
p43579
g9
sS'exposure,and,the'
p43580
g3
sS'metabolic,enzymes,and'
p43581
g3
sS'of,protein,synthesis'
p43582
g3
sS'action,of,initial'
p43583
g9
sS'initial,oral,dose'
p43584
g9
sS'or,with,particularly'
p43585
g9
sS'has,a,considerable'
p43586
g9
sS'in,serum,concentrations'
p43587
g3
sS'digitalis,enhanced,possibility'
p43588
g3
sS'or,tubular,secretion'
p43589
g3
sS'the,exogenous,respiration'
p43590
g3
sS'a,specific,treatment'
p43591
g3
sS'combined,data,from'
p43592
g3
sS'use,glucose,dehydrogenase'
p43593
g3
sS'effect,on,prothrombin'
p43594
g3
sS'with,iopidine,ophthalmic'
p43595
g3
sS'may,exacerbate,rebound'
p43596
g9
sS'days,increases,plasma'
p43597
g3
sS'in,animals,indicate'
p43598
g9
sS'mental,status,in'
p43599
g3
sS'healthy,volunteers,under'
p43600
g3
sS'administration,of,ethyol'
p43601
g9
sS'and,pth,and'
p43602
g9
sS'cyp3a4,inhibitors,but'
p43603
g3
sS'comparable,in,effects'
p43604
g3
sS'rats,to,assess'
p43605
g3
sS'a,strong,inhibitor'
p43606
g9
sS'protein,may,displace'
p43607
g3
sS'decreased,response,to'
p43608
g3
sS'at,least,partially'
p43609
g9
sS'crises,have,resulted'
p43610
g9
sS'replacement,therapy,free'
p43611
g9
sS'the,acid,metabolite'
p43612
g3
sS'by,lowering,the'
p43613
g9
sS'and,to,mouse'
p43614
g3
sS'immune,system,are'
p43615
g3
sS'and,local,agents'
p43616
g3
sS'patients,receiving,treatment'
p43617
g3
sS'either,oral,or'
p43618
g9
sS'and,increases,of'
p43619
g3
sS'therefore,when,and'
p43620
g9
sS'on,cure,rates'
p43621
g3
sS'information,to,increase'
p43622
g9
sS'of,erection,disorders'
p43623
g3
sS'aripiprazole,also,does'
p43624
g3
sS'in,normal,volunteers'
p43625
g9
sS'utilizing,a,volatile'
p43626
g3
sS'study,the,pancreatic'
p43627
g3
sS'indicate,that,levels'
p43628
g9
sS'not,normally,be'
p43629
g3
sS'protein,kinase,c'
p43630
g3
sS'substantia,gelatinosa,neurons'
p43631
g3
sS'levels,up,to'
p43632
g3
sS'p,a,were'
p43633
g3
sS'arrhythmias,may,respond'
p43634
g3
sS'that,may,decrease'
p43635
g9
sS'in,type,diabetes'
p43636
g9
sS'position,and,if'
p43637
g3
sS'acetate,affected,the'
p43638
g9
sS'shown,that,rr'
p43639
g3
sS'given,very,high'
p43640
g9
sS'concentrations,in,bile'
p43641
g9
sS'another,tnf-blocking,agent'
p43642
g9
sS'crixivan,fortovase,invirase'
p43643
g9
sS'following,a,g'
p43644
g3
sS'the,most,significant'
p43645
g3
sS'in,proliferating,cell'
p43646
g3
sS'check,your,b12'
p43647
g3
sS'although,trough,plasma'
p43648
g9
sS'effects,have,frequently'
p43649
g3
sS'not,depend,on'
p43650
g3
sS'force,of,contraction'
p43651
g3
sS'and,severe,rhabdomyolysis'
p43652
g9
sS'to,m,g'
p43653
g9
sS'though,this,has'
p43654
g9
sS'serotonin,release,by'
p43655
g3
sS'they,are,administered'
p43656
g3
sS'either,levels,or'
p43657
g3
sS'with,elevations,in'
p43658
g9
sS'to,m,v'
p43659
g3
sS'best,tool,for'
p43660
g3
sS'additive,toxicity,especially'
p43661
g3
sS'coadministration,with,invirase'
p43662
g3
sS'digoxin,salicylate,and'
p43663
g9
sS'experience,a,reversible'
p43664
g9
sS'mg,daily,had'
p43665
g3
sS'not,to,be'
p43666
g3
sS'gel,in,combination'
p43667
g3
sS'not,be,analyzed'
p43668
g3
sS'was,performed,in'
p43669
g3
sS'any,efficacy,benefit'
p43670
g3
sS'metabolite,of,does'
p43671
g3
sS'labelled,and,in'
p43672
g3
sS'reduced,cmax,up'
p43673
g9
sS'effects,of,pcp'
p43674
g3
sS'h,antagonists,the'
p43675
g3
sS'methotrexate,mexate,use'
p43676
g9
sS'requirements,may,be'
p43677
g3
sS'pressor,activity,and'
p43678
g3
sS'products,and,may'
p43679
g9
sS'dicumarol,and,may'
p43680
g3
sS'concentrations,of,concomitant'
p43681
g9
sS'in,the,serum'
p43682
g9
sS'uncontrolled,data,suggest'
p43683
g3
sS'with,intravenous,hydration'
p43684
g3
sS'schizophrenia,or,related'
p43685
g3
sS'have,a,dramatic'
p43686
g3
sS'of,plasma,concentrations'
p43687
g3
sS'of,metabolism,and'
p43688
g9
sS'or,patients,using'
p43689
g9
sS'or,its,effects'
p43690
g3
sS'hydrochloride,with,in'
p43691
g9
sS'pathway,showed,a'
p43692
g9
sS'development,consistent,with'
p43693
g3
sS'at,least,the'
p43694
g3
sS'strains,and,six'
p43695
g3
sS'decreased,when,given'
p43696
g9
sS'in,using,preparations'
p43697
g3
sS'on,the,serum'
p43698
g3
sS'plasma,and,kht'
p43699
g3
sS'marked,changes,in'
p43700
g9
sS'of,biocytin,with'
p43701
g3
sS'mean,steady-state,plasma'
p43702
g9
sS'in,normal,healthy'
p43703
g3
sS'patients,taking,revia'
p43704
g9
sS'the,appropriate,dose'
p43705
g3
sS'nicotinic,receptors,mc'
p43706
g3
sS'sustiva,is,given'
p43707
g3
sS'p450,a4,may'
p43708
g9
sS'with,a,strong'
p43709
g9
sS'of,mg,has'
p43710
g3
sS'unchanged,following,a'
p43711
g3
sS'tests,benedict,s'
p43712
g3
sS'tablets,to,avoid'
p43713
g3
sS'onset,of,maximum'
p43714
g9
sS'at,a,plasma'
p43715
g3
sS'a4,as,well'
p43716
g3
sS'should,therefore,be'
p43717
g3
sS'administration,of,substrates'
p43718
g3
sS'instances,and,antagonism'
p43719
g9
sS'alone,at,therapeutic'
p43720
g3
sS'indomethacin,concomitant,use'
p43721
g9
sS'capsules,every,hours'
p43722
g9
sS'to,determine,blood'
p43723
g3
sS'the,block,with'
p43724
g3
sS'in,cases,and'
p43725
g3
sS'progress,very,rapidly'
p43726
g3
sS'on,half-life,the'
p43727
g9
sS'of,and,monitoring'
p43728
g9
sS'urine,of,both'
p43729
g3
sS'however,initial,dose'
p43730
g3
sS'of,free,had'
p43731
g3
sS'of,at,steady'
p43732
g3
sS'these,effects,is'
p43733
g9
sS'be,given,tot'
p43734
g3
sS'combination,therapy,is'
p43735
g3
sS'observed,there,were'
p43736
g3
sS'breakfast,cereals,on'
p43737
g3
sS'significant,degree,when'
p43738
g3
sS'by,through,the'
p43739
g3
sS'received,tended,to'
p43740
g3
sS'hypotension,developed,in'
p43741
g9
sS'or,their,guardians'
p43742
g3
sS'level,serum,levels'
p43743
g3
sS'concomitant,crohn,s'
p43744
g3
sS'long,lasting,inhibition'
p43745
g3
sS'is,found,in'
p43746
g3
sS'pharmacokinetics,of,have'
p43747
g3
sS'contrast,mm,and'
p43748
g3
sS'by,inhibiting,their'
p43749
g9
sS'either,increase,or'
p43750
g9
sS'interactions,the,bioavailability'
p43751
g3
sS'concomitantly,with,antagonists'
p43752
g9
sS'interaction,to,patients'
p43753
g3
sS'among,the,polyene'
p43754
g3
sS'dose,administered,once'
p43755
g3
sS'blocked,the,secretory'
p43756
g9
sS'promptly,if,such'
p43757
g3
sS'with,caution,when'
p43758
g3
sS'preparation,this,parenteral'
p43759
g9
sS'simultaneous,ingestion,of'
p43760
g9
sS'hyperaminotransferasemia,significant,elevations'
p43761
g3
sS'receiving,the,cyp3a4'
p43762
g9
sS'are,metabolized,through'
p43763
g3
sS'receiving,concurrently,with'
p43764
g9
sS'prinivil,given,concomitantly'
p43765
g3
sS'considerable,evidence,indicating'
p43766
g3
sS'may,affect,gastrointestinal'
p43767
g9
sS'it,is,known'
p43768
g9
sS'the,liver,to'
p43769
g3
sS'of,cyp2d6,may'
p43770
g3
sS'however,the,effects'
p43771
g3
sS'the,suitability,of'
p43772
g3
sS'a,patient,requires'
p43773
g9
sS'extrapolated,to,other'
p43774
g3
sS'is,structurally,similar'
p43775
g3
sS'limited,experience,with'
p43776
g3
sS'subjects,taking,placebo'
p43777
g3
sS'administration,of,drugs'
p43778
g9
sS'i,p,dmpge2'
p43779
g3
sS'must,be,paid'
p43780
g3
sS'initial,presentation,of'
p43781
g9
sS'mefenamic,acid,monoamine'
p43782
g9
sS'clamps,mmol,l'
p43783
g3
sS'can,form,chelation'
p43784
g9
sS'have,effects,on'
p43785
g3
sS'than,usually,prescribed'
p43786
g3
sS'when,and,were'
p43787
g9
sS'on,bleeding,time'
p43788
g3
sS'hormonal,and,the'
p43789
g3
sS'given,concomitantly,physicians'
p43790
g9
sS'of,either,one'
p43791
g9
sS'the,known,cyp3a4'
p43792
g9
sS'particularly,in,the'
p43793
g9
sS'was,achieved,indicating'
p43794
g3
sS'interaction,with,drugs'
p43795
g3
sS'no,measurable,effect'
p43796
g3
sS'difluoroacetone,mg,kg'
p43797
g3
sS'octapeptide,was,replaced'
p43798
g3
sS'that,can,either'
p43799
g3
sS'cyp3a4,eg,or'
p43800
g9
sS'use,of,ergotamine-containing'
p43801
g9
sS'in,mean,area'
p43802
g9
sS'to,screen,for'
p43803
g3
sS'studied,certain,may'
p43804
g9
sS'useful,in,therapy'
p43805
g3
sS'not,significantly,higher'
p43806
g3
sS'muscle,relaxants,may'
p43807
g9
sS'because,oral,may'
p43808
g9
sS'due,to,reductions'
p43809
g3
sS'reflects,an,approximate'
p43810
g9
sS'and,type,of'
p43811
g3
sS'placebo,was,and'
p43812
g3
sS'or,mg,every'
p43813
g3
sS'cephalosporins-cephalosporins,containing,side'
p43814
g3
sS'administered,until,a'
p43815
g9
sS'h,also,indicated'
p43816
g3
sS'by,hour,and'
p43817
g9
sS'ems,selective,inhibitors'
p43818
g3
sS'when,is,the'
p43819
g3
sS'the,maximum,plasma'
p43820
g9
sS'against,engaging,in'
p43821
g3
sS'with,care,when'
p43822
g9
sS'not,been,performed'
p43823
g3
sS'or,fertility,studies'
p43824
g3
sS'since,may,prolong'
p43825
g9
sS'psa,levels,are'
p43826
g3
sS'of,hcl,no'
p43827
g9
sS'and,agents,other'
p43828
g9
sS'in,excessive,effects'
p43829
g9
sS'the,hydroxylation,during'
p43830
g3
sS'metabolites,were,studied'
p43831
g3
sS'given,simultaneously,with'
p43832
g9
sS'mg,both,a'
p43833
g3
sS'complexes,thereof,are'
p43834
g3
sS'bid,on,the'
p43835
g3
sS'the,mortality,rate'
p43836
g3
sS'with,hyperthyroidism,hypertension'
p43837
g3
sS'irritability,and,may'
p43838
g9
sS'treatment,with,wellbutrin'
p43839
g9
sS'at,various,temperatures'
p43840
g3
sS'in,a,rabbit'
p43841
g3
sS'concomitant,use,should'
p43842
g3
sS'in,some,normal'
p43843
g9
sS'that,are,on'
p43844
g9
sS'approximately,half,of'
p43845
g3
sS'have,clinically,significant'
p43846
g3
sS'resumed,during,therapy'
p43847
g3
sS'than,the,therapeutic'
p43848
g3
sS'manufacturers,have,not'
p43849
g3
sS'delayed,until,after'
p43850
g3
sS'on,repeated,challenge'
p43851
g3
sS'p2,may,result'
p43852
g3
sS'of,on,was'
p43853
g3
sS'equal,to,micrograms'
p43854
g3
sS'taken,before,morning'
p43855
g3
sS'p450,a2,an'
p43856
g9
sS'injectable,produces,depression'
p43857
g9
sS'nevirapine,and,should'
p43858
g9
sS'agents,iodine-containing,compounds'
p43859
g3
sS'active,metabolite,at'
p43860
g3
sS'after,the,initial'
p43861
g9
sS'speed-up,this,process'
p43862
g3
sS'different,tasks,in'
p43863
g3
sS'includes,most,genotoxic'
p43864
g3
sS'thought,to,play'
p43865
g3
sS'prescribed,with,caution'
p43866
g9
sS'a,delay,in'
p43867
g9
sS'chinese,hamster,s'
p43868
g3
sS'milk,products,and'
p43869
g9
sS'effect,of,combined'
p43870
g3
sS'method,such,as'
p43871
g3
sS'was,evident,in'
p43872
g3
sS'reducing,the,number'
p43873
g9
sS'with,increased,serum'
p43874
g9
sS'reports,of,deaths'
p43875
g3
sS'desired,therapeutic,effect'
p43876
g3
sS'have,a,specific'
p43877
g3
sS'associated,with,somatic'
p43878
g3
sS'pharmacokinetic,basis,of'
p43879
g3
sS'demonstrate,that,iga'
p43880
g3
sS'cannot,be,further'
p43881
g3
sS'volunteers,it,was'
p43882
g9
sS'interaction,probably,is'
p43883
g9
sS'migraines,such,as'
p43884
g3
sS'kappa-selective,was,significantly'
p43885
g3
sS'received,days,of'
p43886
g9
sS'increased,intracellular,ca'
p43887
g3
sS'that,necessitated,changes'
p43888
g9
sS'observation,is,required'
p43889
g9
sS'case,reports,of'
p43890
g9
sS'this,interaction,should'
p43891
g9
sS'serum,half-life,of'
p43892
g9
sS'man,include,aminosalicylic'
p43893
g9
sS'hydrochloride,therapy,to'
p43894
g9
sS'asymptomatic,transitory,changes'
p43895
g3
sS'rate,of,dissolution'
p43896
g3
sS'tubular,organic,cation'
p43897
g9
sS'the,normal,range'
p43898
g3
sS'need,for,dosage'
p43899
g3
sS'despite,the,several-fold'
p43900
g3
sS'the,exposure,auc'
p43901
g9
sS'was,totally,inhibited'
p43902
g3
sS'a,one,week'
p43903
g9
sS'nateglinide,is,highly'
p43904
g3
sS'the,auc,ss'
p43905
g9
sS'not,been,shown'
p43906
g9
sS'levo-dromoran,has,been'
p43907
g9
sS'aerosol,particles,and'
p43908
g3
sS'function,care,should'
p43909
g3
sS'by,the,reduction'
p43910
g3
sS'and,therapy,eg'
p43911
g3
sS'kg,days,mg'
p43912
g3
sS'and,the,bactec'
p43913
g3
sS'potential,there,has'
p43914
g3
sS'medium,rpmi1640,containing'
p43915
g3
sS'patients,with,diabetes'
p43916
g3
sS'that,induce,or'
p43917
g3
sS'one-week,course,of'
p43918
g9
sS'use,forms,of'
p43919
g3
sS'a,clinical,trial'
p43920
g3
sS'equivalent,volume,of'
p43921
g3
sS'was,given,alone'
p43922
g3
sS'interactions,of,herbal'
p43923
g3
sS'stomach,irritation,subjects'
p43924
g3
sS'using,for,example'
p43925
g3
sS'coadministered,with,kerlone'
p43926
g3
sS'comparative,analysis,of'
p43927
g3
sS'as,mhd,the'
p43928
g3
sS'reaction,after,remained'
p43929
g3
sS'conduction,such,as'
p43930
g9
sS'and,was,significantly'
p43931
g9
sS'be,reviewed,after'
p43932
g3
sS'greater,risk,of'
p43933
g3
sS'or,pharmacodynamic,interactions'
p43934
g3
sS'consider,the,possibility'
p43935
g9
sS'same,areas,of'
p43936
g3
sS'study,to,study'
p43937
g3
sS'methods,the,study'
p43938
g3
sS'the,fluoride,and'
p43939
g9
sS'a,bacteriostatic,may'
p43940
g9
sS'of,an,nsaid'
p43941
g9
sS'glucose,some,patients'
p43942
g3
sS'principal,pathway,for'
p43943
g9
sS'clearance,of,decreased'
p43944
g9
sS'inhibitor,to,mg'
p43945
g9
sS'once,daily,the'
p43946
g9
sS'that,raise,the'
p43947
g3
sS'received,mg,day'
p43948
g3
sS'the,glucosyl,transferase'
p43949
g3
sS'could,lead,to'
p43950
g9
sS'in,healthy,male'
p43951
g3
sS'the,is,only'
p43952
g3
sS'enzyme,inhibitors,aminosalicylic'
p43953
g9
sS'be,monitored,carefully'
p43954
g9
sS'therapeutic,windows,that'
p43955
g3
sS'effect,for,i'
p43956
g9
sS'be,discontinued,and'
p43957
g3
sS'cimetidine,increases,hcl'
p43958
g9
sS'in,renal,transplant'
p43959
g9
sS'use,of,bromocriptine'
p43960
g9
sS'block,may,be'
p43961
g9
sS'were,nonsteroidal,agents'
p43962
g3
sS'together,may,decrease'
p43963
g9
sS'although,the,daily'
p43964
g3
sS'to,which,the'
p43965
g3
sS'concentrations,ic50,from'
p43966
g3
sS'alt,in,a'
p43967
g9
sS'or,inhibit,the'
p43968
g9
sS'or,the,strength'
p43969
g9
sS'fold,and,auc'
p43970
g9
sS'to,displace,from'
p43971
g9
sS'neither,inhibitors,of'
p43972
g3
sS'than,changes,seen'
p43973
g3
sS'humans,may,result'
p43974
g9
sS'of,severe,adverse'
p43975
g3
sS'quinolones,have,been'
p43976
g9
sS'of,agents,such'
p43977
g3
sS'made,by,using'
p43978
g3
sS'related,to,a'
p43979
g3
sS'be,an,inducer'
p43980
g3
sS'excretion,as,well'
p43981
g3
sS'symptoms,indicates,deterioration'
p43982
g3
sS'higher,end,of'
p43983
g3
sS'vehicle,or,low-dose'
p43984
g9
sS'methylxanthines,and,diuretics'
p43985
g9
sS'furosemide,when,was'
p43986
g9
sS'efficacious,effects,and'
p43987
g3
sS'without,altering,prothrombin'
p43988
g9
sS'because,active,metabolite'
p43989
g3
sS'have,received,such'
p43990
g3
sS'of,prostaglandin,f2alpha'
p43991
g9
sS'that,contain,deet'
p43992
g9
sS'increase,the,concentration'
p43993
g9
sS'tablets,containing,mg'
p43994
g3
sS'the,year,monthly'
p43995
g3
sS'corticosteroids,may,increase'
p43996
g9
sS'malignant,phenotype,were'
p43997
g3
sS'from,their,binding'
p43998
g3
sS'between,cerebral,memory'
p43999
g3
sS'frova,is,not'
p44000
g3
sS'therefore,when,sodium'
p44001
g9
sS'hypotension,was,more'
p44002
g3
sS'with,for,less'
p44003
g3
sS'was,prolonged,from'
p44004
g9
sS'other,non-steroidal,anti-inflammatory'
p44005
g9
sS'as,a,function'
p44006
g3
sS'high,to,toxic'
p44007
g9
sS'doxorubicin,doxorubicin,caused'
p44008
g9
sS'logistic,probability,distribution'
p44009
g3
sS'betaseron,and,other'
p44010
g3
sS'chemotherapy,plus,haart'
p44011
g3
sS'morphine-induced,tail-flick,inhibition'
p44012
g3
sS'increases,in,resorptions'
p44013
g3
sS'aeds,phenytoin,tiagabine'
p44014
g3
sS'subjects,administered,a'
p44015
g9
sS'concomitant,administration,trough'
p44016
g3
sS'kidney,recipients,suggest'
p44017
g3
sS'alternatively,the,effect'
p44018
g3
sS'can,be,seen'
p44019
g3
sS'diuretics,concomitant,treatment'
p44020
g9
sS'carcinogenesis,mutagenesis,and'
p44021
g3
sS'between,these,events'
p44022
g3
sS'antagonists,and,oral'
p44023
g3
sS'or,excess,may'
p44024
g9
sS'substrate,for,p-glycoprotein'
p44025
g3
sS'of,certain,concomitant'
p44026
g3
sS'may,increase,respiratory'
p44027
g9
sS'alterations,in,the'
p44028
g3
sS'including,with,a'
p44029
g9
sS'a,pheochromocytoma,and'
p44030
g3
sS'three,equal,groups'
p44031
g3
sS'antagonists,should,be'
p44032
g9
sS'survival,was,increased'
p44033
g3
sS'anaesthesia,and,the'
p44034
g3
sS'enzymes,or,other'
p44035
g3
sS'the,enhancement,of'
p44036
g9
sS'dosing,or,chronic'
p44037
g3
sS'cell,mutation,assay'
p44038
g3
sS'theoretically,might,blunt'
p44039
g3
sS'administering,other,that'
p44040
g3
sS'results,in,approximately'
p44041
g9
sS'failure,were,not'
p44042
g3
sS'were,drawn,at'
p44043
g3
sS'viracept,may,not'
p44044
g3
sS'demonstrated,in,all'
p44045
g3
sS'because,some,have'
p44046
g9
sS'were,about,higher'
p44047
g9
sS'of,animals,dosed'
p44048
g3
sS'hypokalemia,they,should'
p44049
g3
sS'to,their,possible'
p44050
g3
sS'with,impaired,ventricular'
p44051
g3
sS'days,and,cohort'
p44052
g3
sS'when,treated,with'
p44053
g3
sS'in,any,unexpected'
p44054
g3
sS'of,the,elimination'
p44055
g3
sS'or,weakness,associated'
p44056
g3
sS'healthy,male,and'
p44057
g3
sS'lower,in,epileptic'
p44058
g9
sS'these,trace,elements'
p44059
g3
sS'observed,by,measuring'
p44060
g3
sS'solutions,but,not'
p44061
g3
sS'betaseron,administration,to'
p44062
g9
sS'used,in,caution'
p44063
g3
sS'steps,include,regular'
p44064
g3
sS'received,both,and'
p44065
g3
sS'dose,of,videx'
p44066
g9
sS'pathways,and,prescription'
p44067
g3
sS'shown,to,provoke'
p44068
g3
sS'of,walking,without'
p44069
g3
sS'qt,c,interval'
p44070
g9
sS'a,substrate,for'
p44071
g3
sS'blood,sugar,some'
p44072
g3
sS'of,diabetic,patients'
p44073
g3
sS'or,too,low'
p44074
g3
sS'administration,of,uricosuric'
p44075
g9
sS'addition,based,on'
p44076
g3
sS'interactions,the,cns-depressant'
p44077
g9
sS'populations,such,as'
p44078
g3
sS'if,they,are'
p44079
g3
sS'to,which,resulted'
p44080
g9
sS'it,would,be'
p44081
g9
sS'these,disorders,can'
p44082
g3
sS'anesthesia,severe,hypotension'
p44083
g9
sS'the,following,interactions'
p44084
g3
sS'dl,were,observed'
p44085
g3
sS'respectively,of,the'
p44086
g3
sS'therefore,can,generally'
p44087
g3
sS'to,be,reversed'
p44088
g9
sS'although,activation,of'
p44089
g3
sS'affected,response,duration'
p44090
g9
sS'known,risk,factor'
p44091
g3
sS'therefore,advised,in'
p44092
g9
sS'conducted,for,colazal'
p44093
g3
sS'of,with,these'
p44094
g3
sS'bleeding,reduced,dosage'
p44095
g9
sS'contrast,nucleophosmin,b23'
p44096
g3
sS'each,other,when'
p44097
g9
sS'precaution,is,required'
p44098
g3
sS'in,eight,experiments'
p44099
g3
sS'broad,spectrum,of'
p44100
g3
sS'redistribution,redistribution,accumulation'
p44101
g3
sS'administration,of,decreased'
p44102
g9
sS'is,initiated,adjusted'
p44103
g9
sS'not,metabolize,to'
p44104
g3
sS'the,auc,but'
p44105
g9
sS'whose,mothers,received'
p44106
g3
sS'that,are,contraindicated'
p44107
g3
sS'change,the,amount'
p44108
g9
sS't,cell,mitogen'
p44109
g3
sS'has,been,characterized'
p44110
g3
sS'of,intravenous,and'
p44111
g9
sS'increase,toxicity,in'
p44112
g9
sS'channel,subtypes,although'
p44113
g3
sS'studies,on,two'
p44114
g3
sS'a-chloralose,anesthetized,swine'
p44115
g3
sS'have,been,proposed'
p44116
g3
sS'involved,either,the'
p44117
g3
sS'when,amitriptyline,hcl'
p44118
g9
sS'channel,blockers,l-type'
p44119
g3
sS'auc,and,cmax'
p44120
g3
sS'seizure,threshold,concurrent'
p44121
g9
sS'include,but,are'
p44122
g3
sS'anticoagulation,should,be'
p44123
g3
sS'daily,a,potent'
p44124
g9
sS'norethindrone,coadministration,of'
p44125
g9
sS'or,therapeutic,agents'
p44126
g3
sS'that,included,a'
p44127
g3
sS'caused,identical,and'
p44128
g3
sS'when,is,added'
p44129
g9
sS'additional,at,three'
p44130
g3
sS'available,from,the'
p44131
g3
sS'fluoxetine,indanavir,ketoconazole'
p44132
g3
sS'size,mydriasis,resulting'
p44133
g9
sS'observed,following,concurrent'
p44134
g9
sS'interaction,was,noted'
p44135
g3
sS'serious,cardiac,dysrhythmias'
p44136
g9
sS'expected,to,cause'
p44137
g3
sS'blood,pressure,response'
p44138
g3
sS'binding,of,acetylsalicylic'
p44139
g3
sS'recommended,that,allegra'
p44140
g3
sS'in,markedly,increased'
p44141
g9
sS'not,observed,in'
p44142
g9
sS'bioavailability,or,due'
p44143
g3
sS'gonadotropin,levels,may'
p44144
g3
sS'reduced,by,about'
p44145
g9
sS'has,shown,a'
p44146
g9
sS'including,produce,cns-depressant'
p44147
g9
sS'as,demonstrated,by'
p44148
g3
sS'streptococcus,pyogenes,and'
p44149
g3
sS'of,decreased,the'
p44150
g9
sS'documented,hypokalemia,and'
p44151
g3
sS'effect,on,blood'
p44152
g3
sS'interactions,when,and'
p44153
g9
sS'report,nine,patients'
p44154
g9
sS'form,a,sudden'
p44155
g9
sS'was,preceded,by'
p44156
g3
sS'result,in,lower'
p44157
g9
sS'before,to,attenuate'
p44158
g3
sS'of,cyp2d6,i'
p44159
g9
sS'of,these,resulting'
p44160
g9
sS'and,a,prolongation'
p44161
g3
sS'their,usual,recommended'
p44162
g3
sS'cns,effect,caution'
p44163
g9
sS'this,may,occur'
p44164
g9
sS'exposures,to,may'
p44165
g9
sS'receiving,other,antianxiety'
p44166
g9
sS'not,appear,to'
p44167
g3
sS'of,nalfon,the'
p44168
g9
sS'mg,each,administered'
p44169
g9
sS'to,of,those'
p44170
g3
sS'integrity,of,the'
p44171
g3
sS'examine,the,interaction'
p44172
g3
sS'that,resists,dissolution'
p44173
g3
sS'drug,interactions,oral'
p44174
g3
sS'serum,total,bilirubin'
p44175
g3
sS'serum,and,sodium'
p44176
g3
sS'danazol,the,risk'
p44177
g9
sS'performed,prior,to'
p44178
g3
sS'dose,once,daily'
p44179
g3
sS'of,in,vitro'
p44180
g9
sS'observation,is,related'
p44181
g3
sS'enhances,the,manifestation'
p44182
g9
sS'eight,hiv-infected,individuals'
p44183
g3
sS'the,biological,levels'
p44184
g3
sS'to,see,if'
p44185
g9
sS'not,a,contraindication'
p44186
g3
sS'patients,on,and'
p44187
g9
sS'acutely,worsened,by'
p44188
g9
sS'report,of,severe'
p44189
g9
sS'in,mortality,was'
p44190
g3
sS'or,other,oral'
p44191
g9
sS'for,the,clinician'
p44192
g3
sS'produce,clinically,significant'
p44193
g9
sS'treated,with,ibandronate'
p44194
g3
sS'with,benedicts,solution'
p44195
g3
sS'aluminum-containing,antacid,products'
p44196
g3
sS'of,the,intravenous'
p44197
g9
sS'acidifying,agents,glutamic'
p44198
g9
sS'suggest,an,increased'
p44199
g3
sS'respectively,a,strong'
p44200
g9
sS'a4,enzyme,activity'
p44201
g9
sS'mao,inhibitors,duragesic'
p44202
g9
sS'the,long,half-life'
p44203
g3
sS'increased,by,the'
p44204
g9
sS'in,such,concurrent'
p44205
g3
sS'users,the,incidence'
p44206
g3
sS'capsules,at,the'
p44207
g3
sS'myelosuppression,was,more'
p44208
g9
sS'treated,with,other'
p44209
g3
sS'should,be,informed'
p44210
g3
sS'normal,menstrual,rhythm'
p44211
g3
sS'treated,with,non-pegylated'
p44212
g3
sS'indocin,and,potassium-sparing'
p44213
g9
sS'thereafter,and,the'
p44214
g9
sS'following,use,with'
p44215
g9
sS'with,dose,reduction'
p44216
g3
sS'laboratory,tests,have'
p44217
g3
sS'intervals,until,the'
p44218
g3
sS'metabolite,of,associated'
p44219
g3
sS'effects,of,blockers'
p44220
g3
sS'produce,false-positive,test'
p44221
g3
sS'on,combination,therapy'
p44222
g3
sS'fold,and,the'
p44223
g9
sS'doctor,before,starting'
p44224
g3
sS'change,to,a'
p44225
g9
sS'by,decreased,clearance'
p44226
g9
sS'of,on,voltage-dependent'
p44227
g3
sS'nhl,characteristics,hiv'
p44228
g3
sS'other,when,is'
p44229
g9
sS'with,heparin-induced,thrombocytopenia'
p44230
g3
sS'conjunction,with,central'
p44231
g9
sS'may,be,related'
p44232
g3
sS'to,one,third'
p44233
g9
sS'other,may,increase'
p44234
g9
sS'have,excluded,patients'
p44235
g3
sS'or,human,studies'
p44236
g3
sS'receiving,careful,monitoring'
p44237
g9
sS'vitamin-d,mediated,signalling'
p44238
g3
sS'were,above,or'
p44239
g9
sS'a,molecular,basis'
p44240
g9
sS'response,to,soriatane'
p44241
g3
sS'over-the,counter,cough'
p44242
g3
sS'salt,intake,prior'
p44243
g9
sS'such,as,acetylsalicylic'
p44244
g9
sS'renin,activity,pra'
p44245
g3
sS'series,of,visual'
p44246
g3
sS'including,immune,system'
p44247
g3
sS'receiving,intravenous,amphotericin'
p44248
g9
sS'antipsychotic,action,of'
p44249
g3
sS'inhibitory,effect,on'
p44250
g3
sS'animal,studies,with'
p44251
g9
sS'be,introduced,at'
p44252
g9
sS'serum,endogenous,vitamin'
p44253
g3
sS'per,day,are'
p44254
g3
sS'supersensitive,to,when'
p44255
g9
sS'on,the,plasma'
p44256
g9
sS'were,significantly,altered'
p44257
g9
sS'mao,inhibitors,has'
p44258
g9
sS'from,the,other'
p44259
g3
sS'causal,relationship,has'
p44260
g3
sS'when,the,is'
p44261
g9
sS'in,vitro,interferes'
p44262
g9
sS'control,pills,sleeping'
p44263
g3
sS'fluconazole,concomitant,administration'
p44264
g9
sS'p450,enzymes,carbamazepine'
p44265
g3
sS'pathogenic,species,was'
p44266
g3
sS'treatment,during,the'
p44267
g3
sS'dip-stick,methodology,used'
p44268
g3
sS'and,or,pd'
p44269
g3
sS'a,large,reduction'
p44270
g9
sS'because,of,a'
p44271
g3
sS'involvement,of,other'
p44272
g9
sS'are,used,in'
p44273
g9
sS'increasing,the,effectiveness'
p44274
g9
sS'the,desired,and'
p44275
g9
sS'approximately,when,coadministered'
p44276
g9
sS'over,the,dosage'
p44277
g9
sS'once,a,day'
p44278
g3
sS'the,oral,dose'
p44279
g9
sS'and,greater,than'
p44280
g3
sS'activity,among,asian'
p44281
g3
sS'of,whether,these'
p44282
g9
sS'other,diagnostic,or'
p44283
g3
sS'acid,and,related'
p44284
g3
sS'clinically,relevant,laboratory'
p44285
g3
sS'other,amphotericin,b'
p44286
g9
sS'is,notable,that'
p44287
g3
sS'significant,interaction,between'
p44288
g9
sS'may,arise,in'
p44289
g3
sS'neostgmine,can,enhance'
p44290
g3
sS'data,in,a'
p44291
g3
sS'and,amphotericin,b'
p44292
g9
sS'result,in,fold'
p44293
g9
sS'retrospectively,a,group'
p44294
g3
sS'efficacy,and,safety'
p44295
g3
sS'administration,of,non-steroidal'
p44296
g9
sS'fixed-interval,fixed-ratio,fi'
p44297
g3
sS'substrates,drugs,which'
p44298
g9
sS'the,median,survival'
p44299
g3
sS'as,compulsion,loss'
p44300
g3
sS'approximately,and,fold'
p44301
g3
sS'without,a,functioning'
p44302
g9
sS'cell,growth,both'
p44303
g3
sS'and,may,result'
p44304
g9
sS'to,daily,treatment'
p44305
g3
sS'patients,under,treatment'
p44306
g3
sS'acetaminophen,may,produce'
p44307
g3
sS'was,evident,following'
p44308
g3
sS'in,cmax,and'
p44309
g9
sS'this,metabolic,pathway'
p44310
g3
sS'of,and,effects'
p44311
g3
sS'of,seizures,have'
p44312
g9
sS'ask,your,physician'
p44313
g3
sS'on,the,degree'
p44314
g9
sS'decreases,aldosterone,production'
p44315
g3
sS'of,buforin,ii'
p44316
g3
sS'adverse,interaction,to'
p44317
g3
sS'relaxants,could,be'
p44318
g9
sS'cause,an,alteration'
p44319
g3
sS'capsules,there,have'
p44320
g9
sS'hemorrhage,should,be'
p44321
g3
sS'eg,grapefruit,juice'
p44322
g3
sS'in,a,given'
p44323
g3
sS'fluids,might,be'
p44324
g3
sS'protein,bound,should'
p44325
g3
sS'daily,resulted,in'
p44326
g9
sS'potent,cytochrome,p450'
p44327
g9
sS'on,the,concomitant'
p44328
g9
sS'added,drug,should'
p44329
g3
sS'and,ast,when'
p44330
g9
sS'although,specific,interaction'
p44331
g3
sS'in,a,month'
p44332
g3
sS'with,bioavailability,parameters'
p44333
g3
sS'as,plasma,asparagine'
p44334
g9
sS'of,mm,or'
p44335
g3
sS'a,defined,medium'
p44336
g3
sS'blood,glucose,monitoring'
p44337
g3
sS'to,possible,cns'
p44338
g3
sS'the,sole,protease'
p44339
g3
sS'while,taking,this'
p44340
g3
sS'least,halved,and'
p44341
g9
sS'the,antipsychotic,action'
p44342
g3
sS'pharmacokinetics,of,sonata'
p44343
g3
sS'acarbose,was,bioequivalent'
p44344
g3
sS'achieved,indicating,that'
p44345
g3
sS'antihistamines,amphetamines,may'
p44346
g9
sS'received,mg,of'
p44347
g3
sS'hormone,concentrations,may'
p44348
g3
sS'prudent,evaluation,of'
p44349
g3
sS'be,due,to'
p44350
g3
sS'is,an,interactive'
p44351
g3
sS'enhancing,selective,tumor'
p44352
g3
sS'with,indicate,that'
p44353
g9
sS'cyp3a4,inhibitor,is'
p44354
g3
sS'interactions,the,dosage'
p44355
g3
sS'added,of,the'
p44356
g9
sS'incidence,of,benign'
p44357
g3
sS'pregnancy,pregnancy,category'
p44358
g3
sS'of,was,generally'
p44359
g3
sS'contents,of,the'
p44360
g3
sS'between,and,were'
p44361
g3
sS'flucytosine,while,a'
p44362
g9
sS'thus,support,its'
p44363
g3
sS'may,influence,the'
p44364
g3
sS'affect,metabolism,pharmacokinetics'
p44365
g3
sS'compared,to,its'
p44366
g3
sS'suggests,that,an'
p44367
g3
sS'and,which,has'
p44368
g3
sS'actually,produced,enhanced'
p44369
g3
sS'the,appropriate,interval'
p44370
g3
sS'kg,via,dehydrogenase'
p44371
g9
sS'telithromycin,hiv,protease'
p44372
g3
sS'days,does,not'
p44373
g3
sS'arise,from,a'
p44374
g3
sS'and,mg,day'
p44375
g3
sS'inherent,in,any'
p44376
g9
sS'max,increased,by'
p44377
g9
sS'and,with,plus'
p44378
g3
sS'enoxacin,is,a'
p44379
g9
sS'decreased,levels,in'
p44380
g3
sS'transferred,to,the'
p44381
g3
sS'determined,on,day'
p44382
g9
sS'before,or,four'
p44383
g3
sS'anticoagulants,in,a'
p44384
g3
sS'provoke,toxicity,because'
p44385
g3
sS'reported,during,with'
p44386
g9
sS'and,total,body'
p44387
g3
sS'of,mg,increased'
p44388
g9
sS'activase,in,the'
p44389
g3
sS'of,and,should'
p44390
g9
sS'effects,on,av'
p44391
g9
sS'inactivated,due,to'
p44392
g9
sS'use,of,in'
p44393
g3
sS'metabolism,are,unlikely'
p44394
g3
sS'an,animal,model'
p44395
g9
sS'is,advised,to'
p44396
g3
sS'or,monoamine,oxidase'
p44397
g9
sS'if,pregnancy,occurs'
p44398
g3
sS'auc,ss,of'
p44399
g9
sS'the,behaviour,of'
p44400
g3
sS'physician,or,are'
p44401
g9
sS'grapefruit,juice,given'
p44402
g3
sS'this,combination,of'
p44403
g3
sS'some,preliminary,data'
p44404
g3
sS'and,subcutaneous,injections'
p44405
g3
sS'use,of,is'
p44406
g9
sS'species,of,bacteria'
p44407
g3
sS'patients,although,combining'
p44408
g3
sS'other,highly,plasma'
p44409
g3
sS'to,cause,coronary'
p44410
g9
sS'symptoms,of,hyperlipidemia'
p44411
g9
sS'patient,or,partner'
p44412
g3
sS'addition,new,cases'
p44413
g3
sS'human,dose,of'
p44414
g3
sS'as,toxic,epidermal'
p44415
g3
sS'increased,dose,mg'
p44416
g9
sS'no,alteration,of'
p44417
g3
sS'took,either,mg'
p44418
g3
sS'furosemide,should,not'
p44419
g9
sS'fever,tremulousness,and'
p44420
g9
sS'test,interactions,positive'
p44421
g3
sS'significance,of,reduced'
p44422
g3
sS'micromol,l,or'
p44423
g3
sS'pharmacological,interactions,pi'
p44424
g3
sS'cells,rr,had'
p44425
g3
sS'about,and,greater'
p44426
g9
sS'treatment,study,and'
p44427
g3
sS'agents,dynamic,and'
p44428
g3
sS'aucs,of,unbound'
p44429
g3
sS'barbiturates,may,decrease'
p44430
g9
sS'levels,of,metabolized'
p44431
g3
sS'diagnosis,of,deficiency'
p44432
g3
sS'cyp1a2,inhibit,cyp1a2'
p44433
g3
sS'auc,a,fold'
p44434
g9
sS'in,the,results'
p44435
g3
sS'clinical,bleeding,has'
p44436
g9
sS'should,be,placed'
p44437
g3
sS'stadol,ns,was'
p44438
g9
sS'or,use,may'
p44439
g3
sS'the,concomitant,intake'
p44440
g3
sS'other,nonsteroidal,can'
p44441
g9
sS'urinary,hydroxy-corticosteroids,by'
p44442
g3
sS'metabolism,of,nonsedating'
p44443
g9
sS'is,given,to'
p44444
g3
sS'for,diagnosis,of'
p44445
g3
sS'intrathecal,micrograms,had'
p44446
g9
sS'contraception,alone,when'
p44447
g3
sS'evaluate,interactions,with'
p44448
g3
sS'by,the,major'
p44449
g3
sS'a,bioequivalence,study'
p44450
g3
sS'since,photic,evoked'
p44451
g3
sS'seen,in,livers'
p44452
g3
sS'substrates,and,inhibitors'
p44453
g3
sS'and,rises,in'
p44454
g9
sS'bleeding,parameters,in'
p44455
g9
sS'to,normal,within'
p44456
g3
sS'protein,and,therefore'
p44457
g3
sS'increase,in,arc'
p44458
g9
sS'starting,other,therapy'
p44459
g3
sS'narcotic,such,as'
p44460
g9
sS'and,fundus,pulsation'
p44461
g3
sS'subjects,ingesting,these'
p44462
g9
sS'antiseizure,medication,and'
p44463
g3
sS'is,usually,well'
p44464
g9
sS'clinical,studies,performed'
p44465
g3
sS'samples,were,drawn'
p44466
g3
sS'tolerance,allowing,gradually'
p44467
g3
sS'heart,rate,at'
p44468
g3
sS'or,the,pediatric'
p44469
g9
sS'serum-deprived,serum,nih-3t3'
p44470
g3
sS'day,was,similar'
p44471
g3
sS'reports,of,adverse'
p44472
g9
sS'was,observed,when'
p44473
g9
sS'with,sustained-release,channel'
p44474
g3
sS'received,concomitant,and'
p44475
g3
sS'didanosine-placebo,tablets,a'
p44476
g9
sS'suitable,anticoagulation,test'
p44477
g9
sS'often,used,in'
p44478
g3
sS'function,as,co-activator'
p44479
g3
sS'studies,on,the'
p44480
g3
sS'and,thus,lower'
p44481
g9
sS'coadministered,with,cyp2d6'
p44482
g9
sS'that,can,deplete'
p44483
g9
sS'and,extensive,cyp2d6'
p44484
g3
sS'myocardial,infarction,myocarditis'
p44485
g9
sS'as,because,of'
p44486
g9
sS'community,or,seen'
p44487
g3
sS'agents,and,angiotensin'
p44488
g3
sS'be,given,concomitantly'
p44489
g3
sS'eye,drops,unless'
p44490
g3
sS'such,as,convulsions'
p44491
g9
sS'agents,may,enhance'
p44492
g9
sS'on,adult,data'
p44493
g9
sS'of,events,or'
p44494
g3
sS'view,however,the'
p44495
g3
sS'were,significantly,greater'
p44496
g3
sS'presence,of,hydrophobic'
p44497
g3
sS'assay,in,mouse'
p44498
g3
sS'depressants,including,concomitantly'
p44499
g9
sS'glucuronidation,and,intestinal'
p44500
g3
sS'activity,of,buforin'
p44501
g3
sS'deferred,until,therapy'
p44502
g9
sS'a,fluoroquinolone,has'
p44503
g9
sS'days,with,a'
p44504
g9
sS'plasma,and,epoxide'
p44505
g3
sS'epidural,include,hypotension'
p44506
g9
sS'addition,of,to'
p44507
g9
sS'dietary,concentrations,showing'
p44508
g3
sS'have,similar,affinities'
p44509
g3
sS'inhibit,cyp3a4,activity'
p44510
g3
sS'revia,the,amount'
p44511
g9
sS'with,tikosyn,or'
p44512
g3
sS'etc,and,the'
p44513
g3
sS'more,pronounced,when'
p44514
g9
sS'times,the,human'
p44515
g3
sS'taken,closely,in'
p44516
g9
sS'vancomycin,resistance,reversal'
p44517
g3
sS'blocker,should,be'
p44518
g9
sS'secreted,via,this'
p44519
g9
sS'excreted,in,human'
p44520
g3
sS'undergoing,vigorous,physical'
p44521
g3
sS'data,where,iressa'
p44522
g9
sS'apoptosis,can,be'
p44523
g3
sS'requiring,an,increase'
p44524
g9
sS'any,prescription,or'
p44525
g3
sS'patients,taking,that'
p44526
g3
sS'menstrual,irregularities,have'
p44527
g3
sS'for,the,p-glycoprotein'
p44528
g3
sS'especially,in,renal'
p44529
g3
sS'b6,d6,e1'
p44530
g3
sS'and,or,a'
p44531
g9
sS'are,increased,by'
p44532
g9
sS'potential,for,to'
p44533
g3
sS'metabolically,active,when'
p44534
g3
sS'of,distribution,of'
p44535
g9
sS'copegus,and,is'
p44536
g9
sS'reduction,of,growth'
p44537
g3
sS'of,distribution,or'
p44538
g3
sS'shown,that,acarbose'
p44539
g3
sS'was,variably,increased'
p44540
g3
sS'other,nsaids,have'
p44541
g9
sS'blockade,by,of'
p44542
g9
sS'proper,interval,has'
p44543
g3
sS'failure,in,two'
p44544
g9
sS'variability,in,individual'
p44545
g3
sS'mean,increase,in'
p44546
g9
sS'organ,transplants,malignancy'
p44547
g3
sS'significantly,different,from'
p44548
g3
sS'analyses,of,patient'
p44549
g9
sS'levels,with,co-administration'
p44550
g9
sS'concomitantly,in,the'
p44551
g9
sS'incidence,of,lymphatic'
p44552
g9
sS'the,bactericidal,effect'
p44553
g9
sS'dentistry,cannot,be'
p44554
g3
sS'with,epilepsy,also'
p44555
g3
sS'treatment,should,be'
p44556
g9
sS'these,are,taken'
p44557
g9
sS'column,or,t4'
p44558
g3
sS'lh,follicle-stimulating,hormone'
p44559
g3
sS'extent,to,which'
p44560
g9
sS'renal,and,cardiac'
p44561
g9
sS'diabetes,mellitus,may'
p44562
g3
sS'n1,n2,and'
p44563
g3
sS'with,the,individual'
p44564
g3
sS'partially,related,to'
p44565
g9
sS'if,coreg,is'
p44566
g9
sS'pharmacokinetic,interactions,occurred'
p44567
g3
sS'supplementation,with,water-miscible'
p44568
g3
sS'with,equal,concentrations'
p44569
g3
sS'cannot,be,excluded'
p44570
g3
sS'the,fetal,immune'
p44571
g3
sS'increased,about,compared'
p44572
g9
sS'except,leukemia,in'
p44573
g9
sS'mcg,ml,nor'
p44574
g3
sS'effectiveness,of,proleukin'
p44575
g9
sS'reduced,protein,binding'
p44576
g9
sS'cmax,a,increase'
p44577
g9
sS'certain,narcotic,such'
p44578
g9
sS'methotrexate,lodine,like'
p44579
g9
sS'concentrations,are,increased'
p44580
g9
sS'concurrent,enbrel,and'
p44581
g9
sS'concomitantly,with,significantly'
p44582
g9
sS'used,to,generate'
p44583
g3
sS'value,of,serum'
p44584
g3
sS'and,laboratory,evidence'
p44585
g3
sS'rupture,or,cervical'
p44586
g9
sS'clinical,studies,one'
p44587
g9
sS'prolonging,av,conduction'
p44588
g9
sS'or,may,not'
p44589
g9
sS'agents,that,are'
p44590
g9
sS'tnfa-blocking,agents,including'
p44591
g9
sS'grapefruit,juice,and'
p44592
g9
sS'beta-adrenergic,neuroeffector,defects'
p44593
g3
sS'inhibited,by,and'
p44594
g9
sS'four,diets,containing'
p44595
g3
sS'and,or,mg'
p44596
g3
sS'clearance,and,or'
p44597
g9
sS'identified,through,searches'
p44598
g3
sS'with,platelet-aggregation,reactions'
p44599
g9
sS'diastolic,blood,pressure'
p44600
g9
sS'cholecystokinin,octapeptide,was'
p44601
g3
sS'the,injection,site'
p44602
g3
sS'histologic,type,depth'
p44603
g3
sS'cyclosporine,and,concentrations'
p44604
g9
sS'hydrochloride,does,not'
p44605
g3
sS'be,reduced,higher'
p44606
g3
sS'general,if,a'
p44607
g3
sS'unaltered,in,the'
p44608
g3
sS'conducted,on,days'
p44609
g3
sS'and,which,competes'
p44610
g9
sS'concomitant,on,the'
p44611
g3
sS'inhibitors,nalidixic,acid'
p44612
g9
sS'patient,demographics,nhl'
p44613
g3
sS'or,enzyme,function'
p44614
g3
sS'changes,in,effects'
p44615
g9
sS'has,been,determined'
p44616
g3
sS'mice,selectively,bred'
p44617
g3
sS'as,and,which'
p44618
g3
sS'clinically,important,effects'
p44619
g3
sS'may,raise,the'
p44620
g9
sS'in,the,literature'
p44621
g9
sS'this,interaction,appears'
p44622
g3
sS'in,overdose,especially'
p44623
g9
sS'for,the,first-pass'
p44624
g9
sS'the,activity,of'
p44625
g3
sS'the,pesticide,the'
p44626
g3
sS'pharmacokinetic,studies,indicate'
p44627
g3
sS'be,concomitantly,administered'
p44628
g3
sS'metabolizers,of,such'
p44629
g3
sS'were,of,maternal'
p44630
g3
sS'auc,and,changes'
p44631
g3
sS'that,has,benefits'
p44632
g3
sS'completely,metabolised,therefore'
p44633
g3
sS'than,expected,plasma'
p44634
g3
sS'antagonistic,to,beta-lactam'
p44635
g9
sS'studies,of,iopidine'
p44636
g9
sS'to,be,a'
p44637
g3
sS'users,of,combined'
p44638
g3
sS'expected,steady-state,serum'
p44639
g9
sS'hydrochloride,is,to'
p44640
g9
sS'non-governmental,organisation,m'
p44641
g3
sS'felodipine,may,increase'
p44642
g3
sS'gleevec,with,cyp3a4'
p44643
g9
sS'were,investigated,against'
p44644
g3
sS'since,the,concomitant'
p44645
g9
sS'by,a,liquid'
p44646
g3
sS'produce,persistently,elevated'
p44647
g3
sS'rats,was,investigated'
p44648
g3
sS'accompanied,by,detailed'
p44649
g3
sS'before,any,oral'
p44650
g9
sS'even,decrease,the'
p44651
g3
sS'de,novo,renal'
p44652
g3
sS'circulating,fluids,might'
p44653
g3
sS'other,ht1,agonists'
p44654
g9
sS'in,the,usual'
p44655
g3
sS'on,renal,and'
p44656
g3
sS'of,this,paper'
p44657
g3
sS'severe,dietary,salt'
p44658
g9
sS'regardless,of,the'
p44659
g3
sS'laboratory,test,alterations'
p44660
g3
sS'plasma,kinetics,of'
p44661
g3
sS'the,serum,uric'
p44662
g9
sS'animals,to,screen'
p44663
g3
sS'with,a,pharmacological'
p44664
g3
sS'of,renal,clearance'
p44665
g3
sS'inhibitors,and,others'
p44666
g3
sS'propantheline,and,by'
p44667
g9
sS'conjugation,with,glutathione'
p44668
g9
sS'effect,of,skeletal'
p44669
g9
sS'the,enzyme,system'
p44670
g3
sS'mao,inhibitors,such'
p44671
g3
sS'and,sodium,excretion'
p44672
g9
sS'combined,actions,desirable'
p44673
g3
sS'cns-active,drugs,ethanol'
p44674
g9
sS'in,dogs,anesthetized'
p44675
g9
sS'enzymes,such,as'
p44676
g3
sS'dose-dependently,inhibits,the'
p44677
g9
sS'in,opioid-dependent,patients'
p44678
g3
sS'maoi,such,as'
p44679
g3
sS'added,to,human'
p44680
g3
sS'potassium-sparing,with,nsaids'
p44681
g9
sS'inhibitors,and,with'
p44682
g9
sS'on,the,metabolism'
p44683
g3
sS'exacerbated,by,other'
p44684
g9
sS'when,considering,the'
p44685
g9
sS'the,co-administration,of'
p44686
g9
sS'salivary,cortisol,and'
p44687
g3
sS'bile,acids,may'
p44688
g3
sS'metabolite,concentrations,when'
p44689
g9
sS'recovery,from,twitch'
p44690
g9
sS'rings,with,or'
p44691
g3
sS'the,anti-glaucoma,and'
p44692
g3
sS'closely,for,evidence'
p44693
g9
sS'of,femara,in'
p44694
g3
sS'not,been,adequately'
p44695
g3
sS'commonly,employed,clinical'
p44696
g3
sS'before,the,first'
p44697
g3
sS'at,least,a'
p44698
g9
sS'study,week,of'
p44699
g3
sS'a,drugs,enhancing'
p44700
g3
sS'the,nephrotoxicity,and'
p44701
g3
sS'gi,bleeding,a'
p44702
g3
sS'at,their,usual'
p44703
g3
sS'known,cyp3a4,inducer'
p44704
g9
sS'or,epoxide,hydrolase'
p44705
g3
sS'could,be,an'
p44706
g3
sS'adl,mg,or'
p44707
g3
sS'to,when,mg'
p44708
g9
sS'prostaglandin,synthesis,have'
p44709
g9
sS'concentrations,auc,by'
p44710
g9
sS'nizoral,tablets,with'
p44711
g9
sS'person,and,plasma'
p44712
g3
sS'load,constitutes,the'
p44713
g3
sS'of,either,humira'
p44714
g3
sS'may,occur,due'
p44715
g3
sS'used,with,caution'
p44716
g9
sS'reflex,and,shorter'
p44717
g3
sS'toxicity,including,adverse'
p44718
g3
sS'to,mg,tricor'
p44719
g9
sS'offered,by,this'
p44720
g3
sS'changes,in,gene'
p44721
g3
sS'its,two,metabolites'
p44722
g3
sS'under,acidic,conditions'
p44723
g9
sS'continuous,intravenous,infusion'
p44724
g3
sS'pregnancies,have,been'
p44725
g3
sS'and,the,risk'
p44726
g3
sS'and,by,means'
p44727
g3
sS'the,requirements,in'
p44728
g9
sS'trials,and,hepatitis'
p44729
g3
sS'system,depressants,may'
p44730
g9
sS'these,patients,approximately'
p44731
g3
sS'prothrombin,time,response'
p44732
g3
sS'are,obtained,should'
p44733
g9
sS'deep-seated,infection,with'
p44734
g3
sS'receiving,brovana,has'
p44735
g3
sS'non-diabetic,and,streptozotocin-induced'
p44736
g3
sS'for,days,does'
p44737
g3
sS'which,effectiveness,is'
p44738
g3
sS'definitely,that,the'
p44739
g3
sS'due,not,only'
p44740
g9
sS'anticoagulants,interaction,studies'
p44741
g3
sS'with,inhibitors,of'
p44742
g9
sS'underlying,the,link'
p44743
g3
sS'enhance,the,effect'
p44744
g9
sS'from,faslodex,in'
p44745
g3
sS'prothrombin,time,beyond'
p44746
g9
sS'may,be,used'
p44747
g3
sS'of,therapeutic,response'
p44748
g3
sS'pcp,combination,procedures'
p44749
g3
sS'were,allowed,in'
p44750
g3
sS'with,inhibitors,or'
p44751
g3
sS'to,patients,not'
p44752
g9
sS'and,renal,clearances'
p44753
g9
sS'expected,and,uroxatral'
p44754
g9
sS'bound,monoamine,oxidase'
p44755
g9
sS'conduction,disturbances,including'
p44756
g3
sS'reviewed,after,the'
p44757
g3
sS'magnitude,and,relative'
p44758
g3
sS'rashes,in,patients'
p44759
g9
sS'of,metabolism,mediated'
p44760
g3
sS'acid,from,membrane'
p44761
g3
sS'elimination,of,sodium'
p44762
g9
sS'are,available,to'
p44763
g3
sS'allopurinol,the,principal'
p44764
g9
sS'an,inflammatory,recall'
p44765
g3
sS'or,if,therapy'
p44766
g3
sS'in,man,in'
p44767
g3
sS'intracellular,ca,concentration'
p44768
g9
sS'liver,increasing,from'
p44769
g3
sS'defined,as,compulsion'
p44770
g3
sS'of,mineral,oil'
p44771
g9
sS'regarding,interactions,when'
p44772
g3
sS'particularly,have,been'
p44773
g9
sS'this,isoenzyme,macrolide'
p44774
g9
sS'for,aerobic,facultative'
p44775
g3
sS'use,the,safety'
p44776
g3
sS'a,long-acting,is'
p44777
g3
sS'therefore,exposure,may'
p44778
g3
sS'mechanism,of,clozapine'
p44779
g3
sS'nsaids,concomitantly,with'
p44780
g9
sS'of,human,fungal'
p44781
g3
sS'than,plasma,after'
p44782
g3
sS'juices,such,as'
p44783
g3
sS'diabetic,patient,maintained'
p44784
g9
sS'a,cyp3a,the'
p44785
g3
sS'peripheral,neuropathy,pancreatitis'
p44786
g3
sS'pharmacological,interactions,of'
p44787
g3
sS'a4,may,cause'
p44788
g9
sS'this,alteration,in'
p44789
g3
sS'augmentation,of,component'
p44790
g3
sS'to,sensitize,resistant'
p44791
g3
sS'these,medications,should'
p44792
g3
sS'anticoagulation,levels,should'
p44793
g9
sS'critical,role,in'
p44794
g3
sS'small,study,of'
p44795
g3
sS'of,iopidine,ophthalmic'
p44796
g9
sS'blocker,of,renal'
p44797
g3
sS'accordance,with,the'
p44798
g3
sS'hours,after,receiving'
p44799
g9
sS'of,the,low'
p44800
g3
sS'may,affect,bioavailabillty'
p44801
g3
sS'contraceptives,including,oral'
p44802
g9
sS'anesthetics,sedatives,hypnotics'
p44803
g9
sS'of,this,class'
p44804
g3
sS'or,potentiating,effects'
p44805
g9
sS'of,aranesp,have'
p44806
g3
sS'separate,studies,of'
p44807
g3
sS'bioavailability,of,valproic'
p44808
g3
sS'a,d-gal,binding'
p44809
g3
sS'reports,and,any'
p44810
g3
sS'ulceration,and,may'
p44811
g9
sS'probenecid,the,oral'
p44812
g9
sS'the,basal,and'
p44813
g3
sS'effect,of,either'
p44814
g9
sS'cyp3a4,inhibitor,produced'
p44815
g9
sS'adult-onset,diabetics,dosage'
p44816
g9
sS'tacrolimus,co-administration,of'
p44817
g3
sS'to,times,rat'
p44818
g3
sS'effects,of,either'
p44819
g3
sS'and,have,been'
p44820
g3
sS'of,some,organisms'
p44821
g9
sS'cmax,by,approximately'
p44822
g9
sS'expected,to,compromise'
p44823
g9
sS'plasma,concentration,altered'
p44824
g9
sS'with,betagan,and'
p44825
g9
sS'supplements,and,potassium-sparing'
p44826
g9
sS'inhibits,cyp3a4,activity'
p44827
g3
sS'the,pharmacology-related,endocrine'
p44828
g3
sS'mg,followed,by'
p44829
g3
sS'agents,patients,taking'
p44830
g9
sS'can,have,a'
p44831
g3
sS'susceptibility,to,bruising'
p44832
g3
sS'glucose,tests,based'
p44833
g3
sS'of,particular,importance'
p44834
g3
sS'withdrawn,from,treatment'
p44835
g9
sS'selective,inhibitors,of'
p44836
g3
sS'and,toxicity,have'
p44837
g9
sS'or,prophylactic,doses'
p44838
g3
sS'of,min,after'
p44839
g9
sS'and,within,hours'
p44840
g9
sS'oxidase,inhibiting,may'
p44841
g9
sS'concentrations,have,been'
p44842
g3
sS'and,sodium,the'
p44843
g3
sS'in,psychopathology,rating'
p44844
g3
sS'tests,the,combination'
p44845
g9
sS'and,other,myelosuppressive'
p44846
g3
sS'because,the,potential'
p44847
g9
sS'response,to,pressor'
p44848
g3
sS'to,exposure,to'
p44849
g3
sS'taking,and,together'
p44850
g9
sS'arava,with,a'
p44851
g9
sS'drawn,regarding,the'
p44852
g3
sS'occurred,during,a'
p44853
g3
sS'tricyclic,antidepressants,use'
p44854
g9
sS'greater,than,one-tenth'
p44855
g9
sS'in,dose,for'
p44856
g3
sS'cmax,and,extent'
p44857
g9
sS'the,aptt,to'
p44858
g3
sS'the,use,of'
p44859
g3
sS'blockade,of,the'
p44860
g9
sS'to,the,rbc'
p44861
g3
sS'agenerase,crixivan,fortovase'
p44862
g9
sS'dosing,with,camptosar'
p44863
g9
sS'triple,therapy,with'
p44864
g3
sS'group,sh,ea'
p44865
g3
sS'soft,and,watery'
p44866
g3
sS'hc1,concomitant,use'
p44867
g9
sS'however,plasma,concentrations'
p44868
g3
sS'by,cyp1a2,in'
p44869
g3
sS'similar,to,controls'
p44870
g3
sS'mg,with,coadministered'
p44871
g9
sS'periodic,measurement,of'
p44872
g3
sS'presence,of,both'
p44873
g9
sS'to,cause,an'
p44874
g3
sS'pcp,discrimination,and'
p44875
g3
sS'does,not,result'
p44876
g3
sS'with,human,volunteers'
p44877
g3
sS'hepatic,metabolism,rifampin'
p44878
g9
sS'metabolites,had,no'
p44879
g3
sS'with,a,sensitivity'
p44880
g3
sS'in,both,groups'
p44881
g3
sS'qtc,interval,must'
p44882
g9
sS'related,with,the'
p44883
g3
sS'post,marketing,observations'
p44884
g9
sS'again,allowed,to'
p44885
g3
sS'technique,it,was'
p44886
g3
sS'oral,dose,have'
p44887
g3
sS'hepatotoxic,medications,is'
p44888
g9
sS'use,may,potentiate'
p44889
g3
sS'has,occurred,more'
p44890
g3
sS'products,may,interfere'
p44891
g9
sS'undertaken,with,equal'
p44892
g3
sS'leading,to,increased'
p44893
g9
sS'pentagastrin-,and,histamine-induced'
p44894
g3
sS'gram-negative,and,some'
p44895
g3
sS'when,the,are'
p44896
g3
sS'the,initial,dose'
p44897
g3
sS'pulse,of,a'
p44898
g3
sS'of,one,patient'
p44899
g9
sS'determinations,of,these'
p44900
g9
sS'well,as,g'
p44901
g9
sS'the,visual,cortex'
p44902
g3
sS'and,cadmium,mixtures'
p44903
g3
sS'is,a,study'
p44904
g3
sS'since,may,antagonize'
p44905
g9
sS'and,mc,block'
p44906
g9
sS'oral,produced,minor'
p44907
g9
sS'to,the,dietary'
p44908
g3
sS'complex,fashion,and'
p44909
g3
sS'reported,to,cause'
p44910
g9
sS'the,liver,microsomes'
p44911
g3
sS'of,psychotic,patients'
p44912
g3
sS'this,review,discusses'
p44913
g3
sS'the,lower,end'
p44914
g9
sS'and,lodine,should'
p44915
g3
sS'intravenous,route,may'
p44916
g3
sS'psychomotor,performance,was'
p44917
g9
sS'and,reducing,absorption'
p44918
g9
sS'small,to,allow'
p44919
g3
sS'those,of,low'
p44920
g3
sS'resulting,in,death'
p44921
g9
sS'to,suggest,that'
p44922
g3
sS'is,virtually,complete'
p44923
g3
sS'can,result,in'
p44924
g9
sS'v,nacmc,conjugated'
p44925
g3
sS'intervals,caution,should'
p44926
g3
sS'interactions,with,isosorbide'
p44927
g3
sS'when,mg,day'
p44928
g3
sS'detected,although,the'
p44929
g3
sS'hormones,and,estrogen-containing'
p44930
g9
sS'uptake-1,in,human'
p44931
g3
sS'acid,nonsteroidal,anti-inflammatory'
p44932
g9
sS'inactivation,of,the'
p44933
g3
sS'the,porter-silber,test'
p44934
g3
sS'therapy,at,to'
p44935
g3
sS'to,extravasation,were'
p44936
g3
sS'groups,of,rats'
p44937
g3
sS'associated,with,elevated'
p44938
g9
sS'test,interactions,cephalosporins'
p44939
g3
sS'however,since,there'
p44940
g3
sS'tromethamine,control,vs'
p44941
g9
sS'or,elevated,serum'
p44942
g9
sS'such,interactions,have'
p44943
g3
sS'with,which,to'
p44944
g3
sS'a,closely,related'
p44945
g9
sS'the,acquisition,of'
p44946
g3
sS'that,the,acute'
p44947
g9
sS'medications,at,any'
p44948
g3
sS'amevive,a,decision'
p44949
g3
sS'indicated,because,of'
p44950
g3
sS'effect,of,an'
p44951
g3
sS'than,the,normal'
p44952
g3
sS'an,oral,and'
p44953
g9
sS'a,with,diethyl'
p44954
g3
sS'the,hypotensive,effect'
p44955
g9
sS'p-glycoprotein,in,vivo'
p44956
g9
sS'azlocillin,should,not'
p44957
g9
sS'increasing,the,force'
p44958
g3
sS'anastrozole,did,not'
p44959
g3
sS'that,are,cyp'
p44960
g9
sS'resulting,from,intravenous'
p44961
g3
sS'are,not,metabolized'
p44962
g3
sS'hepatotoxic,effects,with'
p44963
g9
sS'the,age,of'
p44964
g3
sS'no,interaction,studies'
p44965
g3
sS'between,and,laboratory'
p44966
g3
sS'induces,a,more'
p44967
g3
sS'evaluated,after,concomitant'
p44968
g9
sS'therefore,agents,affecting'
p44969
g3
sS'serious,clinical,bleeding'
p44970
g9
sS'and,in,the'
p44971
g3
sS'activity,induced,by'
p44972
g3
sS'per,kg,diet'
p44973
g9
sS'the,low,dietary'
p44974
g3
sS'on,sgpt,alt'
p44975
g9
sS'function,or,av'
p44976
g9
sS'in,human,trials'
p44977
g9
sS'system,depressants,are'
p44978
g9
sS'the,anticoagulants,should'
p44979
g3
sS'by,concomitant,in'
p44980
g3
sS'intraocular,pressure,may'
p44981
g3
sS'of,trileptal,the'
p44982
g9
sS'prior,to,concurrent'
p44983
g9
sS'were,observed,in'
p44984
g3
sS'properly,and,and'
p44985
g3
sS'sublingual,mg,taken'
p44986
g9
sS'form,unless,absolute'
p44987
g3
sS'foods,or,may'
p44988
g9
sS'all,animal,species'
p44989
g3
sS'alteration,of,either'
p44990
g3
sS'combination,therapy,should'
p44991
g3
sS'that,these,reactions'
p44992
g3
sS'these,six,cases'
p44993
g3
sS'interactions,measurement,of'
p44994
g3
sS'while,the,patient'
p44995
g9
sS'tamponades,in,conjunction'
p44996
g3
sS'be,interrupted,or'
p44997
g3
sS'humans,is,not'
p44998
g3
sS'from,to,m'
p44999
g9
sS'considered,when,these'
p45000
g9
sS'conducted,to,date'
p45001
g3
sS'with,d,h'
p45002
g9
sS'cause,an,increase'
p45003
g9
sS'specific,studies,with'
p45004
g3
sS'time,of,onset'
p45005
g9
sS'multivalent,cations,such'
p45006
g9
sS'hormonal,may,decrease'
p45007
g9
sS'activity-regulated,cytoskeleton-associated,that'
p45008
g3
sS'range,of,the'
p45009
g9
sS'igm,can,be'
p45010
g3
sS'treatment,with,antithrombin'
p45011
g9
sS'suppression,of,growth'
p45012
g3
sS'used,concurrently,resulting'
p45013
g9
sS'of,or,hepatic'
p45014
g9
sS'increases,in,half-life'
p45015
g3
sS'and,have,similar'
p45016
g3
sS'situations,occur,which'
p45017
g3
sS'severe,enterocolitis,diarrhea'
p45018
g9
sS'nondepolarizing,relaxants,are'
p45019
g3
sS'these,include,and'
p45020
g3
sS'has,no,significant'
p45021
g3
sS'occur,which,may'
p45022
g3
sS'during,the,course'
p45023
g3
sS'modulates,in,an'
p45024
g9
sS'contraceptive,effect,of'
p45025
g9
sS'susceptibility,to,cardiac'
p45026
g3
sS'was,recently,instituted'
p45027
g9
sS'monitored,and,patients'
p45028
g3
sS'cyp3a4,or,potentially'
p45029
g3
sS'prescribed,daily,dose'
p45030
g3
sS'a,significant,effect'
p45031
g3
sS'kg,day,twice'
p45032
g3
sS'inhibitors,and,leading'
p45033
g3
sS'mechanism,of,action'
p45034
g3
sS'the,successive,application'
p45035
g9
sS'clastogenic,in,multiple'
p45036
g3
sS'of,deaths,induced'
p45037
g3
sS'animals,male,or'
p45038
g3
sS'may,occur,when'
p45039
g9
sS'here,we,show'
p45040
g3
sS'observed,that,had'
p45041
g3
sS'the,recommended,weekly'
p45042
g3
sS'anticoagulants,ten,patients'
p45043
g3
sS'heavy,intake,for'
p45044
g9
sS'studies,in,human'
p45045
g3
sS'patients,no,effect'
p45046
g3
sS'not,altered,by'
p45047
g3
sS'a,risk,that'
p45048
g9
sS'should,be,accompanied'
p45049
g3
sS'including,indocin,has'
p45050
g9
sS'properties,of,the'
p45051
g9
sS'although,not,posing'
p45052
g3
sS'week,course,of'
p45053
g9
sS'first,post-transplant,year'
p45054
g3
sS'of,this,finding'
p45055
g3
sS'be,based,on'
p45056
g3
sS'see,clinical,pharmacology'
p45057
g9
sS'more,than,times'
p45058
g9
sS'so,that,intoxication'
p45059
g9
sS'hg,higher,respectively'
p45060
g3
sS'there,is,evidence'
p45061
g3
sS'nelfinavir,steady-state,cmax'
p45062
g9
sS'because,accutane,use'
p45063
g9
sS'or,other,metabolized'
p45064
g9
sS'dog,that,was'
p45065
g3
sS'risk,of,metabolic'
p45066
g3
sS'biogen,pregnancy,registry'
p45067
g3
sS'in,this,section'
p45068
g3
sS'gain,somnolence,dizziness'
p45069
g3
sS'include,certain,especially'
p45070
g9
sS'coadministered,in,de'
p45071
g3
sS'have,expanded,our'
p45072
g3
sS'less,frequent,maintenance'
p45073
g9
sS'of,cytochrome,p450'
p45074
g3
sS'may,delay,or'
p45075
g9
sS'of,hepatic,enzyme'
p45076
g9
sS'to,additional,pharmacokinetic'
p45077
g3
sS'of,the,stereoisomers'
p45078
g3
sS'induced,by,concomitant'
p45079
g3
sS'the,disruptive,effects'
p45080
g9
sS'plasma,concentrations,peak'
p45081
g9
sS'coadministered,with,were'
p45082
g9
sS'the,non-myelinated,axons'
p45083
g3
sS'had,intoxication,after'
p45084
g3
sS'benefit,justifies,the'
p45085
g3
sS'max,and,mean'
p45086
g3
sS'of,and,alone'
p45087
g3
sS'agonist,in,patients'
p45088
g3
sS'was,coadministered,for'
p45089
g3
sS'carefully,monitored,because'
p45090
g9
sS'in,contrast,acute'
p45091
g3
sS'due,to,interference'
p45092
g3
sS'capsules,since,there'
p45093
g9
sS'a,day,regimen'
p45094
g9
sS'cordarone,i,v'
p45095
g3
sS'of,reduced,efficacy'
p45096
g3
sS'been,reported,for'
p45097
g3
sS'atorvastatin,plasma,concentrations'
p45098
g3
sS'production,including,may'
p45099
g3
sS'model,possibly,increasing'
p45100
g9
sS'of,adverse,reactions'
p45101
g3
sS'was,prepared,in'
p45102
g3
sS'is,not,significantly'
p45103
g3
sS'of,concomitant,use'
p45104
g3
sS'failed,to,identify'
p45105
g3
sS'be,maximal,to'
p45106
g9
sS'to,fulminant,pancreatitis'
p45107
g9
sS'by,the,slow'
p45108
g3
sS'dose,adjustment,of'
p45109
g3
sS'decreased,the,time'
p45110
g3
sS'bacteria,should,therefore'
p45111
g3
sS'or,prolongation,of'
p45112
g3
sS'common,adverse,reaction'
p45113
g3
sS'not,significantly,altered'
p45114
g3
sS'of,previously,stable'
p45115
g9
sS'of,and,when'
p45116
g9
sS'or,systemic,medications'
p45117
g9
sS'are,available,on'
p45118
g3
sS'and,ci,in'
p45119
g3
sS'experience,fewer,infusion'
p45120
g3
sS'administration,should,be'
p45121
g3
sS'inhibitor,of,iiia4'
p45122
g9
sS'and,local,which'
p45123
g9
sS'such,as,selective'
p45124
g9
sS'a,reduction,that'
p45125
g3
sS'sans,fronti,res'
p45126
g3
sS'significant,interactions,when'
p45127
g3
sS'they,modify,the'
p45128
g9
sS'by,profound,collapse'
p45129
g3
sS'iron-fortified,infant,formula'
p45130
g3
sS'p,a,substrates'
p45131
g3
sS'the,following,eye'
p45132
g9
sS'may,decrease,blood'
p45133
g9
sS'to,increase,resulting'
p45134
g9
sS'although,acid-base,and'
p45135
g9
sS'response,to,the'
p45136
g3
sS'in,the,context'
p45137
g3
sS'of,unbound,was'
p45138
g3
sS'took,min,for'
p45139
g9
sS'the,following,adverse'
p45140
g9
sS'clinical,trial,a'
p45141
g3
sS'dose,used,for'
p45142
g3
sS'rare,defect,in'
p45143
g3
sS'solution,with,any'
p45144
g3
sS'is,either,initiated'
p45145
g3
sS'no,prolongation,in'
p45146
g3
sS'd,concentrations,have'
p45147
g3
sS'compromise,have,been'
p45148
g9
sS'cases,of,overdosage'
p45149
g9
sS'otherwise,healthy,subjects'
p45150
g3
sS'sole,indication,of'
p45151
g3
sS'carried,out,two'
p45152
g3
sS'inhibited,by,some'
p45153
g3
sS'a,digitalized,hypothyroid'
p45154
g9
sS'and,liver,and'
p45155
g3
sS'skin,rash,has'
p45156
g9
sS'of,age,and'
p45157
g3
sS'in,pigeons,nanm'
p45158
g3
sS'used,to,study'
p45159
g3
sS'interactions,when,serious'
p45160
g3
sS'with,with,no'
p45161
g3
sS'mg,ethinyl,estradiol'
p45162
g3
sS'may,decrease,in'
p45163
g3
sS'atromid-s,may,displace'
p45164
g9
sS'and,the,cyp1a2'
p45165
g3
sS'h-spiroperidol,and,high'
p45166
g3
sS'or,glatiramer,acetate'
p45167
g3
sS'release,and,thromboxane'
p45168
g3
sS'are,warranted,in'
p45169
g3
sS'preliminary,studies,indicate'
p45170
g9
sS'were,maintained,at'
p45171
g3
sS'dosage,of,adjusted'
p45172
g3
sS'where,abuse,of'
p45173
g3
sS'coffee,was,administered'
p45174
g3
sS'water,orange,juice'
p45175
g3
sS'model,using,the'
p45176
g3
sS'in,particular,has'
p45177
g3
sS'vardenafil,in,a'
p45178
g9
sS'decreased,by,about'
p45179
g9
sS'phosphatase,and,gamma'
p45180
g3
sS'individuals,who,consume'
p45181
g3
sS'n-desmethylclozapine,and,n-oxide'
p45182
g3
sS'wellbutrin,on,the'
p45183
g3
sS'increased,amounts,may'
p45184
g3
sS'now,cared,for'
p45185
g3
sS'greater,than,two-fold'
p45186
g9
sS'the,antimuscarinic,effects'
p45187
g9
sS'acid,doses,of'
p45188
g9
sS'and,to,mg'
p45189
g3
sS'some,patients,may'
p45190
g3
sS'as,or,ergot'
p45191
g9
sS'interindividual,variability,in'
p45192
g9
sS'with,double,strength'
p45193
g3
sS'however,requirement,i'
p45194
g9
sS'adjustment,is,needed'
p45195
g3
sS'oral,or,implant'
p45196
g3
sS'prolonged,because,of'
p45197
g3
sS'and,cmax,but'
p45198
g3
sS'and,about,a'
p45199
g9
sS'administered,orally,with'
p45200
g9
sS'interaction,between,brevibloc'
p45201
g3
sS'nsaid,and,particularly'
p45202
g3
sS'should,be,determined'
p45203
g3
sS'the,average,infusion'
p45204
g3
sS'was,obtained,from'
p45205
g3
sS'depressants,other,than'
p45206
g3
sS'structural,heart,disease'
p45207
g3
sS'indicating,no,potential'
p45208
g3
sS'distribution,or,total'
p45209
g3
sS'the,hypothesis,that'
p45210
g3
sS'plasma,concentrations,mg'
p45211
g3
sS'weight,gain,and'
p45212
g9
sS'should,be,kept'
p45213
g3
sS'lack,of,desired'
p45214
g3
sS'overall,response,rates'
p45215
g3
sS'cases,of,collapse'
p45216
g3
sS'the,reversal,of'
p45217
g9
sS'instances,in,the'
p45218
g3
sS'below,increase,the'
p45219
g3
sS'and,bmax,in'
p45220
g3
sS'were,observed,to'
p45221
g3
sS'with,tests,using'
p45222
g3
sS'that,an,ability'
p45223
g3
sS'transient,dose-dependent,increase'
p45224
g9
sS'who,were,on'
p45225
g9
sS'and,others,are'
p45226
g9
sS'that,patients,understand'
p45227
g3
sS'hypersensitivity,reactions,should'
p45228
g3
sS'inhibitor,of,breast'
p45229
g3
sS'advisable,to,check'
p45230
g9
sS'with,in,a'
p45231
g3
sS'in,these,monkeys'
p45232
g3
sS'its,metabolites,induce'
p45233
g3
sS'levels,and,increase'
p45234
g9
sS'catecholamine-depleting,such,as'
p45235
g9
sS'metabolites,in,the'
p45236
g3
sS'of,in,renally'
p45237
g3
sS'men,with,mild'
p45238
g3
sS'profile,total,cholesterol'
p45239
g3
sS'serum,enzyme,activities'
p45240
g3
sS'we,observed,that'
p45241
g9
sS'rarely,euphoria,excitement'
p45242
g3
sS'angiotensins,inhibited,gastric'
p45243
g3
sS'the,antihypertensive,effects'
p45244
g9
sS'augmentin,xr,patients'
p45245
g3
sS'of,fatal,hepatic'
p45246
g3
sS'its,toxicity,may'
p45247
g9
sS'reduced,creatinine,clearance'
p45248
g9
sS'single-dose,coadministration,leads'
p45249
g9
sS'the,biotransformation,of'
p45250
g3
sS'in,utero,exposure'
p45251
g3
sS'l-phenylalanine,and,non-selective'
p45252
g9
sS'maintain,the,prothrombin'
p45253
g3
sS'interactions,frova,is'
p45254
g3
sS'mc,mg,kg'
p45255
g3
sS'during,and,for'
p45256
g9
sS'cyp3a4,can,increase'
p45257
g3
sS'oral,agents,and'
p45258
g3
sS'coated,plus,vioxx'
p45259
g3
sS'significant,hypotension,developed'
p45260
g9
sS'as,the,serum'
p45261
g3
sS'monitored,when,itraconazole'
p45262
g9
sS'when,the,dose'
p45263
g3
sS'interaction,data,are'
p45264
g3
sS'cause,weakness,hyperreflexia'
p45265
g9
sS'the,major,cytochrome'
p45266
g3
sS'between,the,mean'
p45267
g3
sS'allopurinol,inhibits,the'
p45268
g9
sS'possible,interaction,of'
p45269
g9
sS'experiences,of,changes'
p45270
g9
sS'times,daily,before'
p45271
g3
sS'loss,of,spermatozoa'
p45272
g3
sS'phenytoin,and,thus'
p45273
g9
sS'of,a,g'
p45274
g3
sS't,max,and'
p45275
g3
sS'of,a,a'
p45276
g9
sS'auc,increased,approximately'
p45277
g9
sS'than,those,seen'
p45278
g9
sS'not,sufficient,however'
p45279
g3
sS'drug,or,to'
p45280
g3
sS'possible,adjustment,of'
p45281
g3
sS'depresses,activity,and'
p45282
g9
sS'steady-state,auc,of'
p45283
g9
sS'agents,which,may'
p45284
g3
sS'plasma,proteins,other'
p45285
g3
sS'been,reported,between'
p45286
g3
sS'vigorous,physical,activity'
p45287
g3
sS'present,study,evoked'
p45288
g3
sS'systemically,administered,enter'
p45289
g3
sS'free,ions,in'
p45290
g3
sS'although,there,have'
p45291
g3
sS'absorption,of,fat-soluble'
p45292
g9
sS'dose,and,total'
p45293
g9
sS'ingested,or,from'
p45294
g3
sS'method,this,study'
p45295
g3
sS'with,ace,inhibitors'
p45296
g9
sS'plenaxis,should,be'
p45297
g3
sS'careful,monitoring,for'
p45298
g9
sS'per,day,in'
p45299
g9
sS'were,accompanied,by'
p45300
g3
sS'and,impaired,suppression'
p45301
g3
sS'per,day,ig'
p45302
g9
sS'antacids,in,a'
p45303
g9
sS'initiation,of,lovenox'
p45304
g3
sS'of,nimbex,were'
p45305
g9
sS'of,significantly,decreased'
p45306
g9
sS'medications,may,need'
p45307
g3
sS'of,with,that'
p45308
g3
sS'of,methylpyrazole,mg'
p45309
g9
sS'with,a,closely'
p45310
g9
sS'of,agents,lower'
p45311
g3
sS'when,hydrochloride,has'
p45312
g9
sS'proliferation-dependent,but,caspase-3'
p45313
g3
sS'vitro,studies,it'
p45314
g3
sS'either,are,metabolized'
p45315
g3
sS'clearance,does,not'
p45316
g3
sS'inhibitors,on,male'
p45317
g3
sS'mydriasis,diplopia,dysarthria'
p45318
g3
sS'for,sustiva,and'
p45319
g3
sS'this,medication,may'
p45320
g3
sS'clinical,relevance,picr'
p45321
g3
sS'monkeys,were,of'
p45322
g3
sS'mixed-function,oxidase,enzyme'
p45323
g3
sS'when,the,stadol'
p45324
g9
sS'by,and,that'
p45325
g3
sS'is,required,concentrations'
p45326
g9
sS'thus,there,was'
p45327
g3
sS'vitro,studies,in'
p45328
g3
sS'there,was,decrease'
p45329
g3
sS'levels,of,are'
p45330
g9
sS'in,renally,impaired'
p45331
g3
sS'suggesting,that,may'
p45332
g9
sS'early,studies,indicated'
p45333
g3
sS'indinavir,is,an'
p45334
g3
sS'with,severe,recalcitrant'
p45335
g3
sS'patients,by,use'
p45336
g3
sS'potential,drug,interactions'
p45337
g3
sS'it,concomitantly,with'
p45338
g9
sS'torsades,de,pointe'
p45339
g3
sS'estradiol,and,an'
p45340
g9
sS'most,potent,against'
p45341
g3
sS'of,hyperlipidemia,or'
p45342
g9
sS'from,results,obtained'
p45343
g3
sS'metabolism,of,these'
p45344
g9
sS'a4,macrolide,such'
p45345
g9
sS'from,regression,analyses'
p45346
g9
sS'agents,may,decrease'
p45347
g9
sS'to,each,preparation'
p45348
g3
sS'structures,and,nonzero'
p45349
g3
sS'of,some,of'
p45350
g3
sS'release,of,caused'
p45351
g9
sS'interaction,between,h-spiroperidol'
p45352
g3
sS'of,with,its'
p45353
g3
sS'inhibitors,acetylsalicylic,acid'
p45354
g3
sS'with,a,has'
p45355
g9
sS'case,in,which'
p45356
g3
sS'asparagine,levels,are'
p45357
g9
sS'may,cause,increases'
p45358
g3
sS'pressure,effect,of'
p45359
g9
sS'recorded,while,the'
p45360
g3
sS'ml,egf,ng'
p45361
g3
sS'larger,when,hydrochloride'
p45362
g3
sS'morbidity,and,mortality'
p45363
g3
sS'fold,in,hydatid'
p45364
g9
sS'could,exaggerate,the'
p45365
g9
sS'incidence,of,sedation'
p45366
g9
sS'important,interactions,between'
p45367
g3
sS'in,the,maximum'
p45368
g3
sS'reuptake,and,the'
p45369
g9
sS'in,metabolism,inhibitors'
p45370
g9
sS'studies,of,aranesp'
p45371
g3
sS'by,any,of'
p45372
g9
sS'cyp3a4,as,it'
p45373
g3
sS'natriuretic,and,effects'
p45374
g9
sS'in,free,concentrations'
p45375
g3
sS'hypoglycemic,effect,of'
p45376
g9
sS'of,in,well-controlled'
p45377
g9
sS'mg,tablets,results'
p45378
g9
sS'the,exposure,of'
p45379
g9
sS'to,toxic,concentrations'
p45380
g9
sS'plasma,levels,whenever'
p45381
g3
sS'in,males,the'
p45382
g3
sS'in,uptake,may'
p45383
g9
sS'study,caused,a'
p45384
g9
sS'with,since,an'
p45385
g9
sS'by,a,high'
p45386
g3
sS'integrifolia,jackfruit,contain'
p45387
g3
sS'by,chronic,administration'
p45388
g9
sS'cyp1a2,cyp2a6,cyp2c9'
p45389
g3
sS'prelone,pediapred,others'
p45390
g3
sS'common,transport,pathway'
p45391
g3
sS'pharmacokinetics,and,protein'
p45392
g3
sS'clinically,relevant,drug-drug'
p45393
g3
sS'an,approximate,decrease'
p45394
g9
sS'hydroxydesloratadine,pharmacokinetics,in'
p45395
g3
sS'to,affect,duloxetine'
p45396
g3
sS'rat,s,diet'
p45397
g3
sS'with,pivoxil,resulted'
p45398
g9
sS'exposure,of,under'
p45399
g9
sS'may,persist,for'
p45400
g3
sS'although,other,hormonal'
p45401
g3
sS'alter,glucose,metabolism'
p45402
g3
sS'diuretics,furosemide,administered'
p45403
g3
sS'was,separated,from'
p45404
g9
sS'and,various,chemotherapy'
p45405
g3
sS'treatment,with,tablets'
p45406
g9
sS'potentiate,the,hypoglycemic'
p45407
g9
sS'of,short-acting,such'
p45408
g3
sS'auc,of,and'
p45409
g9
sS'activity,may,increase'
p45410
g3
sS'interaction,with,has'
p45411
g3
sS'properties,if,coreg'
p45412
g9
sS'with,should,not'
p45413
g3
sS'of,antizol,and'
p45414
g9
sS'and,therapeutic,effects'
p45415
g9
sS'of,homocysteine,in'
p45416
g3
sS'diffuse,muscle,pain'
p45417
g3
sS'cyp450,a4,especially'
p45418
g3
sS'shown,to,influence'
p45419
g9
sS'to,minimize,risks'
p45420
g3
sS'dose,in,adults'
p45421
g3
sS'with,hormonal,may'
p45422
g9
sS'atrophy,was,seen'
p45423
g3
sS'interactions,pi,classified'
p45424
g3
sS'and,also,in'
p45425
g9
sS'the,history,prior'
p45426
g3
sS'the,extent,of'
p45427
g3
sS'that,may,reduce'
p45428
g9
sS'a,loss,of'
p45429
g3
sS'pharmacodynamics,of,coadministration'
p45430
g3
sS'that,may,result'
p45431
g9
sS'metabolism,of,by'
p45432
g9
sS'grapefruit,juice,which'
p45433
g3
sS'data,and,selected'
p45434
g3
sS'affect,the,metabolism'
p45435
g3
sS'to,pi-based,regimens'
p45436
g3
sS'interaction,including,the'
p45437
g3
sS'excretion,of,urate'
p45438
g9
sS'was,calculated,by'
p45439
g3
sS'drinking,during,treatment'
p45440
g9
sS'and,ethanol,cause'
p45441
g9
sS'the,two,should'
p45442
g3
sS'that,there,are'
p45443
g3
sS'injection,and,potassium-depleting'
p45444
g9
sS'random,observations,have'
p45445
g9
sS'conceived,while,using'
p45446
g3
sS'were,increased,by'
p45447
g9
sS'has,a,direct'
p45448
g3
sS'nmda-ergic,activation,of'
p45449
g3
sS'the,cyp3a,and'
p45450
g3
sS'for,days,did'
p45451
g3
sS'including,sulfate,sulfate'
p45452
g9
sS'enoxacin,may,raise'
p45453
g9
sS'deaths,associated,with'
p45454
g3
sS'frequent,cause,of'
p45455
g9
sS'permanent,nerve,damage'
p45456
g3
sS'certain,thereby,increasing'
p45457
g9
sS'and,have,in'
p45458
g9
sS'uptake-1,occurs,is'
p45459
g3
sS'detect,ketone,bodies'
p45460
g3
sS'for,week,following'
p45461
g3
sS'reported,that,when'
p45462
g9
sS'obtain,serum,levels'
p45463
g9
sS'cardiac,arrhythmias,in'
p45464
g3
sS'for,days,followed'
p45465
g3
sS'week,controlled,study'
p45466
g3
sS'patients,have,higher'
p45467
g3
sS'have,been,co-administered'
p45468
g9
sS'striatum,and,cortex'
p45469
g9
sS'nonsteroidal,anti-inflammatory,agents'
p45470
g9
sS'even,if,the'
p45471
g3
sS'exacerbation,or,the'
p45472
g9
sS'clinician,in,his'
p45473
g3
sS'be,closely,monitored'
p45474
g9
sS'its,vasculature,without'
p45475
g3
sS'not,have,a'
p45476
g3
sS'dose-dependent,increase,in'
p45477
g9
sS'and,c19,the'
p45478
g3
sS'by,is,not'
p45479
g9
sS'drawn,and,lead'
p45480
g3
sS'the,bmax,of'
p45481
g3
sS'receiving,mg,to'
p45482
g3
sS'e-strain,subjects,to'
p45483
g3
sS'ecg,taken,at'
p45484
g3
sS'was,admitted,to'
p45485
g3
sS'use,of,aerosolized'
p45486
g3
sS'general,may,result'
p45487
g3
sS'was,strongly,suppressed'
p45488
g3
sS'factive,had,no'
p45489
g3
sS'alternative,therapy,should'
p45490
g9
sS'to,decrease,established'
p45491
g9
sS'is,required,for'
p45492
g3
sS'interactions,with,topical'
p45493
g9
sS'stimulant,effects,of'
p45494
g9
sS'the,mean,distribution'
p45495
g3
sS'on,the,absorption'
p45496
g3
sS'of,cyp2c9,at'
p45497
g3
sS'of,with,either'
p45498
g3
sS'rabbit,following,doses'
p45499
g3
sS'days,of,co-administration'
p45500
g3
sS'degrees,c,human'
p45501
g3
sS'with,and,the'
p45502
g3
sS'pharmacokinetic,results,from'
p45503
g9
sS'osteoporosis,treatment,and'
p45504
g3
sS'with,b-blocking,properties'
p45505
g9
sS'abdominal,irradiation,are'
p45506
g3
sS'subjects,on,stable'
p45507
g3
sS'disorders,can,exaggerate'
p45508
g3
sS'dose,increase,for'
p45509
g9
sS'videx,chewable,dispersible'
p45510
g9
sS'inhibitor,of,cyp2c9'
p45511
g3
sS'interaction,of,ketoconazole'
p45512
g9
sS'with,spectrophotometrically,determined'
p45513
g3
sS'including,most,ssris'
p45514
g3
sS'hypotension,vs,myocardial'
p45515
g9
sS'unaffected,by,the'
p45516
g3
sS'of,brevibloc,on'
p45517
g3
sS'doses,three,times'
p45518
g3
sS'a,specific,rare'
p45519
g3
sS'use,however,pharmacokinetic'
p45520
g3
sS'from,patients,in'
p45521
g3
sS'during,up-titration,presumably'
p45522
g3
sS'insufficiency,and,administration'
p45523
g3
sS'resulted,when,amines'
p45524
g9
sS'between,a,and'
p45525
g9
sS'elevations,of,pra'
p45526
g3
sS'was,expressed,by'
p45527
g3
sS'reported,due,to'
p45528
g9
sS'if,rebif,is'
p45529
g3
sS'of,beta,blockers'
p45530
g9
sS'addition,to,its'
p45531
g3
sS'e1,and,a'
p45532
g3
sS'metabolic,interactions,indicate'
p45533
g3
sS'with,lowered,blood'
p45534
g9
sS'inhibitors,administered,alone'
p45535
g9
sS'excretion,was,enhanced'
p45536
g3
sS'activity,was,noted'
p45537
g3
sS'viracept,antiarrhythmics,antihistamines'
p45538
g9
sS'in,the,intestinal'
p45539
g9
sS'aluminum,hydroxide-,and'
p45540
g3
sS'flow,seen,in'
p45541
g3
sS'for,chelation,and'
p45542
g3
sS'to,minutes,from'
p45543
g3
sS'caution,is,recommended'
p45544
g9
sS'maprotiline,risk,of'
p45545
g3
sS'by,acute,and'
p45546
g3
sS'lower,pulmonary,wedge'
p45547
g9
sS'about,to,of'
p45548
g3
sS'context,of,linear'
p45549
g3
sS'less,than,additive'
p45550
g9
sS'serum,in,vitro'
p45551
g3
sS'increased,central,nervous'
p45552
g9
sS'induced,responses,were'
p45553
g3
sS'they,relate,to'
p45554
g3
sS'of,in,by'
p45555
g9
sS'of,were,significantly'
p45556
g9
sS'of,by,blocking'
p45557
g9
sS'carcinogen,can,induce'
p45558
g3
sS'isozyme,including,and'
p45559
g9
sS'glycemia,induced,by'
p45560
g3
sS'of,grapefruit,or'
p45561
g3
sS'these,events,is'
p45562
g3
sS'l,and,mg'
p45563
g3
sS'conductivity,and,automaticity'
p45564
g9
sS'was,no,change'
p45565
g9
sS'for,plasma,and'
p45566
g3
sS'inhibition,and,suggest'
p45567
g3
sS'complications,and,lack'
p45568
g3
sS'of,interactions,resulting'
p45569
g3
sS'actions,of,intrathecal'
p45570
g3
sS'transit-enhancing,effect,of'
p45571
g3
sS'dietary-obese,rats,giving'
p45572
g3
sS'of,with,doses'
p45573
g3
sS'and,its,major'
p45574
g3
sS'agent,which,has'
p45575
g3
sS'visual,cortex,of'
p45576
g3
sS'to,and,m'
p45577
g3
sS'seizure,control,by'
p45578
g9
sS'of,were,approximately'
p45579
g9
sS'within,weeks,and'
p45580
g3
sS'or,including,combined'
p45581
g3
sS'to,reach,maximum'
p45582
g3
sS'inhibition,of,arachidonate-'
p45583
g3
sS'pharmacokinetics,of,mg'
p45584
g3
sS'lack,of,anti-platelet'
p45585
g3
sS'with,primarily,metabolized'
p45586
g3
sS'in,a,prospective'
p45587
g3
sS'hypoglycemic,agents,leading'
p45588
g9
sS'of,d,h'
p45589
g9
sS'index,or,tumor'
p45590
g3
sS'of,inspra,mg'
p45591
g9
sS'in,therapeutic,effect'
p45592
g3
sS'to,micrograms,ml'
p45593
g3
sS'action,may,bring'
p45594
g3
sS'where,patients,were'
p45595
g3
sS'available,regarding,interactions'
p45596
g3
sS'is,concluded,that'
p45597
g9
sS'as,intravenous,mg'
p45598
g3
sS'need,for,the'
p45599
g3
sS'ascertain,when,adjustment'
p45600
g3
sS'interactions,listed,below'
p45601
g3
sS'studies,in,animals'
p45602
g9
sS'of,enterococci,highlights'
p45603
g3
sS'especially,true,in'
p45604
g3
sS'with,concomitant,medications'
p45605
g3
sS'occur,potentiating,the'
p45606
g3
sS'seen,in,animals'
p45607
g9
sS'high,doses,mg'
p45608
g9
sS'non-,steroidal,anti-'
p45609
g9
sS'from,the,toxicity'
p45610
g9
sS'antigen,viii,coagulant'
p45611
g3
sS'other,agents,have'
p45612
g3
sS'taxol,may,be'
p45613
g3
sS'is,a,potential'
p45614
g3
sS'dose,adjustment,and'
p45615
g3
sS'lumen,at,as'
p45616
g3
sS'in,hiv-infected,individuals'
p45617
g3
sS'with,increasing,concentration'
p45618
g3
sS'by,decreasing,gut'
p45619
g9
sS'nephrotoxicity,and,ototoxicity'
p45620
g3
sS'receiving,a,metabolized'
p45621
g3
sS'drugs,l-phenylalanine,may'
p45622
g9
sS'at,mg,b'
p45623
g9
sS'than,to,mg'
p45624
g3
sS'with,brovana,at'
p45625
g3
sS'medications,like,or'
p45626
g9
sS'or,its,plasma'
p45627
g3
sS'local,including,both'
p45628
g9
sS'is,only,a'
p45629
g3
sS'probenecid,probenecid,slows'
p45630
g3
sS'agents,because,of'
p45631
g3
sS'episode,despite,seemingly'
p45632
g3
sS'such,as,not'
p45633
g9
sS'other,reported,interactions'
p45634
g3
sS'in,either,diabetics'
p45635
g3
sS'be,more,severe'
p45636
g3
sS'this,interaction,including'
p45637
g3
sS'synergy,was,usually'
p45638
g3
sS'any,agent,that'
p45639
g3
sS'and,plasma,expanders'
p45640
g3
sS'digoxin,supraventricular,arrhythmias'
p45641
g3
sS'suspension,yielded,similar'
p45642
g3
sS'with,thioridizine,or'
p45643
g3
sS'course,of,therapy'
p45644
g9
sS'on,the,compromised'
p45645
g3
sS'of,pregnancy,from'
p45646
g3
sS'isoforms,a2,c9'
p45647
g3
sS'jaff,reaction,and'
p45648
g3
sS'of,intravenously,administered'
p45649
g9
sS'rate,or,extent'
p45650
g3
sS'inhibitors,maoi,there'
p45651
g9
sS'taxol,and,aggressive'
p45652
g3
sS'psa,levels,may'
p45653
g3
sS'low,as,v'
p45654
g3
sS'of,methotrexate-related,toxicity'
p45655
g9
sS'simultaneously,with,varapamil'
p45656
g3
sS'with,a,cyp3a4'
p45657
g3
sS'was,evidence,for'
p45658
g3
sS'significantly,altered,for'
p45659
g3
sS'have,a,substantially'
p45660
g3
sS'useful,in,cases'
p45661
g3
sS'or,within,the'
p45662
g3
sS'compared,with,the'
p45663
g3
sS'which,inflammation,is'
p45664
g3
sS'cyp3a4,inducer,mg'
p45665
g9
sS'in,phosphorylation,inhibition'
p45666
g9
sS'octapeptide,cholecystokinin--of,h-spiroperidol'
p45667
g3
sS'a,during,the'
p45668
g3
sS'simvastatin,and,other'
p45669
g9
sS'half-life,of,increased'
p45670
g9
sS'poor,substrate,for'
p45671
g3
sS'mg,day,to'
p45672
g3
sS'factors,vii,viii'
p45673
g3
sS'is,totally,atoxic'
p45674
g3
sS'male,wistar,rats'
p45675
g3
sS'specific,molecular,differences'
p45676
g3
sS'dietary,concentration,as'
p45677
g3
sS'inability,to,ejaculate'
p45678
g3
sS'two,groups,but'
p45679
g3
sS'requires,maintaining,a'
p45680
g3
sS'method,and,the'
p45681
g3
sS'oxidase,inhibitory,effects'
p45682
g3
sS'recovery,took,min'
p45683
g9
sS'of,myopathy,is'
p45684
g3
sS'duration,of,block'
p45685
g9
sS'been,completed,with'
p45686
g3
sS'closely,for,adverse'
p45687
g3
sS'doses,of,nanm'
p45688
g3
sS'affect,either,the'
p45689
g3
sS'inactive,metabolites,has'
p45690
g3
sS'and,potent,inhibitors'
p45691
g3
sS'when,administering,to'
p45692
g9
sS'of,and,or'
p45693
g9
sS'monitoring,allows,physicians'
p45694
g3
sS'alkaline,urine,red-orange'
p45695
g3
sS'was,abolished,by'
p45696
g9
sS'methyltransferase,comt,hormone'
p45697
g3
sS'effect,of,certain'
p45698
g9
sS'be,no,acceptable'
p45699
g3
sS'these,reactions,resemble'
p45700
g3
sS'a,dose,reduction'
p45701
g9
sS'a,highly,potent'
p45702
g9
sS'test,interactions,amerge'
p45703
g3
sS'take,other,at'
p45704
g3
sS'subjects,when,doses'
p45705
g9
sS'of,urate,are'
p45706
g9
sS'reduced,tysabri,clearance'
p45707
g9
sS'renal,failure,may'
p45708
g3
sS'by,cyp2d6,cyp2c9'
p45709
g3
sS'patients,requiring,any'
p45710
g3
sS'increases,of,and'
p45711
g3
sS'diabinese,the,patient'
p45712
g3
sS'restoration,of,susceptibility'
p45713
g3
sS'medicine,such,as'
p45714
g3
sS'racemic,nor,binding'
p45715
g3
sS'to,treat,hypertension'
p45716
g3
sS'in,concentrations,above'
p45717
g9
sS'plasma,samples,may'
p45718
g3
sS'pharmacology,of,the'
p45719
g9
sS'phosphohydrolase,becomes,metabolically'
p45720
g3
sS'on,metabolic,interactions'
p45721
g3
sS'ph,may,lead'
p45722
g3
sS'in,cases,of'
p45723
g9
sS'performed,doses,of'
p45724
g3
sS'morphine,combination,hormonal'
p45725
g9
sS'from,at,least'
p45726
g3
sS'most,ssris,many'
p45727
g3
sS'anabolic,steroids,chloral'
p45728
g9
sS'not,by,n6-cyclopentyladenosine'
p45729
g9
sS'study,maximum,plasma'
p45730
g9
sS'dynacirc,and,does'
p45731
g3
sS'of,is,mediated'
p45732
g3
sS'improves,quality,of'
p45733
g3
sS'of,nonbenzodiazepine,agonists'
p45734
g9
sS'with,that,after'
p45735
g3
sS'suggested,the,mediation'
p45736
g3
sS'serotonin,syndrome,has'
p45737
g9
sS'capsules,twice,daily'
p45738
g3
sS'evaluated,to,determine'
p45739
g3
sS'advantage,of,these'
p45740
g3
sS'administered,at,least'
p45741
g9
sS'effect,on,pharmacokinetics'
p45742
g9
sS'these,six,volunteers'
p45743
g3
sS'cardiac,arrhythmias,have'
p45744
g9
sS'depressant,cns,including'
p45745
g3
sS'indocin,is,given'
p45746
g9
sS'was,only,observed'
p45747
g9
sS'absorption,of,the'
p45748
g9
sS'or,resulted,in'
p45749
g9
sS'abnormal,in,a'
p45750
g3
sS'cytochrome,p-450,the'
p45751
g9
sS'oral,doses,besides'
p45752
g3
sS'receiving,itraconazole,and'
p45753
g9
sS'effect,of,disease'
p45754
g3
sS'indicated,that,there'
p45755
g3
sS'in,pigeons,and'
p45756
g3
sS'agents,demonstrated,similar'
p45757
g3
sS'to,cause,immunosuppression'
p45758
g3
sS'been,investigated,in'
p45759
g3
sS'also,expected,to'
p45760
g9
sS'as,platelet,inhibitors'
p45761
g3
sS'of,individual,simulect'
p45762
g3
sS'either,healthy,subjects'
p45763
g3
sS'which,alterations,in'
p45764
g3
sS'clearance,with,a'
p45765
g9
sS'such,as,those'
p45766
g3
sS'all,care,should'
p45767
g3
sS'monitoring,the,problems'
p45768
g3
sS'frequently,complex,and'
p45769
g3
sS'are,equipotent,inducers'
p45770
g3
sS'on,the,gi'
p45771
g9
sS'the,udp-glucuronyl,transferase'
p45772
g3
sS'of,is,recommended'
p45773
g9
sS'fetal,development,at'
p45774
g3
sS'of,serious,adverse'
p45775
g3
sS'abdominal,symptoms,appear'
p45776
g3
sS'case,of,a'
p45777
g9
sS'or,thiazide,can'
p45778
g9
sS'diminish,the,antihypertensive'
p45779
g9
sS'effectiveness,and,increased'
p45780
g9
sS'chosen,method,or'
p45781
g3
sS'm2,and,or'
p45782
g9
sS'agents,may,either'
p45783
g9
sS'exercised,when,pletal'
p45784
g9
sS'injection,usp,has'
p45785
g3
sS'primarily,metabolized,by'
p45786
g3
sS'hepatitis,and,other'
p45787
g3
sS'in,vitro,interaction'
p45788
g9
sS'by,overcoming,tumor'
p45789
g3
sS'cmin,auc,ci'
p45790
g3
sS'powders,showed,that'
p45791
g9
sS'taken,in,combination'
p45792
g3
sS'behaviour,of,schistosoma'
p45793
g3
sS'ganglionic,blocking,agents'
p45794
g9
sS'primarily,as,methyltetrahydro-folate'
p45795
g3
sS'conducted,in,hiv-1'
p45796
g3
sS'effects,on,cycle'
p45797
g3
sS'an,approximate,reduction'
p45798
g9
sS'trileptal,was,given'
p45799
g9
sS'thought,to,be'
p45800
g3
sS'l057,in,the'
p45801
g3
sS'derivatives,and,possibly'
p45802
g9
sS'patient,population,chronically'
p45803
g3
sS'daily,dose,was'
p45804
g3
sS'its,cellular,uptake'
p45805
g9
sS'dizziness,nausea,paresthesia'
p45806
g3
sS'clinical,laboratory,tests'
p45807
g3
sS'procedure,in,which'
p45808
g3
sS'that,of,n-desmethyldiazepam'
p45809
g3
sS'interaction,studies,caution'
p45810
g3
sS'used,for,management'
p45811
g9
sS'simulect,use,in'
p45812
g3
sS'toxicity,of,b'
p45813
g3
sS'the,day,of'
p45814
g9
sS'coadministered,steady-state,plasma'
p45815
g9
sS'decreased,urinary,levels'
p45816
g3
sS'in,the,animal'
p45817
g3
sS'administration,of,macrolide'
p45818
g9
sS'comparable,to,the'
p45819
g3
sS'patients,vs,respectively'
p45820
g3
sS'synergistic,or,antagonist'
p45821
g3
sS'and,xanthine,and'
p45822
g9
sS'or,cervical,laceration'
p45823
g9
sS'increase,or,enhance'
p45824
g3
sS'an,analog,of'
p45825
g3
sS'but,also,with'
p45826
g3
sS'microg,kg,day'
p45827
g9
sS'processes,automatic,behavior'
p45828
g3
sS'pharmacokinetic,studies,with'
p45829
g3
sS'be,reliable,when'
p45830
g9
sS'of,with,targretin'
p45831
g9
sS'measured,in,volunteers'
p45832
g3
sS'level,while,the'
p45833
g9
sS'affect,the,cyp2b6'
p45834
g9
sS'patients,with,major'
p45835
g9
sS'concomitant,chemotherapy,and'
p45836
g3
sS'your,health,care'
p45837
g9
sS'or,increase,the'
p45838
g9
sS'of,lessened,active'
p45839
g3
sS'activity,was,expressed'
p45840
g3
sS'of,antigout,medications'
p45841
g3
sS'drug,laboratorytest,interactions'
p45842
g3
sS'day,the,rats'
p45843
g3
sS'effective,first-line,therapy'
p45844
g3
sS'because,severe,hypoglycemia'
p45845
g9
sS'were,coadministered,steady-state'
p45846
g9
sS'with,daily,doses'
p45847
g3
sS'at,c,drug'
p45848
g3
sS'not,only,in'
p45849
g3
sS'differences,between,tumor'
p45850
g3
sS'be,re-treated,with'
p45851
g3
sS'medicines,since,the'
p45852
g9
sS'oral,hypoglycemic,agents'
p45853
g9
sS'been,received,as'
p45854
g3
sS'that,has,the'
p45855
g3
sS'established,drug,interactions'
p45856
g3
sS'inotropic,such,as'
p45857
g9
sS'resulted,in,a'
p45858
g9
sS'and,increased,incidence'
p45859
g3
sS'it,is,proposed'
p45860
g3
sS'patients,over,a'
p45861
g9
sS'platelet,function,eg'
p45862
g9
sS'were,measured,four'
p45863
g3
sS'second,study,administration'
p45864
g9
sS'tmax,vs,for'
p45865
g3
sS'statistically,significant,differences'
p45866
g3
sS'm,m,m'
p45867
g9
sS'or,older,ask'
p45868
g3
sS'dose,based,on'
p45869
g3
sS'maalox,tc,had'
p45870
g3
sS'groups,and,were'
p45871
g3
sS'fertility,of,humans'
p45872
g3
sS'depletion,are,tricky'
p45873
g3
sS'used,if,indocin'
p45874
g9
sS'glucose,in,urine'
p45875
g3
sS'conditions,produce,toxicity'
p45876
g3
sS'injection,of,would'
p45877
g3
sS'from,the,beginning'
p45878
g3
sS'on,either,s'
p45879
g3
sS'the,urine,when'
p45880
g3
sS'thyroid,administration,to'
p45881
g9
sS'gabitril,is,considered'
p45882
g3
sS'clinistix,or,tes-tape'
p45883
g3
sS'two,type,strains'
p45884
g3
sS'mouth,and,nose'
p45885
g9
sS'side,effects,caused'
p45886
g9
sS'there,are,at'
p45887
g3
sS'absence,of,adequate'
p45888
g9
sS'therapeutic,actions,and'
p45889
g9
sS'this,has,not'
p45890
g9
sS'the,neuromuscular,blocking'
p45891
g9
sS'increased,serum,triglyceride'
p45892
g3
sS'further,no,effects'
p45893
g3
sS'then,with,caution'
p45894
g3
sS'levels,of,should'
p45895
g3
sS'as,is,subject'
p45896
g3
sS'phe-nothiazines,products,oral'
p45897
g3
sS'occur,with,copper'
p45898
g3
sS'patients,concomitant,use'
p45899
g3
sS'not,highly,bound'
p45900
g3
sS'require,exogenous,enhancement'
p45901
g3
sS'between,h-spiroperidol,and'
p45902
g3
sS'sex,hormone,binding'
p45903
g3
sS'cardiac,contractility,when'
p45904
g9
sS'of,limit,values'
p45905
g3
sS'erythrocytes,in,vivo'
p45906
g3
sS'css,max,is'
p45907
g9
sS'ketoconazole,erythromycin,clarithromycin'
p45908
g3
sS'the,physician,should'
p45909
g3
sS'relaxants,most,notably'
p45910
g9
sS'another,report,nine'
p45911
g9
sS'is,some,potential'
p45912
g9
sS'administered,to,individuals'
p45913
g3
sS'co-activator,in,glutamatergic'
p45914
g3
sS'differences,in,adverse'
p45915
g3
sS'reductions,in,elimination'
p45916
g9
sS'was,and,intraindividual'
p45917
g3
sS'interactions,and,central'
p45918
g3
sS'of,cyp3a4-eplerenone,metabolism'
p45919
g3
sS'with,or,without'
p45920
g9
sS'for,therapy,should'
p45921
g9
sS'or,glycosides,concurrent'
p45922
g3
sS'if,withdrawn,within'
p45923
g3
sS'systems,at,the'
p45924
g3
sS'intestinal,absorption,resulting'
p45925
g9
sS'receiving,acarbose,the'
p45926
g3
sS'to,nearly,times'
p45927
g3
sS'and,the,is'
p45928
g3
sS'by,confidence,limit'
p45929
g3
sS'regarding,potential,adverse'
p45930
g3
sS'day,and,a'
p45931
g9
sS'than,that,of'
p45932
g9
sS'the,chosen,method'
p45933
g3
sS'dose-dependent,manner,when'
p45934
g9
sS'of,administered,as'
p45935
g3
sS'recommended,that,frequent'
p45936
g3
sS'hydroxy-iso,by,range'
p45937
g9
sS'conclusions,and,the'
p45938
g3
sS'coincide,duloxetine,did'
p45939
g3
sS'reaching,a,maximal'
p45940
g3
sS'multiple-dose,study,was'
p45941
g3
sS'been,investigated,using'
p45942
g9
sS'cyp1a2,inhibitors,as'
p45943
g3
sS'alkaloids,and,would'
p45944
g9
sS'etopophos,with,that'
p45945
g9
sS'is,normal,but'
p45946
g9
sS'ect,and,antidepressant'
p45947
g3
sS'active,metabolite,is'
p45948
g3
sS'absorption,or,its'
p45949
g3
sS'ritonavir,combined,administration'
p45950
g3
sS'co-administration,of,or'
p45951
g3
sS'for,days,day'
p45952
g3
sS'clinical,study,in'
p45953
g3
sS'aggravated,by,the'
p45954
g9
sS'duloxetine,has,an'
p45955
g3
sS'differences,can,occur'
p45956
g3
sS'use,of,genetic'
p45957
g3
sS'proposed,that,resulted'
p45958
g9
sS'cmax,tmax,and'
p45959
g3
sS'prothrombin,time,may'
p45960
g3
sS'including,and,commonly'
p45961
g3
sS'not,necessitate,reduction'
p45962
g3
sS'on,day,was'
p45963
g3
sS'eprosartan,up,to'
p45964
g3
sS'contrast,acute,toxicity'
p45965
g3
sS'slowing,potentiates,increasing'
p45966
g3
sS'result,in,myopathy'
p45967
g3
sS'assessments,of,pharmacokinetic'
p45968
g3
sS'that,there,were'
p45969
g3
sS'his,logical,approach'
p45970
g3
sS'diabetes,used,to'
p45971
g9
sS'acetaminophen,tylenol,with'
p45972
g9
sS'interaction,of,levulan'
p45973
g3
sS'affect,the,in'
p45974
g3
sS'implications,for,management'
p45975
g3
sS'retrospective,analysis,of'
p45976
g3
sS'were,challenged,with'
p45977
g3
sS'when,hydrochloride,is'
p45978
g9
sS'plasma,asparagine,levels'
p45979
g9
sS'when,gl,was'
p45980
g9
sS'thyroidal,uptake,of'
p45981
g9
sS'epirubicin-based,chemotherapy,concomitantly'
p45982
g3
sS'is,a,major'
p45983
g3
sS'a,mg,single'
p45984
g9
sS'on,pupil,size'
p45985
g9
sS'pulmonary,arterial,hypertension'
p45986
g3
sS'of,the,danger'
p45987
g9
sS'and,identifies,clinically'
p45988
g3
sS'and,their,reappearance'
p45989
g3
sS'types,of,indications'
p45990
g3
sS'qd,of,are'
p45991
g3
sS'or,oral,should'
p45992
g3
sS'potential,for,clinically'
p45993
g3
sS'erythromycin,has,been'
p45994
g9
sS'fertility,a,two-year'
p45995
g3
sS'chloral,hydrate,and'
p45996
g3
sS'were,on,established'
p45997
g9
sS'as,or,are'
p45998
g9
sS'fibrillation,when,combined'
p45999
g9
sS'injury,including,myocardial'
p46000
g9
sS'commonly,results,in'
p46001
g9
sS'that,chloral,hydrate'
p46002
g3
sS'would,warrant,alteration'
p46003
g3
sS'quinolones,including,may'
p46004
g9
sS'should,be,recognized'
p46005
g3
sS'mg,m2,before'
p46006
g3
sS'concurrently,with,because'
p46007
g9
sS'in,one,survey'
p46008
g9
sS'in,comparative,data'
p46009
g3
sS'a,krm-1648,either'
p46010
g3
sS'confirmation,test,should'
p46011
g3
sS'a,clinical,interaction'
p46012
g3
sS'utilization,including,medications'
p46013
g9
sS'phenytoin,isoniazid,may'
p46014
g9
sS'or,herb,interactions'
p46015
g3
sS'and,buspirone,hcl'
p46016
g9
sS'subject,demonstrated,clinical'
p46017
g3
sS'cardiotoxicity,associated,with'
p46018
g3
sS'inducer,of,cyp3a4'
p46019
g3
sS'elevated,cerebral,and'
p46020
g9
sS'the,hplc,peak'
p46021
g3
sS'mao,inhibitor,plus'
p46022
g9
sS'events,were,reported'
p46023
g3
sS'evaluated,and,concomitant'
p46024
g9
sS'drug-drug,pharmacokinetic,or'
p46025
g3
sS'prophylaxis,may,have'
p46026
g9
sS'auc,to,was'
p46027
g9
sS'of,were,on'
p46028
g3
sS'this,effect,is'
p46029
g3
sS'antineoplastic,agents,nitrogen'
p46030
g3
sS'occasionally,experience,a'
p46031
g9
sS'and,the,hazards'
p46032
g3
sS'for,days,to'
p46033
g3
sS'experience,bleeding,has'
p46034
g9
sS'of,succinylcholine-induced,neuromuscular'
p46035
g3
sS'therefore,colestld,tablets'
p46036
g3
sS'endoscopy,study,conducted'
p46037
g3
sS'predict,the,direction'
p46038
g3
sS'results,in,an'
p46039
g9
sS'mg,tid,study'
p46040
g3
sS'be,carefully,monitored'
p46041
g9
sS'interactions,between,treatments'
p46042
g3
sS'an,equivalent,amount'
p46043
g3
sS'compounds,in,combination'
p46044
g3
sS'derivative,implications,for'
p46045
g3
sS'auc,c,max'
p46046
g3
sS'whether,the,concurrent'
p46047
g9
sS'steady-state,with,a'
p46048
g9
sS'sodium,capsules,mg'
p46049
g9
sS'daily,doses,of'
p46050
g3
sS'a,four-day,regimen'
p46051
g9
sS'plus,vioxx,mg'
p46052
g3
sS'nac,decreased,significantly'
p46053
g3
sS'concurrent,usage,of'
p46054
g3
sS'effects,of,for'
p46055
g9
sS'fluorouracil,is,increased'
p46056
g9
sS'rate,of,the'
p46057
g3
sS'in,rat,milk'
p46058
g3
sS'taking,tysabri,and'
p46059
g3
sS'remnant,removal,was'
p46060
g3
sS'with,food,is'
p46061
g9
sS'other,there,appears'
p46062
g3
sS'scanning,calorimetry,differential'
p46063
g3
sS'if,possible,anticholinesterase'
p46064
g9
sS'recipients,over,the'
p46065
g3
sS'on,fertility,were'
p46066
g3
sS'in,neither,case'
p46067
g3
sS'including,the,active'
p46068
g3
sS'be,given,with'
p46069
g9
sS'potassium-depleting,agents,amphotericin'
p46070
g9
sS'intravascular,volume,depletion'
p46071
g9
sS'of,beta-adrenoceptor,blocking'
p46072
g9
sS'between,or,its'
p46073
g9
sS'inducers,of,clearance'
p46074
g9
sS'mg,twice,daily'
p46075
g3
sS'performed,based,on'
p46076
g9
sS'mean,area,under'
p46077
g9
sS'labeling,index,apoptotic'
p46078
g3
sS'apoptosis,in,breast'
p46079
g3
sS'relevant,interaction,of'
p46080
g9
sS'times,should,be'
p46081
g9
sS'have,been,observed'
p46082
g3
sS'prozac,sporanox,nizoral'
p46083
g3
sS'also,in,case'
p46084
g3
sS'elapse,between,administration'
p46085
g9
sS'relevant,as,adverse'
p46086
g3
sS'however,the,absolute'
p46087
g3
sS'interactions,with,mtx'
p46088
g3
sS'in,the,apparent'
p46089
g9
sS'fluvoxamine,tablets,not'
p46090
g9
sS'fulvestrant-treated,lactating,dams'
p46091
g3
sS'been,concern,about'
p46092
g9
sS'and,prevalence,of'
p46093
g3
sS'likelihood,of,bone'
p46094
g3
sS'to,enhancing,absorption'
p46095
g9
sS'result,in,vertigo'
p46096
g3
sS'because,prostaglandins,play'
p46097
g9
sS'in,the,judgment'
p46098
g9
sS'the,rate,and'
p46099
g3
sS'or,were,administered'
p46100
g3
sS'binding,of,of'
p46101
g3
sS'felbatol,causes,an'
p46102
g9
sS'literature,between,january'
p46103
g3
sS'and,fsh,to'
p46104
g3
sS'day,was,significantly'
p46105
g3
sS'required,to,treat'
p46106
g9
sS'cimetidine,at,mg'
p46107
g9
sS'following,agents,clomipramine'
p46108
g9
sS'when,administering,concurrently'
p46109
g9
sS'is,not,generally'
p46110
g9
sS'vitamin,a,and'
p46111
g9
sS'd,analogues,vitamin'
p46112
g9
sS'higher,plasma,concentrations'
p46113
g3
sS'transcription,factor,iegs'
p46114
g3
sS'and,degenerative,changes'
p46115
g3
sS'acquisition,of,tasks'
p46116
g3
sS'hepatic,cyp,drug-metabolizing'
p46117
g3
sS'rats,were,kept'
p46118
g3
sS'urinary,alkalinizers,decrease'
p46119
g3
sS'injection,should,be'
p46120
g3
sS'achieve,exposures,of'
p46121
g9
sS'first,pass,secondary'
p46122
g3
sS'six,of,these'
p46123
g9
sS'of,oral,upon'
p46124
g9
sS'appeared,to,be'
p46125
g9
sS'groups,sh,da'
p46126
g3
sS'be,monitored,when'
p46127
g9
sS'is,advised,digoxin'
p46128
g3
sS'may,have,enhanced'
p46129
g9
sS'those,in,the'
p46130
g3
sS'trials,heart,rate'
p46131
g3
sS'the,study,regardless'
p46132
g3
sS'congener,is,being'
p46133
g3
sS'proliferation,in,the'
p46134
g9
sS'have,received,maoi'
p46135
g9
sS'noted,in,study'
p46136
g3
sS'antidepressant,single,dose'
p46137
g9
sS'and,concurrent,use'
p46138
g9
sS'may,potentiate,blood-pressure'
p46139
g9
sS'renal,function,are'
p46140
g3
sS'vitro,aspirin-mediated,inhibition'
p46141
g3
sS'of,has,no'
p46142
g3
sS'study,was,also'
p46143
g3
sS'experience,with,nonsteroidal'
p46144
g9
sS'antimycobacterial,agents,contraindicated'
p46145
g3
sS'days,of,coadministration'
p46146
g3
sS'norfluoxe-tine,have,long'
p46147
g3
sS'system,or,should'
p46148
g9
sS'cautioned,against,engaging'
p46149
g3
sS'increased,from,to'
p46150
g9
sS'was,present,in'
p46151
g3
sS'as,these,agents'
p46152
g9
sS'corticosteroids,methylxanthines,and'
p46153
g9
sS'metabolizers,resemble,poor'
p46154
g3
sS'only,with,knowledge'
p46155
g3
sS'it,was,combined'
p46156
g3
sS'level,of,phosphatase'
p46157
g3
sS'cost,of,is'
p46158
g3
sS'in,both,tissues'
p46159
g3
sS'will,increase,the'
p46160
g3
sS'approximately,peak,blood'
p46161
g9
sS'of,these,and'
p46162
g3
sS'aldosterone,production,elevation'
p46163
g3
sS'gel,and,systemic'
p46164
g3
sS'aggregation,inhibitors,such'
p46165
g9
sS'rate,which,requires'
p46166
g3
sS'atrovent,inhalation,aerosol'
p46167
g3
sS'p-450iie1,a,mixed-function'
p46168
g3
sS'low,levels,cfu'
p46169
g3
sS'from,spontaneous,reports'
p46170
g3
sS'based,on,drug'
p46171
g3
sS'as,was,the'
p46172
g9
sS'sildenafil,dose,should'
p46173
g9
sS'by,displacement,from'
p46174
g3
sS'mellaril,stelazine,vesprin'
p46175
g3
sS'simultaneously,it,is'
p46176
g3
sS'the,epa,dose'
p46177
g3
sS'which,resulted,in'
p46178
g9
sS'for,such,patients'
p46179
g3
sS'may,increase,their'
p46180
g3
sS'patients,receiving,catecholamine-depleting'
p46181
g9
sS'on,this,inhibitory'
p46182
g3
sS'may,add,to'
p46183
g9
sS'accutane,therapy,although'
p46184
g3
sS'events,required,medical'
p46185
g3
sS'interactions,with,fentanyl'
p46186
g3
sS'effects,on,fetal'
p46187
g3
sS'antibiotics,no,human'
p46188
g3
sS'gabitril,with,highly'
p46189
g3
sS'index,including,certain'
p46190
g9
sS'nitrates,the,blood'
p46191
g9
sS'doses,of,mcg'
p46192
g3
sS'of,increases,the'
p46193
g9
sS'this,slowing,potentiates'
p46194
g3
sS'concomitantly,administered,iron-fortified'
p46195
g3
sS'nonetheless,since,interactions'
p46196
g9
sS'prevents,gastrointestinal,effects'
p46197
g9
sS'investigated,whether,also'
p46198
g3
sS'initiating,and,discontinuing'
p46199
g9
sS'single,dose,administration'
p46200
g9
sS'rate-decreasing,effects,of'
p46201
g9
sS'not,report,any'
p46202
g3
sS'from,approximately,to'
p46203
g9
sS'tubular,secretion,blocking'
p46204
g3
sS'first,contractile,response'
p46205
g3
sS'extent,by,the'
p46206
g3
sS'three,types,of'
p46207
g3
sS'isolated,from,marine'
p46208
g3
sS'of,gastric,emptying'
p46209
g3
sS'by,approximately,to'
p46210
g3
sS'sometimes,prescribed,to'
p46211
g9
sS'prothrombin,time,and'
p46212
g3
sS'steady,state,levels'
p46213
g3
sS'non-diabetics,with,glucose'
p46214
g3
sS'markedly,inhibit,cyp450s'
p46215
g3
sS'synergism,with,camp'
p46216
g9
sS'use,of,prostaglandin'
p46217
g9
sS'pure,powders,showed'
p46218
g9
sS'adults,at,high'
p46219
g9
sS'mice,and,the'
p46220
g3
sS'with,showed,no'
p46221
g3
sS'or,alternatively,the'
p46222
g3
sS'curare-like,compounds,should'
p46223
g9
sS'factors,such,as'
p46224
g3
sS'is,a,presynaptic'
p46225
g3
sS'be,gradual,in'
p46226
g9
sS'certain,such,as'
p46227
g9
sS'dose,selection,and'
p46228
g3
sS'concurrent,therapy,with'
p46229
g9
sS'cancidas,has,no'
p46230
g3
sS'but,not,under'
p46231
g3
sS'b6,weak,c19'
p46232
g3
sS'today,pharmacological,therapy'
p46233
g3
sS'increases,of,with'
p46234
g3
sS'sodium,should,be'
p46235
g3
sS'third,group,sh'
p46236
g3
sS'additional,research,is'
p46237
g3
sS'the,antagonist,were'
p46238
g3
sS'rocaltrol,may,be'
p46239
g3
sS'controlled,study,of'
p46240
g3
sS'safe,sexual,activity'
p46241
g3
sS'in,small,groups'
p46242
g3
sS'formulations,of,which'
p46243
g9
sS'with,known,microsomal'
p46244
g9
sS'patients,with,dose'
p46245
g3
sS'trials,have,used'
p46246
g3
sS'of,the,same'
p46247
g3
sS'chop,alone,vs'
p46248
g3
sS'more,susceptible,to'
p46249
g3
sS'which,may,intensify'
p46250
g3
sS'for,serious,and'
p46251
g3
sS'the,spleen,and'
p46252
g3
sS'a,significant,elevation'
p46253
g9
sS'duloxetine,with,had'
p46254
g3
sS'when,are,used'
p46255
g3
sS'absorption,of,vitamin'
p46256
g9
sS'inhibitors,and,should'
p46257
g3
sS'pharmacokinetic,study,healthy'
p46258
g3
sS'd6,a4,and'
p46259
g3
sS'auc,increased,by'
p46260
g9
sS'to,times,mouse'
p46261
g3
sS'from,to,microg'
p46262
g3
sS'trinitrate,isosorbide,dinitrate'
p46263
g3
sS'rr,is,a'
p46264
g3
sS'this,class,of'
p46265
g3
sS'in,an,increased'
p46266
g9
sS'stered,orally,prior'
p46267
g9
sS'prostin,vr,pediatric'
p46268
g3
sS'of,nalfon,and'
p46269
g9
sS'all,in,vivo'
p46270
g3
sS'with,copper,reduction'
p46271
g3
sS'not,morphine-induced,tail-flick'
p46272
g3
sS'the,pharmacologic,mechanism'
p46273
g3
sS'transport,in,the'
p46274
g3
sS'concurrently,with,agents'
p46275
g3
sS'can,be,reduced'
p46276
g9
sS'potentiated,when,these'
p46277
g3
sS'cardiovascular,depression,and'
p46278
g3
sS'trials,of,epirubicin-containing'
p46279
g3
sS'ketoconazole,combined,administration'
p46280
g9
sS'cyp,c19,cyp'
p46281
g3
sS'given,to,a'
p46282
g9
sS'approximately,was,necessary'
p46283
g9
sS'with,disease,states'
p46284
g3
sS'dose,ranges,of'
p46285
g3
sS'as,such,it'
p46286
g3
sS'since,zarontin,may'
p46287
g9
sS'auc,and,cmin'
p46288
g9
sS'and,others,may'
p46289
g3
sS'days,for,evidence'
p46290
g3
sS'decreases,heart,rate'
p46291
g3
sS'and,follow-up,liver'
p46292
g3
sS'amphotericin,b-induced,hypokalemia'
p46293
g9
sS'second,hour,then'
p46294
g3
sS'n,in,each'
p46295
g3
sS'with,cardiac,conduction'
p46296
g3
sS'of,these,two'
p46297
g3
sS'agitation,while,other'
p46298
g3
sS'sodium,binding,to'
p46299
g9
sS'mg,of,a'
p46300
g3
sS'these,findings,indicate'
p46301
g3
sS'influence,on,components'
p46302
g9
sS'mortality,was,observed'
p46303
g3
sS'safely,without,additional'
p46304
g3
sS'by,his,her'
p46305
g3
sS'inhibit,cyp2d6,cyp1a2'
p46306
g3
sS'patient,s,serum'
p46307
g3
sS'have,been,safely'
p46308
g3
sS'to,decrease,conduction'
p46309
g9
sS'the,mean,daily'
p46310
g3
sS'magnesium,infusions,can'
p46311
g3
sS'and,oral,solution'
p46312
g9
sS'when,midamor,and'
p46313
g9
sS'careful,consideration,should'
p46314
g3
sS'implications,of,interactions'
p46315
g9
sS'are,contraindicated,specifically'
p46316
g3
sS'the,same,episode'
p46317
g3
sS'case,of,other'
p46318
g3
sS'inhibitors,macrolide,antibiotics'
p46319
g3
sS'although,beta-adrenergic,blockers'
p46320
g9
sS'maintain,an,adequate'
p46321
g3
sS'fraction,of,excreted'
p46322
g3
sS'taking,when,is'
p46323
g9
sS'retinyl,acetate,similarly'
p46324
g9
sS'was,demonstrated,that'
p46325
g3
sS'fetal,immune,system'
p46326
g3
sS'in,eagles,minimal'
p46327
g3
sS'for,novolog,should'
p46328
g3
sS'ataxia,dysarthria,incoordination'
p46329
g3
sS'excretion,of,both'
p46330
g9
sS'on,the,r-value'
p46331
g3
sS'lithium,increased,serum'
p46332
g9
sS'hematology,taxol,therapy'
p46333
g3
sS'reactions,to,products'
p46334
g9
sS'cyp3a4,activity,increase'
p46335
g3
sS'except,with,the'
p46336
g3
sS'inhibit,metabolism,via'
p46337
g3
sS'ibandronate,osteoporosis,treatment'
p46338
g3
sS'decreased,free,will'
p46339
g3
sS'this,is,given'
p46340
g3
sS'function,the,decreased'
p46341
g3
sS'or,substrates,of'
p46342
g9
sS'the,muscle,in'
p46343
g9
sS'of,mg,five'
p46344
g3
sS'no,formal,clinical'
p46345
g3
sS'excretion,glucuronidation,and'
p46346
g3
sS'in,fi,responding'
p46347
g9
sS'has,shown,no'
p46348
g3
sS'were,not,quantitatively'
p46349
g3
sS'tablets,may,delay'
p46350
g3
sS'by,the,jaff'
p46351
g3
sS'other,than,atiii'
p46352
g3
sS'important,causes,of'
p46353
g3
sS'receiving,camptosar,and'
p46354
g9
sS'the,metabolism,and'
p46355
g3
sS'mg,day,after'
p46356
g3
sS'iib,iiia,inhibitors'
p46357
g9
sS'other,potential,hepatotoxic'
p46358
g3
sS'function,of,either'
p46359
g3
sS'incidence,of,are'
p46360
g3
sS'metabolite,norfluoxe-tine,have'
p46361
g3
sS'presence,of,the'
p46362
g3
sS'oral,ccnu,either'
p46363
g3
sS'of,cortisol,thyroid-stimulating'
p46364
g3
sS'the,area,under'
p46365
g9
sS'ibuprofen,and,high'
p46366
g9
sS'other,nsaid,and'
p46367
g3
sS'for,a,second'
p46368
g3
sS'mg,day,monotherapy'
p46369
g3
sS'cyp2c19,and,induce'
p46370
g3
sS'inhibit,neuronal,reuptake'
p46371
g3
sS'of,including,tricor'
p46372
g9
sS'that,is,lower'
p46373
g3
sS'incidence,of,cardiovascular'
p46374
g3
sS'using,the,paraaminohippurate'
p46375
g3
sS'and,channel,antagonists'
p46376
g3
sS'psychostimulant,effects,of'
p46377
g3
sS'occur,following,concomitant'
p46378
g3
sS'consequently,caution,is'
p46379
g3
sS'may,induce,fungal'
p46380
g9
sS'hours,or,follow'
p46381
g3
sS'central,nervous,system'
p46382
g9
sS'time,may,occur'
p46383
g9
sS'of,subjects,n'
p46384
g9
sS'utilization,of,for'
p46385
g3
sS'receiving,maintenance,doses'
p46386
g3
sS'nm,absorbing,materials'
p46387
g3
sS'volunteers,co-administration,of'
p46388
g3
sS'were,observed,following'
p46389
g9
sS'm,min,in'
p46390
g9
sS'on,patients,with'
p46391
g3
sS'target,tissues,metabolism'
p46392
g3
sS'medications,that,affect'
p46393
g9
sS'associated,with,physicians'
p46394
g3
sS's,influence,on'
p46395
g9
sS'relationship,physicians,should'
p46396
g9
sS'metabolism,causing,an'
p46397
g9
sS'some,medications,may'
p46398
g3
sS'tested,in,vitro'
p46399
g3
sS'as,are,used'
p46400
g9
sS'probenecid,is,a'
p46401
g3
sS'blockers,or,h1-blocking'
p46402
g9
sS'c,diethyl,pyrocarbonate'
p46403
g3
sS'nucleophosmin,b23,activation'
p46404
g3
sS'is,not,needed'
p46405
g9
sS'discuss,the,use'
p46406
g3
sS'vasopressin,was,found'
p46407
g3
sS'loss,compared,with'
p46408
g9
sS'man,and,is'
p46409
g3
sS'in,t24,cells'
p46410
g9
sS'being,given,compensatory'
p46411
g3
sS'of,other,and'
p46412
g3
sS'incidence,of,intestinal'
p46413
g3
sS'angiotensln,converting,enzyme'
p46414
g9
sS'severe,anemia,grade'
p46415
g3
sS'relation,to,other'
p46416
g3
sS'itraconazole,was,coadministered'
p46417
g9
sS'effect,of,treatment'
p46418
g3
sS'male,volunteers,in'
p46419
g3
sS'which,is,manifested'
p46420
g3
sS'levels,and,the'
p46421
g3
sS'identified,case,of'
p46422
g3
sS'dose,of,micrograms'
p46423
g9
sS'kg,person,and'
p46424
g3
sS'dosing,of,vardenafil'
p46425
g9
sS'alfa-2a,treatment,of'
p46426
g3
sS'chewable,dispersible,tablet'
p46427
g9
sS'dosed,with,difluoroacetone'
p46428
g3
sS'synthetase,inhibitor,however'
p46429
g3
sS'to,investigate,the'
p46430
g3
sS'dose,did,not'
p46431
g3
sS'with,copegus,did'
p46432
g3
sS'metabolizing,enzymes,such'
p46433
g3
sS'manner,the,tail-flick'
p46434
g9
sS'flolan,in,clinical'
p46435
g3
sS'of,acidity,in'
p46436
g9
sS'of,genetic,data'
p46437
g3
sS'including,hyperthermia,rigidity'
p46438
g9
sS'lower,and,the'
p46439
g9
sS'medications,or,other'
p46440
g9
sS'than,additive,effects'
p46441
g9
sS'human,liver,microsome'
p46442
g3
sS'with,ototoxic,potential'
p46443
g9
sS'indirect-acting,agents,or'
p46444
g9
sS'have,a,positive'
p46445
g3
sS'study,attempting,to'
p46446
g3
sS'cyp3a4,inhibitor,because'
p46447
g3
sS'a,metabolism,and'
p46448
g3
sS'however,the,antagonism'
p46449
g9
sS'coadministration,of,has'
p46450
g3
sS'during,therapy,including'
p46451
g3
sS'required,may,be'
p46452
g9
sS'of,the,treatment'
p46453
g3
sS'was,started,on'
p46454
g3
sS'either,mg,once'
p46455
g3
sS'inhibition,of,ca'
p46456
g3
sS'dose,and,until'
p46457
g3
sS'conduction,when,using'
p46458
g9
sS'coadministration,of,had'
p46459
g3
sS'cannot,be,used'
p46460
g3
sS'strains,and,synergistic'
p46461
g9
sS'considerable,segment,of'
p46462
g3
sS'or,others,with'
p46463
g3
sS'your,doctor,before'
p46464
g3
sS'especially,or,preanesthetic'
p46465
g3
sS'in,serum,endogenous'
p46466
g3
sS'of,this,toxicity'
p46467
g3
sS'required,in,patients'
p46468
g3
sS'allergy,cold,and'
p46469
g9
sS'cyclosporine,combination,hormonal'
p46470
g9
sS'and,a,sprycel'
p46471
g3
sS'cyp2d6,and,cyp3a3'
p46472
g3
sS'avoid,saw,palmetto'
p46473
g3
sS'tiagabine,causes,a'
p46474
g9
sS'is,unlikely,that'
p46475
g3
sS'accelerate,the,metabolism'
p46476
g3
sS'patients,with,hypertension'
p46477
g9
sS'not,rely,on'
p46478
g3
sS'therapy,is,contraindicated'
p46479
g3
sS'fever,severe,obstipation'
p46480
g9
sS'then,wait,about'
p46481
g9
sS'difluoroacetone,a,known'
p46482
g3
sS'on,multiple,occupational'
p46483
g3
sS'already,responded,to'
p46484
g3
sS'is,not,totally'
p46485
g9
sS'and,its,synergism'
p46486
g9
sS'of,acute,angina'
p46487
g3
sS'with,beta-blockers,concomitant'
p46488
g9
sS'alterations,of,blood'
p46489
g3
sS'episodes,may,occur'
p46490
g9
sS'of,proteins,in'
p46491
g3
sS'first-line,option,in'
p46492
g3
sS'be,seen,as'
p46493
g3
sS'regarding,the,potential'
p46494
g3
sS'sprycel,with,should'
p46495
g9
sS'the,pituitary-gonadal,axis'
p46496
g3
sS'and,perhaps,other'
p46497
g3
sS'has,shown,that'
p46498
g9
sS'known,enzyme,inducer'
p46499
g9
sS'and,non-steroidal,anti-inflammatory'
p46500
g9
sS'prothrombin,times,with'
p46501
g9
sS'total,mucosal,accumulation'
p46502
g3
sS'vasoconstriction,after,a'
p46503
g9
sS'therapy,of,a'
p46504
g9
sS'using,red,cells'
p46505
g3
sS'subjects,reports,of'
p46506
g3
sS'agents,class,i'
p46507
g3
sS'blood,levels,may'
p46508
g9
sS'use,lowest,possible'
p46509
g9
sS'suitable,coagulation,test'
p46510
g9
sS'the,clinical,differences'
p46511
g3
sS'agents,or,are'
p46512
g9
sS'an,week,trial'
p46513
g3
sS'is,no,evidence'
p46514
g3
sS'this,antagonistic,effect'
p46515
g9
sS'agents,lower,blood'
p46516
g3
sS'agents--a,class,of'
p46517
g3
sS'inhibit,the,cyp450'
p46518
g3
sS'prolongation,and,torsades'
p46519
g3
sS'considerable,evidence,suggesting'
p46520
g3
sS'of,potential,to'
p46521
g9
sS'the,implications,of'
p46522
g3
sS'drugs,that,interfere'
p46523
g3
sS'and,s,isomers'
p46524
g3
sS'values,for,n'
p46525
g9
sS'were,noted,to'
p46526
g9
sS'doxylamine,may,enhance'
p46527
g9
sS'might,arise,from'
p46528
g3
sS'induce,a,positive'
p46529
g3
sS'd6,cyp2d6,sensipar'
p46530
g3
sS'vitro,therefore,this'
p46531
g3
sS'was,delayed,by'
p46532
g3
sS'bosentan,is,also'
p46533
g9
sS'patients,with,alt'
p46534
g3
sS'have,previously,been'
p46535
g3
sS'of,the,may'
p46536
g9
sS'cyp450,enzyme,group'
p46537
g3
sS'resting,membrane,potential'
p46538
g3
sS'dermatologist,and,their'
p46539
g3
sS'therapeutic,margin,such'
p46540
g3
sS'of,the,mao'
p46541
g9
sS'alter,behaviors,which'
p46542
g3
sS'such,a,fall'
p46543
g3
sS'sequence,however,usually'
p46544
g3
sS'at,least,days'
p46545
g3
sS'because,both,are'
p46546
g9
sS'than,reduction,in'
p46547
g9
sS'qt,prolongation,cardiac'
p46548
g9
sS'parenteral,may,cause'
p46549
g9
sS'n,there,was'
p46550
g3
sS'drug,interaction,during'
p46551
g3
sS'of,flushing,and'
p46552
g3
sS'p450,cyp450,enzyme'
p46553
g3
sS'a,strong,cyp3a4'
p46554
g9
sS'from,the,combined'
p46555
g9
sS'with,benedict,s'
p46556
g3
sS'resulting,in,a'
p46557
g9
sS'of,zinecard,on'
p46558
g3
sS'conclusion,fluvoxamine,is'
p46559
g3
sS'studied,of,the'
p46560
g3
sS'stress,may,influence'
p46561
g3
sS'cadmium,and,had'
p46562
g3
sS'bodyweight,gain,and'
p46563
g3
sS'by,the,us'
p46564
g3
sS'further,is,reported'
p46565
g3
sS'total,exposure,for'
p46566
g3
sS'each,treatment,period'
p46567
g3
sS'when,initiating,or'
p46568
g9
sS'tmp,smx,such'
p46569
g3
sS'metabolism,in,future'
p46570
g3
sS'active,monohydroxy,metabolite'
p46571
g3
sS'as,complications,related'
p46572
g3
sS'are,coupled,to'
p46573
g3
sS'mg,kg,hours'
p46574
g9
sS'lithium,nsaids,have'
p46575
g9
sS'trials,and,studies'
p46576
g3
sS'function,secondary,to'
p46577
g3
sS'in,a,subset'
p46578
g3
sS'thereby,delaying,elimination'
p46579
g9
sS'cation-containing,products,such'
p46580
g9
sS'activity,may,reduce'
p46581
g3
sS'a,luciferase,reporter'
p46582
g3
sS'of,brovana,treated'
p46583
g3
sS'doses,as,low'
p46584
g3
sS'behavioral,mechanisms,underlying'
p46585
g3
sS'administration,of,non-potassium'
p46586
g9
sS'adjustments,are,necessary'
p46587
g3
sS'accutane,use,has'
p46588
g9
sS'psoriasis,rheumatoid,arthritis'
p46589
g3
sS'compounds,should,only'
p46590
g9
sS'cmax,respectively,of'
p46591
g3
sS'antisense,gene,cassette'
p46592
g3
sS'p450,d6,the'
p46593
g3
sS'prothrombin,and,partial'
p46594
g3
sS'therapy,a,baseline'
p46595
g9
sS'for,the,concomitant'
p46596
g9
sS'within,less,than'
p46597
g3
sS'be,initiated,and'
p46598
g3
sS'of,this,sequence'
p46599
g3
sS'no,data,are'
p46600
g3
sS'advised,nonetheless,since'
p46601
g3
sS'return,to,normal'
p46602
g3
sS'well,controlled,on'
p46603
g9
sS'without,coadministration,of'
p46604
g3
sS'for,increases,in'
p46605
g9
sS'should,be,discontinued'
p46606
g3
sS'acid,has,been'
p46607
g9
sS'during,therapy,such'
p46608
g3
sS'those,in,whom'
p46609
g9
sS'n,demonstrated,that'
p46610
g3
sS'decreased,clearance,of'
p46611
g9
sS'demonstrated,no,evidence'
p46612
g3
sS'due,to,inhibition'
p46613
g9
sS'or,no,capacity'
p46614
g3
sS'the,body,by'
p46615
g3
sS'exposure,to,but'
p46616
g9
sS'of,by,the'
p46617
g9
sS'administration,of,including'
p46618
g9
sS'demonstrate,any,alterations'
p46619
g3
sS'concentrations,increased,by'
p46620
g9
sS'taking,mao,inhibitors'
p46621
g9
sS'chlorthalidone,and,related'
p46622
g9
sS's,diet,did'
p46623
g3
sS'of,and,coadministration'
p46624
g9
sS'of,adverse,events'
p46625
g3
sS'substrates,for,cyp3a4'
p46626
g3
sS'b,and,may'
p46627
g9
sS'however,the,pharmacodynamic'
p46628
g3
sS'are,expected,with'
p46629
g9
sS'by,this,procedure'
p46630
g3
sS'cmax,cmin,auc'
p46631
g3
sS'juice,should,not'
p46632
g3
sS'subjects,ages,to'
p46633
g9
sS'a,strong,selective'
p46634
g9
sS'ataxia,blurred,vision'
p46635
g3
sS'medicine,you,take'
p46636
g9
sS'no,clinical,studies'
p46637
g3
sS'effect,of,administration'
p46638
g3
sS'experienced,tremor,as'
p46639
g9
sS'symptoms,but,not'
p46640
g3
sS'in,neonates,and'
p46641
g3
sS'following,acetazolamide,azole'
p46642
g9
sS'with,the,nerve'
p46643
g3
sS'reduce,the,morbidity'
p46644
g3
sS'number,of,in'
p46645
g3
sS'following,mptp,administration'
p46646
g3
sS'acute,effect,of'
p46647
g3
sS'directly,affect,renal'
p46648
g3
sS'insufficient,intake,which'
p46649
g3
sS'decrease,sprycel,plasma'
p46650
g3
sS'when,at,an'
p46651
g9
sS'dynamic,and,release'
p46652
g3
sS'abolish,the,effect'
p46653
g9
sS'these,hormones,were'
p46654
g3
sS'advised,when,beginning'
p46655
g9
sS'eliminated,or,are'
p46656
g3
sS'and,other,psychotropic'
p46657
g9
sS'strong,inhibitors,or'
p46658
g3
sS'have,been,extensively'
p46659
g3
sS'failure,where,and'
p46660
g3
sS'antibiotics,rifampin,is'
p46661
g3
sS'not,exceed,micrograms'
p46662
g3
sS'and,diamond,patient'
p46663
g9
sS'variable,elevations,in'
p46664
g3
sS'strong,inhibitors,of'
p46665
g3
sS'it,was,administered'
p46666
g3
sS'etodolac,is,highly'
p46667
g3
sS'treatments,with,an'
p46668
g3
sS'both,the,liver'
p46669
g3
sS'small,gtp-binding,proteins'
p46670
g3
sS'the,measurable,limit'
p46671
g9
sS'also,showed,good'
p46672
g3
sS'in,addition,new'
p46673
g3
sS'nevertheless,clinical,studies'
p46674
g9
sS'terms,of,proportionate'
p46675
g3
sS'concomitantly,serum,levels'
p46676
g9
sS'since,sodium,does'
p46677
g3
sS'last,years,on'
p46678
g3
sS'reversible,nonselective,inhibitor'
p46679
g3
sS'when,this,is'
p46680
g3
sS'tablets,administered,once'
p46681
g3
sS'recommended,to,avoid'
p46682
g9
sS'transcriptase,inhibitors,nnrtis'
p46683
g9
sS'or,within,several'
p46684
g3
sS'direct,treatment,costs'
p46685
g3
sS'the,antiprothrombinemic,effect'
p46686
g3
sS'whereas,the,effects'
p46687
g3
sS'desired,and,or'
p46688
g9
sS'not,nanm,antagonized'
p46689
g9
sS'antagonist,may,precipitate'
p46690
g3
sS'against,positive,and'
p46691
g3
sS'treatment,with,axert'
p46692
g9
sS'experienced,problems,with'
p46693
g3
sS'cell,of,the'
p46694
g3
sS'now,difficult,to'
p46695
g3
sS'and,uptake,of'
p46696
g3
sS'daily,dose,of'
p46697
g9
sS'of,chronically,implanted'
p46698
g3
sS'c,eg,and'
p46699
g9
sS'and,irrational,behavior'
p46700
g9
sS'about,mm,hg'
p46701
g9
sS'increased,at,the'
p46702
g3
sS'cmc-cys,exhibiting,m'
p46703
g3
sS'cases,of,diabetes'
p46704
g3
sS'cmax,auc,and'
p46705
g9
sS'no,influence,in'
p46706
g3
sS'however,there,was'
p46707
g3
sS'which,is,about'
p46708
g3
sS'than,times,higher'
p46709
g9
sS'to,use,folate'
p46710
g3
sS'and,frova,within'
p46711
g9
sS'pharmacokinetic,interactions,between'
p46712
g3
sS'were,killed,at'
p46713
g3
sS'in,the,clinic'
p46714
g3
sS'taking,are,at'
p46715
g3
sS'of,sodium,kg'
p46716
g9
sS'formal,drug,interaction'
p46717
g3
sS'and,discusses,current'
p46718
g3
sS'immunoanalytical,methods,to'
p46719
g3
sS'between,xanthine,and'
p46720
g9
sS'use,of,psychotropic'
p46721
g9
sS'consider,doubling,the'
p46722
g3
sS'vitro,interaction,of'
p46723
g9
sS'more,inhalations,than'
p46724
g3
sS'hepatic,and,the'
p46725
g3
sS'romazicon,is,not'
p46726
g3
sS'levels,and,possible'
p46727
g3
sS'therapy,of,human'
p46728
g3
sS'a,single,agent'
p46729
g3
sS'also,have,potentially'
p46730
g3
sS'with,the,specific'
p46731
g9
sS'male,adult,wistar'
p46732
g3
sS'ether,and,sodium'
p46733
g9
sS'fall,in,blood'
p46734
g3
sS'cardiovascular,effects,can'
p46735
g3
sS'with,ovcon-35,resulted'
p46736
g9
sS'of,it,is'
p46737
g9
sS'p-glycoprotein,mediated,transport'
p46738
g3
sS'number,of,responses'
p46739
g3
sS'imidazole,compounds,like'
p46740
g9
sS'a,mg,neurontin'
p46741
g9
sS'causal,relationship,between'
p46742
g3
sS'decrease,the,effect'
p46743
g9
sS'the,hypertensive,response'
p46744
g9
sS'vitro,and,decrease'
p46745
g3
sS'elevated,levels,of'
p46746
g3
sS'may,be,less'
p46747
g9
sS'distinctive,effects,in'
p46748
g3
sS'to,avoid,concurrent'
p46749
g9
sS'by,intraventricular,and'
p46750
g3
sS'drug,food,interactions'
p46751
g3
sS'package,insert,labeling'
p46752
g3
sS'minor,symptoms,such'
p46753
g3
sS'test,for,hours'
p46754
g9
sS'as,v,and'
p46755
g3
sS'clinical,trials,of'
p46756
g3
sS'if,labetalol,hcl'
p46757
g9
sS'not,meaningfully,alter'
p46758
g3
sS'or,led,to'
p46759
g9
sS'time,caused,by'
p46760
g3
sS'alter,the,renal'
p46761
g9
sS'use,of,ace'
p46762
g3
sS'as,inr,was'
p46763
g9
sS'observed,for,metabolite'
p46764
g3
sS'to,its,enantiomer'
p46765
g3
sS'everolimus,exhibited,dose-proportional'
p46766
g3
sS'bound,such,as'
p46767
g3
sS'disease,and,screening'
p46768
g3
sS'other,oral,with'
p46769
g9
sS'medication,and,mefloquine'
p46770
g3
sS'diuretic,agents,may'
p46771
g9
sS'tikosyn,does,not'
p46772
g3
sS'are,incompatible,with'
p46773
g3
sS'protease,inhibitor,pi'
p46774
g3
sS'r,or,s-'
p46775
g3
sS'lesions,actually,produced'
p46776
g3
sS'new,cases,of'
p46777
g3
sS'lesions,or,dysfunction'
p46778
g3
sS'administered,minutes,after'
p46779
g9
sS'of,side,effects'
p46780
g9
sS'mechanism,under,lying'
p46781
g9
sS'sites,in,the'
p46782
g3
sS'cerubidine,in,a'
p46783
g9
sS'is,limited,therefore'
p46784
g9
sS'ganciclovir,administration,of'
p46785
g9
sS'not,be,changed'
p46786
g3
sS'prostacyclin,which,could'
p46787
g3
sS'from,infectious,complications'
p46788
g3
sS'of,and,acetylsalicylic'
p46789
g9
sS'reported,with,therapeutic'
p46790
g9
sS'from,women,who'
p46791
g3
sS'women,who,use'
p46792
g3
sS'with,other,central'
p46793
g9
sS'treated,with,within'
p46794
g3
sS'plasma,or,factors'
p46795
g3
sS'pharmacokinetics,of,r-warfarin'
p46796
g3
sS'ht1,agonists,have'
p46797
g9
sS'was,washed,out'
p46798
g3
sS'following,enzymes,in'
p46799
g3
sS'an,additive,or'
p46800
g9
sS'cause,increased,free'
p46801
g3
sS'to,be,unlikely'
p46802
g3
sS'may,decrease,thyroidal'
p46803
g9
sS'cyp2e1,or,uridine'
p46804
g3
sS'is,little,published'
p46805
g3
sS'clolar,with,other'
p46806
g3
sS'volunteers,the,concomitant'
p46807
g9
sS'tended,to,experience'
p46808
g3
sS'time,or,clotting'
p46809
g3
sS'effect,and,in'
p46810
g3
sS'creatinine,and,because'
p46811
g9
sS'significant,difference,was'
p46812
g3
sS'section,were,obtained'
p46813
g3
sS'c,a,increase'
p46814
g9
sS'increase,plasma,concentration'
p46815
g9
sS'orasone,others,medrol'
p46816
g3
sS'a,tool,for'
p46817
g3
sS'lower,relative,absorption'
p46818
g3
sS'by,the,lack'
p46819
g3
sS'suppression,of,the'
p46820
g9
sS'is,no,information'
p46821
g3
sS'therapy,or,daily'
p46822
g3
sS'role,of,cyp2d6'
p46823
g3
sS'and,cardiac,dysrhythmias'
p46824
g9
sS'little,published,information'
p46825
g3
sS'or,might,have'
p46826
g3
sS'terminate,treatment,with'
p46827
g3
sS'no,chemical,or'
p46828
g3
sS'n,and,volunteers'
p46829
g9
sS'discontinuing,or,changing'
p46830
g9
sS'nicotinic,acid,calcium'
p46831
g3
sS'have,been,exploited'
p46832
g3
sS'were,observed,but'
p46833
g3
sS'single,pancreatic,acinar'
p46834
g3
sS'sedatives,hypnotics,contraindicated'
p46835
g3
sS'interact,with,that'
p46836
g3
sS'marked,and,persistent'
p46837
g9
sS'and,against,cryptosporidium'
p46838
g3
sS'with,caution,especially'
p46839
g3
sS'as,most,excretion'
p46840
g3
sS'antitumour,activity,of'
p46841
g9
sS'interfere,with,clinical'
p46842
g3
sS'argatroban,with,thrombolytic'
p46843
g3
sS'whenever,an,agent'
p46844
g3
sS'concentrations,and,pharmacologic'
p46845
g3
sS'male,fertility,have'
p46846
g3
sS'in,excretion,of'
p46847
g9
sS'affect,gastrointestinal,absorption'
p46848
g9
sS'wait,about,minutes'
p46849
g9
sS'and,creatinine,an'
p46850
g9
sS'inducers,iodinated,cholestographic'
p46851
g3
sS'of,certain,intravenously'
p46852
g9
sS'multicenter,randomized,double-blind'
p46853
g3
sS'sensitivity,of,rat'
p46854
g3
sS'channel,blocker,on'
p46855
g3
sS'in,exposure,and'
p46856
g3
sS'half-life,of,decreased'
p46857
g9
sS'increase,in,serum'
p46858
g9
sS'cyp2d6,and,have'
p46859
g3
sS'balance,were,only'
p46860
g3
sS'p450,isoenzymes,cyp2c8'
p46861
g3
sS'relaxants,and,may'
p46862
g9
sS'significantly,reduced,and'
p46863
g9
sS'a,release,of'
p46864
g3
sS'the,following,specific'
p46865
g3
sS'of,the,substrate'
p46866
g3
sS'levels,the,adverse'
p46867
g3
sS'anafranil,by,other'
p46868
g3
sS'of,fibrinolysis,is'
p46869
g3
sS'sedative,effects,and'
p46870
g9
sS'of,therapy,allow'
p46871
g3
sS'taking,should,be'
p46872
g3
sS'analyzed,for,creatinine'
p46873
g3
sS'relaxants,and,mac'
p46874
g9
sS'coadministration,of,relative'
p46875
g9
sS'reduction,in,dosage'
p46876
g9
sS'water,for,days'
p46877
g3
sS'from,a,cns'
p46878
g3
sS'of,the,biological'
p46879
g3
sS'the,possibility,nitric'
p46880
g9
sS'naloxone-sensitive,endorphinergic,system'
p46881
g3
sS'hepatic,metabolism,of'
p46882
g9
sS'derivatives,antimycobacterial,agents'
p46883
g9
sS'potential,danger,of'
p46884
g9
sS'containing,or,or'
p46885
g9
sS'is,still,advisable'
p46886
g9
sS'significant,teratogenic,and'
p46887
g3
sS'three,different,concentrations'
p46888
g3
sS'and,fenofibric,acid'
p46889
g3
sS'these,subjects,increased'
p46890
g9
sS'that,the,pharmacokinetics'
p46891
g3
sS'the,other,which'
p46892
g3
sS'the,continuing,surveillance'
p46893
g3
sS'and,of,the'
p46894
g9
sS'pointer,dogs,have'
p46895
g3
sS'absorption,as,well'
p46896
g3
sS'hepatotoxicity,are,suggested'
p46897
g9
sS'severity,of,chloride-induced'
p46898
g9
sS'digitalized,patient,slow'
p46899
g3
sS'as,decreasing,its'
p46900
g9
sS'resulted,in,reversible'
p46901
g9
sS'current,information,on'
p46902
g3
sS'overly,cautious,and'
p46903
g3
sS'receiving,the,plasma'
p46904
g9
sS'are,potentiated,by'
p46905
g9
sS'or,due,to'
p46906
g3
sS'increased,sedation,if'
p46907
g9
sS'dose,of,with'
p46908
g9
sS'an,eg,valproic'
p46909
g9
sS'as,slowly,dissolving'
p46910
g9
sS'an,initial,dose'
p46911
g3
sS'through,inhibition,of'
p46912
g9
sS'max,and,auc'
p46913
g3
sS'formulation,of,increased'
p46914
g9
sS'of,action,it'
p46915
g9
sS'tubular,secretion,and'
p46916
g9
sS'meclofenamate,sodium,does'
p46917
g3
sS'or,stopped,to'
p46918
g9
sS'since,the,french'
p46919
g3
sS'total,clearance,of'
p46920
g9
sS'have,demonstrated,the'
p46921
g3
sS'as,anorexia,tachypnea'
p46922
g9
sS'from,normal,subjects'
p46923
g3
sS'led,to,an'
p46924
g9
sS'previous,studies,have'
p46925
g9
sS'exjade,with,has'
p46926
g3
sS'by,pretreatment,with'
p46927
g9
sS'since,may,reduce'
p46928
g9
sS'tremor,hemiballismus,hyperreflexia'
p46929
g3
sS'clinitest,benedicts,solution'
p46930
g3
sS'mouth,or,by'
p46931
g3
sS'of,ames,company'
p46932
g3
sS'and,some,pronestyl'
p46933
g9
sS'monitoring,is,not'
p46934
g3
sS'is,recommended,during'
p46935
g9
sS'mesylate,injection,usp'
p46936
g9
sS'of,in,an'
p46937
g9
sS'interaction,with,food'
p46938
g3
sS'circumstances,as,prophylaxis'
p46939
g3
sS'a,member,have'
p46940
g9
sS'interaction,between,toradoliv'
p46941
g3
sS'which,can,follow'
p46942
g9
sS'both,ethynyl,and'
p46943
g3
sS'were,observed,hours'
p46944
g3
sS'the-curve,auc,hours'
p46945
g3
sS'excessive,ingestion,should'
p46946
g3
sS'for,subsequent,courses'
p46947
g3
sS'clearance,of,zebeta'
p46948
g9
sS'no,dose,adjustments'
p46949
g3
sS'daily,dose,is'
p46950
g9
sS'cyp3a4,patients,who'
p46951
g3
sS'or,copd,symptoms'
p46952
g3
sS'acetaminophen,and,valproic'
p46953
g3
sS'whether,injection,of'
p46954
g3
sS'of,zebeta,may'
p46955
g9
sS'fat,enlargement,buffalo'
p46956
g3
sS'drugs,increased,side'
p46957
g3
sS'parietal,cell,from'
p46958
g3
sS'have,significant,interactions'
p46959
g3
sS'cream,and,other'
p46960
g3
sS'may,be,helpful'
p46961
g3
sS'initial,or,prolonged'
p46962
g3
sS'discontinuation,of,in'
p46963
g9
sS'inflammatory,disorders,has'
p46964
g9
sS'the,chance,of'
p46965
g9
sS'likely,to,occur'
p46966
g3
sS'occur,when,the'
p46967
g9
sS'additional,reductions,in'
p46968
g9
sS'in,patients,taking'
p46969
g9
sS'methadone,dose,was'
p46970
g3
sS'contrast,in,isolated'
p46971
g3
sS'other,day,dosing'
p46972
g3
sS'are,necessary,during'
p46973
g3
sS'methotrexate-related,toxicity,when'
p46974
g9
sS'subsequent,to,initiation'
p46975
g3
sS'both,sensory,and'
p46976
g9
sS'of,although,overall'
p46977
g9
sS'to,insure,that'
p46978
g9
sS'pharmacodynamic,interactions,with'
p46979
g9
sS'inhibitors,maoi,maoi'
p46980
g9
sS'exposures,of,fully'
p46981
g3
sS'alter,the,absorption'
p46982
g3
sS'preliminary,data,suggest'
p46983
g3
sS'by,known,to'
p46984
g3
sS'p450-based,metabolic,interactions'
p46985
g3
sS'drawn,up,and'
p46986
g3
sS'receiving,hydrochloride,is'
p46987
g9
sS'case,that,you'
p46988
g9
sS'concomitantly,with,has'
p46989
g9
sS'by,consulting,the'
p46990
g3
sS'other,dialysis,solutions'
p46991
g3
sS'have,been,occasional'
p46992
g9
sS'they,bring,into'
p46993
g3
sS'and,agents,and'
p46994
g3
sS'which,inhibit,cyp2d6'
p46995
g3
sS'of,escherichia,coli'
p46996
g3
sS'cerebral,memory,systems'
p46997
g3
sS'to,treatpatients,co-infected'
p46998
g3
sS'hypericum,perforatum,warning'
p46999
g3
sS'concentrations,of,do'
p47000
g3
sS'impactor,for,characterization'
p47001
g3
sS'hormone,and,levels'
p47002
g3
sS'possible,increased,responsiveness'
p47003
g3
sS'and,inhibited,to'
p47004
g3
sS'of,felbatol,to'
p47005
g9
sS'inr,days,after'
p47006
g9
sS'oral,agents,receiving'
p47007
g9
sS'of,palythoa,tuberculosa'
p47008
g3
sS'serious,adverse,events'
p47009
g3
sS'negligible,interactions,due'
p47010
g3
sS'and,kytril,have'
p47011
g3
sS'like,other,nsaids'
p47012
g9
sS'metabolized,by,cyp'
p47013
g3
sS'and,or,inhibitors'
p47014
g9
sS'antidepressant,or,the'
p47015
g3
sS'failure,during,which'
p47016
g3
sS'prothrombin,response,by'
p47017
g9
sS'significantly,affected,by'
p47018
g3
sS'nevertheless,associated,in'
p47019
g3
sS'or,altering,their'
p47020
g3
sS'are,not,readily'
p47021
g3
sS'regimens,and,superiority'
p47022
g3
sS'increases,in,circulating'
p47023
g3
sS'stabilized,on,maintenance'
p47024
g3
sS'increased,or,decreased'
p47025
g3
sS'tam,which,also'
p47026
g3
sS'reaction,to,a'
p47027
g3
sS'that,mixing,novolog'
p47028
g3
sS'use,of,mao'
p47029
g9
sS'auc0-24hr,in,patients'
p47030
g9
sS'a,partially,impaired'
p47031
g3
sS'of,patients,in'
p47032
g3
sS'isoenzyme,including,many'
p47033
g3
sS'of,the,use'
p47034
g3
sS'unclear,patients,on'
p47035
g3
sS'scores,on,the'
p47036
g9
sS'uptake,may,occur'
p47037
g9
sS'range,of,doses'
p47038
g3
sS'in,the,medium'
p47039
g3
sS'ache,activity,appeared'
p47040
g9
sS'effects,of,may'
p47041
g9
sS'function,seen,with'
p47042
g3
sS'to,hours,or'
p47043
g9
sS'occur,in,patients'
p47044
g3
sS'in,previously,stable'
p47045
g9
sS'by,cyp2c9,and'
p47046
g3
sS'is,impaired,in'
p47047
g9
sS'r-warfarin,and,s-warfarin'
p47048
g9
sS'individuals,were,treated'
p47049
g3
sS'daily,taken,in'
p47050
g3
sS'in,addition,that'
p47051
g9
sS'of,patients,is'
p47052
g3
sS'of,the,treatments'
p47053
g3
sS'in,study,patients'
p47054
g3
sS'heart,failure,as'
p47055
g3
sS'known,metabolite,of'
p47056
g3
sS'this,interaction,probably'
p47057
g9
sS'worsening,asthma,decreased'
p47058
g3
sS'subjects,who,were'
p47059
g3
sS'be,prolonged,by'
p47060
g9
sS'conducted,in,vitro'
p47061
g3
sS'updated,review,of'
p47062
g3
sS'produced,by,high'
p47063
g9
sS'disorder,attention,should'
p47064
g3
sS'of,and,resulted'
p47065
g9
sS'in,another,female'
p47066
g3
sS'bone,and,joint'
p47067
g9
sS'highintersubject,variability,however'
p47068
g3
sS'significantly,decreased,in'
p47069
g3
sS'changing,from,intravenous'
p47070
g3
sS'inhibitors,of,cyp3a4-eplerenone'
p47071
g3
sS'warfarin,when,healthy'
p47072
g3
sS'a,single,subject'
p47073
g9
sS'other,potent,cyp3a4'
p47074
g9
sS'dosage,adjustment,or'
p47075
g3
sS'avoided,also,see'
p47076
g9
sS'decreased,auc,by'
p47077
g9
sS'with,and,concurrently'
p47078
g9
sS'decrease,mean,c'
p47079
g3
sS'exceed,a,single'
p47080
g9
sS'teratogenic,effects,were'
p47081
g3
sS'information,was,obtained'
p47082
g3
sS'administration,of,particularly'
p47083
g9
sS'that,a,potent'
p47084
g9
sS'adults,were,conducted'
p47085
g3
sS'still,other,pathways'
p47086
g3
sS'dosage,adjustment,of'
p47087
g3
sS'interfere,with,your'
p47088
g3
sS'atracurium,infusion,was'
p47089
g3
sS'heart,failure,who'
p47090
g3
sS'used,concomitantly,indicate'
p47091
g9
sS'vitro,studies,demonstrated'
p47092
g3
sS'with,modest,increases'
p47093
g9
sS'co-administered,with,multiple'
p47094
g9
sS'lying,the,interference'
p47095
g9
sS'ill,and,to'
p47096
g3
sS'tc,had,no'
p47097
g3
sS'and,cardiac,glycosides'
p47098
g9
sS'administered,to,hypertensive'
p47099
g3
sS'kinetics,and,renal'
p47100
g9
sS'slight,decreases,in'
p47101
g9
sS'judged,from,the'
p47102
g3
sS'cyp3a4,substrate,response'
p47103
g3
sS'to,a,variety'
p47104
g3
sS'maois,selegiline,hydrochloride'
p47105
g9
sS'prostate,epithelium,by'
p47106
g9
sS'increase,when,patients'
p47107
g9
sS'taking,celebrex,did'
p47108
g3
sS'interfere,with,platelet-aggregation'
p47109
g9
sS'labetalol,hcl,has'
p47110
g3
sS'because,is,coadministered'
p47111
g3
sS'test,for,urinary'
p47112
g3
sS'protein,synthesis,within'
p47113
g3
sS'the,normal,variability'
p47114
g9
sS'of,microtubules,on'
p47115
g3
sS'reactions,related,to'
p47116
g3
sS'play,a,critical'
p47117
g3
sS'effect,of,is'
p47118
g9
sS'when,these,products'
p47119
g3
sS'application,of,offers'
p47120
g3
sS'the,microvascular,complications'
p47121
g3
sS'mg,experienced,a'
p47122
g9
sS'interferes,with,all'
p47123
g3
sS'ocs,macrolide,antibiotics'
p47124
g3
sS'only,in,the'
p47125
g9
sS'is,no,experience'
p47126
g3
sS'test,interaction,captopril'
p47127
g3
sS'auc,higher,in'
p47128
g9
sS'possible,cns,and'
p47129
g3
sS'used,in,any'
p47130
g9
sS'of,the,disulfiram-ethanol'
p47131
g3
sS'and,inn,when'
p47132
g3
sS'fixed,g,m2'
p47133
g3
sS'topical,glaucoma,or'
p47134
g9
sS'action,of,on'
p47135
g9
sS'with,coly-mycin,m'
p47136
g3
sS'action,of,of'
p47137
g9
sS'primary,cns,effect'
p47138
g9
sS'prescriber,when,the'
p47139
g3
sS'aluminum-,or,magnesium-containing'
p47140
g9
sS'one,hour,before'
p47141
g3
sS'and,they,do'
p47142
g3
sS'can,enhance,toxicity'
p47143
g3
sS'about,fold,prolongation'
p47144
g3
sS'virus-positive,patients,by'
p47145
g3
sS'hctz,mg,qd'
p47146
g3
sS'not,reached,whereas'
p47147
g3
sS'intravenous,injection,of'
p47148
g9
sS'clearance,of,fell'
p47149
g9
sS'effects,of,these'
p47150
g3
sS'to,cardiac,patients'
p47151
g3
sS'induced,by,a'
p47152
g3
sS'lessened,active,metabolite'
p47153
g3
sS'far,greater,extent'
p47154
g3
sS'suspension,results,in'
p47155
g9
sS'other,b-lactam,renal'
p47156
g9
sS'elapse,between,discontinuation'
p47157
g9
sS'or,ml,twice'
p47158
g9
sS'factor,bacterial,mutation'
p47159
g3
sS'day,of,were'
p47160
g9
sS'been,identified,that'
p47161
g3
sS'with,other,which'
p47162
g3
sS'when,and,other'
p47163
g9
sS'all,that,inhibit'
p47164
g3
sS'into,consideration,in'
p47165
g3
sS'crossover,study,of'
p47166
g3
sS'eggs,was,inhibited'
p47167
g3
sS'specifically,due,to'
p47168
g3
sS'supersensitivity,to,the'
p47169
g9
sS'other,antineoplastic,agents'
p47170
g9
sS'several-,fold,increases'
p47171
g3
sS'test,interaction,studies'
p47172
g3
sS'administration,of,doubled'
p47173
g9
sS'will,be,decreased'
p47174
g3
sS'between,doses,may'
p47175
g9
sS'with,the,antidepressant'
p47176
g9
sS'by,increased,exposure'
p47177
g9
sS'day,racemic,for'
p47178
g3
sS'free,concentrations,of'
p47179
g3
sS'the,occurrence,has'
p47180
g9
sS'with,alfenta,can'
p47181
g9
sS'be,performed,on'
p47182
g3
sS'repeated,exposure,in'
p47183
g3
sS'mice,on,the'
p47184
g3
sS'co-administration,of,resulted'
p47185
g9
sS'serum,concentrations,increase'
p47186
g9
sS'in,the,kd'
p47187
g3
sS'with,continuation,of'
p47188
g3
sS'was,shown,on'
p47189
g3
sS'clinically,significant,changes'
p47190
g3
sS'provide,therapeutic,levels'
p47191
g3
sS'therapeutic,efficacy,of'
p47192
g9
sS'glycosides,may,be'
p47193
g3
sS'no,apparent,pharmacokinetic'
p47194
g3
sS'exercised,when,indocin'
p47195
g9
sS'with,as,this'
p47196
g3
sS'statins,co-administration,of'
p47197
g9
sS'another,botulinum,prior'
p47198
g9
sS'for,some,strains'
p47199
g3
sS'examples,include,the'
p47200
g3
sS'of,pregnancy,rates'
p47201
g3
sS'shown,that,antagonized'
p47202
g9
sS'while,left,ventricular'
p47203
g3
sS'one,animal,in'
p47204
g3
sS'substrate,and,its'
p47205
g9
sS'this,medicine,with'
p47206
g3
sS'occurred,when,lotensin'
p47207
g3
sS'of,a,facilitates'
p47208
g3
sS'of,incubation,in'
p47209
g3
sS'but,has,no'
p47210
g3
sS'the,urine,of'
p47211
g3
sS'modify,the,effect'
p47212
g3
sS'diabetics,with,microalbuminuria'
p47213
g9
sS'the,presence,or'
p47214
g3
sS'unless,the,potential'
p47215
g9
sS'human,plasma,indicate'
p47216
g3
sS'a,separate,study'
p47217
g3
sS'repeated,dosing,or'
p47218
g3
sS'acetate,l-histidine,was'
p47219
g9
sS'the,presence,of'
p47220
g3
sS'other,aeds,and'
p47221
g3
sS'amicar,transient,peak'
p47222
g3
sS'and,uroxatral,should'
p47223
g9
sS'following,oral,and'
p47224
g3
sS'considered,when,rebif'
p47225
g3
sS'renal,elimination,of'
p47226
g3
sS'interferes,with,clinical'
p47227
g3
sS'urine,may,occur'
p47228
g3
sS'dysfunction,associated,with'
p47229
g3
sS'factors,when,administered'
p47230
g3
sS'available,hmgcoa,reductase'
p47231
g3
sS'allergens,may,have'
p47232
g3
sS'n-cetyl,gallate,also'
p47233
g3
sS'ames,n-multistix,sg'
p47234
g3
sS'in,tmax,of'
p47235
g3
sS'coumarin-type,the,physician'
p47236
g9
sS'studies,with,normal'
p47237
g3
sS'protein-bound,pbi,levels'
p47238
g3
sS'in,placental,weight'
p47239
g3
sS'or,stimulus,response'
p47240
g3
sS'over,three,hours'
p47241
g3
sS'that,use,of'
p47242
g3
sS'of,adrenergic,agonists'
p47243
g9
sS'm,i,mg'
p47244
g9
sS'as,with,some'
p47245
g9
sS'surface,area,bsa'
p47246
g3
sS'a,tnf,antagonist'
p47247
g9
sS'in,a,min'
p47248
g9
sS'treating,patients,receiving'
p47249
g3
sS'pregnancy,occurs,in'
p47250
g3
sS'increases,the,auc'
p47251
g9
sS'testing,of,newborns'
p47252
g3
sS'on,low-dose,combination'
p47253
g3
sS'administered,safely,with'
p47254
g3
sS'cell,activation,and'
p47255
g3
sS'cause,renal,impairment'
p47256
g9
sS'are,no,known'
p47257
g3
sS'significantly,greater,in'
p47258
g3
sS'substances,affect,glucose'
p47259
g3
sS'on,the,activity'
p47260
g3
sS'distribution,of,decreased'
p47261
g9
sS'contain,a,lectin'
p47262
g3
sS'cimetidine,and,may'
p47263
g9
sS'flavoridin,alone,was'
p47264
g9
sS'enzyme,induction,potential'
p47265
g3
sS'if,plasma,levels'
p47266
g3
sS'as,noted,below'
p47267
g3
sS'to,be,consistent'
p47268
g3
sS'exposure,or,renal'
p47269
g3
sS'nitrous,oxide,to'
p47270
g9
sS'these,imidazole,and'
p47271
g3
sS'increase,with,the'
p47272
g3
sS'medicines,during,the'
p47273
g9
sS'theophylline-induced,anxiogenic,effects'
p47274
g9
sS'has,a,well-defined'
p47275
g3
sS'on,the,literature'
p47276
g3
sS'patients,receiving,the'
p47277
g3
sS'other,and,antiparkinsonian'
p47278
g9
sS'to,study,the'
p47279
g3
sS'brain,was,longer'
p47280
g9
sS'and,the,immune'
p47281
g3
sS'cyp1a2,inhibitors,including'
p47282
g9
sS'with,other,b-lactam'
p47283
g9
sS'expensive,or,to'
p47284
g3
sS'eg,valproic,acid'
p47285
g9
sS'on,known,metabolic'
p47286
g3
sS'impaired,fertility,or'
p47287
g3
sS'respiration,was,unaffected'
p47288
g3
sS'significantly,altered,by'
p47289
g3
sS'with,available,data'
p47290
g9
sS'clinical,pharmacology,studies'
p47291
g3
sS'anaphylactic,reaction,to'
p47292
g3
sS'and,the,parenteral'
p47293
g3
sS'rapidly,growing,class'
p47294
g3
sS'further,in,a'
p47295
g3
sS'weight,and,subcutaneous'
p47296
g3
sS'antiacid,didanosine,fluconazole'
p47297
g3
sS'with,either,mg'
p47298
g3
sS'through,the,cytochrome'
p47299
g3
sS'action,of,and'
p47300
g9
sS'when,an,oral'
p47301
g9
sS'studied,in,cat'
p47302
g3
sS'are,anticipated,due'
p47303
g3
sS'nitrates,the,concomitant'
p47304
g3
sS'of,or,the'
p47305
g3
sS'period,in,patients'
p47306
g9
sS'studies,in,humans'
p47307
g3
sS'therapy,is,prolonged'
p47308
g3
sS'in,vivo,data'
p47309
g9
sS'binding,of,by'
p47310
g9
sS'an,elevation,of'
p47311
g9
sS'antinociceptive,effect,of'
p47312
g9
sS'affect,bleeding,time'
p47313
g3
sS'to,years,old'
p47314
g3
sS'four,doses,did'
p47315
g3
sS'and,ng,ml'
p47316
g9
sS'given,concurrently,and'
p47317
g3
sS'when,the,orally'
p47318
g9
sS'be,more,susceptible'
p47319
g3
sS'the,glucosylation,of'
p47320
g3
sS'medicine,blood,thinners'
p47321
g9
sS'or,the,mean'
p47322
g3
sS'permeability,of,the'
p47323
g3
sS'function,should,be'
p47324
g9
sS'containing,a,vanh'
p47325
g3
sS'amprenavir,is,metabolized'
p47326
g3
sS'exposure,to,substances'
p47327
g3
sS'these,enzymes,would'
p47328
g3
sS'dose,that,maximally'
p47329
g3
sS'by,inhibition,of'
p47330
g3
sS'from,the,atac'
p47331
g9
sS'any,great,extent'
p47332
g3
sS'adjuvant,treatment,of'
p47333
g9
sS'expected,with,whose'
p47334
g3
sS'with,such,medications'
p47335
g9
sS'of,a,potent'
p47336
g3
sS'behavioral,changes,induced'
p47337
g3
sS'of,welchol,with'
p47338
g3
sS'normal,healthy,subjects'
p47339
g3
sS'or,symptoms,of'
p47340
g9
sS'patient,currently,receiving'
p47341
g9
sS'wort,based,on'
p47342
g3
sS'not,cause,significant'
p47343
g3
sS'nursing,or,discontinue'
p47344
g3
sS'activity,and,increase'
p47345
g9
sS'the,signs,of'
p47346
g3
sS'free,t4,concentration'
p47347
g3
sS'to,of,type'
p47348
g3
sS'of,bioavailability,of'
p47349
g3
sS'formulations,containing,divalent'
p47350
g9
sS'and,possibly,other'
p47351
g9
sS'concentration,mic,of'
p47352
g3
sS'dose,of,when'
p47353
g3
sS'eg,and,is'
p47354
g9
sS'diabetic,patients,and'
p47355
g9
sS'equetrotm,may,reduce'
p47356
g3
sS'fixed-ratio,fi,fr'
p47357
g3
sS'concurrently,with,phenurone'
p47358
g9
sS'only,re-results,in'
p47359
g3
sS'trough,plasma,levels'
p47360
g9
sS'in,inhibiting,yeast'
p47361
g3
sS'recommended,weekly,human'
p47362
g3
sS'of,approximately,msec'
p47363
g9
sS'or,its,closely'
p47364
g3
sS'that,a,single'
p47365
g3
sS'pcp-induced,behavioral,changes'
p47366
g3
sS'of,prostigmin,may'
p47367
g3
sS'fever,renal,insufficiency'
p47368
g9
sS'the,nonpredisposed,strain'
p47369
g3
sS'the,obstetrical,cardiological'
p47370
g3
sS'significant,sustained,elevation'
p47371
g9
sS'like,mc,probably'
p47372
g3
sS'on,high,threshold'
p47373
g3
sS'relapses,for,periods'
p47374
g3
sS'started,or,stopped'
p47375
g9
sS'importance,of,a'
p47376
g3
sS'sustiva,mg,all'
p47377
g3
sS'and,l-ccg,was'
p47378
g3
sS'intermittent,hemodialysis,until'
p47379
g3
sS'cyclosporine,diclofenac,like'
p47380
g3
sS'inducing,activity,should'
p47381
g3
sS'both,a,potent'
p47382
g3
sS'of,the,tysabri'
p47383
g3
sS'ambulatory,patients,the'
p47384
g3
sS'patients,in,three'
p47385
g3
sS'for,the,secretion'
p47386
g3
sS'presence,of,while'
p47387
g3
sS'studies,in,mice'
p47388
g3
sS'no,experience,with'
p47389
g3
sS'induce,the,major'
p47390
g3
sS'the,beneficial,effects'
p47391
g9
sS'dose,should,not'
p47392
g9
sS'interval,decrease,mean'
p47393
g3
sS'vanh,promoter-vana,antisense'
p47394
g3
sS'on,severe,dietary'
p47395
g9
sS'phosphorylated,which,may'
p47396
g9
sS'means,of,reducing'
p47397
g3
sS'to,sensitize,the'
p47398
g9
sS'and,that,these'
p47399
g3
sS'of,dogs,deprived'
p47400
g3
sS'to,measure,over'
p47401
g3
sS'given,sc,injections'
p47402
g3
sS'acid,nsaids,and'
p47403
g3
sS'fibrulation,and,torsades'
p47404
g9
sS'glucose,was,determined'
p47405
g3
sS'interaction,has,not'
p47406
g9
sS'two,are,given'
p47407
g3
sS'agents,anesthetics,general'
p47408
g9
sS'duloxetine,with,other'
p47409
g9
sS'model,the,joint'
p47410
g3
sS'acidifying,agents,used'
p47411
g9
sS'different,and,neither'
p47412
g3
sS'possible,when,administered'
p47413
g3
sS'degree,of,enhancement'
p47414
g3
sS'by,cytochrome,p450iid6'
p47415
g3
sS'receiving,accutane,have'
p47416
g3
sS'a,cause,and'
p47417
g9
sS'vioxx,is,not'
p47418
g3
sS'of,cyp3a4,mg'
p47419
g9
sS'aldosterone,excretion,and'
p47420
g3
sS'pressor,activity,of'
p47421
g3
sS'monitored,carefully,and'
p47422
g9
sS'beta-adrenoceptor,blocking,agents'
p47423
g9
sS'additive,cns,depressant'
p47424
g9
sS'demonstrated,efficacy,in'
p47425
g3
sS'lower,than,expected'
p47426
g3
sS'conditions,to,normal'
p47427
g3
sS'cause,respiratory,depression'
p47428
g9
sS'decrease,elimination,and'
p47429
g9
sS'was,maintained,at'
p47430
g3
sS'pharmacist,of,all'
p47431
g3
sS'with,reduced,requirements'
p47432
g3
sS'five,days,of'
p47433
g3
sS'in,inr,or'
p47434
g3
sS'do,not,outweigh'
p47435
g9
sS'arteries,from,both'
p47436
g3
sS'host,defense,may'
p47437
g3
sS'neuronal,reuptake,of'
p47438
g3
sS'of,with,primarily'
p47439
g3
sS'ganglion,blocking,compounds'
p47440
g3
sS'interactions,there,may'
p47441
g3
sS'with,copper,sulfate'
p47442
g3
sS'type,c,and'
p47443
g9
sS'of,l-phenylalanine,and'
p47444
g9
sS'analogues,should,be'
p47445
g3
sS'measured,at,steady'
p47446
g3
sS'but,not,mc'
p47447
g3
sS'differ,from,control'
p47448
g3
sS'histamine-,or,camp-stimulated'
p47449
g9
sS'theoretically,the,anion'
p47450
g3
sS'additive,central,nervous'
p47451
g9
sS'patients,receiving,tricyclic'
p47452
g9
sS'morning,and,evening'
p47453
g3
sS'following,cyclosporine,a'
p47454
g3
sS'have,generally,not'
p47455
g3
sS'd3,oh,d3'
p47456
g3
sS'or,concomitant,strong'
p47457
g3
sS'color,is,due'
p47458
g9
sS'function,and,in'
p47459
g9
sS'receiving,multiple,doses'
p47460
g9
sS'of,myalgia,and'
p47461
g9
sS'and,mhd,did'
p47462
g3
sS'on,inositol,trisphosphate'
p47463
g3
sS'expected,based,on'
p47464
g3
sS'determinations,are,important'
p47465
g3
sS'and,therefore,potentiate'
p47466
g3
sS'trials,the,safety'
p47467
g3
sS'with,with,and'
p47468
g9
sS'studied,and,is'
p47469
g3
sS'cardiovascular,in,patients'
p47470
g3
sS'combination,of,arimidex'
p47471
g3
sS'adjustment,of,sensipar'
p47472
g9
sS'effects,of,use'
p47473
g3
sS'serum,plasma,proteins'
p47474
g3
sS'exacerbate,rebound,hypertension'
p47475
g9
sS'to,measure,glucose'
p47476
g3
sS'observed,that,mptp'
p47477
g9
sS'flexible,and,involve'
p47478
g3
sS'do,not,contain'
p47479
g9
sS'vs,and,bone'
p47480
g9
sS'were,increased,over'
p47481
g9
sS'or,and,possibly'
p47482
g9
sS'the,minimum,effective'
p47483
g3
sS'inhibits,the,biotransformation'
p47484
g9
sS'non-opioid,agonist,effects'
p47485
g3
sS'therefore,concomitant,use'
p47486
g9
sS'antagonized,by,such'
p47487
g9
sS'reports,of,rhabdomyolysis'
p47488
g3
sS'because,of,potential'
p47489
g9
sS'that,and,had'
p47490
g3
sS'or,the,therapeutic'
p47491
g3
sS'liver,microsomes,showed'
p47492
g3
sS'this,secretory,diarrhea'
p47493
g3
sS'consequences,following,methyl-4'
p47494
g3
sS'increase,in,qtc'
p47495
g9
sS'net,decrease,in'
p47496
g9
sS'of,hepatitis,has'
p47497
g9
sS'any,unexpected,adverse'
p47498
g3
sS'however,when,any'
p47499
g9
sS'agonists,hepatic,enzyme'
p47500
g3
sS'directed,and,proquin'
p47501
g3
sS'decreased,probably,related'
p47502
g3
sS'the,bactercidal,effect'
p47503
g9
sS'dose,and,type'
p47504
g3
sS'combination,of,conjugated'
p47505
g3
sS'discusses,the,actions'
p47506
g3
sS'that,these,compounds'
p47507
g3
sS'is,particularly,susceptible'
p47508
g3
sS'volunteers,developed,rash'
p47509
g9
sS'use,of,supplements'
p47510
g9
sS'amines,but,not'
p47511
g3
sS'on,day,when'
p47512
g9
sS'the,first,double-blind'
p47513
g3
sS'may,occur,with'
p47514
g3
sS'for,urinary,tract'
p47515
g3
sS'or,more,pharmacologic'
p47516
g3
sS'periods,of,time'
p47517
g3
sS'sensipar,sensipar,is'
p47518
g3
sS'preparations,or,beta-adrenergic'
p47519
g3
sS'complete,loss,of'
p47520
g3
sS'hypokalemia,that,may'
p47521
g9
sS'nervous,system,depressant'
p47522
g3
sS'did,not,influence'
p47523
g3
sS'mg,has,been'
p47524
g3
sS'there,is,insufficient'
p47525
g9
sS'diminished,response,to'
p47526
g9
sS'that,maximally,suppresses'
p47527
g3
sS'wheal,and,flare'
p47528
g3
sS'reduced,the,amplitude'
p47529
g3
sS'have,been,established'
p47530
g3
sS'by,tromethamine,control'
p47531
g9
sS'occur,up,to'
p47532
g9
sS'are,not,known'
p47533
g3
sS'antacids,or,h'
p47534
g9
sS'effects,of,vardenafil'
p47535
g3
sS'elevations,of,concentrations'
p47536
g9
sS'that,are,specific'
p47537
g3
sS'both,minimal,inhibitory'
p47538
g3
sS'steroid,hormones,such'
p47539
g9
sS'of,hydroxide,with'
p47540
g9
sS'or,of,the'
p47541
g3
sS'by,cytochrome,p-450'
p47542
g9
sS'hours,subsequent,to'
p47543
g3
sS'therefore,the,combined'
p47544
g9
sS'that,hippocampal,lesions'
p47545
g3
sS'investigated,against,cercariae'
p47546
g3
sS'prolonged,administration,twice'
p47547
g3
sS'adverse,effects,especially'
p47548
g3
sS'combination,with,avastin'
p47549
g3
sS'was,coadministered,on'
p47550
g9
sS'and,only,if'
p47551
g3
sS'alt,and,total'
p47552
g3
sS'bioavailabillty,and,may'
p47553
g3
sS'depletion,which,becomes'
p47554
g3
sS'and,coadministration,of'
p47555
g9
sS'frequently,if,prinivil'
p47556
g9
sS'fibrillation,and,cardiovascular'
p47557
g3
sS'control,inflammation,associated'
p47558
g9
sS'cerebyx,with,other'
p47559
g3
sS'necessary,to,maintain'
p47560
g9
sS'be,made,of'
p47561
g9
sS'taxol,at,a'
p47562
g3
sS'of,dosage,is'
p47563
g3
sS'be,made,on'
p47564
g3
sS'as,cyp3a4,inhibitors'
p47565
g9
sS'clinically,relevant,as'
p47566
g3
sS'antiepilepsy,aeds,whether'
p47567
g3
sS'weight,range,kg'
p47568
g3
sS'result,in,substantial'
p47569
g9
sS'when,is,initiated'
p47570
g9
sS'promoter-vana,antisense,gene'
p47571
g3
sS'doses,may,be'
p47572
g9
sS'may,induce,the'
p47573
g9
sS'volunteers,the,auc'
p47574
g9
sS'change,in,plasma'
p47575
g9
sS'minimized,to,mg'
p47576
g3
sS'conservative,approach,to'
p47577
g3
sS'in,the,elderly'
p47578
g3
sS'lower,than,the'
p47579
g3
sS'greater,proportion,of'
p47580
g9
sS'amiodarone,is,also'
p47581
g3
sS'not,affect,any'
p47582
g3
sS'study,the,nonpredisposed'
p47583
g3
sS'studies,as,a'
p47584
g3
sS'ratio,or,inr'
p47585
g9
sS'solvents,can,give'
p47586
g3
sS'as,those,on'
p47587
g9
sS'these,pharmacokinetic,effects'
p47588
g9
sS'usually,well,tolerated'
p47589
g9
sS'ventricular,arrhythmias,in'
p47590
g3
sS'potentiate,the,effects'
p47591
g9
sS'by,oxc,and'
p47592
g3
sS'be,taken,as'
p47593
g3
sS'who,may,need'
p47594
g9
sS'duration,of,administration'
p47595
g3
sS'on,the,action'
p47596
g9
sS'effects,of,felbatol'
p47597
g9
sS'have,been,treated'
p47598
g9
sS'skeletal,muscle,relaxants'
p47599
g9
sS'while,mc,and'
p47600
g3
sS'and,other,medications'
p47601
g9
sS'while,other,studies'
p47602
g3
sS'of,at,steady-state'
p47603
g9
sS'through,increased,the'
p47604
g9
sS'slowly,over,several'
p47605
g9
sS'for,the,metabolism'
p47606
g3
sS'tract,hydoxide,hydrochloride'
p47607
g9
sS'giving,up,smoking'
p47608
g3
sS'micrograms,ml,for'
p47609
g3
sS'pulsation,amplitude,but'
p47610
g3
sS'of,other,potassium-sparing'
p47611
g9
sS'laboratorytest,interactions,dactinomycin'
p47612
g3
sS'copd,should,not'
p47613
g3
sS'and,elimination,of'
p47614
g3
sS'systematically,in,clinical'
p47615
g3
sS'serum,protein-bound,pbi'
p47616
g3
sS'identifies,clinically,important'
p47617
g3
sS'of,neurontin,in'
p47618
g3
sS'been,administered,to'
p47619
g3
sS'alternate,or,additional'
p47620
g3
sS'blood,cell,counts'
p47621
g3
sS'adult,volunteers,toradoloral'
p47622
g3
sS'mg,sular,tablets'
p47623
g9
sS's,disease,including'
p47624
g3
sS'impaired,by,all'
p47625
g3
sS'table,is,not'
p47626
g3
sS'the,specific,pharmacokinetic'
p47627
g3
sS'discontinuation,ordinarily,should'
p47628
g3
sS'to,one,of'
p47629
g3
sS'to,define,the'
p47630
g3
sS'adapting,of,diet'
p47631
g3
sS'useful,tool,for'
p47632
g3
sS'too,low,to'
p47633
g3
sS'liver,by,cyp2c19'
p47634
g3
sS'give,little,consideration'
p47635
g3
sS'iegs,has,been'
p47636
g3
sS'would,be,expected'
p47637
g3
sS'threshold,should,be'
p47638
g9
sS'cyp2d6,i,selective'
p47639
g9
sS'therapy,compliance,especially'
p47640
g3
sS'of,nanm,but'
p47641
g9
sS'zebeta,should,not'
p47642
g9
sS'orlistat-orlistat,may,decrease'
p47643
g9
sS'a,patient,initiates'
p47644
g9
sS'might,also,contribute'
p47645
g9
sS'ascertained,between,mealtime'
p47646
g3
sS'nutritional,supplement,food'
p47647
g3
sS'a,small,study'
p47648
g3
sS'treatment,costs,of'
p47649
g3
sS'who,are,concurrently'
p47650
g9
sS'course,of,taxol'
p47651
g3
sS'humans,and,experimental'
p47652
g3
sS'study,cynomolgus,monkeys'
p47653
g3
sS'some,physicians,are'
p47654
g3
sS'to,be,well'
p47655
g9
sS'from,masking,symptoms'
p47656
g3
sS'that,are,either'
p47657
g3
sS'become,more,feasible'
p47658
g3
sS'were,not,noted'
p47659
g3
sS'enzyme,inducers,iodinated'
p47660
g3
sS'of,elemental,reduced'
p47661
g9
sS'known,to,have'
p47662
g9
sS'has,been,no'
p47663
g3
sS'was,added,to'
p47664
g9
sS'use,of,monoamine'
p47665
g9
sS'hctz,hydrodiuril,diuril'
p47666
g3
sS'certain,drugs,tend'
p47667
g3
sS'celebrex,with,since'
p47668
g9
sS'h-spiroperidol,binding,after'
p47669
g3
sS'the,uptake,inhibitors'
p47670
g9
sS'the,fractional,inhibitory'
p47671
g3
sS'quinolones,including,decrease'
p47672
g9
sS'some,would,be'
p47673
g3
sS'highly,potent,cyp3a4'
p47674
g9
sS'the,resulting,respiratory'
p47675
g9
sS'an,week,controlled'
p47676
g3
sS'therapeutic,effect,for'
p47677
g3
sS'to,solvents,this'
p47678
g3
sS'tranxene,is,to'
p47679
g3
sS'such,that,users'
p47680
g9
sS'and,associated,dental'
p47681
g9
sS'and,extends,its'
p47682
g9
sS'potential,for,interaction'
p47683
g3
sS'caused,subnormal,release'
p47684
g3
sS'glucose,lowering,effect'
p47685
g9
sS'azole,antifungals,protease'
p47686
g3
sS'acid,may,be'
p47687
g3
sS'was,detected,although'
p47688
g3
sS'hydrochloride,could,pose'
p47689
g3
sS'by,the,leakage'
p47690
g3
sS'the,liver,was'
p47691
g3
sS'this,study,we'
p47692
g3
sS'lower,doses,of'
p47693
g9
sS'and,other,therapies'
p47694
g3
sS'coadministered,with,inhibitors'
p47695
g9
sS'dose-dependent,manner,relative'
p47696
g3
sS'adverse,events,by'
p47697
g9
sS'reduction,in,the'
p47698
g9
sS'are,rare,reports'
p47699
g9
sS'both,and,under'
p47700
g3
sS'to,prevent,folic'
p47701
g3
sS'anti-inflammatory,action,by'
p47702
g9
sS'formal,drug,drug'
p47703
g3
sS'concomitant,augmentin,xr'
p47704
g3
sS'cr,lower,plasma'
p47705
g9
sS'with,other,primarily'
p47706
g3
sS'not,been,done'
p47707
g9
sS'indocin,are,made'
p47708
g3
sS'relational,the,hippocampus'
p47709
g3
sS'alternatives,are,not'
p47710
g3
sS'however,in,the'
p47711
g9
sS'daily,alternating,therapy'
p47712
g3
sS'associated,with,increased'
p47713
g3
sS'with,food,one'
p47714
g9
sS'auc,values,for'
p47715
g9
sS'platelet,effects,vioxx'
p47716
g3
sS'one,report,suggesting'
p47717
g9
sS'was,noted,with'
p47718
g3
sS'with,other,in'
p47719
g3
sS'of,polyenes,are'
p47720
g3
sS'volunteers,a,six-day'
p47721
g9
sS'on,gi,bleeding'
p47722
g9
sS'induction,the,concomitant'
p47723
g9
sS'small,yet,statistically'
p47724
g3
sS'in,a,ten-subject'
p47725
g9
sS'drugs,are,withdrawn'
p47726
g3
sS'therefore,to,maximize'
p47727
g3
sS'is,susceptible,to'
p47728
g3
sS'eg,an,antiparkinsonian'
p47729
g9
sS'to,reported,to'
p47730
g9
sS'while,taking,the'
p47731
g3
sS'radiation,therapy,diabetes'
p47732
g3
sS'the,danger,of'
p47733
g9
sS'receiving,the,patient'
p47734
g3
sS'increase,its,serum'
p47735
g9
sS'isoenzymes,and,therefore'
p47736
g3
sS'rhabdomyolysis,have,occasionally'
p47737
g3
sS'liver,function,secondary'
p47738
g3
sS'in,studies,in'
p47739
g3
sS'inr,should,be'
p47740
g9
sS'years,of,age'
p47741
g3
sS'response,of,male'
p47742
g9
sS'patients,taking,beta'
p47743
g9
sS'of,udp-glucuronyl,transferase'
p47744
g3
sS'correlated,with,at'
p47745
g3
sS'and,concomitantly,of'
p47746
g3
sS'observed,but,were'
p47747
g3
sS'of,were,unchanged'
p47748
g3
sS'peripherally,restricted,antagonist'
p47749
g9
sS'the,decrease,in'
p47750
g3
sS'and,mumol,liter'
p47751
g9
sS'curve,at,steady'
p47752
g9
sS'although,it,has'
p47753
g9
sS'receiving,no,significant'
p47754
g3
sS'plasma,concentrations,should'
p47755
g9
sS'the,weekly,dosage'
p47756
g9
sS'tests,based,on'
p47757
g3
sS'is,no,documentation'
p47758
g3
sS'on,the,ninth'
p47759
g3
sS'directly,to,the'
p47760
g3
sS'early,evidence,of'
p47761
g3
sS'well,as,increasing'
p47762
g3
sS'these,effects,are'
p47763
g3
sS'decrease,conduction,through'
p47764
g9
sS'of,simulect,was'
p47765
g9
sS'reactions,consisted,of'
p47766
g3
sS'inhibitor,of,microsomal'
p47767
g9
sS'affect,this,activity'
p47768
g3
sS'such,measurements,are'
p47769
g3
sS'values,of,the'
p47770
g3
sS'reports,of,prolongation'
p47771
g9
sS'f2alpha,and,synthetic'
p47772
g3
sS'enterococcus,faecalis,and'
p47773
g3
sS'a,direct,pharmacokinetic'
p47774
g3
sS'discontinued,and,hoof'
p47775
g3
sS'to,extend,the'
p47776
g9
sS'an,effector,ieg'
p47777
g3
sS'acid,higher,doses'
p47778
g9
sS'its,active,metabolite'
p47779
g9
sS'interaction,may,be'
p47780
g3
sS'some,of,the'
p47781
g3
sS'level,has,been'
p47782
g9
sS'be,closely,watched'
p47783
g3
sS'hypokalemia,and,then'
p47784
g3
sS'of,glucocorticoid-induced,mouse'
p47785
g3
sS'that,might,occur'
p47786
g3
sS'premature,ventricular,arrhythmias'
p47787
g3
sS'concentrations,have,not'
p47788
g3
sS'hemostasis,and,has'
p47789
g9
sS'binding,of,salicylic'
p47790
g9
sS'these,interactions,on'
p47791
g3
sS'resistance,or,cardiovascular'
p47792
g3
sS'be,increased,and'
p47793
g9
sS'taking,mg,daily'
p47794
g3
sS'neutralizing,agent,for'
p47795
g9
sS'oral,and,plasma'
p47796
g9
sS'substrate,are,likely'
p47797
g3
sS'oral,products,ace'
p47798
g3
sS'conversion,of,difluoro-2'
p47799
g9
sS'auc,by,approximately'
p47800
g9
sS'mouth,constipation,blurred'
p47801
g9
sS'volunteers,receiving,low'
p47802
g9
sS'release,of,arachidonic'
p47803
g3
sS'results,of,these'
p47804
g3
sS'without,and,with'
p47805
g3
sS'interaction,data,described'
p47806
g3
sS'by,fold,on'
p47807
g9
sS'the,extent,and'
p47808
g3
sS'given,and,didanosine-placebo'
p47809
g9
sS'reduction,should,be'
p47810
g3
sS'used,to,measure'
p47811
g3
sS'well,after,clinical'
p47812
g3
sS'events,with,nnrtis'
p47813
g3
sS'rbc,were,used'
p47814
g3
sS'given,the,properties'
p47815
g3
sS'taking,vitamin,supplements'
p47816
g9
sS'and,lodine,capsules'
p47817
g9
sS'be,exacerbated,in'
p47818
g3
sS'who,is,receiving'
p47819
g9
sS'rejection,episodes,permit'
p47820
g3
sS'inhibitor,mg,increased'
p47821
g9
sS'infusion,rate,requirement'
p47822
g3
sS'hour,of,taxol'
p47823
g3
sS'altering,their,need'
p47824
g3
sS'the,stimulatory,effects'
p47825
g9
sS'risk,of,central'
p47826
g9
sS'not,contain,an'
p47827
g9
sS'elimination,of,a'
p47828
g3
sS'somatropin,excessive,concurrent'
p47829
g3
sS'naproxen,may,decrease'
p47830
g3
sS'with,known,substrates'
p47831
g3
sS'the,principal,pathway'
p47832
g9
sS'dietary,interferes,with'
p47833
g3
sS'the,antianginal,effectiveness'
p47834
g3
sS'if,tranxene,tablets'
p47835
g3
sS'tarceva,with,and'
p47836
g9
sS'gold,is,excreted'
p47837
g3
sS'simultaneously,because,both'
p47838
g9
sS'absorption,and,thus'
p47839
g3
sS'large,numbers,of'
p47840
g3
sS'increase,the,formation'
p47841
g3
sS'to,increase,cmax'
p47842
g9
sS'endometrium,and,the'
p47843
g3
sS'products,containing,or'
p47844
g9
sS'drugs,that,suppress'
p47845
g3
sS'amphetamines,potentiate,the'
p47846
g9
sS'produces,cardiopulmonary,stimulation'
p47847
g3
sS'addition,several,cardiovascular'
p47848
g3
sS'additional,effect,is'
p47849
g9
sS'with,carbamazepine,concomitant'
p47850
g9
sS'the,protective,effect'
p47851
g9
sS'are,used,concomitantly'
p47852
g9
sS'the,increased,regional'
p47853
g3
sS'affect,behaviors,most'
p47854
g3
sS'established,that,both'
p47855
g3
sS'its,approval,by'
p47856
g3
sS'protein,binding,sites'
p47857
g3
sS'because,anafranil,is'
p47858
g9
sS'of,followed,by'
p47859
g9
sS'usually,such,inactivation'
p47860
g3
sS'could,theoretically,affect'
p47861
g9
sS'cmax,of,a'
p47862
g3
sS'compounds,because,a'
p47863
g3
sS'history,of,anaphylactic'
p47864
g3
sS'other,with,potent'
p47865
g9
sS'colestid,tablets,to'
p47866
g3
sS'of,subjects,dosed'
p47867
g9
sS'target,sites,in'
p47868
g3
sS'potent,cyp3a4,inhibitors'
p47869
g9
sS'some,including,have'
p47870
g9
sS'grams,three,times'
p47871
g9
sS'kg,once,every'
p47872
g3
sS'administration,of,indocin'
p47873
g9
sS'may,inhibit,k'
p47874
g3
sS'of,elevated,plasma'
p47875
g3
sS'm2,basis,did'
p47876
g3
sS'decreased,with,coadministration'
p47877
g9
sS'rate,and,extent'
p47878
g3
sS'in,fat,and'
p47879
g3
sS'for,the,oral'
p47880
g3
sS'was,similar,to'
p47881
g3
sS'receptor,antagonists,cimetidine'
p47882
g9
sS'system,careful,consideration'
p47883
g3
sS'cancidas,did,not'
p47884
g3
sS'rheumatoid,arthritis,n'
p47885
g3
sS'for,example,since'
p47886
g9
sS'with,compounds,that'
p47887
g9
sS'decrease,hepatic,toxicity'
p47888
g9
sS'from,a,number'
p47889
g3
sS'on,target,tissues'
p47890
g3
sS'blood,sampling,for'
p47891
g3
sS'and,respectively,in'
p47892
g3
sS'or,dysfunction,is'
p47893
g3
sS'because,there,is'
p47894
g9
sS'maximum,relaxation,of'
p47895
g3
sS'than,of,this'
p47896
g3
sS'interactions,of,clinical'
p47897
g3
sS'human,fungal,infections'
p47898
g3
sS'bioavailabillty,when,they'
p47899
g9
sS'by,monitoring,and'
p47900
g3
sS'these,if,given'
p47901
g3
sS'explain,the,increased'
p47902
g3
sS'urinary,homocysteine,following'
p47903
g3
sS'reactions,is,unknown'
p47904
g3
sS'this,article,looks'
p47905
g3
sS'if,the,patients'
p47906
g3
sS'cimetidine,albendazole,sulfoxide'
p47907
g9
sS'celebrex,is,introduced'
p47908
g9
sS'no,human,interaction'
p47909
g3
sS'recommended,not,to'
p47910
g9
sS'received,under,steady'
p47911
g3
sS'with,m,g'
p47912
g3
sS'interactions,has,been'
p47913
g3
sS'paraclinical,pattern,of'
p47914
g3
sS'chlorpropamide,chlorpropamides,plasma'
p47915
g9
sS'some,patients,taking'
p47916
g9
sS'related,to,competitive'
p47917
g3
sS'fasted,and,the'
p47918
g3
sS'discontinued,it,is'
p47919
g9
sS'atcc,showed,the'
p47920
g3
sS'the,relative,bioavailability'
p47921
g3
sS'after,stopping,before'
p47922
g9
sS'ht1,agonists,has'
p47923
g3
sS'with,doses,corresponding'
p47924
g3
sS'generally,recommended,because'
p47925
g9
sS'patients,receiving,azopt'
p47926
g3
sS'during,concomitant,use'
p47927
g9
sS'and,pharmacotherapy,of'
p47928
g3
sS'pcp,dcg-iv,and'
p47929
g3
sS'a,rapidly,hydrolyzed'
p47930
g3
sS'of,oxypurines,in'
p47931
g3
sS'at,min,after'
p47932
g3
sS'to,experience,fewer'
p47933
g3
sS'the,daily,dose'
p47934
g9
sS'frequency,and,severity'
p47935
g9
sS'and,mg,experienced'
p47936
g9
sS'tablet,was,given'
p47937
g9
sS'and,a,subsequent'
p47938
g9
sS'of,have,demonstrated'
p47939
g3
sS'mtx,nsaids,tnf'
p47940
g3
sS'inhibitory,concentration,index'
p47941
g3
sS'deficiencies,constitute,the'
p47942
g3
sS'system,such,as'
p47943
g3
sS'be,given,together'
p47944
g3
sS'produced,significant,decreases'
p47945
g9
sS'moreover,the,mechanisms'
p47946
g3
sS'the,patient,to'
p47947
g9
sS'a,given,situation'
p47948
g3
sS'a,rapid,avoidance'
p47949
g3
sS'inhibitors,should,be'
p47950
g9
sS'experienced,users,particularly'
p47951
g9
sS'clearance,leading,to'
p47952
g3
sS'peripheral,neuropathy,the'
p47953
g3
sS'for,its,prevention'
p47954
g3
sS'low,molecular,weight'
p47955
g3
sS'anticoagulants,oral,co-administration'
p47956
g9
sS'tambocor,and,were'
p47957
g3
sS'light,zone,in'
p47958
g3
sS'the,hypoglycemic,action'
p47959
g9
sS'was,no,evidence'
p47960
g3
sS'both,plasma,and'
p47961
g3
sS'dosing,with,failed'
p47962
g3
sS'and,beta,cells'
p47963
g3
sS'warned,of,this'
p47964
g3
sS'felbatol,causes,a'
p47965
g9
sS'administered,twice,daily'
p47966
g3
sS'be,obtained,under'
p47967
g3
sS'metabolic,profiles,clinically'
p47968
g3
sS'inducers,that,have'
p47969
g9
sS'in,zollinger-ellison,ze'
p47970
g3
sS'ascorbic,acid,and'
p47971
g3
sS'administered,rapidly,by'
p47972
g3
sS'also,indicate,that'
p47973
g3
sS'relative,to,administration'
p47974
g3
sS'dosing,of,mg'
p47975
g3
sS'of,allergens,may'
p47976
g3
sS'mac,was,correlated'
p47977
g3
sS'increased,side,effects'
p47978
g3
sS'clinitest,tablets,benedicts'
p47979
g3
sS'felt,that,in'
p47980
g9
sS'mineral,oil-concomitant,intake'
p47981
g9
sS'than,second,in'
p47982
g3
sS'monitored,appropriately,regardless'
p47983
g3
sS'human,interaction,studies'
p47984
g3
sS'cyp3a4,cyp3a4,is'
p47985
g3
sS'crisis,until,the'
p47986
g9
sS'that,histaminergic,and'
p47987
g3
sS'dosage,of,and'
p47988
g3
sS'complete,after,a'
p47989
g3
sS'guide,to,further'
p47990
g9
sS'of,and,moderate'
p47991
g9
sS'of,correlation,between'
p47992
g3
sS'opportunistic,infections,have'
p47993
g3
sS'and,the,total'
p47994
g3
sS'the,growth,of'
p47995
g3
sS'in,in,vitro'
p47996
g3
sS'of,with,various'
p47997
g3
sS'produced,reliable,increases'
p47998
g3
sS'vet,or,the'
p47999
g9
sS'three,pharmacokinetic,studies'
p48000
g3
sS'increasingly,those,with'
p48001
g3
sS'other,hand,the'
p48002
g3
sS'at,doses,of'
p48003
g9
sS'during,treatment,and'
p48004
g9
sS'increased,susceptibility,to'
p48005
g3
sS'generally,believed,to'
p48006
g3
sS'concurrently,without,any'
p48007
g3
sS'cumulative,doses,of'
p48008
g9
sS'ml,when,was'
p48009
g3
sS'was,significantly,decreased'
p48010
g9
sS'should,consider,monitoring'
p48011
g3
sS'lodine,or,any'
p48012
g3
sS'contraceptives,an,interaction'
p48013
g9
sS'seen,during,clinical'
p48014
g3
sS'every,hours,should'
p48015
g9
sS'therefore,precaution,should'
p48016
g3
sS'effects,prolonged,sodation'
p48017
g9
sS'qt,interval,certain'
p48018
g9
sS'tests,with,a'
p48019
g3
sS'on,furosemide-stimulated,diuresis'
p48020
g3
sS'other,which,directly'
p48021
g3
sS'combining,with,other'
p48022
g9
sS'activity,may,enhance'
p48023
g9
sS'a,single,intravenous'
p48024
g3
sS'theoretically,may,potentiate'
p48025
g9
sS'because,of,reports'
p48026
g9
sS'systemic,medications,were'
p48027
g9
sS'of,agents,in'
p48028
g3
sS'may,weaken,or'
p48029
g3
sS'other,and,type'
p48030
g9
sS'alerted,to,the'
p48031
g3
sS'human,pharmacokinetic,data'
p48032
g9
sS'of,nuromax,and'
p48033
g3
sS'during,use,of'
p48034
g3
sS'characterized,to,define'
p48035
g3
sS'result,in,clinically-'
p48036
g3
sS'also,compromise,the'
p48037
g3
sS'millions,of,men'
p48038
g3
sS'each,may,be'
p48039
g3
sS'impact,on,the'
p48040
g3
sS'cancer,metastasis,through'
p48041
g3
sS'the,early,components'
p48042
g9
sS'a4,or,st'
p48043
g9
sS'factor,concentration,that'
p48044
g3
sS'volunteers,took,mg'
p48045
g3
sS'pyrantel,antiminth,taking'
p48046
g9
sS'both,free,and'
p48047
g9
sS'greater,when,and'
p48048
g9
sS'were,co-administered,has'
p48049
g9
sS'gallic,acid,itself'
p48050
g3
sS'to,in,of'
p48051
g9
sS'therapy,with,an'
p48052
g9
sS'produced,minor,changes'
p48053
g9
sS'dysfunction,is,nevertheless'
p48054
g3
sS'obtained,with,a'
p48055
g3
sS'if,possible,be'
p48056
g9
sS'level,that,was'
p48057
g3
sS'with,human,liver'
p48058
g3
sS'enhanced,when,alfenta'
p48059
g9
sS'blood,pressure,effect'
p48060
g9
sS'via,the,human'
p48061
g3
sS'properties,such,as'
p48062
g9
sS'time,may,lead'
p48063
g3
sS'papers,published,over'
p48064
g3
sS'blunted,by,and'
p48065
g9
sS'enablex,with,other'
p48066
g9
sS'effects,of,prinivil'
p48067
g3
sS'behaviour,when,briefly'
p48068
g3
sS'mood,states,and'
p48069
g3
sS'diabetic,nsaids,like'
p48070
g9
sS'activity,and,may'
p48071
g9
sS'suggest,that,the'
p48072
g3
sS'underlying,disease,rather'
p48073
g3
sS'coadministration,of,beta-adrenergic'
p48074
g3
sS'did,not,result'
p48075
g3
sS'd,of,compared'
p48076
g3
sS'when,patients,being'
p48077
g3
sS'major,metabolic,pathway'
p48078
g3
sS'polymer,p,app'
p48079
g3
sS'experience,enhanced,side'
p48080
g9
sS'inducer,of,microsomal'
p48081
g3
sS'delayed,until,the'
p48082
g3
sS'glyburide,the,concomitant'
p48083
g9
sS'or,type,it'
p48084
g9
sS'and,an,increase'
p48085
g9
sS'molecule,thereby,increasing'
p48086
g9
sS'of,may,potentiate'
p48087
g9
sS'supplement,st,johns'
p48088
g3
sS'usedas,the,sole'
p48089
g9
sS'of,for,which'
p48090
g3
sS'at,different,times'
p48091
g3
sS'the,degree,of'
p48092
g9
sS'because,many,drugs'
p48093
g3
sS'cause,striking,and'
p48094
g9
sS'rats,in,basal'
p48095
g3
sS'on,day,relative'
p48096
g9
sS'to,relieve,acute'
p48097
g3
sS'moieties,are,known'
p48098
g3
sS'isoform,also,involved'
p48099
g9
sS'dosage,of,should'
p48100
g3
sS'and,or,outpatient'
p48101
g3
sS'patients,who,discontinue'
p48102
g9
sS'mg,daily,the'
p48103
g9
sS'covalently,linked,to'
p48104
g3
sS'further,deterioration,of'
p48105
g9
sS'blocking,agents,did'
p48106
g3
sS'by,about,in'
p48107
g9
sS'potentiate,blood-pressure,and'
p48108
g9
sS'empiric,adjustment,of'
p48109
g3
sS'hydroxide-containing,maalox,on'
p48110
g3
sS'when,administering,gleevec'
p48111
g9
sS'hydroxyphenyl,piperidine,prevents'
p48112
g9
sS'occur,with,the'
p48113
g9
sS'as,ace,inhibitors'
p48114
g3
sS'to,desbutyl,levobupivacaine'
p48115
g3
sS'amprenavir,decreased,the'
p48116
g3
sS'significance,is,not'
p48117
g9
sS'levels,and,valproic'
p48118
g9
sS'hit,may,vary'
p48119
g3
sS'while,taking,acarbose'
p48120
g3
sS'as,judged,from'
p48121
g3
sS'resulting,from,interactions'
p48122
g3
sS'not,experience,an'
p48123
g3
sS'multivitamins,or,other'
p48124
g9
sS'be,administered,within'
p48125
g9
sS'shown,to,alter'
p48126
g3
sS'of,some,has'
p48127
g9
sS'given,consideration,in'
p48128
g9
sS'meals,for,four'
p48129
g3
sS'that,in,alcoholics'
p48130
g3
sS'and,elevation,of'
p48131
g3
sS'the,organic,cationic'
p48132
g3
sS'to,were,not'
p48133
g3
sS'those,with,conditions'
p48134
g3
sS'affinities,than,for'
p48135
g3
sS'adenocard,should,be'
p48136
g3
sS'of,inapsine,required'
p48137
g3
sS'a,comparison,of'
p48138
g3
sS'index,digoxin,sonata'
p48139
g3
sS'the,continued,need'
p48140
g3
sS'and,impaired,psychomotor'
p48141
g9
sS'be,well,acquainted'
p48142
g3
sS'studied,following,subcutaneous'
p48143
g3
sS'days,plus,mg'
p48144
g3
sS'in,the,district'
p48145
g3
sS'may,have,additive'
p48146
g9
sS'of,the,metabolism'
p48147
g9
sS'when,itraconazole,was'
p48148
g9
sS'of,taxotere,with'
p48149
g3
sS'drugs,which,themselves'
p48150
g9
sS'the,blood-glucose,lowering'
p48151
g3
sS'or,may,increase'
p48152
g3
sS'observed,when,was'
p48153
g9
sS'requires,an,increase'
p48154
g3
sS'incidence,of,cancer'
p48155
g3
sS'with,as,a'
p48156
g3
sS'which,may,accentuate'
p48157
g3
sS'a,metabolite,of'
p48158
g9
sS'and,intracellular,mobilization'
p48159
g3
sS'a,non-specific,cyp-450'
p48160
g3
sS'of,either,class'
p48161
g3
sS'as,urinary,excretion'
p48162
g3
sS'with,in,five'
p48163
g9
sS'active,epoxide,which'
p48164
g3
sS'be,unaffected,by'
p48165
g3
sS'treatment,with,equetrotm'
p48166
g3
sS'lowered,from,microg'
p48167
g3
sS'stabilized,for,at'
p48168
g3
sS'a,patient,already'
p48169
g3
sS'therefore,appropriate,dose'
p48170
g3
sS'that,iressa,may'
p48171
g9
sS'doses,corresponding,to'
p48172
g3
sS'patients,using,cardiovascular'
p48173
g3
sS'renal,excretion,of'
p48174
g9
sS'for,long,periods'
p48175
g3
sS'measurement,of,urinary'
p48176
g3
sS'hypotension,was,found'
p48177
g3
sS'in,serum,clearance'
p48178
g9
sS'retinal,tamponades,in'
p48179
g3
sS'neuromuscular,block,may'
p48180
g9
sS'carinii,pneumonia,treatment'
p48181
g9
sS'in,the,general'
p48182
g3
sS'correspond,to,approximately'
p48183
g3
sS'mhd,did,occur'
p48184
g3
sS'conjugation,at,nacmc'
p48185
g3
sS'together,with,rr'
p48186
g9
sS'on,felbatol,phenytoin'
p48187
g9
sS'well,matched,with'
p48188
g3
sS'significance,of,these'
p48189
g3
sS'reduced,and,the'
p48190
g3
sS'onset,and,may'
p48191
g9
sS'or,did,not'
p48192
g3
sS'pharmacokinetic,or,pharmacodynamic'
p48193
g3
sS'can,affect,the'
p48194
g3
sS'and,alpha-adrenergic,stimulants'
p48195
g9
sS'addressing,information,to'
p48196
g3
sS'incompatibility,of,these'
p48197
g3
sS'administered,as,oral'
p48198
g3
sS'cardiovascular,status,at'
p48199
g3
sS'other,highly,bound'
p48200
g3
sS'that,the,coadministration'
p48201
g3
sS'other,which,may'
p48202
g9
sS'increase,the,photosensitivity'
p48203
g9
sS'produce,vertigo,syncope'
p48204
g9
sS'either,alone,the'
p48205
g9
sS'hyperinsulinaemia,on,the'
p48206
g3
sS'fluconazole,and,the'
p48207
g3
sS'two,capsules,twice'
p48208
g3
sS'blocking,properties,that'
p48209
g9
sS'we,have,examined'
p48210
g3
sS'with,to,extend'
p48211
g9
sS'cyp,isoenzymes,tested'
p48212
g3
sS'cardiovascular,effects,may'
p48213
g9
sS'who,inactivate,by'
p48214
g9
sS'risk,of,adverse'
p48215
g3
sS'ibandronate,should,be'
p48216
g9
sS'or,aluminum-containing,products'
p48217
g9
sS'dosage,of,oral'
p48218
g3
sS'that,may,interfere'
p48219
g9
sS'was,approximately,doubled'
p48220
g3
sS'may,be,of'
p48221
g3
sS'more,severe,events'
p48222
g3
sS'reported,dose,used'
p48223
g3
sS'may,counteract,the'
p48224
g9
sS'between,june,and'
p48225
g3
sS'aerobic,facultative,and'
p48226
g3
sS'occur,with,tests'
p48227
g3
sS'experience,significantly,underestimates'
p48228
g3
sS'patients,taking,bextra'
p48229
g9
sS'p450,isozyme,cyp2c9'
p48230
g3
sS'action,ija,models'
p48231
g3
sS'conducted,to,evaluate'
p48232
g3
sS'pathways,which,are'
p48233
g3
sS'some,resulting,in'
p48234
g9
sS'hydoxide,hydrochloride,ferrous'
p48235
g9
sS'min,over,hours'
p48236
g3
sS'test,agent,for'
p48237
g3
sS'approved,in,the'
p48238
g3
sS'contribute,to,a'
p48239
g9
sS'associated,with,resistance'
p48240
g3
sS'should,be,initiated'
p48241
g9
sS're-results,in,almost'
p48242
g3
sS'heart,function,is'
p48243
g9
sS'serotonin,reuptake,inhibitors'
p48244
g3
sS'the,has,reduced'
p48245
g9
sS'reported,in,a'
p48246
g9
sS'blockers,should,be'
p48247
g9
sS'interaction,studies,other'
p48248
g3
sS'metabolism,by,cyp3a4'
p48249
g9
sS'require,dose,adjustment'
p48250
g3
sS'fi,and,fr'
p48251
g3
sS'concurent,therapy,with'
p48252
g9
sS'bio-rad,laboratories,platelia'
p48253
g3
sS'prothrombin,times,were'
p48254
g3
sS'liver,and,in'
p48255
g9
sS'metabolite,at,least'
p48256
g3
sS'by,cimetidines,known'
p48257
g9
sS'antagonist,and,another'
p48258
g9
sS'with,occasional,doses'
p48259
g3
sS'gallate,showed,the'
p48260
g3
sS'system,development,was'
p48261
g3
sS'used,concomitantly,closely'
p48262
g3
sS'of,sular,tended'
p48263
g9
sS'normal,range,and'
p48264
g3
sS'worsen,the,tremor'
p48265
g3
sS'increased,exposures,in'
p48266
g3
sS'inhibition,of,this'
p48267
g3
sS'these,reactions,include'
p48268
g3
sS'antiaddictive,efficacy,toxicity'
p48269
g3
sS'could,prolong,the'
p48270
g9
sS'containing,divalent,and'
p48271
g9
sS'iv,attenuate,loss'
p48272
g9
sS'with,the,mao-b'
p48273
g3
sS'significantly,reduced,when'
p48274
g3
sS'patients,met,acr'
p48275
g3
sS'either,single,mg'
p48276
g3
sS'no,significant,drug-drug'
p48277
g3
sS'other,substances,demonstrated'
p48278
g9
sS'as,or,use'
p48279
g9
sS'these,two,are'
p48280
g3
sS'serious,infections,and'
p48281
g9
sS'were,treated,concurrently'
p48282
g3
sS'because,there,have'
p48283
g9
sS'are,concurrently,taking'
p48284
g3
sS'doses,are,lower'
p48285
g3
sS'the,brovana,treated'
p48286
g3
sS'superiority,compared,with'
p48287
g3
sS'herbs,do,not'
p48288
g3
sS'coadministration,with,that'
p48289
g9
sS'treat,pneumocystis,carinii'
p48290
g9
sS'approximately,by,the'
p48291
g9
sS'of,future,studies'
p48292
g3
sS'that,have,secondary'
p48293
g9
sS'had,no,clinically'
p48294
g3
sS'system,maybe,useful'
p48295
g3
sS'inhibitor,and,an'
p48296
g3
sS'indicated,by,elevated'
p48297
g9
sS'are,using,the'
p48298
g9
sS'torsades,de,pointes-type'
p48299
g3
sS'ionized,concurrent,treatment'
p48300
g3
sS'levels,and,followed'
p48301
g3
sS'administration,with,signs'
p48302
g9
sS'of,t4,and'
p48303
g3
sS'thus,the,hypothesis'
p48304
g3
sS'or,additional,method'
p48305
g3
sS'd6,in,human'
p48306
g3
sS'in,a,mouse'
p48307
g3
sS'were,evident,in'
p48308
g3
sS'apparatus,of,spontaneous'
p48309
g3
sS'of,with,atacand'
p48310
g9
sS'antiprothrombinemic,effect,of'
p48311
g3
sS'main,route,of'
p48312
g3
sS'chronically,receiving,resulted'
p48313
g3
sS'critically,reviews,the'
p48314
g3
sS'for,the,welfare'
p48315
g3
sS'numbers,of,two'
p48316
g3
sS'renal,prostaglandins,and'
p48317
g3
sS'of,may,lower'
p48318
g9
sS'absorption,results,in'
p48319
g3
sS'blood,concentration-time,curve'
p48320
g3
sS'naflu,compared,to'
p48321
g3
sS'para-aminosalicylic,acid,and'
p48322
g9
sS'reactions,including,reactions'
p48323
g3
sS'aggressively,with,intravenous'
p48324
g3
sS'are,excreted,in'
p48325
g3
sS'mean,percentage,increase'
p48326
g9
sS'on,the,pr'
p48327
g9
sS'containing,cremophor,el'
p48328
g9
sS'the,dependency,of'
p48329
g3
sS'usp,is,a'
p48330
g9
sS'be,the,smallest'
p48331
g3
sS'duloxetine,to,affect'
p48332
g3
sS'early,as,three'
p48333
g9
sS'age,or,older'
p48334
g3
sS'in,both,the'
p48335
g3
sS'is,probably,accomplished'
p48336
g3
sS'although,hydroxy-corticosteroid,measurements'
p48337
g3
sS'a4,inhibitors,may'
p48338
g3
sS'and,their,combined'
p48339
g9
sS'with,inhibiting,cyp3a'
p48340
g3
sS'seventeen,percent,of'
p48341
g3
sS'at,all,with'
p48342
g9
sS'toxic,effects,and'
p48343
g3
sS'higher,than,peak'
p48344
g3
sS'however,due,to'
p48345
g9
sS'equivalent,amount,of'
p48346
g3
sS'epidural,injection,clonidine'
p48347
g9
sS'other,day,and'
p48348
g3
sS'blocking,agents,with'
p48349
g9
sS'significantly,reduce,exposure'
p48350
g3
sS'were,dosed,weekly'
p48351
g3
sS'usual,daily,maintenance'
p48352
g9
sS'medicinal,products,have'
p48353
g3
sS'of,cyp3a4,did'
p48354
g3
sS'that,a,satisfactory'
p48355
g9
sS'on,travelers,receiving'
p48356
g9
sS'shampoos,for,dandruff'
p48357
g3
sS'the,antithrombotic,agent'
p48358
g9
sS'antidiabetic,oral,agents'
p48359
g3
sS'metabolism,and,therefore'
p48360
g3
sS'phosphorylation,of,zdv'
p48361
g9
sS's,nephrotoxicity,and'
p48362
g3
sS'metabolizers,of,the'
p48363
g9
sS'and,instructions,for'
p48364
g3
sS'affect,leukocyte,production'
p48365
g3
sS'microsomal,ethoxycoumarine,deethylase'
p48366
g3
sS'be,expressed,in'
p48367
g3
sS'during,omnicef,therapy'
p48368
g9
sS'and,activity,at'
p48369
g3
sS'of,exposure,the'
p48370
g3
sS'close,to,the'
p48371
g3
sS'antidepressant,when,therapy'
p48372
g9
sS'other,interactions,vardenafil'
p48373
g3
sS'chloral,hydrate,may'
p48374
g9
sS'administration,of,equetrotm'
p48375
g3
sS'adjustment,of,is'
p48376
g9
sS'dose-dependent,fashion,at'
p48377
g3
sS'of,angiotensin,converting'
p48378
g9
sS'glycosides,heart,medicine'
p48379
g9
sS'tests,performed,in'
p48380
g3
sS'oral,and,fluvoxamine'
p48381
g9
sS'and,being,treated'
p48382
g3
sS'may,increase,susceptibility'
p48383
g3
sS'agents,folic,acid'
p48384
g3
sS'ie,increased,prothrombin'
p48385
g9
sS'a,precursor,to'
p48386
g3
sS'mechanism,of,coagulation'
p48387
g3
sS'that,should,not'
p48388
g9
sS'when,initiating,adjusting'
p48389
g9
sS'becomes,metabolically,active'
p48390
g3
sS'permitil,compazine,phenergan'
p48391
g3
sS'for,weeks,in'
p48392
g9
sS'were,no,alterations'
p48393
g3
sS'day,for,one'
p48394
g3
sS'too,was,increased'
p48395
g3
sS'no,study,data'
p48396
g9
sS'the,central,stimulant'
p48397
g9
sS'response,to,additional'
p48398
g3
sS'interactions,attributed,to'
p48399
g9
sS'ecg,intervals,caution'
p48400
g3
sS'of,functionally,distinguishes'
p48401
g3
sS'or,from,breast'
p48402
g3
sS'time,is,recommended'
p48403
g9
sS'thrombocytopenia,or,x'
p48404
g3
sS'that,produced,plasma'
p48405
g3
sS'alternative,or,additional'
p48406
g3
sS'johns,wort,based'
p48407
g3
sS'frequently,co-administered,with'
p48408
g3
sS'steadystate,cmin,to'
p48409
g9
sS'the,patients,on'
p48410
g3
sS'mefloquine,have,not'
p48411
g3
sS'this,agent,and'
p48412
g3
sS'may,significantly,decrease'
p48413
g9
sS'oxytocic,agents,is'
p48414
g3
sS'administered,with,or'
p48415
g9
sS'of,mg,b'
p48416
g9
sS'new,anaesthetic,agents'
p48417
g3
sS'of,mg,a'
p48418
g9
sS'is,nevertheless,associated'
p48419
g3
sS'the,inhibiting,effects'
p48420
g3
sS'significant,difference,exists'
p48421
g3
sS'exposure,when,coadministered'
p48422
g9
sS'effects,on,decreased'
p48423
g9
sS'the,following,enzymes'
p48424
g3
sS'proteins,indicate,that'
p48425
g3
sS'because,false,positive'
p48426
g3
sS'variability,and,limited'
p48427
g3
sS'was,inhibited,by'
p48428
g3
sS'potentiation,by,mao'
p48429
g9
sS'prothrombin,time,pt'
p48430
g9
sS'between,area,under'
p48431
g3
sS'acarbose,may,affect'
p48432
g3
sS'with,each,of'
p48433
g3
sS'the,strength,of'
p48434
g9
sS'for,increased,sedation'
p48435
g9
sS'combination,therapy,any'
p48436
g3
sS'effects,of,nephrotoxic'
p48437
g3
sS'of,a,number'
p48438
g9
sS'decreases,stomach,acidity'
p48439
g3
sS'changes,seen,with'
p48440
g3
sS'of,which,must'
p48441
g3
sS'is,essentially,completely'
p48442
g3
sS'is,indicated,when'
p48443
g3
sS'as,and,and'
p48444
g9
sS'contained,in,proprietary'
p48445
g9
sS'the,levels,or'
p48446
g9
sS'with,mefloquine,although'
p48447
g9
sS'to,have,a'
p48448
g3
sS'is,initiated,a'
p48449
g3
sS'states,or,concomitant'
p48450
g3
sS'particles,of,were'
p48451
g3
sS'taken,when,enablex'
p48452
g9
sS'found,minutes,post'
p48453
g3
sS'at,m,or'
p48454
g9
sS'most,common,medications'
p48455
g3
sS'the,levels,of'
p48456
g3
sS'sucralfate,should,not'
p48457
g9
sS'to,achieve,the'
p48458
g9
sS'in,patients,exposed'
p48459
g9
sS'with,less,enzyme'
p48460
g3
sS'are,developed,regarding'
p48461
g3
sS'preparations,incubated,at'
p48462
g3
sS'in,or,concentrations'
p48463
g3
sS'with,very,high'
p48464
g3
sS'enzyme,group,specifically'
p48465
g3
sS'between,the,th'
p48466
g3
sS'polysaccharides,and,polyfuranoses'
p48467
g3
sS'advised,against,the'
p48468
g9
sS'and,potassium-sparing,each'
p48469
g3
sS'of,sodium,capsules'
p48470
g9
sS'kaposi,s,sarcoma'
p48471
g3
sS'taken,into,consideration'
p48472
g3
sS'additive,effects,such'
p48473
g9
sS'most,closely,associated'
p48474
g3
sS'containing,or,other'
p48475
g9
sS'of,a,increase'
p48476
g9
sS'also,inhibits,cyp3a4'
p48477
g3
sS'when,briefly,exposed'
p48478
g3
sS'was,administered,minutes'
p48479
g9
sS'recommended,as,they'
p48480
g3
sS'different,site,ie'
p48481
g3
sS'the,urinary,recovery'
p48482
g3
sS'with,full,recovery'
p48483
g3
sS'site,of,previous'
p48484
g3
sS'to,approximately,fold'
p48485
g9
sS'and,class,iii'
p48486
g9
sS'is,group,therapy'
p48487
g3
sS'anxiety,depressive,symptoms'
p48488
g3
sS'to,use,short-acting'
p48489
g9
sS'on,indicates,that'
p48490
g9
sS'controlled,clinical,trial'
p48491
g3
sS'of,is,evidently'
p48492
g3
sS'results,of,the'
p48493
g3
sS'concentrations,may,be'
p48494
g3
sS'of,hcl,should'
p48495
g9
sS'ethanol,or,triazolam'
p48496
g3
sS'release,of,in'
p48497
g3
sS'management,of,schizophrenia'
p48498
g3
sS'or,should,not'
p48499
g9
sS'a,known,strong'
p48500
g3
sS'both,and,can'
p48501
g9
sS'compliance,poor,absorption'
p48502
g3
sS'these,are,to'
p48503
g3
sS'the,listed,isoforms'
p48504
g3
sS'aprepitant,with,each'
p48505
g9
sS'similarly,to,or'
p48506
g9
sS'of,the,volume'
p48507
g3
sS'with,lotensin,can'
p48508
g9
sS'failing,heart,can'
p48509
g3
sS'nsaids,the,concomitant'
p48510
g9
sS'these,combinations,should'
p48511
g3
sS'limited,pk,and'
p48512
g3
sS'are,all,metabolized'
p48513
g9
sS'of,time,concomitant'
p48514
g3
sS'demonstrated,to,interfere'
p48515
g9
sS'infusion,to,maintain'
p48516
g3
sS'plasma,concentrations,recognition'
p48517
g3
sS'the,ames,bacterial'
p48518
g3
sS'resistance,is,involved'
p48519
g3
sS'solutions,with,quantitative'
p48520
g3
sS'a,p53,mouse'
p48521
g3
sS'increase,by,about'
p48522
g9
sS'mug,ml,and'
p48523
g3
sS'humira,has,not'
p48524
g3
sS'only,a,increase'
p48525
g9
sS'or,parenteral,forms'
p48526
g3
sS'in,increases,in'
p48527
g9
sS'when,intravenous,and'
p48528
g9
sS'glucose,levels,have'
p48529
g3
sS'in,their,dosage'
p48530
g9
sS'after,starting,the'
p48531
g3
sS'to,the,prescribing'
p48532
g3
sS'with,alphagan,p'
p48533
g9
sS'cmax,of,an'
p48534
g3
sS'administered,agents,but'
p48535
g9
sS'and,that,are'
p48536
g3
sS'of,is,approximately'
p48537
g9
sS'for,days,in'
p48538
g9
sS'azithromycin,had,no'
p48539
g9
sS'toxic,levels,of'
p48540
g9
sS'the,sst,mice'
p48541
g3
sS'theoretically,l-arginine,supplements'
p48542
g9
sS'activity,against,hepatic'
p48543
g3
sS'mean,cmax,a'
p48544
g9
sS'and,some,are'
p48545
g3
sS'are,minimally,excreted'
p48546
g3
sS'study,in,human'
p48547
g9
sS'early,and,numerous'
p48548
g3
sS'absorption,of,concomitant'
p48549
g9
sS'extremely,acidic,conditions'
p48550
g3
sS'ethyl,increases,the'
p48551
g9
sS'alteration,of,hepatic'
p48552
g3
sS'of,mg,bid'
p48553
g9
sS'and,its,n-demethylated'
p48554
g3
sS'antagonists,the,absorption'
p48555
g9
sS'in,the,initial'
p48556
g3
sS'monitor,tca,plasma'
p48557
g3
sS'be,drawn,regarding'
p48558
g3
sS'have,little,or'
p48559
g3
sS'observed,hours,after'
p48560
g3
sS'initiation,of,or'
p48561
g3
sS'doses,of,of'
p48562
g3
sS'monoamine,oxidase,mao'
p48563
g3
sS'of,the,non-ionized'
p48564
g9
sS'and,escherichia,coli'
p48565
g3
sS'confirmation,should,be'
p48566
g3
sS'levels,the,potential'
p48567
g9
sS'in,elucidating,the'
p48568
g3
sS'of,escalating,doses'
p48569
g3
sS'state,level,serum'
p48570
g3
sS'or,pharmacodynamic,drug-drug'
p48571
g3
sS'transit,time,from'
p48572
g9
sS'videx,therapy,see'
p48573
g3
sS'potent,iiia4,inhibitor'
p48574
g9
sS'cannot,be,advocated'
p48575
g3
sS'the,central,nervous'
p48576
g3
sS'admission,the,patient'
p48577
g3
sS'since,the,excretion'
p48578
g9
sS'didanosine,it,is'
p48579
g3
sS'has,been,termed'
p48580
g3
sS'cardiovascular,disease,morbidity'
p48581
g3
sS'subset,of,the'
p48582
g3
sS'lesions,resulting,from'
p48583
g3
sS'levels,be,monitored'
p48584
g9
sS'of,aom,mg'
p48585
g3
sS'of,n-desmethyldiazepam,to'
p48586
g3
sS'have,higher,virologic'
p48587
g3
sS'effect,on,cytochrome'
p48588
g3
sS'higher,than,mg'
p48589
g3
sS'in,a,kg'
p48590
g3
sS'can,be,expressed'
p48591
g3
sS'the,same,effects'
p48592
g3
sS'fully,define,the'
p48593
g3
sS'been,performed,with'
p48594
g3
sS'considered,whenever,these'
p48595
g3
sS'effect,on,excystment'
p48596
g3
sS'laboratory,tests,interactions'
p48597
g3
sS'of,both,species'
p48598
g9
sS'acute,pulmonary,toxicity'
p48599
g9
sS'polymorphic,proliferation,and'
p48600
g3
sS'result,in,high'
p48601
g3
sS'experience,large,increases'
p48602
g3
sS'colestipol-concomitant,intake,of'
p48603
g9
sS'benedict,s,or'
p48604
g3
sS'checkerboard,assay,for'
p48605
g3
sS'studies,have,been'
p48606
g3
sS'gastrointestinal,ulceration,and'
p48607
g9
sS'and,regulation,of'
p48608
g3
sS'potential,for,flolan'
p48609
g9
sS'need,to,increase'
p48610
g9
sS'is,a,member'
p48611
g9
sS'paraaminohippurate,method,the'
p48612
g3
sS'doses,besides,their'
p48613
g3
sS'with,the,patch-clamp'
p48614
g3
sS'a,local,factor'
p48615
g3
sS'its,use,with'
p48616
g3
sS'and,or,bleeding'
p48617
g9
sS'disturbances,and,exacerbation'
p48618
g3
sS'the,residual,effects'
p48619
g9
sS'administration,of,withdrawal'
p48620
g3
sS'as,seen,with'
p48621
g3
sS'electrophilic,agents,or'
p48622
g3
sS'effects,with,or'
p48623
g9
sS'that,was,sacrificed'
p48624
g3
sS'as,hypercalcemia,in'
p48625
g9
sS'onset,of,of'
p48626
g3
sS'active,ra,were'
p48627
g9
sS'decreased,blood,levels'
p48628
g9
sS'gl,with,four'
p48629
g9
sS'clearance,of,when'
p48630
g9
sS'use,of,should'
p48631
g9
sS'fractions,of,either'
p48632
g3
sS'resistance,of,enterococci'
p48633
g3
sS'retention,and,blurred'
p48634
g9
sS'p,in,auc'
p48635
g3
sS'of,either,due'
p48636
g3
sS'with,a,dopa'
p48637
g3
sS'be,expected,with'
p48638
g3
sS'concentrations,of,interfere'
p48639
g9
sS'cyp3a4,and,c19'
p48640
g3
sS'inhibits,c9,c19'
p48641
g3
sS'population,of,the'
p48642
g3
sS'category,c,pegasys'
p48643
g3
sS'observed,training-induced,neurobiological'
p48644
g3
sS'in,those,with'
p48645
g9
sS'interaction,of,aprepitant'
p48646
g3
sS'promotes,the,translocation'
p48647
g3
sS'titrated,to,mg'
p48648
g3
sS'presence,of,a'
p48649
g3
sS'drugs,demonstrated,to'
p48650
g9
sS'treatment,with,accutane'
p48651
g9
sS'alert,to,the'
p48652
g9
sS'rat,liver,and'
p48653
g3
sS'nervous,system,or'
p48654
g9
sS'presence,of,m'
p48655
g3
sS'effect,of,amevive'
p48656
g3
sS'nephrotoxicity,has,been'
p48657
g9
sS'pharmacodynamic,effect,of'
p48658
g3
sS'treated,with,mg'
p48659
g3
sS'both,species,during'
p48660
g9
sS'well,as,urinary'
p48661
g3
sS'warfarin,when,maleate'
p48662
g9
sS'amphotericin,b-,induced'
p48663
g9
sS'diminished,when,it'
p48664
g9
sS'cause,hypotension,bradycardia'
p48665
g3
sS'these,reports,are'
p48666
g3
sS'differs,from,what'
p48667
g3
sS'following,observations,i'
p48668
g3
sS'instances,however,and'
p48669
g3
sS'either,the,dose'
p48670
g3
sS'months,the,combination'
p48671
g3
sS'in,these,subjects'
p48672
g3
sS'were,in,excess'
p48673
g3
sS'variability,in,the'
p48674
g9
sS'of,theo-dur,key'
p48675
g9
sS'used,together,at'
p48676
g3
sS'not,markedly,inhibit'
p48677
g3
sS'patients,may,experience'
p48678
g9
sS'distilled,and,fermented'
p48679
g3
sS'dose,followed,by'
p48680
g9
sS'as,phlebitis,cellulitis'
p48681
g3
sS'with,local,close'
p48682
g3
sS'and,may,therefore'
p48683
g3
sS'with,emtriva,has'
p48684
g3
sS'and,international,normalized'
p48685
g9
sS'enhancement,of,toxicity'
p48686
g9
sS'mean,confidence,interval'
p48687
g9
sS'events,when,baraclude'
p48688
g3
sS'the,that,could'
p48689
g3
sS'abnormalities,also,see'
p48690
g3
sS'subjective,and,behavioral'
p48691
g3
sS'rats,suggest,that'
p48692
g9
sS'the,specific,interaction'
p48693
g3
sS'placed,on,the'
p48694
g3
sS'concentration,may,lead'
p48695
g3
sS'a,therapeutic,supplement'
p48696
g9
sS'inhibition,and,the'
p48697
g9
sS'particularly,cautious,in'
p48698
g3
sS'concomitantly,of,whom'
p48699
g3
sS'system,although,the'
p48700
g3
sS'platelet,aggregation,and'
p48701
g3
sS'action,of,effect'
p48702
g3
sS'this,inhibitory,action'
p48703
g3
sS'thereby,increasing,the'
p48704
g3
sS'with,type,i'
p48705
g3
sS'basis,did,not'
p48706
g3
sS'impaired,suppression,of'
p48707
g3
sS'the,major,are'
p48708
g9
sS'any,alterations,in'
p48709
g3
sS'effect,on,other'
p48710
g3
sS'on,the,effect'
p48711
g3
sS'anti-cryptosporidial,activity,of'
p48712
g3
sS'for,alone,and'
p48713
g9
sS'ml,nor,is'
p48714
g3
sS'blood,pressure,should'
p48715
g3
sS'to,lower,respectively'
p48716
g3
sS'whether,would,cause'
p48717
g3
sS'there,was,not'
p48718
g3
sS'potential,components,are'
p48719
g3
sS'with,a,to'
p48720
g9
sS'cyp1a2,and,also'
p48721
g3
sS'chemotherapy,or,surgery'
p48722
g3
sS'grapefruit,juice,have'
p48723
g3
sS'in,two,instances'
p48724
g9
sS'vivo,effects,when'
p48725
g3
sS'control,and,half-life'
p48726
g9
sS'the,metabolite,of'
p48727
g3
sS'hourly,diuresis,electrocardiogram'
p48728
g3
sS'upon,cytochrome,p450'
p48729
g3
sS'time,in,patients'
p48730
g9
sS'caution,in,individuals'
p48731
g3
sS'inflammatory,with,a'
p48732
g9
sS'of,strains,of'
p48733
g3
sS'as,but,not'
p48734
g9
sS'thereof,are,suggested'
p48735
g3
sS'exercised,when,combining'
p48736
g3
sS'a,soft,and'
p48737
g3
sS'metabolized,in,proof'
p48738
g3
sS'or,potentiate,the'
p48739
g9
sS'variability,for,auc'
p48740
g3
sS'of,equetrotm,and'
p48741
g3
sS'man,significantly,include'
p48742
g9
sS'although,the,clearance'
p48743
g9
sS'may,pose,clinical'
p48744
g9
sS'activation,factor,bacterial'
p48745
g3
sS'dosage,adjustment,may'
p48746
g3
sS'incidence,of,fetal'
p48747
g3
sS'ocupress,should,be'
p48748
g9
sS'interaction,with,central'
p48749
g3
sS'use,in,conjunction'
p48750
g9
sS'mg,of,cancidas'
p48751
g9
sS'of,most,likely'
p48752
g9
sS'this,strategy,can'
p48753
g3
sS'potential,pharmacokinetic,interactions'
p48754
g3
sS'need,to,take'
p48755
g9
sS'tumor,vascularity,of'
p48756
g3
sS'with,dopa,decarboxylase'
p48757
g3
sS'that,an,acute'
p48758
g3
sS'myocardium,p,but'
p48759
g9
sS'mucocutaneous,and,cytoprotective'
p48760
g3
sS'other,that,significantly'
p48761
g3
sS'studies,with,anti-neoplastic'
p48762
g3
sS'and,emit-d,a'
p48763
g3
sS'of,anticholinesterase,poisoning'
p48764
g9
sS'for,drugs,associated'
p48765
g3
sS'requirement,i,mac'
p48766
g9
sS'age,may,influence'
p48767
g3
sS'and,cyp3a4,that'
p48768
g3
sS'faster,with,prior'
p48769
g9
sS'days,and,and'
p48770
g3
sS'hoof,twitch,allowed'
p48771
g3
sS'and,oxo-desethylzaleplon,glucuronide'
p48772
g3
sS'and,vitamin,k'
p48773
g9
sS'conducting,an,arbutamine-mediated'
p48774
g9
sS'also,increase,generation'
p48775
g3
sS'data,are,available'
p48776
g3
sS'the,steady-state,serum'
p48777
g9
sS'resulted,in,greater'
p48778
g9
sS'the,new,anaesthetic'
p48779
g3
sS'metabolite,may,result'
p48780
g3
sS'patient,only,where'
p48781
g9
sS'which,impair,glomerular'
p48782
g3
sS'administration,of,during'
p48783
g9
sS'injection,and,oral'
p48784
g9
sS'use,of,cerubidine'
p48785
g9
sS'cmax,and,fold'
p48786
g3
sS'transfer,from,the'
p48787
g3
sS'sprague-dawley,rats,fasted'
p48788
g3
sS'further,designs,can'
p48789
g3
sS'the,pharmacology,of'
p48790
g3
sS'in,thedosage,of'
p48791
g3
sS'replacement,therapy,may'
p48792
g3
sS'other,psychotropic,agents'
p48793
g9
sS'in,uninfected,volunteers'
p48794
g9
sS'the,main,non-infection'
p48795
g3
sS'the,unrestricted,use'
p48796
g3
sS'of,gemzar,and'
p48797
g3
sS'd,and,a'
p48798
g9
sS'lesser,extent,enhanced'
p48799
g3
sS'effects,of,triazo'
p48800
g3
sS'two,hepatic,and'
p48801
g3
sS'of,both,resorptions'
p48802
g9
sS'induce,cytochromes,particularly'
p48803
g3
sS'to,patients,with'
p48804
g3
sS'post-marketing,experience,of'
p48805
g9
sS'concurrently,with,kineret'
p48806
g9
sS'inhibited,the,cyp'
p48807
g3
sS'affect,hepatic,metabolism'
p48808
g9
sS'reported,to,prolong'
p48809
g9
sS'control,of,blood'
p48810
g3
sS'evident,in,females'
p48811
g3
sS'agents,for,migraine'
p48812
g9
sS'reactions,of,if'
p48813
g9
sS'and,auc,a'
p48814
g9
sS'either,toxicities,or'
p48815
g3
sS'not,change,significantly'
p48816
g3
sS'with,within,days'
p48817
g3
sS'aluminum-containing,administered,concomitantly'
p48818
g9
sS'expected,to,substantially'
p48819
g3
sS'to,decreased,serum'
p48820
g9
sS'assessed,the,ability'
p48821
g3
sS'demonstrated,that,administration'
p48822
g3
sS'to,indirect-acting,agents'
p48823
g9
sS'with,hepatic,or'
p48824
g3
sS'heart,rate,increased'
p48825
g3
sS'frequent,involvement,of'
p48826
g9
sS'postmarketing,experience,when'
p48827
g9
sS'abstinence,is,the'
p48828
g3
sS'adjustment,when,starting'
p48829
g3
sS'postmarketing,reports,describing'
p48830
g9
sS'and,it,has'
p48831
g9
sS'if,is,added'
p48832
g3
sS'for,gout,and'
p48833
g3
sS'is,advisable,not'
p48834
g3
sS'discontinuing,the,or'
p48835
g9
sS'the,hypotensive,effects'
p48836
g9
sS'function,since,a'
p48837
g3
sS'may,produce,vertigo'
p48838
g9
sS'of,pregnant,rhesus'
p48839
g3
sS'compared,with,and'
p48840
g3
sS'are,highly,effective'
p48841
g3
sS'used,with,in'
p48842
g9
sS'by,chloral,hydrate'
p48843
g3
sS'administration,of,revia'
p48844
g3
sS'i,d,co-administered'
p48845
g9
sS'in,dosage,should'
p48846
g9
sS'patients,were,on'
p48847
g3
sS'by,the,activation'
p48848
g3
sS'hrs,of,and'
p48849
g3
sS'on,the,cmax'
p48850
g9
sS'diphen-hydramine,and,h2'
p48851
g3
sS'had,been,receiving'
p48852
g3
sS'aprepitant,is,a'
p48853
g3
sS'auc,values,are'
p48854
g3
sS'to,report,a'
p48855
g3
sS'and,the,hydroxytamoxifen'
p48856
g3
sS'assay,methods,toxi-lab'
p48857
g3
sS'monitored,especially,when'
p48858
g9
sS'there,are,reports'
p48859
g9
sS'phospholine,iodide,potentiates'
p48860
g9
sS'multiple-dose,pharmacokinetic,profiles'
p48861
g3
sS'mg,daily,did'
p48862
g3
sS'and,and,on'
p48863
g3
sS'the,general,concern'
p48864
g3
sS'pi,classified,using'
p48865
g3
sS'are,taken,concurrently'
p48866
g9
sS'intensify,the,and'
p48867
g9
sS'producing,of,the'
p48868
g3
sS'cimetidine,in,subjects'
p48869
g9
sS'hepatitis,c,treated'
p48870
g3
sS'theasinensin,a,potently'
p48871
g3
sS'medication,iodine-containing,products'
p48872
g3
sS'the,literature,reports'
p48873
g3
sS'nsaids,in,clinical'
p48874
g3
sS'antiparkinson,or,may'
p48875
g9
sS'additionally,anti-malarial,such'
p48876
g9
sS'used,to,characterize'
p48877
g3
sS'ii-vii,x,complex'
p48878
g3
sS'addition,most,are'
p48879
g9
sS'education,on,recovery'
p48880
g3
sS'indicate,cyp3a4,isoform'
p48881
g3
sS'the,intestinal,permeation'
p48882
g3
sS'of,would,permit'
p48883
g3
sS'urine,creatinine,levels'
p48884
g3
sS'this,was,seen'
p48885
g3
sS'anticoagulants,while,studies'
p48886
g9
sS'contraindicated,since,the'
p48887
g3
sS'healthy,volunteers,resulting'
p48888
g3
sS'with,either,single'
p48889
g3
sS'resulted,in,lower'
p48890
g9
sS'the,size,of'
p48891
g3
sS'subjects,have,not'
p48892
g3
sS'increased,factors,ii'
p48893
g3
sS'drugs,these,drugs'
p48894
g3
sS'and,to,a'
p48895
g3
sS'is,prolonged,because'
p48896
g3
sS'intestine,thus,impairing'
p48897
g9
sS'cmax,when,co-administered'
p48898
g9
sS'artocarpus,integrifolia,jackfruit'
p48899
g3
sS'receiving,growth,factor'
p48900
g3
sS'on,the,clearance'
p48901
g3
sS'in,the,magnitude'
p48902
g3
sS'times,the,cmax'
p48903
g3
sS'add,to,or'
p48904
g9
sS'doses,of,are'
p48905
g9
sS'in,contrast,nucleophosmin'
p48906
g3
sS'high-dose,with,sodium'
p48907
g9
sS'agents,but,the'
p48908
g9
sS'by,a,microdilution'
p48909
g3
sS'in,binding,decrease'
p48910
g9
sS'intravenous,bolus,injections'
p48911
g3
sS'to,be,metabolized'
p48912
g9
sS'above,of,should'
p48913
g9
sS'combination,with,respect'
p48914
g3
sS'escalating,use,of'
p48915
g3
sS'on,concomitant,treatment'
p48916
g9
sS'another,positively-charged,bile'
p48917
g3
sS'metabolite,hydroxy-estazolam,and'
p48918
g3
sS'of,chop,plus'
p48919
g3
sS'mg,with,viracept'
p48920
g9
sS'are,obtained,either'
p48921
g3
sS'colestld,tablets,may'
p48922
g3
sS'behavioral,response,of'
p48923
g3
sS'paper,was,to'
p48924
g3
sS'the,and,other'
p48925
g3
sS'and,a,catecholamine'
p48926
g3
sS'to,the,other'
p48927
g3
sS'or,which,inhibit'
p48928
g9
sS'concentration,ca,i'
p48929
g9
sS'for,albumin,may'
p48930
g3
sS'light,meal,hour'
p48931
g3
sS'trials,using,the'
p48932
g3
sS'and,safety,of'
p48933
g3
sS'relapse,rehospitalisation,was'
p48934
g3
sS'valproate,a,recent'
p48935
g9
sS'the,following,laboratory'
p48936
g3
sS'prescription,or,over-the'
p48937
g3
sS'of,a,disulfiram-like'
p48938
g3
sS'clearance,or,no'
p48939
g3
sS'tablets,the,hypoglycemic'
p48940
g9
sS'conclusions,macrolide,inhibit'
p48941
g9
sS'pbi,t4,by'
p48942
g3
sS'compounds,that,could'
p48943
g9
sS'how,age,may'
p48944
g3
sS'or,no,first-pass'
p48945
g3
sS'of,seriously,worsening'
p48946
g3
sS'hydrolase,inhibitors,it'
p48947
g3
sS'txb2,generation,in'
p48948
g3
sS'toxicology,study,male'
p48949
g3
sS'by,gram-negative,organisms'
p48950
g3
sS'that,of,crude'
p48951
g3
sS'synergistic,effect,compared'
p48952
g3
sS'at,a,dose'
p48953
g9
sS'acid,depakene,use'
p48954
g3
sS'antizol,by,approximately'
p48955
g9
sS'interaction,study,evaluated'
p48956
g3
sS'blocker,on,the'
p48957
g3
sS'an,increased,risk'
p48958
g9
sS'or,decreased,by'
p48959
g9
sS'weeks,with,concurrent'
p48960
g9
sS'the,other,added'
p48961
g3
sS'sensitization,to,the'
p48962
g3
sS'in,the,recording'
p48963
g3
sS'in,the,frequency'
p48964
g9
sS'of,regranex,gel'
p48965
g3
sS'in,the,appearance'
p48966
g3
sS'metabolized,by,cyp2d6'
p48967
g3
sS'take,epa,supplements'
p48968
g3
sS'with,potential,risk'
p48969
g3
sS'study,in,diabetics'
p48970
g9
sS'therefore,co-administration,of'
p48971
g9
sS'the,therapeutic,effects'
p48972
g9
sS'lower,doses,than'
p48973
g3
sS'hypotension,and,or'
p48974
g9
sS'locomotor,activity,than'
p48975
g3
sS'the,biologic,half-life'
p48976
g9
sS'to,one-half,of'
p48977
g9
sS'may,bind,other'
p48978
g9
sS'other,components,of'
p48979
g3
sS'due,to,wide'
p48980
g9
sS'patients,mean,age'
p48981
g3
sS'confirmed,these,effects'
p48982
g3
sS'proliferation,of,prostatic'
p48983
g9
sS'induce,cyp3a4,with'
p48984
g3
sS'blood-pressure,and,heart-rate'
p48985
g9
sS'of,upon,chylomicron'
p48986
g3
sS'moreover,as,noted'
p48987
g9
sS'diabetes,mellitus,certain'
p48988
g3
sS'significantly,higher,approximately'
p48989
g3
sS'known,to,accelerate'
p48990
g3
sS'enzymes,including,cyp1a2'
p48991
g3
sS'thus,requiring,an'
p48992
g9
sS'cyclophosphamide,used,concurrently'
p48993
g9
sS'including,and,requires'
p48994
g9
sS'and,no,clinically'
p48995
g3
sS'might,be,manifested'
p48996
g3
sS'with,the,therapeutic'
p48997
g9
sS'mg,qd,has'
p48998
g3
sS'high-density,lipoprotein,cholesterol'
p48999
g3
sS'involved,in,functional'
p49000
g3
sS'remain,some,indications'
p49001
g3
sS'used,clinically,because'
p49002
g3
sS'cytochrome,p450,a4'
p49003
g3
sS'separately,by,different'
p49004
g9
sS'cytochrome,p450,a2'
p49005
g3
sS'evidence,of,increased'
p49006
g3
sS'dose,of,tca'
p49007
g3
sS'area,basis,this'
p49008
g3
sS'metabolism,of,which'
p49009
g9
sS'mg,starlix,three'
p49010
g3
sS'in,resistance,mesenteric'
p49011
g3
sS'safety,of,at'
p49012
g3
sS'to,adult,diabetics'
p49013
g3
sS'of,acarbose,and'
p49014
g9
sS'if,the,patient'
p49015
g9
sS'was,given,at'
p49016
g9
sS'was,given,as'
p49017
g3
sS'structurally,similar,to'
p49018
g3
sS'as,p-glycoprotein,in'
p49019
g9
sS'transferring,the,phosphohydrolase'
p49020
g3
sS'administration,of,factive'
p49021
g9
sS'phenytoin,is,a'
p49022
g3
sS'patients,no,dose'
p49023
g3
sS'interaction,with,tikosyn'
p49024
g3
sS'excessive,fall,in'
p49025
g9
sS'patients,nor,other'
p49026
g3
sS'occur,in,therapeutic'
p49027
g3
sS'inhibitors,of,hmg-coa'
p49028
g3
sS'max,although,c'
p49029
g3
sS'and,mcg,of'
p49030
g3
sS'direction,and,degree'
p49031
g3
sS'clinically,necessary,because'
p49032
g9
sS'prior,to,this'
p49033
g9
sS'test,interactions,certain'
p49034
g3
sS'patient,group,is'
p49035
g3
sS'clonidine,may,potentiate'
p49036
g9
sS'drugs,aeds,on'
p49037
g9
sS'potassium-sparing,and,others'
p49038
g3
sS'for,the,purification'
p49039
g3
sS'higher,when,was'
p49040
g9
sS'a,cardioselective,could'
p49041
g3
sS'of,allergens,either'
p49042
g3
sS'test,it,is'
p49043
g3
sS'aliskiren,based,on'
p49044
g3
sS'a,clinical,study'
p49045
g9
sS'baseline,and,on'
p49046
g3
sS'receiving,a,beta-adrenergic'
p49047
g9
sS'fatigue,hypotension,oliguria'
p49048
g3
sS'cell,type,and'
p49049
g3
sS'no,additional,benefit'
p49050
g9
sS'when,evaluating,serum'
p49051
g3
sS'for,alterations,in'
p49052
g9
sS'adverse,events,were'
p49053
g9
sS'induced,long,lasting'
p49054
g9
sS'also,used,the'
p49055
g9
sS'assess,the,potential'
p49056
g3
sS'with,medications,that'
p49057
g9
sS'fruit,juices,etc'
p49058
g9
sS'sodium,is,augmented'
p49059
g9
sS'degree,of,inhibition'
p49060
g9
sS'decrease,by,concomitant'
p49061
g9
sS'administered,one,mg'
p49062
g3
sS'equal,to,the'
p49063
g3
sS'depression,tricyclic,flupenthixol'
p49064
g9
sS'that,small,quantities'
p49065
g3
sS'photosensitivity,reaction,of'
p49066
g9
sS'since,and,may'
p49067
g9
sS'but,may,represent'
p49068
g3
sS'fraction,fdf,at'
p49069
g9
sS'in,the,international'
p49070
g3
sS'after,repeated,co-administration'
p49071
g9
sS'in,humans,show'
p49072
g9
sS'the,human,dose'
p49073
g3
sS'doses,should,not'
p49074
g3
sS'increased,the,plasma'
p49075
g9
sS'lengthened,and,the'
p49076
g9
sS'mg,day,racemic'
p49077
g3
sS'which,was,higher'
p49078
g9
sS'aspergillus,eia,test'
p49079
g3
sS'renal,clearance,was'
p49080
g3
sS'reduced,levels,up'
p49081
g3
sS'and,high-estradiol,treated'
p49082
g9
sS'time,sst,and'
p49083
g3
sS'elderly,patients,are'
p49084
g3
sS'affinity,for,protein'
p49085
g3
sS'oral,an,and'
p49086
g9
sS'on,cycle,duration'
p49087
g3
sS'treatment,is,cas'
p49088
g3
sS'platelet,activation,and'
p49089
g3
sS'may,reach,toxic'
p49090
g3
sS'a,greater,than'
p49091
g9
sS'false-positive,direct,coombs'
p49092
g3
sS'characterize,the,steady-state'
p49093
g3
sS'the,potential,danger'
p49094
g9
sS'pd2,values,for'
p49095
g3
sS'are,predominantly,metabolized'
p49096
g9
sS'a,cytostatic,agent'
p49097
g9
sS'to,form,or'
p49098
g9
sS'buspirone,hcl,and'
p49099
g9
sS'the,drug,or'
p49100
g3
sS'however,from,marketing'
p49101
g9
sS'toxic,to,normal'
p49102
g3
sS'laboratory,test,interferences'
p49103
g3
sS'monomeric,members,of'
p49104
g3
sS'significant,p,endothelial'
p49105
g3
sS'displacement,from,albumin'
p49106
g3
sS'of,in,vivo'
p49107
g3
sS'nabilone,has,been'
p49108
g9
sS'mefloquineuine,and,the'
p49109
g3
sS'results,and,pancreatic'
p49110
g9
sS'experiences,and,achieve'
p49111
g9
sS'of,hepatic,extraction'
p49112
g3
sS'cyp3a4,inducers,such'
p49113
g9
sS'users,is,at'
p49114
g3
sS'medicine,with,st'
p49115
g3
sS'interaction,use,of'
p49116
g9
sS'which,it,was'
p49117
g3
sS'the,general,population'
p49118
g3
sS'this,study,was'
p49119
g3
sS'addicts,vs,logs'
p49120
g3
sS'of,hydrochloride,and'
p49121
g3
sS'reported,in,which'
p49122
g9
sS'dose,of,each'
p49123
g9
sS'other,cyp3a4,inducers'
p49124
g3
sS'from,these,problems'
p49125
g3
sS'female,cynomolgus,monkeys'
p49126
g3
sS'apparently,t,cell-independent'
p49127
g3
sS'clearance,of,as'
p49128
g3
sS'h-triolein,at,baseline'
p49129
g3
sS'continuously,observed,for'
p49130
g9
sS'that,and,do'
p49131
g3
sS'to,maximizing,benefit'
p49132
g3
sS'combination,with,should'
p49133
g3
sS'laboratory,tests,response'
p49134
g3
sS'metabolized,primarily,by'
p49135
g3
sS'all,inclusive,viracept'
p49136
g3
sS'reductase,inhibitor,has'
p49137
g9
sS'accordance,with,standard'
p49138
g3
sS'encystment,at,concentrations'
p49139
g3
sS'is,cas,a'
p49140
g3
sS'each,task,induced'
p49141
g3
sS'some,substances,are'
p49142
g3
sS'between,the,and'
p49143
g3
sS'reported,to,fluctuate'
p49144
g9
sS'with,mhd,and'
p49145
g3
sS'glutathione,levels,in'
p49146
g9
sS'isocarboxazid,may,persist'
p49147
g3
sS'the,elderly,in'
p49148
g9
sS'group,took,either'
p49149
g3
sS'decrease,the,metabolic'
p49150
g9
sS'increases,in,liver'
p49151
g9
sS'profiles,comparable,to'
p49152
g3
sS'change,in,prothrombin'
p49153
g3
sS'two,of,the'
p49154
g3
sS'relative,importance,of'
p49155
g3
sS'and,weight,loss'
p49156
g9
sS'great,an,interval'
p49157
g3
sS'is,used,concurrently'
p49158
g9
sS'suspected,to,be'
p49159
g3
sS'we,examined,the'
p49160
g3
sS'humans,remain,to'
p49161
g3
sS'effect,although,the'
p49162
g3
sS'with,infusion,solutions'
p49163
g3
sS'that,the,changes'
p49164
g3
sS'warfarin,quinolones,including'
p49165
g9
sS'dipyridamole,may,counteract'
p49166
g9
sS'cell,the,result'
p49167
g3
sS'mg,day,proved'
p49168
g3
sS'can,either,mask'
p49169
g3
sS'can,be,employed'
p49170
g3
sS'of,is,narrow'
p49171
g3
sS'gi,motility,agents'
p49172
g3
sS'during,treatment,or'
p49173
g3
sS'h2,blockers,and'
p49174
g3
sS'cytochrome,p-450,a'
p49175
g9
sS'protein-bound,pbi,t4'
p49176
g3
sS'stimulants,including,those'
p49177
g9
sS'increasing,incidence,of'
p49178
g3
sS'used,to,sensitize'
p49179
g3
sS'gabapentin,had,no'
p49180
g3
sS'should,be,alert'
p49181
g9
sS'to,rule,out'
p49182
g3
sS'of,on,gastric'
p49183
g3
sS'lead,electrocardiograms,performed'
p49184
g3
sS'administering,etopophos,with'
p49185
g9
sS'than,when,these'
p49186
g9
sS'in,dietary-obese,rats'
p49187
g3
sS'grade,i,roegnik'
p49188
g3
sS'application,of,or'
p49189
g9
sS'of,epirubicin-containing,cef-120'
p49190
g3
sS'evidence,for,reduction'
p49191
g3
sS'inhibitors,and,mumol'
p49192
g9
sS'effect,beyond,that'
p49193
g9
sS'piperacillin,sodium,may'
p49194
g9
sS'days,mg,times'
p49195
g3
sS'to,control,atrial'
p49196
g9
sS'mucosal,accumulation,of'
p49197
g3
sS'concurrently,resulting,in'
p49198
g9
sS'observations,now,appearing'
p49199
g3
sS'acid,from,masking'
p49200
g3
sS'and,that,caution'
p49201
g3
sS'are,at,least'
p49202
g3
sS'be,directed,to'
p49203
g9
sS'a,water,pill'
p49204
g3
sS'decrease,in,cmax'
p49205
g9
sS'demonstrated,that,mixing'
p49206
g3
sS'dose,on,bsa'
p49207
g3
sS'was,more,potent'
p49208
g3
sS'potentiate,the,vasoconstrictive'
p49209
g9
sS'be,considered,as'
p49210
g3
sS'with,was,evaluated'
p49211
g3
sS'c8,and,a4'
p49212
g3
sS'propranolol,increases,hydralazines'
p49213
g9
sS'and,and,hours'
p49214
g3
sS'that,of,most'
p49215
g9
sS'classes,of,cardiovascular'
p49216
g3
sS'of,malignant,hyperthermia'
p49217
g9
sS'synergistic,relationship,with'
p49218
g9
sS'and,mm,hg'
p49219
g3
sS'an,increase,in'
p49220
g9
sS'exaggerated,hypertensive,responses'
p49221
g9
sS'drug,interactions,under'
p49222
g3
sS'b-blocking,properties,and'
p49223
g9
sS'the,time,scale'
p49224
g3
sS'dilute,solutions,should'
p49225
g3
sS'the,labeling,index'
p49226
g3
sS'with,allopurinol,the'
p49227
g9
sS'is,not,required'
p49228
g3
sS'twofold,greater,antitumour'
p49229
g3
sS'in,such,patients'
p49230
g9
sS'clinical,trials,however'
p49231
g3
sS'dilaudid,may,exhibit'
p49232
g9
sS'by,suggest,that'
p49233
g3
sS'poor,metabolizers,suggesting'
p49234
g9
sS'test,could,be'
p49235
g3
sS'french,non-governmental,organisation'
p49236
g3
sS'including,reactions,secondary'
p49237
g3
sS'collapse,respiratory,arrest'
p49238
g3
sS'non-myelinated,axons,of'
p49239
g3
sS'and,cmin,are'
p49240
g3
sS'of,a,study'
p49241
g9
sS'together,with,bezalip'
p49242
g9
sS'dexamethasone,suppression,test'
p49243
g3
sS'may,induce,bleeding'
p49244
g9
sS'and,this,may'
p49245
g3
sS'the,bioavailabillty,when'
p49246
g9
sS'urine,levels,considerably'
p49247
g9
sS'release,and,less'
p49248
g3
sS'the,plasma,was'
p49249
g3
sS'risk,of,decreased'
p49250
g3
sS'significantly,increased,plasma'
p49251
g9
sS'some,instances,a'
p49252
g9
sS'itraconazole,co-administration,of'
p49253
g3
sS'fertility,of,male'
p49254
g3
sS'an,additive,pharmacodynamic'
p49255
g3
sS'co-administration,of,reduced'
p49256
g9
sS's,regimen,particularly'
p49257
g9
sS'obtained,by,the'
p49258
g3
sS'groups,without,change'
p49259
g3
sS'can,prolong,the'
p49260
g9
sS'to,chemically,modify'
p49261
g3
sS'as,appropriate,in'
p49262
g3
sS'hcl,may,have'
p49263
g9
sS'with,aluminum-,and'
p49264
g3
sS'with,human,serum'
p49265
g3
sS'another,drug,is'
p49266
g3
sS'many,of,these'
p49267
g3
sS'leukocytes,and,lipids'
p49268
g3
sS'and,other,potent'
p49269
g9
sS'mac,was,depressed'
p49270
g9
sS'videx,didanosine,chewable'
p49271
g9
sS'to,significantly,interact'
p49272
g3
sS'seropositive,subjects,unless'
p49273
g3
sS'min,mean,standard'
p49274
g9
sS'n,compared,with'
p49275
g9
sS'blood,glucose,including'
p49276
g9
sS'however,it,should'
p49277
g3
sS'betaseron,on,metabolism'
p49278
g9
sS'of,mg,of'
p49279
g9
sS'mg,kg,decreases'
p49280
g3
sS'considered,in,patients'
p49281
g3
sS'to,the,manufacturer'
p49282
g3
sS'of,mg,on'
p49283
g3
sS'bactercidal,effect,of'
p49284
g9
sS'breakdown,products,and'
p49285
g9
sS'of,mg,or'
p49286
g9
sS'mg,kg,decreased'
p49287
g9
sS'of,administration,with'
p49288
g3
sS'unlikely,to,interact'
p49289
g3
sS'certain,anticancer,and'
p49290
g9
sS'amphotericin,b,and'
p49291
g9
sS'reactions,to,such'
p49292
g3
sS'reviews,recent,studies'
p49293
g3
sS'dose,required,for'
p49294
g3
sS'reduce,the,effect'
p49295
g9
sS'studied,but,these'
p49296
g9
sS'false-positive,urine,test'
p49297
g3
sS'necessary,because,of'
p49298
g9
sS'a,thin-layer,chromatographic'
p49299
g3
sS'actions,and,side-effects'
p49300
g9
sS'extravasation,were,usually'
p49301
g3
sS'values,of,approximately'
p49302
g9
sS'of,and,asa'
p49303
g3
sS'such,as,high-dose'
p49304
g3
sS'of,hypertriglyceridemia,was'
p49305
g3
sS'mg,capsule,within'
p49306
g9
sS'the,following,concomitant'
p49307
g3
sS'levels,of,phenytoin'
p49308
g3
sS'observed,for,the'
p49309
g9
sS'rats,hours,prior'
p49310
g3
sS'serum,concentration,and'
p49311
g9
sS'cautiously,as,toxic'
p49312
g3
sS'of,this,property'
p49313
g3
sS'affected,by,the'
p49314
g3
sS'induced,locomotion,and'
p49315
g3
sS'approximately,twice,those'
p49316
g9
sS'bleeding,tendency,produced'
p49317
g9
sS'co-administration,of,may'
p49318
g3
sS'atorvastatin,increases,the'
p49319
g9
sS'inhibitor,of,cyp3a'
p49320
g3
sS'the,biochemical,activity'
p49321
g3
sS'morphine,pharmacokinetic,parameter'
p49322
g3
sS'be,treated,with'
p49323
g3
sS'information,to,be'
p49324
g3
sS'and,followed,by'
p49325
g3
sS'auc,of,on'
p49326
g3
sS'several,clinical,trials'
p49327
g3
sS'is,both,a'
p49328
g3
sS'on,the,pharmacokinetic'
p49329
g9
sS'prostin,e2,may'
p49330
g9
sS'contraction,followed,by'
p49331
g3
sS'six,healthy,volunteers'
p49332
g9
sS's,augmentation,of'
p49333
g3
sS'the,supplements,affect'
p49334
g3
sS'tumors,and,testicular'
p49335
g3
sS'effect,with,cns'
p49336
g9
sS'anion,because,of'
p49337
g3
sS'treated,animals,than'
p49338
g3
sS'therapeutic,indices,as'
p49339
g9
sS'in,heart,rate'
p49340
g9
sS'to,administration,of'
p49341
g3
sS'discrimination,and,it'
p49342
g3
sS'characteristics,in,the'
p49343
g3
sS'as,minimal,bactericidal'
p49344
g3
sS'by,without,altering'
p49345
g9
sS'determined,by,their'
p49346
g3
sS'human,cyp,enzymes'
p49347
g3
sS'shown,that,concomitant'
p49348
g9
sS'in,most,common'
p49349
g3
sS'of,dehydration,secondary'
p49350
g9
sS'accutane,have,experienced'
p49351
g3
sS'and,then,hoof'
p49352
g3
sS'to,its,active'
p49353
g3
sS'when,given,once'
p49354
g9
sS'preliminary,clinical,data'
p49355
g9
sS'a,potent,inhibitor'
p49356
g9
sS'the,possible,adverse'
p49357
g3
sS'may,show,on-treatment'
p49358
g3
sS'that,could,have'
p49359
g3
sS'reported,that,prolongs'
p49360
g9
sS'regulated,by,movement'
p49361
g3
sS'cardiovascular,hypotension,bradycardia'
p49362
g3
sS'amiodarone,taken,concomitantly'
p49363
g3
sS'and,was,performed'
p49364
g3
sS'and,mg,daily'
p49365
g3
sS'at,degrees,c'
p49366
g3
sS'on,other,antiepileptic'
p49367
g9
sS'to,prinivil,given'
p49368
g3
sS'monitoring,of,levels'
p49369
g3
sS'bleeding,events,compared'
p49370
g9
sS'the,subjective,and'
p49371
g3
sS'because,is,not'
p49372
g3
sS'be,given,hour'
p49373
g9
sS'pregnancy,outcomes,in'
p49374
g3
sS'unchanged,accounts,for'
p49375
g3
sS'hrs,of,decreased'
p49376
g9
sS'auc,by,and'
p49377
g9
sS'known,whether,or'
p49378
g3
sS'of,or,an'
p49379
g3
sS'receiving,oral,the'
p49380
g3
sS'but,had,no'
p49381
g9
sS'tuberculosis,andusing,a'
p49382
g3
sS'dose,of,antidepressant'
p49383
g3
sS'preparations,have,been'
p49384
g3
sS'cholestyramine,binds,both'
p49385
g9
sS'p450-mediated,metabolism,of'
p49386
g3
sS'combination,with,other'
p49387
g3
sS'carbamazepine,in,healthy'
p49388
g9
sS'can,displace,such'
p49389
g9
sS'approximately,fold,and'
p49390
g9
sS'in,the,guinea-pig'
p49391
g3
sS'taking,which,can'
p49392
g3
sS'by,cyp2c9,such'
p49393
g9
sS'same,group,did'
p49394
g3
sS'in,an,attempt'
p49395
g9
sS'with,high,doses'
p49396
g9
sS'function,in,the'
p49397
g3
sS'relationships,between,area'
p49398
g3
sS'heart,disease,in'
p49399
g3
sS'disease,is,considered'
p49400
g3
sS'is,a,useful'
p49401
g3
sS'mg,kg,doses'
p49402
g9
sS'intravascular,catabolism,has'
p49403
g3
sS'to,invirase,or'
p49404
g3
sS'classified,as,protease'
p49405
g9
sS'monitored,during,and'
p49406
g9
sS'in,and,of'
p49407
g3
sS'experience,an,excessive'
p49408
g9
sS'of,to,healthy'
p49409
g3
sS'is,receiving,a'
p49410
g9
sS'to,mg,daily'
p49411
g3
sS'in,increased,plasma'
p49412
g3
sS'identified,as,causally'
p49413
g3
sS'administered,during,days'
p49414
g3
sS'although,these,results'
p49415
g9
sS'in,and,or'
p49416
g9
sS'antacids,or,substantially'
p49417
g9
sS'and,others,or'
p49418
g3
sS'controlled,studies,failed'
p49419
g3
sS'studies,evaluating,the'
p49420
g3
sS'use,of,adenocard'
p49421
g9
sS'of,the,concentration'
p49422
g3
sS'one,report,that'
p49423
g9
sS'significant,differences,among'
p49424
g3
sS'rats,was,more'
p49425
g3
sS'interactions,between,these'
p49426
g3
sS'n,had,no'
p49427
g3
sS'that,topoisomerase,activity'
p49428
g3
sS'apoptotic,morphology,pyknotic'
p49429
g3
sS'carcinogenicity,study,at'
p49430
g3
sS'to,or,the'
p49431
g9
sS'most,like,due'
p49432
g9
sS'increase,of,in'
p49433
g3
sS'an,apparent,factor'
p49434
g3
sS'sodium,iodide,i131'
p49435
g9
sS'an,increased,potential'
p49436
g3
sS'and,central,nervous'
p49437
g3
sS'manifested,significantly,longer'
p49438
g3
sS'i,alone,produced'
p49439
g3
sS'in,luteinizing,hormone'
p49440
g3
sS'to,increase,steadystate'
p49441
g9
sS'the,first,response'
p49442
g3
sS'usually,occurred,within'
p49443
g3
sS'interfere,with,neuromuscular'
p49444
g3
sS'response,of,cancer'
p49445
g3
sS'considered,during,the'
p49446
g9
sS'days,to,of'
p49447
g3
sS'increasing,its,cellular'
p49448
g9
sS'antisense,oligomer,significantly'
p49449
g3
sS'with,other,ht1'
p49450
g3
sS'effects,potentially,increased'
p49451
g3
sS'or,angiotensin,ii'
p49452
g3
sS'reduced,the,rate'
p49453
g9
sS'high,affinity,substrates'
p49454
g3
sS'of,and,proleukin'
p49455
g9
sS'in,five,normal'
p49456
g9
sS'the,concomitant,use'
p49457
g9
sS'diabetes,coagulation,factors'
p49458
g3
sS'properties,may,enhance'
p49459
g9
sS'with,ml,maalox'
p49460
g9
sS'administration,of,another'
p49461
g9
sS'and,pulsatile,choroidal'
p49462
g3
sS'cluster,of,metabolic'
p49463
g3
sS'increased,dosages,may'
p49464
g9
sS'variability,of,individual'
p49465
g3
sS'drugs,that,lower'
p49466
g9
sS'form,a,nitrosamine'
p49467
g9
sS'this,conjugated,system'
p49468
g3
sS'normal,subjects,single-dose'
p49469
g3
sS'isoenzyme,cyp2d6,activity'
p49470
g3
sS'trough,concentrations,and'
p49471
g3
sS'of,viracept,and'
p49472
g3
sS'patients,receiving,without'
p49473
g3
sS'uptake,inhibitor,hydrogen-3'
p49474
g3
sS'inhibit,the,following'
p49475
g3
sS'critically,important,for'
p49476
g3
sS'impairment,and,patients'
p49477
g3
sS'intravenous,has,been'
p49478
g3
sS'diethyl,pyrocarbonate,at'
p49479
g3
sS'cancer,cells,that'
p49480
g9
sS'are,also,using'
p49481
g9
sS'viral,loads,treated'
p49482
g3
sS'of,amphotericin,b'
p49483
g9
sS'and,min,following'
p49484
g3
sS'h,by,infusion'
p49485
g3
sS'of,clonazepam,on'
p49486
g3
sS'determine,whether,injection'
p49487
g3
sS'these,have,negative'
p49488
g9
sS'to,bind,other'
p49489
g3
sS'er,extended,release'
p49490
g3
sS'is,becoming,increasingly'
p49491
g3
sS'thus,if,a'
p49492
g3
sS'raise,the,question'
p49493
g3
sS'shortly,after,initiation'
p49494
g3
sS'inhibitor,can,be'
p49495
g9
sS'for,example,sparing'
p49496
g3
sS'metabolizing,isozyme,cytochrome'
p49497
g3
sS'slow,metabolizers,which'
p49498
g3
sS'infants,a,decision'
p49499
g3
sS'of,cyp3a4,eg'
p49500
g9
sS'with,any,that'
p49501
g3
sS'in,the,second'
p49502
g9
sS'time,has,been'
p49503
g3
sS's,disease,medications'
p49504
g3
sS'of,oral,is'
p49505
g9
sS'these,enzymes,may'
p49506
g3
sS'patients,with,hepatic'
p49507
g3
sS'phenytoin,and,are'
p49508
g3
sS'adrenocorticoids,cortisone-like,medicine'
p49509
g9
sS'if,sprycel,must'
p49510
g3
sS'and,oral,markedly'
p49511
g9
sS'ibandronate,was,similar'
p49512
g3
sS'a,further,deterioration'
p49513
g9
sS'copegus,therapy,is'
p49514
g3
sS'drugs,with,a'
p49515
g3
sS'potentiating,effect,with'
p49516
g9
sS'ergotamine,concurrent,use'
p49517
g9
sS'to,be,unaffected'
p49518
g3
sS'is,still,unknown'
p49519
g3
sS'cardioselective,could,be'
p49520
g3
sS'drugs,such,as'
p49521
g9
sS'for,the,induction'
p49522
g3
sS'potential,for,arava'
p49523
g9
sS'p450,substrates,has'
p49524
g3
sS'bile,acid,binding'
p49525
g9
sS'does,induce,p-450iie1'
p49526
g3
sS'and,served,as'
p49527
g3
sS'fehlings,solution,or'
p49528
g3
sS'inhibitor,added,in'
p49529
g3
sS'who,discontinue,after'
p49530
g9
sS'theoretically,coadministration,of'
p49531
g9
sS'until,the,effects'
p49532
g3
sS'these,findings,should'
p49533
g3
sS'same,study,it'
p49534
g3
sS'cell,functions,transcription'
p49535
g3
sS'inhibited,high,threshold'
p49536
g3
sS'the,second,pregnancy'
p49537
g3
sS'had,a,ki'
p49538
g3
sS'that,may,cause'
p49539
g3
sS'effect,of,has'
p49540
g9
sS'including,continuous,and'
p49541
g3
sS'activity,preclinical,researchers'
p49542
g3
sS'inhibition,of,cyp3a4'
p49543
g3
sS'decrease,prior,to'
p49544
g3
sS'co-administration,of,and'
p49545
g9
sS'as,used,for'
p49546
g9
sS'observed,in,of'
p49547
g3
sS'least,months,received'
p49548
g3
sS'infections,caused,by'
p49549
g3
sS'production,of,catecholamines'
p49550
g3
sS'that,be,administered'
p49551
g3
sS'inhibited,in,vitro'
p49552
g3
sS'oral,supplements,has'
p49553
g3
sS'cyp3a4,eg,could'
p49554
g9
sS'the,drug,taking'
p49555
g3
sS'p-450,isozymes,responsible'
p49556
g9
sS'unknown,in,patients'
p49557
g3
sS'sucralfate,metal,cations'
p49558
g3
sS'data,on,possible'
p49559
g9
sS'studies,with,acetylsalicylic'
p49560
g3
sS'normal,when,a'
p49561
g3
sS'significant,fluctuations,in'
p49562
g9
sS'the,clinician,depends'
p49563
g3
sS'actively,secreted,via'
p49564
g9
sS'as,mug,ml'
p49565
g3
sS'serotonergic,agents,co-administration'
p49566
g3
sS'a,with,metabolism'
p49567
g3
sS'auc,and,for'
p49568
g9
sS'potential,for,medications'
p49569
g3
sS'a,agonist,it'
p49570
g9
sS'rate,in,such'
p49571
g3
sS'of,a,known'
p49572
g9
sS'reduction,at,hr'
p49573
g3
sS'noncardioselective,porpranolol,may'
p49574
g9
sS'a,vana,glycopeptide-resistant'
p49575
g3
sS'with,agents,that'
p49576
g3
sS'mg,when,used'
p49577
g3
sS'hypercalcemia,in,such'
p49578
g9
sS'concurrently,with,may'
p49579
g9
sS'basal,medium,rpmi1640'
p49580
g3
sS'one-half,and,prothrombin'
p49581
g3
sS'clinically,relevant,interactions'
p49582
g3
sS'akineton,are,administered'
p49583
g9
sS'not,require,empiric'
p49584
g3
sS'escherichia,coli,in'
p49585
g3
sS'alternatives,in,dealing'
p49586
g3
sS'absorbed,while,taking'
p49587
g3
sS'ovarian,cancer,indicated'
p49588
g9
sS'two,reverse,transcriptase'
p49589
g3
sS'made,when,these'
p49590
g3
sS'way,crossover,studies'
p49591
g3
sS'and,to,inhibitors'
p49592
g3
sS'overlap,to,any'
p49593
g3
sS'particularly,diabetics,or'
p49594
g9
sS'of,hormone,may'
p49595
g3
sS'on,oral,agents'
p49596
g9
sS'aspirin,when,lodine'
p49597
g9
sS'reports,of,skeletal'
p49598
g3
sS'purification,protocol,for'
p49599
g3
sS'infusions,must,be'
p49600
g3
sS'discontinued,promptly,if'
p49601
g3
sS'metformin,when,starlix'
p49602
g3
sS'cyp,drug,metabolizing'
p49603
g3
sS'krm-1648,either,alone'
p49604
g3
sS'with,other,members'
p49605
g9
sS'seen,on,plasma'
p49606
g3
sS'in,approximately,a'
p49607
g9
sS'potassium,levels,should'
p49608
g3
sS'heart,rate,when'
p49609
g9
sS'a,lectin,which'
p49610
g3
sS'of,the,iatrogenic'
p49611
g3
sS'in,a,statistically'
p49612
g3
sS'failure,receiving,or'
p49613
g9
sS'in,the,patients'
p49614
g3
sS'course,of,the'
p49615
g3
sS'isoenzymes,cyp1a2,c8'
p49616
g3
sS'are,decreased,when'
p49617
g9
sS'of,wheal,and'
p49618
g3
sS'agents,aspirin,may'
p49619
g9
sS'for,tubular,secretion'
p49620
g9
sS'between,the,survanta'
p49621
g3
sS'risks,of,bleeding'
p49622
g3
sS'was,observed,for'
p49623
g3
sS'adjustment,of,sustiva'
p49624
g3
sS'and,hmg-coa,reductase'
p49625
g9
sS'fluvoxamine,tablets,the'
p49626
g9
sS'function,were,not'
p49627
g3
sS'bleeding,time,caused'
p49628
g3
sS'decrease,of,phosphorylated'
p49629
g3
sS'renal,function,care'
p49630
g3
sS'serum,level,has'
p49631
g9
sS'infarction,liver,disease'
p49632
g3
sS'a4,were,found'
p49633
g3
sS'healthy,adults,and'
p49634
g3
sS'in,mind,when'
p49635
g3
sS'exposure,in,mice'
p49636
g3
sS'inhibitor,of,the'
p49637
g9
sS'steady-state,conditions,to'
p49638
g3
sS'increases,in,prothrombin'
p49639
g9
sS'fertility,and,embryonic'
p49640
g3
sS'in,vivo,effects'
p49641
g3
sS'clomiphene,citrate,tablets'
p49642
g3
sS'can,attenuate,loss'
p49643
g9
sS'free,fraction,fdf'
p49644
g9
sS'responses,both,ca'
p49645
g9
sS'and,progestogen,administration'
p49646
g3
sS'therapy,is,to'
p49647
g9
sS'of,non-nucleoside,reverse'
p49648
g3
sS'been,more,than'
p49649
g3
sS'over,the,last'
p49650
g3
sS'in,single,and'
p49651
g9
sS'demonstrated,that,did'
p49652
g3
sS'to,assess,if'
p49653
g3
sS'and,lack,of'
p49654
g3
sS'could,have,a'
p49655
g3
sS'counteract,the,anticoagulation'
p49656
g9
sS'associated,with,significant'
p49657
g3
sS'encephalopathy,in,the'
p49658
g3
sS'with,have,not'
p49659
g3
sS'ferrous,sulfate,sodium'
p49660
g9
sS'with,dsm-iv,diagnosed'
p49661
g9
sS'prior,to,starting'
p49662
g3
sS'and,does,not'
p49663
g3
sS'or,was,added'
p49664
g3
sS'diminution,is,not'
p49665
g3
sS'co-administration,of,two'
p49666
g3
sS'reduced,the,oral'
p49667
g9
sS'and,serosal,surfaces'
p49668
g3
sS'the,small,magnitude'
p49669
g3
sS'atropinization,flushing,mydriasis'
p49670
g9
sS'fecal,and,urinary'
p49671
g3
sS'elderly,patients,receiving'
p49672
g9
sS'cases,a,pronounced'
p49673
g9
sS'when,either,or'
p49674
g9
sS'discontinuing,in,clinical'
p49675
g3
sS'determine,whether,has'
p49676
g3
sS'on,the,bioavailability'
p49677
g3
sS'class,drug,name'
p49678
g3
sS'anions,other,than'
p49679
g3
sS'shown,that,lodine'
p49680
g9
sS'blood,pressure,in'
p49681
g3
sS'month,prior,to'
p49682
g3
sS'and,achieve,the'
p49683
g9
sS'produce,a,well'
p49684
g3
sS'more,frequently,and'
p49685
g3
sS'and,leading,to'
p49686
g9
sS'administration,of,known'
p49687
g3
sS'the,antitumor,activity'
p49688
g3
sS'at,a,lower'
p49689
g3
sS'of,either,or'
p49690
g3
sS'addiction,research,center'
p49691
g3
sS'is,erroneous,and'
p49692
g3
sS'two,different,types'
p49693
g3
sS'avoided,unless,the'
p49694
g9
sS'monitoring,devices,and'
p49695
g3
sS'increased,appetite,and'
p49696
g3
sS'drug,interactions,caused'
p49697
g3
sS'effects,similar,to'
p49698
g3
sS'its,prevention,in'
p49699
g3
sS'a,week,course'
p49700
g9
sS'and,nose,may'
p49701
g9
sS'and,commonly,used'
p49702
g3
sS'not,considered,clinically'
p49703
g3
sS'similar,effects,would'
p49704
g3
sS'pediatric,powder,or'
p49705
g9
sS'mild,decrease,in'
p49706
g9
sS'clorazepate,dipotassium,prolongs'
p49707
g9
sS'levels,and,prolongation'
p49708
g9
sS'the,soluble,to'
p49709
g3
sS'av,node,conduction'
p49710
g9
sS'with,caution,because'
p49711
g9
sS'not,act,on'
p49712
g3
sS'cmax,of,however'
p49713
g3
sS'increased,by,co-administration'
p49714
g3
sS'by,protein-bound,pbi'
p49715
g3
sS'effect,of,oral'
p49716
g3
sS'or,renal,tubular'
p49717
g9
sS'hour,after,starting'
p49718
g3
sS'when,this,combination'
p49719
g9
sS'increase,in,local'
p49720
g3
sS'pregnant,and,in'
p49721
g3
sS'd2o,was,present'
p49722
g3
sS'be,augmented,by'
p49723
g9
sS'failing,hearts,new'
p49724
g3
sS'interact,with,blood'
p49725
g9
sS'if,hydrochloride,is'
p49726
g9
sS'and,mean,plasma'
p49727
g3
sS'compensatory,increases,in'
p49728
g3
sS'with,that,are'
p49729
g3
sS'not,been,established'
p49730
g9
sS'in,more,than'
p49731
g3
sS'genotypes,of,cyp2c9'
p49732
g3
sS'withdrawn,in,conjunction'
p49733
g3
sS'antifibrinolytic,therapies,i'
p49734
g3
sS'correlation,between,blood'
p49735
g3
sS'increase,or,decrease'
p49736
g9
sS'copying,test,and'
p49737
g9
sS'relationship,measurement,of'
p49738
g3
sS'in,prothrombin,times'
p49739
g3
sS'in,a,few'
p49740
g9
sS'history,of,injection'
p49741
g3
sS'hypoglycemics,diclofenac,does'
p49742
g3
sS'muscle,relaxants,intravenous'
p49743
g3
sS'with,potentially,important'
p49744
g3
sS'published,over,the'
p49745
g3
sS'medications,and,timing'
p49746
g3
sS'tcamay,become,abruptly'
p49747
g3
sS'thus,when,and'
p49748
g9
sS'citalopram,since,is'
p49749
g9
sS'migraine,therapy,such'
p49750
g9
sS'be,an,increased'
p49751
g3
sS'p450,isozymes,including'
p49752
g3
sS'p450,c,p'
p49753
g3
sS'and,with,a'
p49754
g9
sS'experience,increased,concentrations'
p49755
g3
sS'effective,due,to'
p49756
g9
sS'consisted,of,two'
p49757
g3
sS'ec50,values,for'
p49758
g3
sS'pd,studies,investigating'
p49759
g3
sS'synergistic,activity,while'
p49760
g9
sS'estradiol,were,similar'
p49761
g3
sS'of,drug,interactions'
p49762
g3
sS'a,false-positive,reaction'
p49763
g3
sS'as,acute,toxicity'
p49764
g3
sS'active,suggesting,that'
p49765
g3
sS'and,careful,adjustment'
p49766
g3
sS'in,addition,patients'
p49767
g3
sS'inhibit,gastrointestinal,absorption'
p49768
g3
sS'by,a,type'
p49769
g3
sS'patients,in,ra'
p49770
g3
sS'isoniazid,is,known'
p49771
g9
sS'inhibitors,concomitant,use'
p49772
g3
sS'test,interactions,acetaminophen'
p49773
g3
sS'orally,inhaled,and'
p49774
g9
sS'reviewed,the,clinical'
p49775
g3
sS'effects,of,competitive'
p49776
g3
sS'between,and,an'
p49777
g3
sS'suggest,that,concomitant'
p49778
g9
sS'also,although,minimal'
p49779
g3
sS'be,necessary,if'
p49780
g3
sS'its,inhibitory,effect'
p49781
g9
sS'which,is,a'
p49782
g3
sS'performed,and,a'
p49783
g3
sS'and,increased,risk'
p49784
g9
sS'ionized,species,of'
p49785
g9
sS'has,led,to'
p49786
g9
sS'p450,pathway,suggesting'
p49787
g3
sS'dose,even,when'
p49788
g3
sS'that,mediate,and'
p49789
g3
sS'recovery,from,single'
p49790
g3
sS'sites,or,a'
p49791
g9
sS'who,have,had'
p49792
g9
sS'limbic,system,and'
p49793
g3
sS'or,ergot-type,medications'
p49794
g9
sS'who,consume,and'
p49795
g9
sS'serum,i,corticosteroid'
p49796
g3
sS'concentrations,when,compared'
p49797
g3
sS'with,peripheral,because'
p49798
g9
sS'with,lodosyn,and'
p49799
g3
sS'receptors,thus,inhibiting'
p49800
g9
sS'lipids,pretreatment,and'
p49801
g3
sS'ras,nucleophosmin,b23'
p49802
g3
sS'in,the,treated'
p49803
g3
sS'that,the,diabetic'
p49804
g3
sS'your,skin,that'
p49805
g3
sS'more,commonly,reported'
p49806
g9
sS'auc,were,not'
p49807
g3
sS'given,should,be'
p49808
g9
sS'risk,of,having'
p49809
g3
sS'in,either,striatum'
p49810
g3
sS'cyp3a4,mg,daily'
p49811
g9
sS'natriuretic,and,antihypertensive'
p49812
g9
sS'during,the,months'
p49813
g3
sS'pharmacological,effect,when'
p49814
g9
sS'long-,and,short-acting'
p49815
g3
sS'one,strain,of'
p49816
g3
sS'hydrochloride,was,administered'
p49817
g3
sS'antifungals,grapefruit,juice'
p49818
g9
sS'of,on,monoamine'
p49819
g3
sS'per,day,to'
p49820
g3
sS'compared,to,a'
p49821
g9
sS'the,binding,of'
p49822
g3
sS'limited,to,and'
p49823
g3
sS'and,the,and'
p49824
g9
sS'oral,the,coagulation'
p49825
g3
sS'as,well,and'
p49826
g3
sS'includes,anafranil,with'
p49827
g3
sS'accumulation,characteristic,of'
p49828
g3
sS'in,a,supine'
p49829
g3
sS'or,total,bilirubin'
p49830
g3
sS'synthetase,inhibitors,also'
p49831
g3
sS'intravenous,application,of'
p49832
g3
sS'its,metabolites,n-desmethylclozapine'
p49833
g3
sS'hcl,has,been'
p49834
g9
sS'aprepitant,increased,the'
p49835
g9
sS'of,great,interest'
p49836
g3
sS'administering,hcl,to'
p49837
g9
sS'to,have,similar'
p49838
g3
sS'observed,for,clinical'
p49839
g3
sS'was,to,study'
p49840
g3
sS'rebif,is,used'
p49841
g3
sS'the,acute,myocardial'
p49842
g3
sS'abundance,and,wide'
p49843
g3
sS'and,a,increase'
p49844
g9
sS'kg,on,balance'
p49845
g9
sS'in,metabolite,or'
p49846
g3
sS'levels,usually,only'
p49847
g3
sS'ras-3t3,cells,with'
p49848
g3
sS'deplete,and,monoamine'
p49849
g9
sS'to,function,normally'
p49850
g3
sS'tool,with,which'
p49851
g3
sS'although,certain,medicines'
p49852
g3
sS'elevated,plasma,levels'
p49853
g9
sS'similarly,might,also'
p49854
g3
sS'or,coagulation,should'
p49855
g3
sS'heparinized,patients,may'
p49856
g9
sS'to,increase,levels'
p49857
g3
sS'inderal,tenormin,sectral'
p49858
g3
sS'diethyl,pyrocarbonate,abolished'
p49859
g3
sS'studies,m1,was'
p49860
g3
sS'if,casodex,is'
p49861
g9
sS'although,they,may'
p49862
g3
sS'hypoglycemics,agents,with'
p49863
g9
sS'acquisition,after,day'
p49864
g3
sS'on,may,be'
p49865
g9
sS'other,nondepolarizing,neuromuscular'
p49866
g9
sS'in,decreases,of'
p49867
g9
sS'and,enhance,activity'
p49868
g9
sS'and,the,numerous'
p49869
g3
sS'interactions,between,betaseron'
p49870
g3
sS'tests,elevations,of'
p49871
g3
sS'concurrently,with,enbrel'
p49872
g9
sS'postmarketing,reports,of'
p49873
g9
sS'use,of,nsaids'
p49874
g9
sS'tc99m,uptake,of'
p49875
g3
sS'activate,the,renin-angiotensin'
p49876
g3
sS'mefloquine,although,theoretically'
p49877
g9
sS'dose,of,one'
p49878
g3
sS'when,was,co-administered'
p49879
g9
sS'estrogen-containing,oral,increase'
p49880
g3
sS'monitoring,can,avoid'
p49881
g9
sS'inhibitors,in,studies'
p49882
g9
sS'of,absorption,but'
p49883
g3
sS'was,not,mutagenic'
p49884
g3
sS'injection,medicine,for'
p49885
g3
sS'seen,when,two'
p49886
g3
sS'novolog,is,mixed'
p49887
g3
sS'agents,in,one'
p49888
g3
sS'concomitantly,by,patients'
p49889
g9
sS'auc,ci,kg'
p49890
g3
sS'although,the,dose-limiting'
p49891
g3
sS'acid,metabolism,could'
p49892
g3
sS'of,thio,compounds'
p49893
g3
sS'pharmacokinetics,and,gastric'
p49894
g3
sS'effects,may,depend'
p49895
g3
sS'to,maintain,inhibition'
p49896
g3
sS'was,seen,in'
p49897
g3
sS'binding,of,fibrinogen'
p49898
g3
sS'is,an,inducer'
p49899
g3
sS'of,the,medicines'
p49900
g3
sS'reported,activity,they'
p49901
g3
sS'administration,of,targretin'
p49902
g9
sS'monitoring,and,dose'
p49903
g9
sS'to,cite,primary'
p49904
g3
sS'clearance,of,some'
p49905
g9
sS'disalcid,others,choline'
p49906
g9
sS'drops,containing,are'
p49907
g3
sS'of,zebeta,resulting'
p49908
g9
sS'opioid-induced,gastrointestinal,effects'
p49909
g9
sS'insulin-dependent,diabetes,mellitus'
p49910
g3
sS'syndrome,has,been'
p49911
g9
sS'a,non-steroidal,anti-inflammatory'
p49912
g9
sS'used,concomitantly,serum'
p49913
g9
sS'novolog,should,not'
p49914
g3
sS'therapy,patients,on'
p49915
g9
sS'more,than,doubled'
p49916
g3
sS'the,risks,of'
p49917
g9
sS'coagulation,should,have'
p49918
g3
sS'both,its,therapeutic'
p49919
g3
sS'numbers,of,colony'
p49920
g3
sS'some,potential,for'
p49921
g9
sS'prevent,the,conversion'
p49922
g9
sS'receiving,either,concomitant'
p49923
g3
sS'apparent,total,body'
p49924
g9
sS'of,daily,increases'
p49925
g9
sS'has,much,lower'
p49926
g3
sS'as,may,also'
p49927
g3
sS'surface,histidine,residues'
p49928
g3
sS'administered,with,that'
p49929
g3
sS'of,alone,versus'
p49930
g3
sS'of,in,patients'
p49931
g3
sS'sources,for,virtually'
p49932
g3
sS'bone,marrow,function'
p49933
g3
sS's-alt,levels,have'
p49934
g3
sS'or,repeated,mg'
p49935
g3
sS'made,whether,to'
p49936
g3
sS'receiving,mg,bid'
p49937
g9
sS'binding,of,to'
p49938
g9
sS'test,sample,is'
p49939
g3
sS'acid,and,the'
p49940
g3
sS'currently,there,are'
p49941
g3
sS'given,with,but'
p49942
g9
sS'd6,e1,and'
p49943
g3
sS'albicans,one,of'
p49944
g3
sS'and,in,vitro'
p49945
g3
sS'cimetidine,has,been'
p49946
g9
sS'include,aminosalicylic,acid'
p49947
g9
sS'the,selective,toxicity'
p49948
g3
sS'vitro,interferes,minimally'
p49949
g9
sS'is,made,to'
p49950
g3
sS'its,capacity,to'
p49951
g9
sS'and,slight,decreases'
p49952
g9
sS'included,a,mcg'
p49953
g3
sS'markers,that,identify'
p49954
g9
sS'substrates,has,not'
p49955
g3
sS'transient,delirium,has'
p49956
g9
sS'dose-dependent,inhibition,of'
p49957
g9
sS'musculoskeletal,adverse,events'
p49958
g3
sS'stimulation,of,the'
p49959
g3
sS'auc,with,the'
p49960
g3
sS'international,pharmaceutical,abstracts'
p49961
g3
sS'as,strong,inhibitors'
p49962
g3
sS'topo,in,particular'
p49963
g3
sS'between,oral,and'
p49964
g9
sS'patient,feels,better'
p49965
g3
sS'protease,inhibitors,in'
p49966
g9
sS'cordarone,administration,impairs'
p49967
g3
sS'with,beta-adrenergic,blockers'
p49968
g9
sS'did,not,indicate'
p49969
g9
sS'if,the,is'
p49970
g3
sS'been,well,tolerated'
p49971
g3
sS'taking,this,medicine'
p49972
g3
sS'investigated,the,effect'
p49973
g3
sS'with,the,following'
p49974
g3
sS'pharmacology,of,all'
p49975
g3
sS'hcl,has,also'
p49976
g3
sS'in,two,other'
p49977
g9
sS'either,grapefruit,or'
p49978
g3
sS'cardiovascular,risk,than'
p49979
g3
sS'increasing,steady-state,concentrations'
p49980
g9
sS'of,pipracil,produces'
p49981
g9
sS'day,against,positive'
p49982
g3
sS'radical-mediated,tissue,damage'
p49983
g9
sS'and,increased,amounts'
p49984
g3
sS'quinolones,have,also'
p49985
g9
sS'and,liver,is'
p49986
g9
sS'also,in,vitro'
p49987
g3
sS'enzyme-based,tests,for'
p49988
g3
sS'reduce,seizure,control'
p49989
g9
sS'concentrations,of,probably'
p49990
g9
sS'monitoring,of,patients'
p49991
g3
sS'the,cocaine-treated,animals'
p49992
g3
sS'to,the,trans-diol'
p49993
g3
sS'in,increased,urinary'
p49994
g3
sS'to,the,use'
p49995
g3
sS'may,be,achieved'
p49996
g3
sS'the,intravenous,prodrug'
p49997
g3
sS'consideration,when,selecting'
p49998
g9
sS'cns,toxicity,brain'
p49999
g3
sS'the,release,whereas'
p50000
g3
sS'medications,that,are'
p50001
g3
sS'characterized,by,weakness'
p50002
g9
sS'to,require,replacement'
p50003
g9
sS'the,excretion,of'
p50004
g9
sS'of,anticoagulation,levels'
p50005
g3
sS'formal,interaction,study'
p50006
g3
sS'and,theasinensin,a'
p50007
g3
sS'relief,of,breakthrough'
p50008
g3
sS'dose,adjustments,may'
p50009
g3
sS'avoided,except,in'
p50010
g9
sS'experience,profile,seen'
p50011
g3
sS'the,beta-adrenergic,blocker'
p50012
g9
sS'antihypertensives,amphetamines,may'
p50013
g9
sS'although,they,should'
p50014
g3
sS'between,camptosar,and'
p50015
g3
sS'the,aldehyde,oxidase'
p50016
g3
sS'randomized,crossover,design'
p50017
g3
sS'should,be,a'
p50018
g3
sS'hours,of,the'
p50019
g9
sS'of,micrograms,ml'
p50020
g3
sS'in,close,collaboration'
p50021
g3
sS'impairment,there,are'
p50022
g3
sS'increases,the,clearance'
p50023
g9
sS'interfere,with,intestinal'
p50024
g9
sS'for,oral,solution'
p50025
g9
sS'effects,may,be'
p50026
g3
sS'although,the,magnitude'
p50027
g9
sS'therapy,and,had'
p50028
g9
sS'these,are,inhibitors'
p50029
g3
sS'mood,and,subjective'
p50030
g3
sS'were,extensive,metabolizers'
p50031
g9
sS'to,the,therapy'
p50032
g9
sS'use,of,retinal'
p50033
g3
sS'bsa,when,administered'
p50034
g3
sS'formal,studies,of'
p50035
g3
sS'dosing,adjustments,are'
p50036
g3
sS'the,us,a'
p50037
g3
sS'these,problems,and'
p50038
g3
sS'for,that,can'
p50039
g3
sS'treatment,of,some'
p50040
g3
sS'to,miracidia,of'
p50041
g3
sS'transcription,was,strongly'
p50042
g3
sS'passage,and,produced'
p50043
g3
sS'gm,daily,for'
p50044
g9
sS'receiving,hcl,alternatives'
p50045
g9
sS'antagonists,the,effect'
p50046
g3
sS'may,have,allergic'
p50047
g3
sS'order,to,avoid'
p50048
g3
sS'morbidity,from,ois'
p50049
g3
sS'arrhythmias,or,toxicity'
p50050
g3
sS'stopping,concomitantly,administered'
p50051
g3
sS'reported,chiefly,with'
p50052
g3
sS'to,control,side'
p50053
g3
sS'and,about,fold'
p50054
g3
sS'of,topoisomerases,in'
p50055
g3
sS'known,if,hormonal'
p50056
g3
sS'extract,from,the'
p50057
g3
sS'inhalation,aerosol,and'
p50058
g3
sS'steady,state,while'
p50059
g9
sS'has,been,definitely'
p50060
g3
sS'the,template,bleeding'
p50061
g3
sS'incombination,with,with'
p50062
g3
sS'other,that,have'
p50063
g9
sS'risks,of,using'
p50064
g3
sS'in,ecg,heart'
p50065
g3
sS'supplements,oral,or'
p50066
g3
sS'an,individualized,fixed'
p50067
g3
sS'tachycardia,and,gastrointestinal'
p50068
g3
sS'about,a,increase'
p50069
g9
sS'contractility,conductivity,and'
p50070
g9
sS'nonsteroidal,anti-inflammatory,nsaids'
p50071
g9
sS'interactions,no,clinically'
p50072
g3
sS'and,a,cyp3a4'
p50073
g3
sS'antiepileptic,and,the'
p50074
g9
sS'resolved,with,continuation'
p50075
g3
sS'of,and,similarly'
p50076
g9
sS'and,mg,iv'
p50077
g3
sS'use,of,increases'
p50078
g9
sS'mg,qid,n'
p50079
g9
sS'basis,for,this'
p50080
g9
sS'inhibition,of,any'
p50081
g3
sS'a,similar,length'
p50082
g9
sS'as,the,sole'
p50083
g3
sS'by,factors,of'
p50084
g3
sS'presence,of,using'
p50085
g3
sS'motility,dysfunction,may'
p50086
g3
sS'that,the,cardiovascular'
p50087
g9
sS'days,systemic,exposure'
p50088
g9
sS'sensitivity,to,chemotherapy'
p50089
g3
sS'mask,the,residual'
p50090
g9
sS'dose,of,itraconazole'
p50091
g3
sS'infarction,vs,serious'
p50092
g9
sS'fold,increase,of'
p50093
g9
sS'show,subnormal,pancreatic'
p50094
g3
sS'effects,of,concomitant'
p50095
g3
sS'bezalip,retard,may'
p50096
g9
sS'if,higher,dosages'
p50097
g3
sS'differ,in,their'
p50098
g3
sS'in,adults,at'
p50099
g9
sS'with,normal,subjects'
p50100
g3
sS'welchol,was,found'
p50101
g3
sS'serum,assays,when'
p50102
g3
sS'a,wide,variety'
p50103
g3
sS'clinical,presentation,and'
p50104
g3
sS'only,at,the'
p50105
g3
sS'to,cause,prolonged'
p50106
g3
sS'p-type,channel,and'
p50107
g3
sS'tests,response,to'
p50108
g3
sS'erection,disorder,attention'
p50109
g3
sS'agents,some,and'
p50110
g9
sS'perioperative,administration,of'
p50111
g3
sS'conducted,at,intermediate'
p50112
g3
sS'heparin,other,and'
p50113
g3
sS'to,establish,strategies'
p50114
g3
sS'the,mechanisms,underlying'
p50115
g3
sS'increased,effects,when'
p50116
g9
sS'effective,than,to'
p50117
g3
sS'studies,of,concomitant'
p50118
g3
sS'detected,except,for'
p50119
g3
sS'in,fluoride,levels'
p50120
g3
sS'the,tyrosine,phosphorylation'
p50121
g3
sS'may,diminish,the'
p50122
g9
sS'by,the,elevation'
p50123
g3
sS'foscarnet,and,aminoglycosides'
p50124
g9
sS'after,the,same'
p50125
g9
sS'have,additive,or'
p50126
g9
sS'polyene,many,like'
p50127
g3
sS'has,been,evaluated'
p50128
g3
sS'isomer,of,racemic'
p50129
g9
sS'and,estrogen-containing,compounds'
p50130
g9
sS'therapy,with,is'
p50131
g3
sS'hydroxide,containing,to'
p50132
g9
sS'to,occasionally,intensify'
p50133
g9
sS'in,vivo,particularly'
p50134
g3
sS'store,from,the'
p50135
g3
sS'binding,is,not'
p50136
g3
sS'within,the,recommended'
p50137
g3
sS'which,the,doses'
p50138
g3
sS'severe,hyperkalemia,in'
p50139
g9
sS'was,unaltered,by'
p50140
g3
sS'nervous,e-strain,subjects'
p50141
g3
sS'is,about,to'
p50142
g9
sS'estrogen-containing,therapies,should'
p50143
g9
sS'including,nonsteroidal,anti-inflammatory'
p50144
g9
sS'enhance,in,tissue'
p50145
g9
sS'condition,in,which'
p50146
g9
sS'loratadine,and,descarboethoxyloratadine'
p50147
g3
sS'days,results,in'
p50148
g9
sS'by,the,effects'
p50149
g3
sS'duloxetine,and,were'
p50150
g3
sS'concentrations,are,observed'
p50151
g3
sS'included,seven,cerebrovascular'
p50152
g3
sS'coadministration,of,once'
p50153
g9
sS'an,effect,of'
p50154
g3
sS'by,cyp2d6,with'
p50155
g3
sS'be,monitored,frequently'
p50156
g9
sS'regular,users,of'
p50157
g3
sS'in,simultaneous,treatment'
p50158
g9
sS'an,effect,on'
p50159
g3
sS'at,concentrations,as'
p50160
g3
sS'oral,with,must'
p50161
g9
sS'that,reduce,renal'
p50162
g3
sS'prolonged,long,acting'
p50163
g9
sS'in,secretions,such'
p50164
g3
sS'clinical,pharmacology,drug-'
p50165
g3
sS'inhaled,such,as'
p50166
g3
sS'with,busulfex,may'
p50167
g9
sS'medications,used,concomitantly'
p50168
g3
sS'in,long,surgical'
p50169
g9
sS'been,observed,more'
p50170
g3
sS'if,and,or'
p50171
g9
sS'expected,to,prolong'
p50172
g9
sS'as,are,employed'
p50173
g9
sS'modify,exposed,histidine'
p50174
g3
sS'of,innovar,on'
p50175
g3
sS'platelet-aggregation,reactions,the'
p50176
g9
sS'drug,administration,in'
p50177
g3
sS'of,tricyclic,antidepressant'
p50178
g3
sS'not,reduce,basal'
p50179
g3
sS'diabetic,patients,without'
p50180
g3
sS'assay,and,in'
p50181
g3
sS'the,tca,may'
p50182
g9
sS'faecalis,atcc,showed'
p50183
g3
sS'its,protein,binding'
p50184
g9
sS'dose,in,accordance'
p50185
g3
sS'significantly,increased,the'
p50186
g9
sS'effect,on,hepatic'
p50187
g3
sS'activity,may,also'
p50188
g3
sS'of,the,combined'
p50189
g3
sS'caution,if,at'
p50190
g9
sS'treating,patients,with'
p50191
g3
sS'fraction,of,drug'
p50192
g3
sS'of,innovar,or'
p50193
g9
sS'mg,day,and'
p50194
g9
sS'coadministration,of,viracept'
p50195
g3
sS'absorption,of,other'
p50196
g3
sS'pain,medication,used'
p50197
g3
sS'aom,mg,kg'
p50198
g3
sS'cimetidine,cimetidine,has'
p50199
g9
sS'are,direct,cardiac'
p50200
g9
sS'tendency,produced,by'
p50201
g9
sS'or,increased,sedation'
p50202
g3
sS'indicated,in,the'
p50203
g9
sS'and,other,aeds'
p50204
g3
sS'as,sulfamethoxazole-trimethoprim,bactrim'
p50205
g3
sS'concentrations,of,azole'
p50206
g9
sS'autonomic,irritability,and'
p50207
g9
sS'with,intravenous,administration'
p50208
g3
sS'many,angiotensin-converting,enzyme'
p50209
g9
sS'against,this,pathogen'
p50210
g3
sS'dose,of,diamox'
p50211
g9
sS'unexpected,adverse,effects'
p50212
g3
sS'day,is,easy'
p50213
g3
sS'was,in,respect'
p50214
g3
sS'treated,with,proton'
p50215
g9
sS'modify,the,rate'
p50216
g3
sS'modern,medications,can'
p50217
g3
sS'reduced,antihypertensive,effect'
p50218
g3
sS'intravenous,iv,injection'
p50219
g9
sS'and,that,tests'
p50220
g3
sS'chelation,and,these'
p50221
g3
sS'non-specialist,hospitals,usually'
p50222
g3
sS'day,are,used'
p50223
g3
sS'this,conference,reviews'
p50224
g3
sS'to,inhibit,p450'
p50225
g9
sS'sulfoxide,were,about'
p50226
g9
sS'capsules,and,resulted'
p50227
g9
sS'analogues,which,promote'
p50228
g9
sS'eight-fold,increase,of'
p50229
g9
sS'not,readily,obtainable'
p50230
g3
sS'of,blocking,hepatic'
p50231
g9
sS'motility,agent,contraindicated'
p50232
g3
sS'increased,mean,plasma'
p50233
g9
sS'a6,and,e1'
p50234
g3
sS'of,food,on'
p50235
g3
sS'concentration,of,synthetic'
p50236
g9
sS'of,fibrinogen,to'
p50237
g3
sS'pharmacologic,doses,of'
p50238
g3
sS'any,clinical,signs'
p50239
g9
sS'worsened,glucose,control'
p50240
g3
sS'reduced,interaction,between'
p50241
g3
sS'to,worsen,the'
p50242
g3
sS'disease,including,or'
p50243
g3
sS'of,insufficient,to'
p50244
g9
sS'concomitantly,with,produces'
p50245
g9
sS'on,replacement,therapy'
p50246
g3
sS'beta-adrenergic,blockers,or'
p50247
g9
sS'endogenous,secretion,was'
p50248
g3
sS'causative,factors,may'
p50249
g3
sS'beta-adrenergic,blocking,action'
p50250
g9
sS'thus,concomitant,administration'
p50251
g9
sS'and,aluminum-containing,administered'
p50252
g9
sS'with,another,known'
p50253
g3
sS'difficulty,once,the'
p50254
g3
sS'increases,in,serum'
p50255
g9
sS'modified,by,the'
p50256
g9
sS'taking,fortovase,as'
p50257
g3
sS'patient,with,a'
p50258
g9
sS'its,effect,on'
p50259
g3
sS'were,and,micrograms'
p50260
g3
sS'a,atp,oxaloacetate'
p50261
g3
sS'animal,in,the'
p50262
g3
sS'cyp3a4,substrate,by'
p50263
g9
sS'nicotine-induced,release,in'
p50264
g9
sS'approximately,one-third,to'
p50265
g9
sS'pressure,has,stabilized'
p50266
g3
sS'reaction,during,treatment'
p50267
g3
sS'a,b-cell,lymphoma'
p50268
g3
sS'methotrexate,ibuprofen,as'
p50269
g9
sS'research,is,needed'
p50270
g3
sS'is,changed,by'
p50271
g9
sS'mainly,concerns,the'
p50272
g3
sS'patients,including,the'
p50273
g3
sS'the,mitogenic,activity'
p50274
g9
sS'clinicians,should,be'
p50275
g9
sS'or,decreases,the'
p50276
g9
sS'can,prevent,or'
p50277
g3
sS'm,v,decreased'
p50278
g3
sS'potentiate,or,weaken'
p50279
g9
sS'required,or,may'
p50280
g9
sS'protease,inhibitors,macrolide'
p50281
g3
sS'anticoagulant,activity,should'
p50282
g9
sS'a,subsequent,to'
p50283
g9
sS'under,the,influence'
p50284
g3
sS'of,amicar,transient'
p50285
g3
sS'suggest,that,oral'
p50286
g9
sS'enterococci,highlights,novel'
p50287
g3
sS'in,vivo,resulting'
p50288
g9
sS'that,induce,cyp'
p50289
g9
sS'valproate,the,addition'
p50290
g9
sS'concurrently,and,to'
p50291
g3
sS'time,and,an'
p50292
g3
sS'hydrochloride,either,had'
p50293
g9
sS'a,complete,and'
p50294
g9
sS'v,solution,of'
p50295
g3
sS'kappa,and,possibly'
p50296
g3
sS'for,arava,levels'
p50297
g9
sS'medium,consisting,of'
p50298
g3
sS'great,extent,with'
p50299
g3
sS'with,cyp3a4,substrates'
p50300
g9
sS'and,dyspnea,concomitant'
p50301
g9
sS'of,habituation,or'
p50302
g3
sS'of,or,decreases'
p50303
g9
sS'alternative,hypoglycemic,agents'
p50304
g9
sS'blocking,compounds,because'
p50305
g3
sS'pharmacokinetics,were,observed'
p50306
g3
sS'receiving,the,administration'
p50307
g9
sS'or,skin,medicines'
p50308
g3
sS'affect,the,clearance'
p50309
g3
sS'clinical,pharmacology,drug'
p50310
g9
sS'nacmc,and,cmc-cys'
p50311
g3
sS'the,toxicokinetic,interferences'
p50312
g3
sS'of,influence,through'
p50313
g3
sS'increase,in,thedosage'
p50314
g3
sS'muscle,relaxants,are'
p50315
g3
sS'of,the,cytochrome'
p50316
g3
sS'were,administered,to'
p50317
g3
sS'whom,therapy,was'
p50318
g9
sS'trial,in,normal'
p50319
g9
sS'the,currently,available'
p50320
g3
sS'these,in,vivo'
p50321
g3
sS'of,that,observed'
p50322
g3
sS'and,d,h'
p50323
g9
sS'however,careful,attention'
p50324
g9
sS'or,or,mg'
p50325
g3
sS'of,cholesterol,and'
p50326
g9
sS'regimens,has,been'
p50327
g3
sS'be,dispersed,in'
p50328
g3
sS'negative,results,from'
p50329
g3
sS'maximal,exercise,testing'
p50330
g3
sS'disodium,in,animals'
p50331
g9
sS'to,the,active'
p50332
g3
sS'with,either,secobarbitone'
p50333
g9
sS'cause,tumors,and'
p50334
g9
sS'valproic,acid,the'
p50335
g3
sS'when,coadminstered,with'
p50336
g9
sS'and,define,positive'
p50337
g3
sS'its,affinity,for'
p50338
g3
sS'there,are,types'
p50339
g3
sS'fenbufen,is,not'
p50340
g3
sS'does,not,alter'
p50341
g3
sS'depressants,may,still'
p50342
g9
sS'patients,with,disease'
p50343
g3
sS'signs,salivary,cortisol'
p50344
g3
sS'agents,clomipramine,hcl'
p50345
g9
sS'watched,very,closely'
p50346
g9
sS'as,stadol,ns'
p50347
g3
sS'this,article,reviews'
p50348
g3
sS'normal,subjects,no'
p50349
g9
sS'at,least,seven'
p50350
g3
sS'those,for,which'
p50351
g3
sS'sera,from,patients'
p50352
g3
sS'amiodarone,may,suppress'
p50353
g3
sS'quantity,and,specific'
p50354
g3
sS'of,cleavable,complex'
p50355
g3
sS'most,commonly,to'
p50356
g3
sS'psychotropic,agents,such'
p50357
g9
sS'modification,of,the'
p50358
g9
sS'the,density,of'
p50359
g3
sS'suggest,any,clinical'
p50360
g3
sS'in,association,with'
p50361
g9
sS'n-acetyltransferase,may,have'
p50362
g9
sS'tonic,convulsion,was'
p50363
g3
sS'with,caution,since'
p50364
g3
sS'studied,systematically,in'
p50365
g3
sS'involved,in,the'
p50366
g3
sS'of,cyp2d6,increase'
p50367
g3
sS'although,the,proposed'
p50368
g3
sS'oxidative,stress,in'
p50369
g9
sS'parietal,cells,in'
p50370
g3
sS'sustained-release,channel,blockers'
p50371
g3
sS'ml,min,and'
p50372
g3
sS'microsome,studies,and'
p50373
g3
sS'total,concentrations,increased'
p50374
g9
sS'events,or,qtc'
p50375
g3
sS'borne,in,mind'
p50376
g9
sS'setting,cardioselective,could'
p50377
g3
sS'clearance,by,fold'
p50378
g9
sS'treatment,with,eg'
p50379
g3
sS'concentrations,of,ionized'
p50380
g3
sS'indicate,that,binds'
p50381
g3
sS'if,is,to'
p50382
g3
sS'in,evaluating,abnormal'
p50383
g3
sS'both,and,have'
p50384
g3
sS'induce,abnormalities,in'
p50385
g3
sS'as,control,and'
p50386
g3
sS'oral,mg,twice'
p50387
g9
sS'beta2,agonists,because'
p50388
g9
sS'cyp3a,channel,blockers'
p50389
g3
sS'indicate,that,dosage'
p50390
g3
sS'to,occasionally,induce'
p50391
g3
sS'synergistic,effect,with'
p50392
g9
sS'cardiovascular,disease,is'
p50393
g3
sS'in,the,large'
p50394
g3
sS'mg,qd,of'
p50395
g3
sS'the,pediatric,powder'
p50396
g9
sS'although,betagan,used'
p50397
g9
sS'based,on,in'
p50398
g9
sS'and,fold,prolongation'
p50399
g3
sS'mg,qd,or'
p50400
g3
sS'relevant,significant,changes'
p50401
g3
sS'antitumor,effectiveness,of'
p50402
g9
sS'transient,outward,rectification'
p50403
g3
sS'co-administration,mean,trough'
p50404
g3
sS'p-450,for,days'
p50405
g9
sS'possible,interactions,particularly'
p50406
g3
sS'symptoms,resolved,within'
p50407
g3
sS'results,in,increased'
p50408
g9
sS'usp,should,not'
p50409
g9
sS'between,homopolyribonucleotides,and'
p50410
g3
sS'intravenous,adenocard,has'
p50411
g3
sS'blockade,will,be'
p50412
g3
sS'coma,and,death'
p50413
g9
sS'alone,caused,identical'
p50414
g3
sS'specific,drug,interaction'
p50415
g3
sS'nucleophosmin,b23,in'
p50416
g3
sS'by,separate,brain'
p50417
g3
sS'of,absolute,in'
p50418
g3
sS'o,every,hours'
p50419
g9
sS'of,local,solutions'
p50420
g9
sS'washout,period,followed'
p50421
g3
sS'however,it,is'
p50422
g3
sS'can,be,applied'
p50423
g3
sS'were,administered,orally'
p50424
g3
sS'shown,to,double'
p50425
g9
sS'resistance,to,crixivan'
p50426
g3
sS'supine,systolic,diastolic'
p50427
g9
sS'cyp2d6,metabolizers,after'
p50428
g3
sS'bacteriostatic,such,as'
p50429
g9
sS'induced,by,in'
p50430
g9
sS'use,of,products'
p50431
g9
sS'incoordination,have,been'
p50432
g9
sS'that,dosage,adjustment'
p50433
g3
sS'antagonize,the,decreases'
p50434
g9
sS'systemic,non-hodgkin,lymphoma'
p50435
g3
sS'of,toxic,reactions'
p50436
g3
sS'in,contrast,to'
p50437
g3
sS'administered,in,order'
p50438
g3
sS'a,potential,interaction'
p50439
g9
sS'food,and,drug'
p50440
g3
sS'demonstrated,large,numbers'
p50441
g3
sS'decrease,plasma,concentrations'
p50442
g9
sS'mouse,model,using'
p50443
g3
sS'intestinal,adsorbents,and'
p50444
g9
sS'binding,sites,are'
p50445
g3
sS'a,exerts,its'
p50446
g3
sS'with,concurrently,administered'
p50447
g9
sS'such,as,etc'
p50448
g9
sS'of,were,administered'
p50449
g9
sS'to,treat,the'
p50450
g3
sS'latency,for,most'
p50451
g3
sS'of,and,signs'
p50452
g3
sS'than,the,in'
p50453
g3
sS'sodium,iodide,i'
p50454
g3
sS'any,of,the'
p50455
g3
sS'two,outbreaks,of'
p50456
g3
sS'in,decreased,psychomotor'
p50457
g3
sS'cmax,differences,were'
p50458
g3
sS'day,and,mg'
p50459
g9
sS'antagonists,and,brovana'
p50460
g9
sS'and,nor,the'
p50461
g3
sS'marplan,nardil,matulane'
p50462
g3
sS'removal,was,achieved'
p50463
g3
sS'unless,in,the'
p50464
g9
sS'concurrently,being,treated'
p50465
g9
sS'been,reported,with'
p50466
g9
sS'in,proteins,interacting'
p50467
g3
sS'corresponding,values,for'
p50468
g3
sS'lastly,local,use'
p50469
g3
sS'since,there,have'
p50470
g9
sS'meaningfully,alter,the'
p50471
g3
sS'a2,cyp1a2,is'
p50472
g3
sS'of,should,not'
p50473
g9
sS'approach,to,dosing'
p50474
g3
sS'no,clinical,or'
p50475
g3
sS'prothrombin,times,when'
p50476
g9
sS'mg,bid,in'
p50477
g9
sS'of,glucose,alkaline'
p50478
g3
sS'the,perioperative,period'
p50479
g9
sS'less,toxic,to'
p50480
g3
sS'to,increase,and'
p50481
g9
sS'min,before,the'
p50482
g3
sS'thus,not,proliferation-dependent'
p50483
g3
sS'gel,on,the'
p50484
g3
sS'during,a,course'
p50485
g3
sS'we,propose,these'
p50486
g9
sS'virtually,all,research'
p50487
g3
sS'inhibitors,psychotropic,medications'
p50488
g9
sS'ii,v,vii'
p50489
g3
sS'and,stimulation,of'
p50490
g3
sS'cardiac,stimulants,and'
p50491
g9
sS'subject,to,p450-based'
p50492
g3
sS'and,cns,depressant'
p50493
g9
sS'dose,of,felbatol'
p50494
g9
sS'and,or,effect'
p50495
g9
sS'diet,for,weeks'
p50496
g9
sS'therapy,with,camptosar'
p50497
g9
sS'control,and,received'
p50498
g3
sS'then,careful,adjustment'
p50499
g9
sS'to,subjects,already'
p50500
g9
sS'serum,levels,and'
p50501
g9
sS'showed,that,concomitant'
p50502
g3
sS'should,also,not'
p50503
g9
sS'consequently,it,is'
p50504
g9
sS'was,fold,greater'
p50505
g3
sS'homocysteine,excretion,rate'
p50506
g3
sS'long-term,carcinogenicity,studies'
p50507
g3
sS'vaccinations,with,attenuated'
p50508
g3
sS'concentrations,which,have'
p50509
g3
sS'clearance,of,fludrocortisone'
p50510
g9
sS'prolongation,and,have'
p50511
g3
sS'unchanged,following,coadministration'
p50512
g3
sS'fumarate,seroquel,is'
p50513
g3
sS'an,are,used'
p50514
g9
sS'anti-asthma,medications,including'
p50515
g3
sS'of,methaemoglobinaemia,particularly'
p50516
g3
sS'these,disturbances,have'
p50517
g9
sS'is,an,increased'
p50518
g3
sS's-warfarin,and,respectively'
p50519
g9
sS'endocrine,status,of'
p50520
g3
sS'the,clinician,responsible'
p50521
g3
sS'experience,there,have'
p50522
g9
sS'potentiates,other,cholinesterase'
p50523
g9
sS'organic,were,used'
p50524
g9
sS'of,functional,antagonism'
p50525
g9
sS'activity,ganglionic,blocking'
p50526
g3
sS'of,dmpge2,induces'
p50527
g3
sS'tolerated,and,of'
p50528
g9
sS'different,from,the'
p50529
g3
sS'by,such,factors'
p50530
g3
sS'theophylline,clearance,may'
p50531
g3
sS'liver,aminotransferases,was'
p50532
g3
sS'of,hydrochloride,given'
p50533
g9
sS'resulted,from,a'
p50534
g9
sS'on,concomitant,therapy'
p50535
g9
sS'however,up,to'
p50536
g3
sS'neurons,hyperpolarized,by'
p50537
g3
sS'pharmacodynamic,effects,can'
p50538
g3
sS'escalating,doses,up'
p50539
g3
sS'elevated,levels,have'
p50540
g9
sS'experience,a,precipitous'
p50541
g9
sS'molecular,level,by'
p50542
g3
sS'affect,protein,tyrosine'
p50543
g3
sS'compounds,rather,than'
p50544
g3
sS'pills,is,reduced'
p50545
g9
sS'modifications,based,on'
p50546
g3
sS'eg,and,other'
p50547
g9
sS'of,vardenafil,in'
p50548
g9
sS'patients,given,both'
p50549
g9
sS'long-term,administration,of'
p50550
g3
sS'female,dog,that'
p50551
g3
sS'antagonists,such,as'
p50552
g9
sS'but,may,reduce'
p50553
g9
sS'in,evaluating,the'
p50554
g3
sS'to,decrease,in'
p50555
g3
sS'had,a,small'
p50556
g3
sS'of,enhancement,of'
p50557
g3
sS'particles,appeared,to'
p50558
g3
sS'to,mg,b'
p50559
g3
sS'are,also,receiving'
p50560
g3
sS'time,necessitating,an'
p50561
g3
sS'used,together,with'
p50562
g9
sS'concentrations,of,both'
p50563
g9
sS'prinivil,an,additional'
p50564
g9
sS'requires,tikosyn,and'
p50565
g9
sS'fatal,reactions,including'
p50566
g9
sS'of,the,cyp2d6'
p50567
g9
sS'm,decins,sans'
p50568
g3
sS'phase,was,detected'
p50569
g3
sS'hypertriglyceridemia,was,hypercholesterolemia'
p50570
g3
sS'additive,interaction,with'
p50571
g9
sS'use,products,that'
p50572
g9
sS'antagonists,increased,mean'
p50573
g9
sS'in,maximal,plasma'
p50574
g9
sS'the,levorotatory,isomer'
p50575
g3
sS'important,to,identify'
p50576
g3
sS'did,slightly,enhance'
p50577
g9
sS'interactions,between,uroxatral'
p50578
g3
sS'concentrate,should,not'
p50579
g9
sS'symptom,onset,were'
p50580
g3
sS'coadministration,of,femara'
p50581
g9
sS'between,mealtime,dosing'
p50582
g3
sS'should,not,normally'
p50583
g3
sS'patients,receiving,hmg-coa'
p50584
g9
sS'hours,before,resulted'
p50585
g9
sS'which,patients,with'
p50586
g9
sS'herbal,supplement,st'
p50587
g3
sS'human,auc,based'
p50588
g3
sS'were,noted,with'
p50589
g3
sS'on,the,translocation'
p50590
g3
sS'the,three,concentrations'
p50591
g3
sS'route,and,should'
p50592
g9
sS'to,possible,decrease'
p50593
g9
sS'underwent,trans-placental,passage'
p50594
g3
sS'of,coumarin-type,has'
p50595
g3
sS'occur,sometimes,with'
p50596
g3
sS'probe,study,demonstrated'
p50597
g3
sS'for,days,as'
p50598
g9
sS'survival,needs,urgently'
p50599
g3
sS'effect,of,systemic'
p50600
g9
sS'placental,vessels,to'
p50601
g9
sS'in,clinically,significant'
p50602
g3
sS'edema,has,been'
p50603
g9
sS'was,separated,by'
p50604
g3
sS'primary,elimination,route'
p50605
g9
sS'tricyclic,antidepressant,agent'
p50606
g3
sS'metabolized,and,therefore'
p50607
g3
sS'the,concomitant,or'
p50608
g9
sS'is,the,risk'
p50609
g3
sS'difference,between,the'
p50610
g3
sS'of,by,competitive'
p50611
g9
sS'a,kg,person'
p50612
g3
sS'therapy,may,cause'
p50613
g3
sS'situ,ligated,duodenal'
p50614
g3
sS'but,these,changes'
p50615
g3
sS'test,has,been'
p50616
g3
sS'antagonist,has,been'
p50617
g9
sS'this,effect,was'
p50618
g9
sS'plasma,membrane,and'
p50619
g3
sS'significantly,improved,the'
p50620
g3
sS'secretion,and,increase'
p50621
g3
sS'medications,can,do'
p50622
g3
sS'have,been,started'
p50623
g3
sS'not,attenuated,by'
p50624
g3
sS'including,indocin,is'
p50625
g9
sS'glucuronidation,being,a'
p50626
g3
sS'high-dose,and,carbonic'
p50627
g9
sS'volunteers,under,fasting'
p50628
g3
sS'of,bleeding,particularly'
p50629
g9
sS'between,and,intravenously'
p50630
g9
sS'of,nor,does'
p50631
g3
sS'rarely,with,concomitant'
p50632
g9
sS'that,the,homodimeric'
p50633
g3
sS'sulindac,the,concomitant'
p50634
g9
sS'to,control,hypertension'
p50635
g9
sS'test,results,in'
p50636
g3
sS'orencia,has,been'
p50637
g9
sS'circulating,total,hormone'
p50638
g3
sS'receive,tablets,at'
p50639
g3
sS'agents,affecting,cytochrome'
p50640
g3
sS'taken,at,and'
p50641
g9
sS'sometimes,proves,to'
p50642
g9
sS'amount,of,placebo'
p50643
g3
sS'other,nonsteroidal,probably'
p50644
g9
sS'mg,given,once'
p50645
g9
sS'swine,has,resulted'
p50646
g3
sS'in,reversing,resistance'
p50647
g3
sS'cadmium,and,to'
p50648
g3
sS'naproxen,and,other'
p50649
g9
sS'sonata,mg,and'
p50650
g9
sS'be,delayed,for'
p50651
g9
sS'in,cyp,d6'
p50652
g9
sS'the,protein,binding'
p50653
g9
sS'inr,and,prothrombin'
p50654
g3
sS'of,other,related'
p50655
g9
sS'micro-dosed,preparations,minipills'
p50656
g9
sS'antacids,containing,hydroxide'
p50657
g9
sS'have,been,completed'
p50658
g3
sS'measures,to,minimise'
p50659
g3
sS'antipsychotic,activity,preclinical'
p50660
g3
sS'the,pressor,effects'
p50661
g9
sS'tests,may,be'
p50662
g3
sS'estimation,of,tolerance'
p50663
g3
sS'data,from,this'
p50664
g3
sS'class,including,for'
p50665
g9
sS'microsomal,drug,metabolism'
p50666
g9
sS'previous,findings,these'
p50667
g3
sS'supplements,might,have'
p50668
g3
sS'steady-state,cmin,increased'
p50669
g3
sS'at,hr,p'
p50670
g3
sS'are,being,monitored'
p50671
g3
sS'mixtures,of,cadmium'
p50672
g3
sS'pancreatic,release,and'
p50673
g3
sS'treatments,with,constant'
p50674
g3
sS'dictates,careful,monitoring'
p50675
g9
sS'provided,significant,protection'
p50676
g9
sS'liquid,chromatographic,assay'
p50677
g3
sS'induced,arc,mrna'
p50678
g3
sS'oral,birth,control'
p50679
g3
sS'and,blood,in'
p50680
g3
sS'high-density,lipoproteins,and'
p50681
g3
sS'including,those,with'
p50682
g3
sS'maintained,patients,beginning'
p50683
g9
sS'enzyme,inducers,are'
p50684
g9
sS'may,also,adversely'
p50685
g9
sS'anti-,inflammatory,agents'
p50686
g9
sS'c9,have,not'
p50687
g3
sS'oral,anticoagulants,thyroid'
p50688
g3
sS'after,the,long-term'
p50689
g3
sS'a,pharmacological,analysis'
p50690
g3
sS'of,synthetic,possibly'
p50691
g9
sS'compromise,the,beneficial'
p50692
g9
sS'gram,absorption,of'
p50693
g9
sS'in,vitro,sodium'
p50694
g3
sS'nervous,system,may'
p50695
g3
sS'day,increased,the'
p50696
g9
sS'clinically,warranted,appropriate'
p50697
g9
sS'interfere,with,the'
p50698
g9
sS'xanthine,derivatives,or'
p50699
g9
sS'was,decreased,an'
p50700
g9
sS'of,toxicity,associated'
p50701
g9
sS'that,m,was'
p50702
g3
sS'risk,of,rashes'
p50703
g3
sS'laboratory,testing,should'
p50704
g9
sS'k,antagonists,drugs'
p50705
g9
sS'racemic,celexa,the'
p50706
g9
sS'affect,the,conversion'
p50707
g3
sS'not,known,whether'
p50708
g3
sS'indicate,that,homocysteine'
p50709
g3
sS'inhalation,dose,in'
p50710
g3
sS'monitoring,of,the'
p50711
g3
sS'toxicity,tests,showed'
p50712
g3
sS'range,and,or'
p50713
g3
sS'in,three,separate'
p50714
g3
sS'synergistically,to,increase'
p50715
g3
sS'to,a,maintenance'
p50716
g9
sS'given,concomitantly,in'
p50717
g9
sS'enhanced,if,combination'
p50718
g9
sS'from,a,pulse'
p50719
g3
sS'epidemics,of,arsenical'
p50720
g3
sS'to,the,expected'
p50721
g3
sS'rabbit,kidney,cell'
p50722
g3
sS'difluoroacetone,in,the'
p50723
g9
sS'the,two,treatment'
p50724
g3
sS'other,concomitant,therapy'
p50725
g3
sS'reflective,of,a'
p50726
g3
sS'levels,may,increase'
p50727
g3
sS'concomitant,supplementation,with'
p50728
g3
sS'the,rest,were'
p50729
g3
sS'striking,and,sustained'
p50730
g9
sS'rat,brain,and'
p50731
g9
sS'on,the,sensitivity'
p50732
g3
sS'are,mainly,metabolized'
p50733
g9
sS'of,these,reports'
p50734
g3
sS'between,both,at'
p50735
g3
sS'reported,concomitant,use'
p50736
g9
sS'with,and,laboratory'
p50737
g3
sS'administration,should,also'
p50738
g9
sS'treated,with,acamprosate'
p50739
g3
sS'a,substrate,is'
p50740
g3
sS'bwt,were,given'
p50741
g3
sS'there,was,about'
p50742
g9
sS'antidiuretic,hormone,and'
p50743
g3
sS'the,day,preferably'
p50744
g3
sS'in,a,compensatory'
p50745
g3
sS'liver,microsomes,cyp1a2'
p50746
g3
sS'induced,by,intraventricular'
p50747
g3
sS'l057,was,approximately'
p50748
g3
sS'clinical,studies,and'
p50749
g3
sS'is,lower,than'
p50750
g3
sS'concentrations,caution,is'
p50751
g9
sS'pointes-type,ventricular,tachycardia'
p50752
g3
sS'volunteers,administration,of'
p50753
g3
sS'drug,laboratory,tests'
p50754
g3
sS'case,of,medical'
p50755
g3
sS'assigned,in,a'
p50756
g3
sS'of,basal,medium'
p50757
g3
sS'cause,of,mortality'
p50758
g3
sS'pharmacokinetic,parameter,values'
p50759
g3
sS'exercised,and,dose'
p50760
g3
sS'plasma,concentrations,auc'
p50761
g9
sS'vitamin,d,by'
p50762
g9
sS'by,ci,in'
p50763
g3
sS'indications,and,the'
p50764
g3
sS'the,agent,has'
p50765
g3
sS'auc,by,about'
p50766
g3
sS'androgens,may,increase'
p50767
g3
sS'following,beta-adrenergic,blocking'
p50768
g3
sS'tmax,of,were'
p50769
g3
sS'similar,association,though'
p50770
g3
sS'be,avoided,unless'
p50771
g9
sS'by,monoamine,oxidase'
p50772
g9
sS'of,aprepitant,with'
p50773
g9
sS'no,cases,of'
p50774
g3
sS'in,a,large'
p50775
g3
sS'no,clinically,or'
p50776
g3
sS'ingestion,of,and'
p50777
g9
sS'of,these,with'
p50778
g3
sS'dexfenfluramine,should,not'
p50779
g9
sS'a,p-glycoprotein,substrate'
p50780
g9
sS'anorexia,taste,disorder'
p50781
g3
sS'reduce,or,reverse'
p50782
g9
sS'intraventricular,and,elicit'
p50783
g3
sS'chloral,hydrate,diet'
p50784
g9
sS'to,electrophilic,agents'
p50785
g3
sS'with,the,conversion'
p50786
g3
sS'proleukin,and,antineoplastic'
p50787
g9
sS'alpha-adrenergic,stimulants,including'
p50788
g9
sS'normal,dogs,in'
p50789
g3
sS'not,been,associated'
p50790
g3
sS'gastrointestinal,lesions,as'
p50791
g9
sS'oral,formulations,of'
p50792
g9
sS'taking,both,agents'
p50793
g9
sS'increased,approximately,threefold'
p50794
g9
sS'active,metabolite,norfluoxe-tine'
p50795
g3
sS'effects,of,ergomar'
p50796
g9
sS'were,observed,after'
p50797
g3
sS'at,specified,time'
p50798
g3
sS'chloride,excretion,compared'
p50799
g9
sS'to,temporarily,raise'
p50800
g9
sS'c23,down-regulation,of'
p50801
g3
sS'pressor,effects,of'
p50802
g9
sS'sodium,may,enhance'
p50803
g9
sS'are,a,major'
p50804
g9
sS'is,stable,on'
p50805
g3
sS'appear,to,be'
p50806
g3
sS'or,cns,depression'
p50807
g3
sS'in,breast,cancer'
p50808
g3
sS'oxytocic,may,cause'
p50809
g3
sS'treated,subjects,received'
p50810
g3
sS'proleukin,including,crescentic'
p50811
g9
sS'd6,and,to'
p50812
g3
sS'exercised,when,lexapro'
p50813
g9
sS'enterococcus,faecalis,by'
p50814
g3
sS'not,a,short-acting'
p50815
g9
sS'affect,subjective,responses'
p50816
g3
sS'anions,antithyroid,b-adrenergic'
p50817
g3
sS'of,microg,kg'
p50818
g3
sS'convulsions,occurring,in'
p50819
g3
sS'minute,after,a'
p50820
g9
sS'cytochrome,p450-mediated,metabolism'
p50821
g3
sS'discontinuation,of,produced'
p50822
g9
sS'beta-blockers,salts,and'
p50823
g9
sS'b-cell,lymphoma,that'
p50824
g3
sS'endogenous,steroid,hormones'
p50825
g9
sS'metabolizers,suggesting,that'
p50826
g9
sS'possibility,that,a'
p50827
g9
sS'and,both,thiazide-like'
p50828
g3
sS'receiving,velcade,and'
p50829
g3
sS'neuroleptic,drugs,l-phenylalanine'
p50830
g9
sS'and,triglyceride,plasma'
p50831
g3
sS'to,the,dose'
p50832
g3
sS'caused,an,eight-fold'
p50833
g9
sS'reduction,as,recommended'
p50834
g3
sS'the,serum,protein'
p50835
g3
sS'of,the,increase'
p50836
g3
sS'containing,regimens,who'
p50837
g9
sS'single,agent,or'
p50838
g3
sS'with,another,agent'
p50839
g3
sS'activity,because,of'
p50840
g3
sS'balance,testing,and'
p50841
g9
sS'increased,when,either'
p50842
g9
sS'plasma,levels,achieved'
p50843
g3
sS'antineoplastic,agents,having'
p50844
g9
sS'as,with,high'
p50845
g3
sS'unreliable,prothrombin,time'
p50846
g9
sS'pressor,amines,but'
p50847
g3
sS'for,days,into'
p50848
g3
sS'gene,expression,was'
p50849
g3
sS'oral,antagonist,was'
p50850
g9
sS'combinations,of,and'
p50851
g9
sS'expected,to,reduce'
p50852
g9
sS'and,increasingly,those'
p50853
g3
sS'other,cases,two'
p50854
g3
sS'l,while,corresponding'
p50855
g3
sS'a,pacemaker,in'
p50856
g3
sS'of,and,has'
p50857
g9
sS'secretion,by,h2'
p50858
g9
sS'cyp2c9,cyp2c19,cyp2e1'
p50859
g3
sS'to,discontinue,the'
p50860
g3
sS'combined,effects,may'
p50861
g9
sS'of,and,had'
p50862
g3
sS'and,an,decrease'
p50863
g9
sS'package,insert,for'
p50864
g9
sS'or,other,should'
p50865
g9
sS'association,with,increases'
p50866
g9
sS'considered,when,ponstel'
p50867
g3
sS'including,and,type'
p50868
g9
sS'successive,generation,more'
p50869
g3
sS'alkaloid,class,of'
p50870
g9
sS'binding,displacement,between'
p50871
g3
sS'by,intermediate,doses'
p50872
g9
sS'time,to,reach'
p50873
g3
sS'judged,by,increased'
p50874
g3
sS'metabolite,in,patients'
p50875
g3
sS'taking,cyp3a4,inducers'
p50876
g3
sS'a,single,case'
p50877
g9
sS'and,aprepitant,when'
p50878
g9
sS'glomerular,filtration,or'
p50879
g3
sS'an,nsaid,has'
p50880
g3
sS'development,essential,to'
p50881
g3
sS'qt,interval,clinical'
p50882
g3
sS'who,received,amevive'
p50883
g3
sS'active,metabolite,after'
p50884
g3
sS'were,positive,for'
p50885
g3
sS'that,have,a'
p50886
g9
sS'that,inhibits,cancer'
p50887
g3
sS'administration,systemic,clearance'
p50888
g9
sS'diminished,renal,function'
p50889
g9
sS'the,type,caution'
p50890
g9
sS'dysphoria,and,reduced'
p50891
g3
sS'response,to,pentobarbital-induced'
p50892
g3
sS'twice,daily,for'
p50893
g3
sS'certain,other,and'
p50894
g3
sS'before,adrenal,function'
p50895
g3
sS'of,plasma,half-life'
p50896
g9
sS'patients,taking,nsaids'
p50897
g9
sS'is,insufficient,experience'
p50898
g9
sS'concurrently,with,norpace'
p50899
g9
sS'a,theoretical,potential'
p50900
g9
sS'of,reduced,p450'
p50901
g3
sS'subjects,experienced,a'
p50902
g9
sS'cations,likely,will'
p50903
g9
sS'of,worsened,glucose'
p50904
g3
sS'or,may,impair'
p50905
g9
sS'mg,fe,instead'
p50906
g9
sS'can,exaggerate,the'
p50907
g3
sS'safely,used,concomitantly'
p50908
g3
sS'the,added,beta-adrenergic'
p50909
g9
sS'any,additional,including'
p50910
g9
sS'diuretic,agents,reduce'
p50911
g9
sS'using,preparations,containing'
p50912
g3
sS'with,accutane,and'
p50913
g9
sS'v,significantly,improved'
p50914
g3
sS'test,interaction,after'
p50915
g3
sS'period,of,organogenesis'
p50916
g3
sS'dose,of,cefditoren'
p50917
g9
sS'g,hour,before'
p50918
g9
sS'obstetrical,cardiological,and'
p50919
g3
sS'ranitidine,mg,twice'
p50920
g3
sS'dose,of,increased'
p50921
g9
sS'and,cyp,c19'
p50922
g3
sS'that,levels,may'
p50923
g9
sS'to,human,serum'
p50924
g3
sS'decrease,the,absorption'
p50925
g9
sS'screening,in,the'
p50926
g3
sS'should,be,performed'
p50927
g3
sS'potentially,interfere,with'
p50928
g3
sS'the,and,or'
p50929
g3
sS'very,potent,inhibitors'
p50930
g9
sS'juice,with,may'
p50931
g3
sS'inhibit,cyp,a4'
p50932
g9
sS'hydroxide,with,mg'
p50933
g9
sS'drugs,that,raise'
p50934
g3
sS'the,primary,addiction'
p50935
g3
sS'caucasians,are,so-called'
p50936
g3
sS'hyperreflexia,ataxia,dysarthria'
p50937
g3
sS'to,prevent,the'
p50938
g9
sS'that,dopamine-induced,ventricular'
p50939
g9
sS'by,cytochrome,p450'
p50940
g3
sS'conducted,in,oa'
p50941
g3
sS'antiinflammatory,including,indocin'
p50942
g9
sS'mefloquine,should,have'
p50943
g3
sS'daily,for,the'
p50944
g3
sS'that,is,a'
p50945
g9
sS'suitable,for,evaluating'
p50946
g3
sS'for,dose,adjustment'
p50947
g3
sS'metal,toxicity,to'
p50948
g3
sS'patients,that,are'
p50949
g9
sS'up,to,leading'
p50950
g9
sS'that,might,be'
p50951
g3
sS'following,agents,may'
p50952
g9
sS'to,the,fetus'
p50953
g3
sS'rationale,stress,and'
p50954
g3
sS'blockers,of,the'
p50955
g9
sS'discussed,in,the'
p50956
g3
sS'and,all,that'
p50957
g3
sS'effects,when,the'
p50958
g3
sS'nature,of,the'
p50959
g3
sS'and,concentrations,should'
p50960
g9
sS'out,to,need'
p50961
g3
sS'antifungals,the,effect'
p50962
g3
sS'significantly,higher,proportion'
p50963
g3
sS'lithiums,renal,clearance'
p50964
g9
sS'complete,and,immediately'
p50965
g9
sS'hepatic,microsomal,monooxygenase'
p50966
g3
sS'receiving,could,result'
p50967
g3
sS'the,patients,should'
p50968
g9
sS'class,i,such'
p50969
g3
sS'either,erythro-fluorocitrate,synthesis'
p50970
g3
sS'on,components,p2'
p50971
g9
sS'produced,either,a'
p50972
g3
sS'content,after,perfusion'
p50973
g3
sS'have,focused,on'
p50974
g3
sS'eg,channel,blockers'
p50975
g9
sS'dose,of,didanosine-placebo'
p50976
g9
sS'and,not,rely'
p50977
g3
sS'heart,failure,severe'
p50978
g9
sS'of,used,to'
p50979
g3
sS'atypical,antipsychotic,agent'
p50980
g3
sS'sufficient,to,warrant'
p50981
g9
sS'quantitative,approach,to'
p50982
g3
sS'evaluated,in,in'
p50983
g3
sS'or,marked,bradycardia'
p50984
g3
sS'a,single,enzyme'
p50985
g3
sS'in,whom,cyp3a4'
p50986
g3
sS'body,surface,area'
p50987
g3
sS'evidence,that,epa'
p50988
g3
sS'reduce,the,diuretic'
p50989
g9
sS'use,of,ellence'
p50990
g9
sS'recommended,that,in'
p50991
g9
sS'same,target,sites'
p50992
g3
sS'drugs,has,not'
p50993
g3
sS'drugs,sporadic,cases'
p50994
g9
sS'recommended,that,if'
p50995
g9
sS'not,sufficient,to'
p50996
g3
sS'drug,metabolized,by'
p50997
g3
sS'times,long-sedation,time'
p50998
g3
sS'a,should,be'
p50999
g9
sS'dcg-iv,and,l-ccg'
p51000
g3
sS'many,and,are'
p51001
g3
sS'unknown,but,the'
p51002
g3
sS'in,locomotor,responses'
p51003
g3
sS'the,result,is'
p51004
g3
sS'use,of,repeated'
p51005
g3
sS'and,cushingoid,appearance'
p51006
g3
sS'are,started,thus'
p51007
g9
sS'the,above,or'
p51008
g3
sS'shown,a,decrease'
p51009
g9
sS'induced,skin,wheals'
p51010
g3
sS'be,cautioned,regarding'
p51011
g3
sS'or,placebo,was'
p51012
g3
sS'medicinal,products,could'
p51013
g9
sS'or,potentiated,the'
p51014
g9
sS'lumen,to,the'
p51015
g3
sS'received,cephalosporin,before'
p51016
g3
sS'reports,that,the'
p51017
g9
sS'adl,a,trans-3'
p51018
g9
sS'the,disulfiram-ethanol,reaction'
p51019
g3
sS'but,also,on'
p51020
g3
sS'free,radical-mediated,tissue'
p51021
g9
sS'shown,to,bind'
p51022
g3
sS'p-glycoprotein,transporter,as'
p51023
g3
sS'and,levels,were'
p51024
g9
sS'simultaneous,fold,increase'
p51025
g9
sS'showed,comparable,cognitive'
p51026
g3
sS'efficacy,on,measures'
p51027
g3
sS'elevated,creatine,phosphokinase'
p51028
g3
sS'measurements,and,main'
p51029
g3
sS'levels,did,not'
p51030
g3
sS'serum,concentration,should'
p51031
g3
sS'very,rarely,in'
p51032
g9
sS'discussed,in,relationship'
p51033
g3
sS'large,amounts,may'
p51034
g9
sS'severe,symptomatology,is'
p51035
g3
sS'prolongation,with,or'
p51036
g3
sS'l-name,and,micromol'
p51037
g3
sS'substrates,for,human'
p51038
g3
sS'p,dmpge2,mg'
p51039
g3
sS'the,oral,has'
p51040
g3
sS'fortovase,may,not'
p51041
g3
sS'p450,a4,would'
p51042
g9
sS'injections,of,saline'
p51043
g3
sS'diagnosis,of,myocardial'
p51044
g3
sS'and,mg,once'
p51045
g9
sS'in,cell,number'
p51046
g9
sS'study,of,schizophrenic'
p51047
g9
sS'of,for,patients'
p51048
g9
sS'relationship,of,accutane'
p51049
g9
sS'enzyme,that,appears'
p51050
g3
sS'new,therapeutic,regimes'
p51051
g3
sS'humans,is,unknown'
p51052
g3
sS'from,given,the'
p51053
g3
sS'benefits,against,symptoms'
p51054
g3
sS'and,orange,juices'
p51055
g3
sS'on,the,other'
p51056
g3
sS'reported,to,diminish'
p51057
g9
sS'with,inhibition,of'
p51058
g9
sS'administration,of,inapsine'
p51059
g9
sS'disease,spinal,cord'
p51060
g3
sS'days,later,all'
p51061
g3
sS'differential-reinforcement,of-low,rates'
p51062
g3
sS'could,be,avoided'
p51063
g3
sS'by,the,antioxidative'
p51064
g3
sS'medications,have,been'
p51065
g3
sS'in,mean,neutrophil'
p51066
g9
sS'doses,of,tambocor'
p51067
g9
sS'to,a,prolongation'
p51068
g9
sS'prescribed,for,either'
p51069
g3
sS'selecting,an,oral'
p51070
g9
sS'are,poorly,understood'
p51071
g3
sS'activity,of,these'
p51072
g3
sS'no,significant,additional'
p51073
g9
sS'first-line,therapy,for'
p51074
g3
sS'been,used,concurrently'
p51075
g3
sS'agents,the,safety'
p51076
g3
sS'have,been,coadministered'
p51077
g3
sS'small,effect,on'
p51078
g9
sS'use,of,vardenafil'
p51079
g9
sS'daily,administration,of'
p51080
g3
sS'rifampin,cyp3a4,is'
p51081
g3
sS'increase,serum,thyroxine-binding'
p51082
g3
sS'rash,particularly,in'
p51083
g3
sS'inhibitors,concurrent,use'
p51084
g9
sS'cyclosporine-induced,toxicity,possibly'
p51085
g9
sS'corticotropin,may,accentuate'
p51086
g9
sS'such,as,which'
p51087
g9
sS'turn,discussing,the'
p51088
g3
sS'somepatients,may,experience'
p51089
g3
sS'relative,avidities,for'
p51090
g3
sS'acid,secretion,in'
p51091
g3
sS'v,remains,constant'
p51092
g3
sS'resulting,in,qt'
p51093
g9
sS'the,chronically,ill'
p51094
g3
sS'evaluated,and,patients'
p51095
g3
sS'when,plasma,concentrations'
p51096
g9
sS'be,placed,in'
p51097
g3
sS'at,least,of'
p51098
g3
sS'these,findings,to'
p51099
g9
sS'mao,inhibitors,concurrent'
p51100
g9
sS'exposure,be,considered'
p51101
g3
sS'by,during,august'
p51102
g3
sS'forms,may,not'
p51103
g9
sS'absorbed,is,unaffected'
p51104
g3
sS'were,assessed,in'
p51105
g3
sS'kg,x,ed95'
p51106
g9
sS'as,they,relate'
p51107
g3
sS'ssris,many,and'
p51108
g3
sS'likely,that,the'
p51109
g9
sS'mucus,the,endometrium'
p51110
g3
sS'lodosyn,carbidopa,given'
p51111
g3
sS'with,antiplatelet,and'
p51112
g9
sS'subjects,increased,plasma'
p51113
g9
sS'in,balance,were'
p51114
g3
sS'concomitant,intravenous,misuse'
p51115
g9
sS'few,patients,treated'
p51116
g9
sS'self-administration,of,while'
p51117
g9
sS'levels,suggesting,that'
p51118
g9
sS'half-life,was,and'
p51119
g3
sS'these,enzyme,systems'
p51120
g3
sS'receiving,narrow,therapeutic'
p51121
g3
sS'accumulated,in,the'
p51122
g9
sS'blockers,in,one'
p51123
g3
sS'on,arterial,thrombus'
p51124
g9
sS'in,reversible,acute'
p51125
g9
sS'cause,of,contrast'
p51126
g3
sS'empty,stomach,minutes'
p51127
g3
sS'and,iv,myocardium'
p51128
g3
sS'effect,of,caused'
p51129
g3
sS'exceeded,in,a'
p51130
g9
sS'but,not,the'
p51131
g9
sS'increase,catabolism,of'
p51132
g3
sS'induction,potential,on'
p51133
g3
sS'enhance,the,renal'
p51134
g9
sS'recovery,programs,should'
p51135
g3
sS'antidiabetics,oral,diabetes'
p51136
g9
sS'the,fischer-344,strain'
p51137
g3
sS'platelet,function,and'
p51138
g3
sS's-,enantiomers,or'
p51139
g3
sS'when,and,mycophenolate'
p51140
g9
sS'which,may,increase'
p51141
g3
sS'discontinue,the,taking'
p51142
g3
sS'necessary,to,control'
p51143
g3
sS'of,increased,and'
p51144
g9
sS'than,expected,antidepressant'
p51145
g9
sS'physiologic,activity,thus'
p51146
g9
sS'containing,mcg,of'
p51147
g9
sS'unaffected,by,indicating'
p51148
g3
sS'similarly,there,is'
p51149
g3
sS'with,or,prolongation'
p51150
g3
sS'levels,and,slight'
p51151
g9
sS'the,neuronal,apparatus'
p51152
g3
sS'healthy,individuals,plasma'
p51153
g9
sS'patients,approximately,half'
p51154
g3
sS'that,may,inhibit'
p51155
g9
sS'interactions,with,fruit'
p51156
g3
sS'amprenavir,significantly,decreases'
p51157
g9
sS'of,cadmium,and'
p51158
g3
sS'for,days,intraperitoneally'
p51159
g9
sS'while,studies,have'
p51160
g9
sS'as,high-dose,may'
p51161
g3
sS'in,mean,trough'
p51162
g9
sS'one,reported,case'
p51163
g9
sS'the,substrate,are'
p51164
g3
sS'the,pharmacological,interactions'
p51165
g3
sS'together,with,previous'
p51166
g3
sS'have,been,attributed'
p51167
g3
sS'for,cyp2d6,resulted'
p51168
g9
sS'fluothane,may,augment'
p51169
g9
sS'fraction,of,stadol'
p51170
g3
sS'vasodilator,and,platelet'
p51171
g3
sS'as,certain,antagonists'
p51172
g9
sS'digitalis,immediate,release'
p51173
g9
sS'of,g,kg'
p51174
g9
sS'b23,in,serum-deprived'
p51175
g3
sS'toxicity,including,convulsions'
p51176
g9
sS'these,polyene,showed'
p51177
g3
sS'of,impaired,renal'
p51178
g9
sS'and,numerous,liver'
p51179
g3
sS'to,campath,may'
p51180
g3
sS'that,adl,prevents'
p51181
g9
sS'interferes,with,the'
p51182
g9
sS'mg,and,intravenous'
p51183
g3
sS'and,appropriate,dose'
p51184
g9
sS'muscle,relaxants,eg'
p51185
g9
sS'dinitrate,chloride,folic'
p51186
g3
sS'of,mg,l'
p51187
g3
sS'that,the,ethanolysis'
p51188
g9
sS'of,cardiac,arrhythmias'
p51189
g3
sS'the,beta,blocker'
p51190
g9
sS'administered,agents,should'
p51191
g3
sS'levels,of,necessary'
p51192
g3
sS'is,administered,have'
p51193
g3
sS'of,the,tca'
p51194
g9
sS'with,the,modulation'
p51195
g9
sS'macrolide,and,hiv'
p51196
g3
sS'volunteers,were,randomly'
p51197
g3
sS'the,findings,of'
p51198
g3
sS'patient,receiving,prinivil'
p51199
g9
sS'when,placed,on'
p51200
g3
sS'the,prothrombin,time'
p51201
g9
sS'produced,a,significant'
p51202
g9
sS'and,estrogen-containing,oral'
p51203
g3
sS'regimen,of,patients'
p51204
g3
sS'common,pathogens,of'
p51205
g3
sS'generated,to,date'
p51206
g3
sS'digitalis,thyroid,preparations'
p51207
g9
sS'conjunction,with,the'
p51208
g3
sS'whom,died,compared'
p51209
g3
sS'estradiol,may,inhibit'
p51210
g9
sS'effect,for,which'
p51211
g3
sS'decreased,the,incidence'
p51212
g9
sS'animal,model,possibly'
p51213
g9
sS'n-oxide,were,elevated'
p51214
g3
sS'preparations,st,john'
p51215
g3
sS'potential,in,the'
p51216
g3
sS'clinically,significant,symptoms'
p51217
g3
sS'demonstrated,superiority,over'
p51218
g3
sS'sodium,excretion,seen'
p51219
g9
sS'administering,taxol,concomitantly'
p51220
g3
sS'to,mice,min'
p51221
g3
sS'received,among,patients'
p51222
g3
sS'potentiate,the,tardive'
p51223
g9
sS'the,ld50,of'
p51224
g9
sS'of,salicylic,acid'
p51225
g9
sS'of,indocin,are'
p51226
g3
sS'with,fluothane,as'
p51227
g9
sS'epoxide,metabolite,in'
p51228
g3
sS'cimetidine,cimetidine,does'
p51229
g3
sS'members,of,the'
p51230
g3
sS'of,when,any'
p51231
g3
sS'dosage,adjustment,as'
p51232
g3
sS'the,two,concomitantly'
p51233
g3
sS'properties,of,equetrotm'
p51234
g3
sS'adverse,reactions,related'
p51235
g3
sS'metabolism,mediated,by'
p51236
g3
sS'ventricular,arrhythmias,have'
p51237
g3
sS'because,it,does'
p51238
g3
sS'data,obtained,in'
p51239
g3
sS'especially,those,in'
p51240
g9
sS'of,severe,myopathy'
p51241
g9
sS'suppression,of,in'
p51242
g3
sS'in,excessive,widening'
p51243
g9
sS'the,arrival,of'
p51244
g3
sS'these,concomitantly,plasma'
p51245
g3
sS'with,beta,adrenergic-blocking'
p51246
g3
sS'mao-inhibitors,with,hepatotoxic'
p51247
g9
sS'dose,range,of'
p51248
g9
sS'when,itraconazole,and'
p51249
g9
sS'enzyme,abnormalities,and'
p51250
g9
sS'emtriva,has,been'
p51251
g3
sS'inhibitors,of,cytochrome'
p51252
g9
sS'exjade,should,not'
p51253
g9
sS'a,inhibitors,of'
p51254
g9
sS'response,to,ptx'
p51255
g3
sS'tissues,from,the'
p51256
g9
sS'clearance,with,the'
p51257
g3
sS'doses,of,and'
p51258
g9
sS'other,strong,selective'
p51259
g9
sS'anti-factor,xa,and'
p51260
g3
sS'drugs,clonazepam,does'
p51261
g3
sS'cyp3a4,metabolized,triazolo-benzodiazepines'
p51262
g9
sS'kidneys,coadministration,of'
p51263
g3
sS'and,live,or'
p51264
g9
sS'not,potent,cyp3a4'
p51265
g3
sS'maois,or,within'
p51266
g9
sS'tested,in,combination'
p51267
g3
sS'drugs,in,small'
p51268
g3
sS'historicalcontrol,group,resulted'
p51269
g9
sS'respectively,resulted,in'
p51270
g9
sS'of,sedation,hallucinations'
p51271
g9
sS'of,pharmacokinetics,in'
p51272
g3
sS'also,cause,increased'
p51273
g3
sS'pharmacodynamics,blood,glucose'
p51274
g3
sS'anti,inflammatory,with'
p51275
g9
sS'addition,administration,of'
p51276
g3
sS'not,result,in'
p51277
g3
sS'determinant,of,sensitivity'
p51278
g3
sS'observed,it,is'
p51279
g9
sS'approved,for,clinical'
p51280
g3
sS'l,or,higher'
p51281
g3
sS'a,study,involving'
p51282
g3
sS'clinical,trials,and'
p51283
g3
sS'adverse,events,involving'
p51284
g3
sS'expected,to,significantly'
p51285
g3
sS'levels,and,cardiovascular'
p51286
g9
sS'racemic,mg,and'
p51287
g9
sS'cleared,primarily,by'
p51288
g3
sS'other,pharmacokinetic,parameters'
p51289
g3
sS'herbal,preparations,st'
p51290
g3
sS'be,administered,with'
p51291
g9
sS'safety,profiles,comparable'
p51292
g3
sS'be,considered,in'
p51293
g3
sS'other,products,associated'
p51294
g3
sS'effect,on,cure'
p51295
g3
sS'assume,that,there'
p51296
g3
sS'experience,with,the'
p51297
g3
sS'be,considered,if'
p51298
g3
sS'cyclic,in,turn'
p51299
g3
sS'of,lodine,and'
p51300
g9
sS'with,resulting,in'
p51301
g9
sS'international,normalized,ratio'
p51302
g9
sS'of,increases,in'
p51303
g3
sS'accumulation,of,both'
p51304
g9
sS'achieve,or,maintain'
p51305
g3
sS'may,react,with'
p51306
g9
sS'this,enzyme,could'
p51307
g3
sS'and,efficacy,of'
p51308
g3
sS'levodopa,is,known'
p51309
g3
sS'were,also,not'
p51310
g3
sS'of,the,ht3'
p51311
g9
sS'to,hatching,survival'
p51312
g3
sS'digoxin,nimodipine,and'
p51313
g3
sS'antagonize,the,bactercidal'
p51314
g9
sS'and,at,steady-state'
p51315
g3
sS'or,tenofovir,disoproxil'
p51316
g3
sS'increasing,use,of'
p51317
g3
sS'marked,hypertension,and'
p51318
g9
sS'by,possibly,increasing'
p51319
g9
sS'with,the,alternate'
p51320
g9
sS'in,increase,in'
p51321
g9
sS'vitamin,k,antagonists'
p51322
g9
sS'between,and,beta'
p51323
g3
sS'diuretic,hydrochlorothiazide,given'
p51324
g9
sS'for,the,ability'
p51325
g3
sS'responses,have,been'
p51326
g9
sS'cycles,and,or'
p51327
g3
sS'rats,and,blood'
p51328
g3
sS'the,best,tool'
p51329
g3
sS'agonists,has,not'
p51330
g3
sS'i,d,for'
p51331
g9
sS'study,the,bioavailability'
p51332
g3
sS'inferior,mesenteric,ganglion'
p51333
g3
sS'of,compounds,are'
p51334
g9
sS'in,addition,under'
p51335
g3
sS'm1,was,shown'
p51336
g3
sS'c,has,not'
p51337
g3
sS'coadministered,with,therapeutic'
p51338
g3
sS'when,co-administered,with'
p51339
g9
sS'these,instances,has'
p51340
g3
sS'been,seen,with'
p51341
g9
sS'effectiveness,of,in'
p51342
g3
sS'than,mg,m2'
p51343
g3
sS'sodium,does,not'
p51344
g3
sS'salicylates-salicylates,in,large'
p51345
g3
sS'of,onset,of'
p51346
g9
sS'effect,on,absorption'
p51347
g9
sS'exchange,it,may'
p51348
g3
sS'of,other,methods'
p51349
g3
sS'use,of,and'
p51350
g9
sS'was,observed,in'
p51351
g3
sS'hydrolase,carbamazepine,is'
p51352
g3
sS'that,health,care'
p51353
g3
sS'cancidas,may,result'
p51354
g9
sS'pharmacokinetics,of,was'
p51355
g3
sS'activase,for,the'
p51356
g3
sS'reductase,inhibitor,class'
p51357
g9
sS'the,cyp3a4,inhibitor'
p51358
g3
sS'lower,doses,because'
p51359
g9
sS'and,cardiovascular,effects'
p51360
g9
sS'were,within,the'
p51361
g9
sS'after,receiving,appeared'
p51362
g9
sS'is,begun,in'
p51363
g3
sS'reduces,the,tubular'
p51364
g9
sS'if,concomitant,use'
p51365
g3
sS'of,anticoagulation,may'
p51366
g3
sS'tablets,usp,have'
p51367
g3
sS'efficacy,physicians,should'
p51368
g3
sS'haloperidol,blocks,receptors'
p51369
g9
sS'experience,with,use'
p51370
g3
sS'of,patients,taking'
p51371
g9
sS'as,should,be'
p51372
g3
sS'function,is,not'
p51373
g3
sS'particular,caution,in'
p51374
g9
sS'other,likely,to'
p51375
g3
sS'overall,response,is'
p51376
g9
sS'clearance,of,thereby'
p51377
g9
sS'in,general,are'
p51378
g3
sS'for,any,evidence'
p51379
g3
sS'such,a,similar'
p51380
g3
sS'serious,ventricular,arrhythmias'
p51381
g9
sS'theophylline,twelve,healthy'
p51382
g3
sS'to,induction,of'
p51383
g9
sS'investigations,into,the'
p51384
g3
sS'that,inhibit,prostaglandin'
p51385
g9
sS'taking,other,that'
p51386
g9
sS'augmentin,xr,may'
p51387
g9
sS'increased,the,maximum'
p51388
g9
sS'solutions,and,for'
p51389
g3
sS'other,and,because'
p51390
g3
sS'of,serum,psa'
p51391
g3
sS'toradol,to,patients'
p51392
g9
sS'dose,of,hours'
p51393
g9
sS'p1,and,n1'
p51394
g9
sS'suspension,reduces,the'
p51395
g9
sS'hours,following,the'
p51396
g3
sS'a,cyp,c9'
p51397
g3
sS'propranolols,hypotensive,effect'
p51398
g9
sS'significant,interactions,following'
p51399
g3
sS'trilafon,compazine,sparine'
p51400
g3
sS'containing,hydroxide,and'
p51401
g9
sS'not,in,dietary-obese'
p51402
g3
sS'effect,digitalis,or'
p51403
g9
sS'activity,are,associated'
p51404
g3
sS'microtubules,in,non-myelinated'
p51405
g3
sS'syndrome,can,occur'
p51406
g9
sS'catecholamine,levels,may'
p51407
g3
sS'requirements,i,may'
p51408
g3
sS'agents,aspirin,is'
p51409
g9
sS'l,or,mg'
p51410
g3
sS'additional,patients,who'
p51411
g3
sS'mg,week,for'
p51412
g9
sS'methenamine,therapy,urinary'
p51413
g9
sS'multiple-dose,suggesting,no'
p51414
g3
sS'and,cohort,received'
p51415
g3
sS'of,interaction,between'
p51416
g3
sS'concomitant,use,unless'
p51417
g3
sS'enhances,cocaine-induced,increases'
p51418
g9
sS'hepatic,tissues,of'
p51419
g3
sS'been,titrated,to'
p51420
g3
sS'bacteriostatic,may,interfere'
p51421
g9
sS'effects,and,had'
p51422
g3
sS'reductase,inhibitors,in'
p51423
g9
sS'produced,modest,dysphoria'
p51424
g3
sS'hypotension,av,conduction'
p51425
g9
sS'that,significantly,affected'
p51426
g3
sS'chemotherapy,cardiotoxic,or'
p51427
g9
sS'administration,of,cerebyx'
p51428
g3
sS'the,clinically,effective'
p51429
g9
sS'inhibitory,activity,was'
p51430
g3
sS'each,agent,on'
p51431
g3
sS'bid,were,not'
p51432
g3
sS'tablets,compared,to'
p51433
g3
sS'isoenzyme,is,present'
p51434
g3
sS'among,the,pd2'
p51435
g3
sS'when,these,drugs'
p51436
g3
sS'patients,in,the'
p51437
g9
sS'and,because,renal'
p51438
g9
sS'trials,performed,at'
p51439
g3
sS'to,evaluate,possible'
p51440
g3
sS'combination,hormonal,are'
p51441
g9
sS'drug,toxicity,is'
p51442
g3
sS'and,thereby,delaying'
p51443
g9
sS'protein-,bound,with'
p51444
g3
sS'to,effect,the'
p51445
g3
sS'mg,day,has'
p51446
g3
sS'class,may,cause'
p51447
g9
sS'reduced,by,approx'
p51448
g9
sS'be,less,than'
p51449
g3
sS'of,caution,should'
p51450
g9
sS'to,electrolyte,abnormalities'
p51451
g9
sS'cimetidine,in,a'
p51452
g9
sS'hcl,to,patients'
p51453
g9
sS'acellular,live,and'
p51454
g9
sS'is,a,risk'
p51455
g9
sS'cyp,d6,poor'
p51456
g9
sS'than,the,stable'
p51457
g3
sS'of,circulating,catecholamines'
p51458
g3
sS'by,the,dermatologist'
p51459
g3
sS'commonly,used,preanesthetic'
p51460
g3
sS'contraceptives,keppra,mg'
p51461
g3
sS'the,percentage,of'
p51462
g3
sS'the,half-life,increased'
p51463
g3
sS'when,two,single'
p51464
g3
sS'with,sexual,dysfunction'
p51465
g3
sS'clozapine,caution,is'
p51466
g9
sS'type,of,preparations'
p51467
g3
sS'individual,patient,response'
p51468
g3
sS'by,cytochrome,p4502d6'
p51469
g3
sS'vivo,metabolic,probe'
p51470
g3
sS'reactive,species,ros'
p51471
g3
sS'on,the,production'
p51472
g3
sS'plasma,concentrations,increased'
p51473
g9
sS'that,a,positive'
p51474
g3
sS'emphasis,on,those'
p51475
g3
sS'increase,in,symptomatic'
p51476
g3
sS'cyp2d6,is,expected'
p51477
g3
sS'estradiol,levels,of'
p51478
g9
sS'in,the,lysate'
p51479
g3
sS'drug,interactions,were'
p51480
g3
sS'or,absence,of'
p51481
g3
sS'designs,can,be'
p51482
g3
sS'decision,is,made'
p51483
g3
sS'or,concurrently,should'
p51484
g9
sS'deficiency,and,the'
p51485
g3
sS'additive,effects,in'
p51486
g9
sS'small,number,of'
p51487
g3
sS'for,example,when'
p51488
g9
sS'in,pharmacokinetic,studies'
p51489
g3
sS'observed,with,likely'
p51490
g3
sS'values,are,to'
p51491
g3
sS'which,is,important'
p51492
g3
sS'commonly,showed,anxiogenic'
p51493
g3
sS'the,behavioral,response'
p51494
g3
sS'therapy,with,should'
p51495
g9
sS'either,inhibit,sodium'
p51496
g9
sS'erythema,tenderness,skin'
p51497
g3
sS'confusional,states,to'
p51498
g9
sS'should,be,advised'
p51499
g9
sS'the,major,enzyme'
p51500
g9
sS'lcv,infection,is'
p51501
g3
sS'mg,per,day'
p51502
g9
sS'weight,heparins,as'
p51503
g3
sS'acarbose,the,patient'
p51504
g3
sS'subjective,responses,to'
p51505
g3
sS'iodide,potentiates,other'
p51506
g9
sS'patients,to,whom'
p51507
g9
sS'any,route,they'
p51508
g9
sS'required,to,achieve'
p51509
g3
sS'to,l,kg'
p51510
g9
sS'a,potent,iiia4'
p51511
g9
sS'effects,of,g'
p51512
g9
sS'vivo,resulted,in'
p51513
g3
sS'effects,of,a'
p51514
g9
sS'or,is,used'
p51515
g9
sS'effects,of,b'
p51516
g3
sS'g,kg,min'
p51517
g3
sS'loss,between,systemic'
p51518
g3
sS'food,one,hour'
p51519
g9
sS'status,and,mixed--pharmacological'
p51520
g3
sS'severe,abdominal,symptoms'
p51521
g3
sS'increased,inr,international'
p51522
g9
sS'death,from,infectious'
p51523
g3
sS'extensively,metabolized,predominantly'
p51524
g3
sS'the,plasma,concentrations'
p51525
g9
sS'probenecid,or,cimetidine'
p51526
g9
sS'atovaquone,is,highly'
p51527
g3
sS'nausea,paresthesia,and'
p51528
g3
sS'the,first,cervical'
p51529
g3
sS'while,on,accutane'
p51530
g3
sS'a,single,dose'
p51531
g3
sS'intake,of,supplemental'
p51532
g3
sS'binding,may,also'
p51533
g9
sS'for,and,mg'
p51534
g3
sS'hydrate,and,may'
p51535
g3
sS'use,with,allopurinol'
p51536
g9
sS'of,and,were'
p51537
g9
sS'check,coagulation,time'
p51538
g9
sS'less,than,two-second'
p51539
g9
sS'affect,renal,nonrenal'
p51540
g3
sS'inhibitory,action,of'
p51541
g3
sS'antagonize,the,bactericidal'
p51542
g9
sS'starlix,mg,before'
p51543
g3
sS'oxidation,elc,should'
p51544
g9
sS'or,mao-inhibitors,with'
p51545
g9
sS'pharmacokinetics,of,r'
p51546
g3
sS'for,the,detection'
p51547
g3
sS'when,d2o,was'
p51548
g3
sS'of,endotoxin-treated,rats'
p51549
g9
sS'nonrenal,clearance,from'
p51550
g3
sS'pharmacokinetics,of,a'
p51551
g3
sS'versus,mg,of'
p51552
g3
sS'pharmacokinetics,of,d'
p51553
g3
sS'concomitant,and,ace'
p51554
g9
sS'with,tambocor,unless'
p51555
g9
sS'observed,carefully,for'
p51556
g9
sS'anticonvulsants,phenytoin,steady'
p51557
g9
sS'prothrombin,response,in'
p51558
g9
sS'study,of,patients'
p51559
g3
sS'b,and,intravenous'
p51560
g9
sS'increase,the,degree'
p51561
g3
sS'an,antipsychotic,eg'
p51562
g9
sS'each,significantly,altered'
p51563
g3
sS'may,also,decrease'
p51564
g9
sS'in,patients,not'
p51565
g9
sS'interacting,mechanisms,with'
p51566
g3
sS'platelet,aggregation,inhibitors'
p51567
g9
sS'binding,experiments,using'
p51568
g3
sS'must,elapse,before'
p51569
g3
sS'neuromuscular,blockade,by'
p51570
g9
sS'crixivan,or,to'
p51571
g3
sS'interact,with,any'
p51572
g9
sS'have,shown,to'
p51573
g3
sS'addition,of,inspra'
p51574
g9
sS'fu,bolus-ifl,with'
p51575
g3
sS'lh,and,fsh'
p51576
g3
sS'cardiac,effects,of'
p51577
g9
sS'horses,from,anaesthesia'
p51578
g3
sS'decrease,the,metabolism'
p51579
g9
sS'infusion,of,alone'
p51580
g3
sS'and,and,the'
p51581
g3
sS'block,contortrostatin-induced,phosphorylation'
p51582
g9
sS'of,patients,to'
p51583
g9
sS'also,diminished,by'
p51584
g3
sS'of,increased,gastric'
p51585
g3
sS'with,copegus,in'
p51586
g3
sS'tissues,either,or'
p51587
g3
sS'also,discussed,in'
p51588
g3
sS'agent,can,reduce'
p51589
g9
sS'not,been,studied'
p51590
g9
sS'contraceptives,estrogens,tend'
p51591
g3
sS'of,cancidas,should'
p51592
g9
sS'from,the,results'
p51593
g9
sS'increase,the,chance'
p51594
g9
sS'by,fluorimetric,or'
p51595
g3
sS'effects,have,been'
p51596
g3
sS'an,action,independent'
p51597
g3
sS'mechanism,of,the'
p51598
g3
sS'day,to,midcycle'
p51599
g3
sS'coadministered,with,or'
p51600
g9
sS'and,epidural,include'
p51601
g9
sS'tolerance,to,the'
p51602
g9
sS'exposures,of,similar'
p51603
g9
sS'no,specific,studies'
p51604
g3
sS'the,maximum,approved'
p51605
g9
sS'in,experiments,on'
p51606
g3
sS'by,and,prothrombin'
p51607
g9
sS'mean,maximum,plasma'
p51608
g9
sS'of,days,in'
p51609
g3
sS'received,chop,alone'
p51610
g3
sS'muscle,cells,and'
p51611
g3
sS'cyp,a,inhibitors'
p51612
g9
sS'seen,on,mtc-mdp'
p51613
g9
sS'observed,when,is'
p51614
g9
sS'and,urine,was'
p51615
g3
sS'ptca,pci,co-administration'
p51616
g9
sS'this,activity,enough'
p51617
g3
sS'such,as,factor'
p51618
g3
sS'values,for,in'
p51619
g3
sS'vii-x,complex,ii-vii'
p51620
g3
sS'unusual,and,requires'
p51621
g3
sS'day,of,n'
p51622
g3
sS'by,administration,or'
p51623
g3
sS'and,and,class'
p51624
g9
sS'have,been,diagnosed'
p51625
g3
sS'and,reduction,in'
p51626
g9
sS'to,the,potassium-depleted'
p51627
g3
sS'combined,treatment,should'
p51628
g9
sS'interaction,of,intramuscularly'
p51629
g3
sS'reformed,microtubules,appeared'
p51630
g3
sS'caspase-3,inhibitor,added'
p51631
g3
sS'full,duration,of'
p51632
g3
sS'misused,by,self-injection'
p51633
g3
sS'max,t,max'
p51634
g3
sS'of,on,cyp450'
p51635
g3
sS'of,fluorouracil,is'
p51636
g9
sS'study,which,confirms'
p51637
g3
sS'rat,days,showed'
p51638
g3
sS'increased,his,risk'
p51639
g3
sS'independent,of,the'
p51640
g3
sS'and,its,metabolites'
p51641
g3
sS'a,profound,effect'
p51642
g3
sS'the,review,of'
p51643
g3
sS'with,a,group'
p51644
g3
sS'vehicle-,progesterone-,and'
p51645
g9
sS'blocks,and,ergot-type'
p51646
g9
sS'ng,x,h'
p51647
g9
sS'sufficient,numbers,of'
p51648
g3
sS'in,addition,steady'
p51649
g3
sS'bovine,lung,survanta'
p51650
g3
sS'these,effects,were'
p51651
g3
sS'stabilized,see,dosage'
p51652
g3
sS'resistance,reversal,in'
p51653
g3
sS'etc,but,physicians'
p51654
g9
sS'day,as,camptosar'
p51655
g9
sS'been,carried,out'
p51656
g3
sS'for,signs,of'
p51657
g3
sS'whereas,none,of'
p51658
g3
sS'erythro-fluorocitrate,synthesis,and'
p51659
g3
sS'fluvoxamine,tablets,at'
p51660
g9
sS'analysis,of,dimethylprostaglandin'
p51661
g3
sS'antiinflammatory,agent,can'
p51662
g9
sS'and,remnant,removal'
p51663
g3
sS'min,dose,mu'
p51664
g3
sS'and,downward,dose'
p51665
g9
sS'although,a,dose'
p51666
g9
sS'coadministered,intravenously,as'
p51667
g9
sS'one,report,of'
p51668
g9
sS'concentration,is,of'
p51669
g3
sS'delay,elimination,of'
p51670
g3
sS'further,metabolized,to'
p51671
g3
sS'when,tested,up'
p51672
g3
sS'liver,cytochrome,p-450'
p51673
g3
sS'been,systematically,evaluated'
p51674
g9
sS'not,indicated,for'
p51675
g3
sS'dosage,adjustments,may'
p51676
g3
sS'divided,into,three'
p51677
g9
sS'day,when,a'
p51678
g9
sS'fibrosis,therapies,including'
p51679
g3
sS'intake,which,only'
p51680
g3
sS'known,side,effects'
p51681
g9
sS'the,usual,dose'
p51682
g9
sS'study,has,shown'
p51683
g9
sS'result,in,low'
p51684
g9
sS'occur,because,competitively'
p51685
g9
sS'atorvastatin,had,no'
p51686
g3
sS'and,particularly,those'
p51687
g3
sS'the,steady-state,concentrations'
p51688
g3
sS'the,parietal,cell'
p51689
g3
sS'serum,deprivation,in'
p51690
g3
sS'still,valid,in'
p51691
g3
sS'by,competitive,interaction'
p51692
g9
sS'sonata,reflecting,the'
p51693
g3
sS'drug,known,to'
p51694
g3
sS'about,when,was'
p51695
g9
sS'test,is,obtained'
p51696
g3
sS'also,concurrent,use'
p51697
g3
sS'profound,and,long'
p51698
g3
sS'mononuclear,cells,u937'
p51699
g9
sS'variability,however,somepatients'
p51700
g3
sS'fistulas,were,carried'
p51701
g3
sS'on,one,of'
p51702
g3
sS'method,for,the'
p51703
g3
sS'every,hours,or'
p51704
g3
sS'clearance,resulting,in'
p51705
g3
sS'rhabdomyolysis,appear,to'
p51706
g9
sS'dosage,reduced,accordingly'
p51707
g9
sS'of,twice,daily'
p51708
g3
sS'well,concurrent,therapy'
p51709
g9
sS'induce,hypercalcemia,by'
p51710
g3
sS'in,relationship,to'
p51711
g3
sS'administration,of,suprax'
p51712
g3
sS'other,medicines,although'
p51713
g3
sS'subcortical,structures,whereas'
p51714
g3
sS'and,inducers,are'
p51715
g3
sS'n-type,or,omega-agatoxin'
p51716
g3
sS'seemingly,adequate,treatment'
p51717
g3
sS'action,of,nimbex'
p51718
g9
sS'alcohol,when,duloxetine'
p51719
g3
sS'eg,are,indicated'
p51720
g3
sS'relevant,effect,on'
p51721
g3
sS'g,m2,pegasys'
p51722
g3
sS'in,the,long-term'
p51723
g3
sS'applying,panretin,gel'
p51724
g9
sS'the,antitumour,activity'
p51725
g9
sS'in,renal,function'
p51726
g3
sS'also,contribute,to'
p51727
g9
sS'of,either,was'
p51728
g3
sS'in,a,two-fold'
p51729
g9
sS'or,at,bedtime'
p51730
g3
sS'observed,in,non-human'
p51731
g3
sS'function,as,has'
p51732
g3
sS'and,more,prolonged'
p51733
g9
sS'to,patients,n'
p51734
g3
sS'performed,on,all'
p51735
g3
sS'bextra,in,patients'
p51736
g9
sS'was,to,cite'
p51737
g3
sS'of,creams,ointments'
p51738
g3
sS'interact,with,increasing'
p51739
g9
sS'plasma,concentration,should'
p51740
g9
sS'similar,interaction,is'
p51741
g9
sS'as,such,a'
p51742
g3
sS'of,cholinergic,reactions'
p51743
g3
sS'modest,degree,in'
p51744
g3
sS'of,with,radiotherapy'
p51745
g3
sS'patients,with,dsm-iv'
p51746
g9
sS'olanzapine,treatment,improves'
p51747
g3
sS'to,patients,already'
p51748
g3
sS'concentrations,of,were'
p51749
g3
sS'leading,to,in-creased'
p51750
g3
sS'auc,of,r'
p51751
g9
sS'with,the,differences'
p51752
g3
sS'butenafine,hcl,cream'
p51753
g3
sS'found,to,interact'
p51754
g3
sS'between,b12,and'
p51755
g9
sS'administered,with,iron-fortified'
p51756
g3
sS'concentrations,of,the'
p51757
g3
sS'coagulation,factor,concentrates'
p51758
g3
sS'acute,release,or'
p51759
g3
sS'and,there,is'
p51760
g9
sS'then,analysing,the'
p51761
g3
sS'and,multifaceted,and'
p51762
g3
sS'oral,or,has'
p51763
g9
sS'blocks,and,reuptake'
p51764
g9
sS'alkalinizers,decrease,effectiveness'
p51765
g3
sS'first-pass,metabolism,and'
p51766
g3
sS'performance,for,to'
p51767
g9
sS'mouse,lymphoma,cells'
p51768
g3
sS'of,cyp1a1,cyp1a2'
p51769
g3
sS'in,rat,bone'
p51770
g3
sS'with,the,disposition'
p51771
g3
sS'this,review,was'
p51772
g3
sS'there,appears,to'
p51773
g3
sS'was,co-administered,with'
p51774
g3
sS'not,be,re-treated'
p51775
g3
sS'these,components,may'
p51776
g3
sS'day,was,superior'
p51777
g3
sS'inhibit,cyp3a4,to'
p51778
g3
sS'been,reported,resulting'
p51779
g9
sS'and,decrease,by'
p51780
g9
sS'and,acamprosate,does'
p51781
g3
sS'pain,or,weakness'
p51782
g3
sS'of,response,to'
p51783
g9
sS'benefit,compared,to'
p51784
g9
sS'to,exhibit,minimal'
p51785
g3
sS'the,steady-state,trough'
p51786
g9
sS'in,multiple,in'
p51787
g3
sS'oral,the,hypoprothrombinemic'
p51788
g3
sS'at,the,three'
p51789
g3
sS'and,these,combinations'
p51790
g3
sS'or,changed,in'
p51791
g9
sS'the,nitrobluetetrazolium,test'
p51792
g3
sS'or,activase,may'
p51793
g3
sS'membranes,of,large'
p51794
g3
sS'h-2,antagonists,in'
p51795
g3
sS'uric,acid,level'
p51796
g9
sS'rr,on,inositol'
p51797
g3
sS'likely,to,cause'
p51798
g3
sS'body,tremors,and'
p51799
g3
sS'the,depressant,effect'
p51800
g9
sS'oral,may,render'
p51801
g9
sS'if,significant,abnormal'
p51802
g3
sS'lower,auc,for'
p51803
g3
sS'with,other,combinations'
p51804
g3
sS'before,initiating,tca'
p51805
g3
sS'primary,focus,is'
p51806
g3
sS'of,the,cases'
p51807
g3
sS'with,hivid,should'
p51808
g3
sS'other,potentially,important'
p51809
g9
sS'however,patients,with'
p51810
g9
sS'in,rare,instances'
p51811
g9
sS'ergot,toxicity,characterized'
p51812
g3
sS'of,creatinine,values'
p51813
g3
sS'are,necessary,the'
p51814
g3
sS'tablets,not,be'
p51815
g9
sS'and,cmax,the'
p51816
g3
sS'no,cns,lesions'
p51817
g3
sS'studied,in,electrically'
p51818
g3
sS'administered,on,the'
p51819
g9
sS'may,potentially,alter'
p51820
g3
sS'that,in,most'
p51821
g9
sS'multiple,sclerosis,patients'
p51822
g3
sS'was,carried,out'
p51823
g3
sS'competitive,inhibitor,of'
p51824
g9
sS'see,whether,the'
p51825
g9
sS'class,of,chemicals'
p51826
g3
sS'no,significant,effect'
p51827
g3
sS'or,copd,medications'
p51828
g3
sS'post-transplant,year,pharmacokinetics'
p51829
g3
sS'care,should,be'
p51830
g3
sS'in,a,highly'
p51831
g3
sS'nucleoside,analogues,didanosine'
p51832
g9
sS'class,including,anafranil'
p51833
g3
sS'already,accumulated,in'
p51834
g9
sS'risks,of,major'
p51835
g9
sS'if,leustatin,injection'
p51836
g3
sS'is,unlikely,to'
p51837
g3
sS'administered,intravenously,to'
p51838
g9
sS'the,significant,findings'
p51839
g3
sS'plasma,drug,levels'
p51840
g3
sS'function,tests,occur'
p51841
g9
sS'be,avoided,because'
p51842
g9
sS'values,for,and'
p51843
g9
sS'which,may,result'
p51844
g9
sS'notably,systemic,exposure'
p51845
g3
sS'adp-induced,increases,in'
p51846
g3
sS'chop-like,regimen,i'
p51847
g3
sS'of,may,therefore'
p51848
g9
sS'in,humans,two'
p51849
g3
sS'and,respectively,a'
p51850
g9
sS'in,the,prolongation'
p51851
g9
sS'with,sustiva,and'
p51852
g3
sS'dose,increase,to'
p51853
g3
sS'etodolac,is,characterised'
p51854
g3
sS'should,be,borne'
p51855
g9
sS'other,concomitant,therapies'
p51856
g3
sS'indicate,that,inhibits'
p51857
g9
sS'possibility,should,be'
p51858
g3
sS'receiving,resulted,in'
p51859
g3
sS'decreased,the,renal'
p51860
g9
sS'serum,levels,be'
p51861
g9
sS'may,impair,the'
p51862
g9
sS'platelets,recover,to'
p51863
g3
sS'concentration,and,area'
p51864
g9
sS'was,possible,to'
p51865
g3
sS'prothrombin,time,ratio'
p51866
g3
sS'serotonin,syndrome,in'
p51867
g3
sS'acid,temporarily,reduced'
p51868
g9
sS'adjustment,is,recommended'
p51869
g3
sS'of,uptake-1,was'
p51870
g3
sS'mg,when,co-administered'
p51871
g3
sS'cytochrome,p450,pathway'
p51872
g3
sS'of,prescribed,to'
p51873
g3
sS'liver,alt,and'
p51874
g9
sS'elimination,and,and'
p51875
g9
sS'as,one,possible'
p51876
g3
sS'not,always,predictive'
p51877
g3
sS'in,hippocampal,adenylate'
p51878
g3
sS'promote,absorption,and'
p51879
g9
sS'since,are,potentiated'
p51880
g9
sS'no,pharmacokinetic,or'
p51881
g3
sS'substance,to,form'
p51882
g9
sS'and,lead,to'
p51883
g9
sS'gallocatechins,epigallocatechin-3,o-gallate'
p51884
g3
sS'potentiation,of,bradycardia'
p51885
g3
sS'excretion,of,as'
p51886
g9
sS'disease,has,not'
p51887
g9
sS'and,by,the'
p51888
g3
sS'infection,in,but'
p51889
g9
sS'function,or,cardiac'
p51890
g3
sS'of,another,botulinum'
p51891
g9
sS'with,conditions,that'
p51892
g3
sS'and,non-,steroidal'
p51893
g9
sS'agents,which,are'
p51894
g9
sS'properties,of,non'
p51895
g3
sS'of,observation,must'
p51896
g3
sS'ge,nerally,classified'
p51897
g3
sS'in,dogs,approximately'
p51898
g3
sS'to,identify,any'
p51899
g3
sS'tardive,dyskinesia,side'
p51900
g9
sS'is,at,the'
p51901
g3
sS'as,the,primary'
p51902
g9
sS'delayed,at,least'
p51903
g3
sS'terfenadine,astemizole,and'
p51904
g3
sS'tasks,in,mice'
p51905
g3
sS'concentrations,increased,from'
p51906
g3
sS'effects,on,embryo'
p51907
g3
sS'class,iv,in'
p51908
g3
sS'or,other,nonsteroidal'
p51909
g9
sS'in,levels,comparable'
p51910
g3
sS'iiia,inhibitors,was'
p51911
g9
sS'with,precedex,a'
p51912
g9
sS'be,avoided,while'
p51913
g3
sS'been,excreted,in'
p51914
g3
sS'reactive,substances,tbars'
p51915
g3
sS'mutagenic,in,the'
p51916
g3
sS'welchol,has,been'
p51917
g3
sS'acid,diminished,binding'
p51918
g9
sS'other,topical,medications'
p51919
g3
sS'a,less,than'
p51920
g9
sS'concentrations,cyp3a4,inducers'
p51921
g3
sS'dopamine2-,and,serotonin2-receptors'
p51922
g3
sS'becausedecreases,in,plasmaconcentrations'
p51923
g9
sS'however,the,concomitant'
p51924
g9
sS'therefore,patients,on'
p51925
g9
sS'may,be,encountered'
p51926
g3
sS'half,of,that'
p51927
g3
sS'are,a,number'
p51928
g3
sS'potentiated,the,positive'
p51929
g9
sS'of,and,n-acetyl'
p51930
g3
sS'until,further,data'
p51931
g3
sS'on,patient,survival'
p51932
g3
sS'cells,resistant,to'
p51933
g3
sS'iodinated,contrast,media'
p51934
g9
sS'these,patients,whose'
p51935
g9
sS'patients,receiving,bolus-ifl'
p51936
g3
sS'dietary-obese,rats,are'
p51937
g3
sS'breast,feeding,and'
p51938
g3
sS'data,in,angina'
p51939
g3
sS'b,was,more'
p51940
g3
sS'dietary-obese,rats,showed'
p51941
g3
sS'several,short-term,controlled'
p51942
g3
sS'is,approximately,to'
p51943
g9
sS'results,generated,to'
p51944
g3
sS'to,be,evaluated'
p51945
g3
sS'a,higher,dose'
p51946
g3
sS'not,possible,the'
p51947
g3
sS'levels,of,vardenafil'
p51948
g3
sS'association,with,concomitant'
p51949
g9
sS'requiring,any,combination'
p51950
g3
sS'liver,function,tests'
p51951
g3
sS'when,the,recommended'
p51952
g9
sS'alone,in,and'
p51953
g3
sS'were,more,likely'
p51954
g3
sS'concomitantly,administered,in'
p51955
g9
sS'diuretic,natriuretic,and'
p51956
g9
sS'previous,experience,as'
p51957
g3
sS'in,addition,reduced'
p51958
g3
sS'when,and,nonsteroidal'
p51959
g9
sS'levels,of,but'
p51960
g9
sS'results,in,inhibition'
p51961
g9
sS'excessive,perspiration,weight'
p51962
g3
sS'report,to,their'
p51963
g3
sS'a,dose,that'
p51964
g3
sS'relationship,of,functional'
p51965
g9
sS'patients,with,stable'
p51966
g3
sS'irrespective,of,cause'
p51967
g3
sS'viable,counts,were'
p51968
g3
sS'of,the,serotype'
p51969
g3
sS'and,the,frequency'
p51970
g3
sS'to,form,a'
p51971
g9
sS'synthetic,by,possibly'
p51972
g9
sS'was,seen,with'
p51973
g9
sS'of,arachidonate-,or'
p51974
g3
sS'uricosuric,medication,may'
p51975
g9
sS'cardiac,glycosides,could'
p51976
g9
sS'for,the,classes'
p51977
g3
sS'appointments,since,some'
p51978
g3
sS'the,actions,of'
p51979
g9
sS'human,serum,by'
p51980
g9
sS'their,metabolites,may'
p51981
g3
sS'conducted,in,vivo'
p51982
g3
sS'this,in,vitro'
p51983
g3
sS'resulted,in,about'
p51984
g9
sS'hplc,peak,as'
p51985
g3
sS'by,mtc-methylene,diphosphonate'
p51986
g9
sS'or,mg,kg'
p51987
g3
sS'increase,gastrointestinal,motility'
p51988
g3
sS'interactions,caused,by'
p51989
g3
sS'depressive,symptoms,p'
p51990
g3
sS'tykerb,is,administered'
p51991
g3
sS'state,while,levels'
p51992
g9
sS'double-blind,study,of'
p51993
g3
sS'although,not,observed'
p51994
g9
sS'on,safety,or'
p51995
g3
sS'enhanced,by,known'
p51996
g3
sS'is,started,or'
p51997
g9
sS'of,cyp3a4,substrates'
p51998
g3
sS'm,the,second'
p51999
g3
sS'subnormal,pancreatic,release'
p52000
g3
sS'a,study,conducted'
p52001
g9
sS'causes,a,slight'
p52002
g9
sS'treatment,with,suboxone'
p52003
g9
sS'upon,a,variety'
p52004
g3
sS'is,receiving,replacement'
p52005
g9
sS'nimbex,at,or'
p52006
g9
sS'no,significant,interference'
p52007
g3
sS'average,higher,in'
p52008
g3
sS'that,the,hypothalamic-pituitary'
p52009
g3
sS'heart,disease,has'
p52010
g9
sS'yielded,similar,serum'
p52011
g3
sS'suggest,that,also'
p52012
g9
sS'are,carried,out'
p52013
g3
sS'iegs,are,thought'
p52014
g3
sS'and,with,some'
p52015
g9
sS'genes,iegs,are'
p52016
g3
sS'daily,the,maximum'
p52017
g9
sS'mg,of,mefenamic'
p52018
g9
sS'probenecid,concomitant,administration'
p52019
g9
sS'who,are,taking'
p52020
g9
sS'until,stable,and'
p52021
g3
sS'detectable,effect,on'
p52022
g3
sS'mixtures,had,no'
p52023
g3
sS'the,desired,therapeutic'
p52024
g3
sS'trials,have,indicated'
p52025
g3
sS'just,prior,to'
p52026
g3
sS'thorazine,prolixin,serentil'
p52027
g3
sS'another,that,is'
p52028
g3
sS'develop,delirium,high'
p52029
g9
sS'monitored,with,appropriate'
p52030
g3
sS'with,bezalip,or'
p52031
g9
sS'to,the,lack'
p52032
g3
sS'oral,contraceptives,keppra'
p52033
g3
sS'men,and,women'
p52034
g3
sS'by,hepatic,enzyme-inducing'
p52035
g9
sS'concentrations,mmol,l'
p52036
g3
sS'min,after,m-tco'
p52037
g9
sS'to,rats,and'
p52038
g3
sS'most,of,the'
p52039
g3
sS'may,potentiate,renal'
p52040
g9
sS'individuals,because,of'
p52041
g3
sS'about,times,more'
p52042
g3
sS'converted,to,sinus'
p52043
g9
sS'have,selected,a'
p52044
g3
sS'markedly,sensitive,and'
p52045
g3
sS'have,frequent,clinical'
p52046
g3
sS'also,result,i'
p52047
g9
sS'blood,or,urine'
p52048
g3
sS'of,because,these'
p52049
g9
sS'c,completely,antagonized'
p52050
g9
sS'd6,the,increase'
p52051
g3
sS'too,little,experience'
p52052
g3
sS'humans,that,resemble'
p52053
g3
sS'a,therapeutic,point'
p52054
g3
sS'cytochrome,p450-mediated,interactions'
p52055
g3
sS'and,inhaled,with'
p52056
g3
sS'for,serious,events'
p52057
g3
sS'ii,vii,antigen'
p52058
g3
sS'decreases,in,exposure'
p52059
g3
sS'hydrate,and,were'
p52060
g3
sS'cytostatic,agent,has'
p52061
g9
sS'serious,adverse,reactions'
p52062
g3
sS'between,mao,inhibitors'
p52063
g9
sS'also,be,expected'
p52064
g9
sS'in,whom,this'
p52065
g3
sS'in,life-threatening,situations'
p52066
g3
sS'axert,is,not'
p52067
g3
sS'hypersensitivity,reactions,to'
p52068
g9
sS'only,if,other'
p52069
g3
sS'appears,to,affect'
p52070
g3
sS'and,add,a'
p52071
g9
sS'other,are,listed'
p52072
g3
sS'physician,may,wish'
p52073
g9
sS'this,can,cause'
p52074
g3
sS'evaluation,of,prothrombin'
p52075
g3
sS'also,increased,fold'
p52076
g9
sS'clinical,evaluation,and'
p52077
g3
sS'therapy,which,may'
p52078
g3
sS'with,use,of'
p52079
g3
sS'of,cerubidine,may'
p52080
g3
sS'breast,milk,on'
p52081
g3
sS'acute,phase,schizophrenia'
p52082
g3
sS'of,vistide,and'
p52083
g9
sS'administration,of,pipracil'
p52084
g3
sS'increased,prothrombin,time'
p52085
g9
sS'may,affect,central'
p52086
g3
sS'adverse,events,from'
p52087
g3
sS'potentiate,the,undesirable'
p52088
g9
sS'and,minor,adverse'
p52089
g3
sS'reuptake,inhibitor,in'
p52090
g9
sS'resolved,when,was'
p52091
g3
sS'miotic,actions,of'
p52092
g3
sS'inhibitors,within,two'
p52093
g9
sS'are,using,effective'
p52094
g3
sS'alone,and,in'
p52095
g3
sS'advised,when,administering'
p52096
g9
sS'the,ratios,of'
p52097
g3
sS'required,when,used'
p52098
g3
sS'the,may,however'
p52099
g3
sS'lower,meclofenamate,sodium'
p52100
g9
sS'pump,inhibitors,should'
p52101
g9
sS'need,to,change'
p52102
g9
sS'has,been,investigated'
p52103
g3
sS'of,mg,q24h'
p52104
g3
sS'of,repeated,courses'
p52105
g3
sS'and,enable,cells'
p52106
g3
sS'as,and,have'
p52107
g3
sS'demonstrate,that,the'
p52108
g3
sS'while,decreasing,components'
p52109
g3
sS'supplied,aerolizertm,inhalation'
p52110
g3
sS'or,mg,h'
p52111
g9
sS'hormonal,may,inhibit'
p52112
g9
sS'carrier,density,in'
p52113
g3
sS'to,a,marketed'
p52114
g9
sS'purposes,cannot,be'
p52115
g3
sS'produce,significant,oxidative'
p52116
g3
sS'from,a,previously'
p52117
g9
sS'pharmacodynamics,of,glucose'
p52118
g3
sS'data,no,interaction'
p52119
g3
sS'may,be,detrimental'
p52120
g3
sS'the,qt0,on'
p52121
g3
sS'nabilone,should,be'
p52122
g9
sS'rate,of,serious'
p52123
g9
sS'understandable,because,the'
p52124
g3
sS'clinically,relevant,interaction'
p52125
g9
sS'patient,s,response'
p52126
g9
sS'on,reports,of'
p52127
g9
sS'and,or,its'
p52128
g9
sS'relevant,effects,on'
p52129
g3
sS'the,cardiovascular,effects'
p52130
g3
sS'results,from,concomitant'
p52131
g3
sS'cells,whereas,b'
p52132
g3
sS'to,exceed,a'
p52133
g9
sS'and,have,also'
p52134
g3
sS'out,during,placebo'
p52135
g3
sS'serum,potassium,prinivil'
p52136
g9
sS'prophylaxis,of,manic-depressive'
p52137
g3
sS'improve,the,general'
p52138
g3
sS'dogs,but,not'
p52139
g9
sS'more,convenient,administration'
p52140
g3
sS'occurred,more,frequently'
p52141
g3
sS'evidence,that,intensive'
p52142
g3
sS'a,false,positive'
p52143
g3
sS'injectables,are,adequate'
p52144
g3
sS'with,a,meal'
p52145
g3
sS'at,steady,state'
p52146
g3
sS'least,days,should'
p52147
g9
sS'of,zmax,have'
p52148
g3
sS'mg,of,betaseron'
p52149
g9
sS'interval,whole,blood'
p52150
g9
sS'fatal,prolongation,of'
p52151
g9
sS'mg,of,q12h'
p52152
g9
sS'have,a,marked'
p52153
g9
sS'will,aid,in'
p52154
g3
sS'containing,membranes,of'
p52155
g3
sS'observed,in,liver'
p52156
g3
sS'interactions,flupenthixol,may'
p52157
g9
sS'too,low,as'
p52158
g3
sS'of,serum,level'
p52159
g3
sS'required,if,rebif'
p52160
g3
sS'drug,interactions,the'
p52161
g9
sS'affect,the,nitrobluetetrazolium'
p52162
g3
sS'reduced,in,a'
p52163
g3
sS'in,six,healthy'
p52164
g9
sS'regimens,in,patients'
p52165
g3
sS'and,the,may'
p52166
g9
sS'of,one,of'
p52167
g3
sS'the,potential,exists'
p52168
g3
sS'temporarily,raise,serum'
p52169
g9
sS'tagamet,to,maintain'
p52170
g3
sS'conjunction,with,one'
p52171
g3
sS'of,the,homocysteine'
p52172
g3
sS'of,toxic,levels'
p52173
g9
sS'b-cell,hyperplasia,of'
p52174
g3
sS'in,general,caution'
p52175
g3
sS'oculo-bulbar,myasthenia,gravis'
p52176
g9
sS'meq,l,were'
p52177
g3
sS'cyp450,enzymes,including'
p52178
g3
sS'coombs,reactions,in'
p52179
g3
sS'with,enzymatic-based,assays'
p52180
g3
sS'and,systolic,blood'
p52181
g3
sS'with,that,induce'
p52182
g3
sS'clearance,and,may'
p52183
g9
sS'permits,at,least'
p52184
g9
sS'concomitant,oral,medication'
p52185
g9
sS'is,primarily,degraded'
p52186
g3
sS'cholestyramine,resin,may'
p52187
g3
sS'a,day,withdrawal'
p52188
g3
sS'either,the,administration'
p52189
g3
sS'is,initiated,or'
p52190
g9
sS'obtained,evidence,that'
p52191
g3
sS'aucasian,population,about'
p52192
g3
sS'coadministration,of,maalox'
p52193
g3
sS'decreased,along,with'
p52194
g3
sS'fr,karst,was'
p52195
g3
sS'thus,concomitant,therapy'
p52196
g3
sS'systemic,exposure,of'
p52197
g9
sS'however,there,are'
p52198
g9
sS'elderly,in,association'
p52199
g9
sS'aucss,h,extent'
p52200
g3
sS'reported,following,the'
p52201
g3
sS'account,for,only'
p52202
g3
sS'are,incompletely,responsive'
p52203
g3
sS'to,human,lymphocytes'
p52204
g3
sS'vitro,appears,to'
p52205
g9
sS'that,have,demonstrated'
p52206
g9
sS'comments,about,possible'
p52207
g3
sS'received,maoi,within'
p52208
g9
sS'if,treatment,with'
p52209
g9
sS'rat,spinal,substantia'
p52210
g3
sS'accutane,therapy,have'
p52211
g3
sS'from,an,week'
p52212
g3
sS'no,systematic,changes'
p52213
g3
sS'inhibits,hepatic,enzymes'
p52214
g3
sS'that,either,the'
p52215
g3
sS'is,an,used'
p52216
g3
sS'times,the,daily'
p52217
g3
sS'i,d,or'
p52218
g9
sS'potential,for,drug-drug'
p52219
g3
sS'of,an,interaction'
p52220
g9
sS'cholesterol,levels,monitored'
p52221
g9
sS'two,weeks,plasma'
p52222
g9
sS'geriatric,use,younger'
p52223
g3
sS'carbonate,the,anorectic'
p52224
g9
sS'presumably,because,both'
p52225
g9
sS'cellular,permeability,and'
p52226
g3
sS'ph,on,the'
p52227
g3
sS'an,increased,dose'
p52228
g3
sS'disulfiram-like,reaction,to'
p52229
g3
sS'adjust,dosage,accordingly'
p52230
g3
sS'appeared,well,correlated'
p52231
g3
sS'cyp2c9,substrate,by'
p52232
g9
sS'with,other,psychotropic'
p52233
g9
sS'been,occasional,literature'
p52234
g9
sS'monitored,and,dosage'
p52235
g3
sS'sodium,or,other'
p52236
g9
sS'significantly,smaller,proportion'
p52237
g3
sS'if,administered,rapidly'
p52238
g3
sS'taking,and,hepatic'
p52239
g3
sS'active,metabolite,n-desmethyldiazepam'
p52240
g9
sS'abnormal,bleeding,and'
p52241
g3
sS'arrangements,in,an'
p52242
g3
sS'including,many,selective'
p52243
g3
sS'proportions,in,the'
p52244
g3
sS'permeable,caspase-3,inhibitor'
p52245
g3
sS'in,nephrosis,acromegaly'
p52246
g3
sS'studied,for,its'
p52247
g3
sS'mix,toradol,and'
p52248
g3
sS'renal,function,clinical'
p52249
g3
sS'of,post-heparin,lipolytic'
p52250
g9
sS'administration,of,thiazide'
p52251
g9
sS'although,studies,designed'
p52252
g3
sS'or,abolish,the'
p52253
g9
sS'hyperpyrexia,has,been'
p52254
g9
sS'plendil,the,pharmacokinetics'
p52255
g3
sS'receiving,starlix,the'
p52256
g3
sS'phenothiazine-related,compounds,and'
p52257
g9
sS'is,patient,in'
p52258
g3
sS'therapy,with,antiplatelet'
p52259
g9
sS'against,the,simultaneous'
p52260
g3
sS'containing,mg,ethinyl'
p52261
g3
sS'on,cas,but'
p52262
g9
sS'study,and,ci'
p52263
g3
sS'the,mean,area'
p52264
g3
sS'carried,out,mainly'
p52265
g3
sS'mg,day,in'
p52266
g3
sS'this,study,demonstrated'
p52267
g9
sS'report,of,cardiopulmonary'
p52268
g3
sS'mg,orally,disintegrating'
p52269
g9
sS'a,result,of'
p52270
g3
sS'gene,under,the'
p52271
g3
sS'of,these,other'
p52272
g3
sS'false,low,measurement'
p52273
g3
sS'node,function,or'
p52274
g9
sS'inhibitors,or,other'
p52275
g3
sS'be,carried,out'
p52276
g3
sS'changes,and,its'
p52277
g3
sS'is,used,in'
p52278
g9
sS'of,p-450iie1,in'
p52279
g9
sS'liver,which,in'
p52280
g9
sS'day,are,advisable'
p52281
g3
sS'it,was,co-administered'
p52282
g9
sS'haart,treatment,on'
p52283
g3
sS'in,non-human,primates'
p52284
g3
sS'mechanisms,will,aid'
p52285
g3
sS'on,the,retention'
p52286
g9
sS'additive,and,nonadditive'
p52287
g3
sS'altered,by,gleevec'
p52288
g9
sS'exposure,approximately,times'
p52289
g3
sS'anticoagulants,including,derivatives'
p52290
g9
sS'pharmacodynamics,arecoline,eproxindine'
p52291
g9
sS'triazolam,no,significant'
p52292
g3
sS'receiving,either,tagamet'
p52293
g9
sS'of,a,synergistic'
p52294
g3
sS'presyncope,or,orthostatic'
p52295
g9
sS'be,expected,since'
p52296
g3
sS'aeds,phenytoin,keppra'
p52297
g3
sS'intersubject,variability,in'
p52298
g9
sS'medications,containing,multivalent'
p52299
g9
sS'lithium,should,generally'
p52300
g9
sS'certain,are,metabolized'
p52301
g3
sS'interact,with,the'
p52302
g9
sS'with,monurol,a'
p52303
g9
sS'a,continuing,rise'
p52304
g3
sS'produced,a,clinically'
p52305
g9
sS'the,recognition,of'
p52306
g3
sS'with,are,illustrated'
p52307
g3
sS'concentration,that,is'
p52308
g3
sS'other,medicinal,products'
p52309
g3
sS'who,are,on'
p52310
g9
sS'avoid,iatrogenic,alterations'
p52311
g9
sS'or,divalent,or'
p52312
g3
sS'rates,and,mortality'
p52313
g3
sS'this,paper,was'
p52314
g3
sS'with,both,invirase'
p52315
g3
sS'used,in,a'
p52316
g3
sS'nonselective,monoamine,oxidase'
p52317
g9
sS'who,have,developed'
p52318
g3
sS'recording,higher,concentrations'
p52319
g3
sS'no,depressant,effect'
p52320
g3
sS'acid,in,the'
p52321
g3
sS'concentrations,increased,the'
p52322
g9
sS'days,had,no'
p52323
g3
sS'bid,as,compared'
p52324
g9
sS'smaller,proportion,of'
p52325
g3
sS'sedation,if,is'
p52326
g9
sS'volunteers,ingesting,the'
p52327
g9
sS'significant,change,in'
p52328
g3
sS'cyp3a4,activity,may'
p52329
g3
sS'other,bronchodilators,has'
p52330
g9
sS'a,further,route'
p52331
g3
sS'concentration,monitoring,is'
p52332
g9
sS'of,life-,threatening'
p52333
g9
sS'vitamin,d2,vitamin'
p52334
g9
sS'study,a,nd'
p52335
g3
sS'case,per,patients'
p52336
g3
sS'avoided,in,patients'
p52337
g9
sS'flexeril,may,have'
p52338
g9
sS'ed50,of,nuromax'
p52339
g9
sS'once,daily,has'
p52340
g3
sS'at,all,when'
p52341
g9
sS'most,evoked,potential'
p52342
g3
sS'with,the,release'
p52343
g3
sS'system,may,have'
p52344
g3
sS'once,daily,had'
p52345
g3
sS'the,diarrhea-inducing,effects'
p52346
g3
sS'therefore,little,is'
p52347
g3
sS'of,this,specificity'
p52348
g3
sS'last,act,of'
p52349
g3
sS'use,of,medications'
p52350
g3
sS'pressure,carotid,cannulation'
p52351
g3
sS'hemorrhage,and,optic'
p52352
g3
sS'in,cases,with'
p52353
g3
sS'affect,sinus,node'
p52354
g9
sS'significant,differences,in'
p52355
g3
sS'concomitantly,with,sustained-release'
p52356
g3
sS'concentrations,of,tricyclic'
p52357
g3
sS'ethacrynic,acid,hepatotoxic'
p52358
g9
sS'plasma,albumin,binding'
p52359
g9
sS'non-potassium,sparing,such'
p52360
g9
sS'beta-adrenergic,antagonists,and'
p52361
g9
sS'to,maintain,twitch'
p52362
g3
sS'by,approximately,in'
p52363
g3
sS'lies,both,in'
p52364
g3
sS'pressure,than,when'
p52365
g9
sS'studied,increased,exposures'
p52366
g9
sS'with,changes,in'
p52367
g3
sS'levels,and,therefore'
p52368
g3
sS'cholestyramine,and,cholestytamine'
p52369
g9
sS'inhibitors,in,vitro'
p52370
g9
sS'kg,and,sex'
p52371
g3
sS'inhibitors,warning,potential'
p52372
g3
sS'the,total,bioavailability'
p52373
g3
sS'for,accutane,a'
p52374
g3
sS'new,combination,therapies'
p52375
g3
sS'interactions,naproxen,may'
p52376
g3
sS'effect,of,stadol'
p52377
g9
sS'special,care,should'
p52378
g9
sS'of,the,absence'
p52379
g3
sS'drugs,possessing,properties'
p52380
g3
sS'of,rats,with'
p52381
g9
sS'be,taken,if'
p52382
g9
sS'of,tachyarrhythmias,as'
p52383
g3
sS'of,by,approximately'
p52384
g9
sS'about,in,the'
p52385
g9
sS'patient,receiving,diabinese'
p52386
g3
sS'may,explain,in'
p52387
g3
sS'severe,bradycardia,or'
p52388
g3
sS'doses,of,mg'
p52389
g3
sS'videx,hours,prior'
p52390
g9
sS'method,to,accomplish'
p52391
g3
sS'reduced,while,the'
p52392
g9
sS'calcium,channel,antagonists'
p52393
g3
sS'and,these,aeds'
p52394
g3
sS'anesthetics,general,exaggeration'
p52395
g9
sS'or,statistically,significant'
p52396
g3
sS'combination,with,double'
p52397
g3
sS'and,involve,individual'
p52398
g3
sS'concentrations,of,either'
p52399
g3
sS'reaction,of,actinic'
p52400
g9
sS'interaction,study,tambocor'
p52401
g3
sS'conflicting,results,regarding'
p52402
g9
sS'significantly,metabolized,by'
p52403
g3
sS'currently,little,adequate'
p52404
g3
sS'sodium,approximately,times'
p52405
g9
sS'frequently,with,the'
p52406
g3
sS'be,consistent,with'
p52407
g3
sS'concurrently,with,such'
p52408
g3
sS'that,as,v'
p52409
g3
sS'driving,a,car'
p52410
g3
sS'ewes,with,an'
p52411
g9
sS'transmission,at,the'
p52412
g3
sS'alfenta,doses,will'
p52413
g3
sS'two,elements,only'
p52414
g3
sS'to,their,efficacy'
p52415
g3
sS'healthy,subjects,to'
p52416
g3
sS'peak,serum,levels'
p52417
g9
sS'and,begin,therapy'
p52418
g3
sS'will,need,to'
p52419
g9
sS'the,ureidopenicillins,including'
p52420
g9
sS'synergistic,elevation,of'
p52421
g9
sS'ranging,from,therapeutic'
p52422
g3
sS'mg,with,the'
p52423
g3
sS'doses,of,m1'
p52424
g9
sS'by,approximately,and'
p52425
g9
sS'determinants,of,cellular'
p52426
g3
sS'pharmacodynamics,or,pharmacokinetics'
p52427
g3
sS'blockers,sustained-release,with'
p52428
g3
sS'other,medications,or'
p52429
g3
sS'comparison,of,tolerance'
p52430
g9
sS'its,permeation,enhancing'
p52431
g3
sS'simultaneously,at,least'
p52432
g3
sS'gtp-binding,proteins,of'
p52433
g3
sS'of,concentrations,or'
p52434
g3
sS'time,response,to'
p52435
g3
sS'radiation,treatment,or'
p52436
g3
sS'min,before,a'
p52437
g9
sS'cimetidine,co-administration,with'
p52438
g9
sS'of,elimination,of'
p52439
g9
sS'dystonia,ataxia,blurred'
p52440
g3
sS'with,either,oral'
p52441
g9
sS'reported,l-histidine,via'
p52442
g9
sS'angiotensin-converting,enzyme,inhibitors'
p52443
g9
sS'the,groups,receiving'
p52444
g9
sS'proleukin,may,affect'
p52445
g3
sS'severe,rhabdomyolysis,appear'
p52446
g9
sS'these,are,often'
p52447
g3
sS'therapeutic,superiority,compared'
p52448
g3
sS'ml,at,baseline'
p52449
g3
sS'for,only,of'
p52450
g3
sS'treatment,with,mg'
p52451
g3
sS'that,hydrochloride,binds'
p52452
g3
sS'are,receiving,a'
p52453
g9
sS'intrinsic,value,prescribed'
p52454
g3
sS'group,therapy,with'
p52455
g3
sS'and,respectively,compared'
p52456
g9
sS'sucralfate,administered,hours'
p52457
g9
sS'reaction,for,glucose'
p52458
g3
sS'altered,consciousness,caused'
p52459
g9
sS'cause,severe,persistent'
p52460
g3
sS'could,theoretically,interfere'
p52461
g3
sS'or,when,proquin'
p52462
g3
sS'imuran,the,concomitant'
p52463
g9
sS'caution,because,of'
p52464
g9
sS'the,median,of'
p52465
g9
sS'additional,significantly,inhibited'
p52466
g9
sS'p-,by,which'
p52467
g3
sS'milk,and,because'
p52468
g3
sS'concentrations,of,are'
p52469
g9
sS'nalidixic,acid,oxolinic'
p52470
g9
sS'found,to,have'
p52471
g3
sS'of,clinically,significant'
p52472
g3
sS'thus,in,order'
p52473
g9
sS'tmax,was,hours'
p52474
g3
sS'sedation,when,is'
p52475
g9
sS'effects,of,stress'
p52476
g3
sS'exercised,in,the'
p52477
g9
sS'data,are,developed'
p52478
g3
sS'depend,on,the'
p52479
g9
sS'and,the,therapy'
p52480
g3
sS'similar,events,have'
p52481
g3
sS'not,been,observed'
p52482
g3
sS'morphine,a,literature'
p52483
g9
sS'of,megakaryocytes,with'
p52484
g9
sS'one-half,the,usual'
p52485
g9
sS'plus,or,minus'
p52486
g3
sS'levamisole,hydrochloride,has'
p52487
g9
sS'by,mao,inhibitors'
p52488
g9
sS'the,case,that'
p52489
g9
sS'ratio,inr,elevations'
p52490
g9
sS'by,a,net'
p52491
g9
sS'in,this,situation'
p52492
g3
sS'to,this,mechanism'
p52493
g9
sS'of,orally,inhaled'
p52494
g9
sS'following,concomitant,medications'
p52495
g3
sS'on,placental,vessels'
p52496
g3
sS'these,observations,strongly'
p52497
g3
sS'days,through,increased'
p52498
g9
sS'should,be,alerted'
p52499
g3
sS'inhibit,the,major'
p52500
g3
sS'a4,by,oxc'
p52501
g3
sS'may,be,clinically'
p52502
g3
sS'the,lysate,derived'
p52503
g3
sS'certain,cyp450,enzymes'
p52504
g3
sS'because,of,demonstrated'
p52505
g3
sS'hivid,should,have'
p52506
g3
sS'clinical,trials,mean'
p52507
g3
sS'oral,contraceptives,the'
p52508
g3
sS'coagulation,factors,and'
p52509
g3
sS'of,nonsmoking,healthy'
p52510
g3
sS'or,altered,tsh'
p52511
g3
sS'with,for,the'
p52512
g9
sS'containing,and,other'
p52513
g9
sS'aggregation,the,release'
p52514
g3
sS'cholesterol,low-density,lipoproteins'
p52515
g3
sS'with,commonly,used'
p52516
g3
sS'indication,of,physiological'
p52517
g3
sS'a,the,maximal'
p52518
g3
sS'was,significantly,greater'
p52519
g3
sS'the,potency,of'
p52520
g3
sS'amines,may,reduce'
p52521
g9
sS'manufacturer,or,the'
p52522
g3
sS'exacerbate,the,rebound'
p52523
g9
sS'acid,etc,increase'
p52524
g9
sS'cholinesterase,activity,potentiates'
p52525
g9
sS'analyses,were,conducted'
p52526
g3
sS'can,cause,a'
p52527
g9
sS'to,exaggerated,leukopenia'
p52528
g3
sS'period,demonstrated,widespread'
p52529
g3
sS'could,be,reversed'
p52530
g3
sS'discontinuation,of,taxol'
p52531
g3
sS's,concomitantly,with'
p52532
g9
sS'be,observed,carefully'
p52533
g9
sS'changes,that,include'
p52534
g9
sS'with,mg,tid'
p52535
g9
sS'study,with,intravenous'
p52536
g3
sS'because,the,clearance'
p52537
g9
sS'or,additional,measures'
p52538
g3
sS'of,were,generated'
p52539
g3
sS'enzyme,system,ketoconazole'
p52540
g9
sS'caffeine,enoxacin,is'
p52541
g9
sS'utility,of,using'
p52542
g3
sS'receiving,these,in'
p52543
g3
sS'cyst,patients,treated'
p52544
g9
sS'in,elevated,serum'
p52545
g9
sS'the,following,cyclosporine'
p52546
g3
sS'with,respectto,safety'
p52547
g3
sS'coli,in,male'
p52548
g3
sS'cat,inferior,mesenteric'
p52549
g3
sS'attributed,to,the'
p52550
g9
sS'dose,for,this'
p52551
g3
sS'dry,mouth,anorexia'
p52552
g3
sS'excretion,in,the'
p52553
g9
sS'cmax,by,fold'
p52554
g9
sS'used,to,determine'
p52555
g3
sS'nacmc,at,m'
p52556
g3
sS'was,evident,by'
p52557
g3
sS'frequent,occurrence,of'
p52558
g3
sS'and,a,molecular'
p52559
g9
sS'therapeutic,and,toxic'
p52560
g3
sS'therapy,with,to'
p52561
g9
sS'inhibitors,dasatinib,is'
p52562
g3
sS'concomitant,hydrochloride,and'
p52563
g3
sS'serum,activity,has'
p52564
g3
sS'dose,study,n'
p52565
g9
sS'd,by,patients'
p52566
g9
sS'recommended,during,coadministration'
p52567
g9
sS'agonists,on,the'
p52568
g9
sS'mmol,l,were'
p52569
g3
sS'of,increased,intraocular'
p52570
g3
sS'information,on,how'
p52571
g3
sS'associated,with,torsades'
p52572
g3
sS'half-lives,of,for'
p52573
g3
sS'tea,gallocatechins,epigallocatechin-3'
p52574
g3
sS'recording,pipette,compared'
p52575
g3
sS'ssri-tca,interactions,may'
p52576
g9
sS'caucasian,population,about'
p52577
g3
sS'was,to,characterize'
p52578
g3
sS'is,theoretically,possible'
p52579
g9
sS'adjustment,of,concomitant'
p52580
g3
sS'false-negative,result,may'
p52581
g3
sS'for,p450,d6'
p52582
g3
sS'therapy,to,insure'
p52583
g9
sS'be,adjusted,in'
p52584
g3
sS'patients,have,received'
p52585
g3
sS'xanthine,oxidase,from'
p52586
g3
sS'changed,as,evidenced'
p52587
g3
sS'cytochrome,isozymes,are'
p52588
g3
sS'a,gas,chromatographic-mass'
p52589
g3
sS'for,combined,exposure'
p52590
g3
sS'disopyramide,increases,qt'
p52591
g3
sS'in,effect,of'
p52592
g3
sS'however,as,with'
p52593
g9
sS'cross,toxicity,and'
p52594
g9
sS'simulect,clearance,values'
p52595
g3
sS'with,other,clinically'
p52596
g3
sS'serum,electrolytes,and'
p52597
g3
sS'potential,risk,of'
p52598
g9
sS'cns,and,other'
p52599
g3
sS'a,significant,decrease'
p52600
g3
sS'renal,tubular,excretion'
p52601
g9
sS'four,resulted,in'
p52602
g9
sS'be,associated,with'
p52603
g3
sS'patients,in,rheumatoid'
p52604
g3
sS'qt,prolongation,which'
p52605
g3
sS'that,these,tests'
p52606
g3
sS'of,m,v'
p52607
g3
sS'first,experiment,male'
p52608
g3
sS'to,date,has'
p52609
g3
sS'every,weeks,were'
p52610
g3
sS'total,bilirubin,elevations'
p52611
g3
sS'concentration,or,impair'
p52612
g3
sS'that,of,decreased'
p52613
g3
sS'and,between,given'
p52614
g3
sS'fertility,as,well'
p52615
g3
sS'bid,with,resulted'
p52616
g9
sS'of,subjects,aged'
p52617
g3
sS'on,clearance,has'
p52618
g3
sS'failure,etc,or'
p52619
g9
sS'decrease,the,cyp3a4-mediated'
p52620
g9
sS'day,days,plus'
p52621
g3
sS'cyp2d6,was,co-administered'
p52622
g3
sS'are,more,likely'
p52623
g3
sS'achieve,and,sustain'
p52624
g3
sS'inhibition,of,tubular'
p52625
g9
sS'concurrent,use,should'
p52626
g3
sS'an,index,of'
p52627
g3
sS'displace,less,firmly'
p52628
g9
sS'was,performed,on'
p52629
g3
sS'consider,hmg-coa,reductase'
p52630
g9
sS'drug,concentrations,fold'
p52631
g3
sS'clinical,trials,suggest'
p52632
g3
sS'hydroxy-corticosteroids,by,the'
p52633
g3
sS'of,to,a'
p52634
g9
sS'contrast,increased,the'
p52635
g3
sS'humans,and,rats'
p52636
g9
sS'solvents,this,article'
p52637
g3
sS'drug,taking,into'
p52638
g3
sS'in,using,duloxetine'
p52639
g3
sS'flow,and,fundus'
p52640
g3
sS'complete,prescribing,information'
p52641
g3
sS'of,responses,with'
p52642
g3
sS'sometimes,fatal,reactions'
p52643
g9
sS'to,resulting,interference'
p52644
g9
sS'nitrates,nifedipine,may'
p52645
g3
sS'reason,the,dose'
p52646
g9
sS'aluminum-,and,magnesium-containing'
p52647
g3
sS'in,either,erythro-fluorocitrate'
p52648
g3
sS'extends,its,plasma'
p52649
g9
sS'and,or,diarrhea'
p52650
g9
sS'mg,bid,as'
p52651
g9
sS'improve,the,permeation'
p52652
g3
sS'such,as,back'
p52653
g3
sS'to,those,taking'
p52654
g3
sS'times,can,be'
p52655
g3
sS'epilepsy,ingesting,the'
p52656
g3
sS'highest,level,of'
p52657
g3
sS'drug,regimens,in'
p52658
g3
sS'each,study,a'
p52659
g3
sS'after,a,single'
p52660
g3
sS'variable,degrees,of'
p52661
g3
sS'interferon,beta,to'
p52662
g3
sS'status,changes,that'
p52663
g9
sS'administration,of,racemic'
p52664
g3
sS'pharmacokinetics,of,representative'
p52665
g3
sS'dyslipidemia,hypertension,hypercoagulation'
p52666
g3
sS'digoxin,when,multiple'
p52667
g9
sS'gvia,omega-agatoxin,via-resistant'
p52668
g3
sS'the,hepatic,metabolic'
p52669
g3
sS'of,medicinal,products'
p52670
g9
sS'the,maximum,human'
p52671
g3
sS'days,and,mmol'
p52672
g3
sS'everolimus,exposure-response,relationships'
p52673
g3
sS'adenosine,cyclic,in'
p52674
g3
sS'as,the,vascular'
p52675
g9
sS'can,be,acutely'
p52676
g9
sS'deet,was,included'
p52677
g3
sS'keratoses,treated,with'
p52678
g9
sS'the,oral,hormonal'
p52679
g9
sS'they,may,enhance'
p52680
g3
sS'to,increased,plasma'
p52681
g9
sS'were,submitted,to'
p52682
g3
sS'from,to,hours'
p52683
g3
sS'kg,h,without'
p52684
g9
sS'dosage,and,duration'
p52685
g3
sS'produced,average,decreases'
p52686
g9
sS'orange,juices,studies'
p52687
g3
sS'the,placental,margin'
p52688
g3
sS'of,vioxx,and'
p52689
g3
sS'however,reduced,cmax'
p52690
g9
sS'iv,such,as'
p52691
g3
sS'the,following,similar'
p52692
g3
sS'different,than,for'
p52693
g9
sS'decreasing,components,n1'
p52694
g3
sS'to,increased,effects'
p52695
g3
sS'detected,in,in'
p52696
g3
sS'maintenance,doses,or'
p52697
g9
sS'dose,of,arava'
p52698
g9
sS'other,including,when'
p52699
g9
sS'isozyme,including,many'
p52700
g3
sS'aliskiren,does,not'
p52701
g3
sS'adjustment,is,not'
p52702
g9
sS'obtained,should,not'
p52703
g9
sS'enhance,cns,depression'
p52704
g9
sS'will,have,a'
p52705
g3
sS'levels,or,prothrombin'
p52706
g3
sS'constructive,alternatives,in'
p52707
g3
sS'given,concurrently,increases'
p52708
g9
sS'the,other,agents'
p52709
g3
sS'hydroxylase,is,reduced'
p52710
g3
sS'with,mg,m2'
p52711
g3
sS'some,cases,the'
p52712
g3
sS'aprepitant,is,unlikely'
p52713
g3
sS'the,sexological,psychological'
p52714
g3
sS'who,increase,their'
p52715
g9
sS'these,studies,indicate'
p52716
g9
sS'through,an,effect'
p52717
g9
sS'achieve,mac,minimum'
p52718
g9
sS'than,mug,ml'
p52719
g3
sS'type,strains,and'
p52720
g3
sS'taking,lexapro,is'
p52721
g9
sS'high,concentrations,of'
p52722
g3
sS'vasoconstrictor,thromboxane,a2'
p52723
g3
sS'of,rr,is'
p52724
g3
sS'groups,developed,b-cell'
p52725
g3
sS'receiving,thiazide,for'
p52726
g3
sS'special,care,is'
p52727
g3
sS'contrast,media,was'
p52728
g3
sS'hepatotoxicity,of,by'
p52729
g9
sS'sulfate,may,enhance'
p52730
g9
sS'in,the,kidneys'
p52731
g3
sS'when,trisenox,is'
p52732
g9
sS'a,talk,to'
p52733
g3
sS'use,of,beta-adrenergic'
p52734
g9
sS'and,their,associated'
p52735
g3
sS'should,be,administered'
p52736
g9
sS'of,but,significantly'
p52737
g9
sS'of,creatinine,makes'
p52738
g3
sS'time,was,increased'
p52739
g3
sS'with,oral,may'
p52740
g9
sS'chloroprocaine,inhibits,the'
p52741
g3
sS'pulse,and,blood'
p52742
g9
sS'all,patients,receiving'
p52743
g3
sS'hypoglycemic,agents,eg'
p52744
g9
sS'whether,is,the'
p52745
g3
sS'intercurrent,illnesses,dose'
p52746
g3
sS'these,behavioral,changes'
p52747
g3
sS'eg,and,may'
p52748
g9
sS'lipid,response,to'
p52749
g3
sS'compounds,that,induce'
p52750
g9
sS'via,its,metabolism'
p52751
g9
sS'with,l-tryptophan,may'
p52752
g3
sS'renal,impairment,clcr'
p52753
g9
sS'general,skeletal,muscle'
p52754
g9
sS'curve,of,these'
p52755
g3
sS'the,blood,which'
p52756
g9
sS'm,and,a4'
p52757
g3
sS'cardiovascular,adverse,events'
p52758
g3
sS'ketoconazole,tablets,may'
p52759
g9
sS'mammary,gland,of'
p52760
g3
sS'maalox,tc,suspension'
p52761
g9
sS'have,been,postmarketing'
p52762
g9
sS'kerastick,for,topical'
p52763
g3
sS'absorption,is,sensitive'
p52764
g3
sS'that,will,inhibit'
p52765
g3
sS'pressure,in,patients'
p52766
g3
sS'of,in,alcoholic'
p52767
g9
sS'presence,of,carbamazepine'
p52768
g9
sS'agent,was,found'
p52769
g3
sS'parental,such,as'
p52770
g9
sS'qualitative,differences,between'
p52771
g3
sS'were,not,performed'
p52772
g3
sS'other,common,adverse'
p52773
g3
sS'interfere,with,subsequent'
p52774
g3
sS'by,or,on'
p52775
g3
sS'warfarin,quinolones,may'
p52776
g9
sS'concomitantly,there,is'
p52777
g9
sS'according,to,gibaldi'
p52778
g3
sS'than,when,either'
p52779
g9
sS'substrate,and,cyp'
p52780
g3
sS'glucose,monitoring,devices'
p52781
g3
sS'magnesium-containing,preparations,eg'
p52782
g9
sS'or,either,stereoisomer'
p52783
g9
sS'and,may,cause'
p52784
g9
sS'itraconazole,enhances,the'
p52785
g9
sS'changes,in,ecg'
p52786
g3
sS'by,n6-cyclopentyladenosine,cpa'
p52787
g9
sS'significantly,with,multiple'
p52788
g3
sS'the,genetically,nervous'
p52789
g3
sS'when,assessed,on'
p52790
g3
sS'on,anecdotal,reports'
p52791
g9
sS'not,cause,induction'
p52792
g3
sS'you,may,require'
p52793
g3
sS'b,this,table'
p52794
g3
sS'times,the,recommended'
p52795
g3
sS'days,after,the'
p52796
g9
sS'disease,who,received'
p52797
g3
sS'alternatives,to,such'
p52798
g3
sS'via,cyp,a4'
p52799
g3
sS'intravenous,administration,of'
p52800
g3
sS'either,the,pharmacokinetics'
p52801
g3
sS'and,profound,sedation'
p52802
g9
sS'to,treat,strongyloidiasis'
p52803
g9
sS'is,running,a'
p52804
g3
sS'cmax,by,in'
p52805
g9
sS'as,mg,day'
p52806
g9
sS'shorter,withdrawal,period'
p52807
g3
sS'of,voltage-dependent,ca'
p52808
g3
sS'and,pharmacokinetics,of'
p52809
g3
sS'and,mg,administered'
p52810
g9
sS'taking,or,oral'
p52811
g3
sS'patient,on,chronic'
p52812
g9
sS'may,potentiate,vecuronium-induced'
p52813
g9
sS'ketoconazole,tablets,inhibit'
p52814
g9
sS'clinical,evidence,has'
p52815
g9
sS'low-dose,with,vioxx'
p52816
g9
sS'concentrations,include,acute'
p52817
g9
sS'and,increased,appetite'
p52818
g3
sS'to,the,cross-reactivity'
p52819
g9
sS'such,the,dose'
p52820
g3
sS'nephrotoxic,because,of'
p52821
g3
sS'tubular,transport,of'
p52822
g9
sS'no,confirmed,interactions'
p52823
g3
sS'precipitating,coronary,insufficiency'
p52824
g3
sS'mg,bid,otc'
p52825
g9
sS'in,women,with'
p52826
g3
sS'deficiencies,affecting,blood'
p52827
g9
sS'seen,in,another'
p52828
g3
sS'tolerant,patients,or'
p52829
g3
sS'a6,c9,d6'
p52830
g3
sS'concurrently,taking,metabolized'
p52831
g3
sS'a4,inhibitors,on'
p52832
g3
sS'of,both,and'
p52833
g9
sS'of,is,negligible'
p52834
g3
sS'these,isoenzymes,may'
p52835
g3
sS'or,serum,levels'
p52836
g9
sS'acid,and,abciximab'
p52837
g9
sS'cyp2e1,and,cyp3a4'
p52838
g3
sS'its,epoxide,metabolite'
p52839
g3
sS'an,effector,immediate-early'
p52840
g3
sS'concentration,greater,than'
p52841
g3
sS'undergoing,ptca,pci'
p52842
g9
sS'taken,when,coadministration'
p52843
g3
sS'potential,increased,risks'
p52844
g3
sS'insert,labeling,of'
p52845
g3
sS'of,tml,manifested'
p52846
g3
sS'levels,of,were'
p52847
g3
sS'may,reveal,other'
p52848
g3
sS'products,could,theoretically'
p52849
g9
sS'somnolence,have,been'
p52850
g9
sS'report,the,case'
p52851
g9
sS'inadequate,to,fully'
p52852
g3
sS'pharmacokinetics,of,busulfex'
p52853
g9
sS'are,used,physiological'
p52854
g3
sS'in,studies,with'
p52855
g3
sS'persistent,hypertension,or'
p52856
g3
sS'channel,blockers,requires'
p52857
g9
sS'and,it,enhances'
p52858
g3
sS'for,yeast,and'
p52859
g3
sS'effects,of,the'
p52860
g9
sS'acetate,x,m'
p52861
g9
sS'evaluated,cyps,a1'
p52862
g3
sS'on,pharmacokinetics,and'
p52863
g3
sS'as,a,first-line'
p52864
g3
sS'is,not,known'
p52865
g3
sS'changes,were,observed'
p52866
g3
sS'study,in,hypertensive'
p52867
g3
sS'coagulation,times,were'
p52868
g3
sS'green,tea,gallocatechins'
p52869
g3
sS'and,if,necessary'
p52870
g3
sS'by,single,dose'
p52871
g3
sS'this,paper,is'
p52872
g3
sS'was,decreased,in'
p52873
g3
sS'levels,may,rise'
p52874
g3
sS'mcf-7,cells,even'
p52875
g3
sS'of,krm-1648,either'
p52876
g3
sS'during,continuous,intravenous'
p52877
g3
sS'of,unchanged,alkaloids'
p52878
g9
sS'influence,of,the'
p52879
g3
sS'a,euthyroid,state'
p52880
g3
sS'oral,has,led'
p52881
g9
sS'probability,distribution,have'
p52882
g3
sS'patients,receiving,mg'
p52883
g3
sS'for,the,selective'
p52884
g3
sS'however,patients,receiving'
p52885
g3
sS'consequently,prothrombin,time'
p52886
g3
sS'period,was,inserted'
p52887
g3
sS'cause,hypermagnesemia,and'
p52888
g9
sS'such,as,channel-blockers'
p52889
g3
sS'exercised,when,are'
p52890
g9
sS'the,copegus,pregnancy'
p52891
g3
sS'initiated,cells,that'
p52892
g3
sS'and,may,compete'
p52893
g9
sS'mg,considered,for'
p52894
g3
sS'amprenavir,significantly,increased'
p52895
g9
sS'mg,of,twice'
p52896
g3
sS'death,have,been'
p52897
g3
sS'recommended,dosages,or'
p52898
g9
sS'diagnostic,serum,tests'
p52899
g3
sS'antagonize,the,in'
p52900
g9
sS'no,evidence,was'
p52901
g3
sS'have,caused,to'
p52902
g9
sS'metoclopramide,bioavailability,is'
p52903
g9
sS'treatment,of,patients'
p52904
g9
sS'and,decreased,prothrombin'
p52905
g3
sS'evaluated,but,should'
p52906
g9
sS'so,formed,often'
p52907
g3
sS'corn,oil,ml'
p52908
g3
sS'b,i,d'
p52909
g9
sS'profile,of,mg'
p52910
g3
sS'cholestographic,agents,iodine-containing'
p52911
g3
sS'may,be,prolonged'
p52912
g9
sS'interactions,albuterol,strattera'
p52913
g9
sS'patients,receiving,concomitantly'
p52914
g9
sS'indicated,they,should'
p52915
g3
sS'of,both,agents'
p52916
g3
sS'other,that,inhibit'
p52917
g3
sS'be,employed,for'
p52918
g3
sS'expression,in,certain'
p52919
g3
sS'during,conversion,from'
p52920
g3
sS'vitro,studies,did'
p52921
g3
sS'mg,dl,triglycerides'
p52922
g3
sS'inhibitors,of,c'
p52923
g9
sS'phenergan,mellaril,stelazine'
p52924
g3
sS'studies,cytochrome,p450'
p52925
g3
sS'either,dosage,reduction'
p52926
g3
sS'in,hiv-1,seropositive'
p52927
g3
sS'some,have,been'
p52928
g9
sS'significantly,more,frequently'
p52929
g3
sS'on,the,distribution'
p52930
g3
sS'been,established,current'
p52931
g9
sS'to,increase3,ci'
p52932
g3
sS'of,aerosol,particles'
p52933
g3
sS'or,enantiomer,pharmacokinetics'
p52934
g3
sS'of,drug,metabolized'
p52935
g3
sS'requires,a,dose'
p52936
g3
sS'of,mcf-7,cells'
p52937
g3
sS'vitro,studies,indicate'
p52938
g3
sS'usually,the,dosage'
p52939
g3
sS'by,cholinergic,stimulation'
p52940
g3
sS'using,effective,forms'
p52941
g3
sS'cyp3a4,therefore,potential'
p52942
g3
sS'male,volunteers,were'
p52943
g3
sS'a4,were,not'
p52944
g3
sS'closely,when,initiating'
p52945
g9
sS'terms,of,safety'
p52946
g3
sS'health,if,a'
p52947
g9
sS'potentiate,the,cns-depressive'
p52948
g9
sS'toradol,on,clearance'
p52949
g3
sS'in,the,ibandronate'
p52950
g3
sS'situation,has,the'
p52951
g3
sS'glucose,dehydrogenase,pyrroloquinolinequinone'
p52952
g3
sS'and,mg,for'
p52953
g3
sS'not,antagonized,by'
p52954
g3
sS'elevated,serum,enzymes'
p52955
g9
sS'intoxication,plasma,levels'
p52956
g3
sS'are,taken,as'
p52957
g9
sS'was,reduced,from'
p52958
g9
sS'clonazepam,would,be'
p52959
g3
sS'may,cause,abnormal'
p52960
g9
sS'proteins,may,be'
p52961
g3
sS'concentration,to,suppression'
p52962
g3
sS's,alpha,and'
p52963
g3
sS'anticoagulants,caution,should'
p52964
g9
sS'patients,on,therapy'
p52965
g9
sS'in,amiodarone-treated,patients'
p52966
g3
sS'after,one,day'
p52967
g3
sS'lower,end,of'
p52968
g9
sS'its,effect,could'
p52969
g9
sS'terfenadine,in,a'
p52970
g3
sS'p450,a4,had'
p52971
g3
sS'better,after,initiating'
p52972
g3
sS'positive,and,anxiety'
p52973
g3
sS'methotrexate,humira,has'
p52974
g3
sS'resulted,in,more'
p52975
g3
sS'of,apparent,total'
p52976
g9
sS'in,addition,interfere'
p52977
g9
sS'would,coincide,duloxetine'
p52978
g3
sS'acth,intensified,electrolyte'
p52979
g3
sS'patients,taking,are'
p52980
g3
sS'known,substrates,or'
p52981
g3
sS'monkeys,responding,under'
p52982
g3
sS'bone,marrow,erythrocytes'
p52983
g3
sS'committed,step,of'
p52984
g9
sS'and,fold,on'
p52985
g9
sS'depressasnts,such,as'
p52986
g9
sS'and,release,of'
p52987
g3
sS'in,both,renal'
p52988
g3
sS'elimination,of,by'
p52989
g9
sS'of,causes,an'
p52990
g9
sS'to,was,not'
p52991
g9
sS'methods,from,the'
p52992
g3
sS'do,not,vary'
p52993
g3
sS'possible,anticholinesterase,agents'
p52994
g9
sS'was,times,maximum'
p52995
g3
sS'clinically,important,effect'
p52996
g3
sS'that,induce,cyp3a4'
p52997
g3
sS'dehydrogenase,pyrroloquinolinequinone,gdh'
p52998
g3
sS'pruritus,and,hypotension'
p52999
g3
sS'to,sinus,rhythm'
p53000
g9
sS'binding,lectin,and'
p53001
g3
sS'for,any,interaction'
p53002
g3
sS'frequent,the,development'
p53003
g3
sS'should,receive,low-molecular'
p53004
g3
sS'oral,in,healthy'
p53005
g3
sS'may,be,extrapolated'
p53006
g3
sS'when,agents,such'
p53007
g9
sS'hydrochloride,may,potentiate'
p53008
g9
sS'its,inhibitory,effects'
p53009
g3
sS'blood,concentration,should'
p53010
g3
sS'should,be,approximately'
p53011
g3
sS'a,hit,in'
p53012
g3
sS'but,statistically,significant'
p53013
g9
sS'concentrations,were,also'
p53014
g3
sS'of,american,coffee'
p53015
g3
sS'the,latency,to'
p53016
g3
sS'addition,steady,state'
p53017
g3
sS'with,pegasys,in'
p53018
g3
sS'cholesterol,synthesis,and'
p53019
g3
sS'we,present,clearly'
p53020
g3
sS'aprepitant,with,in'
p53021
g3
sS'a,well-known,potential'
p53022
g3
sS'test,interactions,naproxen'
p53023
g3
sS'changes,may,be'
p53024
g3
sS'p450,c9,c19'
p53025
g3
sS'that,a,the'
p53026
g3
sS'a,similar,proportion'
p53027
g9
sS'reasonable,to,expect'
p53028
g3
sS'opioid,analgesics,agonist'
p53029
g9
sS'and,dosage,adjustments'
p53030
g3
sS'qd,increased,the'
p53031
g9
sS'is,necessary,to'
p53032
g9
sS'inhibitors,ssris,and'
p53033
g3
sS'of,mg,four'
p53034
g3
sS'and,extended,release'
p53035
g9
sS'with,a,non-specific'
p53036
g3
sS'be,enhanced,if'
p53037
g9
sS'is,generally,not'
p53038
g9
sS'isoenzyme,could,increase'
p53039
g3
sS'produced,significantly,increased'
p53040
g9
sS'the,is,required'
p53041
g3
sS'coadministration,of,atrovent'
p53042
g9
sS'with,cancidas,may'
p53043
g9
sS'level,that,has'
p53044
g9
sS'since,symptoms,of'
p53045
g3
sS'effects,of,antimicrobial'
p53046
g3
sS'variations,of,glycemic'
p53047
g3
sS'the,kd,of'
p53048
g3
sS'to,be,given'
p53049
g9
sS'by,antihypertensive,agents'
p53050
g9
sS'extensively,metabolized,by'
p53051
g9
sS'significant,drug,interactions'
p53052
g3
sS'effects,when,coadministered'
p53053
g9
sS'the,depression,of'
p53054
g9
sS'class,see,warnings'
p53055
g9
sS'modified,histidine,residues'
p53056
g3
sS'noted,in,patients'
p53057
g9
sS'evaluated,in,an'
p53058
g3
sS'may,enhance,cns'
p53059
g9
sS'patients,using,cardiac'
p53060
g3
sS'and,other,strong'
p53061
g9
sS'aspirin-mediated,inhibition,of'
p53062
g3
sS'stadol,ns,and'
p53063
g3
sS'cells,revealed,that'
p53064
g9
sS'vitro,show,that'
p53065
g3
sS'with,altered,renal'
p53066
g3
sS'which,inhibits,cyp3a4'
p53067
g3
sS'drugs,drugs,metabolized'
p53068
g3
sS'a,decrease,and'
p53069
g3
sS'depression,of,the'
p53070
g9
sS'normal,cells,that'
p53071
g3
sS'no,related,changes'
p53072
g3
sS'is,easy,and'
p53073
g3
sS'support,was,significantly'
p53074
g3
sS'vivo,studies,cytochrome'
p53075
g3
sS'schizophrenia,were,significantly'
p53076
g3
sS'vardenafil,experienced,a'
p53077
g9
sS'data,suggest,these'
p53078
g3
sS'however,co-administration,of'
p53079
g3
sS'or,channel,blockers'
p53080
g9
sS'concentration,of,fluorouracil'
p53081
g9
sS'used,only,with'
p53082
g3
sS'is,advised,in'
p53083
g3
sS'volunteer,was,administered'
p53084
g3
sS'allopurinol,the,auc'
p53085
g9
sS'high,doses,has'
p53086
g9
sS'inhibition,of,fibrinolysis'
p53087
g3
sS'if,patients,receive'
p53088
g3
sS'is,advised,if'
p53089
g3
sS'mg,day,lexapro'
p53090
g9
sS'hospital,for,worsening'
p53091
g3
sS'neuromuscular,blocking,action'
p53092
g9
sS'chronic,treatment,following'
p53093
g9
sS'of,co,and'
p53094
g3
sS'plasma,levels,during'
p53095
g9
sS'lapatinib,undergoes,extensive'
p53096
g3
sS'of,nuromax,before'
p53097
g3
sS'paper,critically,reviews'
p53098
g3
sS'clostridium,difficile,a'
p53099
g3
sS'although,romazicon,exerts'
p53100
g9
sS'regimen,particularly,in'
p53101
g9
sS'other,complications,in'
p53102
g3
sS'whose,hypertension,was'
p53103
g9
sS'capsule,with,an'
p53104
g9
sS'use,unless,necessary'
p53105
g3
sS'established,but,an'
p53106
g3
sS'when,bactericidal,activity'
p53107
g3
sS'genetically,nervous,e-strain'
p53108
g3
sS'rr,microm,inhibited'
p53109
g9
sS'in,and,may'
p53110
g3
sS'is,not,clear'
p53111
g3
sS'of,duloxetine,and'
p53112
g9
sS'reduction,in,iop'
p53113
g3
sS'products,are,needed'
p53114
g3
sS'hypnotics,opioids,co-administration'
p53115
g9
sS'immunodeficiency,virus-positive,patients'
p53116
g3
sS'kg,and,oral'
p53117
g3
sS'been,shown,in'
p53118
g9
sS'therefore,close,monitoring'
p53119
g9
sS'antihypertensives,bumetanide,may'
p53120
g9
sS'or,structural,alterations'
p53121
g3
sS'sinus,arrest,and'
p53122
g3
sS'bioavailability,of,n'
p53123
g9
sS'of,phosphatase,activity'
p53124
g3
sS'not,be,usedas'
p53125
g9
sS'tablet,if,a'
p53126
g9
sS'study,suggested,to'
p53127
g3
sS'are,cyp3a4,inhibitors'
p53128
g9
sS'more,rapid,progression'
p53129
g3
sS'occurred,significantly,more'
p53130
g3
sS'can,inhibit,elimination'
p53131
g9
sS'or,dietary,interferes'
p53132
g3
sS'and,reduced,ligand'
p53133
g3
sS'been,established,and'
p53134
g3
sS'in,an,effort'
p53135
g3
sS'hydroxide,and,with'
p53136
g9
sS'not,only,with'
p53137
g3
sS'a,known,enzyme'
p53138
g9
sS'clindamycin,has,been'
p53139
g9
sS'in,induction,of'
p53140
g9
sS'automaticity,as,well'
p53141
g9
sS'hand,promoted,significant'
p53142
g3
sS'acidifying,agents,ammonium'
p53143
g9
sS'nacmc,with,moieties'
p53144
g3
sS'nitric,oxide,donor'
p53145
g9
sS'most,subjects,who'
p53146
g9
sS'and,displacement,of'
p53147
g9
sS'and,cyp1a2,inhibitors'
p53148
g3
sS'prescribed,foradil,should'
p53149
g3
sS'and,an,inducer'
p53150
g3
sS'metabolism,very,sensitive'
p53151
g3
sS'abnormalities,in,rats'
p53152
g3
sS'here,we,have'
p53153
g3
sS'safety,profile,of'
p53154
g3
sS'discriminates,among,the'
p53155
g3
sS'blockade,was,studied'
p53156
g3
sS'to,take,and'
p53157
g9
sS'may,suppress,reactions'
p53158
g3
sS'primarily,being,metabolized'
p53159
g3
sS'href,frova_od,htm'
p53160
g9
sS'each,healthy,subject'
p53161
g3
sS'amounts,may,be'
p53162
g3
sS'mg,kg,the'
p53163
g3
sS'with,narrow,therapeutic'
p53164
g3
sS'is,unavailable,a'
p53165
g3
sS'studies,however,are'
p53166
g3
sS'given,with,such'
p53167
g9
sS'the,three,study'
p53168
g3
sS'occasional,doses,of'
p53169
g3
sS'in,each,task'
p53170
g3
sS'not,have,effects'
p53171
g3
sS'by,indicating,no'
p53172
g3
sS'cyp3a4,have,not'
p53173
g3
sS'tumors,when,administered'
p53174
g3
sS'these,are,administered'
p53175
g3
sS'male,volunteers,no'
p53176
g3
sS'believed,to,be'
p53177
g3
sS'usual,concentrations,following'
p53178
g3
sS'in,the,differential'
p53179
g3
sS'new,oral,therapies'
p53180
g3
sS'may,increase,cyp'
p53181
g9
sS'cercariae,and,metacercariae'
p53182
g3
sS'week,leaving,only'
p53183
g3
sS'by,therapeutic,monitoring'
p53184
g3
sS'indications,of,the'
p53185
g3
sS'inducers,cyp3a4,inducers'
p53186
g3
sS'amicar,at,dosages'
p53187
g3
sS'medicines,may,be'
p53188
g3
sS'be,accompanied,by'
p53189
g3
sS'had,a,synergistic'
p53190
g3
sS'of,to,volunteers'
p53191
g3
sS'arteries,preconstricted,with'
p53192
g3
sS'which,the,use'
p53193
g3
sS'hepatic,injury,should'
p53194
g3
sS'or,from,their'
p53195
g9
sS'respectively,in,subjects'
p53196
g3
sS'reaction,profile,of'
p53197
g3
sS'and,laboratory,tests'
p53198
g3
sS'cytochrome,p450,isoenzyme'
p53199
g3
sS'do,not,mix'
p53200
g3
sS'pgp,increased,concentrations'
p53201
g3
sS'ssris,and,inhibit'
p53202
g3
sS'with,possible,rapid'
p53203
g9
sS'antihistamines,benzodiazepines,gi'
p53204
g3
sS'was,not,due'
p53205
g3
sS'clinician,responsible,for'
p53206
g3
sS'interferon,induction,tool'
p53207
g3
sS'chop,patients,vs'
p53208
g3
sS'may,also,interfere'
p53209
g9
sS'reactions,dyspnea,hypotension'
p53210
g3
sS'and,anaerobic,bacteria'
p53211
g3
sS'doses,of,given'
p53212
g9
sS'bicarbonate,used,concurrently'
p53213
g9
sS'perforatum,may,decrease'
p53214
g3
sS'by,at,the'
p53215
g9
sS'as,implants,and'
p53216
g3
sS'same,procedure,the'
p53217
g3
sS'of,an,aluminum-containing'
p53218
g3
sS'duration,suggesting,that'
p53219
g9
sS'interconversion,between,and'
p53220
g3
sS'administered,dilute,solutions'
p53221
g3
sS'a,presynaptic,defect'
p53222
g3
sS'between,both,dietary'
p53223
g3
sS'human,pharmacokinetics,data'
p53224
g9
sS'postdose,a,similar'
p53225
g9
sS'effect,and,products'
p53226
g3
sS'but,definite,nondepolarizing'
p53227
g3
sS'experienced,a,standing'
p53228
g9
sS'if,is,excreted'
p53229
g3
sS'concentrations,of,sn38'
p53230
g3
sS'blood,flow,caused'
p53231
g3
sS'plasma,pharmacokinetics,or'
p53232
g3
sS'nerve,transmission,at'
p53233
g3
sS'arrest,cardiac,arrest'
p53234
g3
sS'certain,may,induce'
p53235
g9
sS'viii,coagulant,activity'
p53236
g3
sS'guidelines,are,provided'
p53237
g3
sS'shown,no,effect'
p53238
g3
sS'of,this,reduction'
p53239
g9
sS'by,resecting,the'
p53240
g3
sS'metabolism,of,etc'
p53241
g9
sS'is,given,or'
p53242
g3
sS'weather,prolonged,long'
p53243
g9
sS'antagonism,has,been'
p53244
g9
sS'receptors,such,as'
p53245
g9
sS'prolongation,which,could'
p53246
g3
sS'in,effects,on'
p53247
g3
sS'to,subjects,the'
p53248
g9
sS'are,being,designed'
p53249
g3
sS'are,altered,by'
p53250
g9
sS'in,effects,of'
p53251
g9
sS'severe,hypersensitivity,reactions'
p53252
g3
sS'cerivastatin,plasma,concentrations'
p53253
g3
sS'a,psychotic,reaction'
p53254
g3
sS'clearance,by,increased'
p53255
g9
sS'coadministered,with,and'
p53256
g9
sS'mm,or,mg'
p53257
g3
sS'treatment,with,agents'
p53258
g9
sS'of,to,regimens'
p53259
g3
sS'interaction,with,affected'
p53260
g3
sS'water,pill,such'
p53261
g3
sS'weakness,myoclonus,tremor'
p53262
g3
sS'concomitantly,with,the'
p53263
g9
sS'enzymes,is,an'
p53264
g3
sS'acid,will,not'
p53265
g3
sS'other,through,competition'
p53266
g3
sS'blocking,agents,has'
p53267
g9
sS'xigris,is,used'
p53268
g3
sS'starting,a,non-selective'
p53269
g9
sS'toxicology,studies,of'
p53270
g9
sS'than,fold,increases'
p53271
g9
sS'is,useful,in'
p53272
g3
sS'supplements,or,salt'
p53273
g3
sS'potentiation,of,coumarin-type'
p53274
g3
sS'to,intravenous,and'
p53275
g9
sS'assess,the,effect'
p53276
g3
sS'or,anticoagulation,should'
p53277
g3
sS'lesions,characterized,by'
p53278
g3
sS'significance,on,the'
p53279
g9
sS'systemic,eg,flu-like'
p53280
g3
sS'clearance,by,up'
p53281
g9
sS'of,selective,peripheral'
p53282
g9
sS'of,angina,or'
p53283
g9
sS'cefotan,and,an'
p53284
g9
sS'affect,the,plasma'
p53285
g3
sS'and,international,pharmaceutical'
p53286
g3
sS'and,vitamin,c'
p53287
g3
sS'augmented,by,that'
p53288
g9
sS'should,be,even'
p53289
g9
sS'conjunction,with,demonstrated'
p53290
g3
sS'with,a,decrease'
p53291
g9
sS'tricyclic,antidepressants,concurrent'
p53292
g3
sS'periodic,monitoring,of'
p53293
g3
sS'chemotherapy,concomitantly,with'
p53294
g3
sS'therefore,should,be'
p53295
g9
sS'thromboplastin,times,have'
p53296
g3
sS'basis,of,antistress'
p53297
g3
sS'supraspinal,brain,sites'
p53298
g3
sS'should,be,interpreted'
p53299
g3
sS'see,warnings,congestive'
p53300
g3
sS'therapeutic,advantage,when'
p53301
g3
sS'tablets,injection,and'
p53302
g9
sS'and,anti-infectives,without'
p53303
g3
sS'the,effects,of'
p53304
g3
sS'multiple,dosing,caution'
p53305
g9
sS'intact,liver,blood'
p53306
g3
sS'suggest,that,alcoholic'
p53307
g3
sS'in,rodent,pups'
p53308
g3
sS'the,effects,on'
p53309
g3
sS'were,to,times'
p53310
g3
sS'to,have,centroblast'
p53311
g3
sS'category,and,then'
p53312
g3
sS'development,of,drug-induced'
p53313
g3
sS'the,systemic,exposure'
p53314
g3
sS'complications,which,may'
p53315
g3
sS'ability,of,to'
p53316
g9
sS'salts,medicine,for'
p53317
g3
sS'precipitation,in,cell'
p53318
g3
sS'and,increasing,blood'
p53319
g9
sS'b23,and,apoptosis'
p53320
g3
sS'with,other,that'
p53321
g3
sS'given,concomitantly,the'
p53322
g9
sS'with,other,than'
p53323
g3
sS'potential,for,binding'
p53324
g3
sS'of,cyp1a2,results'
p53325
g9
sS'day,days,after'
p53326
g9
sS'to,start,therapy'
p53327
g3
sS'to,and,may'
p53328
g9
sS'of,using,pcp'
p53329
g3
sS'parameters,in,patients'
p53330
g9
sS'compared,to,similar'
p53331
g3
sS'of,mg,oral'
p53332
g9
sS'impaired,vs,spared'
p53333
g3
sS'nonsteroidal,agents,and'
p53334
g9
sS'the,positive,inotropic'
p53335
g9
sS'a,newly,introduced'
p53336
g3
sS'caution,in,prothrombin'
p53337
g3
sS'binding,sites,in'
p53338
g3
sS'significant,effects,caution'
p53339
g3
sS'oral,regular,monitoring'
p53340
g3
sS'tested,for,its'
p53341
g3
sS'taken,when,using'
p53342
g3
sS'test,interactions,frova'
p53343
g3
sS'and,laboratory,studies'
p53344
g3
sS'antagonism,in,vivo'
p53345
g3
sS'carried,out,to'
p53346
g3
sS'with,wshow,no'
p53347
g3
sS'two,appear,to'
p53348
g9
sS'to,the,inhibition'
p53349
g9
sS'treatment,regimen,of'
p53350
g3
sS'reviewed,in,an'
p53351
g9
sS'shown,that,mcf-7'
p53352
g3
sS'cases,the,onset'
p53353
g3
sS'respectively,have,been'
p53354
g3
sS'several,studies,ie'
p53355
g3
sS'three,separate,controlled'
p53356
g3
sS'resulted,in,ventricular'
p53357
g3
sS'report,a,case'
p53358
g3
sS'metenkephalinamide,or,on'
p53359
g3
sS'the,alternate,sequence'
p53360
g9
sS'alone,can,cause'
p53361
g3
sS'dose,for,incombination'
p53362
g3
sS'steady-state,cmax,a'
p53363
g9
sS'incidence,of,infections'
p53364
g3
sS'during,the,test'
p53365
g9
sS'mediation,of,influence'
p53366
g3
sS'safely,tolerated,in'
p53367
g3
sS'normal,antiasthmatic,dose'
p53368
g3
sS'other,cns-depressant,should'
p53369
g9
sS'oral,platelet,inhibitors'
p53370
g3
sS'requires,more,or'
p53371
g3
sS'few,spontaneous,reports'
p53372
g9
sS'medicinal,products,sharing'
p53373
g9
sS'half-life,and,the'
p53374
g9
sS'in,ci,of'
p53375
g3
sS'in,normal,subjects'
p53376
g3
sS'of,formal,clinical'
p53377
g3
sS's,interresponse,times'
p53378
g3
sS'absorption,of,and'
p53379
g9
sS'or,nucleus,accumbens'
p53380
g3
sS'avonex,and,study'
p53381
g3
sS'ketamine,when,administered'
p53382
g9
sS'of,patient,pharmacokinetic'
p53383
g9
sS'leads,to,higher'
p53384
g9
sS'given,prior,to'
p53385
g9
sS'absorption,of,any'
p53386
g3
sS'thiobarbituric,acid,reactive'
p53387
g3
sS'of,was,increased'
p53388
g9
sS'with,such,medication'
p53389
g3
sS'because,of,its'
p53390
g3
sS'liver,enzymes,was'
p53391
g9
sS'but,one,volunteer'
p53392
g3
sS'concurrently,with,iopidine'
p53393
g3
sS'plasma,area-under,the-curve'
p53394
g3
sS'maintained,on,without'
p53395
g3
sS'or,deleted,from'
p53396
g9
sS'findings,of,these'
p53397
g3
sS'the,cmax,and'
p53398
g9
sS'and,which,inhibit'
p53399
g9
sS'especially,important,in'
p53400
g3
sS'of,the,unbound'
p53401
g9
sS'significant,additional,efficacy'
p53402
g9
sS'protease,inhibitor,therapy'
p53403
g9
sS'to,lie,in'
p53404
g3
sS'food,isoniazid,should'
p53405
g3
sS'of,g,and'
p53406
g9
sS'in,vivo,and'
p53407
g3
sS'which,are,substrates'
p53408
g3
sS'microtubules,appeared,to'
p53409
g3
sS'may,be,diminished'
p53410
g9
sS'p450,a4,cyp3a4'
p53411
g3
sS'other,antianxiety,agents'
p53412
g9
sS'activity,ix,x'
p53413
g3
sS'anhydrase,inhibitors,concomitant'
p53414
g3
sS'of,with,strong'
p53415
g9
sS'reductions,in,both'
p53416
g3
sS'etc,increase,the'
p53417
g9
sS'have,been,cases'
p53418
g9
sS'when,atromid-s,is'
p53419
g9
sS'were,given,injections'
p53420
g3
sS'subsequent,to,increase'
p53421
g9
sS'flushing,skin,reactions'
p53422
g3
sS'or,insulin-induced,proliferation'
p53423
g9
sS'are,expected,to'
p53424
g9
sS'evidence,that,resistance'
p53425
g3
sS'meth,has,been'
p53426
g3
sS'cases,of,seizures'
p53427
g9
sS'effects,with,proleukin'
p53428
g9
sS'other,than,those'
p53429
g3
sS'remedies,nephropathies,and'
p53430
g3
sS'same,in,cecectomized'
p53431
g3
sS'since,elevations,of'
p53432
g3
sS'treatment,dosage,adjustment'
p53433
g9
sS'or,deletion,of'
p53434
g3
sS's,disease,clinical'
p53435
g3
sS'severe,autonomic,neurotoxicity'
p53436
g3
sS'were,well,matched'
p53437
g3
sS'interaction,was,not'
p53438
g3
sS'auc,and,a'
p53439
g9
sS'effect,on,any'
p53440
g3
sS'affecting,cytochrome,p450'
p53441
g3
sS'seen,when,romazicon'
p53442
g3
sS'of,the,patients'
p53443
g3
sS'as,antineoplastic,agents'
p53444
g9
sS'cells,to,increase'
p53445
g3
sS'hypertriglyceridemia,is,patient'
p53446
g3
sS'since,inhibits,platelet'
p53447
g9
sS'although,combining,these'
p53448
g3
sS'strains,of,salmonella'
p53449
g3
sS'of,nondepolarizing,neuromuscular'
p53450
g9
sS'the,remaining,ci'
p53451
g3
sS'metabolite,concentration,and'
p53452
g9
sS'methotrexate,piperacillin,sodium'
p53453
g9
sS'risk,of,developing'
p53454
g9
sS'coadministration,of,gly-buride'
p53455
g3
sS'ecg,of,given'
p53456
g3
sS'sensitivity,of,at'
p53457
g3
sS'kg,day,and'
p53458
g3
sS'patients,enrolled,in'
p53459
g3
sS'of,toxic,action'
p53460
g3
sS'via,a,different'
p53461
g3
sS'patients,currently,receiving'
p53462
g9
sS'k,antagonists,are'
p53463
g9
sS'although,have,been'
p53464
g9
sS'that,may,make'
p53465
g3
sS'dose,for,at'
p53466
g3
sS'pseudomonas,aeruginosa,particularly'
p53467
g3
sS'elisa,and,reduced'
p53468
g3
sS'be,cautioned,against'
p53469
g3
sS'hypnotics,contraindicated,due'
p53470
g3
sS'levels,meq,l'
p53471
g3
sS'of,compounds,requiring'
p53472
g3
sS'pharmacological,actions,via'
p53473
g3
sS'combinations,are,sometimes'
p53474
g3
sS'unwanted,effects,ways'
p53475
g3
sS'tight,seal,recordings'
p53476
g3
sS'hcl,in,association'
p53477
g9
sS'the,effects,may'
p53478
g9
sS'male,volunteers,treatment'
p53479
g9
sS'test,interactions,see'
p53480
g3
sS'observed,that,is'
p53481
g3
sS'screen,compounds,for'
p53482
g3
sS'degrees,of,inhibition'
p53483
g9
sS'the,medication,interferes'
p53484
g3
sS'edema,excessive,perspiration'
p53485
g3
sS'standard,deviation,to'
p53486
g9
sS'and,losartan,bosentan'
p53487
g3
sS'are,impaired,vs'
p53488
g3
sS'metabolite,i,alone'
p53489
g3
sS'was,administered,hours'
p53490
g9
sS'digoxin,in,patients'
p53491
g3
sS'of,antacids,on'
p53492
g3
sS'study,evoked,potentials'
p53493
g3
sS'ratio,when,arava'
p53494
g9
sS'reduction,in,mac'
p53495
g3
sS'cmin,concentration,was'
p53496
g9
sS'considered,the,same'
p53497
g3
sS'daily,and,one'
p53498
g9
sS'may,reduce,plasma'
p53499
g9
sS'weeks,after,stopping'
p53500
g9
sS'analgesia,must,be'
p53501
g9
sS'were,potentiated,by'
p53502
g9
sS'to,the,combined'
p53503
g9
sS'with,other,tnf-blocking'
p53504
g9
sS'with,inducers,of'
p53505
g9
sS'possible,to,escalate'
p53506
g3
sS'insp,mediated,responses'
p53507
g3
sS'with,and,several'
p53508
g3
sS'various,cytochrome,p450'
p53509
g3
sS'including,have,also'
p53510
g9
sS'doxepin,is,primarily'
p53511
g3
sS'hormone,therapy,oral'
p53512
g3
sS'is,important,when'
p53513
g3
sS'enlargement,buffalo,hump'
p53514
g3
sS'to,produce,antabuse-like'
p53515
g9
sS'the,west,midlands'
p53516
g3
sS'essential,to,the'
p53517
g3
sS'following,eye,product'
p53518
g9
sS'in,some,studies'
p53519
g9
sS'myopathy,is,also'
p53520
g3
sS'with,a,consequent'
p53521
g9
sS'prescription,dose,co-administered'
p53522
g9
sS'of,with,causes'
p53523
g9
sS'possibility,that,may'
p53524
g9
sS'hormone-binding,globulin,shbg'
p53525
g3
sS'a,highly,lethal'
p53526
g3
sS'p450,a,family'
p53527
g3
sS'pharmacokinetics,were,not'
p53528
g3
sS'indicates,either,poor'
p53529
g3
sS'interactions,cimetidine,concomitant'
p53530
g3
sS'significantly,bound,to'
p53531
g3
sS'of,should,therefore'
p53532
g9
sS'approximately,doubled,in'
p53533
g3
sS'with,other,products'
p53534
g3
sS'to,min,compared'
p53535
g3
sS'output,and,usually'
p53536
g9
sS'and,a4,but'
p53537
g3
sS'showed,good,inhibition'
p53538
g3
sS'similar,agents,since'
p53539
g9
sS'dipyridamole,has,been'
p53540
g9
sS'frequent,vital,sign'
p53541
g3
sS'in,addition,does'
p53542
g3
sS'data,are,neither'
p53543
g3
sS'aortic,rings,with'
p53544
g9
sS'clinical,and,laboratory'
p53545
g3
sS'gallates,is,of'
p53546
g3
sS'therefore,may,increase'
p53547
g3
sS'with,glutathione,use'
p53548
g9
sS'before,taking,tell'
p53549
g9
sS'one,ng,ml'
p53550
g3
sS'by,hippocampal,lesions'
p53551
g3
sS'via,p450,c9'
p53552
g9
sS'there,was,an'
p53553
g3
sS'of,ruthenium,red'
p53554
g3
sS'conclusions,the,combination'
p53555
g3
sS'oral,inhaled,and'
p53556
g3
sS'significant,respiratory,depression'
p53557
g9
sS'for,days,however'
p53558
g9
sS'and,or,some'
p53559
g9
sS'or,tsh,levels'
p53560
g3
sS'vitro,results,are'
p53561
g3
sS'elevations,and,infrequent'
p53562
g3
sS'i,and,have'
p53563
g3
sS'of,but,may'
p53564
g9
sS'volunteers,or,given'
p53565
g3
sS'that,the,incidence'
p53566
g9
sS'coombs,testing,of'
p53567
g3
sS'posing,a,safety'
p53568
g3
sS'omega-conotoxin,gvia,n-type'
p53569
g3
sS'trials,hypoglycemia,and'
p53570
g3
sS'cancer,metastasis,to'
p53571
g3
sS'possibility,of,interactions'
p53572
g3
sS'refrain,from,treatment'
p53573
g3
sS'lead,to,enhanced'
p53574
g3
sS'pharmacokinetics,of,gemzar'
p53575
g3
sS'that,may,potentiate'
p53576
g9
sS'may,decrease,vascular'
p53577
g9
sS'developed,in,a'
p53578
g9
sS'determination,of,creatinine'
p53579
g3
sS'indanedione,including,or'
p53580
g3
sS'taken,within,hours'
p53581
g9
sS'on,all,patients'
p53582
g3
sS'the,or,may'
p53583
g9
sS'or,with,salts'
p53584
g3
sS'vitro,studies,demonstrate'
p53585
g3
sS'problems,that,may'
p53586
g3
sS'other,in,patients'
p53587
g3
sS'or,to,be'
p53588
g3
sS'employed,for,the'
p53589
g3
sS'by,similar,personality'
p53590
g3
sS'therefore,subtle,cell'
p53591
g3
sS'therapy,haart,is'
p53592
g3
sS'hydroxy-3,methylglutaryl,coenzyme'
p53593
g3
sS'and,is,comparable'
p53594
g3
sS'data,on,the'
p53595
g3
sS'patients,of,childbearing'
p53596
g3
sS'depress,the,nervous'
p53597
g9
sS'systems,and,the'
p53598
g3
sS'that,may,underlie'
p53599
g3
sS'glands,with,synergistically'
p53600
g3
sS'failure,secondary,to'
p53601
g3
sS'brovana,has,not'
p53602
g3
sS'use,should,be'
p53603
g3
sS'luciferase,reporter,gene'
p53604
g3
sS'enhance,the,magnitude'
p53605
g9
sS'haldol,has,not'
p53606
g3
sS'indandione,derivatives,and'
p53607
g9
sS'administration,of,had'
p53608
g3
sS'with,increases,the'
p53609
g3
sS'interactions,and,socioeconomic'
p53610
g3
sS'with,increased,levels'
p53611
g9
sS'of,synthetic,by'
p53612
g9
sS'may,experience,a'
p53613
g9
sS'or,fortovase,and'
p53614
g3
sS'nor,high,affinity'
p53615
g3
sS'separate,study,concomitant'
p53616
g3
sS'and,or,marked'
p53617
g9
sS'dose-dependent,modification,of'
p53618
g9
sS'tablets,or,the'
p53619
g9
sS'fluvoxamine,tablets,should'
p53620
g9
sS'inhibitor,mg,q'
p53621
g9
sS'each,other,should'
p53622
g9
sS'cyp1a2,isoform,mediate'
p53623
g3
sS'been,taking,on'
p53624
g3
sS'reported,to,increase'
p53625
g9
sS'subjects,to,a'
p53626
g3
sS'of,racemic,were'
p53627
g3
sS'tricyclic,in,combination'
p53628
g9
sS'dosing,recommendations,for'
p53629
g3
sS'have,no,effect'
p53630
g3
sS'general,exaggeration,of'
p53631
g9
sS'and,immediately,beginning'
p53632
g9
sS'been,tested,in'
p53633
g3
sS'administration,of,has'
p53634
g3
sS'time,when,was'
p53635
g9
sS'and,serotonin2-receptors,underlies'
p53636
g3
sS'to,elucidate,metal'
p53637
g3
sS'was,significantly,reduced'
p53638
g3
sS'sedatives,hypnotics,opioids'
p53639
g9
sS'and,decreased,the'
p53640
g9
sS'recommended,it,should'
p53641
g9
sS'were,taken,before'
p53642
g3
sS'a,net,decrease'
p53643
g9
sS'one-third,to,one-fourth'
p53644
g9
sS'been,studied,in'
p53645
g3
sS'increase,in,levels'
p53646
g3
sS'to,receive,adl'
p53647
g3
sS'time,of,minutes'
p53648
g3
sS'may,worsen,side'
p53649
g9
sS'the,hind,paw'
p53650
g3
sS'determine,the,presence'
p53651
g3
sS'reactions,all,patients'
p53652
g3
sS'or,more,with'
p53653
g9
sS'compounds,like,may'
p53654
g9
sS'cytochrome,p-,by'
p53655
g3
sS'severity,of,bone'
p53656
g3
sS'use,of,prinivil'
p53657
g9
sS'delayed,by,a'
p53658
g3
sS'a2,c9,c19'
p53659
g3
sS'and,which,have'
p53660
g9
sS'the,hour,lag'
p53661
g3
sS'prolongs,and,potentiates'
p53662
g3
sS'evaluate,possible,interactions'
p53663
g3
sS's,sarcoma,taxol'
p53664
g3
sS'administration,of,because'
p53665
g9
sS'nimbex,and,therefore'
p53666
g3
sS'that,may,either'
p53667
g9
sS'blood,concentrations,and'
p53668
g3
sS'may,possibly,have'
p53669
g3
sS'starting,dose,should'
p53670
g3
sS'course,of,septic'
p53671
g3
sS'but,dose-dependently,inhibits'
p53672
g9
sS'that,results,from'
p53673
g3
sS'clearance,of,approximately'
p53674
g9
sS'tablets,may,alter'
p53675
g9
sS'in,phase,was'
p53676
g3
sS'concomitantly,with,injectable'
p53677
g9
sS'require,replacement,therapy'
p53678
g9
sS'and,requires,a'
p53679
g3
sS'a,smaller,week'
p53680
g3
sS'the,patients,who'
p53681
g3
sS'trypanosomiasis,in,the'
p53682
g3
sS'patients,received,concomitant'
p53683
g3
sS'long-term,consequences,of'
p53684
g3
sS'three,weeks,after'
p53685
g9
sS'cecectomized,rats,prepared'
p53686
g3
sS'agent,for,that'
p53687
g9
sS'of,phosphorylation,of'
p53688
g3
sS'coombs,test,may'
p53689
g3
sS'as,has,been'
p53690
g9
sS'be,given,the'
p53691
g9
sS'including,or,their'
p53692
g3
sS'fold,than,plasma'
p53693
g3
sS'patients,with,first-episode'
p53694
g3
sS'literature,suggests,that'
p53695
g3
sS'maois,may,enhance'
p53696
g9
sS'adrenergic,neuron,blocking'
p53697
g3
sS'such,an,effect'
p53698
g9
sS'healthy,volunteers,increased'
p53699
g3
sS'significantly,affect,steady-state'
p53700
g3
sS'with,an,nsaid'
p53701
g3
sS'antagonized,evidently,the'
p53702
g9
sS'added,as,well'
p53703
g3
sS'the,interaction,is'
p53704
g9
sS'prothrombin,time,necessitating'
p53705
g3
sS'other,neurotoxic,and'
p53706
g3
sS'ml,and,greater'
p53707
g3
sS'labelling,of,histidine'
p53708
g3
sS'trisphosphate-induced,responses,in'
p53709
g3
sS'mean,auc,values'
p53710
g3
sS'drugs,are,needed'
p53711
g3
sS'response,to,various'
p53712
g3
sS'dose,of,enablex'
p53713
g9
sS'or,other,highly'
p53714
g3
sS'serum,half-life,leading'
p53715
g3
sS'gastrointestinal,irritation,caution'
p53716
g9
sS'patients,receiving,known'
p53717
g9
sS'topical,solution,with'
p53718
g3
sS'have,not,altered'
p53719
g3
sS'class,produced,optic'
p53720
g3
sS'monitor,the,plasma'
p53721
g3
sS'conversely,at,exposure'
p53722
g3
sS'patients,where,or'
p53723
g3
sS'inhibitors,including,quinolone'
p53724
g9
sS'alternate-day,administration,of'
p53725
g9
sS'b,cells,for'
p53726
g3
sS'frequently,in,patients'
p53727
g3
sS'estradiol,mg,mcg'
p53728
g3
sS'the,kidney,and'
p53729
g3
sS'exclusively,by,the'
p53730
g3
sS'observed,closely,for'
p53731
g3
sS'lowering,the,plasma'
p53732
g9
sS'use,of,such'
p53733
g3
sS'pharmacokinetics,of,an'
p53734
g3
sS'be,restricted,and'
p53735
g3
sS'was,observed,that'
p53736
g3
sS'recommended,based,on'
p53737
g3
sS'metabolism,to,might'
p53738
g9
sS'mg,or,more'
p53739
g3
sS'therefore,this,conjugated'
p53740
g3
sS'and,natural,history'
p53741
g3
sS'substances,that,may'
p53742
g3
sS'impaired,by,include'
p53743
g9
sS'increase,the,levels'
p53744
g3
sS'one,day,and'
p53745
g3
sS'were,observed,between'
p53746
g3
sS'vitro,studies,studies'
p53747
g3
sS'of,taxol,infusion'
p53748
g3
sS'relaxation,of,at'
p53749
g3
sS'followed,by,cardiac'
p53750
g9
sS'sustiva,in,treatment-naive'
p53751
g3
sS'results,demonstrate,that'
p53752
g3
sS'kg,weekly,for'
p53753
g3
sS'the,variability,of'
p53754
g3
sS'mg,h,s'
p53755
g9
sS'a,possible,increase'
p53756
g9
sS'hiv,protease,inhibitors'
p53757
g3
sS'were,also,higher'
p53758
g9
sS'coadministration,of,a'
p53759
g3
sS'treated,with,should'
p53760
g9
sS'objective,this,paper'
p53761
g3
sS'of,and,was'
p53762
g3
sS'anticoagulants,are,given'
p53763
g9
sS'total,circulating,and'
p53764
g3
sS'of,an,interleukin-1'
p53765
g9
sS'pancreatic,supplements,may'
p53766
g9
sS'results,are,consistent'
p53767
g3
sS'actinic,keratoses,treated'
p53768
g9
sS'was,increased,indicating'
p53769
g3
sS'males,and,in'
p53770
g9
sS'to,during,short-term'
p53771
g3
sS'bacterial,mutation,assay'
p53772
g3
sS'of,inapsine,the'
p53773
g9
sS'of,s,and'
p53774
g9
sS'ketoconazole,may,inhibit'
p53775
g9
sS'p450,system,inhibitors'
p53776
g3
sS'highly,protein-bound,would'
p53777
g3
sS'significant,interference,with'
p53778
g3
sS'interactions,with,mixed'
p53779
g9
sS'recommended,that,doxil'
p53780
g3
sS'been,established,if'
p53781
g3
sS'bid,resulted,in'
p53782
g9
sS'characteristic,of,animals'
p53783
g3
sS'range,of,concentrations'
p53784
g3
sS'hypermagnesaemia,high,oral'
p53785
g3
sS'day,and,or'
p53786
g3
sS'subjects,receiving,gm'
p53787
g9
sS'erection,disorders,in'
p53788
g3
sS'effect,by,the'
p53789
g3
sS'i,d,had'
p53790
g3
sS'peritoneal,metastasis,of'
p53791
g9
sS'in,the,nucleus'
p53792
g3
sS'and,brevibloc,were'
p53793
g9
sS'probably,secondary,to'
p53794
g9
sS'reaction,time,for'
p53795
g9
sS'of,that,undergo'
p53796
g9
sS'regimens,including,and'
p53797
g3
sS'of,including,ethacrynic'
p53798
g9
sS'one,man,the'
p53799
g9
sS'hour,after,administration'
p53800
g9
sS'value,of,m'
p53801
g3
sS'and,a,major'
p53802
g3
sS'minimal,bactericidal,concentration'
p53803
g3
sS'value,of,b'
p53804
g3
sS'plasma,prothrombin,activity'
p53805
g9
sS'of,neutropenia,and'
p53806
g9
sS'with,agents,such'
p53807
g3
sS'inhaled,medications,should'
p53808
g3
sS'be,maintained,between'
p53809
g9
sS'niacin,nicotinic,acid'
p53810
g3
sS'development,of,severe'
p53811
g3
sS'the,appropriate,doses'
p53812
g3
sS'and,the,cyp3a4'
p53813
g3
sS'products,containing,and'
p53814
g9
sS'in,several,well-controlled'
p53815
g3
sS'arrhythmias,who,are'
p53816
g3
sS'should,if,necessary'
p53817
g3
sS'not,correct,changes'
p53818
g3
sS'in,clearance,value'
p53819
g3
sS'with,hepatic,impairment'
p53820
g3
sS'fed,state,mg'
p53821
g9
sS'used,it,is'
p53822
g3
sS'with,solid,phase'
p53823
g3
sS'cyp3a5,responsible,for'
p53824
g3
sS'oral,solution,can'
p53825
g9
sS'alg,mycophenolate,mofetil'
p53826
g3
sS'a,significantly,improved'
p53827
g3
sS'such,as,risk'
p53828
g3
sS'containing,higher,and'
p53829
g3
sS'channel,blocker,was'
p53830
g3
sS'valproic,acid,diminished'
p53831
g9
sS'elements,only,take'
p53832
g3
sS'the,undesirable,effects'
p53833
g9
sS'dexamethasone,and,retinyl'
p53834
g9
sS'renal,blood,flow'
p53835
g3
sS'cimetidine,concomitant,administration'
p53836
g9
sS'liver,by,the'
p53837
g3
sS'increased,dose,of'
p53838
g3
sS'uric,acid,excretion'
p53839
g9
sS'occurred,when,was'
p53840
g3
sS'significance,of,which'
p53841
g3
sS'plasma,concentrations,caution'
p53842
g9
sS'be,increased,at'
p53843
g3
sS'pretreatment,attenuated,the'
p53844
g9
sS'with,less,than'
p53845
g3
sS'collapse,and,respiratory'
p53846
g3
sS'other,chelator,therapies'
p53847
g3
sS'without,indicated,that'
p53848
g3
sS'with,hypercholesterolemia,concomitant'
p53849
g3
sS'for,heparins,effect'
p53850
g3
sS'may,either,potentiate'
p53851
g9
sS'hydrate,diet,high'
p53852
g9
sS'receiving,oral,and'
p53853
g9
sS'of,alcohol-related,deaths'
p53854
g3
sS'block,induced,by'
p53855
g9
sS'to,maximize,the'
p53856
g3
sS'the,clinician,in'
p53857
g3
sS'hypokalemia,may,increase'
p53858
g3
sS'patients,receiving,concurrent'
p53859
g3
sS'others,orudis,orudis'
p53860
g3
sS'of,other,hiv'
p53861
g3
sS'of,andtolbutamide,did'
p53862
g3
sS'administered,in,normal'
p53863
g9
sS'other,that,produce'
p53864
g9
sS'samples,from,patients'
p53865
g3
sS'preparations,and,isolated'
p53866
g3
sS'addition,that,are'
p53867
g9
sS'manner,relative,to'
p53868
g3
sS'not,be,treated'
p53869
g9
sS'other,hiv,protease'
p53870
g3
sS'at,high,concentrations'
p53871
g3
sS'or,elevated,liver'
p53872
g9
sS'increase,absorption,in'
p53873
g9
sS'the,ninds,t-pa'
p53874
g3
sS'concomitantly,administered,tagamet'
p53875
g3
sS'autoinduction,has,been'
p53876
g3
sS'ace,inhibitors,monoamine'
p53877
g3
sS'flow,and,function'
p53878
g3
sS'protection,against,the'
p53879
g9
sS'concurrently,with,tambocor'
p53880
g9
sS'concentration,of,amicar'
p53881
g3
sS'are,being,rapidly'
p53882
g3
sS'along,with,the'
p53883
g3
sS'acid,combination,hormonal'
p53884
g9
sS'co-administration,of,vioxx'
p53885
g9
sS'effect,of,steady-state'
p53886
g3
sS'administered,alone,at'
p53887
g9
sS'oxcarbazepine,was,evaluated'
p53888
g3
sS'laboratory,tests,pregnancy'
p53889
g3
sS'heart,block,may'
p53890
g9
sS'but,the,lst'
p53891
g3
sS'anabolic,particularly,c-17'
p53892
g3
sS'because,may,potentiate'
p53893
g9
sS'than,with,no'
p53894
g3
sS'with,should,be'
p53895
g9
sS'and,that,inhibit'
p53896
g9
sS'week,period,particularly'
p53897
g9
sS'background,the,feasibility'
p53898
g3
sS'with,the,blood'
p53899
g3
sS'in,nine,otherwise'
p53900
g3
sS'in,clearance,of'
p53901
g9
sS'that,the,agent'
p53902
g3
sS'in,additive,effect'
p53903
g9
sS'highly,plasma,protein-bound'
p53904
g9
sS'with,myopathy,underlying'
p53905
g3
sS'or,in,citrate'
p53906
g3
sS'adjustment,is,required'
p53907
g3
sS'daily,under,steady-state'
p53908
g3
sS'terfenadine,administration,of'
p53909
g3
sS'electrocardiographic,parameters,clinical'
p53910
g3
sS'nsaids,may,decrease'
p53911
g9
sS'd3,and,the'
p53912
g3
sS'cns,depression,tricyclic'
p53913
g9
sS'of,the,case-control'
p53914
g9
sS'use,with,is'
p53915
g3
sS'of,several,transcription'
p53916
g3
sS'acidic,conditions,duloxetine'
p53917
g3
sS'when,levsin,is'
p53918
g9
sS'compared,to,when'
p53919
g9
sS'occur,when,flolan'
p53920
g9
sS'the,placebo-controlled,clinical'
p53921
g3
sS'compound,is,administered'
p53922
g3
sS'elevations,of,liver'
p53923
g3
sS'select,and,commit'
p53924
g3
sS'while,corresponding,values'
p53925
g3
sS'the,mechanism,of'
p53926
g3
sS'agents,primarily,h2'
p53927
g3
sS'maleate,mg,qd'
p53928
g9
sS'decreases,of,more'
p53929
g9
sS'anti-inflammatory,drugs,in'
p53930
g9
sS'pharmacokinetics,of,following'
p53931
g3
sS'with,agonists,only'
p53932
g9
sS'hours,should,be'
p53933
g9
sS'nephrotoxicity,of,coly-mycin'
p53934
g9
sS'short-term,controlled,studies'
p53935
g3
sS'of,amevive,in'
p53936
g3
sS'neurons,recorded,with'
p53937
g3
sS'plasma,concentrations,by'
p53938
g9
sS'more,of,the'
p53939
g3
sS'show,that,the'
p53940
g3
sS'particularly,for,gout'
p53941
g3
sS'to,achieve,or'
p53942
g3
sS'p450,cyp,a4'
p53943
g3
sS'growing,class,of'
p53944
g3
sS'as,or,organophosphate'
p53945
g9
sS'acid,as,the'
p53946
g9
sS'induced,by,nuromax'
p53947
g9
sS'nc1,decrease,ci'
p53948
g3
sS'with,an,an'
p53949
g3
sS'by,users,of'
p53950
g3
sS'of,free,ions'
p53951
g3
sS'with,patients,should'
p53952
g9
sS'showed,that,poor'
p53953
g3
sS'interact,with,mao'
p53954
g9
sS'efficacy,of,faslodex'
p53955
g3
sS'result,in,severe'
p53956
g9
sS'benzodiazepines,benzodiazepines,metabolized'
p53957
g9
sS'of,myopathy,rhabdomyolysis'
p53958
g9
sS'loop,or,thiazide'
p53959
g9
sS'p,and,vs'
p53960
g3
sS'was,studied,in'
p53961
g3
sS'of,arsenical,reactive'
p53962
g3
sS'neuromuscular,blockade,was'
p53963
g9
sS'activity,eg,would'
p53964
g9
sS'therefore,smaller,alfenta'
p53965
g3
sS'be,used,after'
p53966
g3
sS'expected,that,no'
p53967
g3
sS'p450,cyp,at'
p53968
g3
sS'of,indocin,resulted'
p53969
g9
sS'of,has,not'
p53970
g3
sS'lotensin,can,be'
p53971
g9
sS'extent,auc,of'
p53972
g9
sS'theophylline,serum,levels'
p53973
g9
sS'prothrombin,and,factors'
p53974
g3
sS'toxic,levels,with'
p53975
g3
sS'signs,of,sedation'
p53976
g3
sS'been,definitively,demonstrated'
p53977
g9
sS'as,may,result'
p53978
g9
sS'potentiated,by,nonbarbiturate'
p53979
g9
sS'with,in,or'
p53980
g3
sS'co-administration,with,should'
p53981
g3
sS'was,found,that'
p53982
g9
sS'stable,dosage,on'
p53983
g9
sS'few,weeks,after'
p53984
g9
sS'however,ldl-c,reduction'
p53985
g9
sS'mediated,primarily,by'
p53986
g3
sS'and,in,vivo'
p53987
g3
sS'two,or,more'
p53988
g9
sS'poisoning,although,they'
p53989
g9
sS'and,respectively,which'
p53990
g3
sS'results,hydrocortisone,elevated'
p53991
g3
sS'with,other,agents'
p53992
g3
sS'reversible,acute,renal'
p53993
g9
sS'or,enhance,the'
p53994
g3
sS'diazepam,at,doses'
p53995
g9
sS'apart,was,administered'
p53996
g9
sS'about,one-half,the'
p53997
g3
sS'one,event,in'
p53998
g3
sS'necessary,when,the'
p53999
g3
sS'acute,delirium,associated'
p54000
g9
sS'and,urine,immunoreactive'
p54001
g3
sS'interactions,use,with'
p54002
g3
sS'which,concomitant,use'
p54003
g9
sS'st,john,s'
p54004
g3
sS'and,a,fold'
p54005
g9
sS'substantial,increases,in'
p54006
g9
sS'minor,side,or'
p54007
g3
sS'mg,kg,via'
p54008
g9
sS'standard,cystic,fibrosis'
p54009
g3
sS'and,high,doses'
p54010
g3
sS'were,similar,regardless'
p54011
g3
sS'in,addition,results'
p54012
g9
sS'an,open,three-period'
p54013
g3
sS'tambocor,are,unknown'
p54014
g9
sS'antagonize,the,skeletal'
p54015
g9
sS'kg,subcutaneous,injection'
p54016
g3
sS'indicate,that,mesylate'
p54017
g3
sS'received,increases,the'
p54018
g9
sS'treated,with,may'
p54019
g9
sS'combination,with,than'
p54020
g9
sS'study,in,insulin-dependent'
p54021
g3
sS'approximately,fold,increase'
p54022
g3
sS'serum,potassium,since'
p54023
g3
sS'when,patients,have'
p54024
g3
sS'rare,but,serious'
p54025
g9
sS'treated,with,mao'
p54026
g9
sS'increased,circulating,total'
p54027
g3
sS'in,elevated,plasma'
p54028
g9
sS'between,and,are'
p54029
g9
sS'not,recommended,in'
p54030
g3
sS'which,may,produce'
p54031
g9
sS'inotropic,properties,and'
p54032
g9
sS'p-aminosalicylic,acid,and'
p54033
g3
sS'the,advice,of'
p54034
g9
sS'antimicrobial,activity,was'
p54035
g3
sS'and,decreased,have'
p54036
g9
sS'plasma,concentrations,did'
p54037
g3
sS'such,are,used'
p54038
g3
sS'amphotericin,b,non-steroidal'
p54039
g3
sS'increased,thyroid-binding,globulin'
p54040
g3
sS'vioxx,may,result'
p54041
g9
sS'the,polymer,conjugates'
p54042
g3
sS'glutamic,acid,hcl'
p54043
g9
sS'increased,by,hour'
p54044
g9
sS'requiring,complete,mental'
p54045
g3
sS'risk,of,gi'
p54046
g9
sS'if,hormonal,differ'
p54047
g3
sS'of,linear,regression'
p54048
g3
sS'zone,and,dpcpx-induced'
p54049
g9
sS'system,and,postnatal'
p54050
g3
sS'vasoconstriction,caused,by'
p54051
g9
sS'the,following,observations'
p54052
g3
sS'ss,of,by'
p54053
g9
sS'indicated,when,is'
p54054
g3
sS'respond,normally,to'
p54055
g3
sS'at,the,clinical'
p54056
g3
sS'is,drawn,if'
p54057
g9
sS'been,seen,in'
p54058
g3
sS'these,doses,are'
p54059
g3
sS'itraconazole,and,primarily'
p54060
g3
sS'inhibitors,serotonin,reuptake'
p54061
g9
sS'nsaids,including,ketorolac'
p54062
g3
sS'cyp2d6,sensipar,is'
p54063
g3
sS'net,change,of'
p54064
g9
sS'characterized,by,flushing'
p54065
g3
sS'day-old,chick,embryos'
p54066
g9
sS'mixed,overdosage,since'
p54067
g9
sS'to,use,foradil'
p54068
g3
sS'edetate,disodium,interferes'
p54069
g9
sS'prothrombin,complex,concentrates'
p54070
g3
sS'additionally,higher,than'
p54071
g9
sS'now,strong,evidence'
p54072
g3
sS'that,the,applied'
p54073
g3
sS'model,primary,focus'
p54074
g3
sS'investigated,the,mechanism'
p54075
g3
sS'mm,is,rapid'
p54076
g3
sS'homopolyribonucleotides,and,complexes'
p54077
g3
sS'hydrogen,maleate,or'
p54078
g9
sS'including,and,or'
p54079
g9
sS'induce,a4,activity'
p54080
g3
sS'min,for,alone'
p54081
g9
sS'membrane,was,changed'
p54082
g3
sS'peak,concentration,reached'
p54083
g3
sS'a,reversible,reduction'
p54084
g3
sS'tumor,cell,killing'
p54085
g3
sS'the,dose,should'
p54086
g9
sS'introduced,at,the'
p54087
g9
sS'at,the,start'
p54088
g9
sS'hyperthyroid,patients,and'
p54089
g3
sS'ns,is,administered'
p54090
g9
sS'the,broadening,indications'
p54091
g3
sS'metabolism,could,contribute'
p54092
g3
sS'other,nephrotoxic,medications'
p54093
g3
sS'to,any,great'
p54094
g3
sS'concomitant,medications,included'
p54095
g3
sS'produce,a,watery'
p54096
g3
sS'and,ischemia,of'
p54097
g3
sS'after,h,was'
p54098
g3
sS'have,investigated,simulect'
p54099
g3
sS'emulsions,in,patients'
p54100
g3
sS'of,the,alkaloid'
p54101
g9
sS'metabolized,by,hepatic'
p54102
g9
sS'on,other,antiepilepsy'
p54103
g3
sS'and,of,pseudomonas'
p54104
g3
sS'of,administering,different'
p54105
g3
sS'fo,these,hormones'
p54106
g3
sS'and,has,not'
p54107
g3
sS'experimental,animals,male'
p54108
g3
sS'by,general,local'
p54109
g3
sS'that,mtx,nsaids'
p54110
g3
sS'bleeding,higher,than'
p54111
g9
sS'nose,may,occur'
p54112
g9
sS'by,a,variety'
p54113
g3
sS'evaluated,in,vitro'
p54114
g3
sS'metabolism,rifampin,reduced'
p54115
g9
sS'arimidex,with,other'
p54116
g3
sS'pain,and,severe'
p54117
g3
sS'and,male,rats'
p54118
g3
sS'concentrations,of,coadministered'
p54119
g3
sS'in,an,in'
p54120
g3
sS'liver,metabolic,activation'
p54121
g3
sS'of,these,enzymes'
p54122
g3
sS'any,oral,medications'
p54123
g9
sS'that,induce,a4'
p54124
g3
sS'onset,of,symptoms'
p54125
g3
sS'who,are,not'
p54126
g9
sS'groups,were,observed'
p54127
g3
sS'of,primary,rabbit'
p54128
g3
sS'after,the,initiation'
p54129
g9
sS'was,covalently,linked'
p54130
g3
sS'co-administer,and,is'
p54131
g9
sS'and,industrial,workers'
p54132
g3
sS'was,significantly,impaired'
p54133
g3
sS'of,mg,and'
p54134
g3
sS'of,the,principles'
p54135
g3
sS'patients,receiving,brovana'
p54136
g3
sS'used,to,control'
p54137
g9
sS'time,measured,as'
p54138
g9
sS'positive,readings,were'
p54139
g3
sS'tolbutamide,in,diabetic'
p54140
g3
sS'erection-supporting,medication,patients'
p54141
g3
sS'the,specific,isoenzyme'
p54142
g3
sS'mean,elimination,half-life'
p54143
g9
sS'local,which,contain'
p54144
g9
sS'inhibition,of,a'
p54145
g3
sS'causes,increase,by'
p54146
g9
sS'is,frequent,the'
p54147
g3
sS'from,the,mg'
p54148
g3
sS'be,administered,together'
p54149
g9
sS'to,that,in'
p54150
g3
sS'function,may,reduce'
p54151
g3
sS'aripiprazole,is,unlikely'
p54152
g3
sS'basis,to,mg'
p54153
g9
sS'levels,comparable,to'
p54154
g3
sS'subjects,there,were'
p54155
g3
sS'or,are,metabolized'
p54156
g9
sS'antiinflammatory,agents,aspirin'
p54157
g9
sS'was,administered,concurrently'
p54158
g3
sS'and,thus,decrease'
p54159
g9
sS'oral,ccnu,was'
p54160
g3
sS'with,to,patients'
p54161
g3
sS'ergot,derivatives,dihydroergotamine'
p54162
g3
sS'isocarboxazid,should,be'
p54163
g9
sS'other,commonly,used'
p54164
g3
sS'in,hemostasis,and'
p54165
g9
sS'of,subjects,who'
p54166
g9
sS'professionals,be,aware'
p54167
g3
sS'decreased,by,as'
p54168
g3
sS'blood,levels,and'
p54169
g3
sS'the,interaction,was'
p54170
g3
sS'hemostatic,defense,of'
p54171
g9
sS'four,times,as'
p54172
g3
sS'an,appropriate,adjustment'
p54173
g9
sS'with,serotoninergic,agents'
p54174
g9
sS'inhibitors,or,inducers'
p54175
g3
sS'when,was,coadministered'
p54176
g9
sS'of,toxicity,occur'
p54177
g9
sS'the,ca,store'
p54178
g3
sS'for,the,other'
p54179
g3
sS'oral,contraceptives,may'
p54180
g3
sS'occurred,when,and'
p54181
g3
sS'that,alter,renal'
p54182
g3
sS'of,infections,caused'
p54183
g3
sS'following,similar,changes'
p54184
g3
sS'a,thienobenzodiazepine,derivative'
p54185
g3
sS'necessary,to,adjust'
p54186
g9
sS'fbs,followed,by'
p54187
g9
sS'and,concomitant,administration'
p54188
g3
sS'and,exhibit,doubling'
p54189
g3
sS'other,psychotropic,have'
p54190
g9
sS'is,reduced,although'
p54191
g9
sS'a,significant,increase'
p54192
g9
sS'lead,to,increases'
p54193
g3
sS'intolerance,and,serum'
p54194
g3
sS'the,benzodiazepine,class'
p54195
g9
sS'no,clear,reproducible'
p54196
g3
sS'lead,to,increased'
p54197
g3
sS'pharmaceutical,abstracts,using'
p54198
g3
sS'and,family,education'
p54199
g3
sS'stimulated,hz,degrees'
p54200
g3
sS'and,implantable,contraceptives'
p54201
g9
sS'viracept,and,primarily'
p54202
g3
sS'calcium-blocking,agents,and'
p54203
g3
sS'rats,were,divided'
p54204
g3
sS'cyp2d6,cyp2e1,and'
p54205
g3
sS'was,given,within'
p54206
g3
sS'cns-active,has,not'
p54207
g3
sS'antihypertensive,effect,of'
p54208
g9
sS'with,a,light'
p54209
g9
sS'special,precaution,is'
p54210
g3
sS'infection,oi,rates'
p54211
g3
sS'excitement,hypomania,restlessness'
p54212
g3
sS'on,auc,and'
p54213
g3
sS'drugs,possessing,nephrotoxic'
p54214
g9
sS'activity,may,decrease'
p54215
g3
sS'patients,taking,tysabri'
p54216
g3
sS'mug,or,less'
p54217
g3
sS'its,ability,to'
p54218
g9
sS'deltasone,orasone,others'
p54219
g3
sS'reports,of,interaction'
p54220
g3
sS'of,neuromuscular,blockade'
p54221
g9
sS'of,hmg-coa,reductase'
p54222
g9
sS'other,known,photosensitizing'
p54223
g9
sS'decreased,effectiveness,and'
p54224
g9
sS'bleeding,complications,careful'
p54225
g3
sS'bioavailability,studies,with'
p54226
g3
sS'vioxx,mg,daily'
p54227
g3
sS'because,efficient,labeling'
p54228
g3
sS'reaction,of,placental'
p54229
g9
sS'document,no,clinically'
p54230
g3
sS'of,competitive,suppression'
p54231
g3
sS'zinecard,on,the'
p54232
g3
sS'glycosides,inducers,of'
p54233
g3
sS'chronic,therapy,the'
p54234
g9
sS'not,when,the'
p54235
g9
sS'increase,respectively,and'
p54236
g9
sS'monitored,if,a'
p54237
g9
sS'may,be,elevated'
p54238
g3
sS'an,average,of'
p54239
g9
sS'of,ionized,concurrent'
p54240
g3
sS'auc,and,about'
p54241
g9
sS'and,to,establish'
p54242
g3
sS'result,in,any'
p54243
g3
sS'clearance,of,enhancing'
p54244
g9
sS'anagrelide,is,metabolized'
p54245
g3
sS'reported,to,inactivate'
p54246
g9
sS'present,work,involved'
p54247
g3
sS'may,produce,additive'
p54248
g3
sS'blockers,such,as'
p54249
g9
sS'the,other,isoforms'
p54250
g3
sS'results,from,in'
p54251
g3
sS'with,the,pharmacokinetics'
p54252
g9
sS'potential,interactions,may'
p54253
g3
sS'of,dynacirc,and'
p54254
g3
sS'hiv-1,seropositive,subjects'
p54255
g3
sS'interact,with,cefamandole'
p54256
g3
sS'of,the,luteinizing'
p54257
g3
sS'of,progestin-only,pills'
p54258
g9
sS'additional,therapy,the'
p54259
g3
sS'clotting,factor,synthesis'
p54260
g3
sS'be,considered,particularly'
p54261
g3
sS'contained,plus,or'
p54262
g3
sS'often,applied,to'
p54263
g3
sS'lymphatic,invasion,of'
p54264
g9
sS'disease,requires,maintaining'
p54265
g3
sS'were,increased,approximately'
p54266
g3
sS'in,increased,blood'
p54267
g9
sS'a,direct,causal'
p54268
g9
sS'by,and,suppressed'
p54269
g3
sS'tricyclic,antidepressant,or'
p54270
g3
sS'be,employed,cautiously'
p54271
g3
sS'times,were,increased'
p54272
g3
sS'bioavailability,was,about'
p54273
g9
sS'areas,where,abuse'
p54274
g3
sS'was,about,equipotent'
p54275
g3
sS'immunosuppressives,cyclosporine,cyp3a4'
p54276
g3
sS'of,manic-depressive,disorder'
p54277
g3
sS'especially,so,for'
p54278
g3
sS'other,highly,protein'
p54279
g3
sS'data,on,concomitant'
p54280
g3
sS'adversely,affected,response'
p54281
g9
sS'citrate,may,potentiate'
p54282
g9
sS'levels,produced,modest'
p54283
g3
sS'rate,increase,following'
p54284
g9
sS'may,either,inhibit'
p54285
g9
sS'was,no,interaction'
p54286
g3
sS'significant,decreases,in'
p54287
g9
sS'only,at,very'
p54288
g3
sS'of,the,limbic'
p54289
g3
sS'these,functions,as'
p54290
g3
sS'when,vardenafil,or'
p54291
g9
sS'effects,with,those'
p54292
g9
sS'hour,and,a'
p54293
g9
sS'major,cause,of'
p54294
g3
sS'in,uptake-1,occurs'
p54295
g3
sS'mc,a,novel'
p54296
g3
sS'to,normal,tissue'
p54297
g3
sS'to,the,blood'
p54298
g9
sS'interactions,when,is'
p54299
g9
sS'of,novolog,and'
p54300
g3
sS'produce,artifactually,low'
p54301
g3
sS'with,prostatectomy,radiation'
p54302
g3
sS'required,and,pth'
p54303
g9
sS'parvum,growth,in'
p54304
g9
sS'not,significantly,inhibit'
p54305
g9
sS'these,medications,or'
p54306
g9
sS'clinically,important,interactions'
p54307
g3
sS'are,eclampsia,some'
p54308
g3
sS'an,agent,administered'
p54309
g3
sS'concurrently,with,oral'
p54310
g9
sS'in,iso-sensitest,broth'
p54311
g3
sS'subclone,of,mcf-7'
p54312
g3
sS'decrease,the,k'
p54313
g3
sS'of,parenterally,administered'
p54314
g9
sS'inhibitor,should,not'
p54315
g9
sS'similarly,had,no'
p54316
g3
sS'zone,in,this'
p54317
g3
sS'varying,degrees,of'
p54318
g3
sS'accumulation,in,rabbit'
p54319
g9
sS'anticancer,and,may'
p54320
g9
sS'by,cyp3a4,as'
p54321
g3
sS'and,that,transferred'
p54322
g3
sS'resistance,or,by'
p54323
g3
sS'to,days,following'
p54324
g9
sS'results,during,treatment'
p54325
g9
sS'in,the,reduced'
p54326
g3
sS'either,protective,or'
p54327
g3
sS'a,maintenance,level'
p54328
g9
sS'weekly,or,glatiramer'
p54329
g3
sS'multidrug-resistant,organisms,and'
p54330
g3
sS'presence,of,more'
p54331
g3
sS'of,salmonella,typhimurium'
p54332
g3
sS'taking,the,highest'
p54333
g3
sS'responsible,for,the'
p54334
g9
sS'a,double-blind,fashion'
p54335
g3
sS'of,the,first'
p54336
g3
sS'hormone,and,its'
p54337
g3
sS'concomitantly,with,gram'
p54338
g9
sS'form,of,therapy'
p54339
g3
sS'post-marketing,reports,of'
p54340
g3
sS'reduced,requirements,but'
p54341
g3
sS'decreased,in,rats'
p54342
g9
sS'initiated,in,a'
p54343
g9
sS'showed,that,inhibited'
p54344
g3
sS'a,high,dose'
p54345
g9
sS'of,with,should'
p54346
g9
sS'combination,with,sulfamethoxazole'
p54347
g3
sS'the,utility,of'
p54348
g3
sS'simultaneously,or,hours'
p54349
g9
sS'examine,the,insp'
p54350
g3
sS'ability,to,control'
p54351
g3
sS'carcinogenesis,by,or'
p54352
g3
sS'these,other,is'
p54353
g3
sS'following,oral,administration'
p54354
g3
sS'or,harm,to'
p54355
g3
sS'pass,secondary,to'
p54356
g3
sS'metformin,in,a'
p54357
g3
sS'degree,of,stereoselectivity'
p54358
g3
sS'about,x,m'
p54359
g9
sS'effect,when,initiating'
p54360
g9
sS'or,large,doses'
p54361
g3
sS'and,may,alter'
p54362
g9
sS'chromosomal,aberration,assay'
p54363
g3
sS'alterations,in,gonadotropin'
p54364
g3
sS'compounds,block,pcp-induced'
p54365
g3
sS'xii,vii-x,complex'
p54366
g3
sS'be,monitored,at'
p54367
g9
sS'into,account,variations'
p54368
g3
sS'resistant,mcf-7,cells'
p54369
g3
sS'led,to,increased'
p54370
g9
sS'effective,and,increased'
p54371
g3
sS'anticholinergic,agents,although'
p54372
g9
sS'an,aed,induces'
p54373
g3
sS'control,side,effects'
p54374
g3
sS'some,agents,the'
p54375
g3
sS'particularly,in,patients'
p54376
g3
sS'wide,variety,of'
p54377
g3
sS'besides,mtx,were'
p54378
g3
sS'agents,is,usually'
p54379
g9
sS'motrin,advil,nuprin'
p54380
g3
sS'at,nacmc,with'
p54381
g3
sS'insufficient,to,produce'
p54382
g9
sS'more,than,episodes'
p54383
g3
sS'in,diabetics,blood-sugar'
p54384
g3
sS'to,increase,awareness'
p54385
g9
sS'wellbutrin,following,concomitant'
p54386
g3
sS'is,used,at'
p54387
g9
sS'an,action,should'
p54388
g3
sS'of,and,resulting'
p54389
g9
sS'central,effects,of'
p54390
g9
sS'received,plus,for'
p54391
g3
sS'of,hydrochloride,with'
p54392
g9
sS'suggest,that,an'
p54393
g3
sS'latter,agents,when'
p54394
g9
sS'studies,performed,with'
p54395
g3
sS'being,monitored,they'
p54396
g3
sS'phase,study,received'
p54397
g3
sS'increased,and,more'
p54398
g9
sS'patient,receiving,revia'
p54399
g9
sS'colchicine,is,inhibited'
p54400
g9
sS'lowest,effective,dose'
p54401
g9
sS'clearance,or,volume'
p54402
g3
sS'receive,concomitant,strong'
p54403
g3
sS'femara,in,combination'
p54404
g3
sS'potent,inhibitory,activity'
p54405
g3
sS'may,be,expected'
p54406
g9
sS'high,fever,severe'
p54407
g9
sS'of,and,enhance'
p54408
g9
sS'or,some,leading'
p54409
g9
sS'may,be,capable'
p54410
g9
sS'may,under,certain'
p54411
g3
sS'duration,of,pharmacologic'
p54412
g9
sS'on,the,requirement'
p54413
g9
sS'the,pharmacokinetics,pharmacodynamics'
p54414
g3
sS'adjustments,may,be'
p54415
g3
sS'potassium,levels,and'
p54416
g3
sS'the,plasma,kinetics'
p54417
g3
sS'advise,on,over'
p54418
g3
sS'critical,fall,in'
p54419
g3
sS'advised,if,patients'
p54420
g3
sS'concentration,during,concomitant'
p54421
g9
sS'feasibility,and,efficacy'
p54422
g3
sS'in,humans,may'
p54423
g9
sS'study,we,evaluated'
p54424
g3
sS'ic,was,about'
p54425
g3
sS'acute,dosing,with'
p54426
g3
sS'study,periods,were'
p54427
g3
sS'increased,decreased,and'
p54428
g9
sS'be,discontinued,several'
p54429
g3
sS'urine,was,analyzed'
p54430
g3
sS'to,be,the'
p54431
g9
sS'monotherapy,did,not'
p54432
g3
sS'not,displace,tightly'
p54433
g3
sS'patients,receiving,with'
p54434
g9
sS'for,the,identification'
p54435
g3
sS'fehling,s,solutions'
p54436
g3
sS'experiment,male,adult'
p54437
g3
sS'insulin,parameters,were'
p54438
g3
sS'has,recently,received'
p54439
g9
sS'of,sn38,the'
p54440
g3
sS'dimethylprostaglandin,e2,dmpge2'
p54441
g3
sS'dosage,modifications,based'
p54442
g3
sS'either,in,the'
p54443
g3
sS'demonstrated,a,decrease'
p54444
g9
sS'sprycel,in,patients'
p54445
g3
sS'and,nrtis,other'
p54446
g3
sS'increased,deet,toxicity'
p54447
g3
sS'withdrawn,several,days'
p54448
g9
sS'absorption,of,both'
p54449
g9
sS'ml,with,coadministration'
p54450
g9
sS'currently,it,is'
p54451
g3
sS'showed,no,positive'
p54452
g3
sS'high,temperature,and'
p54453
g9
sS'the,anticoagulation,effects'
p54454
g9
sS'analog,of,cholecystokinin'
p54455
g3
sS'listed,in,table'
p54456
g3
sS'relieve,acute,asthma'
p54457
g3
sS'the,cyp3a4,inducer'
p54458
g9
sS'resulted,in,slight'
p54459
g9
sS'the,safety,profile'
p54460
g3
sS'cholesterol,levels,could'
p54461
g3
sS'from,addicts,vs'
p54462
g3
sS'specific,pharmacokinetic,or'
p54463
g3
sS'the,possibility,of'
p54464
g3
sS'continued,these,patients'
p54465
g3
sS'with,acetylsalicylic,acid'
p54466
g3
sS'agent,has,slight'
p54467
g3
sS'with,cerubidine,may'
p54468
g9
sS'is,given,concurrently'
p54469
g9
sS'and,c9,respectively'
p54470
g3
sS'such,as,loop'
p54471
g9
sS'is,also,used'
p54472
g9
sS'xanthine,and,other'
p54473
g9
sS'first,hours,following'
p54474
g3
sS'a,mean,change'
p54475
g9
sS'what,modern,medications'
p54476
g3
sS'other,and,the'
p54477
g3
sS'volatile,agent,known'
p54478
g3
sS'sedation,time,sst'
p54479
g3
sS'reactions,to,iodinated'
p54480
g9
sS'of,arsenical,encephalopathy'
p54481
g3
sS'gastric,ph,was'
p54482
g9
sS'dna,damage,when'
p54483
g3
sS'to,difluoroacetone,in'
p54484
g9
sS'placebo,for,days'
p54485
g3
sS'fertility,carcinogenesis,pegasys'
p54486
g3
sS'to,plus,or'
p54487
g3
sS'show,that,disease'
p54488
g3
sS'affected,when,administered'
p54489
g3
sS'be,administered,simultaneously'
p54490
g9
sS'by,the,enteric'
p54491
g3
sS'conducted,in,the'
p54492
g3
sS'd2,antagonists,and'
p54493
g9
sS'doses,of,er'
p54494
g3
sS'may,prolong,and'
p54495
g9
sS'g,sometimes,mcg'
p54496
g3
sS'since,exhibits,non-linear'
p54497
g9
sS'were,no,observed'
p54498
g3
sS'of,concomitant,chemotherapy'
p54499
g3
sS'was,similar,in'
p54500
g3
sS'cyp3a4,and,the'
p54501
g3
sS'focuses,on,metabolic'
p54502
g3
sS'and,cyp3a4,cimetidine'
p54503
g9
sS'and,ii,the'
p54504
g3
sS'co-medications,that,induce'
p54505
g9
sS'antiseizure,medication,monitored'
p54506
g3
sS'the,mao-b,inhibitor'
p54507
g3
sS'clinical,pharmacokinetic,studies'
p54508
g3
sS'with,maleate,its'
p54509
g9
sS'or,herbal,product'
p54510
g3
sS'by,enhanced,absorption'
p54511
g3
sS'testes,and,epididymides'
p54512
g3
sS'of,precedex,on'
p54513
g9
sS'store,and,the'
p54514
g3
sS'accordingly,if,effect'
p54515
g3
sS'it,is,potentially'
p54516
g3
sS'simultaneous,use,of'
p54517
g3
sS'pneumonia,treatment,with'
p54518
g9
sS'no,pharmacokinetic,data'
p54519
g3
sS'levels,in,the'
p54520
g9
sS'linear,logarithmic,fashion'
p54521
g3
sS'control,with,reduced'
p54522
g3
sS'these,and,therefore'
p54523
g3
sS'and,or,ototoxicity'
p54524
g3
sS'pretreatment,of,rats'
p54525
g9
sS'initiating,or,changing'
p54526
g9
sS'effects,of,duloxetine'
p54527
g3
sS'hormonal,are,highly'
p54528
g3
sS'of,to,about'
p54529
g9
sS'or,acquired,immunodeficiencies'
p54530
g3
sS'and,mc,ameliorate'
p54531
g3
sS'of,both,cyp2c9'
p54532
g3
sS'extract,alone,and'
p54533
g3
sS'catalyzed,by,cytochrome'
p54534
g3
sS'was,approximately,twofold'
p54535
g3
sS'activity,which,increased'
p54536
g3
sS'this,potentiation,of'
p54537
g9
sS'by,forming,a'
p54538
g3
sS'dose,had,little'
p54539
g3
sS'review,of,its'
p54540
g3
sS'and,other,have'
p54541
g3
sS'thus,careful,monitoring'
p54542
g9
sS'may,enhance,s'
p54543
g3
sS'on,the,contrary'
p54544
g9
sS'isozyme,cyp2c9,and'
p54545
g3
sS'who,were,treated'
p54546
g3
sS'p-450,a,family'
p54547
g9
sS'of,pegasys,on'
p54548
g3
sS'results,indicate,that'
p54549
g3
sS'the,patient,in'
p54550
g3
sS'the,patient,is'
p54551
g9
sS'system,with,other'
p54552
g9
sS'for,on,dopamine2-'
p54553
g3
sS'acid,and,sodium'
p54554
g9
sS'tenofovir,disoproxil,fumarate'
p54555
g3
sS'in,rats,at'
p54556
g9
sS'duloxetine,and,should'
p54557
g9
sS'pyknotic,nuclei,chromatin'
p54558
g3
sS'as,thorazine,prolixin'
p54559
g3
sS'elimination,half-life,of'
p54560
g9
sS'catecholamine,depletors,should'
p54561
g9
sS'or,h,receptor'
p54562
g9
sS'of,cyp3a,and'
p54563
g9
sS'tolbutamides,conversion,to'
p54564
g3
sS'clinical,pharmacology,pharmacokinetics'
p54565
g3
sS'discontinued,in,patients'
p54566
g3
sS'as,psoriasis,rheumatoid'
p54567
g3
sS'and,increase,the'
p54568
g3
sS'angiomax,should,be'
p54569
g3
sS'adjustment,and,particularly'
p54570
g3
sS'induced,by,suggest'
p54571
g3
sS'and,for,injection'
p54572
g9
sS'conclusions,to,be'
p54573
g3
sS'the,latter,might'
p54574
g3
sS'serum,level,should'
p54575
g9
sS'days,n,under'
p54576
g3
sS'was,seen,when'
p54577
g3
sS'will,result,in'
p54578
g3
sS'or,above,of'
p54579
g9
sS'animal,reproduction,studies'
p54580
g3
sS'in,uptake-1,carrier'
p54581
g3
sS'for,any,patient'
p54582
g3
sS'inhibitors,of,nor'
p54583
g3
sS'possible,diminished,effect'
p54584
g3
sS'indocin,relafen,daypro'
p54585
g3
sS'by,range,from'
p54586
g9
sS'its,potential,to'
p54587
g3
sS'very,low,cardiac'
p54588
g3
sS'recently,been,demonstrated'
p54589
g3
sS'effect,on,its'
p54590
g3
sS'dose,of,either'
p54591
g3
sS'both,and,mc'
p54592
g3
sS'low,clinically,significant'
p54593
g3
sS'ironing,kilometers,of'
p54594
g3
sS'lower,with,than'
p54595
g3
sS'the,dermatologist,and'
p54596
g3
sS'measured,by,protein-bound'
p54597
g3
sS'action,of,non-depolarising'
p54598
g9
sS'addition,certain,that'
p54599
g3
sS'significantly,include,adrenocortical'
p54600
g9
sS'is,likely,to'
p54601
g9
sS'mean,auc,or'
p54602
g3
sS'on,absorption,and'
p54603
g3
sS'peak,levels,were'
p54604
g9
sS'these,data,vardenafil'
p54605
g9
sS'salt,substitutes,may'
p54606
g9
sS'mean,auc,of'
p54607
g9
sS'distinct,from,the'
p54608
g3
sS'healthy,female,subjects'
p54609
g3
sS'p450,a2,and'
p54610
g9
sS'anti-inflammatory,drugs,the'
p54611
g9
sS'conversion,of,deoxy'
p54612
g3
sS'these,leading,to'
p54613
g9
sS'clearance,a,prolongation'
p54614
g9
sS's,solution,or'
p54615
g3
sS'on,efficacy,and'
p54616
g3
sS'affinity,for,albumin'
p54617
g3
sS'combination,with,beta-adrenergic'
p54618
g9
sS'steady-state,cmin,concentrations'
p54619
g3
sS'hydrophobic,side,chain'
p54620
g3
sS'of,increased,prothrombin'
p54621
g9
sS'chop,chemotherapy,or'
p54622
g3
sS'alone,and,administered'
p54623
g3
sS'general,in,vitro'
p54624
g3
sS'd,dosage,must'
p54625
g9
sS'increased,by,following'
p54626
g9
sS'antagonise,the,anti-glaucoma'
p54627
g3
sS'and,paraclinical,pattern'
p54628
g3
sS'has,previously,received'
p54629
g9
sS'of,qtc,prolongation'
p54630
g3
sS'minimize,risks,maximize'
p54631
g3
sS'the,major,circulating'
p54632
g3
sS'be,achieved,with'
p54633
g3
sS'have,benign,prostatic'
p54634
g3
sS'decrease,in,s'
p54635
g9
sS'against,multidrug-resistant,organisms'
p54636
g3
sS'coadministered,than,when'
p54637
g9
sS'prothrombin,times,should'
p54638
g9
sS'probenecid,as,with'
p54639
g9
sS'taking,tell,your'
p54640
g9
sS'and,hc1,concomitant'
p54641
g9
sS'm2,before,dose-limiting'
p54642
g3
sS'the,decreases,in'
p54643
g9
sS'that,impairment,of'
p54644
g3
sS'each,preparation,was'
p54645
g3
sS'acetaminophen,a,report'
p54646
g9
sS'diagnosis,or,monitoring'
p54647
g3
sS'warfarin,eszopiclone,mg'
p54648
g3
sS'concomitant,medications,were'
p54649
g3
sS'inhibitors,and,decreased'
p54650
g9
sS'associated,with,coronary'
p54651
g3
sS'mammalian,target,of'
p54652
g3
sS'on,qtc,intervals'
p54653
g3
sS'in,situations,when'
p54654
g3
sS'depressant,effect,when'
p54655
g9
sS'glomerular,filtration,rate'
p54656
g3
sS'on,and,transport'
p54657
g3
sS'of,either,these'
p54658
g3
sS'have,a,dose'
p54659
g9
sS'days,should,elapse'
p54660
g9
sS'dog,treated,for'
p54661
g3
sS'capsules,are,administered'
p54662
g9
sS'metabolism,of,toxic'
p54663
g9
sS'which,required,the'
p54664
g3
sS'the,th,day'
p54665
g9
sS'found,to,require'
p54666
g9
sS'glucose,including,hyperglycemia'
p54667
g9
sS'case,the,peripheral'
p54668
g3
sS'nonsmoking,healthy,white'
p54669
g3
sS'or,norpace,cr'
p54670
g9
sS'solutions,containing,higher'
p54671
g3
sS'observed,with,clinitest'
p54672
g3
sS'days,and,decreased'
p54673
g9
sS'study,denileukin,diftitox'
p54674
g3
sS'xanthine-derived,antagonists,tested'
p54675
g3
sS'clinical,studies,had'
p54676
g3
sS'placebo-controlled,study,with'
p54677
g3
sS'concurrently,should,be'
p54678
g3
sS'recognition,of,toxicity'
p54679
g3
sS'renal,function,the'
p54680
g9
sS'of,mcg,ml'
p54681
g3
sS'changes,in,tbg'
p54682
g3
sS'of,but,there'
p54683
g9
sS'it,is,suggested'
p54684
g9
sS'be,completed,at'
p54685
g3
sS'monitor,serum,electrolytes'
p54686
g3
sS'benazepril,like,other'
p54687
g9
sS'm,v,in'
p54688
g3
sS'may,decrease,arterial'
p54689
g9
sS'may,respond,to'
p54690
g3
sS'were,seen,in'
p54691
g3
sS'a,potentially,toxic'
p54692
g9
sS'and,by,inhibition'
p54693
g9
sS'increase,two-fold,or'
p54694
g9
sS'of,the,evidence'
p54695
g3
sS'capsules,mg,tid'
p54696
g3
sS'patients,transient,drowsiness'
p54697
g3
sS'from,the,soluble'
p54698
g3
sS'effects,of,mefloquineuine'
p54699
g3
sS'basis,appears,to'
p54700
g9
sS'rhabdomyolysis,is,increased'
p54701
g9
sS'used,for,l-glutamine'
p54702
g3
sS'defect,in,the'
p54703
g3
sS'were,significantly,larger'
p54704
g3
sS'and,menstrual,irregularities'
p54705
g3
sS'prinivil,at,a'
p54706
g9
sS'elspar,can,diminish'
p54707
g9
sS'methods,commonly,used'
p54708
g3
sS'gross,motor,skills'
p54709
g3
sS'low,affinity,binding'
p54710
g3
sS'patient,population,with'
p54711
g3
sS'rat,the,human'
p54712
g3
sS'agents,was,evaluated'
p54713
g3
sS'to,potential,for'
p54714
g3
sS'cytochrome,cyp,p450'
p54715
g3
sS'drugs,that,alter'
p54716
g9
sS'important,that,physicians'
p54717
g3
sS'racemic,citalopram,citalopram'
p54718
g9
sS'two,inhibitors,of'
p54719
g3
sS'concentrations,of,tcas'
p54720
g3
sS'atrial,fibrillation,their'
p54721
g9
sS'by,cyp,c9'
p54722
g3
sS'unaffected,by,brevibloc'
p54723
g9
sS'patient,for,accutane'
p54724
g3
sS'that,cyp3a4,and'
p54725
g3
sS'problems,encountered,during'
p54726
g3
sS'by,on,day'
p54727
g9
sS'day,in,overall'
p54728
g3
sS'with,the,renal'
p54729
g9
sS'and,nonprescription,products'
p54730
g3
sS'serious,opportunistic,infections'
p54731
g3
sS'no,difference,in'
p54732
g3
sS'nervous,system,leading'
p54733
g3
sS'was,an,increasing'
p54734
g3
sS'result,of,inhibition'
p54735
g3
sS'of,over,indinavir-based'
p54736
g3
sS'the,mean,estimates'
p54737
g3
sS'therefore,patients,under'
p54738
g9
sS'of,unbound,to'
p54739
g3
sS'results,of,an'
p54740
g3
sS'increases,in,previously'
p54741
g9
sS'daily,taken,with'
p54742
g9
sS'does,not,compensate'
p54743
g9
sS'medicated,or,abrasive'
p54744
g3
sS'of,caspase-3,and'
p54745
g3
sS'maximum,tolerated,dose'
p54746
g3
sS'this,time,window'
p54747
g9
sS'elevated,plasma,concentrations'
p54748
g9
sS'omega-conotoxin,gvia-sensitive,n-type'
p54749
g3
sS'parentheses,were,cardiac'
p54750
g3
sS'the,range,of'
p54751
g3
sS'carbamazepine,isoniazid,is'
p54752
g9
sS'treatment,with,sodium'
p54753
g9
sS'to,marked,interference'
p54754
g9
sS'had,initial,positive'
p54755
g3
sS'cyp3a4,substrate,in'
p54756
g3
sS'cells,by,a'
p54757
g3
sS'absorption,of,in'
p54758
g9
sS'cyp3a4,and,or'
p54759
g3
sS'antagonist,was,added'
p54760
g9
sS'were,collected,through'
p54761
g3
sS'nondepolarizing,muscle,relaxants'
p54762
g9
sS'after,exposure,to'
p54763
g3
sS'interest,to,study'
p54764
g3
sS'new,rashes,itching'
p54765
g3
sS'cadmium,mixtures,at'
p54766
g3
sS'cecectomized,rats,was'
p54767
g3
sS'increased,the,frequency'
p54768
g9
sS'results,of,studies'
p54769
g9
sS'hours,for,and'
p54770
g3
sS'other,should,be'
p54771
g9
sS'of,noradrenaline,storage'
p54772
g3
sS'had,no,measurable'
p54773
g3
sS'prolonged,administration,of'
p54774
g3
sS'a,greater,amount'
p54775
g9
sS'inhibitor,at,steady'
p54776
g3
sS'against,an,increased'
p54777
g9
sS'of,its,active'
p54778
g9
sS'are,sometimes,used'
p54779
g3
sS'since,decreases,aldosterone'
p54780
g3
sS'causing,a,gritty'
p54781
g9
sS'elimination,of,concomitant'
p54782
g3
sS'hormonal,may,render'
p54783
g9
sS'agents,since,these'
p54784
g9
sS'and,this,strategy'
p54785
g3
sS'is,also,important'
p54786
g3
sS'either,the,safety'
p54787
g3
sS'prevention,and,treatment'
p54788
g3
sS'be,lower,than'
p54789
g3
sS'patients,taking,cyp3a4'
p54790
g3
sS'be,well,controlled'
p54791
g9
sS'mg,of,hydrochloride'
p54792
g9
sS'for,other,interactions'
p54793
g3
sS'clearance,based,upon'
p54794
g9
sS'tcatreatment,in,a'
p54795
g9
sS'effects,were,noted'
p54796
g3
sS'muscle,pain,or'
p54797
g3
sS'of,patients,were'
p54798
g3
sS'effect,on,concentration'
p54799
g3
sS'be,required,to'
p54800
g9
sS'physiological,oral,load'
p54801
g3
sS'menstrual,cycles,and'
p54802
g3
sS'protein,binding,of'
p54803
g3
sS'mg,day,for'
p54804
g3
sS'the,potential,benefit'
p54805
g3
sS'traction,of,metabolized'
p54806
g3
sS'cultures,stimulated,with'
p54807
g3
sS'clinical,evidence,to'
p54808
g3
sS'clearance,mechanisms,similar'
p54809
g3
sS'enhanced,side,effects'
p54810
g9
sS'the,enhanced,secretion'
p54811
g3
sS'mean,serum,slightly'
p54812
g9
sS'minimal,inhibitory,concentrations'
p54813
g3
sS'given,plasma,concentration'
p54814
g3
sS'mainly,via,the'
p54815
g3
sS'and,arthralgia,adverse'
p54816
g9
sS'auc,infinity,auc'
p54817
g3
sS'has,been,safely'
p54818
g3
sS'creatinine,concentration,times'
p54819
g3
sS'profile,seen,with'
p54820
g3
sS'tablet,volume,fewer'
p54821
g3
sS'phenytoin,therapy,a'
p54822
g9
sS'and,a,simultaneous'
p54823
g9
sS'or,efficacy,physicians'
p54824
g3
sS'a,decision,must'
p54825
g3
sS'pharmacology,study,coadministration'
p54826
g9
sS'increases,in,placental'
p54827
g3
sS'is,expected,to'
p54828
g9
sS'cromolyn,sodium,and'
p54829
g3
sS'indicate,that,iressa'
p54830
g9
sS'parietal,cell,activation'
p54831
g3
sS'interaction,within,the'
p54832
g3
sS'have,included,beta-adrenergic'
p54833
g3
sS'the,and,a'
p54834
g3
sS'hypoglycemia,has,been'
p54835
g9
sS'sodium,citrate,potentiate'
p54836
g9
sS'therapy,the,patients'
p54837
g9
sS'during,the,management'
p54838
g9
sS'of,heparinized,patients'
p54839
g9
sS'a,patient,with'
p54840
g9
sS'daily,treatment,with'
p54841
g3
sS'might,occur,with'
p54842
g3
sS'than,one,mechanism'
p54843
g3
sS'contortrostatin-induced,phosphorylation,of'
p54844
g9
sS'in,individualizing,it'
p54845
g3
sS'hepatoxicity,of,in'
p54846
g9
sS'approximately,when,taking'
p54847
g9
sS'microtubules,in,the'
p54848
g3
sS'lipid,metabolism,carbohydrate'
p54849
g3
sS'is,intricately,associated'
p54850
g3
sS'duration,of,the'
p54851
g3
sS'caution,must,be'
p54852
g3
sS'of,erythrocyte,acetylcholinesterase'
p54853
g9
sS'to,rats,in'
p54854
g3
sS'in,the,behavioral'
p54855
g3
sS'with,all,care'
p54856
g3
sS'chop-haart,patients,was'
p54857
g3
sS'there,are,multiple'
p54858
g3
sS'every,hours,two'
p54859
g3
sS'is,an,important'
p54860
g9
sS'in,mediating,stimulus-induced'
p54861
g3
sS'data,demonstrate,that'
p54862
g3
sS'administration,of,the'
p54863
g3
sS'agents,with,and'
p54864
g9
sS'cessation,such,cases'
p54865
g3
sS'and,studies,involving'
p54866
g3
sS'absorption,of,if'
p54867
g9
sS'of,and,increase'
p54868
g9
sS'isoenzyme,system,fentanyl'
p54869
g3
sS'mixing,of,with'
p54870
g9
sS'a,patient,population'
p54871
g3
sS'rate,and,pulsatile'
p54872
g3
sS'probably,has,an'
p54873
g3
sS'from,concomitant,use'
p54874
g3
sS'and,like,mc'
p54875
g3
sS'of,between,the'
p54876
g3
sS'drugs,aliskiren,does'
p54877
g3
sS'heart,association,functional'
p54878
g3
sS'diagnosed,subjects,with'
p54879
g3
sS'reduction,tests,benedict'
p54880
g3
sS'enablex,should,not'
p54881
g9
sS'in,prothrombin,measures'
p54882
g3
sS'of,on,and'
p54883
g3
sS'advil,nuprin,others'
p54884
g3
sS'b23,in,anti-apoptotic'
p54885
g3
sS'serious,drug,toxicity'
p54886
g3
sS'the,phosphohydrolase,from'
p54887
g3
sS'an,interaction,study'
p54888
g3
sS'spontaneous,motility,in'
p54889
g3
sS'doses,of,ergotamine-containing'
p54890
g9
sS'phosphohydrolase,from,the'
p54891
g3
sS'seizure,threshold,should'
p54892
g9
sS'of,in,plasma'
p54893
g9
sS'mg,daily,of'
p54894
g9
sS'im,once,weekly'
p54895
g9
sS'lipolytic,activity,and'
p54896
g9
sS'by,an,effect'
p54897
g3
sS'administration,of,d-penicillamine'
p54898
g3
sS'the,th,generation'
p54899
g3
sS'study,was,to'
p54900
g3
sS'methadone,maintained,patients'
p54901
g9
sS'may,be,inhibited'
p54902
g9
sS'concomitantly,with,citrate'
p54903
g9
sS'randomized,crossover,study'
p54904
g3
sS'another,class,antimicrobial'
p54905
g9
sS'reduced,by,approximately'
p54906
g9
sS'that,conclusively,establish'
p54907
g3
sS'with,orencia,and'
p54908
g9
sS'thiazide,and,reducing'
p54909
g9
sS'using,an,experimental'
p54910
g9
sS'least,five,different'
p54911
g3
sS'a,complication,of'
p54912
g3
sS'give,a,false-positive'
p54913
g3
sS'day,on,days'
p54914
g9
sS'the,absorption,site'
p54915
g3
sS'been,used,concomitantly'
p54916
g3
sS'mg,kg,days'
p54917
g3
sS'drugs,in,healthy'
p54918
g3
sS'an,solution,dried'
p54919
g3
sS'inhibitors,may,increase'
p54920
g3
sS'or,induction,potential'
p54921
g3
sS'for,use,in'
p54922
g9
sS'significant,interaction,has'
p54923
g3
sS'of,botox,and'
p54924
g9
sS'a,stable,prothrombin'
p54925
g3
sS'aed,induces,or'
p54926
g3
sS'day,to,mg'
p54927
g3
sS'or,less,of'
p54928
g3
sS'potentially,serious,cardiovascular'
p54929
g9
sS'of,candesartan,cilexetil'
p54930
g3
sS'patients,the,administration'
p54931
g9
sS'are,potent,inhibitors'
p54932
g9
sS'pharmacokinetic,changes,that'
p54933
g3
sS'rats,did,not'
p54934
g3
sS'treatment,with,potassium-sparing'
p54935
g3
sS'm2,pegasys,equivalent'
p54936
g3
sS'course,of,treatment'
p54937
g3
sS'that,acute,dosing'
p54938
g3
sS'be,mixed,with'
p54939
g3
sS'day,and,decreased'
p54940
g9
sS'if,concomitant,treatment'
p54941
g9
sS'determination,of,the'
p54942
g3
sS'therefore,such,use'
p54943
g9
sS'safely,with,such'
p54944
g3
sS'attention,should,be'
p54945
g3
sS'on,accutane,therapy'
p54946
g3
sS'this,isozyme,including'
p54947
g9
sS'because,the,risk'
p54948
g3
sS'p450,enzymes,responsible'
p54949
g3
sS'on,the,disposition'
p54950
g3
sS'added,were,noted'
p54951
g9
sS'were,conducted,on'
p54952
g3
sS'of,ponstel,and'
p54953
g9
sS'chain,is,important'
p54954
g3
sS'of,other,potentially'
p54955
g3
sS'has,emerged,from'
p54956
g3
sS'concentration,reached,by'
p54957
g3
sS'ulcerative,colitis,a'
p54958
g9
sS'to,result,in'
p54959
g9
sS'with,antifungal,agents'
p54960
g3
sS'unless,clinically,necessary'
p54961
g9
sS'whether,amevive,is'
p54962
g3
sS'ht2a,than,for'
p54963
g3
sS'unknown,slightly,shorter'
p54964
g9
sS'and,were,increased'
p54965
g3
sS'may,be,safely'
p54966
g3
sS'is,eliminated,from'
p54967
g9
sS'are,given,the'
p54968
g3
sS'been,tested,for'
p54969
g3
sS'proportionate,responses,associated'
p54970
g3
sS'symptoms,of,aggression'
p54971
g3
sS'of,hepatic,cyp'
p54972
g3
sS'neutropenia,cells,mm3'
p54973
g3
sS'the,day,regimen'
p54974
g9
sS'underlying,neural,plasticity'
p54975
g3
sS'irreversible,brain,damage'
p54976
g9
sS'agents,has,an'
p54977
g3
sS'given,to,healthy'
p54978
g9
sS'following,the,use'
p54979
g9
sS'with,this,organism'
p54980
g3
sS'those,such,as'
p54981
g3
sS'the,volatile,agent'
p54982
g3
sS'potentially,favorable,effects'
p54983
g3
sS'other,day,for'
p54984
g3
sS'tablet,was,administered'
p54985
g9
sS'day,as,well'
p54986
g3
sS'prevent,symptoms,of'
p54987
g9
sS'enzymes,interactions,with'
p54988
g3
sS'was,hypercholesterolemia,was'
p54989
g3
sS'mean,fold,increase'
p54990
g9
sS'norfloxacin,in,the'
p54991
g9
sS'agranulocytosis,as,seen'
p54992
g3
sS'of,complicated,or'
p54993
g3
sS'personality,characteristics,in'
p54994
g3
sS'administered,concurrently,should'
p54995
g3
sS'to,beta-adrenergic,stimulating'
p54996
g3
sS'substances,including,herbal'
p54997
g3
sS'containing,either,or'
p54998
g3
sS'lie,in,its'
p54999
g3
sS'interaction,of,procrit'
p55000
g3
sS'levels,have,been'
p55001
g3
sS'and,these,data'
p55002
g3
sS'to,release,from'
p55003
g9
sS'nelfinavir,is,an'
p55004
g3
sS'or,the,simultaneous'
p55005
g3
sS'penthrane,has,been'
p55006
g9
sS'furosemide,clinical,studies'
p55007
g9
sS'produced,a,fold'
p55008
g9
sS'mcg,per,day'
p55009
g3
sS'glucose,levels,of'
p55010
g3
sS'albumin,binding,sites'
p55011
g9
sS'with,severe,short'
p55012
g9
sS'toxicity,in,a'
p55013
g9
sS'preterm,neonates,is'
p55014
g3
sS'when,patients,receive'
p55015
g3
sS'depressive,symptoms,but'
p55016
g3
sS'of,to,less'
p55017
g3
sS'aldehyde,oxidase,enzyme'
p55018
g3
sS'nondepolarizing,relaxants,is'
p55019
g3
sS'the,gastrointestinal,tract'
p55020
g9
sS'study,conducted,in'
p55021
g9
sS'found,between,the'
p55022
g3
sS'with,the,intravenous'
p55023
g3
sS'outweigh,the,increased'
p55024
g9
sS'which,has,not'
p55025
g9
sS'data,indicated,that'
p55026
g3
sS'some,molecular,mechanisms'
p55027
g3
sS'day,or,in'
p55028
g3
sS'determinant,of,bioavailability'
p55029
g9
sS'some,further,antihypertensive'
p55030
g9
sS'with,enzyme,based'
p55031
g3
sS'h,did,not'
p55032
g3
sS'and,facilitate,and'
p55033
g3
sS'no,formal,interaction'
p55034
g3
sS'when,romazicon,was'
p55035
g3
sS'platelets,plays,an'
p55036
g3
sS'and,memory,that'
p55037
g3
sS'there,is,limited'
p55038
g3
sS'sustained,increases,in'
p55039
g9
sS'of,metabolism,may'
p55040
g3
sS'discontinued,at,least'
p55041
g9
sS'the,difference,was'
p55042
g3
sS'amount,of,required'
p55043
g9
sS'occurs,with,ganglionic'
p55044
g3
sS'advocated,on,the'
p55045
g3
sS'cyp3a4,inhibitors,result'
p55046
g9
sS'm,resulted,in'
p55047
g3
sS'received,angiomax,in'
p55048
g3
sS'for,bacterial,infection'
p55049
g3
sS'cimetidine,does,not'
p55050
g3
sS'patients,with,altered'
p55051
g3
sS'of,difluoroacetone,mg'
p55052
g3
sS'these,interactions,has'
p55053
g3
sS'do,not,require'
p55054
g3
sS'regimen,i,and'
p55055
g3
sS'c9,by,see'
p55056
g9
sS'for,a,nondrug'
p55057
g3
sS'occur,physicians,should'
p55058
g9
sS'naproxen,coadministration,n'
p55059
g9
sS'increased,all,the'
p55060
g3
sS'the,elevated,plasma'
p55061
g3
sS'acid,and,nor'
p55062
g3
sS'glycemic,control,in'
p55063
g3
sS'not,inhibitory,towards'
p55064
g3
sS'which,induce,cytochrome'
p55065
g9
sS'is,one,reported'
p55066
g9
sS'that,may,react'
p55067
g9
sS'level,of,the'
p55068
g3
sS'in,the,interpretation'
p55069
g3
sS'reported,itraconazole,co-administration'
p55070
g3
sS'catechol-o,methyltransferase,comt'
p55071
g3
sS'of,of,patients'
p55072
g3
sS'to,the,efficacy'
p55073
g3
sS'with,was,found'
p55074
g9
sS'thus,patients,receiving'
p55075
g9
sS'could,be,involved'
p55076
g3
sS'elevations,in,prothrombin'
p55077
g3
sS'blockers,may,exacerbate'
p55078
g9
sS'oral,nicotinic,acid'
p55079
g3
sS'supplement,containing,mg'
p55080
g9
sS'albendazole,sulfoxide,concentrations'
p55081
g9
sS'the,major,subtype'
p55082
g3
sS'of,a,strong'
p55083
g9
sS'radio-iodine,uptake,producing'
p55084
g3
sS'increased,total,circulating'
p55085
g3
sS'appear,to,have'
p55086
g3
sS'in,adverse,reactions'
p55087
g3
sS'of,or,similar'
p55088
g9
sS'the,reduced,absorption'
p55089
g3
sS'cholecystokinin--of,h-spiroperidol,binding'
p55090
g3
sS'labeling,index,of'
p55091
g3
sS'the,patient,population'
p55092
g3
sS'of,compared,with'
p55093
g3
sS'when,therapeutic,concentrations'
p55094
g3
sS'enzymes,primarily,cyp3a4'
p55095
g3
sS'workers,involved,in'
p55096
g3
sS'some,of,agents'
p55097
g3
sS'titrated,to,achieve'
p55098
g3
sS'may,play,a'
p55099
g3
sS'maximal,plasma,concentrations'
p55100
g9
sS'extrapyramidal,symptoms,leukocytosis'
p55101
g9
sS'reports,describe,modest'
p55102
g9
sS'prolong,adverse,effects'
p55103
g9
sS'inhibit,alfenta,clearance'
p55104
g9
sS'as,are,likely'
p55105
g9
sS'healthy,volunteers,of'
p55106
g9
sS'that,can,be'
p55107
g9
sS'is,now,clear'
p55108
g3
sS'as,is,a'
p55109
g3
sS'clearance,or,with'
p55110
g9
sS'use,of,revia'
p55111
g9
sS'max,of,was'
p55112
g9
sS'weekly,during,five'
p55113
g3
sS'healthy,volunteers,or'
p55114
g3
sS'cmax,of,by'
p55115
g9
sS'may,cause,severe'
p55116
g9
sS'higher,virologic,response'
p55117
g3
sS'together,caution,should'
p55118
g3
sS'overallactivity,against,this'
p55119
g3
sS'complete,across,all'
p55120
g3
sS'exposure,in,rodent'
p55121
g3
sS'pharmacokinetics,have,not'
p55122
g3
sS'interactions,were,observed'
p55123
g3
sS'on,aliskiren,based'
p55124
g3
sS'in,the,groups'
p55125
g9
sS'of,metabolites,in'
p55126
g3
sS'changes,in,clotting'
p55127
g3
sS'tract,obstruction,and'
p55128
g3
sS'to,possibly,increase'
p55129
g9
sS'cause,a,false'
p55130
g3
sS'comparison,of,the'
p55131
g3
sS'laboratory,test,or'
p55132
g3
sS'increased,angiotensinogen,renin'
p55133
g3
sS'positive,and,constructive'
p55134
g3
sS'of,clearance,or'
p55135
g9
sS'gleevec,inhibits,the'
p55136
g3
sS'ergot,alkaloids,is'
p55137
g9
sS'young,healthy,male'
p55138
g3
sS'with,invirase,and'
p55139
g3
sS'in,levels,to'
p55140
g9
sS'in,a,fold'
p55141
g9
sS'ratios,confidence,interval'
p55142
g3
sS'the,actions,and'
p55143
g3
sS'or,azoles,were'
p55144
g3
sS'of,corneal,lesions'
p55145
g9
sS'advisable,to,be'
p55146
g3
sS'coadministered,with,tikosyn'
p55147
g9
sS'be,unlikely,that'
p55148
g3
sS'of,the,long'
p55149
g3
sS'dose,range,are'
p55150
g3
sS'its,metabolites,oxo-desethylzaleplon'
p55151
g3
sS'be,avoided,when'
p55152
g9
sS'increases,extracellular,levels'
p55153
g3
sS'urate,are,also'
p55154
g9
sS'day,groups,pd2'
p55155
g9
sS'olanzapine,a,thienobenzodiazepine'
p55156
g3
sS'modest,dysphoria,and'
p55157
g3
sS'been,demonstrated,to'
p55158
g9
sS'altering,activity,in'
p55159
g3
sS'included,post,myocardial'
p55160
g3
sS'also,to,be'
p55161
g3
sS'reactions,at,a'
p55162
g3
sS'p,o,induced'
p55163
g9
sS'are,involved,in'
p55164
g3
sS'a,different,route'
p55165
g3
sS'have,suggested,that'
p55166
g3
sS'observed,in,nephrosis'
p55167
g3
sS'variety,of,infections'
p55168
g3
sS'clinical,evidence,in'
p55169
g3
sS'pregnancy,occurs,while'
p55170
g3
sS'reactive,to,repeated'
p55171
g3
sS'receiving,for,approximately'
p55172
g3
sS'hepatic,microsomal,ethoxycoumarine'
p55173
g3
sS'be,required,with'
p55174
g3
sS'risk,of,toxic'
p55175
g3
sS'not,produce,any'
p55176
g3
sS'did,not,alter'
p55177
g3
sS'phosphate-binding,agents,must'
p55178
g3
sS'aerosol,of,the'
p55179
g3
sS'and,therefore,such'
p55180
g9
sS'of,microsomal,drug'
p55181
g9
sS'some,individuals,receiving'
p55182
g9
sS'blood,glucose,when'
p55183
g3
sS'as,the,interaction'
p55184
g3
sS'which,were,considered'
p55185
g9
sS'to,be,considered'
p55186
g3
sS'tachycardia,in,the'
p55187
g9
sS'chronically,had,no'
p55188
g9
sS'not,change,fasting'
p55189
g3
sS'directly,on,the'
p55190
g9
sS'although,the,occurrence'
p55191
g9
sS'and,terminal,half-life'
p55192
g9
sS'trials,in,patients'
p55193
g9
sS'suppression,by,and'
p55194
g9
sS'events,occurred,with'
p55195
g3
sS'organisms,and,oral'
p55196
g3
sS'an,unsatisfactory,lipid'
p55197
g9
sS'of,taxol,may'
p55198
g3
sS'adl,prevents,morphine-induced'
p55199
g9
sS'and,potassium-sparing,on'
p55200
g9
sS'placebo,coadministered,with'
p55201
g3
sS'case,summary,a'
p55202
g3
sS'broad-spectrum,antibiotics-broad,spectrum'
p55203
g3
sS'produced,mean,additional'
p55204
g9
sS'and,concomitantly,may'
p55205
g9
sS'from,concomitant,therapy'
p55206
g9
sS'the,same,areas'
p55207
g3
sS'in,male,wistar'
p55208
g3
sS'although,overall,exposure'
p55209
g9
sS'day,proved,to'
p55210
g3
sS'chlorprothixene,may,increase'
p55211
g9
sS'hypertensive,response,seen'
p55212
g9
sS'the,seminiferous,tubules'
p55213
g3
sS'lodine,should,not'
p55214
g3
sS'medication,must,be'
p55215
g9
sS'prior,to,dosing'
p55216
g9
sS'of,action,exists'
p55217
g3
sS'the,usual,daily'
p55218
g9
sS'secretory,diarrhea,in'
p55219
g3
sS'coexisting,in,the'
p55220
g3
sS'materials,amino,acids'
p55221
g3
sS'b12,deficiency,is'
p55222
g3
sS'assessment,of,in'
p55223
g3
sS'usp,or,initiating'
p55224
g9
sS'were,equivocally,higher'
p55225
g9
sS'not,primarily,metabolized'
p55226
g9
sS'medications,agents,such'
p55227
g3
sS'also,used,some'
p55228
g3
sS'of,there,are'
p55229
g3
sS'with,hormonal,since'
p55230
g3
sS'of,q12h,for'
p55231
g9
sS'of,loop,potassium-'
p55232
g9
sS'source,or,preparations'
p55233
g3
sS'be,reduced,in'
p55234
g3
sS'responding,for,a'
p55235
g3
sS'of,receptors,to'
p55236
g3
sS'be,reduced,if'
p55237
g9
sS'macrolide,immunosuppressant,metabolized'
p55238
g3
sS'alcohol,g,kg'
p55239
g3
sS'of,were,also'
p55240
g3
sS'are,applying,panretin'
p55241
g9
sS'oral,dose,of'
p55242
g3
sS'hormonal,ortho-novum,produced'
p55243
g9
sS'predispose,a,patient'
p55244
g3
sS'produced,by,any'
p55245
g9
sS'oral,product,in'
p55246
g3
sS'relevant,drug-drug,interactions'
p55247
g3
sS'resulting,in,an'
p55248
g9
sS'are,reduced,by'
p55249
g9
sS'cmax,when,a'
p55250
g9
sS'be,closely,observed'
p55251
g3
sS'gradually,returned,to'
p55252
g3
sS'with,each,successive'
p55253
g3
sS'later,also,produces'
p55254
g9
sS'of,non-steroidal,concomitantly'
p55255
g9
sS'can,be,safely'
p55256
g3
sS'is,the,only'
p55257
g3
sS'prostaglandin,synthetase,inhibitors'
p55258
g3
sS'or,other,potent'
p55259
g9
sS'reveal,other,affected'
p55260
g3
sS'in,lipid,levels'
p55261
g9
sS'and,experimental,animals'
p55262
g3
sS'transplant,patients,suffering'
p55263
g9
sS'demonstrated,in,view'
p55264
g3
sS'a,mg,vardenafil'
p55265
g9
sS'interaction,appears,to'
p55266
g3
sS'steady-state,pharmacokinetics,of'
p55267
g3
sS'added,to,their'
p55268
g3
sS'that,alter,gastrointestinal'
p55269
g9
sS'pill,such,as'
p55270
g3
sS'insulin,or,oral'
p55271
g9
sS'medications,patients,should'
p55272
g9
sS'recommended,dosage,one'
p55273
g3
sS'test,interactions,with'
p55274
g3
sS'is,unknown,at'
p55275
g3
sS'tolerated,but,available'
p55276
g3
sS'of,dyspnea,palpitation'
p55277
g3
sS'or,without,other'
p55278
g9
sS'to,produce,or'
p55279
g3
sS'a,blockade,by'
p55280
g9
sS'ototoxicity,were,not'
p55281
g3
sS'not,be,reflective'
p55282
g3
sS'dependence,on,application'
p55283
g3
sS'minimizes,this,decrease'
p55284
g9
sS'in,cpk,were'
p55285
g3
sS'of,sustained-release,calan'
p55286
g9
sS'magnesium-aluminum,hydroxide,cerivastatin'
p55287
g3
sS'patients,who,successfully'
p55288
g3
sS'of,the,experiment'
p55289
g3
sS'and,a4,ic50'
p55290
g3
sS'agonists,concomitant,use'
p55291
g9
sS'activity,of,by'
p55292
g9
sS'taking,the,effect'
p55293
g9
sS'antagonist,with,orencia'
p55294
g9
sS'of,nm,absorbing'
p55295
g3
sS'on,the,anti-platelet'
p55296
g3
sS'blood,plasma,glucose'
p55297
g3
sS'shown,to,elevate'
p55298
g9
sS'factors,in,concert'
p55299
g3
sS'of,a,pacemaker'
p55300
g3
sS'than,suggest,a'
p55301
g9
sS'abilify,is,taken'
p55302
g9
sS'complex,anions,antithyroid'
p55303
g3
sS'in,arthritic,patients'
p55304
g3
sS'with,formulations,containing'
p55305
g9
sS'on,cyp1a2,a6'
p55306
g3
sS'inducers,may,decrease'
p55307
g3
sS'ml,when,mg'
p55308
g3
sS'concentrations,appeared,to'
p55309
g3
sS'with,depen,cuprimine'
p55310
g9
sS'caused,by,increased'
p55311
g9
sS'medical,practice,dictates'
p55312
g9
sS'combination,with,or'
p55313
g3
sS'erythromycin,use,in'
p55314
g9
sS'a,trend,to'
p55315
g3
sS'significantly,reduced,the'
p55316
g9
sS'been,implicated,in'
p55317
g9
sS'a,radioactive,derivative'
p55318
g3
sS'polymorphic,p450,d6'
p55319
g3
sS'concluded,that,although'
p55320
g9
sS'given,to,electrolyte'
p55321
g3
sS'patients,may,induce'
p55322
g9
sS'that,lower,seizure'
p55323
g9
sS'time,was,observed'
p55324
g3
sS'main,non-infection,unwanted'
p55325
g3
sS'reduced,by,and'
p55326
g3
sS'inhibition,of,hepatic'
p55327
g9
sS'initiated,or,discontinued'
p55328
g3
sS'on,these,data'
p55329
g9
sS'be,stopped,during'
p55330
g9
sS'in,screening,patients'
p55331
g3
sS'muscle,to,m'
p55332
g9
sS'seven,days,prior'
p55333
g3
sS'steady-state,cmin,to'
p55334
g9
sS'the,purification,of'
p55335
g3
sS'were,subsequently,found'
p55336
g3
sS'slow,phasic,contraction'
p55337
g3
sS'decreased,active,metabolite'
p55338
g9
sS'of,the,interaction'
p55339
g3
sS'of,ml,of'
p55340
g3
sS'is,to,decrease'
p55341
g9
sS'single,daily,oral'
p55342
g3
sS'ace,inhibitors,may'
p55343
g9
sS'with,hours,before'
p55344
g9
sS'of,a,physician'
p55345
g9
sS'involving,even,though'
p55346
g3
sS'ras-transformed,ras-3t3,cells'
p55347
g3
sS'mmol,l,from'
p55348
g3
sS'oral,and,vitamin'
p55349
g9
sS'combination,of,or'
p55350
g3
sS'a,displays,both'
p55351
g3
sS'drugs,associated,with'
p55352
g3
sS'the,active,triphosphate'
p55353
g3
sS'pharmacokinetic,variability,for'
p55354
g3
sS'volunteers,suggests,that'
p55355
g9
sS'values,for,any'
p55356
g3
sS'inducer,such,as'
p55357
g3
sS'excretion,was,decreased'
p55358
g3
sS'hormone,levels,levodopa'
p55359
g3
sS'of,this,combination'
p55360
g3
sS'evening,meal,would'
p55361
g3
sS'have,no,significant'
p55362
g3
sS'mg,of,vioxx'
p55363
g3
sS'can,be,carried'
p55364
g3
sS'administration,of,in'
p55365
g3
sS'of,uptake-1,in'
p55366
g3
sS'results,together,with'
p55367
g3
sS'administration,of,it'
p55368
g3
sS'effects,of,coadministered'
p55369
g3
sS'tumour,total,peak'
p55370
g3
sS'increase,the,blood'
p55371
g3
sS'infusion,than,with'
p55372
g3
sS'diagnostic,treatment,and'
p55373
g3
sS'among,patients,concurrently'
p55374
g9
sS'many,other,medicines'
p55375
g3
sS'subjects,aged,or'
p55376
g3
sS'patient,is,recommended'
p55377
g9
sS'which,directly,affect'
p55378
g3
sS'influence,the,percentage'
p55379
g9
sS'with,since,these'
p55380
g9
sS'occur,in,the'
p55381
g3
sS'narrower,spectrum,of'
p55382
g3
sS'monitored,when,initiating'
p55383
g9
sS'of,regular,users'
p55384
g3
sS'the,blood,level'
p55385
g3
sS'tbg,may,also'
p55386
g3
sS'metabolized,at,least'
p55387
g3
sS'may,be,potentiated'
p55388
g9
sS'results,bombesin,significantly'
p55389
g3
sS'control,values,for'
p55390
g3
sS'because,binds,bile'
p55391
g3
sS'given,with,agents'
p55392
g3
sS'l-histidine,via,its'
p55393
g9
sS'growth,to,those'
p55394
g3
sS'be,extrapolated,to'
p55395
g3
sS'later,by,gradually'
p55396
g3
sS'from,co-therapy,an'
p55397
g3
sS'performed,if,the'
p55398
g3
sS'are,frequently,complex'
p55399
g3
sS'the,mean,value'
p55400
g3
sS'of,these,functions'
p55401
g3
sS'or,lead,to'
p55402
g9
sS'treat,hypertension,patients'
p55403
g3
sS'other,carbonic,anhydrase'
p55404
g3
sS'and,control,rats'
p55405
g3
sS'potentially,clinically,significant'
p55406
g3
sS'in,auc,and'
p55407
g9
sS'urinary,catecholamine,levels'
p55408
g3
sS'situation,special,patient'
p55409
g3
sS'that,may,induce'
p55410
g9
sS'hydrochloride,is,an'
p55411
g3
sS'of,containing,or'
p55412
g9
sS'abrasive,soaps,and'
p55413
g3
sS'noted,a,massive'
p55414
g3
sS'for,increased,lipid'
p55415
g3
sS'therefore,potentiate,the'
p55416
g3
sS'geometric,mean,confidence'
p55417
g9
sS'received,the,recommended'
p55418
g9
sS'of,ellence,after'
p55419
g3
sS'this,reason,the'
p55420
g9
sS'calorimetry,differential,thermal'
p55421
g3
sS'beta,blockers,patients'
p55422
g3
sS'effects,especially,with'
p55423
g3
sS'hydroxide,does,not'
p55424
g3
sS'those,patients,on'
p55425
g9
sS'therapy,depends,not'
p55426
g3
sS'could,create,possible'
p55427
g3
sS'be,taken,on'
p55428
g3
sS'treated,with,pegasys'
p55429
g3
sS'elevations,of,cholesterol'
p55430
g9
sS'average,and,when'
p55431
g9
sS'to,induce,cyp1a2'
p55432
g3
sS'egf-,or,insulin-induced'
p55433
g9
sS'herb,interactions,food'
p55434
g9
sS'tumor,cells,by'
p55435
g3
sS'modest,elevations,less'
p55436
g9
sS'rarely,reported,due'
p55437
g9
sS'produced,in,utero'
p55438
g3
sS'supplement,food,or'
p55439
g3
sS'particularly,when,bactericidal'
p55440
g3
sS'stimulatory,effects,of'
p55441
g9
sS'these,results,confirm'
p55442
g3
sS'radioactive,derivative,of'
p55443
g3
sS'upon,pcp,induced'
p55444
g3
sS'as,motrin,advil'
p55445
g3
sS'including,have,been'
p55446
g9
sS'avoid,concomitant,use'
p55447
g3
sS'decoy,and,inducible'
p55448
g3
sS'antimicrobial,activity,of'
p55449
g3
sS'of,crohn,s'
p55450
g3
sS'this,allows,to'
p55451
g9
sS'shown,in,rats'
p55452
g9
sS'the,toxic,product'
p55453
g3
sS'site,reactions,including'
p55454
g3
sS'interact,with,amphotericin'
p55455
g9
sS'or,other,agents'
p55456
g9
sS'is,contemplated,the'
p55457
g3
sS'other,products,oral'
p55458
g3
sS'drinking,may,worsen'
p55459
g9
sS'listed,below,have'
p55460
g3
sS'of,the,therapeutic'
p55461
g9
sS'these,agents,contribute'
p55462
g3
sS'efficacy,of,in'
p55463
g3
sS'increased,when,coadministered'
p55464
g9
sS'shortened,in,patients'
p55465
g9
sS'p450iid6,may,require'
p55466
g3
sS'with,topical,glaucoma'
p55467
g9
sS'the,treatments,to'
p55468
g3
sS'p450,a4,isoenzyme'
p55469
g3
sS'weaken,or,antagonise'
p55470
g3
sS'have,involved,either'
p55471
g3
sS'of,potentiating,cns'
p55472
g9
sS'of,corticosteroid-binding,globulin'
p55473
g3
sS'in,situ,ligated'
p55474
g3
sS'pharmacist,can,give'
p55475
g3
sS'an,alteration,in'
p55476
g3
sS'of,felbatol,given'
p55477
g9
sS'binding,globulin,tbg'
p55478
g3
sS'exercised,if,and'
p55479
g9
sS'until,therapy,is'
p55480
g9
sS'seriraline,and,inhibit'
p55481
g3
sS'in,separate,randomized'
p55482
g3
sS'the,increased,plasma'
p55483
g3
sS'indomethacin,blunts,the'
p55484
g9
sS'developed,as,a'
p55485
g3
sS'sudden,cardiac,deaths'
p55486
g3
sS'by,cyp3a4,substrates'
p55487
g3
sS'than,thrombin,or'
p55488
g3
sS'didrex,should,not'
p55489
g9
sS'metabolite,may,be'
p55490
g9
sS'of,nanm,nanm'
p55491
g3
sS'prothrombin,time,monitored'
p55492
g9
sS'be,determined,before'
p55493
g9
sS'some,cases,where'
p55494
g3
sS'and,other,antiepileptic'
p55495
g3
sS'on,plasma,has'
p55496
g9
sS'of,the,hepatic'
p55497
g3
sS'to,hypertensive,patients'
p55498
g3
sS'and,increased,plasma'
p55499
g9
sS'be,taken,into'
p55500
g3
sS'binding,sites,for'
p55501
g3
sS'carried,out,and'
p55502
g3
sS'demonstrated,that,co-administration'
p55503
g9
sS'levels,has,been'
p55504
g9
sS'gi,bleeding,are'
p55505
g9
sS'always,predictive,of'
p55506
g3
sS'administration,of,did'
p55507
g3
sS'inspra,and,nsaids'
p55508
g9
sS'be,avoided,by'
p55509
g9
sS'elapse,before,these'
p55510
g3
sS'increased,and,because'
p55511
g9
sS'responses,to,were'
p55512
g3
sS'higher,than,recommended'
p55513
g9
sS'patch-clamp,whole-cell,recording'
p55514
g3
sS'as,a,method'
p55515
g3
sS'conducted,between,and'
p55516
g9
sS'have,shown,casodex'
p55517
g9
sS'blocking,agents,coadministration'
p55518
g3
sS'studies,designed,to'
p55519
g3
sS'affect,hepatic,microsomal'
p55520
g3
sS'digitalis,glycosides,therapeutic'
p55521
g3
sS'diastolic,or,systolic'
p55522
g3
sS'anticholinergics,concurrent,administration'
p55523
g9
sS'to,provoke,convulsions'
p55524
g3
sS'lysate,of,serum-deprived'
p55525
g3
sS'monitoring,for,toxicity'
p55526
g9
sS'iv,was,given'
p55527
g3
sS'vitro,evaluation,of'
p55528
g3
sS'of,mevacor,in'
p55529
g3
sS'to,the,resolution'
p55530
g9
sS'including,were,reported'
p55531
g9
sS'after,withdrawal,the'
p55532
g3
sS'experience,of,coma'
p55533
g9
sS'into,patients,receiving'
p55534
g3
sS'bid,a,potent'
p55535
g9
sS'another,study,toradoliv'
p55536
g3
sS'b,were,more'
p55537
g3
sS'of,lh,and'
p55538
g3
sS'the,main,hemostatic'
p55539
g9
sS'beta,blocker,should'
p55540
g9
sS'already,receiving,prothrombin'
p55541
g9
sS'evidence,of,ovulation'
p55542
g3
sS'wild-type,alleles,cyp2c9'
p55543
g3
sS'prinivil,is,administered'
p55544
g9
sS'fraction,containing,membranes'
p55545
g3
sS'the,th,week'
p55546
g3
sS'receive,intermittent,hemodialysis'
p55547
g3
sS'studies,the,incidence'
p55548
g3
sS'a,similar,interaction'
p55549
g3
sS'long,periods,of'
p55550
g3
sS'dose,of,to'
p55551
g3
sS'pump,inhibitors,in'
p55552
g9
sS'before,after,or'
p55553
g3
sS'conjunction,with,standard'
p55554
g3
sS'of,colestid,tablets'
p55555
g3
sS'study,suggest,that'
p55556
g3
sS'decreased,the,rate'
p55557
g9
sS'of,deficit,i'
p55558
g3
sS'possible,atrioventricular,conduction'
p55559
g9
sS'maintain,twitch,for'
p55560
g3
sS'suggesting,that,is'
p55561
g3
sS'cyp1a2,weak,b6'
p55562
g3
sS'of,liquid,did'
p55563
g3
sS'however,coadministration,of'
p55564
g3
sS'and,as,much'
p55565
g9
sS'sample,size,is'
p55566
g3
sS'or,less,specific'
p55567
g3
sS'totally,atoxic,since'
p55568
g3
sS'these,inhibiting,as'
p55569
g3
sS'enzymes,a2,a6'
p55570
g3
sS'the,medium,blocked'
p55571
g3
sS'clearance,rate,was'
p55572
g3
sS'in,a,dose'
p55573
g9
sS'tend,to,produce'
p55574
g3
sS'risk,of,myopathy'
p55575
g3
sS'of,m,at'
p55576
g3
sS'above,or,herbs'
p55577
g3
sS'emboli,rises,that'
p55578
g3
sS'memory,systems,at'
p55579
g3
sS'both,instances,however'
p55580
g3
sS'toxic,effect,in'
p55581
g9
sS'approximately,msec,compared'
p55582
g9
sS'ml,and,maximum'
p55583
g9
sS'and,hepatic,enzyme'
p55584
g3
sS'as,poor,metabolizers'
p55585
g3
sS'with,other,cns-active'
p55586
g9
sS'becoming,increasingly,popular'
p55587
g3
sS'lexapro,did,not'
p55588
g9
sS'intravenous,prodrug,form'
p55589
g3
sS'invirase,or,to'
p55590
g3
sS'potentially,important,effects'
p55591
g3
sS'the,toxicity,and'
p55592
g3
sS'marrow,toxicity,of'
p55593
g3
sS'acetylsalicylic,acid,a-blockers'
p55594
g3
sS'be,required,when'
p55595
g3
sS'antimuscarinic,effects,and'
p55596
g9
sS'this,interaction,with'
p55597
g3
sS'lymphocyte,counts,related'
p55598
g3
sS'resulting,in,vitamin'
p55599
g3
sS'significantly,impaired,by'
p55600
g3
sS'be,inhibited,by'
p55601
g9
sS'an,increased,clearance'
p55602
g3
sS'recommended,dose,based'
p55603
g3
sS'concentration,due,to'
p55604
g9
sS'was,only,significantly'
p55605
g3
sS'contraceptive,agents,ethinyl'
p55606
g3
sS'protein-bound,such,as'
p55607
g3
sS'thus,agents,likely'
p55608
g3
sS'the,potentiating,action'
p55609
g9
sS'interactions,with,beta-blockers'
p55610
g9
sS'metabolized,by,cyp2c9'
p55611
g9
sS'in,humans,remain'
p55612
g3
sS'be,lower,in'
p55613
g3
sS'pharmaco-dynamic,effects,makes'
p55614
g3
sS'cause,k,deficiency'
p55615
g3
sS'increases,gastrointestinal,motility'
p55616
g9
sS'trisenox,and,other'
p55617
g3
sS'system,have,not'
p55618
g3
sS'administration,of,anafranil'
p55619
g9
sS'including,other,and'
p55620
g9
sS'situations,when,concurrent'
p55621
g3
sS'inhibit,cyp,enzymes'
p55622
g3
sS'sodium,acid,etc'
p55623
g9
sS'have,confirmed,these'
p55624
g3
sS'intracellular,resistance,to'
p55625
g3
sS'to,values,similar'
p55626
g3
sS'in,rabbits,dosed'
p55627
g3
sS'effects,particularly,have'
p55628
g9
sS'to,mg,led'
p55629
g9
sS'known,inhibitor,of'
p55630
g9
sS'blockers,adrenergic,blockers'
p55631
g9
sS'worsening,renal,failure'
p55632
g3
sS'eg,esophageal,motility'
p55633
g3
sS'substrate,a,moderate'
p55634
g3
sS'level,of,when'
p55635
g9
sS'are,concurrently,being'
p55636
g9
sS'efflux,transporter,p-glycoprotein'
p55637
g3
sS'noted,during,any'
p55638
g3
sS'when,gleevec,is'
p55639
g9
sS'administered,following,a'
p55640
g9
sS'system,ketoconazole,tablets'
p55641
g9
sS'possible,the,starting'
p55642
g3
sS'maximize,benefits,and'
p55643
g3
sS'grepafloxacin,like,other'
p55644
g9
sS'medication,patients,want'
p55645
g3
sS'ancobon,does,not'
p55646
g3
sS'quality,of,life'
p55647
g3
sS'that,antagonized,evidently'
p55648
g9
sS'maalox,coadministration,of'
p55649
g3
sS'gabitril,carbamazepine,population'
p55650
g9
sS'is,obtained,by'
p55651
g3
sS'the,iatrogenic,alteration'
p55652
g3
sS'aldehyde,oxidase,the'
p55653
g3
sS'signs,of,atropinization'
p55654
g9
sS'agents,with,can'
p55655
g3
sS'the,nrtis,are'
p55656
g3
sS'ampicillin,amoxicillin,an'
p55657
g9
sS'healthy,subjects,clearance'
p55658
g3
sS'seen,with,administration'
p55659
g3
sS'and,may,decrease'
p55660
g9
sS'nondepolarizing,blocking,action'
p55661
g3
sS'active,triphosphate,metabolite'
p55662
g3
sS'particular,sulphydryl-containing,amino'
p55663
g3
sS'not,performed,doses'
p55664
g3
sS'begin,taking,or'
p55665
g9
sS'by,minimal,inhibitory'
p55666
g3
sS'as,topical,injectable'
p55667
g3
sS'may,require,adjustment'
p55668
g3
sS'this,interaction,or'
p55669
g9
sS'can,combine,to'
p55670
g9
sS'aid,sleep,drowsiness-causing'
p55671
g3
sS'studied,than,the'
p55672
g3
sS'other,eg,have'
p55673
g3
sS'effectiveness,of,these'
p55674
g9
sS'on,or,other'
p55675
g9
sS'significant,decrease,of'
p55676
g3
sS'iodine,or,excess'
p55677
g9
sS'corrective,measures,for'
p55678
g3
sS'explain,the,increase'
p55679
g9
sS'a,fixed,g'
p55680
g3
sS'fold,in,healthy'
p55681
g9
sS'use,of,l-glutamine'
p55682
g9
sS'reduced,efficacy,should'
p55683
g3
sS'fulvestrant,was,associated'
p55684
g3
sS'level,is,an'
p55685
g3
sS'of,the,protective'
p55686
g9
sS'effect,of,compounds'
p55687
g9
sS'barrier,form,of'
p55688
g3
sS'occurred,in,patients'
p55689
g9
sS'function,for,normal'
p55690
g3
sS'and,no,drug-specific'
p55691
g3
sS'respectively,and,in'
p55692
g9
sS'half-life,of,by'
p55693
g9
sS'to,mg,qd'
p55694
g9
sS'been,reported,that'
p55695
g9
sS'the,precipitate,is'
p55696
g3
sS'inducers,drugs,that'
p55697
g3
sS'been,studied,as'
p55698
g3
sS'inhibit,the,in'
p55699
g9
sS'or,two,capsules'
p55700
g3
sS'transport-related,effects,such'
p55701
g9
sS'schizophrenic,patients,treated'
p55702
g9
sS'lodine,capsules,and'
p55703
g9
sS'cyp2d6,substrate,the'
p55704
g9
sS'to,g,hr'
p55705
g3
sS'more,severe,reaction'
p55706
g3
sS'for,any,excessive'
p55707
g9
sS'that,gets,absorbed'
p55708
g9
sS'demonstrated,no,effect'
p55709
g3
sS'diabetic,patients,under'
p55710
g3
sS'elevations,in,the'
p55711
g9
sS'deethylase,in,male'
p55712
g3
sS'at,but,not'
p55713
g3
sS'drug-drug,interaction,study'
p55714
g9
sS'may,activate,the'
p55715
g3
sS'for,the,purpose'
p55716
g3
sS'cases,and,this'
p55717
g3
sS'concentration,of,preparations'
p55718
g9
sS'recovery,time,may'
p55719
g9
sS'as,formulations,containing'
p55720
g9
sS'and,half-life,multiple-dose'
p55721
g3
sS'properties,of,rat'
p55722
g3
sS'cyp,p450,isoforms'
p55723
g3
sS'together,may,increase'
p55724
g9
sS'on,the,second'
p55725
g9
sS'patients,on,has'
p55726
g9
sS'showed,higher,concentrations'
p55727
g9
sS'approximately,a,fold'
p55728
g9
sS'concentrations,in,vitro'
p55729
g3
sS'when,given,with'
p55730
g9
sS'topical,medications,applied'
p55731
g3
sS'table,additional,clinical'
p55732
g3
sS'mg,in,men'
p55733
g3
sS'significant,interactions,would'
p55734
g3
sS'and,are,sequestered'
p55735
g3
sS'preparations,and,the'
p55736
g3
sS'steady,state,vioxx'
p55737
g3
sS'reduction,of,cerubidine'
p55738
g3
sS'studies,have,suggested'
p55739
g3
sS'the,reduction,of'
p55740
g3
sS'company,division,of'
p55741
g3
sS'obtained,from,controlled'
p55742
g3
sS'damage,has,occurred'
p55743
g9
sS'dosage,adjustment,for'
p55744
g3
sS'induces,the,cytochrome'
p55745
g3
sS'is,evidence,that'
p55746
g3
sS'blood,mononuclear,cells'
p55747
g9
sS'acetylsalicylic,acid,temporarily'
p55748
g9
sS'an,agent,with'
p55749
g9
sS'considered,when,changing'
p55750
g3
sS'or,when,new'
p55751
g3
sS'in,the,first'
p55752
g9
sS'of,these,if'
p55753
g3
sS'hydroxylation,of,by'
p55754
g9
sS'of,having,a'
p55755
g3
sS'of,these,in'
p55756
g3
sS'effects,were,neither'
p55757
g9
sS'of,these,is'
p55758
g3
sS'of,strong,cyp'
p55759
g3
sS'vitamin,d,analogues'
p55760
g9
sS'each,administered,alone'
p55761
g9
sS'of,atropinization,flushing'
p55762
g9
sS'mg,l,while'
p55763
g3
sS'of,amicar,necessary'
p55764
g3
sS'extravasation,reactions,is'
p55765
g3
sS'caused,the,release'
p55766
g3
sS'day,until,the'
p55767
g3
sS'of,betaseron,on'
p55768
g9
sS'xigris,may,affect'
p55769
g3
sS'and,appears,to'
p55770
g3
sS'adjustment,for,any'
p55771
g3
sS'theophylline,as,with'
p55772
g9
sS'the,hyperplasia,observed'
p55773
g3
sS'idv,does,not'
p55774
g3
sS'fecal,blood,loss'
p55775
g3
sS'guardians,carefully,about'
p55776
g3
sS'proleukin,in,combination'
p55777
g3
sS'y1,cells,stably'
p55778
g3
sS'therefore,extreme,caution'
p55779
g9
sS'and,area-under,the-curve'
p55780
g9
sS'time,kill,curves'
p55781
g9
sS'than,the,number'
p55782
g3
sS'day,divided,into'
p55783
g9
sS'usually,in,close'
p55784
g3
sS'to,alert,clinicians'
p55785
g9
sS'labeling,of,progestin-only'
p55786
g3
sS'the,prevention,and'
p55787
g3
sS'antagonists,based,on'
p55788
g9
sS'been,studied,the'
p55789
g9
sS'oxidized,metabolites,with'
p55790
g3
sS'optimal,therapeutic,dose'
p55791
g3
sS'complications,blurred,vision'
p55792
g9
sS'against,the,potential'
p55793
g3
sS'alone,and,following'
p55794
g3
sS'its,metabolites,have'
p55795
g3
sS'didanosine,fluconazole,fluoxetine'
p55796
g3
sS'deficit,i,acute'
p55797
g3
sS'norpace,and,resulted'
p55798
g9
sS'metabolite,have,been'
p55799
g3
sS'exposure,to,and'
p55800
g3
sS'the,central,importance'
p55801
g3
sS'cyp3a4,inducers,cyp3a4'
p55802
g3
sS'data,from,these'
p55803
g9
sS'survey,of,patients'
p55804
g9
sS'plasma,protein,zaleplon'
p55805
g3
sS'or,fehling,s'
p55806
g3
sS'selected,for,response'
p55807
g3
sS'of,these,isoenzymes'
p55808
g3
sS'to,their,concomitant'
p55809
g3
sS'patient,had,been'
p55810
g3
sS'of,may,reduce'
p55811
g9
sS'regimen,did,not'
p55812
g9
sS'affinities,for,kappa'
p55813
g3
sS'reflex,and,duration'
p55814
g3
sS'in,serum,uric'
p55815
g3
sS'potentiate,the,cns'
p55816
g9
sS'of,chemotherapy,plus'
p55817
g3
sS'humira,has,been'
p55818
g3
sS'caution,and,patients'
p55819
g9
sS'plus,haart,with'
p55820
g3
sS'volunteers,resulting,in'
p55821
g3
sS'used,cautiously,if'
p55822
g3
sS'using,these,techniques'
p55823
g3
sS'd,h,e'
p55824
g9
sS'during,dosing,with'
p55825
g9
sS'curariform,muscle,relaxants'
p55826
g9
sS'reflect,the,interaction'
p55827
g3
sS'used,cautiously,in'
p55828
g9
sS'pharmacologic,interactions,in'
p55829
g3
sS'in,low-density,lipoprotein'
p55830
g3
sS'approximately,to,the'
p55831
g9
sS'subjects,on,concomitant'
p55832
g3
sS'or,inhibits,hepatic'
p55833
g3
sS'we,have,selected'
p55834
g3
sS'of,the,clinical'
p55835
g3
sS'in,bioavailability,was'
p55836
g9
sS'lithium,diclofenac,decreases'
p55837
g9
sS'have,decreased,symptoms'
p55838
g9
sS'effects,were,not'
p55839
g3
sS'inhibitor,does,not'
p55840
g3
sS'metabolized,similarly,to'
p55841
g9
sS'glatiramer,acetate,were'
p55842
g3
sS'made,with,any'
p55843
g9
sS'acetazolamide,may,prevent'
p55844
g9
sS'and,sodium,citrate'
p55845
g9
sS'rats,received,a'
p55846
g3
sS'concentration,of,in'
p55847
g9
sS'or,efficacy,of'
p55848
g3
sS'that,falsely,identify'
p55849
g3
sS'patient,shows,no'
p55850
g3
sS'a,non-matched,historicalcontrol'
p55851
g9
sS'increases,both,free'
p55852
g9
sS'six,clinical,isolates'
p55853
g3
sS'agents,now,available'
p55854
g3
sS'chloramphenicol,or,may'
p55855
g9
sS'clearance,and,an'
p55856
g9
sS'to,lessen,the'
p55857
g3
sS'on,performance,of'
p55858
g3
sS'in,the,liver'
p55859
g3
sS'activity,increase,the'
p55860
g3
sS'and,its,pharmacologically'
p55861
g3
sS'effects,of,clozapine'
p55862
g9
sS'of,patients,interaction'
p55863
g3
sS'plasma,exposure,when'
p55864
g9
sS'dizziness,effects,constipation'
p55865
g3
sS'rr,reduced,adp-induced'
p55866
g3
sS'and,collected,by'
p55867
g3
sS'states,to,emerge'
p55868
g9
sS'of,the,capsule'
p55869
g9
sS'of,potassium-sparing,supplements'
p55870
g3
sS'of,other,medical'
p55871
g3
sS'this,class,produced'
p55872
g3
sS'taking,certain,such'
p55873
g3
sS'decreased,psychomotor,performance'
p55874
g3
sS'and,six,clinical'
p55875
g3
sS'fixed,daily,dose'
p55876
g3
sS'and,function,for'
p55877
g3
sS'reduced,activity,of'
p55878
g3
sS'miracidia,from,eggs'
p55879
g3
sS'with,enzyme-based,tests'
p55880
g3
sS'necessitating,a,reduction'
p55881
g9
sS'before,you,take'
p55882
g3
sS'by,mg,once'
p55883
g3
sS'reduction,in,low-density'
p55884
g3
sS'effect,and,susceptibility'
p55885
g3
sS'sgpt,alt,in'
p55886
g9
sS'development,of,clinical'
p55887
g3
sS'available,uncontrolled,data'
p55888
g3
sS'misonidazole,also,reduced'
p55889
g3
sS'observed,in,some'
p55890
g3
sS'this,increase,is'
p55891
g3
sS'this,category,and'
p55892
g3
sS'having,a,pheochromocytoma'
p55893
g3
sS'other,drugs,drugs'
p55894
g3
sS'particularly,at,to'
p55895
g9
sS'along,with,either'
p55896
g9
sS'sufficient,to,rule'
p55897
g3
sS'a,slower,onset'
p55898
g9
sS'inhibitors,has,not'
p55899
g3
sS'this,increase,in'
p55900
g3
sS'the,maximal,effects'
p55901
g3
sS'potentially,significant,drug'
p55902
g3
sS'subpopulations,of,initiated'
p55903
g3
sS'gastrointestinal,motility,lowers'
p55904
g9
sS'reached,by,to'
p55905
g3
sS'adverse,events,and'
p55906
g3
sS'interaction,study,in'
p55907
g3
sS'domestic,studies,suggest'
p55908
g3
sS'in,glomerular,filtration'
p55909
g3
sS'basis,and,as'
p55910
g3
sS'nephrotoxicity,with,decreases'
p55911
g9
sS'is,reported,to'
p55912
g3
sS'altered,topo,i'
p55913
g3
sS'codeine,in,combination'
p55914
g9
sS'the,for,urinary'
p55915
g3
sS'patients,already,receiving'
p55916
g9
sS'donor,compounds,including'
p55917
g9
sS'however,administration,of'
p55918
g3
sS'dosing,regimens,prediction'
p55919
g3
sS'intraluminally,was,only'
p55920
g3
sS'blockers,isolated,cases'
p55921
g9
sS'disorders,unrelated,to'
p55922
g3
sS'may,compete,for'
p55923
g9
sS'changes,of,mice'
p55924
g3
sS'catecholamine,depletor,should'
p55925
g3
sS'number,of,sites'
p55926
g3
sS'any,hypokalemic,effect'
p55927
g9
sS'similar,proportion,of'
p55928
g9
sS'cmax,of,was'
p55929
g9
sS'of,by,on'
p55930
g9
sS'calcium,antagonists,after'
p55931
g9
sS'of,toxicity,have'
p55932
g9
sS'of,cyp2a6,hydroxylation'
p55933
g9
sS'inhibiting,may,result'
p55934
g9
sS'that,protects,against'
p55935
g9
sS'p450iid6,such,as'
p55936
g9
sS'of,by,or'
p55937
g9
sS'expected,between,viracept'
p55938
g3
sS'therapy,with,small'
p55939
g9
sS'treatment,of,acute'
p55940
g3
sS'less,effective,while'
p55941
g9
sS'including,and,these'
p55942
g3
sS'potential,terfenadine,astemizole'
p55943
g3
sS'a,mao,inhibitor'
p55944
g9
sS'the,vasoconstrictive,action'
p55945
g9
sS'no,information,on'
p55946
g3
sS'preliminary,data,which'
p55947
g9
sS'potassium-sparing,may,be'
p55948
g3
sS'except,that,a'
p55949
g9
sS'or,in,whom'
p55950
g9
sS'ht3,zofran,and'
p55951
g3
sS'a,slight,delay'
p55952
g9
sS'intravenous,and,non-steroidal'
p55953
g9
sS'exogenous,also,appeared'
p55954
g9
sS'of,the,hind'
p55955
g3
sS'and,agents,used'
p55956
g3
sS'rhabdomyolysis,including,chronic'
p55957
g3
sS'parkinsons,disease,patients'
p55958
g3
sS'phase,days,mg'
p55959
g3
sS'of,at,concentrations'
p55960
g3
sS'whereas,in,an'
p55961
g3
sS'effects,in,clinical'
p55962
g3
sS'cyp3a4,ingestion,of'
p55963
g3
sS'of,ethyol,in'
p55964
g9
sS'did,not,report'
p55965
g3
sS'and,clinical,response'
p55966
g3
sS'and,the,antithrombotic'
p55967
g9
sS'increased,concentrations,of'
p55968
g3
sS'with,coadministration,whereas'
p55969
g9
sS'therapeutic,range,of'
p55970
g3
sS'interaction,was,observed'
p55971
g3
sS'immunosuppressive,drugs,fibric'
p55972
g3
sS'was,increased,fold'
p55973
g9
sS'the,oral,or'
p55974
g9
sS'total,cholesterol,low-density'
p55975
g3
sS'possible,interactions,between'
p55976
g3
sS'aeds,do,not'
p55977
g3
sS'of,the,tail-flick'
p55978
g9
sS'flu-like,effects,may'
p55979
g3
sS'patients,with,conditions'
p55980
g3
sS'secretion,via,the'
p55981
g3
sS'safety,and,effectiveness'
p55982
g3
sS'and,the,area'
p55983
g9
sS'cyp2c8,drugs,substances'
p55984
g3
sS'since,in,high'
p55985
g9
sS'survanta,on,the'
p55986
g3
sS'bioequivalence,study,the'
p55987
g3
sS'potentiation,of,camp-mediated'
p55988
g3
sS'prothrom-bin,time,response'
p55989
g9
sS'concomitant,administration,with'
p55990
g9
sS'mcg,of,ethinyl'
p55991
g9
sS'rat,days,and'
p55992
g3
sS'fold,which,significantly'
p55993
g9
sS'such,patients,with'
p55994
g3
sS'as,these,disorders'
p55995
g3
sS'gi,ulceration,and'
p55996
g9
sS'the,dosage,was'
p55997
g3
sS'used,the,risk'
p55998
g9
sS'vertigo,syncope,or'
p55999
g3
sS'or,ergot,alkaloids'
p56000
g9
sS'effect,on,activity'
p56001
g9
sS'oral,and,can'
p56002
g9
sS'live,or,inactivated'
p56003
g9
sS'used,to,improve'
p56004
g3
sS'slightly,reduced,by'
p56005
g9
sS'discusses,current,information'
p56006
g3
sS'lose,the,righting'
p56007
g3
sS'dyspnea,requiring,angioedema'
p56008
g3
sS'on,renal,prostaglandins'
p56009
g9
sS'of,lower,doses'
p56010
g3
sS'of,the,dst'
p56011
g3
sS'leading,to,reduced'
p56012
g3
sS'and,renal,clearance'
p56013
g9
sS'important,interaction,with'
p56014
g3
sS'particularly,in,infants'
p56015
g3
sS'studies,and,an'
p56016
g3
sS'its,enantiomer,nanm'
p56017
g3
sS'too,high,or'
p56018
g3
sS'on,the,last'
p56019
g3
sS'expanded,our,understanding'
p56020
g3
sS'change,in,their'
p56021
g9
sS'target,of,inhibitor'
p56022
g3
sS'the,complete,prescribing'
p56023
g3
sS'cyclic,may,emerge'
p56024
g9
sS'mc,and,have'
p56025
g3
sS'cannot,be,taken'
p56026
g3
sS'for,total,were'
p56027
g3
sS'endothelial,function,is'
p56028
g3
sS'qd,for,five'
p56029
g3
sS'presumably,a,threshold'
p56030
g3
sS'on,the,mechanisms'
p56031
g3
sS'with,gastric,fistulas'
p56032
g3
sS'additive,with,d'
p56033
g9
sS'immunosuppression,are,now'
p56034
g3
sS'state,conditions,to'
p56035
g3
sS'drug,classes,that'
p56036
g3
sS'following,initiation,of'
p56037
g9
sS'no,autoinduction,has'
p56038
g3
sS'administration,on,day'
p56039
g3
sS'few,days,after'
p56040
g9
sS'i,severe,dry'
p56041
g9
sS'wish,to,withhold'
p56042
g9
sS'laboratory,tests,vital'
p56043
g3
sS'without,additional,caution'
p56044
g3
sS'v,as,these'
p56045
g3
sS'depression,in,diabetic'
p56046
g3
sS'inhalation,are,reduced'
p56047
g9
sS'on,a,variety'
p56048
g3
sS'elimination,is,active'
p56049
g3
sS'antiglobulin,coombs,tests'
p56050
g3
sS'of,when,it'
p56051
g9
sS'of,vasoconstrictor,thromboxane'
p56052
g3
sS'of,when,is'
p56053
g9
sS'skin,wheals,and'
p56054
g3
sS'contraction,of,guinea-pig'
p56055
g3
sS'or,medications,with'
p56056
g9
sS'manic-depressive,disorder,requires'
p56057
g3
sS'the,predominant,sterol'
p56058
g3
sS'that,platelet,function'
p56059
g3
sS'alone,was,found'
p56060
g9
sS'evident,in,female'
p56061
g3
sS'interference,with,the'
p56062
g3
sS'its,metabolite,may'
p56063
g3
sS'it,affect,the'
p56064
g3
sS'effects,of,combined'
p56065
g3
sS'temperatures,on,microtubules'
p56066
g3
sS'study,concomitant,administration'
p56067
g9
sS'and,in,absorption'
p56068
g9
sS'for,any,conclusions'
p56069
g3
sS'activation,of,these'
p56070
g3
sS'reduction,of,excretion'
p56071
g3
sS'or,the,absence'
p56072
g3
sS'concentrations,and,appropriate'
p56073
g3
sS'june,and,october'
p56074
g3
sS'as,post-marketing,observations'
p56075
g9
sS'severe,hypotension,and'
p56076
g9
sS'no,significant,inhibitory'
p56077
g3
sS'hepatotoxic,medications,such'
p56078
g3
sS'male,animals,were'
p56079
g3
sS'efficacy,of,the'
p56080
g9
sS'other,nsaids,concomitant'
p56081
g9
sS'kg,of,alone'
p56082
g3
sS'protein,binding,entacapone'
p56083
g3
sS'for,any,dose'
p56084
g3
sS'is,not,a'
p56085
g3
sS'monkeys,given,sc'
p56086
g3
sS'fulvestrant,was,not'
p56087
g3
sS'although,neither,nor'
p56088
g9
sS'lodine,as,measured'
p56089
g3
sS'of,itraconazole,therapy'
p56090
g9
sS'did,not,systematically'
p56091
g3
sS'used,in,combination'
p56092
g9
sS'eprosartan,has,been'
p56093
g3
sS'or,may,produce'
p56094
g9
sS'used,in,interpreting'
p56095
g3
sS'or,trivalent,cations'
p56096
g3
sS'keppra,mg,daily'
p56097
g3
sS'subcutaneous,infusion,pumps'
p56098
g3
sS'such,use,is'
p56099
g9
sS'disease,and,poor-risk'
p56100
g3
sS'be,withdrawn,at'
p56101
g9
sS'system,and,result'
p56102
g3
sS'with,that,prolong'
p56103
g3
sS'threshold,voltage-dependent,ca'
p56104
g3
sS'hiv,disease,and'
p56105
g3
sS'a,separate,group'
p56106
g9
sS'tacrolimus,felodipine,may'
p56107
g3
sS'induce,hepatic,enzymes'
p56108
g9
sS'concentrations,and,toxicity'
p56109
g9
sS'reduce,proleukin-induced,side'
p56110
g9
sS'used,with,oral'
p56111
g9
sS'neuromuscular,blockade,of'
p56112
g9
sS'evidence,for,a'
p56113
g3
sS'the,endometrium,and'
p56114
g3
sS'who,do,not'
p56115
g3
sS'and,decrease,the'
p56116
g9
sS'to,the,clinical'
p56117
g3
sS'mutagenesis,impairment,of'
p56118
g3
sS'inhibits,the,gastrointestinal'
p56119
g9
sS'rhesus,monkeys,treated'
p56120
g3
sS'and,hearing,impairment'
p56121
g9
sS'of,and,produced'
p56122
g9
sS'rodent,pups,from'
p56123
g3
sS'with,multiple,dosing'
p56124
g9
sS'of,in,parkinsons'
p56125
g9
sS'of,withdrawal,symptoms'
p56126
g3
sS'both,parental,and'
p56127
g3
sS'selected,patient,data'
p56128
g3
sS'isomer,on,the'
p56129
g3
sS'in,incomplete,depletion'
p56130
g3
sS'with,other,cns-depressant'
p56131
g9
sS'might,be,required'
p56132
g3
sS'although,these,effects'
p56133
g3
sS'learning,and,memory'
p56134
g3
sS'one,study,tentatively'
p56135
g3
sS'reductions,in,serum'
p56136
g3
sS'interactions,following,administration'
p56137
g3
sS'observed,for,loss'
p56138
g3
sS'pregnancy,registry,by'
p56139
g3
sS'that,the,neuromuscular'
p56140
g9
sS'a,toxic,effect'
p56141
g9
sS'during,accutane,therapy'
p56142
g3
sS'produce,significant,increases'
p56143
g3
sS'accordingly,renal,function'
p56144
g3
sS'rapidly,and,essentially'
p56145
g3
sS'the,human,recommended'
p56146
g3
sS'and,r-warfarin,a'
p56147
g9
sS'with,other,medications'
p56148
g3
sS'age,sex,number'
p56149
g3
sS'of,enablex,should'
p56150
g9
sS'cold,and,sinus'
p56151
g9
sS'erroneous,and,cannot'
p56152
g3
sS'increased,peak,plasma'
p56153
g9
sS'to,representing,a'
p56154
g9
sS'using,immunoanalytical,methods'
p56155
g3
sS'the,observed,training-induced'
p56156
g3
sS'tubular,secretion,may'
p56157
g3
sS'some,patients,concomitant'
p56158
g3
sS'the,patients,receiving'
p56159
g3
sS'with,an,hydroxide'
p56160
g9
sS'systems,has,been'
p56161
g9
sS'alkalinizing,agents,increase'
p56162
g3
sS'mac,out,of'
p56163
g3
sS'and,gastrointestinal,disturbances'
p56164
g3
sS'or,may,interact'
p56165
g9
sS'serum,levels,may'
p56166
g3
sS'carefully,and,the'
p56167
g9
sS'using,bromocriptine,mesylate'
p56168
g9
sS'of,these,oral'
p56169
g9
sS'qd,days,with'
p56170
g9
sS'reported,resulting,in'
p56171
g9
sS'inhibitors,of,either'
p56172
g3
sS'with,more,than'
p56173
g3
sS'p450,a4,such'
p56174
g9
sS'sampling,were,conducted'
p56175
g3
sS'suggest,these,agents'
p56176
g3
sS'several,hours,apart'
p56177
g3
sS'increased,the,steady-state'
p56178
g9
sS'and,iv,have'
p56179
g3
sS'hcl,should,receive'
p56180
g9
sS'beta,blockers,may'
p56181
g9
sS'inhibitors,inhibitors,of'
p56182
g3
sS'susceptible,patients,following'
p56183
g3
sS'increased,approximately,in'
p56184
g9
sS'adjusted,in,patients'
p56185
g3
sS'acid,antagonists,such'
p56186
g9
sS'effects,on,positive'
p56187
g3
sS'displacement,of,protein-bound'
p56188
g3
sS'profound,hypotensive,episodes'
p56189
g9
sS'and,maximum,concentration'
p56190
g9
sS'sodium,levels,may'
p56191
g3
sS'following,table,effects'
p56192
g3
sS'calcitriol,and,calcidiol'
p56193
g9
sS'acid,because,of'
p56194
g9
sS'block,were,more'
p56195
g3
sS'demonstrates,that,concurrent'
p56196
g9
sS'an,active,metabolite'
p56197
g3
sS'live,and,live-attenuated'
p56198
g9
sS'renal,failure,and'
p56199
g9
sS'gdh,pqq,based'
p56200
g3
sS'follow-up,of,months'
p56201
g3
sS'on,glycemia,in'
p56202
g3
sS'intimately,related,to'
p56203
g3
sS'or,oral,agents'
p56204
g3
sS'pulmonary,extract,from'
p56205
g3
sS'that,absorption,metabolism'
p56206
g3
sS'blockade,was,prolonged'
p56207
g9
sS'after,administration,reaching'
p56208
g3
sS'however,no,clinically'
p56209
g3
sS'phosphorylation,at,high'
p56210
g9
sS'therapies,that,take'
p56211
g3
sS'interaction,between,exogenous'
p56212
g3
sS'a,liquid,impinger'
p56213
g3
sS'protease,inhibitor,in'
p56214
g3
sS'v,concentrations,up'
p56215
g3
sS'parasite,reduction,at'
p56216
g3
sS'myocardium,versus,nonfailing'
p56217
g3
sS'more,profound,when'
p56218
g9
sS'levels,indicating,that'
p56219
g3
sS'failure,as,a'
p56220
g3
sS'be,made,carefully'
p56221
g3
sS'in,one,man'
p56222
g9
sS'an,enteric,coating'
p56223
g3
sS'cautiously,coadministered,with'
p56224
g9
sS'the,total,were'
p56225
g3
sS'and,others,that'
p56226
g9
sS'coadministration,of,potent'
p56227
g9
sS'older,and,younger'
p56228
g3
sS'not,altered,its'
p56229
g3
sS'is,dependent,on'
p56230
g3
sS'magnesium,aluminum-containing,antacid'
p56231
g3
sS'and,hepatitis,has'
p56232
g3
sS'were,coadministered,than'
p56233
g9
sS'striatal,but,these'
p56234
g9
sS'which,prolong,ecg'
p56235
g3
sS'and,these,are'
p56236
g3
sS'antimicrobial,agents,available'
p56237
g3
sS'not,be,maintained'
p56238
g3
sS'however,patients,who'
p56239
g3
sS'demonstrated,that,pretreatment'
p56240
g3
sS'amicar,may,occur'
p56241
g3
sS'in,healthy,women'
p56242
g3
sS'use,to,avoid'
p56243
g3
sS'have,their,plasma'
p56244
g9
sS'tablets,should,have'
p56245
g9
sS'both,s-warfarin,a'
p56246
g9
sS'of,effect,of'
p56247
g3
sS'it,has,greater'
p56248
g3
sS'an,additive,interaction'
p56249
g9
sS'which,healthy,subjects'
p56250
g3
sS'interaction,observed,between'
p56251
g9
sS'of,cardiac,function'
p56252
g9
sS'consequence,of,blocking'
p56253
g9
sS'lipolysis,and,remnant'
p56254
g3
sS'who,take,lodine'
p56255
g3
sS'subjects,clearance,and'
p56256
g3
sS'alkaline,phosphatase,and'
p56257
g3
sS'although,may,increase'
p56258
g9
sS'shown,no,significant'
p56259
g3
sS'in,normal,and'
p56260
g3
sS'of,this,protein'
p56261
g9
sS'nervous,system,careful'
p56262
g3
sS'a,pregnancy,test'
p56263
g3
sS'compounds,metabolized,by'
p56264
g3
sS'not,cause,transient'
p56265
g3
sS'enkephalinergic,neurons,and'
p56266
g9
sS'influence,the,pharmacokinetics'
p56267
g3
sS'acid,in,large'
p56268
g9
sS'avoided,because,of'
p56269
g9
sS'and,during,concomitant'
p56270
g3
sS'or,induces,the'
p56271
g3
sS'complication,of,treatment'
p56272
g3
sS'study,it,was'
p56273
g3
sS'partly,antagonized,the'
p56274
g9
sS'be,carefully,titrated'
p56275
g9
sS'two,times,the'
p56276
g3
sS'significant,oxidative,stress'
p56277
g3
sS'system,regardless,of'
p56278
g9
sS'other,niacin,nicotinic'
p56279
g3
sS'and,pharmacological,therapy'
p56280
g3
sS'converting,difluoro-2,propanol'
p56281
g9
sS'tests,corticosteroids,may'
p56282
g3
sS'to,increase,catabolism'
p56283
g3
sS'a,thorough,medication'
p56284
g3
sS'by,causing,bone'
p56285
g9
sS'evidence,to,date'
p56286
g3
sS'vistide,and,agents'
p56287
g9
sS'with,agents,known'
p56288
g9
sS'rats,given,high'
p56289
g9
sS'the,reported,dose'
p56290
g3
sS'such,considerations,as'
p56291
g3
sS'humans,can,lead'
p56292
g9
sS'case,of,toxicity'
p56293
g9
sS'results,from,an'
p56294
g3
sS'h,receptor,antagonists'
p56295
g9
sS'clozapine,induced,agranulocytosis'
p56296
g3
sS'supplements,may,result'
p56297
g3
sS'ketoconazole,did,not'
p56298
g3
sS'a,lesser,extent'
p56299
g3
sS'containing,vitamin,a'
p56300
g9
sS'agents,in,four'
p56301
g3
sS'kg,w,in'
p56302
g9
sS'parorchis,acanthus,obtained'
p56303
g3
sS'in,extremely,acidic'
p56304
g3
sS'rapid,while,transfer'
p56305
g3
sS'in,many,of'
p56306
g3
sS'suggest,that,affect'
p56307
g3
sS'up,to,of'
p56308
g3
sS'with,prinivil,can'
p56309
g9
sS'other,monomeric,members'
p56310
g3
sS'well,as,for'
p56311
g3
sS'increase,the,risks'
p56312
g9
sS'cell,lines,u937'
p56313
g9
sS'other,agents,with'
p56314
g9
sS'cyp3a4,inducer,such'
p56315
g3
sS'which,inhibit,cyp'
p56316
g9
sS'the,homocysteine,excretion'
p56317
g3
sS'interactions,with,antacids'
p56318
g9
sS'membrane,sterol,in'
p56319
g3
sS'to,reductions,in'
p56320
g3
sS'negative,bacteria,by'
p56321
g3
sS'partners,of,women'
p56322
g3
sS'imidazole,and,triazole'
p56323
g3
sS'of,cyp-2c19,by'
p56324
g3
sS'coadministration,of,decreases'
p56325
g9
sS'vioxx,therapy,in'
p56326
g9
sS'dose,pharmacokinetics,of'
p56327
g3
sS'therefore,proton,pump'
p56328
g9
sS'effective,in,the'
p56329
g9
sS'ointments,or,oils'
p56330
g3
sS'beta,adrenergic-blocking,agents'
p56331
g3
sS'induce,microsomal,enzymes'
p56332
g9
sS'of,be,reduced'
p56333
g9
sS'coadministration,of,decreased'
p56334
g9
sS'a,valid,prothrombin'
p56335
g9
sS'led,to,elevated'
p56336
g9
sS'and,systemic,and'
p56337
g9
sS'mg,kg,mc'
p56338
g3
sS'usually,a,lower'
p56339
g9
sS'to,as,nsaids'
p56340
g3
sS'with,clinitest,tablets'
p56341
g3
sS'administering,cerebyx,with'
p56342
g3
sS'mg,m2,and'
p56343
g9
sS'potentials,with,either'
p56344
g3
sS'call,that,is'
p56345
g3
sS'for,a,continuing'
p56346
g3
sS'tested,was,observed'
p56347
g3
sS'as,differin,gel'
p56348
g3
sS'soon,after,administration'
p56349
g9
sS'they,respond,differently'
p56350
g3
sS'patients,along,with'
p56351
g3
sS'can,cause,headaches'
p56352
g3
sS'glucose,metabolism,in'
p56353
g3
sS'are,not,effected'
p56354
g3
sS'nizoral,tablets,and'
p56355
g9
sS'biochemical,activity,of'
p56356
g3
sS'co-administration,of,with'
p56357
g9
sS'be,usedas,the'
p56358
g9
sS'induced,by,administration'
p56359
g3
sS'apparent,pharmacokinetic,interaction'
p56360
g3
sS'and,appropriate,dosage'
p56361
g3
sS'daily,followed,by'
p56362
g9
sS'of,measured,at'
p56363
g3
sS'its,effects,on'
p56364
g3
sS'rhythm,following,administration'
p56365
g9
sS'in,the,concentration'
p56366
g9
sS'interference,with,expected'
p56367
g3
sS'the,clearance,or'
p56368
g3
sS'with,can,be'
p56369
g9
sS'when,cime-tidine,therapy'
p56370
g9
sS'tested,more,frequently'
p56371
g3
sS'effects,on,blood'
p56372
g3
sS'was,used,concomitantly'
p56373
g3
sS'plans,for,patients'
p56374
g3
sS'and,and,possibly'
p56375
g9
sS'should,take,other'
p56376
g3
sS'that,may,affect'
p56377
g3
sS'been,well,studied'
p56378
g3
sS'serum,levels,in'
p56379
g9
sS'however,it,adversely'
p56380
g9
sS'serum,levels,is'
p56381
g9
sS'the,choice,of'
p56382
g3
sS'function,or,compete'
p56383
g3
sS'confirmed,for,in'
p56384
g3
sS'adverse,event,profile'
p56385
g3
sS'be,an,inhibitor'
p56386
g3
sS'be,noted,that'
p56387
g9
sS'because,the,degree'
p56388
g9
sS'and,sodium,an'
p56389
g3
sS'foscavir,should,be'
p56390
g9
sS'potentiates,the,muscle'
p56391
g9
sS'these,agents,is'
p56392
g3
sS'terms,viagra,and'
p56393
g3
sS'were,not,significantly'
p56394
g3
sS'orthostatic,hypotension,has'
p56395
g9
sS'in,the,diabetics'
p56396
g3
sS'or,nitrous,oxide'
p56397
g3
sS'busulfex,at,the'
p56398
g9
sS'were,tested,for'
p56399
g3
sS'an,oral,antagonist'
p56400
g9
sS'normal,but,should'
p56401
g9
sS'potential,to,select'
p56402
g3
sS'inhibitory,effects,toward'
p56403
g3
sS'inhibit,cyp3a4,eg'
p56404
g9
sS'task,it,substituted'
p56405
g3
sS'pharmacokinetic,dosing,of'
p56406
g3
sS'strong,and,completely'
p56407
g9
sS'that,accompany,high'
p56408
g9
sS'concomitantly,within14,days'
p56409
g9
sS'following,alfenta,induction'
p56410
g9
sS'fdf,at,micromol'
p56411
g9
sS'affect,pharmacokinetics,except'
p56412
g9
sS'of,and,ortho-novum'
p56413
g9
sS'addition,of,is'
p56414
g3
sS'r,b,the'
p56415
g3
sS'less,enzyme,induction'
p56416
g3
sS'mixture,toxicity,investigation'
p56417
g3
sS'effect,on,certain'
p56418
g9
sS'and,laboratory,abnormalities'
p56419
g3
sS'with,an,erection'
p56420
g3
sS'ketoconazole,ketoconazole,and'
p56421
g3
sS'metal,cations,or'
p56422
g9
sS'high,affinity,binding'
p56423
g3
sS'indicate,that,has'
p56424
g3
sS'hyperthermia,crisis,until'
p56425
g9
sS'major,circulating,metabolite'
p56426
g3
sS'may,alter,the'
p56427
g9
sS'bone,marrow,depression'
p56428
g9
sS'use,of,activated'
p56429
g3
sS'the,following,agents'
p56430
g9
sS'to,exhibit,additive'
p56431
g3
sS'acumen,but,also'
p56432
g3
sS'of,increased,interaction'
p56433
g3
sS'induced,concentration-dependent,relaxation'
p56434
g3
sS'inhibition,of,total'
p56435
g9
sS'sodium,is,unaffected'
p56436
g3
sS'decreased,thiazides,should'
p56437
g3
sS'blocking,agents,the'
p56438
g9
sS'normal,volunteers,concomitant'
p56439
g9
sS'potent,in,inhibiting'
p56440
g3
sS'for,months,at'
p56441
g3
sS'closely,monitor,the'
p56442
g3
sS'and,human,liver'
p56443
g3
sS'controlled-release,capsule,was'
p56444
g9
sS'results,that,are'
p56445
g3
sS'red-orange,which,may'
p56446
g3
sS'occurred,with,similar'
p56447
g3
sS'therapeutic,index,and'
p56448
g3
sS'receiving,zyvox,may'
p56449
g9
sS'temporarily,discontinued,hours'
p56450
g3
sS'and,the,development'
p56451
g3
sS'of,intravenous,in'
p56452
g3
sS'levels,increased,by'
p56453
g9
sS'cevimeline,might,interfere'
p56454
g3
sS'in,mice,after'
p56455
g3
sS'on-treatment,additive,toxicity'
p56456
g3
sS'elevations,of,aminotransferase'
p56457
g3
sS'concentrations,producing,of'
p56458
g3
sS'and,addicts,were'
p56459
g9
sS'slow-channel,blockers,such'
p56460
g3
sS'these,changes,has'
p56461
g3
sS'and,at,concentrations'
p56462
g3
sS'coadministration,of,sular'
p56463
g9
sS'but,available,data'
p56464
g3
sS'biweekly,intervals,until'
p56465
g3
sS'l,from,both'
p56466
g3
sS'antidepressant,levels,and'
p56467
g9
sS'necessary,in,order'
p56468
g3
sS'carbamazepine,is,known'
p56469
g3
sS'much,lower,affinities'
p56470
g3
sS'patients,with,normal'
p56471
g9
sS'fasted,for,h'
p56472
g3
sS'and,subjective,effects'
p56473
g3
sS'inhibitor,is,administered'
p56474
g9
sS'to,situate,the'
p56475
g3
sS'administration,of,hydrochloride'
p56476
g9
sS'epithelium,proliferates,in'
p56477
g3
sS'neutralized,the,increase'
p56478
g3
sS'may,be,reduced'
p56479
g3
sS'elevation,of,conjugated'
p56480
g3
sS'vivo,by,inhibition'
p56481
g3
sS'desired,lactulose-induced,drop'
p56482
g9
sS'these,is,likely'
p56483
g9
sS'above,and,other'
p56484
g3
sS'study,of,over'
p56485
g3
sS'as,or,a'
p56486
g3
sS'it,is,felt'
p56487
g9
sS'one,third,of'
p56488
g9
sS'self-injection,of,crushed'
p56489
g3
sS'inhibit,p450,d6'
p56490
g3
sS'a,highest,level'
p56491
g3
sS'the,interaction,observed'
p56492
g9
sS'chromaffin,cell,including'
p56493
g3
sS'studies,with,xigris'
p56494
g3
sS'less,than,months'
p56495
g3
sS'factor,treatment,for'
p56496
g3
sS'day,followed,by'
p56497
g9
sS'treatment,discontinuation,is'
p56498
g3
sS'lethargy,and,coma'
p56499
g9
sS'indicate,that,an'
p56500
g3
sS'of,oral,and'
p56501
g9
sS'toradol,induces,or'
p56502
g3
sS'nizoral,sporanox,lipitor'
p56503
g9
sS'concomitantly,with,should'
p56504
g9
sS'and,should,therefore'
p56505
g9
sS'users,experiencing,breakthrough'
p56506
g3
sS'patient,survival,needs'
p56507
g3
sS'time,plasma,thrombin'
p56508
g3
sS'a,genetic,predisposition'
p56509
g3
sS'pressure,reductions,of'
p56510
g9
sS'and,pulmonary,emboli'
p56511
g3
sS'subjective,effects,addiction'
p56512
g3
sS'with,the,commonly'
p56513
g3
sS'given,as,antiemetic'
p56514
g3
sS'this,isoenzyme,including'
p56515
g9
sS'severe,and,prolonged'
p56516
g3
sS'therapies,standard,monitoring'
p56517
g3
sS'escherichia,coli,and'
p56518
g3
sS'c,max,and'
p56519
g3
sS'lovastatin,is,metabolized'
p56520
g3
sS'blockers,although,the'
p56521
g9
sS'pesticide,the,metabolism'
p56522
g3
sS'wort,in,patients'
p56523
g3
sS'may,also,be'
p56524
g3
sS'have,detrimental,effects'
p56525
g3
sS'impairment,clcr,and'
p56526
g9
sS'low-dose,hcl,and'
p56527
g9
sS'to,be,administered'
p56528
g9
sS'of,suggested,the'
p56529
g3
sS'symptomatic,hypotension,in'
p56530
g3
sS'supplements,with,their'
p56531
g3
sS'metabolism,or,on'
p56532
g3
sS'the,proteins,that'
p56533
g3
sS'of,patients,who'
p56534
g3
sS'pcp,for,days'
p56535
g3
sS'evidence,of,neurological'
p56536
g3
sS'carefully,monitored,see'
p56537
g3
sS'coombs,test,could'
p56538
g3
sS'but,the,rate'
p56539
g3
sS'when,was,administered'
p56540
g9
sS'gabitril,on,other'
p56541
g3
sS'of,coronary,insufficiency'
p56542
g3
sS'factors,studied,two'
p56543
g9
sS'metabolized,in,part'
p56544
g3
sS'and,this,neurotoxic'
p56545
g9
sS'products,medicated,or'
p56546
g3
sS'substrates,for,the'
p56547
g3
sS'antacid,maalox,maalox'
p56548
g9
sS'as,clinistix,and'
p56549
g3
sS'finally,it,is'
p56550
g3
sS'were,explored,with'
p56551
g3
sS'of,mental,and'
p56552
g3
sS'a,lower,plasma'
p56553
g3
sS'included,in,this'
p56554
g3
sS'treatment,folic,acid'
p56555
g9
sS'usually,within,the'
p56556
g9
sS'by,effects,on'
p56557
g3
sS'sedative,effects,of'
p56558
g9
sS'its,abrupt,suppression'
p56559
g9
sS'is,an,anion'
p56560
g3
sS'delayed,adverse,reactions'
p56561
g9
sS'potential,for,other'
p56562
g3
sS'strains,of,enterococci'
p56563
g3
sS'involvement,labeling,index'
p56564
g3
sS'reaction,on,repeated'
p56565
g3
sS'peripheral,neuropathy,or'
p56566
g9
sS'use,of,usually'
p56567
g9
sS'n,combination,study'
p56568
g9
sS'to,about,absorption'
p56569
g3
sS'e,mg,kg'
p56570
g9
sS'on,the,pharmacokinetits'
p56571
g3
sS'closely,monitored,and'
p56572
g9
sS'vascular,response,to'
p56573
g9
sS'renal,insufficiency,was'
p56574
g3
sS'into,account,the'
p56575
g3
sS'dyspnea,hypotension,or'
p56576
g3
sS'ketoconazole,at,mg'
p56577
g9
sS'and,combined,exposures'
p56578
g3
sS'as,have,been'
p56579
g9
sS'patient,care,and'
p56580
g3
sS'for,several,days'
p56581
g9
sS'are,dose,limiting'
p56582
g3
sS'chlorthalidone,may,add'
p56583
g9
sS'is,mediated,primarily'
p56584
g3
sS'diabetics,who,were'
p56585
g3
sS'humans,have,demonstrated'
p56586
g3
sS'and,were,in'
p56587
g3
sS'to,reduce,proleukin-induced'
p56588
g9
sS'patients,receiving,will'
p56589
g9
sS'greater,than,when'
p56590
g9
sS'together,with,depen'
p56591
g9
sS'ergot-containing,have,been'
p56592
g3
sS'its,dose,should'
p56593
g9
sS'to,may,be'
p56594
g9
sS'vitro,studies,vardenafil'
p56595
g3
sS'aeruginosa,particularly,serotype'
p56596
g3
sS'days,and,a'
p56597
g9
sS'infarction,patients,who'
p56598
g3
sS'intestinal,beta-glucuronidase,are'
p56599
g3
sS'of,administered,to'
p56600
g3
sS'use,of,from'
p56601
g3
sS'number,of,steps'
p56602
g3
sS'by,plate,counts'
p56603
g3
sS'following,immunosuppressives,cyclosporine'
p56604
g3
sS'characterize,the,aerosol'
p56605
g3
sS'among,these,patients'
p56606
g3
sS'and,may,be'
p56607
g9
sS'refer,to,the'
p56608
g9
sS'chemical,color,development'
p56609
g3
sS'the,antimicrobial,effect'
p56610
g3
sS'a,gritty,substance'
p56611
g9
sS'and,unpredictable,potentiation'
p56612
g9
sS'pharmacokinetic,changes,are'
p56613
g3
sS'appetite,and,compared'
p56614
g3
sS'secretion,of,based'
p56615
g9
sS'subsequent,cycles,of'
p56616
g3
sS'assumed,that,increased'
p56617
g3
sS'and,the,therapeutic'
p56618
g3
sS'of,serious,cardiovascular'
p56619
g3
sS'effects,and,interactions'
p56620
g3
sS'with,dosage,adjustment'
p56621
g3
sS'increases,in,lymphocyte'
p56622
g3
sS'specific,blockade,of'
p56623
g3
sS'oral,and,other'
p56624
g9
sS'potential,for,pharmacokinetic'
p56625
g3
sS'who,are,pregnant'
p56626
g3
sS'seen,with,other'
p56627
g3
sS'mean,changes,were'
p56628
g3
sS'potential,interactions,with'
p56629
g3
sS'in,rats,in'
p56630
g9
sS'as,a,mg'
p56631
g3
sS'efficiently,inhibited,by'
p56632
g3
sS'inhibit,p450,a6'
p56633
g3
sS'diazepam,the,co-administration'
p56634
g9
sS'the,plasma,half-life'
p56635
g3
sS'transit,time,hydrogen'
p56636
g3
sS'as,or,or'
p56637
g3
sS'two,studies,in'
p56638
g9
sS'concentrations,were,to'
p56639
g9
sS'omega-conotoxin,gvia,omega-agatoxin'
p56640
g3
sS'of,indicate,that'
p56641
g3
sS'aucs,and,cmin'
p56642
g3
sS'of,retinopathy,nephropathy'
p56643
g3
sS'pharmacodynamics,of,or'
p56644
g3
sS'c,min,or'
p56645
g3
sS'consider,monitoring,levels'
p56646
g3
sS'in,the,promotion'
p56647
g3
sS'pharmacology,drug,interactions'
p56648
g9
sS'main,results,in'
p56649
g3
sS'pain,tinnitus,slurred'
p56650
g3
sS'and,were,variable'
p56651
g3
sS'in,the,pharmacodynamic'
p56652
g3
sS'i,d,and'
p56653
g9
sS'with,concomitantly,administered'
p56654
g3
sS'and,motor,effects'
p56655
g9
sS'enzyme,system,is'
p56656
g3
sS'tests,are,carried'
p56657
g3
sS'enhances,the,degree'
p56658
g9
sS'of,mg,causing'
p56659
g3
sS'with,cgs,an'
p56660
g9
sS'for,the,plasma'
p56661
g3
sS'regional,perfusion,in'
p56662
g3
sS'dexbrompheniramine,can,interact'
p56663
g9
sS'initially,and,returned'
p56664
g3
sS'onset,can,be'
p56665
g9
sS'physicians,needing,to'
p56666
g3
sS'who,switched,from'
p56667
g3
sS'monitor,the,infusion'
p56668
g3
sS'plasmaconcentration,of,other'
p56669
g9
sS'in,subjects,with'
p56670
g3
sS'centroblast,proliferation,in'
p56671
g3
sS'plasma,concentration,and'
p56672
g9
sS'in,significantly,elevating'
p56673
g9
sS'one,hour,apart'
p56674
g9
sS'extent,with,that'
p56675
g3
sS'bun,and,fbs'
p56676
g9
sS'level,of,exposure'
p56677
g9
sS'generally,this,phenomenon'
p56678
g3
sS'after,colestid,tablets'
p56679
g3
sS'slight,delay,in'
p56680
g9
sS'products,absorption,of'
p56681
g3
sS'enterococcus,three,strains'
p56682
g3
sS'average,for,the'
p56683
g3
sS'cardiovascular,disease,erectile'
p56684
g3
sS'risk,of,prolonged'
p56685
g9
sS'of,this,pharmacodynamic'
p56686
g3
sS'may,reduce,endogenous'
p56687
g9
sS'of,duloxetine,it'
p56688
g3
sS'tested,and,no'
p56689
g3
sS'previous,extravasation,following'
p56690
g3
sS'in,serum,have'
p56691
g3
sS'future,trends,are'
p56692
g3
sS'the,oral,compared'
p56693
g3
sS'associated,in,intact'
p56694
g3
sS'after,missing,a'
p56695
g3
sS'injection,lorazepam,injection'
p56696
g9
sS'reduce,hepatic,metabolism'
p56697
g9
sS'acitretin,interferes,with'
p56698
g9
sS'which,could,cause'
p56699
g3
sS'femara,with,these'
p56700
g3
sS'therapy,with,and'
p56701
g9
sS'nacmc,conjugated,with'
p56702
g3
sS'sulfate,prednisolone,sodium'
p56703
g3
sS'flow,caused,by'
p56704
g3
sS'increased,during,concomitant'
p56705
g9
sS'quickens,the,onset'
p56706
g9
sS'lofexidine,may,enhance'
p56707
g9
sS'the,contraceptive,effect'
p56708
g9
sS'of,the,ultimate'
p56709
g3
sS'vardenafil,or,mg'
p56710
g9
sS'arginine,in,the'
p56711
g3
sS'system,that,in'
p56712
g3
sS'glomerular,filtration,may'
p56713
g3
sS'inducer,of,udp-glucuronyl'
p56714
g3
sS'and,may,occur'
p56715
g9
sS'and,hydroxides,and'
p56716
g3
sS'is,almost,always'
p56717
g3
sS'comparison,study,and'
p56718
g3
sS'concurrently,subjects,should'
p56719
g9
sS'doses,of,desmopressin'
p56720
g3
sS'the,concurrent,use'
p56721
g3
sS'of,various,such'
p56722
g9
sS'microsomal,enzymes,were'
p56723
g3
sS'pretreatment,augmented,the'
p56724
g9
sS'in,general,most'
p56725
g3
sS'oruvail,voltaren,cataflam'
p56726
g3
sS'used,inconcomitant,administration'
p56727
g3
sS'doses,of,intravenous'
p56728
g3
sS'cmax,levels,achieved'
p56729
g3
sS'for,therapeutic,efficacy'
p56730
g3
sS'in,vitro,has'
p56731
g9
sS'cyp2d6,with,cyp1a2'
p56732
g3
sS'cause,significant,sustained'
p56733
g9
sS'ranging,from,in'
p56734
g3
sS'acetate,were,inconclusive'
p56735
g3
sS'of,other,antituberculous'
p56736
g9
sS'vivo,and,in'
p56737
g3
sS'increased,blood,at'
p56738
g3
sS'treated,with,plus'
p56739
g9
sS'monitored,in,the'
p56740
g9
sS'both,products,are'
p56741
g3
sS'a,or,any'
p56742
g9
sS'has,been,suggested'
p56743
g3
sS'cholino-,and,adrenoreceptors'
p56744
g3
sS'who,begin,taking'
p56745
g9
sS'can,suppress,the'
p56746
g9
sS'altered,decrease,in'
p56747
g9
sS'of,interactions,with'
p56748
g3
sS'survey,of,hospital'
p56749
g3
sS'daily,dose,once'
p56750
g3
sS'animal,studies,also'
p56751
g3
sS'capsule,n,mean'
p56752
g9
sS'and,nsaids,are'
p56753
g9
sS'about,three,weeks'
p56754
g3
sS'and,respectively,suggesting'
p56755
g9
sS'substrates,in,vitro'
p56756
g3
sS'i-labelled,antigen,validation'
p56757
g3
sS'acid,monoamine,oxidase'
p56758
g9
sS'insurances,and,job'
p56759
g3
sS'curariform,effect,of'
p56760
g9
sS'peripheral,mononuclear,cells'
p56761
g3
sS'to,have,significant'
p56762
g3
sS'study,adverse,effects'
p56763
g9
sS'virologic,response,rates'
p56764
g3
sS'of,nor,high'
p56765
g3
sS'more,frequent,laboratory'
p56766
g3
sS'crixivan,and,primarily'
p56767
g3
sS'single,dose,of'
p56768
g9
sS'variety,of,settings'
p56769
g3
sS'a,rauwolfia,alkaloid'
p56770
g9
sS'those,with,moderate'
p56771
g3
sS'associated,with,concomitant'
p56772
g3
sS'variability,of,effect'
p56773
g3
sS'initial,release,of'
p56774
g9
sS'i,selective,serotonin'
p56775
g9
sS'single,dose,or'
p56776
g3
sS'buspirone,hcl,may'
p56777
g9
sS'interact,with,known'
p56778
g3
sS'and,ergot-type,oxytocic'
p56779
g9
sS'be,required,and'
p56780
g9
sS'and,efficacy,ectopic'
p56781
g3
sS'with,any,antineoplastic'
p56782
g3
sS'mind,when,orudis'
p56783
g3
sS'bacteria,except,for'
p56784
g3
sS'enzyme,system,at'
p56785
g9
sS'result,in,coma'
p56786
g9
sS'effect,of,sodium'
p56787
g9
sS'adequately,studied,and'
p56788
g3
sS'these,in,vitro'
p56789
g3
sS'activity,of,this'
p56790
g3
sS'enzymes,d6,a4'
p56791
g3
sS'average,of,ci'
p56792
g9
sS'effectiveness,of,a'
p56793
g9
sS'of,may,increase'
p56794
g9
sS'periods,were,separated'
p56795
g3
sS'system,depressants,including'
p56796
g9
sS'detecting,alterations,in'
p56797
g3
sS'emptying,by,could'
p56798
g3
sS'need,to,decrease'
p56799
g3
sS'which,could,decrease'
p56800
g3
sS'other,coumarin-like,should'
p56801
g9
sS'by,any,route'
p56802
g9
sS'combination,of,chop'
p56803
g3
sS'and,alkaline,phosphatase'
p56804
g3
sS'little,has,been'
p56805
g3
sS'of,breakthrough,bleeding'
p56806
g3
sS'and,injectables,are'
p56807
g3
sS'from,trials,using'
p56808
g3
sS'in,toxicity,in'
p56809
g9
sS'activity,of,within'
p56810
g3
sS'paroxetine,produced,only'
p56811
g9
sS'receiving,and,which'
p56812
g9
sS'patients,using,should'
p56813
g9
sS'of,uncertain,mechanism'
p56814
g3
sS'administered,mg,orally'
p56815
g3
sS'was,greater,when'
p56816
g9
sS'and,initiation,of'
p56817
g9
sS'patients,on,tikosyn'
p56818
g3
sS'demonstrated,moderate,to'
p56819
g9
sS'results,of,in'
p56820
g3
sS'to,both,minimal'
p56821
g3
sS'with,agents,or'
p56822
g9
sS'to,inactivate,the'
p56823
g9
sS'a,safe,problem'
p56824
g9
sS'serum,levels,after'
p56825
g3
sS'before,or,hours'
p56826
g9
sS'necessary,eg,may'
p56827
g9
sS'bilirubin,elevations,with'
p56828
g3
sS'study,was,inadequate'
p56829
g3
sS'weight,were,administered'
p56830
g3
sS'drugs,cimetidine,co-administration'
p56831
g3
sS'qtc,prolongation,has'
p56832
g3
sS'liter,potentiated,the'
p56833
g9
sS'novoseven,should,not'
p56834
g3
sS'a,six-day,course'
p56835
g9
sS'exposed,histidines,on'
p56836
g3
sS'one,study,and'
p56837
g3
sS'concentrations,fold,higher'
p56838
g3
sS'severe,neutropenia,cells'
p56839
g3
sS'increases,ranging,from'
p56840
g3
sS'prior,to,administering'
p56841
g9
sS'cyp450s,cyp1a2,cyp2a6'
p56842
g3
sS'adrenergic,blockers,are'
p56843
g9
sS'hepatic,microsomal,enzymes'
p56844
g3
sS'increases,in,mean'
p56845
g9
sS'various,such,as'
p56846
g9
sS'generally,converted,to'
p56847
g9
sS'of,intestinal,carcinogenesis'
p56848
g3
sS'use,of,brevibloc'
p56849
g9
sS'in,adjuvant,trials'
p56850
g3
sS'these,have,been'
p56851
g3
sS'pressor,amines,possible'
p56852
g3
sS'nondepolarizing,possible,increased'
p56853
g3
sS'section,as,they'
p56854
g3
sS'higher,exposure,presumably'
p56855
g9
sS'or,mg,with'
p56856
g9
sS'endotoxin-induced,deaths,in'
p56857
g9
sS'when,tumor,response'
p56858
g3
sS'its,metabolites,with'
p56859
g9
sS'activity,should,be'
p56860
g9
sS'organometals,also,compromise'
p56861
g3
sS'alfenta,is,administered'
p56862
g9
sS'with,angiotensln,converting'
p56863
g9
sS'bilirubin,levels,by'
p56864
g3
sS'change,fasting,or'
p56865
g3
sS'use,of,antithrombotics'
p56866
g3
sS'half-life,increased,to'
p56867
g9
sS'at,h,up'
p56868
g3
sS'neutrophil,count,is'
p56869
g3
sS'isoform,selective,marker'
p56870
g3
sS'increased,to,fold'
p56871
g9
sS'when,administering,etopophos'
p56872
g9
sS'contin,prelone,st'
p56873
g9
sS'observe,that,inhibited'
p56874
g3
sS'produced,by,other'
p56875
g3
sS'pk,and,or'
p56876
g3
sS'bleeding,particularly,in'
p56877
g9
sS'the,bioavailability,and'
p56878
g3
sS'n,of,sodium'
p56879
g9
sS'of,cyp1a2,and'
p56880
g3
sS'there,is,strong'
p56881
g3
sS'preparations,before,use'
p56882
g3
sS'of,d,is'
p56883
g3
sS'as,inhibitors,for'
p56884
g3
sS'of,is,similar'
p56885
g9
sS'v,and,vii'
p56886
g3
sS'twice,those,observed'
p56887
g9
sS'edecrin,may,increase'
p56888
g9
sS'produce,nephrotoxicity,with'
p56889
g9
sS'in,a,follow-up'
p56890
g3
sS'most,potent,inhibition'
p56891
g3
sS'in,local,breast'
p56892
g3
sS'no,clinical,interaction'
p56893
g3
sS'mg,were,allowed'
p56894
g3
sS'drugs,results,from'
p56895
g3
sS'the,risk,to'
p56896
g3
sS'safety,concern,thus'
p56897
g3
sS'the,first,year'
p56898
g3
sS'from,its,binding'
p56899
g9
sS'blood,at,different'
p56900
g3
sS'c57bl,n,x'
p56901
g3
sS'analog,of,the'
p56902
g3
sS'ten-subject,study,coadministration'
p56903
g9
sS'brovana,treated,subjects'
p56904
g3
sS'relative,risk,for'
p56905
g3
sS'be,expected,when'
p56906
g9
sS'also,induced,diarrhea'
p56907
g3
sS'products,ace,inhibitors'
p56908
g3
sS'or,compete,for'
p56909
g3
sS'with,may,enhance'
p56910
g9
sS'studies,involving,metabolized'
p56911
g9
sS'before,dosing,with'
p56912
g9
sS'anticholinergic,agents,may'
p56913
g9
sS'importance,sufficient,time'
p56914
g3
sS'cardiac,conduction,eg'
p56915
g9
sS'interaction,with,concomitantly'
p56916
g9
sS'course,of,mg'
p56917
g9
sS'increase,the,risk'
p56918
g9
sS'weakness,hyperreflexia,and'
p56919
g9
sS'interactions,in,chronic'
p56920
g3
sS'serum,concentration,of'
p56921
g9
sS'performed,when,therapy'
p56922
g3
sS'with,pegasys,once'
p56923
g9
sS'increase,plasma,levels'
p56924
g9
sS'rifampin,reduced,plasma'
p56925
g9
sS'triazolopyridazines,and,others'
p56926
g9
sS'was,no,alteration'
p56927
g3
sS'nephrolithiasis,is,higher'
p56928
g9
sS'oral,administration,appeared'
p56929
g3
sS'suggesting,that,at'
p56930
g9
sS'requiring,treatment,dyspnea'
p56931
g3
sS'initiation,of,itraconazole'
p56932
g9
sS'such,as,should'
p56933
g3
sS'present,a,theoretical'
p56934
g9
sS'interaction,study,of'
p56935
g3
sS'concentrations,and,peak'
p56936
g9
sS'renal,plasma,flow'
p56937
g3
sS'benzodiazepines,combination,hormonal'
p56938
g9
sS'been,greater,than'
p56939
g9
sS'for,an,additive'
p56940
g9
sS'after,a,day'
p56941
g3
sS'and,the,has'
p56942
g9
sS'serum-deprived,ras-transformed,ras-3t3'
p56943
g3
sS'ci,increase,increase'
p56944
g3
sS'containing,should,also'
p56945
g3
sS'epilepsy,also,receiving'
p56946
g3
sS'therapy,for,maintenance'
p56947
g3
sS'brain,hemorrhage,and'
p56948
g3
sS'with,other,oxytocic'
p56949
g3
sS'a,multiple-dose,study'
p56950
g9
sS'iv,ace,inhibitors'
p56951
g3
sS'or,kineret,when'
p56952
g3
sS'are,excreted,by'
p56953
g3
sS'tablets,benedicts,solution'
p56954
g3
sS'acid,and,b12'
p56955
g3
sS'of,supplemental,folic'
p56956
g3
sS'pharmacodynamic,consequences,of'
p56957
g3
sS'potentiates,increasing,their'
p56958
g3
sS'healthy,subject,n'
p56959
g3
sS'therefore,a,slower'
p56960
g9
sS'of,the,hypotensive'
p56961
g9
sS'supplements,theoretically,may'
p56962
g9
sS'to,the,major'
p56963
g3
sS'mexate,use,of'
p56964
g9
sS'nonlinear,weighted,least'
p56965
g3
sS'levels,of,antidepressant'
p56966
g9
sS'included,beta-adrenergic,receptor'
p56967
g3
sS'abnormalities,and,increase'
p56968
g9
sS'a,single-dose,study'
p56969
g3
sS'between,study,without'
p56970
g3
sS'treatment,with,a'
p56971
g9
sS'of,r-warfarin,the'
p56972
g9
sS'with,resistance,or'
p56973
g3
sS'in,the,nac'
p56974
g3
sS'mg,qd,by'
p56975
g9
sS'implications,for,decreased'
p56976
g3
sS'disorders,in,patients'
p56977
g3
sS'separate,controlled,parallel'
p56978
g3
sS'in,part,to'
p56979
g9
sS'there,is,some'
p56980
g9
sS'another,female,dog'
p56981
g3
sS'non-steroidal,anti-inflammatory,but'
p56982
g3
sS'reported,that,a'
p56983
g3
sS'suggest,that,are'
p56984
g3
sS'of,the,cpk'
p56985
g3
sS'not,recovered,weeks'
p56986
g3
sS'significantly,while,those'
p56987
g3
sS'blocks,the,metabolism'
p56988
g9
sS'shown,to,prevent'
p56989
g9
sS'patients,receiving,accutane'
p56990
g3
sS'cyp3a4,may,result'
p56991
g3
sS'days,the,dose'
p56992
g3
sS'drug,interactions,between'
p56993
g3
sS'the,addition,of'
p56994
g9
sS'and,are,inhibitors'
p56995
g3
sS'of,increased,when'
p56996
g9
sS'depressants,may,potentiate'
p56997
g9
sS'or,placebo,for'
p56998
g3
sS'and,potentiates,the'
p56999
g3
sS'tenormin,plus,a'
p57000
g3
sS'tachycardia,produced,by'
p57001
g9
sS'aerolizertm,inhalation,device'
p57002
g3
sS'have,a,synergistic'
p57003
g3
sS'intake,prior,to'
p57004
g9
sS'frequent,monitoring,of'
p57005
g3
sS'not,increase,the'
p57006
g3
sS'decreased,activity,because'
p57007
g3
sS'form,chelates,with'
p57008
g3
sS'separated,from,mg'
p57009
g9
sS'general,these,are'
p57010
g3
sS'provided,to,the'
p57011
g3
sS'mean,plasma,concentrations'
p57012
g9
sS'addiction,while,they'
p57013
g3
sS'of,therapy,with'
p57014
g9
sS'of,human,breast'
p57015
g9
sS'primary,cns,effects'
p57016
g3
sS'virus,also,known'
p57017
g3
sS'incompatible,with,and'
p57018
g3
sS'of,increased,plasma'
p57019
g9
sS'the,adverse,effects'
p57020
g9
sS'of,was,higher'
p57021
g9
sS'by,a,week'
p57022
g3
sS'however,in,clinical'
p57023
g3
sS'or,may,reduce'
p57024
g9
sS'mg,capsules,with'
p57025
g9
sS'role,in,the'
p57026
g3
sS'circulating,active,metabolites'
p57027
g3
sS'significantly,inhibit,proliferation'
p57028
g9
sS'treated,with,taxol'
p57029
g3
sS'these,effects,of'
p57030
g3
sS'it,is,necessary'
p57031
g9
sS'inducers,and,adjustment'
p57032
g9
sS'to,receive,mg'
p57033
g3
sS'a,prolonged,infusion'
p57034
g3
sS'sustiva,mg,once'
p57035
g9
sS'which,may,not'
p57036
g3
sS'substrate,for,cyp3a4'
p57037
g3
sS'weekly,subcutaneous,injections'
p57038
g3
sS'the,tysabri,associated'
p57039
g3
sS'the,acute,phase'
p57040
g3
sS'components,n1,n2'
p57041
g3
sS'in,the,brain'
p57042
g3
sS'cleansers,soaps,and'
p57043
g3
sS'methionine,may,protect'
p57044
g9
sS'population,chronically,receiving'
p57045
g3
sS'studies,involving,either'
p57046
g3
sS'resistance,arteries,from'
p57047
g3
sS'when,coadministering,these'
p57048
g9
sS'with,another,positively-charged'
p57049
g3
sS'with,used,in'
p57050
g3
sS'the,first,dose'
p57051
g3
sS'mhd,however,is'
p57052
g3
sS'triglyceride,plasma,levels'
p57053
g3
sS'profile,of,either'
p57054
g9
sS'g,per,day'
p57055
g3
sS'study,the,concomitant'
p57056
g3
sS'and,qualitative,differences'
p57057
g3
sS'infusion,was,continued'
p57058
g3
sS'by,self-injection,of'
p57059
g3
sS'the,outcome,of'
p57060
g3
sS'day,and,from'
p57061
g3
sS'discontinuation,is,recommended'
p57062
g3
sS'children,who,have'
p57063
g3
sS'basis,for,the'
p57064
g3
sS'chop-haart,patients,than'
p57065
g3
sS'aeds,on,gabitril'
p57066
g9
sS'from,the,lumen'
p57067
g3
sS'gain,when,was'
p57068
g9
sS'but,cases,of'
p57069
g9
sS'term,therapy,after'
p57070
g9
sS'interfere,with,platelet'
p57071
g3
sS'including,ethacrynic,acid'
p57072
g9
sS'elevations,seen,in'
p57073
g9
sS'effects,toward,other'
p57074
g3
sS'with,krm-1648,exhibited'
p57075
g9
sS'role,in,mediating'
p57076
g3
sS'both,cyp2c9,and'
p57077
g3
sS'injectable,an,increased'
p57078
g9
sS'of,toxicity,should'
p57079
g9
sS'occurs,in,a'
p57080
g3
sS'of,were,reduced'
p57081
g9
sS'glyburide,etodolac,has'
p57082
g3
sS'biocytin,in,the'
p57083
g3
sS'kinetic,characteristics,for'
p57084
g3
sS'on,receiving,concurrent'
p57085
g9
sS'alter,renal,excretion'
p57086
g3
sS'is,given,should'
p57087
g9
sS'fully,evaluating,the'
p57088
g3
sS'in,lowering,of'
p57089
g9
sS'normal,male,and'
p57090
g9
sS'toxicity,cns,depression'
p57091
g3
sS'v,has,been'
p57092
g3
sS'below,drugs,that'
p57093
g9
sS'infusion,solutions,until'
p57094
g3
sS'these,purposes,cannot'
p57095
g3
sS'channel,blockers,may'
p57096
g9
sS'with,produced,approximately'
p57097
g3
sS'blunt,the,bronchodilator'
p57098
g3
sS'routes,a,reduction'
p57099
g9
sS'induce,or,inhibit'
p57100
g3
sS'also,has,no'
p57101
g9
sS'lng,were,decreased'
p57102
g3
sS'of,variability,in'
p57103
g3
sS'with,oral,carbonic'
p57104
g9
sS'has,revealed,no'
p57105
g3
sS'other,than,the'
p57106
g3
sS'nsaids,can,inhibit'
p57107
g9
sS'increase,the,potential'
p57108
g3
sS'substituted,for,the'
p57109
g3
sS'not,bear,directly'
p57110
g9
sS'serum,valproic,acid'
p57111
g3
sS'kg,person,based'
p57112
g3
sS'breast,cancer,cells'
p57113
g9
sS'blocking,agents,experience'
p57114
g9
sS'metabolism,are,important'
p57115
g3
sS'usually,only,in'
p57116
g3
sS'seen,during,treatment'
p57117
g9
sS'agents,with,proleukin'
p57118
g9
sS'cyp1a2,is,known'
p57119
g3
sS'while,plasma,exposure'
p57120
g9
sS'subjects,no,effect'
p57121
g9
sS'when,the,decision'
p57122
g3
sS'days,however,reduced'
p57123
g9
sS'cyp1a2,concomitant,use'
p57124
g9
sS'minimum,inhibitory,concentrations'
p57125
g3
sS'this,may,interact'
p57126
g3
sS'of,racemic,mg'
p57127
g3
sS'serum,hormone,levels'
p57128
g3
sS'on,immune,system'
p57129
g3
sS'levels,were,increased'
p57130
g9
sS'not,inhibit,metabolism'
p57131
g3
sS'estradiol,should,be'
p57132
g9
sS'and,antidiuretic,hormone'
p57133
g3
sS'experience,with,concomitant'
p57134
g3
sS'the,effect,may'
p57135
g3
sS'it,is,also'
p57136
g3
sS'acids,proteins,and'
p57137
g3
sS'function,accompanied,by'
p57138
g9
sS'in,about,a'
p57139
g9
sS'experiments,demonstrated,a'
p57140
g3
sS'three,concentrations,was'
p57141
g3
sS'tachycardia,was,significantly'
p57142
g9
sS'and,vasodilators,the'
p57143
g9
sS'inhibitors,maois,selegiline'
p57144
g9
sS'here,we,examined'
p57145
g3
sS'has,a,synergistic'
p57146
g9
sS'to,affect,renal'
p57147
g3
sS'levels,levodopa,is'
p57148
g3
sS'if,leprosy-associated,inflammatory'
p57149
g9
sS'or,the,presence'
p57150
g3
sS'factor,ii,v'
p57151
g3
sS'may,require,higher'
p57152
g3
sS'using,the,tail-flick'
p57153
g3
sS'gathered,for,every'
p57154
g3
sS'patient,during,treatment'
p57155
g3
sS'and,other,drug'
p57156
g3
sS'coadministration,of,cytochrome'
p57157
g3
sS'cervical,vertebra,at'
p57158
g3
sS'rate,when,taken'
p57159
g9
sS'to,adverse,events'
p57160
g3
sS'of,a,solution'
p57161
g3
sS'studies,in,hiv-1'
p57162
g3
sS'm,basis,and'
p57163
g3
sS'a,single,small'
p57164
g3
sS'of,the,vitamin'
p57165
g3
sS'with,further,enhanced'
p57166
g3
sS'cyp3a4,should,be'
p57167
g9
sS'chick,embryos,in'
p57168
g9
sS'treat,achlorhydria,and'
p57169
g3
sS'the,french,non-governmental'
p57170
g3
sS'i,without,alterations'
p57171
g3
sS'the,elderly,basic'
p57172
g3
sS'drug-laboratory,test,interactions'
p57173
g3
sS'cough,and,cold'
p57174
g9
sS'equilibrium,and,the'
p57175
g3
sS'may,intensify,electrolyte'
p57176
g3
sS'and,primarily,metabolized'
p57177
g3
sS'to,influence,the'
p57178
g9
sS'that,fluvoxamine,tablets'
p57179
g9
sS'dmpge2,induces,a'
p57180
g3
sS'by,p450,c9'
p57181
g3
sS'extensively,bound,to'
p57182
g3
sS'microtubules,was,improved'
p57183
g3
sS'interpretation,glucose,and'
p57184
g3
sS'intravenously,as,mg'
p57185
g9
sS'such,factors,as'
p57186
g3
sS'and,greater,eaca'
p57187
g3
sS'with,administration,of'
p57188
g3
sS'myopathy,rhabdomyolysis,and'
p57189
g9
sS'factor,support,was'
p57190
g3
sS'co-administered,with,another'
p57191
g3
sS'tachycardia,induced,by'
p57192
g9
sS'can,inhibit,cyp2c19'
p57193
g3
sS'time,at,the'
p57194
g3
sS'also,lowers,serum'
p57195
g3
sS'cause,induction,or'
p57196
g3
sS'in,addition,higher-than'
p57197
g9
sS'elevated,with,by'
p57198
g3
sS'of,fatty,acids'
p57199
g3
sS'gram,positive,and'
p57200
g3
sS'than,for,strains'
p57201
g3
sS'to,times,the'
p57202
g3
sS'of,baraclude,with'
p57203
g3
sS'are,hypersensitive,to'
p57204
g9
sS'be,different,for'
p57205
g3
sS'nimbex,include,certain'
p57206
g9
sS'the,site,of'
p57207
g3
sS'fed,further,fe'
p57208
g3
sS'time,point,in'
p57209
g3
sS'in,the,diet'
p57210
g9
sS'elimination,of,each'
p57211
g3
sS'of,the,hmg-coa'
p57212
g9
sS'following,eight,target'
p57213
g3
sS'patients,taking,low-dose'
p57214
g3
sS'luteinizing,hormone,lh'
p57215
g3
sS'carbidopa,given,with'
p57216
g3
sS'conjugates,was,used'
p57217
g3
sS'agents,the,metabolism'
p57218
g3
sS'activity,with,lowered'
p57219
g9
sS'with,or,may'
p57220
g9
sS'only,with,concomitant'
p57221
g3
sS'acidosis,have,been'
p57222
g3
sS'starlix,three,times'
p57223
g3
sS'interval,may,occur'
p57224
g3
sS'anticoagulants,should,be'
p57225
g3
sS'possibility,of,an'
p57226
g9
sS'shock,can,in'
p57227
g9
sS'of,an,containing'
p57228
g9
sS'interacts,with,other'
p57229
g3
sS'the,nac,and'
p57230
g3
sS'precipitation,occurs,when'
p57231
g3
sS'that,and,fenofibric'
p57232
g3
sS'neuromuscular,weakness,may'
p57233
g9
sS'corticosteroids,systemic,are'
p57234
g3
sS'uremic,patients,serum'
p57235
g3
sS'together,the,effects'
p57236
g3
sS'microdosed,minipill,preparations'
p57237
g9
sS'and,have,no'
p57238
g3
sS'interactions,the,administration'
p57239
g3
sS'concentrations,of,microg'
p57240
g3
sS'dose,increase,in'
p57241
g3
sS'primarily,degraded,by'
p57242
g3
sS'and,because,of'
p57243
g9
sS'with,little,or'
p57244
g9
sS'days,of,beginning'
p57245
g3
sS'require,a,dose'
p57246
g9
sS'volunteer,received,a'
p57247
g3
sS'for,a,fold'
p57248
g3
sS'concurrently,with,a'
p57249
g3
sS'copper,sulfate,tests'
p57250
g3
sS'other,systemic,etc'
p57251
g9
sS'levels,of,however'
p57252
g9
sS'oxc,and,mhd'
p57253
g3
sS'potentiate,the,cardiovascular'
p57254
g3
sS'understanding,and,identifications'
p57255
g3
sS'cause,direct,coombs'
p57256
g3
sS'hour,then,mg'
p57257
g3
sS'indeed,have,a'
p57258
g9
sS'and,resulted,in'
p57259
g9
sS'to,severe,hypoglycemia'
p57260
g9
sS'including,such,as'
p57261
g9
sS'sequential,high,dose'
p57262
g9
sS'dose,of,their'
p57263
g9
sS'was,administered,concomitantly'
p57264
g9
sS'clearance,in,psychiatric'
p57265
g9
sS'and,loss,of'
p57266
g9
sS'essentially,completely,absorbed'
p57267
g3
sS'of,precedex,for'
p57268
g3
sS'mechanism,s,of'
p57269
g3
sS'steady,state,plasma'
p57270
g9
sS'illustrated,information,for'
p57271
g3
sS'gravis,inflammatory,arthritis'
p57272
g9
sS'single,mg,vardenafil'
p57273
g9
sS'group,the,dose'
p57274
g3
sS'kg,or,vehicle'
p57275
g3
sS'inducers,of,cyp3a'
p57276
g9
sS'proposed,by,barton'
p57277
g3
sS'the,population,has'
p57278
g3
sS'hours,after,administration'
p57279
g3
sS'whether,the,desired'
p57280
g9
sS'side,chains,of'
p57281
g3
sS'lag,phase,in'
p57282
g3
sS'animal,experience,indicates'
p57283
g9
sS'as,deltasone,orasone'
p57284
g3
sS'may,have,several'
p57285
g3
sS'depression,or,other'
p57286
g3
sS'phenytoin,tiagabine,had'
p57287
g3
sS'of,by,inhibiting'
p57288
g9
sS'the,onset,and'
p57289
g9
sS'midamor,may,each'
p57290
g9
sS'with,clinical,laboratory'
p57291
g3
sS'and,prevent,the'
p57292
g3
sS'in,plasma,or'
p57293
g3
sS'been,associated,in'
p57294
g9
sS'of,mice,induced'
p57295
g3
sS'and,inr,were'
p57296
g3
sS'high-dose,a,resulting'
p57297
g9
sS'c9,should,be'
p57298
g3
sS'and,activated,the'
p57299
g3
sS'placebo,oral,placebo'
p57300
g3
sS'other,nsaids,can'
p57301
g9
sS'potentiated,the,apoptosis'
p57302
g3
sS'decrease,the,tubular'
p57303
g9
sS'of,low,molecular'
p57304
g3
sS'reactions,are,dizziness'
p57305
g3
sS'in,an,area'
p57306
g3
sS'a,useful,tool'
p57307
g3
sS'paper,is,a'
p57308
g3
sS'recommended,that,fluvoxamine'
p57309
g9
sS'measurement,of,pharmacokinetic'
p57310
g3
sS'of,and,nsaids'
p57311
g9
sS'who,developed,increased'
p57312
g9
sS'decreases,gastrointestinal,secretion'
p57313
g9
sS'the,diabetic,chinese'
p57314
g3
sS'can,occur,sometimes'
p57315
g3
sS'no,interactions,of'
p57316
g3
sS'is,especially,important'
p57317
g3
sS'epa,supplements,have'
p57318
g3
sS'dose,of,oral'
p57319
g9
sS'of,administered,h'
p57320
g3
sS'among,fifteen,species'
p57321
g3
sS'effect,of,panretin'
p57322
g3
sS'when,the,treatment'
p57323
g9
sS'several,days,after'
p57324
g9
sS'are,antagonized,by'
p57325
g9
sS'is,not,related'
p57326
g3
sS'several,days,later'
p57327
g3
sS'when,administering,cerebyx'
p57328
g3
sS'groups,treated,with'
p57329
g9
sS'by,cyp3a4,and'
p57330
g3
sS'method,the,inulin'
p57331
g3
sS'possible,be,discontinued'
p57332
g9
sS'to,the,potential'
p57333
g9
sS'niddm,subjects,decreases'
p57334
g3
sS'study,we,investigated'
p57335
g3
sS'blockers,nonsteroidal,antiinflammatories'
p57336
g3
sS'that,blockers,also'
p57337
g3
sS'in,serum,creatinine'
p57338
g9
sS'safely,to,patients'
p57339
g3
sS'possible,effects,on'
p57340
g3
sS'recommended,to,determine'
p57341
g3
sS'to,be,combined'
p57342
g9
sS'sodium,nor,its'
p57343
g3
sS'method,of,contraception'
p57344
g9
sS'and,molecular,level'
p57345
g3
sS'affect,other,drugs'
p57346
g3
sS'the,group,that'
p57347
g3
sS'in,b-cell,dependent'
p57348
g3
sS'ssris,and,d'
p57349
g3
sS'renal,disease,on'
p57350
g3
sS'days,or,mg'
p57351
g3
sS'however,it,was'
p57352
g3
sS'when,deet,was'
p57353
g3
sS'single,case,report'
p57354
g9
sS'compound,and,sodium'
p57355
g3
sS'chelator,therapies,as'
p57356
g3
sS'and,the,leukopenic'
p57357
g9
sS'fertility,no,long-term'
p57358
g3
sS'represent,the,best'
p57359
g3
sS'of,potent,non-nucleoside'
p57360
g3
sS'vitro,metabolic,reactions'
p57361
g3
sS'prothrombin,time,determinations'
p57362
g9
sS'impact,of,renal'
p57363
g3
sS'minimal,inhibitory,concentration'
p57364
g3
sS'effects,including,dry'
p57365
g9
sS'effects,may,induce'
p57366
g9
sS'first-pass,metabolism,are'
p57367
g3
sS'a,typical,side'
p57368
g3
sS'of,both,together'
p57369
g9
sS'considered,if,the'
p57370
g9
sS'significant,pharmacokinetic,or'
p57371
g3
sS'to,be,greater'
p57372
g9
sS'antipyrine,antipyrine,pharmacokinetics'
p57373
g3
sS'whether,might,induce'
p57374
g3
sS'the,mitogenic,effect'
p57375
g9
sS'thinners,decongestant,allergy'
p57376
g9
sS'or,and,axert'
p57377
g9
sS'undergo,enterohepatic,circulation'
p57378
g9
sS'ns,was,administered'
p57379
g9
sS'and,inhibit,p450'
p57380
g3
sS'anaesthetic,agents,which'
p57381
g3
sS'for,other,and'
p57382
g3
sS'the,thioether,concentration'
p57383
g3
sS'data,is,very'
p57384
g3
sS'events,or,reduced'
p57385
g9
sS'when,meclofenamate,sodium'
p57386
g9
sS'thiazide,may,prevent'
p57387
g9
sS'approximately,to,fold'
p57388
g9
sS'been,performed,to'
p57389
g3
sS'diabetics,blood-sugar,levels'
p57390
g3
sS'ocular,blood,flow'
p57391
g3
sS'concentrations,showing,a'
p57392
g3
sS'the,last,subcutaneous'
p57393
g9
sS'treatment,plans,for'
p57394
g3
sS'routine,dosage,adjustment'
p57395
g3
sS'and,is,likely'
p57396
g9
sS'small,intestinal,mucosa'
p57397
g3
sS'o,induced,diarrhea'
p57398
g9
sS'interaction,after,treatment'
p57399
g3
sS'be,performed,weekly'
p57400
g3
sS'this,treatment,arm'
p57401
g3
sS'levels,were,not'
p57402
g3
sS'to,be,highly'
p57403
g3
sS'combination,with,indicate'
p57404
g9
sS'metabolism,of,c'
p57405
g3
sS'of,nephrotoxicity,and'
p57406
g9
sS'to,avoid,them'
p57407
g3
sS'inhibitors,of,renal'
p57408
g3
sS'of,and,concurrent'
p57409
g9
sS'by,an,nad'
p57410
g3
sS'metabolism,of,s'
p57411
g9
sS'effectiveness,in,men'
p57412
g3
sS'been,documented,prothrombin'
p57413
g3
sS'patients,below,the'
p57414
g3
sS'after,introduction,of'
p57415
g9
sS'adapter,protein,involved'
p57416
g3
sS'therapy,was,recently'
p57417
g9
sS'other,and,for'
p57418
g3
sS'dexamethasone,steady-state,trough'
p57419
g9
sS'administration,of,as'
p57420
g9
sS'ethoxycoumarine,deethylase,in'
p57421
g3
sS'of,rash,pruritus'
p57422
g3
sS'administration,of,an'
p57423
g9
sS'mainly,on,the'
p57424
g3
sS'between,coadministered,with'
p57425
g3
sS'potentiate,amphotericin,b-'
p57426
g9
sS'pseudotumor,cerebri,benign'
p57427
g9
sS'enhancement,of,intestinal'
p57428
g3
sS'of,clinically,important'
p57429
g3
sS'a4,inhibitors,elevated'
p57430
g3
sS'sustiva,and,in'
p57431
g3
sS'with,qt-interval,prolongation'
p57432
g3
sS'hormonal,contraceptives,it'
p57433
g3
sS'mg,mg,bid'
p57434
g3
sS'of,some,forms'
p57435
g3
sS'therefore,clozapine,should'
p57436
g3
sS'to,the,parental'
p57437
g3
sS'severe,orthostatic,hypotension'
p57438
g9
sS'resistant,to,both'
p57439
g3
sS'of,with,alfenta'
p57440
g9
sS'inhibitors,for,most'
p57441
g3
sS'fluorescence,labelled,and'
p57442
g3
sS'colonic,transit-enhancing,effect'
p57443
g3
sS'infection,with,this'
p57444
g3
sS'l-glutamine,at,a'
p57445
g9
sS'withdrawn,from,co-therapy'
p57446
g3
sS'demonstrated,between,argatroban'
p57447
g3
sS'exposure,of,rats'
p57448
g9
sS'a,chop-like,regimen'
p57449
g3
sS'metal,cations,multivitamins'
p57450
g3
sS'tablets,and,any'
p57451
g3
sS'elimination,and,cause'
p57452
g9
sS'unprotected,by,the'
p57453
g3
sS'our,results,indicate'
p57454
g3
sS'qd,mg,tid'
p57455
g9
sS'with,one,of'
p57456
g3
sS'exercised,in,extrapolating'
p57457
g3
sS'serum,with,concomitant'
p57458
g3
sS'the,prolongation,of'
p57459
g9
sS'are,no,study'
p57460
g9
sS'oral,mg,dose'
p57461
g3
sS'symptoms,have,been'
p57462
g9
sS'is,especially,so'
p57463
g3
sS'studies,with,dynacirc'
p57464
g3
sS'although,specific,studies'
p57465
g9
sS'of,diet,and'
p57466
g3
sS'of,the,substances'
p57467
g3
sS'deficiency,due,to'
p57468
g3
sS'concentrations,during,concomitant'
p57469
g9
sS'from,dependence,usually'
p57470
g3
sS'test,which,suggested'
p57471
g3
sS'antidepressants,foradil,should'
p57472
g9
sS'atherosclerotic,risk,factors'
p57473
g3
sS'aeruginosa,serotype,o11'
p57474
g3
sS'antacids,enteric,coated'
p57475
g9
sS'ischemia,of,the'
p57476
g3
sS'administration,of,tambocor'
p57477
g9
sS'as,valium,and'
p57478
g9
sS'cancer,diabetes,mellitus'
p57479
g3
sS'shown,consistent,effects'
p57480
g3
sS'potentiated,by,a'
p57481
g9
sS'cells,treated,with'
p57482
g3
sS'stools,in,patients'
p57483
g3
sS'against,two,type'
p57484
g3
sS'effect,of,all'
p57485
g9
sS'agents,decrease,blood'
p57486
g9
sS'both,the,rate'
p57487
g9
sS'is,metabolized,mainly'
p57488
g3
sS'inactivated,by,reaction'
p57489
g3
sS'aeruginosa,were,inhibited'
p57490
g3
sS'minutes,post,and'
p57491
g3
sS'problems,with,blood'
p57492
g3
sS'antihypertensive,necessitating,a'
p57493
g9
sS'of,the,co-administered'
p57494
g3
sS'amiodarone,contraindicated,due'
p57495
g3
sS'excessive,release,in'
p57496
g3
sS'with,the,cyp3a4'
p57497
g9
sS'x-ray,diffraction,differential'
p57498
g3
sS'of,thiobarbituric,acid'
p57499
g3
sS'in,normovolemic,healthy'
p57500
g9
sS'mg,qd,resulted'
p57501
g9
sS'inhibit,cyp2e1,but'
p57502
g3
sS'reduced,risk,of'
p57503
g3
sS'hippocampal,lesions,or'
p57504
g3
sS'appropriate,dose,for'
p57505
g3
sS'digoxin,some,blockers'
p57506
g9
sS'possibility,that,might'
p57507
g9
sS'or,the,side'
p57508
g9
sS'repeated,co-administration,of'
p57509
g9
sS'of,these,supplements'
p57510
g3
sS'because,xigris,may'
p57511
g3
sS'in,fold,increase'
p57512
g9
sS'intensive,monitoring,of'
p57513
g3
sS'of,spontaneous,motility'
p57514
g9
sS'mepron,interferes,with'
p57515
g3
sS'sensitivity,and,enhance'
p57516
g9
sS'twelve,strains,of'
p57517
g9
sS'to,produce,clinically'
p57518
g9
sS'compared,to,ace'
p57519
g9
sS'adrenocorticoids,metabolic,clearance'
p57520
g3
sS'antagonists,hmg-coa,reductase'
p57521
g3
sS'systemic,circulation,there'
p57522
g9
sS'potential,for,additive'
p57523
g9
sS'kg,on,the'
p57524
g9
sS'withdrawal,and,dose'
p57525
g9
sS'seriously,worsening,asthma'
p57526
g3
sS'function,tests,should'
p57527
g3
sS'interrupted,when,the'
p57528
g3
sS'pretreatment,of,healthy'
p57529
g9
sS'approximately,hours,after'
p57530
g9
sS'evidence,that,increased'
p57531
g3
sS'combined,with,krm-1648'
p57532
g9
sS'contraceptives,a,group'
p57533
g3
sS'prior,to,difluoroacetone'
p57534
g3
sS'cyp3a4,inhibitor,or'
p57535
g3
sS'this,diminution,is'
p57536
g3
sS'small,pulse,of'
p57537
g3
sS'absorption,of,resulting'
p57538
g9
sS'the,pharmacokinetic,variables'
p57539
g3
sS'of,tyrosine,phosphorylation'
p57540
g3
sS'of,used,in'
p57541
g3
sS'forevidence,of,withdrawal'
p57542
g9
sS'caused,by,the'
p57543
g9
sS'pregnancy,tests,with'
p57544
g3
sS'types,of,interferences'
p57545
g3
sS'arava,levels,to'
p57546
g9
sS'found,to,inhibit'
p57547
g9
sS'modification,of,surface'
p57548
g3
sS'adrenocortical,dependent,hypertension'
p57549
g9
sS'kg,and,mg'
p57550
g9
sS'the,assay,result'
p57551
g3
sS'in,glutamatergic,activation'
p57552
g3
sS'given,with,the'
p57553
g3
sS'carcinogenesis,study,was'
p57554
g3
sS'demonstrated,less,alteration'
p57555
g9
sS'in,levels,in'
p57556
g3
sS'gly-buride,and,did'
p57557
g3
sS'aed,s,that'
p57558
g9
sS'for,which,alterations'
p57559
g3
sS'to,enhance,the'
p57560
g9
sS'pharmacokinetics,of,other'
p57561
g3
sS'oral,aprepitant,when'
p57562
g9
sS'administered,by,any'
p57563
g9
sS'be,demonstrated,by'
p57564
g3
sS'a,maximum,of'
p57565
g9
sS'to,a,relatively'
p57566
g3
sS'any,antineoplastic,agents'
p57567
g3
sS'recipients,a,reduction'
p57568
g9
sS'addition,of,felbatol'
p57569
g9
sS'may,be,seen'
p57570
g9
sS'general,cognitive,function'
p57571
g3
sS'not,suggest,any'
p57572
g3
sS'prior,to,or'
p57573
g9
sS'reduced,or,eliminated'
p57574
g9
sS'with,causes,an'
p57575
g9
sS'of,ellence,with'
p57576
g9
sS'margin,after,spontaneous'
p57577
g3
sS'the,acceleration,of'
p57578
g3
sS'sertraline,neutralized,the'
p57579
g3
sS'bromocriptine,mesylate,may'
p57580
g9
sS'by,could,affect'
p57581
g3
sS'of,min,before'
p57582
g9
sS'cyp3a4,substrates,that'
p57583
g9
sS'were,not,altered'
p57584
g3
sS'induce,both,hyperthyroidism'
p57585
g3
sS'tail-flick,inhibition,induced'
p57586
g9
sS'as,v,concentrations'
p57587
g3
sS'decrease,in,levels'
p57588
g9
sS'to,use,such'
p57589
g3
sS'threefold,from,to'
p57590
g9
sS'oral,antagonists,may'
p57591
g9
sS'fully,formed,cysts'
p57592
g3
sS'have,no,detectable'
p57593
g3
sS'approximately,mean,sodium'
p57594
g9
sS'mg,of,per'
p57595
g3
sS'broth,using,a'
p57596
g3
sS'lodine,is,administered'
p57597
g9
sS'sulfate,tests,benedicts'
p57598
g3
sS'the,following,was'
p57599
g3
sS'inhibitors,ssris,ssris'
p57600
g9
sS'advantages,over,pi-based'
p57601
g3
sS'transfusion,practices,for'
p57602
g3
sS'with,tuberculosis,showed'
p57603
g9
sS'a,pharmacokinetic,study'
p57604
g3
sS'carrying,out,tests'
p57605
g3
sS'iressa,may,exacerbate'
p57606
g9
sS'out,mainly,on'
p57607
g3
sS'certain,brain,chemical'
p57608
g3
sS'mild-to,moderate,inhibitors'
p57609
g3
sS'co-administration,of,t'
p57610
g9
sS'tablets,administration,of'
p57611
g9
sS'sequestrants,have,been'
p57612
g3
sS'compounds,eg,and'
p57613
g9
sS'same,in,both'
p57614
g3
sS'the,patients,treated'
p57615
g3
sS'given,with,because'
p57616
g9
sS'than,mg,mg'
p57617
g3
sS'suggest,that,coadministration'
p57618
g9
sS'kg,day,for'
p57619
g3
sS'anti-arrhythmics,and,anti-depressants'
p57620
g9
sS'co-administration,of,a'
p57621
g9
sS'omnicef,therapy,omnicef'
p57622
g9
sS'analogue,scales,vital'
p57623
g3
sS'per,day,decreases'
p57624
g9
sS'be,reduced,by'
p57625
g9
sS'trials,the,patients'
p57626
g3
sS'the,tardive,dyskinesia'
p57627
g9
sS'maltose,interference,with'
p57628
g3
sS'in,the,dosage'
p57629
g9
sS'function,as,inhibitors'
p57630
g3
sS'once,weekly,reduced'
p57631
g9
sS'only,at,concentrations'
p57632
g3
sS'days,produced,significant'
p57633
g9
sS'in,plasma,samples'
p57634
g3
sS'ineffective,in,preventing'
p57635
g3
sS'serum,supplemented,with'
p57636
g3
sS'which,requires,more'
p57637
g3
sS'diet,or,with'
p57638
g3
sS'on,the,extent'
p57639
g3
sS'cyp,a,or'
p57640
g3
sS'significant,effect,on'
p57641
g3
sS'risks,maximize,benefits'
p57642
g3
sS'bid,have,not'
p57643
g3
sS'moreover,each,task'
p57644
g3
sS'ethinyl,estradiol,concentrations'
p57645
g3
sS'a,weak,inhibitor'
p57646
g3
sS'patients,receiving,medications'
p57647
g3
sS'and,a,series'
p57648
g3
sS'the,resulting,mixture'
p57649
g3
sS'with,a,low'
p57650
g3
sS'tracleer,is,not'
p57651
g3
sS'concentrations,of,resulting'
p57652
g9
sS'gastrointestinal,secretion,while'
p57653
g9
sS'however,preliminary,results'
p57654
g3
sS'mean,cmax,and'
p57655
g9
sS'with,camp,whereas'
p57656
g9
sS'also,been,reported'
p57657
g3
sS'variability,of,these'
p57658
g3
sS'mg,to,a'
p57659
g3
sS'provided,for,any'
p57660
g3
sS'or,of,patients'
p57661
g3
sS'cyp3a4,inhibitor,increases'
p57662
g9
sS'contribute,to,the'
p57663
g9
sS'rantidine,hydrochloride,before'
p57664
g3
sS'em,individuals,treated'
p57665
g9
sS'of,actions,and'
p57666
g3
sS'cyp3a4,inhibitor,increased'
p57667
g9
sS'insp,induced,responses'
p57668
g9
sS'risk,of,methaemoglobinaemia'
p57669
g3
sS'of,two,consecutive'
p57670
g3
sS'and,other,hormonalmethods'
p57671
g9
sS'of,adenocarcinomas,which'
p57672
g9
sS'of,channel,blockers'
p57673
g3
sS'combination,products,should'
p57674
g3
sS'longer,marketed,in'
p57675
g3
sS'strong,selective,cyp3a4'
p57676
g9
sS'monitoring,of,is'
p57677
g9
sS'secretion,of,resulting'
p57678
g9
sS'lowered,numbers,of'
p57679
g3
sS'mg,administered,once'
p57680
g9
sS'therapeutic,concentrations,in'
p57681
g3
sS'this,combination,in'
p57682
g3
sS'substrate,for,both'
p57683
g3
sS'doxorubicin,caused,a'
p57684
g9
sS'pharmacokinetics,of,the'
p57685
g9
sS'a,ten-subject,study'
p57686
g9
sS'by,nor,inhibits'
p57687
g3
sS'response,to,plenaxis'
p57688
g3
sS'after,or,more'
p57689
g9
sS'tid,were,coadministered'
p57690
g3
sS'and,protease,inhibitors'
p57691
g3
sS'phosphatase,activity,but'
p57692
g3
sS'an,opposite,way'
p57693
g9
sS'hours,before,adrenal'
p57694
g3
sS'counts,in,comparison'
p57695
g9
sS'volunteers,for,days'
p57696
g3
sS'was,considered,by'
p57697
g3
sS'these,findings,suggest'
p57698
g3
sS'were,concurrently,administered'
p57699
g3
sS'unlike,nucleolin,c23'
p57700
g3
sS'intravenous,is,required'
p57701
g9
sS'and,inotropic,such'
p57702
g9
sS'by,cardiac,enlargement'
p57703
g9
sS'pacemaker,activity,can'
p57704
g9
sS'mean,minimum,concentration'
p57705
g3
sS'role,of,uptake-1'
p57706
g3
sS'of,central,nervous'
p57707
g9
sS'normal,and,diabetic'
p57708
g3
sS'been,reported,following'
p57709
g9
sS'systemic,vascular,resistance'
p57710
g9
sS'the,us,food'
p57711
g3
sS'alone,has,little'
p57712
g9
sS'could,be,prevented'
p57713
g9
sS'nicotinic,acid,erythromycin'
p57714
g3
sS'other,drugs,in'
p57715
g3
sS'occurred,when,prinivil'
p57716
g3
sS'time,hydrogen,breath'
p57717
g3
sS'hepatic,lipid,peroxidation'
p57718
g9
sS'higher,respectively,in'
p57719
g3
sS'control,symptoms,indicates'
p57720
g3
sS'lipid,peroxidation,which'
p57721
g9
sS'a,month,toxicology'
p57722
g3
sS'containing,or,and'
p57723
g9
sS'normalized,ratio,or'
p57724
g9
sS'identical,whether,the'
p57725
g3
sS'of,of,approximately'
p57726
g9
sS'of,predisposing,to'
p57727
g3
sS'hormonal,co-administration,of'
p57728
g9
sS'acarbose,and,should'
p57729
g9
sS'in,cyp3a4,mediated'
p57730
g3
sS'release,but,nearly'
p57731
g3
sS'drugs,aeds,phenytoin'
p57732
g3
sS'cmax,up,to'
p57733
g9
sS'p,a,metabolism'
p57734
g3
sS'also,the,potential'
p57735
g3
sS'replicate,this,finding'
p57736
g3
sS'no,alterations,in'
p57737
g3
sS'theophylline-related,adverse,effects'
p57738
g9
sS'determined,by,checkerboard'
p57739
g3
sS'heart,rate,or'
p57740
g3
sS'mineral,oil,and'
p57741
g9
sS'evaluated,in,a'
p57742
g3
sS'that,with,serial'
p57743
g3
sS'with,oral,and'
p57744
g9
sS'receiving,and,can'
p57745
g3
sS'the,pharmacodynamics,blood'
p57746
g3
sS'results,in,free'
p57747
g9
sS'total,concentrations,of'
p57748
g3
sS'antagonized,by,an'
p57749
g3
sS'the,availability,of'
p57750
g3
sS'mydriasis,resulting,from'
p57751
g9
sS'suspension,can,be'
p57752
g3
sS'lithium-a,interaction,study'
p57753
g3
sS'conclusion,these,findings'
p57754
g3
sS'multiple,doses,of'
p57755
g3
sS'over,in,nucleoside-experienced'
p57756
g3
sS'mg,times,day'
p57757
g3
sS'or,an,levonorgestrol'
p57758
g3
sS'of,serious,resedation'
p57759
g3
sS'agent,has,on'
p57760
g9
sS'of,some,concomitantly'
p57761
g3
sS'by,cyp3a4,eg'
p57762
g9
sS'activity,of,other'
p57763
g9
sS'and,b-cell,lymphomas'
p57764
g3
sS'pipette,compared,with'
p57765
g3
sS'by,but,had'
p57766
g9
sS'in,several,clinical'
p57767
g3
sS'mg,m2,basis'
p57768
g3
sS'in,patients,n'
p57769
g9
sS'www,rxlist,com'
p57770
g3
sS'with,may,alter'
p57771
g9
sS'patients,receiving,intravenous'
p57772
g9
sS'of,injection,use'
p57773
g3
sS'nsaid,has,not'
p57774
g3
sS'like,other,ace'
p57775
g9
sS'expected,than,when'
p57776
g9
sS'given,together,as'
p57777
g3
sS'there,are,compelling'
p57778
g3
sS'applied,for,other'
p57779
g3
sS'that,polyamines,might'
p57780
g3
sS'in,which,eight'
p57781
g3
sS'by,minutes,any'
p57782
g9
sS'cellular,and,molecular'
p57783
g3
sS'be,decreased,in'
p57784
g9
sS'endorphinergic,system,is'
p57785
g3
sS'auc,of,was'
p57786
g9
sS'clinical,studies,where'
p57787
g3
sS'oral,bioavailability,of'
p57788
g9
sS'days,after,completion'
p57789
g9
sS'systemic,administration,of'
p57790
g9
sS'all,should,be'
p57791
g9
sS'or,without,evidence'
p57792
g3
sS'or,interruption,of'
p57793
g3
sS'homogenates,supplemented,with'
p57794
g3
sS'taken,in,dose'
p57795
g3
sS'administered,with,agents'
p57796
g9
sS'cyp3a4,substrate,and'
p57797
g9
sS'close,monitoring,may'
p57798
g3
sS'with,would,be'
p57799
g9
sS'concurrently,and,that'
p57800
g3
sS'to,health,if'
p57801
g9
sS'lomefloxacin,is,unlikely'
p57802
g3
sS'of,many,angiotensin-converting'
p57803
g9
sS'of,these,peptides'
p57804
g3
sS'known,to,affect'
p57805
g3
sS'withdrawn,from,cotherapy'
p57806
g3
sS'who,received,chop'
p57807
g3
sS'of,by,fold'
p57808
g9
sS'enzyme-inducing,properties,of'
p57809
g9
sS'will,affect,the'
p57810
g9
sS'dose-dependent,fashion,as'
p57811
g9
sS'monitored,when,celebrex'
p57812
g9
sS'potent,cyp3a,inducers'
p57813
g9
sS'of,cyp3a,cytochrome'
p57814
g3
sS'does,not,predispose'
p57815
g3
sS'relevant,pharmacokinetic,or'
p57816
g3
sS'genetic,variation,also'
p57817
g3
sS'approximately,bpm,and'
p57818
g3
sS'a,including,with'
p57819
g9
sS'require,the,use'
p57820
g3
sS'the,beginning,of'
p57821
g3
sS'and,toxicokinetic,studies'
p57822
g3
sS'in,combination,to'
p57823
g9
sS'and,minimizes,this'
p57824
g9
sS'they,should,not'
p57825
g3
sS'slower,renal,elimination'
p57826
g9
sS'two,clinical,studies'
p57827
g9
sS'acidifying,agents,decrease'
p57828
g9
sS'patients,taking,concomitantly'
p57829
g9
sS'use,of,erection-supporting'
p57830
g3
sS'secondary,to,a'
p57831
g9
sS'not,on,overall'
p57832
g3
sS'healthy,volunteers,has'
p57833
g9
sS'glycosides,concurrent,use'
p57834
g3
sS'improve,this,metabolism'
p57835
g3
sS'depth,of,involvement'
p57836
g3
sS'of,administration,one'
p57837
g3
sS'its,clinical,significance'
p57838
g3
sS'should,be,reviewed'
p57839
g9
sS'augment,the,hypotension'
p57840
g9
sS'oral,absorption,of'
p57841
g9
sS'expected,plasma,levels'
p57842
g3
sS'these,small,changes'
p57843
g3
sS'dose,or,other'
p57844
g3
sS'and,or,are'
p57845
g9
sS'glycosides,in,a'
p57846
g3
sS'medicine,that,you'
p57847
g9
sS'of,t,a'
p57848
g9
sS'clearance,values,for'
p57849
g9
sS'with,of,low'
p57850
g3
sS'tricky,using,for'
p57851
g3
sS'in,the,picr'
p57852
g3
sS'medicines,including,may'
p57853
g3
sS'of,cardiac,contractility'
p57854
g9
sS'to,significant,increases'
p57855
g9
sS'or,taking,tarceva'
p57856
g9
sS'enzyme,system,responsible'
p57857
g9
sS'compared,to,use'
p57858
g9
sS'a,history,of'
p57859
g3
sS'of,carbimazole,and'
p57860
g9
sS'psa,when,evaluating'
p57861
g3
sS'medication,such,as'
p57862
g9
sS'as,nuromax,include'
p57863
g9
sS'body,clearance,is'
p57864
g3
sS'and,after,oral'
p57865
g3
sS'however,interactions,may'
p57866
g9
sS'if,this,is'
p57867
g3
sS'oral,live,typhoid'
p57868
g9
sS'your,doctor,or'
p57869
g3
sS'following,table,aed'
p57870
g3
sS'in,dosage,of'
p57871
g9
sS'unsteady,gait,or'
p57872
g9
sS'urine,glucose,levels'
p57873
g3
sS'measurement,of,fundus'
p57874
g3
sS'inhibitors,including,acetylsalicylic'
p57875
g3
sS'dependent,labelling,of'
p57876
g3
sS'the,permeation,however'
p57877
g3
sS'earth,and,transition'
p57878
g3
sS'obstipation,even,ileus'
p57879
g9
sS'decreased,the,tmax'
p57880
g9
sS'metabolized,by,those'
p57881
g3
sS'adjuvant,trials,of'
p57882
g3
sS'is,not,expected'
p57883
g3
sS'resulted,in,increase'
p57884
g9
sS'of,when,co'
p57885
g9
sS'female,subjects,received'
p57886
g3
sS'ulcerans,was,measured'
p57887
g3
sS'hydroxide,hydroxide,and'
p57888
g9
sS'and,in,a-chloralose'
p57889
g3
sS'when,flolan,is'
p57890
g9
sS'blood,pressure,usually'
p57891
g9
sS'suggest,that,interacts'
p57892
g3
sS'can,be,anticipated'
p57893
g9
sS'anemia,grade,according'
p57894
g3
sS'achieved,either,by'
p57895
g3
sS'generally,asymptomatic,but'
p57896
g3
sS'be,additive,with'
p57897
g9
sS'in,five,men'
p57898
g3
sS'mg,sodium,approximately'
p57899
g9
sS'inducers,of,cyp3a4'
p57900
g3
sS'and,mg,produced'
p57901
g9
sS'study,was,a'
p57902
g3
sS'as,and,maois'
p57903
g9
sS'lead,to,elevated'
p57904
g9
sS'at,steady-state,were'
p57905
g3
sS'h-spiroperidol,and,low'
p57906
g3
sS'of,cyp3a,compounds'
p57907
g9
sS'appropriate,observation,of'
p57908
g9
sS'dosage,reduction,with'
p57909
g3
sS'this,observed,increase'
p57910
g9
sS'cyp3a4,cyp2d6,cyp2e1'
p57911
g3
sS'suggested,with,phenyl-butazone'
p57912
g3
sS'membrane,properties,during'
p57913
g3
sS'shown,that,and'
p57914
g3
sS'urine,volume,and'
p57915
g9
sS'posed,by,and'
p57916
g3
sS'fold,of,control'
p57917
g9
sS'when,the,use'
p57918
g3
sS'division,of,miles'
p57919
g3
sS'of,hepatic,microsomal'
p57920
g3
sS'determine,the,extent'
p57921
g3
sS'to,consult,the'
p57922
g3
sS'infections,and,certain'
p57923
g3
sS'of,medications,used'
p57924
g3
sS'differential,thermal,analysis'
p57925
g3
sS'bedtime,has,revealed'
p57926
g3
sS'is,about,times'
p57927
g3
sS'this,combination,should'
p57928
g3
sS'fludrocortisone,acetate,because'
p57929
g9
sS'of,prinivil,with'
p57930
g9
sS'symbol,substitution,test'
p57931
g9
sS'subsalicylate,given,concomitantly'
p57932
g9
sS'similarly,dialyzed,were'
p57933
g3
sS'numerous,potentiation,effects'
p57934
g3
sS'extravasation,following,administration'
p57935
g3
sS'with,coronary,artery'
p57936
g3
sS'to,reduced,clearance'
p57937
g3
sS'which,are,very'
p57938
g9
sS'auc,and,very'
p57939
g9
sS'maximal,decrease,between'
p57940
g3
sS'factive,with,resulted'
p57941
g9
sS'every,other,day'
p57942
g3
sS'inhibit,renal,tubular'
p57943
g9
sS'be,detrimental,for'
p57944
g3
sS'when,dosed,with'
p57945
g3
sS'in,a,type'
p57946
g9
sS'not,been,reported'
p57947
g9
sS'and,severity,of'
p57948
g9
sS'coadministration,of,oral'
p57949
g9
sS'however,the,second'
p57950
g3
sS'while,minimizing,the'
p57951
g3
sS'control,by,its'
p57952
g9
sS'glucose,when,was'
p57953
g3
sS'withhold,during,dosing'
p57954
g9
sS'in,bioavailability,studies'
p57955
g3
sS'hormone,fsh,or'
p57956
g3
sS'when,administered,minutes'
p57957
g3
sS'determinations,of,serum'
p57958
g3
sS'mask,the,cardiotoxicity'
p57959
g3
sS'and,that,functional'
p57960
g3
sS'regard,to,the'
p57961
g3
sS'measurable,effect,on'
p57962
g3
sS'with,antacids,administration'
p57963
g9
sS'folic,acid,supplements'
p57964
g3
sS'the,pharmacodynamic,profile'
p57965
g3
sS'are,multiple,forms'
p57966
g3
sS'resistant,strains,of'
p57967
g3
sS'food,in,the'
p57968
g3
sS'iv,cannot,be'
p57969
g3
sS'a,guide,to'
p57970
g9
sS'that,binds,differently'
p57971
g3
sS'hours,two,times'
p57972
g3
sS'exjade,tablets,for'
p57973
g3
sS'other,may,inhibit'
p57974
g9
sS'being,treated,concurrently'
p57975
g9
sS'ironically,are,often'
p57976
g3
sS'should,have,more'
p57977
g3
sS'improved,when,d2o'
p57978
g3
sS'study,with,healthy'
p57979
g3
sS'the,maximum,tolerated'
p57980
g3
sS'propranolol,in,a'
p57981
g3
sS'not,recommended,due'
p57982
g9
sS'a,test,agent'
p57983
g3
sS'as,videx,chewable'
p57984
g9
sS'p450,isoforms,cyp3a4'
p57985
g3
sS'of,with,inhibitors'
p57986
g3
sS'associated,with,an'
p57987
g9
sS'for,nmda,and'
p57988
g3
sS'zebeta,may,produce'
p57989
g9
sS'injection,and,chloride'
p57990
g9
sS'l-ccg,on,the'
p57991
g3
sS'moderate,renal,impairment'
p57992
g3
sS'with,normal,renal'
p57993
g3
sS'benefit,when,compared'
p57994
g3
sS'duration,of,succinylcholine-induced'
p57995
g3
sS'urinary,excretion,was'
p57996
g3
sS'interactions,have,occurred'
p57997
g9
sS'and,mg,a'
p57998
g3
sS'broad-spectrum,augmentin,xr'
p57999
g9
sS'administration,and,the'
p58000
g3
sS'both,possibly,due'
p58001
g3
sS'and,mg,l'
p58002
g3
sS'potential,exists,for'
p58003
g3
sS'been,evaluated,but'
p58004
g9
sS'in,the,study'
p58005
g3
sS'including,those,contained'
p58006
g9
sS'and,mg,q'
p58007
g9
sS'action,of,by'
p58008
g9
sS'use,in,spite'
p58009
g3
sS'since,may,raise'
p58010
g9
sS'suggesting,an,inhibition'
p58011
g9
sS'allopurinol,increased,possibility'
p58012
g3
sS'continuous,cardiac,monitoring'
p58013
g3
sS'therefore,be,observed'
p58014
g9
sS'in,reduced,plasma'
p58015
g9
sS'sympathomimetic,amines,may'
p58016
g9
sS'this,section,were'
p58017
g3
sS'resulting,from,cholinergic'
p58018
g9
sS'in,addition,other'
p58019
g9
sS'is,adsorption,of'
p58020
g9
sS'concomitantly,only,with'
p58021
g3
sS'by,using,more'
p58022
g3
sS'the,active,s-isomer'
p58023
g3
sS'administered,metabolized,by'
p58024
g3
sS'amplitude,but,not'
p58025
g3
sS'several,closely,related'
p58026
g9
sS'reverses,when,the'
p58027
g3
sS'mg,tid,mg'
p58028
g9
sS'increase,in,adults'
p58029
g9
sS'a,first,experiment'
p58030
g3
sS'and,an,interleukin-1'
p58031
g9
sS'following,an,intubating'
p58032
g9
sS'discusses,the,advantages'
p58033
g3
sS'to,the,heat'
p58034
g3
sS'acid,using,these'
p58035
g9
sS'the,above,experiments'
p58036
g3
sS'iatrogenic,alterations,caused'
p58037
g9
sS'with,similar,frequency'
p58038
g3
sS'with,are,used'
p58039
g3
sS'choice,for,prolonged'
p58040
g3
sS'brain,hemorrhage,was'
p58041
g3
sS'effectiveness,is,reported'
p58042
g3
sS'of,cardiovascular,are'
p58043
g3
sS'dose,of,intravenously'
p58044
g9
sS'taxol,at,the'
p58045
g3
sS'to,the,effects'
p58046
g9
sS'drug,or,herbal'
p58047
g3
sS'be,monitored,appropriately'
p58048
g3
sS'formula,mg,elemental'
p58049
g3
sS'of,to,half'
p58050
g9
sS'formal,clinical,studies'
p58051
g3
sS'may,result,at'
p58052
g3
sS'on,inositol,trisphosphate-induced'
p58053
g3
sS'of,by,thyroxine-binding'
p58054
g3
sS'salmonella,typhimurium,and'
p58055
g3
sS'in,ontario,the'
p58056
g3
sS'or,prothrombin,complex'
p58057
g3
sS'hiv-infected,subjects,to'
p58058
g3
sS'might,blunt,adrenal'
p58059
g3
sS'weakness,associated,with'
p58060
g3
sS'and,suboxone,should'
p58061
g9
sS'of,while,under'
p58062
g9
sS'and,the,nature'
p58063
g3
sS'however,in,vitro'
p58064
g3
sS'periods,blood,and'
p58065
g3
sS'in,vitro,and'
p58066
g3
sS'from,albumin,binding'
p58067
g3
sS'appears,to,lie'
p58068
g3
sS'observed,with,benedict'
p58069
g3
sS'of,the,influence'
p58070
g3
sS'responses,alternative,error'
p58071
g3
sS'nih-3t3,cells,during'
p58072
g3
sS'improves,the,intestinal'
p58073
g3
sS'drug,interaction,data'
p58074
g3
sS'concomitant,may,decrease'
p58075
g9
sS'single,mg,and'
p58076
g3
sS'from,m,v'
p58077
g3
sS'of,and,and'
p58078
g9
sS'hours,of,frova'
p58079
g3
sS'will,depend,on'
p58080
g9
sS'corrected,qt,intervals'
p58081
g3
sS'when,is,coadministered'
p58082
g9
sS'doses,on,the'
p58083
g3
sS'c,treated,with'
p58084
g3
sS'general,although,there'
p58085
g3
sS'and,nsaids,affect'
p58086
g9
sS'cautiously,in,patients'
p58087
g9
sS'observed,when,videx'
p58088
g9
sS'on,gabitril,carbamazepine'
p58089
g9
sS'displaces,from,protein'
p58090
g9
sS'developed,increased,bun'
p58091
g9
sS'studies,with,several'
p58092
g3
sS'of,the,polymer'
p58093
g3
sS'class,not,to'
p58094
g3
sS'receive,large,doses'
p58095
g3
sS'antagonism,has,the'
p58096
g9
sS'concomitantly,prothrombin,or'
p58097
g3
sS'and,interactions,and'
p58098
g3
sS'of,topoisomerases,is'
p58099
g3
sS'two,groups,achieving'
p58100
g3
sS'with,an,inhibition'
p58101
g9
sS'female,fertility,to'
p58102
g3
sS'and,contraindications,indications'
p58103
g3
sS'effect,of,food'
p58104
g3
sS'exacerbation,of,tachyarrhythmias'
p58105
g3
sS'of,a,sensitive'
p58106
g9
sS'safely,coadministered,with'
p58107
g3
sS'on,the,cytochrome'
p58108
g3
sS'increased,approximately,with'
p58109
g9
sS'infarction,in,ephesus'
p58110
g3
sS'lowered,blood,levels'
p58111
g9
sS'observed,when,they'
p58112
g9
sS'with,plus,without'
p58113
g3
sS'interferes,with,nutrition'
p58114
g3
sS'occurred,when,cefotan'
p58115
g3
sS'single-dose,administration,of'
p58116
g3
sS'higher,approximately,fold'
p58117
g3
sS'and,general,have'
p58118
g9
sS'as,is,seen'
p58119
g3
sS'reactions,patients,with'
p58120
g9
sS'since,there,is'
p58121
g3
sS'for,injection,concentrate'
p58122
g9
sS'of,tmp,and'
p58123
g3
sS'corrected,whenever,possible'
p58124
g3
sS'd6,many,other'
p58125
g3
sS'we,reviewed,the'
p58126
g3
sS'was,changed,as'
p58127
g3
sS'and,cyp2d6,or'
p58128
g3
sS'frequency,of,monitoring'
p58129
g3
sS'to,the,nature'
p58130
g3
sS'in,cyclosporine-induced,toxicity'
p58131
g9
sS'synergism,has,been'
p58132
g9
sS'concomitant,therapy,with'
p58133
g3
sS'pretreatment,period,with'
p58134
g3
sS'stavudine,and,zidovudine'
p58135
g9
sS'hepatic,impairment,there'
p58136
g3
sS'exacerbate,the,neutropenic'
p58137
g9
sS'mm,promoted,the'
p58138
g3
sS'and,the,remaining'
p58139
g3
sS'observed,in,any'
p58140
g3
sS'muscle,relaxants,nondepolarizing'
p58141
g3
sS'a,slight,decrease'
p58142
g9
sS'secondary,to,its'
p58143
g9
sS'describing,patients,with'
p58144
g9
sS'patients,reveiving,phenytoin'
p58145
g9
sS'the,joint,dose-response'
p58146
g3
sS'both,agents,demonstrated'
p58147
g3
sS'in,vivo,evidence'
p58148
g3
sS'with,iv,such'
p58149
g3
sS'cholestyramine,increases,enterohepatic'
p58150
g3
sS'be,unlikely,to'
p58151
g3
sS'with,viracept,resulted'
p58152
g9
sS'electrocardiographic,abnormalities,and'
p58153
g9
sS'bound,should,not'
p58154
g3
sS'principles,observed,the'
p58155
g3
sS'cascade,impactor,for'
p58156
g3
sS'causes,a,profound'
p58157
g3
sS'of,possible,enhancement'
p58158
g3
sS'can,continue,to'
p58159
g3
sS'evidence,on,either'
p58160
g3
sS'are,taking,while'
p58161
g9
sS'should,be,co-administered'
p58162
g9
sS'susceptible,patients,and'
p58163
g9
sS'nnrtis,nevirapine,may'
p58164
g9
sS'is,indicated,that'
p58165
g3
sS'rapid,contraction,followed'
p58166
g3
sS'are,cytochrome,p450'
p58167
g9
sS'metabolites,has,been'
p58168
g3
sS'parameters,and,as'
p58169
g3
sS'for,binding,of'
p58170
g3
sS'be,considered,prior'
p58171
g9
sS'of,combined,hyperglycaemia'
p58172
g3
sS'vivo,animal,studies'
p58173
g9
sS'concentrations,of,after'
p58174
g3
sS'in,the,occurrence'
p58175
g3
sS'iressa,and,therefore'
p58176
g9
sS'of,taxol,but'
p58177
g3
sS'reactions,catalyzed,by'
p58178
g3
sS'by,that,of'
p58179
g9
sS'a,prolongation,of'
p58180
g3
sS'renal,failure,as'
p58181
g3
sS'nonketotic,genetically,diabetic'
p58182
g3
sS'derivatives,in,a'
p58183
g3
sS'responds,excessively,to'
p58184
g3
sS'with,caution,as'
p58185
g9
sS'even,when,grown'
p58186
g3
sS'flolan,to,increase'
p58187
g9
sS'also,not,be'
p58188
g9
sS'treatment,in,renal'
p58189
g9
sS'and,some,resulting'
p58190
g9
sS'shock,in,a'
p58191
g3
sS'oral,agents,pharmacokinetic'
p58192
g3
sS'were,studied,following'
p58193
g3
sS'such,a,potential'
p58194
g9
sS'neuronal,apparatus,of'
p58195
g3
sS'tissues,of,mice'
p58196
g3
sS'and,h-triolein,at'
p58197
g3
sS'particular,importance,sufficient'
p58198
g3
sS'on,circulating,levels'
p58199
g3
sS'of,hypoglycemia,secondary'
p58200
g9
sS'given,with,caution'
p58201
g3
sS'with,the,clearance'
p58202
g9
sS'subsequent,synthesis,and'
p58203
g3
sS'bid,the,usual'
p58204
g9
sS'that,concurrent,use'
p58205
g9
sS'article,reported,that'
p58206
g9
sS'mg,kg,weekly'
p58207
g3
sS'or,prolong,both'
p58208
g3
sS'and,and,higher'
p58209
g9
sS'verified,by,equilibrium'
p58210
g3
sS'morning,dose,of'
p58211
g3
sS'concentrations,of,a'
p58212
g9
sS'which,eight,hiv-infected'
p58213
g3
sS'reviewed,and,the'
p58214
g9
sS'of,to,induce'
p58215
g9
sS'concentrations,of,m'
p58216
g9
sS'were,mainly,receiving'
p58217
g3
sS'of,about,when'
p58218
g9
sS'fractions,on,the'
p58219
g3
sS'inhibitors,as,anorexia'
p58220
g9
sS'dose,adjustments,considered'
p58221
g9
sS'or,pharmacodynamics,of'
p58222
g3
sS'well-defined,pharmacokinetic-pharmacodynamic,relationship'
p58223
g3
sS'concomitant,n,hypotension'
p58224
g9
sS'want,to,know'
p58225
g3
sS'the,antidepressant,single'
p58226
g9
sS'survanta,also,increased'
p58227
g3
sS'ci,of,the'
p58228
g3
sS'interval,certain,or'
p58229
g9
sS'inhibited,the,absorption'
p58230
g9
sS'bioavailability,of,and'
p58231
g9
sS'important,determinant,of'
p58232
g9
sS'of,arc,gene'
p58233
g3
sS'induce,bleeding,and'
p58234
g9
sS'severe,high,blood'
p58235
g9
sS'ibogaine,attenuates,but'
p58236
g9
sS'edema,it,has'
p58237
g9
sS'hydrochlorothiazide,hctz,alone'
p58238
g3
sS'application,of,rr'
p58239
g3
sS'taking,tricyclic,which'
p58240
g3
sS'prothrombin,time,was'
p58241
g3
sS'or,oral,regular'
p58242
g3
sS'study,with,concomitant'
p58243
g3
sS'methotrexate,renal,tubular'
p58244
g9
sS'range,when,assessed'
p58245
g3
sS'increase,the,marrow'
p58246
g3
sS'it,was,demonstrated'
p58247
g3
sS'agitation,motor,weakness'
p58248
g3
sS'to,alpha,interferons'
p58249
g3
sS'and,multiple,dose'
p58250
g9
sS'increased,metabolic,clearance'
p58251
g9
sS'hypotension,occurs,the'
p58252
g3
sS'differences,in,safety'
p58253
g3
sS'concentrations,resulted,in'
p58254
g3
sS'only,to,slower'
p58255
g9
sS'be,determined,on'
p58256
g3
sS'levels,carbamazepine,levels'
p58257
g9
sS'some,urinary,assays'
p58258
g3
sS'taking,to,whom'
p58259
g9
sS'on,a,body'
p58260
g3
sS'augmentation,persisted,even'
p58261
g3
sS'a,routine,dosage'
p58262
g3
sS'lithium,ibuprofen,produced'
p58263
g9
sS'interactions,have,also'
p58264
g3
sS'age,objective,responses'
p58265
g3
sS'possibly,increasing,the'
p58266
g9
sS'p,the,possibility'
p58267
g9
sS'argatroban,g,kg'
p58268
g3
sS'group,did,not'
p58269
g3
sS'leukopenia,was,similar'
p58270
g3
sS'concentration,of,other'
p58271
g3
sS'mucosa,caused,an'
p58272
g9
sS'nevertheless,caution,should'
p58273
g3
sS'with,peripheral,neuropathy'
p58274
g3
sS'it,by,a'
p58275
g3
sS'this,product,can'
p58276
g3
sS'complete,heart,block'
p58277
g3
sS'immobilised,cmc-cys7,from'
p58278
g3
sS'of,mg,should'
p58279
g3
sS'by,multiple,enzyme'
p58280
g3
sS'similar,affinities,for'
p58281
g3
sS'while,only,a'
p58282
g3
sS'of,unchanged,accounts'
p58283
g3
sS'dea,concentrations,were'
p58284
g3
sS'have,essentially,no'
p58285
g3
sS'of,mg,qd'
p58286
g9
sS'can,cause,in'
p58287
g3
sS'hypoparathyroid,patients,who'
p58288
g9
sS'their,possible,role'
p58289
g3
sS'with,co-administration,leading'
p58290
g9
sS'not,show,a'
p58291
g3
sS'activity,of,mixed-function'
p58292
g3
sS'resists,dissolution,until'
p58293
g3
sS'lead,to,low'
p58294
g3
sS'small,quantities,of'
p58295
g3
sS'myocardial,infarction,vs'
p58296
g9
sS'hours,after,dosing'
p58297
g3
sS'controls,was,evident'
p58298
g3
sS'concentrations,of,glucose'
p58299
g3
sS'antipsychotic,was,tested'
p58300
g3
sS'oxide,donor,compounds'
p58301
g9
sS'be,reserved,for'
p58302
g3
sS'increases,the,mean'
p58303
g9
sS'orally,min,before'
p58304
g3
sS'minutes,following,alfenta'
p58305
g9
sS'with,serum,total'
p58306
g3
sS'of,two,or'
p58307
g9
sS'a,diminished,prothrombin'
p58308
g9
sS'patients,who,may'
p58309
g3
sS'augmented,the,response'
p58310
g3
sS'administration,of,robinul'
p58311
g9
sS'notable,that,xanthine-derived'
p58312
g3
sS'either,the,or'
p58313
g3
sS'and,sensitization,to'
p58314
g3
sS'administered,concomitantly,with'
p58315
g9
sS'by,about,and'
p58316
g9
sS'ions,are,intimately'
p58317
g3
sS'or,retinyl,acetate'
p58318
g9
sS'inhibition,of,cholinesterase'
p58319
g9
sS'the,following,acetaminophen'
p58320
g9
sS'predisposing,to,a'
p58321
g9
sS'volunteer,showed,hormonal'
p58322
g3
sS'monitor,levels,or'
p58323
g3
sS'inhibitors,simvastatin,cyp3a4'
p58324
g3
sS'of,absorbed,while'
p58325
g3
sS'elevated,serum,concentrations'
p58326
g9
sS'for,recovery,from'
p58327
g3
sS'long,acting,triclofos'
p58328
g9
sS'celebrex,is,not'
p58329
g3
sS'guardians,of,children'
p58330
g3
sS'observed,to,occasionally'
p58331
g9
sS'or,concurrent,with'
p58332
g9
sS'increased,auc,values'
p58333
g9
sS'subjects,the,auc'
p58334
g9
sS'and,animal,studies'
p58335
g9
sS'with,other,potent'
p58336
g3
sS'to,co-administer,and'
p58337
g9
sS'in,normal,male'
p58338
g9
sS'have,additive,hypotensite'
p58339
g9
sS'protein,involved,in'
p58340
g3
sS'were,approximately,twice'
p58341
g9
sS'be,modified,if'
p58342
g3
sS'as,and,some'
p58343
g9
sS'to,a,clinically'
p58344
g3
sS'deficits,in,learning'
p58345
g3
sS'by,agents,used'
p58346
g3
sS'the,data,suggest'
p58347
g3
sS'hr,should,achieve'
p58348
g3
sS'correct,changes,in'
p58349
g3
sS'converting,enzyme,inhibitors'
p58350
g3
sS'tablets,simultaneous,administration'
p58351
g9
sS'ace,inhibitor,mg'
p58352
g9
sS'taxol,a,substrate'
p58353
g3
sS'this,patient,group'
p58354
g3
sS'activity,of,both'
p58355
g9
sS'human,in,vitro'
p58356
g3
sS'those,observed,when'
p58357
g9
sS'following,infusions,of'
p58358
g3
sS'childbearing,potential,make'
p58359
g3
sS'additional,interaction,studies'
p58360
g3
sS'some,other,nondepolarizing'
p58361
g9
sS'enhance,nutrient,absorption'
p58362
g9
sS'enable,cells,to'
p58363
g3
sS'been,reported,from'
p58364
g9
sS'once,daily,or'
p58365
g3
sS'from,to,took'
p58366
g9
sS'or,other,suitable'
p58367
g3
sS'labeled,with,c-cholesteryl'
p58368
g3
sS'in,rat,brain'
p58369
g9
sS'cautiously,with,careful'
p58370
g9
sS'an,hydroxide,hydroxide'
p58371
g9
sS'and,the,deaths'
p58372
g3
sS'dogs,in,a'
p58373
g3
sS'anaphylactic,shock,can'
p58374
g9
sS'response,to,treatment'
p58375
g3
sS'once,daily,of'
p58376
g3
sS'the,unbound,by'
p58377
g9
sS'for,protein,binding'
p58378
g3
sS'that,increased,stability'
p58379
g3
sS'combined,transcriptional,activator'
p58380
g3
sS'may,increase,the'
p58381
g9
sS'events,such,as'
p58382
g3
sS'use,of,agents'
p58383
g3
sS'who,become,pregnant'
p58384
g3
sS'be,tested,more'
p58385
g3
sS'dose,adjustment,is'
p58386
g3
sS'diarrhea,would,be'
p58387
g9
sS'rhythm,followed,cessation'
p58388
g3
sS'stereoselective,behavioral,effects'
p58389
g3
sS'glyburide,in,a'
p58390
g3
sS'male,lean,and'
p58391
g3
sS'and,women,were'
p58392
g3
sS'agents,of,class'
p58393
g3
sS'sensipar,may,be'
p58394
g9
sS'with,maxipime,because'
p58395
g9
sS'than,have,not'
p58396
g3
sS'wide,interindividual,variability'
p58397
g9
sS'steady-state,serum,concentrations'
p58398
g9
sS'while,gallic,acid'
p58399
g3
sS'been,rarely,reported'
p58400
g9
sS'amphotericin,foscarnet,and'
p58401
g9
sS'in,higher,increases'
p58402
g9
sS'the,patient,for'
p58403
g3
sS'nelfinavir,is,metabolized'
p58404
g3
sS'presence,of,and'
p58405
g3
sS'patients,if,dosage'
p58406
g9
sS'see,contraindications,significant'
p58407
g3
sS'or,nephrotoxic,because'
p58408
g3
sS'and,acetylsalicylic,acid'
p58409
g9
sS'vitamin,d,dosage'
p58410
g9
sS'did,not,change'
p58411
g3
sS'laboratory,tests,the'
p58412
g9
sS'use,of,hivid'
p58413
g9
sS'of,alfenta,my'
p58414
g3
sS'h,extent,of'
p58415
g3
sS'trials,have,investigated'
p58416
g3
sS'development,of,a'
p58417
g3
sS'sites,for,on'
p58418
g3
sS'the,short-acting,adrenergic'
p58419
g3
sS'optimal,designs,for'
p58420
g3
sS'potential,only,when'
p58421
g3
sS'the,longterm,treatment'
p58422
g3
sS'with,or,innovar'
p58423
g9
sS'nonlethal,dose,of'
p58424
g9
sS'in,the,us'
p58425
g3
sS'mechanism,of,interaction'
p58426
g9
sS'electrolyte,disturbances,patients'
p58427
g3
sS'disorders,plasmacytic,hyperplasia'
p58428
g3
sS'with,monoamine,oxidase'
p58429
g9
sS'if,the,usual'
p58430
g3
sS'several,human,interaction'
p58431
g3
sS'higher,risk,of'
p58432
g3
sS'and,at,periodic'
p58433
g9
sS'tumors,and,it'
p58434
g9
sS'triclofos,sodium,unreliable'
p58435
g9
sS'p450,system,should'
p58436
g3
sS'support,these,conclusions'
p58437
g3
sS'to,and,should'
p58438
g9
sS'medicines,may,make'
p58439
g3
sS'are,neither,sufficient'
p58440
g3
sS'the,same,degree'
p58441
g3
sS'receiving,n,n'
p58442
g3
sS'with,other,administered'
p58443
g3
sS'subcortical,structures,of'
p58444
g3
sS'and,cmax,respectively'
p58445
g3
sS'smaller,doses,of'
p58446
g9
sS'titration,are,warranted'
p58447
g3
sS'butyrophenones,such,as'
p58448
g9
sS'aprepitant,has,been'
p58449
g9
sS'long,half-lives,to'
p58450
g3
sS'of,neuromuscular,block'
p58451
g9
sS'injection,is,administered'
p58452
g3
sS'in,table,additional'
p58453
g3
sS'produce,any,interaction'
p58454
g3
sS'a,dose-dependent,fashion'
p58455
g9
sS'further,in,clinical'
p58456
g3
sS'of,each,of'
p58457
g3
sS'studies,in,vitro'
p58458
g3
sS'nanm,were,compared'
p58459
g3
sS'who,require,additional'
p58460
g3
sS'triglycerides,mg,dl'
p58461
g3
sS'that,may,produce'
p58462
g3
sS'time,window,is'
p58463
g9
sS'six,volunteers,received'
p58464
g3
sS'of,mixing,novolog'
p58465
g3
sS'adrenergic,antagonism,has'
p58466
g9
sS'oral,increased,the'
p58467
g9
sS'receptors,mc,has'
p58468
g3
sS'sexual,dysfunction,eg'
p58469
g3
sS'normal,volunteers,had'
p58470
g9
sS'recommended,and,if'
p58471
g3
sS'superiority,over,in'
p58472
g3
sS'excretion,of,by'
p58473
g9
sS'mg,tablets,administered'
p58474
g3
sS'time,the,plasma'
p58475
g3
sS'co-administration,of,myobloc'
p58476
g9
sS'doses,for,this'
p58477
g3
sS'receptor,antagonists,hypertension'
p58478
g9
sS'exposure,may,be'
p58479
g3
sS'with,highly,protein-bound'
p58480
g3
sS'losartan,bosentan,has'
p58481
g3
sS'renal,function,is'
p58482
g3
sS'alertness,and,impaired'
p58483
g9
sS'normal,volunteers,has'
p58484
g3
sS'in,prothrombin,test'
p58485
g3
sS'be,exceeded,in'
p58486
g9
sS'index,fici,was'
p58487
g3
sS'of,in,proportion'
p58488
g3
sS'of,reduction,at'
p58489
g3
sS'treated,with,indocin'
p58490
g3
sS'findings,these,results'
p58491
g3
sS'and,reduce,its'
p58492
g9
sS'monoamine,oxidase,inhibitory'
p58493
g3
sS'the,cytochrome,p450'
p58494
g3
sS'heart,failure,nyha'
p58495
g3
sS'monoamine,oxidase,inhibitors'
p58496
g9
sS'are,taking,certain'
p58497
g3
sS'and,copegus,should'
p58498
g3
sS'cancidas,mg,daily'
p58499
g9
sS'been,used,it'
p58500
g3
sS'enzymes,were,investigated'
p58501
g3
sS'interest,in,administering'
p58502
g3
sS'regard,to,patient'
p58503
g3
sS'hypoglycemia,oral,products'
p58504
g3
sS'altered,safety,and'
p58505
g3
sS'subjects,did,not'
p58506
g3
sS'of,is,moderately'
p58507
g3
sS'be,decreased,when'
p58508
g3
sS'substrate,for,many'
p58509
g3
sS'these,subjects,did'
p58510
g3
sS'that,had,a'
p58511
g3
sS'electrophysiologic,interactions,have'
p58512
g3
sS'hypotension,and,profound'
p58513
g9
sS'treated,with,zyvox'
p58514
g9
sS'suggest,that,co-administration'
p58515
g9
sS'combination,with,and'
p58516
g3
sS'acetylcholinesterase,ache,activity'
p58517
g9
sS'total,auc,increased'
p58518
g9
sS'steady-state,plasma,concentration'
p58519
g3
sS'such,as,garlic'
p58520
g9
sS'ca,and,current'
p58521
g9
sS'doubling,in,a'
p58522
g9
sS'of,a,tnf'
p58523
g9
sS'plasma,elimination,half-life'
p58524
g3
sS'aggregation,and,serum'
p58525
g3
sS'when,giving,these'
p58526
g3
sS'decrease,the,dose'
p58527
g3
sS'recovery,of,the'
p58528
g3
sS'elevations,in,cpk'
p58529
g3
sS'heart,failure,where'
p58530
g3
sS'toxicity,occur,when'
p58531
g9
sS'total,drug,concentrations'
p58532
g3
sS'microm,inhibited,insp'
p58533
g9
sS'of,known,to'
p58534
g3
sS'alcohol,although,lexapro'
p58535
g9
sS'other,nonsteroidal,that'
p58536
g9
sS'alkaloids,amphetamines,inhibit'
p58537
g9
sS'cholestyramine,may,interfere'
p58538
g9
sS'during,the,period'
p58539
g3
sS'coly-mycin,m,parenteral'
p58540
g9
sS'in,and,addicts'
p58541
g9
sS'arteries,from,lean'
p58542
g3
sS'may,exhibit,a'
p58543
g9
sS'mechanisms,of,action'
p58544
g3
sS'been,studied,but'
p58545
g9
sS'of,the,physician'
p58546
g9
sS'average,increase,in'
p58547
g9
sS'or,kidney,diseases'
p58548
g3
sS'oral,doses,of'
p58549
g9
sS'both,a,decrease'
p58550
g3
sS'thus,leading,to'
p58551
g9
sS'these,studies,it'
p58552
g3
sS'have,examined,whether'
p58553
g3
sS'sample,of,mac'
p58554
g3
sS'concomitant,use,is'
p58555
g3
sS'with,eg,rt-pa'
p58556
g3
sS'capable,of,inducing'
p58557
g3
sS'and,aspecific,treatments'
p58558
g3
sS'such,as,ophthalmic'
p58559
g9
sS'because,they,reduce'
p58560
g9
sS'as,and,respectively'
p58561
g3
sS'from,a,urine'
p58562
g3
sS'proposed,mechanisms,of'
p58563
g3
sS'and,no,additional'
p58564
g9
sS'who,has,received'
p58565
g9
sS'the,mechanism,under'
p58566
g9
sS'the,exact,length'
p58567
g3
sS'however,there,were'
p58568
g3
sS'both,the,mucosal'
p58569
g3
sS'and,those,of'
p58570
g3
sS'dose-response,models,based'
p58571
g3
sS'device,and,how'
p58572
g3
sS'clinical,trial,data'
p58573
g9
sS'with,a,separate'
p58574
g9
sS'potent,parental,such'
p58575
g9
sS'survive,in,and'
p58576
g3
sS'or,another,such'
p58577
g9
sS'cns,agents,concurrent'
p58578
g9
sS'additive,hypotensive,effect'
p58579
g9
sS'well,as,to'
p58580
g3
sS'squirrel,monkeys,responding'
p58581
g3
sS'hand,had,effects'
p58582
g3
sS'serum,levels,at'
p58583
g3
sS'an,encephalopathic,syndrome'
p58584
g9
sS'be,repeated,each'
p58585
g3
sS'test,do,not'
p58586
g3
sS'urine,samples,for'
p58587
g3
sS'mice,induced,by'
p58588
g3
sS'times,a,day'
p58589
g3
sS'efficacy,benefit,when'
p58590
g3
sS'cyp,c9,substrates'
p58591
g3
sS'd,were,co-administered'
p58592
g9
sS'to,is,expected'
p58593
g9
sS'tell,your,doctor'
p58594
g3
sS'prednisolone,ethinyl,estradiol'
p58595
g9
sS'alt,and,or'
p58596
g3
sS'to,offer,patients'
p58597
g3
sS'can,antagonize,the'
p58598
g9
sS'therapy,and,overuse'
p58599
g3
sS'adjustment,of,dosages'
p58600
g3
sS'always,seen,in'
p58601
g3
sS'significantly,fewer,extrapyramidal'
p58602
g3
sS'effects,and,the'
p58603
g9
sS'may,be,ineffective'
p58604
g9
sS'therapy,if,diminished'
p58605
g9
sS'h2,blockers,proton'
p58606
g9
sS'than,with,based'
p58607
g3
sS'period,will,affect'
p58608
g9
sS'low,dietary,concentration'
p58609
g3
sS'of,substances,affect'
p58610
g3
sS'as,the,effect'
p58611
g9
sS'gi,motility,agent'
p58612
g3
sS'per,day,or'
p58613
g3
sS'starlix,mg,in'
p58614
g3
sS'of,chylomicron-like,emulsions'
p58615
g3
sS'presence,of,that'
p58616
g9
sS'phenobarbital,or,primidone'
p58617
g3
sS'use,of,argatroban'
p58618
g9
sS'infusion,rate,requirements'
p58619
g9
sS'or,other,central'
p58620
g3
sS'types,of,adrenocortical'
p58621
g9
sS'showed,behavioral,sensitization'
p58622
g3
sS'presence,of,than'
p58623
g9
sS'necessitate,an,adjustment'
p58624
g3
sS'are,the,following'
p58625
g9
sS'be,manifested,by'
p58626
g3
sS'shown,that,administration'
p58627
g9
sS'can,follow,the'
p58628
g9
sS'a,concentration,of'
p58629
g3
sS'increase,in,a'
p58630
g3
sS'despite,reduction,in'
p58631
g3
sS'of,nimbex,and'
p58632
g9
sS'of,the,microtubules'
p58633
g3
sS'avastin,had,a'
p58634
g3
sS'pharmacokinetic,parameters,is'
p58635
g3
sS'in,patients,using'
p58636
g3
sS'should,be,the'
p58637
g3
sS'of,and,by'
p58638
g9
sS'blocked,the,decrease'
p58639
g3
sS'providing,for,results'
p58640
g3
sS'a,slower,absorption'
p58641
g9
sS'pharmacokinetics,but,significantly'
p58642
g9
sS'rheumatoid,arthritis,and'
p58643
g3
sS'in,separate,single'
p58644
g3
sS'p450,d6,debrisoquin'
p58645
g3
sS'thus,lower,the'
p58646
g9
sS'l-ccg,were,not'
p58647
g3
sS'qd,did,not'
p58648
g3
sS'observed,only,at'
p58649
g3
sS'are,not,recommended'
p58650
g9
sS'widespread,effects,for'
p58651
g3
sS'tests,should,be'
p58652
g3
sS'inhibitors,or,known'
p58653
g9
sS'ethanolysis,reaction,may'
p58654
g9
sS'disorders,and,therapy'
p58655
g3
sS'concomitantly,any,reduction'
p58656
g9
sS'blood,flow,and'
p58657
g3
sS'evidence,to,suggest'
p58658
g3
sS'k,antagonists,should'
p58659
g9
sS'when,or,its'
p58660
g9
sS'mucosal,and,serosal'
p58661
g3
sS'or,other,significantly'
p58662
g9
sS'the,possible,effects'
p58663
g3
sS'thus,the,exogenous'
p58664
g3
sS'u937,and,molt-4'
p58665
g9
sS'hydroxy-corticosteroid,measurements,porter-silber'
p58666
g3
sS'aminotransferase,determinations,are'
p58667
g3
sS'pra,induced,by'
p58668
g3
sS'treatment,ataxia,a'
p58669
g3
sS'males,dosed,at'
p58670
g3
sS'following,acetaminophen,oral'
p58671
g9
sS'most,significant,interactions'
p58672
g3
sS'to,result,from'
p58673
g9
sS'metabolism,of,may'
p58674
g9
sS'pregnant,rhesus,monkeys'
p58675
g3
sS'administering,different,botulinum'
p58676
g3
sS'single,metal,toxicity'
p58677
g3
sS'side,effects,including'
p58678
g9
sS'ip,injections,of'
p58679
g3
sS'regulation,of,the'
p58680
g3
sS'all,of,these'
p58681
g3
sS'about,one-third,as'
p58682
g9
sS'and,elicit,their'
p58683
g3
sS'and,and,potent'
p58684
g3
sS'and,brain,edema'
p58685
g9
sS'of,and,following'
p58686
g3
sS'amount,of,hydroxylated'
p58687
g9
sS'times,weekly,during'
p58688
g3
sS'from,protein,binding'
p58689
g9
sS'followed,by,mg'
p58690
g9
sS'since,hydrochloride,is'
p58691
g3
sS'continue,the,initiate'
p58692
g9
sS'myocardial,infarction,during'
p58693
g3
sS'with,containing,may'
p58694
g9
sS'were,a,dihydropyridine'
p58695
g3
sS'cerebri,benign,intracranial'
p58696
g9
sS'were,conducted,with'
p58697
g3
sS'data,in,kidney'
p58698
g3
sS'could,increase,the'
p58699
g3
sS'with,high,viral'
p58700
g3
sS'bleeding,are,synergistic'
p58701
g9
sS'exposure,were,assessed'
p58702
g3
sS'pregnancy,test,female'
p58703
g3
sS'antagonize,the,neuron'
p58704
g9
sS'possibility,of,hypotensive'
p58705
g9
sS'current,responses,in'
p58706
g9
sS'done,at,baseline'
p58707
g3
sS'clinical,effects,of'
p58708
g3
sS'also,conducted,with'
p58709
g3
sS'increasingly,popular,in'
p58710
g3
sS'in,its,use'
p58711
g3
sS'effect,on,either'
p58712
g3
sS'reactive,encephalopathy,are'
p58713
g3
sS'clinical,studies,of'
p58714
g9
sS'channel,blockers,isolated'
p58715
g9
sS'report,l-glutamine,at'
p58716
g9
sS'reactions,to,and'
p58717
g3
sS'doses,of,have'
p58718
g3
sS'levels,and,symptoms'
p58719
g9
sS'cyp,isoenzymes,therefore'
p58720
g3
sS'of,serious,sometimes'
p58721
g9
sS'the,is,maintained'
p58722
g3
sS'problems,and,if'
p58723
g3
sS'kg,body,weight'
p58724
g3
sS'index,apoptotic,index'
p58725
g3
sS'lower,maintenance,doses'
p58726
g9
sS'of,metal,toxicity'
p58727
g3
sS'or,minutes,following'
p58728
g9
sS'therefore,we,investigated'
p58729
g3
sS'also,be,approached'
p58730
g9
sS'in,sensitivity,to'
p58731
g3
sS'not,been,investigated'
p58732
g9
sS'expect,that,a'
p58733
g3
sS'and,to,broadly'
p58734
g3
sS'an,effect,may'
p58735
g9
sS'eldepryl,and,parnate'
p58736
g3
sS'or,are,taken'
p58737
g9
sS'bactericidal,action,of'
p58738
g9
sS'metabolite,averaged,s'
p58739
g3
sS'in,a,potentiation'
p58740
g9
sS'because,of,reduced'
p58741
g3
sS'in,transferring,the'
p58742
g3
sS'care,is,required'
p58743
g3
sS'hcl,no,greater'
p58744
g9
sS'be,increased,an'
p58745
g9
sS'for,cyp1a2,inhibit'
p58746
g3
sS'drugs,whose,efficacy'
p58747
g9
sS'clinical,trial,in'
p58748
g3
sS'pocs,and,fertility'
p58749
g3
sS'oral,may,interfere'
p58750
g9
sS'c,drug,interactions'
p58751
g3
sS'doses,of,up'
p58752
g3
sS'such,patients,careful'
p58753
g3
sS'of,see,clinical'
p58754
g3
sS'ml,the,binding'
p58755
g9
sS'month,of,therapy'
p58756
g3
sS'concentrations,were,above'
p58757
g9
sS'treatment,of,trypanosomiasis'
p58758
g3
sS'and,negative,symptoms'
p58759
g3
sS'assessed,by,electrocardiographic'
p58760
g3
sS'when,taken,at'
p58761
g9
sS'of,concentrations,after'
p58762
g9
sS'the,phase,study'
p58763
g3
sS'interaction,studies,no'
p58764
g3
sS'before,initiating,tcatreatment'
p58765
g9
sS'alone,and,concomitantly'
p58766
g9
sS'pressure,after,initiation'
p58767
g9
sS'you,are,years'
p58768
g3
sS'in,peripheral,blood'
p58769
g9
sS'its,pharmacologically,active'
p58770
g3
sS'additional,benefit,compared'
p58771
g9
sS'mg,l,to'
p58772
g9
sS'trials,currently,exist'
p58773
g3
sS'of,hypoxic,respiratory'
p58774
g3
sS'table,summary,of'
p58775
g3
sS'during,sexual,activity'
p58776
g3
sS'sedation,with,concurrent'
p58777
g3
sS'that,concomitant,administration'
p58778
g9
sS'see,if,clearance'
p58779
g9
sS'disturbances,and,left'
p58780
g9
sS'these,medications,have'
p58781
g3
sS'cyp,inducers,that'
p58782
g9
sS'be,formed,with'
p58783
g9
sS'microtubules,on,cooling'
p58784
g3
sS'mg,tid,the'
p58785
g9
sS'and,for,and'
p58786
g3
sS'agonists,in,induction'
p58787
g9
sS'resistant,clinical,isolates'
p58788
g3
sS'de,pointes,have'
p58789
g3
sS'concentrations,increase,when'
p58790
g9
sS'when,addiction,is'
p58791
g3
sS'slight,decrease,in'
p58792
g9
sS'chelated,extracellular,ca'
p58793
g3
sS'acute,ischemic,stroke'
p58794
g3
sS'dosing,by,at'
p58795
g3
sS'duodenum,and,no'
p58796
g3
sS'described,in,this'
p58797
g3
sS'levels,thereby,providing'
p58798
g3
sS'weakness,may,be'
p58799
g9
sS'are,substrates,of'
p58800
g3
sS'is,applicable,across'
p58801
g3
sS'case,were,the'
p58802
g3
sS'photic,evoked,potentials'
p58803
g3
sS'not,only,to'
p58804
g9
sS'a,single,dosage'
p58805
g3
sS'single,enzyme,may'
p58806
g3
sS'that,reportedly,may'
p58807
g9
sS'more,potent,than'
p58808
g3
sS'benzylpenicillin,and,have'
p58809
g3
sS'thioridizine,or,within'
p58810
g3
sS'inhibitor,maoi,such'
p58811
g3
sS'that,have,significant'
p58812
g9
sS'increase,when,the'
p58813
g9
sS'will,be,less'
p58814
g3
sS'in,systemic,levels'
p58815
g9
sS'and,plasma,concentrations'
p58816
g9
sS'absorption,can,be'
p58817
g9
sS'patient,on,phenytoin'
p58818
g9
sS'with,an,increase'
p58819
g9
sS'patients,undergoing,vigorous'
p58820
g3
sS'of,an,isocaloric'
p58821
g3
sS'result,in,higher'
p58822
g9
sS'ethinyl,estradiol,and'
p58823
g9
sS'inhibitor,to,prevent'
p58824
g3
sS'effect,of,carbimazole'
p58825
g9
sS'ventricular,fibrillation,and'
p58826
g3
sS'more,pronounced,than'
p58827
g3
sS'oral,containing,may'
p58828
g9
sS'bid,decreased,the'
p58829
g9
sS'ibogaine,produces,whole'
p58830
g3
sS'deaths,reveal,frequent'
p58831
g9
sS'therapeutic,index,digoxin'
p58832
g3
sS'actions,or,side'
p58833
g3
sS'other,neither,sodium'
p58834
g3
sS'of,grade,diarrhea'
p58835
g3
sS'administered,tagamet,to'
p58836
g3
sS'serotonergic,agents,including'
p58837
g9
sS'concentrations,were,unchanged'
p58838
g3
sS'performed,in,which'
p58839
g3
sS'presumably,through,inhibition'
p58840
g9
sS'infusion,of,had'
p58841
g3
sS'suspending,use,of'
p58842
g9
sS'a,case,the'
p58843
g3
sS'a,large,number'
p58844
g3
sS'mg,of,kg'
p58845
g3
sS'between,toradol,and'
p58846
g9
sS'possibly,other,cause'
p58847
g9
sS'thyroxine-binding,prealbumin,tbpa'
p58848
g3
sS'be,continuously,observed'
p58849
g9
sS'nimbex,before,to'
p58850
g3
sS'this,regimen,did'
p58851
g9
sS'to,controls,was'
p58852
g3
sS'on,sodium,excretion'
p58853
g9
sS'beta-receptor,blockers,antagonists'
p58854
g3
sS'of,extraneals,effects'
p58855
g3
sS'hippocampal,adenylate,cyclase'
p58856
g3
sS'follicle-stimulating,hormone,fsh'
p58857
g3
sS'action,of,fatty'
p58858
g3
sS'with,features,resembling'
p58859
g3
sS'to,induce,abnormalities'
p58860
g3
sS'intake,of,this'
p58861
g3
sS'etodolac-treated,patients,receiving'
p58862
g9
sS'number,of,adverse'
p58863
g3
sS'in,these,in'
p58864
g3
sS'hydrochloride,and,therapy'
p58865
g3
sS'coupled,with,population'
p58866
g3
sS'and,normal,cells'
p58867
g3
sS'in,humans,can'
p58868
g9
sS'hydroxylation,during,treatment'
p58869
g3
sS'affect,the,blood'
p58870
g3
sS'channel,blockers,could'
p58871
g9
sS'of,induction,or'
p58872
g3
sS'this,pharmacological,interaction'
p58873
g9
sS'subset,of,patients'
p58874
g3
sS'the,chemical,resemblance'
p58875
g9
sS'times,were,not'
p58876
g3
sS'cns,depressant,should'
p58877
g9
sS'warranted,appropriate,observation'
p58878
g9
sS'animals,dosed,at'
p58879
g3
sS'p-glycoprotein,mediated,clearance'
p58880
g3
sS'or,with,changes'
p58881
g3
sS'marked,inhibition,in'
p58882
g3
sS'not,affected,significantly'
p58883
g3
sS'of,gabitril,with'
p58884
g3
sS'may,produce,excessive'
p58885
g9
sS'cells,compared,with'
p58886
g3
sS'for,this,combination'
p58887
g3
sS'pre-,and,postsedative'
p58888
g3
sS'no,differential,effects'
p58889
g3
sS'interaction,between,mao'
p58890
g9
sS'or,is,receiving'
p58891
g9
sS'the,first,sixty'
p58892
g9
sS'xigris,have,not'
p58893
g3
sS'determinations,are,advisable'
p58894
g3
sS'are,discussed,herein'
p58895
g3
sS'clinical,effects,prolonged'
p58896
g9
sS'brain,levels,of'
p58897
g3
sS'the,lipid-lowering,activity'
p58898
g3
sS'channel,and,omega-conotoxin'
p58899
g3
sS'is,minimized,to'
p58900
g3
sS'of,the,ace'
p58901
g9
sS'of,tcamay,become'
p58902
g3
sS'adjustments,of,agents'
p58903
g9
sS'decrease,serum,concentrations'
p58904
g9
sS'of,deficit,and'
p58905
g3
sS'elevated,in,serum'
p58906
g3
sS'and,n3,for'
p58907
g3
sS'known,whether,these'
p58908
g3
sS'replacement,is,needed'
p58909
g3
sS'of,block,is'
p58910
g9
sS'were,not,tested'
p58911
g3
sS'these,compounds,block'
p58912
g3
sS'species,of,the'
p58913
g9
sS'infarction,during,sexual'
p58914
g3
sS'days,in,healthy'
p58915
g9
sS'antagonists,and,alpha-adrenergic'
p58916
g9
sS'phosphate,transport,in'
p58917
g3
sS'temporary,decrease,in'
p58918
g3
sS'unknown,how,the'
p58919
g3
sS'aluminum-containing,products,containing'
p58920
g9
sS'the,patients,as'
p58921
g3
sS'concomitantly,with,angiotensin-'
p58922
g3
sS'the,cumulative,incidence'
p58923
g3
sS'and,received,an'
p58924
g3
sS'studies,on,patients'
p58925
g3
sS'and,the,combination'
p58926
g9
sS'in,plasma,levels'
p58927
g9
sS'pgf2alpha,produced,significantly'
p58928
g9
sS'disturbances,have,led'
p58929
g3
sS'rapid,avoidance,behaviour'
p58930
g3
sS'administered,to,or'
p58931
g3
sS'plus,a,catecholamine'
p58932
g3
sS'severe,toxicity,including'
p58933
g9
sS'reports,of,increased'
p58934
g9
sS'anabolic,hormones,and'
p58935
g9
sS'is,conceived,that'
p58936
g3
sS'tambocor,and,on'
p58937
g9
sS'and,other,drugs'
p58938
g9
sS'was,discussed,in'
p58939
g3
sS'and,intravenous,may'
p58940
g9
sS'reports,of,increases'
p58941
g3
sS'higher,doses,may'
p58942
g9
sS'amoxicillin,an,increase'
p58943
g9
sS'available,data,from'
p58944
g9
sS'studies,of,mefenamic'
p58945
g3
sS'year,indicating,strong'
p58946
g3
sS'cytochrome,p450,system'
p58947
g3
sS'ventricular,tachycardia,ventricular'
p58948
g9
sS'their,need,for'
p58949
g3
sS'patients,concomitantly,taking'
p58950
g3
sS'in,vitro,cytogenetics'
p58951
g3
sS'ibuprofen,l-arginine,may'
p58952
g9
sS'receiving,low,therapeutic'
p58953
g3
sS'for,the,predominant'
p58954
g3
sS'but,a,lower'
p58955
g3
sS'of,concomitant,medications'
p58956
g3
sS'increased,plasma,concentrations'
p58957
g9
sS'inhibited,by,combination'
p58958
g9
sS'mg,capsules,or'
p58959
g9
sS'a,potently,enhanced'
p58960
g3
sS'obtained,before,starting'
p58961
g3
sS'intraluminal,concentrations,have'
p58962
g3
sS'and,observations,on'
p58963
g3
sS'urine,when,using'
p58964
g3
sS'the,combined,use'
p58965
g9
sS'the,experiments,reported'
p58966
g3
sS'this,did,not'
p58967
g3
sS'subjects,received,concomitant'
p58968
g3
sS'to,normal,levels'
p58969
g3
sS'summary,of,aed'
p58970
g3
sS'any,on,the'
p58971
g3
sS'as,uncompromised,elderly'
p58972
g3
sS'oxypurines,in,patients'
p58973
g3
sS'or,amenorrhea,were'
p58974
g3
sS'taken,and,hours'
p58975
g9
sS'adverse,effects,could'
p58976
g9
sS'benedict,s,solution'
p58977
g3
sS'multiple-dose,administration,of'
p58978
g9
sS'increase,of,to'
p58979
g9
sS'may,increase,toxicity'
p58980
g9
sS'may,substantially,decrease'
p58981
g9
sS'on,a,are'
p58982
g3
sS'clinically,important,potentiation'
p58983
g3
sS'krm-1648,has,a'
p58984
g3
sS'in,the,release'
p58985
g3
sS'containing,gram,of'
p58986
g9
sS'of,precipitating,coronary'
p58987
g3
sS'infant,formula,mg'
p58988
g3
sS'muscle,relaxing,effect'
p58989
g9
sS'disulfiram,should,be'
p58990
g9
sS'latter,might,arise'
p58991
g3
sS'may,produce,serious'
p58992
g3
sS'healthy,volunteers,with'
p58993
g9
sS'with,cyp3a4,inhibitors'
p58994
g3
sS'perfusion,in,diabetes'
p58995
g3
sS'in,false-positive,findings'
p58996
g3
sS'metabolic,probe,study'
p58997
g3
sS'volunteers,the,pharmacokinetics'
p58998
g9
sS'received,pelvic,abdominal'
p58999
g3
sS'cancer,cells,in'
p59000
g3
sS'of,administration,of'
p59001
g3
sS'spices,or,lime'
p59002
g3
sS'potentiate,sulfate,neuromuscular'
p59003
g3
sS'no,evidence,in'
p59004
g3
sS'mg,sodium,and'
p59005
g9
sS'in,the,within'
p59006
g9
sS'was,monitored,by'
p59007
g3
sS'synergism,in,two'
p59008
g9
sS'oral,and,through'
p59009
g3
sS'of,the,non-depolarizing'
p59010
g9
sS'picr,in,the'
p59011
g3
sS'plasma,concentrations,cyp3a4'
p59012
g3
sS'amitriptyline,hcl,is'
p59013
g9
sS'suggesting,that,coadministration'
p59014
g3
sS'from,cholinergic,blockade'
p59015
g9
sS'indicate,that,or'
p59016
g9
sS'postulated,that,some'
p59017
g3
sS'one,of,these'
p59018
g3
sS'observed,in,this'
p59019
g9
sS'joint,action,data'
p59020
g3
sS'pharmacodynamic,drug-drug,interactions'
p59021
g3
sS'one,must,not'
p59022
g3
sS'mean,trough,concentrations'
p59023
g3
sS'concomitant,therapies,may'
p59024
g3
sS'n,n-diethyl,m-toluamide'
p59025
g9
sS'alter,the,metabolism'
p59026
g9
sS'concentrations,drugs,that'
p59027
g9
sS'data,from,several'
p59028
g3
sS'and,for,week'
p59029
g3
sS'corresponding,to,relevant'
p59030
g3
sS'either,mg,every'
p59031
g3
sS'pharmacokinetics,or,renal'
p59032
g3
sS'intraperitoneal,doses,of'
p59033
g9
sS'cholinesterase,inhibitors,thereby'
p59034
g9
sS'another,investigator,found'
p59035
g3
sS'increased,intestinal,permeability'
p59036
g9
sS'tablets,have,been'
p59037
g3
sS'in,non-myelinated,axons'
p59038
g3
sS'contribute,to,regimen'
p59039
g3
sS'on,thiazide,and'
p59040
g9
sS'volunteers,hormone,replacement'
p59041
g3
sS'protease,inhibitors,and'
p59042
g3
sS'conjugation,at,and'
p59043
g3
sS'as,interaction,sites'
p59044
g3
sS'between,folic,acid'
p59045
g3
sS'matrix,protein,reorganization'
p59046
g3
sS'peptides,in,mice'
p59047
g3
sS'other,combinations,or'
p59048
g3
sS'coumarin,anticoagulants,altered'
p59049
g9
sS'levels,or,altering'
p59050
g3
sS'study,with,co-administered'
p59051
g3
sS'and,are,obtained'
p59052
g9
sS'monitored,and,its'
p59053
g9
sS'estrogens,tend,to'
p59054
g3
sS'lotensin,has,been'
p59055
g3
sS'reach,to10,m'
p59056
g9
sS'taking,since,the'
p59057
g9
sS'study,dosed,subjects'
p59058
g3
sS'been,attributed,to'
p59059
g3
sS'significant,and,no'
p59060
g3
sS'for,converting,difluoro-2'
p59061
g9
sS'trials,database,three'
p59062
g3
sS'coadministered,orally,as'
p59063
g9
sS'respectively,of,those'
p59064
g9
sS'increased,free,concentrations'
p59065
g3
sS'experiences,have,been'
p59066
g3
sS'of,and,require'
p59067
g9
sS'of,there,is'
p59068
g9
sS'paw,at,mg'
p59069
g3
sS'test,and,the'
p59070
g9
sS'or,regimen,may'
p59071
g3
sS'vasoconstrictors,d,h'
p59072
g9
sS'would,permit,larger'
p59073
g3
sS'professional,know,if'
p59074
g9
sS'preceded,by,an'
p59075
g3
sS'corticosteroids,may,also'
p59076
g9
sS'contribute,in,part'
p59077
g3
sS'inhibitors,felodipine,is'
p59078
g3
sS'mg,of,subjects'
p59079
g9
sS'kineret,when,the'
p59080
g3
sS'p-450iie1,in,the'
p59081
g9
sS'in,patients,where'
p59082
g3
sS'with,water-miscible,or'
p59083
g3
sS'p450,cyp,isoforms'
p59084
g3
sS'works,differently,from'
p59085
g3
sS'cns,depressants,may'
p59086
g9
sS'concomitant,or,hot'
p59087
g3
sS'pressure,control,in'
p59088
g3
sS'antihypertensives,amiodarone,should'
p59089
g3
sS'observed,in,cynomolgus'
p59090
g3
sS'they,have,focused'
p59091
g3
sS'had,no,influence'
p59092
g3
sS'neither,racemic,nor'
p59093
g3
sS'been,reported,itraconazole'
p59094
g3
sS'daily,mcg,twice'
p59095
g3
sS'following,an,initial'
p59096
g3
sS'known,to,influence'
p59097
g3
sS'plasma,levels,mcg'
p59098
g9
sS'here,may,also'
p59099
g3
sS'between,the,two'
p59100
g3
sS'understand,how,to'
p59101
g3
sS'lithium,serum,concentrations'
p59102
g9
sS'cell,accumulation,of'
p59103
g3
sS'indinavir-based,regimens,has'
p59104
g3
sS'biliary,route,with'
p59105
g3
sS'excretion,a,study'
p59106
g3
sS'the,seizure,risk'
p59107
g9
sS'terminated,the,b-blocking'
p59108
g9
sS'is,essential,the'
p59109
g3
sS'may,have,either'
p59110
g3
sS'inhibitors,coadministration,of'
p59111
g9
sS'illustrated,by,six'
p59112
g3
sS'bombesin-enhanced,peritoneal,metastasis'
p59113
g9
sS'such,as,uncompromised'
p59114
g3
sS'reports,the,same'
p59115
g3
sS'sodium,from,the'
p59116
g9
sS'group,of,subjects'
p59117
g9
sS'increases,in,concentrations'
p59118
g9
sS'thus,when,nsaids'
p59119
g9
sS'formation,of,hydroxylamine'
p59120
g3
sS'be,taken,during'
p59121
g9
sS'measured,using,the'
p59122
g3
sS'was,noted,in'
p59123
g3
sS'these,on,the'
p59124
g3
sS'noninsulin,dependent,diabetic'
p59125
g3
sS'low,measurement,of'
p59126
g3
sS'd6,isozyme,activity'
p59127
g3
sS'n-methyllevallorphan,mg,kg'
p59128
g9
sS'proteins,and,related'
p59129
g9
sS'and,can,suppress'
p59130
g9
sS'in,renal,and'
p59131
g9
sS'if,other,muscle'
p59132
g3
sS'interaction,studies,when'
p59133
g3
sS'dexrazoxane,was,not'
p59134
g3
sS'carried,out,as'
p59135
g3
sS'and,were,also'
p59136
g3
sS'between,and,a'
p59137
g9
sS'higher,absolute,but'
p59138
g3
sS'the,interference,of'
p59139
g3
sS'hemorrhages,edema,and'
p59140
g3
sS'by,and,increased'
p59141
g9
sS'at,doses,as'
p59142
g3
sS'highly,protein-bound,such'
p59143
g3
sS'agent,that,alters'
p59144
g3
sS'secretion,chronic,experiments'
p59145
g3
sS'the,antagonism,of'
p59146
g9
sS'in,patients,treated'
p59147
g3
sS'cells,to,the'
p59148
g3
sS'possibly,related,to'
p59149
g9
sS'pharmacodynamic,interactions,have'
p59150
g3
sS'of,the,week'
p59151
g3
sS'interactions,were,noted'
p59152
g3
sS'unlikely,to,compete'
p59153
g3
sS'not,known,to'
p59154
g3
sS'amount,of,extractable'
p59155
g3
sS'normal,volunteers,there'
p59156
g3
sS'prostatic,hyperplasia,bph'
p59157
g3
sS'require,careful,titration'
p59158
g3
sS'c19,the,enzymes'
p59159
g3
sS'angiomax,with,or'
p59160
g9
sS'can,be,potentiated'
p59161
g9
sS'to,premature,ventricular'
p59162
g3
sS'is,needed,should'
p59163
g3
sS'lymphomas,occur,in'
p59164
g3
sS'neuromuscular,blockade,associated'
p59165
g3
sS'not,only,on'
p59166
g3
sS'rating,scales,and'
p59167
g3
sS'conclusions,everolimus,exhibited'
p59168
g3
sS'the,electrocardiographic,parameters'
p59169
g3
sS'active,when,it'
p59170
g3
sS'regulation,of,tyrosine'
p59171
g3
sS'proves,to,be'
p59172
g9
sS'single-dose,interaction,study'
p59173
g3
sS'with,angina,pectoris'
p59174
g9
sS'when,proquin,xr'
p59175
g3
sS'the,hmg-coa,reductase'
p59176
g9
sS'central,obesity,dorsocervical'
p59177
g3
sS'nitrobluetetrazolium,test,for'
p59178
g3
sS'narrow,therapeutic,window'
p59179
g9
sS'of,with,the'
p59180
g9
sS'in,the,experiments'
p59181
g3
sS'a,bile,acid'
p59182
g9
sS'retention,in,the'
p59183
g3
sS'potential,for,drug-induced'
p59184
g3
sS'injection,with,other'
p59185
g9
sS'to,check,your'
p59186
g3
sS'an,can,not'
p59187
g9
sS'with,attenuated,live'
p59188
g3
sS'strongly,support,the'
p59189
g3
sS'a,wax,matrix'
p59190
g9
sS'blockers,calcium,channel'
p59191
g3
sS'treated,with,tikosyn'
p59192
g3
sS'interferons,such,as'
p59193
g3
sS'augmented,by,antihypertensive'
p59194
g9
sS'kinetics,of,a'
p59195
g3
sS'recommended,for,use'
p59196
g9
sS'lithium,toxicity,was'
p59197
g9
sS'maximum,human,therapeutic'
p59198
g9
sS'mouse,and,to'
p59199
g3
sS'vardenafil,mg,when'
p59200
g3
sS'increase,cyp,metabolism'
p59201
g9
sS'sulfoxide,concentrations,in'
p59202
g9
sS'as,recommended,in'
p59203
g3
sS'nsaids,have,been'
p59204
g9
sS'bioavailability,of,may'
p59205
g9
sS'injections,of,trimethyl'
p59206
g3
sS'interrupted,in,order'
p59207
g3
sS'folate,may,also'
p59208
g3
sS'metabolic,abnormalities,has'
p59209
g3
sS'an,open-label,two-way'
p59210
g3
sS'including,products,and'
p59211
g9
sS'disposition,of,other'
p59212
g3
sS'on,clearance,this'
p59213
g3
sS'not,affect,subjective'
p59214
g3
sS'is,advised,especially'
p59215
g3
sS'pcp,in,two-lever'
p59216
g3
sS'a,sharp,fall'
p59217
g9
sS'was,prevented,by'
p59218
g9
sS'a,resulting,in'
p59219
g9
sS'have,been,some'
p59220
g9
sS'this,technique,it'
p59221
g3
sS'physiological,behavioral,or'
p59222
g3
sS'a,dramatic,effect'
p59223
g3
sS'of,rural,health'
p59224
g3
sS'prothrombin,time,of'
p59225
g3
sS'intracellular,ca,release'
p59226
g3
sS'if,or,other'
p59227
g9
sS'or,pd,studies'
p59228
g3
sS'when,subjects,were'
p59229
g3
sS'the,maximum,recommended'
p59230
g3
sS'the,ability,to'
p59231
g3
sS'natriuretic,effect,of'
p59232
g9
sS'significant,drug-drug,pharmacokinetic'
p59233
g3
sS'and,toxicity,in'
p59234
g9
sS'respiratory,depression,hypotension'
p59235
g9
sS'with,oral,treatment'
p59236
g9
sS'when,inspra,and'
p59237
g9
sS'investigated,in,vivo'
p59238
g3
sS'ssris,may,increase'
p59239
g9
sS'patients,on,diuretic'
p59240
g9
sS'exaggerate,the,depression'
p59241
g9
sS'and,are,co'
p59242
g9
sS'the,pharmacologically,predictable'
p59243
g9
sS'tested,in,man'
p59244
g3
sS'indicating,no,change'
p59245
g3
sS'this,number,fell'
p59246
g3
sS'potentiate,the,release'
p59247
g3
sS'drugs,that,are'
p59248
g3
sS'diuretics,diclofenac,and'
p59249
g9
sS'but,presumably,to'
p59250
g3
sS'detect,an,effect'
p59251
g3
sS'other,oral,or'
p59252
g3
sS'to,vehicle-,progesterone-'
p59253
g9
sS'further,reduced,the'
p59254
g3
sS'lunch,doses,of'
p59255
g3
sS'when,administered,in'
p59256
g9
sS'literature,suggest,that'
p59257
g9
sS'of,hydrochloride,on'
p59258
g9
sS'cytoprotective,properties,of'
p59259
g3
sS'selective,tumor,cell'
p59260
g3
sS'this,small,decrease'
p59261
g9
sS'patients,who,take'
p59262
g3
sS'in,humans,have'
p59263
g3
sS'does,affect,the'
p59264
g3
sS'as,dose,and'
p59265
g3
sS'sexual,intercourse,without'
p59266
g3
sS'ns,absorbed,is'
p59267
g3
sS'of,carcinogen,can'
p59268
g3
sS'supplements,use,of'
p59269
g9
sS'samples,also,were'
p59270
g3
sS'enzymes,showed,that'
p59271
g3
sS'kg,ip,or'
p59272
g9
sS'similar,effect,would'
p59273
g3
sS'receiving,these,who'
p59274
g3
sS'and,specific,activity'
p59275
g3
sS'events,or,hits'
p59276
g3
sS'of,zyvox,and'
p59277
g9
sS'of,fetal,toxicity'
p59278
g3
sS'hypokalemic,effect,of'
p59279
g9
sS'cimetidine,co-administration,of'
p59280
g3
sS'clinically,relevant,elevation'
p59281
g9
sS'quinidine,and,raise'
p59282
g9
sS'p450,a2,c8'
p59283
g3
sS'sem,to,within'
p59284
g3
sS'non-steroidal,and,herbs'
p59285
g9
sS'may,bind,and'
p59286
g9
sS'investigated,using,higher'
p59287
g9
sS'a,dose,decrease'
p59288
g9
sS'and,fold,respectively'
p59289
g9
sS'that,in,patients'
p59290
g9
sS'and,those,off'
p59291
g3
sS'dimethylprostaglandin,e2-induced,diarrhea'
p59292
g3
sS'when,multiple,doses'
p59293
g9
sS'all,patients,in'
p59294
g3
sS'minimum,effective,concentration'
p59295
g3
sS'safety,however,its'
p59296
g3
sS'of,with,potent'
p59297
g3
sS'by,electrocardiographic,parameters'
p59298
g3
sS'optic,nerve,vacuolation'
p59299
g3
sS'occasion,in,the'
p59300
g3
sS'may,result,from'
p59301
g9
sS'may,have,elevated'
p59302
g9
sS'or,metabolic,responses'
p59303
g3
sS'worse,and,prevent'
p59304
g3
sS'prostaglandin,synthase,inhibiting'
p59305
g9
sS'excessive,reduction,of'
p59306
g9
sS'are,important,in'
p59307
g3
sS'effects,conditioning,processes'
p59308
g3
sS'infusion,reactions,compared'
p59309
g3
sS'this,included,post'
p59310
g3
sS'the,therapeutic,efficacy'
p59311
g9
sS'diazepam,valium,is'
p59312
g3
sS'relative,to,the'
p59313
g3
sS'is,active,renal'
p59314
g3
sS'fi,or,fr'
p59315
g9
sS'receiving,medications,that'
p59316
g3
sS'the,serum,sex'
p59317
g9
sS'by,in,combination'
p59318
g3
sS'no,other,interactions'
p59319
g3
sS'exposure,is,limited'
p59320
g3
sS'demonstrated,an,association'
p59321
g9
sS'medications,for,migraines'
p59322
g3
sS'amphetamines,may,counteract'
p59323
g9
sS'the,relative,risk'
p59324
g3
sS'a,statistically,significant'
p59325
g3
sS'then,remained,stable'
p59326
g3
sS'and,symptomatic,hyperlactatemia'
p59327
g3
sS'of,exogenous,on'
p59328
g3
sS'in,the,doses'
p59329
g9
sS'antibiotics-broad,spectrum,may'
p59330
g3
sS'probenecid,interferes,with'
p59331
g9
sS'hyperkalemia,in,patients'
p59332
g9
sS'be,required,in'
p59333
g3
sS'in,man,include'
p59334
g9
sS'and,were,studied'
p59335
g3
sS'recovery,from,neuromuscular'
p59336
g3
sS'value,one,must'
p59337
g3
sS'be,required,if'
p59338
g3
sS'if,oral,are'
p59339
g3
sS'constipation,blurred,vision'
p59340
g9
sS'on,this,reported'
p59341
g3
sS'ssris,seriraline,and'
p59342
g3
sS'that,the,desired'
p59343
g3
sS'serum,creatinine,concentration'
p59344
g3
sS'nonsteroidal,can,interfere'
p59345
g9
sS'other,antiepilepsy,drugs'
p59346
g9
sS'of,isosorbide,dinitrate'
p59347
g9
sS'between,the,ca'
p59348
g3
sS'enuresis,urinary,retention'
p59349
g3
sS'the,same,cytochrome'
p59350
g3
sS'when,new,agents'
p59351
g3
sS'protein-bound,anafranil,by'
p59352
g3
sS'discontinuation,of,which'
p59353
g9
sS'cyp3a4,metabolized,should'
p59354
g9
sS'indicates,that,clorazepate'
p59355
g9
sS'with,on,performance'
p59356
g3
sS'used,when,it'
p59357
g3
sS'interaction,between,two'
p59358
g3
sS'in,chapter,including'
p59359
g3
sS'tsh,levels,generally'
p59360
g3
sS'of,the,other'
p59361
g3
sS'united,states,but'
p59362
g3
sS'also,using,a'
p59363
g9
sS'that,in,the'
p59364
g3
sS'with,transient,elevations'
p59365
g9
sS'nsaids,concomitant,use'
p59366
g9
sS'benedicts,solution,or'
p59367
g3
sS'methyltetrahydro-folate,and,in'
p59368
g3
sS'dosages,of,the'
p59369
g3
sS'these,results,together'
p59370
g3
sS'tubular,secretion,of'
p59371
g9
sS'with,whose,metabolism'
p59372
g3
sS'careful,titration,should'
p59373
g3
sS'reported,intermenstrual,bleeding'
p59374
g3
sS'two,of,four'
p59375
g9
sS'observed,on,the'
p59376
g9
sS'results,the,two'
p59377
g3
sS'by,cerulein--an,analog'
p59378
g3
sS'a,multiple,fixed-interval'
p59379
g3
sS'of,our,patient'
p59380
g9
sS'resulted,in,additive'
p59381
g9
sS'aggregation,response,against'
p59382
g3
sS'lessen,its,efficacy'
p59383
g3
sS'p450,a4,c19'
p59384
g3
sS'substances,tbars,in'
p59385
g3
sS'used,when,administering'
p59386
g9
sS'smx,such,as'
p59387
g3
sS'healthy,volunteers,significantly'
p59388
g9
sS'pretreatment,with,cgs'
p59389
g9
sS'oil,interferes,with'
p59390
g9
sS'that,patients,take'
p59391
g3
sS'extraction,j,chromatogr'
p59392
g3
sS'fasting,conditions,or'
p59393
g3
sS'as,a,result'
p59394
g3
sS'and,indanedione,including'
p59395
g3
sS'inhibits,the,ermbt'
p59396
g3
sS'between,mentax,butenafine'
p59397
g3
sS'this,effect,on'
p59398
g9
sS'in,this,test'
p59399
g3
sS'ethinyl,estradiol,mg'
p59400
g3
sS'of,because,the'
p59401
g3
sS'approached,with,caution'
p59402
g9
sS'lung,survanta,on'
p59403
g3
sS'this,effect,of'
p59404
g3
sS'reaction,and,lead'
p59405
g9
sS'juices,fruit,juices'
p59406
g3
sS'veratrum,alkaloids,may'
p59407
g9
sS'of,day-old,chick'
p59408
g9
sS'be,increased,when'
p59409
g9
sS'after,bilateral,ovariectomy'
p59410
g3
sS'hydrochloride,on,the'
p59411
g9
sS'taken,within,the'
p59412
g3
sS'also,increase,risk'
p59413
g3
sS'be,a,useful'
p59414
g3
sS'cases,two,different'
p59415
g3
sS'determined,that,the'
p59416
g3
sS'after,chronic,treatment'
p59417
g3
sS'concomitant,serotonergic,agents'
p59418
g9
sS'formation,from,combined'
p59419
g9
sS'arthritis,or,crohn'
p59420
g3
sS'one,of,which'
p59421
g3
sS'some,form,of'
p59422
g3
sS'in,lowering,the'
p59423
g9
sS'measured,near,the'
p59424
g3
sS'by,competing,for'
p59425
g9
sS'unrestricted,use,of'
p59426
g3
sS'at,steady-state,in'
p59427
g3
sS'diethyl,pyrocarbonate,revealed'
p59428
g3
sS'the,bile-acidsequestering,agent'
p59429
g3
sS'not,systematically,studied'
p59430
g9
sS'the,mean,steady-state'
p59431
g3
sS'in,no,clinically'
p59432
g3
sS'dose,and,the'
p59433
g3
sS'effects,and,therefore'
p59434
g3
sS'population,about,of'
p59435
g3
sS'muscle,relaxant,effect'
p59436
g9
sS'with,or,affect'
p59437
g3
sS'both,and,creatinine'
p59438
g9
sS'products,are,administered'
p59439
g3
sS'as,a,single'
p59440
g3
sS'over,a,period'
p59441
g3
sS'may,thereby,cause'
p59442
g3
sS'on,placebo,and'
p59443
g3
sS'immune,response,to'
p59444
g3
sS'inotropic,effects,of'
p59445
g9
sS'was,measured,from'
p59446
g3
sS'secondary,to,extravasation'
p59447
g3
sS'cynomolgus,monkeys,at'
p59448
g3
sS'healthy,subjects,was'
p59449
g9
sS'which,promote,absorption'
p59450
g9
sS'when,using,for'
p59451
g3
sS'of,or,and'
p59452
g3
sS'oxidase,and,cyp3a4'
p59453
g9
sS'deaths,from,severe'
p59454
g9
sS'additive,effects,and'
p59455
g9
sS'withdrawal,the,sst'
p59456
g3
sS'by,the,cyp2d6'
p59457
g3
sS'mrna,in,layers'
p59458
g3
sS'herbal,therapy,and'
p59459
g3
sS'be,necessary,in'
p59460
g3
sS'not,been,definitively'
p59461
g9
sS'antagonist,eg,and'
p59462
g9
sS'containing,may,lead'
p59463
g3
sS'fluorescein,naflu,and'
p59464
g3
sS'compared,pharmacokinetics,and'
p59465
g3
sS'vasopressor,and,of'
p59466
g3
sS'anticoagulants,potentiation,of'
p59467
g3
sS'on,the,digit'
p59468
g9
sS'hcl,a,specific'
p59469
g3
sS'by,the,alveoli'
p59470
g3
sS'days,of,multipledose'
p59471
g3
sS'potentiate,the,neuromuscular'
p59472
g9
sS'for,results,that'
p59473
g3
sS'a4,enzymes,lapatinib'
p59474
g3
sS'the,dose,reduced'
p59475
g9
sS'severe,reactions,such'
p59476
g3
sS'clozapine,may,potentiate'
p59477
g9
sS'caverject,the,potential'
p59478
g3
sS'likely,will,interfere'
p59479
g9
sS'for,relief,of'
p59480
g3
sS'and,following,treatment'
p59481
g3
sS'identified,and,new'
p59482
g3
sS'were,conducted,to'
p59483
g3
sS'that,resistance,is'
p59484
g3
sS'exposure,auc0-12,of'
p59485
g3
sS'locomotor,and,or'
p59486
g3
sS'are,sequestered,in'
p59487
g3
sS'side,effects,breast'
p59488
g3
sS'in,vitro,on'
p59489
g3
sS'inhibit,platelet,function'
p59490
g9
sS'if,any,clinically'
p59491
g3
sS'during,pregnancy,only'
p59492
g3
sS'the,to,nonopioid'
p59493
g3
sS'when,is,co-administered'
p59494
g9
sS'allegra,should,not'
p59495
g9
sS'before,meals,for'
p59496
g3
sS'therapy,with,vitamin'
p59497
g9
sS'monitor,prothrombin,levels'
p59498
g3
sS'tachycardia,ventricular,fibrulation'
p59499
g9
sS'because,the,action'
p59500
g9
sS'macrolide,and,azoles'
p59501
g3
sS'relevant,changes,in'
p59502
g3
sS'ph,is,an'
p59503
g9
sS'the,best,approach'
p59504
g3
sS'arecoline,eproxindine,ethanol'
p59505
g9
sS'and,for,the'
p59506
g3
sS'patient,already,receiving'
p59507
g3
sS'of,subpopulations,of'
p59508
g3
sS'renal,impairment,and'
p59509
g3
sS'these,three,products'
p59510
g9
sS'may,cause,changes'
p59511
g9
sS'have,been,reported'
p59512
g9
sS'and,shorter,durations'
p59513
g3
sS'a,beta,blocker'
p59514
g9
sS'to,repeated,exposure'
p59515
g3
sS'to,the,characteristics'
p59516
g3
sS'cns,depressants,or'
p59517
g9
sS'mg,appears,to'
p59518
g9
sS'other,factors,such'
p59519
g3
sS'reportedly,are,increased'
p59520
g9
sS'cns,depression,cns'
p59521
g3
sS'and,inhibit,platelet'
p59522
g3
sS'their,main,route'
p59523
g3
sS'on,bsa,increases'
p59524
g3
sS'nitrogen,mustard,etc'
p59525
g3
sS'likelihood,of,congestive'
p59526
g9
sS'increase,risk,of'
p59527
g3
sS'of,a,cyp2c9'
p59528
g9
sS'recommended,dose,in'
p59529
g9
sS'prothrombin,time,measured'
p59530
g9
sS'cases,in,which'
p59531
g9
sS'folic,acid,and'
p59532
g3
sS'human,immunodeficiency,virus-related'
p59533
g3
sS'nalfon,has,not'
p59534
g9
sS'can,cause,increased'
p59535
g9
sS'unless,otherwise,specified'
p59536
g3
sS'and,mg,single'
p59537
g3
sS'fewer,interactions,and'
p59538
g3
sS'who,received,angiomax'
p59539
g3
sS'electrically,stimulated,hz'
p59540
g3
sS'p450,isoenzymes,carbamazepine'
p59541
g3
sS'd-penicillamine,or,did'
p59542
g3
sS'either,s,bioavailability'
p59543
g3
sS'when,and,cerebyx'
p59544
g3
sS'than,two-second,increase'
p59545
g9
sS'rats,in,a'
p59546
g9
sS'blocking,agents,without'
p59547
g3
sS'once,daily,brovana'
p59548
g3
sS'metab-olizers,resemble,poor'
p59549
g3
sS'is,little,risk'
p59550
g3
sS'those,listed,here'
p59551
g3
sS'long,withdrawal,period'
p59552
g3
sS'interval,for,coadministration'
p59553
g3
sS'sugar,concentrations,during'
p59554
g9
sS'in,unexpectedly,high'
p59555
g3
sS'recurrence,relative,to'
p59556
g3
sS'dose,of,theophylline'
p59557
g3
sS'reduced,clearance,a'
p59558
g9
sS'with,schizophrenia,or'
p59559
g3
sS'who,must,receive'
p59560
g3
sS'greater,than,fold'
p59561
g9
sS'unlikely,to,produce'
p59562
g3
sS'several,with,which'
p59563
g3
sS'phenytoin,may,decrease'
p59564
g3
sS'toxicity,brain,hemorrhage'
p59565
g3
sS'reported,both,weight'
p59566
g9
sS'antiinflammatory,agents,and'
p59567
g9
sS'from,the,fraction'
p59568
g3
sS'that,a,combination'
p59569
g3
sS'clinical,experience,may'
p59570
g3
sS'vitamin,d,the'
p59571
g3
sS'interactions,with,the'
p59572
g3
sS'of,against,of'
p59573
g3
sS'symptomatic,orthostatic,hypotension'
p59574
g9
sS'mortality,were,significantly'
p59575
g3
sS'risks,arising,from'
p59576
g3
sS'of,fade,hoof'
p59577
g9
sS'cocaine-treated,sst,and'
p59578
g3
sS'prophylactic,low,dose'
p59579
g3
sS'antagonists,angiotensin,converting'
p59580
g3
sS'aggression,and,agitation'
p59581
g3
sS'therefore,these,combinations'
p59582
g3
sS'use,of,herbal'
p59583
g3
sS'possibility,that,the'
p59584
g9
sS'inr,elevations,and'
p59585
g9
sS'altered,coagulation,parameters'
p59586
g9
sS'and,to,times'
p59587
g3
sS'administered,a,single'
p59588
g9
sS'well,as,pure'
p59589
g9
sS'procedures,during,or'
p59590
g9
sS'while,the,rats'
p59591
g3
sS'blood,area,under'
p59592
g9
sS'interpretation,of,serum'
p59593
g3
sS'increase,generation,of'
p59594
g3
sS'may,produce,aucs'
p59595
g9
sS'be,effectively,and'
p59596
g3
sS'nonetheless,the,possibility'
p59597
g3
sS'patients,with,maximum'
p59598
g3
sS'by,concentrations,of'
p59599
g3
sS'either,had,no'
p59600
g9
sS'inhibitor,or,channel'
p59601
g3
sS'increase,the,severity'
p59602
g9
sS'sacrificed,and,aortic'
p59603
g3
sS'light,zone,and'
p59604
g9
sS'controlled,study,in'
p59605
g3
sS'levels,and,adjustment'
p59606
g9
sS'female,rats,was'
p59607
g3
sS'when,the,concentration'
p59608
g3
sS'contraception,and,not'
p59609
g3
sS'investigated,in,a'
p59610
g3
sS'weekly,human,dose'
p59611
g3
sS'although,consistent,with'
p59612
g3
sS'their,effectiveness,when'
p59613
g3
sS'gland,has,sufficient'
p59614
g3
sS'the,listed,below'
p59615
g3
sS'concerning,have,been'
p59616
g9
sS'herbal,remedies,with'
p59617
g3
sS'general,caution,should'
p59618
g3
sS'is,contraindicated,and'
p59619
g9
sS'anion,plasma,levels'
p59620
g9
sS'with,their,physicians'
p59621
g3
sS'cholinesterase,inhibitors,such'
p59622
g9
sS'depakene,use,of'
p59623
g3
sS'phenytoin,levels,should'
p59624
g3
sS'is,administered,concomitantly'
p59625
g9
sS'development,of,spontaneous'
p59626
g9
sS'to,a,different'
p59627
g9
sS'fibrinolysis,is,mmol'
p59628
g3
sS'determine,whether,would'
p59629
g3
sS'with,or,to'
p59630
g3
sS'higher,was,significantly'
p59631
g3
sS'mycophenolate,mofetil,ml'
p59632
g3
sS'diarrhea,in,cecectomized'
p59633
g3
sS'cardiovascular,adverse,effects'
p59634
g9
sS'by,column,or'
p59635
g3
sS'edetate,disodium,in'
p59636
g9
sS'levels,fluctuated,there'
p59637
g3
sS'use,of,this'
p59638
g3
sS'and,agents,may'
p59639
g9
sS'alkaline,phosphatase,should'
p59640
g3
sS'starting,or,stopping'
p59641
g3
sS'pharmacodynamic,interaction,between'
p59642
g3
sS'activities,requiring,complete'
p59643
g3
sS'was,bioequivalent,to'
p59644
g3
sS'interactions,the,presence'
p59645
g3
sS'variety,of,parametric'
p59646
g3
sS'studies,some,associated'
p59647
g3
sS'phosphorylation,of,proteins'
p59648
g3
sS'cardiovascular,disease,are'
p59649
g3
sS'lesser,but,still'
p59650
g3
sS'study,comparing,the'
p59651
g3
sS'indicate,a,significant'
p59652
g9
sS'an,adequate,and'
p59653
g3
sS'wshow,that,given'
p59654
g9
sS'therefore,simultaneous,use'
p59655
g3
sS'for,any,significant'
p59656
g3
sS'after,the,dose'
p59657
g9
sS'with,clomiphene,citrate'
p59658
g3
sS'products,should,be'
p59659
g3
sS'been,compared,to'
p59660
g3
sS'well-controlled,studies,was'
p59661
g3
sS'vs,when,plasma'
p59662
g9
sS'diamox,may,decrease'
p59663
g9
sS'it,was,shown'
p59664
g9
sS'smaller,initial,dose'
p59665
g9
sS'furthermore,caution,should'
p59666
g3
sS'a,critical,role'
p59667
g3
sS's,serum,should'
p59668
g3
sS'carcinogen,may,depend'
p59669
g3
sS'than,those,receiving'
p59670
g9
sS'increased,gastric,ph'
p59671
g3
sS'initiated,at,the'
p59672
g9
sS'some,like,monoamine'
p59673
g9
sS'if,renal,function'
p59674
g3
sS'for,hydroxy-iso,by'
p59675
g9
sS'brain,edema,it'
p59676
g9
sS'both,than,from'
p59677
g3
sS'eszopiclone,mg,administered'
p59678
g3
sS'dose-response,curves,relatively'
p59679
g3
sS'decrease,platelet,aggregation'
p59680
g3
sS'increased,steady-state,levels'
p59681
g3
sS'as,and,would'
p59682
g9
sS'their,practitioners,any'
p59683
g3
sS'for,colazal,however'
p59684
g3
sS'cancidas,reduced,the'
p59685
g9
sS'since,falsely,elevated'
p59686
g3
sS'altered,by,concomitant'
p59687
g9
sS'a,that,has'
p59688
g3
sS'patient,who,was'
p59689
g3
sS'complex,and,or'
p59690
g9
sS'to,be,drawn'
p59691
g3
sS'to,minutes,of'
p59692
g3
sS'on,milk,ejection'
p59693
g3
sS'the,jaffe,reaction'
p59694
g3
sS'on,pregnancy,and'
p59695
g3
sS'volunteers,n,resulted'
p59696
g9
sS'inhibit,cyp3a,may'
p59697
g3
sS'with,affected,by'
p59698
g3
sS'activity,may,result'
p59699
g3
sS'trisphosphate,the,major'
p59700
g3
sS'chewable,buffered,tablets'
p59701
g9
sS'failure,cannot,be'
p59702
g3
sS'of,the,fischer-344'
p59703
g3
sS'if,you,are'
p59704
g3
sS'inspra,should,not'
p59705
g3
sS'chapters,cover,interactions'
p59706
g3
sS'whereas,it,had'
p59707
g9
sS'secretion,of,when'
p59708
g9
sS'or,decrease,the'
p59709
g9
sS'careful,adjustment,of'
p59710
g3
sS'accompanied,by,a'
p59711
g9
sS'an,additional,effect'
p59712
g9
sS'or,s-warfarin,with'
p59713
g3
sS'decrease,the,rate'
p59714
g3
sS'safety,and,efficacy'
p59715
g3
sS'between,the,administration'
p59716
g3
sS'failure,elevated,creatine'
p59717
g3
sS'not,been,tested'
p59718
g3
sS'agents,have,also'
p59719
g3
sS'only,significantly,affected'
p59720
g3
sS'concentration,may,prolong'
p59721
g9
sS'use,may,be'
p59722
g3
sS'epoxide,steady-state,cmin'
p59723
g3
sS'distribution,of,with'
p59724
g3
sS'individuals,receiving,zyvox'
p59725
g9
sS'be,cautioned,about'
p59726
g3
sS'coadministration,of,with'
p59727
g9
sS'tablets,with,and'
p59728
g3
sS'taking,mg,and'
p59729
g9
sS'agents,include,medications'
p59730
g3
sS'seropositive,subjects,have'
p59731
g3
sS'a,predisposition,for'
p59732
g3
sS'of,the,active'
p59733
g9
sS'well-known,potential,to'
p59734
g3
sS'between,wellbutrin,and'
p59735
g9
sS'kg,the,diarrhea-inducing'
p59736
g3
sS'irrational,behavior,has'
p59737
g9
sS'special,populations,such'
p59738
g3
sS'clinically,significant,adverse'
p59739
g3
sS'to,prolong,further'
p59740
g9
sS'are,encouraged,to'
p59741
g3
sS'in,the,half-'
p59742
g3
sS'exposed,to,high'
p59743
g9
sS'administered,parenterally,special'
p59744
g3
sS'cmax,by,and'
p59745
g9
sS'nondepolarizing,agents,such'
p59746
g9
sS'of,hypotension,or'
p59747
g3
sS'substrate,and,r-warfarin'
p59748
g9
sS'to,reduce,intestinal'
p59749
g9
sS'results,do,not'
p59750
g9
sS'are,all,associated'
p59751
g9
sS'may,require,reduction'
p59752
g3
sS'of,to,modify'
p59753
g3
sS'relevance,of,the'
p59754
g3
sS'to,minimise,the'
p59755
g3
sS'carbamazepine,felbatol,causes'
p59756
g9
sS'of,competitive,renal'
p59757
g9
sS'protease,inhibitors,the'
p59758
g3
sS'between,and,more'
p59759
g3
sS'capsule,within,minutes'
p59760
g9
s.